PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kobayashi, I; Kobayashi-Sun, J; Kim, AD; Pouget, C; Fujita, N; Suda, T; Traver, D				Kobayashi, Isao; Kobayashi-Sun, Jingjing; Kim, Albert D.; Pouget, Claire; Fujita, Naonobu; Suda, Toshio; Traver, David			Jam1a-Jam2a interactions regulate haematopoietic stem cell fate through Notch signalling	NATURE			English	Article							AORTIC ENDOTHELIUM; JAM-B; ZEBRAFISH; GENE; EXPRESSION; MAINTENANCE; SPADETAIL; RECEPTOR	Notch signalling plays a key role in the generation of haematopoietic stem cells (HSCs) during vertebrate development(1-3) and requires intimate contact between signal-emitting and signal-receiving cells, although little is known regarding when, where and how these intercellular events occur. We previously reported that the somitic Notch ligands, Dlc and Dld, are essential for HSC specification(4). It has remained unclear, however, how these somitic requirements are connected to the later emergence of HSCs from the dorsal aorta. Here we show in zebrafish that Notch signalling establishes HSC fate as their shared vascular precursors migrate across the ventral face of the somite and that junctional adhesion molecules (JAMs) mediate this required Notch signal transduction. HSC precursors express jam1a (also known as f11r) and migrate axially across the ventral somite, where Jam2a and the Notch ligands Dlc and Dld are expressed. Despite no alteration in the expression of Notch ligand or receptor genes, loss of function of jam1a led to loss of Notch signalling and loss of HSCs. Enforced activation of Notch in shared vascular precursors rescued HSCs in jam1a or jam2a deficient embryos. Together, these results indicate that Jam1a-Jam2a interactions facilitate the transduction of requisite Notch signals from the somite to the precursors of HSCs, and that these events occur well before formation of the dorsal aorta.	[Kobayashi, Isao; Kobayashi-Sun, Jingjing; Kim, Albert D.; Pouget, Claire; Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Fujita, Naonobu; Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab, Dept Cell Differentiat,Shinjuku Ku, Tokyo 1608582, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; Keio University	Traver, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	dtraver@ucsd.edu	Pouget, Claire/M-9761-2016; Suda, Toshio/H-6761-2013; Fujita, Naonobu/A-1218-2010	Pouget, Claire/0000-0003-4598-6291; Suda, Toshio/0000-0001-7540-1771; Fujita, Naonobu/0000-0003-1914-8438	JSPS; California Institute of Regenerative Medicine; National Institutes of Health [R01-DK074482]; American Heart Association; Grants-in-Aid for Scientific Research [26221309] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074482] Funding Source: NIH RePORTER	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank G. Wright for providing the jam2a<SUP>hu3319</SUP> line, A. Shimizu for help in generating transgenic lines, M. Osato for providing the I-SceI-pBSII SK+ vector, M. Distel for providing phldb1:Gal4-mCherry animals, and W. Clements, Y. Lee and E. Butko provided critical evaluation of the manuscript. This work was supported in part by a JSPS Research fellowship for Young Scientists and a JSPS Postdoctoral fellowship for Research Abroad (I.K.), by a New Investigator Award from the California Institute of Regenerative Medicine, R01-DK074482 from the National Institutes of Health, and an Innovative Science Award from the American Heart Association (D.T.).	Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Arcangeli ML, 2011, BLOOD, V118, P4609, DOI 10.1182/blood-2010-12-323972; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kobayashi I, 2008, BLOOD, V111, P1131, DOI 10.1182/blood-2007-08-104299; Kobayashi I, 2010, BLOOD, V115, pE1, DOI 10.1182/blood-2009-07-232322; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Powell GT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040810; Powell GT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001216; Qian F, 2007, PLOS BIOL, V5, P1110, DOI 10.1371/journal.pbio.0050132; Sakaguchi T, 2006, MOL CELL BIOL, V26, P6557, DOI 10.1128/MCB.00729-06; Sugano Y, 2008, BLOOD, V111, P1167, DOI 10.1182/blood-2007-03-081554; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wilkinson RN, 2012, BLOOD, V120, P477, DOI 10.1182/blood-2011-10-383729; Yoon MJ, 2008, MOL CELL BIOL, V28, P4794, DOI 10.1128/MCB.00436-08; Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033	32	85	91	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					319	+		10.1038/nature13623	http://dx.doi.org/10.1038/nature13623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119047	Green Accepted			2022-12-24	WOS:000340508200037
J	Hart, LE				Hart, Lawrence E.			Methotrexate reduced pain and improved function in symptomatic knee osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Hart, LE (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Wenham CYJ, 2013, RHEUMATOLOGY, V52, P888, DOI 10.1093/rheumatology/kes386	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC6	10.7326/0003-4819-161-4-201408190-02006	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133385				2022-12-24	WOS:000342347300005
J	Li, XD; Liang, YQ; LeBlanc, M; Benner, C; Zheng, Y				Li, Xudong; Liang, Yuqiong; LeBlanc, Mathias; Benner, Chris; Zheng, Ye			Function of a Foxp3 cis-Element in Protecting Regulatory T Cell Identity	CELL			English	Article							TRANSCRIPTION FACTOR FOXP3; DNA METHYLATION; GENE-EXPRESSION; IN-VIVO; INTRACHROMOSOMAL INTERACTIONS; REG CELLS; DIFFERENTIATION; INFLAMMATION; BETA; ACTIVATION	The homeostasis of multicellular organisms requires terminally differentiated cells to preserve their lineage specificity. However, it is unclear whether mechanisms exist to actively protect cell identity in response to environmental cues that confer functional plasticity. Regulatory T (Treg) cells, specified by the transcription factor Foxp3, are indispensable for immune system homeostasis. Here, we report that conserved noncoding sequence 2 (CNS2), a CpG-rich Foxp3 intronic cis-element specifically demethylated in mature Tregs, helps maintain immune homeostasis and limit autoimmune disease development by protecting Treg identity in response to signals that shape mature Treg functions and drive their initial differentiation. In activated Tregs, CNS2 helps protect Foxp3 expression from destabilizing cytokine conditions by sensing TCR/NFAT activation, which facilitates the interaction between CNS2 and Foxp3 promoter. Thus, epigenetically marked cis-elements can protect cell identity by sensing key environmental cues central to both cell identity formation and functional plasticity without interfering with initial cell differentiation.	[Li, Xudong; Liang, Yuqiong; LeBlanc, Mathias; Zheng, Ye] Salk Inst Biol Studies, Nomis Fdn Labs Immunobiol & Microbial Pathogenesi, La Jolla, CA 92037 USA; [Benner, Chris] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Zheng, Y (corresponding author), Salk Inst Biol Studies, Nomis Fdn Labs Immunobiol & Microbial Pathogenesi, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yzheng@salk.edu	Zheng, Ye/G-4866-2015; Li, Xudong/A-9065-2017	Zheng, Ye/0000-0001-5012-4309; Benner, Christopher/0000-0002-4618-0719	Nomis Foundation; Rita Allen Foundation; Emerald Foundation; Hearst Foundation; National Multiple Sclerosis Society; National Institute of Health [AI099295, AI107027]; National Cancer Institute [CA014195]; James B. Pendleton Charitable Trust; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107027, R56AI099295] Funding Source: NIH RePORTER	Nomis Foundation; Rita Allen Foundation; Emerald Foundation; Hearst Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James B. Pendleton Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Y. Zhang, C. Gordon, and C. Zhou for mouse colony management; M. Ku and S. Heinz for assistance in RNA-seq experiments; L.-F.Lu, S.Z. Josefowicz, and C.S. Hsieh for critical comments on the manuscript; and A.Y. Rudensky for providing critical reagents and helpful discussion. X.L. was supported by a postdoc fellowship from the Nomis Foundation. Y.Z. was supported by the Nomis Foundation, the Rita Allen Foundation, the Emerald Foundation, the Hearst Foundation, the National Multiple Sclerosis Society, and National Institute of Health (AI099295, AI107027). This work was also supported by National Cancer Institute funded Salk Institute Cancer Center core facilities (CA014195) and the James B. Pendleton Charitable Trust.	Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	53	172	176	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					734	748		10.1016/j.cell.2014.07.030	http://dx.doi.org/10.1016/j.cell.2014.07.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126782	Green Accepted, Bronze			2022-12-24	WOS:000340944700007
J	Cantrell, KA; Sutton, S; Gaur, AH				Cantrell, Kathryn A.; Sutton, Sylvia; Gaur, Aditya H.			Pause, Listen, Share	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NARRATIVE MEDICINE; ILLNESS NARRATIVES		[Cantrell, Kathryn A.] Univ Massachusetts, Dept Counseling, Boston, MA 02125 USA; [Cantrell, Kathryn A.] Univ Massachusetts, Sch Psychol, Boston, MA 02125 USA; [Sutton, Sylvia; Gaur, Aditya H.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; St Jude Children's Research Hospital	Gaur, AH (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	aditya.gaur@stjude.org	Gaur, Aditya H/N-8057-2018	Gaur, Aditya H/0000-0002-6639-5231; Cantrell, Kathryn/0000-0001-7198-3807	NCI NIH HHS [CA 21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; DasGupta S, 2007, PEDIATRICS, V119, pE1384, DOI 10.1542/peds.2006-2619; Ezzy D, 2000, SOC SCI MED, V50, P605, DOI 10.1016/S0277-9536(99)00306-8; Frank A., 2010, WOUNDED STORYTELLER; Frank AW, 1998, FAMILIES SYSTEMS HLT, V16, P197, DOI [DOI 10.1037/H0089849, 10.1037/h0089849]; Kleinman A., 1988, ILLNESS NARRATIVES; Nowaczyk MJM, 2013, AM J MED GENET A, V161, P2117, DOI 10.1002/ajmg.a.36114	7	2	2	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					345	346		10.1001/jama.2014.6201	http://dx.doi.org/10.1001/jama.2014.6201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038350				2022-12-24	WOS:000339257800018
J	Chamberlain, PI				Chamberlain, Paul Ivor			An assisted dying law might save me from a lingering and unpleasant death Paul Ivor Chamberlain has motor neurone disease and explains why he backs Lord Falconer's bill	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												paul.chamberlain@sky.com						Dyer C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4739	1	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2014	349								g4784	10.1136/bmj.g4784	http://dx.doi.org/10.1136/bmj.g4784			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VN	25052048				2022-12-24	WOS:000339565700015
J	Narain, C				Narain, Charvy			GENETICS Complex expressions	NATURE			English	Editorial Material																		Glasscock E, 2007, NAT NEUROSCI, V10, P1554, DOI 10.1038/nn1999; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Lerche H, 2013, J PHYSIOL-LONDON, V591, P753, DOI 10.1113/jphysiol.2012.240606; Thomas EA, 2010, EPILEPSIA, V51, P136, DOI 10.1111/j.1528-1167.2009.02202.x	4	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S8	S9		10.1038/511S8a	http://dx.doi.org/10.1038/511S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019127				2022-12-24	WOS:000338649800004
J	Chinthapalli, K				Chinthapalli, Krishna			ALZHEIMER'S DISEASE Alzheimer's disease: still a perplexing problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TASK-FORCE; FOLLOW-UP; DEMENTIA; THERAPY; BETA; ASSOCIATION; DIAGNOSIS; MUTATION; TRIALS; TAU		Royal Surrey Cty Hosp, Guildford, Surrey, England	Royal Surrey County Hospital	Chinthapalli, K (corresponding author), Royal Surrey Cty Hosp, Guildford, Surrey, England.	kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Aisen PS, 2011, ARCH MED SCI, V7, P102, DOI 10.5114/aoms.2011.20612; Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Booth P, 2008, STANDPOINT       NOV; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Cameron D., 2014, GIRL SUMMIT SPEECH; Castellani RJ, 2011, J PATHOL, V224, P147, DOI 10.1002/path.2885; Coric V, 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI 10.1001/archneurol.2012.2194; Danysz W, 2012, BRIT J PHARMACOL, V167, P324, DOI 10.1111/j.1476-5381.2012.02057.x; DEAKIN JFW, 1983, BRIT MED J, V287, P1323, DOI 10.1136/bmj.287.6402.1323; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Ferrer I, 2012, PROG NEUROBIOL, V97, P38, DOI 10.1016/j.pneurobio.2012.03.005; Fineberg NA, 2013, J PSYCHOPHARMACOL, V27, P761, DOI 10.1177/0269881113495118; Frisoni GB, 2013, NEUROLOGY, V81, P487, DOI 10.1212/WNL.0b013e31829d86e8; Giacobini E, 2013, NAT REV NEUROL, V9, P677, DOI 10.1038/nrneurol.2013.223; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; HARRISON PJ, 1986, J ROY SOC MED, V79, P347, DOI 10.1177/014107688607900612; Hawkes N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7529; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007, 10.1016/j.jalz.2013.06.001]; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010; Karran E, 2014, NEW ENGL J MED, V370, P377, DOI 10.1056/NEJMe1313943; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Muller U, 2013, LANCET NEUROL, V12, P129, DOI 10.1016/S1474-4422(12)70307-1; Nygaard HB, 2013, CLIN THER, V35, P1480, DOI 10.1016/j.clinthera.2013.09.009; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Richards M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4670; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Strassnig Martin, 2005, Psychiatry (Edgmont), V2, P30; SUMMERS WK, 1986, NEW ENGL J MED, V315, P1241, DOI 10.1056/NEJM198611133152001; Welge V, 2009, J NEURAL TRANSM, V116, P203, DOI 10.1007/s00702-008-0177-6; Winblad B, 2012, LANCET NEUROL, V11, P597, DOI 10.1016/S1474-4422(12)70140-0; Wischik CM, 2014, BIOCHEM PHARMACOL, V88, P529, DOI 10.1016/j.bcp.2013.12.008; Zetterberg H, 2014, EXPERT REV NEUROTHER, V14, P621, DOI 10.1586/14737175.2014.915740	48	2	4	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4433	10.1136/bmj.g4433	http://dx.doi.org/10.1136/bmj.g4433			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005430				2022-12-24	WOS:000338993300008
J	Xue, ZH; Ye, QH; Anson, SR; Yang, JC; Xiao, G; Kowbel, D; Glass, NL; Crosthwaite, SK; Liu, Y				Xue, Zhihong; Ye, Qiaohong; Anson, Simon R.; Yang, Jichen; Xiao, Guanghua; Kowbel, David; Glass, N. Louise; Crosthwaite, Susan K.; Liu, Yi			Transcriptional interference by antisense RNA is required for circadian clock function	NATURE			English	Article							NEUROSPORA-CRASSA; POLYMERASE-II; TEMPERATURE COMPENSATION; WHITE COLLAR-1; LIGHT; FREQUENCY; GENE; FRQ; INACTIVATION; METHYLATION	Eukaryotic circadian oscillators consist of negative feedback loops that generate endogenous rhythmicities(1). Natural antisense RNAs are found in a wide range of eukaryotic organisms(2-5). Nevertheless, the physiological importance and mode of action of most antisense RNAs are not clear(6-9). frequency (frq) encodes a component of the Neurospora core circadian negative feedback loop, which was thought to generate sustained rhythmicity(10). Transcription of qrf, the long non-coding frq antisense RNA, is induced by light, and its level oscillates in antiphase to frq sense RNA(3). Here we show that qrf transcription is regulated by both light-dependent and light-independent mechanisms. Light-dependent qrf transcription represses frq expression and regulates clock resetting. Light-independent qrf expression, on the other hand, is required for circadian rhythmicity. frq transcription also inhibits qrf expression and drives the antiphasic rhythm of qrf transcripts. The mutual inhibition of frq and qrf transcription thus forms a double negative feedback loop that is interlocked with the core feedback loop. Genetic and mathematical modelling analyses indicate that such an arrangement is required for robust and sustained circadian rhythmicity. Moreover, our results suggest that antisense transcription inhibits sense expression by mediating chromatin modifications and premature termination of transcription. Taken together, our results establish antisense transcription as an essential feature in a circadian system and shed light on the importance and mechanism of antisense action.	[Xue, Zhihong; Ye, Qiaohong; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Anson, Simon R.; Crosthwaite, Susan K.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Yang, Jichen; Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Kowbel, David; Glass, N. Louise] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Manchester; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu	Glass, N. Louise/ABA-7303-2021; yang, jichen/HDL-9203-2022	Xue, Zhihong/0000-0003-3568-2964	National Institutes of Health [GM068496, GM062591, GM081597]; Welch Foundation [I-1560]; Cancer Prevention Research Institute of Texas [RP101496]; Biotechnology and Biological Sciences Research Council [BBS/S/C2005/13012]; Biotechnology and Biological Sciences Research Council [BBS/B/11710] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084283, R01GM062591, R01GM068496, R24GM081597, R35GM118118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention Research Institute of Texas; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Cha, Y. Dang and H. Yuan for technical assistance, and B. Li for critical comments. Supported by grants from the National Institutes of Health to Y. L. (GM068496, GM062591) and N.L.G. (GM081597), the Welch Foundation (I-1560) to Y. L., the Cancer Prevention Research Institute of Texas (RP101496) to Z. X., and the Biotechnology and Biological Sciences Research Council (BBS/S/C2005/13012) to S. R. A. and S.K.C.	Adhvaryu KK, 2005, EUKARYOT CELL, V4, P1455, DOI 10.1128/EC.4.8.1455-1464.2005; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Bardiya N, 2007, FUNGAL GENET BIOL, V44, P307, DOI 10.1016/j.fgb.2006.12.011; BARLOW JJ, 1963, BIOCHEM BIOPH RES CO, V13, P61, DOI 10.1016/0006-291X(63)90163-3; Belden WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002166; BellPedersen D, 1996, MOL CELL BIOL, V16, P513; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dang YK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003761; Deuve JL, 2011, ANNU REV CELL DEV BI, V27, P611, DOI 10.1146/annurev-cellbio-092910-154020; DHARMANANDA S, 1980, THESIS U CALIFORNIA; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Ermentrout B., 2007, SCHOLARPEDIA, DOI [DOI 10.4249/SCH0LARPEDIA.1399, 10.4249/scholarpedia.1399]; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; GEAR CW, 1971, IEEE T CIRCUITS SYST, VCT18, P89, DOI 10.1109/TCT.1971.1083221; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Hong CI, 2008, BIOPHYS J, V94, P1221, DOI 10.1529/biophysj.107.115154; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kramer C, 2003, NATURE, V421, P948, DOI 10.1038/nature01427; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Pall M. L., 1993, FUNGAL GENET NEWSL, V40, P57; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Ruoff P, 2005, P NATL ACAD SCI USA, V102, P17681, DOI 10.1073/pnas.0505137102; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Yoon OK, 2010, RNA, V16, P1256, DOI 10.1261/rna.2038810; Yu YH, 2007, P NATL ACAD SCI USA, V104, P2809, DOI 10.1073/pnas.0611005104; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710; Zhou ZP, 2013, P NATL ACAD SCI USA, V110, pE4867, DOI 10.1073/pnas.1315133110	44	69	69	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					650	+		10.1038/nature13671	http://dx.doi.org/10.1038/nature13671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25132551	Green Accepted, Green Submitted			2022-12-24	WOS:000343801500054
J	Goodman, JL				Goodman, Jesse L.			Studying "Secret Serums" - Toward Safe, Effective Ebola Treatments	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTECTION; VIRUS; MARBURG		[Goodman, Jesse L.] Georgetown Univ, Dept Med, Div Infect Dis, Washington, DC 20007 USA; [Goodman, Jesse L.] Georgetown Univ, Ctr Med Prod Access Safety & Stewardship, Washington, DC USA; [Goodman, Jesse L.] Vet Affairs Med Ctr, Div Infect Dis, Dept Med, Washington, DC 20422 USA	Georgetown University; Georgetown University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Goodman, JL (corresponding author), Georgetown Univ, Dept Med, Div Infect Dis, Washington, DC 20007 USA.							Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Iversen PL, 2012, VIRUSES-BASEL, V4, P2806, DOI 10.3390/v4112806; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Uebelhoer LS, 2014, ANTIVIR RES, V106, P86, DOI 10.1016/j.antiviral.2014.03.018; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027	6	49	55	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1086	1089		10.1056/NEJMp1409817	http://dx.doi.org/10.1056/NEJMp1409817			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9PI	25140857				2022-12-24	WOS:000341687300003
J	Saha, SK; Parachoniak, CA; Ghanta, KS; Fitamant, J; Ross, KN; Najem, MS; Gurumurthy, S; Akbay, EA; Sia, D; Cornella, H; Miltiadous, O; Walesky, C; Deshpande, V; Zhu, AX; Hezel, AF; Yen, KE; Straley, KS; Travins, J; Popovici-Muller, J; Gliser, C; Ferrone, CR; Apte, U; Llovet, JM; Wong, KK; Ramaswamy, S; Bardeesy, N				Saha, Supriya K.; Parachoniak, Christine A.; Ghanta, Krishna S.; Fitamant, Julien; Ross, Kenneth N.; Najem, Mortada S.; Gurumurthy, Sushma; Akbay, Esra A.; Sia, Daniela; Cornella, Helena; Miltiadous, Oriana; Walesky, Chad; Deshpande, Vikram; Zhu, Andrew X.; Hezel, Aram F.; Yen, Katharine E.; Straley, Kimberly S.; Travins, Jeremy; Popovici-Muller, Janeta; Gliser, Camelia; Ferrone, Cristina R.; Apte, Udayan; Llovet, Josep M.; Wong, Kwok-Kin; Ramaswamy, Sridhar; Bardeesy, Nabeel			Mutant IDH inhibits HNF-4 alpha to block hepatocyte differentiation and promote biliary cancer	NATURE			English	Article							INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER-REGENERATION; MUTATION; GROWTH; MICE; PROLIFERATION; PROGENITORS; HOMEOSTASIS; EXPRESSION	Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are among the most common genetic alterations in intrahepatic cholangiocarcinoma (IHCC), a deadly liver cancer(1-5). Mutant IDH proteins in IHCC and other malignancies acquire an abnormal enzymatic activity allowing themto convert alpha-ketoglutarate (alpha KG) to 2-hydroxyglutarate (2HG), which inhibits the activity of multiple alpha KG-dependent dioxygenases, and results in alterations in cell differentiation, survival, and extracellular matrix maturation(6-10). However, the molecular pathways by which IDH mutations lead to tumour formation remain unclear. Here we show that mutant IDH blocks liver progenitor cells from undergoing hepatocyte differentiation through the production of 2HG and suppression of HNF-4 alpha, a master regulator of hepatocyte identity and quiescence. Correspondingly, genetically engineered mouse models expressing mutant IDH in the adult liver show an aberrant response to hepatic injury, characterized by HNF-4 alpha silencing, impaired hepatocyte differentiation, and markedly elevated levels of cell proliferation. Moreover, IDH and Kras mutations, genetic alterations that co-exist in a subset of human IHCCs4,5, cooperate to drive the expansion of liver progenitor cells, development of premalignant biliary lesions, and progression to metastatic IHCC. These studies provide a functional link between IDH mutations, hepatic cell fate, and IHCC pathogenesis, and present a novel genetically engineered mouse model of IDH-driven malignancy.	[Saha, Supriya K.; Parachoniak, Christine A.; Ghanta, Krishna S.; Fitamant, Julien; Ross, Kenneth N.; Najem, Mortada S.; Gurumurthy, Sushma; Deshpande, Vikram; Zhu, Andrew X.; Ferrone, Cristina R.; Ramaswamy, Sridhar; Bardeesy, Nabeel] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Akbay, Esra A.; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Dept Med, Boston, MA 02115 USA; [Sia, Daniela; Cornella, Helena; Llovet, Josep M.] Univ Barcelona, Hosp Clin, Barcelona Clin Liver Canc Grp, HCC Translat Res Lab,IDIBAPS,Liver Unit, Catalonia 08036, Spain; [Sia, Daniela; Miltiadous, Oriana; Llovet, Josep M.] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, Mt Sinai Liver Canc Program, New York, NY 10029 USA; [Sia, Daniela] Natl Canc Inst, Gastrointestinal Surg & Liver Transplantat Unit, I-20133 Milan, Italy; [Sia, Daniela] Dept Expt Oncol, I-20133 Milan, Italy; [Walesky, Chad; Apte, Udayan] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Hezel, Aram F.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Yen, Katharine E.; Straley, Kimberly S.; Travins, Jeremy; Popovici-Muller, Janeta; Gliser, Camelia] Agios Pharmaceut, Cambridge, MA 02139 USA; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Catalonia, Spain; [Llovet, Josep M.] Univ Barcelona, Catalonia 08036, Spain; [Ramaswamy, Sridhar] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Icahn School of Medicine at Mount Sinai; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Kansas; University of Kansas Medical Center; University of Rochester; Agios Pharmaceuticals; ICREA; University of Barcelona; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bardeesy, N (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA.	Bardeesy.Nabeel@mgh.harvard.edu	Saha, Supriya/AAC-5365-2019; Ghanta, Krishna S./M-1307-2019; Llovet, Josep M/D-4340-2014; Llovet, Josep M/ABB-6264-2021	Ghanta, Krishna S./0000-0001-7502-3141; Llovet, Josep M/0000-0003-0547-2667; Llovet, Josep M/0000-0003-0547-2667; wong, kwok kin/0000-0001-6323-235X; Sia, Daniela/0000-0002-9000-611X; Miltiadous, Oriana/0000-0002-1571-3893; Akbay, Esra/0000-0002-4149-2529	TargetCancer Foundation; National Institutes of Health [R01CA136567-02, P50CA1270003]; Cholangiocarcinoma Foundation/Conquer Cancer Foundation of ASCO Young Investigator Award; American Cancer Society Postdoctoral Fellowship [PF-13-294-01-TBG]; Canadian Institutes of Health Research postdoctoral fellowship; Asociacion Espanola para el Estudio del Cancer; NATIONAL CANCER INSTITUTE [R01CA136567, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007792, R01DK098414] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	TargetCancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cholangiocarcinoma Foundation/Conquer Cancer Foundation of ASCO Young Investigator Award; American Cancer Society Postdoctoral Fellowship(American Cancer Society); Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); Asociacion Espanola para el Estudio del Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ICREA(ICREA)	We thank R. Mostoslavsky, L. Ellisen, A. Kimmelman, and members of the Bardeesy laboratory for valuable input. We also thank S. Thorgeirsson and J. Andersen for sharing unpublished data sets. This work was supported by grants from TargetCancer Foundation and the National Institutes of Health (R01CA136567-02 and P50CA1270003) to N.B. N.B. holds the Gallagher Endowed Chair in Gastrointestinal Cancer Research at Massachusetts General Hospital. S. K. S. is the recipient of a Cholangiocarcinoma Foundation/Conquer Cancer Foundation of ASCO Young Investigator Award, and an American Cancer Society Postdoctoral Fellowship (PF-13-294-01-TBG). C. A. P. is the recipient of a Canadian Institutes of Health Research postdoctoral fellowship. N.B., J. M. L. and D. S are members of the Samuel Waxman Cancer Research Foundation Institute Without Walls. J. M. L. and D. S. are supported by the Asociacion Espanola para el Estudio del Cancer.	Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davis MI, 2014, J BIOL CHEM, V289, P13717, DOI 10.1074/jbc.M113.511030; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Hezel AF, 2010, J CLIN ONCOL, V28, P3531, DOI 10.1200/JCO.2009.27.4787; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Michalopoulos GK, 2013, COMPR PHYSIOL, V3, P485, DOI 10.1002/cphy.c120014; O'Dell MR, 2012, CANCER RES, V72, P1557, DOI 10.1158/0008-5472.CAN-11-3596; Oishi N, 2012, HEPATOLOGY, V56, P1792, DOI 10.1002/hep.25890; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Preisegger KH, 1999, LAB INVEST, V79, P103; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; Tefferi A, 2010, LEUKEMIA, V24, P1302, DOI 10.1038/leu.2010.113; Torres-Padilla ME, 2001, MECH DEVELOP, V109, P183, DOI 10.1016/S0925-4773(01)00521-4; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Voss JS, 2013, HUM PATHOL, V44, P1216, DOI 10.1016/j.humpath.2012.11.006; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112	38	293	305	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					110	+		10.1038/nature13441	http://dx.doi.org/10.1038/nature13441			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043045	Green Accepted			2022-12-24	WOS:000341174800040
J	Chen, XY; Tung, KK				Chen, Xianyao; Tung, Ka-Kit			Varying planetary heat sink led to global-warming slowdown and acceleration	SCIENCE			English	Article							MERIDIONAL OVERTURNING CIRCULATION; ATLANTIC MULTIDECADAL OSCILLATION; SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; DECADAL CHANGES; EARTHS ENERGY; UPPER-OCEAN; VARIABILITY; 20TH-CENTURY; HIATUS	A vacillating global heat sink at intermediate ocean depths is associated with different climate regimes of surface warming under anthropogenic forcing: The latter part of the 20th century saw rapid global warming as more heat stayed near the surface. In the 21st century, surface warming slowed as more heat moved into deeper oceans. In situ and reanalyzed data are used to trace the pathways of ocean heat uptake. In addition to the shallow La Nina-like patterns in the Pacific that were the previous focus, we found that the slowdown is mainly caused by heat transported to deeper layers in the Atlantic and the Southern oceans, initiated by a recurrent salinity anomaly in the subpolar North Atlantic. Cooling periods associated with the latter deeper heat-sequestration mechanism historically lasted 20 to 35 years.	[Chen, Xianyao] Ocean Univ China, Key Lab Phys Oceanog, Qingdao, Peoples R China; [Chen, Xianyao; Tung, Ka-Kit] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA	Ocean University of China; University of Washington; University of Washington Seattle	Tung, KK (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	ktung@uw.edu		Tung, Ka-Kit/0000-0001-8667-7167	NSF [AGS-1262231]; Natural Science Foundation of China [41330960, 41176029]; Div Atmospheric & Geospace Sciences [1262231] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The research of K.-K. T. is supported by NSF under AGS-1262231. X. C. is supported by Natural Science Foundation of China under 41330960 and 41176029. He thanks First Institute of Oceanography of China for its support during his visit to University of Washington. The authors are grateful to many colleagues and the anonymous reviewers who commented on the manuscript and helped improve it. The data sets used in this study are publicly available in http://rda.ucar.edu/datasets/ds285.3/ and https://climatedataguide.ucar.edu/climate-data/oras4-ecmwf-ocean-reanalysis-and-derived-ocean-heat-content.	Balmaseda MA, 2013, Q J ROY METEOR SOC, V139, P1132, DOI 10.1002/qj.2063; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Curry R, 2003, NATURE, V426, P826, DOI 10.1038/nature02206; Danabasoglu G, 2012, J CLIMATE, V25, P5153, DOI 10.1175/JCLI-D-11-00463.1; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Dima M, 2007, J CLIMATE, V20, P2706, DOI 10.1175/JCLI4174.1; Easterling DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037810; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Hansen J, 2011, ATMOS CHEM PHYS, V11, P13421, DOI 10.5194/acp-11-13421-2011; Hatun H, 2005, SCIENCE, V309, P1841, DOI 10.1126/science.1114777; Intergovernmental Panel on Climate Change, 2007, SUMM POL CLIM CHANG; Ishii M, 2005, INT J CLIMATOL, V25, P865, DOI 10.1002/joc.1169; Ishii M, 2006, J OCEANOGR, V62, P155, DOI 10.1007/s10872-006-0041-y; Ishii M, 2009, J OCEANOGR, V65, P287, DOI 10.1007/s10872-009-0027-7; Jungclaus JH, 2005, J CLIMATE, V18, P4013, DOI 10.1175/JCLI3462.1; Katsman CA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048417; Kaufmann RK, 2011, P NATL ACAD SCI USA, V108, P11790, DOI 10.1073/pnas.1102467108; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Lyman JM, 2008, J CLIMATE, V21, P5629, DOI 10.1175/2008JCLI2259.1; Lyman JM, 2014, J CLIMATE, V27, P1945, DOI 10.1175/JCLI-D-12-00752.1; Lyman JM, 2010, NATURE, V465, P334, DOI 10.1038/nature09043; Meehl GA, 2013, J CLIMATE, V26, P7298, DOI 10.1175/JCLI-D-12-00548.1; Meehl GA, 2011, NAT CLIM CHANGE, V1, P360, DOI 10.1038/NCLIMATE1229; Polyakov IV, 2010, CLIM DYNAM, V34, P439, DOI 10.1007/s00382-008-0522-3; Roemmich D, 2009, OCEANOGRAPHY, V22, P46, DOI 10.5670/oceanog.2009.65; Santer BD, 2014, NAT GEOSCI, V7, P185, DOI [10.1038/ngeo2098, 10.1038/NGEO2098]; Schmidt GA, 2014, NAT GEOSCI, V7, P158, DOI 10.1038/ngeo2105; Solomon S, 2011, SCIENCE, V333, P866, DOI 10.1126/science.1206027; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; Trenberth KE, 2014, J CLIMATE, V27, P3129, DOI 10.1175/JCLI-D-13-00294.1; Trenberth KE, 2013, EARTHS FUTURE, V1, P19, DOI 10.1002/2013EF000165; Trenberth KE, 2010, SCIENCE, V328, P316, DOI 10.1126/science.1187272; Tung KK, 2013, P NATL ACAD SCI USA, V110, P2058, DOI 10.1073/pnas.1212471110; Wang CZ, 2013, J CLIMATE, V26, P6137, DOI 10.1175/JCLI-D-12-00721.1; Welch WT, 1998, J ATMOS SCI, V55, P1285, DOI 10.1175/1520-0469(1998)055<1285:NBAAWS>2.0.CO;2; Wu ZH, 2011, CLIM DYNAM, V37, P759, DOI 10.1007/s00382-011-1128-8; Wyatt MG, 2014, CLIM DYNAM, V42, P2763, DOI 10.1007/s00382-013-1950-2; Wyatt MG, 2012, CLIM DYNAM, V38, P929, DOI 10.1007/s00382-011-1071-8; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030225; Zhang R, 2013, J ATMOS SCI, V70, P1135, DOI 10.1175/JAS-D-12-0331.1; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028683; Zhang R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035463; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031601; Zhou JS, 2010, J CLIMATE, V23, P3234, DOI 10.1175/2010JCLI3232.1	47	326	379	21	313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					897	903		10.1126/science.1254937	http://dx.doi.org/10.1126/science.1254937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146282				2022-12-24	WOS:000340524700037
J	Nguyen, PV				Nguyen, Paul V.			PERSONAL VIEW Electronic health records may threaten blinding in trials of statins	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE; ROSUVASTATIN-JUPITER; PRIMARY PREVENTION; LOW-RISK; CHOLESTEROL; METAANALYSIS; PEOPLE		Ctr Hosp Univ Montreal, Montreal, PQ H2W 1T8, Canada	Universite de Montreal	Nguyen, PV (corresponding author), Ctr Hosp Univ Montreal, 3840 St Urbain, Montreal, PQ H2W 1T8, Canada.	pnguyen920@aol.com						Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; de Lorgeril M, 2010, ARCH INTERN MED, V170, P1032, DOI 10.1001/archinternmed.2010.184; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Hassouneh B, 2013, FUTURE SCI, P62; Kazi DS, 2012, CIRC-CARDIOVASC QUAL, V5, P249, DOI 10.1161/CIRCOUTCOMES.112.965764; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6989; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Vos E, 2010, CIRCULATION, V122, pE576, DOI 10.1161/CIRCULATIONAHA.110.954016; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	12	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2014	349								g5239	10.1136/bmj.g5239	http://dx.doi.org/10.1136/bmj.g5239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FL	25143525				2022-12-24	WOS:000340838700005
J	Gagnon, MG; Lin, JZ; Bulkley, D; Steitz, TA				Gagnon, Matthieu G.; Lin, Jinzhong; Bulkley, David; Steitz, Thomas A.			Crystal structure of elongation factor 4 bound to a clockwise ratcheted ribosome	SCIENCE			English	Article							TRANSFER-RNA; ESCHERICHIA-COLI; HYBRID STATE; LEPA; RESISTANCE; GTPASES; SITE	Elongation factor 4 (EF4/LepA) is a highly conserved guanosine triphosphatase translation factor. It was shown to promote back-translocation of tRNAs on posttranslocational ribosome complexes and to compete with elongation factor G for interaction with pretranslocational ribosomes, inhibiting the elongation phase of protein synthesis. Here, we report a crystal structure of EF4-guanosine diphosphate bound to the Thermus thermophilus ribosome with a P-site tRNA at 2.9 angstroms resolution. The C-terminal domain of EF4 reaches into the peptidyl transferase center and interacts with the acceptor stem of the peptidyl-tRNA in the P site. The ribosome is in an unusual state of ratcheting with the 30S subunit rotated clockwise relative to the 50S subunit, resulting in a remodeled decoding center. The structure is consistent with EF4 functioning either as a back-translocase or a ribosome sequester.	[Gagnon, Matthieu G.; Lin, Jinzhong; Bulkley, David; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gagnon, Matthieu G.; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Bulkley, David; Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu	Lin, Jinzhong/I-9131-2016	Lin, Jinzhong/0000-0001-5666-8526; Gagnon, Matthieu/0000-0003-4516-604X; Bulkley, David/0000-0002-2535-904X	NIH [GM022778]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Moore, S. Seetharaman, I. Lomakin, and Y. Polikanov for valuable discussions and critical reading of the manuscript along with G. Blaha for help in designing and generating the mutant T. thermophilus strain. We thank A. Dahlberg and S. Gregory for providing the thermostable kanamycin gene and advice with genetic manipulations of T. thermophilus. We thank R. Grodzicki for preparing the Phe-tRNA<SUP>Phe</SUP>. We also thank the staffs of the Advanced Photon Source beamline 24-ID and the National Synchrotron Light Source beamlines X25 and X29 for help during data collection and the Center for Structural Biology facility at Yale University for computational support. This work was supported by NIH grant GM022778 (to T.A.S.). Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 4QJS and 4QJT.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; Clementi N, 2010, RNA BIOL, V7, P521, DOI 10.4161/rna.7.5.12467; Colca JR, 2003, J BIOL CHEM, V278, P21972, DOI 10.1074/jbc.M302109200; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Evans RN, 2008, P NATL ACAD SCI USA, V105, P4673, DOI 10.1073/pnas.0801308105; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Liu HQ, 2011, P NATL ACAD SCI USA, V108, P16223, DOI 10.1073/pnas.1103820108; Liu HQ, 2010, J MOL BIOL, V396, P1043, DOI 10.1016/j.jmb.2009.12.043; Maguire BA, 2005, MOL CELL, V20, P427, DOI 10.1016/j.molcel.2005.09.009; MARCH PE, 1985, J BIOL CHEM, V260, P7206; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pech M, 2011, P NATL ACAD SCI USA, V108, P3199, DOI 10.1073/pnas.1012994108; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Qin Y, 2006, CELL, V127, P721, DOI 10.1016/j.cell.2006.09.037; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Selmer M, 2012, ACTA CRYSTALLOGR D, V68, P578, DOI 10.1107/S0907444912006348; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yamamoto H, 2014, NAT REV MICROBIOL, V12, P89, DOI 10.1038/nrmicro3176; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zhang DJ, 2013, BIOCHEM J, V452, P173, DOI 10.1042/BJ20121792; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086; Zhou J, 2012, RNA, V18, P230, DOI 10.1261/rna.031187.111	32	31	33	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					684	687		10.1126/science.1253525	http://dx.doi.org/10.1126/science.1253525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104389	Green Accepted			2022-12-24	WOS:000339962800042
J	Barbui, C; Purgato, M				Barbui, Corrado; Purgato, Marianna			Decisions on WHO's essential medicines need more scrutiny	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIPSYCHOTIC-DRUGS; SCHIZOPHRENIA; LIST		[Barbui, Corrado; Purgato, Marianna] Univ Verona, WHO Collaborating Ctr Res & Training Mental Hlth, Dept Publ Hlth & Community Med, Sect Psychiat,Policlini GB Rossi, I-37134 Verona, Italy	University of Verona	Barbui, C (corresponding author), Univ Verona, WHO Collaborating Ctr Res & Training Mental Hlth, Dept Publ Hlth & Community Med, Sect Psychiat,Policlini GB Rossi, Piazzale Scuro 10, I-37134 Verona, Italy.	corrado.barbui@univr.it						Barbui C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001530; Barbui C, 2013, LANCET, V382, P1234, DOI 10.1016/S0140-6736(13)60255-X; Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322; Chirac P, 2001, LANCET, V357, P1134, DOI 10.1016/S0140-6736(00)04291-4; Hill S, 2007, LANCET, V369, P1842, DOI 10.1016/S0140-6736(07)60676-X; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Purgato M, 2012, EPIDEMIOL PSYCH SCI, V21, P343, DOI 10.1017/S204579601200039X; WHO, WHO MED STRAT REV PR	10	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2014	349								g4798	10.1136/bmj.g4798	http://dx.doi.org/10.1136/bmj.g4798			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NW	25081250				2022-12-24	WOS:000339907800002
J	Moore, TJ; Cohen, MR; Mattison, DR				Moore, Thomas J.; Cohen, Michael R.; Mattison, Donald R.			Dabigatran, bleeding, and the regulators	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MECHANICAL HEART-VALVES; ATRIAL-FIBRILLATION; WARFARIN; ETEXILATE; SAFETY		[Moore, Thomas J.; Cohen, Michael R.] Inst Safe Medicat Practices, Horsham, PA 19044 USA; [Mattison, Donald R.] Risk Sci Int, Ottawa, ON, Canada; [Mattison, Donald R.] Univ Ottawa, Ottawa, ON, Canada	University of Ottawa	Moore, TJ (corresponding author), Inst Safe Medicat Practices, 200 Lakeside Dr,Suite 200, Horsham, PA 19044 USA.	tmoore@ismp.org	; Mattison, Donald/L-4661-2013	Moore, Thomas/0000-0003-0994-836X; Mattison, Donald/0000-0001-5623-0874				Advisory Committee Briefing Document, 2010, DRUG SUBST DAB ET; [Anonymous], 2012, MIN ANSW CHMP HOC AD; [Anonymous], 2011, CHMP ASSESSMENT REPO; [Anonymous], 2014, PRESCR INF XARELTO R; [Anonymous], 2014, FDA STUDY MEDICARE P; [Anonymous], 2014, PRESCR INF PRADAXA D; [Anonymous], 2012, CHMP ASSESSMENT REPO; [Anonymous], 2008, CHMP ASSESSMENT REPO; [Anonymous], 2012, U12107201; [Anonymous], 2012, BIPIPRA0028572360KLI; [Anonymous], 2014, PRESCR INF ELIZUIS A; [Anonymous], 2012, CV SCIENT ADV GROUP; Avorn J, 2013, CIRCULATION, V128, P745, DOI 10.1161/CIRCULATIONAHA.113.003419; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cardiovascular and Renal Drugs Advisory Committee, 2010, M MOND SEP 20 2010 F; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Eikelboom JW, 2013, J AM COLL CARDIOL, V62, P900, DOI 10.1016/j.jacc.2013.05.042; FDA Drug Safety Communication, 2012, UPD RISK SER BLEED E; FDA Drug Safety Communication, SAF REV POST MARK RE; Larsen TB, 2013, J AM COLL CARDIOL, V61, P2264, DOI 10.1016/j.jacc.2013.03.020; Luik S, 2010, BIPIPRA006011738; Moore T. J., 2012, QUARTERWATCH; Moore TJ, 2011, QUARTERWATCH; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Southworth MR, 2013, NEW ENGL J MED, V368, P1272, DOI 10.1056/NEJMp1302834; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; ten Cate H, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-8; Unger EF, 2010, SUMMARY REVIEW DEPUT; Van de Werf F, 2012, AM HEART J, V163, P931, DOI 10.1016/j.ahj.2012.03.011	32	59	59	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4517	10.1136/bmj.g4517	http://dx.doi.org/10.1136/bmj.g4517			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VP	25056265				2022-12-24	WOS:000339565900002
J	Casadei, CM; Gumiero, A; Metcalfe, CL; Murphy, EJ; Basran, J; Concilio, MG; Teixeira, SCM; Schrader, TE; Fielding, AJ; Ostermann, A; Blakeley, MP; Raven, EL; Moody, PCE				Casadei, Cecilia M.; Gumiero, Andrea; Metcalfe, Clive L.; Murphy, Emma J.; Basran, Jaswir; Concilio, Maria Grazia; Teixeira, Susana C. M.; Schrader, Tobias E.; Fielding, Alistair J.; Ostermann, Andreas; Blakeley, Matthew P.; Raven, Emma L.; Moody, Peter C. E.			Neutron cryo-crystallography captures the protonation state of ferryl heme in a peroxidase	SCIENCE			English	Article							CYTOCHROME-C PEROXIDASE; COMPOUND-I FORMATION; H BOND ACTIVATION; HORSERADISH-PEROXIDASE; CATALYTIC PATHWAY; CRYSTAL-STRUCTURE; ES; INTERMEDIATE; MECHANISM; RESONANCE	Heme enzymes activate oxygen through formation of transient iron-oxo (ferryl) intermediates of the heme iron. A long-standing question has been the nature of the iron-oxygen bond and, in particular, the protonation state. We present neutron structures of the ferric derivative of cytochrome c peroxidase and its ferryl intermediate; these allow direct visualization of protonation states. We demonstrate that the ferryl heme is an Fe(IV)=O species and is not protonated. Comparison of the structures shows that the distal histidine becomes protonated on formation of the ferryl intermediate, which has implications for the understanding of O-O bond cleavage in heme enzymes. The structures highlight the advantages of neutron cryo-crystallography in probing reaction mechanisms and visualizing protonation states in enzyme intermediates.	[Casadei, Cecilia M.; Basran, Jaswir; Moody, Peter C. E.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Casadei, Cecilia M.; Basran, Jaswir; Moody, Peter C. E.] Univ Leicester, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England; [Casadei, Cecilia M.; Teixeira, Susana C. M.; Blakeley, Matthew P.] Inst Max Von Laue Paul Langevin, F-38000 Grenoble, France; [Gumiero, Andrea; Metcalfe, Clive L.; Murphy, Emma J.; Raven, Emma L.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Concilio, Maria Grazia; Fielding, Alistair J.] Univ Manchester, Photon Sci Inst, Manchester M13 9PL, Lancs, England; [Teixeira, Susana C. M.] Keele Univ, EPSAM, Keele ST5 5BG, Staffs, England; [Schrader, Tobias E.] Forschungszentrum Julich, JCNS, Outstn MLZ, D-85747 Garching, Germany; [Ostermann, Andreas] Tech Univ Munich, Heinz Maier Leibnitz Zentrum MLZ, D-85748 Garching, Germany	University of Leicester; University of Leicester; Institut Laue-Langevin (ILL); University of Leicester; University of Manchester; Keele University; Helmholtz Association; Research Center Julich; Technical University of Munich	Raven, EL (corresponding author), Univ Leicester, Dept Chem, Univ Rd, Leicester LE1 7RH, Leics, England.	emma.raven@le.ac.uk; peter.moody@le.ac.uk	Teixeira, Susana C. M./H-2205-2016; Concilio, Maria Grazia/GRX-4452-2022; Moody, Peter/A-6832-2008; Teixeira, Susana/H-2824-2013; Blakeley, Matthew Paul/G-7984-2015; Fielding, Alistair J./AAR-3101-2021	Teixeira, Susana C. M./0000-0002-6603-7936; Concilio, Maria Grazia/0000-0002-6534-4838; Moody, Peter/0000-0003-1762-9238; Teixeira, Susana/0000-0002-1967-0026; Blakeley, Matthew Paul/0000-0002-6412-4358; Fielding, Alistair J./0000-0002-4437-9791; Raven, Emma/0000-0002-1643-8694; Metcalfe, Clive/0000-0002-7856-8574; Schrader, Tobias Erich/0000-0001-5159-0846; Murphy, Emma/0000-0003-4551-8068	Leverhulme Trust [F/00 212/Q]; Biotechnology and Biological Sciences Research Council [BB/C001184/1]; Wellcome Trust, an Institut Laue-Langevin studentship [WT094104MA]; EU [283883]; Bruker UK; Biotechnology and Biological Sciences Research Council [BB/K015656/1] Funding Source: researchfish; BBSRC [BB/K015656/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust, an Institut Laue-Langevin studentship; EU(European Commission); Bruker UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Collison for assistance with EPR, P. Ortiz de Montellano for discussions on the mechanisms, S. Fisher for assistance with the joint x-ray/neutron refinement, and the University of Leicester BioMedical Workshop for custom building of microspectrophotometry equipment, and J. Devos and the D-lab for experimental support. Atomic coordinates have been deposited in the Protein Data Bank under accession codes 4CVI for ferric CcP and 4CVJ for compound I. This work was supported by The Leverhulme Trust (grant F/00 212/Q to E.L.R./P.C.E.M.), Biotechnology and Biological Sciences Research Council (grant BB/C001184/1 to E.L.R./P.C.E.M., and a studentship to E. J. M.), The Wellcome Trust (grant WT094104MA to P.C.E.M./E.L.R.), an Institut Laue-Langevin studentship (to C. M. C.) and beam time at LADI-III and BIODIFF (EU FP7 NMI3-II grant 283883), Bruker UK (Sponsorship of A.J.F. and M. G. C.), and beam time at LADI-III and BIODIFF. P. C. E. M., M. P. B., and E. L. R. designed the research; C. M. C., A. G., M. P. B., A.O., S. C. M. T, T. E. S., C. L. M., E.J.M., and P. C. E. M. performed crystallographic experiments; C. M. C., A. G., M. P. B., S. C. M. T., A.O., T. E. S., E. L. R., and P. C. E. M. analyzed crystallographic data; C. M. C., A.J.F., M. G. C., J.B., and P. C. E. M. performed spectroscopic experiments; C. M. C., A. G., A.J.F., M. G. C., E. L. R., and P. C. E. M. analyzed spectra; and E. L. R., M. P. B., and P. C. E. M. wrote the paper, with contributions from all authors.	Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Blakeley MP, 2009, CRYSTALLOGR REV, V15, P157, DOI 10.1080/08893110902965003; Blakeley MP, 2004, P NATL ACAD SCI USA, V101, P16405, DOI 10.1073/pnas.0405109101; Davidson VL, 2011, NAT CHEM, V3, P662, DOI 10.1038/nchem.1122; Derat E, 2006, J PHYS CHEM B, V110, P10526, DOI 10.1021/jp055412e; Dunford H. B., 2010, PEROXIDASES CATALASE; Dunford H. B., 1999, HEME PEROXIDASES; EDWARDS SL, 1987, BIOCHEMISTRY-US, V26, P1503, DOI 10.1021/bi00380a002; Efimov I, 2011, J AM CHEM SOC, V133, P15376, DOI 10.1021/ja2007017; ERMAN JE, 1992, J AM CHEM SOC, V114, P6592, DOI 10.1021/ja00042a068; ERMAN JE, 1975, BIOCHIM BIOPHYS ACTA, V393, P350, DOI 10.1016/0005-2795(75)90061-6; Groves JT, 2014, NAT CHEM, V6, P89, DOI 10.1038/nchem.1855; Gumiero A, 2011, J BIOL CHEM, V286, P1260, DOI 10.1074/jbc.M110.183483; HORI H, 1985, J BIOL CHEM, V260, P349; HUYETT JE, 1995, J AM CHEM SOC, V117, P9033, DOI 10.1021/ja00140a021; Karlin KD, 2010, NATURE, V463, P168, DOI 10.1038/463168a; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; McDonald AR, 2011, NAT CHEM, V3, P761, DOI 10.1038/nchem.1153; Meharenna YT, 2010, BIOCHEMISTRY-US, V49, P2984, DOI 10.1021/bi100238r; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Pond AE, 1998, INORG CHIM ACTA, V276, P250; POULOS TL, 1980, J BIOL CHEM, V255, P8199; POULOS TL, 1980, J BIOL CHEM, V255, P575; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; SITTER AJ, 1985, J BIOL CHEM, V260, P7515; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Sligar SG, 2010, SCIENCE, V330, P924, DOI 10.1126/science.1197881; Terner J, 2006, J INORG BIOCHEM, V100, P480, DOI 10.1016/j.jinorgbio.2006.01.008; Vidossich P, 2010, J PHYS CHEM B, V114, P5161, DOI 10.1021/jp911170b; Yosca TH, 2013, SCIENCE, V342, P825, DOI 10.1126/science.1244373	34	117	117	0	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					193	197		10.1126/science.1254398	http://dx.doi.org/10.1126/science.1254398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013070	Green Accepted, Green Submitted			2022-12-24	WOS:000339409900048
J	Zolla-Pazner, S				Zolla-Pazner, Susan			A critical question for HIV vaccine development: Which antibodies to induce?	SCIENCE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; POTENT NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; HIV-1-INFECTED INDIVIDUALS; V3 LOOP; CONFORMATIONAL EPITOPE; EFFICACY TRIAL; CD4 BINDING; BROAD; SUPERINFECTION	A vaccine against HIV-1 must prevent infection against genetically diverse virus strains. Two approaches are currently being pursued to elicit antibody-mediated protection: vaccines that induce potent and broadly reactive neutralizing antibodies (bnAbs) or vaccines that induce "conventional antibodies," which are less potent and broadly neutralizing in comparison. Although bnAbs may provide the greatest level of protection, their structural and genetic characteristics make their elicitation through vaccination a major challenge. In contrast, conventional HIV-1 antibodies have been induced by vaccination and correlated with reduced HIV-1 infection in a phase III vaccine trial. Here, I present evidence that both approaches should be pursued with equal vigor.	[Zolla-Pazner, Susan] New York Vet Affairs Harbor Healthcare Syst, New York, NY 10010 USA; [Zolla-Pazner, Susan] NYU, Sch Med, New York, NY 10016 USA	New York University	Zolla-Pazner, S (corresponding author), New York Vet Affairs Harbor Healthcare Syst, New York, NY 10010 USA.	zollas01@med.nyu.edu	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100151] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL059725, R01 HL59725] Funding Source: Medline; NIAID NIH HHS [P01 AI100151, P01 AI 100151] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrus L, 1998, J INFECT DIS, V177, P889, DOI 10.1086/515251; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Basu D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-76; Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Blish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Delany I, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012476; EMINI EA, 1990, J VIROL, V64, P3674, DOI 10.1128/JVI.64.8.3674-3678.1990; Forthal DN, 2013, JAIDS-J ACQ IMM DEF, V63, P31, DOI 10.1097/QAI.0b013e3182874d41; Georgiev IS, 2014, J IMMUNOL, V192, P1100, DOI 10.4049/jimmunol.1302515; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Haynes BF, 2014, SCIENCE, V344, P588, DOI 10.1126/science.1254990; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Israel ZR, 1997, AIDS, V11, P128; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lambert JS, 1997, J INFECT DIS, V175, P283, DOI 10.1093/infdis/175.2.283; Li LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039534; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Moore PL, 2013, J VIROL, V87, P4882, DOI 10.1128/JVI.03424-12; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Ronen K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003593; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Totrov M, 2010, VIROLOGY, V405, P513, DOI 10.1016/j.virol.2010.06.027; Vaine M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013916; Verrier F, 2001, J VIROL, V75, P9177, DOI 10.1128/JVI.75.19.9177-9186.2001; VijhWarrier S, 1996, J VIROL, V70, P4466, DOI 10.1128/JVI.70.7.4466-4473.1996; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner Susan, 2005, Human Antibodies, V14, P69; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629; Zolla-Pazner S, 2011, J VIROL, V85, P9887, DOI 10.1128/JVI.05086-11	67	27	35	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					167	168		10.1126/science.1256526	http://dx.doi.org/10.1126/science.1256526			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013066	Green Accepted			2022-12-24	WOS:000339409900040
J	Gravitz, L				Gravitz, Lauren			SOCIOLOGY Shedding the shame	NATURE			English	Editorial Material							EPILEPSY											Ekenze OS, 2013, EPILEPSY BEHAV, V26, P87, DOI 10.1016/j.yebeh.2012.10.016; Kale R, 1997, BRIT MED J, V315, P2, DOI 10.1136/bmj.315.7099.2; Meador KJ, 2011, NEUROLOGY, V77, P1305, DOI 10.1212/WNL.0b013e318230a18f	3	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S10	S11		10.1038/511S10a	http://dx.doi.org/10.1038/511S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8AP	25019128	Bronze			2022-12-24	WOS:000338649800005
J	Li, Y; Calvo, SE; Gutman, R; Liu, JS; Mootha, VK				Li, Yang; Calvo, Sarah E.; Gutman, Roee; Liu, Jun S.; Mootha, Vamsi K.			Expansion of Biological Pathways Based on Evolutionary Inference	CELL			English	Article							MITOCHONDRIAL CALCIUM UNIPORTER; PROTEOMIC ANALYSIS; COMPLEX; PROTEIN; GENES; GENOMICS; DISEASE; IDENTIFICATION; PREDICTION; TRANSPORT	The availability of diverse genomes makes it possible to predict gene function based on shared evolutionary history. This approach can be challenging, however, for pathways whose components do not exhibit a shared history but rather consist of distinct "evolutionary modules." We introduce a computational algorithm, clustering by inferred models of evolution (CLIME), which inputs a eukaryotic species tree, homology matrix, and pathway (gene set) of interest. CLIME partitions the gene set into disjoint evolutionary modules, simultaneously learning the number of modules and a tree-based evolutionary history that defines each module. CLIME then expands each module by scanning the genome for new components that likely arose under the inferred evolutionary model. Application of CLIME to similar to 1,000 annotated human pathways and to the proteomes of yeast, red algae, and malaria reveals unanticipated evolutionary modularity and coevolving components. CLIME is freely available and should become increasingly powerful with the growing wealth of eukaryotic genomes.	[Li, Yang; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Li, Yang; Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Li, Yang; Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02141 USA; [Gutman, Roee] Brown Univ, Dept Biostat, Providence, RI 02912 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Brown University; Harvard University; Harvard Medical School	Liu, JS (corresponding author), Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.	jliu@stat.harvard.edu; vamsi@hms.harvard.edu	Gutman, Roee/J-2355-2014; /AAD-1516-2020	Gutman, Roee/0000-0001-7095-3016; 	NIH [GM0077465]; National Science Foundations [DMS-1007762, IIS-1017967]; Shenzhen Special Fund for Strategic Emerging Industry grant [ZD201111080127A]; Investigator of the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [1007762] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundations(National Science Foundation (NSF)); Shenzhen Special Fund for Strategic Emerging Industry grant; Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank Jagesh Shah for curation of cilia-related genes and Eran Mick and Daniel Arlow for manuscript feedback. This work was supported in part by grants from the NIH (GM0077465 to V.K.M.), National Science Foundations (DMS-1007762 and IIS-1017967 to J.S.L.), and the Shenzhen Special Fund for Strategic Emerging Industry grant (ZD201111080127A to J.S.L.). V.K.M. is an Investigator of the Howard Hughes Medical Institute.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; Barker D, 2007, BIOINFORMATICS, V23, P14, DOI 10.1093/bioinformatics/btl558; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bick AG, 2012, SCIENCE, V336, P886, DOI 10.1126/science.1214977; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; DORFMAN BZ, 1969, GENETICS, V61, P377; DOVEY HF, 1984, MOL BIOCHEM PARASIT, V11, P157, DOI 10.1016/0166-6851(84)90062-8; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Gabaldon T, 2005, EVOL BIOINFORM, V1, P51; Glazko GV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r32; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jamerson M, 2012, MICROBIOL-SGM, V158, P791, DOI 10.1099/mic.0.055020-0; Jim K, 2004, GENOME RES, V14, P109; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kensche PR, 2008, J R SOC INTERFACE, V5, P151, DOI 10.1098/rsif.2007.1047; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lim L, 2010, PHILOS T R SOC B, V365, P749, DOI 10.1098/rstb.2009.0273; Liu J.S., 2008, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-76371-2, DOI 10.1007/978-0-387-76371-2]; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Smith JC, 2005, J PROTEOME RES, V4, P909, DOI 10.1021/pr050013h; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Zhou Y, 2006, J MOL BIOL, V359, P1150, DOI 10.1016/j.jmb.2006.04.011	45	71	73	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					213	225		10.1016/j.cell.2014.05.034	http://dx.doi.org/10.1016/j.cell.2014.05.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995987	Bronze, Green Accepted			2022-12-24	WOS:000340943100019
J	Wang, XT; Ota, N; Manzanillo, P; Kates, L; Zavala-Solorio, J; Eidenschenk, C; Zhang, J; Lesch, J; Lee, WP; Ross, J; Diehl, L; van Bruggen, N; Kolumam, G; Ouyang, WJ				Wang, Xiaoting; Ota, Naruhisa; Manzanillo, Paolo; Kates, Lance; Zavala-Solorio, Jose; Eidenschenk, Celine; Zhang, Juan; Lesch, Justin; Lee, Wyne P.; Ross, Jed; Diehl, Lauri; van Bruggen, Nicholas; Kolumam, Ganesh; Ouyang, Wenjun			Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes	NATURE			English	Article							INDUCED INSULIN-RESISTANCE; FOOD-INTAKE; CITROBACTER-RODENTIUM; GUT MICROBIOME; PPAR-GAMMA; OBESITY; LEPTIN; CELLS; INFLAMMATION; MICE	The connection between an altered gut microbiota and metabolic disorders such as obesity, diabetes, and cardiovascular disease is well established(1,2). Defects in preserving the integrity of the mucosal barriers can result in systemic endotoxaemia that contributes to chronic low-grade inflammation, which further promotes the development ofmetabolic syndrome(3-5). Interleukin (IL)-22 exerts essential roles in eliciting antimicrobial immunity and maintaining mucosal barrier integrity within the intestine(6,7). Here we investigate the connection between IL-22 and metabolic disorders. We find that the induction of IL-22 from innate lymphoid cells and CD4(+) T cells is impaired in obese mice under various immune challenges, especially in the colon during infection with Citrobacter rodentium. While innate lymphoid cell populations are largely intact in obese mice, the upregulation of IL-23, a cytokine upstream of IL-22, is compromised during the infection. Consequently, these mice are susceptible to C. rodentium infection, and both exogenous IL-22 and IL-23 are able to restore the mucosal host defence. Importantly, we further unveil unexpected functions of IL-22 in regulating metabolism. Mice deficient in IL-22 receptor and fed with high-fat diet are prone to developing metabolic disorders. Strikingly, administration of exogenous IL-22 in genetically obese leptin-receptor-deficient (db/db) mice and mice fed with high-fat diet reverses many of the metabolic symptoms, including hyperglycaemia and insulin resistance. IL-22 shows diverse metabolic benefits, as it improves insulin sensitivity, preserves gut mucosal barrier and endocrine functions, decreases endotoxaemia and chronic inflammation, and regulates lipid metabolism in liver and adipose tissues. In summary, we identify the IL-22 pathway as a novel target for therapeutic intervention in metabolic diseases.	[Wang, Xiaoting; Ota, Naruhisa; Manzanillo, Paolo; Eidenschenk, Celine; Zhang, Juan; Lesch, Justin; Lee, Wyne P.; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Kates, Lance; Zavala-Solorio, Jose; Ross, Jed; van Bruggen, Nicholas; Kolumam, Ganesh] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA; [Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	kolumam@gene.com; ouyang@gene.com	Ouyang, Wenjun/ABA-8763-2020	Ouyang, Wenjun/0000-0002-1811-5864				Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guo X, 2011, MUCOSAL IMMUNOL, V4, P294, DOI 10.1038/mi.2010.76; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ortiz AA, 2007, J PHARMACOL EXP THER, V323, P692, DOI 10.1124/jpet.107.125211; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sham HP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003539; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Yang L, 2010, J HEPATOL, V53, P339, DOI 10.1016/j.jhep.2010.03.004; Yu YY, 2013, J IMMUNOL, V190, P3054, DOI 10.4049/jimmunol.1203275; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	37	282	305	6	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					237	+		10.1038/nature13564	http://dx.doi.org/10.1038/nature13564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119041				2022-12-24	WOS:000342663100044
J	Mulepati, S; Heroux, A; Bailey, S				Mulepati, Sabin; Heroux, Annie; Bailey, Scott			Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target	SCIENCE			English	Article							IN-VITRO RECONSTITUTION; IMMUNE-SYSTEM; THERMUS-THERMOPHILUS; INTERFERENCE COMPLEX; ANTIVIRAL DEFENSE; CAS SYSTEMS; DNA TARGET; CASCADE; PROTEIN; PROKARYOTES	In prokaryotes, RNA derived from type I and type III CRISPR loci direct large ribonucleoprotein complexes to destroy invading bacteriophage and plasmids. In Escherichia coli, this 405-kilodalton complex is called Cascade. We report the crystal structure of Cascade bound to a single-stranded DNA (ssDNA) target at a resolution of 3.03 angstroms. The structure reveals that the CRISPR RNA and target strands do not form a double helix but instead adopt an underwound ribbon-like structure. This noncanonical structure is facilitated by rotation of every sixth nucleotide out of the RNA-DNA hybrid and is stabilized by the highly interlocked organization of protein subunits. These studies provide insight into both the assembly and the activity of this complex and suggest a mechanism to enforce fidelity of target binding.	[Mulepati, Sabin; Bailey, Scott] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Heroux, Annie] Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; United States Department of Energy (DOE); Brookhaven National Laboratory	Bailey, S (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	scott.bailey@jhu.edu	Bailey, Scott/N-7248-2019		NIH [GM097330, P41GM103473, P41GM103393]; Office of Biological and Environmental Research of U.S. Department of Energy (DOE); Office of Basic Energy Sciences of U.S. Department of Energy (DOE); National Center for Research Resources [P41RR012408]; DOE Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P41GM103473, R01GM097330] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Biological and Environmental Research of U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Office of Basic Energy Sciences of U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. McMacken, B. Learn, J. Berger, D. Leahy, and J. Kavran for helpful discussions; J. Bosch for providing the tungsten clusters used in the soaking experiments; I. Mathews for help with data collection; and J. Kavran for critical reading of the manuscript. Supported by NIH grant GM097330 (S.B). Data for this study were measured at beamline X25 of the National Synchrotron Light Source (NSLS) and at beamlines 7-1, 11-1, and 12-2 of the Stanford Synchrotron Radiation Lightsource (SSRL). Funding for X25 comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the U.S. Department of Energy (DOE) and from National Center for Research Resources grant P41RR012408 and NIH grant P41GM103473. Use of the SSRL is supported by the DOE Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIH grant P41GM103393. The atomic coordinates and structure factors have been deposited into the Protein Data Bank with the accession code 4QYZ.	Agari Y, 2008, PROTEINS, V73, P1063, DOI 10.1002/prot.22224; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Heidrich N, 2013, MOL CELL, V52, P4, DOI 10.1016/j.molcel.2013.09.023; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Hrle A, 2013, RNA BIOL, V10, P1670, DOI 10.4161/rna.26500; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Koo Y, 2013, J MOL BIOL, V425, P3799, DOI 10.1016/j.jmb.2013.02.032; Kowalczykowski SC, 2008, NATURE, V453, P463, DOI 10.1038/453463a; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Mulepati S, 2012, J BIOL CHEM, V287, P22445, DOI 10.1074/jbc.C112.379503; Nam KH, 2012, FEBS LETT, V586, P3956, DOI 10.1016/j.febslet.2012.09.041; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Savir Y, 2010, MOL CELL, V40, P388, DOI 10.1016/j.molcel.2010.10.020; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	38	157	164	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1479	1484		10.1126/science.1256996	http://dx.doi.org/10.1126/science.1256996			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25123481	Green Accepted			2022-12-24	WOS:000341752900035
J	Fauci, AS				Fauci, Anthony S.			Ebola - Underscoring the Global Disparities in Health Care Resources	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.							[Anonymous], CHRON EB HEM FEV OUT; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Feldmann H, 2014, NEW ENGL J MED, V371, P1375, DOI 10.1056/NEJMp1405314; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8	5	114	122	1	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1084	1086		10.1056/NEJMp1409494	http://dx.doi.org/10.1056/NEJMp1409494			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9PI	25119491				2022-12-24	WOS:000341687300002
J	Li, B; Qiu, B; Lee, DSM; Walton, ZE; Ochocki, JD; Mathew, LK; Mancuso, A; Gade, TPF; Keith, B; Nissim, I; Simon, MC				Li, Bo; Qiu, Bo; Lee, David S. M.; Walton, Zandra E.; Ochocki, Joshua D.; Mathew, Lijoy K.; Mancuso, Anthony; Gade, Terence P. F.; Keith, Brian; Nissim, Itzhak; Simon, M. Celeste			Fructose-1,6-bisphosphatase opposes renal carcinoma progression	NATURE			English	Article							CELL CARCINOMA; IDENTIFICATION; METABOLISM; INACTIVATION; DISEASE	Clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer(1), is characterized by elevated glycogen levels and fat deposition(2). These consistent metabolic alterations are associated with normoxic stabilization of hypoxia-inducible factors (HIFs)3 secondary to von Hippel-Lindau (VHL) mutations that occur in over 90% of ccRCC tumours(4). However, kidney-specific VHL deletion in mice fails to elicit ccRCC-specific metabolic phenotypes and tumour formation(5), suggesting that additional mechanisms are essential. Recent large-scale sequencing analyses revealed the loss of several chromatin remodelling enzymes in a subset of ccRCC (these included polybromo-1, SET domain containing 2 and BRCA1 -associated protein-1, among others)(6-9), indicating that epigenetic perturbations are probably important contributors to the natural history of this disease. Here we used an integrative approach comprising pan-metabolomic profiling and metabolic gene set analysis and determined that the gluconeogenic enzyme fructose-1,6-bisphosphatase 1 (FBP1)(10) is uniformly depleted in over six hundred ccRCC tumours examined. Notably, the human FBP1 locus resides on chromosome 9q22, the loss of which is associated with poor prognosis for ccRCC patients". Our data further indicate that FBP1 inhibits ccRCC progression through two distinct mechanisms. First, FBP1 antagonizes glycolytic flux in renal tubular epithelial cells, the presumptive ccRCC cell of origin(12), thereby inhibiting a potential Warburg effect(13,14). Second, in pVHL (the protein encoded by the VHL gene)-deficient ccRCC cells, FBP1 restrains cell proliferation, glycolysis and the pentose phosphate pathway in a catalyticactivity-independent manner, by inhibiting nuclear HIF function via direct interaction with the HIF inhibitory domain. This unique dual function of the FBP1 protein explains its ubiquitous loss in ccRCC, distinguishing FBP1 from previously identified tumour suppressors that are not consistently mutated in all tumours(6,7,15).	[Li, Bo; Qiu, Bo; Lee, David S. M.; Walton, Zandra E.; Ochocki, Joshua D.; Mathew, Lijoy K.; Mancuso, Anthony; Keith, Brian; Simon, M. Celeste] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Lee, David S. M.; Mathew, Lijoy K.; Simon, M. Celeste] Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Walton, Zandra E.; Mancuso, Anthony; Keith, Brian] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Mancuso, Anthony; Gade, Terence P. F.] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Nissim, Itzhak] Univ Penn, Dept Pediat,Biochem & Biophys, Philadelphia, PA 19104 USA; [Nissim, Itzhak] Childrens Hosp Philadelphia, Div Child Dev & Metab Dis, Philadelphia, PA 19104 USA; [Simon, M. Celeste] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Simon, MC (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	Lorkiewicz, Pawel/A-2126-2011; Li, Bo/O-7127-2019; Simon, Celeste/AAG-3941-2021; Li, Bo/M-2192-2013; Li, Bo/Y-2835-2019	Lorkiewicz, Pawel/0000-0002-1755-9826; Li, Bo/0000-0002-7979-8339; Li, Bo/0000-0002-7979-8339; Lee, David/0000-0002-8821-9028; Qiu, Bo/0000-0003-4199-1659; Walton, Zandra/0000-0002-0465-0153	Howard Hughes Medical Institute, NIH Grant [CA104838, DK053761]; NATIONAL CANCER INSTITUTE [P01CA104838, F32CA192758, P30CA016520, F30CA177106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK053761, R01DK053761] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, NIH Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Daikhin, O. Horyn and Ilana Nissim for assistance with the isotopomer enrichment analysis in the Metabolomic Core facility, Children's Hospital of Philadelphia. We also thank J. Tobias for help with processing the TCGA RNA-sequencing data. This work was supported by the Howard Hughes Medical Institute, NIH Grant CA104838 to M.C.S. and DK053761 to I.N. M.C.S. is an Investigator of the Howard Hughes Medical Institute.	Asberg C, 2010, J INHERIT METAB DIS, V33, pS113, DOI 10.1007/s10545-009-9034-5; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Dondeti VR, 2012, CANCER RES, V72, P112, DOI 10.1158/0008-5472.CAN-11-1698; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Moore LE, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.14; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nissim I, 2012, BIOCHEM J, V444, P537, DOI 10.1042/BJ20120163; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Salway JG, 2004, METABOLISM GLANCE; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; Valera VA, 2011, NAT REV UROL, V8, P321, DOI 10.1038/nrurol.2011.64; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2	30	334	347	2	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					251	+		10.1038/nature13557	http://dx.doi.org/10.1038/nature13557			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043030	Green Accepted			2022-12-24	WOS:000341362800054
J	Yelshanskaya, MV; Li, MF; Sobolevsky, AI				Yelshanskaya, Maria V.; Li, Minfen; Sobolevsky, Alexander I.			Structure of an agonist-bound ionotropic glutamate receptor	SCIENCE			English	Article							LIGAND-BINDING DOMAIN; AMPA RECEPTOR; KAINATE RECEPTORS; CRYSTAL-STRUCTURE; DESENSITIZATION; ACTIVATION; MECHANISMS; IMPACT; DYNAMICS; SUBUNITS	Ionotropic glutamate receptors (iGluRs) mediate most excitatory neurotransmission in the central nervous system and function by opening their ion channel in response to binding of agonist glutamate. Here, we report a structure of a homotetrameric rat GluA2 receptor in complex with partial agonist (S)-5-nitrowillardiine. Comparison of this structure with the closed-state structure in complex with competitive antagonist ZK 200775 suggests conformational changes that occur during iGluR gating. Guided by the structures, we engineered disulfide cross-links to probe domain interactions that are important for iGluR gating events. The combination of structural information, kinetic modeling, and biochemical and electrophysiological experiments provides insight into the mechanism of iGluR gating.	[Yelshanskaya, Maria V.; Li, Minfen; Sobolevsky, Alexander I.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Sobolevsky, AI (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 West 168th St, New York, NY 10032 USA.	as4005@columbia.edu			National Institute of General Medical Sciences, NIH [P41 GM103403]; DOE Office of Science [DE-AC02-06CH11357]; NIH [NS083660]; Klingenstein Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, P41GM111244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083660] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the personnel at beamlines X4A, X4C, X25, and X29 of the National Synchrotron Light Source and at beamlines 24-ID-C and 24-ID-E of the Advanced Photon Source. 24-ID-C and 24-ID-E are the Northeastern Collaborative Access Team beamlines, which are supported by a grant from the National Institute of General Medical Sciences (P41 GM103403) from the NIH. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. We thank L. Wollmuth and R. Kazi for help in setting up electrophysiological experiments and K. Saotome for comments on the manuscript. This work was supported by the NIH (NS083660) and the Klingenstein Foundation (A. I. S.). Coordinates and structure factors have been deposited in the Protein Data Bank with accession numbers 4U4F for GluA2<INF>NOW</INF> and 4U4G for GluA2<INF>ZK</INF>.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmed AH, 2013, J BIOL CHEM, V288, P27658, DOI 10.1074/jbc.M113.495564; Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Black MD, 2005, PSYCHOPHARMACOLOGY, V179, P154, DOI 10.1007/s00213-004-2065-6; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Carbone AL, 2012, NEURON, V74, P845, DOI 10.1016/j.neuron.2012.04.020; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenwick MK, 2010, J BIOL CHEM, V285, P12334, DOI 10.1074/jbc.M109.086371; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; MacLean DM, 2011, J NEUROSCI, V31, P2136, DOI 10.1523/JNEUROSCI.4314-10.2011; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Midgett CR, 2012, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmol.2011.00056, 10.3389/fnmo1.2011.00056]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; PATNEAU DK, 1992, J NEUROSCI, V12, P595; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Poon K, 2011, MOL PHARMACOL, V80, P49, DOI 10.1124/mol.111.071688; Poon K, 2010, BIOPHYS J, V99, P1437, DOI 10.1016/j.bpj.2010.06.058; Postila PA, 2011, J CHEM INF MODEL, V51, P1037, DOI 10.1021/ci2000055; Ramaswamy S, 2012, J BIOL CHEM, V287, P43557, DOI 10.1074/jbc.M112.371815; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Yao YN, 2013, STRUCTURE, V21, P1788, DOI 10.1016/j.str.2013.07.011; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008	50	85	86	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1070	1074		10.1126/science.1256508	http://dx.doi.org/10.1126/science.1256508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25103407	Green Accepted			2022-12-24	WOS:000340870900045
J	Cory, RM; Ward, CP; Crump, BC; Kling, GW				Cory, Rose M.; Ward, Collin P.; Crump, Byron C.; Kling, George W.			Sunlight controls water column processing of carbon in arctic fresh waters	SCIENCE			English	Article							DISSOLVED ORGANIC-CARBON; PERMAFROST-CARBON; SURFACE WATERS; CLIMATE-CHANGE; HUMIC LAKE; MATTER; TUNDRA; CYCLE; CONSUMPTION; ATMOSPHERE	Carbon in thawing permafrost soils may have global impacts on climate change; however, the factors that control its processing and fate are poorly understood. The dominant fate of dissolved organic carbon (DOC) released from soils to inland waters is either complete oxidation to CO2 or partial oxidation and river export to oceans. Although both processes are most often attributed to bacterial respiration, we found that photochemical oxidation exceeds rates of respiration and accounts for 70 to 95% of total DOC processed in the water column of arctic lakes and rivers. At the basin scale, photochemical processing of DOC is about one-third of the total CO2 released from surface waters and is thus an important component of the arctic carbon budget.	[Cory, Rose M.; Ward, Collin P.] Univ Michigan, Ann Arbor, MI 48109 USA; [Crump, Byron C.] Oregon State Univ, Corvallis, OR 97331 USA; [Kling, George W.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Oregon State University; University of Michigan System; University of Michigan	Cory, RM (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	rmcory@umich.edu	Kling, George W/C-7867-2015; Cory, Rose M/C-4198-2016; Crump, Byron/ABF-3711-2020	Kling, George W/0000-0002-6349-8227; Crump, Byron/0000-0001-7062-1273; Ward, Collin/0000-0003-2979-0280	NSF [OPP 1023270/1022876, PLR 1107593, DEB-1147378/1347042, DEB-1026843, 455541, 1048361.]; Direct For Biological Sciences [1026843, 1147336] Funding Source: National Science Foundation; Directorate For Geosciences [1421603, 1107593] Funding Source: National Science Foundation; Division Of Environmental Biology [1347042] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1022876] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank K. Harrold, J. Dobkowski, S. Fortin, S. Michael, J. Olsen, B. Papworth, A. Clinger, A. Rocha, W. Eugster, and researchers and technicians of the Toolik Lake Arctic LTER and Toolik Lake Field Station (GIS, R. Fulweber, J. Stuckey) for assistance. Supported by NSF grants OPP 1023270/1022876, PLR 1107593, and DEB-1147378/1347042. The data set provided by the Arctic Long Term Ecological Research Program (table S1) was supported by NSF grant DEB-1026843. The data set provided by the Toolik Field Station Environmental Data Center (table S1) was supported by NSF grants 455541 and 1048361. Other experimental data are presented in the supplementary materials.	Amon RMW, 1996, GEOCHIM COSMOCHIM AC, V60, P1783, DOI 10.1016/0016-7037(96)00055-5; Amon RMW, 2004, MAR CHEM, V92, P311, DOI 10.1016/j.marchem.2004.06.034; Andrews SS, 2000, LIMNOL OCEANOGR, V45, P267, DOI 10.4319/lo.2000.45.2.0267; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Belanger S, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002708; Berggren M, 2012, ISME J, V6, P984, DOI 10.1038/ismej.2011.157; Carignan R, 2000, LIMNOL OCEANOGR, V45, P189, DOI 10.4319/lo.2000.45.1.0189; COLE JJ, 1994, SCIENCE, V265, P1568, DOI 10.1126/science.265.5178.1568; Cory RM, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000343; Cory RM, 2013, P NATL ACAD SCI USA, V110, P3429, DOI 10.1073/pnas.1214104110; Graneli W, 1996, LIMNOL OCEANOGR, V41, P698, DOI 10.4319/lo.1996.41.4.0698; Hobbie J. E., 2014, CHANGING ARCTIC ECOL; Hobbie J. E., 1980, LIMNOLOGY TUNDRA PON; Judd KE, 2007, AQUAT SCI, V69, P96, DOI 10.1007/s00027-006-0908-4; KLING GW, 1991, SCIENCE, V251, P298, DOI 10.1126/science.251.4991.298; Koehler B., 2014, GLOBAL BIOGEOCHEM CY; MacDougall AH, 2012, NAT GEOSCI, V5, P719, DOI [10.1038/ngeo1573, 10.1038/NGEO1573]; Mann PJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001798; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; Molot LA, 1997, GLOBAL BIOGEOCHEM CY, V11, P357, DOI 10.1029/97GB01198; Pace Michael L., 2005, P103, DOI 10.1093/acprof:oso/9780198527084.003.0007; RAMLAL PS, 1994, BIOGEOCHEMISTRY, V24, P145; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Reader HE, 2014, LIMNOL OCEANOGR, V59, P182, DOI 10.4319/lo.2014.59.1.0182; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Tranvik LJ, 2001, ECOL LETT, V4, P458, DOI 10.1046/j.1461-0248.2001.00245.x; Vahatalo AV, 2000, LIMNOL OCEANOGR, V45, P664; Vahatalo AV, 2003, ARCH HYDROBIOL, V156, P287, DOI 10.1127/0003-9136/2003/0156-0287; Vallieres C, 2008, J MARINE SYST, V74, P756, DOI 10.1016/j.jmarsys.2007.12.002; Vonk JE, 2013, NAT GEOSCI, V6, P675, DOI 10.1038/ngeo1937; White EM, 2010, MAR CHEM, V118, P11, DOI 10.1016/j.marchem.2009.10.001; Zhang Y, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007284	36	315	326	28	419	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					925	928		10.1126/science.1253119	http://dx.doi.org/10.1126/science.1253119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146289				2022-12-24	WOS:000340524700045
J	Muller, NZ				Muller, Nicholas Z.			ECONOMICS Boosting GDP growth by accounting for the environment	SCIENCE			English	Editorial Material									[Muller, Nicholas Z.] Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA; [Muller, Nicholas Z.] Middlebury Coll, Environm Studies Program, Middlebury, VT 05753 USA; [Muller, Nicholas Z.] Natl Bur Econ Res, Cambridge, MA 02138 USA	National Bureau of Economic Research	Muller, NZ (corresponding author), Middlebury Coll, Dept Econ, Middlebury, VT 05753 USA.	nmuller@middlebury.edu						Abraham KG, 2006, STUD INCOME, V66, P161; Banzhaf HS, 2004, RESOUR ENERGY ECON, V26, P317, DOI 10.1016/j.reseneeco.2003.10.002; Bartelmus P, 2009, ECOL ECON, V68, P1850, DOI 10.1016/j.ecolecon.2008.12.011; Muller N. Z., 2014, NBER BOOK S IN PRESS; Muller NZ, 2011, AM ECON REV, V101, P1649, DOI 10.1257/aer.101.5.1649; Muller NZ, 2011, BE J ECON ANAL POLI, V11, DOI 10.2202/1935-1682.2925; National Academy of Sciences National Research Council, 2010, HIDD COSTS EN UNPR C; Nordhaus W.D., 1999, NAT NUMB EXP US NAT; Nordhaus W. D., 2006, NEW ARCHITECTURE US, V66; United States Department of Energy Energy Information Administration, 2013, 2013 MONTHL EN REV T; United States Environmental Protection Agency, 1999, 410R99001 EPA; United States Office of Management and Budget, 2013, 12866 US OFF MAN BUD	12	39	39	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					873	874		10.1126/science.1253506	http://dx.doi.org/10.1126/science.1253506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN3YL	25146270				2022-12-24	WOS:000340524700021
J	Bingel, U				Bingel, Ulrike			Avoiding Nocebo Effects to Optimize Treatment Outcome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Duisburg Essen, Dept Neurol, Univ Hosp Essen, D-45147 Essen, Germany	University of Duisburg Essen	Bingel, U (corresponding author), Univ Duisburg Essen, Dept Neurol, Univ Hosp Essen, Hufelandstr 55, D-45147 Essen, Germany.	ulrike.bingel@uk-essen.de						Benedetti F, 2014, PAIN, V155, P921, DOI 10.1016/j.pain.2014.01.016; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Colloca L, 2012, JAMA-J AM MED ASSOC, V307, P567, DOI 10.1001/jama.2012.115; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Faasse K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5613; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Kessner S, 2013, JAMA INTERN MED, V173, P1468, DOI 10.1001/jamainternmed.2013.6705; Rief W, 2006, ARCH INTERN MED, V166, P155, DOI 10.1001/archinte.166.2.155; Varelmann D, 2010, ANESTH ANALG, V110, P868, DOI 10.1213/ANE.0b013e3181cc5727	9	113	114	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					693	694		10.1001/jama.2014.8342	http://dx.doi.org/10.1001/jama.2014.8342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25003609				2022-12-24	WOS:000340438700013
J	Lu, JT; Campeau, PM; Lee, BH				Lu, James T.; Campeau, Philippe M.; Lee, Brendan H.			Genotype-Phenotype Correlation - Promiscuity in the Era of Next-Generation Sequencing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[Lu, James T.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lu, James T.] Baylor Coll Med, Dept Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lee, Brendan H.] Howard Hughes Med Inst, Houston, TX 77030 USA; [Campeau, Philippe M.] Univ Montreal, Hop St Justine, Dept Pediat, Med Genet Serv, Montreal, PQ H3T 1C5, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Universite de Montreal	Lu, JT (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.		Campeau, Philippe/J-8614-2015	Campeau, Philippe/0000-0001-9713-7107				Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	5	62	63	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					593	596		10.1056/NEJMp1400788	http://dx.doi.org/10.1056/NEJMp1400788			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZL	25119605	Green Published			2022-12-24	WOS:000340819600004
J	Millard, C; Brhlikova, P; Pollock, AM				Millard, Colin; Brhlikova, Petra; Pollock, Allyson M.			Commentary: Evidence versus influence in the WHO procedure for approving essential medicines: misoprostol for maternal health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTPARTUM HEMORRHAGE		[Millard, Colin; Brhlikova, Petra; Pollock, Allyson M.] Univ London, Global Hlth Policy & Innovat Unit, London, England	University of London	Millard, C (corresponding author), Univ London, Global Hlth Policy & Innovat Unit, London, England.	colin.millard@qmul.ac.uk		Brhlikova, Petra/0000-0003-2085-0304; pollock, allyson/0000-0002-7388-3110				Chu CS, 2012, J ROY SOC MED, V105, P336, DOI 10.1258/jrsm.2012.120044; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Gynuity Health Projects, MIS POSTP HEM MOV RE; Hofmeyr GJ, 2013, COCHRANE DB SYST REV, V7; Hoj L, 2005, BMJ-BRIT MED J, V331, P723, DOI 10.1136/bmj.331.7519.723; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Mobeen N, 2011, BJOG-INT J OBSTET GY, V118, P353, DOI 10.1111/j.1471-0528.2010.02807.x; Pollock AM, 2013, BJOG, V120, P287; Starrs A, 2012, INT J GYNECOL OBSTET, V116, P1, DOI 10.1016/j.ijgo.2011.10.005; Tuncalp O, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000494.pub4; Venture Strategies Innovations, 2009, REACH WOM THEY AR; Venture Strategies Innovations, 2011, CONN WOM CAR; Walraven G, 2005, BJOG-INT J OBSTET GY, V112, P1277, DOI 10.1111/j.1471-0528.2005.00711.x; WHO, 2012, SEL US ESS MED REP W; WHO Expert Committee on the Selection and Use of Essential Medicines, 2009, SEL US ESS MED REP W; World Health Organization, ESS MED SEL	16	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2014	349								g4823	10.1136/bmj.g4823	http://dx.doi.org/10.1136/bmj.g4823			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NW	25081251				2022-12-24	WOS:000339907800003
J	Desai, SA; Miller, LH				Desai, Sanjay A.; Miller, Louis H.			MALARIA Protein-export pathway illuminated	NATURE			English	Editorial Material							PLASMODIUM-FALCIPARUM; HOST ERYTHROCYTES; VIRULENCE; PARASITES; MEMBRANE; REVEALS; CHANNEL; PTEX		[Desai, Sanjay A.; Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Desai, SA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	sdesai@niaid.nih.gov; lmiller@niaid.nih.gov		Desai, Sanjay/0000-0003-2150-2483	Intramural NIH HHS [ZIA AI000882-13] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000882, ZIAAI000241] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Gehde N, 2009, MOL MICROBIOL, V71, P613, DOI 10.1111/j.1365-2958.2008.06552.x; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Papakrivos J, 2005, MOL MICROBIOL, V55, P1272, DOI 10.1111/j.1365-2958.2004.04468.x; Pesce E.-R., 2014, PARASITOLOGY; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084	16	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					541	542		10.1038/nature13646	http://dx.doi.org/10.1038/nature13646			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043009	Green Accepted			2022-12-24	WOS:000339566300023
J	Marx, V				Marx, Vivien			STOP THE MICROBIAL CHATTER	NATURE			English	Editorial Material							IDENTIFICATION; BACTERIA											Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Hastings JW, 1999, J BACTERIOL, V181, P2667, DOI 10.1128/JB.181.9.2667-2668.1999; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100	8	13	14	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					493	497		10.1038/511493a	http://dx.doi.org/10.1038/511493a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056065	Bronze			2022-12-24	WOS:000339335700052
J	Sydeman, WJ; Garcia-Reyes, M; Schoeman, DS; Rykaczewski, RR; Thompson, SA; Black, BA; Bograd, SJ				Sydeman, W. J.; Garcia-Reyes, M.; Schoeman, D. S.; Rykaczewski, R. R.; Thompson, S. A.; Black, B. A.; Bograd, S. J.			Climate change and wind intensification in coastal upwelling ecosystems	SCIENCE			English	Article							CALIFORNIA CURRENT; TRENDS; FUTURE	In 1990, Andrew Bakun proposed that increasing greenhouse gas concentrations would force intensification of upwelling-favorable winds in eastern boundary current systems that contribute substantial services to society. Because there is considerable disagreement about whether contemporary wind trends support Bakun's hypothesis, we performed a meta-analysis of the literature on upwelling-favorable wind intensification. The preponderance of published analyses suggests that winds have intensified in the California, Benguela, and Humboldt upwelling systems and weakened in the Iberian system over time scales ranging up to 60 years; wind change is equivocal in the Canary system. Stronger intensification signals are observed at higher latitudes, consistent with the warming pattern associated with climate change. Overall, reported changes in coastal winds, although subtle and spatially variable, support Bakun's hypothesis of upwelling intensification in eastern boundary current systems.	[Sydeman, W. J.; Garcia-Reyes, M.; Thompson, S. A.] Farallon Inst Adv Ecosyst Res, Petaluma, CA 94952 USA; [Schoeman, D. S.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld 4558, Australia; [Rykaczewski, R. R.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Rykaczewski, R. R.] Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA; [Thompson, S. A.] Univ Washington, Climate Impacts Grp, Seattle, WA 98195 USA; [Black, B. A.] Univ Texas Richardson, Inst Marine Sci, Port Aransas, TX 78373 USA; [Bograd, S. J.] NOAA, Environm Res Div, Southwest Fisheries Sci Ctr, Pacific Grove, CA 93950 USA	University of the Sunshine Coast; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Dallas; National Oceanic Atmospheric Admin (NOAA) - USA	Sydeman, WJ (corresponding author), Farallon Inst Adv Ecosyst Res, Suite Q,101 H St, Petaluma, CA 94952 USA.	wsydeman@comcast.net	Bograd, Steven/AAA-4824-2021; Rykaczewski, Ryan/A-8625-2016; Black, Bryan/A-7057-2009	Rykaczewski, Ryan/0000-0001-8893-872X; Black, Bryan/0000-0001-6851-257X; Schoeman, David/0000-0003-1258-0885	NSF [1130125]; NOAA's Environmental Research Division; Australian Research Council's Collaborative Research Network; Directorate For Geosciences [1026607] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NOAA's Environmental Research Division; Australian Research Council's Collaborative Research Network(Australian Research Council); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support for this study was provided by NSF award no. 1130125, NOAA's Environmental Research Division, and donors to the Farallon Institute. D.S. was supported by the Australian Research Council's Collaborative Research Network. The data reported in this paper are tabulated in the supplementary materials; electronic files of the tabulated data are available upon request from the senior author and at www.faralloninstitute.org.	BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Barton ED, 2013, PROG OCEANOGR, V116, P167, DOI 10.1016/j.pocean.2013.07.007; Baumann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067596; Black BA, 2011, GLOBAL CHANGE BIOL, V17, P2536, DOI 10.1111/j.1365-2486.2011.02422.x; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Botsford LW, 2006, DEEP-SEA RES PT II, V53, P3116, DOI 10.1016/j.dsr2.2006.07.011; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Cropper TE, 2014, DEEP-SEA RES PT I, V86, P94, DOI 10.1016/j.dsr.2014.01.007; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Hakkinen S, 2011, SCIENCE, V334, P655, DOI 10.1126/science.1205683; Kahru M, 2012, DEEP-SEA RES PT II, V77-80, P89, DOI 10.1016/j.dsr2.2012.04.007; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Narayan N, 2010, OCEAN SCI, V6, P815, DOI 10.5194/os-6-815-2010; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Schroeder ID, 2009, MAR ECOL PROG SER, V393, P211, DOI 10.3354/meps08103; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; Thomas BR, 2008, INT J CLIMATOL, V28, P747, DOI 10.1002/joc.1570; Visbeck, 2003, GEOPHYS MONOGR SER, V134, P1, DOI [DOI 10.1029/134GM01, 10.1029/134GM01]; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270	25	334	348	16	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					77	80		10.1126/science.1251635	http://dx.doi.org/10.1126/science.1251635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994651				2022-12-24	WOS:000338284400053
J	Geary, C; Rothemund, PWK; Andersen, ES				Geary, Cody; Rothemund, Paul W. K.; Andersen, Ebbe S.			A single-stranded architecture for cotranscriptional folding of RNA nanostructures	SCIENCE			English	Article							DNA NANOSTRUCTURES; COMPLEX; DESIGN; ACID; NANOTECHNOLOGY; ASSEMBLIES; JUNCTIONS; SEQUENCE; SHAPES; FORM	Artificial DNA and RNA structures have been used as scaffolds for a variety of nanoscale devices. In comparison to DNA structures, RNA structures have been limited in size, but they also have advantages: RNA can fold during transcription and thus can be genetically encoded and expressed in cells. We introduce an architecture for designing artificial RNA structures that fold from a single strand, in which arrays of antiparallel RNA helices are precisely organized by RNA tertiary motifs and a new type of crossover pattern. We constructed RNA tiles that assemble into hexagonal lattices and demonstrated that lattices can be made by annealing and/or cotranscriptional folding. Tiles can be scaled up to 660 nucleotides in length, reaching a size comparable to that of large natural ribozymes.	[Geary, Cody; Andersen, Ebbe S.] Aarhus Univ, Ctr DNA Nanotechnol, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark; [Geary, Cody; Andersen, Ebbe S.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Rothemund, Paul W. K.] CALTECH, Pasadena, CA 91125 USA	Aarhus University; Aarhus University; California Institute of Technology	Andersen, ES (corresponding author), Aarhus Univ, Ctr DNA Nanotechnol, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark.	esa@inano.au.dk	Geary, Cody/L-7685-2019; Andersen, Ebbe S/O-3936-2014	Andersen, Ebbe S/0000-0002-6236-8164; Geary, Cody/0000-0003-2083-4259	Danish Council for Independent Research (Sapere Aude Starting Grant) [DFF-0602-01772]; Danish National Research Foundation funding Centre for DNA Nanotechnology [DNRF81]; U.S. National Science Foundation for Expeditions in Computing [0832824]; Army Research Office [W911NF-11-1-0117]	Danish Council for Independent Research (Sapere Aude Starting Grant); Danish National Research Foundation funding Centre for DNA Nanotechnology; U.S. National Science Foundation for Expeditions in Computing; Army Research Office	The authors thank E. Winfree and M. Dong for use of their AFM facilities. We acknowledge financial support from the Danish Council for Independent Research (Sapere Aude Starting Grant DFF-0602-01772), the Danish National Research Foundation funding Centre for DNA Nanotechnology (grant DNRF81, http://cdna.au.dk/), the U.S. National Science Foundation for Expeditions in Computing funding for the Molecular Programming Project (grant nos. 0832824 and 1317694, http://molecular-programming.org), and Army Research Office award W911NF-11-1-0117. C. G., P. W. K. R., and E. S. A planned experiments and wrote the paper together. C. G. performed all experiments. The authors declare no competing financial interests.	Afonin KA, 2010, NAT NANOTECHNOL, V5, P676, DOI [10.1038/NNANO.2010.160, 10.1038/nnano.2010.160]; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; ARNOTT S, 1973, J MOL BIOL, V81, P107, DOI 10.1016/0022-2836(73)90183-6; Bai XC, 2012, P NATL ACAD SCI USA, V109, P20012, DOI 10.1073/pnas.1215713109; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; DICKERSON RE, 1982, SCIENCE, V216, P475, DOI 10.1126/science.7071593; Ennifar E, 2001, NAT STRUCT BIOL, V8, P1064, DOI 10.1038/nsb727; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Geary C, 2011, NUCLEIC ACIDS RES, V39, P1066, DOI 10.1093/nar/gkq748; Grabow Wade, 2013, F1000Prime Rep, V5, P46, DOI 10.12703/P5-46; Grabow WW, 2014, ACCOUNTS CHEM RES, V47, P1871, DOI 10.1021/ar500076k; Grabow WW, 2011, NANO LETT, V11, P878, DOI 10.1021/nl104271s; Guo PX, 1998, MOL CELL, V2, P149, DOI 10.1016/S1097-2765(00)80124-0; Hamada S, 2009, ANGEW CHEM INT EDIT, V48, P6820, DOI 10.1002/anie.200902662; Heilman-Miller SL, 2003, RNA, V9, P722, DOI 10.1261/rna.5200903; Hochrein LM, 2013, J AM CHEM SOC, V135, P17322, DOI 10.1021/ja404676x; Horiya S, 2003, CHEM BIOL, V10, P645, DOI 10.1016/S1074-5521(03)00146-7; Isambert H, 2009, METHODS, V49, P189, DOI 10.1016/j.ymeth.2009.06.005; Jaeger L, 2000, ANGEW CHEM INT EDIT, V39, P2521, DOI 10.1002/1521-3773(20000717)39:14<2521::AID-ANIE2521>3.0.CO;2-P; Jaeger L, 2006, CURR OPIN STRUC BIOL, V16, P531, DOI 10.1016/j.sbi.2006.07.001; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Kasprzak W, 2011, METHODS, V54, P239, DOI 10.1016/j.ymeth.2010.12.010; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Lee AJ, 1998, STRUCTURE, V6, P993, DOI 10.1016/S0969-2126(98)00101-4; Lee J, 2014, P NATL ACAD SCI USA, V111, P2122, DOI 10.1073/pnas.1313039111; Li Z, 2009, J AM CHEM SOC, V131, P13093, DOI 10.1021/ja903768f; Lin CX, 2008, P NATL ACAD SCI USA, V105, P17626, DOI 10.1073/pnas.0805416105; MOLINARO M, 1995, NUCLEIC ACIDS RES, V23, P3056, DOI 10.1093/nar/23.15.3056; Ohno H, 2011, NAT NANOTECHNOL, V6, P115, DOI 10.1038/nnano.2010.268; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Severcan I, 2010, NAT CHEM, V2, P772, DOI [10.1038/nchem.733, 10.1038/NCHEM.733]; Severcan I, 2009, NANO LETT, V9, P1270, DOI 10.1021/nl900261h; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Sun XP, 2009, J AM CHEM SOC, V131, P13248, DOI 10.1021/ja906475w; Tanaka Y, 1999, NUCLEIC ACIDS RES, V27, P949, DOI 10.1093/nar/27.4.949; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	47	207	221	3	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					799	804		10.1126/science.1253920	http://dx.doi.org/10.1126/science.1253920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124436				2022-12-24	WOS:000340593100041
J	Heath, I; Evans, S; Furberg, C; Hippisley-Cox, J; Krumholz, H; Mulrow, C; Wicks, P				Heath, Iona; Evans, Stephen; Furberg, Curt; Hippisley-Cox, Julia; Krumholz, Harlan; Mulrow, Cynthia; Wicks, Paul			Report of the independent panel considering the retraction of two articles in The BMJ	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BONE MORPHOGENETIC PROTEIN-2; PRIMARY PREVENTION; STATINS; SAFETY; FUSION; RISK		[Heath, Iona] Royal Coll Gen Practitioners, London, England; [Evans, Stephen] London Sch Hyg & Trop Med, London, England; [Furberg, Curt] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Hippisley-Cox, Julia] Univ Nottingham, Nottingham NG7 2RD, England; [Krumholz, Harlan] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Wicks, Paul] Patients Like Me, Cambridge, MA USA	University of London; London School of Hygiene & Tropical Medicine; Wake Forest University; University of Nottingham; Yale University	Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.		Wicks, Paul/C-6128-2011; Hippisley-Cox, Julia/AAY-2788-2020; , Harlan/AAI-2875-2020	Wicks, Paul/0000-0002-2293-9284; Hippisley-Cox, Julia/0000-0002-2479-7283; Evans, Stephen/0000-0002-1474-2596				Abramson JD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3329; Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Buettner C, 2008, J GEN INTERN MED, V23, P1182, DOI 10.1007/s11606-008-0636-7; Committee on Publication Ethics, 2009, RETR GUID; Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006; Malhotra A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3332; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Mansi I, 2013, BMJ-BRIT MED J, V173, P1; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; MRC/BHF Heart Protection Study Collaborative Group, 2009, BMC Clin Pharmacol, V9, P6, DOI 10.1186/1472-6904-9-6; Prasad V, 2014, ANN INTERN MED, V160, P867, DOI 10.7326/M13-2974; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Takhar A., 2013, BMJ; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Turchin A, 2014, BMJ; Zhang HB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3652; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	23	4	4	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2014	349								g5176	10.1136/bmj.g5176	http://dx.doi.org/10.1136/bmj.g5176			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RZ	25128486	Green Accepted			2022-12-24	WOS:000340507500004
J	Jones, I; Shakespeare, J				Jones, Ian; Shakespeare, Judy			EASILY MISSED? Postnatal depression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTPARTUM WOMEN		[Jones, Ian] Cardiff Univ, Natl Ctr Mental Hlth, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales; [Shakespeare, Judy] Royal Coll Gen Practitioners, London, England	Cardiff University	Jones, I (corresponding author), Cardiff Univ, Natl Ctr Mental Hlth, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales.	jonesir1@cf.ac.uk	Jones, Ian R/B-4925-2009	Jones, Ian R/0000-0001-5821-5889	Medical Research Council [MR/L010305/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Berle JO, 2011, CURR WOMENS HEALTH R, V7, P28, DOI 10.2174/157340411794474784; Di Florio A, POSTPARTUM DEPRESSIO; Di Florio A, 2013, JAMA PSYCHIAT, V70, P168, DOI 10.1001/jamapsychiatry.2013.279; Jones I, 2009, ADV PSYCHIAT TREAT, V15, P411, DOI [10.1192/apt.bp.107.004333, DOI 10.1192/apt.bp.107.004333]; Jones I, 2010, OXFORD TEXTBOOK OF W; Musters C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a736; National Institute for Health and Care Excellence, 2007, ANTENATAL AND POSTNA; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Scottish Intercollegiate Guidelines Network (SIGN), 2012, MANAGEMENT OF PERINA; Sharma V, 2008, BIPOLAR DISORD, V10, P742, DOI 10.1111/j.1399-5618.2008.00606.x; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Wisner KL, 2013, JAMA PSYCHIAT, V70, P490, DOI 10.1001/jamapsychiatry.2013.87	12	2	2	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2014	349								g4500	10.1136/bmj.g4500	http://dx.doi.org/10.1136/bmj.g4500			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RX	25125284				2022-12-24	WOS:000340507300002
J	Richardson, SS; Daniels, CR; Gillman, MW; Golden, J; Kukla, R; Kuzawa, C; Rich-Edwards, J				Richardson, Sarah S.; Daniels, Cynthia R.; Gillman, Matthew W.; Golden, Janet; Kukla, Rebecca; Kuzawa, Christopher; Rich-Edwards, Janet			Don't blame the mothers	NATURE			English	Editorial Material							PREGNANCY		Harvard Univ, Cambridge, MA 02138 USA; [Daniels, Cynthia R.] Rutgers State Univ, New Brunswick, NJ 08903 USA; [Gillman, Matthew W.] Harvard Univ, Sch Med, Obes Prevent Program, Boston, MA USA; [Golden, Janet] Rutgers State Univ, Camden, NJ 08102 USA; [Kukla, Rebecca] Georgetown Univ, Washington, DC USA; [Kukla, Rebecca] Northwestern Univ, Evanston, IL USA; [Rich-Edwards, Janet] Harvard Univ, Sch Med, Connors Ctr Womens Hlth & Gender Biol, Boston, MA USA	Harvard University; Rutgers State University New Brunswick; Harvard University; Harvard Medical School; Rutgers State University Camden; Rutgers State University New Brunswick; Georgetown University; Northwestern University; Harvard University; Harvard Medical School	Richardson, SS (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	srichard@fas.harvard.edu						Barker D, 2013, NATURE, V504, P209, DOI 10.1038/504209a; de Assis S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2058; Frank DA, 2001, JAMA-J AM MED ASSOC, V285, P1613, DOI 10.1001/jama.285.12.1613; KASKUTAS L, 1992, DRUG ALCOHOL DEPEN, V31, P1, DOI 10.1016/0376-8716(92)90002-T; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1180, DOI 10.1111/j.1471-0528.2012.03393.x; Parboosing R, 2013, JAMA PSYCHIAT, V70, P677, DOI 10.1001/jamapsychiatry.2013.896; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622	7	137	137	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					131	132		10.1038/512131a	http://dx.doi.org/10.1038/512131a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM9KO	25119222	Bronze			2022-12-24	WOS:000340200700009
J	Fontana, L; Kennedy, BK; Longo, VD				Fontana, Luigi; Kennedy, Brian K.; Longo, Valter D.			Prepare for human testing	NATURE			English	Editorial Material									[Fontana, Luigi] Washington Univ, St Louis, MO 63130 USA; [Fontana, Luigi] Univ Brescia, I-25121 Brescia, Italy; [Kennedy, Brian K.] Buck Inst Res Aging, Novato, CA USA; [Longo, Valter D.] Univ So Calif, Longev Inst, Los Angeles, CA USA	Washington University (WUSTL); University of Brescia; Buck Institute for Research on Aging; University of Southern California	Fontana, L (corresponding author), Washington Univ, St Louis, MO 63130 USA.	fontana.luigi@gmail.com		Fontana, Luigi/0000-0001-8500-5537; Kennedy, Brian/0000-0002-5754-1874					0	158	168	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					405	406		10.1038/511405a	http://dx.doi.org/10.1038/511405a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL7SO	25056047	Bronze			2022-12-24	WOS:000339335700021
J	Neuman, MD; Rosenbaum, PR; Ludwig, JM; Zubizarreta, JR; Silber, JH				Neuman, Mark D.; Rosenbaum, Paul R.; Ludwig, Justin M.; Zubizarreta, Jose R.; Silber, Jeffrey H.			Anesthesia Technique, Mortality, and Length of Stay After Hip Fracture Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENERAL-ANESTHESIA; ELDERLY-PATIENTS; POSTOPERATIVE DELIRIUM; CONFIDENCE-INTERVALS; SENSITIVITY-ANALYSIS; BIAS REDUCTION; OUTCOMES; CARE; ASSOCIATION; INSTRUMENT	IMPORTANCE More than 300 000 hip fractures occur each year in the United States. Recent practice guidelines have advocated greater use of regional anesthesia for hip fracture surgery. OBJECTIVE To test the association of regional (ie, spinal or epidural) anesthesia vs general anesthesia with 30-day mortality and hospital length of stay after hip fracture. DESIGN, SETTING, AND PATIENTS We conducted a matched retrospective cohort study involving patients 50 years or older who were undergoing surgery for hip fracture at general acute care hospitals in New York State between July 1, 2004, and December 31, 2011. Our main analysis was a near-far instrumental variable match that paired patients who lived at different distances from hospitals that specialized in regional or general anesthesia. Supplementary analyses included a within-hospital match that paired patients within the same hospital and an across-hospital match that paired patients at different hospitals. EXPOSURES Spinal or epidural anesthesia; general anesthesia. MAIN OUTCOMES AND MEASURES Thirty-day mortality and hospital length of stay. Because the distribution of length of stay had long tails, we characterized this outcome using the Huber M estimate with Huber weights, a robust estimator similar to a trimmed mean. RESULTS Of 56 729 patients, 15 904 (28%) received regional anesthesia and 40 825 (72%) received general anesthesia. Overall, 3032 patients (5.3%) died. The M estimate of the length of stay was 6.2 days (95% CI, 6.2 to 6.2). The near-far matched analysis showed no significant difference in 30-day mortality by anesthesia type among the 21 514 patients included in this match: 583 of 10 757 matched patients (5.4%) who lived near a regional anesthesia-specialized hospital died vs 629 of 10 757 matched patients (5.8%) who lived near a general anesthesia-specialized hospital (instrumental variable estimate of risk difference, -1.1%; 95% CI, -2.8 to 0.5; P = .20). Supplementary analyses of within and across hospital patient matches yielded mortality findings to be similar to the main analysis. In the near-far match, regional anesthesia was associated with a 0.6-day shorter length of stay than general anesthesia (95% CI, -0.8 to -0.4, P < .001). Supplementary analyses also showed regional anesthesia to be associated with shorter length of stay, although the observed association was smaller in magnitude than in the main analysis. CONCLUSIONS AND RELEVANCE Among adults in acute care hospitals in New York State undergoing hip repair, the use of regional anesthesia compared with general anesthesia was not associated with lower 30-day mortality but was associated with a modestly shorter length of stay. These findings do not support a mortality benefit for regional anesthesia in this setting.	[Neuman, Mark D.; Silber, Jeffrey H.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Neuman, Mark D.; Rosenbaum, Paul R.; Silber, Jeffrey H.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Rosenbaum, Paul R.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Ludwig, Justin M.; Silber, Jeffrey H.] Childrens Hosp Philadelphia, Ctr Outcomes Res, Philadelphia, PA USA; [Zubizarreta, Jose R.] Columbia Business Sch, Div Decis Risk & Operat, New York, NY USA; [Zubizarreta, Jose R.] Columbia Univ, Dept Stat, New York, NY USA; [Silber, Jeffrey H.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Neuman, MD (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, 1119 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	neumanm@mail.med.upenn.edu	Rosenbaum, Paul R/H-8687-2012		Foundation for Anesthesia Education and Research; National Institute on Aging [1K08AG043548]; National Science Foundation [1260782]; NATIONAL INSTITUTE ON AGING [K08AG043548] Funding Source: NIH RePORTER	Foundation for Anesthesia Education and Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants to MDN from the Foundation for Anesthesia Education and Research and 1K08AG043548 from the National Institute on Aging (Dr Neuman) and by grant 1260782 the from the National Science Foundation, (Dr Rosenbaum).	Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Baiocchi M, 2012, HEALTH SERV OUTCOME, V12, P237, DOI 10.1007/s10742-012-0091-0; Baiocchi M, 2010, J AM STAT ASSOC, V105, P1285, DOI 10.1198/jasa.2010.ap09490; BERGGREN D, 1987, ANESTH ANALG, V66, P497; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; Boulton C, 2014, NATL HIP FRACTURE DA; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; DAVIS FM, 1987, BRIT J ANAESTH, V59, P561, DOI 10.1093/bja/59.5.561; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Foss NB, 2005, ANESTHESIOLOGY, V102, P1197, DOI 10.1097/00000542-200506000-00020; Griffiths R, 2012, ANAESTHESIA, V67, P85, DOI 10.1111/j.1365-2044.2011.06957.x; Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Huber PJ, 1981, ROBUST STAT; Imbens GW, 2005, J ROY STAT SOC A STA, V168, P109, DOI 10.1111/j.1467-985X.2004.00339.x; Lee HB, 2011, J AM GERIATR SOC, V59, P2306, DOI 10.1111/j.1532-5415.2011.03725.x; Lorch SA, 2012, PEDIATRICS, V130, P270, DOI 10.1542/peds.2011-2820; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Maritz J. S., 1995, DISTRIBUTION FREE ST, V2nd; Neuman MD, 2012, ANESTHESIOLOGY, V117, P72, DOI 10.1097/ALN.0b013e3182545e7c; Neuman MD, 2010, MED CARE, V48, P314, DOI 10.1097/MLR.0b013e3181ca4126; O'Hara DA, 2000, ANESTHESIOLOGY, V92, P947, DOI 10.1097/00000542-200004000-00011; Parker MJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000521.PUB2; Polsky D, 2008, HEALTH SERV RES, V43, P1388, DOI 10.1111/j.1475-6773.2008.00837.x; Radcliff TA, 2008, J BONE JOINT SURG AM, V90A, P34, DOI 10.2106/JBJS.G.00065; Regan EA, 2013, COPD, V10, P11, DOI 10.3109/15412555.2012.723072; Rosenbaum PR, 2007, BIOMETRICS, V63, P456, DOI 10.1111/j.1541-0420.2006.00717.x; Rosenbaum PR, 2007, J AM STAT ASSOC, V102, P75, DOI 10.1198/016214506000001059; Rosenbaum PR, 2012, J COMPUT GRAPH STAT, V21, P57, DOI 10.1198/jcgs.2011.09219; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; RUBIN DB, 1980, BIOMETRICS, V36, P293, DOI 10.2307/2529981; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Scheinin H, 2000, ACTA ANAESTH SCAND, V44, P1061, DOI 10.1034/j.1399-6576.2000.440905.x; Scottish Intercollegiate Guidelines Network, 2009, MAN HIP FRACT OLD PE; Sheffield KM, 2013, JAMA-J AM MED ASSOC, V310, P812, DOI 10.1001/jama.2013.276205; Sieber FE, 2010, J CLIN ANESTH, V22, P179, DOI 10.1016/j.jclinane.2009.06.005; Sieber FE, 2010, MAYO CLIN PROC, V85, P18, DOI 10.4065/mcp.2009.0469; Silber JH, 2007, MED CARE, V45, P918, DOI 10.1097/MLR.0b013e31812e01cc; Silber JH, 2001, MED CARE, V39, P1048, DOI 10.1097/00005650-200110000-00003; Small DS, 2008, J AM STAT ASSOC, V103, P924, DOI 10.1198/016214507000001247; UK National Clinical Guideline Centre, 2011, MAN HIP FRACT AD; VALENTIN N, 1986, BRIT J ANAESTH, V58, P284, DOI 10.1093/bja/58.3.284; White SM, 2014, ANAESTHESIA, V69, P224, DOI 10.1111/anae.12542; White SM, 2010, ANAESTHESIA, V65, P243, DOI 10.1111/j.1365-2044.2009.06208.x; Zubizarreta JR, 2012, J AM STAT ASSOC, V107, P1360, DOI 10.1080/01621459.2012.703874	49	178	191	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2508	2517		10.1001/jama.2014.6499	http://dx.doi.org/10.1001/jama.2014.6499			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058085	Green Accepted, Green Published			2022-12-24	WOS:000337757000024
J	Parekh, AK; Kronick, R; Tavenner, M				Parekh, Anand K.; Kronick, Richard; Tavenner, Marilyn			Optimizing Health for Persons With Multiple Chronic Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Parekh, Anand K.] US Dept HHS, Off Assistant Secretary Hlth, Washington, DC 20201 USA; [Kronick, Richard] US Dept HHS, Agcy Healthcare Res & Qual, Washington, DC 20201 USA; [Tavenner, Marilyn] US Dept HHS, Ctr Medicare & Medicaid Serv, Washington, DC 20201 USA	Agency for Healthcare Research & Quality; Centers for Medicare & Medicaid Services	Parekh, AK (corresponding author), US Dept HHS, Off Assistant Secretary Hlth, 200 Independence Ave SW, Washington, DC 20201 USA.	anand.parekh@hhs.gov						Blumenthal D, 2012, NEW ENGL J MED, V366, P1953, DOI 10.1056/NEJMp1203427; Lochner KA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120137; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Schwenk TL, 2014, JAMA-J AM MED ASSOC, V311, P802, DOI 10.1001/jama.2014.352; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203	7	39	39	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1199	1200		10.1001/jama.2014.10181	http://dx.doi.org/10.1001/jama.2014.10181			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25133982				2022-12-24	WOS:000341990600016
J	Murakami, H; Keeney, S				Murakami, Hajime; Keeney, Scott			Temporospatial Coordination of Meiotic DNA Replication and Recombination via DDK Recruitment to Replisomes	CELL			English	Article							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; S-PHASE; CDC7-DBF4 KINASE; CDC7 KINASE; INITIATION; MRC1; PHOSPHORYLATION; PROTEINS; MEIOSIS	It has been long appreciated that, during meiosis, DNA replication is coordinated with the subsequent formation of the double-strand breaks (DSBs) that initiate recombination, but a mechanistic understanding of this process was elusive. We now show that, in yeast, the replisome-associated components Tof1 and Csm3 physically associate with the Dbf4-dependent Cdc7 kinase (DDK) and recruit it to the replisome, where it phosphorylates the DSB-promoting factor Mer2 in the wake of the replication fork, synchronizing replication with an early prerequisite for DSB formation. Recruiting regulatory kinases to replisomes may be a general mechanism to ensure spatial and temporal coordination of replication with other chromosomal processes.	[Murakami, Hajime; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA.	s-keeney@ski.mskcc.org	Murakami, Hajime/AAX-9411-2021; Keeney, Scott/GVR-8515-2022	Keeney, Scott/0000-0002-1283-6417; Murakami, Hajime/0000-0002-7022-6887	NIH [R01 GM058673]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Agnes Viale (Memorial Sloan Kettering Cancer Center [MSKCC] Genomics Core Laboratory) for DNA sequencing, Nicholas Socci (MSKCC Bioinformatics Core) for mapping sequence reads and advice on data analysis; Nicolas Nocetti, Adolfo Cuesta, Hyejin Choi and Zhicheng Qiu for experimental assistance; Bruce Stillman for anti-Orc6 antibody; Michael Lichten and Valerie Borde for strains and plasmids; Franz Klein and Hannah Blitzblau for sharing unpublished data; Dirk Remus and members of the S.K. laboratory, especially Corentin Claeys Bouuaert, Sarah Kim, Isabel Lam, Neeman Mohibullah, Megan van Overbeek, and Xuan Zhu, for discussion and comments on the manuscript; Andrea Farina and Satoko Murakami for experimental support to H.M. This work was supported by NIH grant R01 GM058673.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Baker SP, 2010, NAT CELL BIOL, V12, P294, DOI 10.1038/ncb2030; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Blitzblau HG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002643; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Cha RS, 2000, GENE DEV, V14, P493; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; HOLLINGSWORTH RE, 1993, CHROMOSOMA, V102, P415, DOI 10.1007/BF00360406; Katis VL, 2010, DEV CELL, V18, P397, DOI 10.1016/j.devcel.2010.01.014; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; LeClere AR, 2013, FUNGAL GENET BIOL, V50, P33, DOI 10.1016/j.fgb.2012.10.007; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Matsumoto S, 2005, J BIOL CHEM, V280, P42536, DOI 10.1074/jbc.M510575200; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; Miyoshi T, 2012, MOL CELL, V47, P722, DOI 10.1016/j.molcel.2012.06.023; Murakami H, 2003, NUCLEIC ACIDS RES, V31, P4085, DOI 10.1093/nar/gkg441; Murakami H, 2001, NAT GENET, V28, P290, DOI 10.1038/90142; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Murakami H, 2009, METHODS MOL BIOL, V557, P117, DOI 10.1007/978-1-59745-527-5_9; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Ogino K, 2006, J BIOL CHEM, V281, P1338, DOI 10.1074/jbc.M505767200; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; SCHILD D, 1978, CHROMOSOMA, V70, P109, DOI 10.1007/BF00292220; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; Tonami Y, 2005, P NATL ACAD SCI USA, V102, P5797, DOI 10.1073/pnas.0407236102; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Wan LH, 2006, GENETICS, V174, P1767, DOI 10.1534/genetics.106.064303; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Weinreich M, 2001, P NATL ACAD SCI USA, V98, P11211, DOI 10.1073/pnas.201387198; Wu PYJ, 2014, MOL CELL, V53, P655, DOI 10.1016/j.molcel.2014.01.022; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x	45	76	76	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					861	873		10.1016/j.cell.2014.06.028	http://dx.doi.org/10.1016/j.cell.2014.06.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126790	Bronze, Green Accepted			2022-12-24	WOS:000340944700016
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Courage is treating patients with Ebola	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2014, BBC NEWS AFRICA 0730; [Anonymous], 2014, FRONT PAGE AFRI 0703; Black B., 2014, MED SANS FRONTI 0707; Fofana U., 2014, REUTERS AFRICA  0723; HARDEN B, 2001, NY TIMES MAGAZINE; WHO, 2014, EB VIR DIS W AFR UPD; Withnall Adam, 2014, INDEPENDENT	7	3	3	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2014	349								g4987	10.1136/bmj.g4987	http://dx.doi.org/10.1136/bmj.g4987			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MO	25092659	Green Published, Bronze			2022-12-24	WOS:000340205900001
J	Mehrabadi, A; Liu, SL; Bartholomew, S; Hutcheon, JA; Magee, LA; Kramer, MS; Liston, RM; Joseph, KS				Mehrabadi, Azar; Liu, Shiliang; Bartholomew, Sharon; Hutcheon, Jennifer A.; Magee, Laura A.; Kramer, Michael S.; Liston, Robert M.; Joseph, K. S.		Canadian Perinatal Surveillance	Hypertensive disorders of pregnancy and the recent increase in obstetric acute renal failure in Canada: population based retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEVERE MATERNAL MORBIDITY; ACUTE KIDNEY INJURY; ATONIC POSTPARTUM HEMORRHAGE; TEMPORAL TRENDS; RISK; PREECLAMPSIA; ADMISSION; OUTCOMES; RATES	Objective To examine whether changes in postpartum haemorrhage, hypertensive disorders of pregnancy, or other risk factors explain the increase in obstetric acute renal failure in Canada. Design Retrospective cohort study. Setting Canada (excluding the province of Quebec). Participants All hospital deliveries from 2003 to 2010 (n=2 193 425). Main outcome measures Obstetric acute renal failure identified by ICD-10 diagnostic codes. Methods Information on all hospital deliveries in Canada (excluding Quebec) between 2003 and 2010 (n=2 193 425) was obtained from the Canadian Institute for Health Information. Temporal trends in obstetric acute renal failure were assessed among women with and without postpartum haemorrhage, hypertensive disorders of pregnancy, or other risk factors. Logistic regression was used to determine if changes in risk factors explained the temporal increase in obstetric acute renal failure. Results Rates of obstetric acute renal failure rose from 1.66 to 2.68 per 10 000 deliveries between 2003-04 and 2009-10 (61% increase, 95% confidence interval 24% to 110%). Adjustment for postpartum haemorrhage, hypertensive disorders, and other factors did not attenuate the increase. The temporal increase in acute renal failure was restricted to deliveries with hypertensive disorders (adjusted increase 95%, 95% confidence interval 38% to 176%), and was especially pronounced among women with gestational hypertension with significant proteinuria (adjusted increase 171%, 71% to 329%). No significant increase occurred among women without hypertensive disorders (adjusted increase 12%, -28 to 72%). Conclusions The increase in obstetric acute renal failure in Canada between 2003 and 2010 was restricted to women with hypertensive disorders and was especially pronounced among women with pre-eclampsia. Further study is required to determine the cause of the increase among women with pre-eclampsia.	[Mehrabadi, Azar; Hutcheon, Jennifer A.; Magee, Laura A.; Liston, Robert M.; Joseph, K. S.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Mehrabadi, Azar; Hutcheon, Jennifer A.; Magee, Laura A.; Liston, Robert M.; Joseph, K. S.] Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC, Canada; [Mehrabadi, Azar; Hutcheon, Jennifer A.; Magee, Laura A.; Joseph, K. S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Liu, Shiliang; Bartholomew, Sharon] Publ Hlth Agcy Canada, Maternal & Infant Hlth Sect, Ottawa, ON, Canada; [Magee, Laura A.] Univ British Columbia, Fac Med, Div Gen Internal Med, Vancouver, BC, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	University of British Columbia; BC Women's Hospital & Health Centre; University of British Columbia; Public Health Agency of Canada; University of British Columbia; McGill University; McGill University	Mehrabadi, A (corresponding author), Womens Hosp British Columbia, Vancouver, BC V6H 3N1, Canada.	azar@alumni.ubc.ca		Hutcheon, Jennifer/0000-0002-6618-6018; Joseph, K.S./0000-0003-2317-5607	Canadian Institutes of Health Research (CIHR) [MAH-115445]; CIHR; Michael Smith Foundation for Health Research; British Columbia's Women's Hospital and Health Centre; Child and Family Research Institute; CIHR chair in maternal, fetal, and infant health services research [APR-126338]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); British Columbia's Women's Hospital and Health Centre; Child and Family Research Institute; CIHR chair in maternal, fetal, and infant health services research(Canadian Institutes of Health Research (CIHR))	This work is supported by a Canadian Institutes of Health Research (CIHR) team grant in severe maternal morbidity (MAH-115445). JAH is the recipient of a CIHR new investigator award and a scholar award from the Michael Smith Foundation for Health Research. LAM receives salary support from British Columbia's Women's Hospital and Health Centre. KSJ is supported by an investigator award from the Child and Family Research Institute and a CIHR chair in maternal, fetal, and infant health services research (APR-126338). The funding sources had no role in the design, analysis, interpretation of the results, or the writing of the manuscript.	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Acharya A, 2013, ADV CHRONIC KIDNEY D, V20, P215, DOI 10.1053/j.ackd.2013.02.002; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Blomberg M, 2011, OBSTET GYNECOL, V118, P561, DOI 10.1097/AOG.0b013e31822a6c59; Callaghan WM, 2012, OBSTET GYNECOL, V120, P1029, DOI [10.1097/AOG.0b013e31826d60c5, http://10.1097/AOG.0b013e31826d60c5]; Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011; Choudhury D, 2006, NAT CLIN PRACT NEPHR, V2, P80, DOI 10.1038/ncpneph0076; Dormuth CR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f880; Drakeley AJ, 2002, AM J OBSTET GYNECOL, V186, P253, DOI 10.1067/mob.2002.120279; Ford JB, 2007, INT J GYNECOL OBSTET, V98, P237, DOI 10.1016/j.ijgo.2007.03.011; Gammill Hilary S, 2005, Crit Care Med, V33, pS372, DOI 10.1097/01.CCM.0000183155.46886.C6; Gandhi S, 2013, JAMA-J AM MED ASSOC, V310, P2544, DOI 10.1001/jama.2013.282426; Gurrieri C, 2012, ARCH GYNECOL OBSTET, V286, P567, DOI 10.1007/s00404-012-2323-5; Harrell FE, 2001, REGRESSION MODELING; Howe CJ, 2011, EPIDEMIOLOGY, V22, P874, DOI 10.1097/EDE.0b013e31823029dd; Hwang YJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001821; Joseph KS, 2007, BJOG-INT J OBSTET GY, V114, P751, DOI 10.1111/j.1471-0528.2007.01316.x; Joseph KS, 2010, J OBSTET GYNAECOL CA, V32, P837, DOI 10.1016/S1701-2163(16)34655-2; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Koren G, 2006, LANCET, V368, P704, DOI 10.1016/S0140-6736(06)69255-6; KRANE NK, 1988, ARCH INTERN MED, V148, P2347, DOI 10.1001/archinte.148.11.2347; Lapi F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8525; Lewis G, 2004, 6 REPORT CONFIDENTIA; Liu SL, 2010, J OBSTET GYNAECOL CA, V32, P847, DOI 10.1016/S1701-2163(16)34656-4; Lutomski JE, 2012, BJOG-INT J OBSTET GY, V119, P306, DOI 10.1111/j.1471-0528.2011.03198.x; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Mehrabadi A, 2013, BJOG-INT J OBSTET GY, V120, P853, DOI 10.1111/1471-0528.12149; Mehrabadi A, 2014, J OBSTET GYNAECOL CA, V36, P21, DOI 10.1016/S1701-2163(15)30680-0; Nzerue CM, 1998, J NATL MED ASSOC, V90, P486; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Rossen J, 2011, OBSTET GYNECOL SURV, V66, P18; Royal College of Obstetricians and Gynaelcologists, 2006, GUIDELINE; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P777, DOI 10.1016/0002-9378(90)91009-2; So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161; STEWART GK, 1971, OBSTET GYNECOL, V37, P510; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Thornton CE, 2011, HYPERTENS PREGNANCY, V30, P169, DOI 10.3109/10641950902972140; Tuffnell DJ, 2005, BJOG-INT J OBSTET GY, V112, P875, DOI 10.1111/j.1471-0528.2005.00565.x; TURNEY JH, 1989, BRIT J OBSTET GYNAEC, V96, P679, DOI 10.1111/j.1471-0528.1989.tb03282.x; Vikse BE, 2013, LANCET, V382, P104, DOI 10.1016/S0140-6736(13)60741-2; von Dadelszen P, 2010, OBSTET GYNECOL, V116, P659, DOI 10.1097/AOG.0b013e3181eb669d; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073	43	63	68	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2014	349								g4731	10.1136/bmj.g4731	http://dx.doi.org/10.1136/bmj.g4731			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NP	25077825	hybrid, Green Published			2022-12-24	WOS:000339907000002
J	Ball, SJ; Pereira, G; Jacoby, P; de Klerk, N; Stanley, FJ				Ball, Stephen J.; Pereira, Gavin; Jacoby, Peter; de Klerk, Nicholas; Stanley, Fiona J.			Re-evaluation of link between interpregnancy interval and adverse birth outcomes: retrospective cohort study matching two intervals per mother	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRETERM BIRTH; PREGNANCY INTERVAL; PERINATAL OUTCOMES; HEALTH; CHILD; RISK; ASSOCIATION; WEIGHT; INFANT	Objective To re-evaluate the causal effect of interpregnancy interval on adverse birth outcomes, on the basis that previous studies relying on between mother comparisons may have inadequately adjusted for confounding by maternal risk factors. Design Retrospective cohort study using conditional logistic regression (matching two intervals per mother so each mother acts as her own control) to model the incidence of adverse birth outcomes as a function of interpregnancy interval; additional unconditional logistic regression with adjustment for confounders enabled comparison with the unmatched design of previous studies. Setting Perth, Western Australia, 1980-2010. Participants 40 441 mothers who each delivered three liveborn singleton neonates. Main outcome measures Preterm birth (< 37 weeks), small for gestational age birth (< 10th centile of birth weight by sex and gestational age), and low birth weight (< 2500 g). Results Within mother analysis of interpregnancy intervals indicated a much weaker effect of short intervals on the odds of preterm birth and low birth weight compared with estimates generated using a traditional between mother analysis. The traditional unmatched design estimated an adjusted odds ratio for an interpregnancy interval of 0-5 months (relative to the reference category of 18-23 months) of 1.41 (95% confidence interval 1.31 to 1.51) for preterm birth, 1.26 (1.15 to 1.37) for low birth weight, and 0.98 (0.92 to 1.06) for small for gestational age birth. In comparison, the matched design showed a much weaker effect of short interpregnancy interval on preterm birth (odds ratio 1.07, 0.86 to 1.34) and low birth weight (1.03, 0.79 to 1.34), and the effect for small for gestational age birth remained small (1.08, 0.87 to 1.34). Both the unmatched and matched models estimated a high odds of small for gestational age birth and low birth weight for long interpregnancy intervals (longer than 59 months), but the estimated effect of long interpregnancy intervals on the odds of preterm birth was much weaker in the matched model than in the unmatched model. Conclusion This study questions the causal effect of short interpregnancy intervals on adverse birth outcomes and points to the possibility of unmeasured or inadequately specified maternal factors in previous studies.	[Ball, Stephen J.; Pereira, Gavin; Jacoby, Peter; de Klerk, Nicholas; Stanley, Fiona J.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6872, Australia; [Pereira, Gavin] Yale Univ, Yale Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT 06510 USA	Telethon Kids Institute; University of Western Australia; Yale University	Ball, SJ (corresponding author), Univ Western Australia, Telethon Kids Inst, POB 855, Perth, WA 6872, Australia.	stephen.ball@telethonkids.org.au	Pereira, Gavin/D-7136-2014; de Klerk, Nicholas H/D-8388-2016	Pereira, Gavin/0000-0003-3740-8117; de Klerk, Nicholas H/0000-0001-9223-0767	Australian National Health and Medical Research Council [572742, 1052236]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this research was received from the Australian National Health and Medical Research Council as a program grant (572742) and early career fellowship (1052236 to GP). The authors maintained full control over the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, and approval of the manuscript.	Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Cheslack-Postava K, 2011, PEDIATRICS, V127, P246; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Conde-Agudelo A, 2005, OBSTET GYNECOL, V106, P359, DOI 10.1097/01.AOG.0000171118.79529.a3; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; ERICKSON JD, 1978, J EPIDEMIOL COMMUN H, V32, P124, DOI 10.1136/jech.32.2.124; Gee V, 1994, VALIDATION STUDY WES; Grisaru-Granovsky S, 2009, CONTRACEPTION, V80, P512, DOI 10.1016/j.contraception.2009.06.006; Gunawardana L, 2011, BRIT J PSYCHIAT, V199, P338, DOI 10.1192/bjp.bp.111.092916; Howard EJ, 2013, MATERN CHILD HLTH J, V17, P933, DOI 10.1007/s10995-012-1073-0; Huynh M, 2006, PAEDIATR PERINAT EP, V20, P454, DOI 10.1111/j.1365-3016.2006.00759.x; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Klebanoff MA, 1999, NEW ENGL J MED, V340, P643, DOI 10.1056/NEJM199902253400809; Kwon S, 2012, J PERINATOL, V32, P45, DOI 10.1038/jp.2011.49; Lindblad F, 2010, NICOTINE TOB RES, V12, P408, DOI 10.1093/ntr/ntq017; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Marston C., 2005, REPORT WHO TECHNICAL; McClennan W., 1996, 20390 AUSTR BUR STAT; MILLER JE, 1991, FAM PLANN PERSPECT, V23, P62, DOI 10.2307/2135451; Read A W, 1993, Paediatr Perinat Epidemiol, V7, P177, DOI 10.1111/j.1365-3016.1993.tb00392.x; Ritsmitchai S, 1997, J OCCUP HEALTH, V39, P217, DOI 10.1539/joh.39.217; Rousso D, 2002, EUR J OBSTET GYN R B, V105, P4, DOI 10.1016/S0301-2115(02)00077-5; Shachar BZ, 2012, OBSTET GYNECOL SURV, V67, P584, DOI 10.1097/OGX.0b013e31826b2c3e; Wendt A, 2012, PAEDIATR PERINAT EP, V26, P239, DOI 10.1111/j.1365-3016.2012.01285.x; WINIKOFF B, 1983, STUD FAMILY PLANN, V14, P231, DOI 10.2307/1965748; Zhu Bao-Ping, 2003, Matern Child Health J, V7, P169, DOI 10.1023/A:1025184304391; Zhu BP, 2005, INT J GYNECOL OBSTET, V89, pS25, DOI 10.1016/j.ijgo.2004.08.002; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	29	116	120	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4333	10.1136/bmj.g4333	http://dx.doi.org/10.1136/bmj.g4333			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM0VP	25056260	Green Published, hybrid			2022-12-24	WOS:000339565900001
J	Doshi, P				Doshi, Peter			DRUGS FOR NEGLECTED DISEASES US incentive scheme for neglected diseases: a good idea gone wrong?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pdoshi@bmj.com						Bryceson ADM, 2006, T ROY SOC TROP MED H, V100, pS1, DOI 10.1016/j.trstmh.2006.02.016; Ridley DB, 2010, LANCET, V376, P922, DOI 10.1016/S0140-6736(10)60669-1; Ridley DB, 2006, HEALTH AFFAIR, V25, P313, DOI 10.1377/hlthaff.25.2.313; TDR, 2014, BANGL BEATS DEADL SC; TDR, 2007, VISC LEISHM EL DRAFT	5	8	9	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2014	349								g4665	10.1136/bmj.g4665	http://dx.doi.org/10.1136/bmj.g4665			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VM	25099712				2022-12-24	WOS:000339565600004
J	Chandel, NS; Tuveson, DA				Chandel, Navdeep S.; Tuveson, David A.			The Promise and Perils of Antioxidants for Cancer Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Tuveson, David A.] Cold Spring Harbor Lab, Lustgarten Fdn Lab, Cold Spring Harbor, NY 11724 USA	Northwestern University; Feinberg School of Medicine; Cold Spring Harbor Laboratory	Chandel, NS (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.							Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107	5	135	141	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					177	178		10.1056/NEJMcibr1405701	http://dx.doi.org/10.1056/NEJMcibr1405701			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	25006725				2022-12-24	WOS:000338645500015
J	Lee, CH; Lu, W; Michel, JC; Goehring, A; Du, J; Song, XQ; Gouaux, E				Lee, Chia-Hsueh; Lu, Wei; Michel, Jennifer Carlisle; Goehring, April; Du, Juan; Song, Xianqiang; Gouaux, Eric			NMDA receptor structures reveal subunit arrangement and pore architecture	NATURE			English	Article							AMINO-TERMINAL DOMAIN; SIZE-EXCLUSION CHROMATOGRAPHY; LIGAND-BINDING DOMAIN; HIGH-LEVEL EXPRESSION; D-ASPARTATE RECEPTORS; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURE; ALLOSTERIC INHIBITION; MOLECULAR-BASIS; CENTRAL NEURONS	N-methyl-D-aspartate (NMDA) receptors are Hebbian-like coincidence detectors, requiring binding of glycine and glutamate in combination with the relief of voltage-dependent magnesium block to open an ion conductive pore across the membrane bilayer. Despite the importance of the NMDA receptor in the development and function of the brain, a molecular structure of an intact receptor has remained elusive. Here we present X-ray crystal structures of the Xenopus laevis GluN1-GluN2B NMDA receptor with the allosteric inhibitor, Ro25-6981, partial agonists and the ion channel blocker, MK-801. Receptor subunits are arranged in a 1-2-1-2 fashion, demonstrating extensive interactions between the amino-terminal and ligand-binding domains. The transmembrane domains harbour a closed-blocked ion channel, a pyramidal central vestibule lined by residues implicated in binding ion channel blockers and magnesium, and a twofold symmetric arrangement of ion channel pore loops. These structures provide new insights into the architecture, allosteric coupling and ion channel function of NMDA receptors.	[Lee, Chia-Hsueh; Lu, Wei; Michel, Jennifer Carlisle; Goehring, April; Du, Juan; Song, Xianqiang; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Michel, Jennifer Carlisle; Goehring, April; Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Song, Xianqiang/B-9768-2017	Gouaux, Eric/0000-0002-8549-2360; Song, Xianqiang/0000-0002-5637-3119	Oregon Brain Institute Graduate Student Fellowship; NIH; Vollum Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS038631] Funding Source: NIH RePORTER	Oregon Brain Institute Graduate Student Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vollum Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All members of the Gouaux laboratory are gratefully acknowledged for their support and assistance, especially L. Chen, K. Duerr and K. Wang. We thank L. Vaskalis for assistance with the figures, G. Westbrook and C. Jahr for comments on the manuscript, H. Owen for proofreading and I. Baconguis for making the animation. E. G. acknowledges the generous support of R. LaCroute, B. LaCroute and J. LaCroute. This work was also supported by an Oregon Brain Institute Graduate Student Fellowship (C. H. L.), the NIH (E. G.) and the Vollum Institute (E. G.). E. G. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALLAN RD, 1990, J MED CHEM, V33, P2905, DOI 10.1021/jm00172a036; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delano W.L, 2002, PYMOL USERS MANUAL; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Hansen KB, 2012, J NEUROSCI, V32, P6197, DOI 10.1523/JNEUROSCI.5757-11.2012; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; HART HE, 1979, MOL IMMUNOL, V16, P265, DOI 10.1016/0161-5890(79)90065-8; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Lee CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019180; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Peery HE, 2012, AUTOIMMUN REV, V11, P863, DOI 10.1016/j.autrev.2012.03.001; Pohlsgaard J, 2011, NEUROPHARMACOLOGY, V60, P135, DOI 10.1016/j.neuropharm.2010.08.004; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; REICHLING DB, 1991, J PHYSIOL-LONDON, V441, P199, DOI 10.1113/jphysiol.1991.sp018746; Riou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035134; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; SHERRY AD, 1975, BIOCHEMISTRY-US, V14, P2191, DOI 10.1021/bi00681a023; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soto David, 2014, Commun Integr Biol, V7, pe27887, DOI 10.4161/cib.27887; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tovar KR, 2013, J NEUROSCI, V33, P9150, DOI 10.1523/JNEUROSCI.0829-13.2013; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WATSON GB, 1990, NEUROPHARMACOLOGY, V29, P727, DOI 10.1016/0028-3908(90)90125-B; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	68	340	349	4	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					191	+		10.1038/nature13548	http://dx.doi.org/10.1038/nature13548			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008524	Green Accepted			2022-12-24	WOS:000338649800037
J	Wiebe, S				Wiebe, Samuel			PERSPECTIVE The surgical solution	NATURE			English	Editorial Material							TEMPORAL-LOBE EPILEPSY; SURGERY; TRIAL		Univ Calgary, Calgary, AB T2N 1N4, Canada	University of Calgary	Wiebe, S (corresponding author), Univ Calgary, Calgary, AB T2N 1N4, Canada.							Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Fiest KM, 2014, EPILEPSIA; Jette N, 2012, NEUROLOGY, V79, P1084, DOI 10.1212/WNL.0b013e3182698c4c; Schmidt D, 2009, EPILEPSIA, V50, P1301, DOI 10.1111/j.1528-1167.2008.01997.x; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wiebe S, 2012, NAT REV NEUROL, V8, P669, DOI 10.1038/nrneurol.2012.181	7	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S7	S7		10.1038/511S7a	http://dx.doi.org/10.1038/511S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019126	Bronze			2022-12-24	WOS:000338649800003
J	Steen, R; Jana, S; Reza-Paul, S; Richter, M				Steen, Richard; Jana, Smarajit; Reza-Paul, Sushena; Richter, Marlise			Trafficking, sex work, and HIV: efforts to resolve conflicts	LANCET			English	Editorial Material							HARM REDUCTION; PREVENTION; PROSTITUTION; POLICY		[Steen, Richard] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 Rotterdam, Netherlands; [Steen, Richard; Jana, Smarajit] Durbar Mahila Samanwaya Comm, Kolkata, W Bengal, India; [Reza-Paul, Sushena] Univ Manitoba, Community Hlth Serv, Winnipeg, MB R3T 2N2, Canada; [Reza-Paul, Sushena] Ashodaya Samithi, Mysore, Karnataka, India; [Richter, Marlise] Univ Witwatersrand, African Ctr Migrat & Soc, Johannesburg, South Africa; [Richter, Marlise] Sonke Gender Justice, Cape Town, South Africa; [Richter, Marlise] Univ Cape Town, Dept Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa	Erasmus University Rotterdam; Erasmus MC; University of Manitoba; University of Witwatersrand; University of Cape Town	Steen, R (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 Rotterdam, Netherlands.	steenr7@gmail.com						Brandt Allan M., 1987, NO MAGIC BULLET SOCI; Busza J, 2006, HEALTH POLICY PLANN, V21, P329, DOI 10.1093/heapol/czl016; Busza Joanna, 2004, HLTH HUMAN RIGHTS, V7, P231, DOI DOI 10.2307/4065357; Butcher K, 2003, LANCET, V361, P1983, DOI 10.1016/S0140-6736(03)13596-9; Decker MR, 2014, LANCET; Ditmore MH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17354; Jana S, 2006, LANCET, V367, P814, DOI 10.1016/S0140-6736(06)68331-1; Jana S, 2013, J PUBLIC HLTH OXF; Pearshouse Richard, 2008, HIV AIDS Policy Law Rev, V13, P21; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Reza-Paul S, 2012, INDIAN J MED RES, V135, P98, DOI 10.4103/0971-5916.93431; Richter M, 2014, J IMMIGR MINOR HEALT, V16, P7, DOI 10.1007/s10903-012-9758-4; Richter ML, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-1; Shahmanesh M, 2009, SOC SCI MED, V69, P604, DOI 10.1016/j.socscimed.2009.06.020; Thomson N, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-31; Weitzer R, 2014, ANN AM ACAD POLIT SS, V653, P6, DOI 10.1177/0002716214521562	16	15	15	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					94	96		10.1016/S0140-6736(14)60966-1	http://dx.doi.org/10.1016/S0140-6736(14)60966-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25059945				2022-12-24	WOS:000347715900006
J	Annas, GJ				Annas, George J.			Medical Marijuana, Physicians, and State Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.							Annas GJ, 1997, NEW ENGL J MED, V337, P435, DOI 10.1056/NEJM199708073370621; [Anonymous], 2014, NY TIMES; Cole JM, 2013, GUIDANCE REGARDING M; Kassirer JP, 1997, NEW ENGL J MED, V336, P366, DOI 10.1056/NEJM199701303360509	4	19	20	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					983	985		10.1056/NEJMp1408965	http://dx.doi.org/10.1056/NEJMp1408965			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25099473				2022-12-24	WOS:000341382800002
J	Gostin, LO				Gostin, Lawrence O.			The ACA's Contraceptive Mandate Religious Freedom, Women's Health, and Corporate Personhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], NONCONTRACEPTIVE BEN; Cohen IG, 2014, NEW ENGL J MED, V371, P596, DOI 10.1056/NEJMp1407965; Gemzell-Danielsson K, 2013, CONTRACEPTION, V87, P300, DOI 10.1016/j.contraception.2012.08.021; Gossett DR, 2013, JAMA-J AM MED ASSOC, V309, P1997, DOI 10.1001/jama.2013.4262; LIPTAK A, 2013, NY TIMES, pA1; Wiley Lindsay F., 2016, PUBL HLTH LAW POW, V3rd	6	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					785	786		10.1001/jama.2014.9455	http://dx.doi.org/10.1001/jama.2014.9455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25014562				2022-12-24	WOS:000340788500015
J	Belew, AT; Meskauskas, A; Musalgaonkar, S; Advani, VM; Sulima, SO; Kasprzak, WK; Shapiro, BA; Dinman, JD				Belew, Ashton Trey; Meskauskas, Arturas; Musalgaonkar, Sharmishtha; Advani, Vivek M.; Sulima, Sergey O.; Kasprzak, Wojciech K.; Shapiro, Bruce A.; Dinman, Jonathan D.			Ribosomal frameshifting in the CCR5 mRNA is regulated by miRNAs and the NMD pathway	NATURE			English	Article							TRANSLATIONAL FIDELITY; SEQUENCE ALIGNMENT; GENE; MODEL; EFFICIENCY; DATABASE; BINDING; VERSION; SIGNAL; CELLS	Programmed -1 ribosomal frameshift (-1 PRF) signals redirect translating ribosomes to slip back one base on messenger RNAs. Although well characterizedin viruses, how these elements may regulate cellular gene expression is not understood. Here we describe a -1 PRF signal in the human mRNA encoding CCR5, the HIV-1 co-receptor. CCR5 mRNA-mediated -1 PRF is directed by an mRNA pseudoknot, and is stimulated by at least two microRNAs. Mapping the mRNA-miRNA interaction suggests that formation of a triplex RNA structure stimulates -1 PRF. A -1 PRF event on the CCR5 mRNA directs translating ribosomes to a premature termination codon, destabilizing it through the nonsense-mediated mRNA decay pathway. At least one additional mRNA decay pathway is also involved. Functional -1 PRF signals that seem to be regulated by miRNAs are also demonstrated in mRNAs encoding six other cytokine receptors, suggesting a novel mode through which immune responses may be fine-tuned in mammalian cells.	[Belew, Ashton Trey; Meskauskas, Arturas; Musalgaonkar, Sharmishtha; Advani, Vivek M.; Sulima, Sergey O.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Meskauskas, Arturas] Vilnius State Univ, Dept Biotechnol & Microbiol, LT-03101 Vilnius, Lithuania; [Kasprzak, Wojciech K.] Leidos Biomed Res Inc, Basic Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Shapiro, Bruce A.] NCI, Basic Res Lab, Frederick, MD 21702 USA	University System of Maryland; University of Maryland College Park; Vilnius University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dinman, JD (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dinman@umd.edu	Advani, Vivek/L-1827-2019	Advani, Vivek/0000-0002-0584-8989; Dinman, Jonathan/0000-0002-2402-9698	National Institutes of Health [5 R01GM058859, R21GM068123]; National Science Foundation [MCB-0084559]; University of Maryland College of CMNS Hockmeyer Fellowship; NIH/NIGMS [T32GM080201]; Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; Intramural Research Program of the National Institutes of Health, Center for Cancer Research;  [NIH/NIAIDT32AI051967]; NATIONAL CANCER INSTITUTE [ZIABC008382] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI051967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM068123, T32GM080201, R01GM058859, R01GM117177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Maryland College of CMNS Hockmeyer Fellowship; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Frederick National Laboratory for Cancer Research, NIH; Intramural Research Program of the National Institutes of Health, Center for Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to J.D.D. from the National Institutes of Health (5 R01GM058859, R21GM068123) and from the National Science Foundation(MCB-0084559). A. T. B. was supported by NIH/NIAID T32AI051967, and a University of Maryland College of CMNS Hockmeyer Fellowship. S.O.S. was supported by NIH/NIGMS T32GM080201. This publication has also been funded in part with federal funds from the Frederick National Laboratory for Cancer Research, NIH, under Contract HHSN261200800001E to W. K. K. This research was supported in part by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research to B. A. S. The content of this publication does not necessarily reflect the views or policies of the DHHS, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Advani VM, 2013, TRANSLATION, V1, DOI 10.4161/trla.24418; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Belew AT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-339; Belew AT, 2011, NUCLEIC ACIDS RES, V39, P2799, DOI 10.1093/nar/gkq1220; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Case DA, 2012, AMBER 12; Clark MB, 2007, J BIOL CHEM, V282, P37359, DOI 10.1074/jbc.M705676200; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; de Messieres M, 2014, BIOPHYS J, V106, P244, DOI 10.1016/j.bpj.2013.09.036; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Dinman JD, 2010, NUCLEIC ACIDS MOL BI, V24, P321, DOI 10.1007/978-0-387-89382-2_15; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grentzmann G, 1998, RNA, V4, P479; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hekman KE, 2012, HUM MOL GENET, V21, P5472, DOI 10.1093/hmg/dds392; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; HU JC, 1983, NUCLEIC ACIDS RES, V11, P4823, DOI 10.1093/nar/11.14.4823; Jack K, 2011, MOL CELL, V44, P660, DOI 10.1016/j.molcel.2011.09.017; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Jin H, 2009, MOL CELL BIOL, V29, P5789, DOI 10.1128/MCB.00653-09; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Manktelow E, 2005, NUCLEIC ACIDS RES, V33, P1553, DOI 10.1093/nar/gki299; Martinez HM, 2008, J BIOMOL STRUCT DYN, V25, P669, DOI 10.1080/07391102.2008.10531240; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; PEATTIE DA, 1980, P NATL ACAD SCI-BIOL, V77, P4679, DOI 10.1073/pnas.77.8.4679; Plant EP, 2005, NUCLEIC ACIDS RES, V33, P1825, DOI 10.1093/nar/gki329; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; Popenda M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-231; Ritchie DB, 2012, P NATL ACAD SCI USA, V109, P16167, DOI 10.1073/pnas.1204114109; Staple DW, 2005, J MOL BIOL, V349, P1011, DOI 10.1016/j.jmb.2005.03.038; Sulima SO, 2014, P NATL ACAD SCI USA, V111, P5640, DOI 10.1073/pnas.1400247111; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wills NM, 2006, J BIOL CHEM, V281, P7082, DOI 10.1074/jbc.M511629200; Ysla RM, 2008, METHOD ENZYMOL, V449, P47, DOI 10.1016/S0076-6879(08)02403-8; Zhang YW, 1999, MOL BIOL EVOL, V16, P1145, DOI 10.1093/oxfordjournals.molbev.a026205	48	102	105	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					265	+		10.1038/nature13429	http://dx.doi.org/10.1038/nature13429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25043019	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000340508200025
J	Goldner, A; Herold, N; Huber, M				Goldner, A.; Herold, N.; Huber, M.			Antarctic glaciation caused ocean circulation changes at the Eocene-Oligocene transition	NATURE			English	Article							CIRCUMPOLAR CURRENT; DRAKE PASSAGE; ONSET; PARAMETERIZATION; SENSITIVITY; GREENHOUSE; INITIATION; IMPACTS; GATEWAY; MODEL	Two main hypotheses compete to explain global cooling and the abrupt growth of the Antarctic ice sheet across the Eocene-Oligocene transition about 34 million years ago: thermal isolation of Antarctica due to southern ocean gateway opening(1-4), and declining atmospheric CO2 (refs 5, 6). Increases in ocean thermal stratification and circulation in proxies across the Eocene-Oligocene transition have been interpreted as a unique signature of gateway opening(2,4),but at present both mechanisms remain possible. Here, using a coupled ocean-atmosphere model, we show that the rise of Antarctic glaciation, rather than altered palaeogeography, is best able to explain the observed oceanographic changes. We find that growth of the Antarctic ice sheet caused enhanced northward transport of Antarctic intermediate water and invigorated the formation of Antarctic bottom water, fundamentally reorganizing ocean circulation. Conversely, gateway openings had much less impact on ocean thermal stratification and circulation. Our results support available evidence that CO2 draw down not gateway opening-caused Antarctic ice sheet growth, and further show that these feedbacks in turn altered ocean circulation. The precise timing and rate of glaciation, and thus its impacts on ocean circulation, reflect the balance between potentially positive feedbacks (increases in sea ice extent and enhanced primary productivity) and negative feedbacks (stronger southward heat transport and localized high-latitude warming). The Antarctic ice sheet had a complex, dynamic role in ocean circulation and heat fluxes during its initiation, and these processes are likely to operate in the future.	[Goldner, A.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Goldner, A.] Amer Geophys Union, Washington, DC 20009 USA; [Herold, N.; Huber, M.] Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA; [Huber, M.] Univ New Hampshire, Earth Syst Res Ctr, Inst Earth Ocean & Space Sci, Durham, NH 03824 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire	Goldner, A (corresponding author), Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA.	aarongoldner@gmail.com; matthew.huber@unh.edu	Huber, Matthew/A-7677-2008	Huber, Matthew/0000-0002-2771-9977	Graduate Assistance in Areas of National Need (GAANN) fellowship through the Computational Sciences and Engineering Program at Purdue University; National Science Foundation (NSF) [OCE 0902882, EAR 1049921]; National Center for Atmospheric Research; NSF; Division Of Earth Sciences [1445404] Funding Source: National Science Foundation; EPSCoR [1101245] Funding Source: National Science Foundation	Graduate Assistance in Areas of National Need (GAANN) fellowship through the Computational Sciences and Engineering Program at Purdue University; National Science Foundation (NSF)(National Science Foundation (NSF)); National Center for Atmospheric Research; NSF(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	A.G. was funded by a Graduate Assistance in Areas of National Need (GAANN) fellowship through the Computational Sciences and Engineering Program at Purdue University. M.H. and N.H. were supported by National Science Foundation (NSF) P2C2 grants OCE 0902882 and EAR 1049921. Computing was performed on Rosen Center for Advanced Computing resources on the Hansen and Coates cluster at Purdue University. Proxy records were compiled from refs 2, 4, and specific records and references are described in extended data. The CESM model is supported and developed by the National Center for Atmospheric Research, which is supported by the NSF.	Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Bijl PK, 2013, P NATL ACAD SCI USA, V110, P9645, DOI 10.1073/pnas.1220872110; Bitz CM, 2012, J CLIMATE, V25, P3053, DOI 10.1175/JCLI-D-11-00290.1; Bohaty SM, 2012, EARTH PLANET SC LETT, V317, P251, DOI 10.1016/j.epsl.2011.11.037; Broecker WS, 1989, PALEOCEANOGRAPHY, V4, P207, DOI 10.1029/PA004i002p00207; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; Cramer BS, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001683; Dalziel IWD, 2014, GEOLOGY, V42, P367, DOI 10.1130/focus042014.1; Danabasoglu G, 2008, J CLIMATE, V21, P1192, DOI 10.1175/2007JCLI1508.1; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeConto R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001350; Eldrett JS, 2009, NATURE, V459, P969, DOI 10.1038/nature08069; Ferrari R, 2009, ANNU REV FLUID MECH, V41, P253, DOI 10.1146/annurev.fluid.40.111406.102139; Foster GL, 2013, P NATL ACAD SCI USA, V110, P1209, DOI 10.1073/pnas.1216073110; Fox-Kemper B, 2008, J PHYS OCEANOGR, V38, P1145, DOI 10.1175/2007JPO3792.1; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; GENT PR, 1990, J PHYS OCEANOGR, V20, P150, DOI 10.1175/1520-0485(1990)020<0150:IMIOCM>2.0.CO;2; Goldner A, 2013, CLIM PAST, V9, P173, DOI 10.5194/cp-9-173-2013; Heavens NG, 2012, J ADV MODEL EARTH SY, V4, DOI 10.1029/2012MS000166; Hill DJ, 2013, GEOPHYS RES LETT, V40, P5199, DOI 10.1002/grl.50941; Houben AJP, 2013, SCIENCE, V340, P341, DOI 10.1126/science.1223646; Hren MT, 2013, P NATL ACAD SCI USA, V110, P7562, DOI 10.1073/pnas.1210930110; Huber M, 2006, PALAEOGEOGR PALAEOCL, V231, P9, DOI 10.1016/j.palaeo.2005.07.037; Huber M, 2011, CLIM PAST, V7, P603, DOI 10.5194/cp-7-603-2011; Jochum M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005030; Katz ME, 2008, NAT GEOSCI, V1, P329, DOI 10.1038/ngeo179; Katz ME, 2011, SCIENCE, V332, P1076, DOI 10.1126/science.1202122; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Knorr G, 2014, NAT GEOSCI, V7, P376, DOI [10.1038/NGEO2119, 10.1038/ngeo2119]; Large WG, 2006, J CLIMATE, V19, P2325, DOI 10.1175/JCLI3740.1; Large WG, 2001, J PHYS OCEANOGR, V31, P518, DOI 10.1175/1520-0485(2001)031<0518:ECOAGO>2.0.CO;2; Lawrence DM, 2012, J CLIMATE, V25, P2240, DOI 10.1175/JCLI-D-11-00103.1; Lawver LA, 2011, AM GEOPHYS UNION SP, V63, P5, DOI 10.1029/2010SP001017; Lear CH, 2008, GEOLOGY, V36, P251, DOI 10.1130/G24584A.1; Lefebvre V, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002345; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Lyle M, 2007, GEOLOGY, V35, P691, DOI 10.1130/G23806A.1; Miller KG, 2009, GEOL SOC AM SPEC PAP, V452, P169, DOI 10.1130/2009.2452(11); Pagani M, 2011, SCIENCE, V334, P1261, DOI 10.1126/science.1203909; Pearson PN, 2009, NATURE, V461, P1110, DOI 10.1038/nature08447; Pollard D, 2005, GLOBAL PLANET CHANGE, V45, P9, DOI 10.1016/j.gloplacha.2004.09.011; Sijp WP, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002143; Sijp WP, 2009, J CLIMATE, V22, P6639, DOI 10.1175/2009JCLI3003.1; Toggweiler J. R., 1994, DEEP SEA RES OCEANOG, V42, P477; Wilson DS, 2013, GEOPHYS RES LETT, V40, P4305, DOI 10.1002/grl.50797; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001	46	106	109	5	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					574	+		10.1038/nature13597	http://dx.doi.org/10.1038/nature13597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079555				2022-12-24	WOS:000339566300031
J	Fauci, AS; Marston, HD; Folkers, GK				Fauci, Anthony S.; Marston, Hilary D.; Folkers, Gregory K.			An HIV Cure Feasibility, Discovery, and Implementation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CCR5		[Fauci, Anthony S.; Marston, Hilary D.; Folkers, Gregory K.] NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; UN Joint Programme on HIV/AIDS (UNAIDS), GLOB REP UN REP GLOB; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052	8	25	25	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					335	336		10.1001/jama.2014.4754	http://dx.doi.org/10.1001/jama.2014.4754			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038345				2022-12-24	WOS:000339257800013
J	Edenhofer, O; Minx, J				Edenhofer, Ottmar; Minx, Jan			Mapmakers and navigators, facts and values	SCIENCE			English	Editorial Material													Edenhofer, Ottmar/E-1886-2013; Minx, Jan C/AAC-5948-2019	Edenhofer, Ottmar/0000-0001-6029-5208; Minx, Jan C/0000-0002-2862-0178				Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1	1	44	44	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					37	38		10.1126/science.1255998	http://dx.doi.org/10.1126/science.1255998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2XU	24994640				2022-12-24	WOS:000338284400039
J	Foth, C; Tischlinger, H; Rauhut, OWM				Foth, Christian; Tischlinger, Helmut; Rauhut, Oliver W. M.			New specimen of Archaeopteryx provides insights into the evolution of pennaceous feathers	NATURE			English	Article							LONG FEATHERS; CHINA; DINOSAUR; FLIGHT; THEROPOD; PLUMAGE; ORIGIN; BIRDS	Discoveries of bird-like theropod dinosaurs and basal avialans in recent decades have helped to put the iconic 'Urvogel' Archaeopteryx(1) into context(2-6) and have yielded important new data on the origin and early evolution of feathers(7). However, the biological context under which pennaceous feathers evolved is still debated. Here we describe a new specimen of Archaeopteryx with extensive feather preservation, not only on the wings and tail, but also on the body and legs. The new specimen shows that the entire body was covered in pennaceous feathers, and that the hindlimbs had long, symmetrical feathers along the tibiotarsus but short feathers on the tarsometatarsus. Furthermore, the wing plumage demonstrates that several recent interpretations(8,9) are problematic. An analysis of the phylogenetic distribution of pennaceous feathers on the tail, hindlimb and arms of advanced maniraptorans and basal avialans strongly indicates that these structures evolved in a functional context other than flight, most probably in relation to display, as suggested by some previous studies(10-12). Pennaceous feathers thus represented an exaptation and were later, in several lineages and following different patterns, recruited for aerodynamic functions. This indicates that the origin of flight in avialans was more complex than previously thought and might have involved several convergent achievements of aerial abilities.	[Foth, Christian; Rauhut, Oliver W. M.] Bayer Staatssammlung Palaontol & Geol, Staatliche Nat Wissenschaftliche Sammlungen Bayer, D-80333 Munich, Germany; [Foth, Christian; Rauhut, Oliver W. M.] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Foth, Christian; Rauhut, Oliver W. M.] Univ Munich, GeoBioCtr, D-80333 Munich, Germany	University of Munich; University of Munich	Rauhut, OWM (corresponding author), Bayer Staatssammlung Palaontol & Geol, Staatliche Nat Wissenschaftliche Sammlungen Bayer, Richard Wagner Str 10, D-80333 Munich, Germany.	o.rauhut@lrz.uni-muenchen.de	Rauhut, Oliver/AAG-1029-2020	Rauhut, Oliver/0000-0003-3958-603X	Volkswagen Foundation [I/84 640]	Volkswagen Foundation(Volkswagen)	We thank B. Pohl for making the specimen available for study, C. Keilmann and R. Albersdorfer for assistance, Xu X. for access to material, and R. Carney, G. Mayr and A. Lopez-Arbarello for discussions. This study was supported by the Volkswagen Foundation under grant I/84 640 (to O.W.M.R.).	Chiappe LM, 2002, ANNU REV ECOL SYST, V33, P91, DOI 10.1146/annurev.ecolsys.33.010802.150517; Chiappe LM, 2014, PEERJ, V2, DOI 10.7717/peerj.234; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Foth C, 2012, PALAEONTOL Z, V86, P91, DOI 10.1007/s12542-011-0111-3; Gatesy SM, 1996, EVOLUTION, V50, P2037, DOI 10.1111/j.1558-5646.1996.tb03590.x; Godefroit Pascal, 2013, Nature Communications, V4, P1; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Qiang, 2005, Dizhi Tongbao, V24, P197; Li QG, 2012, SCIENCE, V335, P1215, DOI 10.1126/science.1213780; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Longrich NR, 2012, CURR BIOL, V22, P2262, DOI 10.1016/j.cub.2012.09.052; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; Lucas A. M., 1972, AVIAN ANATOMY INTEGU, P197; Meseguer Jose, 2012, Spanish Journal of Palaeontology, V27, P125; NACHTIGALL W, 1971, Z VERGL PHYSIOL, V71, P326, DOI 10.1007/BF00298144; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; O'Connor J, 2013, P NATL ACAD SCI USA, V110, P17404, DOI 10.1073/pnas.1316979110; O'Connor JK, 2012, GEOSCIENCES, V2, P157, DOI 10.3390/geosciences2030157; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Turner AH, 2012, B AM MUS NAT HIST, P5; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753	30	138	143	0	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					79	U421		10.1038/nature13467	http://dx.doi.org/10.1038/nature13467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990749				2022-12-24	WOS:000338199400039
J	Kong, XX; Banks, A; Liu, T; Kazak, L; Rao, RR; Cohen, P; Wang, X; Yu, S; Lo, JC; Tseng, YH; Cypess, AM; Xue, R; Kleiner, S; Kang, S; Spiegelman, BM; Rosen, ED				Kong, Xingxing; Banks, Alexander; Liu, Tiemin; Kazak, Lawrence; Rao, Rajesh R.; Cohen, Paul; Wang, Xun; Yu, Songtao; Lo, James C.; Tseng, Yu-Hua; Cypess, Aaron M.; Xue, Ruidan; Kleiner, Sandra; Kang, Sona; Spiegelman, Bruce M.; Rosen, Evan D.			IRF4 Is a Key Thermogenic Transcriptional Partner of PGC-1 alpha	CELL			English	Article							BROWN ADIPOSE-TISSUE; REGULATORY FACTOR 4; UNCOUPLING PROTEIN GENE; RECEPTOR-ALPHA; COLD-EXPOSURE; FAT; EXPRESSION; CELL; COACTIVATOR; EXPANSION	Brown fat can reduce obesity through the dissipation of calories as heat. Control of thermogenic gene expression occurs via the induction of various coactivators, most notably PGC-1 alpha. In contrast, the transcription factor partner(s) of these cofactors are poorly described. Here, we identify interferon regulatory factor 4 (IRF4) as a dominant transcriptional effector of thermogenesis. IRF4 is induced by cold and cAMP in adipocytes and is sufficient to promote increased thermogenic gene expression, energy expenditure, and cold tolerance. Conversely, knockout of IRF4 in UCP1(+) cells causes reduced thermogenic gene expression and energy expenditure, obesity, and cold intolerance. IRF4 also induces the expression of PGC-1 alpha and PRDM16 and interacts with PGC-1 alpha, driving Ucp1 expression. Finally, cold, beta-agonists, or forced expression of PGC-1 alpha are unable to cause thermogenic gene expression in the absence of IRF4. These studies establish IRF4 as a transcriptional driver of a program of thermogenic gene expression and energy expenditure.	[Kong, Xingxing; Liu, Tiemin; Wang, Xun; Kang, Sona; Rosen, Evan D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA; [Kong, Xingxing; Liu, Tiemin; Wang, Xun; Kang, Sona; Rosen, Evan D.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Banks, Alexander; Kazak, Lawrence; Rao, Rajesh R.; Cohen, Paul; Lo, James C.; Kleiner, Sandra; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Banks, Alexander; Kazak, Lawrence; Rao, Rajesh R.; Cohen, Paul; Lo, James C.; Kleiner, Sandra; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; [Yu, Songtao] Northwestern Univ, Childrens Mem Res Ctr, Sch Med, Dept Pediat, Chicago, IL 60614 USA; [Tseng, Yu-Hua; Cypess, Aaron M.; Xue, Ruidan] Harvard Univ, Joslin Diabet Ctr, Sch Med, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Rosen, Evan D.] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Northwestern University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rosen, ED (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA.	erosen@bidmc.harvard.edu	Lo, James/GYR-1149-2022; ç, æ /AAU-6965-2020; Tseng, Yu-Hua/AAE-6471-2021; Banks, Alexander/B-4832-2012	Lo, James/0000-0003-0244-1670; Tseng, Yu-Hua/0000-0003-2053-9559; Banks, Alexander/0000-0003-1787-6925	American Heart Association (AHA) postdoctoral fellowship; NIH [R01 DK31405, R01 DK085171]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102170, R01DK085171, K08DK097303, ZIADK075112, T32DK007516, R01DK031405, P30DK043351, R01DK054477, R01DK077097] Funding Source: NIH RePORTER	American Heart Association (AHA) postdoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors gratefully acknowledge Ulf Klein (Columbia University) for the Irf4<SUP>flox</SUP> mice. PGC-1 alpha constructs were the gift of Pere Puigserver; other plasmids were from Lisa Madisen and Hongkui Zeng. The Electron Microscopy core of the Beth Israel Deaconess Medical Center (BIDMC) performed the EM analysis. We thank members of the E. D. R. and B. M. S. laboratories, and Saverio Cinti, for helpful discussions and technical advice. This work was funded by an American Heart Association (AHA) postdoctoral fellowship to X. K., NIH R01 DK31405 to B. M. S., and NIH R01 DK085171 to E. D. R. B. M. S. is a founder of and shareholder in Ember Therapeutics, and S. K. is an employee of the Genomics Institute of the Novartis Research Foundation.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; BOYER BB, 1991, MOL CELL BIOL, V11, P4147, DOI 10.1128/MCB.11.8.4147; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Eguchi J, 2013, DIABETES, V62, P3394, DOI 10.2337/db12-1327; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Ferrer MD, 2009, J SPORT SCI, V27, P49, DOI 10.1080/02640410802409683; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jiang DS, 2013, HYPERTENSION, V61, P1193, DOI 10.1161/HYPERTENSIONAHA.111.00614; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Larose M, 1996, J BIOL CHEM, V271, P31533, DOI 10.1074/jbc.271.49.31533; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liew CW, 2013, NAT MED, V19, P217, DOI 10.1038/nm.3056; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Manfredi LH, 2013, J APPL PHYSIOL, V115, P1496, DOI 10.1152/japplphysiol.00474.2013; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; RICQUIER D, 1986, J BIOL CHEM, V261, P13905; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; TOKUYAMA K, 1986, AM J PHYSIOL, V251, pE407, DOI 10.1152/ajpendo.1986.251.4.E407; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 2007, EXPERT OPIN THER TAR, V11, P1329, DOI 10.1517/14728222.11.10.1329; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	57	174	178	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					69	83		10.1016/j.cell.2014.04.049	http://dx.doi.org/10.1016/j.cell.2014.04.049			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995979	Green Accepted, Bronze			2022-12-24	WOS:000340943100008
J	Lo, JC; Ljubicic, S; Leibiger, B; Kern, M; Leibiger, IB; Moede, T; Kelly, ME; Bhowmick, DC; Murano, I; Cohen, P; Banks, AS; Khandekar, MJ; Dietrich, A; Flier, JS; Cinti, S; Blueher, M; Danial, NN; Berggren, PO; Spiegelman, BM				Lo, James C.; Ljubicic, Sanda; Leibiger, Barbara; Kern, Matthias; Leibiger, Ingo B.; Moede, Tilo; Kelly, Molly E.; Bhowmick, Diti Chatterjee; Murano, Incoronata; Cohen, Paul; Banks, Alexander S.; Khandekar, Melin J.; Dietrich, Arne; Flier, Jeffrey S.; Cinti, Saverio; Blueher, Matthias; Danial, Nika N.; Berggren, Per-Olof; Spiegelman, Bruce M.			Adipsin Is an Adipokine that Improves beta Cell Function in Diabetes	CELL			English	Article							COMPLEMENT FACTOR-D; ADIPOSE-TISSUE; INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; OBESITY; SECRETION; INFLAMMATION; PATHWAY; ADIPONECTIN; ADIPOCYTE	A hallmark of type 2 diabetes mellitus (T2DM) is the development of pancreatic beta cell failure, which results in insulinopenia and hyperglycemia. We show that the adipokine adipsin has a beneficial role in maintaining beta cell function. Animals genetically lacking adipsin have glucose intolerance due to insulinopenia; isolated islets from these mice have reduced glucose-stimulated insulin secretion. Replenishment of adipsin to diabetic mice treated hyperglycemia by boosting insulin secretion. We identify C3a, a peptide generated by adipsin, as a potent insulin secretagogue and show that the C3a receptor is required for these beneficial effects of adipsin. C3a acts on islets by augmenting ATP levels, respiration, and cytosolic free Ca2+. Finally, we demonstrate that T2DM patients with b cell failure are deficient in adipsin. These findings indicate that the adipsin/C3a pathway connects adipocyte function to b cell physiology, and manipulation of this molecular switch may serve as a therapy in T2DM.	[Lo, James C.; Ljubicic, Sanda; Kelly, Molly E.; Bhowmick, Diti Chatterjee; Cohen, Paul; Banks, Alexander S.; Khandekar, Melin J.; Danial, Nika N.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Lo, James C.; Ljubicic, Sanda; Kelly, Molly E.; Bhowmick, Diti Chatterjee; Cohen, Paul; Banks, Alexander S.; Khandekar, Melin J.; Danial, Nika N.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; [Lo, James C.; Cohen, Paul] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Leibiger, Barbara; Leibiger, Ingo B.; Moede, Tilo; Berggren, Per-Olof] Rolf Luft Res Ctr Diabet & Endocrinol, Karolinska Inst, S-17176 Stockholm, Sweden; [Kern, Matthias; Blueher, Matthias] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Murano, Incoronata; Cinti, Saverio] Univ Ancona, Dept Expt & Clin Med, I-60020 Ancona, Italy; [Dietrich, Arne] Univ Leipzig, Dept Surg, D-04103 Leipzig, Germany; [Flier, Jeffrey S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Karolinska Institutet; Leipzig University; Marche Polytechnic University; Leipzig University; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Banks, Alexander/B-4832-2012; Lo, James/GYR-1149-2022; Flier, jeffrey/AAG-6223-2019	Banks, Alexander/0000-0003-1787-6925; Lo, James/0000-0003-0244-1670; Moede, Tilo/0000-0002-2045-9244; CINTI, Saverio/0000-0003-0362-5017; Berggren, Per-Olof/0000-0001-8991-413X	Swiss National Science Foundation postdoctoral fellowship; Swedish Research Council; Family Erling-Persson Foundation; Novo Nordisk Foundation; Stichting af Jochnick Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; Knut and Alice Wallenberg Foundation; DIABAT [HEALTH-F2-2011-278373]; Deutsche Forschungsgemeinschaft "Obesity mechanisms'' [SFB 1052/1, B01]; NIH [DK097303, DK078081, DK031405];  [ERC-2013-AdG 338936-BetaImage]; Novo Nordisk Fonden [NNF12OC1016557] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031405, K08DK097303, R01DK078081, P30DK043351, R01DK031405] Funding Source: NIH RePORTER	Swiss National Science Foundation postdoctoral fellowship(Swiss National Science Foundation (SNSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Erling-Persson Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Stichting af Jochnick Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); DIABAT; Deutsche Forschungsgemeinschaft "Obesity mechanisms''(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Gregory L. Stahl (Brigham and Women's Hospital) for generously providing Adipsin<SUP>-/-</SUP> mice. We are grateful to Drs. Rana Gupta, Shingo Kajimura, Jennifer Estall, Christiane Wrann, Linus Tsai, Susan Bonner-Weir, Pere Puigserver, and Evan Rosen for helpful discussions. We thank Jennifer Hollister-Lock and the Islet Isolation Core at Joslin Diabetes Center for help with islet perfusions. Fluorescence images were acquired in the Confocal and Light Microscopy Core Facility at the Dana-Farber Cancer Institute. S. L. was supported by a Swiss National Science Foundation postdoctoral fellowship. This work was supported by the Swedish Research Council, the Family Erling-Persson Foundation, the Novo Nordisk Foundation, the Stichting af Jochnick Foundation, the Strategic Research Program in Diabetes at Karolinska Institutet, the ERC-2013-AdG 338936-BetaImage, the Knut and Alice Wallenberg Foundation, DIABAT HEALTH-F2-2011-278373 (S. C.), Deutsche Forschungsgemeinschaft the SFB 1052/1: "Obesity mechanisms'' (project B01 to M. B.), and NIH grants DK097303 (J.C.L.), DK078081 (N.N.D.), and DK031405 (B. M. S.).	Ahren B, 2003, INT J OBESITY, V27, P1037, DOI 10.1038/sj.ijo.0802369; Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; Bluher M, 2009, J CLIN ENDOCR METAB, V94, P2507, DOI 10.1210/jc.2009-0002; CHOY LN, 1992, J BIOL CHEM, V267, P12736; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Dahlke K, 2011, J IMMUNOL, V186, P3066, DOI 10.4049/jimmunol.1002741; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Dunmore SJ, 2013, J ENDOCRINOL, V216, pT37, DOI 10.1530/JOE-12-0278; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Enerback L., 1986, MAST CELL DIFFERENTI, P167; Ferrannini E, 2010, CELL METAB, V11, P349, DOI 10.1016/j.cmet.2010.04.009; Festa A, 2006, DIABETES, V55, P1114, DOI 10.2337/diabetes.55.04.06.db05-1100; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; NAPOLITANO A, 1994, INT J OBESITY, V18, P213; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Okamoto M, 2008, DIABETOLOGIA, V51, P827, DOI 10.1007/s00125-008-0944-9; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; PLATT KA, 1994, J BIOL CHEM, V269, P28558; Pomeroy C, 1997, CLIN EXP IMMUNOL, V108, P507, DOI 10.1046/j.1365-2249.1997.3921287.x; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001; Stahl GL, 2003, AM J PATHOL, V162, P449, DOI 10.1016/S0002-9440(10)63839-4; Staiger K, 2005, J CLIN ENDOCR METAB, V90, P6707, DOI 10.1210/jc.2005-0467; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011; TURNER RC, 1995, DIABETES, V44, P1249; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wetsel RA, 1999, J BIOL CHEM, V274, P19429, DOI 10.1074/jbc.274.27.19429; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Winzell MS, 2004, BIOCHEM BIOPH RES CO, V321, P154, DOI 10.1016/j.bbrc.2004.06.130; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Zhang JH, 2007, AM J PHYSIOL-ENDOC M, V292, pE1433, DOI 10.1152/ajpendo.00664.2006	61	215	227	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					41	53		10.1016/j.cell.2014.06.005	http://dx.doi.org/10.1016/j.cell.2014.06.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995977	Green Accepted, Bronze			2022-12-24	WOS:000340943100006
J	Fatkenheuer, G; Hirschel, B; Harbarth, S				Faetkenheuer, Gerd; Hirschel, Bernard; Harbarth, Stephan			Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence	LANCET			English	Editorial Material							INTERRUPTED TIME-SERIES; INTENSIVE-CARE UNITS; OF-THE-LITERATURE; SURGICAL-PATIENTS; CONTACT ISOLATION; INFECTION-CONTROL; RANDOMIZED-TRIAL; IMPACT; ACQUISITION; HOSPITALS		[Faetkenheuer, Gerd] Univ Hosp Cologne, Dept Internal Med 1, D-50937 Cologne, Germany; [Faetkenheuer, Gerd] German Ctr Infect Res DZIF, Bonn, Germany; [Hirschel, Bernard] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Hirschel, Bernard; Harbarth, Stephan] Fac Med, Geneva, Switzerland; [Harbarth, Stephan] Univ Hosp Geneva, Infect Control Program, Geneva, Switzerland	University of Cologne; German Center for Infection Research; University of Geneva; University of Geneva; University of Geneva	Fatkenheuer, G (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, Kerpener Str 62, D-50937 Cologne, Germany.	g.faetkenheuer@uni-koeln.de						Bessesen MT, 2013, AM J INFECT CONTROL, V41, P1048, DOI 10.1016/j.ajic.2013.01.032; Bouadma L, 2010, CLIN INFECT DIS, V51, P1115, DOI 10.1086/656737; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Derde LPG, 2014, LANCET INFECT DIS, V14, P31, DOI 10.1016/S1473-3099(13)70295-0; Evans HL, 2003, SURGERY, V134, P180, DOI 10.1067/msy.2003.222; Glick SB, 2014, AM J INFECT CONTROL, V42, P148, DOI 10.1016/j.ajic.2013.07.020; Gurieva T, 2012, CLIN INFECT DIS, V54, P1618, DOI 10.1093/cid/cis272; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Hardy K, 2010, CLIN MICROBIOL INFEC, V16, P333, DOI 10.1111/j.1469-0691.2009.02899.x; Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Huskins WC, 2011, NEW ENGL J MED, V364, P1407, DOI 10.1056/NEJMoa1000373; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Jeyaratnam D, 2008, BMJ-BRIT MED J, V336, P927, DOI 10.1136/bmj.39525.579063.BE; Kirkland KB, 2012, BMJ QUAL SAF, V21, P1019, DOI 10.1136/bmjqs-2012-000800; Lee AS, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003126; Lee AS, 2011, CLIN INFECT DIS, V52, P1422, DOI 10.1093/cid/cir233; Lee AS, 2011, INFECT DIS CLIN N AM, V25, P155, DOI 10.1016/j.idc.2010.11.002; MacKenzie FM, 2007, CLIN MICROBIOL INFEC, V13, P269, DOI 10.1111/j.1469-0691.2006.01592.x; McGinigle KL, 2008, CLIN INFECT DIS, V46, P1717, DOI 10.1086/587901; Morgan DJ, 2009, AM J INFECT CONTROL, V37, P85, DOI 10.1016/j.ajic.2008.04.257; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Saint S, 2003, AM J INFECT CONTROL, V31, P354, DOI 10.1016/S0196-6553(02)48250-8; Sroka S, 2010, J HOSP INFECT, V74, P204, DOI 10.1016/j.jhin.2009.08.023; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; Tarzi S, 2001, J HOSP INFECT, V49, P250, DOI 10.1053/jhin.2001.1098; Zingg W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093898	29	47	48	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1146	1149		10.1016/S0140-6736(14)60660-7	http://dx.doi.org/10.1016/S0140-6736(14)60660-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25150745				2022-12-24	WOS:000351270400033
J	McClure, C; Chandler, C; Bissell, S				McClure, Craig; Chandler, Caitlin; Bissell, Susan			Responses to HIV in sexually exploited children or adolescents who sell sex	LANCET			English	Editorial Material							INFECTION; WORKERS; INDIA; AGE		[McClure, Craig] UNICEF, New York, NY 10017 USA; HIV Young Leaders Fund, New York, NY USA	UNICEF	McClure, C (corresponding author), UNICEF, New York, NY 10017 USA.	cmcclure@unicef.org						[Anonymous], 2014, UN IATT TEC IN PRESS; Conner B, 2014, SEXUAL REPR IN PRESS; Goldenberg SM, 2012, AIDS BEHAV, V16, P969, DOI 10.1007/s10461-011-0063-3; Gupta J, 2009, INT J GYNECOL OBSTET, V107, P30, DOI 10.1016/j.ijgo.2009.06.009; Moscicki AB, 2001, J INFECT DIS, V183, P865, DOI 10.1086/319261; Sarkar K, 2008, J HEALTH POPUL NUTR, V26, P223; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Silverman JG, 2011, ARCH DIS CHILD, V96, P478, DOI 10.1136/adc.2009.178715; Strode A, 2009, S AFR J HIV MED, P8; UNAIDS, 2013, REP GLOB AIDS EP; UNICEF, 2010, BLAM BAN UND HIV EP; WHO, 2014, POL BRIEF Y IN PRESS	12	18	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					97	99		10.1016/S0140-6736(14)60979-X	http://dx.doi.org/10.1016/S0140-6736(14)60979-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25059951				2022-12-24	WOS:000347715900007
J	Santos, MA; Faryabi, RB; Ergen, AV; Day, AM; Malhowski, A; Canela, A; Onozawa, M; Lee, JE; Callen, E; Gutierrez-Martinez, P; Chen, HT; Wong, N; Finkel, N; Deshpande, A; Sharrow, S; Rossi, DJ; Ito, K; Ge, K; Aplan, PD; Armstrong, SA; Nussenzweig, A				Santos, Margarida A.; Faryabi, Robert B.; Ergen, Aysegul V.; Day, Amanda M.; Malhowski, Amy; Canela, Andres; Onozawa, Masahiro; Lee, Ji-Eun; Callen, Elsa; Gutierrez-Martinez, Paula; Chen, Hua-Tang; Wong, Nancy; Finkel, Nadia; Deshpande, Aniruddha; Sharrow, Susan; Rossi, Derrick J.; Ito, Keisuke; Ge, Kai; Aplan, Peter D.; Armstrong, Scott A.; Nussenzweig, Andre			DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; OXIDATIVE STRESS; RNA-SEQ; MLL; PROGENITORS; BREAKS; RESISTANCE; DISCOVERY; LYMPHOMA; RENEWAL	Self-renewal is the hallmark feature both of normal stem cells and cancer stem cells(1). Since the regenerative capacity of normal haematopoietic stem cells is limited by the accumulation of reactive oxygen species and DNA double-strand breaks(2-4), we speculated that DNA damage might also constrain leukaemic self-renewal and malignant haematopoiesis. Here we show that the histone methyl-transferase MLL4, a suppressor of B-cell lymphoma(5,6), is required for stem-cell activity and an aggressive form of acutemyeloid leukaemia harbouring the MLL-AF9 oncogene. Deletion of MLL4 enhances myelopoiesis and myeloid differentiation of leukaemic blasts, which protects mice from death related to acute myeloid leukaemia. MLL4 exerts its function by regulating transcriptional programs associated with the antioxidant response. Addition of reactive oxygen species scavengers or ectopic expression of FOXO3 protects MLL-/- MLL-AF9 cells from DNA damage and inhibits myeloid maturation. Similar to MLL4 deficiency, loss of ATM or BRCA1 sensitizes transformed cells to differentiation, suggesting that myeloid differentiation is promoted by loss of genome integrity. Indeed, we show that restriction-enzyme-induced double-strand breaks are sufficient to induce differentiation of MLL-AF9 blasts, which requires cyclin-dependent kinase inhibitor p21(Cip1) (Cdkn1a) activity. In summary, we have uncovered an unexpected tumour-promoting role of genome guardians in enforcing the oncogene-induced differentiation blockade in acute myeloid leukaemia.	[Santos, Margarida A.; Faryabi, Robert B.; Ergen, Aysegul V.; Day, Amanda M.; Malhowski, Amy; Canela, Andres; Callen, Elsa; Chen, Hua-Tang; Wong, Nancy; Finkel, Nadia; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Onozawa, Masahiro; Aplan, Peter D.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Lee, Ji-Eun; Ge, Kai] NIDDKD, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Gutierrez-Martinez, Paula; Rossi, Derrick J.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Gutierrez-Martinez, Paula; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Deshpande, Aniruddha; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Deshpande, Aniruddha; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Sharrow, Susan] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Ito, Keisuke] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Dept Cell Biol, Bronx, NY 10461 USA; [Ito, Keisuke] Albert Einstein Coll Med, Dept Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Nussenzweig, A (corresponding author), NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Lee, Ji-Eun/F-7891-2011; Santos, Margarida/GWR-2285-2022; Aplan, Peter D/K-9064-2016; Ge, Kai/H-2810-2019; Faryabi, Robert/AAN-5512-2020; Faryabi, Robert B/H-3544-2015	Lee, Ji-Eun/0000-0002-3768-7016; Ge, Kai/0000-0002-7442-5138; Faryabi, Robert/0000-0002-7931-2175; Faryabi, Robert B/0000-0002-7931-2175	Leukemia and Lymphoma Society; National Cancer Institute [CA66996, CA140575]; National Institutes of Health; National Cancer Institute; Center for Cancer Research; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA140575, ZICBC009255, R00CA139009, P01CA066996, ZIABC010983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098263, ZIADK075003, R01DK100689] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the A. Nussenzweig laboratory, J. Daniel and P. Love for discussions; L. Granger for flow cytometry; M. J. Kruhlak for microscopy; K. Zhao for RNA sequencing; R. Anderson and K. Smith for animal care; K. Naka for the FOXO3 retrovirus; G. Legube for the pBABE-AsiSI-ER plasmid; J. Zuber for pLEPG and pRT3GEPIR plasmids; O. Fernandez-Capetillo for ATRi; and S. John for suggestions. S. A. A. was supported by the Leukemia and Lymphoma Society and National Cancer Institute grants CA66996 and CA140575. This work was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute and the Center for Cancer Research, and an Ellison Medical Foundation Senior Scholar in Aging Award to A.N.	Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schoppy DW, 2012, J CLIN INVEST, V122, P241, DOI 10.1172/JCI58928; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Somervaille TCP, 2010, INT J HEMATOL, V91, P735, DOI 10.1007/s12185-010-0579-8; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	40	136	138	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					107	+		10.1038/nature13483	http://dx.doi.org/10.1038/nature13483			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25079327	Green Accepted			2022-12-24	WOS:000342420800045
J	Wright, JD; Tergas, AI; Burke, WM; Cui, RR; Ananth, CV; Chen, L; Hershman, DL				Wright, Jason D.; Tergas, Ana I.; Burke, William M.; Cui, Rosa R.; Ananth, Cande V.; Chen, Ling; Hershman, Dawn L.			Uterine Pathology in Women Undergoing Minimally Invasive Hysterectomy Using Morcellation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wright, Jason D.; Tergas, Ana I.; Burke, William M.; Cui, Rosa R.; Ananth, Cande V.; Chen, Ling] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; [Hershman, Dawn L.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Wright, JD (corresponding author), Columbia Univ Coll Phys & Surg, Div Gynecol Oncol, Dept Obstet & Gynecol, 161 Ft Washington Ave,Eighth Floor, New York, NY 10032 USA.	jw2459@columbia.edu	Hershman, Dawn/AAG-2114-2020		NCI NIH HHS [R25 CA094061-11, R01 CA134964, R25 CA094061, R01 CA169121, R01CA134964, R01CA169121-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA169121, R01CA134964, R25CA094061] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2014, LANCET ONCOL, V15, P123; Hagemann IS, 2011, INT J GYNECOL PATHOL, V30, P476, DOI 10.1097/PGP.0b013e3182107ecf; Kho KA, 2014, JAMA-J AM MED ASSOC, V311, P905, DOI 10.1001/jama.2014.1093; Oduyebo T, 2014, GYNECOL ONCOL, V132, P360, DOI 10.1016/j.ygyno.2013.11.024; Seidman MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050058; Wright JD, 2013, JAMA-J AM MED ASSOC, V309, P689, DOI 10.1001/jama.2013.186	6	111	113	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1253	1255		10.1001/jama.2014.9005	http://dx.doi.org/10.1001/jama.2014.9005			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25051495	Green Accepted, Bronze			2022-12-24	WOS:000341990600027
J	Nuotio, I; Hartikainen, JEK; Gronberg, T; Biancari, F; Airaksinen, KEJ				Nuotio, Ilpo; Hartikainen, Juha E. K.; Gronberg, Toni; Biancari, Fausto; Airaksinen, K. E. Juhani			Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Nuotio, Ilpo] Turku Univ Hosp, Div Med, Turku 20521, Finland; [Hartikainen, Juha E. K.] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Gronberg, Toni; Airaksinen, K. E. Juhani] Turku Univ Hosp, Ctr Heart, Turku 20521, Finland; [Biancari, Fausto] Oulu Univ Hosp, Dept Surg, Oulu, Finland	University of Turku; Kuopio University Hospital; University of Eastern Finland; University of Turku; University of Oulu	Airaksinen, KEJ (corresponding author), Turku Univ Hosp, Ctr Heart, POB 52, Turku 20521, Finland.	juhani.airaksinen@tyks.fi	Biancari, Fausto/A-1039-2008; Airaksinen, Juhani/AAC-7857-2021	Biancari, Fausto/0000-0001-5028-8186; Airaksinen, Juhani/0000-0002-0193-568X				Airaksinen KEJ, 2013, J AM COLL CARDIOL, V62, P1187, DOI 10.1016/j.jacc.2013.04.089; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	4	114	119	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					647	649		10.1001/jama.2014.3824	http://dx.doi.org/10.1001/jama.2014.3824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117135	Bronze			2022-12-24	WOS:000340136400025
J	Rabins, PV; Blass, DM; Cotton, D; Rao, JK; Taichman, D; Williams, S				Rabins, Peter V.; Blass, David M.; Cotton, Deborah; Rao, Jaya K.; Taichman, Darren; Williams, Sankey			Dementia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; NURSING-HOME PLACEMENT; QUALITY STANDARDS SUBCOMMITTEE; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIALS; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; NEUROPSYCHIATRIC SYMPTOMS; PRACTICE PARAMETER; AMERICAN-ACADEMY											Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bekelman DB, 2005, J PAIN SYMPTOM MANAG, V30, P208, DOI 10.1016/j.jpainsymman.2005.04.003; Beversdorf DQ, 2004, AM J GERIAT PSYCHIAT, V12, P542, DOI 10.1176/appi.ajgp.12.5.542; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Brodaty H, 2012, AM J PSYCHIAT, V169, P946, DOI 10.1176/appi.ajp.2012.11101529; Brodaty H, 2011, LANCET, V378, P375, DOI 10.1016/S0140-6736(11)61031-3; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Camargos EF, 2014, AM J GERIAT PSYCHIAT, V22, P1565, DOI 10.1016/j.jagp.2013.12.174; Chan DC, 2003, J GERONTOL A-BIOL, V58, P548; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; DeKosky S. T., 2008, JAMA-J AM MED ASSOC, V19, P2253, DOI DOI 10.1001/JAMA.2008.683; DeKosky ST, 2005, CURR ALZHEIMER RES, V2, P541; Dysken MW, 2014, JAMA-J AM MED ASSOC, V311, P33, DOI 10.1001/jama.2013.282834; Ely EW, JAMA; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Haupt M, 2000, INT J GERIATR PSYCH, V15, P1125, DOI 10.1002/1099-1166(200012)15:12<1125::AID-GPS257>3.0.CO;2-F; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Hunt LA, 1997, ARCH NEUROL-CHICAGO, V54, P707, DOI 10.1001/archneur.1997.00550180029008; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Iverson DJ, 2010, NEUROLOGY, V74, P1316, DOI 10.1212/WNL.0b013e3181da3b0f; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007, 10.1016/j.jalz.2013.06.001]; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kales HC, 2014, J AM GERIATR SOC, V62, P762, DOI 10.1111/jgs.12730; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; LARSON EB, 1987, ANN INTERN MED, V107, P169, DOI 10.7326/0003-4819-107-2-169; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Massoud F, 2000, J AM GERIATR SOC, V48, P1204, DOI 10.1111/j.1532-5415.2000.tb02591.x; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Nasreddine Z., 2014, MONTREAL COGNITIVE; Rabins Peter V, 2011, AJOB Prim Res, V2, P61; Rabins PV, 2006, PRACTICAL DEMENTIA C; Redelmeier DA, 2012, NEW ENGL J MED, V367, P1228, DOI 10.1056/NEJMsa1114310; Roalf DR, 2013, ALZHEIMERS DEMENT, V9, P529, DOI 10.1016/j.jalz.2012.10.001; Saint Louis University School of Medicine, SAINT LOUIS U MENT S; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Schmand B, 2014, J ALZHEIMERS DIS, V40, P409, DOI 10.3233/JAD-131484; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; U.S. Preventive Services Task Force, 2014, SCREEN COGN IMP OLD; Valcour VG, 2000, ARCH INTERN MED, V160, P2964, DOI 10.1001/archinte.160.19.2964; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123; Zubenko GS, 2003, AM J PSYCHIAT, V160, P857, DOI 10.1176/appi.ajp.160.5.857	56	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3							ITC1	10.7326/0003-4819-161-3-201408050-01002	http://dx.doi.org/10.7326/0003-4819-161-3-201408050-01002			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RD	25089871				2022-12-24	WOS:000364908500001
J	Forcada, J; Hoffman, JI				Forcada, Jaume; Hoffman, Joseph Ivan			Climate change selects for heterozygosity in a declining fur seal population	NATURE			English	Article							INBREEDING DEPRESSION; ARCTOCEPHALUS-GAZELLA; ADAPTATION; RESPONSES; GENETICS; SUCCESS; STRESS; MODEL; SIZE; LONG	Global environmental change is expected to alter selection pressures in many biological systems(1-3), but the long-term molecular and life history data required to quantify changes in selection are rare(4). An unusual opportunity is afforded by three decades of individual-based data collected from a declining population of Antarctic fur seals in the South Atlantic. Here, climate change has reduced prey availability and caused a significant decline in seal birth weight. However, the mean age and size of females recruiting into the breeding population are increasing. We show that such females have significantly higher heterozygosity (a measure of within-individual genetic variation) than their non-recruiting siblings and their own mothers. Thus, breeding female heterozygosity has increased by 8.5% per generation over the last two decades. Nonetheless, as heterozygosity is not inherited from mothers to daughters, substantial heterozygote advantage is not transmitted from one generation to the next and the decreasing viability of homozygous individuals causes the population to decline. Our results provide compelling evidence that selection due to climate change is intensifying, with far-reaching consequences for demography as well as phenotypic and genetic variation.	[Forcada, Jaume] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Hoffman, Joseph Ivan] Univ Bielefeld, Dept Anim Behav, D-33501 Bielefeld, Germany	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Bielefeld	Forcada, J (corresponding author), British Antarctic Survey, Nat Environm Res Council, Madingley Rd, Cambridge CB3 0ET, England.	jfor@bas.ac.uk	Forcada, Jaume/GYU-0677-2022; Hoffman, Joseph i/K-7725-2012	Hoffman, Joseph i/0000-0001-5895-8949	Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme [PCIG-GA-2011-303618]; Deutsche Forschungsgemeinschaft standard grant [HO 5122/3-1]	Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme; Deutsche Forschungsgemeinschaft standard grant	The authors thank the many fieldworkers who have contributed to data collection over the years. We are also grateful to W. Amos, J. Bascompte, M. Boerner, K. Dasmahapatra, O. Kruger and I. Staniland for advice and feedback on the manuscript, together with T. Coulson for helpful referee comments. This work contributes to the Long Term Monitoring and Survey project and Ecosystems project of the British Antarctic Survey, Natural Environment Research Council, part of the Polar Science for Planet Earth programme. The genetic work was supported by a Marie Curie FP7-Reintegration-Grant within the 7th European Community Framework Programme (PCIG-GA-2011-303618) and a Deutsche Forschungsgemeinschaft standard grant (HO 5122/3-1) awarded to J.I.H.	Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Coulson T, 2010, J ANIM ECOL, V79, P1226, DOI 10.1111/j.1365-2656.2010.01734.x; Di Fonzo MMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019667; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Forcada J, 2005, ECOLOGY, V86, P2408, DOI 10.1890/04-1153; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Franks SJ, 2012, ANNU REV GENET, V46, P185, DOI 10.1146/annurev-genet-110711-155511; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Hoffman JI, 2012, MOL ECOL RESOUR, V12, P861, DOI 10.1111/j.1755-0998.2012.03158.x; Hoffman JI, 2004, EVOLUTION, V58, P2087; Hoffman JI, 2014, P NATL ACAD SCI USA, V111, P3775, DOI 10.1073/pnas.1318945111; Hoffman JI, 2010, J HERED, V101, P527, DOI 10.1093/jhered/esq045; Hoffmann AA, 2000, BIOSCIENCE, V50, P217, DOI 10.1641/0006-3568(2000)050[0217:ESAAEF]2.3.CO;2; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Meredith MP, 2008, DEEP-SEA RES PT II, V55, P2007, DOI 10.1016/j.dsr2.2008.05.020; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; MITTON JB, 1993, HEREDITY, V71, P59, DOI 10.1038/hdy.1993.107; Murphy EJ, 2007, P ROY SOC B-BIOL SCI, V274, P3057, DOI 10.1098/rspb.2007.1180; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; SAMOLLOW PB, 1983, EVOLUTION, V37, P646, DOI 10.1111/j.1558-5646.1983.tb05584.x; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x	26	99	104	1	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					462	+		10.1038/nature13542	http://dx.doi.org/10.1038/nature13542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056064				2022-12-24	WOS:000339335700045
J	Chi, BH; Thirumurthy, H; Stringer, JSA				Chi, Benjamin H.; Thirumurthy, Harsha; Stringer, Jeffrey S. A.			Maximizing Benefits of New Strategies to Prevent Mother-to-Child HIV Transmission Without Harming Existing Services	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AFRICA		[Chi, Benjamin H.; Thirumurthy, Harsha; Stringer, Jeffrey S. A.] Univ N Carolina, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Chi, BH (corresponding author), POB 34681,5032 Great North Rd, Lusaka, Zambia.	bchi@med.unc.edu	Stringer, Jeffrey S. A./AAU-2342-2021	Thirumurthy, Harsha/0000-0002-3308-7603; Stringer, Jeffrey/0000-0002-9590-7216	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075131, K01HD061605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI050410] Funding Source: Medline; NICHD NIH HHS [P2C HD050924, K01 HD061605, R01 HD075131] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Duber HC, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-21; Goodson JL, 2013, JAIDS-J ACQ IMM DEF, V63, pE9, DOI 10.1097/QAI.0b013e31828a3e3f; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Nelson LJ, 2014, AIDS, V28, pS217, DOI 10.1097/QAD.0000000000000239; Rasschaert Freya, 2011, J Int AIDS Soc, V14 Suppl 1, pS3, DOI 10.1186/1758-2652-14-S1-S3; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522	8	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					341	342		10.1001/jama.2014.6929	http://dx.doi.org/10.1001/jama.2014.6929			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038348	Green Accepted			2022-12-24	WOS:000339257800016
J	Eisenstein, M				Eisenstein, Michael			NEUROBIOLOGY Unrestrained excitement	NATURE			English	Editorial Material																		Christian CA, 2013, P NATL ACAD SCI USA, V110, P20278, DOI 10.1073/pnas.1318031110; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Schevon CA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2056; Wykes RC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004190	4	5	5	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S4	S6		10.1038/511S4a	http://dx.doi.org/10.1038/511S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019125	Bronze			2022-12-24	WOS:000338649800002
J	Kapoor, A				Kapoor, Akhil			PERSONAL VIEW A train offers hope to Punjab's patients with cancer but it isn't enough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Sardar Patel Med Coll & Hosp, Acharya Tulsi Reg Canc Treatment & Res Ctr, Dept Radiat Oncol, Bikaner 334003, Rajasthan, India	Sardar Patel Medical College, Bikaner	Kapoor, A (corresponding author), Sardar Patel Med Coll & Hosp, Acharya Tulsi Reg Canc Treatment & Res Ctr, Dept Radiat Oncol, Bikaner 334003, Rajasthan, India.	kapoorakhil1987@gmail.com	Kapoor, Akhil/H-4224-2019	Kapoor, Akhil/0000-0001-6006-2631				Government of Punjab, 2013, STAT WID DOOR DOOR C; Indian Railways, CONC RUL; Kaur J., 2012, GOVERNANCE NOW  0420; Kaur Raminderjeet, 2011, Indian J Hum Genet, V17, P179, DOI 10.4103/0971-6866.92100; Mallath MK, 2014, LANCET ONCOL, V15, pE205, DOI 10.1016/S1470-2045(14)70115-9; Nayak R., 2013, HLTH SITE       0130; Sandhu K., 2009, TRIBUNE INDIA   1001; US Environmental Protection Agency, BANN SEV RESTR PEST; US Library of Congress, COUNTR STUD	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4484	10.1136/bmj.g4484	http://dx.doi.org/10.1136/bmj.g4484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005259				2022-12-24	WOS:000338993300010
J	Taylor, RW; Pyle, A; Griffin, H; Blakely, EL; Duff, J; He, LP; Smertenko, T; Alston, CL; Neeve, VC; Best, A; Yarham, JW; Kirschner, J; Schara, U; Talim, B; Topaloglu, H; Baric, I; Holinski-Feder, E; Abicht, A; Czermin, B; Kleinle, S; Morris, AAM; Vassallo, G; Gorman, GS; Ramesh, V; Turnbull, DM; Santibanez-Koref, M; McFarland, R; Horvath, R; Chinnery, PF				Taylor, Robert W.; Pyle, Angela; Griffin, Helen; Blakely, Emma L.; Duff, Jennifer; He, Langping; Smertenko, Tania; Alston, Charlotte L.; Neeve, Vivienne C.; Best, Andrew; Yarham, John W.; Kirschner, Janbernd; Schara, Ulrike; Talim, Beril; Topaloglu, Haluk; Baric, Ivo; Holinski-Feder, Elke; Abicht, Angela; Czermin, Birgit; Kleinle, Stephanie; Morris, Andrew A. M.; Vassallo, Grace; Gorman, Grainne S.; Ramesh, Venkateswaran; Turnbull, Douglass M.; Santibanez-Koref, Mauro; McFarland, Robert; Horvath, Rita; Chinnery, Patrick F.			Use of Whole-Exome Sequencing to Determine the Genetic Basis of Multiple Mitochondrial Respiratory Chain Complex Deficiencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRANSFER-RNA SYNTHETASE; SIDEROBLASTIC ANEMIA-MLASA; HYPERTROPHIC CARDIOMYOPATHY; LACTIC-ACIDOSIS; I DEFICIENCY; TRANSLATION DEFECT; HIGH-THROUGHPUT; RMND1 MUTATION; DISORDERS; DISEASE	IMPORTANCE Mitochondrial disorders have emerged as a common cause of inherited disease, but their diagnosis remains challenging. Multiple respiratory chain complex defects are particularly difficult to diagnose at the molecular level because of the massive number of nuclear genes potentially involved in intramitochondrial protein synthesis, with many not yet linked to human disease. OBJECTIVE To determine the molecular basis of multiple respiratory chain complex deficiencies. DESIGN, SETTING, AND PARTICIPANTS We studied 53 patients referred to 2 national centers in the United Kingdom and Germany between 2005 and 2012. All had biochemical evidence of multiple respiratory chain complex defects but no primary pathogenic mitochondrial DNA mutation. Whole-exome sequencing was performed using 62-Mb exome enrichment, followed by variant prioritization using bioinformatic prediction tools, variant validation by Sanger sequencing, and segregation of the variant with the disease phenotype in the family. RESULTS Presumptive causal variants were identified in 28 patients (53%; 95% CI, 39%-67%) and possible causal variants were identified in 4 (8%; 95% CI, 2%-18%). Together these accounted for 32 patients (60% 95% CI, 46%-74%) and involved 18 different genes. These included recurrent mutations in RMND1, AARS2, and MTO1, each on a haplotype background consistent with a shared founder allele, and potential novel mutations in 4 possible mitochondrial disease genes (VARS2, GARS, FLAD1, and PTCD1). Distinguishing clinical features included deafness and renal involvement associated with RMND1 and cardiomyopathy with AARS2 and MTO1. However, atypical clinical features were present in some patients, including normal liver function and Leigh syndrome (subacute necrotizing encephalomyelopathy) seen in association with TRMU mutations and no cardiomyopathy with founder SCO2 mutations. It was not possible to confidently identify the underlying genetic basis in 21 patients (40%; 95% CI, 26%-54%). CONCLUSIONS AND RELEVANCE Exome sequencing enhances the ability to identify potential nuclear gene mutations in patients with biochemically defined defects affecting multiple mitochondrial respiratory chain complexes. Additional study is required in independent patient populations to determine the utility of this approach in comparison with traditional diagnostic methods.	[Taylor, Robert W.; Blakely, Emma L.; He, Langping; Alston, Charlotte L.; Yarham, John W.; Gorman, Grainne S.; Turnbull, Douglass M.; McFarland, Robert] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Pyle, Angela; Griffin, Helen; Duff, Jennifer; Smertenko, Tania; Neeve, Vivienne C.; Best, Andrew; Santibanez-Koref, Mauro; Horvath, Rita; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kirschner, Janbernd] Univ Med Ctr Freiburg, Div Neuropediat & Muscle Disorders, Freiburg, Germany; [Schara, Ulrike] Univ Essen Gesamthsch, Dept Neuropediat, Essen, Germany; [Talim, Beril; Topaloglu, Haluk] Hacettepe Univ, Dept Pediat, Ankara, Turkey; [Baric, Ivo] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Paediat, Zagreb 41001, Croatia; [Holinski-Feder, Elke; Abicht, Angela; Czermin, Birgit; Kleinle, Stephanie] Ctr Med Genet, Munich, Germany; [Morris, Andrew A. M.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Willink Biochem Genet Unit, Manchester, Lancs, England; [Vassallo, Grace] Cent Manchester Univ Hosp NHS Fdn Trust, Dept Paediat Neurol, Manchester, Lancs, England; [Ramesh, Venkateswaran; McFarland, Robert] Newcastle Upon Tyne Hosp NHS Trust, Dept Paediat Neurol, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; University of Freiburg; University of Duisburg Essen; Hacettepe University; University of Zagreb; University of Manchester; University of Manchester; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Chinnery, PF (corresponding author), Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Cent Pkwy, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	patrick.chinnery@ncl.ac.uk	Horvath, Rita/AAY-7042-2020; Alston, Charlotte/ABG-9602-2020; Kirschner, Janbernd/Q-1493-2019; TOPALOGLU, HALUK AYDIN/I-9318-2013; Kirschner, Janbernd/H-7418-2016	Alston, Charlotte/0000-0003-2095-5464; Kirschner, Janbernd/0000-0003-1618-7386; Kirschner, Janbernd/0000-0003-1618-7386; Gorman, Grainne/0000-0002-7585-3409; Griffin, Helen R/0000-0002-5288-3322; Chinnery, Patrick/0000-0002-7065-6617; Turnbull, Doug/0000-0002-8878-9901; McFarland, Robert/0000-0002-8833-2688; Horvath, Rita/0000-0002-9841-170X	Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; UK Medical Research Council Centre for Translational Muscle Diseases [G0601943]; Mitochondrial Disease Patient Cohort [G0800674]; UK Medical Research Council [G1000848]; European Research Council [309548]; Wellcome Trust Senior Fellow in Clinical Science [101876/Z/13/Z]; EU FP7 TIRCON; NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University; MRC [G0601943, MR/K006312/1, G0800674, G1000848, MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1, G1000848, MR/K000608/1, G0601943, G0800674] Funding Source: researchfish; National Institute for Health Research [NIHR-HCS-D12-03-04] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish	Wellcome Trust Centre for Mitochondrial Research(Wellcome Trust); UK Medical Research Council Centre for Translational Muscle Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mitochondrial Disease Patient Cohort; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust Senior Fellow in Clinical Science(Wellcome Trust); EU FP7 TIRCON; NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre	Drs Taylor, Turnbull, and Chinnery receive support from the Wellcome Trust Centre for Mitochondrial Research (grant 096919Z/11/Z). Drs Taylor, Gorman, Turnbull, McFarland, Horvath, and Chinnery receive support from the UK Medical Research Council Centre for Translational Muscle Diseases (grant G0601943) and Mitochondrial Disease Patient Cohort (grant G0800674). Dr Horvath was supported by the UK Medical Research Council (grant G1000848) and the European Research Council (grant 309548). Dr Chinnery is a Wellcome Trust Senior Fellow in Clinical Science (grant 101876/Z/13/Z), is a UK National Institute for Health Research (NIHR) senior investigator, and receives additional support from EU FP7 TIRCON and the NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004; Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393; Brizio C, 2006, BIOCHEM BIOPH RES CO, V344, P1008, DOI 10.1016/j.bbrc.2006.04.003; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Garcia-Diaz B, 2012, AM J HUM GENET, V91, P729, DOI 10.1016/j.ajhg.2012.08.019; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Gotz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006; Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577; Janer A, 2012, AM J HUM GENET, V91, P737, DOI 10.1016/j.ajhg.2012.08.020; Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2; McMillan HJ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-36; Papadopoulou LC, 1999, NAT GENET, V23, P333; Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; Rotig A, 2010, DIABETES METAB, V36, P97, DOI 10.1016/j.diabet.2009.11.002; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Skladal D, 2000, J INHERIT METAB DIS, V23, P513, DOI 10.1023/A:1005620515996; Steenweg ME, 2012, ARCH NEUROL-CHICAGO, V69, P718, DOI 10.1001/archneurol.2011.1048; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004	38	229	233	5	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					68	77		10.1001/jama.2014.7184	http://dx.doi.org/10.1001/jama.2014.7184			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	25058219	Green Accepted			2022-12-24	WOS:000338131100022
J	Zhang, QF; Siegel, TN; Martins, RM; Wang, F; Cao, J; Gao, Q; Cheng, X; Jiang, LB; Hon, CC; Scheidig-Benatar, C; Sakamoto, H; Turner, L; Jensen, ATR; Claes, A; Guizetti, J; Malmquist, NA; Scherf, A				Zhang, Qingfeng; Siegel, T. Nicolai; Martins, Rafael M.; Wang, Fei; Cao, Jun; Gao, Qi; Cheng, Xiu; Jiang, Lubin; Hon, Chung-Chau; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Turner, Louise; Jensen, Anja T. R.; Claes, Aurelie; Guizetti, Julien; Malmquist, Nicholas A.; Scherf, Artur			Exonuclease-mediated degradation of nascent RNA silences genes linked to severe malaria	NATURE			English	Article							MUTUALLY EXCLUSIVE EXPRESSION; ANTIGENIC VARIATION; VIRULENCE GENES; PLASMODIUM; EXORIBONUCLEASE; TRANSCRIPTION; DOMAINS; BINDING; SUBSET; SHOWS	Antigenic variation of the Plasmodium falciparum multicopy vargene family enables parasite evasion of immune destruction by host antibodies(1),(2). Expression of a particularvar subgroup, termed upsA, is linked to the obstruction of blood vessels in the brain and to the pathogenesis of human cerebralmalaria(3-6). The mechanism determining upsA activation remains unknown. Here we show that an entirely new type of gene silencing mechanism involving an exonuclease-mediated degradation of nascent RNA controls the silencing of genes linked to severe malaria. We identify a novel chromatin-associated exoribonuclease, termed PfR Nase II, that controls the silencing of upsA var genes by marking their transcription start site and intron-promoter regions leading to short-lived cryptic RNA. Parasites carrying a deficient PfRNase II gene produce full-lengthups Avar transcripts and intron-derived antisense longnon-coding RNA. The presence of stable upsA var transcripts overcomes monoallelic expression, resulting in the simultaneous expression of both upsA and upsC type PfEMP1 proteins on the surface of individual infected red blood cells. In addition, we observe an inverse relationship between transcript levels of PfRNase II andupsA-type var genes in parasites from severe malaria patients, implying a crucial role of PfRNase II in severe malaria. Our results uncover a previously unknown type of post-transcriptional gene silencing mechanism in malaria parasites with repercussions for other organisms. Additionally, the identification of RNase II as a parasite protein controlling the expression of virulence genes involved in pathogenesis in patients with severe malaria may provide new strategies for reducing malaria mortality.	[Zhang, Qingfeng; Wang, Fei] Tongji Univ Sch Med, Shanghai East Hosp, Res Ctr Translat Med, Shanghai 200120, Peoples R China; [Zhang, Qingfeng; Wang, Fei] Tongji Univ Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200120, Peoples R China; [Zhang, Qingfeng; Siegel, T. Nicolai; Martins, Rafael M.; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Claes, Aurelie; Guizetti, Julien; Malmquist, Nicholas A.; Scherf, Artur] Inst Pasteur, Unite Biol Interact Hote Paras, F-75724 Paris, France; [Zhang, Qingfeng; Siegel, T. Nicolai; Martins, Rafael M.; Scheidig-Benatar, Christine; Sakamoto, Hiroshi; Claes, Aurelie; Guizetti, Julien; Malmquist, Nicholas A.; Scherf, Artur] CNRS, URA 2581, F-75724 Paris, France; [Cao, Jun; Gao, Qi] Jiangsu Inst Parasit Dis, Key Lab Parasit Dis Control & Prevent, Minist Hlth, Wuxi 214064, Peoples R China; [Cao, Jun; Gao, Qi] Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi 214064, Peoples R China; [Cheng, Xiu; Jiang, Lubin] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Hon, Chung-Chau] Inst Pasteur, Cell Biol Parasitism Unit, F-75724 Paris, France; [Hon, Chung-Chau] Inst Pasteur, INSERM, U786, F-75724 Paris, France; [Turner, Louise; Jensen, Anja T. R.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Turner, Louise; Jensen, Anja T. R.] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	Tongji University; Tongji University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Copenhagen; Rigshospitalet; University of Copenhagen	Scherf, A (corresponding author), Inst Pasteur, Unite Biol Interact Hote Paras, F-75724 Paris, France.	qfzhangsh@aliyun.com; artur.scherf@pasteur.fr	Jensen, Anja Ramstedt/AAL-3119-2021; Guizetti, Julien/AAF-3793-2020; Jensen, Anja Tatiana TR Ramstedt/T-3583-2017; Cao, Jun/AAR-7268-2020; Siegel, Tim Nicolai/F-2502-2013	Jensen, Anja Ramstedt/0000-0002-4004-7554; Guizetti, Julien/0000-0002-8762-4259; Jensen, Anja Tatiana TR Ramstedt/0000-0002-4004-7554; Cao, Jun/0000-0001-5298-9234; Siegel, Tim Nicolai/0000-0002-1715-7907; Malmquist, Nicholas/0000-0003-2822-8245; ZHANG, Qingfeng/0000-0002-8759-9102; Hon, Chung-Chau/0000-0002-3741-7577; Guizetti, Julien/0000-0002-7735-4689; miyazawa martins, rafael/0000-0001-7449-0696; Turner, Louise/0000-0003-4494-2289; Scherf, Artur/0000-0003-2411-3328; Sakamoto, Hiroshi/0000-0002-8767-2111	European Research Council [250320]; French Parasitology consortium ParaFrap [ANR-11-LABX0024]; National Natural Science Foundation of China (NSFC) [31271388]; French National Research Agency-NSFC [13-ISV3-0003-01, 81361130411]; Fundamental Research Funds for the Central Universities of China [20123283]; Human Frontier Science Program; European Molecular Biology Organization long-term fellowship; NSFC [81271870]; Novo Nordisk Fonden [NNF13OC0006249] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); French Parasitology consortium ParaFrap; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); French National Research Agency-NSFC(French National Research Agency (ANR)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Human Frontier Science Program(Human Frontier Science Program); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); NSFC(National Natural Science Foundation of China (NSFC)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank T. Wandless for providing Shld1 compound. This work was supported by a European Research Council Advanced Grant (PlasmoEscape 250320), the French Parasitology consortium ParaFrap (ANR-11-LABX0024), the National Natural Science Foundation of China (NSFC; no. 31271388), the French National Research Agency (13-ISV3-0003-01)-NSFC (no. 81361130411) International Collaboration Project, and the Fundamental Research Funds for the Central Universities of China (20123283). T.N.S. was supported by the Human Frontier Science Program and a European Molecular Biology Organization long-term fellowship. J.C. was supported by the NSFC (no. 81271870). J.G. was supported by the Human Frontier Science Program.	Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Deitsch KW, 2012, P NATL ACAD SCI USA, V109, P10130, DOI 10.1073/pnas.1207174109; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gudipati RK, 2012, EMBO J, V31, P2427, DOI 10.1038/emboj.2012.81; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kiss DL, 2011, RNA, V17, P1, DOI 10.1261/rna.2364811; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 2003, MOL MICROBIOL, V48, P1339, DOI 10.1046/j.1365-2958.2003.03505.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mancio-Silva Liliana, 2013, Methods Mol Biol, V923, P335; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mourier T, 2008, GENOME RES, V18, P281, DOI 10.1101/gr.6836108; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Ralph SA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r93; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Scherf A, 2008, CELL, V134, P190, DOI 10.1016/j.cell.2008.06.042; Staals RHJ, 2010, EMBO J, V29, P2358, DOI 10.1038/emboj.2010.122; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Zhang QF, 2011, CELL HOST MICROBE, V10, P451, DOI 10.1016/j.chom.2011.09.013	39	52	55	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					431	+		10.1038/nature13468	http://dx.doi.org/10.1038/nature13468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043062				2022-12-24	WOS:000341814900063
J	Durr, KL; Chen, L; Stein, RA; De Zorzi, R; Folea, IM; Walz, T; Mchaourab, HS; Gouaux, E				Duerr, Katharina L.; Chen, Lei; Stein, Richard A.; De Zorzi, Rita; Folea, I. Mihaela; Walz, Thomas; Mchaourab, Hassane S.; Gouaux, Eric			Structure and Dynamics of AMPA Receptor GluA2 in Resting, Pre-Open, and Desensitized States	CELL			English	Article							LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; GLUTAMATE-RECEPTOR; DISTANCE MEASUREMENTS; HIPPOCAMPAL-NEURONS; SYNAPTIC CURRENTS; MOLECULAR-CLONING; TERMINAL DOMAIN; CRYO-EM; ACTIVATION	Ionotropic glutamate receptors (iGluRs) mediate the majority of fast excitatory signaling in the nervous system. Despite the profound importance of iGluRs to neurotransmission, little is known about the structures and dynamics of intact receptors in distinct functional states. Here, we elucidate the structures of the intact GluA2 AMPA receptor in an apo resting/closed state, in an activated/pre-open state bound with partial agonists and a positive allosteric modulator, and in a desensitized/closed state in complex with fluorowilliardiine. To probe the conformational properties of these states, we carried out double electron-electron resonance experiments on cysteine mutants and cryoelectron microscopy studies. We show how agonist binding modulates the conformation of the ligand-binding domain "layer" of the intact receptors and how, upon desensitization, the receptor undergoes large conformational rearrangements of the amino-terminal and ligand-binding domains. We define mechanistic principles by which to understand antagonism, activation, and desensitization in AMPA iGluRs.	[Duerr, Katharina L.; Chen, Lei; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Stein, Richard A.; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [De Zorzi, Rita; Folea, I. Mihaela; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Duerr, Katharina/A-6975-2015	Gouaux, Eric/0000-0002-8549-2360; Walz, Thomas/0000-0003-2606-2835; Duerr, Katharina/0000-0002-3245-4088; DE ZORZI, Rita/0000-0001-7001-7498; Chen, Lei/0000-0002-7619-8311	American Heart Association postdoctoral fellowship [13POST13960004]; Long-Term Fellowship of the European Molecular Biology Organization; institutional National Research Service Award (NRSA); individual NRSA [F32MH100331]; NIH [NCRR 1S10RR028832-01];  [U54-GM087519];  [S10 RR027091]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027091, S10RR028832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077659, U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH100331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800, R01NS038631, R37NS038631] Funding Source: NIH RePORTER	American Heart Association postdoctoral fellowship(American Heart Association); Long-Term Fellowship of the European Molecular Biology Organization; institutional National Research Service Award (NRSA); individual NRSA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Vaskalis for figures, ALS BCSB and APS NE-CAT beamline staff for support, and M. Suga for early work on thermostability mutation screening. We thank P. Penczek for guidance in the use of SPARX and ISAC. L.C. is supported by an American Heart Association postdoctoral fellowship (13POST13960004). K.L.D. was supported by a Long-Term Fellowship of the European Molecular Biology Organization and an institutional National Research Service Award (NRSA) and is currently the recipient of an individual NRSA (F32MH100331). H.S.M. and R.A.S. were supported by grants U54-GM087519 and S10 RR027091. The Orchestra High Performance Compute Cluster at Harvard Medical School is a shared facility partially supported by NIH grant NCRR 1S10RR028832-01. This work was supported by the NIH (E.G.). E.G. and T.W. are investigators with the Howard Hughes Medical Institute.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; BERTOLINO M, 1993, RECEPTOR CHANNEL, V1, P267; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; Christie LA, 2010, P NATL ACAD SCI USA, V107, P9412, DOI 10.1073/pnas.0908206107; Dong H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1362; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; ISAACSON JS, 1991, P NATL ACAD SCI USA, V88, P10936, DOI 10.1073/pnas.88.23.10936; Jeschke G, 2002, CHEMPHYSCHEM, V3, P927, DOI 10.1002/1439-7641(20021115)3:11<927::AID-CPHC927>3.0.CO;2-Q; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Kaae BH, 2007, CHEM BIOL, V14, P1294, DOI 10.1016/j.chembiol.2007.10.012; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Levchenko-Lambert Y, 2011, J NEUROSCI, V31, P9359, DOI 10.1523/JNEUROSCI.6761-10.2011; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Moykkynen T, 2014, J BIOL CHEM, V289, P13197, DOI 10.1074/jbc.M113.526301; O'Neill MJ, 2004, CNS NEUROL DISORD-DR, V3, P181, DOI 10.2174/1568007043337508; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; YAMADA KA, 1992, J PHYSIOL-LONDON, V458, P409, DOI 10.1113/jphysiol.1992.sp019424; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670	50	154	154	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					778	792		10.1016/j.cell.2014.07.023	http://dx.doi.org/10.1016/j.cell.2014.07.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25109876	Green Accepted, Bronze			2022-12-24	WOS:000340944700010
J	Smith, MTJ; Rubinstein, JL				Smith, Martin T. J.; Rubinstein, John L.			STRUCTURAL BIOLOGY Beyond blob-ology	SCIENCE			English	Editorial Material							BEAM-INDUCED MOTION; CRYOELECTRON MICROSCOPY; ELECTRON CRYOMICROSCOPY; CRYO-EM		[Smith, Martin T. J.; Rubinstein, John L.] Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada; [Rubinstein, John L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Rubinstein, John L.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Smith, MTJ (corresponding author), Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada.	john.rubinstein@utoronto.ca						Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; DUBOCHET J, 1982, ULTRAMICROSCOPY, V10, P55, DOI 10.1016/0304-3991(82)90187-5; Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872; Henderson R, 2013, P NATL ACAD SCI USA, V110, P18037, DOI 10.1073/pnas.1314449110; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Ruskin RS, 2013, J STRUCT BIOL, V184, P385, DOI 10.1016/j.jsb.2013.10.016; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041	14	34	35	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					617	619		10.1126/science.1256358	http://dx.doi.org/10.1126/science.1256358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104368				2022-12-24	WOS:000339962800016
J	O'Gara, PT; Harold, JG; Zoghbi, WA				O'Gara, Patrick T.; Harold, John Gordon; Zoghbi, William A.			Thinking globally to transform cardiovascular care	LANCET			English	Editorial Material									[O'Gara, Patrick T.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Harold, John Gordon] Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA; [Zoghbi, William A.] Houston Methodist Hosp, Dept Cardiol, Houston, TX USA	Harvard University; Brigham & Women's Hospital; Cedars Sinai Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston	O'Gara, PT (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	pogara@partners.org	Harold, John Gordon/AAS-9266-2021	Harold, John Gordon/0000-0001-6475-4002				American College of Cardiology, 2014, 47 ANN NEW YORK CARD; American College of Cardiology Brazilian Society of Cardiology, 2014, 3 ANN CARD S BRAZ MA; American College of Cardiology Foundation, 2014, NAT CARD DAT; American College of Cardiology Foundation, PINNACLE IND HEALTHC; American College of Cardiology Foundation, 2012, CARDIOLOGY, V41, P23; CardioSmart American College of Cardiology, 2014, CARD ESP; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; World Health Organization, 2013, PROP PROGR BUDG 2014; World Health Organization, WHO NCD SURV STRAT; World Health Organization, 2013, GLOB ACT PLAN PREV C	10	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					379	380		10.1016/S0140-6736(14)61141-7	http://dx.doi.org/10.1016/S0140-6736(14)61141-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9IV	25088849				2022-12-24	WOS:000340195800005
J	Chang, LF; Zhang, ZG; Yang, J; McLaughlin, SH; Barford, D				Chang, Leifu; Zhang, Ziguo; Yang, Jing; McLaughlin, Stephen H.; Barford, David			Molecular architecture and mechanism of the anaphase-promoting complex	NATURE			English	Article							MITOTIC CHECKPOINT COMPLEX; UBIQUITIN CHAIN ELONGATION; EM STRUCTURE DETERMINATION; CULLIN-RING LIGASES; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; STRUCTURAL INSIGHTS; DEGRON RECOGNITION; SUBSTRATE-BINDING	The ubiquitination of cell cycle regulatory proteins by the anaphase-promoting complex/cyclosome(APC/C) controls sister chromatid segregation, cytokinesis and the establishment of the G1 phase of the cell cycle. The APC/C is an unusually large multimeric cullin-RING ligase. Its activity is strictly dependent on regulatory coactivator subunits that promote APC/C-substrate interactions and stimulate its catalytic reaction. Because the structures of many APC/C subunits and their organization within the assembly are unknown, the molecular basis for these processes is poorly understood. Here, from a cryo-electron microscopy reconstruction of a human APC/C-coactivator-substrate complex at 7.4 angstrom resolution, we have determined the complete secondary structural architecture of the complex. With this information we identified protein folds for structurally uncharacterized subunits, and the definitive location of all 20 APC/C subunits within the 1.2 MDa assembly. Comparison with apo APC/C shows that the coactivator promotes a profound allosteric transition involving displacement of the cullin-RING catalytic subunits relative to the degron-recognition module of coactivator and APC10. This transition is accompanied by increased flexibility of the cullin-RING subunits and enhanced affinity for UBCH10-ubiquitin, changes which may contribute to coactivator-mediated stimulation of APC/C E3 ligase activity.	[Chang, Leifu; Zhang, Ziguo; Yang, Jing; Barford, David] Inst Canc Res, Div Struct Biol, London SW3 6JB, England; [Chang, Leifu; Zhang, Ziguo; Yang, Jing; McLaughlin, Stephen H.; Barford, David] MRC Lab Mol Biol, Cambridge CB2 0QH, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; MRC Laboratory Molecular Biology	Barford, D (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	dbarford@mrc-lmb.cam.ac.uk		Yang, Jing/0000-0002-8984-4503; Barford, David/0000-0001-8810-950X; Zhang, Ziguo/0000-0002-7268-9631; McLaughlin, Stephen/0000-0001-9135-6253	Cancer Research UK; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [MC_UP_1201/6] Funding Source: researchfish; MRC [MC_UP_1201/6] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. da Fonseca for her guidance preparing cryo electron microscopy grids and X. Bai and S. Scheres for help with the use of RELION and A. Plechanovova for advice in preparing stable UBCH10-Ub conjugates. We thank D. Morgan and W. Chao for their comments on the manuscript and D. Morgan for communicating data before publication. This work was funded by a Cancer Research UK grant to D.B.	Au SWN, 2002, J MOL BIOL, V316, P955, DOI 10.1006/jmbi.2002.5399; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Buschhorn BA, 2011, NAT STRUCT MOL BIOL, V18, P6, DOI 10.1038/nsmb.1979; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Frye JJ, 2013, NAT STRUCT MOL BIOL, V20, P827, DOI 10.1038/nsmb.2593; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Han D, 2009, J BIOL CHEM, V284, P15137, DOI 10.1074/jbc.M804887200; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; He J, 2012, STRUCTURE, V20, P513, DOI 10.1016/j.str.2011.12.015; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Li YF, 2012, PROTEIN EXPRES PURIF, V82, P162, DOI 10.1016/j.pep.2011.12.008; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Pfleger CM, 2000, GENE DEV, V14, P655; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Uzunova K, 2012, NAT STRUCT MOL BIOL, V19, P1116, DOI 10.1038/nsmb.2412; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; Wang WP, 2013, NAT CELL BIOL, V15, P797, DOI 10.1038/ncb2755; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zhang ZG, 2013, J MOL BIOL, V425, P4236, DOI 10.1016/j.jmb.2013.04.004; Zhang ZG, 2013, BIOCHEM J, V449, P365, DOI 10.1042/BJ20121374; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	68	148	165	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					388	+		10.1038/nature13543	http://dx.doi.org/10.1038/nature13543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043029	Green Accepted			2022-12-24	WOS:000341814900053
J	Hassaine, G; Deluz, C; Grasso, L; Wyss, R; Tol, MB; Hovius, R; Graff, A; Stahlberg, H; Tomizaki, T; Desmyter, A; Moreau, C; Li, XD; Poitevin, F; Vogel, H; Nury, H				Hassaine, Gherici; Deluz, Cedric; Grasso, Luigino; Wyss, Romain; Tol, Menno B.; Hovius, Ruud; Graff, Alexandra; Stahlberg, Henning; Tomizaki, Takashi; Desmyter, Aline; Moreau, Christophe; Li, Xiao-Dan; Poitevin, Frederic; Vogel, Horst; Nury, Hugues			X-ray structure of the mouse serotonin 5-HT3 receptor	NATURE			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING DOMAIN; SELECTIVITY-FILTER; AGONIST BINDING; PERMEATION; PORE; DETERMINANTS; MECHANISM; CONDUCTANCE	Neurotransmitter-gated ion channels of the Cys-loop receptor family mediate fast neurotransmission throughout the nervous system. The molecular processes of neurotransmitter binding, subsequent opening of the ion channel and ion permeation remain poorly understood. Here we present the X-ray structure of a mammalian Cys-loop receptor, the mouse serotonin 5-HT3 receptor, at 3.5 angstrom resolution. The structure of the proteolysed receptor, made up of two fragments and comprising part of the intracellular domain, was determined in complex with stabilizing nanobodies. The extracellular domain reveals the detailed anatomy of the neurotransmitter binding site capped by a nanobody. The membrane domain delimits an aqueous pore with a 4.6 angstrom constriction. In the intracellular domain, a bundle of five intracellular helices creates a closed vestibule where lateral portals are obstructed by loops. This 5-HT3 receptor structure, revealing part of the intracellular domain, expands the structural basis for understanding the operating mechanism of mammalian Cys-loop receptors.	[Hassaine, Gherici; Deluz, Cedric; Grasso, Luigino; Wyss, Romain; Tol, Menno B.; Hovius, Ruud; Vogel, Horst; Nury, Hugues] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, CH-1015 Lausanne, Switzerland; [Graff, Alexandra; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland; [Tomizaki, Takashi] Paul Scherrer Inst, Swiss Light Source, CH-5234 Villigen, Switzerland; [Desmyter, Aline] CNRS, UMR 7257, F-13288 Marseille, France; [Desmyter, Aline] Univ Aix Marseille, F-13288 Marseille, France; [Moreau, Christophe; Nury, Hugues] Univ Grenoble Alpes, IBS, F-38000 Grenoble, France; [Moreau, Christophe; Nury, Hugues] CNRS, IBS, F-38000 Grenoble, France; [Moreau, Christophe; Nury, Hugues] CEA, DSV, IBS, F-38000 Grenoble, France; [Li, Xiao-Dan] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Poitevin, Frederic] Inst Pasteur, CNRS, UMR3528, Unite Dynam Struct Macromol, F-75015 Paris, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Basel; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nury, H (corresponding author), Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, CH-1015 Lausanne, Switzerland.	horst.vogel@epfl.ch; hugues.nury@ibs.fr	MOREAU, Christophe/AAC-7912-2020; Hovius, Ruud/B-5647-2009; Poitevin, Frederic/K-1718-2014; MOREAU, Christophe J/D-3736-2009; Vogel, Horst/AAJ-5490-2021; Stahlberg, Henning/H-1868-2011	MOREAU, Christophe/0000-0002-5463-9593; Hovius, Ruud/0000-0001-9258-6587; MOREAU, Christophe J/0000-0002-5463-9593; Stahlberg, Henning/0000-0002-1185-4592; Nury, Hugues/0000-0002-3433-256X; li, xiaodan/0000-0001-8647-7317	Swiss National Science Foundation [31003A-133141]; Ecole Polytechnique Federale de Lausanne; European Community [211800]; Human Frontier Science Program; Agence Nationale de la Recherche (VenomPicoScreen project) [ANR-11-RPIB-022-04]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne; European Community(European Commission); Human Frontier Science Program(Human Frontier Science Program); Agence Nationale de la Recherche (VenomPicoScreen project)(French National Research Agency (ANR))	Research in the laboratory of H. V. was supported by the Swiss National Science Foundation (grant 31003A-133141; SystemsX/CINA program), internal funds of the Ecole Polytechnique Federale de Lausanne, the European Community's Seventh Framework Program FP7/2007-2013 under Grant 211800, the Human Frontier Science Program (postdoc fellowship to H.N.). Additional support was provided by The Agence Nationale de la Recherche (VenomPicoScreen project, grant ANR-11-RPIB-022-04). We thank S. Thurnheer and the expression facility, F. Pojer and the crystallization facility at the EPFL, D. Blot, the HTXLab and the SLS and ESRF beamlines staff. We are particularly appreciative of discussions with H. V. laboratory members and E. Pebay-Peyroula. We thank the company Theranyx for the discovery and production of the functional nanobody used for the structure resolution.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aimon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025529; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Carland JE, 2013, J BIOL CHEM, V288, P31592, DOI 10.1074/jbc.M113.503300; Changeux JP, 2013, NAT REV MOL CELL BIO, V14, P819, DOI 10.1038/nrm3695; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Conrath K, 2009, PROTEIN SCI, V18, P619, DOI 10.1002/pro.69; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cymes GD, 2012, NAT CHEM BIOL, V8, P975, DOI [10.1038/NCHEMBIO.1092, 10.1038/nchembio.1092]; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; Dang H, 2000, MOL PHARMACOL, V57, P1114; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hassaine G, 2013, BBA-BIOMEMBRANES, V1828, P2544, DOI 10.1016/j.bbamem.2013.05.028; Herget S, 2008, CARBOHYD RES, V343, P2162, DOI 10.1016/j.carres.2008.03.011; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hovius R, 1998, J NEUROCHEM, V70, P824; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Huang S, 2013, BIOCHEM J, V454, P303, DOI 10.1042/BJ20130636; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kesters D, 2013, EMBO REP, V14, P49, DOI 10.1038/embor.2012.189; Koehl P, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3298862; Kozuska JL, 2014, BRIT J PHARMACOL, V171, P1617, DOI 10.1111/bph.12536; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Livesey MR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.219618; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKinnon NK, 2011, J GEN PHYSIOL, V138, P453, DOI 10.1085/jgp.201110686; Miles TF, 2012, ACS CHEM NEUROSCI, V3, P753, DOI 10.1021/cn3000586; Montes LR, 2007, BIOPHYS J, V93, P3548, DOI 10.1529/biophysj.107.116228; Moroni M, 2011, J BIOL CHEM, V286, P13414, DOI 10.1074/jbc.M110.204610; Mukhtasimova N, 2013, BIOPHYS J, V104, P355, DOI 10.1016/j.bpj.2012.12.013; Muller N, 2005, BIOTECHNOL BIOENG, V89, P400, DOI 10.1002/bit.20358; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Schmauder R, 2011, CHEMBIOCHEM, V12, P2431, DOI 10.1002/cbic.201100302; Schrodinger LLC, 2013, PYMOL MOL GRAPH SYST; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Walstab J, 2010, PHARMACOL THERAPEUT, V128, P146, DOI 10.1016/j.pharmthera.2010.07.001; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088; Zuber B, 2013, P NATL ACAD SCI USA, V110, P10622, DOI 10.1073/pnas.1301277110	75	286	288	5	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					276	+		10.1038/nature13552	http://dx.doi.org/10.1038/nature13552			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119048				2022-12-24	WOS:000340508200027
J	Schumacher, T; Bunse, L; Pusch, S; Sahm, F; Wiestler, B; Quandt, J; Menn, O; Osswald, M; Oezen, I; Ott, M; Keil, M; Balss, J; Rauschenbach, K; Grabowska, AK; Vogler, I; Diekmann, J; Trautwein, N; Eichmuller, SB; Okun, J; Stevanovic, S; Riemer, AB; Sahin, U; Friese, MA; Beckhove, P; von Deimling, A; Wick, W; Platten, M				Schumacher, Theresa; Bunse, Lukas; Pusch, Stefan; Sahm, Felix; Wiestler, Benedikt; Quandt, Jasmin; Menn, Oliver; Osswald, Matthias; Oezen, Iris; Ott, Martina; Keil, Melanie; Balss, Joerg; Rauschenbach, Katharina; Grabowska, Agnieszka K.; Vogler, Isabel; Diekmann, Jan; Trautwein, Nico; Eichmueller, Stefan B.; Okun, Juergen; Stevanovic, Stefan; Riemer, Angelika B.; Sahin, Ugur; Friese, Manuel A.; Beckhove, Philipp; von Deimling, Andreas; Wick, Wolfgang; Platten, Michael			A vaccine targeting mutant IDH1 induces antitumour immunity	NATURE			English	Article							BRAIN-TUMORS; MUTATIONS; CELLS; DIFFERENTIATION; PHENOTYPE; MELANOMA; GLIOMAS; MICE	Monoallelic point mutations of isocitrate dehydrogenase type 1 (IDH1) are an early and defining event in the development of a subgroup of gliomas(1-3) and other types of tumour(4-6). They almost uniformly occur in the critical arginine residue (Arg 132) in the catalytic pocket, resulting in a neomorphic enzymatic function, production of the oncometabolite 2-hydroxyglutarate (2-HG)(7,8), genomic hypermethylation9-11, genetic instability and malignant transformation(12). More than 70% of diffuse grade II and grade III gliomas carry the most frequent mutation, IDH1(R132H) (ref. 3). From an immunological perspective, IDH1(R132H) represents a potential target for immunotherapy as it is a tumour-specific potential neoantigen with high uniformity and penetrance expressed in all tumour cells(13,14). Here we demonstrate that IDH1(R132H) contains an immunogenic epitope suitable formutation-specific vaccination. Peptides encompassing the mutated region are presented on major histocompatibility complexes (MHC) class II and induce mutation-specific CD4(+) T-helper-1 (TH1) responses. CD41 TH1 cells and antibodies spontaneously occurring in patients with IDH1(R132H)-mutated gliomas specifically recognize IDH1(R132H). Peptide vaccination of mice devoid of mouse MHC and transgenic for human MHC class I and II with IDH1(R132H) p123-142 results in an effective MHC class II-restrictedmutation-specific antitumourimmune response and control of pre-established syngeneic IDH1(R132H)-expressing tumours in a CD4(+)T-cell-dependent manner. As IDH1(R132H) is present in all tumour cells of these slow-growing gliomas(15), a mutation-specific anti-IDH1(R132H) vaccine may represent a viable novel therapeutic strategy for IDH1(R132H)-mutated tumours.	[Schumacher, Theresa; Bunse, Lukas; Wiestler, Benedikt; Menn, Oliver; Osswald, Matthias; Oezen, Iris; Ott, Martina; Keil, Melanie; Rauschenbach, Katharina; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Dept Neurooncol, D-69120 Heidelberg, Germany; [Schumacher, Theresa; Bunse, Lukas; Wiestler, Benedikt; Menn, Oliver; Osswald, Matthias; Oezen, Iris; Ott, Martina; Keil, Melanie; Rauschenbach, Katharina; Wick, Wolfgang; Platten, Michael] Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Schumacher, Theresa; Bunse, Lukas; Oezen, Iris; Ott, Martina; Keil, Melanie; Balss, Joerg; Rauschenbach, Katharina; Platten, Michael] German Canc Res Ctr, German Canc Consortium DKTK Clin Cooperat Unit Ne, D-69120 Heidelberg, Germany; [Pusch, Stefan; Sahm, Felix; von Deimling, Andreas] Univ Heidelberg Hosp, Dept Neuropathol, D-69120 Heidelberg, Germany; [Pusch, Stefan; Sahm, Felix; von Deimling, Andreas] Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Pusch, Stefan; Sahm, Felix; Balss, Joerg; von Deimling, Andreas] German Canc Res Ctr, German Canc Consortium DKTK Clin Cooperat Unit Ne, D-69120 Heidelberg, Germany; [Wiestler, Benedikt; Osswald, Matthias; Wick, Wolfgang] German Canc Res Ctr, German Canc Consortium DKTK Clin Cooperat Unit Ne, D-69120 Heidelberg, Germany; [Quandt, Jasmin; Eichmueller, Stefan B.; Beckhove, Philipp] German Canc Res Ctr, Dept Translat Immunol, D-69120 Heidelberg, Germany; [Grabowska, Agnieszka K.; Riemer, Angelika B.] German Canc Res Ctr, Dept Immunotherapy & Prevent Grp, D-69120 Heidelberg, Germany; [Vogler, Isabel] Ribological GmbH, D-55131 Mainz, Germany; [Diekmann, Jan; Sahin, Ugur] Translat Oncol, D-55131 Mainz, Germany; [Trautwein, Nico; Stevanovic, Stefan] Univ Tubingen, Dept Immunol, D-72076 Tubingen, Germany; [Okun, Juergen] Univ Childrens Hosp, Metab Ctr Heidelberg, D-69120 Heidelberg, Germany; [Friese, Manuel A.] Univ Med Ctr, Ctr Mol Neurobiol, D-20251 Hamburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Platten, M (corresponding author), Univ Heidelberg Hosp, Dept Neurooncol, D-69120 Heidelberg, Germany.	m.platten@dkfz.de	Bunse, Lukas/L-2975-2016; von Deimling, Andreas/F-7774-2013; Eichmüller, Stefan B/A-5053-2008; Wick, Wolfgang/AAA-2545-2020; Platten, Michael/F-2902-2013; Sahin, Ugur/L-4818-2017; Bunse, Theresa/AAD-1719-2019; Sahm, Felix/GQY-8202-2022; Pusch, Stefan/H-3152-2019	Bunse, Lukas/0000-0002-4490-7574; von Deimling, Andreas/0000-0002-5863-540X; Eichmüller, Stefan B/0000-0002-3497-6904; Wick, Wolfgang/0000-0002-6171-634X; Platten, Michael/0000-0002-4746-887X; Sahin, Ugur/0000-0003-0363-1564; Sahm, Felix/0000-0001-5441-1962; Pusch, Stefan/0000-0002-3407-4249; Riemer, Angelika/0000-0002-5865-0714; Friese, Manuel A./0000-0001-6380-2420; Wiestler, Benedikt/0000-0002-2963-7772	DKFZ Light Microscopy and Genomics and Proteomics Facilities; NIH; Interdisciplinary Research Program of the National Center for Tumor Diseases Heidelberg [IFP III/2]; Wilhelm Sander Foundation [2012.118.1]; Helmholtz Foundation [VH-NG-306]; Andreas Zimprich Foundation; German Research Foundation [SFB938]; Helmholtz International Graduate School; Heinrich F. C. Behr Foundation; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology MD/PhD program, University Heidelberg; University Hospital Heidelberg	DKFZ Light Microscopy and Genomics and Proteomics Facilities; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Research Program of the National Center for Tumor Diseases Heidelberg; Wilhelm Sander Foundation; Helmholtz Foundation(Helmholtz Association); Andreas Zimprich Foundation; German Research Foundation(German Research Foundation (DFG)); Helmholtz International Graduate School; Heinrich F. C. Behr Foundation; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology MD/PhD program, University Heidelberg; University Hospital Heidelberg	We are indebted to the patients and their relatives who agreed to participate in this study. We thank A. Gardyan, T. Lanz and W. Osen for technical advice, T. Lanz and A. Hertenstein for providing patient blood samples, S. Hundt for cloning, A. Habel and D. Krunic for technical support, W. Nicklas for pathological analysis, and J. Jung for graphics design. We acknowledge the support by the DKFZ Light Microscopy and Genomics and Proteomics Facilities. HLA-DRB1*01:01 MHC class II tetramer bound to IDH1(R132H) p123-142 was provided by NIH tetramer core facility. A2.DR1 mice were provided by Institut Pasteur. This work was supported by the Interdisciplinary Research Program of the National Center for Tumor Diseases Heidelberg (IFP III/2) to M. P. and A. V. D., the Wilhelm Sander Foundation (2012.118.1) to M. P and A. V. D., the Helmholtz Foundation (VH-NG-306) and the Andreas Zimprich Foundation to M. P. and the German Research Foundation (SFB938 TPK) to M. P. and W. W. T. S. and M. K. were supported by the Helmholtz International Graduate School, and L. B. was supported by the Heinrich F. C. Behr Foundation and the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology MD/PhD program, University Heidelberg. F.S. was supported by a postdoctoral fellowship of the University Hospital Heidelberg.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Balss J, 2012, ACTA NEUROPATHOL, V124, P883, DOI 10.1007/s00401-012-1060-y; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Ito K, 1996, J EXP MED, V183, P2635, DOI 10.1084/jem.183.6.2635; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Pajot A, 2004, EUR J IMMUNOL, V34, P3060, DOI 10.1002/eji.200425463; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	26	457	478	3	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					324	+		10.1038/nature13387	http://dx.doi.org/10.1038/nature13387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25043048				2022-12-24	WOS:000340508200038
J	Zuryn, S; Ahier, A; Portoso, M; White, ER; Morin, MC; Margueron, R; Jarriault, S				Zuryn, Steven; Ahier, Arnaud; Portoso, Manuela; White, Esther Redhouse; Morin, Marie-Charlotte; Margueron, Raphael; Jarriault, Sophie			Sequential histone-modifying activities determine the robustness of transdifferentiation	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; CAENORHABDITIS-ELEGANS; COMPLEX; JMJD3; REGENERATION; EXPRESSION; GENES; NANOG; UTX	Natural interconversions between distinct somatic cell types have been reported in species as diverse as jellyfish and mice. The efficiency and reproducibility of some reprogramming events represent unexploited avenues in which to probe mechanisms that ensure robust cell conversion. We report that a conserved H3K27me3/me2 demethylase, JMJD-3.1, and the H3K4 methyltransferase Set1 complex cooperate to ensure invariant transdifferentiation (Td) of postmitotic Caenorhabditis elegans hindgut cells into motor neurons. At single-cell resolution, robust conversion requires stepwise histone-modifying activities, functionally partitioned into discrete phases of Td through nuclear degradation of JMJD-3.1 and phase-specific interactions with transcription factors that have conserved roles in cell plasticity and terminal fate selection. Our results draw parallels between epigenetic mechanisms underlying robust Td in nature and efficient cell reprogramming in vitro.	[Zuryn, Steven; Ahier, Arnaud; White, Esther Redhouse; Morin, Marie-Charlotte; Jarriault, Sophie] Univ Strasbourg, Dept Dev & Stem Cells, Inst Genet & Biol Mol & Cellulaire, CNRS UMR 7104,INSERM U964, F-67404 Illkirch Cu Strasbourg, France; [Portoso, Manuela; Margueron, Raphael] Inst Curie, INSERM U934, CNRS UMR3215, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jarriault, S (corresponding author), Univ Strasbourg, Dept Dev & Stem Cells, Inst Genet & Biol Mol & Cellulaire, CNRS UMR 7104,INSERM U964, F-67404 Illkirch Cu Strasbourg, France.	sophie@igbmc.fr	Margueron, Raphael F/B-9996-2015; Zuryn, Steven/C-7967-2018	Margueron, Raphael F/0000-0002-9093-7977; Zuryn, Steven/0000-0002-3551-6790; Ahier, Arnaud/0000-0002-9999-3887	European Research Council-Stg (REPODDID) grant; ATIP-Avenir grant; Fondation pour la Recherche Medicale (FRM) grant; FRM; Fondation ARC pour la recherche sur le cancer; Association Francaise contre les Myopathies (AFM); Fondation Schlumberger pour l'Enseignement et la Recherche (FSER); European Molecular Biology Organization Young Investigator program (EMBO YIP)	European Research Council-Stg (REPODDID) grant; ATIP-Avenir grant; Fondation pour la Recherche Medicale (FRM) grant; FRM(Fondation pour la Recherche Medicale); Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Schlumberger pour l'Enseignement et la Recherche (FSER); European Molecular Biology Organization Young Investigator program (EMBO YIP)	We are grateful to S. Gasser, R. Klose, M. Labouesse, B. Prud'homme, and R. Schneider for their comments on the manuscript. Work in R.M.'s laboratory is funded by a European Research Council-Stg (REPODDID) grant, an ATIP-Avenir grant, and a Fondation pour la Recherche Medicale (FRM) grant. Work in S.J.'s laboratory is funded by grants from FRM, the Fondation ARC pour la recherche sur le cancer, the Association Francaise contre les Myopathies (AFM), the Fondation Schlumberger pour l'Enseignement et la Recherche (FSER), and the European Molecular Biology Organization Young Investigator program (EMBO YIP). S.Z. is a FRM and ARC postdoctoral fellow, and S.J. is a Centre National de la Recherche Scientifique research director.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jarriault S, 2008, P NATL ACAD SCI USA, V105, P3790, DOI 10.1073/pnas.0712159105; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kagias K, 2012, P NATL ACAD SCI USA, V109, P6596, DOI 10.1073/pnas.1117031109; Karakuzu O, 2009, DEVELOPMENT, V136, P943, DOI 10.1242/dev.029363; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Richard JP, 2011, DEVELOPMENT, V138, P1483, DOI 10.1242/dev.063115; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006; Zuryn S, 2010, GENETICS, V186, P427, DOI 10.1534/genetics.110.119230	23	45	55	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					826	829		10.1126/science.1255885	http://dx.doi.org/10.1126/science.1255885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124442				2022-12-24	WOS:000340593100048
J	Schleich, S; Strassburger, K; Janiesch, PC; Koledachkina, T; Miller, KK; Haneke, K; Cheng, YS; Kuchler, K; Stoecklin, G; Duncan, KE; Teleman, AA				Schleich, Sibylle; Strassburger, Katrin; Janiesch, Philipp Christoph; Koledachkina, Tatyana; Miller, Katharine K.; Haneke, Katharina; Cheng, Yong-Sheng; Kuechler, Katrin; Stoecklin, Georg; Duncan, Kent E.; Teleman, Aurelio A.			DENR-MCT-1 promotes translation re-initiation downstream of uORFs to control tissue growth	NATURE			English	Article							MSL-2 MESSENGER-RNA; OPEN READING FRAMES; CANDIDATE ONCOGENE; INSULIN-RECEPTOR; GENE-EXPRESSION; SEX-LETHAL; DROSOPHILA; MECHANISM; PROTEIN; MCT-1	During cap-dependent eukaryotic translation initiation, ribosomes scan messenger RNA from the 5' end to the first AUG start codon with favourable sequence context(1,2). For many mRNAs this AUG belongs to a short upstream open reading frame (uORF)(3), and translation of the main downstream ORF requires re-initiation, an incompletely understood process(1,4-6). Re-initiation is thought to involve the same factors as standard initiation(1,5,7). It is unknown whether any factors specifically affect translation re-initiation without affecting standard cap-dependent translation. Here we uncover the non-canonical initiation factors density regulated protein (DENR) and multiple copies in T-cell lymphoma-1(MCT-1; also called MCTS1 inhumans) as the first selective regulators of eukaryotic re-initiation. mRNAs containing upstream ORFs with strong Kozak sequences selectively require DENR-MCT-1 for their proper translation, yielding a novel class of mRNAs that can be co-regulated and that is enriched for regulatory proteins such as oncogenic kinases. Collectively, our data reveal that cells have a previously unappreciated translational control system with a key role in supporting proliferation and tissue growth.	[Schleich, Sibylle; Strassburger, Katrin; Haneke, Katharina; Cheng, Yong-Sheng; Stoecklin, Georg; Teleman, Aurelio A.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Schleich, Sibylle; Janiesch, Philipp Christoph; Koledachkina, Tatyana; Miller, Katharine K.; Kuechler, Katrin; Duncan, Kent E.] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol ZMNH, D-20251 Hamburg, Germany; [Haneke, Katharina; Stoecklin, Georg] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Duncan, KE (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol ZMNH, Falkenried 94, D-20251 Hamburg, Germany.	kent.duncan@zmnh.uni-hamburg.de; a.teleman@dkfz.de	kuchler, karl/AAL-6937-2020; Teleman, Aurelio A/E-6864-2013; Teleman, Aurelio/V-8470-2019; Miller, Katharine K/O-6804-2015	kuchler, karl/0000-0003-2719-5955; Teleman, Aurelio A/0000-0002-4237-9368; Teleman, Aurelio/0000-0002-4237-9368; Miller, Katharine K/0000-0002-0690-7426; Duncan, Kent/0000-0003-4290-2670; Cheng, Yong-Sheng/0000-0002-4586-8116; Stoecklin, Georg/0000-0001-9284-9834; Hoerth, Katharina/0000-0002-6676-3583	Hans und Ilse Breuer Foundation; Fritz Thyssen Foundation; Deutsche Forschungsgemeinschaft (DFG); ERC	Hans und Ilse Breuer Foundation; Fritz Thyssen Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	We thank B. Bukau, R. Green and P. Soba for suggestions on the manuscript, V. Benes and T. Bahr-Ivacevic (EMBL Genomics Core Facility) for assistance with microarray experiments, S. Abmayr for anti-Mbc antibody, T. Hsu for anti-Awd antibody, C. Strein and M. Hentze for Drosophila DENR antibodies, P. Jakob for help with testing conditions for S2 in vitro translation extracts, L. Schibalski and J. Grawe for help with cloning, S. Hofmann for help with polysome analysis, and S. Lerch, A. Haffner and M. Schroder for technical assistance. K.K.M. is the recipient of an Alzheimer's Research Scholarship from the Hans und Ilse Breuer Foundation. P.C.J. is supported in part by a grant from the Fritz Thyssen Foundation to K.E.D. This work was supported in part by a Deutsche Forschungsgemeinschaft (DFG) grant and ERC Starting Grant to A.A.T.	Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dierov J, 1999, J CELL BIOCHEM, V74, P544, DOI 10.1002/(SICI)1097-4644(19990915)74:4<544::AID-JCB4>3.3.CO;2-W; Dmitriev SE, 2010, J BIOL CHEM, V285, P26779, DOI 10.1074/jbc.M110.119693; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HAYASHI S, 1993, DEVELOPMENT, V118, P105; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2008, GENETICS, V180, P703, DOI 10.1534/genetics.108.090563; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jackson RJ, 2012, ADV PROTEIN CHEM STR, V86, P45, DOI [10.1016/B978-0-12-386497-0.00002-5, 10.1016/B978-0-12.386497.000002-5]; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; KONGSUWAN K, 1985, NATURE, V317, P555, DOI 10.1038/317555a0; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Mazan-Mamczarz K, 2009, LEUKEMIA RES, V33, P474, DOI 10.1016/j.leukres.2008.08.012; Nandi S, 2007, ONCOGENE, V26, P2283, DOI 10.1038/sj.onc.1210030; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Prosniak M, 1998, CANCER RES, V58, P4233; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Skabkin MA, 2013, MOL CELL, V51, P249, DOI 10.1016/j.molcel.2013.05.026; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wilson TG, 2006, GENETICS, V172, P253, DOI 10.1534/genetics.105.046631; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	104	107	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					208	+		10.1038/nature13401	http://dx.doi.org/10.1038/nature13401			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043021	Green Accepted			2022-12-24	WOS:000340200700035
J	Yudkin, JS; Montori, VM				Yudkin, John S.; Montori, Victor M.			The epidemic of pre-diabetes: the medicine and the politics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTIONS; DIABETES PREVENTION; HEMOGLOBIN A1C; FOLLOW-UP; DEFINITIONS; PROGRESSION; PREVALENCE; REDUCTION; HBA(1C)		[Yudkin, John S.] UCL, Div Med, London, England; [Montori, Victor M.] Mayo Clin, Dept Med, Div Endocrinol & Diabet, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Montori, Victor M.] Mayo Clin, Dept Hlth Sci Res, Div Endocrinol & Diabet, Knowledge & Evaluat Res Unit, Rochester, MN USA	University of London; University College London; Mayo Clinic; Mayo Clinic	Yudkin, JS (corresponding author), UCL, Div Med, London, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008	Montori, Victor/0000-0003-0595-2898	NCATS NIH HHS [UL1 TR000135] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Edelman D, 2004, J GEN INTERN MED, V19, P1175, DOI 10.1111/j.1525-1497.2004.40178.x; Gale EAM, 2013, HEART, V99, P824, DOI 10.1136/heartjnl-2012-302763; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9; HARRIS M, 1979, DIABETES, V28, P1039; Holman RR, 2011, DIABETES CARE, V34, P1265, DOI 10.2337/dc10-1567; Hopper I, 2011, EUR J CARDIOV PREV R, V18, P813, DOI 10.1177/1741826711421687; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; James C, 2011, DIABETES CARE, V34, P387, DOI 10.2337/dc10-1314; Kahn R, 2014, DIABETES CARE, V37, P943, DOI 10.2337/dc13-1954; Knowler WC, 2003, DIABETES CARE, V26, P977; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Montori V, 2007, BMJ-BRIT MED J, V334, P882, DOI 10.1136/bmj.39169.447488.94; Morris DH, 2013, DIABETOLOGIA, V56, P1489, DOI 10.1007/s00125-013-2902-4; Moynihan RN, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001500; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Institute for Health and Care Excellence, 2012, PREV TYP 2 DIAB RISK; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pradhan AD, 2007, AM J MED, V120, P720, DOI 10.1016/j.amjmed.2007.03.022; Selvin E, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-5-201103010-00004; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; W.H. Organization, 1999, DEFINITION DIAGNOSIS; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, 2006, DEF DIAGN DIAB MELL; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yudkin JS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7995; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9; YUDKIN JS, 1990, BRIT MED J, V301, P397, DOI 10.1136/bmj.301.6749.397; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	44	49	49	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2014	349								g4485	10.1136/bmj.g4485	http://dx.doi.org/10.1136/bmj.g4485			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7OZ	25028385	Green Published, Green Submitted			2022-12-24	WOS:000339325400004
J	Power, SB				Power, Scott B.			Expulsion from history	NATURE			English	Editorial Material							UNCERTAINTIES		Bur Meteorol, Melbourne, Vic 3001, Australia	Bureau of Meteorology - Australia	Power, SB (corresponding author), Bur Meteorol, GPO Box 1289, Melbourne, Vic 3001, Australia.	s.power@bom.gov.au	Power, Scott Brendan/AAF-3370-2019	Power, Scott Brendan/0000-0002-9596-4368				Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1; Hawkins E, 2014, NATURE, V511, pE3, DOI 10.1038/nature13523; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Mahlstein I, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034009; Masson-Delmotte V, 2018, SPEC REP GLOB WARM 1; Mora C, 2014, NATURE, V511, pE5, DOI 10.1038/nature13524; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Power SB, 2012, J CLIMATE, V25, P3792, DOI 10.1175/JCLI-D-11-00354.1; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271	11	8	8	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					38	39		10.1038/511038a	http://dx.doi.org/10.1038/511038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK1TN	24990739				2022-12-24	WOS:000338199400027
J	Faehnle, CR; Walleshauser, J; Joshua-Tor, L				Faehnle, Christopher R.; Walleshauser, Jack; Joshua-Tor, Leemor			Mechanism of Dis3l2 substrate recognition in the Lin28-let-7 pathway	NATURE			English	Article							YEAST EXOSOME CORE; PERLMAN SYNDROME; RNA DEGRADATION; MATURATION; ZCCHC11; SUBUNIT; LIN-28; PHENIX; TUT4	The pluripotency factor Lin28 inhibits the biogenesis of the let-7 family of mammalian microRNAs(1-4). Lin28 is highly expressed in embryonic stem cells and has a fundamental role in regulation of development(5), glucose metabolism(6) and tissue regeneration(7). Over-expression of Lin28 is correlated with the onset of numerous cancers(8), whereas let-7, a tumour suppressor, silences several human oncogenes(5). Lin28 binds to precursor let-7 (pre-let-7) hairpins(9), triggering the 39 oligo-uridylation activity of TUT4 and TUT7 (refs 10-12). The oligoU tail added to pre-let-7 serves as a decay signal, as it is rapidly degraded by Dis3l2 (refs 13, 14), a homologue of the catalytic subunit of the RNA exosome. The molecular basis of Lin28-mediated recruitment of TUT4 and TUT7 to pre-let-7 and its subsequent degradation by Dis3l2 is largely unknown. To examine the mechanism of Dis3l2 substrate recognition we determined the structure of mouse Dis3l2 in complex with an oligoU RNA to mimic the uridylated tail of pre-let-7. Three RNA-binding domains form an open funnel on one face of the catalytic domain that allows RNA to navigate a path to the active site different from that of its exosome counterpart. The resulting path reveals an extensive network of uracil-specific interactions spanning the first 12 nucleotides of an oligoU-tailed RNA. We identify three U-specificity zones that explain how Dis3l2 recognizes, binds and processes uridylated pre-let-7 in the final step of the Lin28-let-7 pathway.	[Faehnle, Christopher R.; Walleshauser, Jack; Joshua-Tor, Leemor] WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; [Faehnle, Christopher R.; Walleshauser, Jack; Joshua-Tor, Leemor] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Walleshauser, Jack; Joshua-Tor, Leemor] Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Joshua-Tor, Leemor] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Joshua-Tor, L (corresponding author), WM Keck Struct Biol Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu		Joshua-Tor, Leemor/0000-0001-8185-8049	Watson School of Biological Sciences; Louis Morin Charitable Trust; Robertson Research Fund of Cold Spring Harbor Laboratory; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, T32GM065094] Funding Source: NIH RePORTER	Watson School of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Louis Morin Charitable Trust; Robertson Research Fund of Cold Spring Harbor Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. M. Hammell for comments on this manuscript and members of the Joshua-Tor laboratory for comments and suggestions. We thank A. Heroux for help at the National Synchrotron Light Source, which is supported by Department of Energy, Office of Basic Energy Sciences. We also thank the Protein Core Facility at Columbia University. This work was supported by the Watson School of Biological Sciences (to J.W. and L.J.), the Louis Morin Charitable Trust and the Robertson Research Fund of Cold Spring Harbor Laboratory (to L.J.). L.J. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Astuti D, 2012, NAT GENET, V44, P277, DOI 10.1038/ng.1071; Barbas A, 2009, J BIOL CHEM, V284, P20486, DOI 10.1074/jbc.M109.020693; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; Choi YS, 2012, RNA, V18, P394, DOI 10.1261/rna.029306.111; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lubas M, 2013, EMBO J, V32, P1855, DOI 10.1038/emboj.2013.135; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Reis FP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076504; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Shechner DM, 2011, NAT STRUCT MOL BIOL, V18, P1036, DOI 10.1038/nsmb.2107; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Urbach A, 2014, GENE DEV, V28, P971, DOI 10.1101/gad.237149.113; Ustianenko D, 2013, RNA, V19, P1632, DOI 10.1261/rna.040055.113; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	43	80	83	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					252	+		10.1038/nature13553	http://dx.doi.org/10.1038/nature13553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119025	Green Accepted			2022-12-24	WOS:000342663100047
J	Griffith, LC				Griffith, Leslie C.			NEUROSCIENCE What females really want	NATURE			English	Editorial Material							DROSOPHILA; RECEPTIVITY	The identification of neural subcircuits used by female fruit flies to make a choice about whether to copulate with a potential mate provides a template for understanding how the brain integrates complex information to reach decisions.	[Griffith, Leslie C.] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA; [Griffith, Leslie C.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Griffith, LC (corresponding author), Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA.	griffith@brandeis.edu		Griffith, Leslie/0000-0003-3164-9876	NIGMS NIH HHS [R01 GM054408] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bussell JJ, 2014, CURR BIOL, V24, P1584, DOI 10.1016/j.cub.2014.06.011; Feng K, 2014, NEURON, V83, P135, DOI 10.1016/j.neuron.2014.05.017; Ferveur JF, 2010, CURR OPIN NEUROBIOL, V20, P764, DOI 10.1016/j.conb.2010.09.007; Pavlou HJ, 2013, CURR OPIN NEUROBIOL, V23, P76, DOI 10.1016/j.conb.2012.09.002; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zhou C, 2014, NEURON, V83, P149, DOI 10.1016/j.neuron.2014.05.038	7	1	1	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					138	139		10.1038/512138a	http://dx.doi.org/10.1038/512138a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25119229				2022-12-24	WOS:000340200700015
J	Orru, CD; Bongianni, M; Tonoli, G; Ferrari, S; Hughson, AG; Groveman, BR; Fiorini, M; Pocchiari, M; Monaco, S; Caughey, B; Zanusso, G				Orru, Christina D.; Bongianni, Matilde; Tonoli, Giovanni; Ferrari, Sergio; Hughson, Andrew G.; Groveman, Bradley R.; Fiorini, Michele; Pocchiari, Maurizio; Monaco, Salvatore; Caughey, Byron; Zanusso, Gianluigi			A Test for Creutzfeldt-Jakob Disease Using Nasal Brushings	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUAKING-INDUCED CONVERSION; RECOMBINANT PRION PROTEIN; CHRONIC WASTING DISEASE; CEREBROSPINAL-FLUID; OLFACTORY EPITHELIUM; MAMMALIAN PRIONS; DIAGNOSIS; TRANSMISSION; CRITERIA; SCRAPIE	BACKGROUND Definite diagnosis of sporadic Creutzfeldt-Jakob disease in living patients remains a challenge. A test that detects the specific marker for Creutzfeldt-Jakob disease, the prion protein (PrPCJD), by means of real-time quaking-induced conversion (RT-QuIC) testing of cerebrospinal fluid has a sensitivity of 80 to 90% for the diagnosis of sporadic Creutzfeldt-Jakob disease. We have assessed the accuracy of RT-QuIC analysis of nasal brushings from olfactory epithelium in diagnosing sporadic Creutzfeldt-Jakob disease in living patients. METHODS We collected olfactory epithelium brushings and cerebrospinal fluid samples from patients with and patients without sporadic Creutzfeldt-Jakob disease and tested them using RT-QuIC, an ultrasensitive, multiwell plate-based fluorescence assay involving PrPCJD-seeded polymerization of recombinant PrP into amyloid fibrils. RESULTS The RT-QuIC assays seeded with nasal brushings were positive in 30 of 31 patients with Creutzfeldt-Jakob disease (15 of 15 with definite sporadic Creutzfeldt-Jakob disease, 13 of 14 with probable sporadic Creutzfeldt-Jakob disease, and 2 of 2 with inherited Creutzfeldt-Jakob disease) but were negative in 43 of 43 patients without Creutzfeldt-Jakob disease, indicating a sensitivity of 97% (95% confidence interval [CI], 82 to 100) and specificity of 100% (95% CI, 90 to 100) for the detection of Creutzfeldt-Jakob disease. By comparison, testing of cerebrospinal fluid samples from the same group of patients had a sensitivity of 77% (95% CI, 57 to 89) and a specificity of 100% (95% CI, 90 to 100). Nasal brushings elicited stronger and faster RT-QuIC responses than cerebrospinal fluid (P<0.001 for the between-group comparison of strength of response). Individual brushings contained approximately 105 to 107 prion seeds, at concentrations several logs 10 greater than in cerebrospinal fluid. CONCLUSIONS In this preliminary study, RT-QuIC testing of olfactory epithelium samples obtained from nasal brushings was accurate in diagnosing Creutzfeldt-Jakob disease and indicated substantial prion seeding activity lining the nasal vault.	[Orru, Christina D.; Bongianni, Matilde; Hughson, Andrew G.; Groveman, Bradley R.; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Orru, Christina D.] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Bongianni, Matilde; Ferrari, Sergio; Fiorini, Michele; Monaco, Salvatore; Zanusso, Gianluigi] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Tonoli, Giovanni] Azienda Osped Univ Integrata, Policlin GB Rossi, Clin Otorinolaringoiatr, Verona, Italy; [Pocchiari, Maurizio] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cagliari; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Istituto Superiore di Sanita (ISS)	Caughey, B (corresponding author), NIAID, Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.	bcaughey@nih.gov; gianluigi.zanusso@univr.it	Zanusso, Gianluigi/K-2823-2018; Monaco, Salvatore/K-4659-2018; Ferrari, Sergio/AAE-5649-2019; Pocchiari, Maurizio/J-8443-2018	Zanusso, Gianluigi/0000-0001-5199-6264; Monaco, Salvatore/0000-0003-3191-8597; Pocchiari, Maurizio/0000-0002-7269-2486; ferrari, sergio/0000-0003-3855-5135; Fiorini, Michele/0000-0002-5339-8716	National Institute of Allergy and Infectious Diseases (NIAID); Fondazione Cariverona (Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi); Italian Ministry of Health [RF2009-1474758]; Creutzfeldt-Jakob Disease Foundation; Programma Master and Back-Percorsi di rientro [PRR-MAB-A2011-19199]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001086] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fondazione Cariverona (Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi); Italian Ministry of Health(Ministry of Health, Italy); Creutzfeldt-Jakob Disease Foundation; Programma Master and Back-Percorsi di rientro; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), by a grant from Fondazione Cariverona (Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi, to Dr. Monaco), by a grant from the Italian Ministry of Health (RF2009-1474758, to Drs. Zanusso and Pocchiari), by a grant from the Creutzfeldt-Jakob Disease Foundation (to Dr. Orru), by a fellowship from Programma Master and Back-Percorsi di rientro (PRR-MAB-A2011-19199, to Dr. Orru), and by donations to the NIAID Gift Fund from Mary Hilderman Smith, Zoe Smith Jaye, and Jenny Smith Unruh, in memory of Jeffrey Smith.	Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Bessen RA, 2012, J VIROL, V86, P1777, DOI 10.1128/JVI.06626-11; Bessen RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000837; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brown P, 2012, EMERG INFECT DIS, V18, P901, DOI 10.3201/eid1806.120116; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Cummings JL, 2013, MED CLIN N AM, V97, P363, DOI 10.1016/j.mcna.2013.01.001; Deleault NR, 2008, P NATL ACAD SCI USA, V105, P12636, DOI 10.1073/pnas.0807173105; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Denkers ND, 2010, J GEN VIROL, V91, P1651, DOI 10.1099/vir.0.017335-0; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Haybaeck J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001257; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jones M, 2011, ACTA NEUROPATHOL, V121, P135, DOI 10.1007/s00401-010-0708-8; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kincaid AE, 2007, J VIROL, V81, P4482, DOI 10.1128/JVI.02649-06; Kincaid AE, 2012, J VIROL, V86, P12731, DOI 10.1128/JVI.01930-12; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Krasnianski A, 2006, BRAIN, V129, P2288, DOI 10.1093/brain/awl123; Ladogana A, 2005, NEUROLOGY, V64, P1586, DOI 10.1212/01.WNL.0000160117.56690.B2; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Orru CD, 2012, J CLIN MICROBIOL, V50, P1464, DOI 10.1128/JCM.06099-11; Parchi P, 2012, ACTA NEUROPATHOL, V124, P517, DOI 10.1007/s00401-012-1002-8; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7; Respondek G, 2013, MOVEMENT DISORD, V28, P504, DOI 10.1002/mds.25327; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Tabaton M, 2004, ANN NEUROL, V55, P294, DOI 10.1002/ana.20038; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Zanusso G, 2003, NEW ENGL J MED, V348, P711, DOI 10.1056/NEJMoa022043; Zerr I, 2012, BRAIN, V135, P1335, DOI 10.1093/brain/awr029	37	215	225	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					519	529		10.1056/NEJMoa1315200	http://dx.doi.org/10.1056/NEJMoa1315200			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25099576	Green Accepted			2022-12-24	WOS:000339899100006
J	Tavora, B; Reynolds, LE; Batista, S; Demircioglu, F; Fernandez, I; Lechertier, T; Lees, DM; Wong, PP; Alexopoulou, A; Elia, G; Clear, A; Ledoux, A; Hunter, J; Perkins, N; Gribben, JG; Hodivala-Dilke, KM				Tavora, Bernardo; Reynolds, Louise E.; Batista, Silvia; Demircioglu, Fevzi; Fernandez, Isabelle; Lechertier, Tanguy; Lees, Delphine M.; Wong, Ping-Pui; Alexopoulou, Annika; Elia, George; Clear, Andrew; Ledoux, Adeline; Hunter, Jill; Perkins, Neil; Gribben, John G.; Hodivala-Dilke, Kairbaan M.			Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy	NATURE			English	Article							FOCAL ADHESION KINASE; NF-KAPPA-B; CANCER-CELLS; RESISTANCE; MICROENVIRONMENT; INFLAMMATION; ACTIVATION; ANGIOGENESIS; METASTASIS; EXPRESSION	Chemoresistance is a serious limitation of cancer treatment(1). Until recently, almost all the work done to study this limitation has been restricted to tumour cells(2). Here we identify a novel molecular mechanism by which endothelial cells regulate chemosensitivity. We establish that specific targeting of focal adhesion kinase (FAK; also known as PTK2) in endothelial cells is sufficient to induce tumour-cell sensitization to DNA-damaging therapies and thus inhibit tumour growth in mice. The clinical relevance of this work is supported by our observations that low blood vessel FAK expression is associated with complete remission in human lymphoma. Our study shows that deletion of FAK in endothelial cells has no apparent effect on blood vessel function per se, but induces increased apoptosis and decreased proliferation within perivascular tumour-cell compartments of doxorubicin-and radiotherapy-treated mice. Mechanistically, we demonstrate that endothelial-cell FAK is required for DNA-damage induced NF-kappa B activation in vivo and in vitro, and the production of cytokines from endothelial cells. Moreover, loss of endothelial-cell FAK reduces DNA-damage-induced cytokine production, thus enhancing chemosensitization of tumour cells to DNA-damaging therapies in vitro and in vivo. Overall, our data identify endothelial-cell FAK as a regulator of tumour chemosensitivity. Furthermore, we anticipate that this proof-of-principle data will be a starting point for the development of new possible strategies to regulate chemosensitization by targeting endothelial-cell FAK specifically.	[Tavora, Bernardo; Reynolds, Louise E.; Batista, Silvia; Demircioglu, Fevzi; Fernandez, Isabelle; Lechertier, Tanguy; Lees, Delphine M.; Wong, Ping-Pui; Alexopoulou, Annika; Hodivala-Dilke, Kairbaan M.] Queen Mary Univ London, CR UK Ctr Excellence, Barts Canc Inst, Adhes & Angiogenesis Lab,Ctr Tumour Biol, London EC1M 6BQ, England; [Elia, George] Queen Mary Univ London, CR UK Ctr Excellence, Barts Canc Inst, London EC1M 6BQ, England; [Clear, Andrew; Gribben, John G.] Queen Mary Univ London, CR UK Ctr Excellence, Barts Canc Inst, Ctr Haematooncol, London EC1M 6BQ, England; [Ledoux, Adeline; Hunter, Jill; Perkins, Neil] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci ICaMB, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Newcastle University - UK	Hodivala-Dilke, KM (corresponding author), Queen Mary Univ London, CR UK Ctr Excellence, Barts Canc Inst, Adhes & Angiogenesis Lab,Ctr Tumour Biol, London EC1M 6BQ, England.	K.Hodivala-Dilke@qmul.ac.uk		Ledoux, Adeline/0000-0001-6907-6116; Lees, Delphine M/0000-0002-2119-3978; Lechertier, Tanguy/0000-0002-0202-8424; Fernandez, Isabelle/0000-0003-3390-3284; Wong, Ping Pui/0000-0003-1592-4823; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X	CR-UK [C9218/A12007, C1443/A9215]; AICR [12-1068]; Medical Research Council [G0901609]; National Cancer Institute [P01 CA95426]; Leukemia Lymphoma Research [11022]; MRC [G0901609] Funding Source: UKRI; Cancer Research UK [12007] Funding Source: researchfish; Medical Research Council [1365527] Funding Source: researchfish; Worldwide Cancer Research [12-1068] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA081534, P01CA095426] Funding Source: NIH RePORTER	CR-UK(Cancer Research UK); AICR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Lymphoma Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Papachristodoulou, J. Holdsworth and B. Williams for their help with immunostaining and animal husbandry. Also M. Hemann for his critical appraisal of the manuscript. The work was funded by CR-UK (C9218/A12007), AICR (12-1068), Medical Research Council (G0901609), National Cancer Institute (P01 CA95426:JGG); Leukemia Lymphoma Research (11022); and CR-UK PhD studentship (C1443/A9215).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; De Vita VT, 2001, CANC PRINCIPLES PRAC; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Funakoshi-Tago M, 2003, J BIOL CHEM, V278, P29359, DOI 10.1074/jbc.M213115200; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Hagemeister FB, 2002, CANCER CHEMOTH PHARM, V49, pS13, DOI 10.1007/s00280-002-0447-1; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Lim ST, 2012, J CELL BIOL, V197, P907, DOI 10.1083/jcb.201109067; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; May T, 2005, J BIOTECHNOL, V120, P99, DOI 10.1016/j.jbiotec.2005.03.027; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nakamura J, 2008, BIOCHEM BIOPH RES CO, V374, P699, DOI 10.1016/j.bbrc.2008.07.123; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Rottenberg S, 2008, DRUG RESIST UPDATE, V11, P51, DOI 10.1016/j.drup.2007.11.002; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Tavora B, 2010, EMBO MOL MED, V2, P516, DOI 10.1002/emmm.201000106; Tseng WP, 2010, J CELL PHYSIOL, V223, P389, DOI 10.1002/jcp.22047; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Zhang HFM, 2006, AM J PHYSIOL-CELL PH, V290, pC1310, DOI 10.1152/ajpcell.00450.2005	30	108	114	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					112	+		10.1038/nature13541	http://dx.doi.org/10.1038/nature13541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25079333	Green Accepted			2022-12-24	WOS:000342420800046
J	Gostin, LO; Lucey, D; Phelan, A				Gostin, Lawrence O.; Lucey, Daniel; Phelan, Alexandra			The Ebola Epidemic A Global Health Emergency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Phelan, Alexandra] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, Washington, DC 20001 USA; [Lucey, Daniel] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20001 USA	Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Phelan, Alexandra/0000-0002-3084-9158; Gostin, Lawrence/0000-0001-5286-4044				Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Blinder A., 2014, ATLANTA HOSP ADMITS; Hinshaw D, EBOLA VIRUS INFLICTS; McWhirter C, 2014, GIVING AM DRUG EBOLA; Nossiter A, 2014, NY TIMES, pA1; Williams WCL., 2014, NY TIMES; World Health Organization, 2014, EB VIR DIS GUIN	7	107	114	0	92	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1095	1096		10.1001/jama.2014.11176	http://dx.doi.org/10.1001/jama.2014.11176			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25111044				2022-12-24	WOS:000341624700015
J	Long, CZ; McAnally, JR; Shelton, JM; Mireault, AA; Bassel-Duby, R; Olson, EN				Long, Chengzu; McAnally, John R.; Shelton, John M.; Mireault, Alex A.; Bassel-Duby, Rhonda; Olson, Eric N.			Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA	SCIENCE			English	Article							MODIFIED MESSENGER-RNA; ONE-STEP GENERATION; SATELLITE CELLS; GENE CORRECTION; GENOME; CAS9; EXPRESSION; MOUSE; ENDONUCLEASE; MDX	Duchenne muscular dystrophy (DMD) is an inherited X-linked disease caused by mutations in the gene encoding dystrophin, a protein required for muscle fiber integrity. DMD is characterized by progressive muscle weakness and a shortened life span, and there is no effective treatment. We used clustered regularly interspaced short palindromic repeat/Cas9 (CRISPR/Cas9)-mediated genome editing to correct the dystrophin gene (Dmd) mutation in the germ line of mdx mice, a model for DMD, and then monitored muscle structure and function. Genome editing produced genetically mosaic animals containing 2 to 100% correction of the Dmd gene. The degree of muscle phenotypic rescue in mosaic mice exceeded the efficiency of gene correction, likely reflecting an advantage of the corrected cells and their contribution to regenerating muscle. With the anticipated technological advances that will facilitate genome editing of postnatal somatic cells, this strategy may one day allow correction of disease-causing mutations in the muscle tissue of patients with DMD.	[Long, Chengzu; McAnally, John R.; Mireault, Alex A.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Long, Chengzu; McAnally, John R.; Mireault, Alex A.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu			NIH [HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401]; Robert A. Welch Foundation [1-0025]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100401, R01HL077439, R01HL111665, R01HL093039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Z. Wang and B. Nelson for advice and constructive criticism; L. Sutherland, H. Zhou, and J. Ren for discussions and technical help; C. Xing and R. Kittler for analysis of off-target effects; S. Rovinsky and E. Plautz for grip-strength testing; and R. Hammer, J. Ritter, and J. Richardson for advice. We thank G. Church for hCas9 (human codon optimized Cas9) and the gRNA cloning vector plasmids. This work was supported by grants from NIH (HL-077439, HL-111665, HL-093039, DK-099653, and U01-HL-100401) and the Robert A. Welch Foundation (grant 1-0025 to E.N.O.).	BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Duan JZ, 2014, CELL RES, V24, P1009, DOI 10.1038/cr.2014.87; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Harris TJ, 2010, BIOMATERIALS, V31, P998, DOI 10.1016/j.biomaterials.2009.10.012; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Ousterout DG, 2013, MOL THER, V21, P1718, DOI 10.1038/mt.2013.111; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peng BW, 2005, BIOCHEM BIOPH RES CO, V338, P1490, DOI 10.1016/j.bbrc.2005.10.111; Pigozzo SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072147; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; WORTON RG, 1988, ANNU REV GENET, V22, P601, DOI 10.1146/annurev.ge.22.120188.003125; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682	33	450	505	9	400	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1184	1188		10.1126/science.1254445	http://dx.doi.org/10.1126/science.1254445			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25123483	Green Accepted			2022-12-24	WOS:000341179800048
J	Karasov, TL; Kniskern, JM; Gao, LP; DeYoung, BJ; Ding, J; Dubiella, U; Lastra, RO; Nallu, S; Roux, F; Innes, RW; Barrett, LG; Hudson, RR; Bergelson, J				Karasov, Talia L.; Kniskern, Joel M.; Gao, Liping; DeYoung, Brody J.; Ding, Jing; Dubiella, Ullrich; Lastra, Ruben O.; Nallu, Sumitha; Roux, Fabrice; Innes, Roger W.; Barrett, Luke G.; Hudson, Richard R.; Bergelson, Joy			The long-term maintenance of a resistance polymorphism through diffuse interactions	NATURE			English	Article							DISEASE RESISTANCE; ARABIDOPSIS; COEVOLUTION; SPECIFICITY; EVOLUTION; SELECTION; VARIANCE	Plant resistance (R) genes are a crucial component in plant defence against pathogens(1). Although R genes often fail to provide durable resistance in an agricultural context, they frequently persist as long-lived balanced polymorphisms in nature(2-4). Standard theory explains the maintenance of such polymorphisms through a balance of the costs and benefits of resistance and virulence in a tightly coevolving host-pathogen pair(5,6). However, many plant-pathogen interactions lack such specificity(7). Whether, and how, balanced polymorphisms are maintained in diffusely interacting species(8) is unknown. Here we identify a naturally interacting R gene and effector pair in Arabidopsis thaliana and its facultative plant pathogen, Pseudomonas syringae. The protein encoded by the R gene RPS5 recognizes an AvrPphB homologue (AvrPphB2) and exhibits a balanced polymorphism that has been maintained for over 2 million years (ref. 3). Consistent with the presence of an ancient balanced polymorphism, the R gene confers a benefit when plants are infected with P. syringae carrying avrPphB2 but also incurs a large cost in the absence of infection. RPS5 alleles are maintained at intermediate frequencies in populations globally, suggesting ubiquitous selection for resistance. However, the presence of P. syringae carrying avrPphB is probably insufficient to explain the RPS5 polymorphism. First, avrPphB homologues occur at very low frequencies in P. syringae populations on A. thaliana. Second, AvrPphB only rarely confers a virulence benefit to P. syringae on A. thaliana. Instead, we find evidence that selection for RPS5 involves multiple non-homologous effectors and multiple pathogen species. These results and an associated model suggest that the R gene polymorphism in A. thaliana may not be maintained through a tightly coupled interaction involving a single coevolved R gene and effector pair. More likely, the stable polymorphism is maintained through complex and diffuse community-wide interactions.	[Karasov, Talia L.; Kniskern, Joel M.; Gao, Liping; Ding, Jing; Lastra, Ruben O.; Nallu, Sumitha; Barrett, Luke G.; Hudson, Richard R.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Karasov, Talia L.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [DeYoung, Brody J.; Dubiella, Ullrich; Innes, Roger W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Roux, Fabrice] INRA, LIPM, F-31326 Castanet Tolosan, France; [Roux, Fabrice] CNRS, LIPM, F-31326 Castanet Tolosan, France; [Roux, Fabrice] Univ Sci & Technol Lille Lille 1, Lab Genet & Evolut Populat Vegetales, UMR CNRS 8198, F-59655 Villeneuve Dascq, France	University of Chicago; University of Chicago; Indiana University System; Indiana University Bloomington; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Nallu, Sumitha/D-5382-2017; Dubiella, Ullrich/AAF-6499-2019; Barrett, Luke G/I-5711-2015	Barrett, Luke G/0000-0001-6530-0731; Karasov, Talia/0000-0002-3592-6597; Innes, Roger/0000-0001-9634-1413; Dubiella, Ullrich/0000-0001-9854-9795; Fabrice, Roux/0000-0001-8059-5638; Bergelson, Joy/0000-0001-7893-7387	Department of Education GAANN fellowship; Dropkin Foundation; National Institutes of Health (NIH) Postbaccalaureate Research Education Program award; Laboratory of Excellence (Labex) TULIP [ANR-10-LABX-41, ANR-11-IDEX-0002-02]; NIH-NIGMS [R01 GM046451, R01 GM057994, R01 GM083068]; NSF [MCB0603515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083068, T32GM007197, R01GM062504, R01GM057994, R01GM046451] Funding Source: NIH RePORTER	Department of Education GAANN fellowship(US Department of Education); Dropkin Foundation; National Institutes of Health (NIH) Postbaccalaureate Research Education Program award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laboratory of Excellence (Labex) TULIP; NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Dwyer, M. Kreitman, L. Merwin, C. Morris and M. Nordborg for discussions, D. Baltrus, D. Dahlbeck, J. Greenberg and B. Vinatzer for supplying plasmids, N. Faure for help collecting the French isolates of P. syringae, C. Gode, J. Higgins and A. Stathos for contributions to genotyping RPS5 presence/absence, G. Sperone for mapping, and T. Morton and the staff of the University of Chicago greenhouse for planting and maintaining A. thaliana. T.L.K. was supported by a Department of Education GAANN fellowship, J.M.K. and L.G.B. were supported by postdoctoral fellowships from the Dropkin Foundation, and R.L. was supported by a National Institutes of Health (NIH) Postbaccalaureate Research Education Program award. F.R. was supported by the Laboratory of Excellence (Labex) TULIP (ANR-10-LABX-41; ANR-11-IDEX-0002-02). This work was supported by grants NIH-NIGMS R01 GM046451 to R.W.I., and grants NSF MCB0603515, NIH-NIGMS R01 GM057994 and NIH-NIGMS R01 GM083068 to J.B.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Barrett LG, 2011, ECOL LETT, V14, P1149, DOI 10.1111/j.1461-0248.2011.01687.x; Barrett LG, 2009, NEW PHYTOL, V183, P513, DOI 10.1111/j.1469-8137.2009.02927.x; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Brown JKM, 2011, ANNU REV PHYTOPATHOL, V49, P345, DOI 10.1146/annurev-phyto-072910-095301; FRANK SA, 1992, TRENDS GENET, V8, P213, DOI 10.1016/0168-9525(92)90236-W; Gao LP, 2009, NEW PHYTOL, V184, P485, DOI 10.1111/j.1469-8137.2009.02959.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; HALDANE JBS, 1992, CURR SCI INDIA, V63, P599; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; Jakob K, 2002, MOL PLANT MICROBE IN, V15, P1195, DOI 10.1094/MPMI.2002.15.12.1195; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kniskern JM, 2011, EVOLUTION, V65, P818, DOI 10.1111/j.1558-5646.2010.01157.x; Lockett SF, 2001, J ACQ IMMUN DEF SYND, V27, P277, DOI 10.1097/00126334-200107010-00010; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; Morris CE, 2010, MBIO, V1, DOI 10.1128/mBio.00107-10; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stinchcombe JR, 2001, AM NAT, V158, P376, DOI 10.1086/321990; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Thrall PH, 2012, ECOL LETT, V15, P425, DOI 10.1111/j.1461-0248.2012.01749.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Warren RF, 1999, GENETICS, V152, P401	30	111	111	0	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					436	U472		10.1038/nature13439	http://dx.doi.org/10.1038/nature13439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25043057	Green Accepted			2022-12-24	WOS:000340840600035
J	Ducat, L; Philipson, LH; Anderson, BJ				Ducat, Lee; Philipson, Louis H.; Anderson, Barbara J.			The Mental Health Comorbidities of Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ducat, Lee] Mental Hlth Issues Diabet Fdn, Philadelphia, PA USA; [Philipson, Louis H.] Univ Chicago, Chicago, IL 60637 USA; [Anderson, Barbara J.] Baylor Coll Med, Houston, TX 77030 USA	University of Chicago; Baylor College of Medicine	Anderson, BJ (corresponding author), Baylor Coll Med, Dept Pediat, 1102 Bates Ave,Ste 940, Houston, TX 77030 USA.	bja@bcm.edu			NIDDK NIH HHS [T32 DK064582, P30 DK020595] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064582, P30DK020595] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anderson B.J., 2007, JOSLINS DIABETES DES, V2nd ed., P641; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Goebel-Fabbri A.E., 2013, TYPE 1 DIABETES SOUR, P180; Gonzalez JS, 2013, TYPE 1 DIABETES SOUR, P169; Katon W., 2010, DEPRESSION DIABETES, P81; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593	7	152	157	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					691	692		10.1001/jama.2014.8040	http://dx.doi.org/10.1001/jama.2014.8040			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN2TR	25010529	Green Accepted			2022-12-24	WOS:000340438700012
J	Tschaharganeh, DF; Xue, W; Calvisi, DF; Evert, M; Michurina, TV; Dow, LE; Banito, A; Katz, SF; Kastenhuber, ER; Weissmueller, S; Huang, CH; Lechel, A; Andersen, JB; Capper, D; Zender, L; Longerich, T; Enikolopov, G; Lowe, SW				Tschaharganeh, Darjus F.; Xue, Wen; Calvisi, Diego F.; Evert, Matthias; Michurina, Tatyana V.; Dow, Lukas E.; Banito, Ana; Katz, Sarah F.; Kastenhuber, Edward R.; Weissmueller, Susann; Huang, Chun-Hao; Lechel, Andre; Andersen, Jesper B.; Capper, David; Zender, Lars; Longerich, Thomas; Enikolopov, Grigori; Lowe, Scott W.			p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer	CELL			English	Article							INTERMEDIATE-FILAMENT NESTIN; STEM-CELLS; INTRAHEPATIC CHOLANGIOCARCINOMA; IN-VIVO; P53; EXPRESSION; MICE; GROWTH; DEDIFFERENTIATION; DIFFERENTIATION	The p53 tumor suppressor coordinates a series of antiproliferative responses that restrict the expansion of malignant cells, and as a consequence, p53 is lost or mutated in the majority of human cancers. Here, we show that p53 restricts expression of the stem and progenitor-cell-associated protein nestin in an Sp1/3 transcription-factor-dependent manner and that Nestin is required for tumor initiation in vivo. Moreover, loss of p53 facilitates dedifferentiation of mature hepatocytes into nestin-positive progenitor-like cells, which are poised to differentiate into hepatocellular carcinomas (HCCs) or cholangiocarcinomas (CCs) in response to lineage-specific mutations that target Wnt and Notch signaling, respectively. Many human HCCs and CCs show elevated nestin expression, which correlates with p53 loss of function and is associated with decreased patient survival. Therefore, transcriptional repression of Nestin by p53 restricts cellular plasticity and tumorigenesis in liver cancer.	[Tschaharganeh, Darjus F.; Dow, Lukas E.; Banito, Ana; Kastenhuber, Edward R.; Weissmueller, Susann; Huang, Chun-Hao; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Xue, Wen; Michurina, Tatyana V.; Weissmueller, Susann; Zender, Lars; Enikolopov, Grigori; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Calvisi, Diego F.; Evert, Matthias] Univ Med, Inst Pathol, D-17487 Greifswald, Germany; [Katz, Sarah F.; Lechel, Andre] Univ Ulm, Dept Internal Med 1, D-89070 Ulm, Germany; [Andersen, Jesper B.] NCI, Lab Expt Carcinogenesis, CCR, NIH, Bethesda, MD 20892 USA; [Andersen, Jesper B.] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Capper, David; Longerich, Thomas] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Capper, David] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Ulm University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Copenhagen; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Howard Hughes Medical Institute	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA.	lowes@mskcc.org	Lechel, André/AAQ-2041-2021; Banito, Ana/P-6168-2017; Enikolopov, Grigori/P-5731-2019; Capper, David/I-8500-2014	Lechel, André/0000-0003-0221-6959; Enikolopov, Grigori/0000-0001-8178-8917; Xue, Wen/0000-0002-9797-8042; Banito, Ana/0000-0003-2188-0003; Kastenhuber, Edward/0000-0002-1872-212X; Andersen, Jesper B/0000-0003-1760-5244; Capper, David/0000-0003-1945-497X; Dow, Lukas/0000-0001-7048-1418	National Cancer Institute; National Center for Tumor Disease, Heidelberg; German Research Foundation (DFG) [SFB/TRR77]; German Cancer Aid; German Research Foundation (DFG); NATIONAL CANCER INSTITUTE [P01CA087497, P30CA045508, P01CA013106, P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Tumor Disease, Heidelberg(Deutsche KrebshilfeHelmholtz Association); German Research Foundation (DFG)(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of the Lowe lab for stimulating discussion and, in particular, Dr. Charles J. Sherr for important suggestions and editing the manuscript. We thank D. Grace, J. Simon, the MSKCC animal facility, and MSKCC molecular cytology core for outstanding technical support. This work was supported by program project grants from the National Cancer Institute (S.W.L.). This study was supported by the National Center for Tumor Disease, Heidelberg, and grants of the German Research Foundation (DFG, SFB/TRR77) and the German Cancer Aid (T.L.). D.F.T. is funded by a postdoctoral fellowship of the German Research Foundation (DFG). S.W.L. is the Geoffrey Beene Chair for Cancer Biology and a Howard Hughes Medical Institute investigator.	Andersen JB, 2012, GASTROENTEROLOGY, V142, P1021, DOI 10.1053/j.gastro.2011.12.005; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Broz DK, 2010, CARCINOGENESIS, V31, P1311, DOI 10.1093/carcin/bgp331; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng LP, 2004, FEBS LETT, V565, P195, DOI 10.1016/j.febslet.2004.03.097; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gleiberman AS, 2005, DEV DYNAM, V234, P413, DOI 10.1002/dvdy.20536; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Katz SF, 2012, GASTROENTEROLOGY, V142, P1229, DOI 10.1053/j.gastro.2012.02.009; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Krupkova O, 2010, NEOPLASMA, V57, P291, DOI 10.4149/neo_2010_04_291; Li H, 2012, LIVER INT, V32, P38, DOI 10.1111/j.1478-3231.2011.02646.x; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lu WJ, 2011, INT J CANCER, V128, P343, DOI 10.1002/ijc.25586; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; Neumann O, 2012, HEPATOLOGY, V56, P1817, DOI 10.1002/hep.25870; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; RUMSBY PC, 1994, MOL CARCINOGEN, V9, P71, DOI 10.1002/mc.2940090204; Saborowski A, 2013, P NATL ACAD SCI USA, V110, P19513, DOI 10.1073/pnas.1311707110; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; SODDU S, 1994, BLOOD, V83, P2230, DOI 10.1182/blood.V83.8.2230.bloodjournal8382230; Spike Benjamin T, 2011, Genes Cancer, V2, P404, DOI 10.1177/1947601911410224; Sugimoto K, 2011, TRENDS CELL BIOL, V21, P212, DOI 10.1016/j.tcb.2010.12.004; Takakuwa O, 2013, LUNG CANCER, V81, P174, DOI 10.1016/j.lungcan.2013.04.022; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wu DY, 2006, CELL RES, V16, P319, DOI 10.1038/sj.cr.7310040; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Yun MH, 2013, P NATL ACAD SCI USA, V110, P17392, DOI 10.1073/pnas.1310519110; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang LL, 2000, CANCER RES, V60, P3655; Zhao YY, 2013, ONCOL REP, V30, P1782, DOI 10.3892/or.2013.2627	53	135	139	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					579	592		10.1016/j.cell.2014.05.051	http://dx.doi.org/10.1016/j.cell.2014.05.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083869	Green Accepted, Bronze			2022-12-24	WOS:000340944300011
J	Keranen, KM; Weingarten, M; Abers, GA; Bekins, BA; Ge, S				Keranen, K. M.; Weingarten, M.; Abers, G. A.; Bekins, B. A.; Ge, S.			Sharp increase in central Oklahoma seismicity since 2008 induced by massive wastewater injection	SCIENCE			English	Article							EARTHQUAKE SEQUENCE; STRESS; FLUID; MAGNITUDE; FAULT	Unconventional oil and gas production provides a rapidly growing energy source; however, high-production states in the United States, such as Oklahoma, face sharply rising numbers of earthquakes. Subsurface pressure data required to unequivocally link earthquakes to wastewater injection are rarely accessible. Here we use seismicity and hydrogeological models to show that fluid migration from high-rate disposal wells in Oklahoma is potentially responsible for the largest swarm. Earthquake hypocenters occur within disposal formations and upper basement, between 2- and 5-kilometer depth. The modeled fluid pressure perturbation propagates throughout the same depth range and tracks earthquakes to distances of 35 kilometers, with a triggering threshold of similar to 0.07 megapascals. Although thousands of disposal wells operate aseismically, four of the highest-rate wells are capable of inducing 20% of 2008 to 2013 central U.S. seismicity.	[Keranen, K. M.] Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14850 USA; [Weingarten, M.; Ge, S.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Abers, G. A.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Bekins, B. A.] US Geol Survey, Menlo Pk, CA 94025 USA	Cornell University; University of Colorado System; University of Colorado Boulder; Columbia University; United States Department of the Interior; United States Geological Survey	Keranen, KM (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14850 USA.	keranen@cornell.edu			USGS National Earthquake Hazards Reduction Program (NEHRP) [G13AP00025]; USGS Powell Center [G13AC00023]; NEHRP [G13AP00024]; National Science Foundation	USGS National Earthquake Hazards Reduction Program (NEHRP)(United States Geological Survey); USGS Powell Center; NEHRP(United States Geological Survey); National Science Foundation(National Science Foundation (NSF))	This research benefited from discussion with E. Cochran, W. Ellsworth, and participants in a U.S. Geological Survey (USGS) Powell Center Working Group on Understanding Fluid Injection Induced Seismicity (M. W., B. A. B., and S. G. are part of this group). C. Hogan identified many P and S phases. K. M. K was partially supported by USGS National Earthquake Hazards Reduction Program (NEHRP) grant G13AP00025, M. W. was partially supported by the USGS Powell Center grant G13AC00023, and G. A. A. was partially supported by NEHRP grant G13AP00024. This project used seismic data from EarthScope's Transportable Array, a facility funded by the National Science Foundation. Seismic waveforms are from the Incorporated Research Institutions for Seismology Data Management Center and the USGS CWB Query. Well data are from the Oklahoma Corporation Commission and the Oklahoma Geological Survey. Lists of wells and the local earthquake catalog are available as supplementary materials on Science Online.	[Anonymous], 2013, J GEOPHYS RES, V118, P3506; Chernicky D., 2000, WORLD OIL; Davis S. D., 1993, Seismological Research Letters, V64, P207; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Frohlich C, 2012, P NATL ACAD SCI USA, V109, P13934, DOI 10.1073/pnas.1207728109; Frohlich C, 2011, B SEISMOL SOC AM, V101, P327, DOI 10.1785/0120100131; Gatewood L. E., 1970, AAPG MEMOIR, V14; Gay S.P., 2003, SHALE SHAKER, V54, P39; Holland AA, 2013, SEISMOL RES LETT, V84, P876, DOI 10.1785/0220120153; Horton S, 2012, SEISMOL RES LETT, V83, P250, DOI 10.1785/gssrl.83.2.250; Justinic AH, 2013, B SEISMOL SOC AM, V103, P3083, DOI 10.1785/0120120336; Keranen KM, 2013, GEOLOGY, V41, P699, DOI 10.1130/G34045.1; Luza K. V., 1981, OKLAHOMA GEOLOGICAL, V81-3, P1; McGarr A, 2014, J GEOPHYS RES-SOL EA, V119, P1008, DOI 10.1002/2013JB010597; Murray KE, 2013, ENVIRON SCI TECHNOL, V47, P4918, DOI 10.1021/es4000593; REASENBERG PA, 1992, SCIENCE, V255, P1687, DOI 10.1126/science.255.5052.1687; Seeber L, 2000, NATURE, V407, P69, DOI 10.1038/35024055; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Sumy DF, 2014, J GEOPHYS RES-SOL EA, V119, P1904, DOI 10.1002/2013JB010612; van der Elst NJ, 2013, SCIENCE, V341, P164, DOI 10.1126/science.1238948; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; WELLS DL, 1994, B SEISMOL SOC AM, V84, P974; Zoback MD, 2002, INT GEOL REV, V44, P383, DOI 10.2747/0020-6814.44.5.383; ZOBACK ML, 1992, J GEOPHYS RES-SOL EA, V97, P11703, DOI 10.1029/92JB00221	24	506	513	13	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					448	451		10.1126/science.1255802	http://dx.doi.org/10.1126/science.1255802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	24993347				2022-12-24	WOS:000339655100042
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED "Case finding" in dementia is simply screening with no evidence of benefit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Andermann A, 2008, B WORLD HEALTH ORGAN, V86, P241; [Anonymous], 2010, UK NSC POLICY ALZHEI; [Anonymous], 2011, GUID INT TUB CAS FIN; Brunet MD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8588; Burns A, RE THERE NO EVIDENCE; Wilson JMG, 1968, PRINCIPLES ORACTICE	6	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2014	349								g4791	10.1136/bmj.g4791	http://dx.doi.org/10.1136/bmj.g4791			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VS	25059715	Green Published, Bronze			2022-12-24	WOS:000339566200006
J	Cohen, D				Cohen, Deborah			ANTICOAGULANTS Concerns over data in key dabigatran trial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NONVALVULAR ATRIAL-FIBRILLATION; STROKE PREVENTION; WARFARIN; XIMELAGATRAN; EVENTS					dcohen@bmj.com						Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; [Anonymous], 2011, THERAPEUTICS LETT, V80; Center for Drug Evaluation and Research, 2010, APPL NUMB 22 512; Chatterjee S, 2014, JAMA NEUROL, V71, P371, DOI 10.1001/jamaneurol.2013.6003; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4670; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Hohnloser SH, 2012, CIRCULATION, V125, P669, DOI 10.1161/CIRCULATIONAHA.111.055970	9	20	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4747	10.1136/bmj.g4747	http://dx.doi.org/10.1136/bmj.g4747			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VP	25055831	Green Published, Bronze			2022-12-24	WOS:000339565900009
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED The BMJ is wrong: doctor assisted dying would overmedicalise death	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bingham J., 2014, DAILY TELEGRAPH, DOI [10674267/Family-breakdowncouldcost-taxpayers-46bn.htmlhttp://www.telegraph.co.uk/women/sex/divorce/10674267/Familybreakdown-could-cost-taxpayers-46bn.html, DOI 10674267/FAMILY-BREAKDOWNCOULDCOST-TAXPAYERS-46BN.HTMLHTTP://WWW.TELEGRAPH.CO.UK/WOMEN/SEX/DIVORCE/10674267/FAMILYBREAKDOWN-COULD-COST-TAXPAYERS-46BN.HTML]; Cumberlege J., 2010, FAIR SOC HEARLY LIVE; Delamothe T, 2014, BMJ-BRIT MED J, V348, pg4094; Heath I, 2013, JAMA INTERN MED, V173, P956, DOI 10.1001/jamainternmed.2013.970; McPherson K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3106; The Royal College of Midwives, CAMP NORM BIRTH	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2014	349								g4502	10.1136/bmj.g4502	http://dx.doi.org/10.1136/bmj.g4502			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZB	25005033	Bronze, Green Published			2022-12-24	WOS:000338993300013
J	Smith, MR; Ortega-Hernandez, J				Smith, Martin R.; Ortega-Hernandez, Javier			Hallucigenia's onychophoran-like claws and the case for Tactopoda	NATURE			English	Article							CAMBRIAN LOBOPODIANS; BURGESS SHALE; TARDIGRADES; PHYLOGENY; INSIGHTS; ORGANIZATION; MUSCULATURE; MORPHOLOGY; MICRORNAS; EVOLUTION	The Palaeozoic form-taxon Lobopodia encompasses a diverse range of soft-bodied 'legged worms' known from exceptional fossil deposits1-. Although lobopodians occupy a deep phylogenetic position within Panarthropoda, a shortage of derived characters obscures their evolutionary relationships with extant phyla (Onychophora, Tardigrada and Euarthropoda)(2,3,5,10-15). Here we describe a complex feature in the terminal claws of the mid-Cambrian lobopodian Hallucigenia sparsa-their construction from a stack of constituent elements-and demonstrate that equivalent elements make up the jaws and claws of extant Onychophora. A cladistic analysis, informed by developmental data on panarthropod head segmentation, indicates that the stacked sclerite components in these two taxa are homologous-resolving hallucigeniid lobopodians as stem-group onychophorans. The results indicate a sister-group relationship between Tardigrada and Euarthropoda, adding palaeontological support to the neurological(16,17) and musculoskeletal(18,19) evidence uniting these disparate clades. These findings elucidate the evolutionary transformations that gave rise to the panarthropod phyla, and expound the lobopodian-like morphology of the ancestral panarthropod.	[Smith, Martin R.; Ortega-Hernandez, Javier] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Smith, MR (corresponding author), Univ Cambridge, Dept Earth Sci, Downing Site, Cambridge CB2 3EQ, England.	ms609@cam.ac.uk	Smith, Martin Ross/B-8461-2012	Smith, Martin Ross/0000-0001-5660-1727	Research Fellowships at Clare College; Emmanuel College, University of Cambridge, UK; H.B. Whittington Research Grant (Paleontological Society); Willi Hennig Society	Research Fellowships at Clare College; Emmanuel College, University of Cambridge, UK; H.B. Whittington Research Grant (Paleontological Society); Willi Hennig Society	The authors are supported by Research Fellowships at Clare College (M. R. S.) and Emmanuel College (J.O.-H.),University of Cambridge, UK. Thanks to J.-B. Caron and T. Harvey for images, access to material and discussions. D. Erwin, K. Hollis and P. Fenton facilitated access to museum specimens, and S. Whittaker assisted with electron microscopy. E. kanangrensis were collected from the Blue Mountains, New South Wales, with assistance from G. Budd and N. Tait and funding from an H.B. Whittington Research Grant (Paleontological Society). N. Butterfield and R. Janssen provided additional material. Parks Canada provided research and collection permits to Royal Ontario Museum teams led by D. Collins. The software TNT is funded by the Willi Hennig Society.	Bergstrom J, 2001, ZOOL ANZ, V240, P237, DOI 10.1078/0044-5231-00031; Budd GE, 2001, ZOOL ANZ, V240, P265, DOI 10.1078/0044-5231-00034; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Budd GE, 1996, LETHAIA, V29, P1, DOI 10.1111/j.1502-3931.1996.tb01831.x; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Campiglia S., 1990, PROC 7TH INT CONGR M, P461; Caron JB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1613; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Dewel RA, 1999, ZOOL ANZ, V238, P191; DZIK J, 1989, LETHAIA, V22, P169, DOI 10.1111/j.1502-3931.1989.tb01679.x; Engel Michael S., 2013, P269; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Harvey THP, 2012, ACTA PALAEONTOL POL, V57, P423, DOI 10.4202/app.2011.0028; HOU XG, 1995, ZOOL J LINN SOC-LOND, V114, P3, DOI 10.1006/zjls.1995.0014; Legg DA, 2011, NATURE, V476, pE2, DOI 10.1038/nature10267; Liu JN, 2011, NATURE, V470, P526, DOI 10.1038/nature09704; Ma XY, 2014, J SYST PALAEONTOL, V12, P445, DOI 10.1080/14772019.2013.770418; Marchioro T, 2013, ZOOL J LINN SOC-LOND, V169, P580, DOI 10.1111/zoj.12079; Mirande JM, 2009, CLADISTICS, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Martin C, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00007; Mayer G, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-230; Mayer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059090; Nixon K., 2003, TNT TREE ANALYSIS US; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Olempska E, 2012, HYDROBIOLOGIA, V688, P139, DOI 10.1007/s10750-011-0659-7; Oliveira ID, 2013, J MORPHOL, V274, P1180, DOI 10.1002/jmor.20171; Ou Q, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2272; Ramskold L, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P107; RAUP DAVID M., 1966, J PALEONTOL, V40, P1178; ROBSON EA, 1964, Q J MICROSC SCI, V105, P281; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Schulze Corinna, 2011, Meiofauna Marina, V19, P195; Steiner M, 2012, B GEOSCI, V87, P107, DOI 10.3140/bull.geosci.1280; Topper TP, 2013, LETHAIA, V46, P490, DOI 10.1111/let.12026; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33	39	89	90	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					363	+		10.1038/nature13576	http://dx.doi.org/10.1038/nature13576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25132546	Green Accepted			2022-12-24	WOS:000342988600051
J	Marzeion, B; Cogley, JG; Richter, K; Parkes, D				Marzeion, Ben; Cogley, J. Graham; Richter, Kristin; Parkes, David			Attribution of global glacier mass loss to anthropogenic and natural causes	SCIENCE			English	Article							CLIMATE; BALANCE	The ongoing global glacier retreat is affecting human societies by causing sea-level rise, changing seasonal water availability, and increasing geohazards. Melting glaciers are an icon of anthropogenic climate change. However, glacier response times are typically decades or longer, which implies that the present-day glacier retreat is a mixed response to past and current natural climate variability and current anthropogenic forcing. Here we show that only 25 +/- 35% of the global glacier mass loss during the period from 1851 to 2010 is attributable to anthropogenic causes. Nevertheless, the anthropogenic signal is detectable with high confidence in glacier mass balance observations during 1991 to 2010, and the anthropogenic fraction of global glacier mass loss during that period has increased to 69 +/- 24%.	[Marzeion, Ben; Richter, Kristin; Parkes, David] Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria; [Cogley, J. Graham] Trent Univ, Dept Geog, Peterborough, ON K9J 7B8, Canada	University of Innsbruck; Trent University	Marzeion, B (corresponding author), Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria.	ben.marzeion@uibk.ac.at	Marzeion, Ben/G-6514-2013	Marzeion, Ben/0000-0002-6185-3539; Parkes, David/0000-0002-6339-1681	Austrian Science Fund [PP25362-N26]; Austrian Ministry of Science Bundesministerium fur Wissenschaft und Forschung, UniInfrastrukturprogramm of the Research Platform Scientific Computing at the University of Innsbruck; Austrian Science Fund (FWF) [P 22443] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry of Science Bundesministerium fur Wissenschaft und Forschung, UniInfrastrukturprogramm of the Research Platform Scientific Computing at the University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (grant PP25362-N26) and supported by the Austrian Ministry of Science Bundesministerium fur Wissenschaft und Forschung as part of the UniInfrastrukturprogramm of the Research Platform Scientific Computing at the University of Innsbruck. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups (listed in the table S1) for producing and making available their model output. For CMIP, the U. S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provided coordinating support and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Arendt A., 2012, RANDOLPH GLACIER INV; Cogley JG, 2009, ANN GLACIOL, V50, P96, DOI 10.3189/172756409787769744; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Giesen RH, 2013, CLIM DYNAM, V41, P3283, DOI 10.1007/s00382-013-1743-7; Gregory JM, 2013, J CLIMATE, V26, P4476, DOI 10.1175/JCLI-D-12-00319.1; Harrison WD, 2001, J GLACIOL, V47, P659, DOI 10.3189/172756501781831837; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; JOHANNESSON T, 1989, J GLACIOL, V35, P355, DOI 10.3189/S002214300000928X; Kaser G, 2010, P NATL ACAD SCI USA, V107, P20223, DOI 10.1073/pnas.1008162107; Leclercq PW, 2011, SURV GEOPHYS, V32, P519, DOI 10.1007/s10712-011-9121-7; Marzeion B, 2014, CRYOSPHERE, V8, P59, DOI 10.5194/tc-8-59-2014; Marzeion B, 2012, CRYOSPHERE, V6, P1295, DOI 10.5194/tc-6-1295-2012; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; OERLEMANS J, 1988, J GLACIOL, V34, P333, DOI 10.3189/S0022143000007103; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Pfeffer WT, 2014, J GLACIOL, V60, P537, DOI 10.3189/2014JoG13J176; Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7; Reichert BK, 2002, J CLIMATE, V15, P3069, DOI 10.1175/1520-0442(2002)015<3069:RGREIV>2.0.CO;2; Richardson SD, 2000, QUATERN INT, V65-6, P31, DOI 10.1016/S1040-6182(99)00035-X; Roe GH, 2009, J GLACIOL, V55, P839, DOI 10.3189/002214309790152438; Vaughan DG, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P317	26	191	197	13	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					919	921		10.1126/science.1254702	http://dx.doi.org/10.1126/science.1254702			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25123485				2022-12-24	WOS:000340524700043
J	MacKenzie, T; Gifford, AH; Sabadosa, KA; Quinton, HB; Knapp, EA; Goss, CH; Marshall, BC				MacKenzie, Todd; Gifford, Alex H.; Sabadosa, Kathryn A.; Quinton, Hebe B.; Knapp, Emily A.; Goss, Christopher H.; Marshall, Bruce C.			Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry	ANNALS OF INTERNAL MEDICINE			English	Article							RISK-FACTORS; MORTALITY; ADULTS; CARE; ASSOCIATION; HEALTH; GUIDELINES; DIAGNOSIS; CHILDREN; DISEASE	Background: Advances in treatments for cystic fibrosis (CF) continue to extend survival. An updated estimate of survival is needed for better prognostication and to anticipate evolving adult care needs. Objective: To characterize trends in CF survival between 2000 and 2010 and to project survival for children born and diagnosed with the disease in 2010. Design: Registry-based study. Setting: 110 Cystic Fibrosis Foundation-accredited care centers in the United States. Patients: All patients represented in the Cystic Fibrosis Foundation Patient Registry (CFFPR) between 2000 and 2010. Measurements: Survival was modeled with respect to age, age at diagnosis, gender, race or ethnicity, F508del mutation status, and symptoms at diagnosis. Results: Between 2000 and 2010, the number of patients in the CFFPR increased from 21 000 to 26 000, median age increased from 14.3 to 16.7 years, and adjusted mortality decreased by 1.8% per year (95% CI, 0.5% to 2.7%). Males had a 19% (CI, 13% to 24%) lower adjusted risk for death than females. Median survival of children born and diagnosed with CF in 2010 is projected to be 37 years (CI, 35 to 39 years) for females and 40 years (CI, 39 to 42 years) for males if mortality remains at 2010 levels and more than 50 years if mortality continues to decrease at the rate observed between 2000 and 2010. Limitations: The CFFPR does not include all patients with CF in the United States, and loss to follow-up and missing data were observed. Additional analyses to address these limitations suggest that the survival projections are conservative. Conclusion: Children born and diagnosed with CF in the United States in 2010 are expected to live longer than those born earlier. This has important implications for prognostic discussions and suggests that the health care system should anticipate greater numbers of adults with CF.	[MacKenzie, Todd] Dartmouth Hitchcock Med Ctr, Clin Res Sect, Lebanon, NH 03756 USA; [Gifford, Alex H.; Quinton, Hebe B.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA; [Sabadosa, Kathryn A.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Knapp, Emily A.; Marshall, Bruce C.] Cyst Fibrosis Fdn, Bethesda, MD 20814 USA; [Goss, Christopher H.] Univ Washington, Seattle, WA 98195 USA	Dartmouth College; Dartmouth College; Dartmouth College; Cystic Fibrosis Foundation; University of Washington; University of Washington Seattle	Sabadosa, KA (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, 30 Lafayette St,Suite 300, Lebanon, NH 03766 USA.	Todd.A.MacKenzie@Dartmouth.edu; Kathryn.A.Sabadosa@Dartmouth.edu		Knapp, Emily/0000-0003-3953-9874; Gifford, Alex/0000-0002-6404-3793; Goss, Christopher/0000-0001-8602-0309	Cystic Fibrosis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001086, KL2TR001088] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Cystic Fibrosis Foundation.	ABBOTT J, 1994, THORAX, V49, P115, DOI 10.1136/thx.49.2.115; Al-Aloul M, 2005, PEDIATR PULM, V39, P15, DOI 10.1002/ppul.20138; ANDERSEN D H, 1958, J Chronic Dis, V7, P58, DOI 10.1016/0021-9681(58)90185-1; Andersson-Segesten K, 1989, Scand J Caring Sci, V3, P35; Barr HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4662; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Cystic Fibrosis Foundation, 2012, CYST FIBR PAT REG; Cystic Fibrosis Foundation, 2012, CYST FIBR; Cystic Fibrosis Foundation, 2010, CYST FIBR PAT REG AN; Dasenbrook EC, 2010, JAMA-J AM MED ASSOC, V303, P2386, DOI 10.1001/jama.2010.791; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; ELBORN JS, 1991, THORAX, V46, P881, DOI 10.1136/thx.46.12.881; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Figueroa V, 2002, AM J CLIN NUTR, V75, P1005, DOI 10.1093/ajcn/75.6.1005; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Fogarty AW, 2012, CHEST, V142, P712, DOI 10.1378/chest.11-2124; Gilljam M, 2004, CHEST, V126, P1215, DOI 10.1378/chest.126.4.1215; Godfrey MM, 2014, BMJ QUAL SAF, V23, P23, DOI 10.1136/bmjqs-2014-002804; Hemandez-Jimenez F, 2008, J CYST FIBROS, V7, P343, DOI 10.1016/j.jcf.2008.02.006; Iles N, 2010, HEALTH SOC CARE COMM, V18, P21, DOI 10.1111/j.1365-2524.2009.00871.x; Jackson AD, 2011, THORAX, V66, P674, DOI 10.1136/thoraxjnl-2011-200038; Jackson AD, 2011, J CYST FIBROS, V10, P62, DOI 10.1016/j.jcf.2010.08.021; KLEIN JP, 1990, BIOMETRICS, V46, P795, DOI 10.2307/2532097; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; Kulich M, 2003, J PEDIATR-US, V142, P631, DOI 10.1067/mpd.2003.197; Liou TG, 2001, JAMA-J AM MED ASSOC, V286, P2683, DOI 10.1001/jama.286.21.2683; Marshall BC, 2009, J PEDIATR-US, V155, pS71, DOI 10.1016/j.jpeds.2009.09.004; Mayer-Hamblett N, 2002, AM J RESP CRIT CARE, V166, P1550, DOI 10.1164/rccm.200202-087OC; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; Modi AC, 2008, CHILD HEALTH CARE, V37, P78, DOI 10.1080/02739610701766925; MOESCHBERGER ML, 1985, BIOMETRICS, V41, P253, DOI 10.2307/2530660; Moran A, 2010, DIABETES CARE, V33, P2697, DOI 10.2337/dc10-1768; Nick JA, 2010, AM J RESP CRIT CARE, V182, P614, DOI 10.1164/rccm.201001-0092OC; O'Connor GT, 2002, PEDIATR PULM, V33, P99, DOI 10.1002/ppul.10042; Okumura MJ, 2014, BMJ QUAL SAF, V23, P64, DOI 10.1136/bmjqs-2013-002364; Quittner AL, 2008, CURR OPIN PULM MED, V14, P582, DOI 10.1097/MCP.0b013e3283121cf1; Quon BS, 2011, AM J RESP CRIT CARE, V184, P1147, DOI 10.1164/rccm.201105-0932OC; Rayas MS, 2014, PEDIAT PULMONOL; Riekert KA, 2007, CHEST, V132, P231, DOI 10.1378/chest.06-2474; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; Sabadosa KA, 2014, BMJ QUAL SAF, V23, P90, DOI 10.1136/bmjqs-2013-002782; Sawicki GS, 2009, J CYST FIBROS, V8, P91, DOI 10.1016/j.jcf.2008.09.007; Scarsi KK, 2010, INT J ANTIMICROB AG, V36, P94, DOI 10.1016/j.ijantimicag.2010.02.018; Schechter MS, 2014, BMJ QUAL SAF, V23, P9, DOI 10.1136/bmjqs-2013-002378; Schluchter MD, 2002, STAT MED, V21, P1271, DOI 10.1002/sim.1104; Schwarzenberg SJ, 2007, DIABETES CARE, V30, P1056, DOI 10.2337/dc06-1576; Stallings VA, 2008, J AM DIET ASSOC, V108, P832, DOI 10.1016/j.jada.2008.02.020; Sueblinvong V, 2007, CLIN CHEST MED, V28, P433, DOI 10.1016/j.ccm.2007.02.009; Therneau TM., 2013, PACKAGE SURVIVAL ANA; Wand M. P., 1994, KERNEL SMOOTHING; Zeitlin PL, 2008, J CLIN INVEST, V118, P3841, DOI 10.1172/JCI37778; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	54	226	232	1	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					233	+		10.7326/M13-0636	http://dx.doi.org/10.7326/M13-0636			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP8RU	25133359	Green Accepted			2022-12-24	WOS:000342347300013
J	Hawkes, N				Hawkes, Nigel			PUBLICATION ETHICS Risks in the balance: the statins row	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Boseley S, 2014, GUARDIAN; Hawkes N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4694; Heath I, 2014, BMJ PAPERS      0802; Huffman MD., 2013, BMJ; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3937; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	9	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2014	349								g5007	10.1136/bmj.g5007	http://dx.doi.org/10.1136/bmj.g5007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MR	25103564				2022-12-24	WOS:000340206200002
J	Praetorius, SK; Mix, AC				Praetorius, Summer K.; Mix, Alan C.			Synchronization of North Pacific and Greenland climates preceded abrupt deglacial warming	SCIENCE			English	Article							LAST DEGLACIATION; OCEAN CIRCULATION; SEA-ICE; ATLANTIC; ACCUMULATION; OSCILLATIONS; VARIABILITY; ANTARCTICA; TOPOGRAPHY; HOLOCENE	Some proposed mechanisms for transmission of major climate change events between the North Pacific and North Atlantic predict opposing patterns of variations; others suggest synchronization. Resolving this conflict has implications for regulation of poleward heat transport and global climate change. New multidecadal-resolution foraminiferal oxygen isotope records from the Gulf of Alaska (GOA) reveal sudden shifts between intervals of synchroneity and asynchroneity with the North Greenland Ice Core Project (NGRIP) delta O-18 record over the past 18,000 years. Synchronization of these regions occurred 15,500 to 11,000 years ago, just prior to and throughout the most abrupt climate transitions of the last 20,000 years, suggesting that dynamic coupling of North Pacific and North Atlantic climates may lead to critical transitions in Earth's climate system.	[Praetorius, Summer K.; Mix, Alan C.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Praetorius, SK (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	spraetor@coas.oregonstate.edu			NSF [AGS-0602395, OCE-1204204]; Division Of Ocean Sciences [0962077, 1204204] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank B. Jensen and D. Froese for the tephra analyses; J. Southon for assistance with radiocarbon samples; A. Ross, J. Padman, and J. McKay of the College of Earth, Ocean and Atmospheric Sciences Stable Isotope Lab; and five anonymous reviewers. This work was supported by NSF grants AGS-0602395 (Project PALEOVAR) and OCE-1204204 to A. C. M., and an NSF graduate research fellowship to S. K. P. The data can be found in the supplementary online materials and at the National Oceanic and Atmospheric Administration Paleoclimate Database.	ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; Asahi H, 2007, PROG OCEANOGR, V72, P343, DOI 10.1016/j.pocean.2006.03.021; Bakke J, 2009, NAT GEOSCI, V2, P202, DOI 10.1038/NGEO439; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; Broecker W, 2012, QUATERNARY SCI REV, V57, P17, DOI 10.1016/j.quascirev.2012.09.024; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; Caissie BE, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001671; Chang EKM, 2004, J CLIMATE, V17, P4230, DOI 10.1175/JCLI3195.1; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; Cronin TM, 2010, QUATERNARY SCI REV, V29, P3415, DOI 10.1016/j.quascirev.2010.05.024; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Davies MH, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002051; Davies-Walczak M, 2014, EARTH PLANET SC LETT, V397, P57, DOI 10.1016/j.epsl.2014.04.004; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Gebhardt H, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001513; Justino F, 2005, J CLIMATE, V18, P2826, DOI 10.1175/JCLI3403.1; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Lenton TM, 2012, CLIM PAST, V8, P1127, DOI 10.5194/cp-8-1127-2012; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Li C, 2009, CLIM DYNAM, V32, P753, DOI 10.1007/s00382-009-0529-4; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Lund DC, 1998, PALEOCEANOGRAPHY, V13, P10, DOI 10.1029/97PA02984; Max L, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002292; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mix AC, 1999, GEOPH MONOG SERIES, V112, P127; Monnin E, 2004, EARTH PLANET SC LETT, V224, P45, DOI 10.1016/j.epsl.2004.05.007; Okazaki Y, 2010, SCIENCE, V329, P200, DOI 10.1126/science.1190612; Okumura YM, 2009, J CLIMATE, V22, P1424, DOI 10.1175/2008JCLI2511.1; Pausata FSR, 2011, CLIM PAST, V7, P1089, DOI 10.5194/cp-7-1089-2011; Pedro JB, 2011, CLIM PAST, V7, P671, DOI 10.5194/cp-7-671-2011; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Saenko OA, 2004, J CLIMATE, V17, P2033, DOI 10.1175/1520-0442(2004)017<2033:TAS>2.0.CO;2; Sarnthein M, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000771; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; SHAFFER G, 1994, NATURE, V367, P354, DOI 10.1038/367354a0; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Timmermann A, 2004, CLIM DYNAM, V23, P353, DOI 10.1007/s00382-004-0434-9; Ullman DJ, 2014, CLIM PAST, V10, P487, DOI 10.5194/cp-10-487-2014; Waelbroeck C, 2001, NATURE, V412, P724, DOI 10.1038/35089060; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Wu LX, 2005, J CLIMATE, V18, P331, DOI 10.1175/JCLI-3264.1	46	63	63	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					444	448		10.1126/science.1252000	http://dx.doi.org/10.1126/science.1252000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061208				2022-12-24	WOS:000339655100041
J	Hickman, AB; Ewis, HE; Li, XH; Knapp, JA; Laver, T; Doss, AL; Tolun, G; Steven, AC; Grishaev, A; Bax, A; Atkinson, PW; Craig, NL; Dyda, F				Hickman, Alison B.; Ewis, Hosam E.; Li, Xianghong; Knapp, Joshua A.; Laver, Thomas; Doss, Anna-Louise; Tolun, Goekhan; Steven, Alasdair C.; Grishaev, Alexander; Bax, Ad; Atkinson, Peter W.; Craig, Nancy L.; Dyda, Fred			Structural Basis of hAT Transposon End Recognition by Hermes, an Octameric DNA Transposase from Musca domestica	CELL			English	Article							X-RAY-SCATTERING; BINDING DOMAIN; SUBTERMINAL SEQUENCES; PUTATIVE TRANSPOSASE; V(D)J RECOMBINATION; AC ELEMENT; HOBO; ARABIDOPSIS; DROSOPHILA; REVEALS	Hermes is a member of the hAT transposon superfamily that has active representatives, including McClintock's archetypal Ac mobile genetic element, in many eukaryotic species. The crystal structure of the Hermes transposase-DNA complex reveals that Hermes forms an octameric ring organized as a tetramer of dimers. Although isolated dimers are active in vitro for all the chemical steps of transposition, only octamers are active in vivo. The octamer can provide not only multiple specific DNA-binding domains to recognize repeated subterminal sequences within the transposon ends, which are important for activity, but also multiple nonspecific DNA binding surfaces for target capture. The unusual assembly explains the basis of bipartite DNA recognition at hAT transposon ends, provides a rationale for transposon end asymmetry, and suggests how the avidity provided by multiple sites of interaction could allow a transposase to locate its transposon ends amidst a sea of chromosomal DNA.	[Hickman, Alison B.; Dyda, Fred] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Ewis, Hosam E.; Li, Xianghong; Craig, Nancy L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Knapp, Joshua A.; Atkinson, Peter W.] Univ Calif Riverside, Grad Program Biochem & Mol Biol, Riverside, CA 92521 USA; [Laver, Thomas; Atkinson, Peter W.] Univ Calif Riverside, Grad Program Genet Genom & Bioinformat, Riverside, CA 92521 USA; [Doss, Anna-Louise; Atkinson, Peter W.] Univ Calif Riverside, Grad Program Cell Mol & Dev Biol, Riverside, CA 92521 USA; [Atkinson, Peter W.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Atkinson, Peter W.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Tolun, Goekhan; Steven, Alasdair C.] NIAMSD, Struct Biol Res Lab, NIH, Bethesda, MD 20892 USA; [Grishaev, Alexander; Bax, Ad] NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dyda, F (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	fred.dyda@nih.gov	Wilson, Matthew H/K-3193-2013; TOLUN, Gökhan/D-1971-2012; Tolun, Gokhan/AAG-9606-2021	TOLUN, Gökhan/0000-0001-6166-9451; Tolun, Gokhan/0000-0001-6166-9451; Grishaev, Alexander/0000-0002-9347-2327	NIH Intramural Programs of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Public Health Service (PHS) award [A1045741]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036153] Funding Source: NIH RePORTER	NIH Intramural Programs of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Public Health Service (PHS) award; US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially funded by the NIH Intramural Programs of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (F.D. and A.B.) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (A.C.S.). P.W.A. and N.L.C. were funded by Public Health Service (PHS) award A1045741. Crystallographic data were collected at the SER-CAT 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory (ANL). For the SAXS experiments, we gratefully acknowledge use of the shared scattering beamline 12-IDC resource allocated under the PUP-77 agreement between the National Cancer Institute and ANL and thank Soenke Seifert (ANL) for his support. Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. We thank Sriram Subramaniam and members of his laboratory for their preliminary EM efforts. We also thank Nadine Samara for critical reading of the manuscript, Primrose Musingarimi for help with Sf9-expressed Hermes, Robert Hice for assistance with EMSA and insect cell culture experiments, and Susan Chacko of the Helix systems group, CIT, NIH for advice and help with fuzznuc.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Arensburger P, 2011, GENETICS, V188, P45, DOI 10.1534/genetics.111.126813; ATKINSON PW, 1993, P NATL ACAD SCI USA, V90, P9693, DOI 10.1073/pnas.90.20.9693; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Becker HA, 1997, MOL GEN GENET, V254, P219, DOI 10.1007/s004380050410; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; BLACKMAN RK, 1989, EMBO J, V8, P211, DOI 10.1002/j.1460-2075.1989.tb03366.x; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; Gangadharan S, 2010, P NATL ACAD SCI USA, V107, P21966, DOI 10.1073/pnas.1016382107; Gao J, 2006, INSECT MOL BIOL, V15, P835, DOI 10.1111/j.1365-2583.2006.00690.x; Grishaev A, 2010, J AM CHEM SOC, V132, P15484, DOI 10.1021/ja106173n; Grundy GJ, 2009, MOL CELL, V35, P217, DOI 10.1016/j.molcel.2009.06.022; HALLET B, 1994, MOL MICROBIOL, V14, P131, DOI 10.1111/j.1365-2958.1994.tb01273.x; Hashida SN, 2006, PLANT CELL, V18, P104, DOI 10.1105/tpc.105.037655; HEHL R, 1991, PLANT MOL BIOL, V16, P369, DOI 10.1007/BF00020572; Hickman AB, 2010, CRIT REV BIOCHEM MOL, V45, P50, DOI 10.3109/10409230903505596; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Kahlon AS, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-9; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim YJ, 2011, GENETICA, V139, P985, DOI 10.1007/s10709-011-9600-2; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; KUNZE R, 1989, EMBO J, V8, P3177, DOI 10.1002/j.1460-2075.1989.tb08476.x; Kunze R., 2002, MOBILE DNA, P565, DOI DOI 10.1128/9781555817954.CH24; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Liu D, 1998, GENETICS, V149, P693; Liu D, 2001, GENETICS, V157, P817; Mack AM, 2001, PLANT CELL, V13, P2319, DOI 10.1105/tpc.13.10.2319; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Oh J, 2006, J VIROL, V80, P451, DOI 10.1128/JVI.80.1.451-459.2006; Pribil PA, 2003, J MOL BIOL, V330, P247, DOI 10.1016/S0022-2836(03)00588-6; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Rubin E, 2001, GENETICS, V158, P949; Sarkar A, 1997, GENETICA, V99, P15, DOI 10.1023/A:1018349803656; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; STRECK RD, 1986, EMBO J, V5, P3615, DOI 10.1002/j.1460-2075.1986.tb04690.x; VandenDriessche T, 2009, BLOOD, V114, P1461, DOI 10.1182/blood-2009-04-210427; WARREN WD, 1994, GENET RES, V64, P87, DOI 10.1017/S0016672300032699; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	52	47	52	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					353	367		10.1016/j.cell.2014.05.037	http://dx.doi.org/10.1016/j.cell.2014.05.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036632	Green Accepted, Bronze			2022-12-24	WOS:000340943600015
J	[Anonymous]				[Anonymous]			Cervical Spine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLUNT TRAUMA; INJURY; RULE											CASSARPULLICINO VN, 2006, SPINAL TRAUMA IMAGIN; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Hogan GJ, 2005, RADIOLOGY, V237, P106, DOI 10.1148/radiol.2371040697; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841	4	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2014	349								g2177	10.1136/bmj.g2177	http://dx.doi.org/10.1136/bmj.g2177			32	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FN	25145468				2022-12-24	WOS:000340838900001
J	Flint, E; Cummins, S; Sacker, A				Flint, Ellen; Cummins, Steven; Sacker, Amanda			Associations between active commuting, body fat, and body mass index: population based, cross sectional study in the United Kingdom	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY LEVELS; CARDIOVASCULAR RISK-FACTORS; WEIGHT; OBESITY; WORK; TRANSPORT; OVERWEIGHT; WALKING; HEALTH; SCHOOL	Objective To determine if promotion of active modes of travel is an effective strategy for obesity prevention by assessing whether active commuting (walking or cycling for all or part of the journey to work) is independently associated with objectively assessed biological markers of obesity. Design Cross sectional study of data from the wave 2 Health Assessment subsample of Understanding Society, the UK Household Longitudinal Study (UKHLS). The exposure of interest, commuting mode, was self reported and categorised as three categories: private transport, public transport, and active transport. Participants The analytic samples (7534 for body mass index (BMI) analysis, 7424 for percentage body fat analysis) were drawn from the representative subsample of wave 2 respondents of UKHLS who provided health assessment data (n= 15 777). Main outcome measures Body mass index (weight (kg)/height (m)(2)); percentage body fat (measured by electrical impedance). Results Results from multivariate linear regression analyses suggest that, compared with using private transport, commuting by public or active transport modes was significantly and independently predictive of lower BMI for both men and women. In fully adjusted models, men who commuted via public or active modes had BMI scores 1.10 (95% CI 0.53 to 1.67) and 0.97 (0.40 to 1.55) points lower, respectively, than those who used private transport. Women who commuted via public or active modes had BMI scores 0.72 (0.06 to 1.37) and 0.87 (0.36 to 0.87) points lower, respectively, than those using private transport. Results for percentage body fat were similar in terms of magnitude, significance, and direction of effects. Conclusions Men and women who commuted to work by active and public modes of transport had significantly lower BMI and percentage body fat than their counterparts who used private transport. These associations were not attenuated by adjustment for a range of hypothesised confounding factors.	[Flint, Ellen; Cummins, Steven] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1H 9SH, England; [Sacker, Amanda] UCL, Res Dept Epidemiol & Publ Hlth, ESRC Int Ctr Lifecourse Studies Soc & Hlth, London WC1E 6BT, England	University of London; London School of Hygiene & Tropical Medicine; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of London; University College London	Flint, E (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1H 9SH, England.	ellen.flint@lshtm.ac.uk	Cummins, Steven/C-1230-2009	Cummins, Steven/0000-0002-3957-4357; Sacker, Amanda/0000-0001-8796-5398	UK National Institute of Health Research (NIHR); UK Economic and Social Research Council (ESRC) [ES/J019119/1]; ESRC [ES/J019119/1] Funding Source: UKRI; Economic and Social Research Council [ES/J019119/1] Funding Source: researchfish; National Institute for Health Research [SRF-2010-03-05] Funding Source: researchfish	UK National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	SC and EF are supported by a UK National Institute of Health Research (NIHR) Senior Fellowship to SC. AS is supported by the UK Economic and Social Research Council (ESRC) ES/J019119/1. The authors affirm their independence from these funders. The funders played no part in the study design, collection, analysis or interpretation of data, or in the writing of the report, or in the decision to submit the article for publication. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR or the UK Department of Health.	[Anonymous], UNDERSTANDING SOC WO; Audrey S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-37; Barengo NC, 2006, EUR J CARDIOV PREV R, V13, P51, DOI 10.1097/00149831-200602000-00008; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Boreham R, 2012, UNDERSTANDING SOC W2; Department of Health, 2011, START ACT STAY ACT R; Department of Health, 2004, LEAST 5 WEEK EV IMP; Faulkner GEJ, 2009, PREV MED, V48, P3, DOI 10.1016/j.ypmed.2008.10.017; Fuller D, 2012, PREV MED, V54, P74, DOI 10.1016/j.ypmed.2011.09.021; Goodman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071790; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gutierrez-Fisac JL, 2002, OBES RES, V10, P270, DOI 10.1038/oby.2002.37; Hagenaars A., 1994, POVERTY STAT LATE 19; HAGLUND BJA, 1987, SCAND J SOC MED, V15, P19, DOI 10.1177/140349488701500104; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; He K, 2004, INT J OBESITY, V28, P1569, DOI 10.1038/sj.ijo.0802795; Hu G, 2002, BRIT J NUTR, V88, P91, DOI 10.1079/BJNBJN2002590; JEFFERY RW, 1991, INT J OBESITY, V15, P689; Laverty AA, 2013, AM J PREV MED, V45, P282, DOI 10.1016/j.amepre.2013.04.012; Lindstrom M, 2008, PREV MED, V46, P22, DOI 10.1016/j.ypmed.2007.07.012; Lynn P., 2011, SAMPLE DESIGN UNDERS; McFall S., 2013, UNDERSTANDING SOC UK; National Institute for Health and Care Excellence, 2012, WALK CYCL LOC MEAS P, V41; Office for National Statistics, 2014, 2011 CENS CYCL WORK; Ogilvie D, 2007, BMJ-BRIT MED J, V334, P1204, DOI 10.1136/bmj.39198.722720.BE; Petticrew M, 2005, PUBLIC HEALTH, V119, P751, DOI 10.1016/j.puhe.2004.11.008; Pucher J, 2010, AM J PUBLIC HEALTH, V100, P1986, DOI 10.2105/AJPH.2009.189324; Rissel C, 2012, INT J ENV RES PUB HE, V9, P2454, DOI 10.3390/ijerph9072454; Saunders LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069912; StataCorp, 2011, STAT STAT SOFTW REL; STENDER M, 1993, INT J EPIDEMIOL, V22, P644, DOI 10.1093/ije/22.4.644; Stephens SK, 2014, PREV MED, V62, P167, DOI 10.1016/j.ypmed.2014.02.008; University of Essex. Institute for Social and Economic Research and National Centre for Social Research, 2012, UND SOC WAV 1 2 2009; University of Essex. National Institute for Social and Economic Research and Centre for Social Research, 2013, UND SOC WAV 2 NURS H; Wanner M, 2012, AM J PREV MED, V42, P493, DOI 10.1016/j.amepre.2012.01.030; Xu HL, 2013, ASIA-PAC J PUBLIC HE, V25, P298, DOI 10.1177/1010539513482965	36	72	74	1	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2014	349								g4887	10.1136/bmj.g4887	http://dx.doi.org/10.1136/bmj.g4887			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN8FK	25139861	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000340838500001
J	Crider, KS; Devine, O; Hao, L; Dowling, NF; Li, S; Molloy, AM; Li, Z; Zhu, JH; Berry, RJ				Crider, Krista S.; Devine, Owen; Hao, Ling; Dowling, Nicole F.; Li, Song; Molloy, Anne M.; Li, Zhu; Zhu, Jianghui; Berry, Robert J.			Population red blood cell folate concentrations for prevention of neural tube defects: bayesian model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLIC-ACID FORTIFICATION; DOUBLE-BLIND TRIAL; UNITED-STATES; CHILDBEARING AGE; HOMOCYSTEINE CONCENTRATIONS; ERYTHROCYTE FOLATE; FOOD FORTIFICATION; SPINA-BIFIDA; WOMEN; SUPPLEMENTATION	Objective To determine an optimal population red blood cell (RBC) folate concentration for the prevention of neural tube birth defects. Design Bayesian model. Setting Data from two population based studies in China. Participants 247 831 participants in a prospective community intervention project in China (1993-95) to prevent neural tube defects with 400 mu g/day folic acid supplementation and 1194 participants in a population based randomized trial (2003-05) to evaluate the effect of folic acid supplementation on blood folate concentration among Chinese women of reproductive age. Intervention Folic acid supplementation (400 mu g/day). Main outcome measures Estimated RBC folate concentration at time of neural tube closure (day 28 of gestation) and risk of neural tube defects. Results Risk of neural tube defects was high at the lowest estimated RBC folate concentrations (for example, 25.4 (95% uncertainty interval 20.8 to 31.2) neural tube defects per 10 000 births at 500 nmol/L) and decreased as estimated RBC folate concentration increased. Risk of neural tube defects was substantially attenuated at estimated RBC folate concentrations above about 1000 nmol/L (for example, 6 neural tube defects per 10 000 births at 1180 (1050 to 1340) nmol/L). The modeled dose-response relation was consistent with the existing literature. In addition, neural tube defect risk estimates developed using the proposed model and population level RBC information were consistent with the prevalence of neural tube defects in the US population before and after food fortification with folic acid. Conclusions A threshold for "optimal" population RBC folate concentration for the prevention of neural tube defects could be defined (for example, approximately 1000 nmol/L). Population based RBC folate concentrations, as a biomarker for risk of neural tube defects, can be used to facilitate evaluation of prevention programs as well as to identify subpopulations at elevated risk for a neural tube defect affected pregnancy due to folate insufficiency.	[Crider, Krista S.; Devine, Owen; Dowling, Nicole F.; Berry, Robert J.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; [Hao, Ling; Li, Zhu; Zhu, Jianghui] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Hao, Ling] US Ctr Dis Control & Prevent, US Embassy, Beijing, Peoples R China; [Li, Song] Peking Univ, Hosp 3, Beijing 100871, Peoples R China; [Molloy, Anne M.] Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland; [Zhu, Jianghui] China Natl Ctr Food Safety Risk Assessment, Div Risk Assessment, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA; Peking University; Peking University; Trinity College Dublin	Crider, KS (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.	kcrider@cdc.gov		Berry, Robert/0000-0002-7162-5046; Crider, Krista/0000-0001-6997-5955; Molloy, Anne/0000-0002-1688-9049	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for salaries of CDC employees was provided by the Centers for Disease Control and Prevention. No specific funding was provided for this project. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Adank C, 2003, ANN NUTR METAB, V47, P55, DOI 10.1159/000069278; Agopian AJ, 2013, BIRTH DEFECTS RES A, V97, P42, DOI 10.1002/bdra.23100; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bestwick JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089354; Bradbury KE, 2012, J NUTR, V142, P1633, DOI 10.3945/jn.112.161562; Branum AM, 2013, J NUTR, V143, P486, DOI 10.3945/jn.112.169987; Calonge N, 2009, ANN INTERN MED, V150, P626, DOI 10.7326/0003-4819-150-9-200905050-00009; Chen LT, 2004, NUTR REV, V62, pS40, DOI 10.1301/nr.2004.jun.S40-S43; Cordero A., 2010, Morbidity and Mortality Weekly Report, V59, P980; Cortes F, 2012, AM J MED GENET A, V158A, P1885, DOI 10.1002/ajmg.a.35430; Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671; Cuskelly GJ, 1999, AM J CLIN NUTR, V70, P234; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; Daly S, 1997, LANCET, V350, P1666, DOI 10.1016/S0140-6736(97)07247-4; De Wals P, 2008, BIRTH DEFECTS RES A, V82, P622, DOI 10.1002/bdra.20485; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Green TJ, 2005, ASIA PAC J CLIN NUTR, V14, P173; Hao L, 2003, J NUTR, V133, P3630, DOI 10.1093/jn/133.11.3630; Hao L, 2008, AM J CLIN NUTR, V88, P448, DOI 10.1093/ajcn/88.2.448; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Horn F, 2014, BRATISL MED J, V115, P91, DOI 10.4149/BLL_2014_020; Hursthouse NA, 2011, NUTRIENTS, V3, P49, DOI 10.3390/nu3010049; Lamers Y, 2006, AM J CLIN NUTR, V84, P156, DOI 10.1093/ajcn/84.1.156; Mao RF, 2008, CELL BIOCHEM FUNCT, V26, P352, DOI 10.1002/cbf.1450; McDonnell R, 2014, J PUBLIC HLTH OXF; McMahon DM, 2013, BIRTH DEFECTS RES A, V97, P115, DOI 10.1002/bdra.23113; Milman N, 2006, EUR J HAEMATOL, V76, P200, DOI 10.1111/j.1600-0609.2005.00606.x; Nelson CRM, 2014, CAN J PUBLIC HEALTH, V105, pE40, DOI 10.17269/cjph.105.4155; Norsworthy B, 2004, EUR J CLIN NUTR, V58, P548, DOI 10.1038/sj.ejcn.1601843; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pfeiffer CM, 2012, J NUTR, V142, P886, DOI 10.3945/jn.111.156919; Pfeiffer CM, 2011, J NUTR, V141, P1402, DOI 10.3945/jn.111.141515; Sayed AR, 2008, BIRTH DEFECTS RES A, V82, P211, DOI 10.1002/bdra.20442; SCHORAH CJ, 1983, BRIT J NUTR, V49, P203, DOI 10.1079/BJN19830026; Selhub J, 2008, FOOD NUTR BULL, V29, pS67, DOI 10.1177/15648265080292S110; Shibuya KMC, 1998, HLTH DIMENSIONS SEX, P455; Tinker SC, 2010, AM J PREV MED, V38, P534, DOI 10.1016/j.amepre.2010.01.025; Ubeda N, 2011, NUTRITION, V27, P925, DOI 10.1016/j.nut.2010.10.017; WALD N, 1991, LANCET, V338, P131; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Williams LJ, 2002, TERATOLOGY, V66, P33, DOI 10.1002/tera.10060; Yan LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041689; Yang QH, 2010, AM J CLIN NUTR, V91, P64, DOI 10.3945/ajcn.2009.28401; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059570	48	125	128	0	115	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2014	349								g4554	10.1136/bmj.g4554	http://dx.doi.org/10.1136/bmj.g4554			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NG	25073783	Green Published, hybrid			2022-12-24	WOS:000339906000002
J	Godefroit, P; Sinitsa, SM; Dhouailly, D; Bolotsky, YL; Sizov, AV; McNamara, ME; Benton, MJ; Spagna, P				Godefroit, Pascal; Sinitsa, Sofia M.; Dhouailly, Danielle; Bolotsky, Yuri L.; Sizov, Alexander V.; McNamara, Maria E.; Benton, Michael J.; Spagna, Paul			A Jurassic ornithischian dinosaur from Siberia with both feathers and scales	SCIENCE			English	Article							INTEGUMENTARY STRUCTURES; CHINA; THEROPOD; ORIGIN; EVOLUTION; PLUMAGE; FOSSILS; COLOR; BIRDS	Middle Jurassic to Early Cretaceous deposits from northeastern China have yielded varied theropod dinosaurs bearing feathers. Filamentous integumentary structures have also been described in ornithischian dinosaurs, but whether these filaments can be regarded as part of the evolutionary lineage toward feathers remains controversial. Here we describe a new basal neornithischian dinosaur from the Jurassic of Siberia with small scales around the distal hindlimb, larger imbricated scales around the tail, monofilaments around the head and the thorax, and more complex featherlike structures around the humerus, the femur, and the tibia. The discovery of these branched integumentary structures outside theropods suggests that featherlike structures coexisted with scales and were potentially widespread among the entire dinosaur clade; feathers may thus have been present in the earliest dinosaurs.	[Godefroit, Pascal; Spagna, Paul] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, B-1000 Brussels, Belgium; [Sinitsa, Sofia M.] Inst Nat Resources Ecol & Cryol, Chita 672014, Russia; [Dhouailly, Danielle] Univ Grenoble 1, AGIM, UJF CNRS FRE 3405, F-38706 La Tronche, France; [Bolotsky, Yuri L.] FEB RAS, Inst Geol & Nat Management, Blagoveshchensk, Russia; [Sizov, Alexander V.] SB RAS, Inst Earth Crust, Irkutsk, Russia; [McNamara, Maria E.] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [McNamara, Maria E.; Benton, Michael J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England	Royal Belgian Institute of Natural Sciences; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institute of Geology & Nature Management FEB RAS; Irkutsk Science Centre of the Russian Academy of Sciences; Institute of Earth's Crust of Siberian Branch of the Russian Academy of Sciences; Russian Academy of Sciences; University College Cork; University of Bristol	Godefroit, P (corresponding author), Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Rue Vautier 29, B-1000 Brussels, Belgium.	pascal.godefroit@naturalsciences.be	Benton, Michael J/A-5639-2008; Sinitsa, Sofia/J-3201-2018; Sizov, Alexander/ABH-9485-2020; McNamara, Maria E/C-8431-2014	Benton, Michael J/0000-0002-4323-1824; Sinitsa, Sofia/0000-0002-5074-787X; Sizov, Alexander/0000-0002-3029-9686; McNamara, Maria E/0000-0003-0968-4624	Belgian Science Policy [BL/36/62]; Natural Environment Research Council [NE/I027630/1]; NERC [NE/I027630/1] Funding Source: UKRI	Belgian Science Policy(Belgian Federal Science Policy Office); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank A. B. Ptitsyn for making fossils available for study; Ph. Claeys, J.-M. Baele, and I. Y. Bolosky for help and comments on the manuscript; and P. Golinvaux, J. Dos Remedios Esteves, C. Desmedt, and A. Vandersypen for the drawings and reconstructions. This study was supported by Belgian Science Policy grant BL/36/62 to P. G. and by Natural Environment Research Council Standard Grant NE/I027630/1 awarded to M.J.B.	Bell PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031295; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Buchwitz M, 2012, PALAEONTOL Z, V86, P313, DOI 10.1007/s12542-012-0135-3; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Dhouailly D, 2009, J ANAT, V214, P587, DOI 10.1111/j.1469-7580.2008.01041.x; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; Godefroit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2389; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Lingham-Soliar T, 2008, P ROY SOC B-BIOL SCI, V275, P775, DOI 10.1098/rspb.2007.1342; Lingham-Soliar T, 2007, P ROY SOC B-BIOL SCI, V274, P1823, DOI 10.1098/rspb.2007.0352; Lucas A., 1972, AVIAN ANATOMY INTEGU; Mayr G, 2002, NATURWISSENSCHAFTEN, V89, P361, DOI 10.1007/s00114-002-0339-6; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Prin F, 2004, INT J DEV BIOL, V48, P137, DOI 10.1387/ijdb.15272378; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753	27	76	78	1	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					451	455		10.1126/science.1253351	http://dx.doi.org/10.1126/science.1253351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061209	Green Submitted			2022-12-24	WOS:000339655100043
J	Lewin, SR; Deeks, SG; Barre-Sinoussi, F				Lewin, Sharon R.; Deeks, Steven G.; Barre-Sinoussi, Francoise			Towards a cure for HIV-are we making progress?	LANCET			English	Editorial Material							LATENCY		[Lewin, Sharon R.] Alfred Hlth, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Barre-Sinoussi, Francoise] INSERM, Paris, France; [Barre-Sinoussi, Francoise] Inst Pasteur, Dept Virol, Unit Regulat Retroviral Infect, Paris, France	Monash University; Burnet Institute; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lewin, SR (corresponding author), Alfred Hlth, Dept Infect Dis, Melbourne, Vic 3004, Australia.	sharon.lewin@monash.edu	Lewin, Sharon/Z-3297-2019	Lewin, Sharon Ruth/0000-0002-0330-8241				Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Henrich TJ, 2014, C RETR OPP INF CROI; Maartens G, 2014, LANCET; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Sogaard OS, 2014, 20 INT AIDS C MELB A; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662	14	23	23	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					209	211		10.1016/S0140-6736(14)61181-8	http://dx.doi.org/10.1016/S0140-6736(14)61181-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL8JI	25042220				2022-12-24	WOS:000339384100004
J	Cooper, KL; Sears, KE; Uygur, A; Maier, J; Baczkowski, KS; Brosnahan, M; Antczak, D; Skidmore, JA; Tabin, CJ				Cooper, Kimberly L.; Sears, Karen E.; Uygur, Aysu; Maier, Jennifer; Baczkowski, Karl-Stephan; Brosnahan, Margaret; Antczak, Doug; Skidmore, Julian A.; Tabin, Clifford J.			Patterning and post-patterning modes of evolutionary digit loss in mammals	NATURE			English	Article							APICAL ECTODERMAL RIDGE; PROGRAMMED CELL-DEATH; LIMB DEVELOPMENT; VERTEBRATE LIMB; DEVELOPMENTAL BASIS; REDUCTION; HEDGEHOG; BUD; HEMIERGIS; NUMBER	A reduction in the number of digits has evolved many times in tetrapods, particularly in cursorial mammals that travel over deserts and plains, yet the underlying developmental mechanisms have remained elusive. Here we show that digit loss can occur both during early limbpatterning and at later post-patterning stages of chondrogenesis. In the 'odd-toed' jerboa (Dipus sagitta) and horse and the 'even-toed' camel, extensive cell death sculpts the tissue around the remaining toes. In contrast, digit loss inthepig is orchestrated by earlier limb patterning mechanisms including downregulation of Ptch1 expression but no increase in cell death. Together these data demonstrate remarkable plasticity in the mechanisms of vertebrate limb evolution and shed light on the complexity of morphological convergence, particularly within the artiodactyl lineage.	[Cooper, Kimberly L.; Uygur, Aysu; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sears, Karen E.; Maier, Jennifer] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Baczkowski, Karl-Stephan] Ecole Normale Super Lyon, F-69007 Lyon, France; [Brosnahan, Margaret; Antczak, Doug] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Skidmore, Julian A.] Camel Reprod Ctr, Dubai, U Arab Emirates	Harvard University; Harvard Medical School; University of Illinois System; University of Illinois Urbana-Champaign; Ecole Normale Superieure de Lyon (ENS de LYON); Cornell University	Cooper, KL (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	kcooper@ucsd.edu; ksears@life.illinois.edu		Sears, Karen/0000-0001-9744-9602; Antczak, Douglas/0000-0003-3336-5818	NIH [R37HD032443]; NSF IOS grant [1257873]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IOS grant(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank J. Lopez-Rios and R. Zeller (University of Basel, Switzerland) for generously providing data and discussion before publication. We also thank J. Carlos Izpisua Belmonte and A. Aguirre for sharing space and materials to complete experiments subsequent to review. Jerboa embryos were harvested with the assistance of S. Wu and colleagues in Xinjiang, China. Pig embryos were harvested with the assistance of D. Urban. Additional horse embryos were provided by R. Turner and H. Galatino-Homer (University of Pennsylvania) and by R. Fritsche and S. Lyle (Louisiana State University). Mouse Gli1 probe plasmid, used in the pig in situ, was provided by A. Joyner. This work was supported by NIH grant R37HD032443 to C.J.T., and NSF IOS grant 1257873 to K.E.S.	ALBERCH P, 1983, J EMBRYOL EXP MORPH, V76, P177; Butterfield NC, 2009, DEVELOPMENT, V136, P3515, DOI 10.1242/dev.037507; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Clifford AB, 2010, J VERTEBR PALEONTOL, V30, P1827, DOI 10.1080/02724634.2010.521216; Cooper K. L, 2011, COLD SPRING HARB PRO; Cooper LN, 2007, ANAT REC, V290, P654, DOI 10.1002/ar.20532; Fernandez-Teran MA, 2006, DEV DYNAM, V235, P2521, DOI 10.1002/dvdy.20916; Ferrari D, 1998, DEV BIOL, V197, P12, DOI 10.1006/dbio.1998.8880; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; LANDE R, 1978, EVOLUTION, V32, P73, DOI 10.1111/j.1558-5646.1978.tb01099.x; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Marazzi G, 1997, DEV BIOL, V186, P127, DOI 10.1006/dbio.1997.8576; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Ovchinnikov Dmitry, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5170; Pizette S, 2001, DEVELOPMENT, V128, P4463; Prothero D.R., 2007, EVOLUTION ARTIODACTY; Rasweiler J. J., 2009, COLD SPRING HARB PRO; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Romer A, 1936, VERTEBRATE PALEONTOL; ROSE KD, 1982, SCIENCE, V216, P621, DOI 10.1126/science.216.4546.621; Rose KD, 1996, P NATL ACAD SCI USA, V93, P1705, DOI 10.1073/pnas.93.4.1705; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Sears KE, 2011, EVOL DEV, V13, P533, DOI 10.1111/j.1525-142X.2011.00509.x; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; Shapiro MD, 2002, J MORPHOL, V254, P211, DOI 10.1002/jmor.10027; Shenbrot GI., 2008, JERBOAS MAMMALS RUSS; Skinner A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-310; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Theodor J., 2007, EVOLUTION ARTIODACTY; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Walker E. P., 1964, MAMMALS WORLD; Whole-mount R. R., 2009, COLD SPRING HARB PRO; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuzarte-Luis V, 2005, SEMIN CELL DEV BIOL, V16, P261, DOI 10.1016/j.semcdb.2004.12.004	36	90	93	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					41	U537		10.1038/nature13496	http://dx.doi.org/10.1038/nature13496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990742	Green Accepted			2022-12-24	WOS:000338199400031
J	Fischer, WA; Hynes, NA; Perl, TM				Fischer, William A., II; Hynes, Noreen A.; Perl, Trish M.			Protecting Health Care Workers From Ebola: Personal Protective Equipment Is Critical but Is Not Enough	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27599 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Johns Hopkins Hlth Syst, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Fischer, WA (corresponding author), Univ N Carolina, Chapel Hill Sch Med, Div Pulm & Crit Care Med, Dept Med,Ctr Environm Med Asthma & Lung Biol, 104 Mason Farm Rd, Chapel Hill, NC 27599 USA.	William_Fischer@med.unc.edu	Hynes, Noreen/AAA-2550-2020					[Anonymous], 2014, EB VIR DIS UPD W AFR; Hinshaw D., 2014, WALL STREET J; Khan AS, 1999, J INFECT DIS S1, V179, pS76, DOI DOI 10.1086/514306; The World Bank, 2013, GNI PER CAP RANK ATL; World Bank, 2010, PHYS PER 1000 PEOPL; World Health Organization (WHO), 2014, BARR RAP CONT EB OUT	6	68	70	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					753	U209		10.7326/M14-1953	http://dx.doi.org/10.7326/M14-1953			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25155746				2022-12-24	WOS:000347245600037
J	Wang, KT; Sitsel, O; Meloni, G; Autzen, HE; Andersson, M; Klymchuk, T; Nielsen, AM; Rees, DC; Nissen, P; Gourdon, P				Wang, Kaituo; Sitsel, Oleg; Meloni, Gabriele; Autzen, Henriette Elisabeth; Andersson, Magnus; Klymchuk, Tetyana; Nielsen, Anna Marie; Rees, Douglas C.; Nissen, Poul; Gourdon, Pontus			Structure and mechanism of Zn2+-transporting P-type ATPases	NATURE			English	Article							MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; TRANSMEMBRANE TRANSPORT; CU+ CHAPERONES; METAL-BINDING; CALCIUM-PUMP; ZINC; COORDINATION; SITES; ZNTA	Zinc is an essential micronutrient for all living organisms. It is required for signalling and proper functioning of a range of proteins involved in, for example, DNA binding and enzymatic catalysis(1). In prokaryotes and photosynthetic eukaryotes, Zn2+-transporting P-type ATPases of class IB (ZntA) are crucial for cellular redistribution and detoxification of Zn2+ and related elements(2,3). Here we present crystal structures representing the phosphoenzyme ground state (E2P) and a dephosphorylation intermediate (E2.P-i) of ZntA from Shigella sonnei, determined at 3.2 angstrom and 2.7 angstrom resolution, respectively. The structures reveal a similar fold to Cu+-ATPases, with an amphipathic helix at the membrane interface. A conserved electronegative funnel connects this region to the intramembranous high-affinity ion-binding site and may promote specific uptake of cellular Zn2+ ions by the transporter. The E2P structure displays a wide extracellular release pathway reaching the invariant residues at the high-affinity site, including C392, C394 and D714. The pathway closes in the E2.P-i state, in which D714 interacts with the conserved residue K693, which possibly stimulates Zn2+ release as a built-in counter ion, as has been proposed for H+-ATPases. Indeed, transport studies in liposomes provide experimental support for ZntA activity without counter transport. These findings suggest a mechanistic link between P-IB-type Zn2+-ATPases and P-III-type H+-ATPases and at the same time show structural features of the extracellular release pathway that resemble P-II-type ATPases such as the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase(4,5) (SERCA) and Na+, K+-ATPase(6). These findings considerably increase our understanding of zinc transport in cells and represent new possibilities for biotechnology and biomedicine.	[Wang, Kaituo; Sitsel, Oleg; Meloni, Gabriele; Autzen, Henriette Elisabeth; Klymchuk, Tetyana; Nielsen, Anna Marie; Nissen, Poul; Gourdon, Pontus] Aarhus Univ, Dept Mol Biol & Genet, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus C, Denmark; [Andersson, Magnus] KTH Royal Inst Technol, Dept Theoret Phys, Swedish E Sci Res Ctr, Sci Life Lab, SE-17121 Solna, Sweden; [Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	Aarhus University; Danmarks Grundforskningsfond; Royal Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Gourdon, P (corresponding author), Univ Copenhagen, Dept Biomed Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	pontus@sund.ku.dk	Gourdon, Pontus/E-1076-2014; wang, kaituo/G-9249-2016; Gourdon, Pontus/HCI-8898-2022; Autzen, Henriette Elisabeth/AAI-1084-2019	Gourdon, Pontus/0000-0002-8631-3539; wang, kaituo/0000-0002-5922-7109; Autzen, Henriette Elisabeth/0000-0003-3691-5010; Andersson, Magnus/0000-0002-3364-6647; Meloni, Gabriele/0000-0003-4976-1401; Nissen, Poul/0000-0003-0948-6628	Graduate School of Science and Technology at Aarhus University; Marie Curie International Outgoing Fellowship (European Commission) [252961]; Marie Curie Career Integration Grant [FP7-MC-CIG-618558]; European Research Council [250322 Biomemos]; Lundbeck Foundation; Swedish Research Council [K2013-99X-22251-01-5]; Danscatt program of the Danish Council of Independent Research; BioStruct-X [860]; Lundbeck Foundation [R139-2012-12689] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002082] Funding Source: researchfish	Graduate School of Science and Technology at Aarhus University; Marie Curie International Outgoing Fellowship (European Commission); Marie Curie Career Integration Grant; European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Swedish Research Council(Swedish Research CouncilEuropean Commission); Danscatt program of the Danish Council of Independent Research; BioStruct-X; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank J. L Karlsen for support with crystallographic computing. O.S. and H.E.A. are supported by the Graduate School of Science and Technology at Aarhus University. G.M. is supported by a Marie Curie International Outgoing Fellowship (European Commission, grant no. 252961). M.A. was supported by a Marie Curie Career Integration Grant (FP7-MC-CIG-618558). P.N. was supported by an advanced research grant from the European Research Council (250322 Biomemos), and P.G. was supported, in the later stage, by the Lundbeck Foundation and the Swedish Research Council (K2013-99X-22251-01-5). We are grateful for assistance with crystal screening from Maxlab, beam lines 911-2/3, and with data collection from the Swiss Light Source, beam line X06SA. Access to synchrotron sources was supported by the Danscatt program of the Danish Council of Independent Research and by BioStruct-X contract 860.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Andersson M, 2014, NAT STRUCT MOL BIOL, V21, P43, DOI 10.1038/nsmb.2721; Andreini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026325; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Banci L, 2002, J MOL BIOL, V323, P883, DOI 10.1016/S0022-2836(02)01007-0; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Clausen JD, 2010, J BIOL CHEM, V285, P20780, DOI 10.1074/jbc.M110.116459; Counago RM, 2014, NAT CHEM BIOL, V10, P35, DOI [10.1038/NCHEMBIO.1382, 10.1038/nchembio.1382]; Damjanovic A, 2009, PROTEINS, V76, P1007, DOI 10.1002/prot.22439; DOMINGO JL, 1994, J TOXICOL ENV HEALTH, V42, P123, DOI 10.1080/15287399409531868; Dutta SJ, 2007, BIOCHEMISTRY-US, V46, P3692, DOI 10.1021/bi0616394; Ekberg K, 2013, J BIOL CHEM, V288, P9610, DOI 10.1074/jbc.M112.417345; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Faxen K, 2011, J BIOL CHEM, V286, P1609, DOI 10.1074/jbc.M110.176784; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Izrailev S, 1997, BIOPHYS J, V72, P1568, DOI 10.1016/S0006-3495(97)78804-0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mattle D, 2013, J MOL BIOL, V425, P2299, DOI 10.1016/j.jmb.2013.03.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Okkeri J, 2006, BBA-BIOENERGETICS, V1757, P1485, DOI 10.1016/j.bbabio.2006.06.008; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P69, DOI 10.1074/jbc.M112.420810; Patel K, 2007, BBA-PROTEINS PROTEOM, V1774, P1247, DOI 10.1016/j.bbapap.2007.07.010; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POST RL, 1972, J BIOL CHEM, V247, P6530; Raimunda D, 2012, BBA-BIOMEMBRANES, V1818, P1374, DOI 10.1016/j.bbamem.2012.02.020; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Wu CC, 2006, J BIOL CHEM, V281, P29533, DOI 10.1074/jbc.M604658200; Yang W, 2003, P NATL ACAD SCI USA, V100, P874, DOI 10.1073/pnas.0337432100; Zhitnitsky D, 2014, MOL MICROBIOL, V91, P777, DOI 10.1111/mmi.12495	54	81	83	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					518	+		10.1038/nature13618	http://dx.doi.org/10.1038/nature13618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25132545	Green Accepted			2022-12-24	WOS:000343775900046
J	Frieden, TR; Damon, I; Bell, BP; Kenyon, T; Nichol, S				Frieden, Thomas R.; Damon, Inger; Bell, Beth P.; Kenyon, Thomas; Nichol, Stuart			Ebola 2014-New Challenges, New Global Response and Responsibility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Frieden, Thomas R.; Damon, Inger; Bell, Beth P.; Kenyon, Thomas; Nichol, Stuart] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.			Frieden, Thomas/0000-0002-4759-2256				[Anonymous], 2014, INT GUID EB INF AIRL; Bausch DG, 2007, J INFECT DIS, V196, pS136, DOI 10.1086/520542; Centers for Disease Control and Prevention, 2014, INF PREV CONTR REC H; Centers for Disease Control and Prevention, 2014, OUTBR CHRON EB HEM F; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8	5	157	165	0	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1177	1180		10.1056/NEJMp1409903	http://dx.doi.org/10.1056/NEJMp1409903			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP4WH	25140858				2022-12-24	WOS:000342079700002
J	Butler, J; Braunwald, E; Gheorghiade, M				Butler, Javed; Braunwald, Eugene; Gheorghiade, Mihai			Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; HOSPITALIZATION; THERAPY; RATES		[Butler, Javed] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Braunwald, Eugene] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA; [Gheorghiade, Mihai] Northwestern Univ, Ctr Cardiovasc Innovat, Feinberg Sch Med, Chicago, IL 60611 USA	Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Northwestern University; Feinberg School of Medicine	Gheorghiade, M (corresponding author), Northwestern Univ, Ctr Cardiovasc Innovat, Feinberg Sch Med, 201 E Huron St,Galter 3-150, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu						Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Ambrosy AP, 2013, EUR HEART J, V34, P835, DOI 10.1093/eurheartj/ehs444; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Goldenberg I, 2014, NEW ENGL J MED, V370, P1694, DOI 10.1056/NEJMoa1401426; Schrager J, 2013, ACAD EMERG MED, V20, P554, DOI 10.1111/acem.12147; Skali H, 2014, EUR J HEART FAIL, V16, P560, DOI 10.1002/ejhf.71; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	9	50	63	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					789	790		10.1001/jama.2014.6643	http://dx.doi.org/10.1001/jama.2014.6643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25157719				2022-12-24	WOS:000340788500017
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Adrenaline in cardiac arrest: it's unethical for patients not to know	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EPINEPHRINE; SURVIVAL; OUTCOMES					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2014, BBC; Edwards P, 2005, LANCET, V365, P1957; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Ong MEH, 2007, ANN EMERG MED, V50, P635, DOI 10.1016/j.annemergmed.2007.03.028; Patanwala AE, 2014, MINERVA ANESTESIOL, V80, P831; Ristagno G, 2009, CRIT CARE MED, V37, P1408, DOI 10.1097/CCM.0b013e31819cedc9; Stirton R, 2014, J MED ETHICS	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2014	349								g5258	10.1136/bmj.g5258	http://dx.doi.org/10.1136/bmj.g5258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FP	25148860	Bronze, Green Published			2022-12-24	WOS:000340839100004
J	Delaney, S; Gardella, C; Saracino, M; Magaret, A; Wald, A				Delaney, Shani; Gardella, Carolyn; Saracino, Misty; Magaret, Amalia; Wald, Anna			Seroprevalence of Herpes Simplex Virus Type 1 and 2 Among Pregnant Women, 1989-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							STATES		[Delaney, Shani; Gardella, Carolyn] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Saracino, Misty; Magaret, Amalia] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wald, Anna] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Delaney, S (corresponding author), Univ Washington, Dept Obstet & Gynecol, 1959 NE Pacific St, Seattle, WA 98195 USA.	delaneys@u.washington.edu		Delaney, Shani/0000-0001-8017-5043	NIAID NIH HHS [K24 AI071113, AI-030731, P01 AI030731] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731, K24AI071113] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashley RL, 1988, J CLIN MICROBIOL, V26, P622; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Fanfair RN, 2013, SEX TRANSM DIS, V40, P860, DOI 10.1097/OLQ.0000000000000043; Kropp RY, 2006, PEDIATRICS, V117, P1955, DOI 10.1542/peds.2005-1778; Morris SR, 2008, SEX TRANSM DIS, V35, P14, DOI 10.1097/OLQ.0b013e3180f62bc7	6	22	23	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					746	748		10.1001/jama.2014.4359	http://dx.doi.org/10.1001/jama.2014.4359			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25138337	Bronze, Green Accepted			2022-12-24	WOS:000340438700025
J	Brennan, T; Shrank, W				Brennan, Troyen; Shrank, William			New Expensive Treatments for Hepatitis C Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS-INFECTION; HCV		[Brennan, Troyen; Shrank, William] CVS Caremark, Woonsocket, RI USA		Brennan, T (corresponding author), CVS Caremark, 1 CVS Dr, Woonsocket, RI USA.	troyen.brennan@cvscaremark.com						[Anonymous], SUPP PATH SOV; [Anonymous], 2014, MED MAST DRUG DAT BA; California Technology Assessment Forum, 2014, COMP CLIN EFF VAL SI; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Gounder C., 2013, NEW YORKER; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Ozaras R, 2013, NEW ENGL J MED, V369, P679, DOI 10.1056/NEJMc1307589; Staton T., 2014, EXPRESS SCRIPTS ASSE	9	82	83	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					593	594		10.1001/jama.2014.8897	http://dx.doi.org/10.1001/jama.2014.8897			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25038617				2022-12-24	WOS:000340136400013
J	Oberg, AS; Hernandez-Diaz, S; Frisell, T; Greene, MF; Almqvist, C; Bateman, BT				Oberg, Anna Sara; Hernandez-Diaz, Sonia; Frisell, Thomas; Greene, Michael F.; Almqvist, Catarina; Bateman, Brian T.			Genetic contribution to postpartum haemorrhage in Swedish population: cohort study of 466 686 births	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FAMILIAL AGGREGATION; RISK-FACTORS; FETAL; EPIDEMIOLOGY; PREECLAMPSIA; SAMPLE	Objective To investigate the familial clustering of postpartum haemorrhage in the Swedish population, and to quantify the relative contributions of genetic and environmental effects. Design Register based cohort study. Setting Swedish population (multi-generation and medical birth registers). Main outcome measure Postpartum haemorrhage, defined as >1000 mL estimated blood loss. Participants The first two live births to individuals in Sweden in 1997-2009 contributed to clusters representing intact couples (n=366 350 births), mothers with separate partners (n=53 292), fathers with separate partners (n=47 054), sister pairs (n=97 228), brother pairs (n=91 168), and mixed sibling pairs (n=177 944). Methods Familial clustering was quantified through cluster specific tetrachoric correlation coefficients, and the influence of potential sharing of known risk factors was evaluated with alternating logistic regression. Relative contributions of genetic and environmental effects to the variation in liability for postpartum haemorrhage were quantified with generalised linear mixed models. Results The overall prevalence of postpartum haemorrhage after vaginal deliveries in our sample was 4.6%. Among vaginal deliveries, 18% (95% confidence interval 9% to 26%) of the variation in postpartum haemorrhage liability was attributed to maternal genetic factors, 10% (1% to 19%) to unique maternal environment, and 11% (0% to 26%) to fetal genetic effects. Adjustment for known risk factors only partially explained estimates of familial clustering, suggesting that the observed shared genetic and environmental effects operate in part through pathways independent of known risk factors. There were similar patterns of familial clustering for both of the main subtypes examined (atony and retained placenta), though strongest for haemorrhage after retained placenta. Conclusions There is a maternal genetic predisposition to postpartum haemorrhage, but more than half of the total variation in liability is attributable to factors that are not shared in families.	[Oberg, Anna Sara; Hernandez-Diaz, Sonia] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Oberg, Anna Sara; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Frisell, Thomas] Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, S-17176 Stockholm, Sweden; [Greene, Michael F.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA 02114 USA; [Almqvist, Catarina] Karolinska Univ Hosp, Lung & Allergy Unit, Astrid Lindgren Childrens Hosp, S-17176 Stockholm, Sweden; [Bateman, Brian T.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Bateman, Brian T.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bateman, Brian T.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Bateman, Brian T.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Karolinska Institutet; Karolinska University Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Oberg, AS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	oberg@hsph.harvard.edu	Frisell, Thomas/E-2772-2017; Oberg, Anna Sara/AAH-1078-2021	Frisell, Thomas/0000-0002-5735-9626; Oberg, Anna Sara/0000-0001-6638-1895	Swedish Research Council [2012-340, 2011-3060]; Swedish Initiative for Research on microdata in the Social and Medical Science (SIMSAM) framework [340-2013-5867]; strategic research program in epidemiology at Karolinska Institutet; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [K08HD075831]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Initiative for Research on microdata in the Social and Medical Science (SIMSAM) framework; strategic research program in epidemiology at Karolinska Institutet; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the Swedish Research Council's international postdoc grant 2012-340 (ASO), research grant 2011-3060 (CA), and through the Swedish Initiative for Research on microdata in the Social and Medical Science (SIMSAM) framework grant 340-2013-5867 (ASO, CA), the strategic research program in epidemiology at Karolinska Institutet (CA), as well as by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award No K08HD075831 (BTB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrams ET, 2011, AM ANTHROPOL, V113, P417, DOI 10.1111/j.1548-1433.2011.01351.x; Al Kadri HMF, 2011, ARCH GYNECOL OBSTET, V283, P1207, DOI 10.1007/s00404-010-1522-1; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Blomberg M, 2011, OBSTET GYNECOL, V118, P561, DOI 10.1097/AOG.0b013e31822a6c59; Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257; COMBS CA, 1991, OBSTET GYNECOL, V77, P69; Ford JB, 2007, MED J AUSTRALIA, V187, P391, DOI 10.5694/j.1326-5377.2007.tb01308.x; Ford JB, 2013, AUST NZ J OBSTET GYN, V53, P90, DOI 10.1111/ajo.12019; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kominiarek MA, 2007, SEMIN PERINATOL, V31, P159, DOI 10.1053/j.semperi.2007.03.001; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Magann EF, 2005, SOUTH MED J, V98, P419, DOI 10.1097/01.SMJ.0000152760.34443.86; McLintock C, 2011, J THROMB HAEMOST, V9, P1441, DOI 10.1111/j.1538-7836.2011.04398.x; Multi-generation register, 2010, MULT REG 2009 DESCR, P1; National Board of Health and Welfare, 2011, PREGN DEL NEWB INF S; Oberg AS, 2013, AM J EPIDEMIOL, V177, P531, DOI 10.1093/aje/kws244; Oberg AS, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.872; Oyelese Y, 2010, CLIN OBSTET GYNECOL, V53, P147, DOI 10.1097/GRF.0b013e3181cc406d; Pawitan Y, 2004, STAT MED, V23, P449, DOI 10.1002/sim.1603; Qureshi N, 2012, ANN INTERN MED, V156, P253, DOI 10.7326/0003-4819-156-4-201202210-00002; Rubinstein WS, 2011, GENET MED, V13, P956, DOI 10.1097/GIM.0b013e3182241d88; Sheiner E, 2005, J MATERN-FETAL NEO M, V18, P149, DOI 10.1080/14767050500170088; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Suarez BK, 2005, GENETIC LIABILITY MO; Svensson AC, 2006, AM J OBSTET GYNECOL, V194, P475, DOI 10.1016/j.ajog.2005.08.019; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; Swedish medical birth register, 2003, SWED MED BIRTH REG S; Toledo P, 2007, ANESTH ANALG, V105, P1736, DOI 10.1213/01.ane.0000286233.48111.d8; TRIVERS RL, 1974, AM ZOOL, V14, P249; Walfish M, 2009, BR J ANAESTH S1, V103, pi47, DOI [DOI 10.1093/BJA/AEP303, DOI 10.1093/bja/aep303]	32	12	13	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2014	349								g4984	10.1136/bmj.g4984	http://dx.doi.org/10.1136/bmj.g4984			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RV	25121825	Green Published, hybrid			2022-12-24	WOS:000340507100001
J	Hawkes, N				Hawkes, Nigel			Mixed messages on progress against HIV	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4614; Mills E, 2008, HIV MED, V9, P332, DOI 10.1111/j.1468-1293.2008.00596.x	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2014	349								g4763	10.1136/bmj.g4763	http://dx.doi.org/10.1136/bmj.g4763			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VU	25062743				2022-12-24	WOS:000339566400006
J	Pfeifer, M; Kugler, KG; Sandve, SR; Zhan, BJ; Rudi, H; Hvidsten, TR; Mayer, KFX; Olsen, OA; Rogers, J; Dolezel, J; Pozniak, C; Eversole, K; Feuillet, C; Gill, B; Friebe, B; Lukaszewski, AJ; Sourdille, P; Endo, TR; Kubalakova, M; Cihalikova, J; Dubska, Z; Vrana, J; Sperkova, R; Simkova, H; Febrer, M; Clissold, L; Mclay, K; Singh, K; Chhuneja, P; Singh, NK; Khurana, J; Akhunov, E; Choulet, F; Alberti, A; Barbe, V; Wincker, P; Kanamori, H; Kobayashi, F; Itoh, T; Matsumoto, T; Sakai, H; Tanaka, T; Wu, JZ; Ogihara, Y; Handa, H; Maclachlan, PR; Sharpe, A; Klassen, D; Edwards, D; Batley, J; Lien, S; Steuernagel, B; Wulff, B; Caccamo, M; Ayling, S; Ramirez-Gonzalez, RH; Clavijo, BJ; Wright, J; Spannagl, M; Martis, MM; Mascher, M; Chapman, J; Poland, JA; Scholz, U; Barry, K; Waugh, R; Rokhsar, DS; Muehlbauer, GJ; Stein, N; Gundlach, H; Zytnicki, M; Jamilloux, V; Quesneville, H; Wicker, T; Faccioli, P; Colaiacovo, M; Stanca, AM; Budak, H; Cattivelli, L; Glover, N; Pingault, L; Paux, E; Sharma, S; Appels, R; Bellgard, M; Chapman, B; Nussbaumer, T; Bader, KC; Rimbert, H; Wang, SC; Knox, R; Kilian, A; Alaux, M; Alfama, F; Couderc, L; Guilhot, N; Viseux, C; Loaec, M; Keller, B; Praud, S				Pfeifer, Matthias; Kugler, Karl G.; Sandve, Simen R.; Zhan, Bujie; Rudi, Heidi; Hvidsten, Torgeir R.; Mayer, Klaus F. X.; Olsen, Odd-Arne; Rogers, Jane; Dolezel, Jaroslav; Pozniak, Curtis; Eversole, Kellye; Feuillet, Catherine; Gill, Bikram; Friebe, Bernd; Lukaszewski, Adam J.; Sourdille, Pierre; Endo, Takashi R.; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana; Febrer, Melanie; Clissold, Leah; McLay, Kirsten; Singh, Kuldeep; Chhuneja, Parveen; Singh, Nagendra K.; Khurana, Jitendra; Akhunov, Eduard; Choulet, Frederic; Alberti, Adriana; Barbe, Valerie; Wincker, Patrick; Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Ogihara, Yasunari; Handa, Hirokazu; Maclachlan, P. Ron; Sharpe, Andrew; Klassen, Darrin; Edwards, David; Batley, Jacqueline; Lien, Sigbjorn; Steuernagel, Burkhard; Wulff, Brande; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan; Spannagl, Manuel; Martis, Mihaela M.; Mascher, Martin; Chapman, Jarrod; Poland, Jesse A.; Scholz, Uwe; Barry, Kerrie; Waugh, Robbie; Rokhsar, Daniel S.; Muehlbauer, Gary J.; Stein, Nils; Gundlach, Heidrun; Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Wicker, Thomas; Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Budak, Hikmet; Cattivelli, Luigi; Glover, Natasha; Pingault, Lise; Paux, Etienne; Sharma, Sapna; Appels, Rudi; Bellgard, Matthew; Chapman, Brett; Nussbaumer, Thomas; Bader, Kai Christian; Rimbert, Helene; Wang, Shichen; Knox, Ron; Kilian, Andrzej; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Guilhot, Nicolas; Viseux, Claire; Loaec, Mikael; Keller, Beat; Praud, Sebastien		Int Wheat Genome Sequencing	Genome interplay in the grain transcriptome of hexaploid bread wheat	SCIENCE			English	Article							STARCHY ENDOSPERM; GENE-EXPRESSION; RNA; PROTEIN; IDENTIFICATION; GERMINATION; ALIGNMENT; PROFILES; TRITICUM; REVEALS	Allohexaploid bread wheat (Triticum aestivum L.) provides approximately 20% of calories consumed by humans. Lack of genome sequence for the three homeologous and highly similar bread wheat genomes (A, B, and D) has impeded expression analysis of the grain transcriptome. We used previously unknown genome information to analyze the cell type-specific expression of homeologous genes in the developing wheat grain and identified distinct co-expression clusters reflecting the spatiotemporal progression during endosperm development. We observed no global but cell type-and stage-dependent genome dominance, organization of the wheat genome into transcriptionally active chromosomal regions, and asymmetric expression in gene families related to baking quality. Our findings give insight into the transcriptional dynamics and genome interplay among individual grain cell types in a polyploid cereal genome.	[Pfeifer, Matthias; Kugler, Karl G.; Mayer, Klaus F. X.] Helmholtz Ctr Munich, D-85764 Neuherberg, Germany; [Sandve, Simen R.; Zhan, Bujie; Rudi, Heidi; Olsen, Odd-Arne] Norwegian Univ Life Sci NMBU, Ctr Integrat Genet, Dept Plant Sci, N-1432 As, Norway; [Hvidsten, Torgeir R.] NMBU, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Pfeifer, Matthias; Mayer, Klaus F. X.; Spannagl, Manuel; Martis, Mihaela M.; Gundlach, Heidrun; Sharma, Sapna; Nussbaumer, Thomas; Bader, Kai Christian] Helmholtz Zentrum Munich, Plant Genome & Syst Biol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Rogers, Jane; Eversole, Kellye] Eversole Associates, IWGSC, 5207 Wyoming Rd, Bethesda, MD 20816 USA; [Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana] Inst Expt Bot, Ctr Plant Struct & Funct Genom, Slechtitelu 31, Olomouc 78371, Czech Republic; [Pozniak, Curtis; Maclachlan, P. Ron] Univ Saskatchewan, Dept Plant Sci, Coll Agr & Bioresources, Ctr Crop Dev, 51 Campus Dr, Saskatoon, SK, Canada; [Feuillet, Catherine] Bayer Crop Sci, 3500 Paramount Pkwy, Morrisville, NC 27560 USA; [Gill, Bikram; Friebe, Bernd; Akhunov, Eduard; Wang, Shichen] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Lukaszewski, Adam J.] Univ Calif Riverside, Coll Nat & Agr Sci, Bot & Plant Sci, Riverside, CA 92521 USA; [Endo, Takashi R.] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Kyoto 6068502, Japan; [Febrer, Melanie] Univ Dundee, Genom Sequencing Unit, Dow St, Dundee DD1 5EH, Scotland; [Clissold, Leah; McLay, Kirsten; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan] Norwich Res Pk, Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Singh, Kuldeep] Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana 141004, Punjab, India; [Singh, Nagendra K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Khurana, Jitendra] Univ Delhi, Interdisciplinary Ctr Plant Genom, South Campus, New Delhi 110021, India; [Khurana, Jitendra] Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi 110021, India; [Sourdille, Pierre; Choulet, Frederic; Glover, Natasha; Pingault, Lise; Paux, Etienne; Guilhot, Nicolas] Univ Blaise Pascal, INRA, UMR Genet Divers & Ecophysiol Cereals 1095, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Wincker, Patrick] Commissariat Energie Atom Genoscope, Ctr Natl Sequencage, 2 Rue Gaston Cremieux, F-91057 Evry, France; [Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Handa, Hirokazu] Natl Inst Agrobiol Sci, Plant Genome Res Unit, 2-1-2 Kan Non Dai, Tsukuba, Ibaraki 3058602, Japan; [Ogihara, Yasunari] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Maioka Cho 641-12, Yokohama, Kanagawa 2440813, Japan; [Sharpe, Andrew; Klassen, Darrin] Natl Res Council Canada, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada; [Edwards, David; Batley, Jacqueline] Univ Queensland, Australian Ctr Plant Funct Genom, Sch Agr & Food Sci, St Lucia, Qld 4072, Australia; [Edwards, David; Batley, Jacqueline] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia; [Sandve, Simen R.; Olsen, Odd-Arne] Norwegian Univ Life Sci, Dept Plant Sci, Ctr Integrat Genet CIGENE, N-1432 As, Norway; [Olsen, Odd-Arne] Hedmark Univ Coll, Dept Nat Sci & Technol, N-2318 Elverum, Norway; [Steuernagel, Burkhard; Wulff, Brande] Norwich Res Pk, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Mascher, Martin; Scholz, Uwe] Leibniz Inst Plant Genet & Crop Plant Res IPK, Bioinformat & Informat Technol, D-06466 Seeland Ot Gatersleben, Germany; [Chapman, Jarrod; Barry, Kerrie; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA; [Poland, Jesse A.] USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Poland, Jesse A.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Waugh, Robbie] James Hutton Inst, Dundee DD2 5DA, Scotland; [Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, Dept Plant Biol, St Paul, MN 55108 USA; [Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genome Divers, D-06466 Seeland Ot Gatersleben, Germany; [Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Viseux, Claire; Loaec, Mikael] INRA Versailles, URGI Res Unit Genom Info UR1164, Route St Cyr, F-78026 Versailles, France; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland; [Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Cattivelli, Luigi] Consiglio Ric Sperimentaz Agr, Genom Res Ctr, Via San Protaso 302, I-29017 Fjorenzuola Darda, Italy; [Budak, Hikmet] Sabanci Univ, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Appels, Rudi; Bellgard, Matthew; Chapman, Brett] Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia; [Knox, Ron] Semiarid Prairie Agr Res Ctr, POB 1030, Swift Current, SK S9H 3X2, Canada; [Kilian, Andrzej] Divers Arrays Technol Pty Ltd, 1 Wilf Crane Crescent, Yarralumla, ACT 2600, Australia; [Rimbert, Helene; Praud, Sebastien] Biogemma, Ctr Rech Chappes, Route Ennezat, F-63720 Chappes, France; [Lien, Sigbjorn] Norwegian Univ Life Sci, Dept Anim & Aquicultural Sci, CIGENE, Arboretvelen 6, N-1432 As, Norway	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Norwegian University of Life Sciences; Norwegian University of Life Sciences; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Saskatchewan; Bayer AG; Bayer CropScience; Kansas State University; University of California System; University of California Riverside; Kyoto University; University of Dundee; The Genome Analysis Centre (TGAC); Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); University of Delhi; University of Delhi; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Universite Paris Saclay; National Institute of Agrobiological Sciences - Japan; Yokohama City University; National Research Council Canada; University of Queensland; University of Western Australia; Norwegian University of Life Sciences; Inland Norway University of Applied Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Agriculture (USDA); Kansas State University; James Hutton Institute; University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; INRAE; University of Zurich; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sabanci University; Murdoch University; Norwegian University of Life Sciences	Olsen, OA (corresponding author), Norwegian Univ Life Sci NMBU, Ctr Integrat Genet, Dept Plant Sci, N-1432 As, Norway.	odd-arne.olsen@nmbu.no	Eversole, Kellye/AAN-6141-2020; cattivelli, luigi/AAE-7046-2020; Pfeifer, Matthias/GRJ-4579-2022; Simkova, Hana/F-7734-2014; Budak, Hikmet/S-5835-2017; Pingault, Lise/AAQ-8602-2020; Kubaláková, Marie/F-8269-2014; Hvidsten, Torgeir R./A-3409-2009; Edwards, David/H-3710-2015; Ramírez, Ricardo/H-4808-2019; Mayer, Klaus FX/M-7941-2015; Barry, Kerrie Whitelaw/AAA-5500-2020; Wang, Shichen/E-6213-2012; Sourdille, Pierre/CAF-2780-2022; Stein, Nils/F-7507-2017; Quesneville, Hadi/AAG-1048-2020; Dolezel, Jaroslav/B-7716-2008; Wu, Jian/AAU-5221-2020; Batley, Jacqueline/A-5723-2008; Wicker, Thomas/Z-1978-2019; Kugler, Karl G/B-8406-2015; Budak, Hikmet/U-8517-2019; Wu, Jian/AAU-5221-2020	Eversole, Kellye/0000-0002-8784-4913; cattivelli, luigi/0000-0002-6067-4600; Simkova, Hana/0000-0003-4159-7619; Budak, Hikmet/0000-0002-2556-2478; Pingault, Lise/0000-0002-6149-1267; Hvidsten, Torgeir R./0000-0001-6097-2539; Edwards, David/0000-0001-7599-6760; Ramírez, Ricardo/0000-0001-5745-7085; Mayer, Klaus FX/0000-0001-6484-1077; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Wang, Shichen/0000-0003-1441-2252; Stein, Nils/0000-0003-3011-8731; Quesneville, Hadi/0000-0003-3001-4908; Dolezel, Jaroslav/0000-0002-6263-0492; Wu, Jian/0000-0001-9933-7364; Batley, Jacqueline/0000-0002-5391-5824; Kugler, Karl G/0000-0003-2342-7472; Budak, Hikmet/0000-0002-2556-2478; Wu, Jian/0000-0002-3394-1507; Kilian, Andrzej/0000-0002-2730-7462; Jamilloux, Veronique/0000-0002-6898-4910; Gundlach, Heidrun/0000-0002-6757-0943; Colaiacovo, Moreno/0000-0003-1320-0506; Keller, Beat/0000-0003-2379-9225; Singh, Kuldeep/0000-0001-5239-6586; Spannagl, Manuel/0000-0003-0701-7035; Paux, Etienne/0000-0002-3094-7129; Martis, Mihaela-Maria/0000-0001-7509-2446; , Thomas/0000-0002-6777-7135; Alaux, Michael/0000-0001-9356-4072; Bellgard, Matthew/0000-0002-6303-9469; Scholz, Uwe/0000-0001-6113-3518	Norwegian Research Council [199387]; Deutsche Forschungsgemeinschaft (DFG) [SFB924]; German Federal Ministry of Education and Research (BMBF); European Commission's 7th Framework Program	Norwegian Research Council(Research Council of NorwayEuropean Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission's 7th Framework Program	This work was supported by research grant 199387 from the Norwegian Research Council to the Norwegian University of Life Sciences and Graminor AS to O.A.O. K. F. X. M. acknowledges generous funding by the Deutsche Forschungsgemeinschaft (DFG) to project SFB924 "Molecular mechanisms regulating yield and yield stability in plants," the German Federal Ministry of Education and Research (BMBF) in frame of the Synbreed project, and the European Commission's 7th Framework Program in frame of the TransPLANT project. The data reported in this paper are tabulated in the supplementary materials and archived at the ArrayExpress database www.ebi.ac.uk/arrayexpress, accession no. E-MTAB-2137. No conflict of interest is known for the authors of this manuscript regarding data reported herein. S. I. Chi, E. I. Ako, A. Maharajan, and O. Jorgensen are thankfully acknowledged for grain dissection and plant cultivation. We thank P. Langridge, P. Shewry, B. Keller, and two anonymous reviewers for helpful suggestions on the manuscript. The RNA-seq was carried out at the Norwegian Sequencing Centre of University of Oslo. Graminor AS is acknowledged for generous support throughout this work.	Akhunova AR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-505; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson OD, 2013, FUNCT INTEGR GENOMIC, V13, P261, DOI 10.1007/s10142-013-0321-8; Anderson OD, 2009, FUNCT INTEGR GENOMIC, V9, P397, DOI 10.1007/s10142-009-0122-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Drea S, 2005, PLANT CELL, V17, P2172, DOI 10.1105/tpc.105.034058; Dupont FM, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-10; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feldman M, 2012, J EXP BOT, V63, P5045, DOI 10.1093/jxb/ers192; Finnegan EJ, 2004, CURR BIOL, V14, P911, DOI 10.1016/j.cub.2004.04.045; Gillies SA, 2012, PLANT BIOTECHNOL J, V10, P668, DOI 10.1111/j.1467-7652.2012.00705.x; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hu ZR, 2013, NEW PHYTOL, V197, P1344, DOI 10.1111/nph.12131; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; MOORE G, 1995, TRENDS GENET, V11, P81, DOI 10.1016/S0168-9525(00)89005-8; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Payne P. I., 1983, Cereal Research Communications, V11, P29; Pellny TK, 2012, PLANT PHYSIOL, V158, P612, DOI 10.1104/pp.111.189191; Ravel C, 2009, PLANT PHYSIOL, V151, P2133, DOI 10.1104/pp.109.146076; Rustenholz C, 2011, PLANT PHYSIOL, V157, P1596, DOI 10.1104/pp.111.183921; Serna A, 2001, PLANT J, V25, P687, DOI 10.1046/j.1365-313x.2001.01004.x; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shitsukawa N, 2007, PLANT CELL, V19, P1723, DOI 10.1105/tpc.107.051813; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; THOMPSON RD, 1983, THEOR APPL GENET, V67, P87, DOI 10.1007/BF00303930; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vensel WH, 2005, PROTEOMICS, V5, P1594, DOI 10.1002/pmic.200401034; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wilkinson M, 2008, J CEREAL SCI, V48, P722, DOI 10.1016/j.jcs.2008.03.007; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	53	228	239	7	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1250091	10.1126/science.1250091	http://dx.doi.org/10.1126/science.1250091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035498	Green Published			2022-12-24	WOS:000343420300002
J	Spiegelhalter, DJ				Spiegelhalter, D. J.			STATISTICS The future lies in uncertainty	SCIENCE			English	Editorial Material									Univ Cambridge, Stat Lab, Ctr Math Sci, Cambridge CB3 0WB, England	University of Cambridge	Spiegelhalter, DJ (corresponding author), Univ Cambridge, Stat Lab, Ctr Math Sci, Cambridge CB3 0WB, England.	david@statslab.cam.ac.uk						Aalen OO, 2012, J R STAT SOC A STAT, V175, P831, DOI 10.1111/j.1467-985X.2011.01030.x; Aberdein J, 2013, SIGNIFICANCE, V10, P46; Andrieu C, 2010, J R STAT SOC B, V72, P269, DOI 10.1111/j.1467-9868.2009.00736.x; Aydin B, 2009, ANN APPL STAT, V3, P1597, DOI 10.1214/09-AOAS263; Berry CC, 2014, BIOINFORMATICS, V30, P1493, DOI 10.1093/bioinformatics/btu035; Davidian M, 2013, J AM STAT ASSOC, V108, P1141, DOI 10.1080/01621459.2013.844019; Efron B, 2013, SCIENCE, V340, P1177, DOI 10.1126/science.1236536; Fan JQ, 2012, J AM STAT ASSOC, V107, P1019, DOI 10.1080/01621459.2012.720478; Gaydos B, 2009, DRUG INF J, V43, P539, DOI 10.1177/009286150904300503; Li B, 2012, J AM STAT ASSOC, V107, P152, DOI 10.1080/01621459.2011.644498; Macilwain C, 2014, SCIENCE, V344, P1221, DOI 10.1126/science.344.6189.1221; National Academy of Sciences, 2013, FRONT MASS DAT AN	12	24	25	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					264	265		10.1126/science.1251122	http://dx.doi.org/10.1126/science.1251122			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035471				2022-12-24	WOS:000339400700025
J	West, PC; Gerber, JS; Engstrom, PM; Mueller, ND; Brauman, KA; Carlson, KM; Cassidy, ES; Johnston, M; MacDonald, GK; Ray, DK; Siebert, S				West, Paul C.; Gerber, James S.; Engstrom, Peder M.; Mueller, Nathaniel D.; Brauman, Kate A.; Carlson, Kimberly M.; Cassidy, Emily S.; Johnston, Matt; MacDonald, Graham K.; Ray, Deepak K.; Siebert, Stefan			Leverage points for improving global food security and the environment	SCIENCE			English	Article							CLIMATE-CHANGE; DEFORESTATION; EMISSIONS; DEMAND; YIELD	Achieving sustainable global food security is one of humanity's contemporary challenges. Here we present an analysis identifying key "global leverage points" that offer the best opportunities to improve both global food security and environmental sustainability. We find that a relatively small set of places and actions could provide enough new calories to meet the basic needs for more than 3 billion people, address many environmental impacts with global consequences, and focus food waste reduction on the commodities with the greatest impact on food security. These leverage points in the global food system can help guide how nongovernmental organizations, foundations, governments, citizens' groups, and businesses prioritize actions.	[West, Paul C.; Gerber, James S.; Engstrom, Peder M.; Brauman, Kate A.; Carlson, Kimberly M.; Johnston, Matt; MacDonald, Graham K.; Ray, Deepak K.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Mueller, Nathaniel D.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Cassidy, Emily S.] Environm Working Grp, Washington, DC 20009 USA; [Siebert, Stefan] Univ Bonn, Inst Crop Sci & Resource Conservat, D-53115 Bonn, Germany	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; University of Bonn	West, PC (corresponding author), Univ Minnesota, Inst Environm, St Paul, MN 55108 USA.	pcwest@umn.edu	Ray, Deepak K/F-7720-2012; Mueller, Nathan D/E-5864-2010; West, Paul C./J-1665-2015; Brauman, Kate A/ABD-5349-2021; Siebert, Stefan/B-8621-2009; MacDonald, Graham/L-5648-2019	Mueller, Nathan D/0000-0003-1857-5104; West, Paul C./0000-0001-9024-1657; Brauman, Kate A/0000-0002-8099-285X; Siebert, Stefan/0000-0002-9998-0672; MacDonald, Graham/0000-0002-7120-1366; Gerber, James/0000-0002-6890-0481; Cassidy, Emily/0000-0003-4405-0264; Ray, Deepak/0000-0002-2856-9608	Gordon and Betty Moore Foundation; Institute on the Environment; NASA's Interdisciplinary Earth Science program; Laurel Salton Clark Memorial Fellowship; McKnight Foundation; Grantham Foundation; World Wildlife Fund; Nature Conservancy; Stanford University; NSF; The Natural Sciences and Engineering Research Council of Canada	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Institute on the Environment; NASA's Interdisciplinary Earth Science program; Laurel Salton Clark Memorial Fellowship; McKnight Foundation; Grantham Foundation; World Wildlife Fund; Nature Conservancy; Stanford University(Stanford University); NSF(National Science Foundation (NSF)); The Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research greatly benefited from discussions with J. Foley. S. Carpenter, and E. Bennett, and three anonymous reviewers provided critical feedback that strengthened this paper. Research support was primarily provided by the Gordon and Betty Moore Foundation. Additional research support was from the Institute on the Environment, NASA's Interdisciplinary Earth Science program and Laurel Salton Clark Memorial Fellowship, the McKnight Foundation, the Grantham Foundation, the World Wildlife Fund, the Nature Conservancy, and Stanford University. NSF provided support for N.D.M. The Natural Sciences and Engineering Research Council of Canada provided support for G. K. M. Contributions by General Mills, Mosaic, Cargill, Pentair, Google, Kellogg's, Mars, and PepsiCo supported stakeholder outreach and public engagement. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional data and method details are provided in the supplementary materials.	[Anonymous], 2009, WORLDS WATER 2008 20; Brauman KA, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024030; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cassidy ES, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034015; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/nclimate2153, 10.1038/NCLIMATE2153]; De Klein C., 2006, 2006 IPCC GUIDELINES, pV4; FAO, 2011, FOOD BAL SHEETS; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; International Assessment of Agricultural Knowledge Science and Technology for Development, 2009, AGR CROSSROADS; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Royal Society, 2009, REAP BEN SCI SUST IN; Siebert S, 2010, J HYDROL, V384, P198, DOI 10.1016/j.jhydrol.2009.07.031; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Venterea RT, 2012, FRONT ECOL ENVIRON, V10, P562, DOI 10.1890/120062; Vermeulen SJ, 2012, ANNU REV ENV RESOUR, V37, P195, DOI 10.1146/annurev-environ-020411-130608; West PC, 2010, P NATL ACAD SCI USA, V107, P19645, DOI 10.1073/pnas.1011078107; Yan XY, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003299; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110	30	420	435	35	546	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					325	328		10.1126/science.1246067	http://dx.doi.org/10.1126/science.1246067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035492	Green Submitted			2022-12-24	WOS:000339400700051
J	Kesselheim, AS; Bykov, K; Avorn, J; Tong, A; Doherty, M; Choudhry, NK				Kesselheim, Aaron S.; Bykov, Katsiaryna; Avorn, Jerry; Tong, Angela; Doherty, Michael; Choudhry, Niteesh K.			Burden of Changes in Pill Appearance for Patients Receiving Generic Cardiovascular Medications After Myocardial Infarction Cohort and Nested Case-Control Studies	ANNALS OF INTERNAL MEDICINE			English	Article							BRAND-NAME DRUGS; STATIN THERAPY; ADHERENCE; NONADHERENCE; EQUIVALENCE; PREVENTION; MORTALITY; DISEASE; RISK	Background: Generic prescription drugs made by different manufacturers may vary in color or shape, and switching among these drug products may interrupt medication use. Objective: To determine whether nonpersistent use of generic drugs among patients with cardiovascular disease after myocardial infarction (MI) is associated with inconsistent appearance of their medications. Design: Cohort and nested case-control studies. Setting: Claims from a commercial health insurance database in the United States. Patients: Patients discharged after hospitalization for MI between 2006 and 2011 who initiated treatment with a generic beta-blocker, angiotensin-converting enzyme inhibitor, angiotensin II-receptor blocker, or statin. Case patients discontinued their index medication for at least 1 month; control patients continued treatment. Control patients were matched to case patients on therapeutic class, number of dispensings before nonpersistence, sex, and age. Measurements: Rates of changes in pill color and shape during the year after MI were calculated. Next, 2 refills preceding nonpersistence were evaluated to determine whether pill color or shape had changed. Odds of discordance among case and control patients were compared using conditional logistic regression. Results: A total of 29% of patients (3286 of 11 513) had a change in pill shape or color during the study. Statins had the most changes in appearance, whereas beta-blockers had the fewest. A total of 4573 episodes of nonpersistence was matched to 19 881 control episodes. The odds of nonpersistence in case patients increased by 34% after a change in pill color (adjusted odds ratio, 1.34 [95% CI, 1.12 to 1.59]) and 66% after a change in pill shape (adjusted odds ratio, 1.66 [CI, 1.43 to 1.94]). Limitation: Only 3 categories of drugs indicated after MI were evaluated, and clinical outcomes were not addressed. Conclusion: Variation in the appearance of generic pills is associated with nonpersistent use of these essential drugs after MI among patients with cardiovascular disease.	Brigham & Womens Hosp, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Bykov, Katsiaryna/0000-0003-3336-5412	Agency for Healthcare Research and Quality [K08HS18465-01]; Greenwall Faculty Scholars Program in Bioethics; Harvard Program in Therapeutic Science; Robert Wood Johnson Foundation Investigator Award in Health Policy Research; FDA Office of Generic Drugs; CVS Caremark; Commonwealth Fund; Robert Wood Johnson Foundation; Aetna	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Greenwall Faculty Scholars Program in Bioethics; Harvard Program in Therapeutic Science; Robert Wood Johnson Foundation Investigator Award in Health Policy Research(Robert Wood Johnson Foundation (RWJF)); FDA Office of Generic Drugs; CVS Caremark; Commonwealth Fund; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Aetna	Dr. Kesselheim was supported by a career development award from the Agency for Healthcare Research and Quality (K08HS18465-01), the Greenwall Faculty Scholars Program in Bioethics, the Harvard Program in Therapeutic Science, and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research. Dr. Kesselheim and Dr. Avorn receive research support from the FDA Office of Generic Drugs. Dr. Choudhry was supported by unrestricted research grants from CVS Caremark, Aetna, The Commonwealth Fund, and the Robert Wood Johnson Foundation.	Akincigil A, 2008, J GEN INTERN MED, V23, P115, DOI 10.1007/s11606-007-0351-9; [Anonymous], 2010, CBS NEWS; [Anonymous], 2003, ADHERENCE LONG TERM; [Anonymous], 2011, CLOS LOOK PRESCR BOT; BIRON P, 1974, CAN MED ASSOC J, V110, P1346; Boh M, 2011, INT ANGIOL, V30, P366; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; Center for Drug Evaluation and Research, 2013, GUID IND SI IN PRESS; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Choudhry NK, 2011, ARCH INTERN MED, V171, P814, DOI 10.1001/archinternmed.2010.495; Cohen M, 2011, PHILLY COM      0808; Colivicchi F, 2007, STROKE, V38, P2652, DOI 10.1161/STROKEAHA.107.487017; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Cutler C, 2011, BIOL BLOOD MARROW TR, V17, P285, DOI 10.1016/j.bbmt.2010.11.006; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Dicken JE, 2012, GAO12371R; Engelberg AB, 2011, J MANAGE CARE PHARM, V17, P321, DOI 10.18553/jmcp.2011.17.4.321; Faasse K, 2013, PSYCHOSOM MED, V75, P90, DOI 10.1097/PSY.0b013e3182738826; Fischer MA, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.05.028; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Green JB, 2013, JAMA INTERN MED, V173, P229, DOI 10.1001/jamainternmed.2013.1529; Greene JA, 2011, NEW ENGL J MED, V365, P83, DOI 10.1056/NEJMhle1101722; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Ho P Michael, 2006, BMC Cardiovasc Disord, V6, P48, DOI 10.1186/1471-2261-6-48; Kenagy JW, 2001, AM J HEALTH-SYST PH, V58, P2033, DOI 10.1093/ajhp/58.21.2033; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kesselheim AS, 2013, JAMA INTERN MED, V173, P202, DOI 10.1001/2013.jamainternmed.997; Kronish IM, 2013, PROG CARDIOVASC DIS, V55, P590, DOI 10.1016/j.pcad.2013.02.001; Nightingale SL, 1998, THERAPEUTIC EQUIVALE; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Roullet B, 2005, ADV CONSUM RES, V32, P164; Shah ND, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2008.12.021; Shrank WH, 2011, HEALTH AFFAIR, V30, P1351, DOI 10.1377/hlthaff.2010.0431; Smith DH, 2008, ARCH INTERN MED, V168, P477, DOI 10.1001/archinternmed.2007.132; Sundar RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038819; Yu LX, 2013, JAMA INTERN MED, V173, P208, DOI 10.1001/jamainternmed.2013.2283; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	41	63	63	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					96	+		10.7326/M13-2381	http://dx.doi.org/10.7326/M13-2381			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023248				2022-12-24	WOS:000339764600018
J	Goodarzi, H; Zhang, S; Buss, CG; Fish, L; Tavazoie, S; Tavazoie, SF				Goodarzi, Hani; Zhang, Steven; Buss, Colin G.; Fish, Lisa; Tavazoie, Saeed; Tavazoie, Sohail F.			Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins	NATURE			English	Article							BREAST-CANCER METASTASIS; GENE-EXPRESSION; REGULATORY ELEMENTS; PROTEIN; SEQ; STABILITY; DISCOVERY; INVASION; DISEASE; COMPLEX	Aberrant regulation of RNA stability has an important role in many disease states(1,2). Deregulated post-transcriptional modulation, such as that governed by microRNAs targeting linear sequence elements in messenger RNAs, has been implicated in the progression of many cancer types(3-7). A defining feature of RNA is its ability to fold into structures. However, the roles of structural mRNA elements in cancer progression remain unexplored. Here we performed an unbiased search for post-transcriptional modulators of mRNA stability in breast cancer by conducting whole-genome transcript stability measurements in poorly and highly metastatic isogenic human breast cancer lines. Using a computational framework that searches RNA sequence and structure space(8), we discovered a family of GC-rich structural cis-regulatory RNA elements, termed sRSEs for structural RNA stability elements, which are significantly overrepresented in transcripts displaying reduced stability in highly metastatic cells. By integrating computational and biochemical approaches, we identified TARBP2, a double-stranded RNA-binding protein implicated in microRNA processing, as the trans factor that binds the sRSE family and similar structural elements collectively termed TARBP2-binding structural elements (TBSEs) in transcripts. TARBP2 is overexpressed in metastatic cells and metastatic human breast tumours and destabilizes transcripts containing TBSEs. Endogenous TARBP2 promotes metastatic cell invasion and colonization by destabilizing amyloid precursor protein (APP) and ZNF395 transcripts, two genes previously associated with Alzheimer's and Huntington's disease, respectively. We reveal these genes to be novel metastasis suppressor genes in breast cancer. The cleavage product of APP, extracellular alpha-myloida peptide, directly suppresses invasion while ZNF395 transcriptionally represses a pro-metastatic gene expression program. The expression levels of TARBP2, APP and ZNF395 in human breast carcinomas support their experimentally uncovered roles in metastasis. Our findings establish a non-canonical and direct role for TARBP2 in mammalian gene expression regulation and reveal that regulated RNA destabilization through protein-mediated binding of mRNA structural elements can govern cancer progression.	[Goodarzi, Hani; Zhang, Steven; Buss, Colin G.; Fish, Lisa; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Tavazoie, Saeed] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Tavazoie, Saeed] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA	Rockefeller University; Columbia University; Columbia University	Tavazoie, S (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	st2744@columbia.edu; stavazoie@rockefeller.edu	Buss, Colin/I-5326-2014	Buss, Colin/0000-0001-7771-1685; Fish, Lisa/0000-0001-9184-0512; Goodarzi, Hani/0000-0002-9648-8949	Department of Defense Era of Hope Scholar; Department of Defense Breast Cancer Collaborative Scholars and Innovators Award; National Human Genome Research Institute [R01 HG003219]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003219] Funding Source: NIH RePORTER	Department of Defense Era of Hope Scholar(United States Department of Defense); Department of Defense Breast Cancer Collaborative Scholars and Innovators Award; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank C. Alarcon, N. Halberg, N. Pencheva, P. Furlow and A. Nguyen for technical assistance and comments on previous versions of this manuscript. We thank H. Lee for her help with orthotopic injections. We thank P. Oikonomou for providing the reporter constructs. We thank the Darnell laboratory for their input on the HITS-CLIP methodology. We are also grateful to M. McManus and Z. Mourelatos for providing Dicer-null cells. We thank C. Zhao, W. Zhang and S. Dewell of the Rockefeller Genomics Resource Center for assistance with next-generation RNA-sequencing and microarray profiling. H.G. is an Anderson Cancer Center Fellow at Rockefeller University. S.F.T. is a Department of Defense Era of Hope Scholar and a Department of Defense Breast Cancer Collaborative Scholars and Innovators Award recipient. S.T. was supported by the National Human Genome Research Institute (R01 HG003219). We also acknowledge the efforts of Expression Project for Oncology (ExpO) and International Genomics Consortium (IGC) in providing public access to breast cancer gene expression profiles and annotations.	Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cutroneo KR, 2006, CRIT REV EUKAR GENE, V16, P23; De Vito C, 2012, CANCER CELL, V21, P807, DOI 10.1016/j.ccr.2012.04.023; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Foat BC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.24; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Manley James L, 2013, Cold Spring Harb Protoc, V2013, P156, DOI 10.1101/pdb.prot072934; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Oikonomou P, 2014, CELL REP, V7, P281, DOI 10.1016/j.celrep.2014.03.001; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; STRIETER RM, 1992, AM J PATHOL, V141, P1279; Tanaka K, 2004, J BIOL CHEM, V279, P7275, DOI 10.1074/jbc.M310726200; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	59	62	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					256	+		10.1038/nature13466	http://dx.doi.org/10.1038/nature13466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043050	Green Accepted			2022-12-24	WOS:000341362800055
J	Thompson, IM; Leach, RJ; Ankerst, DP				Thompson, Ian M., Jr.; Leach, Robin J.; Ankerst, Donna P.			Focusing PSA Testing on Detection of High-Risk Prostate Cancers by Incorporating Patient Preferences Into Decision Making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTION TRIAL; MORTALITY		[Thompson, Ian M., Jr.; Leach, Robin J.; Ankerst, Donna P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [Thompson, Ian M., Jr.; Leach, Robin J.; Ankerst, Donna P.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Ankerst, Donna P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Ankerst, Donna P.] Tech Univ Munich, Dept Math, D-80290 Munich, Germany	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Technical University of Munich	Thompson, IM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, 7979 Wurzbach Ave,Ste U627, San Antonio, TX 78229 USA.	thompsoni@uthscsa.edu		Ankerst, Donna/0000-0003-4229-2462; Leach, Robin/0000-0002-3201-5579	NATIONAL CANCER INSTITUTE [P30CA054174, P01CA108964, U01CA086402] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA054174, P01CA108964, P01 CA108964, U01 CA086402] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Ankerst DP, 2014, UROLOGY, V83, P1362, DOI 10.1016/j.urology.2014.02.035; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Nam RK, 2013, J UROLOGY, V189, pS12, DOI 10.1016/j.juro.2012.11.015; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131	9	22	22	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					995	996		10.1001/jama.2014.9680	http://dx.doi.org/10.1001/jama.2014.9680			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25090603	Green Accepted			2022-12-24	WOS:000341385600012
J	Arie, S				Arie, Sophie			INFECTIOUS DISEASES Ebola: an opportunity for a clinical trial?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						Arie S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4123; Baize S., 2014, N ENGL J MED; Chan M., 2014, WHO DIRECTOR GEN ASS; Hotez P. R., 2013, STRENGTHENING MECH P; McGrath M., 2012, COMMERCIAL EBOLA VIR; Torjesen I., 2014, BMJ-BRIT MED J, V349, P4895; United Nations Development Programme, 2014, HUM DEV IND HDI; US Food and Drug Administration, 2014, GUID IND PROD DEV AN; Wellcome Trust, 2014, WE MUST LEARN LESS T; WHO, 2014, EB VIR DIS	10	8	9	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2014	349								g4997	10.1136/bmj.g4997	http://dx.doi.org/10.1136/bmj.g4997			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MQ	25098954	Bronze, Green Published			2022-12-24	WOS:000340206100002
J	Kabiri, M; Jazwinski, AB; Roberts, MS; Schaefer, AJ; Chhatwal, J				Kabiri, Mina; Jazwinski, Alison B.; Roberts, Mark S.; Schaefer, Andrew J.; Chhatwal, Jagpreet			The Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based Predictions	ANNALS OF INTERNAL MEDICINE			English	Article							SOFOSBUVIR PLUS RIBAVIRIN; TREATMENT-NAIVE PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; LIVER FIBROSIS PROGRESSION; INTERFERON-FREE TREATMENT; HCV GENOTYPE 2; HEPATOCELLULAR-CARCINOMA; PEGINTERFERON ALPHA-2A; COST-EFFECTIVENESS; COMBINATION	Background: Chronic hepatitis C virus (HCV) infection causes a substantial health and economic burden in the United States. With the availability of direct-acting antiviral agents, recently approved therapies and those under development, and 1-time birth-cohort screening, the burden of this disease is expected to decrease. Objective: To predict the effect of new therapies and screening on chronic HCV infection and associated disease outcomes. Design: Individual-level state-transition model. Setting: Existing and anticipated therapies and screening for HCV infection in the United States. Patients: Total HCV-infected population in the United States. Measurements: The number of cases of chronic HCV infection and outcomes of advanced-stage HCV infection. Results: The number of cases of chronic HCV infection decreased from 3.2 million in 2001 to 2.3 million in 2013. One-time birth-cohort screening beginning in 2013 is expected to identify 487 000 cases of HCV infection in the next 10 years. In contrast, 1-time universal screening could identify 933 700 cases. With the availability of highly effective therapies, HCV infection could become a rare disease in the next 22 years. Recently approved therapies for HCV infection and 1-time birth-cohort screening could prevent approximately 124 200 cases of decompensated cirrhosis, 78 800 cases of hepatocellular carcinoma, 126 500 liver-related deaths, and 9900 liver transplantations by 2050. Increasing the treatment capacity would further reduce the burden of HCV disease. Limitation: Institutionalized patients with HCV infection were excluded, and empirical data on the effectiveness of future therapies and on the future annual incidence and treatment capacity of HCV infection are lacking. Conclusion: New therapies for HCV infection and widespread implementation of screening and treatment will play an important role in reducing the burden of HCV disease. More aggressive screening recommendations are needed to identify a large pool of infected patients.	Univ Pittsburgh, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; UTMD Anderson Cancer Center	Chhatwal, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Unit 1444, 1515 Holcombe Blvd, Houston, TX 77030 USA.	JChhatwal@mdanderson.org		Kabiri, Mina/0000-0002-3486-7652	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Primary Funding Source: National Institutes of Health.	American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society, 2014, REC TEST MAN TREAT H; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Aronsohn A, 2012, HEPATOLOGY, V56, P1591, DOI 10.1002/hep.25957; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Blatt LM, 2000, J VIRAL HEPATITIS, V7, P196; Bourliere M, 2012, LIVER INT, V32, P113, DOI 10.1111/j.1478-3231.2011.02702.x; Bronowicki JP, 2012, J HEPATOL, V56, pS6, DOI 10.1016/S0168-8278(12)60025-7; CDC, 2013, SURV VIR HEP US 2011; Coffin PO, 2012, CLIN INFECT DIS, V54, P1259, DOI 10.1093/cid/cis011; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Dieterich D, 2012, HEPATOLOGY, V55, P664, DOI 10.1002/hep.25528; Dore GJ, 2013, J HEPATOL, V58, pS570, DOI 10.1016/S0168-8278(13)61417-8; Doyle JS, 2013, BRIT J CLIN PHARMACO, V75, P931, DOI 10.1111/j.1365-2125.2012.04419.x; Drenth JPH, 2013, NEW ENGL J MED, V368, P1931, DOI 10.1056/NEJMe1303818; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Everson GT, 2012, HEPATOLOGY S, V56, pLB3; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Feld JJ, 2012, HEPATOLOGY, V56, p231A; Gane EJ, 2012, J HEPATOL, V56, pS555, DOI 10.1016/S0168-8278(12)61423-8; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gane EJ, 2012, HEPATOLOGY, V56, p306A; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gonzalez Stevan A, 2012, Clin Liver Dis (Hoboken), V1, P2, DOI 10.1002/cld.3; Hagan LM, 2013, LIVER INT, V33, P68, DOI 10.1111/liv.12063; Honeycutt AA, 2007, PUBLIC HEALTH REP, V122, P55, DOI 10.1177/00333549071220S211; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Jacobson I., 2013, 64 ANN M AM ASS STUD; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2012, HEPATOLOGY, V56, p308A; Jacobson IM, 2012, HEPATOLOGY, V56, p232A; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kanwal F, 2014, CLIN GASTROENTEROL H; Kim WR, 2013, AM J TRANSPLANT, V13, P73, DOI 10.1111/ajt.12021; Kowdley KV, 2012, HEPATOLOGY, V56, P1515; Lang K, 2009, J HEPATOL, V50, P89, DOI 10.1016/j.jhep.2008.07.029; Lawitz E., 2013, 64 ANN M AM ASS STUD; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; McGovern BH, 2012, CLIN INFECT DIS, V55, P414, DOI 10.1093/cid/cis378; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Ngo-Metzger Q, 2013, ANN INTERN MED, V159, P364, DOI 10.7326/0003-4819-159-5-201309030-00675; Nguyen Mindie H, 2005, Clin Gastroenterol Hepatol, V3, pS97, DOI 10.1016/S1542-3565(05)00711-1; Osinusi A, 2012, HEPATOLOGY, V56, P1518; Pawlotsky JM, 2012, HEPATOLOGY, V56, p309A; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2012, HEPATOLOGY, V56, p233A; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Ruane PJ, 2013, HEPATOLOGY, V58, p736A; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Siebert U, 2012, VALUE HEALTH, V15, P812, DOI 10.1016/j.jval.2012.06.014; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Soriano V, 2012, HEPATOLOGY, V56, p234A; U.S. Census Bureau, 2012, 2012 NAT POP PROJ; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Zeuzem S, 2013, HEPATOLOGY, V58, p733A; Zeuzem S, 2012, HEPATOLOGY, V56, p308A; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	72	109	109	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3					170	U120		10.7326/M14-0095	http://dx.doi.org/10.7326/M14-0095			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3KH	25089861	Green Accepted			2022-12-24	WOS:000340486000002
J	Lo, WS; Gardiner, E; Xu, ZW; Lau, CF; Wang, F; Zhou, JJ; Mendlein, JD; Nangle, LA; Chiang, KP; Yang, XL; Au, KF; Wong, WH; Guo, M; Zhang, MJ; Schimmel, P				Lo, Wing-Sze; Gardiner, Elisabeth; Xu, Zhiwen; Lau, Ching-Fun; Wang, Feng; Zhou, Jie J.; Mendlein, John D.; Nangle, Leslie A.; Chiang, Kyle P.; Yang, Xiang-Lei; Au, Kin-Fai; Wong, Wing Hung; Guo, Min; Zhang, Mingjie; Schimmel, Paul			Human tRNA synthetase catalytic nulls with diverse functions	SCIENCE			English	Article							PRETRANSFER; EXPRESSION; VARIANTS; PRESSURE; DOMAIN	Genetic efficiency in higher organisms depends on mechanisms to create multiple functions from single genes. To investigate this question for an enzyme family, we chose aminoacyl tRNA synthetases (AARSs). They are exceptional in their progressive and accretive proliferation of noncatalytic domains as the Tree of Life is ascended. Here we report discovery of a large number of natural catalytic nulls (CNs) for each human AARS. Splicing events retain noncatalytic domains while ablating the catalytic domain to create CNs with diverse functions. Each synthetase is converted into several new signaling proteins with biological activities "orthogonal" to that of the catalytic parent. We suggest that splice variants with nonenzymatic functions may be more general, as evidenced by recent findings of other catalytically inactive splice-variant enzymes.	[Lo, Wing-Sze; Xu, Zhiwen; Lau, Ching-Fun; Wang, Feng; Zhou, Jie J.; Yang, Xiang-Lei; Zhang, Mingjie; Schimmel, Paul] Hong Kong Univ Sci & Technol, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China; [Lo, Wing-Sze; Xu, Zhiwen; Lau, Ching-Fun; Wang, Feng; Zhou, Jie J.] Pangu Biopharma, Hong Kong, Hong Kong, Peoples R China; [Gardiner, Elisabeth; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Scripps Labs tRNA Synthetase Res, La Jolla, CA 92037 USA; [Gardiner, Elisabeth; Mendlein, John D.; Nangle, Leslie A.; Chiang, Kyle P.] aTyr Pharma, San Diego, CA 92121 USA; [Au, Kin-Fai] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Wong, Wing Hung] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Guo, Min; Schimmel, Paul] Scripps Florida, Scripps Labs tRNA Synthetase Res, Jupiter, FL 33458 USA; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Scripps Research Institute; University of Iowa; Stanford University; State University System of Florida; University of Florida; Hong Kong University of Science & Technology	Schimmel, P (corresponding author), Hong Kong Univ Sci & Technol, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China.	schimmel@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020; Lo, Cario Wing Sze/DGZ-8810-2022	Yang, Xiang-Lei/0000-0003-2554-084X; Zhang, Mingjie/0000-0001-9404-0190	Innovation and Technology Fund from the Hong Kong Government [UIM181, UIM192, UIM199]; National Foundation for Cancer Research; NIH [R01CA92577, R01GM088278, R01NS085092, R01HG005717, R01GM100136]; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278, R01GM100136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085092] Funding Source: NIH RePORTER	Innovation and Technology Fund from the Hong Kong Government; National Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Innovation and Technology Fund from the Hong Kong Government (UIM181, UIM192, and UIM199); by a fellowship from the National Foundation for Cancer Research; and by NIH grants R01CA92577, R01GM088278, R01NS085092, R01HG005717, and R01GM100136. We thank K. Piehl and J. Li (aTyr Pharma) for help with splice variant cloning and protein expression. We also thank A. Cubitt (aTyr Pharma) for assistance on the transcriptional profiling, V. Trinh and J. Zhao (both formerly of aTyr Pharma) for assistance with cell profiling of recombinant tRNA synthetase fragments, and B. Cravatt (Scripps Research Institute) for help with interpretation of the PROTOMAP data. P. S. is a cofounder and member of the Board of Directors of aTyr Pharma, W. H. W. is a member of the aTyr Pharma Scientific Advisory Board, and X.-L.Y is a scientific cofounder and a member of the Scientific Advisory Board of aTyr Pharma. E. G. has no financial interest with aTyr Pharma. Clones of catalytic nulls are available for research purposes under a Material Transfer Agreement with aTyr Pharma. W.-S. L, L.A.N, and K. P. C. are inventors on patent applications filed by aTyr Pharma Inc. and Pangu Biopharma Ltd. that cover the splice variants described in this work.	Anamika K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-622; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Giege R, 2003, NAT STRUCT BIOL, V10, P414, DOI 10.1038/nsb0603-414; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kawahara A, 2009, TRENDS CARDIOVAS MED, V19, P179, DOI 10.1016/j.tcm.2009.11.001; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; LUDMERER SW, 1987, J BIOL CHEM, V262, P10807; Miyanokoshi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03477; Nakanishi K, 2005, NAT STRUCT MOL BIOL, V12, P931, DOI 10.1038/nsmb988; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Rack JGM, 2014, J MOL BIOL, V426, P1677, DOI 10.1016/j.jmb.2013.10.027; Schwenzer H, 2014, BIOCHIMIE, V100, P18, DOI 10.1016/j.biochi.2013.09.027; Takeda J, 2006, NUCLEIC ACIDS RES, V34, P3917, DOI 10.1093/nar/gkl507; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wang F, 2013, J BIOL CHEM, V288, P29223, DOI 10.1074/jbc.C113.490599; Xu XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1686; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Yadavalli SS, 2008, P NATL ACAD SCI USA, V105, P19031, DOI 10.1073/pnas.0810781106; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	34	80	84	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					328	332		10.1126/science.1252943	http://dx.doi.org/10.1126/science.1252943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035493	Green Accepted, Green Submitted			2022-12-24	WOS:000339400700052
J	Uyanik, M; Hayashi, H; Ishihara, K				Uyanik, Muhammet; Hayashi, Hiroki; Ishihara, Kazuaki			High-turnover hypoiodite catalysis for asymmetric synthesis of tocopherols	SCIENCE			English	Article							VITAMIN-E; ALCOHOLS	The diverse biological activities of tocopherols and their analogs have inspired considerable interest in the development of routes for their efficient asymmetric synthesis. Here, we report that chiral ammonium hypoiodite salts catalyze highly chemo-and enantioselective oxidative cyclization of gamma-(2-hydroxyphenyl) ketones to 2-acyl chromans bearing a quaternary stereocenter, which serve as productive synthetic intermediates for tocopherols. Raman spectroscopic analysis of a solution of tetrabutylammonium iodide and tert-butyl hydroperoxide revealed the in situ generation of the hypoiodite salt as an unstable catalytic active species and triiodide salt as a stable inert species. A high-performance catalytic oxidation system (turnover number of similar to 200) has been achieved through reversible equilibration between hypoiodite and triiodide in the presence of potassium carbonate base. We anticipate that these findings will open further prospects for the development of high-turnover redox organocatalysis.	[Uyanik, Muhammet; Hayashi, Hiroki; Ishihara, Kazuaki] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ishihara, Kazuaki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Ishihara, K (corresponding author), Nagoya Univ, Grad Sch Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	ishihara@cc.nagoya-u.ac.jp	Uyanik, Muhammet/E-1533-2011	Uyanik, Muhammet/0000-0002-9751-1952; Hayashi, Hiroki/0000-0003-2081-6886	Japan Society for the Promotion of Science [24245020, 22750087, 25105722]; Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [25105722] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this project was partially provided by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (KAKENHI) (24245020, 22750087, and 25105722), and Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," Ministry of Education, Culture, Sports, Science and Technology, Japan. Metrical parameters for the structure of compound 2h are available free of charge from the Cambridge Crystallographic Data Centre under reference number CCDC 996935. M. U. and K. I. developed the concept and conceived the experiments. H. H. performed the experiments. H. H. and M. U. analyzed the data. M. U. and K. I. prepared the manuscript, with assistance from H.H.	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Blatt DH, 2004, J NUTR BIOCHEM, V15, P380, DOI 10.1016/j.jnutbio.2003.12.011; CADLE RD, 1950, J PHYS COLLOID CHEM, V54, P1191, DOI 10.1021/j150482a011; Chenevert R, 2006, BIOORGAN MED CHEM, V14, P5389, DOI 10.1016/j.bmc.2006.03.035; Chia Y., 1958, THESIS U CALIFORNIA; Chougnet A, 2010, CHIMIA, V64, P303, DOI 10.2533/chimia.2010.303; Evans DA, 2007, J AM CHEM SOC, V129, P10029, DOI 10.1021/ja072976i; Howard AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1594; Huang PH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003816; Ida A., 2011, U.S. Patent, Patent No. [8,080,676, 8080676]; Koyama H, 2004, J MED CHEM, V47, P3255, DOI 10.1021/jm030621d; List B., 2012, SCI SYNTHESIS ASYMME; Lopez GV, 2005, BIOORGAN MED CHEM, V13, P5787, DOI 10.1016/j.bmc.2005.05.060; Magdziak D, 2004, CHEM REV, V104, P1383, DOI 10.1021/cr0306900; Morimura Y., 2013, Japan patent, Patent No. 5212969; Netscher T, 2007, VITAM HORM, V76, P155, DOI 10.1016/S0083-6729(07)76007-7; Nozawa M, 2000, CHEM PHARM BULL, V48, P272; Ooi T, 2007, ANGEW CHEM INT EDIT, V46, P4222, DOI 10.1002/anie.200601737; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; Sekimoto M, 2010, BIOORG MED CHEM LETT, V20, P1063, DOI 10.1016/j.bmcl.2009.12.034; Shen HC, 2009, TETRAHEDRON, V65, P3931, DOI 10.1016/j.tet.2009.02.002; Tanaka S, 2009, ANGEW CHEM INT EDIT, V48, P8948, DOI 10.1002/anie.200904671; Tietze LF, 2005, ANGEW CHEM INT EDIT, V44, P257, DOI 10.1002/anie.200461629; Tokunou S, 2012, HETEROCYCLES, V84, P1045, DOI 10.3987/COM-11-S(P)82; Tomasetti M, 2007, VITAM HORM, V76, P463, DOI 10.1016/S0083-6729(07)76018-1; Trost BM, 2004, J AM CHEM SOC, V126, P11966, DOI 10.1021/ja048078t; Uyanik M, 2012, CHEMCATCHEM, V4, P177, DOI 10.1002/cctc.201100352; Uyanik M, 2010, SCIENCE, V328, P1376, DOI 10.1126/science.1188217; WALTHER W, 1992, J MICROCOLUMN SEP, V4, P45, DOI 10.1002/mcs.1220040109; WREN JC, 1986, CAN J CHEM, V64, P2284, DOI 10.1139/v86-375; YODA H, 1989, CHEM LETT, P465, DOI 10.1246/cl.1989.465	31	138	138	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					291	294		10.1126/science.1254976	http://dx.doi.org/10.1126/science.1254976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035486				2022-12-24	WOS:000339400700042
J	Scheller, NM; Pasternak, B; Svanstrom, H; Hviid, A				Scheller, Nikolai Madrid; Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders			Quadrivalent Human Papillomavirus Vaccine and the Risk of Venous Thromboembolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CASE SERIES; SAFETY; IMMUNIZATION; AUTOIMMUNE; ADOLESCENT		[Scheller, Nikolai Madrid; Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Scheller, NM (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	nmscheller@gmail.com	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127				Arnheim-Dahlstom L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5906; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Siegrist CA, 2007, CAN MED ASSOC J, V177, P1352, DOI 10.1503/cmaj.071134; Slade BA, 2009, JAMA-J AM MED ASSOC, V302, P750, DOI 10.1001/jama.2009.1201; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	6	25	26	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					187	188		10.1001/jama.2014.2198	http://dx.doi.org/10.1001/jama.2014.2198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005658				2022-12-24	WOS:000338511200027
J	Block, JP; Roberto, CA				Block, Jason P.; Roberto, Christina A.			Potential Benefits of Calorie Labeling in Restaurants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHAIN RESTAURANTS		[Block, Jason P.] Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Obes Prevent Program,Dept Populat Med, Boston, MA 02215 USA; [Roberto, Christina A.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Dept Social & Behav Sci, Boston, MA 02215 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Block, JP (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, 133 Brookline Ave,Sixth Floor, Boston, MA 02215 USA.	jblock1@partners.org			NHLBI NIH HHS [1K23HL111211-01A1, K23 HL111211] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL111211] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Auchincloss AH, 2013, AM J PREV MED, V45, P710, DOI 10.1016/j.amepre.2013.07.014; Bollinger B, 2011, AM ECON J-ECON POLIC, V3, P91, DOI 10.1257/pol.3.1.91; Bruemmer B, 2012, J ACAD NUTR DIET, V112, P1169, DOI 10.1016/j.jand.2012.04.019; Bruni, 2013, NEW YORK TIMES; Clifford Gay, 1977, NEW YORK TIMES; Dumanovsky Tamara, 2011, BMJ, V343, pd4464, DOI 10.1136/bmj.d4464; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Morain S, 2013, HEALTH AFFAIR, V32, P486, DOI 10.1377/hlthaff.2012.0609	8	30	30	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					887	888		10.1001/jama.2014.9239	http://dx.doi.org/10.1001/jama.2014.9239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25077460	Green Accepted			2022-12-24	WOS:000341668600012
J	Chen, L; Durr, KL; Gouaux, E				Chen, Lei; Duerr, Katharina L.; Gouaux, Eric			X-ray structures of AMPA receptor-cone snail toxin complexes illuminate activation mechanism	SCIENCE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; LIGAND-BINDING CORE; CONFORMATIONAL-CHANGES; ION-CHANNEL; KAINATE; DESENSITIZATION; CYCLOTHIAZIDE; ARCHITECTURE; MUTATION; NEURONS	AMPA-sensitive glutamate receptors are crucial to the structural and dynamic properties of the brain, to the development and function of the central nervous system, and to the treatment of neurological conditions from depression to cognitive impairment. However, the molecular principles underlying AMPA receptor activation have remained elusive. We determined multiple x-ray crystal structures of the GluA2 AMPA receptor in complex with a Conus striatus cone snail toxin, a positive allosteric modulator, and orthosteric agonists, at 3.8 to 4.1 angstrom resolution. We show how the toxin acts like a straightjacket on the ligand-binding domain (LBD) "gating ring," restraining the domains via both intra-and interdimer cross-links such that agonist-induced closure of the LBD "clamshells" is transduced into an irislike expansion of the gating ring. By structural analysis of activation-enhancing mutants, we show how the expansion of the LBD gating ring results in pulling forces on the M3 helices that, in turn, are coupled to ion channel gating.	[Chen, Lei; Duerr, Katharina L.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Duerr, Katharina/A-6975-2015	Gouaux, Eric/0000-0002-8549-2360; Chen, Lei/0000-0002-7619-8311; Duerr, Katharina/0000-0002-3245-4088	American Heart Association [13POST13960004]; Long-Term Fellowship of European Molecular Biology Organization; institutional National Research Service Award (NRSA); NRSA [F32MH100331]; NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH100331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038631, R37NS038631] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Long-Term Fellowship of European Molecular Biology Organization; institutional National Research Service Award (NRSA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All members of the Gouaux laboratory and I. Baconguis are gratefully acknowledged for their support and assistance. We thank L. Vaskalis for assistance with figures, the beam line staff at Advanced Light Source-Berkeley Center for Structural Biology and Stanford Synchrotron Radiation Lightsource 12-2 for their support during data collection, B. Olivera for providing crude Conus striatus venom, D. King and L. David for mass spectrum analysis, and M. Suga for early work on thermostability mutation screening. L. C. is supported by an American Heart Association postdoctoral fellowship (13POST13960004). K. L. D. was supported by a Long-Term Fellowship of the European Molecular Biology Organization and an institutional National Research Service Award (NRSA) and is currently a recipient of an individual NRSA (F32MH100331). This work is supported by the NIH (E. G.), and E. G. is an investigator with the Howard Hughes Medical Institute. The coordinates have been deposited in the PDB with codes 4U5B, 4U5C, 4U5D, 4U5E, and 4U5F for the GluA2 receptor toxin complex and codes 4U5G and 4U5H for the isolated toxin. L. C. contributed to all aspects of the research; K. L. D. contributed to thermostabilization mutation screening and initial characterization of native snail venom by two-electrode voltage clamp. E. G. directed the research. All authors contributed to the preparation of the manuscript.	Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kaae BH, 2007, CHEM BIOL, V14, P1294, DOI 10.1016/j.chembiol.2007.10.012; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Moore BS, 2013, J BIOL CHEM, V288, P18842, DOI 10.1074/jbc.M113.465187; O'Neill MJ, 2004, CNS NEUROL DISORD-DR, V3, P181, DOI 10.2174/1568007043337508; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; RAMAN IM, 1992, NEURON, V9, P173, DOI 10.1016/0896-6273(92)90232-3; Rogawski MA, 2013, ACTA NEUROL SCAND, V127, P9, DOI 10.1111/ane.12099; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Walker CS, 2009, CURR BIOL, V19, P900, DOI 10.1016/j.cub.2009.05.017; Wollmuth LP, 2000, J NEUROSCI, V20, P5973, DOI 10.1523/JNEUROSCI.20-16-05973.2000; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	29	87	89	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1021	1026		10.1126/science.1258409	http://dx.doi.org/10.1126/science.1258409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25103405	Green Accepted			2022-12-24	WOS:000340870900031
J	Christner, BC; Priscu, JC; Achberger, AM; Barbante, C; Carter, SP; Christianson, K; Michaud, AB; Mikucki, JA; Mitchell, AC; Skidmore, ML; Vick-Majors, TJ				Christner, Brent C.; Priscu, John C.; Achberger, Amanda M.; Barbante, Carlo; Carter, Sasha P.; Christianson, Knut; Michaud, Alexander B.; Mikucki, Jill A.; Mitchell, Andrew C.; Skidmore, Mark L.; Vick-Majors, Trista J.		WISSARD Sci Team	A microbial ecosystem beneath the West Antarctic ice sheet	NATURE			English	Article							ACTIVE RESERVOIR BENEATH; SUBGLACIAL LAKE WHILLANS; VOSTOK; STREAM; THYMIDINE; BACTERIA; NITRATE; WATERS; SHELF	Liquid water has been known to occur beneath the Antarctic ice sheet for more than 40 years(1), but only recently have these subglacial aqueous environments been recognized as microbial ecosystems that may influence biogeochemical transformations on a global scale(2-4). Here we present the first geomicrobiological description of water and surficial sediments obtained from direct sampling of a subglacial Antarctic lake. Subglacial Lake Whillans (SLW) lies beneath approximately 800m of ice on the lower portion of the Whillans Ice Stream (WIS) in West Antarctica and is part of an extensive and evolving subglacial drainage network(5). The water column of SLW contained metabolically active microorganisms and was derived primarily from glacial ice melt with solute sources from lithogenic weathering and a minor seawater component. Heterotrophic and autotrophic production data together with small subunit ribosomal RNA gene sequencing and biogeochemical data indicate that SLWis a chemosynthetically driven ecosystem inhabited by a diverse assemblage of bacteria and archaea. Our results confirm that aquatic environments beneath the Antarctic ice sheet support viablemicrobial ecosystems, corroborating previous reports suggesting that they contain globally relevant pools of carbon and microbes(2,4) that can mobilize elements from the lithosphere(6) and influence Southern Ocean geochemical and biological systems(7).	[Christner, Brent C.; Achberger, Amanda M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Priscu, John C.; Michaud, Alexander B.; Vick-Majors, Trista J.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Barbante, Carlo] CNR, Inst Dynam Environm Proc, I-30123 Venice, Italy; [Barbante, Carlo] Ca Foscari Univ Venice, Dept Environm Sci Informat & Stat, I-30123 Venice, Italy; [Carter, Sasha P.] Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; [Christianson, Knut] St Olaf Coll, Dept Phys, Northfield, MN 55057 USA; [Mikucki, Jill A.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Mitchell, Andrew C.] Aberystwyth Univ, Dept Geog & Earth Sci, Aberystwyth SY23 3DB, Dyfed, Wales; [Skidmore, Mark L.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	Louisiana State University System; Louisiana State University; Montana State University System; Montana State University Bozeman; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Dinamica dei Processi Ambientali (IDPA-CNR); Universita Ca Foscari Venezia; University of California System; University of California San Diego; Scripps Institution of Oceanography; Saint Olaf College; University of Tennessee System; University of Tennessee Knoxville; Aberystwyth University; Montana State University System; Montana State University Bozeman	Christner, BC (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	xner@lsu.edu; jpriscu@montana.edu	Vick-Majors, Trista/AAQ-6258-2020; Skidmore, Mark/I-4317-2018; Michaud, Alexander B/AAC-4890-2020; Horgan, Huw/I-5847-2019; Barbante, Carlo/B-3195-2011; Tulaczyk, Slawek/O-7375-2018	Vick-Majors, Trista/0000-0002-6868-4010; Michaud, Alexander B/0000-0001-5714-8741; Horgan, Huw/0000-0002-4836-0078; Fricker, Helen Amanda/0000-0002-0921-1432; Tulaczyk, Slawek/0000-0002-9711-4332; Achberger, Amanda/0000-0001-5738-2255; Barbante, Carlo/0000-0003-4177-2288	National Science Foundation from the Division of Polar Programs [0838933, 0838896, 0838941, 0839142, 0839059, 0838885, 0838855, 0838763, 0839107, 0838947, 0838854, 0838764, 1142123]; NSF [1023233, 1115245, 1247192]; Italian National Antarctic Program; NSF's IGERT Program [0654336]; Montana Space Grant Consortium; Directorate For Geosciences [0838885, 0839059] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0839107] Funding Source: National Science Foundation	National Science Foundation from the Division of Polar Programs(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Italian National Antarctic Program; NSF's IGERT Program; Montana Space Grant Consortium; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The Whillans Ice Stream Subglacial Access Research Drilling (WISSARD) project was funded by National Science Foundation grants (0838933, 0838896, 0838941, 0839142, 0839059, 0838885, 0838855, 0838763, 0839107, 0838947, 0838854, 0838764 and 1142123) from the Division of Polar Programs. Partial support was also provided by funds from NSF award 1023233 (B. C. C.), NSF award 1115245 (J.C.P.), the NSF's Graduate Research Fellowship Program (1247192; A. M. A.), the Italian National Antarctic Program (C. B.), and fellowships from the NSF's IGERT Program (0654336) and the Montana Space Grant Consortium (A. B. M.). Logistics were provided by the 139th Expeditionary Airlift Squadron of the New York Air National Guard, Kenn Borek Air, and by many dedicated individuals working as part of the Antarctic Support Contractor, managed by Lockheed-Martin. The drilling was directed by F. Rack; D. Blythe, J. Burnett, C. Carpenter, D. Duling (chief driller), D. Gibson, J. Lemery, A. Melby and G. Roberts provided drill support at SLW. L. Geng, B. Vandenheuvel, A. Schauer and E. Steig provided assistance with the stable isotopic analyses. We thank J. Dore for assistance with the nutrient analysis.	Alawi M, 2007, ISME J, V1, P256, DOI 10.1038/ismej.2007.34; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; American Public Health Association A., 1995, STANDARD METHODS EXA; AZAM F, 1979, SCIENCE, V203, P451, DOI 10.1126/science.203.4379.451; Bell R. T., 1993, HDB METHODS AQUATIC; Bell RE, 2002, NATURE, V416, P307, DOI 10.1038/416307a; BLANKENSHIP DD, 1993, NATURE, V361, P526, DOI 10.1038/361526a0; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carter SP, 2012, ANN GLACIOL, V53, P267, DOI 10.3189/2012AoG60A119; Casciotti KL, 2002, ANAL CHEM, V74, P4905, DOI 10.1021/ac020113w; CHINLEO G, 1988, APPL ENVIRON MICROB, V54, P1934, DOI 10.1128/AEM.54.8.1934-1939.1988; Christianson K, 2012, EARTH PLANET SC LETT, V331, P237, DOI 10.1016/j.epsl.2012.03.013; Christner BC, 2006, LIMNOL OCEANOGR, V51, P2485, DOI 10.4319/lo.2006.51.6.2485; Christner Brent C., 2008, P51, DOI 10.1007/978-3-540-74335-4_4; Costa AW, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047539; Depoorter MA, 2013, NATURE, V502, P89, DOI 10.1038/nature12567; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fricker HA, 2007, SCIENCE, V315, P1544, DOI 10.1126/science.1136897; Fricker HA, 2009, J GLACIOL, V55, P303, DOI 10.3189/002214309788608813; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Girsch G, 2013, ATMOS CHEM PHYS DISC, V13, P9443, DOI DOI 10.5194/ACPD-13-9443-2013; Hansell DA, 1998, NATURE, V395, P263, DOI 10.1038/26200; Haran J., 2005, MODIS MOSAIC ANTARCT, DOI [10.7265/N5ZK5DM5.[28]A., DOI 10.7265/N5ZK5DM5.[28]A]; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; Horgan HJ, 2013, GEOLOGY, V41, P1159, DOI 10.1130/G34654.1; Horgan HJ, 2012, EARTH PLANET SC LETT, V331, P201, DOI 10.1016/j.epsl.2012.02.023; HORRIGAN SG, 1981, LIMNOL OCEANOGR, V26, P378, DOI 10.4319/lo.1981.26.2.0378; Kaiser J, 2007, ANAL CHEM, V79, P599, DOI 10.1021/ac061022s; Karl DM, 1999, SCIENCE, V286, P2144, DOI 10.1126/science.286.5447.2144; Kepner RL, 1998, LIMNOL OCEANOGR, V43, P1754, DOI 10.4319/lo.1998.43.7.1754; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Lanoil B, 2009, ENVIRON MICROBIOL, V11, P609, DOI 10.1111/j.1462-2920.2008.01831.x; Montross SN, 2013, GEOLOGY, V41, P215, DOI 10.1130/G33572.1; OSWALD GKA, 1973, NATURE, V245, P251, DOI 10.1038/245251a0; Priscu J. C., 2008, POLAR LAKES RIVERS; Priscu J. C., 2013, LTER LIMNO METHODS M; PRISCU JC, 1990, MAR ECOL PROG SER, V62, P37, DOI 10.3354/meps062037; Priscu JC, 1999, SCIENCE, V286, P2141, DOI 10.1126/science.286.5447.2141; Priscu JC, 2013, ANTARCT SCI, V25, P637, DOI 10.1017/S0954102013000035; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seeberg-Elverfeldt J, 2005, LIMNOL OCEANOGR-METH, V3, P361, DOI 10.4319/lom.2005.3.361; Siegfried MR, 2014, GEOPHYS RES LETT, V41, P891, DOI 10.1002/2013GL058616; Skidmore M, 2010, HYDROL PROCESS, V24, P517, DOI 10.1002/hyp.7580; Takacs CD, 2001, LIMNOL OCEANOGR, V46, P1189, DOI 10.4319/lo.2001.46.5.1189; Vogel SW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022563; Wadham JL, 2012, NATURE, V488, P633, DOI 10.1038/nature11374; Wadham JL, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003688; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wright A, 2012, ANTARCT SCI, V24, P659, DOI 10.1017/S095410201200048X	50	169	174	5	509	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					310	+		10.1038/nature13667	http://dx.doi.org/10.1038/nature13667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25143114	Green Submitted			2022-12-24	WOS:000340508200035
J	Kastelein, JJP				Kastelein, John J. P.			Dyslipidaemia in perspective	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; OF-FUNCTION MUTATIONS; TRIGLYCERIDES; CHOLESTEROL; EVENTS; TRIAL; APOC3; RISK		Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.kastelein@amc.uva.nl	Kastelein, John/AAF-7950-2020					Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Nicholls SJ, 2014, JAMA-J AM MED ASSOC, V311, P252, DOI 10.1001/jama.2013.282836; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; PEDERSEN TR, 1994, LANCET, V344, P1383; Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4; Ridker PM, 2014, LANCET, V384, P607, DOI 10.1016/S0140-6736(14)61009-6; The FIELD study investigators, 2005, LANCET, V366, P1849; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; White HD, 2014, NEW ENGL J MED, V370, P1702, DOI 10.1056/NEJMoa1315878	14	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					566	568		10.1016/S0140-6736(14)61332-5	http://dx.doi.org/10.1016/S0140-6736(14)61332-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25131971				2022-12-24	WOS:000340573300008
J	Gialdini, G; Nearing, K; Bhave, PD; Bonuccelli, U; Iadecola, C; Healey, JS; Kamel, H				Gialdini, Gino; Nearing, Katherine; Bhave, Prashant D.; Bonuccelli, Ubaldo; Iadecola, Costantino; Healey, Jeff S.; Kamel, Hooman			Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONCARDIAC SURGERY; PREDICTORS; PREVENTION; PROGNOSIS; MORTALITY; ACCURACY; OUTCOMES	IMPORTANCE Clinically apparent atrial fibrillation increases the risk of ischemic stroke. In contrast, perioperative atrial fibrillation may be viewed as a transient response to physiological stress, and the long-term risk of stroke after perioperative atrial fibrillation is unclear. OBJECTIVE To examine the association between perioperative atrial fibrillation and the long-term risk of stroke. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study using administrative claims data on patients hospitalized for surgery (as defined by surgical diagnosis related group codes), and discharged alive and free of documented cerebrovascular disease or preexisting atrial fibrillation from nonfederal California acute care hospitals between 2007 and 2011. Patients undergoing cardiac vs other types of surgery were analyzed separately. MAIN OUTCOMES AND MEASURES Previously validated diagnosis codes were used to identify ischemic strokes after discharge from the index hospitalization for surgery. The primary predictor variable was atrial fibrillation newly diagnosed during the index hospitalization, as defined by previously validated present-on-admission codes. Patients were censored at postdischarge emergency department encounters or hospitalizations with a recorded diagnosis of atrial fibrillation. RESULTS Of 1 729 360 eligible patients, 24 711 (1.43%; 95% CI, 1.41%-1.45%) had new-onset perioperative atrial fibrillation during the index hospitalization and 13 952 (0.81%; 95% CI, 0.79%-0.82%) experienced a stroke after discharge. In a Cox proportional hazards analysis accounting for potential confounders, perioperative atrial fibrillation was associated with subsequent stroke both after noncardiac and cardiac surgery. [GRAPHICS] The association with stroke was significantly stronger for perioperative atrial fibrillation after noncardiac vs cardiac surgery (P < .001 for interaction). CONCLUSIONS AND RELEVANCE Among patients hospitalized for surgery, perioperative atrial fibrillation was associated with an increased long-term risk of ischemic stroke, especially following noncardiac surgery.	[Gialdini, Gino; Iadecola, Costantino; Kamel, Hooman] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA; [Nearing, Katherine; Iadecola, Costantino; Kamel, Hooman] Weill Cornell Med Coll, Dept Neurol, New York, NY 10065 USA; [Bhave, Prashant D.] Univ Iowa, Div Cardiol, Carver Coll Med, Iowa City, IA USA; [Bonuccelli, Ubaldo] Univ Pisa, Neurol Sect, Dept Clin & Expt Med, Pisa, Italy; [Healey, Jeff S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	Cornell University; Cornell University; University of Iowa; University of Pisa; McMaster University; Population Health Research Institute	Kamel, H (corresponding author), Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, Dept Neurol, 407 E 61st St,Fifth Floor, New York, NY 10065 USA.	hok9010@med.cornell.edu	Iadecola, c/ABB-8377-2020; Kamel, Hooman/AGG-9071-2022; Bonuccelli, Ubaldo/K-8681-2016	Bonuccelli, Ubaldo/0000-0001-6218-6312; Iadecola, Costantino/0000-0001-9797-073X	National Institute of Neurological Disorders and Stroke [K23NS082367]; Heart and Stroke Foundation, Ontario Provincial Office [MC7450]; Feil Family Foundation; Michael Goldberg Stroke Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037853, K23NS082367, R01NS034179] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Heart and Stroke Foundation, Ontario Provincial Office(Heart & Stroke Foundation of Ontario); Feil Family Foundation; Michael Goldberg Stroke Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grant K23NS082367 (awarded to Dr Kamel) from the National Institute of Neurological Disorders and Stroke, grant MC7450 (Dr Healey) from the Heart and Stroke Foundation, Ontario Provincial Office, and funding from the Feil Family Foundation (Dr Gialdini) and the Michael Goldberg Stroke Research Fund (Dr Kamel).	Ahlsson A, 2010, EUR J CARDIO-THORAC, V37, P1353, DOI 10.1016/j.ejcts.2009.12.033; Almassi GH, 1997, ANN SURG, V226, P501, DOI 10.1097/00000658-199710000-00011; Bhave PD, 2012, AM HEART J, V164, P918, DOI 10.1016/j.ahj.2012.09.004; Brambatti M, 2014, CIRCULATION, V129, P2094, DOI 10.1161/CIRCULATIONAHA.113.007825; Centers for Medicare & Medicaid Services, FILES FOR FY 2008 FI; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein AE, 2005, CHEST, V128, p24S, DOI 10.1378/chest.128.2_suppl.24S; Goldman LE, 2011, HEALTH SERV RES, V46, P1946, DOI 10.1111/j.1475-6773.2011.01300.x; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Hogue CW, 1999, CIRCULATION, V100, P642, DOI 10.1161/01.CIR.100.6.642; Hollenberg SM, 2000, CRIT CARE MED, V28, pN145, DOI 10.1097/00003246-200010001-00006; Horwich P, 2013, J CARDIAC SURG, V28, P8, DOI 10.1111/jocs.12033; Kaw R, 2011, J THORAC CARDIOV SUR, V141, P1305, DOI 10.1016/j.jtcvs.2010.10.040; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Maisel WH, 2001, ANN INTERN MED, V135, P1061, DOI 10.7326/0003-4819-135-12-200112180-00010; Mariscalco G, 2008, CIRCULATION, V118, P1612, DOI 10.1161/CIRCULATIONAHA.108.777789; O'Neal WT, 2013, J CARDIAC SURG, V28, P484, DOI 10.1111/jocs.12178; Ommen SR, 1997, NEW ENGL J MED, V336, P1429, DOI 10.1056/NEJM199705153362006; REED GL, 1988, NEW ENGL J MED, V319, P1246, DOI 10.1056/NEJM198811103191903; RUBIN DA, 1987, J THORAC CARDIOV SUR, V94, P331; Saxena A, 2012, AM J CARDIOL, V109, P219, DOI 10.1016/j.amjcard.2011.08.033; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; Tanawuttiwat T, 2014, J AM COLL CARDIOL, V63, P1510, DOI 10.1016/j.jacc.2013.11.046; TAYLOR GJ, 1987, AM J CARDIOL, V60, P905, DOI 10.1016/0002-9149(87)91045-9; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Villareal RP, 2004, J AM COLL CARDIOL, V43, P742, DOI 10.1016/j.jacc.2003.11.023; Walkey AJ, 2011, JAMA-J AM MED ASSOC, V306, P2248, DOI 10.1001/jama.2011.1615; Weidinger F, 2014, EUR J CARDIO-THORAC, V45, P318, DOI 10.1093/ejcts/ezt282	32	215	226	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					616	622		10.1001/jama.2014.9143	http://dx.doi.org/10.1001/jama.2014.9143			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117130	Green Accepted, Green Published			2022-12-24	WOS:000340136400020
J	Hallal, PC; Martins, RC; Ramirez, A				Hallal, Pedro C.; Martins, Rafaela C.; Ramirez, Andrea			The Lancet Physical Activity Observatory: promoting physical activity worldwide	LANCET			English	Editorial Material							INACTIVITY		[Hallal, Pedro C.; Martins, Rafaela C.] Univ Fed Pelotas, BR-96020220 Pelotas, RJ, Brazil; [Ramirez, Andrea] Univ Los Andes, Bogota, Colombia	Universidade Federal de Pelotas; Universidad de los Andes (Colombia)	Hallal, PC (corresponding author), Univ Fed Pelotas, BR-96020220 Pelotas, RJ, Brazil.	prchallal@gmail.com	Martins, Rafaela C/E-2819-2014; Hallal, Pedro C/A-3249-2011	Hallal, Pedro C/0000-0003-1470-6461; Ramirez Varela, Andrea/0000-0003-2685-9617; Costa Martins, Rafaela/0000-0003-3538-7228				Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Pratt M, 2012, LANCET, V380, P282, DOI 10.1016/S0140-6736(12)60736-3; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8	7	42	45	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					471	472		10.1016/S0140-6736(14)61321-0	http://dx.doi.org/10.1016/S0140-6736(14)61321-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9JR	25110267				2022-12-24	WOS:000340198300004
J	Sedgwick, P				Sedgwick, Philip			Before and after study designs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Akhtar PC, 2007, BMJ-BRIT MED J, V335, P545, DOI 10.1136/bmj.39311.550197.AE; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5741	2	25	25	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 8	2014	349								g5074	10.1136/bmj.g5074	http://dx.doi.org/10.1136/bmj.g5074			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MS	25106742				2022-12-24	WOS:000340206300002
J	Lee, MSY; Cau, A; Naish, D; Dyke, GJ				Lee, Michael S. Y.; Cau, Andrea; Naish, Darren; Dyke, Gareth J.			Sustained miniaturization and anatomical innovation in the dinosaurian ancestors of birds	SCIENCE			English	Article							BODY-SIZE; EVOLUTION; ORIGIN; THEROPOD; RATES	Recent discoveries have highlighted the dramatic evolutionary transformation of massive, ground-dwelling theropod dinosaurs into light, volant birds. Here, we apply Bayesian approaches (originally developed for inferring geographic spread and rates of molecular evolution in viruses) in a different context: to infer size changes and rates of anatomical innovation (across up to 1549 skeletal characters) in fossils. These approaches identify two drivers underlying the dinosaur-bird transition. The theropod lineage directly ancestral to birds undergoes sustained miniaturization across 50 million years and at least 12 consecutive branches (internodes) and evolves skeletal adaptations four times faster than other dinosaurs. The distinct, prolonged phase of miniaturization along the bird stem would have facilitated the evolution of many novelties associated with small body size, such as reorientation of body mass, increased aerial ability, and paedomorphic skulls with reduced snouts but enlarged eyes and brains.	[Lee, Michael S. Y.] S Australian Museum, Earth Sci Sect, Adelaide, SA 5000, Australia; [Lee, Michael S. Y.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Cau, Andrea] Museo Geol & Paleontol Giovanni Capellini, I-40126 Bologna, Italy; [Cau, Andrea] Alma Mater Studiorum Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, I-40126 Bologna, Italy; [Naish, Darren; Dyke, Gareth J.] Univ Southampton, Southampton SO14 3ZH, Hants, England; [Dyke, Gareth J.] Univ Debrecen, MTA DE Lendulet Behav Ecol Res Grp, Dept Evolutionary Zool & Human Biol, H-4032 Debrecen, Hungary	University of Adelaide; University of Bologna; University of Southampton; University of Debrecen	Lee, MSY (corresponding author), S Australian Museum, Earth Sci Sect, North Terrace, Adelaide, SA 5000, Australia.	mike.lee@samuseum.sa.gov.au	Dyke, Gareth/AAJ-9320-2020; Cau, Andrea/ABB-7972-2021; Cau, Andrea/S-8546-2016	Dyke, Gareth/0000-0002-8390-7817; Cau, Andrea/0000-0001-8761-3720; 	Environment Institute (University of Adelaide); Australian Research Council	Environment Institute (University of Adelaide); Australian Research Council(Australian Research Council)	We thank e-research SA for use of high-performance computing facilities, the Environment Institute (University of Adelaide) and Australian Research Council for funding, and the University of Bologna for logistic support. Author contributions. A. C., G.J.D., and D.N. collected phylogenetic and stratigraphic data; M.S.Y.L. analyzed data and assisted with data collection; all authors contributed to interpretation of results; M.S.Y.L. wrote and revised manuscript with input from all other authors. Data files are archived on Dryad Digital Repository (doi:10.5061/dryad.jm6pj).	Allen V, 2013, NATURE, V497, P104, DOI 10.1038/nature12059; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benson RBJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1780; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Dececchi TA, 2013, EVOLUTION, V67, P2741, DOI 10.1111/evo.12150; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dyke G., 2011, LIVING DINOSAURS EVO; Gaudin Timothy J., 2006, P1; Gauthier J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P7; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Heers AM, 2012, TRENDS ECOL EVOL, V27, P296, DOI 10.1016/j.tree.2011.12.003; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Kemp TS, 2007, P ROY SOC B-BIOL SCI, V274, P1667, DOI 10.1098/rspb.2007.0288; Novas Fernando E, 2012, Rev. Mus. Argent. Cienc. Nat., V14, P57; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Pagel M., 2013, BAYESTRAITS SOFTWARE; Puttick MN, 2014, EVOLUTION, V68, P1497, DOI 10.1111/evo.12363; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Zanno LE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2526; Zelenitsky DK, 2012, SCIENCE, V338, P510, DOI 10.1126/science.1225376; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753	30	162	164	2	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					562	566		10.1126/science.1252243	http://dx.doi.org/10.1126/science.1252243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082702				2022-12-24	WOS:000339651300045
J	Reik, W; Kelsey, G				Reik, Wolf; Kelsey, Gavin			EPIGENETICS Cellular memory erased in human embryos	NATURE			English	Editorial Material							DNA METHYLATION; PATERNAL GENOME; LANDSCAPE; OOCYTES		[Reik, Wolf; Kelsey, Gavin] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Reik, Wolf; Kelsey, Gavin] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 1TN, England; [Reik, Wolf] Wellcome Trust Sanger Inst, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Wellcome Trust Sanger Institute	Reik, W (corresponding author), Babraham Inst, Epigenet Programme, Babraham Res Campus, Cambridge CB22 3AT, England.		Reik, Wolf/I-6794-2012	Kelsey, Gavin/0000-0002-9762-5634; Reik, Wolf/0000-0003-0216-9881	Medical Research Council [MR/K011332/1] Funding Source: Medline; Wellcome Trust [095645] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0403, BBS/E/B/0000H334] Funding Source: researchfish; BBSRC [BBS/E/B/0000H334, BBS/E/B/000C0403] Funding Source: UKRI; MRC [MR/K011332/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	15	13	14	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					540	541		10.1038/nature13648	http://dx.doi.org/10.1038/nature13648			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079550				2022-12-24	WOS:000339566300022
J	Zhang, ZG; Wang, W; Qiu, B				Zhang, Zhengguang; Wang, Wei; Qiu, Bo			Oceanic mass transport by mesoscale eddies	SCIENCE			English	Article							HEAT; VARIABILITY; CIRCULATION	Oceanic transports of heat, salt, fresh water, dissolved CO2, and other tracers regulate global climate change and the distribution of natural marine resources. The time-mean ocean circulation transports fluid as a conveyor belt, but fluid parcels can also be trapped and transported discretely by migrating mesoscale eddies. By combining available satellite altimetry and Argo profiling float data, we showed that the eddy-induced zonal mass transport can reach a total meridionally integrated value of up to 30 to 40 sverdrups (Sv) (1 Sv = 10(6) cubic meters per second), and it occurs mainly in subtropical regions, where the background flows are weak. This transport is comparable in magnitude to that of the large-scale wind-and thermohaline-driven circulation.	[Zhang, Zhengguang; Wang, Wei] Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao, Peoples R China; [Qiu, Bo] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA	Ocean University of China; University of Hawaii System; University of Hawaii Manoa	Wang, W (corresponding author), Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao, Peoples R China.	wei@ouc.edu.cn	Qiu, Bo/D-9569-2017		National Basic Research Priorities Program of China [2013CB430303]; National Natural Science Foundation of China [41276014]; National Global Change Major Research Project of China [2013CB956201]	National Basic Research Priorities Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Global Change Major Research Project of China	We thank the reviewers for their constructive and detailed comments. This research was supported by the National Basic Research Priorities Program of China through grant 2013CB430303, the National Natural Science Foundation of China under grant 41276014, and the National Global Change Major Research Project of China through grant 2013CB956201. The sources of the data used in this paper are contained in the supplementary materials.	BRYDEN HL, 1989, J MAR RES, V47, P55, DOI 10.1357/002224089785076389; Chang YL, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047062; Chelton DB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030812; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; DANABASOGLU G, 1994, SCIENCE, V264, P1123, DOI 10.1126/science.264.5162.1123; de Jong MF, 2014, J PHYS OCEANOGR, V44, P427, DOI 10.1175/JPO-D-13-070.1; Dong CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4294; Early JJ, 2011, J PHYS OCEANOGR, V41, P1535, DOI 10.1175/2011JPO4601.1; FLIERL GR, 1981, GEOPHYS ASTRO FLUID, V18, P39, DOI 10.1080/03091928108208773; Lee MM, 1997, J MAR RES, V55, P483, DOI 10.1357/0022240973224346; LUYTEN JR, 1983, J PHYS OCEANOGR, V13, P292, DOI 10.1175/1520-0485(1983)013<0292:TVT>2.0.CO;2; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Peacock S, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002211; Qiu B, 2000, J PHYS OCEANOGR, V30, P1486, DOI 10.1175/1520-0485(2000)030<1486:IVOTKE>2.0.CO;2; Qiu B, 2003, J PHYS OCEANOGR, V33, P2465, DOI 10.1175/2459.1; Qiu B, 2013, J PHYS OCEANOGR, V43, P344, DOI 10.1175/JPO-D-12-0133.1; RHINES PB, 1982, J FLUID MECH, V122, P347, DOI 10.1017/S0022112082002250; Schmitz Jr W.J., 1996, WHOI9603, V1; Schmitz W.J.J., 1996, WHOI9608, VII; Zhang ZG, 2013, GEOPHYS RES LETT, V40, P3677, DOI 10.1002/grl.50736	24	322	365	22	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					322	324		10.1126/science.1252418	http://dx.doi.org/10.1126/science.1252418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035491				2022-12-24	WOS:000339400700050
J	Hill, A; Cooke, G				Hill, Andrew; Cooke, Graham			Hepatitis C can be cured globally, but at what cost?	SCIENCE			English	Editorial Material							VIRAL-HEPATITIS; ACCESS; BURDEN		[Hill, Andrew] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; [Cooke, Graham] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	University of Liverpool; Imperial College London	Hill, A (corresponding author), Univ Liverpool, Dept Pharmacol & Therapeut, POB 147, Liverpool L69 3BX, Merseyside, England.	microhaart@aol.com		Cooke, Graham/0000-0001-6475-5056	Medical Research Council [MR/K01532X/1] Funding Source: Medline; MRC [MR/K01532X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2013, FAIR PRICING COALITI; Cooke GS, 2013, J VIRAL HEPATITIS, V20, P600, DOI 10.1111/jvh.12123; Ford N, 2012, CLIN INFECT DIS, V54, P1465, DOI 10.1093/cid/cis227; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Medivir, 2012, MED 2012 ANN REP, P26; MSF Drug Access Team, 2012, UNT WEB ANT VIR PROC; Schwartlander B, 2006, LANCET, V368, P541, DOI 10.1016/S0140-6736(06)69164-2; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218	11	55	55	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					141	142		10.1126/science.1257737	http://dx.doi.org/10.1126/science.1257737			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8SS	25013048				2022-12-24	WOS:000339409900023
J	Sedgwick, P				Sedgwick, Philip			Understanding P values	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STATISTICAL QUESTION; TRIAL		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P., 2010, BMJ, V340, pc2673, DOI [10.1136/bmj.c2673, DOI 10.1136/BMJ.C2673]; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4287; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2130; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6282; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1041; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4285; Walsh JM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5605	8	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 11	2014	349								g4550	10.1136/bmj.g4550	http://dx.doi.org/10.1136/bmj.g4550			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZH	25015369				2022-12-24	WOS:000338993900006
J	Brazil, R				Brazil, Rachel			FOOD SCIENCE Fat chance	NATURE			English	Editorial Material							KETOGENIC DIET; EPILEPSY; EFFICACY											Chang PS, 2013, NEUROPHARMACOLOGY, V69, P105, DOI 10.1016/j.neuropharm.2012.11.004; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Hallbook T, 2012, EPILEPSY RES, V100, P304, DOI 10.1016/j.eplepsyres.2011.04.017; Hughes SD, 2014, J NEUROCHEM, V129, P426, DOI 10.1111/jnc.12646; Kobow K, 2013, ACTA NEUROPATHOL, V126, P741, DOI 10.1007/s00401-013-1168-8; Kossoff EH, 2003, NEUROLOGY, V61, P1789, DOI 10.1212/01.WNL.0000098889.35155.72; Kossoff EH, 2009, EPILEPSIA, V50, P304, DOI 10.1111/j.1528-1167.2008.01765.x; Levy RG, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001903.pub2, 10.1002/14651858.CD001903.pub3]; McNally MA, 2012, J NEUROCHEM, V121, P28, DOI 10.1111/j.1471-4159.2012.07670.x; Muzykewicz DA, 2009, EPILEPSIA, V50, P1118, DOI 10.1111/j.1528-1167.2008.01959.x	10	1	1	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S14	S15		10.1038/511S14a	http://dx.doi.org/10.1038/511S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8AP	25019130				2022-12-24	WOS:000338649800007
J	Dubash, NK; Fleurbaey, M; Kartha, S				Dubash, Navroz K.; Fleurbaey, Marc; Kartha, Sivan			Political implications of data presentation	SCIENCE			English	Editorial Material													Fleurbaey, Marc/HHS-9231-2022	Kartha, Sivan/0000-0002-6014-2161					0	16	16	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					36	37		10.1126/science.1255734	http://dx.doi.org/10.1126/science.1255734			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2XU	24994639				2022-12-24	WOS:000338284400038
J	Mingote, LR; Namutamba, D; Apina, F; Barnabas, N; Contreras, C; Elnour, T; Frick, MW; Lee, C; Seaworth, B; Shelly, D; Skipper, N; dos Santos, ET				Mingote, Laia Ruiz; Namutamba, Dorothy; Apina, Francis; Barnabas, Nomampondo; Contreras, Carmen; Elnour, Taharqa; Frick, Mike Watson; Lee, Cynthia; Seaworth, Barbara; Shelly, Debra; Skipper, Natalie; dos Santos Filho, Ezio Tavora			The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities	LANCET			English	Editorial Material							OUTCOMES		[Mingote, Laia Ruiz; Namutamba, Dorothy; Apina, Francis; Barnabas, Nomampondo; Contreras, Carmen; Elnour, Taharqa; Lee, Cynthia; Seaworth, Barbara; Shelly, Debra; Skipper, Natalie; dos Santos Filho, Ezio Tavora] Community Res Advisors Grp, New York, NY USA; [Frick, Mike Watson] Treatment Act Grp, New York, NY 10016 USA		Frick, MW (corresponding author), Treatment Act Grp, 261 5th Ave Suite 2110, New York, NY 10016 USA.	mike.frick@treatmentactiongroup.org						Diacon A, 2014, 2014 C RETR OPP INF; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Edney A., 2012, BLOOMBERG NEWS; FDA. Division of Anti-Infective Products. Office of Antimicrobial Products, 2012, FDA ANT DRUGS ADV CO; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Lessem E., 2013, ACTIVISTS GUIDE BEDA; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; World Health Organization (WHO), 2013, WHONMHNHDEPG131	9	13	14	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 31	2015	385	9966					477	479		10.1016/S0140-6736(14)60523-7	http://dx.doi.org/10.1016/S0140-6736(14)60523-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CT	25018118				2022-12-24	WOS:000348509900035
J	Bhaskaran, K; Douglas, I; Forbes, H; dos-Santos-Silva, I; Leon, DA; Smeeth, L				Bhaskaran, Krishnan; Douglas, Ian; Forbes, Harriet; dos-Santos-Silva, Isabel; Leon, David A.; Smeeth, Liam			Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults	LANCET			English	Article							HORMONE REPLACEMENT THERAPY; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; FOLLOW-UP; OBESITY; VALIDITY; HEIGHT; SIZE; METAANALYSIS; OVERWEIGHT	Background High body-mass index (BMI) predisposes to several site-specific cancers, but a large-scale systematic and detailed characterisation of patterns of risk across all common cancers adjusted for potential confounders has not previously been undertaken. We aimed to investigate the links between BMI and the most common site-specifi c cancers. Methods With primary care data from individuals in the Clinical Practice Research Datalink with BMI data, we fitted Cox models to investigate associations between BMI and 22 of the most common cancers, adjusting for potential confounders. We fitted linear then non-linear (spline) models; investigated effect modification by sex, menopausal status, smoking, and age; and calculated population effects. Findings 5.24 million individuals were included; 166 955 developed cancers of interest. BMI was associated with 17 of 22 cancers, but effects varied substantially by site. Each 5 kg/m(2) increase in BMI was roughly linearly associated with cancers of the uterus (hazard ratio [HR] 1.62, 99% CI 1.56-1. 69; p < 0.0001), gallbladder (1.31, 1.12-1.52; p < 0.0001), kidney (1.25, 1.17-1.33; p < 0.0001), cervix (1.10, 1.03-1 17; p = 0.00035), thyroid (1.09, 1.00-1.19; p = 0.0088), and leukaemia (1.09, 1.05-1.13; p = 0.0001). BMI was positively associated with liver (1.19, 1.12-1 27), colon (1.10, 1.07-1.13), ovarian (1.09, 1.04-1.14), and postmenopausal breast cancers (1.05, 1.03-1.07) overall (all p < 0.0001), but these effects varied by underlying BMI or individual-level characteristics. We estimated inverse associations with prostate and premenopausal breast cancer risk, both overall (prostate 0.98, 0.95-1.00; premenopausal breast cancer 0.89, 0.86-0.92) and in never-smokers (prostate 0.96, 0.93-0.99; premenopausal breast cancer 0.89, 0.85-0.94). By contrast, for lung and oral cavity cancer, we observed no association in never smokers (lung 0.99, 0.93-1.05; oral cavity 1.07, 0.91-1.26): inverse associations overall were driven by current smokers and ex-smokers, probably because of residual confounding by smoking amount. Assuming causality, 41% of uterine and 10% or more of gallbladder, kidney, liver, and colon cancers could be attributable to excess weight. We estimated that a 1 kg/m(2) population-wide increase in BMI would result in 3790 additional annual UK patients developing one of the ten cancers positively associated with BMI. Interpretation BMI is associated with cancer risk, with substantial population-level eff ects. The heterogeneity in the eff ects suggests that different mechanisms are associated with different cancer sites and different patient subgroups. Funding National Institute for Health Research, Wellcome Trust, and Medical Research Council. Copyright (C) Bhaskaran et al. Open Access article distributed under the terms of CC BY.	[Bhaskaran, Krishnan; Douglas, Ian; Forbes, Harriet; dos-Santos-Silva, Isabel; Leon, David A.; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Smeeth, Liam] Farr Inst Hlth Informat Res, London, England	University of London; London School of Hygiene & Tropical Medicine	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	Leon, David A/G-2195-2010; Smeeth, Liam/X-5862-2018	Leon, David A/0000-0001-9747-1762; Smeeth, Liam/0000-0002-9168-6022; dos Santos Silva, Isabel/0000-0002-6596-8798; Forbes, Harriet/0000-0001-6888-2212; Bhaskaran, Krishnan/0000-0001-5364-8757	National Institute for Health Research; Wellcome Trust; Medical Research Council; MRC methodology research fellowship; MRC [G0802403] Funding Source: UKRI; Medical Research Council [G0802403, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [PDF-2011-04-007, NF-SI-0510-10090] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC methodology research fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research, Wellcome Trust, and Medical Research Council.; This report is independent research arising from a postdoctoral fellowship (for KB) supported by the National Institute for Health Research. LS is supported by a Wellcome Trust senior research fellowship in clinical science. ID is supported by an MRC methodology research fellowship. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beral V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001200; Bhaskaran K, REPRESENTATIVENESS O; Boggon R, 2013, PHARMACOEPIDEM DR S, V22, P168, DOI 10.1002/pds.3374; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Campbell PT, 2010, JNCI-J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011; Cancer Research UK, 2012, CANC INC COMM CANC; Crosbie EJ, 2010, CANCER EPIDEM BIOMAR, V19, P3119, DOI 10.1158/1055-9965.EPI-10-0832; Discacciati A, 2012, ANN ONCOL, V23, P1665, DOI 10.1093/annonc/mdr603; Dregan A, 2012, CANCER EPIDEMIOL, V36, P425, DOI 10.1016/j.canep.2012.05.013; Engeland A, 2003, JNCI-J NATL CANCER I, V95, P1244, DOI 10.1093/jnci/djg010; Engeland A, 2006, BRIT J CANCER, V95, P366, DOI 10.1038/sj.bjc.6603249; Glymour M.M., 2008, MODERN EPIDEMIOLOGY, P183; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Her Majesty's Government Department for Communities and Local Government, 2011, IND MULT DEPR; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hoffmeister M, 2013, CANCER EPIDEM BIOMAR, V22, P2303, DOI 10.1158/1055-9965.EPI-13-0239; Hughes LAE, 2012, INT J EPIDEMIOL, V41, P1060, DOI 10.1093/ije/dys055; Hughes LAE, 2011, AM J EPIDEMIOL, V174, P1127, DOI 10.1093/aje/kwr247; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lewis JD, 2004, PHARMACOEPIDEM DR S, V13, P437, DOI 10.1002/pds.902; NHS Information Centre, HLTH SURV ENGL 2010; Parkinson J, 2007, PHARMACOVIGILANCE, P341, DOI DOI 10.1002/9780470059210.CH27; Pylypchuk RD, 2009, AM J EPIDEMIOL, V170, P297, DOI 10.1093/aje/kwp123; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan Andrew G., 2008, Archives of Physiology and Biochemistry, V114, P71, DOI [10.1080/13813450801954303, 10.1080/13813450801954303 ]; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ritte R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3186; Robsahm TE, 2013, EUR J CANCER PREV, V22, P492, DOI 10.1097/CEJ.0b013e328360f434; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Smith L, 2012, JNCI-J NATL CANCER I, V104, P778, DOI 10.1093/jnci/djs179; Song YM, 2008, J CLIN ONCOL, V26, P3395, DOI 10.1200/JCO.2007.15.7867; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Ulmer H, 2012, GYNECOL ONCOL, V125, P330, DOI 10.1016/j.ygyno.2012.01.052; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; WHO, WORLD HLTH STAT 2011; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	39	908	951	10	151	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					755	765		10.1016/S0140-6736(14)60892-8	http://dx.doi.org/10.1016/S0140-6736(14)60892-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DD	25129328	Green Published, Green Accepted			2022-12-24	WOS:000341361500036
J	Radford, EJ; Ito, M; Shi, H; Corish, JA; Yamazawa, K; Isganaitis, E; Seisenberger, S; Hore, TA; Reik, W; Erkek, S; Peters, AHFM; Patti, ME; Ferguson-Smith, AC				Radford, Elizabeth J.; Ito, Mitsuteru; Shi, Hui; Corish, Jennifer A.; Yamazawa, Kazuki; Isganaitis, Elvira; Seisenberger, Stefanie; Hore, Timothy A.; Reik, Wolf; Erkek, Serap; Peters, Antoine H. F. M.; Patti, Mary-Elizabeth; Ferguson-Smith, Anne C.			In utero undernourishment perturbs the adult sperm methylome and intergenerational metabolism	SCIENCE			English	Article							LOW-BIRTH-WEIGHT; PROMOTER DNA METHYLATION; EMBRYONIC STEM-CELLS; TRANSGENERATIONAL INHERITANCE; ACTIVATING MUTATIONS; EPIGENETIC MEMORY; GENE-EXPRESSION; C. ELEGANS; MOUSE; GENOME	Adverse prenatal environments can promote metabolic disease in offspring and subsequent generations. Animal models and epidemiological data implicate epigenetic inheritance, but the mechanisms remain unknown. In an intergenerational developmental programming model affecting F-2 mouse metabolism, we demonstrate that the in utero nutritional environment of F-1 embryos alters the germline DNA methylome of F-1 adult males in a locus-specific manner. Differentially methylated regions are hypomethylated and enriched in nucleosome-retaining regions. A substantial fraction is resistant to early embryo methylation reprogramming, which may have an impact on F-2 development. Differential methylation is not maintained in F-2 tissues, yet locus-specific expression is perturbed. Thus, in utero nutritional exposures during critical windows of germ cell development can impact the male germline methylome, associated with metabolic disease in offspring.	[Radford, Elizabeth J.; Ito, Mitsuteru; Shi, Hui; Corish, Jennifer A.; Yamazawa, Kazuki; Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Isganaitis, Elvira; Patti, Mary-Elizabeth] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Isganaitis, Elvira; Patti, Mary-Elizabeth] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Seisenberger, Stefanie; Hore, Timothy A.; Reik, Wolf] Babraham Inst, Cambridge, England; [Seisenberger, Stefanie; Hore, Timothy A.; Reik, Wolf] Wellcome Trust Sanger Inst, Cambridge, England; [Erkek, Serap; Peters, Antoine H. F. M.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Erkek, Serap; Peters, Antoine H. F. M.] Univ Basel, Fac Sci, Basel, Switzerland; [Erkek, Serap] Swiss Inst Bioinformat, Basel, Switzerland	University of Cambridge; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute; Friedrich Miescher Institute for Biomedical Research; University of Basel; Swiss Institute of Bioinformatics	Patti, ME (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	mary.elizabeth.patti@joslin.harvard.edu; afsmith@mole.bio.cam.ac.uk	Erkek, Serap/AAV-5549-2020; Shi, Hui/Z-1004-2019; Reik, Wolf/I-6794-2012; Peters, Antoine/ABA-6283-2020	Shi, Hui/0000-0001-9126-4607; Reik, Wolf/0000-0003-0216-9881; Erkek, Serap/0000-0003-4439-5203; Isganaitis, Elvira/0000-0003-3477-0305; Radford, Elizabeth/0000-0002-7829-5422; Hore, Timothy/0000-0002-6735-225X; Yamazawa, Kazuki/0000-0003-4895-2759; Peters, Antoine/0000-0002-0311-1887; Ferguson-Smith, Anne/0000-0002-7608-5894	U.K. Medical Research Council; Wellcome Trust; European Commission FP7, EpiGeneSys; European Commission FP7, EpiHealth; Pediatric Endocrine Society; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; American Diabetes Association; Graetz Foundation; NIH [P30DK036836]; Novartis Research Foundation; BBSRC [BBS/E/B/0000S266, BBS/E/B/000C0402] Funding Source: UKRI; MRC [MR/J001597/1] Funding Source: UKRI; Grants-in-Aid for Scientific Research [25713040] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD064793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0402, BBS/E/B/0000S266] Funding Source: researchfish; Medical Research Council [MR/J001597/1] Funding Source: researchfish	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission FP7, EpiGeneSys; European Commission FP7, EpiHealth; Pediatric Endocrine Society; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Diabetes Association(American Diabetes Association); Graetz Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to members of the Ferguson-Smith and Patti labs for useful discussions of this work and to K. Tabbada and D. Oxley for expert technical assistance with Illumina sequencing and mass spectrometry. Work was supported by grants from the U.K. Medical Research Council; Wellcome Trust; and European Commission FP7, EpiGeneSys and EpiHealth (to A.C.F.-S.), from the Pediatric Endocrine Society and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH (to E.I.), and from the American Diabetes Association, the Graetz Foundation, and NIH P30DK036836 (to M.-E.P.). W.R. is a consultant for Cambridge Epigenetix. The MeDIP-Seq data sets have been deposited in GEO with accession number GSE58747. A.H.F.M.P. and S.E. are funded by the Novartis Research Foundation.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRUNO JF, 1994, ENDOCRINOLOGY, V135, P1787, DOI 10.1210/en.135.5.1787; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Isganaitis E, 2009, DIABETES, V58, P1192, DOI 10.2337/db08-1266; Iwanaga T, 2011, BIOMED RES-TOKYO, V32, P73, DOI 10.2220/biomedres.32.73; Jimenez-Chillaron JC, 2005, DIABETES, V54, P702, DOI 10.2337/diabetes.54.3.702; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Laukkanen O, 2004, J CLIN ENDOCR METAB, V89, P6286, DOI 10.1210/jc.2004-1204; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Taiwo O, 2012, NAT PROTOC, V7, P617, DOI 10.1038/nprot.2012.012; Takeuchi T, 2011, ANAL CELL PATHOL, V34, P113, DOI [10.1155/2011/578097, 10.3233/ACP-2011-009]; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; Woo M, 2011, STEM CELLS DEV, V20, P1763, DOI 10.1089/scd.2010.0349; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	42	424	437	6	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					785	+	1255903	10.1126/science.1255903	http://dx.doi.org/10.1126/science.1255903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6ZT	25011554	Green Accepted			2022-12-24	WOS:000349776300001
J	Laviano, A				Laviano, Alessandro			Young Blood	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ERYTHROPOIESIS		Univ Roma La Sapienza, Dept Clin Med, I-00185 Rome, Italy	Sapienza University Rome	Laviano, A (corresponding author), Univ Roma La Sapienza, Dept Clin Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.							Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569	6	21	24	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					573	575		10.1056/NEJMcibr1407158	http://dx.doi.org/10.1056/NEJMcibr1407158			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25099584				2022-12-24	WOS:000339899100016
J	Servick, K				Servick, Kelly			Top heart lab comes under fire	SCIENCE			English	Editorial Material																			0	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					254	254		10.1126/science.345.6194.254	http://dx.doi.org/10.1126/science.345.6194.254			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035470				2022-12-24	WOS:000339400700016
J	Rusakova, M; Rakhmetova, A; Strathdee, SA				Rusakova, Maia; Rakhmetova, Aliya; Strathdee, Steffanie A.			Why are sex workers who use substances at risk for HIV?	LANCET			English	Editorial Material							BORDER CITIES; MALE PARTNERS; INJECT DRUGS; FEMALE; BEHAVIORS; RUSSIA		[Rusakova, Maia] NGO Stellit, St Petersburg, Russia; [Rakhmetova, Aliya] Sex Workers Rights Advocacy Network, Budapest, Hungary; [Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Strathdee, SA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X; Rusakova, Mayya/0000-0003-1381-353X				Cottler LB, 2014, AM J PUBLIC HEALTH, V104, P338, DOI 10.2105/AJPH.2013.301513; Decker MR, 2014, AIDS BEHAV, V18, P562, DOI 10.1007/s10461-013-0577-y; Des Jarlais DC, 2012, DRUG ALCOHOL DEPEN, V124, P95, DOI 10.1016/j.drugalcdep.2011.12.020; Goldenberg SM, 2012, AIDS BEHAV, V16, P969, DOI 10.1007/s10461-011-0063-3; Rolon ML, 2013, J TROP PEDIATRICS, V59, P214, DOI 10.1093/tropej/fmt009; Odinokova V, 2014, INT J DRUG POLICY, V25, P96, DOI 10.1016/j.drugpo.2013.06.008; Open Society Institute, 2008, NOTH US US GREAT MEA; Patterson TL, 2012, JAIDS-J ACQ IMM DEF, V60, P414, DOI 10.1097/QAI.0b013e31825693f2; Platt L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002836; Robertson AM, 2013, SEX TRANSM DIS, V40, P801, DOI 10.1097/OLQ.0000000000000016; Shannon K., 2014, LANCET; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; UNAIDS, 2013, RUSS FED HIV AIDS ES; United Nations & AIDS (UNAIDS), 2012, WORLD AIDS DAY REP; Urada LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033282; World Health Organization, 2013, IMPL COMPR HIV STI P	17	16	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2015	385	9964					211	212		10.1016/S0140-6736(14)61042-4	http://dx.doi.org/10.1016/S0140-6736(14)61042-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ2DL	25059944				2022-12-24	WOS:000348044800009
J	Pollux, BJA; Meredith, RW; Springer, MS; Garland, T; Reznick, DN				Pollux, B. J. A.; Meredith, R. W.; Springer, M. S.; Garland, T.; Reznick, D. N.			The evolution of the placenta drives a shift in sexual selection in livebearing fish	NATURE			English	Article							MOLECULAR PHYLOGENETIC-RELATIONSHIPS; PARENT-OFFSPRING CONFLICT; REPRODUCTIVE ISOLATION; SIZE DIMORPHISM; VIVIPARITY; POECILIA; CYPRINODONTIFORMES; COEVOLUTION; POLYTOMIES; PATTERNS	The evolution of the placenta from a non-placental ancestor causes a shift of maternal investment from pre- to post-fertilization, creating a venue for parent-offspring conflicts during pregnancy(1-4). Theory predicts that the rise of these conflicts should drive a shift from a reliance on pre-copulatory female mate choice to polyandry in conjunction with post-zygotic mechanisms of sexual selection(2). This hypothesis has not yet been empirically tested. Here we apply comparative methods to test a key prediction of this hypothesis, which is that the evolution of placentation is associated with reduced pre-copulatory female mate choice. We exploit a unique quality of the livebearing fish family Poeciliidae: placentas have repeatedly evolved or been lost, creating diversity among closely related lineages in the presence or absence of placentation(5,6). We show that post-zygotic maternal provisioning by means of a placenta is associated with the absence of bright coloration, courtship behaviour and exaggerated ornamental display traits in males. Furthermore, we found that males of placental species have smaller bodies and longer genitalia, which facilitate sneak or coercive mating and, hence, circumvents female choice. Moreover, we demonstrate that post-zygotic maternal provisioning correlates with superfetation, a female reproductive adaptation that may result in polyandry through the formation of temporally overlapping, mixed-paternity litters. Our results suggest that the emergence of prenatal conflict during the evolution of the placenta correlates with a suite of phenotypic and behavioural male traits that is associated with a reduced reliance on pre-copulatory female mate choice.	[Pollux, B. J. A.; Meredith, R. W.; Springer, M. S.; Garland, T.; Reznick, D. N.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Pollux, B. J. A.] Wageningen Univ, Expt Zool Grp, NL-6708 WD Wageningen, Netherlands; [Meredith, R. W.] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ 07043 USA	University of California System; University of California Riverside; Wageningen University & Research; Montclair State University	Pollux, BJA (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	b.pollux@gmail.com; david.reznick@ucr.edu		Garland, Theodore/0000-0002-7916-3552; reznick, david/0000-0002-1144-0568	Netherlands Organisation for Scientific Research [825.07.017]; European Union [299048]; US National Science Foundation [DEB0416085]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); US National Science Foundation(National Science Foundation (NSF))	We thank all individuals and institutions who provided samples for this study (Rehoboth Aquatics, H. Bart Jr, R. Davis, D. Fromm, J. de Greef, H. Hieronimus, B. Hobbs, T. Hrbek, J. Johnson, B. Kohler, J. Langenhammer, C. Li, J. Lundberg, M. Mateos, A. Meyer, D. Nelson, L. Page, L. Parenti, M. Sabaj Perez, R. Robins, R. de Ruiter, S. Schaefer, M. Schartl, J. Sparks, M. Stiassny, J. Travis, J. Trexler and J. Williams); L. Rowe and A. Furness for discussions and reading the manuscript; and C. Oufiero and M. Banet for help in collecting part of the data. This study was supported by Rubicon grant 825.07.017 of the Netherlands Organisation for Scientific Research and Marie Curie - IIF grant 299048 of the European Union to B.J.A.P. and grant DEB0416085 of the US National Science Foundation to D.N.R. and M.S.S.	Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Banet AI, 2010, EVOLUTION, V64, P3172, DOI 10.1111/j.1558-5646.2010.01059.x; BISAZZA A, 1995, ETHOL ECOL EVOL, V7, P169, DOI 10.1080/08927014.1995.9522963; BISAZZA A, 1993, MAR BEHAV PHYSIOL, V23, P257, DOI 10.1080/10236249309378869; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Breden F, 1999, MOL PHYLOGENET EVOL, V12, P95, DOI 10.1006/mpev.1998.0600; Bruggeman J, 2009, NUCLEIC ACIDS RES, V37, pW179, DOI 10.1093/nar/gkp370; Burnham KP., 2002, MODEL SELECTION MULT, V2, P70; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Coleman SW, 2009, AM NAT, V173, P291, DOI 10.1086/596542; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Dugdale HL, 2007, MOL ECOL, V16, P5294, DOI 10.1111/j.1365-294X.2007.03571.x; EVANS J.P., 2011, ECOLOGY EVOLUTION PO; Evans JP, 2011, P ROY SOC B-BIOL SCI, V278, P2611, DOI 10.1098/rspb.2010.2453; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; Garland T, 1999, SYST BIOL, V48, P547, DOI 10.1080/106351599260139; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAIG D, 1990, AM NAT, V136, P550, DOI 10.1086/285113; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Maddison W, MESQUITE MODULAR SYS; Meffe GK, 1989, ECOLOGY EVOLUTION LI; Meredith RW, 2011, MOL PHYLOGENET EVOL, V59, P148, DOI 10.1016/j.ympev.2011.01.014; Meredith RW, 2010, MOL PHYLOGENET EVOL, V55, P631, DOI 10.1016/j.ympev.2009.11.006; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; O'Neill MJ, 2007, P NATL ACAD SCI USA, V104, P12404, DOI 10.1073/pnas.0705048104; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M., 2013, USERS MANUAL BAYES T; Pilastro A, 1997, P ROY SOC B-BIOL SCI, V264, P1125, DOI 10.1098/rspb.1997.0155; Pollux BJA, 2009, ANNU REV ECOL EVOL S, V40, P271, DOI 10.1146/annurev.ecolsys.110308.120209; Pollux BJA, 2011, FUNCT ECOL, V25, P747, DOI 10.1111/j.1365-2435.2011.01831.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ptacek MB, 1998, J FISH BIOL, V53, P64, DOI 10.1006/jfbi.1998.0807; PURVIS A, 1993, SYST BIOL, V42, P569, DOI 10.2307/2992489; Rambaut A., SE AL SEQUENCE ALIGN; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Reznick DN, 2002, SCIENCE, V298, P1018, DOI 10.1126/science.1076018; SAS Institute, 2012, SAS ETS 12 1 US GUID, P1121; Schmidt TR, 1998, COPEIA, P14, DOI 10.2307/1447697; Schrader M, 2012, EVOLUTION, V66, P272, DOI 10.1111/j.1558-5646.2011.01422.x; Schrader M, 2008, AM NAT, V172, P806, DOI 10.1086/592999; SHACKELFORD RM, 1952, AM NAT, V86, P311, DOI 10.1086/281738; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Yamaguchi N, 2006, Q REV BIOL, V81, P33, DOI 10.1086/503923; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Zeh DW, 2000, BIOESSAYS, V22, P938, DOI 10.1002/1521-1878(200010)22:10<938::AID-BIES9>3.0.CO;2-9; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x	59	110	110	1	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					233	+		10.1038/nature13451	http://dx.doi.org/10.1038/nature13451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043015				2022-12-24	WOS:000341362800050
J	Nair-Gupta, P; Baccarini, A; Tung, N; Seyffer, F; Florey, O; Huang, YJ; Banerjee, M; Overholtzer, M; Roche, PA; Tampe, R; Brown, BD; Amsen, D; Whiteheart, SW; Blander, JM				Nair-Gupta, Priyanka; Baccarini, Alessia; Tung, Navpreet; Seyffer, Fabian; Florey, Oliver; Huang, Yunjie; Banerjee, Meenakshi; Overholtzer, Michael; Roche, Paul A.; Tampe, Robert; Brown, Brian D.; Amsen, Derk; Whiteheart, Sidney W.; Blander, J. Magarian			TLR Signals Induce Phagosomal MHC-I Delivery from the Endosomal Recycling Compartment to Allow Cross-Presentation	CELL			English	Article							DENDRITIC CELLS; ANTIGEN; MATURATION; MEMBRANE; IMMUNITY; SNAP-23; CROSSPRESENTATION; PHOSPHORYLATION; RECOGNITION; ACTIVATION	Adaptation of the endoplasmic reticulum (ER) pathway for MHC class I (MHC-I) presentation in dendritic cells enables cross-presentation of peptides derived from phagocytosed microbes, infected cells, or tumor cells to CD8 T cells. How these peptides intersect with MHC-I molecules remains poorly understood. Here, we show that MHC-I selectively accumulate within phagosomes carrying microbial components, which engage Toll-like receptor (TLR) signaling. Although cross-presentation requires Sec22b-mediated phagosomal recruitment of the peptide loading complex from the ER-Golgi intermediate compartment (ERGIC), this step is independent of TLR signaling and does not deliver MHC-I. Instead, MHC-I are recruited from an endosomal recycling compartment (ERC), which is marked by Rab11a, VAMP3/cellubrevin, and VAMP8/endobrevin and holds large reserves of MHC-I. While Rab11a activity stocks ERC stores with MHC-I, MyD88-dependent TLR signals drive I kappa B-kinase (IKK) 2-mediated phosphorylation of phagosome-associated SNAP23. Phospho-SNAP23 stabilizes SNARE complexes orchestrating ERC-phagosome fusion, enrichment of phagosomes with ERC-derived MHC-I, and subsequent cross-presentation during infection.	[Nair-Gupta, Priyanka; Baccarini, Alessia; Tung, Navpreet; Brown, Brian D.; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Tung, Navpreet; Brown, Brian D.; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Nair-Gupta, Priyanka; Tung, Navpreet; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Baccarini, Alessia; Brown, Brian D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Nair-Gupta, Priyanka; Tung, Navpreet] Icahn Sch Med Mt Sinai, Grad Sch Biol Sci, New York, NY 10029 USA; [Seyffer, Fabian; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany; [Florey, Oliver; Overholtzer, Michael] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Huang, Yunjie; Banerjee, Meenakshi; Whiteheart, Sidney W.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Roche, Paul A.] NCI, Expt Cell Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Amsen, Derk] Sanquin Res & Landsteiner Lab, Dept Hematopoiesis, NL-1066 CX Amsterdam, Netherlands	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Goethe University Frankfurt; Memorial Sloan Kettering Cancer Center; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Amsterdam	Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA.	julie.blander@mssm.edu	Banerjee, Meenakshi/AAL-6738-2020; Tampé, Robert/H-2953-2015; Huang, Yunjie/AAW-8751-2021	Tampé, Robert/0000-0002-0403-2160; Roche, Paul/0000-0002-8949-9172; Florey, Oliver/0000-0002-1075-7424; Whiteheart, Sidney/0000-0001-5577-0473; Blander, Julie Magarian/0000-0001-9207-1700; Huang, Yunjie/0000-0002-2151-9499; Banerjee, Meenakshi/0000-0002-5139-5861	NIH [5R24 CA095823-04, S10 RR0 9145-01, AI073899, HL56652, HL082193, AI104848, CA154649, DK072201, AI095245]; NSF [DBI-9724504]; German Research Foundation-Membrane Transport and Communication [SFB 807, TA157/7]; Landsteiner Foundation for Blood Research; Dutch Organization for Science; Burroughs Wellcome Fund; American Cancer Society [117254]; NATIONAL CANCER INSTITUTE [ZIABC011035, R24CA095823, R01CA154649] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091893, R01HL056652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104848, R01AI095245, R01AI073899, R56AI073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); German Research Foundation-Membrane Transport and Communication; Landsteiner Foundation for Blood Research; Dutch Organization for Science; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. S. Trombetta, T. Moran, A. Garcia-Sastre, C. Harding, R. Germain, N. Aronin, M. M. DiFiglia, I. Verma, K. Suzuki, and S. Amigorena for reagents. We are grateful to E. Kavalali, B. Trinite, F. Gebhardt, H. Peche, current J.M.B. laboratory members, H. Gupta, M. Blander, and S.J. Blander for technical assistance, discussions, and support. ISMMS-Microscopy Shared Resource Facility was supported by NIH grants 5R24 CA095823-04, S10 RR0 9145-01, and NSF DBI-9724504. This work was supported by NIH grants AI073899 to J.M.B., HL56652 and HL082193 to S. W. W., AI104848 to B. D. B., CA154649 to M.O., German Research Foundation grants SFB 807-Membrane Transport and Communication and TA157/7 to R. T., and grants from the Landsteiner Foundation for Blood Research and The Dutch Organization for Science to D. A. J.M.B. is supported by NIH grants DK072201 and AI095245, the Burroughs Wellcome Fund, and American Cancer Society grant 117254.	Ackerman AL, 2003, J IMMUNOL, V170, P4178, DOI 10.4049/jimmunol.170.8.4178; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006; Bethani I, 2009, TRAFFIC, V10, P1543, DOI 10.1111/j.1600-0854.2009.00959.x; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Lugrin J, 2014, BIOL CHEM, V395, P203, DOI 10.1515/hsz-2013-0241; Mathan TSM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00372; Nair P, 2011, TRAFFIC, V12, P1669, DOI 10.1111/j.1600-0854.2011.01251.x; Nair-Gupta P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00401; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Sakurai C, 2012, MOL BIOL CELL, V23, P4849, DOI 10.1091/mbc.E12-01-0069; Saraste J, 2007, MOL BIOL CELL, V18, P1430, DOI 10.1091/mbc.E06-10-0933; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Stow JL, 2006, NAT REV IMMUNOL, V6, P919, DOI 10.1038/nri1980; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wagner CS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00138; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451	34	203	211	2	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					506	521		10.1016/j.cell.2014.04.054	http://dx.doi.org/10.1016/j.cell.2014.04.054			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083866	Bronze, Green Accepted			2022-12-24	WOS:000340944300006
J	Heidari, S; Mofenson, LM; Bekker, LG				Heidari, Shirin; Mofenson, Lynne M.; Bekker, Linda-Gail			Realization of an AIDS-Free Generation Ensuring Sustainable Treatment for Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANTIRETROVIRAL THERAPY		[Heidari, Shirin] Inforia, CH-1202 Geneva, Switzerland; [Mofenson, Lynne M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Cape Town	Heidari, S (corresponding author), Inforia, Rue Henri Veyrassat 3, CH-1202 Geneva, Switzerland.	shirin.heidari@inforia.org	Bekker, Linda-Gail/AAZ-8929-2020; Mofenson, Lynne/P-9631-2019	Mofenson, Lynne/0000-0002-2818-9808; Heidari, Shirin/0000-0002-6837-491X; BEKKER, LINDA-GAIL/0000-0002-0755-4386				Penazzato M, 2014, LANCET INFECT DIS, P20; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; UNAIDS, GLOB REP UNAIDS REP; United Nations Joint Programme on HIV/AIDS (UNAIDS), GLOB PLAN EL NEW HIV; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, GLOB UPD HIV TREATM; World Health Organization, CONS GUID US ANT DRU; World Health Organization, MARCH 2014 SUPPL 201	8	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					339	340		10.1001/jama.2014.5806	http://dx.doi.org/10.1001/jama.2014.5806			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038347				2022-12-24	WOS:000339257800015
J	Ohno, H; Kato, S; Naito, Y; Kunitomo, H; Tomioka, M; Iino, Y				Ohno, Hayao; Kato, Shinya; Naito, Yasuki; Kunitomo, Hirofumi; Tomioka, Masahiro; Iino, Yuichi			Role of synaptic phosphatidylinositol 3-kinase in a behavioral learning response in C. elegans	SCIENCE			English	Article							INSULIN-RECEPTOR; PROTEIN; CHEMOTAXIS; PLASTICITY; COMPONENTS; KINESIN-1; CASY-1	The phosphatidylinositol 3-kinase (PI3K) pathway regulates many cellular functions, but its roles in the nervous system are still poorly understood. We found that a newly discovered insulin receptor isoform, DAF-2c, is translocated from the cell body to the synaptic region of the chemosensory neuron in Caenorhabditis elegans by a conditioning stimulus that induces taste avoidance learning. This translocation is essential for learning and is dependent on the mitogen-activated protein kinase-regulated interaction of CASY-1 (the calsyntenin ortholog) and kinesin-1. The PI3K pathway is required downstream of the receptor. Light-regulated activation of PI3K in the synaptic region, but not in other parts of the cell, switched taste-attractive behavior to taste avoidance, mimicking the effect of conditioning. Thus, synaptic PI3K is crucial for the behavioral switch caused by learning.	[Ohno, Hayao; Kato, Shinya; Naito, Yasuki; Kunitomo, Hirofumi; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Ohno, Hayao; Iino, Yuichi] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Naito, Yasuki; Tomioka, Masahiro; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Tomioka, M (corresponding author), Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo 1130033, Japan.	seidai@gen.s.u-tokyo.ac.jp; iino@bs.s.u-tokyo.ac.jp	TOMIOKA, MASAHIRO/G-4890-2014; KUNITOMO, HIROFUMI/G-4963-2014; IINO, YUICHI/G-4962-2014	TOMIOKA, MASAHIRO/0000-0002-7537-714X; KUNITOMO, HIROFUMI/0000-0001-7312-7051; Ohno, Hayao/0000-0003-2635-6964	Ministry of Education, Culture, Sports, Science and Technology of Japan [20115002, 25115010, 21370002, 23112704]; Grants-in-Aid for Scientific Research [25115010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Caenorhabditis Genetics Center (CGC), the National Bioresource Project, R. Iwata, O. Hobert, K. Matsumoto, M. Han, G. Ruvkun, M. Doi, and S. Oda for strains; N. Chronis for the design of the olfactory chip; K. D. Kimura and G. Ruvkun for daf-2a cDNA; and K. Shen, C. Bargmann, K. Takeo, and members of the Iino lab for thoughtful comments and discussions. The primary data of this study are archived in the Iino laboratory in the Department of Biological Sciences, University of Tokyo, and are available upon request. Y.I. was supported by a Grant-in-Aid for Innovative Areas "Systems molecular ethology" (20115002) and "Memory dynamism" (25115010) and for Scientific Research (B) (21370002), and M. T. was supported by a Grant-in-Aid for Innovative Areas "RNA regulation" (23112704), from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Hoerndli FJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004880; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Kunitomo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3210; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Oda S, 2011, J NEUROPHYSIOL, V106, P301, DOI 10.1152/jn.01029.2010; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Preuschhof C, 2010, NEUROPSYCHOLOGIA, V48, P402, DOI 10.1016/j.neuropsychologia.2009.09.031; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Samuel ADT, 2003, J NEUROSCI, V23, P373, DOI 10.1523/JNEUROSCI.23-02-00373.2003; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schioth HB, 2012, MOL NEUROBIOL, V46, P4, DOI 10.1007/s12035-011-8229-6; Tomida T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002983; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Vagnoni A, 2011, J CELL SCI, V124, P1032, DOI 10.1242/jcs.075168; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	24	54	57	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					313	317		10.1126/science.1250709	http://dx.doi.org/10.1126/science.1250709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035490				2022-12-24	WOS:000339400700048
J	Stroebel, D; Paoletti, P				Stroebel, David; Paoletti, Pierre			NEUROSCIENCE A structure to remember	NATURE			English	Editorial Material							VOLTAGE-DEPENDENT BLOCK; SUBUNIT ARRANGEMENT; GLUTAMATE-RECEPTOR; NMDA RECEPTORS; DYNAMICS; BINDING; NEURONS; CHANNEL		[Stroebel, David; Paoletti, Pierre] Ecole Normale Super, Inst Biol, CNRS, INSERM,U1024,UMR8197, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Stroebel, D (corresponding author), Ecole Normale Super, Inst Biol, CNRS, INSERM,U1024,UMR8197, F-75005 Paris, France.	david.stroebel@ens.fr; pierre.paoletti@ens.fr	Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845				Burger PB, 2012, MOL PHARMACOL, V82, P344, DOI 10.1124/mol.112.078568; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Dutta A, 2012, STRUCTURE, V20, P1838, DOI 10.1016/j.str.2012.08.012; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Watkins JC, 2006, BRIT J PHARMACOL, V147, pS100, DOI 10.1038/sj.bjp.0706444; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P13, DOI 10.1111/j.1469-7793.1998.013bx.x; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	14	1	2	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					162	163		10.1038/511162a	http://dx.doi.org/10.1038/511162a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008517				2022-12-24	WOS:000338649800031
J	Fonseca-Pereira, D; Arroz-Madeira, S; Rodrigues-Campos, M; Barbosa, IAM; Domingues, RG; Bento, T; Almeida, ARM; Ribeiro, H; Potocnik, AJ; Enomoto, H; Veiga-Fernandes, H				Fonseca-Pereira, Diogo; Arroz-Madeira, Silvia; Rodrigues-Campos, mariana; Barbosa, Ines A. M.; Domingues, Rita G.; Bento, Teresa; Almeida, Afonso R. M.; Ribeiro, Helder; Potocnik, Alexandre J.; Enomoto, Hideki; Veiga-Fernandes, Henrique			The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function	NATURE			English	Article							NERVOUS-SYSTEM; MICE LACKING; FETAL; EXPRESSION; MIGRATION; COMPONENT; KIDNEY; DEATH	Haematopoiesis is a developmental cascade that generates all blood cell lineages in health and disease. This process relies on quiescent haematopoietic stem cells capable of differentiating, self renewing and expanding upon physiological demand(1,2). However, the mechanisms that regulate haematopoietic stem cell homeostasis and function remain largely unknown. Here we show that the neurotrophic factor receptor RET (rearranged during transfection) drives haematopoietic stem cell survival, expansion and function. We find that haematopoietic stem cells express RET and that its neurotrophic factor partners are produced in the haematopoietic stem cell environment. Ablation of Ret leads to impaired survival and reduced numbers of haematopoietic stem cells with normal differentiation potential, but loss of cell-autonomous stress response and reconstitution potential. Strikingly, RET signals provide haematopoietic stem cells with critical Bcl2 and Bcl2l1 surviving cues, downstream of p38 mitogen-activated protein (MAP) kinase and cyclic-AMP-response element binding protein (CREB) activation. Accordingly, enforced expression of RET downstream targets, Bcl2 or Bcl2l1, is sufficient to restore the activity of Ret null progenitors in vivo. Activation of RET results in improved haematopoietic stem cell survival, expansion and in vivo transplantation efficiency. Remarkably, human cord-blood progenitor expansion and transplantation is also improved by neurotrophic factors, opening the way for exploration of RET agonists in human haematopoietic stem cell transplantation. Ourwork shows that neurotrophic factors are novel components of the haematopoietic stem cell microenvironment, revealing that	[Fonseca-Pereira, Diogo; Arroz-Madeira, Silvia; Rodrigues-Campos, mariana; Barbosa, Ines A. M.; Domingues, Rita G.; Bento, Teresa; Almeida, Afonso R. M.; Ribeiro, Helder; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Mol Med, P-1649028 Lisbon, Portugal; [Potocnik, Alexandre J.] MRC Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England; [Potocnik, Alexandre J.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Enomoto, Hideki] RIKEN Ctr Dev Biol, Lab Neuronal Differentiat & Regenerat, Kobe, Hyogo 6500047, Japan; [Enomoto, Hideki] Kobe Univ, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Universidade de Lisboa; MRC National Institute for Medical Research; University of Edinburgh; RIKEN; Kobe University	Veiga-Fernandes, H (corresponding author), Fac Med Lisbon, Inst Mol Med, Ave Prof Egas Moniz,Edif Egas Moniz, P-1649028 Lisbon, Portugal.	jhfernandes@medicina.ulisboa.pt	da Fonseca Pereira, Diogo/O-9894-2019; Fonseca-Pereira, Diogo/U-1275-2018	Fonseca-Pereira, Diogo/0000-0002-7400-9804; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Rodrigues-Campos, Mariana/0000-0002-6116-5613; Ribeiro, Helder/0000-0002-7090-9274; Barbosa, Ines/0000-0001-8977-0930; Potocnik, Alexandre/0000-0002-4730-8593; Almeida, Afonso/0000-0002-4292-8558	Fundacao para a Ciencia e Tecnologia, Portugal; Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-MII/104931/2008]; European Molecular Biology Organisation [1648]; European Research Council [207057]; National Blood Foundation, USA; Medical Research Council [MC_U117565359] Funding Source: researchfish; MRC [MC_U117565359] Funding Source: UKRI	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Molecular Biology Organisation; European Research Council(European Research Council (ERC)European Commission); National Blood Foundation, USA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank I. Monteiro Grillo and the radiotherapy service at Hospital de Santa Maria; H. Ferreira and the service of obstetrics, gynaecology and reproductive medicine at the Hospital of Santa Maria; the Instituto de Medicina Molecular animal facility, flow cytometry unit, bioimaging unit and histology unit for technical assistance. We also thank all members of H.V.-F. laboratory for discussion. D. F.-P., S. A.-M., R. G. D. and A. R. M. A. were supported by scholarships from Fundacao para a Ciencia e Tecnologia, Portugal. H.V.-F. was supported by Fundacao para a Ciencia e Tecnologia (PTDC/SAU-MII/104931/2008), Portugal, the European Molecular Biology Organisation (Project 1648), European Research Council (Project 207057) and National Blood Foundation, USA.	Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Almeida ARM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052949; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Perianayagam MC, 2006, EUR J CLIN INVEST, V36, P353, DOI 10.1111/j.1365-2362.2006.01637.x; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shukla A, 2009, AM J PATHOL, V175, P2197, DOI 10.2353/ajpath.2009.090400; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Uesaka T, 2010, J NEUROSCI, V30, P5211, DOI 10.1523/JNEUROSCI.6244-09.2010; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053	34	71	73	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					98	+		10.1038/nature13498	http://dx.doi.org/10.1038/nature13498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25079320				2022-12-24	WOS:000342420800043
J	Dannappel, M; Vlantis, K; Kumari, S; Polykratis, A; Kim, C; Wachsmuth, L; Eftychi, C; Lin, J; Corona, T; Hermance, N; Zelic, M; Kirsch, P; Basic, M; Bleich, A; Kelliher, M; Pasparakis, M				Dannappel, Marius; Vlantis, Katerina; Kumari, Snehlata; Polykratis, Apostolos; Kim, Chun; Wachsmuth, Laurens; Eftychi, Christina; Lin, Juan; Corona, Teresa; Hermance, Nicole; Zelic, Matija; Kirsch, Petra; Basic, Marijana; Bleich, Andre; Kelliher, Michelle; Pasparakis, Manolis			RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis	NATURE			English	Article							NECROSIS-FACTOR RECEPTOR; KAPPA-B ACTIVATION; IN-VIVO; CELL; MICE; KINASE; DELETION; KERATINOCYTES; INFLAMMATION; DEFICIENT	Necroptosis has emerged as an important pathway of programmed cell death in embryonic development, tissue homeostasis, immunity and inflammation(1-8). RIPK1 is implicated in inflammatory and cell death signalling(9-13) and its kinase activity is believed to drive RIPK3-mediated necroptosis(14,15). Here we show that kinase-independent scaffolding RIPK1 functions regulate homeostasis and prevent inflammation in barrier tissues by inhibiting epithelial cell apoptosis and necroptosis. Intestinal epithelial cell (IEC)-specific RIPK1 knockout caused IEC apoptosis, villus atrophy, loss of goblet and Paneth cells and premature death in mice. This pathology developed independently of the microbiota and of MyD88 signalling but was partly rescued by TNFR1 (also known as TNFRSF1A) deficiency. Epithelial FADD ablation inhibited IEC apoptosis and prevented the premature death of mice with IEC-specific RIPK1 knockout. However, mice lacking both RIPK1 and FADD in IECs displayed RIPK3-dependent IEC necroptosis, Paneth cell loss and focal erosive inflammatory lesions in the colon. Moreover, a RIPK1 kinase inactive knock-in delayed but did not prevent inflammation caused by FADD deficiency in IECs or keratinocytes, showing that RIPK3-dependent necroptosis of FADD-deficient epithelial cells only partly requires RIPK1 kinase activity. Epidermis-specific RIPK1 knockout triggered keratinocyte apoptosis and necroptosis and caused severe skin inflammation that was prevented by RIPK3 but not FADD deficiency. These findings revealed that RIPK1 inhibits RIPK3-mediated necroptosis in keratinocytes in vivo and identified necroptosis as a more potent trigger of inflammation compared with apoptosis. Therefore, RIPK1 is a master regulator of epithelial cell survival, homeostasis and inflammation in the intestine and the skin.	[Dannappel, Marius; Vlantis, Katerina; Kumari, Snehlata; Polykratis, Apostolos; Kim, Chun; Wachsmuth, Laurens; Eftychi, Christina; Lin, Juan; Corona, Teresa; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50931 Cologne, Germany; [Dannappel, Marius; Vlantis, Katerina; Kumari, Snehlata; Polykratis, Apostolos; Kim, Chun; Wachsmuth, Laurens; Eftychi, Christina; Lin, Juan; Corona, Teresa; Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Hermance, Nicole; Zelic, Matija; Kelliher, Michelle] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Kirsch, Petra] Univ Ulm, Tierforschungszentrum, D-89081 Ulm, Germany; [Basic, Marijana; Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, D-30625 Hannover, Germany	University of Cologne; University of Cologne; University of Massachusetts System; University of Massachusetts Worcester; Ulm University; Hannover Medical School	Pasparakis, M (corresponding author), Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50931 Cologne, Germany.	pasparakis@uni-koeln.de	Kumari, Snehlata/ABA-5739-2020; Corona, Teresa/AAU-8333-2021; Eftychi, Christina/AAB-1135-2020; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017	Kumari, Snehlata/0000-0002-4971-3162; Corona, Teresa/0000-0002-9324-229X; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Polykratis, Apostolos/0000-0001-6720-3302; Wachsmuth, Laurens/0000-0003-1701-9384; Kim, Chun/0000-0001-9497-708X	European Research Council [2012-ADG_20120314]; German Research Council (DFG) [SFB670, SFB829, SPP1656]; European Commission [223404, 223151]; Deutsche Krebshilfe; Else Kroner-Fresenius-Stiftung; Helmholtz Alliance (PCCC); National Institute of Allergy and Infectious Diseases division of the National Institutes of Health [RO1AI075118]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095213, R01AI075118] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); German Research Council (DFG)(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Krebshilfe(Deutsche Krebshilfe); Else Kroner-Fresenius-Stiftung; Helmholtz Alliance (PCCC); National Institute of Allergy and Infectious Diseases division of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to V. Dixit for Ripk3<SUP>-/-</SUP>, D. Gumucio for Villin-Cre and S. Robine for Villin-CreER<SUP>T2</SUP> mice. We thank C. Uthoff-Hachenberg, J. Buchholz, E. Mahlberg, B. Kuhnel, B. Hulser, P. Jankowski, S. Assenmacher and P. Scholl for technical assistance. M. P. acknowledges funding from the European Research Council (2012-ADG_20120314), the German Research Council (DFG; SFB670, SFB829, SPP1656), the European Commission (grants 223404 (Masterswitch) and 223151 (InflaCare)), the Deutsche Krebshilfe, the Else Kroner-Fresenius-Stiftung and the Helmholtz Alliance (PCCC). Research reported in this publication was also supported by the National Institute of Allergy and Infectious Diseases division of the National Institutes of Health under award RO1AI075118 to M.K.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kim JY, 2011, J CELL SCI, V124, P647, DOI 10.1242/jcs.075770; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kumari S, 2013, IMMUNITY, V39, P899, DOI 10.1016/j.immuni.2013.10.009; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mc Guire C, 2010, J IMMUNOL, V185, P7646, DOI 10.4049/jimmunol.1000930; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Piao JH, 2011, J BIOL CHEM, V286, P17879, DOI 10.1074/jbc.M111.221853; Polykratis A, 2014, J IMMUNOL; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Snippert HJ, 2011, NAT PROTOC, V6, P1221, DOI 10.1038/nprot.2011.365; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vlantis K, 2011, J CLIN INVEST, V121, P2781, DOI 10.1172/JCI45349; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	47	355	362	4	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					90	+		10.1038/nature13608	http://dx.doi.org/10.1038/nature13608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25132550	Green Accepted			2022-12-24	WOS:000341174800036
J	Annas, GJ; Ruger, TW; Ruger, JP				Annas, George J.; Ruger, Theodore W.; Ruger, Jennifer Prah			Money, Sex, and Religion - The Supreme Court's ACA Sequel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE		[Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA; [Ruger, Theodore W.] Univ Penn, Sch Law, Philadelphia, PA 19104 USA; [Ruger, Jennifer Prah] Perelman Sch Med, Philadelphia, PA USA; [Ruger, Jennifer Prah] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Boston University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.							Annas GJ, 2009, NEW ENGL J MED, V361, P2589, DOI 10.1056/NEJMp0911513; [Anonymous], 2014, NEW YORK TIMES, pA16; [Anonymous], 2011, COMMITTEE ON PREVENT, P102; [Anonymous], BIRTH CONTROL MEDICI; [Anonymous], 2014, WALL STREET JOURNAL, pA12; Cohen IG, 2014, NEW ENGL J MED, V371, P596, DOI 10.1056/NEJMp1407965; Long H., 2014, HOBBY LOBBY DOES INV; Mariner WK, 2012, NEW ENGL J MED, V367, P1154, DOI 10.1056/NEJMhle1208437; Mariner WK, 2014, HOBBY LOBBY PART 2 D; Ruger JP, 2012, NEW ENGL J MED, V366, P681, DOI 10.1056/NEJMp1200751; Ruger JP, 2009, HEALTH AND SOCIAL JU	11	8	8	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					862	866		10.1056/NEJMhle1408081	http://dx.doi.org/10.1056/NEJMhle1408081			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZN	25029337	Green Published, Green Submitted			2022-12-24	WOS:000340819800014
J	Orlando, L; Willerslev, E				Orlando, Ludovic; Willerslev, Eske			An epigenetic window into the past?	SCIENCE			English	Editorial Material							GENOME SEQUENCE; METHYLATION; DNA; NEANDERTHAL; PATTERNS		[Orlando, Ludovic; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark	University of Copenhagen	Orlando, L (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.	lorlando@snm.ku.dk	Willerslev, Eske/A-9619-2011; Orlando, Ludovic/A-8932-2013; Willerslev, Eske/AAA-5686-2019	Willerslev, Eske/0000-0002-7081-6748; Orlando, Ludovic/0000-0003-3936-1850; 				Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Gokhman D, 2014, SCIENCE, V344, P523, DOI 10.1126/science.1250368; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Llamas B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030226; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Shim J, 2013, SCI REP-UK, V3, DOI [10.1038/srep01389, 10.1038/srep02325]; Smith O, 2014, SCI REP-UK, V4, DOI 10.1038/srep05559; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353	15	25	25	4	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					511	512		10.1126/science.1256515	http://dx.doi.org/10.1126/science.1256515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM2AU	25082684				2022-12-24	WOS:000339651300022
J	Gonzalez, A; Vazquez-Baeza, Y; Knight, R				Gonzalez, Antonio; Vazquez-Baeza, Yoshiki; Knight, Rob			SnapShot: The Human Microbiome	CELL			English	Editorial Material							GUT MICROBIOME		[Gonzalez, Antonio; Knight, Rob] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Vazquez-Baeza, Yoshiki] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Gonzalez, A (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.		Gonzalez, Antonio/A-6421-2018; Vazquez-Baeza, Yoshiki/HCI-4852-2022; Knight, Rob/D-1299-2010	Vazquez-Baeza, Yoshiki/0000-0001-6014-2009; Knight, Rob/0000-0002-0975-9019	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	8	15	17	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					690	U250		10.1016/j.cell.2014.07.019	http://dx.doi.org/10.1016/j.cell.2014.07.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083877	Bronze			2022-12-24	WOS:000340944300020
J	Cohen, IG; Feigenbaum, J; Adashi, EY				Cohen, I. Glenn; Feigenbaum, Jeremy; Adashi, Eli Y.			Reconsideration of the Lifetime Ban on Blood Donation by Men Who Have Sex With Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cohen, I. Glenn; Feigenbaum, Jeremy] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Cohen, I. Glenn] Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	Harvard University; Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						American Medical Association, 2013, AMA OPPOSES LIFETIME; [Anonymous], 2013, COMMUNICATION, P2; [Anonymous], 2013, BLOOD DONATIONS FROM; Suligoil B, 2013, BLOOD TRANSFUS-ITALY, V11, P441, DOI 10.2450/2013.0162-12; US Department of Health and Human Services, 2013, FORTY FOURTH MEETING; US Department of Health and Human Services, 1992, REVISED RECOMMENDATI; US Department of Health and Human Services, 2010, ADVISORY COMMITTEE O	7	15	15	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					337	338		10.1001/jama.2014.8037	http://dx.doi.org/10.1001/jama.2014.8037			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038346				2022-12-24	WOS:000339257800014
J	Orritt, R				Orritt, Rachel			PERSONAL VIEW Dog ownership has unknown risks but known health benefits: we need evidence based policy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BITES; ATTACKS		Lincoln Univ, Sch Psychol, Lincoln LN6 7TS, England	University of Lincoln	Orritt, R (corresponding author), Lincoln Univ, Sch Psychol, Lincoln LN6 7TS, England.	rorritt@lincoln.ac.uk		Orritt, Rachel/0000-0001-8396-7679				Besser R, 2007, BRIT MED J, V334, P425, DOI 10.1136/bmj.39129.471505.94; Christian HE, 2013, J PHYS ACT HEALTH, V10, P750, DOI 10.1123/jpah.10.5.750; Douglas K.S., 1999, LEGAL CRIMINOL PSYCH, V4, P149, DOI [https://doi.org/10.1348/135532599167824, DOI 10.1348/135532599167824]; Headey B, 1999, SOC INDIC RES, V47, P233, DOI 10.1023/A:1006892908532; HSCIC, 2012, HOSP STAT ADM PAT CA; Klaassen B, 1996, INJURY, V27, P89, DOI 10.1016/0020-1383(96)83411-5; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; Morgan M, 2007, BMJ-BRIT MED J, V334, P413, DOI 10.1136/bmj.39105.659919.BE; THOMAS HF, 1990, J ROY SOC HEALTH, V110, P173, DOI 10.1177/146642409011000508; Wells DL, 2007, BRIT J HEALTH PSYCH, V12, P145, DOI 10.1348/135910706X103284	10	6	6	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2014	349								g4081	10.1136/bmj.g4081	http://dx.doi.org/10.1136/bmj.g4081			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL7PI	25034209	Green Submitted			2022-12-24	WOS:000339326400002
J	Beaglehole, R; Bonita, R; Ezzati, M; Alleyne, G; Dain, K; Kishore, SP; Horton, R				Beaglehole, Robert; Bonita, Ruth; Ezzati, Majid; Alleyne, George; Dain, Katie; Kishore, Sandeep P.; Horton, Richard			NCD Countdown 2025: accountability for the 25 x 25 NCD mortality reduction target	LANCET			English	Editorial Material							NONCOMMUNICABLE DISEASES		[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC,PHE Ctr Environm & Hlth, London, England; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Dain, Katie] NCD Alliance, London, England; [Kishore, Sandeep P.] Young Profess Chron Dis Network, New Haven, CT USA; [Horton, Richard] The Lancet, London NW1 7BY, England	University of Auckland; Imperial College London; Pan American Health Organization	Beaglehole, R (corresponding author), 42 Albert Rd, Auckland 0624, New Zealand.	r.beaglehole@auckland.ac.nz			MRC [G0801056] Funding Source: UKRI; Medical Research Council [G0801056] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2014, LANCET; Beaglehole R, 2013, LANCET, V381, P602, DOI 10.1016/S0140-6736(13)60101-4; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Healthy Caribbean Coalition, 2014, RESP NCDS CAR COMM; Requejo JH, 2014, LANCET; Smith R, 2014, LANCET, V383, P1446, DOI 10.1016/S0140-6736(13)61808-5; The NCD Alliance, 2013, NONC DIS JOINT FIGHT; UN Secretary General, 2014, POST 2015 ACC SYST M; UNICEF, 2014, TRANSMONEE 2014 GUID; WHO, 2010, GLOB STAT REP NONC D; World Health Organization, 2013, GLOB ACT PLAN PREV C	11	42	45	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 12	2014	384	9938					105	107		10.1016/S0140-6736(14)61091-6	http://dx.doi.org/10.1016/S0140-6736(14)61091-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL1YC	25012115				2022-12-24	WOS:000338921500008
J	Kass, N				Kass, Nancy			Ebola, Ethics, and Public Health: What Next?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA	Johns Hopkins University	Kass, N (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, 1809 Ashland Ave, Baltimore, MD 21205 USA.	nkass@jhu.edu						[Anonymous], 1871, J BR ARCHAEOL ASSOC, V27, P255; Ezeome ER, 2010, DEV WORLD BIOETH, V10, P1, DOI 10.1111/j.1471-8847.2008.00239.x; Fatima K, 2013, J INFECT DEV COUNTR, V7, P897, DOI 10.3855/jidc.3647; Loria K, 2014, HERES EVERYTHING WE; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Mapp Biopharmaceutical, 2014, ZMAPP INF SHEET; Page-Shafer K, 2005, LANCET, V366, P1499, DOI 10.1016/S0140-6736(05)67146-2; U.S. Food and Drug Administration, 2013, FIN RUL EXP ACC INV; WHO, 2014, EB VIR DIS; World Health Organization, 2014, WHO CONV ETH REV EXP	10	23	24	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					744	U196		10.7326/M14-1864	http://dx.doi.org/10.7326/M14-1864			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25133473				2022-12-24	WOS:000347245600033
J	Kaukua, N; Shahidi, MK; Konstantinidou, C; Dyachuk, V; Kaucka, M; Furlan, A; An, ZW; Wang, LL; Hultman, I; Ahrlund-Richter, L; Blom, H; Brismar, H; Lopes, NA; Pachnis, V; Suter, U; Clevers, H; Thesleff, I; Sharpe, P; Ernfors, P; Fried, K; Adameyko, I				Kaukua, Nina; Shahidi, Maryam Khatibi; Konstantinidou, Chrysoula; Dyachuk, Vyacheslav; Kaucka, Marketa; Furlan, Alessandro; An, Zhengwen; Wang, Longlong; Hultman, Isabell; Ahrlund-Richter, Larsa; Blom, Hans; Brismar, Hjalmar; Lopes, Natalia Assaife; Pachnis, Vassilis; Suter, Ueli; Clevers, Hans; Thesleff, Irma; Sharpe, Paul; Ernfors, Patrik; Fried, Kaj; Adameyko, Igor			Glial origin of mesenchymal stem cells in a tooth model system	NATURE			English	Article							CRANIAL NEURAL CREST; REGENERATION; HOMEOSTASIS; GENERATION; MICE	Mesenchymal stem cells occupy niches in stromal tissues where they provide sources of cells for specialized mesenchymal derivatives during growth and repair(1). The origins of mesenchymal stem cells have been the subject of considerable discussion, and current consensus holds that perivascular cells form mesenchymal stem cells in most tissues. The continuously growing mouse incisor tooth offers an excellent model to address the origin of mesenchymal stem cells. These stem cells dwell in a niche at the tooth apex where they produce a variety of differentiated derivatives. Cells constituting the tooth are mostly derived from two embryonic sources: neural crest ectomesenchyme and ectodermal epithelium(2). It has been thought for decades that the dental mesenchymal stem cells(3) giving rise to pulp cells and odontoblasts derive from neural crest cells after their migration in the early head and formation of ectomesenchymal tissue(4,5). Here we show that a significant population of mesenchymal stem cells during development, self-renewal and repair of a tooth are derived from peripheral nerve-associated glia. Glial cells generate multipotent mesenchymal stem cells that produce pulp cells and odontoblasts. By combining a clonal colour-coding technique(6) with tracing of peripheral glia, we provide new insights into the dynamics of tooth organogenesis and growth.	[Kaukua, Nina; Fried, Kaj] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Konstantinidou, Chrysoula; Pachnis, Vassilis] Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England; [Dyachuk, Vyacheslav; Kaucka, Marketa; Adameyko, Igor] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Dyachuk, Vyacheslav] Russian Acad Sci, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690041, Russia; [Furlan, Alessandro; Lopes, Natalia Assaife; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, S-17177 Stockholm, Sweden; [An, Zhengwen; Wang, Longlong; Sharpe, Paul] Guys Hosp, Inst Dent, Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London SE1 3QD, England; [Hultman, Isabell; Ahrlund-Richter, Larsa] Karolinska Inst, Dept Womens & Childrens Hlth, S-17177 Stockholm, Sweden; [Blom, Hans; Brismar, Hjalmar] Royal Inst Technol, Sci Life Lab, S-17177 Stockholm, Sweden; [Suter, Ueli] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, CH-8093 Zurich, Switzerland; [Clevers, Hans] Koninklijke Nederlandse Akad Wetenschappen KNAW, Hubrecht Inst, NL-3508 AD Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Dept Mol Genet, NL-3508 GA Utrecht, Netherlands; [Clevers, Hans] Univ Helsinki, Dev Biol Program, Inst Biotechnol, FI-00014 Helsinki, Finland	Karolinska Institutet; MRC National Institute for Medical Research; Karolinska Institutet; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Karolinska Institutet; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Karolinska Institutet; Royal Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Helsinki	Adameyko, I (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	Kaj.Fried@ki.se; Igor.Adameyko@ki.se	Suter, Ueli/A-1624-2010; An, Zhengwen/HGE-7458-2022; Furlan, Alessandro/AAM-4680-2021; Kaucka, Marketa/AAG-2000-2021; Dyachuk, Vyacheslav/U-9115-2019; Brismar, Hjalmar/E-8524-2011	An, Zhengwen/0000-0003-0360-7388; Furlan, Alessandro/0000-0001-5149-6331; Kaucka, Marketa/0000-0002-8781-9769; Dyachuk, Vyacheslav/0000-0001-8100-7367; Brismar, Hjalmar/0000-0003-0578-4003; Pachnis, Vassilis/0000-0001-9733-7686; Sharpe, Paul/0000-0003-2116-9561; Adameyko, Igor/0000-0001-5471-0356	Swedish Research Council; Bertil Hallsten Research Foundation; StratRegen; Wallenberg Foundation; Swiss National Science Foundation; Medical Research Council [G0901599]; Wallenberg Scholar and European Research Council; National Graduate School in Odontological Science; Swedish Dental Association; EMBO Long-Term Fellowship; Stockholm County Council; Developmental Studies Hybridoma Bank; MRC [MC_U117537087, G0901599, MR/K018035/1] Funding Source: UKRI; Medical Research Council [MR/K018035/1, MC_U117537087] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Bertil Hallsten Research Foundation; StratRegen; Wallenberg Foundation(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wallenberg Scholar and European Research Council; National Graduate School in Odontological Science; Swedish Dental Association; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Stockholm County Council(Stockholm County Council); Developmental Studies Hybridoma Bank; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	P. Kovaleva and O. Rogachevskaya helped with illustrations. This study was supported by the Swedish Research Council (I. A., K. F., P. E.), The Bertil Hallsten Research Foundation (I. A.), StratRegen and the Wallenberg Foundation (CLICK, I. A.), the Swiss National Science Foundation (U.S.), Medical Research Council (G0901599; P. S.), a Wallenberg Scholar and European Research Council advanced grant (P. E.), National Graduate School in Odontological Science (M. K. S.), the Swedish Dental Association(N.K., M. K. S.), an EMBO Long-Term Fellowship(M. K.) and Stockholm County Council (N.K.) and Developmental Studies Hybridoma Bank.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Adameyko I, 2010, CELL MOL LIFE SCI, V67, P3037, DOI 10.1007/s00018-010-0390-y; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Caton J, 2009, J ANAT, V214, P502, DOI 10.1111/j.1469-7580.2008.01014.x; Chung IH, 2009, STEM CELLS, V27, P866, DOI 10.1002/stem.2; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Dewachter I, 2002, J NEUROSCI, V22, P3445; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; Hari L, 2012, DEVELOPMENT, V139, P2107, DOI 10.1242/dev.073064; Jinno H, 2010, STEM CELLS, V28, P2027, DOI 10.1002/stem.525; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Koussoulakou DS, 2009, INT J BIOL SCI, V5, P226; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Luukko K, 2008, ANN ANAT, V190, P178, DOI 10.1016/j.aanat.2007.10.003; Miletich Isabelle, 2004, Birth Defects Res C Embryo Today, V72, P200, DOI 10.1002/bdrc.20012; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013	18	267	275	4	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					551	+		10.1038/nature13536	http://dx.doi.org/10.1038/nature13536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25079316				2022-12-24	WOS:000342075800041
J	Tan, K; Petrie, KJ; Faasse, K; Bolland, MJ; Grey, A				Tan, Kirin; Petrie, Keith J.; Faasse, Kate; Bolland, Mark J.; Grey, Andrew			Unhelpful information about adverse drug reactions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACEBO GROUPS; MEDICATION; TRIALS; THERAPY; EVENTS; HARMS; ALENDRONATE; BENEFITS; WOMEN		[Tan, Kirin; Bolland, Mark J.; Grey, Andrew] Univ Auckland, Dept Med, Auckland, New Zealand; [Petrie, Keith J.; Faasse, Kate] Univ Auckland, Auckland 1, New Zealand	University of Auckland; University of Auckland	Grey, A (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland, New Zealand.	a.grey@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674; tan, kirin/0000-0003-3842-6093				Amanzio M, 2009, PAIN, V146, P261, DOI 10.1016/j.pain.2009.07.010; Barron AJ, 2013, INT J CARDIOL, V168, P3572, DOI 10.1016/j.ijcard.2013.05.068; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Berry DC, 2002, LANCET, V359, P853, DOI 10.1016/S0140-6736(02)07923-0; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Colloca L, 2012, JAMA-J AM MED ASSOC, V307, P567, DOI 10.1001/jama.2012.115; Compston JE, 2006, LANCET, V368, P973, DOI 10.1016/S0140-6736(06)69394-X; de Langen J, 2008, DRUG SAFETY, V31, P515, DOI 10.2165/00002018-200831060-00006; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Faasse K, 2013, POSTGRAD MED J, V89, P540, DOI 10.1136/postgradmedj-2012-131730; Finegold JA, 2014, EUR J PREV CARDIOL, V21, P464, DOI 10.1177/2047487314525531; Fried TR, 2011, ARCH INTERN MED, V171, P923, DOI 10.1001/archinternmed.2011.32; Goh SK, 2007, J BONE JOINT SURG BR, V89B, P349, DOI 10.1302/0301-620X.89B3.18146; Grimes DA, 2011, CONTRACEPTION, V83, P5, DOI 10.1016/j.contraception.2010.06.010; Horne R, 2013, BRIT J HEALTH PSYCH, V18, P18, DOI 10.1111/j.2044-8287.2012.02071.x; Ioannidis JPA, 2009, ARCH INTERN MED, V169, P1737, DOI 10.1001/archinternmed.2009.313; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Joy TR, 2014, ANN INTERN MED, V160, P301, DOI 10.7326/M13-1921; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Ko DT, 2002, JAMA-J AM MED ASSOC, V288, P351, DOI 10.1001/jama.288.3.351; Law MR, 2011, ANN PHARMACOTHER, V45, P350, DOI 10.1345/aph.1P572; Mondaini N, 2007, J SEX MED, V4, P1708, DOI 10.1111/j.1743-6109.2007.00563.x; MYERS MG, 1987, CLIN PHARMACOL THER, V42, P250, DOI 10.1038/clpt.1987.142; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Petrie KJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005374; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rief W, 2006, ARCH INTERN MED, V166, P155, DOI 10.1001/archinte.166.2.155; Rief W, 2009, DRUG SAFETY, V32, P1041, DOI 10.2165/11316580-000000000-00000; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Tosteson ANA, 2003, AM J MED, V115, P209, DOI 10.1016/S0002-9343(03)00362-0; Wells RE, 2012, AM J BIOETHICS, V12, P22, DOI 10.1080/15265161.2011.652798; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738; Zorzela L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7668	33	35	35	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2014	349								g5019	10.1136/bmj.g5019	http://dx.doi.org/10.1136/bmj.g5019			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RR	25115975				2022-12-24	WOS:000340506700005
J	Haines, A; Whitmee, S; Horton, R				Haines, Andy; Whitmee, Sarah; Horton, Richard			Planetary health: a call for papers	LANCET			English	Editorial Material							CO2		[Haines, Andy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Haines, Andy] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Whitmee, Sarah] UCL, Ctr Biodivers & Environm Res, Dept Genet Evolut & Environm, Div Biosci, London WC1E 6BT, England; [Horton, Richard] Lancet, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Whitmee, S (corresponding author), UCL, Ctr Biodivers & Environm Res, Dept Genet Evolut & Environm, Div Biosci, London WC1E 6BT, England.	s.whitmee@ucl.ac.uk		Whitmee, Sarah/0000-0001-9161-868X; Haines, Andy/0000-0002-8053-4605				Dunne JP, 2013, NAT CLIM CHANGE, V3, P563, DOI 10.1038/NCLIMATE1827; Horton R, 2014, LANCET, V384, P218, DOI 10.1016/S0140-6736(14)61178-8; Horton R, 2014, LANCET, V383, P847, DOI 10.1016/S0140-6736(14)60409-8; Knox J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034032; Myers SS, 2014, NATURE, V510, P139, DOI 10.1038/nature13179; Sanders D, 2006, PLOS MED, V3, P719, DOI 10.1371/journal.pmed.0030186; Taub DR, 2008, GLOBAL CHANGE BIOL, V14, P565, DOI 10.1111/j.1365-2486.2007.01511.x	7	3	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					479	480		10.1016/S0140-6736(14)61289-7	http://dx.doi.org/10.1016/S0140-6736(14)61289-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9JR	25110268				2022-12-24	WOS:000340198300009
J	Furyk, JS; Meek, R; McKenzie, S				Furyk, Jeremy S.; Meek, Robert; McKenzie, Suzanne			THERAPEUTICS Drug treatment of adults with nausea and vomiting in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EMERGENCY-DEPARTMENT; DOUBLE-BLIND; METOCLOPRAMIDE; ONDANSETRON; PROMETHAZINE; MANAGEMENT; TRIAL	This is one of a series of occasional articles on therapeutics for common or serious conditions, covering new drugs and old drugs with important new indications or concerns. The series advisers are Robin Ferner, honorary professor of clinical pharmacology, University of Birmingham and Birmingham City Hospital, and Albert Ferro, professor of cardiovascular clinical pharmacology, King's College London. To suggest a topic, please email us at practice@bmj.com.	[Furyk, Jeremy S.] Townsville Hosp, Townsville, Qld 4810, Australia; [Furyk, Jeremy S.; Meek, Robert] James Cook Univ, Townsville, Qld 4811, Australia; [Meek, Robert; McKenzie, Suzanne] Monash Hlth, Melbourne, Vic, Australia; [McKenzie, Suzanne] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	James Cook University; University of New South Wales Sydney	Furyk, JS (corresponding author), Townsville Hosp, Angus Smith Dr, Townsville, Qld 4810, Australia.	Jeremy.Furyk@health.qld.gov.au		Furyk, Jeremy/0000-0002-9503-0928				American Gastroenterological Association, 2001, Gastroenterology, V120, P261; Australian Government Department of Health, 2013, PHARM BEN SCHEM; Australian Government Department of Health Therapeutic Goods Administration, 2014, SEARCH RES; Barrett TW, 2011, AM J EMERG MED, V29, P247, DOI 10.1016/j.ajem.2009.09.028; Billio A, 2010, COCHRANE DB SYST REV, V1; Braude D, 2006, AM J EMERG MED, V24, P177, DOI 10.1016/j.ajem.2005.08.017; Braude D, 2008, ACAD EMERG MED, V15, P209, DOI 10.1111/j.1553-2712.2008.00060.x; British National Formulary, 2014, BRIT NATL FORMULARY; Carlisle JB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004125.pub2; CARPENTER DO, 1990, CAN J PHYSIOL PHARM, V68, P230, DOI 10.1139/y90-036; Chae J, 2011, EMERG MED AUSTRALAS, V23, P554, DOI 10.1111/j.1742-6723.2011.01444.x; Cham Swee, 2004, Emerg Med Australas, V16, P208, DOI 10.1111/j.1742-6723.2004.00588.x; Colman I, 2004, BMJ-BRIT MED J, V329, P1369, DOI 10.1136/bmj.38281.595718.7C; Egerton-Warburton D, 2014, ANN EMERG MED; Ernst AA, 2000, ANN EMERG MED, V36, P89, DOI 10.1067/mem.2000.108652; European Medicines Agency, 2014, CMDH CONF REC RESTR; Fedorowicz Z, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005506.pub5; Friedman BW, 2009, ANN EMERG MED, V53, P379, DOI 10.1016/j.annemergmed.2008.08.003; Fullerton L, 2012, PREHOSP EMERG CARE, V16, P463, DOI 10.3109/10903127.2012.695430; Jarvis S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3606; LaValley J, 2003, ACAD EMERG MED, V10, P461; Mathews A, 2010, COCHRANE DB SYST REV, V9; Mee MJ, 2011, EMERG MED AUSTRALAS, V23, P162, DOI 10.1111/j.1742-6723.2011.01386.x; Meek R, 2009, ACAD EMERG MED, V16, P1304, DOI 10.1111/j.1553-2712.2009.00581.x; NHS Choices, 2013, MED A Z; Pasternak B, 2013, NEW ENGL J MED, V368, P814, DOI 10.1056/NEJMoa1211035; Quigley EMM, 2001, GASTROENTEROLOGY, V120, P263, DOI 10.1053/gast.2001.20516; Salvucci AA, 2011, PREHOSP EMERG CARE, V15, P34, DOI 10.3109/10903127.2010.519822; Spevak C, 2012, PAIN MED, V13, P1072, DOI 10.1111/j.1526-4637.2012.01406.x; Spinks A., 2011, COCHRANE DB SYST REV, V6, P1	30	4	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2014	349								g4714	10.1136/bmj.g4714	http://dx.doi.org/10.1136/bmj.g4714			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MR	25103458				2022-12-24	WOS:000340206200001
J	Press, MJ				Press, Matthew J.			Instant Replay - A Quarterback's View of Care Coordination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Press, Matthew J.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10021 USA; [Press, Matthew J.] Weill Cornell Med Coll, Dept Med, New York, NY USA	Cornell University; Cornell University	Press, MJ (corresponding author), Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10021 USA.							Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Hinds PJ, 2003, ORGAN SCI, V14, P615, DOI 10.1287/orsc.14.6.615.24872; Press MJ, 2012, AM J MANAG CARE, V18, P778; Stavert RR, 2013, NEW ENGL J MED, V368, P8, DOI 10.1056/NEJMp1210501; 2007, IMPROVING AM HOSP JO	5	44	44	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					489	491		10.1056/NEJMp1406033	http://dx.doi.org/10.1056/NEJMp1406033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM5LE	25099572				2022-12-24	WOS:000339899100001
J	Crump, C				Crump, Casey			Medical history taking in adults should include questions about preterm birth	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH BEHAVIORS; YOUNG ADULTHOOD; GESTATIONAL-AGE; PREMATURE BIRTH; MORTALITY; DISEASE; WOMEN; MEN		Stanford Univ, Dept Med, Palo Alto, CA 94304 USA	Stanford University	Crump, C (corresponding author), Stanford Univ, Dept Med, Palo Alto, CA 94304 USA.	kccrump@stanford.edu	Crump, Casey/AAO-8802-2021	Crump, Casey/0000-0002-2990-1166				Adegboye ARA, 2008, BJOG-INT J OBSTET GY, V115, P886, DOI 10.1111/j.1471-0528.2008.01717.x; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bolton CE, 2012, THORAX, V67, P1110, DOI 10.1136/thoraxjnl-2012-202637; Crump C, 2013, EPIDEMIOLOGY, V24, P270, DOI 10.1097/EDE.0b013e318280da0f; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Wilson BJ, 2009, ANN INTERN MED, V151, P878, DOI [10.7326/0000605-200912150-00177, 10.7326/0003-4819-151-12-200912150-00177]	12	28	30	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2014	349								g4860	10.1136/bmj.g4860	http://dx.doi.org/10.1136/bmj.g4860			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5OF	25085466				2022-12-24	WOS:000339909000002
J	Walz, S; Lorenzin, F; Morton, J; Wiese, KE; von Eyss, B; Herold, S; Rycak, L; Dumay-Odelot, H; Karim, S; Bartkuhn, M; Roels, F; Wustefeld, T; Fischer, M; Teichmann, M; Zender, L; Wei, CL; Sansom, O; Wolf, E; Eilers, M				Walz, Susanne; Lorenzin, Francesca; Morton, Jennifer; Wiese, Katrin E.; von Eyss, Bjoern; Herold, Steffi; Rycak, Lukas; Dumay-Odelot, Helene; Karim, Saadia; Bartkuhn, Marek; Roels, Frederik; Wuestefeld, Torsten; Fischer, Matthias; Teichmann, Martin; Zender, Lars; Wei, Chia-Lin; Sansom, Owen; Wolf, Elmar; Eilers, Martin			Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles	NATURE			English	Article							C-MYC; TRANSCRIPTION; PROMOTER; BINDING; GENOME; DNA; ASSOCIATION; INTEGRATION; INDUCTION; CELLS	In mammalian cells, the MYC oncoprotein binds to thousands of promoters(1-4). During mitogenic stimulation of primary lymphocytes, MYC promotes an increase in the expression of virtually all genes(1). In contrast, MYC-driven tumour cells differ from normal cells in the expression of specific sets of up-and downregulated genes that have considerable prognostic value(5-7). To understand this discrepancy, we studied the consequences of inducible expression and depletion of MYC in human cells and murine tumour models. Changes in MYC levels activate and repress specific sets of direct target genes that are characteristic of MYC-transformed tumour cells. Three factors account for this specificity. First, the magnitude of response parallels the change in occupancy by MYC at each promoter. Functionally distinct classes of target genes differ in the E-box sequence bound by MYC, suggesting that different cellular responses to physiological and oncogenic MYC levels are controlled by promoter affinity. Second, MYC both positively and negatively affects transcription initiation independent of its effect on transcriptional elongation(8). Third, complex formation with MIZ1 (also known as ZBTB17)(9) mediates repression of multiple target genes by MYC and the ratio of MYC and MIZ1 bound to each promoter correlates with the direction of response.	[Walz, Susanne; Lorenzin, Francesca; Wiese, Katrin E.; von Eyss, Bjoern; Herold, Steffi; Wolf, Elmar; Eilers, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Morton, Jennifer; Karim, Saadia; Sansom, Owen] CRUK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Rycak, Lukas] Inst Mol Biol & Tumor Res IMT, D-35033 Marburg, Germany; [Dumay-Odelot, Helene; Teichmann, Martin] Univ Bordeaux, IECB, ARNA Lab, Equipe Labellisee Canc, F-33600 Pessac, France; [Bartkuhn, Marek] Univ Giessen, Inst Genet, D-35390 Giessen, Germany; [Roels, Frederik; Fischer, Matthias] Univ Cologne, Univ Childrens Hosp Cologne, D-50924 Cologne, Germany; [Roels, Frederik; Fischer, Matthias] Univ Cologne, Cologne Ctr Mol Med CMMC, D-50924 Cologne, Germany; [Wuestefeld, Torsten; Zender, Lars] Univ Tubingen Hosp, Div Translat Gastrointestinal Oncol, Dept Internal Med 1, D-72076 Tubingen, Germany; [Zender, Lars] German Canc Res Ctr, German Ctr Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, D-69121 Heidelberg, Germany; [Wei, Chia-Lin] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Wolf, Elmar] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Eilers, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97080 Wurzburg, Germany	University of Wurzburg; Beatson Institute; UDICE-French Research Universities; Universite de Bordeaux; Justus Liebig University Giessen; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); United States Department of Energy (DOE); German Research Foundation (DFG); University of Wurzburg; University of Wurzburg	Eilers, M (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, Hubland, D-97074 Wurzburg, Germany.	elmar.wolf@biozentrum.uni-wuerzburg.de; martin.eilers@biozentrum.uni-wuerzburg.de	Morton, Jennifer/AAJ-5113-2021; von Eyss, Bjoern/P-1077-2019; Wolf, Elmar/AAY-8493-2021; Morton, Jennifer P/E-1633-2011; DUMAY-ODELOT, Hélène/M-7751-2014; Teichmann, Martin/M-7407-2014	Morton, Jennifer/0000-0001-5766-9141; von Eyss, Bjoern/0000-0002-4731-6841; Wolf, Elmar/0000-0002-5299-6335; Morton, Jennifer P/0000-0001-5766-9141; DUMAY-ODELOT, Helene/0000-0002-7245-084X; Wiese, Katrin Evelyn/0000-0002-1603-2846; Teichmann, Martin/0000-0002-5257-0510; Bartkuhn, Marek/0000-0001-6872-9082; Sansom, Owen J./0000-0001-9540-3010; Eilers, Martin/0000-0002-0376-6533	Deutsche Forschungsgemeinschaft (DFG) [222/5-3, 222/12-1]; graduate college 1048 ("Molecular basis of organ development in vertebrates''); DFG Research Center for Experimental Biomedicine; Institut National Du Cancer (INCa); Ligue National Contre le Cancer (Equipe Labellisee); Cancer Research UK core grant; European Research Council investigator grant, "Coloncan''; Cancer Research UK [12481] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); graduate college 1048 ("Molecular basis of organ development in vertebrates''); DFG Research Center for Experimental Biomedicine(German Research Foundation (DFG)); Institut National Du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue National Contre le Cancer (Equipe Labellisee); Cancer Research UK core grant; European Research Council investigator grant, "Coloncan''; Cancer Research UK(Cancer Research UK)	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) through grants 222/5-3 and 222/12-1 (to M.E.), by a stipend of the graduate college 1048 ("Molecular basis of organ development in vertebrates'' to S.W.) and through the DFG Research Center for Experimental Biomedicine (to E.W.). M. T. was supported by grants from the Institut National Du Cancer (INCa) and by the Ligue National Contre le Cancer (Equipe Labellisee). O.S. and J.M. are funded by a Cancer Research UK core grant and a European Research Council investigator grant, "Coloncan''. We thank Y. L. Lee and T. Poh for help with ChIP-sequencing, F. Finkernagel for help with the bioinformatic analysis, A. Au for help with mouse experiments, B. Luscher for critical reading of the manuscript and D. Levens for providing data before publication.	Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Boyd KE, 1997, MOL CELL BIOL, V17, P2529, DOI 10.1128/MCB.17.5.2529; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Wiese KE, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014290; Wolf E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3535; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	38	305	312	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					483	+		10.1038/nature13473	http://dx.doi.org/10.1038/nature13473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043018	Green Accepted			2022-12-24	WOS:000339335700050
J	Jorgensen, ME; Torp-Pedersen, C; Gislason, GH; Jensen, PF; Berger, SM; Christiansen, CB; Overgaard, C; Schmiegelow, MD; Andersson, C				Jorgensen, Mads E.; Torp-Pedersen, Christian; Gislason, Gunnar H.; Jensen, Per Foge; Berger, Siv Mari; Christiansen, Christine Benn; Overgaard, Charlotte; Schmiegelow, Michelle D.; Andersson, Charlotte			Time Elapsed After Ischemic Stroke and Risk of Adverse Cardiovascular Events and Mortality Following Elective Noncardiac Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERIOPERATIVE STROKE; CARDIAC RISK; MYOCARDIAL-INFARCTION; OUTCOMES; ASSOCIATION; VALIDATION; PREDICTORS; GUIDELINES; MANAGEMENT; VALIDITY	IMPORTANCE The timing of surgery in patients with recent ischemic stroke is an important and inadequately addressed issue. OBJECTIVE To assess the safety and importance of time elapsed between stroke and surgery in the risk of perioperative cardiovascular events and mortality. DESIGN, SETTING, AND PARTICIPANTS Danish nationwide cohort study (2005-2011) including all patients aged 20 years or older undergoing elective noncardiac surgeries (n = 481 183 surgeries). EXPOSURES Time elapsed between stroke and surgery in categories and as a continuous measure. MAIN OUTCOMES AND MEASURES Risk of major adverse cardiovascular events (MACE; including ischemic stroke, acutemyocardial infarction, and cardiovascular mortality) and all-cause mortality up to 30 days after surgery. Odds ratios (ORs) were calculated by multivariable logistic regression models. RESULTS Crude incidence rates ofMACE among patients with (n = 7137) and without (n = 474 046) prior stroke were 54.4 (95% CI, 49.1-59.9) vs 4.1 (95% CI, 3.9-4.2) per 1000 patients. Compared with patients without stroke, ORs forMACE were 14.23 (95% CI, 11.61-17.45) for stroke less than 3 months prior to surgery, 4.85 (95% CI, 3.32-7.08) for stroke 3 to less than 6 months prior, 3.04 (95% CI, 2.13-4.34) for stroke 6 to less than 12 months prior, and 2.47 (95% CI, 2.07-2.95) for stroke 12 months or more prior. MACE risks were at least as high for low-risk (OR, 9.96; 95% CI, 5.49-18.07 for stroke < 3 months) and intermediate-risk (OR, 17.12; 95% CI, 13.68-21.42 for stroke < 3 months) surgery compared with high-risk surgery (OR, 2.97; 95% CI, 0.98-9.01 for stroke < 3 months) (P =.003 for interaction). Similar patterns were found for 30-day mortality: ORs were 3.07 (95% CI, 2.30-4.09) for stroke less than 3 months prior, 1.97 (95% CI, 1.22-3.19) for stroke 3 to less than 6 months prior, 1.45 (95% CI, 0.95-2.20) for stroke 6 to less than 12 months prior, and 1.46 (95% CI, 1.21-1.77) for stroke 12 months or more prior to surgery compared with patients without stroke. Cubic regression splines performed on the stroke subgroup supported that risk leveled off after 9 months. CONCLUSIONS AND RELEVANCE A history of stroke was associated with adverse outcomes following surgery, in particular if time between stroke and surgery was less than 9 months. After 9 months, the associated risk appeared stable yet still increased compared with patients with no stroke. The time dependency of risk may warrant attention in future guidelines. Copyright 2014 American Medical Association. All rights reserved.	[Jorgensen, Mads E.; Gislason, Gunnar H.; Berger, Siv Mari; Christiansen, Christine Benn; Schmiegelow, Michelle D.; Andersson, Charlotte] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark; [Torp-Pedersen, Christian; Overgaard, Charlotte] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Gislason, Gunnar H.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Gislason, Gunnar H.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Jensen, Per Foge] Univ Copenhagen, Rigshosp, Dept Cardiothorac Anesthesia, DK-2100 Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Aalborg University; University of Copenhagen; University of Southern Denmark; Rigshospitalet; University of Copenhagen	Jorgensen, ME (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hjertemedicinsk Forskning 1, DK-2900 Hellerup, Denmark.	mads.emil.joergensen@regionh.dk	Andersson, Charlotte/P-4849-2014; Gislason, Gunnar/B-7561-2009; Overgaard, Charlotte/D-8083-2011; Overgaard, Charlotte/Q-2032-2019	Gislason, Gunnar/0000-0002-0548-402X; Overgaard, Charlotte/0000-0002-3370-2338; Overgaard, Charlotte/0000-0002-3370-2338	Danish Agency for Science, Technology and Innovation [FSS-11-120873]; Novo Nordisk Foundation; University of Copenhagen	Danish Agency for Science, Technology and Innovation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); University of Copenhagen	Dr Andersson was funded by an independent research grant from the Danish Agency for Science, Technology and Innovation (grant FSS-11-120873). Dr Gislason is supported by an independent research scholarship from the Novo Nordisk Foundation. Dr Schmiegelow was funded by an independent research grant from the University of Copenhagen.	Andersson C, 2014, JAMA INTERN MED, V174, P336, DOI 10.1001/jamainternmed.2013.11349; Andersson C, 2012, JAMA-J AM MED ASSOC, V308, P882, DOI 10.1001/2012.jama.10779; Andersson C, 2010, ESSENTIAL DURER, P12; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Bateman BT, 2009, ANESTHESIOLOGY, V110, P231, DOI 10.1097/ALN.0b013e318194b5ff; Boersma E, 2005, AM J MED, V118, P1134, DOI 10.1016/j.amjmed.2005.01.064; Bottle A, 2013, ANESTHESIOLOGY, V118, P885, DOI 10.1097/ALN.0b013e3182815912; Brilakis ES, 2007, J AM COLL CARDIOL, V49, P2145, DOI 10.1016/j.jacc.2007.02.046; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Gaist D, 1997, DAN MED BULL, V44, P445; Hawn MT, 2013, JAMA-J AM MED ASSOC, V310, P1462, DOI 10.1001/jama.2013.278787; Hogue CW, 1999, CIRCULATION, V100, P642, DOI 10.1161/01.CIR.100.6.642; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Livhits M, 2011, ANN SURG, V253, P857, DOI 10.1097/SLA.0b013e3182125196; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mashour GA, 2013, ANESTHESIOLOGY, V119, P1340, DOI 10.1097/ALN.0b013e318295a25f; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1289, DOI 10.1097/ALN.0b013e318216e7f4; Ng JLW, 2011, ANESTHESIOLOGY, V115, P879, DOI 10.1097/ALN.0b013e31822e9499; NOMESCO N., 2009, NOMESCO CLASSIFICATI; Noordzij PG, 2010, ANESTHESIOLOGY, V112, P1105, DOI 10.1097/ALN.0b013e3181d5f95c; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Sanders RD, 2012, ANN SURG, V255, P901, DOI 10.1097/SLA.0b013e31824c438d; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Sharifpour M, 2013, ANESTH ANALG, V116, P424, DOI 10.1213/ANE.0b013e31826a1a32; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; van Kuijk JP, 2009, AM J CARDIOL, V104, P1229, DOI 10.1016/j.amjcard.2009.06.038; Vicenzi MN, 2006, BRIT J ANAESTH, V96, P686, DOI 10.1093/bja/ael083	30	90	97	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					269	277		10.1001/jama.2014.8165	http://dx.doi.org/10.1001/jama.2014.8165			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027142	Bronze			2022-12-24	WOS:000338940300024
J	Friedewald, SM; Rafferty, EA; Rose, SL; Durand, MA; Plecha, DM; Greenberg, JS; Hayes, MK; Copit, DS; Carlson, KL; Cink, TM; Barke, LD; Greer, LN; Miller, DP; Conant, EF				Friedewald, Sarah M.; Rafferty, Elizabeth A.; Rose, Stephen L.; Durand, Melissa A.; Plecha, Donna M.; Greenberg, Julianne S.; Hayes, Mary K.; Copit, Debra S.; Carlson, Kara L.; Cink, Thomas M.; Barke, Lora D.; Greer, Linda N.; Miller, Dave P.; Conant, Emily F.			Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE; POPULATION; TRIAL	IMPORTANCE Mammography plays a key role in early breast cancer detection. Single-institution studies have shown that adding tomosynthesis to mammography increases cancer detection and reduces false-positive results. OBJECTIVE To determine if mammography combined with tomosynthesis is associated with better performance of breast screening programs in the United States. DESIGN, SETTING, AND PARTICIPANTS Retrospective analysis of screening performance metrics from 13 academic and nonacademic breast centers using mixed models adjusting for site as a random effect. EXPOSURES Period 1: digital mammography screening examinations 1 year before tomosynthesis implementation (start dates ranged from March 2010 to October 2011 through the date of tomosynthesis implementation); period 2: digital mammography plus tomosynthesis examinations from initiation of tomosynthesis screening (March 2011 to October 2012) through December 31, 2012. MAIN OUTCOMES AND MEASURES Recall rate for additional imaging, cancer detection rate, and positive predictive values for recall and for biopsy. RESULTS A total of 454 850 examinations (n = 281 187 digital mammography; n = 173 663 digital mammography + tomosynthesis) were evaluated. With digital mammography, 29 726 patients were recalled and 5056 biopsies resulted in cancer diagnosis in 1207 patients (n = 815 invasive; n = 392 in situ). With digital mammography + tomosynthesis, 15 541 patients were recalled and 3285 biopsies resulted in cancer diagnosis in 950 patients (n = 707 invasive; n = 243 in situ). Model-adjusted rates per 1000 screens were as follows: for recall rate, 107 (95% CI, 89-124) with digital mammography vs 91 (95% CI, 73-108) with digital mammography + tomosynthesis; difference, -16 (95% CI, -18 to -14; P < .001); for biopsies, 18.1 (95% CI, 15.4-20.8) with digital mammography vs 19.3 (95% CI, 16.6-22.1) with digital mammography + tomosynthesis; difference, 1.3 (95% CI, 0.4-2.1; P = .004); for cancer detection, 4.2 (95% CI, 3.8-4.7) with digital mammography vs 5.4 (95% CI, 4.9-6.0) with digital mammography + tomosynthesis; difference, 1.2 (95% CI, 0.8-1.6; P < .001); and for invasive cancer detection, 2.9 (95% CI, 2.5-3.2) with digital mammography vs 4.1 (95% CI, 3.7-4.5) with digital mammography + tomosynthesis; difference, 1.2 (95% CI, 0.8-1.6; P < .001). The in situ cancer detection rate was 1.4 (95% CI, 1.2-1.6) per 1000 screens with both methods. Adding tomosynthesis was associated with an increase in the positive predictive value for recall from 4.3% to 6.4%(difference, 2.1%; 95% CI, 1.7%-2.5%; P < .001) and for biopsy from 24.2% to 29.2%(difference, 5.0%; 95% CI, 3.0%-7.0%; P < .001). CONCLUSIONS AND RELEVANCE Addition of tomosynthesis to digital mammography was associated with a decrease in recall rate and an increase in cancer detection rate. Further studies are needed to assess the relationship to clinical outcomes.	[Friedewald, Sarah M.] Advocate Lutheran Gen Hosp, Ctr Adv Care, Caldwell Breast Ctr, Park Ridge, IL 60068 USA; [Rafferty, Elizabeth A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Rose, Stephen L.] TOPS Comprehens Breast Ctr, Houston, TX USA; [Rose, Stephen L.] Solis Womens Hlth, Dallas, TX USA; [Durand, Melissa A.] Yale Univ, Sch Med, Dept Diagnost Radiol, Breast Imaging Sect, New Haven, CT 06510 USA; [Plecha, Donna M.] Univ Hosp Case Med Ctr, Dept Radiol, Cleveland, OH USA; [Greenberg, Julianne S.] Washington Radiol Associates, Fairfax, VA USA; [Hayes, Mary K.] Radiol Associates Hollywood, Hollywood, FL USA; [Hayes, Mary K.] Mem Healthcare Syst, Hollywood, FL USA; [Copit, Debra S.] Albert Einstein Healthcare Network, Dept Diagnost Radiol, Philadelphia, PA USA; [Carlson, Kara L.] Evergreen Hlth Breast Ctr, Kirkland, WA USA; [Carlson, Kara L.] Radia Inc, Kirkland, WA USA; [Cink, Thomas M.] Edith Sanford Breast Hlth Inst, Sioux Falls, SD USA; [Barke, Lora D.] Invis Sally Jobe Breast Ctr, Denver, CO USA; [Barke, Lora D.] Radiol Imaging Associates, Denver, CO USA; [Greer, Linda N.] John C Lincoln Breast Hlth & Res Ctr, Phoenix, AZ USA; [Miller, Dave P.] ICON Clin Res, San Francisco, CA USA; [Conant, Emily F.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Yale University; Case Western Reserve University; Case Western Reserve University Hospital; Yeshiva University; ICON plc; University of Pennsylvania; Pennsylvania Medicine	Friedewald, SM (corresponding author), Advocate Lutheran Gen Hosp, Ctr Adv Care, Caldwell Breast Ctr, Third Floor,1700 Luther Ln, Park Ridge, IL 60068 USA.	sarah.friedewald@advocatehealth.com		Plecha, Donna/0000-0003-1714-4337; Miller, Dave/0000-0003-2947-152X	Hologic; National Cancer Institute [5U54CA163316-03]	Hologic; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Drs Friedewald, Rafferty, Rose, Durand, Plecha, Greenberg, Hayes, Copit, Carlson, Cink, Barke, and Greer received a research grant from Hologic. Dr Conant received research grant 5U54CA163316-03 from the National Cancer Institute.	Andersson I, 2008, EUR RADIOL, V18, P2817, DOI 10.1007/s00330-008-1076-9; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carney PA, 2010, RADIOLOGY, V255, P354, DOI 10.1148/radiol.10091636; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Gur D, 2009, AM J ROENTGENOL, V193, P586, DOI 10.2214/AJR.08.2031; Haas BM, 2013, RADIOLOGY, V269, P694, DOI 10.1148/radiol.13130307; Park JM, 2007, RADIOGRAPHICS, V27, pS231, DOI 10.1148/rg.27si075511; Pisano ED, 2005, RADIOLOGY, V234, P353, DOI 10.1148/radiol.2342030897; Rafferty EA, 2013, RADIOLOGY, V266, P104, DOI 10.1148/radiol.12120674; Rose SL, 2013, AM J ROENTGENOL, V200, P1401, DOI 10.2214/AJR.12.9672; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373; Tabar L, 2011, RADIOLOGY, V260, P658, DOI 10.1148/radiol.11110469; US Food and Drug Administration, SEL DIM 3D SYST P080; US Food and Drug Administration, SEL DIM 3D SYST P008; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635	18	558	565	4	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2499	2507		10.1001/jama.2014.6095	http://dx.doi.org/10.1001/jama.2014.6095			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	25058084	Bronze			2022-12-24	WOS:000337757000023
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING The world's deadliest animal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20036 USA		Kamerow, D (corresponding author), Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20036 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Centers for Disease Control and Prevention, DENG US; Centers for Disease Control and Prevention, IMP MAL; Centers for Disease Control and Prevention, CHIK VIR; Centers for Disease Control and Prevention, W NIL VIR; Centers for Disease Control and Prevention, FAQ INS REP US SAF; Gates B, DEADLIEST ANIMAL WOR	6	0	0	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2014	348								g3258	10.1136/bmj.g3258	http://dx.doi.org/10.1136/bmj.g3258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5GP	25134129				2022-12-24	WOS:000336156800005
J	Klompas, M; Diekema, DJ; Fishman, NO; Yokoe, DS				Klompas, Michael; Diekema, Daniel J.; Fishman, Neil O.; Yokoe, Deborah S.			Ebola Fever: Reconciling Planning With Risk in US Hospitals	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEMORRHAGIC-FEVER; VIRUS TRANSMISSION; KIKWIT; CONGO; OUTBREAK		Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Univ Iowa, Carver Coll Med, Iowa City, IA USA; Univ Penn Hlth Syst, Philadelphia, PA USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Iowa; University of Pennsylvania	Klompas, M (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	mklompas@partners.org	Klompas, Michael/Z-2415-2019	Diekema, Daniel/0000-0003-1273-0724				Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Centers for Disease Control and Prevention, 2014, INF PREV CONTR REC H; Centers for Disease Control and Prevention, 2014, OUTBR CHRON EB HEM F; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Kerstiens B, 1999, J INFECT DIS, V179, pS263, DOI 10.1086/514320; Muyembe-Tamfum JJ, 1999, J INFECT DIS, V179, pS259, DOI 10.1086/514302; Richards GA, 2000, CRIT CARE MED, V28, P240, DOI 10.1097/00003246-200001000-00041	8	17	17	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					751	U206		10.7326/M14-1918	http://dx.doi.org/10.7326/M14-1918			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25141883				2022-12-24	WOS:000347245600036
J	Aguzzi, A				Aguzzi, Adriano			Alzheimer's disease under strain	NATURE			English	Editorial Material							PRION STRAINS; KINETICS; SCRAPIE; AGENT; MICE		Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch		Aguzzi, Adriano/0000-0002-0344-6708				Aguzzi A, 2013, CELL, V154, P1182, DOI 10.1016/j.cell.2013.08.049; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Sigurdson CJ, 2006, J VIROL, V80, P12303, DOI 10.1128/JVI.01120-06; Stohr J, 2014, P NATL ACAD SCI USA, V111, P10329, DOI 10.1073/pnas.1408968111; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111	15	30	30	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					32	34		10.1038/512032a	http://dx.doi.org/10.1038/512032a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25100477				2022-12-24	WOS:000339908000022
J	Chao, JT; Wong, AKO; Tavassoli, S; Young, BP; Chruscicki, A; Fang, NN; Howe, LJ; Mayor, T; Foster, LJ; Loewen, CJR				Chao, Jesse T.; Wong, Andrew K. O.; Tavassoli, Shabnam; Young, Barry P.; Chruscicki, Adam; Fang, Nancy N.; Howe, Leann J.; Mayor, Thibault; Foster, Leonard J.; Loewen, Christopher J. R.			Polarization of the Endoplasmic Reticulum by ER-Septin Tethering	CELL			English	Article							MESSENGER-RNA TRANSPORT; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; BUDDING YEAST; CORTICAL ER; CELL CORTEX; PROTEIN; COMPARTMENTALIZATION; ORGANIZATION; BINDING	Polarization of the plasma membrane (PM) into domains is an important mechanism to compartmentalize cellular activities and to establish cell polarity. Polarization requires formation of diffusion barriers that prevent mixing of proteins between domains. Recent studies have uncovered that the endoplasmic reticulum (ER) of budding yeast and neurons is polarized by diffusion barriers, which in neurons controls glutamate signaling in dendritic spines. The molecular identity of these barriers is currently unknown. Here, we show that a direct interaction between the ER protein Scs2 and the septin Shs1 creates the ER diffusion barrier in yeast. Barrier formation requires Epo1, a novel ER-associated subunit of the polarisome that interacts with Scs2 and Shs1. ER-septin tethering polarizes the ER into separate mother and bud domains, one function of which is to position the spindle in the mother until M phase by confining the spindle capture protein Num1 to the mother ER.	[Chao, Jesse T.; Wong, Andrew K. O.; Tavassoli, Shabnam; Young, Barry P.; Loewen, Christopher J. R.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Chruscicki, Adam; Fang, Nancy N.; Howe, Leann J.; Mayor, Thibault; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Fang, Nancy N.; Mayor, Thibault; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Loewen, CJR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	cloewen@mail.ubc.ca		Chao, Jesse/0000-0002-6995-9581	Canadian Institute of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); Canada Foundation for Innovation (CFI)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This research was supported by grants from the Canadian Institute of Health Research (CIHR), the Michael Smith Foundation for Health Research (MSFHR), and the Canada Foundation for Innovation (CFI). C.J.R.L. and T.M. are CIHR New Investigators and MSFHR Scholars, C.J.R.L. is a Tula Foundation Investigator, and L.J.F. is the Canada Research Chair in Organelle Proteomics.	Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Chao Jesse Tzu-Cheng, 2009, J Vis Exp, DOI 10.3791/1225; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cui-Wang TT, 2012, CELL, V148, P309, DOI 10.1016/j.cell.2011.11.056; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Egelhofer TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002022; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; FARKASOVSKY M, 1995, J CELL BIOL, V131, P1003, DOI 10.1083/jcb.131.4.1003; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Fischer MA, 2009, TRAFFIC, V10, P1084, DOI 10.1111/j.1600-0854.2009.00926.x; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Garcia G, 2011, J CELL BIOL, V195, P993, DOI 10.1083/jcb.201107123; Heil-Chapdelaine RA, 2000, J CELL BIOL, V151, P1337, DOI 10.1083/jcb.151.6.1337; Iwase M, 2007, GENETICS, V177, P215, DOI 10.1534/genetics.107.073007; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Newman JRS, 2000, P NATL ACAD SCI USA, V97, P13203, DOI 10.1073/pnas.97.24.13203; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; SEPSENWOL S, 1989, J CELL BIOL, V108, P55, DOI 10.1083/jcb.108.1.55; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tang XY, 2012, J CELL BIOL, V196, P743, DOI 10.1083/jcb.201112017; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687	36	73	73	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					620	632		10.1016/j.cell.2014.06.033	http://dx.doi.org/10.1016/j.cell.2014.06.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083872	Bronze			2022-12-24	WOS:000340944300014
J	Prue, G				Prue, Gillian			Vaccinate boys as well as girls against HPV: it works, and it may be cost effective	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; GENITAL WARTS; MEN		Queens Univ Belfast, Sch Nursing & Midwifery, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	Prue, G (corresponding author), Queens Univ Belfast, Sch Nursing & Midwifery, Belfast BT9 7BL, Antrim, North Ireland.	g.prue@qub.ac.uk						Baandrup L, 2013, SEX TRANSM DIS, V40, P130, DOI 10.1097/OLQ.0b013e31827bd66b; Baio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049699; Bowyer HL, 2014, J FAM PLAN REPROD H, V40, P14, DOI 10.1136/jfprhc-2013-100583; Boyce T., 2013, BR J SCH NURS, V8, P71, DOI [10.12968/bjsn.2013.8.2.71, DOI 10.12968/BJSN.2013.8.2.71]; Burger EA, 2009, PLOS ONE, V201420; Desai S, 2011, SEX TRANSM INFECT, V87, P464, DOI 10.1136/sti.2010.048421; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Marty R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-10; Newman PA, 2013, SEX TRANSM INFECT, V89, P568, DOI 10.1136/sextrans-2012-050980; Public Health England, 2013, ANN HPV VACC COV 201; Public Health England, 2014, HPV VACC PROGR SCHED; Zou HC, 2014, J INFECT DIS, V209, P642, DOI 10.1093/infdis/jit626	12	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2014	349								g4834	10.1136/bmj.g4834	http://dx.doi.org/10.1136/bmj.g4834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NG	25073786	Green Published			2022-12-24	WOS:000339906000007
J	Bhutta, ZA				Bhutta, Zulfiqar Ahmed			Polio eradication hinges on child health in Pakistan	NATURE			English	Editorial Material									[Bhutta, Zulfiqar Ahmed] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar Ahmed] Sick Kids Ctr Global Child Hlth, Toronto, ON, Canada	Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bhutta, ZA (corresponding author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan.	zulfiqar.bhutta@aku.edu						Bhutta ZA, 2013, LANCET, V381, P2207, DOI 10.1016/S0140-6736(12)61999-0; Bhutta ZA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f280; Blake I. M., 2014, P NATL ACAD SCI US; Independent Monitoring Board of the Global Polio Eradication Initiative, 2014, 9 GLOB POL ER IN IND; Mayer BT, 2013, AM J EPIDEMIOL, V177, P1236, DOI 10.1093/aje/kws378; National Institute of Population Studies, 2013, PAK DEM HLTH SURV 20; Rutter PD, 2014, LANCET, V383, P1695, DOI 10.1016/S0140-6736(14)60756-X	7	13	13	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					285	287		10.1038/511285a	http://dx.doi.org/10.1038/511285a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL2YR	25030151	Bronze, Green Published			2022-12-24	WOS:000338992200012
J	George, R				George, Rob			ASSISTED DYING BILL We must not deprive dying people of the most important protection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CROSS-SECTIONAL SURVEY; PREDICTING SURVIVAL; EUTHANASIA; DISEASE; NETHERLANDS; SUICIDE		[George, Rob] Kings Coll London, Cicely Saunders Inst, London WC2R 2LS, England; [George, Rob] Guys & St Thomas Hosp NHS Fdn Trust, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	George, R (corresponding author), Kings Coll London, Cicely Saunders Inst, London WC2R 2LS, England.	rob.george@kcl.ac.uk						Beckford M., 2008, TELEGRAPH; Butler-Schloss E, 2013, TELEGRAPH; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Ganzini L, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1682; Glare P, 2008, EUR J CANCER, V44, P1146, DOI 10.1016/j.ejca.2008.02.030; Goeman JJ, 2004, STAT NEERL, V58, P21, DOI 10.1111/j.1467-9574.2004.00244.x; Groenewoud JH, 2000, NEW ENGL J MED, V342, P551, DOI 10.1056/NEJM200002243420805; Hendin H, 2008, MICH LAW REV, V106, P1613; House of Lords, 2005, ASS DYING TERM ILL B; Onwuteaka-Philipsen BD, 2012, LANCET, V380, P908, DOI 10.1016/S0140-6736(12)61034-4; Oregon Health Authority, DEATH DIGN ACT ANN R; Royal College of Physicians, 2014, NAT CAR DYING AUD HO; Tallis R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3532	13	3	3	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2014	349								g4311	10.1136/bmj.g4311	http://dx.doi.org/10.1136/bmj.g4311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7ZE	24994758				2022-12-24	WOS:000338646100007
J	Treasure, T; Monson, K; Fiorentino, F; Russell, C				Treasure, Tom; Monson, Kathryn; Fiorentino, Francesca; Russell, Christopher			Operating to remove recurrent colorectal cancer: have we got it right?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARCINOEMBRYONIC ANTIGEN; PULMONARY-METASTASECTOMY; LARGE-BOWEL; FOLLOW-UP; CARCINOMA METASTASES; HEPATIC RESECTION; DETECT RECURRENCE; LIVER METASTASES; NATURAL-HISTORY; CLINICAL-TRIAL		[Treasure, Tom] UCL, Clin Operat Res Unit, London, England; [Monson, Kathryn] Univ Sussex, Brighton & Sussex Med Sch, SHORE C, Falmer, England; [Fiorentino, Francesca] Univ London Imperial Coll Sci Technol & Med, Dept Cardiothorac Surg, London, England	University of London; University College London; University of Brighton; University of Sussex; Imperial College London	Treasure, T (corresponding author), UCL, Clin Operat Res Unit, London, England.	tom.treasure@gmail.com						COCHRANE JPS, 1980, BRIT MED J, V280, P593, DOI 10.1136/bmj.280.6214.593; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; ELLIS H, 1975, BRIT J SURG, V62, P830, DOI 10.1002/bjs.1800621020; Fiorentino F, 2011, BRIT J CANCER, V104, P1085, DOI 10.1038/sj.bjc.6606060; Fiorentino F, 2010, J ROY SOC MED, V103, P60, DOI 10.1258/jrsm.2009.090299; GOLDENBERG D M, 1981, British Medical Journal, V282, P373; Grunhagen D, 2013, CRIT REV ONCOL HEMAT, V86, P222, DOI 10.1016/j.critrevonc.2012.10.007; HUGHES ESR, 1982, BRIT J SURG, V69, P410, DOI 10.1002/bjs.1800690718; HUGHES K, 1989, SURG CLIN N AM, V69, P339; HUGHES KS, 1986, SURGERY, V100, P278; HUGHES KS, 1988, SURGERY, V103, P278; Lennon T, 1994, BR J CANC S22, V70, P16; Loder E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3601; MACH JP, 1974, LANCET, V2, P535; MACKAY AM, 1974, BRIT MED J, V4, P382, DOI 10.1136/bmj.4.5941.382; MARTIN EW, 1980, J SURG RES, V28, P389, DOI 10.1016/0022-4804(80)90100-6; MARTIN EW, 1979, AM J SURG, V137, P167, DOI 10.1016/0002-9610(79)90137-5; MCCORMACK PM, 1992, ARCH SURG-CHICAGO, V127, P1403; MEEKER WR, 1978, CANCER, V41, P854, DOI 10.1002/1097-0142(197803)41:3<854::AID-CNCR2820410312>3.0.CO;2-J; NHS, 2012, NAT CANC PAT EXP SUR; NICHOLSON JR, 1978, DIS COLON RECTUM, V21, P163, DOI 10.1007/BF02586559; NORTHOVER J, 1994, JAMA-J AM MED ASSOC, V272, P31, DOI 10.1001/jama.1994.03520010041025; POLK HC, 1971, SURGERY, V69, P9; Poston G, 2011, COLORECTAL CANC DIAG; Primrose JN, 2014, JAMA-J AM MED ASSOC, V311, P263, DOI 10.1001/jama.2013.285718; ROSEN CB, 1992, ANN SURG, V216, P493, DOI 10.1097/00000658-199210000-00012; SCHEELE J, 1990, DIS COLON RECTUM, V33, P745, DOI 10.1007/BF02052319; SCHEELE J, 1990, BRIT J SURG, V77, P1241, DOI 10.1002/bjs.1800771115; SCHEELE J, 1995, WORLD J SURG, V19, P59, DOI 10.1007/BF00316981; SCHEELE J, 1991, SURGERY, V110, P13; Slack W, 1982, PROTOCOL MULTICENTRE, DOI [10.5061/dryad.k8t8b, DOI 10.5061/DRYAD.K8T8B]; STAAB HJ, 1978, J SURG ONCOL, V10, P273, DOI 10.1002/jso.2930100313; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; Treasure T, 2009, EJSO-EUR J SURG ONC, V35, P686, DOI 10.1016/j.ejso.2008.12.005; Treasure T, 2013, BMJ; Treasure T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004385; Treasure T, 2010, J THORAC ONCOL, V5, pS203, DOI 10.1097/JTO.0b013e3181dca239; Treasure T, 2010, J THORAC ONCOL, V5, pS179, DOI 10.1097/JTO.0b013e3181dca251; WANGENSTEEN OH, 1954, SURG GYNECOL OBSTET, V99, P257; WELCH JP, 1978, AM J SURG, V135, P505, DOI 10.1016/0002-9610(78)90028-4	40	15	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2014	348								g2085	10.1136/bmj.g2085	http://dx.doi.org/10.1136/bmj.g2085			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5CN	25134098	Green Submitted			2022-12-24	WOS:000336146200001
J	Boussemart, L; Malka-Mahieu, H; Girault, I; Allard, D; Hemmingsson, O; Tomasic, G; Thomas, M; Basmadjian, C; Ribeiro, N; Thuaud, F; Mateus, C; Routier, E; Kamsu-Kom, N; Agoussi, S; Eggermont, AM; Desaubry, L; Robert, C; Vagner, S				Boussemart, Lise; Malka-Mahieu, Helene; Girault, Isabelle; Allard, Delphine; Hemmingsson, Oskar; Tomasic, Gorana; Thomas, Marina; Basmadjian, Christine; Ribeiro, Nigel; Thuaud, Frederic; Mateus, Christina; Routier, Emilie; Kamsu-Kom, Nyam; Agoussi, Sandrine; Eggermont, Alexander M.; Desaubry, Laurent; Robert, Caroline; Vagner, Stephan			eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies	NATURE			English	Article							TRANSLATION INITIATION; ACQUIRED-RESISTANCE; FEEDBACK INHIBITION; RAF; SILVESTROL	In BRAF(V600)-mutant tumours, most mechanisms of resistance to drugs that target the BRAF and/or MEK kinases rely on reactivation of the RAS-RAF-MEK-ERK mitogen-activated protein kinase (MAPK) signal transduction pathway, on activation of the alternative, PI(3) K-AKT-mTOR, pathway (which is ERK independent) or on modulation of the caspase-dependent apoptotic cascade(1-3). All three pathways converge to regulate the formation of the eIF4F eukaryotic translation initiation complex, which binds to the 7-methylguanylate cap (m(7)G) at the 59 end of messenger RNA, thereby modulating the translation of specific mRNAs(4,5). Here we show that the persistent formation of the eIF4F complex, comprising the eIF4E cap-binding protein, the eIF4G scaffolding protein and the eIF4A RNA helicase, is associated with resistance to anti-BRAF, anti-MEK and anti-BRAF plus anti-MEK drug combinations in BRAF(V600)-mutant melanoma, colon and thyroid cancer cell lines. Resistance to treatment and maintenance of eIF4F complex formation is associated with one of three mechanisms: reactivation of MAPK signalling, persistent ERK-independent phosphorylation of the inhibitory eIF4E-binding protein 4EBP1 or increased pro-apoptotic BCL-2-modifying factor (BMF)-dependent degradation of eIF4G. The development of an in situ method to detect the eIF4E-eIF4G interactions shows that eIF4F complex formation is decreased in tumours that respond to anti-BRAF therapy and increased in resistant metastases compared to tumours before treatment. Strikingly, inhibiting the eIF4F complex, either by blocking the eIF4E-eIF4G interaction or by targeting eIF4A, synergizes with inhibiting BRAF(V600) to kill the cancer cells. eIF4F not only appears to be an indicator of both innate and acquired resistance but also is a promising therapeutic target. Combinations of drugs targeting BRAF(and/or MEK) and eIF4F may overcome most of the resistance mechanisms arising in BRAF(V600)-mutant cancers.	[Boussemart, Lise; Malka-Mahieu, Helene; Girault, Isabelle; Allard, Delphine; Hemmingsson, Oskar; Kamsu-Kom, Nyam; Agoussi, Sandrine; Robert, Caroline; Vagner, Stephan] Inserm UMR981, F-94805 Villejuif, France; [Boussemart, Lise; Malka-Mahieu, Helene; Eggermont, Alexander M.; Robert, Caroline; Vagner, Stephan] Univ Paris Sud, Univ Paris 11, F-94276 Le Kremlin Bicetre, France; [Boussemart, Lise; Thomas, Marina; Mateus, Christina; Routier, Emilie; Eggermont, Alexander M.; Robert, Caroline; Vagner, Stephan] Gustave Roussy, Dermatooncol, F-94805 Villejuif, France; [Tomasic, Gorana] Gustave Roussy, Dept Pathol, F-94805 Villejuif, France; [Basmadjian, Christine; Ribeiro, Nigel; Thuaud, Frederic; Desaubry, Laurent] Strasbourg Univ, CNRS, UMR7200, F-67400 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Robert, C (corresponding author), Inserm UMR981, F-94805 Villejuif, France.	caroline.robert@gustaveroussy.fr; stephan.vagner@inserm.fr	Vagner, Stephan/G-3664-2013; Robert, Caroline/G-6157-2018; Desaubry, Laurent G/R-5446-2017	Robert, Caroline/0000-0002-9493-0238; Desaubry, Laurent G/0000-0002-1192-2970; ALLARD, Delphine/0000-0001-7534-8982; vagner, stephan/0000-0003-1452-7164; Girault, Isabelle/0000-0002-9587-5197	Institut National du CAncer (INCA); Association pour la Recherche sur le Cancer (ARC); Ligue contre le Cancer via an Integrated Research Action Program Melanoma (PAIR Melanome); Canceropole Ile de France and Ensemble Contre le Melanome; ARC; AAREC Filia Research for fellowships; Wenner-Gren Foundation; Swedish Society of Medicine	Institut National du CAncer (INCA)(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer via an Integrated Research Action Program Melanoma (PAIR Melanome); Canceropole Ile de France and Ensemble Contre le Melanome; ARC(Australian Research Council); AAREC Filia Research for fellowships; Wenner-Gren Foundation; Swedish Society of Medicine	The authors thank J. Tanaka for providing hippuristanol. We thank the following Gustave Roussy platforms: Imaging and Cytometry Platform IRCIV (S. Salome-Desmoulez), Module de Developpement en Pathologie, SIRIC SOCRATE (J. Adam), Translational Research Laboratory and Biobank (M. Breckler and L. Lacroix), Plateforme d'evaluation Preclinique (P. Gonin and K. Ser-le Roux), Genomic Core Facility (N. Pata-Merci) and Bioinformatic Core Facility (G. Meurice). We also thank V. Camara-Clayette for help with <SUP>35</SUP>S experiments, S. Roy for patient data collection and L. Saint Ange for text editing. C. R. and S.V.'s team was supported by Institut National du CAncer (INCA), Association pour la Recherche sur le Cancer (ARC) and Ligue contre le Cancer via an Integrated Research Action Program Melanoma (PAIR Melanome), Canceropole Ile de France and Ensemble Contre le Melanome. L. D. was supported by the Association pour la Recherche sur le Cancer (ARC). We also thank the ARC and AAREC Filia Research for fellowships to N. R. and C. B. O.H. was supported by the Wenner-Gren Foundation and the Swedish Society of Medicine.	Blagden SP, 2011, NAT REV CLIN ONCOL, V8, P280, DOI 10.1038/nrclinonc.2011.16; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Cencic R, 2012, METHOD ENZYMOL, V511, P437, DOI 10.1016/B978-0-12-396546-2.00020-6; Cencic R, 2010, LEUKEMIA RES, V34, P535, DOI 10.1016/j.leukres.2009.07.043; Gupta SV, 2011, AAPS J, V13, P357, DOI 10.1208/s12248-011-9276-7; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Liu T, 2012, J MED CHEM, V55, P8859, DOI 10.1021/jm3011542; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Oikonomou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021632; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Sadlish H, 2013, ACS CHEM BIOL, V8, P1519, DOI 10.1021/cb400158t; Shao Y, 2012, CELL DEATH DIFFER, V19, P2029, DOI 10.1038/cdd.2012.94; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Tentori L, 2013, TRENDS PHARMACOL SCI, V34, P656, DOI 10.1016/j.tips.2013.10.003; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thuaud F, 2009, J MED CHEM, V52, P5176, DOI 10.1021/jm900365v	21	240	247	7	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					105	+		10.1038/nature13572	http://dx.doi.org/10.1038/nature13572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25079330				2022-12-24	WOS:000341174800039
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED A trial to extend breast cancer screening may be unethical	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Department of Health, 2011, IMPR OUTC STRAT CANC; ISRCTN Register, 2010, EV AG EXT NHS BREAST; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; National Health Service, 2007, CANC REF STRAT; Public Health England NHS Breast Cancer Screening Programme, WHAT DOES NHS BREAST; Richards M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6843; Science and Technology Committee, 2014, 244 HC SCI TECHN COM	7	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2014	349								g5105	10.1136/bmj.g5105	http://dx.doi.org/10.1136/bmj.g5105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RR	25116342	Green Published, Bronze			2022-12-24	WOS:000340506700008
J	Deyo, RA; Jarvik, JG; Chou, R				Deyo, Richard A.; Jarvik, Jeffrey G.; Chou, Roger			RATIONAL IMAGING Low back pain in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; LUMBAR SPINE; RED FLAGS; METAANALYSIS; STRATEGIES; OUTCOMES; CANCER		[Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97239 USA; [Deyo, Richard A.; Chou, Roger] Oregon Hlth & Sci Univ, Dept Internal Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Deyo, Richard A.; Jarvik, Jeffrey G.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University	Deyo, RA (corresponding author), Oregon Hlth & Sci Univ, Dept Family Med, Mail Code FM, Portland, OR 97239 USA.	deyor@ohsu.edu	Jarvik, Jeffrey/AAL-4292-2021	Chou, Roger/0000-0001-9889-8610				Ash LM, 2008, AM J NEURORADIOL, V29, P1098, DOI 10.3174/ajnr.A0999; Carragee Eugene, 2006, Spine J, V6, P624, DOI 10.1016/j.spinee.2006.03.005; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Downie A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7095; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Joines JD, 2001, J GEN INTERN MED, V16, P14, DOI 10.1111/j.1525-1497.2001.00249.x; Kendrick D, 2001, BRIT MED J, V322, P400, DOI 10.1136/bmj.322.7283.400; Knopp-Sihota JA, 2012, OSTEOPOROSIS INT, V23, P17, DOI 10.1007/s00198-011-1676-0; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; McCullough BJ, 2012, RADIOLOGY, V262, P941, DOI 10.1148/radiol.11110618; National Institute for Health and Care Excellence (NICE, 2009, LOW BACK PAIN EARL M; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Underwood M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7432; Webster BS, 2010, J OCCUP ENVIRON MED, V52, P900, DOI 10.1097/JOM.0b013e3181ef7e53	19	18	21	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2014	349								g4266	10.1136/bmj.g4266	http://dx.doi.org/10.1136/bmj.g4266			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7PE	25030632				2022-12-24	WOS:000339326000002
J	Strathdee, SA; Crago, AL; Butler, J; Bekker, LG; Beyrer, C				Strathdee, Steffanie A.; Crago, Anna-Louise; Butler, Jenny; Bekker, Linda-Gail; Beyrer, Chris			Dispelling myths about sex workers and HIV	LANCET			English	Editorial Material							CONDOM USE; RISK; INTERVENTION		[Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Crago, Anna-Louise] Univ Toronto, Toronto, ON, Canada; [Butler, Jenny] United Nations Populat Fund, New York, NY USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Res Ctr, ZA-7925 Cape Town, South Africa; [Beyrer, Chris] Johns Hopkins Univ, Ctr Publ Hlth & Human Rights, Baltimore, MD USA	University of California System; University of California San Diego; University of Toronto; United Nations Population Fund; University of Cape Town; Johns Hopkins University	Strathdee, SA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Strathdee, Steffanie A/B-9042-2009; Bekker, Linda-Gail/AAZ-8929-2020	Strathdee, Steffanie/0000-0002-7724-691X; BEKKER, LINDA-GAIL/0000-0002-0755-4386	NIAID NIH HHS [P30 AI094189] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; [Anonymous], 2010, REC HIV AIDS WORLD W; [Anonymous], 2001, 42914044992001 ALM R; Baral S, 2013, EXAMINING PREVALENCE; Baral SD, 2014, LANCET; Beckham S. W., 2013, ANY OTHER WOMAN PREG; DODILLET SUSANNE, 2011, INT WORKSHOP DECRIMI; Ghose T, 2011, QUAL HEALTH RES, V21, P587, DOI 10.1177/1049732310395328; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; International Labor Organization, 2012, 21 MILL PEOPL AR NOW; International Labour Organization, 2012, ILO 2012 GLOB EST FO; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Nemoto T, 1999, AIDS CARE, V11, P297, DOI 10.1080/09540129947938; Patterson TL, 2008, AM J PUBLIC HEALTH, V98, P2051, DOI 10.2105/AJPH.2007.130096; Poteat T, 2014, LANCET; RFSL,, 2011, OS SYNL AKT HBT PERS; *SOC, 2000, KANN PROST 1998 1999; Stachowiak JA, 2005, SIECUS REPORT, V22, P18; Steinfatt T. M., 2008, MEASURING EXTENT SEX; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; Stridbeck U., 2004, PURCHASING SEXUAL SE; The Global Alliance Against Traffic in Women, 2011, MOV SUPPL DEM CATCHP; Ulibarri MD, 2012, INT J STD AIDS, V23, P229, DOI 10.1258/ijsa.2011.011184; *UN, PROT PREV SUPPR PUN; UNAIDS, 2012, UNAIDS GUID NOT HIV; United Nations Office on Drugs and Crime, 2014, UN CONV TRANSN ORG C; Wagner Jamie., 2013, WEBCOMIC HOMESTUCK G	28	16	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					4	7		10.1016/S0140-6736(14)60980-6	http://dx.doi.org/10.1016/S0140-6736(14)60980-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX8IW	25059948				2022-12-24	WOS:000347154200007
J	Kennicutt, MC; Chown, SL; Cassano, JJ; Liggett, D; Massom, R; Peck, LS; Rintoul, SR; Storey, JWV; Vaughan, DG; Wilson, TJ; Sutherland, WJ				Kennicutt, Mahlon C., II; Chown, Steven L.; Cassano, John J.; Liggett, Daniela; Massom, Rob; Peck, Lloyd S.; Rintoul, Steve R.; Storey, John W. V.; Vaughan, David G.; Wilson, Terry J.; Sutherland, William J.			Polar Research: Six priorities for Antarctic science	NATURE			English	Editorial Material							WEST ANTARCTICA; THWAITES		[Kennicutt, Mahlon C., II] Texas A&M Univ, College Stn, TX 77843 USA; [Kennicutt, Mahlon C., II] Sci Comm Antarctic Res, The Hague, Netherlands; [Chown, Steven L.] Monash Univ, Clayton, Vic 3800, Australia	Texas A&M University System; Texas A&M University College Station; Monash University	Kennicutt, MC (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	mckennicutt@gmail.com	Rintoul, Stephen R/A-1471-2012; Siegert, Martin/M-9939-2019; Morozova, Polina A./A-3471-2014; Chown, Steven L/H-3347-2011; Siegert, Martin J/A-3826-2008; Schloss, Irene R./U-5411-2018; Chown, Steven/ABD-7646-2021; Lopez-Martinez, Jeronimo/C-5744-2011; Clark, Melody S/D-7371-2014; Vaughan, David/C-8348-2011	Rintoul, Stephen R/0000-0002-7055-9876; Siegert, Martin/0000-0002-0090-4806; Chown, Steven L/0000-0001-6069-5105; Siegert, Martin J/0000-0002-0090-4806; Schloss, Irene R./0000-0002-5917-8925; Lopez-Martinez, Jeronimo/0000-0002-1750-8287; Clark, Melody S/0000-0002-3442-3824; Massom, Robert/0000-0003-1533-5084; Liggett, Daniela/0000-0003-4184-5205; Sutherland, William/0000-0002-6498-0437; /0000-0002-9621-6660; Vaughan, David/0000-0002-9065-0570; Wilson, Gary/0000-0003-0025-3641	NERC [NE/F016646/1, NE/G00465X/1, NE/G00465X/2] Funding Source: UKRI; Natural Environment Research Council [NE/G00465X/1, NE/F016646/1, NE/G00465X/2] Funding Source: researchfish; Division Of Ocean Sciences [1129101] Funding Source: National Science Foundation	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Brady A.-M., 2014, EMERGING POLITICS AN; Brierley, 2014, TIME CHANGE CLIMATE; Chown SL, 2012, SCIENCE, V337, P158, DOI 10.1126/science.1222821; Chown SL, 2012, P NATL ACAD SCI USA, V109, P4938, DOI 10.1073/pnas.1119787109; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Shaw JD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001888; Tin T., 2014, ANTARCTIC FUTURES HU	8	136	141	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					23	25		10.1038/512023a	http://dx.doi.org/10.1038/512023a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM5NX	25100467	Bronze			2022-12-24	WOS:000339908000012
J	Cohen, D				Cohen, Deborah			ANTICOAGULANTS Dabigatran: how the drug company withheld important analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ATRIAL-FIBRILLATION					dcohen@bmj.com						[Anonymous], 2014, J AM COLL CARDIOL; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4747; Committee for Medicinal Products for Human Use (CHMP), 2011, EMACHMP2034682011; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Heneghan C, 2014, BMJ-BRIT MED J, V349, pg4560; Moore T. J., 2012, QUARTERWATCH; Moore TJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4517; Moore TJ, 2012, JAMA-J AM MED ASSOC, V308, P869, DOI 10.1001/jama.2012.9658; NICE Implementation Collaborative, CONS SUPP LOCAL IMPL; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Reilly PA, 2014, J AM COLL CARDIOL, V63, P2885, DOI 10.1016/j.jacc.2014.04.012; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; Staton T, 2012, PRADAXA HITS BLOCKBU	16	91	93	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2014	349								g4670	10.1136/bmj.g4670	http://dx.doi.org/10.1136/bmj.g4670			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VP	25055829	Green Published, hybrid			2022-12-24	WOS:000339565900003
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			The elusive heart fix	SCIENCE			English	Editorial Material																			0	10	10	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					252	257		10.1126/science.345.6194.252	http://dx.doi.org/10.1126/science.345.6194.252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035469				2022-12-24	WOS:000339400700015
J	del Rio, C; Mehta, AK; Lyon, M; Guarner, J				del Rio, Carlos; Mehta, Aneesh K.; Lyon, Marshall, III; Guarner, Jeannette			Ebola Hemorrhagic Fever in 2014: The Tale of an Evolving Epidemic	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VIRUS		Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Anat & Cell Biol, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University	del Rio, C (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.	cdelrio@emory.edu	del Rio, Carlos/B-3763-2012; Mehta, Aneesh/B-8054-2012; Guarner, Jeannette/B-8273-2013	del Rio, Carlos/0000-0002-0153-3517; Mehta, Aneesh/0000-0002-6552-9162; Guarner, Jeannette/0000-0001-5610-3541				Baize S., 2014, N ENGL J MED; Centers for Disease Control and Prevention, 2014, CDC URG ALL US RES A; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; SMADEL JE, 1953, AM J PUBLIC HLTH NAT, V43, P1327; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027; Wong G, 2014, TRENDS MICROBIOL, V22, P456, DOI 10.1016/j.tim.2014.04.002	10	28	28	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					746	U200		10.7326/M14-1880	http://dx.doi.org/10.7326/M14-1880			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25133433				2022-12-24	WOS:000347245600034
J	Van Nostrand, JL; Brady, CA; Jung, HY; Fuentes, DR; Kozak, MM; Johnson, TM; Lin, CY; Lin, CJ; Swiderski, DL; Vogel, H; Bernstein, JA; Attie-Bitach, T; Chang, CP; Wysocka, J; Martin, DM; Attardi, LD				Van Nostrand, Jeanine L.; Brady, Colleen A.; Jung, Heiyoun; Fuentes, Daniel R.; Kozak, Margaret M.; Johnson, Thomas M.; Lin, Chieh-Yu; Lin, Chien-Jung; Swiderski, Donald L.; Vogel, Hannes; Bernstein, Jonathan A.; Attie-Bitach, Tania; Chang, Ching-Pin; Wysocka, Joanna; Martin, Donna M.; Attardi, Laura D.			Inappropriate p53 activation during development induces features of CHARGE syndrome	NATURE			English	Article							NEURAL CREST; EMBRYONIC LETHALITY; PHENOTYPIC SPECTRUM; TUMOR SUPPRESSION; CHD7 MUTATIONS; MICE; GENE; INHIBITION; EXPRESSION; ANOMALIES	CHARGE syndrome is a multiple anomaly disorder in which patients present with a variety of phenotypes, including ocular coloboma, heart defects, choanal atresia, retarded growth and development, genitourinary hypoplasia and ear abnormalities(1). Despite 70-90% of CHARGE syndrome cases resulting from mutations in the gene CHD7, which encodes an ATP-dependent chromatin remodeller, the pathways underlying the diverse phenotypes remain poorly understood(2). Surprisingly, our studies of a knock-in mutant mouse strain that expresses a stabilized and transcriptionally dead variant of the tumour-suppressor protein p53 (p53(25,26,53,54))(3), along with a wild-type allele ofp53 (also known as Trp53), revealed late-gestational embryonic lethality associated with a host of phenotypes that are characteristic of CHARGE syndrome, including coloboma, inner and outer ear malformations, heart outflow tract defects and craniofacial defects. We found that the p53(25,26,53,54) mutant protein stabilized and hyperactivated wildtype p53, which then inappropriately induced its target genes and triggered cell-cycle arrest or apoptosis during development. Importantly, these phenotypes were only observed with a wild-type p53 allele, as p53(25,26,53,54/-) embryos were fully viable. Furthermore, we found that CHD7 can bind to the p53 promoter, thereby negatively regu-lating p53 expression, and that CHD7 loss in mouse neural crest cells or samples from patients with CHARGE syndrome results in p53 activation. Strikingly, we found that p53 heterozygosity partially rescued the phenotypes in Chd7-null mouse embryos, demonstrating that p53 contributes to the phenotypes that result from CHD7 loss. Thus, inappropriate p53 activation during development can promote CHARGE phenotypes, supporting the idea that p53 has a critical role in developmental syndromes and providing important insight into the mechanisms underlying CHARGE syndrome.	[Van Nostrand, Jeanine L.; Brady, Colleen A.; Jung, Heiyoun; Kozak, Margaret M.; Johnson, Thomas M.; Attardi, Laura D.] Stanford Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Fuentes, Daniel R.; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Lin, Chieh-Yu; Vogel, Hannes] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Lin, Chien-Jung; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Swiderski, Donald L.] Univ Michigan, Sch Med, Dept Otolaryngol, Ann Arbor, MI 48109 USA; [Bernstein, Jonathan A.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Attie-Bitach, Tania] Hop Necker Enfants Malad, APHP, Dept Genet, F-75015 Paris, France; [Attie-Bitach, Tania] Univ Paris Descartes Sorbonne Paris Cite, Inst Imagine, Unite INSERM U1163, F-75015 Paris, France; [Chang, Ching-Pin] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Martin, Donna M.] Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA; [Martin, Donna M.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Attardi, Laura D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Michigan System; University of Michigan; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Indiana University System; Indiana University Bloomington; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University	Attardi, LD (corresponding author), Stanford Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA.	attardi@stanford.edu	ATTIE-BITACH, Tania/K-1453-2017	ATTIE-BITACH, Tania/0000-0002-1155-3626; Fuentes, Daniel/0000-0002-0412-6933; Vogel, Otto Hannes/0000-0002-0960-3508; Van Nostrand, Jeanine/0000-0003-1363-9527; Kozak, Margaret/0000-0001-9111-1942	NSF; NCI [1F31CA167917-01]; NIH [RO1 GM095555, R01 HL118087, RO1 HL121197, R01 DC009410, RO1 CA140875]; American Heart Association [12EIA8960018]; March of Dimes Foundation [6-FY11-260]; ACS; LLS; NATIONAL CANCER INSTITUTE [R01CA140875, T32CA009302, F31CA167917] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118087, R01HL121197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009410] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); March of Dimes Foundation(March of Dimes); ACS(American Cancer Society); LLS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank S. Spano-Mello, K. T. Bieging, N. Raj and M. Monje-Deisseroth for reading the manuscript and S. E. Artandi and T. Williams for discussion. We thank H. Chou for immunohistochemistry assistance; E. L. Van Nostrand, P. Lavori, and A. McMillian for statistical analysis; K. Weinberg and D. Min for thymus analysis assistance; M. Shkreli for kidney analysis assistance; B. Liu and J. A. Helms for craniofacial analysis assistance; and M. Bowen for Chd7 mouse experiment assistance. We thank S. E. Artandi for plasmids; S. E. Artandi and P. Khavari for control human fibroblast cell lines; D. Lane and B. Vojtesek for wild-type p53-specific antibody (pAB242); P. Scacheri for wild-type and Chd7-null mouse embryonic stem cells; and T. Denecker and G. Goudefroye for TP53 sequencing in patients. This work was supported by funding from the NSF and NCI (grant number 1F31CA167917-01) to J.L.V.N.; from the NIH (RO1 GM095555) to J.W.; from the American Heart Association (12EIA8960018), March of Dimes Foundation (#6-FY11-260) and NIH (R01 HL118087 and RO1 HL121197) to C.-P.C.; from the NIH (R01 DC009410) to D. M. M.; and from the ACS, LLS and NIH (RO1 CA140875) to L.D.A.	Adams ME, 2007, J COMP NEUROL, V504, P519, DOI 10.1002/cne.21460; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Balow SA, 2013, DEV BIOL, V382, P57, DOI 10.1016/j.ydbio.2013.07.026; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Brock KE, 2003, AM J MED GENET A, V123A, P111, DOI 10.1002/ajmg.a.20526; Corsten-Janssen N, 2013, MOL SYNDROMOL, V4, P235, DOI 10.1159/000351127; Corsten-Janssen N, 2013, CIRC-CARDIOVASC GENE, V6, P248, DOI 10.1161/CIRCGENETICS.113.000054; DAVENPORT SLH, 1986, CLIN GENET, V29, P298; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Inoue H, 2010, EUR J PEDIATR, V169, P839, DOI 10.1007/s00431-009-1126-6; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Lane DP, 1996, ONCOGENE, V12, P2461; Legendre M, 2012, J MED GENET, V49, P698, DOI 10.1136/jmedgenet-2012-100926; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Morimoto AK, 2006, AM J NEURORADIOL, V27, P1663; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Ragan DC, 1999, J UROLOGY, V161, P622, DOI 10.1016/S0022-5347(01)61984-0; Rinon A, 2011, DEVELOPMENT, V138, P1827, DOI 10.1242/dev.053645; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; Sato TN, 2000, METH MOL B, V137, P223; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Zentner GE, 2010, AM J MED GENET A, V152A, P674, DOI 10.1002/ajmg.a.33323	35	98	98	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					228	+		10.1038/nature13585	http://dx.doi.org/10.1038/nature13585			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119037	Green Submitted, Green Accepted			2022-12-24	WOS:000342663100042
J	Kwiatkowski, DJ; Manning, BD				Kwiatkowski, David J.; Manning, Brendan D.			Molecular Basis of Giant Cells in Tuberous Sclerosis Complex	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NOVO PYRIMIDINE SYNTHESIS; MTOR; LYMPHANGIOLEIOMYOMATOSIS; GROWTH; ACTIVATION; TSC2; ANGIOMYOLIPOMA; PROLIFERATION; DOWNSTREAM; EVEROLIMUS		[Kwiatkowski, David J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Kwiatkowski, DJ (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.		Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956				Baybis M, 2004, ANN NEUROL, V56, P478, DOI 10.1002/ana.20211; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bissler JJ, 2013, LANCET, V381, P817, DOI 10.1016/S0140-6736(12)61767-X; Bourneville D., 1880, ARCH NEUROL-CHICAGO, V1, P81; Chan JA, 2004, J NEUROPATH EXP NEUR, V63, P1236, DOI 10.1093/jnen/63.12.1236; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Franz DN, 2013, LANCET, V381, P116; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4	20	38	41	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					778	780		10.1056/NEJMcibr1406613	http://dx.doi.org/10.1056/NEJMcibr1406613			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140966				2022-12-24	WOS:000340509900016
J	Deutsch, C; Berelson, W; Thunell, R; Weber, T; Tems, C; McManus, J; Crusius, J; Ito, T; Baumgartner, T; Ferreira, V; Mey, J; van Geen, A				Deutsch, Curtis; Berelson, William; Thunell, Robert; Weber, Thomas; Tems, Caitlin; McManus, James; Crusius, John; Ito, Taka; Baumgartner, Timothy; Ferreira, Vicente; Mey, Jacob; van Geen, Alexander			Centennial changes in North Pacific anoxia linked to tropical trade winds	SCIENCE			English	Article							ARABIAN SEA; OCEAN; DENITRIFICATION; VARIABILITY; HYPOXIA; PRESERVATION; CIRCULATION; DIAGENESIS; SEDIMENTS; DRIVEN	Climate warming is expected to reduce oxygen (O-2) supply to the ocean and expand its oxygen minimum zones (OMZs). We reconstructed variations in the extent of North Pacific anoxia since 1850 using a geochemical proxy for denitrification (delta N-15) from multiple sediment cores. Increasing delta N-15 since similar to 1990 records an expansion of anoxia, consistent with observed O-2 trends. However, this was preceded by a longer declining delta N-15 trend that implies that the anoxic zone was shrinking for most of the 20th century. Both periods can be explained by changes in winds over the tropical Pacific that drive upwelling, biological productivity, and O-2 demand within the OMZ. If equatorial Pacific winds resume their predicted weakening trend, the ocean's largest anoxic zone will contract despite a global O-2 decline.	[Deutsch, Curtis; Weber, Thomas] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Berelson, William; Tems, Caitlin] Univ So Calif, Dept Earth Sci, Los Angeles, CA USA; [Thunell, Robert] Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA; [McManus, James] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Crusius, John] Univ Washington, Sch Oceanog, US Geol Survey, Seattle, WA 98195 USA; [Ito, Taka] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Baumgartner, Timothy; Ferreira, Vicente] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Biol, Ensenada, Baja California, Mexico; [Mey, Jacob; van Geen, Alexander] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Mey, Jacob] CUNY, Kingsborough Community Coll, Dept Phys Sci, New York, NY 10021 USA	University of Washington; University of Washington Seattle; University of Southern California; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Oregon State University; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; University System of Georgia; Georgia Institute of Technology; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Columbia University; City University of New York (CUNY) System	Deutsch, C (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	cdeutsch@uw.edu	Ito, Takamitsu/F-3856-2010; McManus, James/GSM-7165-2022; Mey, Jacob/D-5957-2014	Ito, Takamitsu/0000-0001-9873-099X; Mey, Jacob/0000-0003-0116-4149	National Science Foundation [OCE-0851483, OCE-1242313, OCE-0727123, OCE-0624777]; Gordon and Betty Moore Foundation [GBMF3775]; U.S. Geological Survey Coastal and Marine Geology Program; Climate Center of Lamont-Doherty Earth Observatory (LDEO); Division Of Ocean Sciences [1232779] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. Geological Survey Coastal and Marine Geology Program(United States Geological Survey); Climate Center of Lamont-Doherty Earth Observatory (LDEO); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by grants from the National Science Foundation (OCE-0851483 to C.D.; OCE-1242313 to T.I.; OCE-0727123 to W.B.; OCE-0624777 to J.M.), by the Gordon and Betty Moore Foundation through Grant GBMF3775 to C.D., and by the U.S. Geological Survey Coastal and Marine Geology Program (J.C.). A grant from the Climate Center of Lamont-Doherty Earth Observatory (LDEO) contributed to the collection and dating of the Soledad Basin core. This is LDEO contribution number 7812.	Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; ALTABET MA, 1989, J GEOPHYS RES-OCEANS, V94, P12771, DOI 10.1029/JC094iC09p12771; Antonov J. I., 2010, NOAA ATLAS NESDROS I, V66; Bopp L, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001445; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; Castro CG, 2001, GLOBAL BIOGEOCHEM CY, V15, P819, DOI 10.1029/2000GB001324; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; DeVries T, 2012, NAT GEOSCI, V5, P547, DOI [10.1038/ngeo1515, 10.1038/NGEO1515]; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Ito T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041595; Ito T, 2013, GLOBAL BIOGEOCHEM CY, V27, P1119, DOI 10.1002/2013GB004567; Jaccard SL, 2012, NAT GEOSCI, V5, P151, DOI [10.1038/ngeo1352, 10.1038/NGEO1352]; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kienast SS, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000650; Koslow JA, 2013, NATURE, V502, P163, DOI 10.1038/502163a; Kritee K, 2012, GEOCHIM COSMOCHIM AC, V92, P243, DOI 10.1016/j.gca.2012.05.020; Lehmann MF, 2002, GEOCHIM COSMOCHIM AC, V66, P3573, DOI 10.1016/S0016-7037(02)00968-7; Matear RJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001997; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; Merrifield MA, 2011, J CLIMATE, V24, P4126, DOI 10.1175/2011JCLI3932.1; Prokopenko MG, 2006, EARTH PLANET SC LETT, V242, P186, DOI 10.1016/j.epsl.2005.11.044; Sherwood OA, 2014, NATURE, V505, P78, DOI 10.1038/nature12784; Sigman D. M., 2001, ENCY OCEAN SCI, V4, P1884; Sigman DM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035784; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Thunell RC, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI [10.1029/2002GB002028, 10.1029/2003GB002185]; Tokinaga H, 2012, NATURE, V491, P439, DOI 10.1038/nature11576; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; van Geen A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000911; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Weber T, 2014, P NATL ACAD SCI USA, V111, P8741, DOI 10.1073/pnas.1317193111	39	106	106	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					665	668		10.1126/science.1252332	http://dx.doi.org/10.1126/science.1252332			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104384				2022-12-24	WOS:000339962800037
J	Ghosh, R; Wang, L; Wang, ES; Perera, BGK; Igbaria, A; Morita, S; Prado, K; Thamsen, M; Caswell, D; Macias, H; Weiberth, KF; Gliedt, MJ; Alavi, MV; Hari, SB; Mitra, AK; Bhhatarai, B; Schurer, SC; Snapp, EL; Gould, DB; German, MS; Backes, BJ; Maly, DJ; Oakes, SA; Papa, FR				Ghosh, Rajarshi; Wang, Likun; Wang, Eric S.; Perera, B. Gayani K.; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Caswell, Deborah; Macias, Hector; Weiberth, Kurt F.; Gliedt, Micah J.; Alavi, Marcel V.; Hari, Sanjay B.; Mitra, Arinjay K.; Bhhatarai, Barun; Schuerer, Stephan C.; Snapp, Erik L.; Gould, Douglas B.; German, Michael S.; Backes, Bradley J.; Maly, Dustin J.; Oakes, Scott A.; Papa, Feroz R.			Allosteric Inhibition of the IRE1 alpha RNase Preserves Cell Viability and Function during Endoplasmic Reticulum Stress	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; NLRP3 INFLAMMASOME; MESSENGER-RNAS; IRE1; KINASE; DEATH; TRANSLATION	Depending on endoplasmic reticulum (ER) stress levels, the ER transmembrane multidomain protein IRE1 alpha promotes either adaptation or apoptosis. Unfolded ER proteins cause IRE1a lumenal domain homo-oligomerization, inducing trans autophosphorylation that further drives homo-oligomerization of its cytosolic kinase/endoribonuclease (RNase) domains to activatem RNA splicing of adaptive XBP1 transcription factor. However, under high/chronic ER stress, IRE1a surpasses an oligomerization threshold that expands RNase substrate repertoire to many ER-localized mRNAs, leading to apoptosis. To modulate these effects, we developed ATP-competitive IRE1a Kinase-Inhibiting RNase Attenuators-KIRAs-that allosterically inhibit IRE1 alpha's RNase by breaking oligomers. One optimized KIRA, KIRA6, inhibits IRE1a in vivo and promotes cell survival under ER stress. Intravitreally, KIRA6 preserves photoreceptor functional viability in rat models of ER stress-induced retinal degeneration. Systemically, KIRA6 preserves pancreatic beta cells, increases insulin, and reduces hyperglycemia in Akita diabetic mice. Thus, IRE1a powerfully controls cell fate but can itself be controlled with small molecules to reduce cell degeneration.	[Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Macias, Hector; Weiberth, Kurt F.; Gliedt, Micah J.; German, Michael S.; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Eric S.; Caswell, Deborah; Oakes, Scott A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Alavi, Marcel V.; Gould, Douglas B.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Gould, Douglas B.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Macias, Hector; Weiberth, Kurt F.; German, Michael S.; Oakes, Scott A.; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Weiberth, Kurt F.; Gliedt, Micah J.; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Ghosh, Rajarshi; Wang, Likun; Igbaria, Aeid; Morita, Shuhei; Prado, Kris; Thamsen, Maike; Weiberth, Kurt F.; Papa, Feroz R.] Univ Calif San Francisco, California Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Perera, B. Gayani K.; Hari, Sanjay B.; Mitra, Arinjay K.; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Schuerer, Stephan C.] Univ Miami, Miller Sch Med, Ctr Computat Sci, Miami, FL 33136 USA; [Bhhatarai, Barun; Schuerer, Stephan C.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Snapp, Erik L.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Miami; University of Miami; Yeshiva University; Albert Einstein College of Medicine	Oakes, SA (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	scott.oakes@ucsf.edu; frpapa@medicine.ucsf.edu	Igbaria, Aeid/S-6871-2019	Alavi, Marcel/0000-0002-1319-3062; Maly, Dustin/0000-0003-0094-0177; Igbaria, Aeid/0000-0003-3940-1824; /0000-0003-0606-9896; Ghosh, Rajarshi/0000-0002-5780-8241; Snapp, Erik/0000-0001-9482-2272; Papa, Feroz/0000-0002-3684-9108; Bhhatarai, Barun/0000-0002-0109-7487	National Institutes of Health [DP2OD001925, RO1 CA136577, RO1 DK080955, RO1 DK095306, RO1 DK100623, PO1 HL108794, P30 DK063720, UO1 DK089541, RO1 DK021344, RO1 GM086858, R21 CA177402, EY019504, EY01919, EY06842, F31-NS083323]; HHMI Physician-Scientist Early Career Award; American Cancer Society Research Scholar Award; Burroughs Wellcome Foundation; Juvenile Diabetes Research Foundation; Harrington Discovery Institute Scholar-Innovator Award; Alfred P. Sloan Foundation; Camille and Henry Dreyfus Foundation; National Science Foundation; American Diabetes Association [ADA-7-07-MN-22]; NATIONAL CANCER INSTITUTE [R21CA177402, R01CA136577] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY001919, F32EY006842, R37EY001919, R01EY006842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021344, R01DK095306, U01DK089541, P30DK063720, R01DK080955, R01DK100623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS083323] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Physician-Scientist Early Career Award(Howard Hughes Medical Institute); American Cancer Society Research Scholar Award(American Cancer Society); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Harrington Discovery Institute Scholar-Innovator Award; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Camille and Henry Dreyfus Foundation; National Science Foundation(National Science Foundation (NSF)); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Michael Matthes and Doug Yasumura for technical assistance with rat models, Vinh Nguyen for islet isolation, and Oakes and Papa lab members for discussions. The work was supported by National Institutes of Health grants DP2OD001925 (F. R. P.), RO1 CA136577 (S. A. O.), RO1 DK080955 (F. R. P.), RO1 DK095306 (S. A. O. and F. R. P.), RO1 DK100623 (D.J.M. and F. R. P.), PO1 HL108794 (F. R. P.), P30 DK063720 (F. R. P. and M. S. G.), UO1 DK089541 (F. R. P. and M. S. G.), RO1 DK021344 (M. S. G.), RO1 GM086858 (D.J.M.), R21 CA177402 (D.J.M.), EY019504 (D. B. G.), EY01919 (D. B. G.), EY06842 (D. B. G.), and F31-NS083323 (E. S. W.); HHMI Physician-Scientist Early Career Award (S. A. O.); American Cancer Society Research Scholar Award (S. A. O.); Burroughs Wellcome Foundation (F. R. P.); Juvenile Diabetes Research Foundation (F. R. P. and S. A. O.); Harrington Discovery Institute Scholar-Innovator Award (S. A. O. and F. R. P.); Alfred P. Sloan Foundation (D.J.M.); Camille and Henry Dreyfus Foundation (D.J.M.); National Science Foundation (E. S. W.); and American Diabetes Association ADA-7-07-MN-22 (H. M. S.).	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Kohno K, 2007, ANTIOXID REDOX SIGN, V9, P2295, DOI 10.1089/ars.2007.1819; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Pennesi ME, 2008, EXP EYE RES, V87, P561, DOI 10.1016/j.exer.2008.09.004; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Shimazawa M, 2007, MOL VIS, V13, P578; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang LK, 2012, NAT CHEM BIOL, V8, P982, DOI [10.1038/NCHEMBIO.1094, 10.1038/nchembio.1094]; Xue Z, 2011, J BIOL CHEM, V286, P30859, DOI 10.1074/jbc.M111.273714; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	38	309	322	2	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					534	548		10.1016/j.cell.2014.07.002	http://dx.doi.org/10.1016/j.cell.2014.07.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25018104	Bronze, Green Accepted			2022-12-24	WOS:000340944300008
J	Johnson, AS; Hall, HI; Hu, XH; Lansky, A; Holtgrave, DR; Mermin, J				Johnson, Anna Satcher; Hall, H. Irene; Hu, Xiaohong; Lansky, Amy; Holtgrave, David R.; Mermin, Jonathan			Trends in Diagnoses of HIV Infection in the United States. 2002-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Johnson, Anna Satcher; Hall, H. Irene; Hu, Xiaohong; Lansky, Amy] Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Atlanta, GA USA; [Holtgrave, David R.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Mermin, Jonathan] CDC, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA	Johnson, AS (corresponding author), CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, 1600 Clifton Rd NE, Atlanta, GA 30329 USA.	ats5@cdc.gov		Holtgrave, David/0000-0002-4321-7395	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Centers for Disease Control and Prevention, MONITORING SELECTED; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Paz-Bailey G, 2013, MMWR-MORBID MORTAL W, V62, P958; Ries LAG, 2002, SEER CANCER STATISTI; Whitmore Suzanne K., 2012, Morbidity and Mortality Weekly Report, V61, P971	6	110	110	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2014	312	4					432	434		10.1001/jama.2014.8534	http://dx.doi.org/10.1001/jama.2014.8534			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL6QN	25038362	Green Accepted, Bronze			2022-12-24	WOS:000339257800030
J	Belcheva, A; Irrazabal, T; Robertson, SJ; Streutker, C; Maughan, H; Rubino, S; Moriyama, EH; Copeland, JK; Kumar, S; Green, B; Geddes, K; Pezo, RC; Navarre, WW; Milosevic, M; Wilson, BC; Girardin, SE; Wolever, TMS; Edelmann, W; Guttman, DS; Philpott, DJ; Martin, A				Belcheva, Antoaneta; Irrazabal, Thergiory; Robertson, Susan J.; Streutker, Catherine; Maughan, Heather; Rubino, Stephen; Moriyama, Eduardo H.; Copeland, Julia K.; Kumar, Sachin; Green, Blerta; Geddes, Kaoru; Pezo, Rossanna C.; Navarre, William W.; Milosevic, Michael; Wilson, Brian C.; Girardin, Stephen E.; Wolever, Thomas M. S.; Edelmann, Winfried; Guttman, David S.; Philpott, Dana J.; Martin, Alberto			Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells	CELL			English	Article							MULTIPLE INTESTINAL NEOPLASIA; DIETARY GLYCEMIC LOAD; COLORECTAL-CANCER; MISMATCH-REPAIR; DNA-DAMAGE; BUTYRATE; TUMORIGENESIS; INFLAMMATION; DEFICIENCY; ACTIVATION	The etiology of colorectal cancer (CRC) has been linked to deficiencies in mismatch repair and adenomatous polyposis coli (APC) proteins, diet, inflammatory processes, and gut microbiota. However, the mechanism through which the microbiota synergizes with these etiologic factors to promote CRC is not clear. We report that altering the microbiota composition reduces CRC in APC(Min/+) MSH2(-/-) mice, and that a diet reduced in carbohydrates phenocopies this effect. Gut microbes did not induce CRC in these mice through an inflammatory response or the production of DNA mutagens but rather by providing carbohydrate-derived metabolites such as butyrate that fuel hyperproliferation of MSH2(-/-) colon epithelial cells. Further, we provide evidence that the mismatch repair pathway has a role in regulating beta-catenin activity and modulating the differentiation of transit-amplifying cells in the colon. These data thereby provide an explanation for the interaction between microbiota, diet, and mismatch repair deficiency in CRC induction.	[Belcheva, Antoaneta; Irrazabal, Thergiory; Robertson, Susan J.; Kumar, Sachin; Green, Blerta; Geddes, Kaoru; Philpott, Dana J.; Martin, Alberto] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Streutker, Catherine] St Michaels Hosp, Dept Lab Med, Toronto, ON M5S 1W8, Canada; [Maughan, Heather] Ronin Inst, Montclair, NJ 07043 USA; [Rubino, Stephen; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5S 1A8, Canada; [Moriyama, Eduardo H.; Wilson, Brian C.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Copeland, Julia K.; Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON M5S 3B2, Canada; [Pezo, Rossanna C.] Univ Toronto, Dept Med Oncol, Toronto, ON M5S 1A8, Canada; [Navarre, William W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Milosevic, Michael] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada; [Wolever, Thomas M. S.] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada; [Edelmann, Winfried] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Yeshiva University; Albert Einstein College of Medicine	Martin, A (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	alberto.martin@utoronto.ca	Wolever, Thomas/AAC-8066-2022	Milosevic, Michael/0000-0002-9620-6876; Irrazabal, Thergiory/0000-0003-0388-131X; Martin, Alberto/0000-0002-0795-0418; Wilson, Brian C./0000-0001-5543-666X; Navarre, William/0000-0002-9293-9220; Belcheva, Antoaneta/0000-0001-5061-7533; Kumar, Sachin/0000-0002-4853-3864	Becas Chile; DFATD Canada; CIHR [MOP-86683, MSH-87729]; Cancer Research Society [MOP66965]; Lotte & John Hecht Memorial Foundation grant of the Canadian Cancer Society [702027]; Canada Research Chair award	Becas Chile; DFATD Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Lotte & John Hecht Memorial Foundation grant of the Canadian Cancer Society; Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We are thankful to Drs. M. Shulman, M. Ohh, J. Mogridge, J. Danska, J. Carlyle, J. Gommerman, R. Bruce, and the Martin laboratory for helpful discussions and for reading the manuscript. We thank Maribel Berru and Kervan Rivera-Rufner for technical help. We acknowledge Becas Chile and DFATD Canada for sponsoring T.I. This research is supported by a CIHR grant to D.S.G. and to W.W.N. (MOP-86683, MSH-87729) and by a Cancer Research Society grant (MOP66965) and the Lotte & John Hecht Memorial Foundation grant of the Canadian Cancer Society (#702027) to A.M., who is supported by a Canada Research Chair award.	Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Arthur JC, 2011, INFLAMM BOWEL DIS, V17, P396, DOI 10.1002/ibd.21354; BARTHOLD SW, 1977, CANCER RES, V37, P4352; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Donohoe DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046589; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Dove WF, 1997, CANCER RES, V57, P812; Fernandes J, 2011, EUR J CLIN NUTR, V65, P1279, DOI 10.1038/ejcn.2011.116; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Franceschi S, 2001, ANN ONCOL, V12, P173, DOI 10.1023/A:1008304128577; FREEMAN HJ, 1986, GASTROENTEROLOGY, V91, P596, DOI 10.1016/0016-5085(86)90628-1; Gnagnarella P, 2008, AM J CLIN NUTR, V87, P1793, DOI 10.1093/ajcn/87.6.1793; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; HERR R, 1990, AM J HEMATOL, V34, P1, DOI 10.1002/ajh.2830340102; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; KLEIN RS, 1977, NEW ENGL J MED, V297, P800, DOI 10.1056/NEJM197710132971503; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kucherlapati MH, 2010, GASTROENTEROLOGY, V138, P993, DOI 10.1053/j.gastro.2009.11.009; Lazarova DL, 2004, INT J CANCER, V110, P523, DOI 10.1002/ijc.20152; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Lupton JR, 2004, J NUTR, V134, P479, DOI 10.1093/jn/134.2.479; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Meyerhardt JA, 2012, JNCI-J NATL CANCER I, V104, P1702, DOI 10.1093/jnci/djs399; Miller PE, 2010, NUTR CANCER, V62, P413, DOI 10.1080/01635580903407114; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Olive PL, 2005, CYTOM PART A, V66A, P1, DOI 10.1002/cyto.a.20154; Peters AC, 2003, DNA REPAIR, V2, P427, DOI 10.1016/S1568-7864(03)00003-X; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Reitmair AH, 1996, CANCER RES, V56, P2922; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Roy Claude C, 2006, Nutr Clin Pract, V21, P351, DOI 10.1177/0115426506021004351; Senda T, 2007, MED MOL MORPHOL, V40, P68, DOI 10.1007/s00795-006-0352-5; Shoemaker AR, 2000, ONCOGENE, V19, P2774, DOI 10.1038/sj.onc.1203574; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sohn KJ, 2003, CARCINOGENESIS, V24, P217, DOI 10.1093/carcin/24.2.217; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015	54	275	285	1	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					288	299		10.1016/j.cell.2014.04.051	http://dx.doi.org/10.1016/j.cell.2014.04.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036629	Bronze			2022-12-24	WOS:000340943600010
J	Hom, EFY; Murray, AW				Hom, Erik F. Y.; Murray, Andrew W.			Niche engineering demonstrates a latent capacity for fungal-algal mutualism	SCIENCE			English	Article							EVOLUTION; TRANSITIONS; SYMBIOSIS; LICHENS	Mutualistic symbioses shape the evolution of species and ecosystems and catalyze the emergence of biological complexity, yet how such symbioses first form is unclear. We show that an obligate mutualism between the yeast Saccharomyces cerevisiae and the alga Chlamydomonas reinhardtii-two model eukaryotes with very different life histories-can arise spontaneously in an environment requiring reciprocal carbon and nitrogen exchange. This capacity for mutualism is phylogenetically broad, extending to other Chlamydomonas and fungal species. Furthermore, we witnessed the spontaneous association of Chlamydomonas algal cells physically interacting with filamentous fungi. These observations demonstrate that under specific conditions, environmental change induces free-living species to become obligate mutualists and establishes a set of experimentally tractable, phylogenetically related, synthetic systems for studying the evolution of symbiosis.	[Hom, Erik F. Y.; Murray, Andrew W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hom, Erik F. Y.; Murray, Andrew W.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Hom, EFY (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	erik@fyhom.com; amurray@mcb.harvard.edu	Hom, Erik/B-3889-2008	Hom, Erik/0000-0003-0964-0031	Jane Coffin Childs postdoctoral fellowship; National Institute of General Medical Sciences Center for Modular Biology (NIH) [P50-GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	Jane Coffin Childs postdoctoral fellowship; National Institute of General Medical Sciences Center for Modular Biology (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Justman, B. Stern, A. Pringle, S. Sasso, M. Dayel, N. Collins, J. Hess, M. Mueller, G. Frenkel, S. Kryazhimskiy, M. McDonald, D. Van Dyken, E. Wallace, K. Zimmerman, P. Boynton, J. Calarco, D. Chiang, Y. Eun, K. Foster, R. Losick, W. Tong, Y. Katz, and members of the Murray and Nelson labs for helpful feedback. We thank D. Thompson, M. Dunham, F. Winston, and N. Rhind for yeast strains; T. Schinko and J. Strauss for A. nidulans strains; and the Fungal Genetics Stock Center (Kansas City, MO) for fungal strains. We thank P. Rogers, M. Tam, and B. Tilton (Faculty of Arts and Sciences Center for Systems Biology FACS Core); B. Goetze, C. Kraft, and D. Richardson (Harvard Center for Biological Imaging); M. Yankova and S. King (Central Electron Microscopy Facility, University of Connecticut Health Center) for their resources and assistance; and U. Goodenough for her help in interpreting electron micrographs. Supported in part by a Jane Coffin Childs postdoctoral fellowship to E.F.Y.H. and by the National Institute of General Medical Sciences Center for Modular Biology (NIH grant P50-GM068763). Additional data described in this work can be found in the online supplementary materials. E.F.Y.H. conceived the project, performed the experiments, and analyzed the data. E.F.Y.H. and A.W.M. devised the research and wrote the manuscript. A.W.M. supported and provided input throughout all stages of this work.	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; AZUARA MP, 1983, PLANT PHYSIOL, V71, P286, DOI 10.1104/pp.71.2.286; Bronstein J.L., 2009, PRINCETON GUIDE ECOL, P233, DOI DOI 10.1515/9781400833023.233; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Douglas A.E., 2010, SYMBIOTIC HABIT; Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; HAWKSWORTH DL, 1988, BOT J LINN SOC, V96, P3, DOI 10.1111/j.1095-8339.1988.tb00623.x; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Holland JN, 2010, ECOLOGY, V91, P1286, DOI 10.1890/09-1163.1; HONEGGER R, 1986, NEW PHYTOL, V103, P785, DOI 10.1111/j.1469-8137.1986.tb00853.x; Honegger R, 2012, FUNGAL ASS, P287, DOI [10.1007/978-3-642-30826-0_15, DOI 10.1007/978-3-642-30826-0_15]; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Kohlmeyer J, 1979, MARINE MYCOLOGY HIGH, P70; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Momeni B, 2011, CELL MOL LIFE SCI, V68, P1353, DOI 10.1007/s00018-011-0649-y; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Muller MJI, 2014, P NATL ACAD SCI USA, V111, P1037, DOI 10.1073/pnas.1313285111; Paracer S, 2000, SYMBIOSIS INTRO BIOL, V2nd; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031	24	133	136	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					94	98		10.1126/science.1253320	http://dx.doi.org/10.1126/science.1253320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994654	Green Accepted			2022-12-24	WOS:000338284400058
J	Dail, M; Wong, J; Lawrence, J; O'Connor, D; Nakitandwe, J; Chen, SC; Xu, J; Lee, LB; Akagi, K; Li, Q; Aster, JC; Pear, WS; Downing, JR; Sampath, D; Shannon, K				Dail, Monique; Wong, Jason; Lawrence, Jessica; O'Connor, Daniel; Nakitandwe, Joy; Chen, Shann-Ching; Xu, Jin; Lee, Leslie B.; Akagi, Keiko; Li, Qing; Aster, Jon C.; Pear, Warren S.; Downing, James R.; Sampath, Deepak; Shannon, Kevin			Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PTEN; MUTATIONS; FREQUENCY	Mutations that deregulate Notch1 and Ras/phosphoinositide 3 kinase (PI3K)/Akt signalling are prevalent in T-cell acute lymphoblastic leukaemia (T-ALL), and often coexist. Here we show that the PI3K inhibitor GDC-0941 is active against primary T-ALLs from wild-type and Kras(G12D) mice, and addition of the MEK inhibitor PD0325901 increases its efficacy. Mice invariably relapsed after treatment with drug-resistant clones, most of which unexpectedly had reduced levels of activated Notch1 protein, downregulated many Notch1 target genes, and exhibited cross-resistance to gamma-secretase inhibitors. Multiple resistant primary T-ALLs that emerged in vivo did not contain somatic Notch1 mutations present in the parental leukaemia. Importantly, resistant clones upregulated PI3K signalling. Consistent with these data, inhibiting Notch1 activated the PI3K pathway, providing a likely mechanism for selection against oncogenic Notch1 signalling. These studies validate PI3K as a therapeutic target in T-ALL and raise the unexpected possibility that dual inhibition of PI3K and Notch1 signalling could promote drug resistance in T-ALL.	[Dail, Monique; Wong, Jason; Lawrence, Jessica; O'Connor, Daniel; Xu, Jin; Shannon, Kevin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Dail, Monique; Wong, Jason; Lawrence, Jessica; O'Connor, Daniel; Xu, Jin; Shannon, Kevin] Univ Calif San Francisco, Benniof Childrens Hosp, San Francisco, CA 94143 USA; [Nakitandwe, Joy; Chen, Shann-Ching; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Lee, Leslie B.; Sampath, Deepak] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Akagi, Keiko] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Li, Qing] Univ Michigan, Dept Med, Div Haematol Oncol, Ann Arbor, MI 48109 USA; [Aster, Jon C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Pear, Warren S.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Pear, Warren S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; St Jude Children's Research Hospital; Roche Holding; Genentech; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Shannon, K (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	shannonk@peds.ucsf.edu	Downing, James R./N-8102-2018		William Lawrence and Blanche Hughes Foundation; Specialized Center of Research (SCOR) from the Leukaemia and Lymphoma Society of America [7019, 7703]; National Institutes of Health [R37 CA72614, R01 CA180037, K99 CA157950, K08 CA134649, P01 CA119070]; ALSAC of St. Jude Children's Research Hospital; Ohio Supercomputer Center [PAS0425]; Ohio Cancer Research Associate [GRT00024299]; American Cancer Society (ACS); NATIONAL CANCER INSTITUTE [K99CA157950, K08CA134649, R01CA180037, R37CA072614, U01CA084221, T32CA128583, P01CA119070, P30CA021765] Funding Source: NIH RePORTER	William Lawrence and Blanche Hughes Foundation; Specialized Center of Research (SCOR) from the Leukaemia and Lymphoma Society of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Ohio Supercomputer Center; Ohio Cancer Research Associate; American Cancer Society (ACS)(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the William Lawrence and Blanche Hughes Foundation to J.C.A. and K. S.; by Specialized Center of Research (SCOR) awards 7019 and 7703 from the Leukaemia and Lymphoma Society of America; by National Institutes of Health grants R37 CA72614 and R01 CA180037 (to K. S.), K99 CA157950 (to M. D.), K08 CA134649 (to Q. L.) and P01 CA119070 (to J.C.A. and W. S. P.), and by the ALSAC of St. Jude Children's Research Hospital (J.R.D.). K. A. is supported by the Ohio Supercomputer Center (#PAS0425) and is an Ohio Cancer Research Associate (#GRT00024299); and J.X received a Research Fellowship from the American Cancer Society (ACS). K. S. is an ACS Research Professor. We are grateful to T. Jacks and D. Tuveson for Kras<SUP>G12D</SUP> mice; to L. Wolff for the MOL4070 virus; and to D. Largaespada and G. Narla for sharing their advice and expertise.	Aster JC, 1997, J BIOL CHEM, V272, P11336; Aster JC, 2012, J CLIN ONCOL, V30, P2418, DOI 10.1200/JCO.2012.42.0992; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Blackburn JS, 2014, CANCER CELL, V25, P366, DOI 10.1016/j.ccr.2014.01.032; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Corcoran RB, 2011, ONCOTARGET, V2, P336; Dail M, 2010, P NATL ACAD SCI USA, V107, P5106, DOI 10.1073/pnas.1001064107; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Gutierrez A, 2011, J EXP MED, V208, P1595, DOI 10.1084/jem.20101691; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Hales EC, 2013, J BIOL CHEM, V288, P22836, DOI 10.1074/jbc.M113.451625; HAWLEY RG, 1994, GENE THER, V1, P136; Jotta PY, 2010, LEUKEMIA, V24, P239, DOI 10.1038/leu.2009.209; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Mansour MR, 2007, CLIN CANCER RES, V13, P6964, DOI 10.1158/1078-0432.CCR-07-1474; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Shieh A., 2013, BLOOD; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Tosello V, 2013, THER ADV HEMATOL, V4, P199, DOI 10.1177/2040620712471368; Trinquand A, 2013, J CLIN ONCOL, V31, P4333, DOI 10.1200/JCO.2012.48.5292; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	33	47	49	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					512	+		10.1038/nature13495	http://dx.doi.org/10.1038/nature13495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043004	Green Accepted			2022-12-24	WOS:000342075800032
J	Kwon, I; Xiang, SH; Kato, M; Wu, L; Theodoropoulos, P; Wang, T; Kim, J; Yun, J; Xie, Y; McKnight, SL				Kwon, Ilmin; Xiang, Siheng; Kato, Masato; Wu, Leeju; Theodoropoulos, Pano; Wang, Tao; Kim, Jiwoong; Yun, Jonghyun; Xie, Yang; McKnight, Steven L.			Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells	SCIENCE			English	Article							SR SPLICING FACTORS; INTRANUCLEAR DISTRIBUTION; HEXANUCLEOTIDE REPEAT; PROTEIN-KINASES; ALS; DEGENERATION; EXPANSION; GRANULES; SEQUENCE; FOCI	Many RNA regulatory proteins controlling pre-messenger RNA splicing contain serine: arginine (SR) repeats. Here, we found that these SR domains bound hydrogel droplets composed of fibrous polymers of the low-complexity domain of heterogeneous ribonucleoprotein A2 (hnRNPA2). Hydrogel binding was reversed upon phosphorylation of the SR domain by CDC2-like kinases 1 and 2 (CLK1/2). Mutated variants of the SR domains changing serine to glycine (SR-to-GR variants) also bound to hnRNPA2 hydrogels but were not affected by CLK1/2. When expressed in mammalian cells, these variants bound nucleoli. The translation products of the sense and antisense transcripts of the expansion repeats associated with the C9orf72 gene altered in neurodegenerative disease encode GR(n) and PRn repeat polypeptides. Both peptides bound to hnRNPA2 hydrogels independent of CLK1/2 activity. When applied to cultured cells, both peptides entered cells, migrated to the nucleus, bound nucleoli, and poisoned RNA biogenesis, which caused cell death.	[Kwon, Ilmin; Xiang, Siheng; Kato, Masato; Wu, Leeju; Theodoropoulos, Pano; McKnight, Steven L.] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Wang, Tao; Kim, Jiwoong; Yun, Jonghyun; Xie, Yang] UT Southwestern Med Ctr, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), UT Southwestern Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu	Wang, Tao/K-3518-2016; Yun, Jonghyun/Z-2461-2019; Xiang, Siheng/A-5063-2010	Yun, Jonghyun/0000-0002-9599-4356; Xiang, Siheng/0000-0003-4475-5707	NIGMS NIH HHS [U01 GM107623] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM107623] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Aubol BE, 2013, J MOL BIOL, V425, P2894, DOI 10.1016/j.jmb.2013.05.013; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Bubulya PA, 2004, J CELL BIOL, V167, P51, DOI 10.1083/jcb.200404120; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Menegay HJ, 2000, J CELL SCI, V113, P3241; Mizielinska S, 2013, ACTA NEUROPATHOL, V126, P845, DOI 10.1007/s00401-013-1200-z; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; NEUGEBAUER KM, 1995, J CELL BIOL, V129, P899, DOI 10.1083/jcb.129.4.899; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; THIRY M, 1995, EUR J CELL BIOL, V68, P14; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	27	395	395	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1139	1145		10.1126/science.1254917	http://dx.doi.org/10.1126/science.1254917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25081482	Green Accepted			2022-12-24	WOS:000341179800037
J	Goldoni, M; Bonini, S; Urban, ML; Palmisano, A; De Palma, G; Galletti, E; Coggiola, M; Buzio, C; Mutti, A; Vaglio, A				Goldoni, Matteo; Bonini, Silvia; Urban, Maria L.; Palmisano, Alessandra; De Palma, Giuseppe; Galletti, Elisa; Coggiola, Marco; Buzio, Carlo; Mutti, Antonio; Vaglio, Augusto			Asbestos and Smoking as Risk Factors for Idiopathic Retroperitoneal Fibrosis	ANNALS OF INTERNAL MEDICINE			English	Article							LUNG-CANCER; CHRONIC PERIAORTITIS; EXPOSURE; DISEASE; GUIDELINES; MECHANISMS	Background: Idiopathic retroperitoneal fibrosis (RPF) is a rare disease. Asbestos exposure has been proposed as a risk factor for idiopathic RPF. Objective: To investigate the role of asbestos and other occupational agents (such as silica, metals, and organic solvents), as well as environmental agents (such as smoking), and their interactions as potential risk factors for idiopathic RPF. Design: Case-control study. Setting: National referral hospital for idiopathic RPF. Patients: 90 patients with idiopathic RPF and 270 control participants matched for age, sex, and region of residency. Measurements: Occupational history was obtained using structured questionnaires administered by blinded specialists in occupational medicine. Exposure to nonoccupational agents and presence of diseases that were potentially predisposing to idiopathic RPF were assessed through patient interviews and examination of medical records. Results: A history of asbestos exposure was associated with idiopathic RPF (odds ratio [OR], 4.22 [95% CI, 2.14 to 8.33]). Both current smoking (OR, 3.21 [CI, 1.46 to 7.07]) and former smoking (OR, 2.93 [CI, 1.39 to 6.14]) were more prevalent among patients than among those who never smoked. A multiplicative effect was found between tobacco smoke and both occupational asbestos exposure (OR, 12.04 [CI, 4.32 to 38.28]) and extraoccupational asbestos exposure (OR, 8.42 [CI, 2.77 to 30.58]). Limitation: Retrospective, questionnaire-based assessment of occupational exposure. Conclusion: Exposure to asbestos and tobacco smoke resulted in strong risk factors for idiopathic RPF. Coexposure to asbestos and smoke had a multiplicative effect on risk compared with single exposure.	Univ Parma, Italian Workers Compensat Author Res Ctr, I-43100 Parma, Italy; Univ Hosp, Parma, Italy; Univ Brescia, Brescia, Italy	University of Parma; University of Parma; University Hospital of Parma; University of Brescia	Vaglio, A (corresponding author), Azienda Osped Univ Parma, Unita Operat Nefrol, Via Gramsci 14, I-43126 Parma, Italy.	augusto.vaglio@virgilio.it	Goldoni, Matteo/E-9153-2011; , De Palma Giuseppe/F-1147-2010; Mutti, Antonio/AAB-9037-2020; Mutti, Antonio/ABE-3833-2021; Mutti, Antonio/C-1095-2011; Vaglio, Augusto/AHE-8117-2022	Goldoni, Matteo/0000-0002-1342-3921; , De Palma Giuseppe/0000-0001-9821-3060; Mutti, Antonio/0000-0003-2189-3808; Mutti, Antonio/0000-0003-2189-3808; Vaglio, Augusto/0000-0002-3814-9172; Urban, Maria Letizia/0000-0003-1334-9538				Berry G, 2004, ANN OCCUP HYG, V48, P459, DOI 10.1093/annhyg/meh023; BOULARD JC, 1995, LANCET, V345, P1379, DOI 10.1016/S0140-6736(95)92584-8; Bovenzi M, 2004, INT ARCH OCC ENV HEA, V77, P10, DOI 10.1007/s00420-003-0462-5; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Case BW, 2006, OCCUP ENVIRON MED, V63, P507, DOI 10.1136/oem.2006.027631; Cronin CG, 2008, AM J ROENTGENOL, V191, P423, DOI 10.2214/AJR.07.3629; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gilkeson GS, 1996, RHEUM DIS CLIN N AM, V22, P23, DOI 10.1016/S0889-857X(05)70260-X; Goldberg M, 2009, EUR J CANCER PREV, V18, P489, DOI 10.1097/CEJ.0b013e32832f9bee; Gustavsson P, 2002, AM J EPIDEMIOL, V155, P1016, DOI 10.1093/aje/155.11.1016; Heiat A, 2001, ARCH INTERN MED, V161, P1194, DOI 10.1001/archinte.161.9.1194; Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P57, DOI 10.1097/BOR.0b013e3283418057; MAGUIRE GP, 1991, NEW YORK STATE J MED, V91, P357; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Martorana D, 2006, ARTHRIT RHEUM-ARTHR, V55, P126, DOI 10.1002/art.21698; MITCHINSON MJ, 1984, HISTOPATHOLOGY, V8, P589, DOI 10.1111/j.1365-2559.1984.tb02371.x; Nesti M, 2004, AM J IND MED, V45, P55, DOI 10.1002/ajim.10313; NICHOLSON W J, 1982, American Journal of Industrial Medicine, V3, P259, DOI 10.1002/ajim.4700030305; PARUMS DV, 1990, ARCH PATHOL LAB MED, V114, P383; Pfau JC, 2005, ENVIRON HEALTH PERSP, V113, P25, DOI 10.1289/ehp.7431; Pipitone N, 2012, BEST PRACT RES CL RH, V26, P439, DOI 10.1016/j.berh.2012.07.004; Semple SE, 2004, SCAND J WORK ENV HEA, V30, P241, DOI 10.5271/sjweh.785; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Uibu T, 2004, LANCET, V363, P1422, DOI 10.1016/S0140-6736(04)16100-X; Uibu T, 2009, BMJ CASE REP, V2009; Vaglio A, 2006, LANCET, V367, P241, DOI 10.1016/S0140-6736(06)68035-5; Vaglio A, 2011, LANCET, V378, P338, DOI 10.1016/S0140-6736(11)60934-3; VAINIO H, 1994, SCAND J WORK ENV HEA, V20, P235, DOI 10.5271/sjweh.1402; van Bommel EFH, 2009, MEDICINE, V88, P193, DOI 10.1097/MD.0b013e3181afc420; Wood DM, 2005, TOB CONTROL, V14, P141, DOI 10.1136/tc.2004.009977; Wraith D, 2008, STAT METHODS MED RES, V17, P171, DOI 10.1177/0962280206075525	31	48	53	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3					181	U130		10.7326/M13-2648	http://dx.doi.org/10.7326/M13-2648			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3KH	25089862				2022-12-24	WOS:000340486000003
J	Rao, JN; Madasu, Y; Dominguez, R				Rao, Jampani Nageswara; Madasu, Yadaiah; Dominguez, Roberto			Mechanism of actin filament pointed-end capping by tropomodulin	SCIENCE			English	Article							BACTERIAL EFFECTOR VOPL; TROPOMYOSIN BINDING; THIN-FILAMENTS; F-ACTIN; MUSCLE; DOMAIN; CELLS; NUCLEATION; MODEL	Proteins that cap the ends of the actin filament are essential regulators of cytoskeleton dynamics. Whereas several proteins cap the rapidly growing barbed end, tropomodulin (Tmod) is the only protein known to cap the slowly growing pointed end. The lack of structural information severely limits our understanding of Tmod's capping mechanism. We describe crystal structures of actin complexes with the unstructured amino-terminal and the leucine-rich repeat carboxy-terminal domains of Tmod. The structures and biochemical analysis of structure-inspired mutants showed that one Tmod molecule interacts with three actin subunits at the pointed end, while also contacting two tropomyosin molecules on each side of the filament. We found that Tmod achieves high-affinity binding through several discrete low-affinity interactions, which suggests a mechanism for controlled subunit exchange at the pointed end.	[Rao, Jampani Nageswara; Madasu, Yadaiah; Dominguez, Roberto] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Dominguez, R (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	droberto@mail.med.upenn.edu		Dominguez, Roberto/0000-0003-3186-5229	NIH [R01 GM073791, GM-0080]; U.S. Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant R01 GM073791. X-ray data collection at beamline X6A of the National Synchrotron Light Source was supported by NIH grant GM-0080 and U.S. Department of Energy contract DE-AC02-98CH10886. We thank G. Rebowski for the preparation of actin and TM for this study and W. Lehman and M. Orzechowski for providing the TM models. The structures have been deposited in the Protein Data Bank under codes 4PKG, 4PKH, and 4PKI.	Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; FOWLER VM, 1993, J CELL BIOL, V120, P411, DOI 10.1083/jcb.120.2.411; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Krieger I, 2002, BIOPHYS J, V83, P2716, DOI 10.1016/S0006-3495(02)75281-8; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; Nag S, 2013, CYTOSKELETON, V70, P360, DOI 10.1002/cm.21117; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; Tsukada T, 2011, J BIOL CHEM, V286, P2194, DOI 10.1074/jbc.M110.186924; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Weber A, 1999, J BIOL CHEM, V274, P34637, DOI 10.1074/jbc.274.49.34637; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; Yamashiro S, 2010, J BIOL CHEM, V285, P33265, DOI 10.1074/jbc.M110.144873; Yao WJ, 2010, J BIOL CHEM, V285, P31408, DOI 10.1074/jbc.M110.130278; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110; Zahm JA, 2013, CELL, V155, P423, DOI 10.1016/j.cell.2013.09.019	27	69	70	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					463	467		10.1126/science.1256159	http://dx.doi.org/10.1126/science.1256159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061212	Green Accepted			2022-12-24	WOS:000339655100046
J	Dolgin, E				Dolgin, Elie			TECHNOLOGY Dressed to detect	NATURE			English	Editorial Material																		Poh MZ, 2012, NEUROLOGY, V78, P1868, DOI 10.1212/WNL.0b013e318258f7f1; Poh MZ, 2012, EPILEPSIA, V53, pe93, DOI 10.1111/j.1528-1167.2012.03444.x	2	16	16	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					S16	S17		10.1038/511S16a	http://dx.doi.org/10.1038/511S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25019131	Bronze			2022-12-24	WOS:000338649800008
J	Kfoury, Y; Mercier, F; Scadden, DT				Kfoury, Youmna; Mercier, Francois; Scadden, David T.			SnapShot: The Hematopoietic Stem Cell Niche	CELL			English	Editorial Material							BONE-MARROW NICHE; LEUKEMIA		[Kfoury, Youmna; Mercier, Francois; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Harvard Stem Cell Inst,Dept Stem Cell & Regenerat, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital	Kfoury, Y (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Harvard Stem Cell Inst,Dept Stem Cell & Regenerat, Cambridge, MA 02138 USA.							Arranz L, 2014, NATURE, V512, P78, DOI 10.1038/nature13383; Hartwell KA, 2013, NAT CHEM BIOL, V9, P840, DOI [10.1038/NCHEMBIO.1367, 10.1038/nchembio.1367]; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Levesque JP, 2013, BIOESSAYS, V35, P183, DOI 10.1002/bies.201200111; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Motabi IH, 2012, BLOOD REV, V26, P267, DOI 10.1016/j.blre.2012.09.003; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034	10	13	14	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					228	U252		10.1016/j.cell.2014.06.019	http://dx.doi.org/10.1016/j.cell.2014.06.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995988	Bronze			2022-12-24	WOS:000340943100022
J	Hewitt, PE; Ijaz, S; Brailsford, SR; Brett, R; Dicks, S; Haywood, B; Kennedy, ITR; Kitchen, A; Patel, P; Poh, J; Russell, K; Tettmar, KI; Tossell, J; Ushiro-Lumb, I; Tedder, RS				Hewitt, Patricia E.; Ijaz, Samreen; Brailsford, Su R.; Brett, Rachel; Dicks, Steven; Haywood, Becky; Kennedy, Iain T. R.; Kitchen, Alan; Patel, Poorvi; Poh, John; Russell, Katherine; Tettmar, Kate I.; Tossell, Joanne; Ushiro-Lumb, Ines; Tedder, Richard S.			Hepatitis E virus in blood components: a prevalence and transmission study in southeast England	LANCET			English	Article							NON-B HEPATITIS; NON-A; INFECTION; DONORS; WALES; RNA; RECIPIENTS; THERAPY; HIV	Background The prevalence of hepatitis E virus (HEV) genotype 3 infections in the English population (including blood donors) is unknown, but is probably widespread, and the virus has been detected in pooled plasma products. HEV-infected donors have been retrospectively identified through investigation of reported cases of possible transfusion-transmitted hepatitis E. The frequency of HEV transmission by transfusion and its outcome remains unknown. We report the prevalence of HEV RNA in blood donations, the transmission of the virus through a range of blood components, and describe the resulting morbidity in the recipients. Methods From Oct 8, 2012, to Sept 30, 2013, 225 000 blood donations that were collected in southeast England were screened retrospectively for HEV RNA. Donations containing HEV were characterised by use of serology and genomic phylogeny. Recipients, who received any blood components from these donations, were identified and the outcome of exposure was ascertained. Findings 79 donors were viraemic with genotype 3 HEV, giving an RNA prevalence of one in 2848. Most viraemic donors were seronegative at the time of donation. The 79 donations had been used to prepare 129 blood components, 62 of which had been transfused before identification of the infected donation. Follow-up of 43 recipients showed 18 (42%) had evidence of infection. Absence of detectable antibody and high viral load in the donation rendered infection more likely. Recipient immunosuppression delayed or prevented seroconversion and extended the duration of viraemia. Three recipients cleared longstanding infection after intervention with ribavirin or alteration in immunosuppressive therapy. Ten recipients developed prolonged or persistent infection. Transaminitis was common, but short-term morbidity was rare; only one recipient developed apparent but clinically mild post-transfusion hepatitis. Interpretation Our findings suggest that HEV genotype 3 infections are widespread in the English population and in blood donors. Transfusion-transmitted infections rarely caused acute morbidity, but in some immunosuppressed patients became persistent. Although at present blood donations are not screened, an agreed policy is needed for the identification of patients with persistent HEV infection, irrespective of origin, so that they can be offered antiviral therapy.	[Hewitt, Patricia E.; Brailsford, Su R.; Brett, Rachel; Dicks, Steven; Kitchen, Alan; Patel, Poorvi; Tettmar, Kate I.; Tossell, Joanne; Ushiro-Lumb, Ines; Tedder, Richard S.] Natl Hlth Serv Blood & Transplant, London, England; [Ijaz, Samreen; Dicks, Steven; Haywood, Becky; Patel, Poorvi; Tettmar, Kate I.; Ushiro-Lumb, Ines; Tedder, Richard S.] Publ Hlth England, Virus Reference Dept, Microbiol Serv, Blood Borne Virus Unit, London NW9 5EQ, England; [Brailsford, Su R.; Kennedy, Iain T. R.; Russell, Katherine] Publ Hlth England, Infect Dis Surveillance Ctr, London NW9 5EQ, England; [Tedder, Richard S.] UCL, London, England	NHS Blood & Transplant (NHSBT); Public Health England; Public Health England; University of London; University College London	Tedder, RS (corresponding author), Publ Hlth England, Virus Reference Dept, Microbiol Serv, Blood Borne Virus Unit, London NW9 5EQ, England.	richard.tedder@phe.gov.uk	Ushiro-Lumb, Ines/GXM-3502-2022	Ushiro-Lumb, Ines/0000-0003-0989-8091; Ijaz, Samreen/0000-0001-6658-3542; Tedder, Richard/0000-0002-9672-5721; Haywood, Becky/0000-0002-1461-9619; Kennedy, Iain/0000-0003-0395-1269	Public Health England; National Health Service Blood and Transplant	Public Health England; National Health Service Blood and Transplant	Public Health England and National Health Service Blood and Transplant.	Andersson MI, 2013, AIDS, V27, P487, DOI 10.1097/QAD.0b013e32835b1074; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; BALAYAN MS, 1990, J MED VIROL, V32, P58, DOI 10.1002/jmv.1890320110; Baylis SA, 2012, VOX SANG, V103, P89, DOI 10.1111/j.1423-0410.2011.01583.x; Beale MA, 2011, VOX SANG, V100, P340, DOI 10.1111/j.1423-0410.2010.01412.x; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Casas M, 2009, VET MICROBIOL, V138, P78, DOI 10.1016/j.vetmic.2009.03.008; Cleland A, 2013, VOX SANG, V105, P283, DOI 10.1111/vox.12056; Coilly A, 2013, TRANSPLANTATION, V96, pE4, DOI 10.1097/TP.0b013e318296c9f7; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Corman VM, 2013, VOX SANG, V104, P179, DOI 10.1111/j.1423-0410.2012.01638.x; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Feray C, 2014, LANCET, V383, P218, DOI 10.1016/S0140-6736(14)60072-6; Garson JA, 2012, J VIROL METHODS, V186, P157, DOI 10.1016/j.jviromet.2012.07.027; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Ijaz S, 2012, VOX SANG, V102, P272, DOI 10.1111/j.1423-0410.2011.01554.x; Ijaz S, 2014, J INFECT DIS, V209, P1212, DOI 10.1093/infdis/jit652; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; Juhl D, 2014, TRANSFUSION, V54, P49, DOI 10.1111/trf.12121; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2013, SEMIN LIVER DIS, V33, P62, DOI 10.1055/s-0033-1338115; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Lewis HC, 2008, EMERG INFECT DIS, V14, P165, DOI 10.3201/eid1401.070307; Masuda JI, 2005, HEPATOL RES, V31, P178, DOI 10.1016/j.hepres.2005.01.008; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Said B, 2014, EPIDEMIOL INFECT, V142, P1467, DOI 10.1017/S0950268813002318; Singh GKJ, 2013, J INFECTION, V66, P103, DOI 10.1016/j.jinf.2011.11.027; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Versluis J, 2013, BLOOD, V122, P1079, DOI 10.1182/blood-2013-03-492363	30	352	360	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1766	1773		10.1016/S0140-6736(14)61034-5	http://dx.doi.org/10.1016/S0140-6736(14)61034-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KX	25078306	Green Submitted			2022-12-24	WOS:000345116400027
J	Horton, DK; Mehta, P; Antao, VC				Horton, D. Kevin; Mehta, Paul; Antao, Vinicius C.			Quantifying a Nonnotifiable Disease in the United States The National Amyotrophic Lateral Sclerosis Registry Model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Horton, D. Kevin; Mehta, Paul; Antao, Vinicius C.] Agcy Tox Subst & Dis Registry, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Horton, DK (corresponding author), Agcy Tox Subst & Dis Registry, 4770 Buford Hwy,Mailstop F-58, Atlanta, GA 30341 USA.	dhorton@cdc.gov	Mehta, Paul/ABH-6582-2020	Mehta, Paul/0000-0002-0796-8861; Horton, D. Kevin/0000-0001-6214-6687	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Buehler James W, 2012, MMWR Suppl, V61, P1; Kaye WE, 2014, AMYOTROPH LAT SCL FR, V15, P433, DOI 10.3109/21678421.2014.887119; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Mehta P, 2014, MMWR SURVEILL SUMM, V63, P1; Mitsumoto H., 1998, AMYOTROPHIC LATERAL	5	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1097	1098		10.1001/jama.2014.9799	http://dx.doi.org/10.1001/jama.2014.9799			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25057819	Green Accepted			2022-12-24	WOS:000341624700016
J	Kessler, DA				Kessler, David A.			Toward More Comprehensive Food Labeling	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kessler, David A.] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Kessler, David A.] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kessler, DA (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA.							Food and Drug Administration Silver Spring, PROP CHANG NUTR FACT; Food Marketing Institute, SUP FACTS IND OV 201; Kessler D.A, 2003, HARVARD HLTH POLICY, V4, P13; Nestle M, 2011, IOM RELEASES TOUGH R; Todd J. E, 2008, DECLINE CONSUMER USE	5	19	19	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					193	195		10.1056/NEJMp1402971	http://dx.doi.org/10.1056/NEJMp1402971			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL3BK	25014683				2022-12-24	WOS:000338999800001
J	Sylvetsky, AC; Dietz, WH				Sylvetsky, Allison C.; Dietz, William H.			Nutrient-Content Claims - Guidance or Cause for Confusion?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOODS		[Sylvetsky, Allison C.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Exercise & Nutr Sci, Washington, DC 20052 USA; [Dietz, William H.] George Washington Univ, Milken Inst Sch Publ Hlth, Sumner M Redstone Global Ctr Prevent & Wellness, Washington, DC USA	George Washington University; George Washington University	Sylvetsky, AC (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth, Dept Exercise & Nutr Sci, Washington, DC 20052 USA.							[Anonymous], 2011, GUID FOOD LAB ADV; Colby SE, 2010, J NUTR EDUC BEHAV, V42, P92, DOI 10.1016/j.jneb.2008.11.002; LeGault L, 2004, J AM DIET ASSOC, V104, P952, DOI 10.1016/j.jada.2004.03.024; Sylvetsky AC, 2013, FASEB J, V27; Williams P, 2005, NUTR REV, V63, P256, DOI [10.1301/nr.2005.jul.256-264, 10.1111/j.1753-4887.2005.tb00382.x]	5	39	40	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					195	198		10.1056/NEJMp1404899	http://dx.doi.org/10.1056/NEJMp1404899			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL3BK	25014684				2022-12-24	WOS:000338999800002
J	Mizielinska, S; Gronke, S; Niccoli, T; Ridler, CE; Clayton, EL; Devoy, A; Moens, T; Norona, FE; Woollacott, IOC; Pietrzyk, J; Cleverley, K; Nicoll, AJ; Pickering-Brown, S; Dols, J; Cabecinha, M; Hendrich, O; Fratta, P; Fisher, EMC; Partridge, L; Isaacs, AM				Mizielinska, Sarah; Groenke, Sebastian; Niccoli, Teresa; Ridler, Charlotte E.; Clayton, Emma L.; Devoy, Anny; Moens, Thomas; Norona, Frances E.; Woollacott, Ione O. C.; Pietrzyk, Julian; Cleverley, Karen; Nicoll, Andrew J.; Pickering-Brown, Stuart; Dols, Jacqueline; Cabecinha, Melissa; Hendrich, Oliver; Fratta, Pietro; Fisher, Elizabeth M. C.; Partridge, Linda; Isaacs, Adrian M.			C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; FRONTOTEMPORAL DEMENTIA; RNA FOCI; GGGGCC REPEAT; ANTISENSE TRANSCRIPTS; MYOTONIC-DYSTROPHY; ALS; TRANSLATION; FTD	An expanded GGGGCC repeat in C9orf72 is the most common genetic cause of frontotemporal dementia and amyotrophic lateral sclerosis. A fundamental question is whether toxicity is driven by the repeat RNA itself and/or by dipeptide repeat proteins generated by repeat-associated, non-ATG translation. To address this question, we developed in vitro and in vivo models to dissect repeat RNA and dipeptide repeat protein toxicity. Expression of pure repeats, but not stop codon-interrupted "RNA-only" repeats in Drosophila caused adult-onset neurodegeneration. Thus, expanded repeats promoted neurodegeneration through dipeptide repeat proteins. Expression of individual dipeptide repeat proteins with a non-GGGGCC RNA sequence revealed that both poly-(glycine-arginine) and poly-(proline-arginine) proteins caused neurodegeneration. These findings are consistent with a dual toxicity mechanism, whereby both arginine-rich proteins and repeat RNA contribute to C9orf72-mediated neurodegeneration.	[Mizielinska, Sarah; Ridler, Charlotte E.; Clayton, Emma L.; Devoy, Anny; Moens, Thomas; Norona, Frances E.; Woollacott, Ione O. C.; Pietrzyk, Julian; Cleverley, Karen; Nicoll, Andrew J.; Fratta, Pietro; Fisher, Elizabeth M. C.; Isaacs, Adrian M.] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Groenke, Sebastian; Niccoli, Teresa; Dols, Jacqueline; Hendrich, Oliver; Partridge, Linda] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Niccoli, Teresa; Moens, Thomas; Cabecinha, Melissa; Partridge, Linda] UCL, Inst Hlth Ageing, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Nicoll, Andrew J.] UCL Inst Neurol, MRC Prion Unit, London WC1N 3BG, England; [Pickering-Brown, Stuart] Univ Manchester, Fac Human & Med Sci, Inst Brain Behav & Mental Hlth, Manchester M13 9PT, Lancs, England; [Fratta, Pietro; Fisher, Elizabeth M. C.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England	University of London; University College London; Max Planck Society; University of London; University College London; University of London; University College London; University of Manchester; University of London; University College London	Isaacs, AM (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England.	l.partridge@ucl.ac.uk; a.isaacs@prion.ucl.ac.uk	Fratta, Pietro/G-1296-2019; Fisher, Elizabeth MC/C-2168-2008; Pickering-Brown, Stuart/D-4008-2009; Partridge, Linda/E-7342-2015	Fratta, Pietro/0000-0002-8762-8188; Fisher, Elizabeth MC/0000-0003-2850-9936; Pickering-Brown, Stuart/0000-0003-1561-6054; Partridge, Linda/0000-0001-9615-0094; Hendrich, Oliver/0000-0003-1185-520X; Clayton, Emma/0000-0003-0937-2874; Gronke, Sebastian/0000-0002-1539-5346; Woollacott, Ione/0000-0003-1166-6417; Devoy, Anny/0000-0002-1293-0630; Niccoli, Teresa/0000-0001-9337-0411; Norona, Frances/0000-0003-3982-8406; Mizielinska, Sarah/0000-0001-8052-600X; fratta, pietro/0000-0002-7554-1632; Moens, Thomas/0000-0002-4783-6257	Alzheimer's Research UK; Motor Neurone Disease Association; Middlesex Hospital; National Institute for Health Research (NIHR)/University College London Hospitals Biomedical Research Centre; BRT; NIHR Academic Clinical Fellowship; UK Medical Research Council; Wellcome Trust; Max Planck Society; Medical School General Charitable Trust; MRC [MR/J004022/1, MR/K018523/1, G1000287, G0701441, MR/L021056/1] Funding Source: UKRI; Alzheimers Research UK [ARUK-PPG2012A-14, ARUK-PhD2012-29] Funding Source: researchfish; Medical Research Council [G0701441, MR/J004022/1, MR/L021056/1, G1000287, MR/K018523/1] Funding Source: researchfish; National Institute for Health Research [ACF-2012-18-009] Funding Source: researchfish; Motor Neurone Disease Association [Isaacs/Apr13/818-791] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Motor Neurone Disease Association; Middlesex Hospital; National Institute for Health Research (NIHR)/University College London Hospitals Biomedical Research Centre(National Institute for Health Research (NIHR)); BRT; NIHR Academic Clinical Fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Medical School General Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Motor Neurone Disease Association	We thank J. Wadsworth and N. Alic for helpful discussion. Funding was provided by Alzheimer's Research UK (A. M. I.), the Motor Neurone Disease Association (A. M. I., E. M. C. F., P. F.), the Middlesex Hospital and Medical School General Charitable Trust (A. M. I.), National Institute for Health Research (NIHR)/University College London Hospitals Biomedical Research Centre (P. F.), BRT (T. M.), a NIHR Academic Clinical Fellowship (I.O.C.W.), the UK Medical Research Council (A. M. I., E. M. C. F., P. F.), the Wellcome Trust (L. P.), and the Max Planck Society (L. P.). Clones from the Isaacs lab will be distributed under material transfer agreements for academic use. L. P. dedicates this work to the memory of Noreen Murray.	Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Beck J, 2013, AM J HUM GENET, V92, P345, DOI 10.1016/j.ajhg.2013.01.011; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fratta P, 2013, ACTA NEUROPATHOL, V126, P401, DOI 10.1007/s00401-013-1147-0; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Harms MB, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.03.006; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lashley T, 2013, NEURON, V77, P597, DOI 10.1016/j.neuron.2013.02.009; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Lillo P, 2009, J CLIN NEUROSCI, V16, P1131, DOI 10.1016/j.jocn.2009.03.005; Mackenzie IR, 2013, ACTA NEUROPATHOL, V126, P859, DOI 10.1007/s00401-013-1181-y; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n; Mizielinska S, 2013, ACTA NEUROPATHOL, V126, P845, DOI 10.1007/s00401-013-1200-z; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sakamoto N, 2001, J BIOL CHEM, V276, P27178, DOI 10.1074/jbc.M101852200; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Suzuki N, 2013, NAT NEUROSCI, V16, P1725, DOI 10.1038/nn.3566; van Blitterswijk M, 2013, LANCET NEUROL, V12, P978, DOI 10.1016/S1474-4422(13)70210-2; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	31	443	447	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1192	1194		10.1126/science.1256800	http://dx.doi.org/10.1126/science.1256800			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25103406	Green Accepted, Green Submitted			2022-12-24	WOS:000341179800050
J	Bech, BH; Kjaersgaard, MIS; Pedersen, HS; Howards, PP; Sorensen, MJ; Olsen, J; Thorlund, E; Pedersen, LH; Vestergaard, M; Christensen, J				Bech, Bodil Hammer; Kjaersgaard, Maiken Ina Siegismund; Pedersen, Henrik Sondergaard; Howards, Penelope P.; Sorensen, Merete Juul; Olsen, Jorn; Thorlund, Erik; Pedersen, Lars Henning; Vestergaard, Mogens; Christensen, Jakob			Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EURAP EPILEPSY; EXPOSURE; WOMEN; MALFORMATIONS; VALPROATE; REGISTRY; COMPLICATIONS	Objective To determine whether use of antiepileptic drugs during pregnancy may increase the risk of spontaneous abortion or stillbirth. Design Population based cohort study. Setting Register based study in Denmark, 1997-2008. Participants 983 305 pregnancies identified in the Danish medical birth register and the Danish national hospital discharge register from 1 February 1997 to 31 December 2008 were linked to the Danish Register of Medicinal Product Statistics to obtain information on use of antiepileptic drugs. Main outcome measures Risk ratio of spontaneous abortion and stillbirth after use of antiepileptic drugs during pregnancy, estimated by using binomial regression adjusting for potential confounders of maternal age, cohabitation, income, education, history of severe mental disorder, and history of drug misuse. Results Antiepileptic drugs were used in a total of 4700 (0.5%) pregnancies. 16 out of 100 pregnant women using antiepileptics and 13 out of 100 pregnant women not using antiepileptics experienced a spontaneous abortion. After adjusting for potential confounders pregnant women using antiepileptics had a 13% higher risk of spontaneous abortions than pregnant women not using antiepileptics (adjusted risk ratio 1.13, 95% confidence interval 1.04 to 1.24). However, the risk of spontaneous abortion was not increased in women with an epilepsy diagnosis (0.98, 0.87 to 1.09), only in women without a diagnosis of epilepsy (1.30, 1.14 to 1.49). In an analysis including women with at least two pregnancies with discordant antiepileptic drug use (for example, use in the first pregnancy but not in the second), the adjusted hazard ratio for spontaneous abortion was 0.83 (0.69 to 1.00) for exposed pregnancies compared with unexposed pregnancies. Stillbirth was identified in 18 women who used antiepileptic drugs (unadjusted risk ratio 1.29, 0.80 to 2.10). Conclusion Among women with epilepsy and when analysing the risk in antiepileptic drug discordant pregnancies in the same woman, we found no overall association between the use of antiepileptic drugs during pregnancy and spontaneous abortions. Therefore unmeasured confounding may explain the slight increased risk for spontaneous abortion with any antiepileptic drug use (among women both with and without epilepsy). We found no association between antiepileptic drug use during pregnancy and stillbirth, but the statistical precision was low.	[Bech, Bodil Hammer; Olsen, Jorn; Pedersen, Lars Henning] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, DK-8000 Aarhus C, Denmark; [Kjaersgaard, Maiken Ina Siegismund; Thorlund, Erik] Aarhus Univ, Dept Publ Hlth, Sect Biostat, DK-8000 Aarhus C, Denmark; [Pedersen, Henrik Sondergaard; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, DK-8000 Aarhus C, Denmark; [Pedersen, Henrik Sondergaard; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, DK-8000 Aarhus C, Denmark; [Howards, Penelope P.] Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Sorensen, Merete Juul] Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, Risskov, Denmark; [Pedersen, Lars Henning] Aarhus Univ, Dept Clin Med Obstet & Gynaecol, DK-8000 Aarhus C, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Emory University; Rollins School Public Health; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Bech, BH (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, DK-8000 Aarhus C, Denmark.	bhb@ph.au.dk	Bech, Bodil Hammer/B-9646-2016; Parner, Erik Thorlund/F-5532-2010; Olsen, Jørn/F-8801-2015; Vestergaard, Mogens/M-9333-2014	Bech, Bodil Hammer/0000-0002-0287-3687; Parner, Erik Thorlund/0000-0003-3661-1922; Olsen, Jørn/0000-0001-7462-5140; Vestergaard, Mogens/0000-0001-8830-2174; Christensen, Jakob/0000-0002-9385-6435	Danish Epilepsy Association; Danish Council for Independent Research	Danish Epilepsy Association; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	JC receives research support from the Danish Epilepsy Association. LHP is supported by a Sapere Aude-Postdoc grant from the Danish Council for Independent Research. The funding sources had no role in the design and conduct of the study; the collection, analysis and interpretation of data; or the preparation, review, or approval of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; ANNEGERS JF, 1988, EPILEPSIA, V29, P451, DOI 10.1111/j.1528-1157.1988.tb03745.x; Bobo WV, 2012, PAEDIATR PERINAT EP, V26, P578, DOI 10.1111/ppe.12004; Borthen I, 2009, BJOG-INT J OBSTET GY, V116, P1736, DOI 10.1111/j.1471-0528.2009.02354.x; Borthen I, 2012, CURR OPIN OBSTET GYN, V24, P78, DOI 10.1097/GCO.0b013e32834feb6a; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Diav-Citrin O, 2008, CNS DRUGS, V22, P325, DOI 10.2165/00023210-200822040-00004; Hauser WA, 1996, MAYO CLIN PROC, V71, P576, DOI 10.4065/71.6.576; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kulaga S, 2011, SEIZURE-EUR J EPILEP, V20, P667, DOI 10.1016/j.seizure.2011.06.012; Lohse Sarah Rytter, 2010, Clin Epidemiol, V2, P247, DOI 10.2147/CLEP.S13815; Mawhinney E, 2012, SEIZURE-EUR J EPILEP, V21, P215, DOI 10.1016/j.seizure.2012.01.005; Meador KJ, 2006, NEUROLOGY, V67, P407, DOI 10.1212/01.wnl.0000227919.81208.b2; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; NAKANE Y, 1980, EPILEPSIA, V21, P663, DOI 10.1111/j.1528-1157.1980.tb04320.x; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Ornoy A, 2008, REPROD TOXICOL, V25, P388, DOI 10.1016/j.reprotox.2008.03.001; Padmanabhan R, 2003, BIRTH DEFECTS RES B, V68, P428, DOI 10.1002/bdrb.10042; Padmanabhan R, 2010, REPROD TOXICOL, V29, P366, DOI 10.1016/j.reprotox.2010.02.005; Pedersen CB, 2006, DAN MED BULL, V53, P441; Richmond JR, 2004, AM J OBSTET GYNECOL, V190, P371, DOI 10.1016/j.ajog.2003.09.020; Schmidt D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g254; SPEIDEL BD, 1972, LANCET, V2, P839; Thomas SV, 2009, SEIZURE-EUR J EPILEP, V18, P163, DOI 10.1016/j.seizure.2008.08.010; Tomson T, 2006, NEUROLOGY, V66, P354; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; WHO Collaborating Centre for Drug Statistics Methodology (WHOCC), 2013, DEF DAIL DOS DEF GEN	27	40	40	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2014	349								g5159	10.1136/bmj.g5159	http://dx.doi.org/10.1136/bmj.g5159			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FP	25150301	Green Published, hybrid			2022-12-24	WOS:000340839100001
J	Brady, O				Brady, Oliver			Scale up the supply of experimental Ebola drugs	NATURE			English	Editorial Material									Univ Oxford, Oxford OX1 2JD, England	University of Oxford	Brady, O (corresponding author), Univ Oxford, Oxford OX1 2JD, England.	oliver.brady@zoo.ox.ac.uk	Hay, Simon Iain/F-8967-2015; Brady, Oliver/P-9421-2019	Hay, Simon Iain/0000-0002-0611-7272; Brady, Oliver/0000-0002-3235-2129					0	8	8	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					233	233		10.1038/512233a	http://dx.doi.org/10.1038/512233a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN3SF	25143079	Green Submitted, Bronze			2022-12-24	WOS:000340508200003
J	Svanstrom, H; Pasternak, B; Hviid, A				Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders			Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TORSADE-DE-POINTES; QT-INTERVAL PROLONGATION; ORAL ERYTHROMYCIN; AZITHROMYCIN; DRUGS; ANTIBIOTICS; MACROLIDES; REGISTER; PATIENT; SYSTEM	Objective To assess the risk of cardiac death associated with the use of clarithromycin and roxithromycin. Design Cohort study. Setting Denmark, 1997-2011. Participants Danish adults, 40-74 years of age, who received seven day treatment courses with clarithromycin (n= 160 297), roxithromycin (n= 588 988), and penicillin V (n= 4 355 309). Main outcome measures The main outcome was risk of cardiac death associated with clarithromycin and roxithromycin, compared with penicillin V. Subgroup analyses were conducted according to sex, age, risk score, and concomitant use of drugs that inhibit the cytochrome P450 3A enzyme, which metabolises macrolides. Results A total of 285 cardiac deaths were observed. Compared with use of penicillin V (incidence rate 2.5 per 1000 person years), use of clarithromycin was associated with a significantly increased risk of cardiac death (5.3 per 1000 person years; adjusted rate ratio 1.76, 95% confidence interval 1.08 to 2.85) but use of roxithromycin was not (2.5 per 1000 person years; adjusted rate ratio 1.04, 0.72 to 1.51). The association with clarithromycin was most pronounced among women (adjusted rate ratios 2.83 (1.50 to 5.36) in women and 1.09 (0.51 to 2.35) in men). Compared with penicillin V, the adjusted absolute risk difference was 37 (95% confidence interval 4 to 90) cardiac deaths per 1 million courses with clarithromycin and 2 (-14 to 25) cardiac deaths per 1 million courses with roxithromycin. Conclusions This large cohort study found a significantly increased risk of cardiac death associated with clarithromycin. No increased risk was seen with roxithromycin. Given the widespread use of clarithromycin, these findings call for confirmation in independent populations.	[Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Svanstrom, H (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark.	htr@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127				Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hensey C, 2008, IRISH J MED SCI, V177, P67, DOI 10.1007/s11845-007-0057-3; Huang BH, 2007, PACE, V30, P1579, DOI 10.1111/j.1540-8159.2007.00912.x; Indiana University School of Medicine, 2013, P450 DRUG INT TABL A; Justo D, 2006, EUR J INTERN MED, V17, P254, DOI 10.1016/j.ejim.2005.12.003; Kamochi H, 1999, JPN CIRC J, V63, P421, DOI 10.1253/jcj.63.421; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Katapadi K, 1997, ANGIOLOGY, V48, P821, DOI 10.1177/000331979704800909; Kezerashvili A, 2007, J INTERV CARD ELECTR, V18, P243, DOI 10.1007/s10840-007-9124-y; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Koh TW, 2001, PACE, V24, P1575, DOI 10.1046/j.1460-9592.2001.01575.x; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mosholder AD, 2013, NEW ENGL J MED, V368, P1665, DOI 10.1056/NEJMp1302726; Ohtani H, 2000, ANTIMICROB AGENTS CH, V44, P2630, DOI 10.1128/AAC.44.10.2630-2637.2000; Owens RC, 2004, DRUGS, V64, P1091, DOI 10.2165/00003495-200464100-00005; Owens RC, 2006, CLIN INFECT DIS, V43, P1603, DOI 10.1086/508873; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Piquette RK, 1999, ANN PHARMACOTHER, V33, P22, DOI 10.1345/aph.18107; Promphan W, 2003, PACE, V26, P1424, DOI 10.1046/j.1460-9592.2003.t01-1-00204.x; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Rubinstein E, 2001, INT J ANTIMICROB AG, V18, pS71, DOI 10.1016/S0924-8579(01)00397-1; Shaffer D, 2002, CLIN INFECT DIS, V35, P197, DOI 10.1086/340861; Straus SMJM, 2005, EUR HEART J, V26, P2007, DOI 10.1093/eurheartj/ehi312; Sturmer T, 2005, AM J EPIDEMIOL, V161, P891, DOI 10.1093/aje/kwi106; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799; Volberg WA, 2002, J PHARMACOL EXP THER, V302, P320, DOI 10.1124/jpet.302.1.320; Yamazaki H, 1998, DRUG METAB DISPOS, V26, P1053; Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363	31	50	53	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2014	349								g4930	10.1136/bmj.g4930	http://dx.doi.org/10.1136/bmj.g4930			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FK	25139799	Green Published, hybrid			2022-12-24	WOS:000340838500002
J	Hoegger, MJ; Fischer, AJ; McMenimen, JD; Ostedgaard, LS; Tucker, AJ; Awadalla, MA; Moninger, TO; Michalski, AS; Hoffman, EA; Zabner, J; Stoltz, DA; Welsh, MJ				Hoegger, Mark J.; Fischer, Anthony J.; McMenimen, James D.; Ostedgaard, Lynda S.; Tucker, Alex J.; Awadalla, Maged A.; Moninger, Thomas O.; Michalski, Andrew S.; Hoffman, Eric A.; Zabner, Joseph; Stoltz, David A.; Welsh, Michael J.			Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis	SCIENCE			English	Article							AIRWAY SUBMUCOSAL GLANDS; LIQUID SECRETION; FLUID SECRETION; MUCIN SECRETION; HCO3-TRANSPORT; CFTR; CLEARANCE; BICARBONATE; CELLS; EXPRESSION	Lung disease in people with cystic fibrosis (CF) is initiated by defective host defense that predisposes airways to bacterial infection. Advanced CF is characterized by a deficit in mucociliary transport (MCT), a process that traps and propels bacteria out of the lungs, but whether this deficit occurs first or is secondary to airway remodeling has been unclear. To assess MCT, we tracked movement of radiodense microdisks in airways of newborn piglets with CF. Cholinergic stimulation, which elicits mucus secretion, substantially reduced microdisk movement. Impaired MCT was not due to periciliary liquid depletion; rather, CF submucosal glands secreted mucus strands that remained tethered to gland ducts. Inhibiting anion secretion in non-CF airways replicated CF abnormalities. Thus, impaired MCT is a primary defect in CF, suggesting that submucosal glands and tethered mucus may be targets for early CF treatment.	[Hoegger, Mark J.; Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Fischer, Anthony J.] Univ Iowa, Dept Pediat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [McMenimen, James D.; Ostedgaard, Lynda S.; Tucker, Alex J.; Awadalla, Maged A.; Michalski, Andrew S.; Hoffman, Eric A.; Zabner, Joseph; Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Moninger, Thomas O.] Univ Iowa, Cent Microscopy Res Facil, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Hoffman, Eric A.; Stoltz, David A.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, HHMI, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Stoltz, DA (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	david-stoltz@uiowa.edu; michael-welsh@uiowa.edu	Hoegger, Mark/K-7926-2019	Stoltz, David/0000-0003-0893-9015; Ostedgaard, Lynda/0000-0001-7717-3442; Awadalla, Maged/0000-0002-6342-8704; Zabner, Joseph/0000-0002-9606-1339; Hoffman, Eric/0000-0001-8456-9437; Welsh, Michael/0000-0002-1646-6206; Fischer, Anthony J./0000-0002-7179-6400	NIH [HL051670, HL091842, DK054759, DP2 HL117744]; Carver Foundation; Cystic Fibrosis Foundation (CFF); Gilead Sciences Research Scholars Program in Cystic Fibrosis; CFF Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051670, DP2HL117744, P01HL091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Foundation; Cystic Fibrosis Foundation (CFF); Gilead Sciences Research Scholars Program in Cystic Fibrosis; CFF Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Abou Alaiwa, R. J. Adam, E. Allard, L. A. Askland, D. C. Bouzek, K. Chaloner, N. D. Gansemer, O. A. Itani, T. A. Mayhew, S. Mobberley, J. H. Morgan, L. R. Reznikov, J. Sieren, M. R. Stroik, P. J. Taft, and T. J. Wallen for valuable assistance and discussions. This work was supported by the NIH (HL051670, HL091842, DK054759), the Carver Foundation, and the Cystic Fibrosis Foundation (CFF). D. A. S. is supported by the Gilead Sciences Research Scholars Program in Cystic Fibrosis and the NIH (DP2 HL117744). A. J. F. is supported by a CFF Fellowship. M. J. W. is an Investigator of the HHMI. The University of Iowa Research Foundation has submitted patent applications for CF pigs and has licensed materials and technologies to Exemplar Genetics. M. J. W. was a cofounder of and holds equity in Exemplar Genetics. E. A. H. is a founder of and holds equity in VIDA Diagnostics, a company commercializing lung image analysis software.	Ballard ST, 2004, J PHYSIOL-LONDON, V556, P1, DOI 10.1113/jphysiol.2003.052779; Ballard ST, 2007, RESP PHYSIOL NEUROBI, V159, P271, DOI 10.1016/j.resp.2007.06.017; Billet A, 2013, J PHYSIOL-LONDON, V591, P5273, DOI 10.1113/jphysiol.2013.261909; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Cohen-Cymberknoh M, 2014, CHEST, V145, P738, DOI 10.1378/chest.13-1162; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Griesenbach U, 2011, AM J RESP CELL MOL, V44, P309, DOI 10.1165/rcmb.2009-0265OC; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Hoegger MJ, 2014, P NATL ACAD SCI USA, V111, P2355, DOI 10.1073/pnas.1323633111; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Lee RJ, 2008, J GEN PHYSIOL, V132, P161, DOI 10.1085/jgp.200810017; Lee RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412817; McShane D, 2004, EUR RESPIR J, V24, P95, DOI 10.1183/09031936.04.00097503; Moon S, 1997, AM J PHYSIOL-LUNG C, V273, pL1208, DOI 10.1152/ajplung.1997.273.6.L1208; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Quinton PM, 2010, AM J PHYSIOL-CELL PH, V299, pC1222, DOI 10.1152/ajpcell.00362.2010; REGNIS JA, 1994, AM J RESP CRIT CARE, V150, P66, DOI 10.1164/ajrccm.150.1.8025774; Robinson M, 2002, PEDIATR PULM, V33, P293, DOI 10.1002/ppul.10079; Staudinger BJ, 2014, AM J RESP CRIT CARE, V189, P812, DOI 10.1164/rccm.201312-2142OC; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Trout L, 1998, AM J PHYSIOL-LUNG C, V275, pL1095, DOI 10.1152/ajplung.1998.275.6.L1095; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; Wu DXY, 1998, AM J PHYSIOL-LUNG C, V274, pL388, DOI 10.1152/ajplung.1998.274.3.L388	30	271	274	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					818	822		10.1126/science.1255825	http://dx.doi.org/10.1126/science.1255825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124441	Green Accepted			2022-12-24	WOS:000340593100046
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED The fight is on: military metaphors for cancer may harm patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Byrne A, 2002, PATIENT EDUC COUNS, V48, P15, DOI 10.1016/S0738-3991(02)00094-0; Diamond J., 1999, C BECAUSE COWARDS GE; Petticrew M, 2002, BRIT MED J, V325, P1066, DOI 10.1136/bmj.325.7372.1066; Rigby E, 2009, SCIENCE BLOG; Wiggins NM, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4706	5	10	10	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2014	349								g5155	10.1136/bmj.g5155	http://dx.doi.org/10.1136/bmj.g5155			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RZ	25128488	Bronze, Green Published			2022-12-24	WOS:000340507500001
J	Claudi, B; Sprote, P; Chirkova, A; Personnic, N; Zankl, J; Schurmann, N; Schmidt, A; Bumann, D				Claudi, Beatrice; Sproete, Petra; Chirkova, Anna; Personnic, Nicolas; Zankl, Janine; Schuermann, Nura; Schmidt, Alexander; Bumann, Dirk			Phenotypic Variation of Salmonella in Host Tissues Delays Eradication by Antimicrobial Chemotherapy	CELL			English	Article							ENTERICA SEROVAR TYPHIMURIUM; BACTERIAL PERSISTENCE; ESCHERICHIA-COLI; FLUORESCENT PROTEIN; GENE-EXPRESSION; GROWTH; MACROPHAGES; METABOLISM; VIRULENCE; OXYGEN	Antibiotic therapy often fails to eliminate a fraction of transiently refractory bacteria, causing relapses and chronic infections. Multiple mechanisms can induce such persisters with high antimicrobial tolerance in vitro, but their in vivo relevance remains unclear. Using a fluorescent growth rate reporter, we detected extensive phenotypic variation of Salmonella in host tissues. This included slow-growing subsets as well as well-nourished fast-growing subsets driving disease progression. Monitoring of Salmonella growth and survival during chemotherapy revealed that antibiotic killing correlated with single-cell division rates. Nondividing Salmonella survived best but were rare, limiting their impact. Instead, most survivors originated from abundant moderately growing, partially tolerant Salmonella. These data demonstrate that host tissues diversify pathogen physiology, with major consequences for disease progression and control.	[Claudi, Beatrice; Sproete, Petra; Chirkova, Anna; Personnic, Nicolas; Schuermann, Nura; Bumann, Dirk] Univ Basel, Focal Area Infect Biol, CH-4056 Basel, Switzerland; [Zankl, Janine] Univ Basel, FACS Core Facil, CH-4056 Basel, Switzerland; [Schmidt, Alexander] Univ Basel, Prote Core Facil Biozentrum, CH-4056 Basel, Switzerland; [Sproete, Petra] BASF SE, D-67056 Ludwigshafen, Germany	University of Basel; University of Basel; University of Basel; BASF	Bumann, D (corresponding author), Univ Basel, Focal Area Infect Biol, CH-4056 Basel, Switzerland.	dirk.bumann@unibas.ch		Personnic, Nicolas/0000-0003-4180-8260	Swiss National Foundation [31003A-121834]; SystemsX.ch ("BattleX"); Marie Curie Intra-European Fellowship [PIEF-GA-2011-301840]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); SystemsX.ch ("BattleX"); Marie Curie Intra-European Fellowship(European Commission)	We thank Sophie Helaine and David Holden for plasmid pFCcGi, Leyla Razik Develioglu and Christoph Hess for various antibiotics, Nela Nikolic and Karl Kochanowski for help with minichemostats, and David Holden and Urs Jenal for helpful discussions. This research was supported by the Swiss National Foundation (31003A-121834), SystemsX.ch ("BattleX"), and a Marie Curie Intra-European Fellowship (PIEF-GA-2011-301840, "BONAFIDE," to A.C.).	ABSHIRE KZ, 1993, J BACTERIOL, V175, P3744, DOI 10.1128/JB.175.12.3744-3748.1993; Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barat S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042007; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; BENJAMIN WH, 1990, J IMMUNOL, V144, P3143; Bishop RE, 1998, J MOL BIOL, V280, P583, DOI 10.1006/jmbi.1998.1894; Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533, DOI 10.1152/ajpheart.2001.280.6.H2533; Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x; Burton NA, 2014, CELL HOST MICROBE, V15, P72, DOI 10.1016/j.chom.2013.12.006; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; Cheminay U, 2004, INFECT IMMUN, V72, P468, DOI 10.1128/IAI.72.1.468-477.2004; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Dominguez-Bernal G, 2004, MOL MICROBIOL, V53, P1437, DOI 10.1111/j.1365-2958.2004.04213.x; ENG RHK, 1991, ANTIMICROB AGENTS CH, V35, P1824, DOI 10.1128/AAC.35.9.1824; Evans MR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-58; Fink RC, 2007, J BACTERIOL, V189, P2262, DOI 10.1128/JB.00726-06; Giraudeau C, 2012, NMR BIOMED, V25, P654, DOI 10.1002/nbm.1781; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; Grant AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003070; Griffin AJ, 2011, INFECT IMMUN, V79, P1479, DOI 10.1128/IAI.01033-10; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Kaiser P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001793; Kaiser P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003532; Kint CI, 2012, TRENDS MICROBIOL, V20, P577, DOI 10.1016/j.tim.2012.08.009; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Mastroeni P, 2011, INFECT IMMUN, V79, P636, DOI 10.1128/IAI.00954-10; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P3230, DOI 10.1128/AAC.00243-13; Peterson CN, 2012, GENE DEV, V26, P548, DOI 10.1101/gad.183517.111; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Ramachandran VK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-25; Richardson EJ, 2011, J BACTERIOL, V193, P3162, DOI 10.1128/JB.00394-11; Rollenhagen C, 2006, INFECT IMMUN, V74, P1649, DOI 10.1128/IAI.74.3.1649-1660.2006; Roostalu J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-68; Ryall B, 2012, MICROBIOL MOL BIOL R, V76, P597, DOI 10.1128/MMBR.05028-11; Sanchez-Vargas FM, 2011, TRAVEL MED INFECT DI, V9, P263, DOI 10.1016/j.tmaid.2011.11.001; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Strack RL, 2010, J AM CHEM SOC, V132, P8496, DOI 10.1021/ja1030084; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; VAUPEL P, 1989, CANCER RES, V49, P6449; Verkhusha VV, 2003, BIOCHEMISTRY-US, V42, P7879, DOI 10.1021/bi034555t; You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446	56	192	193	2	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					722	733		10.1016/j.cell.2014.06.045	http://dx.doi.org/10.1016/j.cell.2014.06.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126781	Bronze			2022-12-24	WOS:000340944700006
J	Guo, M; Ehrlicher, AJ; Jensen, MH; Renz, M; Moore, JR; Goldman, RD; Lippincott-Schwartz, J; Mackintosh, FC; Weitz, DA				Guo, Ming; Ehrlicher, Allen J.; Jensen, Mikkel H.; Renz, Malte; Moore, Jeffrey R.; Goldman, Robert D.; Lippincott-Schwartz, Jennifer; Mackintosh, Frederick C.; Weitz, David A.			Probing the Stochastic, Motor-Driven Properties of the Cytoplasm Using Force Spectrum Microscopy	CELL			English	Article							BREAST-CANCER CELLS; LIVING CELLS; MOLECULAR MOTORS; CHROMOSOMAL LOCI; DIFFUSION; MECHANICS; DYNAMICS; MICRORHEOLOGY; SPECTROSCOPY; MIGRATION	Molecular motors in cells typically produce highly directed motion; however, the aggregate, incoherent effect of all active processes also creates randomly fluctuating forces, which drive diffusive-like, non-thermal motion. Here, we introduce force-spectrum-microscopy (FSM) to directly quantify random forces within the cytoplasm of cells and thereby probe stochastic motor activity. This technique combines measurements of the random motion of probe particles with independent micromechanical measurements of the cytoplasm to quantify the spectrum of force fluctuations. Using FSM, we show that force fluctuations substantially enhance intracellular movement of small and large components. The fluctuations are three times larger in malignant cells than in their benign counterparts. We further demonstrate that vimentin acts globally to anchor organelles against randomly fluctuating forces in the cytoplasm, with no effect on their magnitude. Thus, FSM has broad applications for understanding the cytoplasm and its intracellular processes in relation to cell physiology in healthy and diseased states.	[Guo, Ming; Ehrlicher, Allen J.; Jensen, Mikkel H.; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ehrlicher, Allen J.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Jensen, Mikkel H.; Moore, Jeffrey R.] Boston Univ, Dept Phys & Biophys, Boston, MA 02118 USA; [Renz, Malte; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Mackintosh, Frederick C.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Boston University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Northwestern University; Feinberg School of Medicine; Vrije Universiteit Amsterdam; Harvard University	Weitz, DA (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	weitz@seas.harvard.edu	MacKintosh, Frederick/AAB-9332-2021; MacKintosh, Fred C/A-9450-2008; guo, ming/D-4564-2015; Renz, Malte/L-6186-2019	MacKintosh, Frederick/0000-0002-2607-9541; MacKintosh, Fred C/0000-0002-2607-9541; Renz, Malte/0000-0001-9535-7560; Herholdt Jensen, Mikkel/0000-0002-4821-3318; Ehrlicher, Allen/0000-0003-3030-979X	NIH [PO1GM096971, DK083592, HL86655, HL077280]; Harvard Materials Research Science and Engineering Center [DMR-0820484]; NSF [DMR-1310266]; FOM/NWO; Hannah's Hope Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655, R01HL077280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM096971] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Materials Research Science and Engineering Center(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); FOM/NWO(FOM (The Netherlands)Netherlands Organization for Scientific Research (NWO)); Hannah's Hope Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Rowat, S. Lindstrom, K. Kasza for helpful discussions; we thank F. Deng and A. Pegoraro for comments on the manuscript. This work was supported by the NIH (PO1GM096971), the Harvard Materials Research Science and Engineering Center (DMR-0820484), the NSF (DMR-1310266). A.J.E. was supported by NIH grant DK083592; M.H.J. and J.R.M. were supported by NIH grants HL86655 and HL077280; F.C.M. was supported in part by FOM/NWO. R.D.G. was supported by NIH PO1GM096971 and Hannah's Hope Fund.	Agus DB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01449; Ananthanarayanan V, 2013, CELL, V153, P1526, DOI 10.1016/j.cell.2013.05.020; Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Doyle AD, 2010, NATURE, V466, P192, DOI 10.1038/466192a; Dufrene YF, 2011, NAT METHODS, V8, P123, DOI 10.1038/nmeth0211-123; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Gundersen GG, 2013, CELL, V152, P1376, DOI 10.1016/j.cell.2013.02.031; Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Hale CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007054; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hendricks AG, 2012, P NATL ACAD SCI USA, V109, P18447, DOI 10.1073/pnas.1215462109; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Holzer RG, 2003, BREAST CANCER RES TR, V77, P65, DOI 10.1023/A:1021175931177; Howard J., 2001, MECH MOTOR PROTEINS; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kraning-Rush CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032572; Kyoung M, 2008, BIOPHYS J, V95, P5789, DOI 10.1529/biophysj.108.128934; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; MacKintosh FC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018104; MacKintosh FC, 2012, P NATL ACAD SCI USA, V109, P7138, DOI 10.1073/pnas.1204794109; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Mizuno D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.168102; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Plodinec M, 2013, BIOPHYS J, V104, p321A, DOI 10.1016/j.bpj.2012.11.1779; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Wilhelm C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028101; Wu PH, 2012, NAT PROTOC, V7, P155, DOI 10.1038/nprot.2011.436; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	55	330	332	2	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					822	832		10.1016/j.cell.2014.06.051	http://dx.doi.org/10.1016/j.cell.2014.06.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126787	Green Accepted, Bronze			2022-12-24	WOS:000340944700013
J	Yang, B; Treweek, JB; Kulkarni, RP; Deverman, BE; Chen, CK; Lubeck, E; Shah, S; Cai, L; Gradinaru, V				Yang, Bin; Treweek, Jennifer B.; Kulkarni, Rajan P.; Deverman, Benjamin E.; Chen, Chun-Kan; Lubeck, Eric; Shah, Sheel; Cai, Long; Gradinaru, Viviana			Single-Cell Phenotyping within Transparent Intact Tissue through Whole-Body Clearing	CELL			English	Article							MESSENGER-RNA DETECTION; NEURONS; VISUALIZATION; VECTORS; CLARITY; ORGANS	Understanding the structure-function relationships at cellular, circuit, and organ-wide scale requires 3D anatomical and phenotypical maps, currently unavailable for many organs across species. At the root of this knowledge gap is the absence of a method that enables whole-organ imaging. Herein, we present techniques for tissue clearing in which whole organs and bodies are rendered macromolecule-permeable and optically transparent, thereby exposing their cellular structure with intact connectivity. We describe PACT (passive clarity technique), a protocol for passive tissue clearing and immunostaining of intact organs; RIMS (refractive index matching solution), a mounting media for imaging thick tissue; and PARS (perfusion-assisted agent release in situ), a method for whole-body clearing and immunolabeling. We show that in rodents PACT, RIMS, and PARS are compatible with endogenous-fluorescence, immunohistochemistry, RNA single-molecule FISH, long-term storage, and microscopy with cellular and subcellular resolution. These methods are applicable for high-resolution, high-content mapping and phenotyping of normal and pathological elements within intact organs and bodies.	[Yang, Bin; Treweek, Jennifer B.; Kulkarni, Rajan P.; Deverman, Benjamin E.; Chen, Chun-Kan; Lubeck, Eric; Shah, Sheel; Gradinaru, Viviana] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Kulkarni, Rajan P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Cai, Long] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology	Gradinaru, V (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	viviana@caltech.edu	Treweek, Jennifer/AAL-7647-2021; Treweek, Jennifer/U-8768-2017	Yang, Bin/0000-0002-3878-1530	NIH/NINDS New Innovator [NIH IDP20D017782-01]; NIH [1R01AG047664-01, R01HD075605, 1R01NS085910-01, 1R21MH103824-01]; Startup funds from the President and Provost of California Institute of Technology; Biology and Biological Engineering Division of California Institute of Technology; Beckman Institute of Caltech; Pew Charitable Trust; Sidney Kimmel Foundation; Human Frontiers in Science Program; Mallinckrodt Foundation; Gordon and Betty Moore Foundation; Michael J. Fox Foundation; Caltech-GIST; Caltech Biology Division Training grant [NIH/NRSA 5T32GM07616]; NIH/NIAMS [5T32AR058921]; Colvin Postdoctoral Fellowship; CALTECH Division of BBE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR058921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616, T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH103824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP2NS087949, R01NS085910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047664] Funding Source: NIH RePORTER	NIH/NINDS New Innovator; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Startup funds from the President and Provost of California Institute of Technology; Biology and Biological Engineering Division of California Institute of Technology; Beckman Institute of Caltech; Pew Charitable Trust; Sidney Kimmel Foundation; Human Frontiers in Science Program(Human Frontier Science Program); Mallinckrodt Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Michael J. Fox Foundation; Caltech-GIST; Caltech Biology Division Training grant; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Colvin Postdoctoral Fellowship; CALTECH Division of BBE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the entire Gradinaru lab for helpful discussions. We also thank Drs. Dianne Newman and David Anderson for helpful discussions and suggestions. We thank Drs. Amir Arbabi and Andrei Faraon for assistance with SEM imaging. We thank Richard Bennett and Erik Cabral for assistance with tumor procurement. We thank Leica Microsystems for acquiring some of the images presented with a Leica TCS SP8 with Leica HC FLUOTAR L 253/1.00 IMM CORR objective designed for CLARITY imaging. B. D. and V. G. especially wish to acknowledge the contributions of Paul H. Patterson (1943-2014), whose desire to apply tissue clearing to unresolved questions in neuroscience pushed us to further evolve these methods. This work was funded by: the NIH/NINDS New Innovator (NIH IDP20D017782-01); NIH 1R01AG047664-01; Startup funds from the President and Provost of California Institute of Technology and the Biology and Biological Engineering Division of California Institute of Technology; the Beckman Institute of Caltech; the Pew Charitable Trust; the Sidney Kimmel Foundation (to V. G.). And NIH R01HD075605 (to L. C.). V. G. is also supported by: Human Frontiers in Science Program, the Mallinckrodt Foundation, the Gordon and Betty Moore Foundation, the Michael J. Fox Foundation, Caltech-GIST, NIH 1R01NS085910-01, NIH 1R21MH103824-01. C-K. C., S. S., E. L., acknowledge support from the Caltech Biology Division Training grant (NIH/NRSA 5T32GM07616). R. P. K. acknowledges support from NIH/NIAMS (5T32AR058921). J. B. T. acknowledges the Colvin Postdoctoral Fellowship and CALTECH Division of BBE. B.Y. and V. G. have disclosed these methods and findings to the Caltech Office of Technology Transfer (CIT File No.: CIT-6686-P). V. G. is a cofounder of Circuit Therapeutics and holds related IP and stock (less than 5%). At this writing, V. G. receives no research funding, royalties, or consultant fees from any for-profit organization.	Becker Klaus, 2013, Cold Spring Harb Protoc, V2013, P704, DOI 10.1101/pdb.top076539; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/NMETH.2481, 10.1038/nmeth.2481]; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Deisseroth K.A., 2012, U.S. patent, Patent No. [US 2014030192, 2014030192]; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2013, EXP NEUROL, V242, P57, DOI 10.1016/j.expneurol.2012.10.018; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; George MS, 2000, BIOL PSYCHIAT, V47, P287, DOI 10.1016/S0006-3223(99)00308-X; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; JONKERS BW, 1984, J NEUROSCI METH, V12, P141, DOI 10.1016/0165-0270(84)90013-X; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kim SY, 2013, TRENDS COGN SCI, V17, P596, DOI 10.1016/j.tics.2013.10.005; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; LEONG SK, 1990, J NEUROSCI METH, V32, P15, DOI 10.1016/0165-0270(90)90067-P; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Moy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053753; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; Steinke H, 2001, ANN ANAT, V183, P91, DOI 10.1016/S0940-9602(01)80020-0; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Zhang MD, 2014, P NATL ACAD SCI USA, V111, pE1149, DOI 10.1073/pnas.1402318111	31	595	635	7	213	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					945	958		10.1016/j.cell.2014.07.017	http://dx.doi.org/10.1016/j.cell.2014.07.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25088144	Green Accepted, Bronze			2022-12-24	WOS:000340944700022
J	Naryshkin, NA; Weetall, M; Dakka, A; Narasimhan, J; Zhao, X; Feng, ZH; Ling, KKY; Karp, GM; Qi, HY; Woll, MG; Chen, GM; Zhang, NJ; Gabbeta, V; Vazirani, P; Bhattacharyya, A; Furia, B; Risher, N; Sheedy, J; Kong, R; Ma, JY; Turpoff, A; Lee, CS; Zhang, XY; Moon, YC; Trifillis, P; Welch, EM; Colacino, JM; Babiak, J; Almstead, NG; Peltz, SW; Eng, LA; Chen, KS; Mull, JL; Lynes, MS; Rubin, LL; Fontoura, P; Santarelli, L; Haehnke, D; McCarthy, KD; Schmucki, R; Ebeling, M; Sivaramakrishnan, M; Ko, CP; Paushkin, SV; Ratni, H; Gerlach, I; Ghosh, A; Metzger, F				Naryshkin, Nikolai A.; Weetall, Marla; Dakka, Amal; Narasimhan, Jana; Zhao, Xin; Feng, Zhihua; Ling, Karen K. Y.; Karp, Gary M.; Qi, Hongyan; Woll, Matthew G.; Chen, Guangming; Zhang, Nanjing; Gabbeta, Vijayalakshmi; Vazirani, Priya; Bhattacharyya, Anuradha; Furia, Bansri; Risher, Nicole; Sheedy, Josephine; Kong, Ronald; Ma, Jiyuan; Turpoff, Anthony; Lee, Chang-Sun; Zhang, Xiaoyan; Moon, Young-Choon; Trifillis, Panayiota; Welch, Ellen M.; Colacino, Joseph M.; Babiak, John; Almstead, Neil G.; Peltz, Stuart W.; Eng, Loren A.; Chen, Karen S.; Mull, Jesse L.; Lynes, Maureen S.; Rubin, Lee L.; Fontoura, Paulo; Santarelli, Luca; Haehnke, Daniel; McCarthy, Kathleen D.; Schmucki, Roland; Ebeling, Martin; Sivaramakrishnan, Manaswini; Ko, Chien-Ping; Paushkin, Sergey V.; Ratni, Hasane; Gerlach, Irene; Ghosh, Anirvan; Metzger, Friedrich			SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy	SCIENCE			English	Article							3' ADENYLATION; SURVIVAL; PROTEIN; GENE; EXON; INHIBITORS; POLN	Spinal muscular atrophy (SMA) is a genetic disease caused by mutation or deletion of the survival of motor neuron 1 (SMN1) gene. A paralogous gene in humans, SMN2, produces low, insufficient levels of functional SMN protein due to alternative splicing that truncates the transcript. The decreased levels of SMN protein lead to progressive neuromuscular degeneration and high rates of mortality. Through chemical screening and optimization, we identified orally available small molecules that shift the balance of SMN2 splicing toward the production of full-length SMN2 messenger RNA with high selectivity. Administration of these compounds to D7 mice, a model of severe SMA, led to an increase in SMN protein levels, improvement of motor function, and protection of the neuromuscular circuit. These compounds also extended the life span of the mice. Selective SMN2 splicing modifiers may have therapeutic potential for patients with SMA.	[Naryshkin, Nikolai A.; Weetall, Marla; Dakka, Amal; Narasimhan, Jana; Zhao, Xin; Karp, Gary M.; Qi, Hongyan; Woll, Matthew G.; Chen, Guangming; Zhang, Nanjing; Gabbeta, Vijayalakshmi; Vazirani, Priya; Bhattacharyya, Anuradha; Furia, Bansri; Risher, Nicole; Sheedy, Josephine; Kong, Ronald; Ma, Jiyuan; Turpoff, Anthony; Lee, Chang-Sun; Zhang, Xiaoyan; Moon, Young-Choon; Trifillis, Panayiota; Welch, Ellen M.; Colacino, Joseph M.; Babiak, John; Almstead, Neil G.; Peltz, Stuart W.] PTC Therapeut, South Plainfield, NJ 07080 USA; [Feng, Zhihua; Ling, Karen K. Y.; Ko, Chien-Ping] Univ So Calif, Neurobiol Sect, Dept Biol Sci, Los Angeles, CA 90089 USA; [Eng, Loren A.; Chen, Karen S.; McCarthy, Kathleen D.; Paushkin, Sergey V.] SMA Fdn, New York, NY 10019 USA; [Mull, Jesse L.; Lynes, Maureen S.; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mull, Jesse L.; Lynes, Maureen S.; Rubin, Lee L.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Fontoura, Paulo; Santarelli, Luca; Haehnke, Daniel; Schmucki, Roland; Ebeling, Martin; Sivaramakrishnan, Manaswini; Ratni, Hasane; Gerlach, Irene; Ghosh, Anirvan; Metzger, Friedrich] F Hoffmann La Roche, Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, CH-4070 Basel, Switzerland	University of Southern California; Harvard University; Harvard University; Roche Holding	Metzger, F (corresponding author), F Hoffmann La Roche, Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Grenzacherstr 124, CH-4070 Basel, Switzerland.	speltz@ptcbio.com; friedrich.metzger@roche.com	Ko, Chien-Ping/AAN-2314-2020	Ma, Jiyuan/0000-0001-6538-4023; Hahnke, Daniel/0000-0002-7008-6503; Rubin, Lee/0000-0002-8658-841X	SMA Foundation; Harvard Stem Cell Institute	SMA Foundation; Harvard Stem Cell Institute	We thank O. Khwaja, C. Czech, T. Kremer, L. Muller, W. Muster, S. Kirchner, L. Green, E. Pinard, J. Kazenwadel, C. Horn, O. Spleiss, C. Sarry, P. Kueng, F. Knoflach, L. Himmelein, F. Birzele, K. von Herrmann, A. Mollin, J. Hedrick, M. Dumble, I. Huq, P. Martin, D. Mankoff, S. Jung, J. Crona, M. Haley, T. Yang, S. Choi, S. Hwang, M. Dali, W. Lennox, S. Yeh, J. Yang, J. Petruska, J. Breslin, J. Baird, B. Scharf, T. Tripodi, G. Ryan, J. Tivade, J. Du, D. Minn, C. Romfo, and C. Trotta for help and support with this project. This work was supported by grants from the SMA Foundation and the Harvard Stem Cell Institute. F. Hoffmann-La Roche and PTC Therapeutics have filed three patent applications entitled "Compounds for Treating Spinal Muscular Atrophy" (WO2013/101974 A1, WO2013/112788 A1, and WO2013/119916 A2).	Arkblad E, 2009, ACTA PAEDIATR, V98, P865, DOI 10.1111/j.1651-2227.2008.01201.x; Berg MG, 2012, MOL CELL BIOL, V32, P1271, DOI 10.1128/MCB.05788-11; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Chang JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018643; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Hasegawa M, 2011, ACS CHEM BIOL, V6, P229, DOI 10.1021/cb100248e; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kinjo ER, 2013, EXP NEUROL, V248, P546, DOI 10.1016/j.expneurol.2013.07.022; Kolb SJ, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-6; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Kuhn AN, 2009, RNA, V15, P153, DOI 10.1261/rna.1332609; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lewelt A, 2012, CURR NEUROL NEUROSCI, V12, P42, DOI 10.1007/s11910-011-0240-9; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; Markowitz JA, 2012, PEDIATR NEUROL, V46, P1, DOI 10.1016/j.pediatrneurol.2011.09.001; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Osborne M, 2012, HUM MOL GENET, V21, P4431, DOI 10.1093/hmg/dds285; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; PEARN J, 1980, LANCET, V1, P919; Sahashi K, 2013, EMBO MOL MED, V5, P1586, DOI 10.1002/emmm.201302567; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Seo J, 2013, BBA-MOL BASIS DIS, V1832, P2180, DOI 10.1016/j.bbadis.2013.08.005; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Singh NN, 2013, NUCLEIC ACIDS RES, V41, P8144, DOI 10.1093/nar/gkt609; Singh NN, 2011, RNA BIOL, V8, P600, DOI 10.4161/rna.8.4.16224; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Sugarman EA, 2012, EUR J HUM GENET, V20, P27, DOI 10.1038/ejhg.2011.134; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; Younis I, 2010, MOL CELL BIOL, V30, P1718, DOI 10.1128/MCB.01301-09; Zietlow L, 2009, BIOCHEMISTRY-US, V48, P11817, DOI 10.1021/bi9015346	48	330	355	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					688	693		10.1126/science.1250127	http://dx.doi.org/10.1126/science.1250127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104390				2022-12-24	WOS:000339962800043
J	Gupta, S; Chai, J; Cheng, J; D'Mello, R; Chance, MR; Fu, D				Gupta, Sayan; Chai, Jin; Cheng, Jie; D'Mello, Rhijuta; Chance, Mark R.; Fu, Dax			Visualizing the kinetic power stroke that drives proton-coupled zinc(II) transport	NATURE			English	Article							MASS-SPECTROMETRY; METAL-BINDING; YIIP; SPECIFICITY; SELECTIVITY; MECHANISM; DYNAMICS; VESICLES; FAMILY; FIEF	The proton gradient is a principal energy source for respiration-dependent active transport, but the structural mechanisms of proton-coupled transport processes are poorly understood. YiiP is a proton-coupled zinc transporter found in the cytoplasmic membrane of Escherichia coli. Its transport site receives protons from water molecules that gain access to its hydrophobic environment and transduces the energy of an inward proton gradient to drive Zn(II) efflux(1,2). This membrane protein is a well characterized member3- 7 of the family of cation diffusion facilitators that occurs at all phylogenetic levels(8-10). Here we show, using X-ray-mediated hydroxyl radical labelling of YiiP and mass spectrometry, that Zn( II) binding triggers a highly localized, all-or-nothing change of water accessibility to the transport site and an adjacent hydrophobic gate. Milli-secondtime-resolved dynamics reveal a concerted and reciprocal pattern of accessibility changes along a trans membrane helix, suggesting a rigid-body helical re-orientation linked to Zn( II) binding that triggers the closing of the hydrophobic gate. The gated water access to the transport site enables a stationary proton gradient to facilitate the conversion of zinc-binding energy to the kinetic power stroke of a vectorial zinc transport. The kinetic details provide energetic insights intoaproton-coupled active-transport reaction.	[Gupta, Sayan; Cheng, Jie; D'Mello, Rhijuta] Case Western Reserve Univ, Ctr Synchrotron Biosci, Cleveland, OH 44109 USA; [Gupta, Sayan; D'Mello, Rhijuta; Chance, Mark R.] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44109 USA; [Chai, Jin; Fu, Dax] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Cheng, Jie; Fu, Dax] Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Case Western Reserve University; Case Western Reserve University; United States Department of Energy (DOE); Brookhaven National Laboratory; Johns Hopkins University; Johns Hopkins Medicine	Fu, D (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	mrc16@case.edu; dfu3@jhmi.edu		chai, jin/0000-0002-4760-5811; Fu, Dax/0000-0002-2663-1316	National Institutes of Health [R01GM065137]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE) [DE-AC02-98CH10886]; Physical Biosciences Program, Office of Basic Energy Sciences of the DOE; National Institute for Biomedical Imaging and Bioengineering [P30-EB-09998, R01-EB-09688]; DOE [DE-AC02-98CH10886]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998, R01EB009688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE)(United States Department of Energy (DOE)); Physical Biosciences Program, Office of Basic Energy Sciences of the DOE; National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this work to the memory of Peter C. Maloney, who read and commented on a version of the manuscript. This work was supported in part by the National Institutes of Health under grant R01GM065137(to D.F.), the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE) under contract DE-AC02-98CH10886 (to D.F.); D.F. is primarily supported by the Physical Biosciences Program, Office of Basic Energy Sciences of the DOE and the National Institute for Biomedical Imaging and Bioengineering under grants P30-EB-09998 and R01-EB-09688 (to M.R.C.). The National Synchrotron Light Source at Brookhaven National Laboratory is supported by the DOE under contract DE-AC02-98CH10886.	Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Gupta S, 2007, J SYNCHROTRON RADIAT, V14, P233, DOI 10.1107/S0909049507013118; Gupta S, 2012, P NATL ACAD SCI USA, V109, P14882, DOI 10.1073/pnas.1209060109; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kaur P, 2009, ANAL CHEM, V81, P8141, DOI 10.1021/ac9013644; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lin HL, 2009, BIOCHEM J, V422, P273, DOI 10.1042/BJ20090853; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Podar D, 2012, J BIOL CHEM, V287, P3185, DOI 10.1074/jbc.M111.305649; Ralston CY, 2000, METHOD ENZYMOL, V317, P353; RAMOS S, 1976, P NATL ACAD SCI USA, V73, P1892, DOI 10.1073/pnas.73.6.1892; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047	27	89	91	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					101	+		10.1038/nature13382	http://dx.doi.org/10.1038/nature13382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043033	Green Accepted			2022-12-24	WOS:000339908000040
J	Harjunmaa, E; Seidel, K; Hakkinen, T; Renvoise, E; Corfe, IJ; Kallonen, A; Zhang, ZQ; Evans, AR; Mikkola, ML; Salazar-Ciudad, I; Klein, OD; Jernvall, J				Harjunmaa, Enni; Seidel, Kerstin; Hakkinen, Teemu; Renvoise, Elodie; Corfe, Ian J.; Kallonen, Aki; Zhang, Zhao-Qun; Evans, Alistair R.; Mikkola, Marja L.; Salazar-Ciudad, Isaac; Klein, Ophir D.; Jernvall, Jukka			Replaying evolutionary transitions from the dental fossil record	NATURE			English	Article							MAMMALIAN TEETH; PATTERNS; ECTODYSPLASIN; MOLECULES; RADIATION; DYNAMICS; GENES; MODEL; TREES	The evolutionary relationships of extinct species are ascertained primarily through the analysis of morphological characters. Character inter-dependencies can have a substantial effect on evolutionary interpretations, but the developmental underpinnings of character inter-dependence remain obscure because experiments frequently do not provide detailed resolution of morphological characters. Here we show experimentally and computationally how gradual modification of development differentially affects characters in the mouse dentition. We found that intermediate phenotypes could be produced by gradually adding ectodysplas in A (EDA) protein in culture to tooth explants carrying a null mutation in the tooth-patterning gene Eda. By identifying development-based character inter-dependencies, we show how to predict morphological patterns of teeth among mammalian species. Finally, in vivo inhibition of sonic hedgehog signalling in Eda null teeth enabled us to reproduce characters deep in the rodent ancestry. Taken together, evolutionarily informative transitions can be experimentally reproduced, thereby providing development-based expectations for character-state transitions used in evolutionary studies.	[Harjunmaa, Enni; Hakkinen, Teemu; Renvoise, Elodie; Corfe, Ian J.; Mikkola, Marja L.; Salazar-Ciudad, Isaac; Jernvall, Jukka] Univ Helsinki, Inst Biotechnol, Dev Biol Program, FIN-00014 Helsinki, Finland; [Seidel, Kerstin; Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94114 USA; [Seidel, Kerstin; Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94114 USA; [Kallonen, Aki] Univ Helsinki, Dept Phys, Div Mat Phys, FIN-00014 Helsinki, Finland; [Zhang, Zhao-Qun] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Evans, Alistair R.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Evans, Alistair R.] Museum Victoria, Melbourne, Vic 3001, Australia; [Salazar-Ciudad, Isaac] Univ Autonoma Barcelona, Dept Genet & Microbiol, Genom Bioinformat & Evolut Group, Cerdanyola Del Valles 08193, Spain; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94114 USA; [Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94114 USA	University of Helsinki; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Helsinki; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Monash University; Museum Victoria; Autonomous University of Barcelona; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jernvall, J (corresponding author), Univ Helsinki, Inst Biotechnol, Dev Biol Program, POB 56, FIN-00014 Helsinki, Finland.	ophir.klein@ucsf.edu; jernvall@fastmail.fm	Corfe, Ian/GSN-6109-2022; Salazar-Ciudad, Isaac/R-2238-2018; Evans, Alistair R/D-4239-2011	Evans, Alistair R/0000-0002-4078-4693; Klein, Ophir/0000-0002-6254-7082; Salazar Ciudad, Isaac/0000-0003-1607-0962; Corfe, Ian/0000-0002-1824-755X	Academy of Finland; NIH/NIDCR [R01-DE021420]; NIH [DP2-OD007191]; Australian Research Council; MST [2012CB821904]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021420, K99DE024214] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007191] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); MST; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Fortelius, J. Eronen, I. Thesleff, P. Munne for discussions; S. Alto, M. Makinen, R. Santalahti, R. Savolainen, and M. Christensen for technical assistance; P. Schneider for the Fc-EDA-A1-protein; F. de Sauvage for HhAntag compound; Hou Yemao for tomography; and the Finnish Museum of Natural History (Helsinki, Finland), Museum of Natural History (Stockholm, Sweden), and Museum fur Naturkunde (Berlin, Germany) for specimen loans. This work was supported by the Academy of Finland to J.J., M.M., I.S.-C., R01-DE021420 (NIH/NIDCR) and an NIH Director's New Innovator Award DP2-OD007191 to O.D.K., an Australian Research Council Future Fellowship to A.R.E, and the Major Basic Research Projects (2012CB821904) of MST to Z.-Q.Z. Data are presented in the Supplementary and Extended Data Tables, available in the MorphoBrowser database (http://morphobrowser.biocenter.helsinki.fi/) and from the authors, and models can be accessed at (http://www.biocenter.helsinki.fi/bi/evodevo/toothmaker.html).	Arthur W., 2011, EVOLUTION DEV APPROA; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; BUTLER PM, 1990, BIOL REV, V65, P529, DOI 10.1111/j.1469-185X.1990.tb01237.x; Cho SW, 2011, DEVELOPMENT, V138, P1807, DOI 10.1242/dev.056051; Doyle JJ, 1997, SYST BIOL, V46, P537, DOI 10.2307/2413695; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; Fliniaux I, 2008, DEV BIOL, V320, P60, DOI 10.1016/j.ydbio.2008.04.023; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Goswami Anjali, 2010, P141; GRUNEBERG H, 1965, J EMBRYOL EXP MORPH, V14, P137; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harjunmaa E, 2012, NATURE, V483, P324, DOI 10.1038/nature10876; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Antonanzas RL, 2009, ZOOL J LINN SOC-LOND, V156, P664, DOI 10.1111/j.1096-3642.2008.00494.x; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Mauldin EA, 2009, AM J MED GENET A, V149A, P2045, DOI 10.1002/ajmg.a.32916; Meng Jin, 2001, Journal of Mammalian Evolution, V8, P1, DOI 10.1023/A:1011328616715; Narhi K, 2010, METHODS MOL BIOL, V666, P253, DOI 10.1007/978-1-60761-820-1_16; O'Keefe FR, 2001, SYST BIOL, V50, P657, DOI 10.1080/106351501753328794; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Osborn J.W., 1973, Breviora, VNo. 399, P1; Polly PD, 2008, EVOL BIOL, V35, P83, DOI 10.1007/s11692-008-9020-0; Rice SH, 2008, ANN NY ACAD SCI, V1133, P67, DOI 10.1196/annals.1438.002; Rodrigues HG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3504; Salazar-Ciudad I, 2013, NATURE, V497, P361, DOI 10.1038/nature12142; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; VANVALEN L, 1970, DEV BIOL, V23, P456, DOI 10.1016/0012-1606(70)90110-7; Wake D.B., 1989, Geobios Memoire Special (Villeurbanne), P369; Wessels W., 2009, GEOL ULTRAIECTINA, V307; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	43	75	78	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					44	+		10.1038/nature13613	http://dx.doi.org/10.1038/nature13613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25079326	Green Accepted			2022-12-24	WOS:000339908000027
J	Canaud, G; Bienaime, F; Tabarin, F; Bataillon, G; Seilhean, D; Noel, LH; Dragon-Durey, MA; Snanoudj, R; Friedlander, G; Halbwachs-Mecarelli, L; Legendre, C; Terzi, F				Canaud, Guillaume; Bienaime, Frank; Tabarin, Fanny; Bataillon, Guillaume; Seilhean, Danielle; Noel, Laure-Helene; Dragon-Durey, Marie-Agnes; Snanoudj, Renaud; Friedlander, Gerard; Halbwachs-Mecarelli, Lise; Legendre, Christophe; Terzi, Fabiola			Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIBODY-MEDIATED REJECTION; POLYCYSTIC KIDNEY-DISEASE; SMOOTH-MUSCLE-CELLS; ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODIES; SYNDROME NEPHROPATHY; RAPAMYCIN; VASCULOPATHY; BETA(2)-GLYCOPROTEIN-I; ANGIOPLASTY	BACKGROUND Although thrombosis is considered the cardinal feature of the antiphospholipid syndrome, chronic vascular lesions are common, particularly in patients with life-threatening complications. In patients who require transplantation, vascular lesions often recur. The molecular pathways involved in the vasculopathy of the antiphospholipid syndrome are unknown, and adequate therapies are lacking. METHODS We used double immunostaining to evaluate pathway activation in the mammalian target of rapamycin complex (mTORC) and the nature of cell proliferation in the vessels of patients with primary or secondary antiphospholipid syndrome nephropathy. We also evaluated autopsy specimens from persons who had catastrophic antiphospholipid syndrome. The molecular pathways through which antiphospholipid antibodies modulate the mTORC pathway were evaluated in vitro, and potential pharmacologic inhibitors were also tested in vitro. Finally, we studied the effect of sirolimus in kidney-transplant recipients with the antiphospholipid syndrome. RESULTS The vascular endothelium of proliferating intrarenal vessels from patients with antiphospholipid syndrome nephropathy showed indications of activation of the mTORC pathway. In cultured vascular endothelial cells, IgG antibodies from patients with the antiphospholipid syndrome stimulated mTORC through the phosphatidy-l-inositol 3-kinase (PI3K)-AKT pathway. Patients with antiphospholipid syndrome nephropathy who required transplantation and were receiving sirolimus had no recurrence of vascular lesions and had decreased vascular proliferation on biopsy as compared with patients with antiphospholipid antibodies who were not receiving sirolimus. Among 10 patients treated with sirolimus, 7 (70%) had a functioning renal allograft 144 months after transplantation versus 3 of 27 untreated patients (11%). Activation of mTORC was also found in the vessels of autopsy specimens from patients with catastrophic antiphospholipid syndrome. CONCLUSIONS Our results suggest that the mTORC pathway is involved in the vascular lesions associated with the antiphospholipid syndrome.	[Canaud, Guillaume; Bienaime, Frank; Tabarin, Fanny; Friedlander, Gerard; Halbwachs-Mecarelli, Lise; Legendre, Christophe; Terzi, Fabiola] Univ Paris 05, INSERM, U1151, Inst Necker Enfants Malad,Sorbone Paris Cite, Paris, France; [Canaud, Guillaume; Snanoudj, Renaud; Legendre, Christophe] Hop Necker Enfants Malad, Serv Nephrol Transplantat Adultes, F-75015 Paris, France; [Bienaime, Frank; Friedlander, Gerard] Hop Necker Enfants Malad, Serv Explorat Fonct, F-75015 Paris, France; [Noel, Laure-Helene] Hop Necker Enfants Malad, Serv Anat & Cytol Pathol, F-75015 Paris, France; [Dragon-Durey, Marie-Agnes] Hop Necker Enfants Malad, Serv Immunol Biol, F-75015 Paris, France; [Bataillon, Guillaume; Seilhean, Danielle] Univ Paris 06, Hop Europeen Georges Pompidou, Hop Pitie Salpetriere, AP HP, Paris, France; [Bataillon, Guillaume; Seilhean, Danielle] Univ Paris 06, Neuropathol Lab, Hop Pitie Salpetriere, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Terzi, F (corresponding author), Hop Necker Enfants Malad, INSERM, U1151, 6eme Etage,149 Rue Sevres, F-75015 Paris, France.	fabiola.terzi@inserm.fr	, Dragon-Durey/AGM-3653-2022; Snanoudj, Renaud/AAK-1294-2020	Snanoudj, Renaud/0000-0002-6657-6235; Dragon-Durey, Marie-Agnes/0000-0002-5809-8122; Friedlander, Gerard/0000-0002-6854-4261; Bienaime, Frank/0000-0002-8666-2042	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Funded by INSERM and others.	ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P762; Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Basu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023919; Bayliss J, 2008, TRANSPLANTATION, V86, P991, DOI 10.1097/TP.0b013e318186d734; Canaud G, 2013, AM J TRANSPLANT, V13, P2179, DOI 10.1111/ajt.12319; Canaud G, 2010, AM J TRANSPLANT, V10, P1701, DOI 10.1111/j.1600-6143.2010.03152.x; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Daugas E, 2002, J AM SOC NEPHROL, V13, P42, DOI 10.1681/ASN.V13142; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; Eisen HJ, 2003, NEW ENGL J MED, V349, P847, DOI 10.1056/NEJMoa022171; Espinosa G, 2009, CURR OPIN PULM MED, V15, P413, DOI 10.1097/MCP.0b013e32832d0463; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Gallo R, 1999, CIRCULATION, V99, P2164, DOI 10.1161/01.CIR.99.16.2164; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Heydarkhan-Hagvall S, 2003, J CELL BIOCHEM, V89, P1250, DOI 10.1002/jcb.10583; HUGHSON MD, 1995, HUM PATHOL, V26, P716, DOI 10.1016/0046-8177(95)90218-X; Ivey ME, 2008, ATHEROSCLEROSIS, V199, P237, DOI 10.1016/j.atherosclerosis.2008.03.006; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lepin EJ, 2006, AM J TRANSPLANT, V6, P1560, DOI 10.1111/j.1600-6143.2006.01355.x; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Long BR, 2008, HEMATOL ONCOL CLIN N, V22, P79, DOI 10.1016/j.hoc.2007.10.002; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nochy D, 1999, J AM SOC NEPHROL, V10, P507; Poulton K, 2012, SEMIN ARTHRITIS RHEU, V41, P720, DOI 10.1016/j.semarthrit.2011.09.004; Qi YX, 2011, P NATL ACAD SCI USA, V108, P1908, DOI 10.1073/pnas.1019219108; Ramesh S, 2011, J CLIN INVEST, V121, P120, DOI 10.1172/JCI39828; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shi T, 2006, ARTHRITIS RHEUM-US, V54, P2558, DOI 10.1002/art.21968; Sousa JE, 2001, CIRCULATION, V104, P2007, DOI 10.1161/hc4201.098056; Stylianou K, 2011, NEPHROL DIAL TRANSPL, V26, P498, DOI 10.1093/ndt/gfq496; Tektonidou MG, 2004, ARTHRITIS RHEUM-US, V50, P2569, DOI 10.1002/art.20433; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WARNER LM, 1994, ARTHRITIS RHEUM, V37, P289, DOI 10.1002/art.1780370219; Zhang X, 2009, AM J TRANSPLANT, V9, P2459, DOI 10.1111/j.1600-6143.2009.02819.x	37	193	204	2	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					303	312		10.1056/NEJMoa1312890	http://dx.doi.org/10.1056/NEJMoa1312890			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054716				2022-12-24	WOS:000339339800007
J	Choulet, F; Alberti, A; Theil, S; Glover, N; Barbe, V; Daron, J; Pingault, L; Sourdille, P; Couloux, A; Paux, E; Leroy, P; Mangenot, S; Guilhot, N; Le Gouis, J; Balfourier, F; Alaux, M; Jamilloux, V; Poulain, J; Durand, C; Bellec, A; Gaspin, C; Safar, J; Dolezel, J; Rogers, J; Vandepoele, K; Aury, JM; Mayer, K; Berges, H; Quesneville, H; Wincker, P; Feuillet, C				Choulet, Frederic; Alberti, Adriana; Theil, Sebastien; Glover, Natasha; Barbe, Valerie; Daron, Josquin; Pingault, Lise; Sourdille, Pierre; Couloux, Arnaud; Paux, Etienne; Leroy, Philippe; Mangenot, Sophie; Guilhot, Nicolas; Le Gouis, Jacques; Balfourier, Francois; Alaux, Michael; Jamilloux, Veronique; Poulain, Julie; Durand, Celine; Bellec, Arnaud; Gaspin, Christine; Safar, Jan; Dolezel, Jaroslav; Rogers, Jane; Vandepoele, Klaas; Aury, Jean-Marc; Mayer, Klaus; Berges, Helene; Quesneville, Hadi; Wincker, Patrick; Feuillet, Catherine			Structural and functional partitioning of bread wheat chromosome 3B	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS; GENE DUPLICATION; GENOME SEQUENCE; COMPLEX GENOMES; DRAFT GENOME; EVOLUTION; RECOMBINATION; DIVERSITY; MAP; KARYOTYPE	We produced a reference sequence of the 1-gigabase chromosome 3B of hexaploid bread wheat. By sequencing 8452 bacterial artificial chromosomes in pools, we assembled a sequence of 774 megabases carrying 5326 protein-coding genes, 1938 pseudogenes, and 85% of transposable elements. The distribution of structural and functional features along the chromosome revealed partitioning correlated with meiotic recombination. Comparative analyses indicated high wheat-specific inter-and intrachromosomal gene duplication activities that are potential sources of variability for adaption. In addition to providing a better understanding of the organization, function, and evolution of a large and polyploid genome, the availability of a high-quality sequence anchored to genetic maps will accelerate the identification of genes underlying important agronomic traits.	[Choulet, Frederic; Theil, Sebastien; Glover, Natasha; Daron, Josquin; Pingault, Lise; Sourdille, Pierre; Paux, Etienne; Leroy, Philippe; Guilhot, Nicolas; Le Gouis, Jacques; Balfourier, Francois; Feuillet, Catherine] INRA, UMR1095, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France; [Choulet, Frederic; Theil, Sebastien; Glover, Natasha; Daron, Josquin; Pingault, Lise; Sourdille, Pierre; Paux, Etienne; Leroy, Philippe; Guilhot, Nicolas; Le Gouis, Jacques; Balfourier, Francois; Feuillet, Catherine] Univ Blaise Pascal, UMR1095, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Couloux, Arnaud; Mangenot, Sophie; Poulain, Julie; Durand, Celine; Aury, Jean-Marc; Wincker, Patrick] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Genom, F-91000 Evry, France; [Alaux, Michael; Jamilloux, Veronique; Quesneville, Hadi] INRA Versailles, Res Unit Genom Info, UR1164, INRA, F-78026 Versailles, France; [Bellec, Arnaud; Berges, Helene] INRA, UPR 1258, Ctr Natl Ressources Genom Vegetales, F-31326 Castanet Tolosan, France; [Gaspin, Christine] INRA, Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France; [Safar, Jan; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, CZ-78371 Olomouc, Czech Republic; [Rogers, Jane] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Vandepoele, Klaas] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Vandepoele, Klaas] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Mayer, Klaus] Helmholtz Zentrum Muenchen, Inst Bioinformat & Syst Biol, Munich Informat Ctr Prot Sequences, D-85764 Neuherberg, Germany; [Wincker, Patrick] CNRS, UMR 8030, F-91000 Evry, France; [Wincker, Patrick] Univ Evry, CP5706 Evry, Evry, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CEA; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; The Genome Analysis Centre (TGAC); Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Choulet, F (corresponding author), INRA, UMR1095, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France.	frederic.choulet@clermont.inra.fr	Dolezel, Jaroslav/B-7716-2008; Quesneville, Hadi/AAG-1048-2020; Aury, Jean-Marc/N-1621-2019; Gaspin, Christine/B-6756-2015; Mayer, Klaus FX/M-7941-2015; Pingault, Lise/AAQ-8602-2020; Safar, Jan/G-1038-2014; Vandepoele, Klaas/E-7514-2010; Sourdille, Pierre/CAF-2780-2022; Alberti, Adriana/AAZ-2013-2021; Alberti, Adriana/E-7142-2017	Dolezel, Jaroslav/0000-0002-6263-0492; Quesneville, Hadi/0000-0003-3001-4908; Aury, Jean-Marc/0000-0003-1718-3010; Mayer, Klaus FX/0000-0001-6484-1077; Pingault, Lise/0000-0002-6149-1267; Vandepoele, Klaas/0000-0003-4790-2725; Alberti, Adriana/0000-0003-3372-9423; Alberti, Adriana/0000-0003-3372-9423; Poulain, Julie/0000-0002-8744-3116; BERGES, Helene/0000-0002-5492-1062; Couloux, Arnaud/0000-0003-2356-0062; Choulet, Frederic/0000-0003-1788-7288; Daron, Josquin/0000-0003-3914-5998; Paux, Etienne/0000-0002-3094-7129; Sourdille, Pierre/0000-0002-1027-2224; Jamilloux, Veronique/0000-0002-6898-4910; Alaux, Michael/0000-0001-9356-4072	French National Research Agency [ANR-09-GENM-025 3BSEQ]; France Agrimer; INRA BAP Biologie et Amelioration des Plantes division; European Commission research training program Marie-Curie Actions (FP7-MC-IIF-NoncollinearGenes); French Ministry of Research; Region Auvergne; Ghent University Multidisciplinary Research Partnership ["Bioinformatics: From nucleotides to networks"] [01MR0310W]; Czech Science Foundation [P501/12/G090]; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI	French National Research Agency(French National Research Agency (ANR)); France Agrimer; INRA BAP Biologie et Amelioration des Plantes division; European Commission research training program Marie-Curie Actions (FP7-MC-IIF-NoncollinearGenes); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Region Auvergne(Region Auvergne-Rhone-Alpes); Ghent University Multidisciplinary Research Partnership ["Bioinformatics: From nucleotides to networks"](Ghent University); Czech Science Foundation(Grant Agency of the Czech Republic); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the scientific advisory board (P. Schnable, S. Rounsley, D. Ware, J. Rogers, and K. Eversole) of the 3BSEQ project for fruitful discussions; K. Eversole for critical reading and editing of the manuscript; H. Rimbert, N. Cubizolles, and E. Rey for SNP marker discovery and genotyping; M. Kubalakova and J. Vrana for assistance with the preparation of DNA amplified from flow-sorted chromosome 3B; L. Couderc, A. Keliet, and S. Reboux for their support in database and system administration; and C. Poncet and the "Plateforme GENTYANE" for SNP genotyping. This work was supported by a grant from the French National Research Agency (ANR-09-GENM-025 3BSEQ), a grant from France Agrimer, and a grant (project DL-BLE) from the INRA BAP Biologie et Amelioration des Plantes division. N. G. is funded by a grant from the European Commission research training program Marie-Curie Actions (FP7-MC-IIF-NoncollinearGenes). J. Daron is funded by a grant from the French Ministry of Research. L. P. is funded by a grant from the Region Auvergne. K. V. is supported by the Ghent University Multidisciplinary Research Partnership ["Bioinformatics: From nucleotides to networks" (Project 01MR0310W)]. J. Dolezel is supported by the Czech Science Foundation (award no. P501/12/G090). The chromosome 3B BAC library and the pools of the MTP BAC clones are available upon request under a materials transfer agreement at the French Plant Genomic Center, INRA-Centre National de Ressources Genomiques Vegetales. Annotation data and browser are available at https://urgi.versailles.inra.fr/gb2/gbrowse/wheat_annot_3B. Sequences and annotations of the reference pseudomolecule and unassigned scaffolds have been deposited in ENA (project PRJEB4376) under accession numbers HG670306 and CBUC010000001 to CBUC010001450, respectively. RNA-Seq data were deposited under accession number ERP004714.	Akhunov ED, 2003, P NATL ACAD SCI USA, V100, P10836, DOI 10.1073/pnas.1934431100; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Baucom RS, 2009, GENOME RES, V19, P243, DOI 10.1101/gr.083360.108; Bhat PR, 2007, NUCLEIC ACIDS RES, V35, P2936, DOI 10.1093/nar/gkm148; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Chen J., 2012, PARAMETRIC STATISTIC; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Evans J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079192; Feuillet C, 2011, TRENDS PLANT SCI, V16, P77, DOI 10.1016/j.tplants.2010.10.005; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Goffinet B, 2000, GENETICS, V155, P463; Gottlieb A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054101; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Leroy P, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00005; Li BC, 2013, PLANT J, V73, P952, DOI 10.1111/tpj.12086; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; LUKASZEWSKI AJ, 1993, THEOR APPL GENET, V86, P121, DOI 10.1007/BF00223816; Marx V, 2013, NATURE, V501, P263, DOI 10.1038/501261a; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Pan QC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052777; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Rustenholz C, 2011, PLANT PHYSIOL, V157, P1596, DOI 10.1104/pp.111.183921; Safar J, 2004, PLANT J, V39, P960, DOI 10.1111/j.1365-313X.2004.02179.x; Saintenac C, 2009, GENETICS, V181, P393, DOI 10.1534/genetics.108.097469; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Sergeeva EM, 2010, MOL GENET GENOMICS, V284, P11, DOI 10.1007/s00438-010-0544-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wicker T, 2010, GENOME RES, V20, P1229, DOI 10.1101/gr.107284.110; Wilson ID, 2004, PLANT BIOTECHNOL J, V2, P495, DOI 10.1111/j.1467-7652.2004.00096.x; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yan HH, 2008, PLOS BIOL, V6, P2563, DOI 10.1371/journal.pbio.0060286; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang H, 2012, CHROMOSOME RES, V20, P403, DOI 10.1007/s10577-012-9284-1; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	56	388	408	1	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1249721	10.1126/science.1249721	http://dx.doi.org/10.1126/science.1249721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035497	Green Submitted			2022-12-24	WOS:000343420300001
J	Iversen, L; Tu, HL; Lin, WC; Christensen, SM; Abel, SM; Iwig, J; Wu, HJ; Gureasko, J; Rhodes, C; Petit, RS; Hansen, SD; Thill, P; Yu, CH; Stamou, D; Chakraborty, AK; Kuriyan, J; Groves, JT				Iversen, Lars; Tu, Hsiung-Lin; Lin, Wan-Chen; Christensen, Sune M.; Abel, Steven M.; Iwig, Jeff; Wu, Hung-Jen; Gureasko, Jodi; Rhodes, Christopher; Petit, Rebecca S.; Hansen, Scott D.; Thill, Peter; Yu, Cheng-Han; Stamou, Dimitrios; Chakraborty, Arup K.; Kuriyan, John; Groves, Jay T.			Ras activation by SOS: Allosteric regulation by altered fluctuation dynamics	SCIENCE			English	Article							SINGLE-MOLECULE; SIGNAL-TRANSDUCTION; ENZYME CATALYSIS; PLASMA-MEMBRANE; HISTONE DOMAIN; SEVENLESS; CELL; PROTEINS; TIME; AUTOINHIBITION	Activation of the small guanosine triphosphatase H-Ras by the exchange factor Son of Sevenless (SOS) is an important hub for signal transduction. Multiple layers of regulation, through protein and membrane interactions, govern activity of SOS. We characterized the specific activity of individual SOS molecules catalyzing nucleotide exchange in H-Ras. Single-molecule kinetic traces revealed that SOS samples a broad distribution of turnover rates through stochastic fluctuations between distinct, long-lived (more than 100 seconds), functional states. The expected allosteric activation of SOS by Ras-guanosine triphosphate (GTP) was conspicuously absent in the mean rate. However, fluctuations into highly active states were modulated by Ras-GTP. This reveals a mechanism in which functional output may be determined by the dynamical spectrum of rates sampled by a small number of enzymes, rather than the ensemble average.	[Iversen, Lars; Tu, Hsiung-Lin; Lin, Wan-Chen; Christensen, Sune M.; Wu, Hung-Jen; Petit, Rebecca S.; Hansen, Scott D.; Kuriyan, John; Groves, Jay T.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; [Abel, Steven M.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Iwig, Jeff; Gureasko, Jodi; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rhodes, Christopher] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Thill, Peter; Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Yu, Cheng-Han; Groves, Jay T.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Stamou, Dimitrios] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Stamou, Dimitrios] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] Ragon Inst Massachusetts Gen Hosp MIT & Harvard, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Kuriyan, John; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Kuriyan, John; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Groves, Jay T.] Berkeley Educ Alliance Res Singapore, Singapore 138602, Singapore	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); National University of Singapore; University of Copenhagen; University of Copenhagen; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Groves, JT (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA.	jtgroves@lbl.gov	Tu, Hsiung-Lin/B-6814-2018; Stamou, Dimitrios/D-5042-2016; Yu, Cheng-han/K-8732-2013; Iversen, Lars/C-5298-2011; Wu, Hung-Jen/H-3769-2016	Tu, Hsiung-Lin/0000-0003-1125-1879; Stamou, Dimitrios/0000-0001-8456-8995; Yu, Cheng-han/0000-0002-8821-8877; Iversen, Lars/0000-0002-1314-130X; Wu, Hung-Jen/0000-0003-3082-7431; Abel, Steven/0000-0003-0491-8647; Christensen, Sune/0000-0001-9650-6660	NIH [P01 AI091580]; Danish Council for Independent Research, Natural Sciences; Mechanobiology Institute, National University of Singapore; Berkeley Education Alliance for Research in Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091580] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Mechanobiology Institute, National University of Singapore(National University of Singapore); Berkeley Education Alliance for Research in Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Major support was provided by NIH P01 AI091580. Additional support was provided by the Danish Council for Independent Research, Natural Sciences (L. I., S. M. C., and D. S.), by the Mechanobiology Institute, National University of Singapore (C.-H.Y. and J.T.G.), and by the Berkeley Education Alliance for Research in Singapore (J.T.G.). L. I., H.-L. T., W.-C. L., and J.T.G. planned and designed the research; H.-L. T. and L. I. performed experiments and analyzed data; S. M. C. and W.-C. L. assisted with experiments; H.-L. T., S. M. C., and H.-J.W. developed algorithms for data analysis; H.-L. T., S. M. A., and P. T. performed stochastic simulations; J.I., J.G., and S. D. H. prepared proteins; C.-H.Y., C. R., and R. S. P. prepared patterned substrates; L. I., H.-L. T., and J.T.G. wrote the manuscript; J.T.G. supervised the project. All authors commented on the manuscript.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Ensign DL, 2010, J PHYS CHEM B, V114, P280, DOI 10.1021/jp906786b; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; Groves JT, 2008, ANNU REV BIOMED ENG, V10, P311, DOI 10.1146/annurev.bioeng.10.061807.160431; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Harding AS, 2008, TRENDS CELL BIOL, V18, P364, DOI 10.1016/j.tcb.2008.05.006; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jun JE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00239; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Min W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198302; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; Prakash MK, 2007, P NATL ACAD SCI USA, V104, P15982, DOI 10.1073/pnas.0707859104; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Yadav KK, 2010, P NATL ACAD SCI USA, V107, P3436, DOI 10.1073/pnas.0914315107; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	43	85	87	1	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					50	54		10.1126/science.1250373	http://dx.doi.org/10.1126/science.1250373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994643	Green Accepted			2022-12-24	WOS:000338284400045
J	Pekkurnaz, G; Trinidad, JC; Wang, XN; Kong, D; Schwarz, TL				Pekkurnaz, Gulcin; Trinidad, Jonathan C.; Wang, Xinnan; Kong, Dong; Schwarz, Thomas L.			Glucose Regulates Mitochondrial Motility via Milton Modification by O-GlcNAc Transferase	CELL			English	Article							AXONAL-TRANSPORT; PHOSPHORYLATION; PROTEIN; BRAIN; GLYCOSYLATION; DYNAMICS; NEURONS; IDENTIFICATION; GLCNACYLATION; LOCALIZATION	Cells allocate substantial resources toward monitoring levels of nutrients that can be used for ATP generation by mitochondria. Among the many specialized cell types, neurons are particularly dependent on mitochondria due to their complex morphology and regional energy needs. Here, we report a molecular mechanism by which nutrient availability in the form of extracellular glucose and the enzyme O-GlcNAc Transferase (OGT), whose activity depends on glucose availability, regulates mitochondrial motility in neurons. Activation of OGT diminishes mitochondrial motility. We establish the mitochondrial motor-adaptor protein Milton as a required substrate for OGT to arrest mitochondrial motility by mapping and mutating the key O-GlcNAcylated serine residues. We find that the GlcNAcylation state of Milton is altered by extracellular glucose and that OGT alters mitochondrial motility in vivo. Our findings suggest that, by dynamically regulating Milton GlcNAcylation, OGT tailors mitochondrial dynamics in neurons based on nutrient availability.	[Pekkurnaz, Gulcin; Schwarz, Thomas L.] Harvard Univ, Boston Childrens Hosp, F M Kirby Neurobiol Ctr, Sch Med, Boston, MA 02115 USA; [Pekkurnaz, Gulcin; Schwarz, Thomas L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Trinidad, Jonathan C.] Indiana Univ, Dept Chem, Biol Mass Spectrometry Facil, Bloomington, IN 47405 USA; [Wang, Xinnan] Stanford Univ, Dept Neurosurg, Stanford, CA 94304 USA; [Kong, Dong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Endocrinol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Indiana University System; Indiana University Bloomington; Stanford University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Schwarz, TL (corresponding author), Harvard Univ, Boston Childrens Hosp, F M Kirby Neurobiol Ctr, Sch Med, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu	Trinidad, Jonathan/GWR-2077-2022	Pekkurnaz, Gulcin/0000-0002-7388-6178	IDDRC Molecular Genetics and Imaging Cores [P30HD18655]; Ellison Medical Foundation;  [K01DK094943];  [P30DK46200];  [5R01GM069808-08]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, K01DK094943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069808] Funding Source: NIH RePORTER	IDDRC Molecular Genetics and Imaging Cores; Ellison Medical Foundation(Lawrence Ellison Foundation); ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the gift of plasmid constructs from Drs. P. Aspenstrom for myc-hMiro1/2; G. Hajnoczky for Mito-DsRed; G. W. Hart for OGT and Xpress-hMilton1; X. Yang for eGFP-OGT; H. T. Cline for Syp-CFP; M. Sahin for scrambled shRNA; M. J. Reginato for OGT shRNA; K. J. Verhey for KHC-mCit; and M. Greenberg for pEGFP-N1. We thank S. Vasquez, K. Pereira, K. Apaydin, and Dr. M. Sahin's laboratory for assistance with primary hippocampal neuron cultures; X. Ho, E. Ling, and Y. Guo for technical assistance; L. Ding from Harvard NeuroDiscovery Center, Enhanced Neuroimaging Core for assistance with development of Kymolyzer; the IDDRC Molecular Genetics and Imaging Cores (grant number P30HD18655). We also thank Drs. M. Banghart, R. Cartoni, M. A. Cronin, B. Lowell, G. Yellen, and M. Tantama and A. Nasser and M. Hamilton for support and valuable input. D. K. was supported by K01DK094943 and P30DK46200. This work was supported by 5R01GM069808-08 and the Ellison Medical Foundation.	Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Dash MB, 2013, J NEUROCHEM, V124, P79, DOI 10.1111/jnc.12063; Fort AG, 2011, J BIOL CHEM, V286, P22875, DOI 10.1074/jbc.M111.219709; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Huang CW, 2007, J NEUROSCI RES, V85, P1468, DOI 10.1002/jnr.21284; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Ji S, 2011, AMINO ACIDS, V40, P809, DOI 10.1007/s00726-010-0698-9; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li Y, 2009, J CELL BIOL, V185, P1065, DOI 10.1083/jcb.200811033; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Lopez-Domenech G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1829; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Matthews JA, 2007, MOL CELL BIOCHEM, V298, P109, DOI 10.1007/s11010-006-9358-5; Nie DY, 2012, METHODS MOL BIOL, V821, P393, DOI 10.1007/978-1-61779-430-8_25; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Peppiatt C, 2004, NATURE, V431, P137, DOI 10.1038/431137a; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Pozo KBK, 2011, BBA-MOL CELL RES, V1813, P269, DOI 10.1016/j.bbamcr.2010.10.011; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; SILVER IA, 1994, J NEUROSCI, V14, P5068; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, METHOD ENZYMOL, V457, P319, DOI 10.1016/S0076-6879(09)05018-6; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278	50	171	174	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					54	68		10.1016/j.cell.2014.06.007	http://dx.doi.org/10.1016/j.cell.2014.06.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995978	Bronze, Green Accepted			2022-12-24	WOS:000340943100007
J	Galvani, AP; Ndeffo-Mbah, ML; Wenzel, N; Childs, JE				Galvani, Alison P.; Ndeffo-Mbah, Martial L.; Wenzel, Natasha; Childs, James E.			Ebola Vaccination: If Not Now, When?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VIRUS CHALLENGE; PROTECTION; VACCINES		Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; Yale Univ, New Haven, CT 06520 USA	Yale University; Yale University	Galvani, AP (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling, POB 208034,60 Coll St, New Haven, CT 06520 USA.	alison.galvani@yale.edu		Ndeffo Mbah, Martial/0000-0003-4158-7613	NIGMS NIH HHS [2 U01 GM087719, U01 GM087719, 5 U01 GM105627, U01 GM105627] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719, U01GM105627] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blaney JE, 2011, J VIROL, V85, P10605, DOI 10.1128/JVI.00558-11; Bukreyev A, 2006, J VIROL, V80, P2267, DOI 10.1128/JVI.80.5.2267-2279.2006; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert TW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000225; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Phoolcharoen W, 2011, P NATL ACAD SCI USA, V108, P20695, DOI 10.1073/pnas.1117715108; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Tsuda Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001275; Warfield KL, EBOLA VIRUS LIKE PAR	10	24	25	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					749	U203		10.7326/M14-1904	http://dx.doi.org/10.7326/M14-1904			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25141813	Green Accepted			2022-12-24	WOS:000347245600035
J	Zhao, HT; Sheng, G; Wang, JY; Wang, M; Bunkoczi, G; Gong, WM; Wei, ZY; Wang, YL				Zhao, Hongtu; Sheng, Gang; Wang, Jiuyu; Wang, Min; Bunkoczi, Gabor; Gong, Weimin; Wei, Zhiyi; Wang, Yanli			Crystal structure of the RNA-guided immune surveillance Cascade complex in Escherichia coli	NATURE			English	Article							IN-VITRO RECONSTITUTION; CRISPR-CAS SYSTEMS; TARGET RECOGNITION; ANTIVIRAL DEFENSE; SEED SEQUENCE; DNA; INTERFERENCE; PROKARYOTES; DEGRADATION; CRYSTALLOGRAPHY	Clustered regularly interspaced short palindromic repeats (CRISPR) together with CRISPR-associated (Cas) proteins form the CRISPR/Cas system to defend against foreign nucleic acids of bacterial and archaeal origin(1-9). In the I-E subtype CRISPR/Cas system, eleven subunits from five Cas proteins (CasA(1)B(2)C(6)D(1)E(1)) assemble along a CRISPR RNA (crRNA) to form the Cascade complex(10-13). Here we report on the 3.05 angstrom crystal structure of the 405-kilodalton Escherichia coli Cascade complex that provides molecular details beyond those available from earlier lower-resolution cryo-electron microscopy structures. The bound 61-nucleotide crRNA spans the entire 11-protein subunit-containing complex, where it interacts with all six CasC subunits (named CasC1-6), with its 5 ' and 3 ' terminal repeats anchored by CasD and CasE, respectively. The crRNA spacer region is positioned along a continuous groove on the concave surface generated by the aligned CasC1-6 subunits. The five long beta-hairpins that project from individual CasC2-6 subunits extend across the crRNA, with each beta-hairpin inserting into the gap between the last stacked base and its adjacent splayed counterpart, and positioned within the groove of the preceding CasC subunit. Therefore, instead of continuously stacking, the crRNA spacer region is divided into five equal fragments, with each fragment containing five stacked bases flanked by one flipped-out base. Each of those crRNA spacer fragments interacts with CasC in a similar fashion. Furthermore, our structure explains why the seed sequence, with its outward directed bases, has a critical role in target DNA recognition. Inconclusion, our structure of the Cascade complex provides novel molecular details of protein-protein and protein-RNA alignments and interactions required for generation of a complex mediating RNA-guided immune surveillance.	[Zhao, Hongtu; Sheng, Gang; Wang, Jiuyu; Wang, Min; Gong, Weimin; Wang, Yanli] Chinese Acad Sci, Inst Biophys, Lab RNA Biol, Beijing 100101, Peoples R China; [Zhao, Hongtu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Bunkoczi, Gabor] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Wei, Zhiyi] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Southern University of Science & Technology	Wang, YL (corresponding author), Chinese Acad Sci, Inst Biophys, Lab RNA Biol, Beijing 100101, Peoples R China.	wei.zy@sustc.edu.cn; ylwang@ibp.ac.cn	Wei, Zhiyi/N-9995-2019; Wei, Zhiyi/C-4315-2014	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Wang, Yanli/0000-0002-5969-1745	Chinese Ministry of Science and Technology [2014CB910102, 2011CBA01105]; Natural Science Foundation of China [31222014, 31170705]; Strategic Priority Research program of the Chinese Academy of Sciences [XDB08010203]; South University of Science and Technology of China; Shenzhen Government	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research program of the Chinese Academy of Sciences(Chinese Academy of Sciences); South University of Science and Technology of China; Shenzhen Government	We thank the staff at beamline BL-17U at Shanghai Synchrotron Radiation Facility (SSRF), and beamlines BL-1A, BL-5A and BL-17A at Photon Factory. The research was funded by Chinese Ministry of Science and Technology (2014CB910102 and 2011CBA01105), the Natural Science Foundation of China (31222014 and 31170705), and the Strategic Priority Research program of the Chinese Academy of Sciences (XDB08010203) to Y.W., and was supported by the Research Startup Fund from South University of Science and Technology of China and Shenzhen Government to Z.W. We thank D. Patel for assistance with manuscript editing, H. Wang, H. Li and F. Sun for experimental assistance, and T. Juelich for critical reading and editing of our manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Hrle A, 2013, RNA BIOL, V10, P1670, DOI 10.4161/rna.26500; Jackson RN, 2014, CURR OPIN STRUC BIOL, V24, P106, DOI 10.1016/j.sbi.2014.01.001; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2013, BIOCHEM SOC T, V41, P1392, DOI 10.1042/BST20130038; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Xiong Y, 2008, ACTA CRYSTALLOGR D, V64, P76, DOI 10.1107/S090744490705398X	39	119	127	5	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					147	+		10.1038/nature13733	http://dx.doi.org/10.1038/nature13733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25118175				2022-12-24	WOS:000344187500047
J	Kinsinger, LS; Atkins, D; Provenzale, D; Anderson, C; Petzel, R				Kinsinger, Linda S.; Atkins, David; Provenzale, Dawn; Anderson, Charles; Petzel, Robert			Implementation of a New Screening Recommendation in Health Care: The Veterans Health Administration's Approach to Lung Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kinsinger, Linda S.; Atkins, David; Provenzale, Dawn; Anderson, Charles; Petzel, Robert] Vet Hlth Adm, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kinsinger, LS (corresponding author), Vet Hlth Adm, Natl Ctr Hlth Promot & Dis Prevent, 3022 Croasdaile Dr,Suite 200, Durham, NC 27705 USA.	Linda.Kinsinger@va.gov						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Detterbeck FC, 2014, ANN INTERN MED, V160, P363, DOI 10.7326/M13-2904; Detterbeck FC, 2013, CHEST, V143, pE78, DOI 10.1378/chest.12-2350; Donabedian A., 1980, DEFINITION QUALITY A, V1; Goulart BHL, 2013, ONCOLOGIST, V18, P941, DOI 10.1634/theoncologist.2013-0007; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771	6	31	31	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					597	U97		10.7326/M14-1070	http://dx.doi.org/10.7326/M14-1070			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25111673				2022-12-24	WOS:000343906800022
J	Srivastava, A; Yano, J; Hirozane, Y; Kefala, G; Gruswitz, F; Snell, G; Lane, W; Ivetac, A; Aertgeerts, K; Nguyen, J; Jennings, A; Okada, K				Srivastava, Ankita; Yano, Jason; Hirozane, Yoshihiko; Kefala, Georgia; Gruswitz, Franz; Snell, Gyorgy; Lane, Weston; Ivetac, Anthony; Aertgeerts, Kathleen; Nguyen, Jasmine; Jennings, Andy; Okada, Kengo			High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; FREE FATTY-ACIDS; CRYSTAL-STRUCTURE; ADRENERGIC-RECEPTOR; MOLECULAR-GRAPHICS; INSULIN-SECRETION; MEMBRANE-PROTEINS; OPIOID RECEPTOR; ACTIVATION; BINDING	Human GPR40 receptor (hGPR40), also known as free fatty-acid receptor 1 (FFAR1), is a G-protein-coupled receptor that binds long-chain free fatty acids to enhance glucose-dependent insulin secretion(1). Novel treatments for type-2 diabetes mellitus(2) are therefore possible by targeting hGPR40 with partial or full agonists. TAK-875, or fasiglifam, is an orally available, potent and selective partial agonist(3) of hGPR40 receptor, which reached phase III clinical trials for the potential treatment of type-2 diabetes mellitus(4). Data from clinical studies indicate that TAK-875, which is anago-allosteric modulator of hGPR40 (ref. 3), demonstrates improved glycaemic control and low hypoglycaemic risk in diabetic patients(5). Here we report the crystal structure of hGPR40 receptor bound to TAK-875 at 2.3 angstrom resolution. The co-complex structure reveals a unique binding mode of TAK-875 and suggests that entry to the non-canonical binding pocket most probably occurs via the lipid bilayer. The atomic details of the extensive charge network in the ligand binding pocket reveal additional interactions not identified in previous studies and contribute to a clear understanding of TAK-875 binding to the receptor. The hGPR40-TAK-875 structure also provides insights into the plausible binding of multiple ligands to the receptor, which has been observed in radioligand binding(6) and Ca2+ influx assay studies(3). Comparison of the transmembrane helix architecture with other G-protein-coupled receptors suggests that the crystallized TAK-875-bound hGPR40 complex is in an inactive-like state.	[Srivastava, Ankita; Yano, Jason; Kefala, Georgia; Gruswitz, Franz; Snell, Gyorgy; Lane, Weston; Ivetac, Anthony; Aertgeerts, Kathleen; Nguyen, Jasmine; Jennings, Andy] Takeda Calif, Dept Struct Biol & Core Sci & Technol, San Diego, CA 92121 USA; [Hirozane, Yoshihiko; Okada, Kengo] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Biomol Res Labs, Fujisawa, Kanagawa 2518555, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Takeda Pharmaceutical Company Ltd	Srivastava, A (corresponding author), Takeda Calif, Dept Struct Biol & Core Sci & Technol, 10410 Sci Ctr Dr, San Diego, CA 92121 USA.	ankita.srivastava@takeda.com		Yano, Jason/0000-0002-9774-2611; Gruswitz, Franz/0000-0002-9671-6788	National Institutes of Health and National Institute of General Medical Sciences; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231, DE-AC02-06CH11357]	National Institutes of Health and National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE))	We thank K. P. Wilson, M. Hixon and K. Goodwill for review and feedback on the manuscript; T. Ho and S. Okubo for molecular cloning support; T. Sjoberg for membrane preparation; and C. Dillard for cell culture support. We also thank the staff of the Berkeley Center for Structural Biology, Lawrence Berkeley National Laboratory, which operates Advanced Light Source beamline 5.0.3, and the staff ofGM/CA, Argonne National Laboratory, which operates Advanced Photon Source beamline 23ID-D. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health and National Institute of General Medical Sciences. The GM/CA has been funded in whole or in part with Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). The Advanced Light Source and Advanced Photon Source are supported by the Director, Office of Science, Office of Basic Energy Sciences of the US Department of Energy under contract numbers DE-AC02-05CH11231 and DE-AC02-06CH11357, respectively.	Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Choe HW, 2011, NEUROPHARMACOLOGY, V60, P52, DOI 10.1016/j.neuropharm.2010.07.018; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischetti RF, 2009, J SYNCHROTRON RADIAT, V16, P217, DOI 10.1107/S0909049508040612; Flodgren E, 2007, BIOCHEM BIOPH RES CO, V354, P240, DOI 10.1016/j.bbrc.2006.12.193; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hirozane Y., MOL MEM BIO IN PRESS; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mercier RW, 2010, CHEM BIOL, V17, P1132, DOI 10.1016/j.chembiol.2010.08.010; Negoro N, 2012, J MED CHEM, V55, P3960, DOI 10.1021/jm300170m; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yabuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076280; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	41	257	266	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					124	+		10.1038/nature13494	http://dx.doi.org/10.1038/nature13494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043059				2022-12-24	WOS:000341174800043
J	Khan, MS; Coker, RJ				Khan, Mishal S.; Coker, Richard J.			How to hinder tuberculosis control: five easy steps	LANCET			English	Editorial Material							MULTIDRUG-RESISTANT TUBERCULOSIS; EXTENSIVELY DRUG-RESISTANT; PRIVATE PHARMACIES; RUSSIA; CHINA; TB		[Khan, Mishal S.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Communicable Dis Policy Res Grp, London WC1, England; Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore	University of London; London School of Hygiene & Tropical Medicine; National University of Singapore	Khan, MS (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Communicable Dis Policy Res Grp, London WC1, England.	mishal.khan@lshtm.ac.uk						Auer C, 2000, TROP MED INT HEALTH, V5, P648, DOI 10.1046/j.1365-3156.2000.00615.x; Bosman MCJ, 2000, INT J TUBERC LUNG D, V4, P606; Chuc NTK, 1999, EUR J CLIN PHARMACOL, V55, P325, DOI 10.1007/s002280050636; Coker R, 2000, EUR J PUBLIC HEALTH, V10, P148, DOI 10.1093/eurpub/10.2.148; Coker RJ, 2004, TROP MED INT HEALTH, V9, P25, DOI 10.1046/j.1365-3156.2003.01156.x; Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1; Farmer PE, 2000, EUR J PUBLIC HEALTH, V10, P150, DOI 10.1093/eurpub/10.2.150; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Hazarika I, 2011, J GLOB INFECT DIS, V3, P19, DOI 10.4103/0974-777X.77291; Hu D, 2008, HEALTH POLICY PLANN, V23, P43, DOI 10.1093/heapol/czm038; Hurtig AK, 2000, INT J TUBERC LUNG D, V4, P730; Macfie N, 2014, MED AID GROUP MSF AL; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; Reintjes R., 2008, HLTH SYSTEMS CHALLEN, P141; Shah S K, 2003, East Mediterr Health J, V9, P776; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Tesh S.N., 1988, HIDDEN ARGUMENTS POL; The Global Fund to Fight AIDS, 2014, PERF BAS FUND; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yadav A, 2012, Indian J Chest Dis Allied Sci, V54, P161	23	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					646	648		10.1016/S0140-6736(14)61175-2	http://dx.doi.org/10.1016/S0140-6736(14)61175-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	25064593				2022-12-24	WOS:000341359100010
J	Pfeiff, J; Robinson, J; Hagopian, A; Johnson, W; Fort, M; Gimbel-Sherr, K; Rowden, R; Friedman, E; Davis, P; Adedokun, L; Gloyd, S				Pfeiff, James; Robinson, Julia; Hagopian, Amy; Johnson, Wendy; Fort, Meredith; Gimbel-Sherr, Kenneth; Rowden, Rick; Friedman, Eric; Davis, Paul; Adedokun, Lola; Gloyd, Steve			The end of AIDS and the NGO Code of Conduct	LANCET			English	Editorial Material							HEALTH SYSTEMS		[Pfeiff, James; Robinson, Julia; Hagopian, Amy; Gimbel-Sherr, Kenneth; Gloyd, Steve] Hlth Alliance Int, Seattle, WA 98115 USA; [Pfeiff, James; Robinson, Julia; Hagopian, Amy; Johnson, Wendy; Fort, Meredith; Gimbel-Sherr, Kenneth; Gloyd, Steve] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Fort, Meredith] Univ Colorado Denver, Dept Family Med, Denver, CO USA; [Rowden, Rick] Jawaharlal Nehru Univ, New Delhi 110067, India; [Friedman, Eric] Georgetown Law, Washington, DC USA; [Davis, Paul] Hlth GAP, Washington, DC USA; [Adedokun, Lola] Doris Duke Charitable Fdn, New York, NY USA	University of Washington; University of Washington Seattle; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Jawaharlal Nehru University, New Delhi	Pfeiff, J (corresponding author), Hlth Alliance Int, Seattle, WA 98115 USA.	juliarob@uw.edu		Fort, Meredith/0000-0003-0589-1044	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI027757] Funding Source: Medline; NICHD NIH HHS [R01 HD074557] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bajunirwe F, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002875; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Kharas H., 2012, GLOBAL PARTNERSHIP E; Kim JY, 2013, CALIF SER PUB ANTHR, V26, P184; Luboga S, 2013, 141 AM PUBL HLTH ASS; Pfeiffer J, 2008, AM J PUBLIC HEALTH, V98, P2134, DOI 10.2105/AJPH.2007.125989; President's Emergency Plan for AIDS Relief, 2011, FY 2012 COUNTR OP PL; Sherr K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035840; Simonds RJ, 2012, HEALTH AFFAIR, V31, P1397, DOI 10.1377/hlthaff.2012.0193; Stuckler D, 2011, INT J HEALTH SERV, V41, P67, DOI 10.2190/HS.41.1.e; The Paris Declaration on Aid Effectiveness (2005) & the Accra Agenda for Action, 2008, PARIS DECLARATION AI; World Health Organisation, 2021, CONSOLIDATED GUIDELI	12	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					639	640		10.1016/S0140-6736(14)61259-9	http://dx.doi.org/10.1016/S0140-6736(14)61259-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5CJ	25152262				2022-12-24	WOS:000341359100006
J	Lingaraju, GM; Bunker, RD; Cavadini, S; Hess, D; Hassiepen, U; Renatus, M; Fischer, ES; Thoma, NH				Lingaraju, Gondichatnahalli M.; Bunker, Richard D.; Cavadini, Simone; Hess, Daniel; Hassiepen, Ulrich; Renatus, Martin; Fischer, Eric S.; Thomae, Nicolas H.			Crystal structure of the human COP9 signalosome	NATURE			English	Article							PCI DOMAIN; NEDD8 MODIFICATION; ARABIDOPSIS COP9; ARCHITECTURE; COMPLEX; INITIATION; SUBUNIT; PROTEIN; MODEL; ACTIVATION	Ubiquitination is a crucial cellular signalling process, and is controlled on multiple levels. Cullin-RINGE3 ubiquitin ligases (CRLs) are regulated by the eight-subunit COP9 signalosome (CSN). CSN inactivates CRLs by removing their covalently attached activator, NEDD8. NEDD8 cleavage by CSN is catalysed by CSN5, a Zn2+-dependent isopeptidase that is inactive in isolation. Here we present the crystal structure of the entire similar to 350-kDa human CSN holoenzyme at 3.8 angstrom resolution, detailing the molecular architecture of the complex. CSN has two organizational centres: a horseshoe-shaped ring created by its six proteasome lid-CSN-initiation factor 3 (PCI) domain proteins, and a large bundle formed by the carboxy-terminal a-helices of every subunit. CSN5 and its dimerization partner, CSN6, are intricately embedded at the core of the helical bundle. In the substrate-free holoenzyme, CSN5 is autoinhibited, which precludes access to the active site. We find that neddylated CRL binding to CSN is sensed by CSN4, and communicated to CSN5 with the assistance of CSN6, resulting in activation of the deneddylase.	[Lingaraju, Gondichatnahalli M.; Bunker, Richard D.; Cavadini, Simone; Hess, Daniel; Fischer, Eric S.; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Lingaraju, Gondichatnahalli M.; Bunker, Richard D.; Cavadini, Simone; Fischer, Eric S.; Thomae, Nicolas H.] Univ Basel, CH-4003 Basel, Switzerland; [Hassiepen, Ulrich; Renatus, Martin] Novartis Pharma AG, Inst Biomed Res, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel; Novartis; Universita della Svizzera Italiana	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nicolas.thoma@fmi.ch		Thoma, Nicolas/0000-0003-2685-906X; Bunker, Richard/0000-0001-8866-5290; Fischer, Eric S./0000-0001-7337-6306	Novartis Research Foundation; Swiss National Science Foundation [31003A_144020]; European Research Council (MoBa-CS) [260481]; Novartis (NIBR)	Novartis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (MoBa-CS); Novartis (NIBR)	This work was supported by the Novartis Research Foundation, the Swiss National Science Foundation (31003A_144020) and the European Research Council (MoBa-CS #260481). G. M. L. is the recipient of a Novartis (NIBR) presidential postdoctoral fellowship. Part of this work was performed at beamline X06DA and X10SA of the Swiss Light Source. We thank H. Wu for sharing the A. thaliana CSN1 coordinates before publication; H. Gut, J. Keusch and M. Jones for support; and C. Vonrhein and the BUSTER development group, R. Read, A. McCoy, T. Terwilliger, R. Nicholls, R. Kingston and K. Diederichs for technical advice. We are also grateful for the assistance of B. Martoglio, R. Assenberg, C. Logel and I. Bechtold in developing the PT22 CSN assays.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; Boehringer J, 2012, BIOCHEM J, V448, P55, DOI 10.1042/BJ20120542; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2011, BUSTER VERSION 2 11; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dessau M, 2008, PLANT CELL, V20, P2815, DOI 10.1105/tpc.107.053801; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Echalier A, 2013, P NATL ACAD SCI USA, V110, P1273, DOI 10.1073/pnas.1209345110; Ellisdon Andrew M, 2012, Bioarchitecture, V2, P118, DOI 10.4161/bioa.21131; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khoshnevis S, 2014, NUCLEIC ACIDS RES, V42, P4123, DOI 10.1093/nar/gkt1369; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee JHW, 2013, J HYDRO-ENVIRON RES, V7, P227, DOI 10.1016/j.jher.2013.10.003; Lee M. H., 2011, CELL CYCLE, V10, P3057, DOI [DOI 10.4161/CC.10.18, 10.4161/cc.10.18.17320, DOI 10.4161/CC.10.18.17320]; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Marks BD, 2005, ASSAY DRUG DEV TECHN, V3, P613, DOI 10.1089/adt.2005.3.613; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon S, 2005, METHOD ENZYMOL, V398, P468, DOI 10.1016/S0076-6879(05)98038-5; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pick E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043980; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Tran HJTT, 2003, BIOCHEMISTRY-US, V42, P11460, DOI 10.1021/bi035033g; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Zhang H, 2012, FEBS LETT, V586, P1147, DOI 10.1016/j.febslet.2012.03.029; Zhao RY, 2011, J CLIN INVEST, V121, P851, DOI 10.1172/JCI44111; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	72	143	147	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					161	+		10.1038/nature13566	http://dx.doi.org/10.1038/nature13566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043011				2022-12-24	WOS:000340200700024
J	Moltke, I; Grarup, N; Jorgensen, ME; Bjerregaard, P; Treebak, JT; Fumagalli, M; Korneliussen, TS; Andersen, MA; Nielsen, TS; Krarup, NT; Gjesing, AP; Zierath, JR; Linneberg, A; Wu, XL; Sun, GQ; Jin, X; Al-Aama, J; Wang, J; Borch-Johnsen, K; Pedersen, O; Nielsen, R; Albrechtsen, A; Hansen, T				Moltke, Ida; Grarup, Niels; Jorgensen, Marit E.; Bjerregaard, Peter; Treebak, Jonas T.; Fumagalli, Matteo; Korneliussen, Thorfinn S.; Andersen, Marianne A.; Nielsen, Thomas S.; Krarup, Nikolaj T.; Gjesing, Anette P.; Zierath, Juleen R.; Linneberg, Allan; Wu, Xueli; Sun, Guangqing; Jin, Xin; Al-Aama, Jumana; Wang, Jun; Borch-Johnsen, Knut; Pedersen, Oluf; Nielsen, Rasmus; Albrechtsen, Anders; Hansen, Torben			A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes	NATURE			English	Article							GLYCEMIC TRAITS; GLUCOSE; POPULATION; DISCOVERY; FRAMEWORK; MUTATION	The Greenlandic population, a small and historically isolated founder population comprising about 57,000 inhabitants, has experienced a dramatic increase in type 2 diabetes (T2D) prevalence during the past 25 years(1). Motivated by this, we performed association mapping of T2D-related quantitative traits in up to 2,575 Greenlandic individuals without known diabetes. Using array-based genotyping and exome sequencing, we discovered a nonsense p.Arg684Ter variant (in which arginine is replaced by a termination codon) in the gene TBC1D4 with an allele frequency of 17%. Here we show that homozygous carriers of this variant have markedly higher concentrations of plasma glucose(beta=3.8 mmol l(-1), P = 2.5 X 10(-35)) and serum insulin (beta = 165 pmol l(-1), P = 1.5 X 10(-20)) 2 hours after an oral glucose load compared with individuals with other genotypes (both non-carriers and heterozygous carriers). Furthermore, homozygous carriers have marginally lower concentrations of fasting plasma glucose (beta = -0.18 mmol l(-1), P = 1.1 X 10(-6)) and fasting serum insulin (beta = -8.3 pmol l(-1), P = 0.0014), and their T2D risk is markedly increased (odds ratio (OR) = 10.3, P = 1.6 X 10(-24)). Heterozygous carriers have a moderately higher plasma glucose concentration 2 hours after an oral glucose load than non-carriers (beta = 0.43 mmol l(-1), P = 5.3 X 10(-5)). Analyses of skeletal muscle biopsies showed lower messenger RNA and protein levels of the long isoform of TBC1D4, and lower muscle protein levels of the glucose transporter GLUT4, with increasing number of p.Arg684Ter alleles. These findings are concomitant with a severely decreased insulin-stimulated glucose uptake in muscle, leading to postprandial hyperglycaemia, impaired glucose tolerance and T2D. The observed effect sizes are several times larger than any previous findings in large-scale genome-wide association studies of these traits(2-4) and constitute further proof of the value of conducting genetic association studies outside the traditional setting of large homogeneous populations.	[Moltke, Ida; Albrechtsen, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Moltke, Ida] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Grarup, Niels; Krarup, Nikolaj T.; Gjesing, Anette P.; Wang, Jun; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2100 Copenhagen, Denmark; [Jorgensen, Marit E.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Bjerregaard, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, DK-1353 Copenhagen, Denmark; [Treebak, Jonas T.; Andersen, Marianne A.; Nielsen, Thomas S.; Zierath, Juleen R.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Sect Integrat Physiol, DK-2200 Copenhagen, Denmark; [Fumagalli, Matteo; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Korneliussen, Thorfinn S.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Wu, Xueli; Sun, Guangqing; Jin, Xin; Al-Aama, Jumana; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Al-Aama, Jumana; Wang, Jun] King Abdulaziz Univ, Fac Med, Dept Med Genet, Jeddah 21589, Saudi Arabia; [Al-Aama, Jumana; Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Albrahim Ctr Excellence Res H, Jeddah 21589, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Macau Univ Sci & Technol, Macau 999078, Peoples R China; [Borch-Johnsen, Knut] Holbaek Cent Hosp, DK-4300 Holbaek, Denmark; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, DK-5000 Odense, Denmark	University of Copenhagen; University of Chicago; Novo Nordisk Foundation; University of Copenhagen; Steno Diabetes Center; University of Southern Denmark; Novo Nordisk Foundation; University of Copenhagen; University of California System; University of California Berkeley; University of Copenhagen; Karolinska Institutet; University of Copenhagen; Beijing Genomics Institute (BGI); King Abdulaziz University; King Abdulaziz University; University of Copenhagen; Macau University of Science & Technology; Holbaek Hospital; University of California System; University of California Berkeley; University of Southern Denmark	Hansen, T (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2100 Copenhagen, Denmark.	albrecht@binf.ku.dk; torben.hansen@sund.ku.dk	Treebak, Jonas Thue/B-4521-2017; Pedersen, Oluf/AAG-8015-2020; Korneliussen, Thorfinn Sand/F-6421-2014; Gjesing, Anette/ACC-7521-2022; Jin, Xin/ABF-1329-2020; Al-aama, Jumana/AAA-8653-2021; Albrechtsen, Anders/K-4281-2013; Grarup, Niels/K-2807-2015; Bjerregaard, Peter/ABD-8894-2020; Korneliussen, Thorfinn Sand/ABB-7656-2021; Moltke, Ida/C-6158-2011; Pedersen, Oluf/Z-1731-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; Nielsen, Rasmus/D-4405-2009	Treebak, Jonas Thue/0000-0003-1488-7012; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Gjesing, Anette/0000-0003-4580-1576; Jin, Xin/0000-0001-7554-4975; Albrechtsen, Anders/0000-0001-7306-031X; Grarup, Niels/0000-0001-5526-1070; Bjerregaard, Peter/0000-0001-7153-8447; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Moltke, Ida/0000-0001-7052-8554; Pedersen, Oluf/0000-0002-3321-3972; Andersen, Marianne/0000-0002-4603-9504; Zierath, Juleen/0000-0001-6891-7497; Nielsen, Thomas Svava/0000-0002-9457-8000; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Hansen, Torben/0000-0001-8748-3831; Agerholm Jensen, Marianne/0000-0001-8687-1031; Jorgensen, Marit Eika/0000-0001-8356-5565; Krarup, Nikolaj Thure/0000-0001-6526-8663; Nielsen, Rasmus/0000-0003-0513-6591; Fumagalli, Matteo/0000-0002-4084-2953; Linneberg, Allan/0000-0002-0994-0184	Novo Nordisk Foundation; Danish Council for Independent Research (Medical Sciences); Steno Diabetes Center; Villum Foundation; Karen Elise Jensen's Foundation; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland; NNF Center for Basic Metabolic Research [Treebak Group] Funding Source: researchfish; Villum Fonden [00007171] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Steno Diabetes Center; Villum Foundation(Villum Fonden); Karen Elise Jensen's Foundation; NunaFonden; Medical Research Council of Denmark; Medical Research Council of Greenland; Commission for Scientific Research in Greenland; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Villum Fonden(Villum Fonden)	We thank I. Kleist, as well as all colleagues at the Physician's Clinic, Nuuk, Greenland. We also thank J. F. Wojtaszewski for comments and X. Zhou for discussions about GEMMA. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research centre at the University of Copenhagen and is partly funded by an unrestricted donation from the Novo Nordisk Foundation. This project was also funded by the Danish Council for Independent Research (Medical Sciences), the Steno Diabetes Center and the Villum Foundation. The IHIT study was supported by Karen Elise Jensen's Foundation, NunaFonden, the Medical Research Council of Denmark, the Medical Research Council of Greenland and the Commission for Scientific Research in Greenland. None of the funding agencies had any role in the study design or in the collection or interpretation of the data.	Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baus D, 2008, CELL SIGNAL, V20, P2237, DOI 10.1016/j.cellsig.2008.08.010; Bjerregaard P., 2003, INT J CIRCUMPOL HEAL, V62, P3, DOI [10.3402/ijch.v62i0.18212, DOI 10.3402/IJCH.V62I0.18212]; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cederberg H, 2010, DIABETES CARE, V33, P2077, DOI 10.2337/dc10-0262; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Jorgensen ME, 2013, DIABETES CARE, V36, P2988, DOI 10.2337/dc12-2703; Jorgensen ME, 2002, DIABETES CARE, V25, P1766, DOI 10.2337/diacare.25.10.1766; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moltke I, 2014, BIOINFORMATICS, V30, P1027, DOI 10.1093/bioinformatics/btt652; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Treebak JT, 2009, DIABETOLOGIA, V52, P891, DOI 10.1007/s00125-009-1294-y; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wang HY, 2013, BIOCHEM J, V449, P479, DOI 10.1042/BJ20120702; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	30	242	251	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					190	+		10.1038/nature13425	http://dx.doi.org/10.1038/nature13425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043022	Green Published			2022-12-24	WOS:000340200700031
J	Wang, Q				Wang, Qiang			China should aim for a total cap on emissions	NATURE			English	Editorial Material									Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Wang, Q (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China.	qiangwang7@gmail.com	WANG, Qiang/F-4618-2011	WANG, Qiang/0000-0002-8751-8093					0	33	33	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					115	115		10.1038/512115a	http://dx.doi.org/10.1038/512115a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25119205	Bronze			2022-12-24	WOS:000340200700003
J	Ma, H; Morey, R; O'Neil, RC; He, YP; Daughtry, B; Schultz, MD; Hariharan, M; Nery, JR; Castanon, R; Sabatini, K; Thiagarajan, RD; Tachibana, M; Kang, EJ; Tippner-Hedges, R; Ahmed, R; Gutierrez, NM; Van Dyken, C; Polat, A; Sugawara, A; Sparman, M; Gokhale, S; Amato, P; Wolf, DP; Ecker, JR; Laurent, LC; Mitalipov, S				Ma, Hong; Morey, Robert; O'Neil, Ryan C.; He, Yupeng; Daughtry, Brittany; Schultz, Matthew D.; Hariharan, Manoj; Nery, Joseph R.; Castanon, Rosa; Sabatini, Karen; Thiagarajan, Rathi D.; Tachibana, Masahito; Kang, Eunju; Tippner-Hedges, Rebecca; Ahmed, Riffat; Gutierrez, Nuria Marti; Van Dyken, Crystal; Polat, Alim; Sugawara, Atsushi; Sparman, Michelle; Gokhale, Sumita; Amato, Paula; Wolf, Don P.; Ecker, Joseph R.; Laurent, Louise C.; Mitalipov, Shoukhrat			Abnormalities in human pluripotent cells due to reprogramming mechanisms	NATURE			English	Article							EMBRYONIC STEM-CELLS; CODING MUTATIONS; DNA METHYLATION; DYNAMIC CHANGES; SOMATIC-CELLS; X-CHROMOSOME; COPY NUMBER; MEMORY; LINES; DIFFERENTIATION	Human pluripotent stem cells hold potential for regenerative medicine, but available cell types have significant limitations. Although embryonic stemcells (ES cells) from in vitro fertilized embryos (IVFES cells) represent the 'gold standard', they are allogeneic to patients. Autologous induced pluripotent stem cells (iPS cells) are prone to epigenetic and transcriptional aberrations. To determine whether such abnormalities are intrinsic to somatic cell reprogramming or secondary to the reprogramming method, genetically matched sets of human IVF ES cells, iPS cells and nuclear transfer ES cells (NT ES cells) derived by somatic cell nuclear transfer (SCNT) were subjected to genome-wide analyses. Both NT ES cells and iPS cells derived from the same somatic cells contained comparable numbers of de novo copy number variations. In contrast, DNA methylation and transcriptome profiles of NT ES cells corresponded closely to those of IVF ES cells, whereas iPS cells differed and retained residual DNA methylation patterns typical of parental somatic cells. Thus, human somatic cells can be faithfully reprogrammed to pluripotency by SCNT and are therefore ideal for cell replacement therapies.	[Ma, Hong; Daughtry, Brittany; Kang, Eunju; Tippner-Hedges, Rebecca; Ahmed, Riffat; Gutierrez, Nuria Marti; Van Dyken, Crystal; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, Portland, OR 97239 USA; [Ma, Hong; Daughtry, Brittany; Tachibana, Masahito; Kang, Eunju; Tippner-Hedges, Rebecca; Ahmed, Riffat; Gutierrez, Nuria Marti; Van Dyken, Crystal; Polat, Alim; Sugawara, Atsushi; Sparman, Michelle; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA; [Morey, Robert; Sabatini, Karen; Thiagarajan, Rathi D.; Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [O'Neil, Ryan C.; He, Yupeng; Schultz, Matthew D.; Hariharan, Manoj; Nery, Joseph R.; Castanon, Rosa; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [O'Neil, Ryan C.; He, Yupeng] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Gokhale, Sumita] Boston Univ, Sch Med, Roger Williams Med Ctr, Univ Pathologists LLC, Providence, RI 02918 USA; [Amato, Paula; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol, Portland, OR 97239 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Boston University; Roger Williams Medical Center; Oregon Health & Science University; Howard Hughes Medical Institute; Salk Institute	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, 3303 Southwest Bond Ave, Portland, OR 97239 USA.	ecker@salk.edu; llaurent@ucsd.edu; mitalipo@ohsu.edu	Ecker, Joseph R/B-9144-2008; Hariharan, Manoj/N-2855-2015; Nery, Joseph/AAE-8422-2019	Ecker, Joseph R/0000-0001-5799-5895; Hariharan, Manoj/0000-0002-1006-5372; Nery, Joseph/0000-0003-0153-5659; Laurent, Louise/0000-0002-2095-7534	Leducq Foundation; OHSU; UCSD Department of Reproductive Medicine; Salk International Council Chair fund endowment; Mary K. Chapman Foundation; Swedish Research Council; Collins Medical Trust	Leducq Foundation(Leducq Foundation); OHSU; UCSD Department of Reproductive Medicine; Salk International Council Chair fund endowment; Mary K. Chapman Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Collins Medical Trust	The authors acknowledge the OHSU Embryonic Stem Cell Research Oversight Committee and the Institutional Review Board for providing oversight and guidance. We thank oocyte and sperm donors and the Women's Health Research Unit staff at the Center for Women's Health, University Fertility Consultants and the Reproductive Endocrinology and Infertility Division in the Department of Obstetrics and Gynecology of Oregon Health and Science University for their support and procurement of human gametes. We are grateful to C. Penedo for microsatellite analysis and W. Sanger and D. Zaleski for karyotyping services. We are also indebted to Y. Li, H. Sritanaudomchai and D. Melguizo Sanchis for their technical support. We thank the staff at the Institute for Genomic Medicine Genomics Facility at UCSD for running the Infinium HumanMethylation450 BeadChips and sequencing of the RNA-seq libraries. The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin (http://www.tacc.utexas.edu) and the San Diego Supercomputing Center (through an allocation from the eXtreme Science and Engineering Discovery Environment (XSEDE)) for providing HPC resources that have contributed to the research results reported within this paper. SCNT and iPS cell studies were supported by grants from the Leducq Foundation and OHSU institutional funds. R. M., K. S., R. T. and L. C. L. were supported by the UCSD Department of Reproductive Medicine. Methylome studies were supported by the Salk International Council Chair fund endowment and the Mary K. Chapman Foundation to J.R.E. J.R.E. is an investigator of the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (GMBF3034). A. P. received a fellowship fromthe Swedish Research Council, Vetenskapsra det. E. K. was partially funded by a fellowship from the Collins Medical Trust.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bancroft T, 2013, BIOMETRICS, V69, P1, DOI 10.1111/j.1541-0420.2012.01825.x; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Martin M, 2011, EMBNET J, V17; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Perkins W, 2011, APPL MATH COMPUT, V217, P9072, DOI 10.1016/j.amc.2011.03.124; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Price EM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-4; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Ruiz S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2381; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stelzer Y, 2013, STEM CELL REP, V1, P79, DOI 10.1016/j.stemcr.2013.03.005; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallot C, 2013, NAT GENET, V45, P239, DOI 10.1038/ng.2530; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	43	236	243	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					177	+		10.1038/nature13551	http://dx.doi.org/10.1038/nature13551			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008523	Green Accepted, Green Published			2022-12-24	WOS:000338649800035
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION What is a crossover trial?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2674; Svendsen KB, 2004, BMJ-BRIT MED J, V329, P253, DOI 10.1136/bmj.38149.566979.AE	2	11	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2014	348								g3191	10.1136/bmj.g3191	http://dx.doi.org/10.1136/bmj.g3191			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OT	25134118				2022-12-24	WOS:000335820400004
J	Sanchez, LT				Sanchez, Luis T.			Disruptive Behaviors Among Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sanchez, Luis T.] Massachusetts Med Soc, Phys Hlth Serv, Waltham, MA USA		Sanchez, LT (corresponding author), Phys Hlth Serv Inc, 860 Winter St, Waltham, MA 02451 USA.	ltsanchez@verizon.net						American Medical Association Council on Ethical and Judicial Affairs, 2000, 2A00 AM MED ASS; [Anonymous], 2008, SENTINEL EVENT ALERT, P1; Friedberg MW, 2013, FACTORS AFFECTING PR; Joint Commission Hospital Accreditation Standards, LD030303LD18; Joint Commission on Accreditation of Healthcare Organizations, 2012, JT COMM PERSPECT, V32, P7; Leape LL, 2006, ANN INTERN MED, V144, P107, DOI 10.7326/0003-4819-144-2-200601170-00008; MacDonald O., 2011, DISRUPTIVE PHYS BEHA; Rosenstein AH, 2008, JT COMM J QUAL PATIE, V34, P464, DOI 10.1016/S1553-7250(08)34058-6	8	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2209	2210		10.1001/jama.2014.10218	http://dx.doi.org/10.1001/jama.2014.10218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25144182				2022-12-24	WOS:000345684800010
J	Arlet, JB; Ribeil, JA; Guillem, F; Negre, O; Hazoume, A; Marcion, G; Beuzard, Y; Dussiot, M; Moura, IC; Demarest, S; de Beauchene, IC; Belaid-Choucair, Z; Sevin, M; Maciel, TT; Auclair, C; Leboulch, P; Chretien, S; Tchertanov, L; Baudin-Creuza, V; Seigneuric, R; Fontenay, M; Garrido, C; Hermine, O; Courtois, G				Arlet, Jean-Benoit; Ribeil, Jean-Antoine; Guillem, Flavia; Negre, Olivier; Hazoume, Adonis; Marcion, Guillaume; Beuzard, Yves; Dussiot, Michael; Moura, Ivan Cruz; Demarest, Samuel; de Beauchene, Isaure Chauvot; Belaid-Choucair, Zakia; Sevin, Margaux; Maciel, Thiago Trovati; Auclair, Christian; Leboulch, Philippe; Chretien, Stany; Tchertanov, Luba; Baudin-Creuza, Veronique; Seigneuric, Renaud; Fontenay, Michaela; Garrido, Carmen; Hermine, Olivier; Courtois, Genevieve			HSP70 sequestration by free alpha-globin promotes ineffective erythropoiesis in beta-thalassaemia	NATURE			English	Article							GAMMA-GLOBIN; ERYTHROID PRECURSORS; GENE-EXPRESSION; PROTEIN; GATA-1; DIFFERENTIATION; HEMOGLOBIN; APOPTOSIS; CLEAVAGE; CELLS	beta-Thalassaemia major (beta-TM) is an inherited haemoglobinopathy caused by a quantitative defect in the synthesis of beta-globin chains of haemoglobin, leading to the accumulationof free alpha-globin chains that form toxic aggregates(1,2). Despite extensive knowledge of the molecular defects causing beta-TM, little is known of the mechanisms responsible for the ineffective erythropoiesis observed in the condition, which is characterized by accelerated erythroid differentiation, maturation arrest and apoptosis at the polychromatophilic stage(3-6). We have previously demonstrated that normal human erythroid maturation requires a transient activation of caspase-3 at the later stages of maturation(7). Although erythroid transcription factor GATA-1, themaster transcriptional factor of erythropoiesis, is a caspase-3 target, it is not cleaved during erythroid differentiation. We have shown that, in human erythroblasts, the chaperone heat shock protein70 (HSP70) is constitutively expressed and, at later stages of maturation, translocates into the nucleus and protects GATA-1 from caspase-3 cleavage(8). The primary role of this ubiquitous chaperone is to participate in the refolding of proteins denatured by cytoplasmic stress, thus preventing their aggregation(9). Here we show in vitro that during the maturation of human beta-TM erythroblasts, HSP70 interacts directly with free alpha-globin chains. As a consequence, HSP70 is sequestrated in the cytoplasm and GATA-1 is no longer protected, resulting in end-stage maturation arrest and apoptosis. Transduction of a nuclear-targeted HSP70 mutant or a caspase-3-uncleavable GATA-1 mutant restores terminal maturation of beta-TM erythroblasts, which may provide a rationale for new targeted therapies of beta-TM.	[Arlet, Jean-Benoit; Ribeil, Jean-Antoine; Guillem, Flavia; Dussiot, Michael; Moura, Ivan Cruz; Belaid-Choucair, Zakia; Maciel, Thiago Trovati; Hermine, Olivier; Courtois, Genevieve] Ctr Natl Rech Sci CNRS Equipe Rech Labellisee, UMR 1163, Lab INSERM, 24 Blvd Montparnasse, F-75015 Paris, France; [Arlet, Jean-Benoit] Hop Europeen Georges Pompidou, Sorbonne Paris Cite, Fac Med Paris Descartes, Serv Med Interne, F-75908 Paris, France; [Arlet, Jean-Benoit] Hop Europeen Georges Pompidou, AP HP, F-75908 Paris, France; [Arlet, Jean-Benoit; Ribeil, Jean-Antoine; Guillem, Flavia; Dussiot, Michael; Moura, Ivan Cruz; Belaid-Choucair, Zakia; Maciel, Thiago Trovati; Hermine, Olivier; Courtois, Genevieve] Paris Descartes Sorbonne Paris Cite Univ, Hop Necker, AP HP, Imagine Inst, F-75015 Paris, France; [Arlet, Jean-Benoit; Ribeil, Jean-Antoine; Guillem, Flavia; Dussiot, Michael; Moura, Ivan Cruz; Belaid-Choucair, Zakia; Maciel, Thiago Trovati; Fontenay, Michaela; Hermine, Olivier; Courtois, Genevieve] Lab Excellence GR Ex, F-75015 Paris, France; [Ribeil, Jean-Antoine] Hop Necker Enfants Malad, Sorbonne Paris Cite, Fac Med Paris Descartes, Dept Biotherapie, F-75015 Paris, France; [Ribeil, Jean-Antoine] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France; [Negre, Olivier; Beuzard, Yves; Leboulch, Philippe; Chretien, Stany] CEA, Inst Emerging Dis & Innovat Therapies iMETI, F-92260 Fontenay Aux Roses, France; [Hazoume, Adonis; Marcion, Guillaume; Sevin, Margaux; Garrido, Carmen] INSERM, Equipe Labellisee Ligue Canc, UMR 866, F-21033 Dijon, France; [Hazoume, Adonis; Marcion, Guillaume; Sevin, Margaux; Garrido, Carmen] Assoc Rech Canc, F-21033 Dijon, France; [Hazoume, Adonis; Marcion, Guillaume; Sevin, Margaux; Garrido, Carmen] Lab Excellence Lipoprot & Sante LipSTIC, F-21033 Dijon, France; [Hazoume, Adonis; Marcion, Guillaume; Sevin, Margaux; Seigneuric, Renaud; Garrido, Carmen] Univ Burgundy, Fac Med & Pharm, F-21033 Dijon, France; [Dussiot, Michael; Moura, Ivan Cruz; Maciel, Thiago Trovati] Hop Bichat Claude Bernard, INSERM, UMR 699, F-75018 Paris, France; [Moura, Ivan Cruz; Maciel, Thiago Trovati] Univ Paris 06, F-75013 Paris, France; [Moura, Ivan Cruz; Maciel, Thiago Trovati] Univ Denis Diderot Paris VII, F-75013 Paris, France; [Demarest, Samuel; de Beauchene, Isaure Chauvot; Auclair, Christian; Tchertanov, Luba] Ecole Normale Super, CNRS, UMR 8113, F-94230 Cachan, France; [de Beauchene, Isaure Chauvot; Auclair, Christian; Tchertanov, Luba] LERMIT, Campus Paris Saclay, F-92296 Chatenay Malabry, France; [Leboulch, Philippe] Womens Hosp Med Ctr, Boston, MA 02115 USA; [Leboulch, Philippe] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Baudin-Creuza, Veronique] Univ Paris 11, INSERM, UMR 779, Le Kremlin Bicetre, France; [Fontenay, Michaela] Univ Paris 05, CNRS, INSERM, Inst Cochin,UMR 1016,UMR 8104, F-75014 Paris, France; [Fontenay, Michaela] Hop Cochin, Hop Univ Paris Ctr, AP HP, Serv Hematol Biol, F-75014 Paris, France; [Garrido, Carmen] Ctr Anticanc George Francois Leclerc, F-21079 Dijon, France; [Hermine, Olivier] Fac Med Paris Descartes, Sorbonne Paris Cite, Serv Hematol, F-75015 Paris, France; [Hermine, Olivier] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Hermine, O (corresponding author), Ctr Natl Rech Sci CNRS Equipe Rech Labellisee, UMR 1163, Lab INSERM, 24 Blvd Montparnasse, F-75015 Paris, France.	ohermine@gmail.com; genevieve_courtois@yahoo.fr	Garrido, Carolina/GWM-5557-2022; Hermine, Olivier/Q-7072-2018; Chretien, Stany/M-5166-2018; Garrido, carmen/G-1633-2018; Arlet, Jean Benoit/D-3124-2016; Maciel, Thiago/A-4475-2013; Ribeil, Jean-Antoine/AAK-7979-2020; Maciel, Thiago Trovati/AAF-5462-2021; BAUDIN-CREUZA, Véronique/K-7309-2017; Ribeil, Jean-Antoine/F-7896-2017; , Tchertanov/CAF-3310-2022; NEGRE, Olivier/AAA-2027-2022; Cruz Moura, Ivan/A-9510-2013	Garrido, carmen/0000-0003-1368-1493; Maciel, Thiago/0000-0002-9347-981X; Ribeil, Jean-Antoine/0000-0002-4549-4783; Maciel, Thiago Trovati/0000-0002-9347-981X; BAUDIN-CREUZA, Véronique/0000-0003-1032-3236; Ribeil, Jean-Antoine/0000-0002-5733-9123; Marcion, Guillaume/0000-0002-3634-6316; Hermine, Olivier/0000-0003-2574-3874; Fontenay, Michaela/0000-0002-5492-6349; Moura, Ivan/0000-0002-2977-0354; guillem, flavia/0000-0002-9680-311X; Cruz Moura, Ivan/0000-0002-8418-2803	Societe Nationale Francaise de Medecine Interne (SNFMI); Societe Francaise d'Hematologie (SFH); Centre National de la Recherche Scientifique (CNRS); Assistance publique - Hopitaux de Paris (AP-HP) (poste d'accueil APHP-CNRS); Groupe Pasteur Mutualite; Institut FARMAN (ENS de Cachan); ENS de Cachan; Conseil Regional de Bourgogne; l'Institut National du Cancer, INCa; National Research Agency under the 'Investments for the Future' program [ANR-10-IAHU-01]; Ligue nationale contre le cancer; Fondation pour la recherche medicale (FRM); Fondation de France; French National Research Agency [ANR-11-IDEX-0005-02]	Societe Nationale Francaise de Medecine Interne (SNFMI); Societe Francaise d'Hematologie (SFH); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Assistance publique - Hopitaux de Paris (AP-HP) (poste d'accueil APHP-CNRS); Groupe Pasteur Mutualite; Institut FARMAN (ENS de Cachan); ENS de Cachan; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); l'Institut National du Cancer, INCa; National Research Agency under the 'Investments for the Future' program(French National Research Agency (ANR)); Ligue nationale contre le cancer(Ligue nationale contre le cancer); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); French National Research Agency(French National Research Agency (ANR))	J.-B.A. was a recipient of grants from the Societe Nationale Francaise de Medecine Interne (SNFMI), Societe Francaise d'Hematologie (SFH), Centre National de la Recherche Scientifique (CNRS) and Assistance publique - Hopitaux de Paris (AP-HP) (poste d'accueil APHP-CNRS), and from Groupe Pasteur Mutualite. S.D. was a recipient of funding from Institut FARMAN (ENS de Cachan). I.C.B. was a recipient of a PhD scholarship fund from ENS de Cachan. A. H. was a recipient of a post-doctoral grant from the Conseil Regional de Bourgogne and M. S. from l'Institut National du Cancer, INCa. This program has received a state subsidy managed by the National Research Agency under the 'Investments for the Future' program bearing the reference ANR-10-IAHU-01, Ligue nationale contre le cancer, Fondation pour la recherche medicale (FRM) and Fondation de France. The labex GR-Ex is funded by the program 'Investments for the Future' of the French National Research Agency, reference ANR-11-IDEX-0005-02. We would also like to thank N. Goudin and R. Desvaux from the Plateforme d'imagerie cellulaire de l'IFR94, Faculte de Medecine Necker (Paris, France) for experimental help in image acquisition and analysis on confocal microscopy, and the Department of Biotherapy at the Necker Hospital (Paris, France) for providing blood samples. We thank P. England from CNRS 1129, unite de biochimiecellulaire, Institut Pasteur, Paris, for his experimental help. We thank E. Frisan from the Department of Haematology and INSERM U1016, Hopital Cochin, Paris, and A. de Thonel from INSERM U866, Dijon, for the gift of HSP70(S400A) mutant. We thank U. Testa, A. Zeuner and R. de Maria from the Department of Haematology and Oncology, Instituto Superiore di Santia, Rome, Italy, for the gift of cDNAs of GATA-1. We also thank C. Brouzes from the Department of biological haematology for her help for the smears' reading.	Anson ML, 1930, J GEN PHYSIOL, V13, P469, DOI 10.1085/jgp.13.4.469; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Centis F, 2000, BLOOD, V96, P3624; De Franceschi L, 2007, HAEMATOLOGICA, V92, P1319, DOI 10.3324/haematol.11556; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; DOVER GJ, 1987, BLOOD, V69, P1109; Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Frisan E, 2012, BLOOD, V119, P1532, DOI 10.1182/blood-2011-03-343475; Gabet AS, 2011, CELL DEATH DIFFER, V18, P678, DOI 10.1038/cdd.2010.140; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Khandros E, 2010, HEMATOL ONCOL CLIN N, V24, P1071, DOI 10.1016/j.hoc.2010.08.013; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kim YW, 2011, NUCLEIC ACIDS RES, V39, P6944, DOI 10.1093/nar/gkr253; Libani IV, 2008, BLOOD, V112, P875, DOI 10.1182/blood-2007-12-126938; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Ribeil JA, 2013, SCI WORLD J, DOI 10.1155/2013/394295; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Sankaran VG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011643; Schallmeiner E, 2007, NAT METHODS, V4, P135, DOI 10.1038/nmeth974; Suragani R., 2014, BLOOD; Yao X, 2009, EXP HEMATOL, V37, P889, DOI 10.1016/j.exphem.2009.05.004; YUAN J, 1993, BLOOD, V82, P374, DOI 10.1182/blood.V82.2.374.bloodjournal822374; Zermati Y, 2000, EXP HEMATOL, V28, P885, DOI 10.1016/S0301-472X(00)00488-4; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhu JQ, 2011, BLOOD, V117, P3045, DOI 10.1182/blood-2010-07-294751	28	86	88	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					242	+		10.1038/nature13614	http://dx.doi.org/10.1038/nature13614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25156257				2022-12-24	WOS:000342663100045
J	Calo, S; Shertz-Wall, C; Lee, SC; Bastidas, RJ; Nicolas, FE; Granek, JA; Mieczkowski, P; Torres-Martinez, S; Ruiz-Vazquez, RM; Cardenas, ME; Heitman, J				Calo, Silvia; Shertz-Wall, Cecelia; Lee, Soo Chan; Bastidas, Robert J.; Nicolas, Francisco E.; Granek, Joshua A.; Mieczkowski, Piotr; Torres-Martinez, Santiago; Ruiz-Vazquez, Rosa M.; Cardenas, Maria E.; Heitman, Joseph			Antifungal drug resistance evoked via RNAi-dependent epimutations	NATURE			English	Article							FUNGUS MUCOR-CIRCINELLOIDES; GERMLINE EPIMUTATION; GENE; INTERFERENCE; EXPRESSION; TARGET; INITIATION; ASCOBOLUS; RAPAMYCIN; ELEGANS	Microorganisms evolve via a range of mechanisms that may include or involve sexual/parasexual reproduction, mutators, aneuploidy, Hsp90 and even prions. Mechanisms that may seem detrimental can be repurposed to generate diversity. Here we show that the human fungal pathogen Mucor circinelloides develops spontaneous resistance to the antifungal drug FK506 (tacrolimus) via two distinct mechanisms. One involves Mendelian mutations that confer stable drug resistance; the other occurs via an epigenetic RNA interference (RNAi)-mediated pathway resulting in unstable drug resistance. The peptidylprolyl isomerase FKBP12 interacts with FK506 forming a complex that inhibits the protein phosphatase calcineurin(1). Calcineurin inhibition by FK506 blocks M. circinelloides transition to hyphae and enforces yeast growth(2). Mutations in the fkbA gene encoding FKBP12 or the calcineurin cnbR or cnaA genes confer FK506 resistance and restore hyphal growth. In parallel, RNAi is spontaneously triggered to silence the fkbA gene, giving rise to drug-resistant epimutants. FK506-resistant epimutants readily reverted to the drug-sensitive wild-type phenotype when grown without exposure to the drug. The establishment of these epimutants is accompanied by generation of abundant fkbA small RNAs and requires the RNAi pathway as well as other factors that constrain or reverse the epimutant state. Silencing involves the generation of a double-stranded RNA trigger intermediate using the fkbA mature mRNA as a template to produce antisense fkbA RNA. This study uncovers a novel epigenetic RNAi-based epimutation mechanism controlling phenotypic plasticity, with possible implications for antimicrobial drug resistance and RNAi-regulatory mechanisms in fungi and other eukaryotes.	[Calo, Silvia; Shertz-Wall, Cecelia; Lee, Soo Chan; Bastidas, Robert J.; Granek, Joshua A.; Cardenas, Maria E.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Nicolas, Francisco E.] Reg Campus Int Excellence Campus Mare Nostrum, Murcia 30100, Spain; [Nicolas, Francisco E.; Torres-Martinez, Santiago; Ruiz-Vazquez, Rosa M.] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Murcia 30100, Spain; [Granek, Joshua A.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Granek, Joshua A.] Duke Univ, Med Ctr, Duke Ctr Genom Microbial Syst, Durham, NC 27710 USA; [Mieczkowski, Piotr] Univ N Carolina, High Throughput Sequencing Facil, Chapel Hill, NC 27599 USA	Duke University; University of Murcia; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	heitm001@duke.edu	Ruiz-Vázquez, Rosa María/K-6778-2014; Calo, Silvia/ABG-7530-2020; Heitman, Joseph/ABC-6006-2021; Torres-Martinez, Santiago/K-7660-2014; Paniagua, Enrique/H-3536-2015; Nicolás, Francisco E./D-5717-2014	Ruiz-Vázquez, Rosa María/0000-0002-6675-8506; Calo, Silvia/0000-0003-3014-7372; Torres-Martinez, Santiago/0000-0002-7083-4516; Paniagua, Enrique/0000-0001-5006-6428; Nicolás, Francisco E./0000-0003-3762-5971; Granek, Joshua/0000-0003-3908-5016; Mieczkowski, Piotr/0000-0003-2418-0096	NIH [R37 AI39115-17, R01 AI50438-10, R01 CA154499-04]; Spanish MICINN [BFU2009-07220]; MINECO [BFU2012-32246]; FEDER; NATIONAL CANCER INSTITUTE [R01CA154499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039115, R01AI039115, R01AI050438] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MINECO(Spanish Government); FEDER(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Skalsky and V. Ponnusamy for technical support and J. Wostemeyer for trisporic acid. We thank B. Cullen, T. Petes, B. Billmyre, M. Feretzaki, J. Kingsbury and V. Ponnusamy for critical reading. This work was supported by NIH grants R37 AI39115-17, R01 AI50438-10, R01 CA154499-04 and the Spanish MICINN BFU2009-07220 and MINECO BFU2012-32246, co-financed by FEDER.	Anders S., 2014, HTSEQ PYTHON FRAMEWO; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bastidas RJ, 2012, EUKARYOT CELL, V11, P270, DOI 10.1128/EC.05284-11; Baulcombe DC, 1996, PLANT MOL BIOL, V32, P79, DOI 10.1007/BF00039378; Calo S, 2012, MOL MICROBIOL, V83, P379, DOI 10.1111/j.1365-2958.2011.07939.x; CARDENAS ME, 1995, EMBO J, V14, P5892, DOI 10.1002/j.1460-2075.1995.tb00277.x; Cervantes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069283; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; de Haro JP, 2009, EUKARYOT CELL, V8, P1486, DOI 10.1128/EC.00191-09; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elmayan T, 1996, PLANT J, V9, P787, DOI 10.1046/j.1365-313X.1996.9060787.x; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Gutierrez A, 2011, J MICROBIOL METH, V84, P442, DOI 10.1016/j.mimet.2011.01.002; Heger A., 2013, PYSAM PYTHON INTERFA; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; LASKER BA, 1980, J BACTERIOL, V141, P565, DOI 10.1128/JB.141.2.565-569.1980; Lee SC, 2014, MBIO, V5, DOI 10.1128/mBio.01390-14; Lee SC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003625; Li CH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002086; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Murcia-Flores L, 2007, J BIOL CHEM, V282, P15394, DOI 10.1074/jbc.M610366200; Nicolas FE, 2003, EMBO J, V22, P3983, DOI 10.1093/emboj/cdg384; Nicolas FE, 2007, FUNGAL GENET BIOL, V44, P504, DOI 10.1016/j.fgb.2006.09.003; Nicolas FE, 2010, NUCLEIC ACIDS RES, V38, P5535, DOI 10.1093/nar/gkq301; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; ORLOWSKI M, 1991, MICROBIOL REV, V55, P234, DOI 10.1128/MMBR.55.2.234-258.1991; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; RHOUNIM L, 1992, EMBO J, V11, P4451, DOI 10.1002/j.1460-2075.1992.tb05546.x; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Timmons L, 2004, BIOESSAYS, V26, P715, DOI 10.1002/bies.20078; Wassenegger M, 1998, PLANT MOL BIOL, V37, P349, DOI 10.1023/A:1005946720438; Wetzel J, 2012, MICROBIOL-SGM, V158, P1016, DOI 10.1099/mic.0.054106-0; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716	44	90	93	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					555	+		10.1038/nature13575	http://dx.doi.org/10.1038/nature13575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25079329	Green Published, Green Accepted			2022-12-24	WOS:000342075800042
J	Whelan, R; Watts, R; Orr, CA; Althoff, RR; Artiges, E; Banaschewski, T; Barker, GJ; Bokde, ALW; Buchel, C; Carvalho, FM; Conrod, PJ; Flor, H; Fauth-Buhler, M; Frouin, V; Gallinat, J; Gan, G; Gowland, P; Heinz, A; Ittermann, B; Lawrence, C; Mann, K; Martinot, JL; Nees, F; Ortiz, N; Paillere-Martinot, ML; Paus, T; Pausova, Z; Rietschel, M; Robbins, TW; Smolka, MN; Strohle, A; Schumann, G; Garavan, H				Whelan, Robert; Watts, Richard; Orr, Catherine A.; Althoff, Robert R.; Artiges, Eric; Banaschewski, Tobias; Barker, Gareth J.; Bokde, Arun L. W.; Buechel, Christian; Carvalho, Fabiana M.; Conrod, Patricia J.; Flor, Herta; Fauth-Buehler, Mira; Frouin, Vincent; Gallinat, Juergen; Gan, Gabriela; Gowland, Penny; Heinz, Andreas; Ittermann, Bernd; Lawrence, Claire; Mann, Karl; Martinot, Jean-Luc; Nees, Frauke; Ortiz, Nick; Paillere-Martinot, Marie-Laure; Paus, Tomas; Pausova, Zdenka; Rietschel, Marcella; Robbins, Trevor W.; Smolka, Michael N.; Stroehle, Andreas; Schumann, Gunter; Garavan, Hugh		IMAGEN Consortium	Neuropsychosocial profiles of current and future adolescent alcohol misusers	NATURE			English	Article							SUBSTANCE USE; BRAIN; RISK; REINFORCEMENT; ENDOPHENOTYPES; RELIABILITY; IMPULSIVITY; DYSFUNCTION; INHIBITION; DEPENDENCE	A comprehensive account of the causes of alcohol misuse must accommodate individual differences in biology, psychology and environment, and must disentangle cause and effect. Animal models(1) can demonstrate the effects of neurotoxic substances; however, they provide limited insight into the psycho-social and higher cognitive factors involved in the initiation of substance use and progression to misuse. One can search for pre-existing risk factors by testing for endophenotypic biomarkers(2) in non-using relatives; however, these relatives may have personality or neural resilience factors that protect them from developing dependence(3). A longitudinal study has potential to identify predictors of adolescent substance misuse, particularly if it can incorporate a wide range of potential causal factors, both proximal and distal, and their influence on numerous social, psychological and biological mechanisms(4). Here we apply machine learning to a wide range of data from a large sample of adolescents (n = 692) to generate models of current and future adolescent alcohol misuse that incorporate brain structure and function, individual personality and cognitive differences, environmental factors (including gestational cigarette and alcohol exposure), life experiences, and candidate genes. These models were accurate and generalized to novel data, and point to life experiences, neurobiological differences and personality as important antecedents of binge drinking. By identifying the vulnerability factors underlying individual differences in alcohol misuse, these models shed light on the aetiology of alcohol misuse and suggest targets for prevention.	[Whelan, Robert; Ortiz, Nick; Garavan, Hugh] Univ Vermont, Dept Psychiat, Burlington, VT 05401 USA; [Whelan, Robert] Natl Univ Ireland Univ Coll Dublin, Dept Psychol, Dublin 4, Ireland; [Watts, Richard] Univ Vermont, Dept Radiol, Burlington, VT 05401 USA; [Orr, Catherine A.] Univ Vermont, Vermont Ctr Children Youth & Families, Burlington, VT 05401 USA; [Althoff, Robert R.] Univ Vermont, Dept Pediat, Burlington, VT 05401 USA; [Althoff, Robert R.; Garavan, Hugh] Univ Vermont, Dept Psychol, Burlington, VT 05401 USA; [Artiges, Eric; Martinot, Jean-Luc] Univ Paris 11, CEA, INSERM, Imaging & Psychiat U1000, F-91400 Orsay, France; [Artiges, Eric] Orsay Hosp, Dept Psychiat, F-91400 Orsay, France; [Banaschewski, Tobias; Flor, Herta; Fauth-Buehler, Mira; Mann, Karl; Nees, Frauke; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, D-68159 Mannheim, Germany; [Barker, Gareth J.; Carvalho, Fabiana M.; Conrod, Patricia J.; Schumann, Gunter] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Bokde, Arun L. W.; Garavan, Hugh] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Buechel, Christian; Gallinat, Juergen] Univ Klinikum Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany; [Buechel, Christian] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Conrod, Patricia J.] Univ Montreal, CHU Ste Justine Hosp, Dept Psychiat, Montreal, PQ H3T 1C5, Canada; [Fauth-Buehler, Mira] Heidelberg Univ, Dept Addict Behav & Addict Med, D-68159 Mannheim, Germany; [Frouin, Vincent] 14 CEA, DSV, I2BM, F-91191 Gif Sur Yvette, France; [Gallinat, Juergen; Heinz, Andreas; Paillere-Martinot, Marie-Laure; Stroehle, Andreas] Charite, Dept Psychiat & Psychotherapy, D-10117 Berlin, Germany; [Gan, Gabriela; Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat, D-01062 Dresden, Germany; [Gan, Gabriela; Smolka, Michael N.] Tech Univ Dresden, Neuroimaging Ctr, D-01062 Dresden, Germany; [Gowland, Penny] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Ittermann, Bernd] Phys Tech Bundesanstalt PTB, D-10587 Berlin, Germany; [Lawrence, Claire] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Martinot, Jean-Luc; Paillere-Martinot, Marie-Laure] Univ Paris 05, AP HP, Dept Adolescent Psychopathol & Med, F-75006 Paris, France; [Ortiz, Nick] Univ Vermont, Neurosci Grad Program, Burlington, VT 05401 USA; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON M5R 0A3, Canada; [Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 0A4, Canada; [Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 1TN, England; [Robbins, Trevor W.] Univ Cambridge, Dept Psychol, Cambridge CB2 1TN, England; [Schumann, Gunter] MRC Social Genet & Dev Psychiat SGDP Ctr, London WC2R 2LS, England	University of Vermont; University College Dublin; University of Vermont; University of Vermont; University of Vermont; University of Vermont; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of London; King's College London; Trinity College Dublin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University; Universite de Montreal; Ruprecht Karls University Heidelberg; CEA; UDICE-French Research Universities; Universite Paris Saclay; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Technische Universitat Dresden; University of Nottingham; Physikalisch-Technische Bundesanstalt (PTB); University of Nottingham; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; University of Vermont; University of Toronto; University Toronto Affiliates; Baycrest; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cambridge; University of Cambridge	Whelan, R (corresponding author), Univ Vermont, Dept Psychiat, Burlington, VT 05401 USA.	Robert.whelan@ucd.ie; Hugh.garavan@uvm.edu	Conrod, Patricia J/P-4187-2018; Vollstädt-Klein, Sabine/C-6744-2012; Barker, Gareth J/C-9616-2009; Poustka, Luise/D-9299-2017; Stacey, David/AFX-6013-2022; Artiges, Eric/AAT-7219-2021; Nees, Frauke/AAZ-2150-2020; Martinot, Jean-Luc/N-3704-2018; Heinz, Andreas/ABB-7736-2020; Rapp, Michael/ABB-7573-2020; Lawrence, Claire/P-1058-2018; Robbins, Trevor W/A-7551-2008; Whelan, Robert/E-5365-2010; Williams, Steve C/D-6979-2011; Banaschewski, Tobias/ABE-5985-2020; Gowland, Penny A./I-9016-2012; Smolka, Michael/B-4865-2011; Ströhle, Andreas/E-4286-2012; Artiges, Eric/C-2815-2019; Jia, Tianye/AAC-3925-2019	Vollstädt-Klein, Sabine/0000-0002-6210-672X; Barker, Gareth J/0000-0002-5214-7421; Stacey, David/0000-0002-9392-9235; Artiges, Eric/0000-0003-4461-7646; Heinz, Andreas/0000-0001-5405-9065; Rapp, Michael/0000-0003-0106-966X; Lawrence, Claire/0000-0001-6787-9716; Whelan, Robert/0000-0002-2790-7281; Williams, Steve C/0000-0003-4299-1941; Banaschewski, Tobias/0000-0003-4595-1144; Gowland, Penny A./0000-0002-4900-4817; Smolka, Michael/0000-0001-5398-5569; Artiges, Eric/0000-0003-4461-7646; Jia, Tianye/0000-0001-5399-2953; Robbins, Trevor/0000-0003-0642-5977; Gan, Gabriela/0000-0001-6589-6168; MIRANDA, RUBEN/0000-0002-9445-7348; Flor, Herta/0000-0003-4809-5398; Nees, Frauke/0000-0002-7796-8234; Bokde, Arun/0000-0003-0114-4914	European Union [LSHM-CT- 2007-037286]; FP7 projects IMAGEMEND [602450]; MATRICS [603016]; Innovative Medicine Initiative Project EU-AIMS [115300-2]; Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse" [93558]; Swedish funding agency FORMAS; Medical Research Council; Wellcome Trust (Behavioural and Clinical Neuroscience Institute, University of Cambridge); National Institute for Health Research (NIHR) Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; King's College London; Bundesministerium fur Bildung und Forschung (BMBF) [01GS08152, 01EV0711, eMED SysAlc 01ZX1311A]; Deutsche Forschungsgemeinschaft (DFG) [SP 383/5-1, SM 80/7-1, SFB 940/1, FOR 1617]; French MILDT (Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie); CENIR (Centre de NeuroImagerie de Recherche) within the ICM institute; National Institute of Mental Health [MH082116]; National Institutes of Health Center of Biomedical Research Excellence award from the National Institute of General Medical Sciences [P20GM103644]; Tobacco Centers of Regulatory Science award [P50DA036114]; NASA at University of Vermont [NNX 06AC88G]; Medical Research Council [G0001354B, G0901858, G1000183B, G0001354] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH082116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA036114] Funding Source: NIH RePORTER; MRC [G0901858] Funding Source: UKRI	European Union(European Commission); FP7 projects IMAGEMEND; MATRICS; Innovative Medicine Initiative Project EU-AIMS; Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse"(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish funding agency FORMAS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (Behavioural and Clinical Neuroscience Institute, University of Cambridge); National Institute for Health Research (NIHR) Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London(General Electric); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); French MILDT (Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie); CENIR (Centre de NeuroImagerie de Recherche) within the ICM institute; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health Center of Biomedical Research Excellence award from the National Institute of General Medical Sciences; Tobacco Centers of Regulatory Science award; NASA at University of Vermont; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behaviour in normal brain function and psychopathology) (LSHM-CT- 2007-037286), the FP7 projects IMAGEMEND(602450; IMAging GEnetics for MENtal Disorders) and MATRICS (603016), the Innovative Medicine Initiative Project EU-AIMS (115300-2), a Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse" (93558), the Swedish funding agency FORMAS, the Medical Research Council and the Wellcome Trust (Behavioural and Clinical Neuroscience Institute, University of Cambridge), the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, the Bundesministerium fur Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; eMED SysAlc 01ZX1311A; Forschungsnetz AERIAL), the Deutsche Forschungsgemeinschaft (DFG): Reinhart-Koselleck Award SP 383/5-1 and grants SM 80/7-1, SFB 940/1, FOR 1617), the French MILDT (Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie), the CENIR (Centre de NeuroImagerie de Recherche, Pr. S. Lehericy) within the ICM institute, the National Institute of Mental Health(MH082116), a National Institutes of Health Center of Biomedical Research Excellence award P20GM103644 from the National Institute of General Medical Sciences and the Tobacco Centers of Regulatory Science award P50DA036114. The authors acknowledge the Vermont Advanced Computing Core which is supported by NASA (NNX 06AC88G), at the University of Vermont for providing high performance computing resources that have contributed to the research results reported within this paper.	Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Castellanos-Ryan N, 2013, ALCOHOL CLIN EXP RES, V37, pE281, DOI 10.1111/j.1530-0277.2012.01931.x; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cloninger CR., 1999, TEMPERAMENT CHARACTE; Conrod PJ, 2008, J CHILD PSYCHOL PSYC, V49, P181, DOI [10.1111/j-1469-7610.2007.01826.x, 10.1111/j.1469-7610.2007.01826.x]; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006; Ersche KD, 2012, AM J PSYCHIAT, V169, P926, DOI 10.1176/appi.ajp.2012.11091421; Ersche KD, 2012, SCIENCE, V335, P601, DOI 10.1126/science.1214463; Ghahremani DG, 2013, J ADOLESCENT HEALTH, V53, P139, DOI 10.1016/j.jadohealth.2013.02.010; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gottfredson Denise C, 2003, Prev Sci, V4, P27, DOI 10.1023/A:1021782710278; Grant BF, 2001, J SUBST ABUSE, V13, P493, DOI 10.1016/S0899-3289(01)00096-7; Grant JD, 2006, PSYCHOL MED, V36, P109, DOI 10.1017/S0033291705006045; Grosbras MH, 2006, CEREB CORTEX, V16, P1087; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hibell B, 1997, 1995 ESPAD REPORT AL; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; NEWCOMB MD, 1981, J HEALTH SOC BEHAV, V22, P400, DOI 10.2307/2136681; Nigg JT, 2006, J AM ACAD CHILD PSY, V45, P468, DOI 10.1097/01.chi.0000199028.76452.a9; Norman AL, 2011, DRUG ALCOHOL DEPEN, V119, P216, DOI 10.1016/j.drugalcdep.2011.06.019; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Pausova Z, 2007, HUM BRAIN MAPP, V28, P502, DOI 10.1002/hbm.20402; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Rietschel M, 2013, ANN NY ACAD SCI, V1282, P39, DOI 10.1111/j.1749-6632.2012.06794.x; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Stacey D, 2012, P NATL ACAD SCI USA, V109, P21128, DOI 10.1073/pnas.1211844110; Swendsen J, 2012, ARCH GEN PSYCHIAT, V69, P390, DOI 10.1001/archgenpsychiatry.2011.1503; Tyndale RF, 2003, ANN MED, V35, P94, DOI 10.1080/07853890310010014; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Wechsler D, 1974, WECHSLER INTELLIGENC; Whelan R, 2014, BIOL PSYCHIAT, V75, P746, DOI 10.1016/j.biopsych.2013.05.014; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; Woicik PA, 2009, ADDICT BEHAV, V34, P1042, DOI 10.1016/j.addbeh.2009.07.001; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	43	286	292	9	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					185	+		10.1038/nature13402	http://dx.doi.org/10.1038/nature13402			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM9KO	25043041	Green Submitted, Green Accepted			2022-12-24	WOS:000340200700030
J	Liu, Y; Jesus, AA; Marrero, B; Yang, D; Ramsey, SE; Sanchez, GAM; Tenbrock, K; Wittkowski, H; Jones, OY; Kuehn, HS; Lee, CCR; DiMattia, MA; Cowen, EW; Gonzalez, B; Palmer, I; DiGiovanna, JJ; Biancotto, A; Kim, H; Tsai, WL; Trier, AM; Huang, Y; Stone, DL; Hill, S; Kim, HJ; St Hilaire, C; Gurprasad, S; Plass, N; Chapelle, D; Horkayne-Szakaly, I; Foell, D; Barysenka, A; Candotti, F; Holland, SM; Hughes, JD; Mehmet, H; Issekutz, AC; Raffeld, M; McElwee, J; Fontana, JR; Minniti, CP; Moir, S; Kastner, DL; Gadina, M; Steven, AC; Wingfield, PT; Brooks, SR; Rosenzweig, SD; Fleisher, TA; Deng, Z; Boehm, M; Paller, AS; Goldbach-Mansky, R				Liu, Y.; Jesus, A. A.; Marrero, B.; Yang, D.; Ramsey, S. E.; Sanchez, G. A. Montealegre; Tenbrock, K.; Wittkowski, H.; Jones, O. Y.; Kuehn, H. S.; Lee, C. -C. R.; DiMattia, M. A.; Cowen, E. W.; Gonzalez, B.; Palmer, I.; DiGiovanna, J. J.; Biancotto, A.; Kim, H.; Tsai, W. L.; Trier, A. M.; Huang, Y.; Stone, D. L.; Hill, S.; Kim, H. J.; St Hilaire, C.; Gurprasad, S.; Plass, N.; Chapelle, D.; Horkayne-Szakaly, I.; Foell, D.; Barysenka, A.; Candotti, F.; Holland, S. M.; Hughes, J. D.; Mehmet, H.; Issekutz, A. C.; Raffeld, M.; McElwee, J.; Fontana, J. R.; Minniti, C. P.; Moir, S.; Kastner, D. L.; Gadina, M.; Steven, A. C.; Wingfield, P. T.; Brooks, S. R.; Rosenzweig, S. D.; Fleisher, T. A.; Deng, Z.; Boehm, M.; Paller, A. S.; Goldbach-Mansky, R.			Activated STING in a Vascular and Pulmonary Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOGENIC AUTOINFLAMMATORY DISEASES; FAMILIAL CHILBLAIN LUPUS; CYCLIC GMP-AMP; I INTERFERON; PROTEASOME SUBUNIT; INBORN-ERRORS; DNA; SENSOR; LIPODYSTROPHY; EXPRESSION	BACKGROUND The study of autoinflammatory diseases has uncovered mechanisms underlying cytokine dysregulation and inflammation. METHODS We analyzed the DNA of an index patient with early-onset systemic inflammation, cutaneous vasculopathy, and pulmonary inflammation. We sequenced a candidate gene, TMEM173, encoding the stimulator of interferon genes (STING), in this patient and in five unrelated children with similar clinical phenotypes. Four children were evaluated clinically and immunologically. With the STING ligand cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), we stimulated peripheral-blood mononuclear cells and fibroblasts from patients and controls, as well as commercially obtained endothelial cells, and then assayed transcription of IFNB1, the gene encoding interferon-beta, in the stimulated cells. We analyzed IFNB1 reporter levels in HEK293T cells cotransfected with mutant or nonmutant STING constructs. Mutant STING leads to increased phosphorylation of signal transducer and activator of transcription 1 (STAT1), so we tested the effect of Janus kinase (JAK) inhibitors on STAT1 phosphorylation in lymphocytes from the affected children and controls. RESULTS We identified three mutations in exon 5 of TMEM173 in the six patients. Elevated transcription of IFNB1 and other gene targets of STING in peripheral-blood mononuclear cells from the patients indicated constitutive activation of the pathway that cannot be further up-regulated with stimulation. On stimulation with cGAMP, fibroblasts from the patients showed increased transcription of IFNB1 but not of the genes encoding interleukin-1 (IL1), interleukin-6 (IL6), or tumor necrosis factor (TNF). HEK293T cells transfected with mutant constructs show elevated IFNB1 reporter levels. STING is expressed in endothelial cells, and exposure of these cells to cGAMP resulted in endothelial activation and apoptosis. Constitutive up-regulation of phosphorylated STAT1 in patients' lymphocytes was reduced by JAK inhibitors. CONCLUSIONS STING-associated vasculopathy with onset in infancy (SAVI) is an autoinflammatory disease caused by gain-of-function mutations in TMEM173.	[Liu, Y.; Jesus, A. A.; Marrero, B.; Sanchez, G. A. Montealegre; DiMattia, M. A.; Palmer, I.; Kim, H.; Tsai, W. L.; Trier, A. M.; Huang, Y.; Plass, N.; Chapelle, D.; Gadina, M.; Steven, A. C.; Wingfield, P. T.; Brooks, S. R.; Deng, Z.; Goldbach-Mansky, R.] NIAMSD, NIH, Bethesda, MD 20892 USA; [Lee, C. -C. R.; Cowen, E. W.; DiGiovanna, J. J.; Raffeld, M.] NCI, NIH, Bethesda, MD 20892 USA; [Yang, D.; Biancotto, A.; St Hilaire, C.; Fontana, J. R.; Minniti, C. P.; Boehm, M.] NHLBI, NIH, Bethesda, MD 20892 USA; [Kuehn, H. S.; Gurprasad, S.; Rosenzweig, S. D.; Fleisher, T. A.] NIH, Dept Lab Med, Bethesda, MD 20892 USA; [Stone, D. L.; Candotti, F.; Kastner, D. L.] NHGRI, NIH, Bethesda, MD 20892 USA; [Hill, S.] NIH, Dept Radiol & Imaging Serv, Bethesda, MD 20892 USA; [Kim, H. J.] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD USA; [Holland, S. M.; Moir, S.] NIAID, NIH, Bethesda, MD 20892 USA; [Jones, O. Y.; Horkayne-Szakaly, I.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Ramsey, S. E.; Issekutz, A. C.] Dalhousie Univ, Halifax, NS, Canada; [Tenbrock, K.] Rhein Westfal TH Aachen, D-52062 Aachen, Germany; [Wittkowski, H.; Foell, D.; Barysenka, A.] Univ Hosp Muenster, Munster, Germany; [Gonzalez, B.] Hosp Ninos Luis Calvo Mackenna, Santiago, Chile; [Hughes, J. D.; Mehmet, H.; McElwee, J.] Merck Res Labs, Boston, MA USA; [Paller, A. S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Walter Reed National Military Medical Center; Dalhousie University; RWTH Aachen University; University of Munster; Universidad de Chile; Merck & Company; Northwestern University; Feinberg School of Medicine	Goldbach-Mansky, R (corresponding author), NIAMSD, NIH Bldg 10,Rm 6D-47B,10 Ctr Dr, Bethesda, MD 20892 USA.	goldbacr@mail.nih.gov	Minniti, Caterina/AAX-3187-2021; biancotto, angelique/C-4632-2011; Moir, Susan/AAC-3676-2020; St. Hilaire, Cynthia/R-8205-2017; Lee, Chyi-Chia Richard/AAO-1149-2020; Gadina, Massimo/R-4195-2019; Goldbach-Mansky, Raphaela/N-5917-2017; Lee, Chyi-Chia/I-1938-2013	biancotto, angelique/0000-0003-2271-009X; St. Hilaire, Cynthia/0000-0003-1871-6915; Wingfield, Paul/0000-0002-9515-4752; Trier, Anna/0000-0001-7957-2180; Lee, Chyi-Chia/0000-0002-5306-7781; Paller, Amy/0000-0001-6187-6549; Candotti, Fabio/0000-0001-6399-6042; Kim, Hanna/0000-0002-0595-6533; DiGiovanna, John J./0000-0002-2750-2313	National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL CANCER INSTITUTE [ZICBC011087, ZIDBC011317] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006079, ZIAHL006077] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001122, ZIAAI000825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIDAR041180, ZIAAR041138, ZIAAR027015, ZICAR041181, ZIHAR041173] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases.	Agarwal AK, 2010, AM J HUM GENET, V87, P866, DOI 10.1016/j.ajhg.2010.10.031; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Arima K, 2011, P NATL ACAD SCI USA, V108, P14914, DOI 10.1073/pnas.1106015108; Beuthien W, 2005, CLIN RHEUMATOL, V24, P507, DOI 10.1007/s10067-005-1093-x; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Clark JD, 2014, J MED CHEM; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Goldbach-Mansky R, 2012, CLIN EXP IMMUNOL, V167, P391, DOI 10.1111/j.1365-2249.2011.04533.x; GOODWIN JN, 1974, ARCH SURG-CHICAGO, V108, P780; Graf J, 2013, CURR OPIN RHEUMATOL, V25, P50, DOI 10.1097/BOR.0b013e32835b4449; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Rani MRS, 2007, J LEUKOCYTE BIOL, V82, P1353, DOI 10.1189/jlb.0507273; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rongioletti F, 1999, BRIT J DERMATOL, V140, P948, DOI 10.1046/j.1365-2133.1999.02833.x; Rosengren S, 2012, ANN RHEUM DIS, V71, P440, DOI 10.1136/ard.2011.150284; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Sanchez GAM, 2013, RHEUM DIS CLIN N AM, V39, P701, DOI 10.1016/j.rdc.2013.08.001; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Szilasiova J, 2009, CLIN NEUROPHARMACOL, V32, P301, DOI 10.1097/WNF.0b013e3181a2b5fd; Thornsberry LA, 2013, J AM ACAD DERMATOL, V69, P450, DOI 10.1016/j.jaad.2013.01.043; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van Boxel-Dezaire AHH, 2010, J IMMUNOL, V185, P5888, DOI 10.4049/jimmunol.0902314; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	42	730	767	8	131	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					507	518		10.1056/NEJMoa1312625	http://dx.doi.org/10.1056/NEJMoa1312625			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25029335	Green Accepted			2022-12-24	WOS:000339899100005
J	Guo, HS; Zhu, P; Yan, LY; Li, R; Hu, BQ; Lian, Y; Yan, J; Ren, XL; Lin, SL; Li, JS; Jin, XH; Shi, XD; Liu, P; Wang, XY; Wang, W; Wei, Y; Li, XL; Guo, F; Wu, XL; Fan, XY; Yong, J; Wen, L; Xie, SX; Tang, FC; Qiao, J				Guo, Hongshan; Zhu, Ping; Yan, Liying; Li, Rong; Hu, Boqiang; Lian, Ying; Yan, Jie; Ren, Xiulian; Lin, Shengli; Li, Junsheng; Jin, Xiaohu; Shi, Xiaodan; Liu, Ping; Wang, Xiaoye; Wang, Wei; Wei, Yuan; Li, Xianlong; Guo, Fan; Wu, Xinglong; Fan, Xiaoying; Yong, Jun; Wen, Lu; Xie, Sunney X.; Tang, Fuchou; Qiao, Jie			The DNA methylation landscape of human early embryos	NATURE			English	Article							STEM-CELLS; PREIMPLANTATION DEVELOPMENT; SINGLE-CELL; CHROMATIN STATE; HUMAN GENOME; PATTERNS; MAINTENANCE; EVOLUTION; DYNAMICS; OOCYTES	DNA methylation is a crucial element in the epigenetic regulation of mammalian embryonic development(1-5). However, its dynamic patterns have not been analysed at the genome scale in human preimplantation embryos due to technical difficulties and the scarcity of required materials. Here we systematically profile the methylome of human early embryos from the zygotic stage through to post-implantation by reduced representation bisulphite sequencing and whole-genome bisulphite sequencing. We show that the major wave of genome-wide demethylation is complete at the 2-cell stage, contrary to previous observations in mice. Moreover, the demethylation of the paternal genome is much faster than that of the maternal genome, and by the end of the zygotic stage the genome-wide methylation level in male pronudei is already lower than that in female pronudei. The inverse correlation between promoter methylation and gene expression gradually strengthens during early embryonic development, reaching its peak at the post-implantation stage. Furthermore, we show that active genes, with the trimethylation of histone H3 at lysine 4 (H3K4me3) mark at the promoter regions in pluripotent human embryonic stem cells, are essentially devoid of DNA methylation in both mature gametes and throughout pre-implantation development. Finally, we also show that long interspersed nuclear elements or short interspersed nuclear elements that are evolutionarily young are demethylated to a milder extent compared to older elements in the same family and have higher abundance of transcripts, indicating that early embryos tend to retain higher residual methylation at the evolutionarily younger and more active transposable elements. Our work provides insights into the critical features of the methylome of human early embryos, as well as its functional relation to the regulation of gene expression and the repression of transposable elements.	[Guo, Hongshan; Zhu, Ping; Yan, Liying; Li, Rong; Hu, Boqiang; Lian, Ying; Yan, Jie; Ren, Xiulian; Lin, Shengli; Li, Junsheng; Jin, Xiaohu; Shi, Xiaodan; Liu, Ping; Li, Xianlong; Guo, Fan; Wu, Xinglong; Fan, Xiaoying; Yong, Jun; Wen, Lu; Xie, Sunney X.; Tang, Fuchou; Qiao, Jie] Peking Univ, Hosp 3, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Guo, Hongshan; Zhu, Ping; Yan, Liying; Li, Rong; Hu, Boqiang; Lian, Ying; Yan, Jie; Ren, Xiulian; Lin, Shengli; Li, Junsheng; Jin, Xiaohu; Shi, Xiaodan; Liu, Ping; Li, Xianlong; Guo, Fan; Wu, Xinglong; Fan, Xiaoying; Yong, Jun; Wen, Lu; Xie, Sunney X.; Tang, Fuchou; Qiao, Jie] Peking Univ, Hosp 3, Coll Life Sci, Ctr Reprod Med, Beijing 100871, Peoples R China; [Zhu, Ping] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Yan, Liying; Li, Rong; Lian, Ying; Yan, Jie; Ren, Xiulian; Lin, Shengli; Li, Junsheng; Jin, Xiaohu; Shi, Xiaodan; Liu, Ping; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China; [Wang, Xiaoye; Wang, Wei; Wei, Yuan] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing 100191, Peoples R China; [Yong, Jun; Xie, Sunney X.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Tang, Fuchou] Minist Educ, Key Lab Cell Proliferat & Differentia, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University; Harvard University	Tang, FC (corresponding author), Peking Univ, Hosp 3, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China.	tangfuchou@pku.edu.cn; jie.qiao@263.net	Wu, Xinglong/GQH-0693-2022; Guo, Fan/J-1857-2019; Guo, Fan/AAX-4952-2021	Wu, Xinglong/0000-0003-4373-2511; Guo, Fan/0000-0002-0165-073X; Li, Xianlong/0000-0001-7745-2695; Zhu, Ping/0000-0002-4521-7524; Qiao, Jie/0000-0003-2126-1376	National Basic Research Program of China [2012CB966704, 2011CB944504, 2011CB966303, 2011CB944503]; National Natural Science of China [31322037, 31230047, 31271543, 81170538]; Beijing Municipal Science and Technology Commission [Z131100005213006]; National Natural Science Foundation of China [81000275]; National Key Technologies Research and Development Program [2012BAI32B01]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies Research and Development Program(National Key Technology R&D Program)	F.T. and J.Q. were supported by grants from the National Basic Research Program of China (2012CB966704, 2011CB944504 and 2011CB966303) and from the National Natural Science of China (31322037, 31230047, 31271543 and 81170538). J.Q. and F.T. were supported by a grant from the Beijing Municipal Science and Technology Commission (Z131100005213006). L.Y. was supported by grants from the National Natural Science Foundation of China (81000275) and National Basic Research Program of China (2011CB944503). R.L. was supported by a grant from National Key Technologies Research and Development Program (2012BAI32B01).	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li R, 2008, REPROD BIOMED ONLINE, V16, P627, DOI 10.1016/S1472-6483(10)60475-0; Li R, 2013, EUR J OBSTET GYN R B, V167, P146, DOI 10.1016/j.ejogrb.2012.11.018; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; O'Leary T, 2012, NAT BIOTECHNOL, V30, P278, DOI 10.1038/nbt.2135; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shirane K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003439; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Van der Heijden GW, 2009, MOL REPROD DEV, V76, P101, DOI 10.1002/mrd.20933; Wu H, 2012, CELL STEM CELL, V10, P487, DOI 10.1016/j.stem.2012.04.012; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	40	577	608	10	260	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					606	+		10.1038/nature13544	http://dx.doi.org/10.1038/nature13544			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079557				2022-12-24	WOS:000339566300038
J	Sandler, NG; Bosinger, SE; Estes, JD; Zhu, RTR; Tharp, GK; Boritz, E; Levin, D; Wijeyesinghe, S; Makamdop, KN; del Prete, GQ; Hill, BJ; Timmer, JK; Reiss, E; Yarden, G; Darko, S; Contijoch, E; Todd, JP; Silvestri, G; Nason, M; Norgren, RB; Keele, BF; Rao, S; Langer, JA; Lifson, JD; Schreiber, G; Douek, DC				Sandler, Netanya G.; Bosinger, Steven E.; Estes, Jacob D.; Zhu, Richard T. R.; Tharp, Gregory K.; Boritz, Eli; Levin, Doron; Wijeyesinghe, Sathi; Makamdop, Krystelle Nganou; del Prete, Gregory Q.; Hill, Brenna J.; Timmer, J. Katherina; Reiss, Emma; Yarden, Ganit; Darko, Samuel; Contijoch, Eduardo; Todd, John Paul; Silvestri, Guido; Nason, Martha; Norgren, Robert B., Jr.; Keele, Brandon F.; Rao, Srinivas; Langer, Jerome A.; Lifson, Jeffrey D.; Schreiber, Gideon; Douek, Daniel C.			Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression	NATURE			English	Article							PERSISTENT LCMV INFECTION; CD4(+) T-CELLS; HIV-1 INFECTION; ALPHA; REPLICATION; ACQUISITION; ACTIVATION; BLOCKADE; THERAPY; GENES	Inflammation in HIV infection is predictive of non-AIDS morbidity and death(1), higher set point plasma virus load(2) and virus acquisition3; thus, therapeutic agents are in development to reduce its causes and consequences. However, inflammation may simultaneously confer both detrimental and beneficial effects. This dichotomy is particularly applicable to type I interferons (IFN-I) which, while contributing to innate control of infection(4-10), also provide target cells for the virus during acute infection, impair CD4 T-cell recovery, and are associated with disease progression(6,11-19). Here we manipulated IFN-I signalling in rhesus macaques (Macaca mulatta) during simian immunodeficiency virus (Sly) transmission and acute infection with two complementary in vivo interventions. We show that blockade of the IFN-I receptor caused reduced antiviral gene expression, increased SIV reservoir size and accelerated CD4 T-cell depletion with progression to AIDS despite decreased T-cell activation. In contrast, IFN-a2a administration initially upreg-ulated expression of antiviral genes and prevented systemic infection. However, continued IFN-a2a treatment induced IFN-I desensitization and decreased antiviral gene expression, enabling infection with increased SIV reservoir size and accelerated CD4 T-cell loss. Thus, the timing of IFN-induced innate responses in acute SIV infection profoundly affects overall disease course and outweighs the detrimental consequences of increased immune activation. Yet, the clinical consequences of manipulation of IFN signalling are difficult to predict in vivo and therapeutic interventions in human studies should be approached with caution.	[Sandler, Netanya G.; Zhu, Richard T. R.; Boritz, Eli; Wijeyesinghe, Sathi; Makamdop, Krystelle Nganou; Hill, Brenna J.; Timmer, J. Katherina; Reiss, Emma; Darko, Samuel; Contijoch, Eduardo; Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Bosinger, Steven E.; Tharp, Gregory K.; Silvestri, Guido] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Div Microbiol & Immunol, Atlanta, GA 30322 USA; [Bosinger, Steven E.; Tharp, Gregory K.] Emory Univ, Robert W Woodruff Hlth Sci Ctr, Yerkes Natl Primate Res Ctr, Nonhuman Primate Genom Core, Atlanta, GA 30322 USA; [Estes, Jacob D.; del Prete, Gregory Q.; Keele, Brandon F.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD 21702 USA; [Levin, Doron; Yarden, Ganit; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Todd, John Paul; Rao, Srinivas] NIAID, Lab Anim Med, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nason, Martha] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Norgren, Robert B., Jr.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Langer, Jerome A.] Rutgers Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Nebraska System; University of Nebraska Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Douek, DC (corresponding author), NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ddouek@mail.nih.gov		Wijeyesinghe, Sathi/0000-0002-8819-2654; Utay, Netanya/0000-0002-6407-8670; Norgren, Robert/0000-0002-0021-5875; Contijoch, Eduardo/0000-0002-2873-6808; Langer, Jerome/0000-0002-4617-3260	NIH Intramural Funding; NCI/NIH [HHSN261200800001E]; NIH [R24 RR017444, AI-076174]; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation grant [1775/12]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI076174] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	NIH Intramural Funding; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation grant(Israel Science Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to acknowledge A. Zimin for his work in creating the MuSuRCA rhesus assembly, C. Miller for the gift of 6 rhesus macaques and Y. Peleg and S. Albeck at the Israel Structure Proteomic Center and G. Jona from Weizmann Institute Biological services for helping with protein production and purification; A. Roque and N. Haining for initial work on the pilot study; N. Modi, D. Ambrozak, R. Koup, M. Ghosh, I. Srivastava, R. Schwartz, F. Villinger, K. Zoon, J. Bekisz, K. Ghneim, A. Filali, R. Sekaly, L. Mach and L. Shen for their assistance on the current project; and A. Somasunderam for additional support This project was supported by NIH Intramural Funding, federal funds from NCI/NIH Contract HHSN261200800001E, NIH R24 RR017444, NIH AI-076174, I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation grant No. 1775/12.	Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Asmuth DM, 2008, J MED PRIMATOL, V37, P26, DOI 10.1111/j.1600-0684.2007.00221.x; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Carrington M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007070; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146; Fernandez S, 2011, J INFECT DIS, V204, P1927, DOI 10.1093/infdis/jir659; Fraietta JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003658; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haas DW, 2000, AIDS RES HUM RETROV, V16, P183, DOI 10.1089/088922200309278; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hunt PW, 2014, J INFECT DIS; LANE HC, 1988, LANCET, V2, P1218; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Manion M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030306; McElrath MJ, 2013, JAIDS-J ACQ IMM DEF, V63, P263, DOI 10.1097/QAI.0b013e3182898392; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Roberts L, 2012, J INFECT DIS, V205, P194, DOI 10.1093/infdis/jir715; Schellekens H, 1996, ANTIVIR RES, V32, P1, DOI 10.1016/0166-3542(95)00955-8; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vanderford TH, 2012, BLOOD, V119, P5750, DOI 10.1182/blood-2012-02-411496; Waggoner SN, 2014, J VIROL, V88, P1953, DOI 10.1128/JVI.03002-13; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208	34	332	337	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					601	+		10.1038/nature13554	http://dx.doi.org/10.1038/nature13554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043006	Green Accepted, Green Published			2022-12-24	WOS:000339566300037
J	Zhang, LR; Wang, SX; Yin, S; Hong, S; Kim, KP; Kleckner, N				Zhang, Liangran; Wang, Shunxin; Yin, Shen; Hong, Soogil; Kim, Keun P.; Kleckner, Nancy			Topoisomerase II mediates meiotic crossover interference	NATURE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; CHROMOSOME SYNAPSIS; MITOTIC CHROMOSOMES; CHIASMA FORMATION; YEAST MEIOSIS; RECOMBINATION; PROTEIN	Spatial patterning is a ubiquitous feature of biological systems. Meiotic crossovers provide an interesting example, defined by the classic phenomenon of crossover interference. Here we identify a molecular pathway for interference by analysing crossover patterns in budding yeast. Topoisomerase II plays a central role, thus identifying a new function for this critical molecule. SUMOylation (of topoisomerase II and axis component Red1) and ubiquitin-mediated removal of SUMOylated proteins are also required. The findings support the hypothesis that crossover interference involves accumulation, relief and redistribution of mechanical stress along the protein/ DNA meshwork of meiotic chromosome axes, with topoisomerase II required to adjust spatial relationships among DNA segments.	[Zhang, Liangran; Wang, Shunxin; Yin, Shen; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hong, Soogil; Kim, Keun P.] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea	Harvard University; Chung Ang University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu		Kim, Keun/0000-0002-5973-8259; zhang, liangran/0000-0002-8550-6742	National Institutes of Health [RO1 GM044794]; National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [2012-M3A9C6050367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea - Ministry of Science, ICT and Future Planning; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Hochstrasser, J. Bachant, S. Jentsch, L. Pillus and M. Weinreich for plasmids, J. Fung for Zip2 focus data, D. Zickler for the image in Fig. 6a, and members of the Kleckner laboratory and D. Zickler for advice and discussions. This research, L.Z., S. W., S.Y. and N.K. were supported by a grant to N.K. from the National Institutes of Health (RO1 GM044794); S. H. and K. P. K. were supported by the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning (2012-M3A9C6050367).	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Agostinho M, 2008, CANCER RES, V68, P2409, DOI 10.1158/0008-5472.CAN-07-2092; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Baldwin M, 2009, METHODS MOL BIOL, V582, P209, DOI 10.1007/978-1-60761-340-4_16; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Charles DR, 1938, J GENET, V36, P103, DOI 10.1007/BF02982376; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Darst RP, 2008, MOL CELL BIOL, V28, P1361, DOI 10.1128/MCB.01291-07; de los Santos T, 2003, GENETICS, V164, P81; Deryshire MK, 1996, YEAST, V12, P631; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Drouaud J, 2007, PLOS GENET, V3, P1096, DOI 10.1371/journal.pgen.0030106; Eichinger CS, 2010, P NATL ACAD SCI USA, V107, P11370, DOI 10.1073/pnas.1004248107; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Henderson KA, 2005, BIOESSAYS, V27, P995, DOI 10.1002/bies.20310; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hong S, 2013, MOL CELL, V51, P440, DOI 10.1016/j.molcel.2013.08.008; Hooker GW, 2006, CURR BIOL, V16, P1238, DOI 10.1016/j.cub.2006.04.045; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Kawamura R, 2010, J CELL BIOL, V188, P653, DOI 10.1083/jcb.200910085; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; KING JS, 1990, GENETICS, V126, P1127; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kleckner N., 2011, GENOME ORG FUNCTION, P487; Kleckner N, 2013, SCIENCE, V342, P940, DOI 10.1126/science.1247514; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; Koszul R, 2009, TRENDS CELL BIOL, V19, P716, DOI 10.1016/j.tcb.2009.09.007; Lee MT, 2009, DNA REPAIR, V8, P557, DOI 10.1016/j.dnarep.2009.01.004; Libuda DE, 2013, NATURE, V502, P703, DOI 10.1038/nature12577; Loidl J, 1998, METHOD CELL BIOL, V53, P257; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; MOENS PB, 1989, CHROMOSOMA, V98, P317, DOI 10.1007/BF00292383; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Nagai S, 2011, CELL RES, V21, P474, DOI 10.1038/cr.2011.31; Nishant KT, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001109; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; Pope LH, 2006, MOL BIOL CELL, V17, P104, DOI 10.1091/mbc.e05-04-0321; ROSE D, 1993, MOL CELL BIOL, V13, P3445, DOI 10.1128/MCB.13.6.3445; Serrentino ME, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003416; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Vecchiarelli AG, 2013, P NATL ACAD SCI USA, V110, pE1390, DOI 10.1073/pnas.1302745110; Warsi T. H., 2009, THESIS U CALIF; Wu CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002000; Zhang LR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004042; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	67	108	108	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					551	+		10.1038/nature13442	http://dx.doi.org/10.1038/nature13442			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043020	Green Accepted			2022-12-24	WOS:000339566300026
J	Qin, H; Diaz, A; Blouin, L; Lebbink, RJ; Patena, W; Tanbun, P; LeProust, EM; McManus, MT; Song, JS; Ramalho-Santos, M				Qin, Han; Diaz, Aaron; Blouin, Laure; Lebbink, Robert Jan; Patena, Weronika; Tanbun, Priscilia; LeProust, Emily M.; McManus, Michael T.; Song, Jun S.; Ramalho-Santos, Miguel			Systematic Identification of Barriers to Human iPSC Generation	CELL			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; REVEALS; PATHWAY; DISTINCT	Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) holds enormous promise for regenerative medicine. To elucidate endogenous barriers limiting this process, we systematically dissected human cellular reprogramming by combining a genome-wide RNAi screen, innovative computational methods, extensive single-hit validation, and mechanistic investigation of relevant pathways and networks. We identify reprogramming barriers, including genes involved in transcription, chromatin regulation, ubiquitination, dephosphorylation, vesicular transport, and cell adhesion. Specific a disintegrin and metalloproteinase (ADAM) proteins inhibit reprogramming, and the disintegrin domain of ADAM29 is necessary and sufficient for this function. Clathrin-mediated endocytosis can be targeted with small molecules and opposes reprogramming by positively regulating TGF-beta signaling. Genetic interaction studies of endocytosis or ubiquitination reveal that barrier pathways can act in linear, parallel, or feedforward loop architectures to antagonize reprogramming. These results provide a global view of barriers to human cellular reprogramming.	[Qin, Han; Diaz, Aaron; Blouin, Laure; Lebbink, Robert Jan; Patena, Weronika; Tanbun, Priscilia; McManus, Michael T.; Song, Jun S.; Ramalho-Santos, Miguel] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Qin, Han; Blouin, Laure; Tanbun, Priscilia; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, Dept Ob Gyn, San Francisco, CA 94143 USA; [Qin, Han; Blouin, Laure; Tanbun, Priscilia; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, Dept Pathol, San Francisco, CA 94143 USA; [Qin, Han; Blouin, Laure; Tanbun, Priscilia; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Diaz, Aaron; Song, Jun S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Lebbink, Robert Jan; Patena, Weronika; McManus, Michael T.] Univ Calif San Francisco, Ctr Diabet, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lebbink, Robert Jan; Patena, Weronika; McManus, Michael T.] Univ Calif San Francisco, WM Keck Ctr Noncoding RNAs, San Francisco, CA 94143 USA; [Song, Jun S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Song, Jun S.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [LeProust, Emily M.] Agilent Technol, Genom Solut Unit, Santa Clara, CA 95051 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Agilent Technologies	Song, JS (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	songj@illinois.edu; miguel.ramalho-santos@ucsf.edu	Ramalho-Santos, Miguel/L-9092-2018; Song, Jun S/E-2526-2016; Lebbink, Robert Jan/GNH-5209-2022; Patena, Weronika/AAZ-3275-2020; mcmanus, michael/AAB-1239-2020	Ramalho-Santos, Miguel/0000-0003-0177-5556; Song, Jun S/0000-0002-0422-2175; Patena, Weronika/0000-0002-8388-1303; mcmanus, michael/0000-0003-3013-6569; Lebbink, Robert Jan/0000-0002-1981-0420	NWO Rubicon [825.06.030]; NWO Veni [916.10.138]; UCSF Program for Breakthrough Biomedical Research; NIH [1U01CA168370, R01 GM80783, R01CA163336, DP2OD4698]; Sontag Foundation Distinguished Scientist Award; CIRM [RB4-06028]; NATIONAL CANCER INSTITUTE [R01CA163336, U01CA168370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080783] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004698] Funding Source: NIH RePORTER	NWO Rubicon(Netherlands Organization for Scientific Research (NWO)); NWO Veni(Netherlands Organization for Scientific Research (NWO)); UCSF Program for Breakthrough Biomedical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sontag Foundation Distinguished Scientist Award; CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Robert Blelloch, Keith Mostov, and Zena Werb for critical reading of the manuscript, Jonathan Weissman, Martin Kampann, and Michael Bassick for discussions and help with library generation, Nikki Shariat for input on the experiment design, Xiaoyin Wang for virus production, Fong Ming Koh for providing the pGAMA vector, Charles Nicolet and Henriette O'Geen for support on NGS, and Tara Rambaldo and Michael Kissner for support with FACS. This work was supported by NWO Rubicon grant 825.06.030 and Veni grant 916.10.138 to R.J.L.; the UCSF Program for Breakthrough Biomedical Research and NIH grants 1U01CA168370 and R01 GM80783 to M.T.M.; NIH R01CA163336 and Sontag Foundation Distinguished Scientist Award to J.S.S.; and CIRM grant RB4-06028 and NIH Director's New Innovator Award DP2OD4698 to M.R.-S.E.M.L. is an employee of Agilent Technologies.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/nmeth.1330, 10.1038/NMETH.1330]; Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Daley GQ, 2008, COLD SH Q B, V73, P171, DOI 10.1101/sqb.2008.73.041; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Igarashi T, 2007, FEBS LETT, V581, P2416, DOI 10.1016/j.febslet.2007.04.057; Karpiuk O, 2012, MOL CELL, V46, P705, DOI 10.1016/j.molcel.2012.05.022; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Qin H, 2012, HUM MOL GENET, V21, P2054, DOI 10.1093/hmg/dds023; Ramalho-Santos M, 2009, CELL, V138, P616, DOI 10.1016/j.cell.2009.08.012; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	38	62	62	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					449	461		10.1016/j.cell.2014.05.040	http://dx.doi.org/10.1016/j.cell.2014.05.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036638	Bronze, Green Accepted			2022-12-24	WOS:000340943600022
J	Wolfe, BE; Button, JE; Santarelli, M; Dutton, RJ				Wolfe, Benjamin E.; Button, Julie E.; Santarelli, Marcela; Dutton, Rachel J.			Cheese Rind Communities Provide Tractable Systems for In Situ and In Vitro Studies of Microbial Diversity	CELL			English	Article							FUNCTIONAL-ANALYSIS; BACTERIAL; IDENTIFICATION; SURFACE; PATTERNS; GENOME; COLD	Tractable microbial communities are needed to bridge the gap between observations of patterns of microbial diversity and mechanisms that can explain these patterns. We developed cheese rinds as model microbial communities by characterizing in situ patterns of diversity and by developing an in vitro system for community reconstruction. Sequencing of 137 different rind communities across 10 countries revealed 24 widely distributed and culturable genera of bacteria and fungi as dominant community members. Reproducible community types formed independent of geographic location of production. Intensive temporal sampling demonstrated that assembly of these communities is highly reproducible. Patterns of community composition and succession observed in situ can be recapitulated in a simple in vitro system. Widespread positive and negative interactions were identified between bacterial and fungal community members. Cheese rind microbial communities represent an experimentally tractable system for defining mechanisms that influence microbial community assembly and function.	[Wolfe, Benjamin E.; Button, Julie E.; Santarelli, Marcela; Dutton, Rachel J.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University	Dutton, RJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	rdutton@cgr.harvard.edu			National Institutes of Health [P50 GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Andrew Murray, Bodo Stern, Peter Turnbaugh, the Turnbaugh lab, Lawrence David, Miriam Shiffman, Jon Calarco, Lauren O'Connell, Mike Laub, and Kevin Verstrepen for helpful comments and discussions; Noah Fierer for fungal ITS primers; Christian Daly, Michele Clamp, Claire Reardon, and Noelani Kamelamela for technical support; Mateo and Andy Kehler, Vince Razionale, Jasper Hill Farm, the Cellars at Jasper Hill, Bronwen Percival, Sister Noella Marcellino, Catherine Donnelly, Eric Meredith, Brian Ralph, Ihsan Gurdal, and the many members of the artisan cheese community who made collection of samples possible. This work was supported by the National Institutes of Health (P50 GM068763).	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Amarita F, 2004, APPL ENVIRON MICROB, V70, P7348, DOI 10.1128/AEM.70.12.7348-7354.2004; Beresford TP, 2001, INT DAIRY J, V11, P259, DOI 10.1016/S0958-6946(01)00056-5; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P5214, DOI 10.1128/AEM.00934-13; Brennan NM, 2002, APPL ENVIRON MICROB, V68, P820, DOI 10.1128/AEM.68.2.820-830.2002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheeseman K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3876; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; de Pascale D, 2010, POLAR SCI, V4, P285, DOI 10.1016/j.polar.2010.03.009; de Pascale D, 2008, EXTREMOPHILES, V12, P311, DOI 10.1007/s00792-008-0163-9; Engel AS, 2010, GEOMICROBIOLOGY: MOLECULAR AND ENVIRONMENTAL PERSPECTIVE, P219, DOI 10.1007/978-90-481-9204-5_10; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Feligini M, 2012, J FOOD SCI, V77, pM609, DOI 10.1111/j.1750-3841.2012.02932.x; Fierer N, 2012, ANNU REV ECOL EVOL S, V43, P137, DOI 10.1146/annurev-ecolsys-110411-160307; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fox P.F., 2004, CHEESE CHEM PHYS MIC, V1, DOI DOI 10.1016/S1874-558X(04)80060-5; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kuck U, 2010, APPL MICROBIOL BIOT, V86, P51, DOI 10.1007/s00253-009-2416-7; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MARCELLINO N, 1992, APPL ENVIRON MICROB, V58, P3448, DOI 10.1128/AEM.58.11.3448-3454.1992; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Meersman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081559; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Minhas A, 2009, FEMS YEAST RES, V9, P95, DOI 10.1111/j.1567-1364.2008.00457.x; Monnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015489; Mounier J, 2009, INT J FOOD MICROBIOL, V133, P31, DOI 10.1016/j.ijfoodmicro.2009.04.020; Mounier J, 2008, APPL ENVIRON MICROB, V74, P172, DOI 10.1128/AEM.01338-07; Na Jong-Min, 2011, Korean Journal of Microbiology and Biotechnology, V39, P133; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Passerini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015306; Prax M, 2013, MICROBIOL-SGM, V159, P421, DOI 10.1099/mic.0.061705-0; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reen FJ, 2006, NAT REV MICROBIOL, V4, P697, DOI 10.1038/nrmicro1476; Schroder J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-545; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Sieuwerts S, 2008, APPL ENVIRON MICROB, V74, P4997, DOI 10.1128/AEM.00113-08; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Verdier-Metz I, 2012, APPL ENVIRON MICROB, V78, P326, DOI 10.1128/AEM.06229-11; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	50	326	354	23	235	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					422	433		10.1016/j.cell.2014.05.041	http://dx.doi.org/10.1016/j.cell.2014.05.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036636	Green Accepted, Bronze			2022-12-24	WOS:000340943600020
J	Lansdorp-Vogelaar, I; Gulati, R; Mariotto, AB; Schechter, CB; de Carvalho, TM; Knudsen, AB; van Ravesteyn, NT; Heijnsdijk, EAM; Pabiniak, C; van Ballegooijen, M; Rutter, CM; Kuntz, KM; Feuer, EJ; Etzioni, R; de Koning, HJ; Zauber, AG; Mandelblatt, JS				Lansdorp-Vogelaar, Iris; Gulati, Roman; Mariotto, Angela B.; Schechter, Clyde B.; de Carvalho, Tiago M.; Knudsen, Amy B.; van Ravesteyn, Nicolien T.; Heijnsdijk, Eveline A. M.; Pabiniak, Chester; van Ballegooijen, Marjolein; Rutter, Carolyn M.; Kuntz, Karen M.; Feuer, Eric J.; Etzioni, Ruth; de Koning, Harry J.; Zauber, Ann G.; Mandelblatt, Jeanne S.			Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES TASK-FORCE; COLORECTAL-CANCER; PROSTATE-CANCER; LIFE-STYLE; RECOMMENDATION STATEMENT; POTENTIAL BENEFITS; COST-EFFECTIVENESS; DECISION-ANALYSIS; ELDERLY-PATIENTS; BREAST	Background: Harms and benefits of cancer screening depend on age and comorbid conditions, but reliable estimates are lacking. Objective: To estimate the harms and benefits of cancer screening by age and comorbid conditions to inform decisions about screening cessation. Design: Collaborative modeling with 7 cancer simulation models and common data on average and comorbid condition level-specific life expectancy. Setting: U. S. population. Patients: U. S. cohorts aged 66 to 90 years in 2010 with average health or 1 of 4 comorbid condition levels: none, mild, moderate, or severe. Intervention: Mammography, prostate-specific antigen testing, or fecal immunochemical testing. Measurements: Lifetime cancer deaths prevented and life-years gained (benefits); false-positive test results and overdiagnosed cancer cases (harms). For each comorbid condition level, the age at which harms and benefits of screening were similar to that for persons with average health having screening at age 74 years. Results: Screening 1000 women with average life expectancy at age 74 years for breast cancer resulted in 79 to 96 (range across models) false-positive results, 0.5 to 0.8 overdiagnosed cancer cases, and 0.7 to 0.9 prevented cancer deaths. Although absolute numbers of harms and benefits differed across cancer sites, the ages at which to cease screening were consistent across models and cancer sites. For persons with no, mild, moderate, and severe comorbid conditions, screening until ages 76, 74, 72, and 66 years, respectively, resulted in harms and benefits similar to average-health persons. Limitation: Comorbid conditions influenced only life expectancy. Conclusion: Comorbid conditions are an important determinant of harms and benefits of screening. Estimates of screening benefits and harms by comorbid condition can inform discussions between providers and patients about personalizing screening cessation decisions.	Erasmus Univ, Med Ctr, NL-3000 CA Rotterdam, Netherlands; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Grp Hlth Res Inst, Seattle, WA 98101 USA; NCI, Bethesda, MD 20892 USA; Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Minnesota, Minneapolis, MN 55455 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; Georgetown Univ, Washington, DC 20007 USA	Erasmus University Rotterdam; Erasmus MC; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities; Memorial Sloan Kettering Cancer Center; Georgetown University	Lansdorp-Vogelaar, I (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	i.vogelaar@erasmusmc.nl	Gulati, Roman/AAE-4298-2019; de+Koning, Harry/AAF-9062-2019; Rutter, Carolyn/AAZ-3677-2021	Gulati, Roman/0000-0002-7592-6567; de+Koning, Harry/0000-0003-4682-3646; 	National Cancer Institute at the National Institutes of Health; Centers for Disease Control and Prevention [U01CA097426, U01CA115953, U01CA152959, U01CA157224, U01CA088283, U01CA152958]; National Cancer Institute at the National Institutes of Health [KO5CA96940, P01CA154292, U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, HHSN261201100031C]; Dutch Cancer Society [94-869, 98-1657, 2002-277, 2006-3518]; Netherlands Organisation for Health Research and Development [002822820, 22000106, 50-50110-98-311]; NATIONAL CANCER INSTITUTE [UM1CA182883, U01CA115953, U01CA086082, U01CA070040, K05CA096940, U01CA152958, U01CA070013, U01CA097426, U01CA086076, P30CA008748, U01CA088283, U01CA063736, U01CA152959, U01CA063731, U01CA069976, U01CA063740, U01CA157224, P01CA154292] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute at the National Institutes of Health and the Centers for Disease Control and Prevention (grants U01CA097426, U01CA115953, U01CA152959, U01CA157224, U01CA088283, and U01CA152958) and in part by the National Cancer Institute at the National Institutes of Health (grants KO5CA96940 to Dr. Mandelblatt and P01CA154292 to Drs. Mandelblatt, Schechter, van Ravesteyn, Heijnsdijk, and de Koning), the Dutch Cancer Society (grants 94-869, 98-1657, 2002-277, and 2006-3518 to Drs. Heijnsdijk and de Koning), and the Netherlands Organisation for Health Research and Development (grants 002822820, 22000106, and 50-50110-98-311 to Drs. Heijnsdijk and de Koning). Breast Cancer Surveillance Consortium data collection and sharing used in some variables for modeling breast cancer screening was supported by the National Cancer Institute at the National Institutes of Health (grants U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, and HHSN261201100031C).	Begg CB, 2010, ANN INTERN MED, V152, P540, DOI 10.7326/0003-4819-152-8-201004200-00203; Braithwaite RS, 2010, ANN INTERN MED, V152, P539, DOI 10.7326/0003-4819-152-8-201004200-00201; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Chang YJ, 2012, BREAST CANCER RES TR, V136, P823, DOI 10.1007/s10549-012-2274-3; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; Col NF, 2010, ANN INTERN MED, V152, P542, DOI 10.7326/0003-4819-152-8-201004200-00206; Dinh TA, 2012, J GEN INTERN MED, V27, P730, DOI 10.1007/s11606-011-1972-6; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Gong ZH, 2006, CANCER EPIDEM BIOMAR, V15, P1977, DOI 10.1158/1055-9965.EPI-06-0477; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Gulati R, 2011, CANCER EPIDEM BIOMAR, V20, P740, DOI 10.1158/1055-9965.EPI-10-0718; Gulati R, 2010, BIOSTATISTICS, V11, P707, DOI 10.1093/biostatistics/kxq036; Harewood GC, 2006, J GASTROEN HEPATOL, V21, P1021, DOI 10.1111/j.1440-1746.2006.04218.x; Harris R, 2011, EPIDEMIOL REV, V33, P20, DOI 10.1093/epirev/mxr005; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Ho A, 2010, ANN INTERN MED, V152, P542, DOI 10.7326/0003-4819-152-8-201004200-00207; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Kawachi Mark H, 2007, J Natl Compr Canc Netw, V5, P714; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Klijs B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-378; Ko CW, 2005, GASTROENTEROLOGY, V129, P1163, DOI 10.1053/j.gastro.2005.07.027; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Maheshwari S, 2008, J AGING HEALTH, V20, P126, DOI 10.1177/0898264307309939; Mandelblatt Jeanne, 2006, J Natl Cancer Inst Monogr, P47, DOI 10.1093/jncimonographs/lgj008; Mandelblatt JS, 2013, JAMA INTERN MED, V173, P227, DOI 10.1001/jamainternmed.2013.2127; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mandelblatt JS, 2005, J GEN INTERN MED, V20, P487, DOI 10.1111/j.1525-1497.2005.0116.x; MANDELBLATT JS, 1992, ANN INTERN MED, V116, P722, DOI 10.7326/0003-4819-116-9-722; Nelson NJ, 2012, J NATL CANCER I, V104, P574, DOI 10.1093/jnci/djs213; Qaseem A, 2013, ANN INTERN MED, V158, P761, DOI 10.7326/0003-4819-158-10-201305210-00633; Rich J S, 2000, Eff Clin Pract, V3, P78; Rutter CM, 2010, CANCER EPIDEM BIOMAR, V19, P1992, DOI 10.1158/1055-9965.EPI-09-0954; Schonberg MA, 2011, J AM GERIATR SOC, V59, P1444, DOI 10.1111/j.1532-5415.2011.03523.x; Schonberg MA, 2009, J GEN INTERN MED, V24, P1115, DOI 10.1007/s11606-009-1073-y; Smith RA, 2012, CA CANCER J CLIN; Stevens T, 2003, AM J GASTROENTEROL, V98, P1881, DOI 10.1016/S0002-9270(03)00425-8; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; U.S. Census Bureau, 2013, 2012 NATIONAL POPULA; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Wolk A, 2005, ACTA ONCOL, V44, P277, DOI 10.1080/02841860510029572; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	50	91	92	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					104	+		10.7326/M13-2867	http://dx.doi.org/10.7326/M13-2867			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	25023249	Green Accepted			2022-12-24	WOS:000339764600019
J	Clayton, GM; Wang, Y; Crawford, F; Novikov, A; Wimberly, BT; Kieft, JS; Falta, MT; Bowerman, NA; Marrack, P; Fontenot, AP; Dai, SD; Kappler, JW				Clayton, Gina M.; Wang, Yang; Crawford, Frances; Novikov, Andrey; Wimberly, Brian T.; Kieft, Jeffrey S.; Falta, Michael T.; Bowerman, Natalie A.; Marrack, Philippa; Fontenot, Andrew P.; Dai, Shaodong; Kappler, John W.			Structural Basis of Chronic Beryllium Disease: Linking Allergic Hypersensitivity and Autoimmunity	CELL			English	Article							CD4(+) T-CELLS; MHC-CLASS-II; RECEPTOR TCR INTERACTION; RHEUMATOID-ARTHRITIS; LUNG-DISEASE; PEPTIDES; BINDING; RECOGNITION; PROTEINS; HLA-DP2	T-cell-mediated hypersensitivity to metal cations is common in humans. How the T cell antigen receptor (TCR) recognizes these cations bound to a major histocompatibility complex (MHC) protein and self-peptide is unknown. Individuals carrying the MHCII allele, HLA-DP2, are at risk for chronic beryllium disease (CBD), a debilitating inflammatory lung condition caused by the reaction of CD4 T cells to inhaled beryllium. Here, we show that the T cell ligand is created when a Be2+ cation becomes buried in an HLA-DP2/peptide complex, where it is coordinated by both MHC and peptide acidic amino acids. Surprisingly, the TCR does not interact with the Be2+ itself, but rather with surface changes induced by the firmly bound Be2+ and an accompanying Na+ cation. Thus, CBD, by creating a new antigen by indirectly modifying the structure of preexisting self MHC-peptide complex, lies on the border between allergic hypersensitivity and autoimmunity.	[Clayton, Gina M.; Crawford, Frances; Marrack, Philippa; Kappler, John W.] Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO 80206 USA; [Clayton, Gina M.; Wang, Yang; Crawford, Frances; Novikov, Andrey; Marrack, Philippa; Fontenot, Andrew P.; Dai, Shaodong; Kappler, John W.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Clayton, Gina M.; Wang, Yang; Crawford, Frances; Novikov, Andrey; Marrack, Philippa; Fontenot, Andrew P.; Dai, Shaodong; Kappler, John W.] Univ Colorado, Denver Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA; [Wimberly, Brian T.; Kieft, Jeffrey S.] Univ Colorado, Denver Sch Med, Howard Hughes Med Inst, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Wimberly, Brian T.; Kieft, Jeffrey S.; Marrack, Philippa] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Falta, Michael T.; Bowerman, Natalie A.; Fontenot, Andrew P.] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Wimberly, Brian T.; Kieft, Jeffrey S.; Kappler, John W.] Univ Colorado, Denver Sch Med, Program Struct Biol & Biochem, Aurora, CO 80045 USA	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Dai, SD (corresponding author), Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA.	dais@njhealth.org; kapplerj@njhealth.org	Marrack, Philippa/AHE-6316-2022; Wang, Yang/D-5344-2016	Wang, Yang/0000-0002-6510-6653; Falta, Michael/0000-0002-0835-6904; Marrack, Philippa/0000-0003-1883-3687	NIH [AI17785, HL62410, HL92997, ES011810, AI17134]; CCTSI [KL2TR000156, KL1TR000155]; Boettcher Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000156, KL2TR001080, TL1TR000155, UL1TR001082, TL1TR001081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL102245, R01HL062410, R01HL092997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017134, R56AI017134, R37AI017134, R01AI018785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCTSI; Boettcher Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Igor Kurinov for data collection assistance at APS Argonne National Laboratory, Beamline 24 ID-C and Corie Ralston at ALS Lawrence Berkley National Laboratory, Beamline 822. Oliver Smart (Global Phasing) assisted us with beryllium definitions in AUTOBuster, and Mario Santiago made the BIORAD CFX96 RCT-PCR instrument available to us. We also thank Randy Anselment at the Molecular Resource Center, National Jewish Health, for oligonucleotide synthesis and DNA sequencing. This work was supported in part by NIH grant AI17785 (P. C. M.), by NIH grants HL62410, HL92997, and ES011810 (to A. P. F.), by CCTSI KL2TR000156 and KL1TR000155 and the Boettcher Foundation (to S. D.), and NIH grant AI17134 (to J. W. K).	Alerghi L., 1999, POLYHEDRON, V18, P3305; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bill JR, 2005, J IMMUNOL, V175, P7029, DOI 10.4049/jimmunol.175.10.7029; Bowerman NA, 2011, J IMMUNOL, V187, P3694, DOI 10.4049/jimmunol.1101872; Cordova KN, 2013, J IMMUNOL, V190, P1457, DOI 10.4049/jimmunol.1201517; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Crawford F, 2011, P NATL ACAD SCI USA, V108, P16729, DOI 10.1073/pnas.1113954108; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Dai SD, 2013, CURR OPIN IMMUNOL, V25, P775, DOI 10.1016/j.coi.2013.07.012; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; Diaz G, 2005, IMMUNOGENETICS, V56, P754, DOI 10.1007/s00251-004-0735-5; Diyabalanage HVK, 2008, ANGEW CHEM INT EDIT, V47, P7332, DOI 10.1002/anie.200801965; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Evans PR, 2007, ACTA CRYSTALLOGR D, V63, P58, DOI 10.1107/S090744490604604X; Everest D.A., 1964, TOPICS INORGANIC GEN, V1; Falta MT, 2013, J EXP MED, V210, P1403, DOI 10.1084/jem.20122426; Fontenot AP, 2006, J IMMUNOL, V177, P3874, DOI 10.4049/jimmunol.177.6.3874; Fontenot AP, 2008, SEMIN RESP CRIT CARE, V29, P662, DOI 10.1055/s-0028-1101276; Fontenot AP, 1999, J IMMUNOL, V163, P1019; Fontenot JD, 2004, SEMIN IMMUNOL, V16, P73, DOI 10.1016/j.smim.2003.12.002; Gras S, 2008, CURR OPIN IMMUNOL, V20, P119, DOI 10.1016/j.coi.2007.12.001; Illing PT, 2013, CURR OPIN IMMUNOL, V25, P81, DOI 10.1016/j.coi.2012.10.002; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; KALISH RS, 1990, J INVEST DERMATOL, V94, pS108, DOI 10.1111/1523-1747.ep12876061; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Keizer TS, 2005, J INORG BIOCHEM, V99, P1174, DOI 10.1016/j.jinorgbio.2005.02.017; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; Louis-Dit-Sully Christine, 2014, Exp Suppl, V104, P25, DOI 10.1007/978-3-0348-0726-5_3; Maier LA, 2003, J IMMUNOL, V171, P6910, DOI 10.4049/jimmunol.171.12.6910; Marrack P, 2008, CURR OPIN IMMUNOL, V20, P203, DOI 10.1016/j.coi.2008.03.008; MARTIN S, 1994, INT ARCH ALLERGY IMM, V104, P10, DOI 10.1159/000236703; Mohan JF, 2013, MOL IMMUNOL, V55, P166, DOI 10.1016/j.molimm.2012.10.024; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; SALTINI C, 1989, NEW ENGL J MED, V320, P1103, DOI 10.1056/NEJM198904273201702; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006; Sutton M, 2003, CHEM RES TOXICOL, V16, P1145, DOI 10.1021/tx0256477; Thierse HJ, 2005, TOXICOLOGY, V209, P101, DOI 10.1016/j.tox.2004.12.015; White J, 2000, METH MOL B, V134, P185; Wilson IA, 1997, CURR OPIN STRUC BIOL, V7, P839, DOI 10.1016/S0959-440X(97)80156-X; Yin L, 2012, P NATL ACAD SCI USA, V109, P18517, DOI 10.1073/pnas.1215928109	47	72	75	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					132	142		10.1016/j.cell.2014.04.048	http://dx.doi.org/10.1016/j.cell.2014.04.048			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995984	Bronze, Green Accepted			2022-12-24	WOS:000340943100013
J	Pefanis, E; Wang, JG; Rothschild, G; Lim, J; Chao, J; Rabadan, R; Economides, AN; Basu, U				Pefanis, Evangelos; Wang, Jiguang; Rothschild, Gerson; Lim, Junghyun; Chao, Jaime; Rabadan, Raul; Economides, Aris N.; Basu, Uttiya			Noncoding RNA transcription targets AID to divergently transcribed loci in B cells	NATURE			English	Article							POLYMERASE-II; CHROMOSOMAL REARRANGEMENTS; PROMOTER DIRECTIONALITY; SOMATIC HYPERMUTATION; SEQUENCING REVEALS; EXOSOME; GENOME; DNA; LYMPHOCYTES; TERMINATION	The vast majority of the mammalian genome has the potential to express noncoding RNA (ncRNA). The 11-subunit RNA exosome complex is the main source of cellular 3'-5' exoribonucleolytic activity and potentially regulates the mammalian noncoding transcriptome(1). Here we generated a mouse model in which the essential subunit Exosc3 of the RNA exosome complex can be conditionally deleted. Exosc3-deficient B cells lack the ability to undergo normal levels of class switch recombination and somatic hypermutation, two mutagenic DNA processes used to generate antibody diversity via the B-cell mutator protein activation-induced cytidine deaminase (AID)(2,3). The transcriptome of Exosc3-deficient B cells has revealed the presence of many novel RNA exosome substrate ncRNAs. RNA exosome substrate RNAs include xTSS-RNAs, transcription start site (TSS)-associated antisense transcripts that can exceed 500 base pairs in length and are transcribed divergently from cognate coding gene transcripts. xTSS-RNAs are most strongly expressed at genes that accumulate AID mediated somatic mutations and/or are frequent translocation partners of DNA double-strand breaks generated at Igh in B cells(4,5). Strikingly, translocations near TSSs or within gene bodies occur over regions of RNA exosome substrate ncRNA expression. These RNA exosome-regulated, antisense-transcribed regions of the B-cell genome recruit AID and accumulate single-strand DNA structures containing RNA-DNA hybrids. We propose that RNA exosome regulation of ncRNA recruits AID to single-strand DNA-forming sites of antisense and divergent transcription in the B-cell genome, thereby creating a link between ncRNA transcription and overall maintenance of B-cell genomic integrity.	[Pefanis, Evangelos; Wang, Jiguang; Rothschild, Gerson; Lim, Junghyun; Chao, Jaime; Basu, Uttiya] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Pefanis, Evangelos; Economides, Aris N.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Wang, Jiguang; Rabadan, Raul] Columbia Univ Coll Phys & Surg, Dept Syst Biol, New York, NY 10032 USA; [Wang, Jiguang; Rabadan, Raul] Columbia Univ Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA	Columbia University; Regeneron; Columbia University; Columbia University	Rabadan, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA.	rr2579@columbia.edu; ub2121@columbia.edu	Lim, Junghyun/AAX-3678-2021; Rabadan, Raul/AAZ-7367-2020; Wang, Jiguang/B-2717-2012	Lim, Junghyun/0000-0002-5292-7487; Rabadan, Raul/0000-0001-7946-9255; Wang, Jiguang/0000-0002-6923-4097; Economides, Aris/0000-0002-6508-8942	National Institutes of Health (NIH) [1DP2OD008651-01]; National Institute of Allergy and Infectious Diseases [1R01AI099195-01A1]; NIH [1R01CA185486-01, 1R01CA179044-01A1, 1U54CA121852-05]; NATIONAL CANCER INSTITUTE [R01CA179044, R01CA185486, U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099195] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008651] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Symington, S. Goff, S. Ghosh, S. Silverstein, C. Lima, F. Chedin, L. Macdonald, C.-S. Lin and O. Couronne for critical input and reagents. This work was supported by grants from the National Institutes of Health (NIH; 1DP2OD008651-01) and the National Institute of Allergy and Infectious Diseases (1R01AI099195-01A1) (to U. B.); NIH (1R01CA185486-01; 1R01CA179044-01A1; 1U54CA121852-05) (to R.R.).	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen PR, 2013, NAT STRUCT MOL BIOL, V20, P1367, DOI 10.1038/nsmb.2703; Andersen PK, 2013, WIRES RNA, V4, P233, DOI 10.1002/wrna.1156; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Castellano-Pozo M, 2013, MOL CELL, V52, P583, DOI 10.1016/j.molcel.2013.10.006; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Economides AN, 2013, P NATL ACAD SCI USA, V110, pE3179, DOI 10.1073/pnas.1217812110; Flynn RA, 2012, CURR OPIN GENET DEV, V22, P172, DOI 10.1016/j.gde.2011.11.002; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Frendewey D, 2010, METHOD ENZYMOL, V476, P295, DOI 10.1016/S0076-6879(10)76017-1; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Keim C, 2013, GENE DEV, V27, P1, DOI 10.1101/gad.200014.112; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Oliveira TY, 2012, J IMMUNOL METHODS, V375, P176, DOI 10.1016/j.jim.2011.10.007; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Schneider C, 2013, TRENDS BIOCHEM SCI, V38, P485, DOI 10.1016/j.tibs.2013.06.013; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Storb U, 2014, ADV IMMUNOL, V122, P253, DOI 10.1016/B978-0-12-800267-4.00007-9; Sun JB, 2013, GENE DEV, V27, P1821, DOI 10.1101/gad.210211.112; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	40	116	119	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					389	+		10.1038/nature13580	http://dx.doi.org/10.1038/nature13580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25119026	Green Accepted			2022-12-24	WOS:000342988600057
J	Gonzalez-Munoz, E; Arboleda-Estudillo, Y; Otu, HH; Cibelli, JB				Gonzalez-Munoz, Elena; Arboleda-Estudillo, Yohanna; Otu, Hasan H.; Cibelli, Jose B.			Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming	SCIENCE			English	Article							ACETYLATION; H3; OOCYTES	Unfertilized oocytes have the intrinsic capacity to remodel sperm and the nuclei of somatic cells. The discoveries that cells can change their phenotype from differentiated to embryonic state using oocytes or specific transcription factors have been recognized as two major breakthroughs in the biomedical field. Here, we show that ASF1A, a histone-remodeling chaperone specifically enriched in the metaphase II human oocyte, is necessary for reprogramming of human adult dermal fibroblasts (hADFs) into undifferentiated induced pluripotent stem cell. We also show that overexpression of just ASF1A and OCT4 in hADFs exposed to the oocyte-specific paracrine growth factor GDF9 can reprogram hADFs into pluripotent cells. Our Report underscores the importance of studying the unfertilized MII oocyte as a means to understand the molecular pathways governing somatic cell reprogramming.	[Gonzalez-Munoz, Elena; Arboleda-Estudillo, Yohanna; Cibelli, Jose B.] Ctr Andaluz Nanomed & Biotecnol Andalucia, BIONAND, LARCEL, Lab Andaluz Reprogramac Celular, Seville 29590, Spain; [Otu, Hasan H.] Istanbul Bilgi Univ, Dept Genet & Bioengn, TR-34060 Istanbul, Turkey; [Otu, Hasan H.] Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA; [Cibelli, Jose B.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Cibelli, Jose B.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Istanbul Bilgi University; University of Nebraska System; University of Nebraska Lincoln; Michigan State University; Michigan State University	Cibelli, JB (corresponding author), Ctr Andaluz Nanomed & Biotecnol Andalucia, BIONAND, LARCEL, Lab Andaluz Reprogramac Celular, Seville 29590, Spain.	cibelli@msu.edu	Gonzalez-Munoz, Elena/AAY-4658-2020	Gonzalez-Munoz, Elena/0000-0001-8291-1518; Otu, Hasan/0000-0002-9253-8152; Cibelli, Jose/0000-0002-2176-3854	Fundacion Progreso y Salud, Sevilla, Andalucia, Spain; Michigan State University AgBioResearch, East Lansing, Michigan, USA; Naylor Family Foundation, York, Pennsylvania, USA	Fundacion Progreso y Salud, Sevilla, Andalucia, Spain; Michigan State University AgBioResearch, East Lansing, Michigan, USA; Naylor Family Foundation, York, Pennsylvania, USA	We thank members of LARCEL laboratory for comments and support, A. Wittgreen and N. Lopez Corrales for intellectual input and discussion, and Biobanco del Sistema Sanitario Publico de Andalucia for karyotyping and teratoma assay service. This work was supported by Fundacion Progreso y Salud, Sevilla, Andalucia, Spain; Michigan State University AgBioResearch, East Lansing, Michigan, USA; and the Naylor Family Foundation, York, Pennsylvania, USA. The Gene Expression Omnibus (GEO) accession number for the oocyte transcriptome is GSE12034. E. G.-M. and J.B.C. are listed as inventors on a patent application filed by Fundacion Progreso y Salud, Sevilla, Andalucia, Spain, and Michigan State University, East Lansing, Michigan, USA.	Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Awe JP, 2013, CELL REPROGRAM, V15, P126, DOI 10.1089/cell.2012.0060; Battu A, 2011, NUCLEIC ACIDS RES, V39, P7931, DOI 10.1093/nar/gkr523; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; GURDON JB, 1967, SCI PROG, V55, P259; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Miyamoto K, 2013, SCIENCE, V341, P1002, DOI 10.1126/science.1240376; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan YL, 2013, P NATL ACAD SCI USA, V110, P11493, DOI 10.1073/pnas.1309914110; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620	20	54	57	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					822	825		10.1126/science.1254745	http://dx.doi.org/10.1126/science.1254745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25035411				2022-12-24	WOS:000340593100047
J	Hoadley, KA; Yau, C; Wolf, DM; Cherniack, AD; Tamborero, D; Ng, S; Leiserson, MDM; Niu, BF; McLellan, MD; Uzunangelov, V; Zhang, JS; Kandoth, C; Akbani, R; Shen, H; Omberg, L; Chu, A; Margolin, AA; van't Veer, LJ; Lopez-Bigas, N; Laird, PW; Raphael, BJ; Ding, L; Robertson, AG; Byers, LA; Mills, GB; Weinstein, JN; Van Waes, C; Chen, Z; Collisson, EA; Benz, CC; Perou, CM; Stuart, JM; Abbott, R; Abbott, S; Aksoy, BA; Aldape, K; Ally, A; Amin, S; Anastassiou, D; Auman, JT; Baggerly, KA; Balasundaram, M; Balu, S; Baylin, SB; Benz, SC; Berman, BP; Bernard, B; Bhatt, AS; Birol, I; Black, AD; Bodenheimer, T; Bootwalla, MS; Bowen, J; Bressler, R; Bristow, CA; Brooks, AN; Broom, B; Buda, E; Burton, R; Butterfield, YSN; Carlin, D; Carter, SL; Casasent, TD; Chang, K; Chanock, S; Chin, L; Cho, DY; Cho, J; Chuah, E; Chun, HJE; Cibulskis, K; Ciriello, G; Cleland, J; Cline, M; Craft, B; Creighton, CJ; Danilova, L; Davidsen, T; Davis, C; Dees, ND; Delehaunty, K; Demchok, JA; Dhalla, N; DiCara, D; Dinh, H; Dobson, JR; Dodda, D; Doddapaneni, H; Donehower, L; Dooling, DJ; Dresdner, G; Drummond, J; Eakin, A; Edgerton, M; Eldred, JM; Eley, G; Ellrott, K; Fan, C; Fei, S; Felau, I; Frazer, S; Freeman, SS; Frick, J; Fronick, CC; Fulton, LL; Fulton, R; Gabriel, SB; Gao, JJ; Gastier-Foster, JM; Gehlenborg, N; George, M; Getz, G; Gibbs, R; Goldman, M; Gonzalez-Perez, A; Gross, B; Guin, R; Gunaratne, P; Hadjipanayis, A; Hamilton, MP; Hamilton, SR; Han, L; Han, Y; Harper, HA; Haseley, P; Haussler, D; Hayes, DN; Heiman, DI; Helman, E; Helsel, C; Herbrich, SM; Herman, JG; Hinoue, T; Hirst, C; Hirst, M; Holt, RA; Hoyle, AP; Iype, L; Jacobsen, A; Jeffreys, SR; Jensen, MA; Jones, CD; Jones, SJM; Ju, ZL; Jung, J; Kahles, A; Kahn, A; Kalicki-Veizer, J; Kalra, D; Kanchi, KL; Kane, DW; Kim, H; Kim, J; Knijnenburg, T; Koboldt, DC; Kovar, C; Kramer, R; Kreisberg, R; Kucherlapati, R; Ladanyi, M; Lander, ES; Larson, DE; Lawrence, MS; Lee, D; Lee, E; Lee, S; Lee, W; Lehmann, KV; Leinonen, K; Leraas, KM; Lerner, S; Levine, DA; Lewis, L; Ley, TJ; Li, HI; Li, J; Li, W; Liang, H; Lichtenberg, TM; Lin, J; Lin, L; Lin, P; Liu, WB; Liu, YC; Liu, YX; Lorenzi, PL; Lu, C; Lu, YL; Luquette, LJ; Ma, S; Magrini, VJ; Mahadeshwar, HS; Mardis, ER; Margolin, A; Marra, MA; Mayo, M; McAllister, C; McGuire, SE; McMichael, JF; Melott, J; Meng, SW; Meyerson, M; Mieczkowski, PA; Miller, CA; Miller, ML; Miller, M; Moore, RA; Morgan, M; Morton, D; Mose, LE; Mungall, AJ; Muzny, D; Nguyen, L; Noble, MS; Noushmehr, H; O'Laughlin, M; Ojesina, AI; Yang, TO; Ozenberger, B; Pantazi, A; Parfenov, M; Park, PJ; Parker, JS; Paull, E; Pedamallu, CS; Pihl, T; Pohl, C; Pot, D; Protopopov, A; Przytycka, T; Radenbaugh, A; Ramirez, NC; Ramirez, R; Ratsch, G; Reid, J; Ren, XJ; Reva, B; Reynolds, SM; Rhie, SK; Roach, J; Rovira, H; Ryan, M; Saksena, G; Salama, S; Sander, C; Santoso, N; Schein, JE; Schmidt, H; Schultz, N; Schumacher, SE; Seidman, J; Senbabaoglu, Y; Seth, S; Sharpe, S; Shen, RL; Sheth, M; Shi, Y; Shmulevich, I; Silva, GO; Simons, JV; Sinha, R; Sipahimalani, P; Smith, SM; Sofia, HJ; Sokolov, A; Soloway, MG; Song, XZ; Sougnez, C; Spellman, P; Staudt, L; Stewart, C; Stojanov, P; Su, XP; Sumer, SO; Sun, YC; Swatloski, T; Tabak, B; Tam, A; Tan, DH; Tang, JB; Tarnuzzer, R; Taylor, BS; Thiessen, N; Thorsson, V; Triche, T; Van Den Berg, DJ; Vandin, F; Varhol, RJ; Vaske, CJ; Veluvolu, U; Verhaak, R; Voet, D; Walker, J; Wallis, JW; Waltman, P; Wan, YH; Wang, M; Wang, WY; Wang, ZN; Waring, S; Weinhold, N; Weisenberger, DJ; Wendl, MC; Wheeler, D; Wilkerson, MD; Wilson, RK; Wise, L; Wong, A; Wu, CJ; Wu, CC; Wu, HT; Wu, JY; Wylie, T; Xi, L; Xi, RB; Xia, Z; Xu, AW; Yang, D; Yang, LM; Yang, LX; Yang, Y; Yao, J; Yao, R; Ye, K; Yoshihara, K; Yuan, Y; Yung, AK; Zack, T; Zeng, D; Zenklusen, JC; Zhang, HL; Zhang, JH; Zhang, NX; Zhang, QY; Zhang, W; Zhao, W; Zheng, SY; Zhu, J; Zmuda, E; Zou, LH				Hoadley, Katherine A.; Yau, Christina; Wolf, Denise M.; Cherniack, Andrew D.; Tamborero, David; Ng, Sam; Leiserson, Max D. M.; Niu, Beifang; McLellan, Michael D.; Uzunangelov, Vladislav; Zhang, Jiashan; Kandoth, Cyriac; Akbani, Rehan; Shen, Hui; Omberg, Larsson; Chu, Andy; Margolin, Adam A.; van't Veer, Laura J.; Lopez-Bigas, Nuria; Laird, Peter W.; Raphael, Benjamin J.; Ding, Li; Robertson, A. Gordon; Byers, Lauren A.; Mills, Gordon B.; Weinstein, John N.; Van Waes, Carter; Chen, Zhong; Collisson, Eric A.; Benz, Christopher C.; Perou, Charles M.; Stuart, Joshua M.; Abbott, Rachel; Abbott, Scott; Aksoy, B. Arman; Aldape, Kenneth; Ally, Adrian; Amin, Samirkumar; Anastassiou, Dimitris; Auman, J. Todd; Baggerly, Keith A.; Balasundaram, Miruna; Balu, Saianand; Baylin, Stephen B.; Benz, Stephen C.; Berman, Benjamin P.; Bernard, Brady; Bhatt, Ami S.; Birol, Inanc; Black, Aaron D.; Bodenheimer, Tom; Bootwalla, Moiz S.; Bowen, Jay; Bressler, Ryan; Bristow, Christopher A.; Brooks, Angela N.; Broom, Bradley; Buda, Elizabeth; Burton, Robert; Butterfield, Yaron S. N.; Carlin, Daniel; Carter, Scott L.; Casasent, Tod D.; Chang, Kyle; Chanock, Stephen; Chin, Lynda; Cho, Dong-Yeon; Cho, Juok; Chuah, Eric; Chun, Hye-Jung E.; Cibulskis, Kristian; Ciriello, Giovanni; Cleland, James; Cline, Melisssa; Craft, Brian; Creighton, Chad J.; Danilova, Ludmila; Davidsen, Tanja; Davis, Caleb; Dees, Nathan D.; Delehaunty, Kim; Demchok, John A.; Dhalla, Noreen; DiCara, Daniel; Dinh, Huyen; Dobson, Jason R.; Dodda, Deepti; Doddapaneni, HarshaVardhan; Donehower, Lawrence; Dooling, David J.; Dresdner, Gideon; Drummond, Jennifer; Eakin, Andrea; Edgerton, Mary; Eldred, Jim M.; Eley, Greg; Ellrott, Kyle; Fan, Cheng; Fei, Suzanne; Felau, Ina; Frazer, Scott; Freeman, Samuel S.; Frick, Jessica; Fronick, Catrina C.; Fulton, Lucinda L.; Fulton, Robert; Gabriel, Stacey B.; Gao, Jianjiong; Gastier-Foster, Julie M.; Gehlenborg, Nils; George, Myra; Getz, Gad; Gibbs, Richard; Goldman, Mary; Gonzalez-Perez, Abel; Gross, Benjamin; Guin, Ranabir; Gunaratne, Preethi; Hadjipanayis, Angela; Hamilton, Mark P.; Hamilton, Stanley R.; Han, Leng; Han, Yi; Harper, Hollie A.; Haseley, Psalm; Haussler, David; Hayes, D. Neil; Heiman, David I.; Helman, Elena; Helsel, Carmen; Herbrich, Shelley M.; Herman, James G.; Hinoue, Toshinori; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Hoyle, Alan P.; Iype, Lisa; Jacobsen, Anders; Jeffreys, Stuart R.; Jensen, Mark A.; Jones, Corbin D.; Jones, Steven J. M.; Ju, Zhenlin; Jung, Joonil; Kahles, Andre; Kahn, Ari; Kalicki-Veizer, Joelle; Kalra, Divya; Kanchi, Krishna-Latha; Kane, David W.; Kim, Hoon; Kim, Jaegil; Knijnenburg, Theo; Koboldt, Daniel C.; Kovar, Christie; Kramer, Roger; Kreisberg, Richard; Kucherlapati, Raju; Ladanyi, Marc; Lander, Eric S.; Larson, David E.; Lawrence, Michael S.; Lee, Darlene; Lee, Eunjung; Lee, Semin; Lee, William; Lehmann, Kjong-Van; Leinonen, Kalle; Leraas, Kristen M.; Lerner, Seth; Levine, Douglas A.; Lewis, Lora; Ley, Timothy J.; Li, Haiyan I.; Li, Jun; Li, Wei; Liang, Han; Lichtenberg, Tara M.; Lin, Jake; Lin, Ling; Lin, Pei; Liu, Wenbin; Liu, Yingchun; Liu, Yuexin; Lorenzi, Philip L.; Lu, Charles; Lu, Yiling; Luquette, Lovelace J.; Ma, Singer; Magrini, Vincent J.; Mahadeshwar, Harshad S.; Mardis, Elaine R.; Margolin, Adam; Marra, Marco A.; Mayo, Michael; McAllister, Cynthia; McGuire, Sean E.; McMichael, Joshua F.; Melott, James; Meng, Shaowu; Meyerson, Matthew; Mieczkowski, Piotr A.; Miller, Christopher A.; Miller, Martin L.; Miller, Michael; Moore, Richard A.; Morgan, Margaret; Morton, Donna; Mose, Lisle E.; Mungall, Andrew J.; Muzny, Donna; Nguyen, Lam; Noble, Michael S.; Noushmehr, Houtan; O'Laughlin, Michelle; Ojesina, Akinyemi I.; Yang, TaiHsien Ou; Ozenberger, Brad; Pantazi, Angeliki; Parfenov, Michael; Park, Peter J.; Parker, Joel S.; Paull, Evan; Pedamallu, Chandra Sekhar; Pihl, Todd; Pohl, Craig; Pot, David; Protopopov, Alexei; Przytycka, Teresa; Radenbaugh, Amie; Ramirez, Nilsa C.; Ramirez, Ricardo; Ratsch, Gunnar; Reid, Jeffrey; Ren, Xiaojia; Reva, Boris; Reynolds, Sheila M.; Rhie, Suhn K.; Roach, Jeffrey; Rovira, Hector; Ryan, Michael; Saksena, Gordon; Salama, Sofie; Sander, Chris; Santoso, Netty; Schein, Jacqueline E.; Schmidt, Heather; Schultz, Nikolaus; Schumacher, Steven E.; Seidman, Jonathan; Senbabaoglu, Yasin; Seth, Sahil; Sharpe, Samantha; Shen, Ronglai; Sheth, Margi; Shi, Yan; Shmulevich, Ilya; Silva, Grace O.; Simons, Janae V.; Sinha, Rileen; Sipahimalani, Payal; Smith, Scott M.; Sofia, Heidi J.; Sokolov, Artem; Soloway, Mathew G.; Song, Xingzhi; Sougnez, Carrie; Spellman, Paul; Staudt, Louis; Stewart, Chip; Stojanov, Petar; Su, Xiaoping; Sumer, S. Onur; Sun, Yichao; Swatloski, Teresa; Tabak, Barbara; Tam, Angela; Tan, Donghui; Tang, Jiabin; Tarnuzzer, Roy; Taylor, Barry S.; Thiessen, Nina; Thorsson, Vesteinn; Triche, Timothy, Jr.; Van Den Berg, David J.; Vandin, Fabio; Varhol, Richard J.; Vaske, Charles J.; Veluvolu, Umadevi; Verhaak, Roeland; Voet, Doug; Walker, Jason; Wallis, John W.; Waltman, Peter; Wan, Yunhu; Wang, Min; Wang, Wenyi; Wang, Zhining; Waring, Scot; Weinhold, Nils; Weisenberger, Daniel J.; Wendl, Michael C.; Wheeler, David; Wilkerson, Matthew D.; Wilson, Richard K.; Wise, Lisa; Wong, Andrew; Wu, Chang-Jiun; Wu, Chia-Chin; Wu, Hsin-Ta; Wu, Junyuan; Wylie, Todd; Xi, Liu; Xi, Ruibin; Xia, Zheng; Xu, Andrew W.; Yang, Da; Yang, Liming; Yang, Lixing; Yang, Yang; Yao, Jun; Yao, Rong; Ye, Kai; Yoshihara, Kosuke; Yuan, Yuan; Yung, Alfred K.; Zack, Travis; Zeng, Dong; Zenklusen, Jean Claude; Zhang, Hailei; Zhang, Jianhua; Zhang, Nianxiang; Zhang, Qunyuan; Zhang, Wei; Zhao, Wei; Zheng, Siyuan; Zhu, Jing; Zmuda, Erik; Zou, Lihua		Canc Genome Atlas Res Network	Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin	CELL			English	Article							CELL LUNG-CANCER; MUTATIONS; CISPLATIN; MIGRATION; MODELS; GENES; HEAD	Recent genomic analyses of pathologically defined tumor types identify "within-a-tissue'' disease subtypes. However, the extent to which genomic signatures are shared across tissues is still unclear. We performed an integrative analysis using five genome-wide platforms and one proteomic platform on 3,527 specimens from 12 cancer types, revealing a unified classification into 11 major subtypes. Five subtypes were nearly identical to their tissue-oforigin counterparts, but several distinct cancer types were found to converge into common subtypes. Lung squamous, head and neck, and a subset of bladder cancers coalesced into one subtype typified by TP53 alterations, TP63 amplifications, and high expression of immune and proliferation pathway genes. Of note, bladder cancers split into three pancancer subtypes. The multiplatform classification, while correlated with tissue-of-origin, provides independent information for predicting clinical outcomes. All data sets are available for data-mining from a unified resource to support further biological discoveries and insights into novel therapeutic strategies.	[Hoadley, Katherine A.; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yau, Christina; Benz, Christopher C.] Buck Inst Res Aging, Novato, CA 94945 USA; [Wolf, Denise M.; van't Veer, Laura J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94115 USA; [Cherniack, Andrew D.] Harvard & MIT, Eli & Edythe Broad Inst, Cambridge, MA 02142 USA; [Tamborero, David; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona 08003, Spain; [Ng, Sam; Uzunangelov, Vladislav; Stuart, Joshua M.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Leiserson, Max D. M.; Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Leiserson, Max D. M.; Raphael, Benjamin J.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Niu, Beifang; McLellan, Michael D.; Kandoth, Cyriac; Ding, Li] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Zhang, Jiashan] NCI, NIH, Bethesda, MD 20892 USA; [Akbani, Rehan; Byers, Lauren A.; Mills, Gordon B.; Weinstein, John N.] UT MD Anderson Canc Ctr, Houston, TX 77030 USA; [Shen, Hui; Laird, Peter W.] Univ So Calif, Keck Sch Med, Epigenome Ctr, Los Angeles, CA 90033 USA; [Omberg, Larsson; Margolin, Adam A.] Sage Bionetworks, Seattle, WA 98109 USA; [Chu, Andy; Robertson, A. Gordon] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Lopez-Bigas, Nuria] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain; [Collisson, Eric A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94148 USA; [Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Van Waes, Carter] NIDCD, NIH, Bethesda, MD 20892 USA; [Chen, Zhong] NIDCD, NIH, Head & Neck Surg Branch, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; Buck Institute for Research on Aging; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pompeu Fabra University; University of California System; University of California Santa Cruz; Brown University; Brown University; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Southern California; British Columbia Cancer Agency; ICREA; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Benz, CC (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	cbenz@buckinstitute.org; cperou@med.unc.edu; jstuart@ucsc.edu	Ye, Kai/GSD-9856-2022; Laird, Peter W/G-8683-2012; Mardis, Elaine/W-2202-2019; Birol, Inanc/G-5440-2011; Kucherlapati, Raju/ABC-8807-2021; liu, ying/GXF-4294-2022; Han, Leng/HCH-3491-2022; Cherniack, Andrew D./AAY-8132-2020; N, Houtan/C-9692-2013; Drummond, Jennifer/AAG-1654-2020; Kim, Hoon/AAL-9283-2020; Perou, Charles M/H-9934-2014; Cherniack, Andrew/AAC-5310-2019; BERMAN, BENJAMIN/AAT-3720-2021; Cibulskis, Kristian/AAC-7380-2019; Salama, Sofie/K-6412-2019; Stojanov, Petar/GQI-4462-2022; Weisenberger, Daniel/AAA-8314-2020; Seth, Sahil/I-5809-2019; Xia, Zheng/AAC-5360-2022; Kalra, D/H-6661-2019; Yoshihara, Kosuke/AAU-9874-2020; Wu, Chia-Chin/ABD-5516-2021; Yuan, Yuan/H-4007-2013; Ladanyi, Marc/AAG-8585-2019; Lopez-Bigas, Nuria/F-6193-2011; Reva, Boris/AAB-8932-2022; Pedamallu, Chandra Sekhar/AAV-6723-2020; tamborero, david/M-5283-2015; Pedamallu, Chandra Sekhar/AAV-6745-2020; Gao, JianJiong/B-5673-2016; Schein, Jacquie E/G-3674-2015; Van Den Berg, David J/G-8598-2017; Akbani, Rehan/AAG-1490-2019; Lawrence, Michael/AAC-8202-2020; Magrini, Vincent/AAT-5830-2020; Schultz, Nikolaus/ABE-6347-2020; Parker, Joel/AAG-1108-2019; Verhaak, Roel/ABE-7058-2020; Skanderup, Anders Jacobsen/K-1081-2013; Mungall, Andrew J./U-7067-2018; Zheng, sy/GRS-3136-2022; Staudt, Louis/AAC-5324-2019; Wilson, Richard K./AAF-4139-2019; LIU, YING/GZL-7252-2022; Hirst, Martin/B-7684-2016; Jones, Steven J/C-3621-2009; Li, Jun/AAE-4393-2022; Marra, Marco A/B-5987-2008; Kahles, Andre/ABB-8343-2020; Gasull, Martina/J-4076-2019; Rätsch, Gunnar/O-5914-2017; Holt, Robert A/C-3303-2009; Shen, Hui/AAO-4387-2020; Li, Jun/O-9911-2014; Vaske, Charles/D-6018-2013	Ye, Kai/0000-0002-2851-6741; Laird, Peter W/0000-0001-9117-3641; Birol, Inanc/0000-0003-0950-7839; Han, Leng/0000-0002-7380-2640; Cherniack, Andrew D./0000-0003-0470-0111; N, Houtan/0000-0003-4051-8114; Drummond, Jennifer/0000-0002-2612-5958; Kim, Hoon/0000-0003-4244-6126; Perou, Charles M/0000-0001-9827-2247; BERMAN, BENJAMIN/0000-0002-2099-9005; Stojanov, Petar/0000-0001-7815-776X; Weisenberger, Daniel/0000-0001-8303-2603; Seth, Sahil/0000-0003-4579-3959; Xia, Zheng/0000-0003-3364-8324; Kalra, D/0000-0001-5254-4067; Yoshihara, Kosuke/0000-0002-2254-3378; Wu, Chia-Chin/0000-0002-5208-6016; Yuan, Yuan/0000-0003-4706-7897; Lopez-Bigas, Nuria/0000-0003-4925-8988; tamborero, david/0000-0002-7218-2806; Gao, JianJiong/0000-0002-5739-1781; Van Den Berg, David J/0000-0002-5404-5218; Magrini, Vincent/0000-0002-2019-4872; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Mungall, Andrew J./0000-0002-0905-2742; Wilson, Richard K./0000-0002-1992-1358; Jones, Steven J/0000-0003-3394-2208; Li, Jun/0000-0002-1171-7141; Marra, Marco A/0000-0001-7146-7175; Kahles, Andre/0000-0002-3411-0692; Rätsch, Gunnar/0000-0001-5486-8532; Holt, Robert A/0000-0002-7259-1247; Li, Jun/0000-0002-1171-7141; Triche, Tim/0000-0001-5665-946X; Hoadley, Katherine/0000-0002-1216-477X; Cho, Dongyeon/0000-0002-4421-9982; Ciriello, Giovanni/0000-0003-2021-8683; Cibulskis, Kristian/0000-0003-1343-1582; Przytycka, Teresa/0000-0002-6261-277X; doddapaneni, harshavardhan/0000-0002-2433-633X; Vaske, Charles/0000-0001-8151-6612; Pot, David/0000-0002-1480-9826; Chang, Kyle/0000-0001-5295-9676; Li, Wei/0000-0001-9931-5990; Weinstein, John/0000-0001-9401-6908; Lehmann, Kjong-Van/0000-0002-1936-298X; Sinha, Rileen/0000-0001-5497-5055; Benz, Stephen/0000-0002-4067-0602; Dobson, Jason/0000-0002-2306-2250; Freeman, Samuel/0000-0001-8285-0057; Shen, Hui/0000-0001-9767-4084; Davis, Caleb/0000-0002-5125-0494; Park, Peter/0000-0001-9378-960X; Salama, Sofie/0000-0001-6999-7193; Heiman, David/0000-0001-7895-4259; Omberg, Larsson/0000-0002-4719-9120; MCLELLAN, MICHAEL/0000-0002-2703-8784; Bowen, Jay/0000-0001-6861-9043; Kandoth, Cyriac/0000-0002-1345-3573; Fei, Suzanne/0000-0002-9688-2890; Rhie, Suhn/0000-0002-5522-5296; Levine, Douglas/0000-0003-1038-8232; Jensen, Mark/0000-0001-5215-101X; Gonzalez-Perez, Abel/0000-0002-8582-4660; Auman, James/0000-0002-9328-8829; Xi, Ruibin/0000-0001-7545-7361; Ou Yang, Tai-Hsien/0000-0001-9650-1253; Stuart, Joshua/0000-0002-2171-565X	Chapman Foundation; Dell Foundation; MD Anderson Physician Scientist Award; Burroughs Welcome Career Award at the Scientific Interface; United States National Institutes of Health [K08 CA137153, K08 CA176561, P50 CA083639, R01 CA071468, R01 HG005690, R01 HG007069, R01CA180006, R21 CA155679, U01 CA168394, U24 CA143867-05, U24 CA143883, U24 CA143848, U24 CA143858];  [U54 CA112970];  [U24 CA143799];  [U24 CA143835];  [U24 CA143840];  [U24 CA143843];  [U24 CA143845];  [U24 CA143866];  [U24 CA143867];  [U24 CA143882];  [U24 CA144025];  [U54 HG003273];  [U54 HG003067];  [U54 HG003079];  [ZIA-DC-000073];  [ZIA-DC-000074];  [P30 CA016672]; NATIONAL CANCER INSTITUTE [R21CA176561, P01CA101937, U24CA143835, R01CA071468, U24CA143883, P50CA098258, P30CA016672, U01CA168394, U24CA144025, P50CA100632, U24CA143840, U24CA143858, P01CA099031, R21CA155679, U24CA143882, U24CA143799, P30CA016056, R01CA180006, U24CA143843, U24CA143848, U54CA112970, U24CA143867, R01CA180778, P30CA016086, K08CA137153, P50CA083639, U24CA143866, U24CA180951, U24CA143845] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG003067, R01HG007069, U54HG003079, R01HG005690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000074, ZIADC000073] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Chapman Foundation; Dell Foundation; MD Anderson Physician Scientist Award; Burroughs Welcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); ICREA(ICREA)	We thank the thousands of patients and their loved ones who contributed materially, emotionally, and intellectually to this study. We thank D. A. Wheeler and M. L. Meyerson for scientific review of the work and M. P. Schroeder for help setting up Gitools. We thank K. R. Shaw, B. A. Ozenberger, H.J. Sofia, C. M. Hutter, and J.C. Zenklusen for administrative support. This work was supported by grants from the Chapman Foundation and Dell Foundation to J.N.W., a MD Anderson Physician Scientist Award to L. A. B., a Burroughs Welcome Career Award at the Scientific Interface to B. J. R., and support from the following grants from the United States National Institutes of Health: K08 CA137153, K08 CA176561, P50 CA083639, R01 CA071468, R01 HG005690, R01 HG007069, R01CA180006, R21 CA155679, U01 CA168394, U24 CA143858, U24 CA143867-05, U24 CA143883, U24 CA143848, U24 CA143858, U24 CA143866, U54 CA112970, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, U54 HG003273, U54 HG003067, U54 HG003079, ZIA-DC-000073, ZIA-DC-000074, and P30 CA016672 for the MD Anderson CCSG Functional Proteomics Core.	Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhattacharya A, 2011, CLIN CANCER RES, V17, P7024, DOI 10.1158/1078-0432.CCR-11-1944; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Grilley-Olson JE, 2013, ARCH PATHOL LAB MED, V137, P32, DOI 10.5858/arpa.2012-0033-OA; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Herzog A, 2013, CLIN CANCER RES, V19, P3808, DOI 10.1158/1078-0432.CCR-12-2716; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lu H, 2011, CANCER RES, V71, P6867, DOI 10.1158/0008-5472.CAN-11-2460; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; Martinez E, 2014, ONCOGENE; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ng S, 2012, BIOINFORMATICS, V28, pI640, DOI 10.1093/bioinformatics/bts402; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Vandin F, 2012, BIOCOMPUT-PAC SYM, P55; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Willis DL, 2013, CURR OPIN UROL, V23, P435, DOI 10.1097/MOU.0b013e328363e415; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445	39	905	931	5	162	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					929	944		10.1016/j.cell.2014.06.049	http://dx.doi.org/10.1016/j.cell.2014.06.049			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25109877	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000340944700021
J	Lisewski, AM; Quiros, JP; Ng, CL; Adikesavan, AK; Miura, K; Putluri, N; Eastman, RT; Scanfeld, D; Regenbogen, SJ; Altenhofen, L; Llinas, M; Sreekumar, A; Long, C; Fidock, DA; Lichtarge, O				Lisewski, Andreas Martin; Quiros, Joel P.; Ng, Caroline L.; Adikesavan, Anbu Karani; Miura, Kazutoyo; Putluri, Nagireddy; Eastman, Richard T.; Scanfeld, Daniel; Regenbogen, Sam J.; Altenhofen, Lindsey; Llinas, Manuel; Sreekumar, Arun; Long, Carole; Fidock, David A.; Lichtarge, Olivier			Supergenomic Network Compression and the Discovery of EXP1 as a Glutathione Transferase Inhibited by Artesunate	CELL			English	Article							PLASMODIUM-FALCIPARUM; PROTEIN FUNCTION; OXIDATIVE STRESS; BLOOD STAGES; ARTEMISININ; SEQUENCE; PREDICTION; MECHANISM; ASSOCIATION; SENSITIVITY	A central problem in biology is to identify gene function. One approach is to infer function in large supergenomic networks of interactions and ancestral relationships among genes; however, their analysis can be computationally prohibitive. We show here that these biological networks are compressible. They can be shrunk dramatically by eliminating redundant evolutionary relationships, and this process is efficient because in these networks the number of compressible elements rises linearly rather than exponentially as in other complex networks. Compression enables global network analysis to computationally harness hundreds of interconnected genomes and to produce functional predictions. As a demonstration, we show that the essential, but functionally uncharacterized Plasmodium falciparum antigen EXP1 is a membrane glutathione S-transferase. EXP1 efficiently degrades cytotoxic hematin, is potently inhibited by artesunate, and is associated with artesunate metabolism and susceptibility in drug-pressured malaria parasites. These data implicate EXP1 in the mode of action of a frontline antimalarial drug.	[Lisewski, Andreas Martin; Adikesavan, Anbu Karani; Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lisewski, Andreas Martin; Lichtarge, Olivier] Baylor Coll Med, Computat & Integrat Biomed Res Ctr, Houston, TX 77030 USA; [Quiros, Joel P.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Adikesavan, Anbu Karani; Putluri, Nagireddy; Sreekumar, Arun] Baylor Coll Med, Dept Cell & Mol Biol, Houston, TX 77030 USA; [Putluri, Nagireddy; Sreekumar, Arun; Lichtarge, Olivier] Baylor Coll Med, Verna & Marrs McLean Dept Biochem, Houston, TX 77030 USA; [Putluri, Nagireddy; Sreekumar, Arun; Lichtarge, Olivier] Baylor Coll Med, Alkek Ctr Mol Discovery, Houston, TX 77030 USA; [Sreekumar, Arun] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Regenbogen, Sam J.; Lichtarge, Olivier] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Ng, Caroline L.; Eastman, Richard T.; Scanfeld, Daniel; Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA; [Miura, Kazutoyo; Eastman, Richard T.; Long, Carole] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Altenhofen, Lindsey; Llinas, Manuel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Altenhofen, Lindsey; Llinas, Manuel] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Altenhofen, Lindsey; Llinas, Manuel] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16802 USA; [Altenhofen, Lindsey; Llinas, Manuel] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16802 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Lisewski, AM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	lisewski@bcm.edu; lichtarge@bcm.edu	Miura, Kazutoyo/AAY-9751-2020; Regenbogen, Sam/AAP-7690-2020	Miura, Kazutoyo/0000-0003-4455-2432; Putluri, Nagireddy/0000-0003-4488-7400; Regenbogen, Sam/0000-0002-8588-4911; Fidock, David/0000-0001-6753-8938	NIH [GM066099, GM079656, AI50234, AI109023]; NSF [CCF-0905536, DBI-1062455]; Alkek CMD Grants; Divisions of Intramural Research at the National Institute of Allergy and Infectious Diseases, National Institutes of Health; Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Disease Grant; NIH Director's New Innovators award [1DP2OD001315-01]; Centre for Quantitative Biology [P50 GM071508]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109023, R01AI050234, ZIAAI001020, R37AI050234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079656, P50GM071508, R01GM066099] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001315] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1356569] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Alkek CMD Grants; Divisions of Intramural Research at the National Institute of Allergy and Infectious Diseases, National Institutes of Health; Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Disease Grant; NIH Director's New Innovators award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre for Quantitative Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support came from NIH GM066099 and GM079656 and NSF CCF-0905536, DBI-1062455 (to O.L.) and from NIH AI50234 and AI109023 (to D. A. F.). N.P. and A.S. were supported by Alkek CMD Grants. K.M., R.E., and C.L. were supported by the Divisions of Intramural Research at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. M.L. is funded through a Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Disease Grant and an NIH Director's New Innovators award (1DP2OD001315-01) with generous support from the Centre for Quantitative Biology (P50 GM071508). The authors gratefully acknowledge comments and help from Dr. Theodore Wensel, Dr. Christophe Herman, Dr. Timothy Palzkill, Dr. Santha Kumar, and Dr. David Marciano.	Abu Bakar N, 2010, J CELL SCI, V123, P441, DOI 10.1242/jcs.061499; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cardi D, 2010, J BIOL CHEM, V285, P26406, DOI 10.1074/jbc.M109.090340; CASPERS P, 1991, MOL BIOCHEM PARASIT, V47, P143, DOI 10.1016/0166-6851(91)90173-4; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Chugh M, 2013, P NATL ACAD SCI USA, V110, P5392, DOI 10.1073/pnas.1218412110; Deponte M, 2005, METHOD ENZYMOL, V401, P241, DOI 10.1016/S0076-6879(05)01015-3; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Gruring C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1169; Habig M, 2009, J BIOMOL SCREEN, V14, P679, DOI 10.1177/1087057109336586; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; HOPE IA, 1984, NATURE, V308, P191, DOI 10.1038/308191a0; HOPE IA, 1985, NUCLEIC ACIDS RES, V13, P369, DOI 10.1093/nar/13.2.369; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Klonis N, 2013, CURR OPIN MICROBIOL, V16, P722, DOI 10.1016/j.mib.2013.07.005; Klonis N, 2013, P NATL ACAD SCI USA, V110, P5157, DOI 10.1073/pnas.1217452110; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Lam BK, 1997, J BIOL CHEM, V272, P13923, DOI 10.1074/jbc.272.21.13923; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Melvin I, 2009, BIOINFORMATICS, V25, P121, DOI 10.1093/bioinformatics/btn567; Meraldi V, 2004, PARASITE IMMUNOL, V26, P265, DOI 10.1111/j.0141-9838.2004.00705.x; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Morgenstern R, 2011, DRUG METAB REV, V43, P300, DOI 10.3109/03602532.2011.558511; Mukanganyama S, 2001, FREE RADICAL RES, V35, P427, DOI 10.1080/10715760100300941; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Ochoa A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-90; OEXLE K, 1995, PHYS REV E, V51, P2651, DOI 10.1103/PhysRevE.51.2651; Park DJ, 2012, P NATL ACAD SCI USA, V109, P13052, DOI 10.1073/pnas.1210585109; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; SIMMONS D, 1987, EMBO J, V6, P485, DOI 10.1002/j.1460-2075.1987.tb04779.x; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, P816, DOI 10.1093/nar/gki233; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Teuscher F, 2012, ANTIMICROB AGENTS CH, V56, P428, DOI 10.1128/AAC.05456-11; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Venner E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014286; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wang B, 2009, J CENT SOUTH UNIV T, V16, P474, DOI 10.1007/s11771-009-0079-2; Witkowski B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032620; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09; World Health Organization, 2011, GUID TREATM MAL; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	55	81	88	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					916	928		10.1016/j.cell.2014.07.011	http://dx.doi.org/10.1016/j.cell.2014.07.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126794	Bronze, Green Accepted			2022-12-24	WOS:000340944700020
J	Xue, MS; Atallah, BV; Scanziani, M				Xue, Mingshan; Atallah, Bassam V.; Scanziani, Massimo			Equalizing excitation-inhibition ratios across visual cortical neurons	NATURE			English	Article							RECTIFYING POTASSIUM CHANNELS; IN-VIVO ELECTROPORATION; NETWORK ACTIVITY; GENE-TRANSFER; CORTEX; MOUSE; CHANNELRHODOPSIN-2; CONNECTIVITY; INTERNEURONS; MODULATION	The relationship between synaptic excitation and inhibition (E/I ratio), two opposing forces in the mammalian cerebral cortex, affects many cortical functions such as feature selectivity and gain(1,2). Individual pyramidal cells show stable E/I ratios in time despite fluctuating cortical activity levels. This is because when excitation increases, inhibition increases proportionally through the increased recruitment of inhibitory neurons, a phenomenon referred to as excitation-inhibition balance(3-9). However, little is known about the distribution of E/I ratios across pyramidal cells. Through their highly divergent axons, inhibitory neurons indiscriminately contact most neighbouring pyramidal cells(10,11). Is inhibition homogeneously distributed(12) or is it individually matched to the different amounts of excitation received by distinct pyramidal cells? Here we discover that pyramidal cells in layer 2/3 of mouse primary visual cortex each receive inhibition in a similar proportion to their excitation. As a consequence, E/I ratios are equalized across pyramidal cells. This matched inhibition is mediated by parvalbumin-expressing but not somatostatin-expressing inhibitory cells and results from the independent adjustment of synapses originating from individual parvalbumin-expressing cells targeting different pyramidal cells. Furthermore, this match is activity-dependent as it is disrupted by perturbing pyramidal cell activity. Thus, the equalization of E/I ratios across pyramidal cells reveals an unexpected degree of order in the spatial distribution of synaptic strengths and indicates that the relationship between the cortex's two opposing forces is stabilized not only in time but also in space.	[Xue, Mingshan; Scanziani, Massimo] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Xue, Mingshan; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Atallah, Bassam V.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal; [Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Fundacao Champalimaud; Howard Hughes Medical Institute; University of California System; University of California San Diego	Xue, MS (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	mingshanxue@gmail.com; massimo@ucsd.edu		Atallah, Bassam/0000-0003-2315-7126; Xue, Mingshan/0000-0003-1463-8884	Jane Coffin Childs Memorial Fund for Medical Research; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Chan, J. Evora, A. Linder and P. Abelkop for technical assistance; M. S. Caudill and S. R. Olsen for help with the in vivo physiology recording programme; E. Kim and A. Ghosh for pCAG-Kir2.1-T2A-tdTomato plasmid; J. Isaacson and H. Y. Zoghbi for comments on earlier versions of the manuscript; D. N. Hill, G. I. Allen, E. Arias-Castro and M. Wang for advice on statistical analysis; the members of the Scanziani and Isaacson laboratories for suggestions; and the University of California, San Diego Neuroscience Microscopy Facility (P30 N5047101) for imaging equipment. M.X. was supported by a fellowship from Jane Coffin Childs Memorial Fund for Medical Research. M.S. is an investigator of the Howard Hughes Medical Institute. This work was also supported by the Gatsby Charitable Foundation.	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Benedetti BL, 2013, CEREB CORTEX, V23, P2690, DOI 10.1093/cercor/bhs257; Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Peng YR, 2010, J NEUROSCI, V30, P16220, DOI 10.1523/JNEUROSCI.3085-10.2010; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sim SY, 2013, J NEUROSCI, V33, P7928, DOI 10.1523/JNEUROSCI.1571-12.2013; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Tong YH, 2001, J GEN PHYSIOL, V117, P103, DOI 10.1085/jgp.117.2.103; Turan S, 2010, J MOL BIOL, V402, P52, DOI 10.1016/j.jmb.2010.07.015; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699	50	384	387	4	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					596	+		10.1038/nature13321	http://dx.doi.org/10.1038/nature13321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043046	Green Accepted			2022-12-24	WOS:000339566300036
J	Zhou, W; Yuan, JY				Zhou, Wen; Yuan, Junying			SnapShot: Necroptosis	CELL			English	Editorial Material									[Zhou, Wen; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Zhou, W (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.							Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Zhou ZR, 2012, PROTEIN CELL, V3, P811, DOI 10.1007/s13238-012-2083-9	3	48	51	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					464	U262		10.1016/j.cell.2014.06.041	http://dx.doi.org/10.1016/j.cell.2014.06.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036639	Bronze			2022-12-24	WOS:000340943600025
J	Soroldoni, D; Jorg, DJ; Morelli, LG; Richmond, DL; Schindelin, J; Julicher, F; Oates, AC				Soroldoni, Daniele; Joerg, David J.; Morelli, Luis G.; Richmond, David L.; Schindelin, Johannes; Juelicher, Frank; Oates, Andrew C.			A Doppler effect in embryonic pattern formation	SCIENCE			English	Article							SEGMENTATION CLOCK; VERTEBRATE SEGMENTATION; DYNAMICS; SOMITOGENESIS	During embryonic development, temporal and spatial cues are coordinated to generate a segmented body axis. In sequentially segmenting animals, the rhythm of segmentation is reported to be controlled by the time scale of genetic oscillations that periodically trigger new segment formation. However, we present real-time measurements of genetic oscillations in zebrafish embryos showing that their time scale is not sufficient to explain the temporal period of segmentation. A second time scale, the rate of tissue shortening, contributes to the period of segmentation through a Doppler effect. This contribution is modulated by a gradual change in the oscillation profile across the tissue. We conclude that the rhythm of segmentation is an emergent property controlled by the time scale of genetic oscillations, the change of oscillation profile, and tissue shortening.	[Soroldoni, Daniele; Morelli, Luis G.; Richmond, David L.; Schindelin, Johannes; Oates, Andrew C.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Soroldoni, Daniele; Oates, Andrew C.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Soroldoni, Daniele; Oates, Andrew C.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Joerg, David J.; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Morelli, Luis G.] Univ Buenos Aires, Dept Fis, Fac Ciencias Exactas & Nat, RA-1428 Buenos Aires, DF, Argentina; [Morelli, Luis G.] Consejo Nacl Invest Cient & Tecn, Inst Fis Buenos Aires, RA-1428 Buenos Aires, DF, Argentina; [Schindelin, Johannes] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI 53706 USA	Max Planck Society; MRC National Institute for Medical Research; University of London; University College London; Max Planck Society; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Wisconsin System; University of Wisconsin Madison	Oates, AC (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	aoates@nimr.mrc.ac.uk	Jörg, David/I-3905-2012; Julicher, Frank/B-1828-2009; Zebrafish, UCL/A-3125-2009; Morelli, Luis G/A-6345-2009	Jörg, David/0000-0001-5960-0260; Julicher, Frank/0000-0003-4731-9185; Morelli, Luis G/0000-0001-5614-073X; Oates, Andrew/0000-0002-3015-3978	Max Planck Society; Medical Research Council [MC_UP_1202/3]; European Research Council (ERC) under European Communities 7th Framework Programme [207634]; European Molecular Biology Organization fellowship [ALTF1402-2011]; Wellcome Trust [WT098025MA]; MRC [MC_UP_1202/3] Funding Source: UKRI	Max Planck Society(Max Planck SocietyFoundation CELLEX); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council (ERC) under European Communities 7th Framework Programme(European Research Council (ERC)); European Molecular Biology Organization fellowship(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Wetzel, L. Rohde, C. Poulet, C. Eugster, M. Gonzales-Gaitan, and J. Firmino, for comments on the manuscript; D. Hasselhoff for mental support; and the fish and light microscopy facilities of the Max Planck Institute of Molecular Cell Biology and Genetics. This work was supported by the Max Planck Society and the Medical Research Council (MC_UP_1202/3); D. S., L. G. M., and A.C.O. by the European Research Council (ERC) under the European Communities 7th Framework Programme (FP7/2007-2013)/(ERC grant 207634); D. L. R. by a European Molecular Biology Organization fellowship [ALTF1402-2011]; and A.C.O. and D. S. by the Wellcome Trust (WT098025MA). The original time-lapse recordings in this study are available for anonymous download via the Web site www.nimr.mrc.ac.uk/supplementary/oaties. The ROI and LOI are available as plugins via the Fiji website www.fiji.sc/Fiji. D. S., D. J. J., L. G. M., and A.C.O. designed experiments; D. S. performed experiments; J. S. developed analysis tools; D. S., D. J. J., L. G. M., F. J., and A.C.O. analyzed data; D. S., D. J. J., D. L. R., L. G. M., F. J., and A.C.O. developed the concepts and wrote the paper.	Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Benazeraf B, 2013, ANNU REV CELL DEV BI, V29, P1, DOI 10.1146/annurev-cellbio-101011-155703; Delaune EA, 2012, DEV CELL, V23, P995, DOI 10.1016/j.devcel.2012.09.009; Giudicelli F, 2007, PLOS BIOL, V5, P1309, DOI 10.1371/journal.pbio.0050150; Lauschke VM, 2013, NATURE, V493, P101, DOI 10.1038/nature11804; Mara A, 2007, NAT CELL BIOL, V9, P523, DOI 10.1038/ncb1578; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; Soroldoni D, 2011, CURR OPIN GENET DEV, V21, P600, DOI 10.1016/j.gde.2011.09.006	13	75	75	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					222	225		10.1126/science.1253089	http://dx.doi.org/10.1126/science.1253089			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013078	Green Accepted			2022-12-24	WOS:000339409900056
J	Tian, XY; Hu, TY; Zhang, H; He, LJ; Huang, XZ; Liu, QZ; Yu, W; He, L; Yang, Z; Yan, Y; Yang, X; Zhong, TP; Pu, WT; Zhou, B				Tian, Xueying; Hu, Tianyuan; Zhang, Hui; He, Lingjuan; Huang, Xiuzhen; Liu, Qiaozhen; Yu, Wei; He, Liang; Yang, Zhen; Yan, Yan; Yang, Xiao; Zhong, Tao P.; Pu, William T.; Zhou, Bin			De novo formation of a distinct coronary vascular population in neonatal heart	SCIENCE			English	Article							ENDOTHELIAL-CELLS; ENDOCARDIAL CELLS; ARTERIES; FORM; BIOLOGY	The postnatal coronary vessels have been viewed as developing through expansion of vessels formed during the fetal period. Using genetic lineage tracing, we found that a substantial portion of postnatal coronary vessels arise de novo in the neonatal mouse heart, rather than expanding from preexisting embryonic vasculature. Our data show that lineage conversion of neonatal endocardial cells during trabecular compaction generates a distinct compartment of the coronary circulation located within the inner half of the ventricular wall. This lineage conversion occurs within a brief period after birth and provides an efficient means of rapidly augmenting the coronary vasculature. This mechanism of postnatal coronary vascular growth provides avenues for understanding and stimulating cardiovascular regeneration following injury and disease.	[Tian, Xueying; Hu, Tianyuan; Zhang, Hui; He, Lingjuan; Huang, Xiuzhen; Liu, Qiaozhen; Yu, Wei; He, Liang; Zhou, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai 200031, Peoples R China; [Yang, Zhen; Yan, Yan] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China; [Yang, Xiao] Inst Biotechnol, State Key Lab Prote, Beijing 100071, Peoples R China; [Zhong, Tao P.] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Pu, William T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University; Harvard University; Harvard University; Boston Children's Hospital	Zhou, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai 200031, Peoples R China.	zhoubin@sibs.ac.cn	Pu, William/AAJ-8301-2020	Pu, William/0000-0002-4551-8079; Zhou, Bin/0000-0001-5278-5522	National Basic Research Program of China [2012CB945102, 2013CB945302]; National Natural Science Foundation of China [91339104, 31271552, 31222038, 31301188]; Chinese Academy of Sciences [KSCX2-EW-R-09]; Shanghai Pujiang Program [11PJ1411400]; Basic Research Key Project [14JC1407400]; Organization Department of the CPC Central Committee Bajian Talents Program; AstraZeneca; Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship; NIH [2 R01 HL094683]; American Heart Association Established Investigator Award;  [SIBS-2013KIP311];  [2013M541561]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116461, R01HL094683] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program); Basic Research Key Project; Organization Department of the CPC Central Committee Bajian Talents Program; AstraZeneca(AstraZeneca); Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Red-Horse, Y. Chen, and N. Jin for insightful discussions and R. Adams, H. Zeng, Z. Yang, T. Quertermous, J. Rossant, and A. Nagy for mouse strains. This work was supported by National Basic Research Program of China (2012CB945102 and 2013CB945302), National Natural Science Foundation of China (91339104, 31271552, 31222038, 31301188), Chinese Academy of Sciences (Hundred Talents Program and KSCX2-EW-R-09), Shanghai Pujiang Program (11PJ1411400) and Basic Research Key Project (14JC1407400), Organization Department of the CPC Central Committee Bajian Talents Program, AstraZeneca, Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) Fellowship, Postdoc Fund (SIBS-2013KIP311, China-2013M541561), NIH (2 R01 HL094683), and American Heart Association Established Investigator Award to W.T.P.	Bennett HS, 1936, AM J ANAT, V60, P27, DOI 10.1002/aja.1000600103; del Monte G, 2012, CELL, V151, P932, DOI 10.1016/j.cell.2012.11.004; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Riley P, 2010, NATURE, V464, P498, DOI 10.1038/464498a; Riley PR, 2011, CARDIOVASC RES, V91, P260, DOI 10.1093/cvr/cvr035; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Yi BA, 2010, J CLIN INVEST, V120, P20, DOI 10.1172/JCI40820; Zhou B, 2005, DEVELOPMENT, V132, P1137, DOI 10.1242/dev.01640	14	131	142	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					90	94		10.1126/science.1251487	http://dx.doi.org/10.1126/science.1251487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994653	Green Accepted			2022-12-24	WOS:000338284400057
J	Victor, DG; Gerlagh, R; Baiocchi, G				Victor, David G.; Gerlagh, Reyer; Baiocchi, Giovanni			Getting serious about categorizing countries	SCIENCE			English	Editorial Material									[Victor, David G.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Gerlagh, Reyer] Tilburg Univ, NL-5037 AB Tilburg, Netherlands; [Baiocchi, Giovanni] Univ Maryland, College Pk, MD 20742 USA; Ctr Policy Res, New Delhi 110021, DL, India; Princeton Univ, Princeton, NJ 08544 USA; Stockholm Environm Inst, S-10451 Stockholm, Sweden; Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; Mercator Res Inst Global Commons & Climate Change, D-10829 Berlin, Germany	University of California System; University of California San Diego; Tilburg University; University System of Maryland; University of Maryland College Park; Princeton University; Stockholm Environment Institute; Potsdam Institut fur Klimafolgenforschung	Victor, DG (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.		baiocchi, giovanni/AAN-4104-2021	baiocchi, giovanni/0000-0002-0319-7561; Gerlagh, Reyer/0000-0001-9781-9212					0	28	28	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					34	36		10.1126/science.1255302	http://dx.doi.org/10.1126/science.1255302			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2XU	24994638				2022-12-24	WOS:000338284400037
J	Jais, A; Einwallner, E; Sharif, O; Gossens, K; Lu, TTH; Soyal, SM; Medgyesi, D; Neureiter, D; Paier-Pourani, J; Dalgaard, K; Duvigneau, JC; Lindroos-Christensen, J; Zapf, TC; Amann, S; Saluzzo, S; Jantscher, F; Stiedl, P; Todoric, J; Martins, R; Oberkofler, H; Muller, S; Hauser-Kronberger, C; Kenner, L; Casanova, E; Sutterluty-Fall, H; Bilban, M; Miller, K; Kozlov, AV; Krempler, F; Knapp, S; Lumeng, CN; Patsch, W; Wagner, O; Pospisilik, JA; Esterbauer, H				Jais, Alexander; Einwallner, Elisa; Sharif, Omar; Gossens, Klaus; Lu, Tess Tsai-Hsiu; Soyal, Selma M.; Medgyesi, David; Neureiter, Daniel; Paier-Pourani, Jamile; Dalgaard, Kevin; Duvigneau, J. Catharina; Lindroos-Christensen, Josefine; Zapf, Thea-Christin; Amann, Sabine; Saluzzo, Simona; Jantscher, Florian; Stiedl, Patricia; Todoric, Jelena; Martins, Rui; Oberkofler, Hannes; Mueller, Simone; Hauser-Kronberger, Cornelia; Kenner, Lukas; Casanova, Emilio; Sutterluety-Fall, Hedwig; Bilban, Martin; Miller, Karl; Kozlov, Andrey V.; Krempler, Franz; Knapp, Sylvia; Lumeng, Carey N.; Patsch, Wolfgang; Wagner, Oswald; Pospisilik, J. Andrew; Esterbauer, Harald			Heme Oxygenase-1 Drives Metaflammation and Insulin Resistance in Mouse and Man	CELL			English	Article							ADIPOSE-TISSUE; UP-REGULATION; IKK-BETA; MACROPHAGE POLARIZATION; MITOCHONDRIAL-FUNCTION; COBALT PROTOPORPHYRIN; METABOLIC HOMEOSTASIS; GENE-EXPRESSION; OBESITY; INFLAMMATION	Obesity and diabetes affect more than half a billion individuals worldwide. Interestingly, the two conditions do not always coincide and the molecular determinants of "healthy" versus "unhealthy" obesity remain ill-defined. Chronic metabolic inflammation (metaflammation) is believed to be pivotal. Here, we tested a hypothesized anti-inflammatory role for heme oxygenase-1 (HO-1) in the development of metabolic disease. Surprisingly, in matched biopsies from "healthy" versus insulin-resistant obese subjects we find HO-1 to be among the strongest positive predictors of metabolic disease in humans. We find that hepatocyte and macrophage conditional HO-1 deletion in mice evokes resistance to diet-induced insulin resistance and inflammation, dramatically reducing secondary disease such as steatosis and liver toxicity. Intriguingly, cellular assays show that HO-1 defines prestimulation thresholds for inflammatory skewing and NF-kappa B amplification in macrophages and for insulin signaling in hepatocytes. These findings identify HO-1 inhibition as a potential therapeutic strategy for metabolic disease.	[Jais, Alexander; Einwallner, Elisa; Sharif, Omar; Lindroos-Christensen, Josefine; Zapf, Thea-Christin; Amann, Sabine; Saluzzo, Simona; Jantscher, Florian; Todoric, Jelena; Martins, Rui; Kenner, Lukas; Casanova, Emilio; Sutterluety-Fall, Hedwig; Bilban, Martin; Knapp, Sylvia; Wagner, Oswald; Esterbauer, Harald] Med Univ Vienna, A-1090 Vienna, Austria; [Sharif, Omar; Saluzzo, Simona; Martins, Rui; Knapp, Sylvia] Austrian Acad Sci, Res Ctr Mol Med, CeMM, A-1090 Vienna, Austria; [Gossens, Klaus; Lu, Tess Tsai-Hsiu; Medgyesi, David; Dalgaard, Kevin; Pospisilik, J. Andrew] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Soyal, Selma M.; Neureiter, Daniel; Oberkofler, Hannes; Hauser-Kronberger, Cornelia; Patsch, Wolfgang] Paracelsus Med Univ, A-5020 Salzburg, Austria; [Medgyesi, David] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Paier-Pourani, Jamile; Kozlov, Andrey V.] Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria; [Duvigneau, J. Catharina; Mueller, Simone; Kenner, Lukas] Univ Vet Med Vienna, A-1210 Vienna, Austria; [Stiedl, Patricia; Kenner, Lukas; Casanova, Emilio] Ludwig Boltzmann Inst Canc Res, A-1090 Vienna, Austria; [Miller, Karl; Krempler, Franz] Gen Hosp Hallein, A-5400 Hallein, Austria; [Lumeng, Carey N.] Univ Michigan, Ann Arbor, MI 48109 USA	Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Max Planck Society; Paracelsus Private Medical University; University of Freiburg; Ludwig Boltzmann Institute; University of Veterinary Medicine Vienna; Ludwig Boltzmann Institute; University of Michigan System; University of Michigan	Pospisilik, JA (corresponding author), Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.	pospisilik@ie-freiburg.mpg.de; harald.esterbauer@meduniwien.ac.at	Jais, Alexander/AAQ-9102-2021; Martins, Rui/M-9606-2016; Duvigneau, J. Catharina/AAE-6992-2019; Knapp, Sylvia/J-3973-2013; Casanova, Emilio/Y-6553-2019	Jais, Alexander/0000-0002-9897-4983; Martins, Rui/0000-0001-8106-6324; Knapp, Sylvia/0000-0001-9016-5244; Casanova, Emilio/0000-0001-7992-5361; Sutterluty-Fall, Hedwig/0000-0001-9249-9299; Kozlov, Andrey/0000-0002-0834-4997; Bilban, Martin/0000-0001-7043-7142; Sharif, Omar/0000-0001-7899-2343; Esterbauer, Harald/0000-0001-7343-7455; Duvigneau, Johanna Catharina/0000-0002-2433-3120; Kenner, Lukas/0000-0003-2184-1338; Saluzzo, Simona/0000-0003-2675-4014	Vienna Science and Technology Fund; Max-Planck Society; Austrian Diabetes Association; Medical Scientific Fund of the Mayor of the City of Vienna; Osterreichische Gesellschaft fur Laboratoriumsmedizin und Klinische Chemie; National Institutes of Health [DK090262]; Austrian Science Fund (FWF) [V 344] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090262] Funding Source: NIH RePORTER	Vienna Science and Technology Fund; Max-Planck Society(Max Planck Society); Austrian Diabetes Association; Medical Scientific Fund of the Mayor of the City of Vienna; Osterreichische Gesellschaft fur Laboratoriumsmedizin und Klinische Chemie; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Vienna Science and Technology Fund (J.A.P. and H.E.), the Max-Planck Society (J.A.P.), the Austrian Diabetes Association (H.E.), the Medical Scientific Fund of the Mayor of the City of Vienna (E.E.), the Osterreichische Gesellschaft fur Laboratoriumsmedizin und Klinische Chemie (E.E.), and a grant from the National Institutes of Health (DK090262, C.N.L.). The authors are grateful to J. Husa, J. Kacerovsky, I. Miller, G. Mitterer, M. Ozsvar Kozma, and M. Ruf for critical technical and theoretical help.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Burcelin R, 2012, SEMIN IMMUNOL, V24, P67, DOI 10.1016/j.smim.2011.11.011; Calay ES, 2013, NAT MED, V19, P265, DOI 10.1038/nm.3114; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055369; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Koliaraki V, 2011, ADV EXP MED BIOL, V780, P101, DOI 10.1007/978-1-4419-5632-3_9; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Liu XF, 2013, UNIVERSITAS-TAIWAN, V40, P1; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE1029, DOI 10.1152/ajpendo.90241.2008; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Qatanani M, 2013, DIABETES, V62, P855, DOI 10.2337/db12-0399; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shakeri-Manesch S, 2009, INT J OBESITY, V33, P1257, DOI 10.1038/ijo.2009.160; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Tzima S, 2009, J EXP MED, V206, P1167, DOI 10.1084/jem.20081582; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zheng JY, 2008, MOL CELL BIOCHEM, V319, P153, DOI 10.1007/s11010-008-9888-0	59	190	194	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					25	40		10.1016/j.cell.2014.04.043	http://dx.doi.org/10.1016/j.cell.2014.04.043			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995976	Green Accepted, Bronze			2022-12-24	WOS:000340943100005
J	Jomelli, V; Favier, V; Vuille, M; Braucher, R; Martin, L; Blard, PH; Colose, C; Brunstein, D; He, F; Khodri, M; Bourles, DL; Leanni, L; Rinterknecht, V; Grancher, D; Francou, B; Ceballos, JL; Fonseca, H; Liu, Z; Otto-Bliesner, BL				Jomelli, V.; Favier, V.; Vuille, M.; Braucher, R.; Martin, L.; Blard, P. -H.; Colose, C.; Brunstein, D.; He, F.; Khodri, M.; Bourles, D. L.; Leanni, L.; Rinterknecht, V.; Grancher, D.; Francou, B.; Ceballos, J. L.; Fonseca, H.; Liu, Z.; Otto-Bliesner, B. L.			A major advance of tropical Andean glaciers during the Antarctic cold reversal	NATURE			English	Article							PERUVIAN ANDES; BE-10; CLIMATE; SURFACE; RATES; AGE; FLUCTUATIONS; GLACIATION; INTENSITY; ATLANTIC	The Younger Dryas stadial, a cold event spanning 12,800 to 11,500 years ago, during the last deglaciation, is thought to coincide with the last major glacial re-advance in the tropical Andes(1). This interpretation relies mainly on cosmic-ray exposure dating of glacial deposits. Recent studies, however, have established new production rates' for cosmogenic Be-10 and He-3, which make it necessary to update all chronologies in this region(1,5-15) and revise our understanding of cryospheric responses to climate variability. Here we present a new Be-10 moraine chronology in Colombia showing that glaciers in the northern tropical Andes expanded to a larger extent during the Antarctic cold reversal (14,500 to 12,900 years ago) than during the Younger Dryas. On the basis of a homogenized chronology of all Be-10 and He-3 moraine ages across the tropical Andes, we show that this behaviour was common to the northern and southern tropical Andes. Transient simulations with a coupled global climate model suggest that the common glacier behaviour was the result of Atlantic meridional overturning circulation variability superimposed on a deglacial increase in the atmospheric carbon dioxide concentration. During the Antarctic cold reversal, glaciers advanced primarily in response to cold sea surface temperatures over much of the Southern Hemisphere. During the Younger Dryas, however, northern tropical Andes glaciers retreated owing to abrupt regional warming in response to reduced precipitation and land-surface feedbacks triggered by a weakened Atlantic meridional overturning circulation. Conversely, glacier retreat during the Younger Dryas in the southern tropical Andes occurred as a result of progressive warming, probably influenced by an increase in atmospheric carbon dioxide. Considered with evidence from mid-latitude Andean glaciers(16), our results argue for a common glacier response to cold conditions in the Antarctic cold reversal exceeding that of the Younger Dryas.	[Jomelli, V.; Brunstein, D.; Grancher, D.] Univ Paris 01, CNRS, Lab Geog Phys, F-92195 Meudon, France; [Favier, V.] Univ Grenoble Alpes, LGGE, UMR 5183, F-38041 Grenoble, France; [Vuille, M.; Colose, C.] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA; [Braucher, R.; Bourles, D. L.; Leanni, L.] Aix Marseille Univ, CNRS, Coll France, IRD,CEREGE,UM34, F-13545 Aix En Provence, France; [Martin, L.; Blard, P. -H.] Univ Lorraine, UMR 7358, CNRS, Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; [He, F.] Univ Wisconsin, Nelson Inst Environm Studies, Ctr Climat Res, Madison, WI 53706 USA; [Khodri, M.] Univ Paris 06, IRD, Lab Oceanog & Climat Experimentat & Approche Nume, F-75252 Paris 05, France; [Rinterknecht, V.] Univ St Andrews, Sch Geog & Geosci Irvine Bldg, St Andrews KY16 9AL, Fife, Scotland; [Francou, B.] Inst Rech Dev, La Paz 9214, Bolivia; [Ceballos, J. L.] Inst Hydrol Meteorol & Environm Studies, Bogota 07603, Colombia; [Fonseca, H.] UPTC Sede Secc Sogamoso, Escuela Ingn Geol, Sogamoso, Colombia; [Liu, Z.] Univ Wisconsin, Ctr Climat Res, Madison, WI 53706 USA; [Liu, Z.] Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI 53706 USA; [Otto-Bliesner, B. L.] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80305 USA	Centre National de la Recherche Scientifique (CNRS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); State University of New York (SUNY) System; State University of New York (SUNY) Albany; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; University of Wisconsin System; University of Wisconsin Madison; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; University of St Andrews; Institut de Recherche pour le Developpement (IRD); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Center Atmospheric Research (NCAR) - USA	Jomelli, V (corresponding author), Univ Paris 01, CNRS, Lab Geog Phys, F-92195 Meudon, France.	vincent.jomelli@lgp.cnrs.fr	BLARD, Pierre-Henri/ABB-9401-2021; , Braucher/Q-5971-2017; jomelli, vincent/AAO-9488-2020; Vuille, Mathias/O-8128-2019; Khodri, Myriam/K-1399-2016; Vuille, Mathias/S-3906-2019; Otto-Bliesner, Bette/AAY-7691-2020; Favier, Vincent/T-1936-2017; Martin, Leo/V-5865-2019; He, Feng/B-3583-2008	, Braucher/0000-0002-4637-4302; jomelli, vincent/0000-0002-4512-5216; Vuille, Mathias/0000-0002-9736-4518; Khodri, Myriam/0000-0003-1941-1646; Favier, Vincent/0000-0001-6024-9498; He, Feng/0000-0002-3355-6406; brunstein, daniel/0000-0001-5496-8349; Blard, Pierre-Henri/0000-0002-8455-8014; Rinterknecht, Vincent/0000-0002-5410-2075; Martin, Leo/0000-0001-5405-0175; Bourles, Didier/0000-0001-5991-6126	French ANR El Paso programme [10-blan-68-01]	French ANR El Paso programme(French National Research Agency (ANR))	Financial support was provided by the French ANR El Paso programme no. 10-blan-68-01. The <SUP>10</SUP>Be measurements were performed at the ASTER AMS national facility (CEREGE, Aix en Provence), which is supported by the INSU/CNRS,the French Ministry of Research and Higher Education, IRD and CEA. TRACE21 is supported by the P2C2 programme (NSF), the Abrupt Change Program (DOE), the EaSM programme (DOE) and the INCITE computing programme (DOE and NCAR). We thank M. Arnold, G. Aumaitre and K. Keddadouche for their assistance during <SUP>10</SUP>Be measurements.	Balco G, 2008, QUAT GEOCHRONOL, V3, P174, DOI 10.1016/j.quageo.2007.12.001; Blard PH, 2013, EARTH PLANET SC LETT, V382, P140, DOI 10.1016/j.epsl.2013.09.010; Blard PH, 2013, EARTH PLANET SC LETT, V377, P260, DOI 10.1016/j.epsl.2013.07.006; Blard P. H., QUAT RES IN PRESS; Broecker W, 2013, WHAT DRIVES GLACIER; Bromley GRM, 2011, J QUATERNARY SCI, V26, P37, DOI 10.1002/jqs.1424; Carcaillet J, 2013, QUATERNARY RES, V80, P482, DOI 10.1016/j.yqres.2013.08.001; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; Dunne J, 1999, GEOMORPHOLOGY, V27, P3, DOI 10.1016/S0169-555X(98)00086-5; Farber DL, 2005, J QUATERNARY SCI, V20, P759, DOI 10.1002/jqs.994; Favier V, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020654; Favier V, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004359; Francou B, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004484; Glasser NF, 2009, QUATERNARY SCI REV, V28, P3448, DOI 10.1016/j.quascirev.2009.10.006; Guyodo Y, 1999, NATURE, V399, P249, DOI 10.1038/20420; Hall SR, 2009, QUATERNARY SCI REV, V28, P2991, DOI 10.1016/j.quascirev.2009.08.004; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; He F., 2011, SIMULATING TRANSIENT; He F, 2014, GEOPHYS RES LETT, V41, P623, DOI 10.1002/2013GL058085; He F, 2013, NATURE, V494, P81, DOI 10.1038/nature11822; Jomelli V, 2011, NATURE, V474, P196, DOI 10.1038/nature10150; Jomelli V, 2009, PALAEOGEOGR PALAEOCL, V281, P269, DOI 10.1016/j.palaeo.2008.10.033; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Kelly M., 2010, QUAT GEOCHR IN PRESS; Leduc G, 2007, NATURE, V445, P908, DOI 10.1038/nature05578; Licciardi JM, 2009, SCIENCE, V325, P1677, DOI 10.1126/science.1175010; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Mahaney WC, 2008, GEOMORPHOLOGY, V96, P199, DOI 10.1016/j.geomorph.2007.08.002; Menabreaz L, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009256; Merchel S, 2008, NUCL INSTRUM METH B, V266, P4921, DOI 10.1016/j.nimb.2008.07.031; Muscheler R, 2005, QUATERNARY SCI REV, V24, P1849, DOI 10.1016/j.quascirev.2005.01.012; NISHIIZUMI K, 1989, J GEOPHYS RES-SOLID, V94, P17907, DOI 10.1029/JB094iB12p17907; Nishiizumi K, 2007, NUCL INSTRUM METH B, V258, P403, DOI 10.1016/j.nimb.2007.01.297; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Pierrehumbert RT, 2000, P NATL ACAD SCI USA, V97, P1355, DOI 10.1073/pnas.97.4.1355; Putnam AE, 2010, NAT GEOSCI, V3, P700, DOI 10.1038/NGEO962; Rodbell DT, 2009, QUATERNARY SCI REV, V28, P2165, DOI 10.1016/j.quascirev.2009.03.012; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Smith CA, 2011, QUATERNARY RES, V75, P1, DOI 10.1016/j.yqres.2010.07.001; Smith JA, 2005, SCIENCE, V308, P678, DOI 10.1126/science.1107075; Smith JA, 2010, J QUATERNARY SCI, V25, P243, DOI 10.1002/jqs.1393; Stansell ND, 2010, EARTH PLANET SC LETT, V293, P154, DOI 10.1016/j.epsl.2010.02.040; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; WARD GK, 1978, ARCHAEOMETRY, V20, P19, DOI 10.1111/j.1475-4754.1978.tb00208.x; Yeager SG, 2006, J CLIMATE, V19, P2545, DOI 10.1175/JCLI3744.1; Zech J, 2009, PALAEOGEOGR PALAEOCL, V284, P180, DOI 10.1016/j.palaeo.2009.09.023; Zech R, 2007, CLIM PAST, V3, P623, DOI 10.5194/cp-3-623-2007	50	66	66	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					224	228		10.1038/nature13546	http://dx.doi.org/10.1038/nature13546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25156258				2022-12-24	WOS:000341362800048
J	Udell, JA; Wang, TY; Li, S; Kohli, P; Roe, MT; de Lemos, JA; Wiviott, SD				Udell, Jacob A.; Wang, Tracy Y.; Li, Shuang; Kohli, Payal; Roe, Matthew T.; de Lemos, James A.; Wiviott, Stephen D.			Clinical Trial Participation After Myocardial Infarction in a National Cardiovascular Data Registry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ACUTE CORONARY SYNDROMES; CLOPIDOGREL		[Udell, Jacob A.] Univ Toronto, Womens Coll Hosp, Toronto, ON M5S 1B1, Canada; [Wang, Tracy Y.; Li, Shuang; Roe, Matthew T.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Kohli, Payal] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA; [de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Wiviott, Stephen D.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Womens College Hospital; Duke University; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital	Udell, JA (corresponding author), Univ Toronto, Womens Coll Hosp, 76 Grenville St, Toronto, ON M5S 1B1, Canada.	jay.udell@utoronto.ca	de Lemos, James/ABD-6669-2021; Wiviott, Stephen/HIK-2534-2022	Udell, Jacob/0000-0001-7402-9584; Kohli, Payal/0000-0002-1049-5233	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Antman EM, 2012, JAMA-J AM MED ASSOC, V308, P1743, DOI 10.1001/jama.2012.14841; Chin CT, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.004; Humphreys K, 2013, JAMA INTERN MED, V173, P1029, DOI 10.1001/jamainternmed.2013.496; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	6	38	38	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2014	312	8					841	843		10.1001/jama.2014.6217	http://dx.doi.org/10.1001/jama.2014.6217			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7NX	25157729				2022-12-24	WOS:000340788500028
J	Mellin, JR; Koutero, M; Dar, D; Nahori, MA; Sorek, R; Cossart, P				Mellin, J. R.; Koutero, Mikael; Dar, Daniel; Nahori, Marie-Anne; Sorek, Rotem; Cossart, Pascale			Sequestration of a two-component response regulator by a riboswitch-regulated noncoding RNA	SCIENCE			English	Article							ETHANOLAMINE UTILIZATION; ANTISENSE RNA	Riboswitches are ligand-binding elements contained within the 5' untranslated regions of bacterial transcripts, which generally regulate expression of downstream open reading frames. Here, we show that in Listeria monocytogenes, a riboswitch that binds vitamin B-12 controls expression of a noncoding regulatory RNA, Rli55. Rli55, in turn, controls expression of the eut genes, whose products enable ethanolamine utilization and require B12 as a cofactor. Defects in ethanolamine utilization, or in its regulation by Rli55, significantly attenuate Listeria virulence in mice. Rli55 functions by sequestering the two-component response regulator EutV by means of a EutV-binding site contained within the RNA. Thus, Rli55 is a riboswitch-regulated member of the small group of regulatory RNAs that function by sequestering a protein and reveals a distinctive mechanism of signal integration in bacterial gene regulation.	[Mellin, J. R.; Koutero, Mikael; Nahori, Marie-Anne; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Mellin, J. R.; Koutero, Mikael; Nahori, Marie-Anne; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Mellin, J. R.; Koutero, Mikael; Nahori, Marie-Anne; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Dar, Daniel; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Weizmann Institute of Science	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr		Dar, Daniel/0000-0002-6650-5488; Marie-Anne, Nahori/0000-0002-4066-4528	European Research Council [233348]; ANR [BACNET 09-BLAN-0024-02]; ANR Investissement d'Avenir Programme [10-LABX-62]; Fondation Le Roch; Fondation Jeantet	European Research Council(European Research Council (ERC)European Commission); ANR(French National Research Agency (ANR)); ANR Investissement d'Avenir Programme(French National Research Agency (ANR)); Fondation Le Roch; Fondation Jeantet	We are grateful to D. Garsin and W. Winkler for their exchange of ideas and discussion of unpublished data. We also thank, N. King and J. Pederson for helpful and insightful discussions and Y. Chao and J. Vogel for assistance with the CLIP-seq protocol. This work was supported by grants to P. C., European Research Council advanced grant (233348), ANR (BACNET 09-BLAN-0024-02), ANR Investissement d'Avenir Programme (10-LABX-62), Fondation Le Roch, and Fondation Jeantet. P. C. is an International Senior Research Scholar of the Howard Hughes Medical Institute.	Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Archambaud C, 2012, P NATL ACAD SCI USA, V109, P16684, DOI 10.1073/pnas.1212809109; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; Del Papa MF, 2008, J BACTERIOL, V190, P7147, DOI 10.1128/JB.00952-08; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; KAWAI K, 1974, BIOCHIM BIOPHYS ACTA, V369, P222; Mellin JR, 2013, P NATL ACAD SCI USA, V110, P13132, DOI 10.1073/pnas.1304795110; Ramesh A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002666; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tsoy O, 2009, J BACTERIOL, V191, P7157, DOI 10.1128/JB.00838-09; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winter SE, 2011, GUT MICROBES, V2, P58, DOI 10.4161/gmic.2.1.14911; Wurtzel O, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.11	17	111	115	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					940	943		10.1126/science.1255083	http://dx.doi.org/10.1126/science.1255083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146292	Green Submitted			2022-12-24	WOS:000340524700049
J	Lamborg, CH; Hammerschmidt, CR; Bowman, KL; Swarr, GJ; Munson, KM; Ohnemus, DC; Lam, PJ; Heimburger, LE; Rijkenberg, MJA; Saito, MA				Lamborg, Carl H.; Hammerschmidt, Chad R.; Bowman, Katlin L.; Swarr, Gretchen J.; Munson, Kathleen M.; Ohnemus, Daniel C.; Lam, Phoebe J.; Heimbuerger, Lars-Eric; Rijkenberg, Micha J. A.; Saito, Mak A.			A global ocean inventory of anthropogenic mercury based on water column measurements	NATURE			English	Article							2-STAGE GOLD AMALGAMATION; SEAWATER; MODEL	Mercury is a toxic, bioaccumulating trace metal whose emissions to the environment have increased significantly as a result of anthropogenic activities such as mining and fossil fuel combustion(1,2). Several recent models have estimated that these emissions have increased the oceanic mercury inventory by 36-1,313 million moles since the 1500s(2-9). Such predictions have remained largely untested owing to a lack of appropriate historical data and natural archives. Here we report oceanographic measurements of total dissolved mercury and related parameters from several recent expeditions to the Atlantic, Pacific, Southern and Arctic oceans. We find that deep North Atlantic waters and most intermediate waters are anomalously enriched in mercury relative to the deep waters of the South Atlantic, Southern and Pacific oceans, probably as a result of the incorporation of anthropogenic mercury. We estimate the total amount of anthropogenic mercury present in the global ocean to be 290 +/- 680 million moles, with almost two-thirds residing in water shallower than a thousand metres. Our findings suggest that anthropogenic perturbations to the global mercury cycle have led to an approximately 150 per cent increase in the amount of mercury in thermocline waters and have tripled the mercury content of surface waters compared to pre-anthropogenic conditions. This information may aid our understanding of the processes and the depths at which inorganic mercury species are converted into toxic methyl mercury and subsequently bioaccumulated in marine food webs.	[Lamborg, Carl H.; Swarr, Gretchen J.; Munson, Kathleen M.; Ohnemus, Daniel C.; Lam, Phoebe J.; Saito, Mak A.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Hammerschmidt, Chad R.; Bowman, Katlin L.] Wright State Univ, Dept Earth & Environm Sci, Dayton, OH 45435 USA; [Heimbuerger, Lars-Eric] Univ Toulouse 3, IRD, CNRS, Observ Midi Pyrenees,Lab Geosci Environm, F-31400 Toulouse, France; [Rijkenberg, Micha J. A.] Royal Netherlands Inst Sea Res, Dept Biol Oceanog, NL-1790 AB Den Burg, Netherlands	Woods Hole Oceanographic Institution; University System of Ohio; Wright State University Dayton; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Lamborg, CH (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	clamborg@whoi.edu	Lam, Phoebe/GQQ-7325-2022; Ohnemus, Daniel C/X-7728-2018; Hammerschmidt, Chad/M-3139-2014; Saito, Mak/ADT-4986-2022; Heimbürger-Boavida, Lars-Eric/AAF-6856-2021	Ohnemus, Daniel C/0000-0001-6362-4134; Heimbürger-Boavida, Lars-Eric/0000-0003-0632-5183; Lam, Phoebe J./0000-0001-6609-698X; Adamczyk, Katlin/0000-0003-3324-0062; Lamborg, Carl/0000-0003-4379-3904; Munson, Kathleen/0000-0001-7158-9607	NSF [OCE-0825108, OCE-0825157, OCE-0927274, OCE-0928191, OCE-1031271, OCE-1132480, OCE-1132515];  [ERC-2010-StG_20091028]; Directorate For Geosciences [1232760, 1233261] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the captains and crews of all cruises, as well as: P. Morton, J. Fitzsimmons, R. Shelley, A. Aguilar-Islas, R. Bundy, P. Morris, S. Owens, K. Wang, S. Rigaud and S. Pike for sample collection during the North Atlantic GEOTRACES cruise; L. Groot, D. Weiss, P. Laan, J. de Jong, R. Middag, L. Pena, A. Hartman, J. M. Godoy, L. Gerringa, M. Boye and J. Derot for sample collection during the South Atlantic GEOTRACES cruise; T. Goepfert, E. Bertrand and D. Moran for sampling during the Metalloenzyme cruise; and M. Rutgers van der Loeff and B. Galfond for providing samples from the 2011 Polarstern cruise ARK-XXVI/3-TransArc to the central Arctic Ocean. We are also grateful to D. Cossa and E. Sunderland for providing digital versions of their Southern Ocean and P16 data. We also thank H. Amos, L. Jaegle, B. Jonsson, R. Mason, E. Sunderland and Y. Zhang for discussions and D. Cossa for comments. This work was supported by NSF grant numbers OCE-0825108, OCE-0825157, OCE-0927274, OCE-0928191, OCE-1031271, OCE-1132480 and OCE-1132515. We thank co-Principal Investigators R. Mason and G. Gill. L.-E.H. thanks J. E Sonke for funding Arctic Ocean observations via research grant ERC-2010-StG_20091028 to JES.	Amos HM, 2013, GLOBAL BIOGEOCHEM CY, V27, P410, DOI 10.1002/gbc.20040; ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; [Anonymous], [No title captured]; Bowman K. L., DEEP SEA RE IN PRESS; Cossa D, 2011, GEOCHIM COSMOCHIM AC, V75, P4037, DOI 10.1016/j.gca.2011.05.001; Cutter GA, 2012, LIMNOL OCEANOGR-METH, V10, P425, DOI 10.4319/lom.2012.10.425; EGGIMANN DW, 1976, ANAL CHEM, V48, P886, DOI 10.1021/ac60370a005; FITZGERALD WF, 1979, ANAL CHEM, V51, P1714, DOI 10.1021/ac50047a030; GILL GA, 1987, MAR CHEM, V20, P227, DOI 10.1016/0304-4203(87)90074-0; Gruber N, 1996, GLOBAL BIOGEOCHEM CY, V10, P809, DOI 10.1029/96GB01608; Hammerschmidt CR, 2006, ARCH ENVIRON CON TOX, V51, P416, DOI 10.1007/s00244-005-0265-7; Hammerschmidt CR, 2012, MAR CHEM, V132, P77, DOI 10.1016/j.marchem.2012.02.005; Jaegle L., 2013, 11 INT C MERC GLOB P; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Khatiwala S, 2013, BIOGEOSCIENCES, V10, P2169, DOI 10.5194/bg-10-2169-2013; Lamborg CH, 2008, DEEP-SEA RES PT II, V55, P1540, DOI 10.1016/j.dsr2.2008.04.011; Lamborg CH, 2012, LIMNOL OCEANOGR-METH, V10, P90, DOI 10.4319/lom.2012.10.90; Lamborg CH, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001847; Lamborg CH, 2002, GEOCHIM COSMOCHIM AC, V66, P1105, DOI 10.1016/S0016-7037(01)00841-9; Le Quere C, 2012, EARTH SYST SCI DATA, V5, P1107, DOI [10.5194/ESSDD-5-1107-2012, DOI 10.5194/ESSDD-5-1107-2012]; Mason RP, 2012, ENVIRON RES, V119, P101, DOI 10.1016/j.envres.2012.03.013; Mason RP, 1998, MAR CHEM, V61, P37, DOI 10.1016/S0304-4203(98)00006-1; MASON RP, 1994, GEOCHIM COSMOCHIM AC, V58, P3191, DOI 10.1016/0016-7037(94)90046-9; Morel F.M.M., 2003, TREATISE GEOCHEMISTR, P113, DOI [10.1016/B0-08-043751-6/06108-9, DOI 10.1016/B0-08-043751-6/06108-9]; Pacyna EG, 2010, ATMOS ENVIRON, V44, P2487, DOI 10.1016/j.atmosenv.2009.06.009; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Selin NE, 2014, ENVIRON TOXICOL CHEM, V33, P1202, DOI 10.1002/etc.2374; Selin NE, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003040; Soerensen AL, 2010, ENVIRON SCI TECHNOL, V44, P8574, DOI 10.1021/es102032g; Streets DG, 2011, ENVIRON SCI TECHNOL, V45, P10485, DOI 10.1021/es202765m; Streets DG, 2009, ENVIRON SCI TECHNOL, V43, P2983, DOI 10.1021/es802474j; Strode S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003728; Sunderland EM, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003425; Sunderland EM, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002876; TALLEY LD, 1995, J PHYS OCEANOGR, V25, P475, DOI 10.1175/1520-0485(1995)025<0475:NPIWIT>2.0.CO;2; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9	37	325	329	25	435	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					65	+		10.1038/nature13563	http://dx.doi.org/10.1038/nature13563			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25100482				2022-12-24	WOS:000339908000032
J	Ongen, H; Andersen, CL; Bramsen, JB; Oster, B; Rasmussen, MH; Ferreira, PG; Sandoval, J; Vidal, E; Whiffin, N; Planchon, A; Padioleau, I; Bielser, D; Romano, L; Tomlinson, I; Houlston, RS; Esteller, M; Orntoft, TF; Dermitzakis, ET				Ongen, Halit; Andersen, Claus L.; Bramsen, Jesper B.; Oster, Bodil; Rasmussen, Mads H.; Ferreira, Pedro G.; Sandoval, Juan; Vidal, Enrique; Whiffin, Nicola; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Tomlinson, Ian; Houlston, Richard S.; Esteller, Manel; Orntoft, Torben F.; Dermitzakis, Emmanouil T.			Putative cis-regulatory drivers in colorectal cancer	NATURE			English	Article							MUTATIONS; HETEROZYGOSITY; IDENTIFICATION; MICRORNA; GENE	The cis-regulatory effects responsible for cancer development have not been as extensively studied as the perturbations of the protein coding genome in tumorigenesis(1,2). To better characterize colorectal cancer (CRC) development we conducted an RNA-sequencing experiment of 103 matched tumour and normal colon mucosa samples from Danish CRC patients, 90 of which were germline-genotyped. By investigating allele-specific expression (ASE) we show that the germline genotypes remain important determinants of allelic gene expression in tumours. Using the changes in ASE in matched pairs of samples we discover 71 genes with excess of somaticc is-regulatory effects in CRC, suggesting a cancer driver role. We correlate genotypes and gene expression to identify expression quantitative trait loci (eQTLs) and find 1,693 and 948 eQTLs in normal samples and tumours, respectively. We estimate that 36% of the tumour eQTLs are exclusive to CRC and show that this specificity is partially driven by increased expression of specific transcription factors and changes in methylation patterns. We show that tumour-specific eQTLs are more enriched for low CRC genome-wide association study (GWAS) P values than shared eQTLs, which suggests that some of the GWAS variants are tumour specific regulatory variants. Importantly, tumour-specific eQTL genes also accumulate more somatic mutations when compared to the shared eQTL genes, raising the possibility that they constitute germline-derived cancer regulatory drivers. Collectively the integration of genome and the transcriptome reveals a substantial number of putative somatic and germline cis-regulatory cancer changes that may have a role in tumorigenesis.	[Ongen, Halit; Ferreira, Pedro G.; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Ongen, Halit; Ferreira, Pedro G.; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet & Genom Geneva IGE3, CH-1211 Geneva, Switzerland; [Ongen, Halit; Ferreira, Pedro G.; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Andersen, Claus L.; Bramsen, Jesper B.; Oster, Bodil; Rasmussen, Mads H.; Orntoft, Torben F.] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Sandoval, Juan; Vidal, Enrique] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Catalonia, Spain; [Whiffin, Nicola; Houlston, Richard S.] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Nuffield Dept Clin Med, Oxford OX3 7BN, England; [Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Oxford NIHR Comprehens Biomed Res Ctr, Oxford OX3 7BN, England; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, E-08007 Barcelona, Spain; [Esteller, Manel] ICREA, Barcelona 08010, Spain	University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Aarhus University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of London; Institute of Cancer Research - UK; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Barcelona; ICREA	Ongen, H (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	halit.ongen@unige.ch; emmanouil.dermitzakis@unige.ch	W, Nicola/AAG-3227-2020; Vidal, Enrique/J-7118-2015; Vidal, Enrique/A-9455-2014; Padioleau, Ismaël/AAE-8927-2019; Ferreira, Pedro G/J-6379-2013; Esteller, Manel/L-5956-2014; Ferreira, Pedro/HDO-1346-2022; Andersen, Claus L/C-1477-2017; Vidal, Enrique/R-5593-2019; sandoval, juan/M-4593-2015; Andersen, Claus Lindbjerg/A-9217-2012	W, Nicola/0000-0003-1554-6594; Vidal, Enrique/0000-0002-4217-1807; Vidal, Enrique/0000-0002-4217-1807; Padioleau, Ismaël/0000-0003-4935-3248; Ferreira, Pedro G/0000-0003-3838-8664; Esteller, Manel/0000-0003-4490-6093; Vidal, Enrique/0000-0002-4217-1807; sandoval, juan/0000-0002-5100-973X; Houlston, Richard/0000-0002-5268-0242; Rasmussen, Mads Heilskov/0000-0001-5723-6303; Ongen, Halit/0000-0002-4197-5790; Andersen, Claus Lindbjerg/0000-0002-7406-2103	European Commission SYSCOL FP7 [UE7-SYSCOL-258236]; European Research Council [ERC 260927]; Louis Jeantet Foundation; Swiss National Science Foundation [130326, 130342]; NIH-NIMH [MH090941]; Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Council for Independent Research (Medical Sciences); Danish Council for Strategic Research; Danish Cancer Society; Cellex Foundation; Botin Foundation; Fundacion Olga Torres; Health Department of the Catalan Government (Generalitat de Catalunya); Science Department of the Catalan Government (Generalitat de Catalunya); Cancer Research UK [C1298/A8362]; Oxford Comprehensive Biomedical Research Centre;  [090532/Z/09/Z]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090941] Funding Source: NIH RePORTER; Cancer Research UK [15116] Funding Source: researchfish	European Commission SYSCOL FP7; European Research Council(European Research Council (ERC)European Commission); Louis Jeantet Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Cancer Society(Danish Cancer Society); Cellex Foundation(Foundation CELLEX); Botin Foundation; Fundacion Olga Torres; Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Science Department of the Catalan Government (Generalitat de Catalunya); Cancer Research UK(Cancer Research UK); Oxford Comprehensive Biomedical Research Centre; ; ICREA(ICREA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Cancer Research UK(Cancer Research UK)	This study was designed under the SYSCOL project and samples were collected with informed consent in accordance with local law. This research is supported by grants from European Commission SYSCOL FP7 (UE7-SYSCOL-258236), European Research Council (ERC 260927), Louis Jeantet Foundation, Swiss National Science Foundation (130326, 130342), the NIH-NIMH (MH090941), the Danish National Advanced Technology Foundation, the John and Birthe Meyer Foundation, the Danish Council for Independent Research (Medical Sciences), the Danish Council for Strategic Research, the Danish Cancer Society, The Cellex Foundation, the Botin Foundation, the Fundacion Olga Torres, and the Health and Science Departments of the Catalan Government (Generalitat de Catalunya). The Danish Cancer Biobank is acknowledged for biological material. We thank S. Moran, D. Garcia and C. Arribas for their technical support. This study was also funded by Cancer Research UK and The Oxford Comprehensive Biomedical Research Centre (I.P.T.). Core infrastructure support to the Wellcome Trust Centre for Human Genetics, Oxford, was provided by grant (090532/Z/09/Z). Cancer Research UK provided funding individually to R.S.H. (C1298/A8362-Bobby Moore Fund for Cancer Research UK). This study made use of genotyping data from the 1958 Birth Cohort and NBS samples, kindly made available by the Wellcome Trust Case Control Consortium 2. The computations were performed at the Vital-IT (http://www.vital-it.ch) Center for high-performance computing of the SIB Swiss Institute of Bioinformatics.	Aerts S, 2013, NATURE, V499, P35, DOI 10.1038/499035a; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Dalla-Torre CA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-237; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; EMI M, 1992, CANCER RES, V52, P5368; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; Sun DF, 2013, J BIOL CHEM, V288, P9508, DOI 10.1074/jbc.M112.367763; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Thorsen K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002998; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034	20	105	106	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					87	90		10.1038/nature13602	http://dx.doi.org/10.1038/nature13602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25079323				2022-12-24	WOS:000339908000037
J	Yuen, TJ; Silbereis, JC; Griveau, A; Chang, SM; Daneman, R; Fancy, SPJ; Zahed, H; Maltepe, E; Rowitch, DH				Yuen, Tracy J.; Silbereis, John C.; Griveau, Amelie; Chang, Sandra M.; Daneman, Richard; Fancy, Stephen P. J.; Zahed, Hengameh; Maltepe, Emin; Rowitch, David H.			Oligodendrocyte-Encoded HIF Function Couples Postnatal Myelination and White Matter Angiogenesis	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; NUCLEAR TRANSLOCATOR ARNT; HYPOXIA-INDUCIBLE FACTORS; BETA-CATENIN; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; AXONAL INTEGRITY; PROGENITOR CELLS; CEREBRAL-PALSY	Myelin sheaths provide critical functional and trophic support for axons in white matter tracts of the brain. Oligodendrocyte precursor cells (OPCs) have extraordinary metabolic requirements during development as they differentiate to produce multiple myelin segments, implying that they must first secure adequate access to blood supply. However, mechanisms that coordinate myelination and angiogenesis are unclear. Here, we show that oxygen tension, mediated by OPC-encoded hypoxia-inducible factor (HIF) function, is an essential regulator of postnatal myelination. Constitutive HIF1/2 alpha stabilization resulted in OPC maturation arrest through autocrine activation of canonical Wnt7 alpha/7 beta. Surprisingly, such OPCs also show paracrine activity that induces excessive postnatal white matter angiogenesis in vivo and directly stimulates endothelial cell proliferation in vitro. Conversely, OPC-specific HIF1/2 alpha loss of function leads to insufficient angiogenesis in corpus callosum and catastrophic axon loss. These findings indicate that OPC-intrinsic HIF signaling couples postnatal white matter angiogenesis, axon integrity, and the onset of myelination in mammalian forebrain.	[Yuen, Tracy J.; Silbereis, John C.; Griveau, Amelie; Chang, Sandra M.; Fancy, Stephen P. J.; Zahed, Hengameh; Rowitch, David H.] Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, Dept Pediat, San Francisco, CA 94143 USA; [Yuen, Tracy J.; Silbereis, John C.; Griveau, Amelie; Chang, Sandra M.; Fancy, Stephen P. J.; Zahed, Hengameh; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Silbereis, John C.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Daneman, Richard] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Zahed, Hengameh] Univ Calif San Francisco, Med Sci Training Program, San Francisco, CA 94143 USA; [Maltepe, Emin; Rowitch, David H.] Univ Calif San Francisco, Div Neonatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rowitch, DH (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, Dept Pediat, 513 Parnassus Ave, San Francisco, CA 94143 USA.	rowitchd@peds.ucsf.edu		Yuen, Tracy/0000-0002-3451-9279; Rowitch, David/0000-0002-0079-0060	National Multiple Sclerosis Society (NMSS); NIGMS [T32 GM007449-36]; Ruth Kirschstein NRSA fellowship from NINDS [F31 NS076254-03]; NICHD [HD072544]; NINDS [NS040511, P01NS083513]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076254, R01NS040511, P01NS083513] Funding Source: NIH RePORTER	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth Kirschstein NRSA fellowship from NINDS; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Emily Harrington and April Tenney for expert technical help and Matt Rasband, Nenad Sestan, and Klaus Nave for discussions. We thank Andrew McMahon (USC) for genomic sequence information for Wnt7a and 7b loci, William Kaelin (Dana-Farber Cancer Institute) for floxed VHL transgenic mice, and William Richardson (UCL) for Sox10-cre transgenic mice. We also thank Nina Bauer, who drew all illustrations. T.J.Y. acknowledges a postdoctoral fellowship from the National Multiple Sclerosis Society (NMSS). J.C.S. acknowledges support from training grant T32 GM007449-36 from NIGMS and the Ruth Kirschstein NRSA fellowship F31 NS076254-03 from NINDS. This work was made possible by grants from NICHD (HD072544 to E.M.), NMSS (to D.H.R.) and NINDS (NS040511 and P01NS083513 to D.H.R.). D.H.R. is a HHMI Investigator.	Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Baron W, 2010, FEBS LETT, V584, P1760, DOI 10.1016/j.febslet.2009.10.085; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAMMERMEYER J, 1960, AM J ANAT, V106, P197, DOI 10.1002/aja.1001060303; Cayre M, 2013, DEVELOPMENT, V140, P3107, DOI 10.1242/dev.092999; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Davies AL, 2013, ANN NEUROL, V74, P815, DOI 10.1002/ana.24006; del Rio-Hortega P, 2012, CLIN NEUROPATHOL, V31, P460, DOI 10.5414/NP301000; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Emery Ben, 2013, Cold Spring Harb Protoc, V2013, P854, DOI 10.1101/pdb.prot073973; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franceschini MA, 2007, PEDIATR RES, V61, P546, DOI 10.1203/pdr.0b013e318045be99; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Harb R, 2013, J CEREBR BLOOD F MET, V33, P146, DOI 10.1038/jcbfm.2012.152; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Hirose K, 1996, MOL CELL BIOL, V16, P1706; Hu FH, 2004, SEMIN PERINATOL, V28, P371, DOI 10.1053/j.semperi.2004.10.001; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jiang LD, 2011, TRANSL STROKE RES, V2, P366, DOI 10.1007/s12975-011-0078-0; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lee H, 2006, MOL CELLS, V21, P1; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Ryan HE, 2000, CANCER RES, V60, P4010; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Sawamiphak S, 2010, NAT PROTOC, V5, P1659, DOI 10.1038/nprot.2010.130; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Silbereis JC, 2010, DIS MODEL MECH, V3, P678, DOI 10.1242/dmm.002915; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tan S, 2005, J CHILD NEUROL, V20, P972, DOI 10.1177/08830738050200120801; Tanaka K, 2001, NEUROREPORT, V12, P2169, DOI 10.1097/00001756-200107200-00025; TESSITORE C, 1988, DEV BRAIN RES, V43, P139, DOI 10.1016/0165-3806(88)90159-9; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Weiss J, 2004, EXP NEUROL, V189, P141, DOI 10.1016/j.expneurol.2004.05.018; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Yuen TJ, 2013, BRAIN, V136, P1035, DOI 10.1093/brain/awt024	76	237	245	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					383	396		10.1016/j.cell.2014.04.052	http://dx.doi.org/10.1016/j.cell.2014.04.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25018103	Green Accepted, Bronze			2022-12-24	WOS:000340943600017
J	Wen, ZX; Nguyen, HN; Guo, ZY; Lalli, MA; Wang, XY; Su, YJ; Kim, NS; Yoon, KJ; Shin, J; Zhang, C; Makri, G; Nauen, D; Yu, HM; Guzman, E; Chiang, CH; Yoritomo, N; Kaibuchi, K; Zou, JZ; Christian, KM; Cheng, LZ; Ross, CA; Margolis, RL; Chen, G; Kosik, KS; Song, HJ; Ming, GL				Wen, Zhexing; Ha Nam Nguyen; Guo, Ziyuan; Lalli, Matthew A.; Wang, Xinyuan; Su, Yijing; Kim, Nam-Shik; Yoon, Ki-Jun; Shin, Jaehoon; Zhang, Ce; Makri, Georgia; Nauen, David; Yu, Huimei; Guzman, Elmer; Chiang, Cheng-Hsuan; Yoritomo, Nadine; Kaibuchi, Kozo; Zou, Jizhong; Christian, Kimberly M.; Cheng, Linzhao; Ross, Christopher A.; Margolis, Russell L.; Chen, Gong; Kosik, Kenneth S.; Song, Hongjun; Ming, Guo-li			Synaptic dysregulation in a human iPS cell model of mental disorders	NATURE			English	Article							DE-NOVO MUTATIONS; STEM-CELLS; SCHIZOPHRENIA; GENE; DISEASE; QUANTIFICATION; INTEGRATION; PROTEINS	Dysregulated neurodevelopment with altered structural and functional connectivity is believed to underlie many neuropsychiatric disorders(1), and 'a disease of synapses' is the major hypothesis for the biological basis of schizophrenia(2). Although this hypothesis has gained indirect support from human post-mortem brain analyses' and genetic studies(5-10), little is known about the pathophysiology of synapses in patient neurons and how susceptibility genes for mental disorders could lead to synaptic deficits in humans. Genetics of most psychiatric disorders are extremely complex due to multiple susceptibility variants with low penetrance and variable phenotypes(11). Rare, multiply affected, large families in which a single genetic locus is probably responsible for conferring susceptibility have proven invaluable for the study of complex disorders. Here we generated induced pluripotent stem (iPS) cells from four members of a family in which a frameshift mutation of disrupted in schizophrenia! (DISCI) co-segregated with major psychiatric disorders' and we further produced different isogenic iPS cell lines via gene editing. We showed that mutant DISCI causes synaptic vesicle release deficits in iPS-cell-derived forebrain neurons. Mutant DISCI depletes wild-type DISCI protein and, furthermore, dysregulates expression of many genes related to synapses and psychiatric disorders in human forebrain neurons. Our study reveals that a psychiatric disorder relevant mutation causes synapse deficits and transcriptional dysregulation in human neurons and our findings provide new insight into the molecular and synaptic etiopathology of psychiatric disorders.	[Wen, Zhexing; Ha Nam Nguyen; Wang, Xinyuan; Su, Yijing; Kim, Nam-Shik; Yoon, Ki-Jun; Shin, Jaehoon; Zhang, Ce; Makri, Georgia; Nauen, David; Yu, Huimei; Chiang, Cheng-Hsuan; Zou, Jizhong; Christian, Kimberly M.; Cheng, Linzhao; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Wen, Zhexing; Su, Yijing; Kim, Nam-Shik; Yoon, Ki-Jun; Zhang, Ce; Makri, Georgia; Yu, Huimei; Chiang, Cheng-Hsuan; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ha Nam Nguyen; Shin, Jaehoon; Ross, Christopher A.; Margolis, Russell L.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Guo, Ziyuan; Chen, Gong] Penn State Univ, Huck Inst Life Sci, Dept Biol, University Pk, PA 16802 USA; [Lalli, Matthew A.; Guzman, Elmer; Kosik, Kenneth S.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Dept Mol Cellular & Dev Biol, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Wang, Xinyuan] Fudan Univ, Sch Basic Med Sci, Shanghai 200032, Peoples R China; [Nauen, David] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Chiang, Cheng-Hsuan; Ross, Christopher A.; Margolis, Russell L.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Yoritomo, Nadine; Ross, Christopher A.; Margolis, Russell L.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Showa Ku, Dept Cell Pharmacol, Nagoya, Aichi 4668550, Japan; [Zou, Jizhong; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Santa Barbara; Fudan University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Nagoya University; Johns Hopkins University	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@jhmi.edu	Yoon, Ki-Jun/S-8170-2018; Kaibuchi, Kozo/M-4887-2014; Wen, Zhexing/L-1228-2018; Chiang, Jason/N-2766-2018; wang, xinyuan/HHM-2418-2022	Kaibuchi, Kozo/0000-0003-0714-1992; Wen, Zhexing/0000-0002-1518-3845; Chiang, Jason/0000-0003-3623-8996; Lalli, Matthew/0000-0003-0419-1206; Zou, Jizhong/0000-0003-1021-0549; nauen, david/0000-0002-2652-9944; Yoon, Ki-Jun/0000-0003-2985-2541; Wang, Xinyuan/0000-0002-3107-8359; Ming, Guo-li/0000-0002-2517-6075; Chen JNU, Gong/0000-0002-1857-3670; Guo, Ziyuan/0000-0002-2263-0797	NIH [MH087874, N5047344, NS048271, AG045656, MH102978]; IMHRO; SFARI; NARSAD; MSCRF; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105128, R21MH092740, R33MH087874, F31MH102978, R01MH083911, R21MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344, R37NS047344, R56NS047344, R01NS048271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984, R01AG045656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IMHRO; SFARI; NARSAD(NARSAD); MSCRF; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of Ming and Song laboratories for discussion, and Q. Hussaini, Y. Cai and L. Liu for technical support. This work was supported by grants from the NIH (MH087874, N5047344), IMHRO, SFARI, NARSAD, and MSCRF to H.S.; from MSCRF, NARSAD and the NIH (NS048271) to G.-I.M.; from Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to G.-I.M. and K.S.K.; from the NIH (AG045656) to CC.: from MSCRF and NARSAD to K.M.C.; by postdoctoral fellowships from MSCRF to Z.W.,Y.S., N.S.K., and G.M.; and by a predoctoral fellowship from the NIH (MH102978) to H.N.N.	Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Brennand K, 2014, MOL PSYCHIAT; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Chiang CH, 2011, MOL PSYCHIATR, V16, P358, DOI 10.1038/mp.2011.13; Christian Kimberly M, 2012, Front Biol (Beijing), V7, P179, DOI 10.1007/s11515-012-1216-0; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; HACKETT JT, 1990, J NEUROPHYSIOL, V63, P701, DOI 10.1152/jn.1990.63.4.701; Ho SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-230; Honer WG, 2004, INT REV NEUROBIOL, V59, P175; Johnson RD, 2008, ACTA BIOCHIM POL, V55, P619; Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17; Kenny EM, 2014, MOL PSYCHIATR, V19, P872, DOI 10.1038/mp.2013.127; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Lips ES, 2012, MOL PSYCHIATR, V17, P996, DOI 10.1038/mp.2011.117; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Sachs NA, 2005, MOL PSYCHIATR, V10, P758, DOI 10.1038/sj.mp.4001667; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Thomson Pippa A, 2013, Front Biol (Beijing), V8, P1; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wright R, 2014, JAMA PSYCHIAT, V71, P334, DOI 10.1001/jamapsychiatry.2013.4239; Yu DX, 2014, STEM CELL REP, V2, P295, DOI 10.1016/j.stemcr.2014.01.009	40	337	348	7	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					414	+		10.1038/nature13716	http://dx.doi.org/10.1038/nature13716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25132547	Green Accepted			2022-12-24	WOS:000345770600046
J	Herzfeld, DJ; Vaswani, PA; Marko, MK; Shadmehr, R				Herzfeld, David J.; Vaswani, Pavan A.; Marko, Mollie K.; Shadmehr, Reza			A memory of errors in sensorimotor learning	SCIENCE			English	Article							MOTOR ADAPTATION; TASK VARIATION; SAVINGS; MODELS; MOVEMENT; STIMULI; SYSTEMS; MONKEY	The current view of motor learning suggests that when we revisit a task, the brain recalls the motor commands it previously learned. In this view, motor memory is a memory of motor commands, acquired through trial-and-error and reinforcement. Here we show that the brain controls how much it is willing to learn from the current error through a principled mechanism that depends on the history of past errors. This suggests that the brain stores a previously unknown form of memory, a memory of errors. A mathematical formulation of this idea provides insights into a host of puzzling experimental data, including savings and meta-learning, demonstrating that when we are better at a motor task, it is partly because the brain recognizes the errors it experienced before.	[Herzfeld, David J.; Marko, Mollie K.; Shadmehr, Reza] Johns Hopkins Univ, Sch Med, Lab Computat Motor Control, Dept Biomed Engn, Baltimore, MD 21205 USA; [Vaswani, Pavan A.] Johns Hopkins Univ, Sch Med, Lab Computat Motor Control, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Herzfeld, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Lab Computat Motor Control, Dept Biomed Engn, Baltimore, MD 21205 USA.	dherzfe1@jhmi.edu	Vaswani, Pavan/ABA-4737-2020	Vaswani, Pavan/0000-0002-1826-6275	NIH grants [T32EB003383, T32GM007057, R01NS078311, 1F31NS079121]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB003383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007057, T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS090860, F31NS079121, R01NS078311] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants T32EB003383, T32GM007057, R01NS078311, and 1F31NS079121. We thank J. Krakauer, J.-J. Orban de Xivry, and A. A. Ahmed for comments. D.J.H., P.A.V., M.K.M., and R.S. conceived and designed the experiments. D.J.H. performed the experiments, analyzed the data, and performed the simulations. R.S. and D.J.H. wrote the paper. The data reported in this paper and in the supplementary materials are available from the corresponding author.	Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Castro LNG, 2014, CURR BIOL, V24, P1050, DOI 10.1016/j.cub.2014.03.049; Cheng S, 2006, NEURAL COMPUT, V18, P760, DOI 10.1162/089976606775774651; Donchin O, 2003, J NEUROSCI, V23, P9032; Fine MS, 2006, J NEUROPHYSIOL, V96, P710, DOI 10.1152/jn.00215.2006; Herzfeld DJ, 2014, NEUROIMAGE, V98, P147, DOI 10.1016/j.neuroimage.2014.04.076; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Malone LA, 2011, J NEUROSCI, V31, P15136, DOI 10.1523/JNEUROSCI.1367-11.2011; Marko MK, 2012, J NEUROPHYSIOL, V108, P1752, DOI 10.1152/jn.00177.2012; Mawase F, 2014, J NEUROPHYSIOL, V111, P1444, DOI 10.1152/jn.00734.2013; Patton JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0046466; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Rescorla R. A., 1972, CLASSICAL CONDITIONI; Riedmiller M., 1993, IEEE INT C NEUR NETW, V1, P586, DOI DOI 10.1109/ICNN.1993.298623; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; Sarwary AME, 2013, J NEUROPHYSIOL, V110, P1269, DOI 10.1152/jn.00914.2012; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Smith M, 2004, ADV COMPUTATIONAL MO, P3; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Soetedjo R, 2009, J NEUROSCI, V29, P15213, DOI 10.1523/JNEUROSCI.4296-09.2009; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Trent Michael C, 2013, Front Comput Neurosci, V7, P118, DOI 10.3389/fncom.2013.00118; Turnham EJA, 2012, J NEUROPHYSIOL, V107, P1111, DOI 10.1152/jn.00635.2011; van Beers RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049373; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Zarahn E, 2008, J NEUROPHYSIOL, V100, P2537, DOI 10.1152/jn.90529.2008	32	168	170	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1349	1353		10.1126/science.1253138	http://dx.doi.org/10.1126/science.1253138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25123484	Green Accepted			2022-12-24	WOS:000341483800066
J	Deng, L; Ignacio-Espinoza, JC; Gregory, AC; Poulos, BT; Weitz, JS; Hugenholtz, P; Sullivan, MB				Deng, Li; Ignacio-Espinoza, J. Cesar; Gregory, Ann C.; Poulos, Bonnie T.; Weitz, Joshua S.; Hugenholtz, Philip; Sullivan, Matthew B.			Viral tagging reveals discrete populations in Synechococcus viral genome sequence space	NATURE			English	Article							MARINE VIRUSES; GENE-TRANSFER; CYANOPHAGES; EVOLUTION; DIVERSITY; BACTERIOPHAGE; COMMUNITIES; PROPHAGES; ABUNDANCE; BACTERIAL	Microbes and their viruses drive myriad processes across ecosystems ranging from oceans and soils to bioreactors and humans(1-4). Despite this importance, microbial diversity is only now being mapped at scales relevant to nature(5), while the viral diversity associated with any particular host remains little researched. Here we quantify host-associated viral diversity using viral-tagged metagenomics, which links viruses to specific host cells for high-throughput screening and sequencing. In a single experiment, we screened 10(7) Pacific Ocean viruses against a single strain of Synechococcus and found that naturally occurring cyanophage genome sequence space is statistically clustered into discrete populations. These population-based, host-linked viral ecological data suggest that, for this single host and seawater sample alone, there are at least 26 double-stranded DNA viral populations with estimated relative abundances ranging from 0.06 to 18.2%. These populations include previously cultivated cyanophage and new viral types missed by decades of isolate-based studies. Nucleotide identities of homologous genes mostly varied by less than 1% within populations, even in hypervariable genome regions, and by 42-71% between populations, which provides benchmarks for viral metagenomics and genome-based viral species definitions. Together these findings showcase a new approach to viral ecology that quantitatively links objectively defined environmental viral populations, and their genomes, to their hosts.	[Deng, Li; Gregory, Ann C.; Poulos, Bonnie T.; Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85719 USA; [Ignacio-Espinoza, J. Cesar; Sullivan, Matthew B.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85719 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Hugenholtz, Philip] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Arizona; University of Arizona; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Queensland; University of Queensland	Sullivan, MB (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85719 USA.	mbsulli@email.arizona.edu	Hugenholtz, Philip/AAD-9138-2019; Deng, Li/A-7233-2015; Sullivan, Matthew B/H-3256-2011	Hugenholtz, Philip/0000-0001-5386-7925; Deng, Li/0000-0003-0225-0663; Sullivan, Matthew B/0000-0003-4040-9831; Ignacio Espinoza, J. Cesar/0000-0001-9303-7504	US Department of Energy (DOE) Joint Genome Institute (JGI) Community Sequencing Program; Biosphere 2; BIO5; US National Science Foundation (NSF) [OCE0940390]; Gordon and Betty Moore Foundation grants; NSF [OCE1233760]; Burroughs Wellcome Fund grants; University Information Technology Services Research Computing Group; ARL Biotechnology Computing for high-performance computing clusters (HPCC); DOE JGI Community Sequencing Program under the Office of Science of the US DOE [DE-AC02-05CH11231]; Division Of Physics [1205878] Funding Source: National Science Foundation	US Department of Energy (DOE) Joint Genome Institute (JGI) Community Sequencing Program(United States Department of Energy (DOE)); Biosphere 2; BIO5; US National Science Foundation (NSF)(National Science Foundation (NSF)); Gordon and Betty Moore Foundation grants(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); Burroughs Wellcome Fund grants(Burroughs Wellcome Fund); University Information Technology Services Research Computing Group; ARL Biotechnology Computing for high-performance computing clusters (HPCC); DOE JGI Community Sequencing Program under the Office of Science of the US DOE(United States Department of Energy (DOE)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Funding was provided by the US Department of Energy (DOE) Joint Genome Institute (JGI) Community Sequencing Program, Biosphere 2, BIO5, US National Science Foundation (NSF) OCE0940390, and Gordon and Betty Moore Foundation grants to M.B.S., as well as NSF OCE1233760 and Burroughs Wellcome Fund grants to J.S.W. We thank J. Fuhrman for suggesting stable-isotope-labelled host DNA; A. Z. Warden and the CANON Initiative for the cruise opportunity; Warden laboratory members; the captain and crew of the R/V Western Flyer for operational/sampling support; J. B. Waterbury, S. W. Chisholm and A. Wichels for strains; the Tucson Marine Phage laboratory; Institute of Groundwater Ecology of Helmholtz Munich; and N. Pace, M. Young, S. W. Chisholm and S. Yilmaz for technical/analytical support and manuscript comments. We acknowledge the University of Arizona Genetics Core for viral-tagging metagenomic sequencing; iCyt and the Arizona Cancer Center and Arizona Research Laboratories (ARL) Division of Biotechnology Cytometry Core Facility for cytometry support; the University Information Technology Services Research Computing Group and the ARL Biotechnology Computing for high-performance computing clusters (HPCC) access and support. Community metagenomic sequencing was provided by the DOE JGI Community Sequencing Program under the Office of Science of the US DOE contract no. DE-AC02-05CH11231.	Akhter S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks406; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Ceyssens PJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-134; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chen F, 2002, APPL ENVIRON MICROB, V68, P2589, DOI 10.1128/AEM.68.5.2589-2594.2002; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Deng L, 2008, FRESHWATER BIOL, V53, P1240, DOI 10.1111/j.1365-2427.2007.01947.x; Deng L, 2012, MBIO, V3, DOI 10.1128/mBio.00373-12; Duhaime MB, 2012, ENVIRON MICROBIOL, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fuller NJ, 1998, APPL ENVIRON MICROB, V64, P2051; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Holmfeldt K, 2013, P NATL ACAD SCI USA, V110, P12798, DOI 10.1073/pnas.1305956110; Holmfeldt K, 2012, APPL ENVIRON MICROB, V78, P892, DOI 10.1128/AEM.06580-11; Hurwitz BL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r123; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; John SG, 2011, ENV MICROBIOL REP, V3, P195, DOI 10.1111/j.1758-2229.2010.00208.x; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kuznetsov YG, 2012, MICRON, V43, P1336, DOI 10.1016/j.micron.2012.02.013; Labonte JM, 2013, ISME J, V7, P2169, DOI 10.1038/ismej.2013.110; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; Lu J, 2001, APPL ENVIRON MICROB, V67, P3285, DOI 10.1128/AEM.67.7.3285-3290.2001; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marston MF, 2009, ENVIRON MICROBIOL, V11, P2893, DOI 10.1111/j.1462-2920.2009.02037.x; Marston MF, 2003, APPL ENVIRON MICROB, V69, P4639, DOI 10.1128/AEM.69.8.4639-4647.2003; Millard AD, 2009, ENVIRON MICROBIOL, V11, P2370, DOI 10.1111/j.1462-2920.2009.01966.x; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Solonenko SA, 2013, METHOD ENZYMOL, V531, P143, DOI 10.1016/B978-0-12-407863-5.00008-3; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Wang K, 2008, ENVIRON MICROBIOL, V10, P300, DOI 10.1111/j.1462-2920.2007.01452.x; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P71; Weitz JS, 2013, TRENDS MICROBIOL, V21, P82, DOI 10.1016/j.tim.2012.11.003; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; WILSON WH, 1993, APPL ENVIRON MICROB, V59, P3736, DOI 10.1128/AEM.59.11.3736-3743.1993; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	58	125	125	2	108	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					242	+		10.1038/nature13459	http://dx.doi.org/10.1038/nature13459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043051				2022-12-24	WOS:000341362800052
J	Kupitz, C; Basu, S; Grotjohann, I; Fromme, R; Zatsepin, NA; Rendek, KN; Hunter, MS; Shoeman, RL; White, TA; Wang, DJ; James, D; Yang, JH; Cobb, DE; Reeder, B; Sierra, RG; Liu, HG; Barty, A; Aquila, AL; Deponte, D; Kirian, RA; Bari, S; Bergkamp, JJ; Beyerlein, KR; Bogan, MJ; Caleman, C; Chao, TC; Conrad, CE; Davis, KM; Fleckenstein, H; Galli, L; Hau-Riege, SP; Kassemeyer, S; Laksmono, H; Liang, MN; Lomb, L; Marchesini, S; Martin, AV; Messerschmidt, M; Milathianaki, D; Nass, K; Ros, A; Roy-Chowdhury, S; Schmidt, K; Seibert, M; Steinbrener, J; Stellato, F; Yan, LF; Yoon, C; Moore, TA; Moore, AL; Pushkar, Y; Williams, GJ; Boutet, S; Doak, RB; Weierstall, U; Frank, M; Chapman, HN; Spence, JCH; Fromme, P				Kupitz, Christopher; Basu, Shibom; Grotjohann, Ingo; Fromme, Raimund; Zatsepin, Nadia A.; Rendek, Kimberly N.; Hunter, Mark S.; Shoeman, Robert L.; White, Thomas A.; Wang, Dingjie; James, Daniel; Yang, Jay-How; Cobb, Danielle E.; Reeder, Brenda; Sierra, Raymond G.; Liu, Haiguang; Barty, Anton; Aquila, Andrew L.; Deponte, Daniel; Kirian, Richard A.; Bari, Sadia; Bergkamp, Jesse J.; Beyerlein, Kenneth R.; Bogan, Michael J.; Caleman, Carl; Chao, Tzu-Chiao; Conrad, Chelsie E.; Davis, Katherine M.; Fleckenstein, Holger; Galli, Lorenzo; Hau-Riege, Stefan P.; Kassemeyer, Stephan; Laksmono, Hartawan; Liang, Mengning; Lomb, Lukas; Marchesini, Stefano; Martin, Andrew V.; Messerschmidt, Marc; Milathianaki, Despina; Nass, Karol; Ros, Alexandra; Roy-Chowdhury, Shatabdi; Schmidt, Kevin; Seibert, Marvin; Steinbrener, Jan; Stellato, Francesco; Yan, Lifen; Yoon, Chunhong; Moore, Thomas A.; Moore, Ana L.; Pushkar, Yulia; Williams, Garth J.; Boutet, Sebastien; Doak, R. Bruce; Weierstall, Uwe; Frank, Matthias; Chapman, Henry N.; Spence, John C. H.; Fromme, Petra			Serial time-resolved crystallography of photosystem II using a femtosecond X-ray laser	NATURE			English	Article							OXYGEN-EVOLVING COMPLEX; FREE-ELECTRON LASER; WATER OXIDATION; PROTEIN NANOCRYSTALLOGRAPHY; MN4CA CLUSTER; STRUCTURAL MODELS; CRYSTAL-STRUCTURE; D1 POLYPEPTIDE; S-3 STATES; OMIT MAPS	Photosynthesis, a process catalysed by plants, algae and cyanobacteria converts sunlight to energy thus sustaining all higher life on Earth. Two large membrane protein complexes, photosystem I and II (PSI and PSII), act in series to catalyse the light-driven reactions in photosynthesis. PSII catalyses the light-driven water splitting process, which maintains the Earth's oxygenic atmosphere(1). In this process, the oxygen-evolving complex (OEC) of PSII cycles through five states, S-0 to S-4, in which four electrons are sequentially extracted from the OEC in four light-driven charge-separation events. Here we describe time resolved experiments on PSII nano/microcrystals from Thermosynechococcus elongatus performed with the recently developed(2) technique of serial femtosecond crystallography. Structures have been determined from PSII in the dark S-1 state and after double laser excitation (putative S-3 state) at 5 and 5.5 angstrom resolution, respectively. The results provide evidence that PSII undergoes significant conformational changes at the electron acceptor side and at the Mn4CaO5 core of the OEC. These include an elongation of the metal cluster, accompanied by changes in the protein environment, which could allow for binding of the second substrate water molecule between the more distant protruding Mn (referred to as the 'dangler' Mn) and the Mn3CaOx cubane in the S-2 to S-3 transition, as predicted by spectroscopic and computational studies(3,4). This work shows the great potential for time-resolved serial femtosecond crystallography for investigation of catalytic processes in biomolecules.	[Kupitz, Christopher; Basu, Shibom; Grotjohann, Ingo; Fromme, Raimund; Rendek, Kimberly N.; Hunter, Mark S.; Yang, Jay-How; Cobb, Danielle E.; Reeder, Brenda; Bergkamp, Jesse J.; Chao, Tzu-Chiao; Conrad, Chelsie E.; Ros, Alexandra; Roy-Chowdhury, Shatabdi; Moore, Thomas A.; Moore, Ana L.; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Zatsepin, Nadia A.; Wang, Dingjie; James, Daniel; Liu, Haiguang; Kirian, Richard A.; Schmidt, Kevin; Doak, R. Bruce; Weierstall, Uwe; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Hunter, Mark S.; Hau-Riege, Stefan P.; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Shoeman, Robert L.; Kassemeyer, Stephan; Lomb, Lukas; Nass, Karol; Steinbrener, Jan] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [White, Thomas A.; Barty, Anton; Aquila, Andrew L.; Deponte, Daniel; Kirian, Richard A.; Beyerlein, Kenneth R.; Caleman, Carl; Fleckenstein, Holger; Galli, Lorenzo; Liang, Mengning; Martin, Andrew V.; Nass, Karol; Stellato, Francesco; Yoon, Chunhong; Chapman, Henry N.] Ctr Free Elect Laser Sci, DESY, D-22607 Hamburg, Germany; [Sierra, Raymond G.; Bogan, Michael J.; Laksmono, Hartawan] SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA; [Aquila, Andrew L.; Yoon, Chunhong] European XFEL GmbH, D-22607 Hamburg, Germany; [Deponte, Daniel; Messerschmidt, Marc; Milathianaki, Despina; Seibert, Marvin; Williams, Garth J.; Boutet, Sebastien] Natl Accelerator Lab, Stanford Linear Accelerator Ctr SLAC, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Bari, Sadia; Kassemeyer, Stephan] Ctr Free Elect Laser Sci CFEL, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Bari, Sadia] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Caleman, Carl] Uppsala Univ, Dept Phys & Astron, SE-75237 Uppsala, Sweden; [Chao, Tzu-Chiao] Univ Regina, Regina, SK S4S 0A2, Canada; [Davis, Katherine M.; Yan, Lifen; Pushkar, Yulia] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Galli, Lorenzo; Nass, Karol; Chapman, Henry N.] Univ Hamburg, D-22761 Hamburg, Germany; [Marchesini, Stefano] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Martin, Andrew V.] Univ Melbourne, Dept Phys, Ctr Excellence Coherent Xray Sci, Dept ARC, Melbourne, Vic 3010, Australia; [Seibert, Marvin] Uppsala Univ, S-75312 Uppsala, Sweden; [Chapman, Henry N.] Ctr Ultrafast Imaging, D-22761 Hamburg, Germany	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; European XFEL; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Max Planck Society; Max Planck Society; Uppsala University; University of Regina; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Hamburg; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Melbourne; Uppsala University	Fromme, P (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	pfromme@asu.edu	Frank, Matthias/O-9055-2014; Bari, Sadia/E-6216-2015; Marchesini, Stefano/GYR-1409-2022; Chao, Tzu-Chiao/A-6400-2013; Basu, Shibom/GLU-3308-2022; Zatsepin, Nadia/AAF-2451-2019; Messerschmidt, Marc/Y-8929-2019; Barty, Anton/K-5137-2014; Messerschmidt, Marc/F-3796-2010; FRS, Henry N Chapman/G-2153-2010; Marchesini, Stefano/A-6795-2009; Stellato, Francesco/AAZ-4379-2020; Milathianaki, Despina/AAG-5381-2021; Yan, Lifen/P-3920-2018; Fromme, Raimund/AAG-6578-2019; Fromme, Raimund/C-8885-2012; Fromme, Raimund/W-5838-2019; Beyerlein, Kenneth/ABB-9823-2020; Nass, Karol/K-1970-2012	Bari, Sadia/0000-0003-3985-2051; Basu, Shibom/0000-0001-6484-8236; Messerschmidt, Marc/0000-0002-8641-3302; Barty, Anton/0000-0003-4751-2727; Messerschmidt, Marc/0000-0002-8641-3302; FRS, Henry N Chapman/0000-0002-4655-1743; Marchesini, Stefano/0000-0002-6798-2913; Fromme, Raimund/0000-0003-4835-1080; Fromme, Raimund/0000-0003-4835-1080; Beyerlein, Kenneth/0000-0002-7701-4369; Nass, Karol/0000-0001-8843-1566; Zatsepin, Nadia/0000-0003-1757-0205; White, Thomas/0000-0002-8407-0270; Seibert, Mark Marvin/0000-0003-0251-0744; liu, haiguang/0000-0001-7324-6632; Aquila, Andrew/0000-0003-0358-2774; Fromme, Petra/0000-0003-0953-4909; Frank, Matthias/0000-0002-5244-0791; Davis, Katherine/0000-0002-0258-8907; MARTIN, ANDREW/0000-0003-3704-1829; Schmidt, Kevin/0000-0002-1597-9835; Bergkamp, Jesse/0000-0003-3443-0255	Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center - DOE, Office of Basic Energy Sciences [DE-SC0001016]; National Institutes of Health [1R01GM095583]; US National Science Foundation [MCB-1021557, MCB-1120997]; DFG Clusters of Excellence 'Inflammation at Interfaces' [EXC 306]; DFG Clusters of Excellence 'Center for Ultrafast Imaging'; Max Planck Society, the Atomic, Molecular and Optical Sciences Program; Deutsche Forschungsgemeinschaft (DFG); Chemical Sciences Geosciences and Biosciences Division, DOE OBES; SLAC LDRD program; US DOE through Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; UCOP Lab Fee Program [118036]; LLNL LDRD program [12-ERD-031]; Hamburg Ministry of Science and Research; Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research; U.S. Department of Energy (DOE), Office of Basic Energy Sciences [DE-FG02-12ER16340]; National Science Foundation Graduate Research Fellowship [0833366]; National Science Foundation through the BioFEL Science Technology Center [1231306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583] Funding Source: NIH RePORTER	Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center - DOE, Office of Basic Energy Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); DFG Clusters of Excellence 'Inflammation at Interfaces'; DFG Clusters of Excellence 'Center for Ultrafast Imaging'; Max Planck Society, the Atomic, Molecular and Optical Sciences Program; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Chemical Sciences Geosciences and Biosciences Division, DOE OBES; SLAC LDRD program; US DOE through Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); UCOP Lab Fee Program; LLNL LDRD program; Hamburg Ministry of Science and Research; Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research; U.S. Department of Energy (DOE), Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation through the BioFEL Science Technology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Experiments were carried out at the Linac Coherent Light Source (LCLS), a national user facility operated by Stanford University on behalf of the US Department of Energy (DOE), Office of Basic Energy Sciences (OBES). This work was supported by the following agencies: the Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center funded by the DOE, Office of Basic Energy Sciences (award DE-SC0001016), the National Institutes of Health (award 1R01GM095583), the US National Science Foundation (award MCB-1021557 and MCB-1120997), the DFG Clusters of Excellence 'Inflammation at Interfaces' (EXC 306) and the 'Center for Ultrafast Imaging'; the Deutsche Forschungsgemeinschaft (DFG); the Max Planck Society, the Atomic, Molecular and Optical Sciences Program; Chemical Sciences Geosciences and Biosciences Division, DOE OBES (M.J.B.) and the SLAC LDRD program (M.J.B., H.L.); the US DOE through Lawrence Livermore National Laboratory under the contract DE-AC52-07NA27344 and supported by the UCOP Lab Fee Program (award no. 118036) and the LLNL LDRD program (12-ERD-031); the Hamburg Ministry of Science and Research and Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research. The research at Purdue University was supported by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences DE-FG02-12ER16340 (Y.P.) and the National Science Foundation Graduate Research Fellowship under Grant 0833366 (K.M.D.). We also want to thank the National Science Foundation for providing funding for the publication of this work through the BioFEL Science Technology Center (award 1231306). We thank H. Isobe, M. Shoji, S. Yamanaka, Y. Umena, K. Kawakami, N. Kamiya, J. R. Shen and K. Yamaguchi for permission to show a section of Fig. 6 of their publication ref. 4 in Fig. 3d of this publication. We thank R. Neutze and his team for support and discussions during joint beamtime for the PSII project and his projects on time-resolved wide-angle scattering studies. We thank A. T. Brunger for discussions concerning data analysis. We thank T. Terwilliger for support with parameter setting of phenix.autobuild program for the SA-omit maps. We also wish to thank R. Burnap for discussions concerning interpretation of results of ligand mutagenesis. We thank J. D. Zook for his contributions concerning plastoquinone quantification. We thank M. Zhu for helping to create high resolution figures for this publication. We thank Raytheon for support of our studies by providing night-vision devices.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; Aquila A, 2012, OPT EXPRESS, V20, P2706, DOI 10.1364/OE.20.002706; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5839, DOI 10.1021/bi00017a016; Cox N, 2013, ACCOUNTS CHEM RES, V46, P1588, DOI 10.1021/ar3003249; Dau H, 2012, CURR OPIN CHEM BIOL, V16, P3, DOI 10.1016/j.cbpa.2012.02.011; Davis KM, 2013, J PHYS CHEM B, V117, P9161, DOI 10.1021/jp403654n; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P11912, DOI 10.1021/bi010852r; Debus RJ, 2005, BIOCHEMISTRY-US, V44, P1367, DOI 10.1021/bi047558u; DEKKER JP, 1984, BIOCHIM BIOPHYS ACTA, V767, P176, DOI 10.1016/0005-2728(84)90093-8; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; Dilbeck PL, 2012, BIOCHEMISTRY-US, V51, P1079, DOI 10.1021/bi201659f; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Han GY, 2008, BBA-BIOENERGETICS, V1777, P496, DOI 10.1016/j.bbabio.2008.03.007; Han GY, 2012, J BIOL CHEM, V287, P13422, DOI 10.1074/jbc.M112.342543; Herrmann S, 2013, NUCL INSTRUM METH A, V718, P550, DOI 10.1016/j.nima.2013.01.057; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; Hundelt M, 1998, BIOCHEMISTRY-US, V37, P14450, DOI 10.1021/bi981164j; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kirian RA, 2010, OPT EXPRESS, V18, P5713, DOI 10.1364/OE.18.005713; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Lomb L, 2012, J APPL CRYSTALLOGR, V45, P674, DOI 10.1107/S0021889812024557; Luber S, 2011, BIOCHEMISTRY-US, V50, P6308, DOI 10.1021/bi200681q; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Navarro MP, 2013, P NATL ACAD SCI USA, V110, P15561, DOI 10.1073/pnas.1304334110; Neutze R, 2012, CURR OPIN STRUC BIOL, V22, P651, DOI 10.1016/j.sbi.2012.08.006; Philipp HT, 2011, NUCL INSTRUM METH A, V649, P67, DOI 10.1016/j.nima.2010.11.189; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; Read RJ, 2003, ACTA CRYSTALLOGR D, V59, P1891, DOI 10.1107/S0907444903017918; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Renger G, 2012, BBA-BIOENERGETICS, V1817, P1164, DOI 10.1016/j.bbabio.2012.02.005; Rivalta I, 2012, CURR OPIN CHEM BIOL, V16, P11, DOI 10.1016/j.cbpa.2012.03.003; Sauter NK, 2013, ACTA CRYSTALLOGR D, V69, P1274, DOI 10.1107/S0907444913000863; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Siegbahn PEM, 2013, J AM CHEM SOC, V135, P9442, DOI 10.1021/ja401517e; Spence JCH, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102601; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vellieux FMD, 1997, J APPL CRYSTALLOGR, V30, P396, DOI 10.1107/S0021889896012551; Wampler RD, 2008, J AM CHEM SOC, V130, P14076, DOI 10.1021/ja805983b; Weierstall U, 2008, EXP FLUIDS, V44, P675, DOI 10.1007/s00348-007-0426-8; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Yamaguchi K, 2013, INT J QUANTUM CHEM, V113, P453, DOI 10.1002/qua.24280; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837; Yano J, 2007, PHOTOSYNTH RES, V92, P289, DOI 10.1007/s11120-007-9153-5; Zouni A, 2000, BBA-BIOENERGETICS, V1457, P103, DOI 10.1016/S0005-2728(00)00100-6; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	59	335	361	6	413	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					261	+		10.1038/nature13453	http://dx.doi.org/10.1038/nature13453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043005	Green Accepted			2022-12-24	WOS:000341362800056
J	Halper-Stromberg, A; Lu, CL; Klein, F; Horwitz, JA; Bournazos, S; Nogueira, L; Eisenreich, TR; Liu, C; Gazumyan, A; Schaefer, U; Furze, RC; Seaman, MS; Prinjha, R; Tarakhovsky, A; Ravetch, JV; Nussenzweig, MC				Halper-Stromberg, Ariel; Lu, Ching-Lan; Klein, Florian; Horwitz, Joshua A.; Bournazos, Stylianos; Nogueira, Lilian; Eisenreich, Thomas R.; Liu, Cassie; Gazumyan, Anna; Schaefer, Uwe; Furze, Rebecca C.; Seaman, Michael S.; Prinjha, Rab; Tarakhovsky, Alexander; Ravetch, Jeffrey V.; Nussenzweig, Michel C.			Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice	CELL			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED RHESUS-MONKEYS; TO-CELL SPREAD; IMMUNE-RESPONSES; SYNERGISTIC ACTIVATION; MONOCLONAL-ANTIBODIES; IN-VIVO; MACAQUES; VIREMIA; CYTOTOXICITY	Latent reservoirs of HIV-1-infected cells are refractory to antiretroviral therapies (ART) and remain the major barrier to curing HIV-1. Because latently infected cells are long-lived, immunologically invisible, and may undergo homeostatic proliferation, a "shock and kill" approach has been proposed to eradicate this reservoir by combining ART with inducers of viral transcription. However, all attempts to alter the HIV-1 reservoir in vivo have failed to date. Using humanized mice, we show that broadly neutralizing antibodies (bNAbs) can interfere with establishment of a silent reservoir by Fc-FcR-mediated mechanisms. In established infection, bNAbs or bNAbs plus single inducers are ineffective in preventing viral rebound. However, bNAbs plus a combination of inducers that act by independent mechanisms synergize to decrease the reservoir as measured by viral rebound. Thus, combinations of inducers and bNAbs constitute a therapeutic strategy that impacts the establishment and maintenance of the HIV-1 reservoir in humanized mice.	[Halper-Stromberg, Ariel; Lu, Ching-Lan; Klein, Florian; Horwitz, Joshua A.; Nogueira, Lilian; Eisenreich, Thomas R.; Liu, Cassie; Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Lu, Ching-Lan] Weill Cornell Med Coll, New York, NY 10065 USA; [Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Schaefer, Uwe; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10065 USA; [Furze, Rebecca C.; Prinjha, Rab] GlaxoSmithKline, Med Res Ctr, Immuno Inflammat Therapy Area, Stevenage SG1 2NY, Herts, England; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Rockefeller University; Cornell University; Rockefeller University; Rockefeller University; GlaxoSmithKline; Harvard University; Beth Israel Deaconess Medical Center	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10065 USA.	nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Ravetch, Jeffrey/Z-1596-2019; Bournazos, Stylianos/ABH-1578-2021	Ravetch, Jeffrey/0000-0003-2024-9041; Liu, Cassie/0000-0003-3907-9409	National Institutes of Health (NIH) Medical Scientist Training Program [T32GM07739]; Bill and Melinda Gates Foundation with Comprehensive Antibody Vaccine Immune Monitoring Consortium [1032144]; Collaboration for AIDS Vaccine Discovery Grant [OPP1033115]; National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000043]; National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [AI100663-02]; National Institute Of Allergy and Infectious Diseases of the NIH [AI100148-02, AI081677-05]; American Heart Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148, P01AI081677, T32AI070084, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation with Comprehensive Antibody Vaccine Immune Monitoring Consortium; Collaboration for AIDS Vaccine Discovery Grant; National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; National Institute Of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Roberto Speck and Renier Myburgh for help manufacturing ART feed; CellDex Therapeutics for providing 3BNC117; and all members of the Nussenzweig Laboratory for helpful discussion and advice. This work was supported by the National Institutes of Health (NIH) Medical Scientist Training Program grant T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program (A.H.-S.); Bill and Melinda Gates Foundation with Comprehensive Antibody Vaccine Immune Monitoring Consortium Grant 1032144 (M.S.S.); and Collaboration for AIDS Vaccine Discovery Grant OPP1033115 (M.C.N. and J.V.R.). This work was also supported, in part, by grant # 8 UL1 TR000043 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery AI100663-02 (M.C.N.), and National Institute Of Allergy and Infectious Diseases of the NIH Grants AI100148-02 and AI081677-05 (M.C.N. and J.V.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. S.B. receives fellowship support from the American Heart Association. M.C.N. is a Howard Hughes Medical Institute Investigator. R.P. and R.F. are employees of GlaxoSmithKline (GSK).	Abela IA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002634; Agosto LM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003982; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2014, J INFECT DIS; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Brehm MA, 2014, J IMMUNOL METHODS, DOI 10.1016j.jim.02.011; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chung AW, 2011, P NATL ACAD SCI USA, V108, P7505, DOI 10.1073/pnas.1016048108; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Dar RD, 2014, SCIENCE, V344, P1392, DOI 10.1126/science.1250220; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dybul M, 2002, J INFECT DIS, V185, P61, DOI 10.1086/338123; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Ferrantelli F, 2007, VIROLOGY, V358, P69, DOI 10.1016/j.virol.2006.07.056; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Forthal D, 2013, CURR OPIN HIV AIDS, V8, P393, DOI 10.1097/COH.0b013e328363d486; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Horton HM, 2010, BLOOD, V116, P3004, DOI 10.1182/blood-2010-01-265280; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Krejsgaard T, 2010, EXP DERMATOL, V19, P1096, DOI 10.1111/j.1600-0625.2010.01138.x; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kwon ED, 1997, P NATL ACAD SCI USA, V94, P8099, DOI 10.1073/pnas.94.15.8099; Lafeuillade A, 2001, J ACQ IMMUN DEF SYND, V26, P44, DOI 10.1097/00126334-200101010-00006; Landovitz RJ, 2009, NEW ENGL J MED, V361, P1768, DOI 10.1056/NEJMcp0904189; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Malbec M, 2013, J EXP MED, V210, P2813, DOI 10.1084/jem.20131244; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nischang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038853; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Quivy V, 2002, J VIROL, V76, P11091, DOI 10.1128/JVI.76.21.11091-11103.2002; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Schiffner T, 2013, VACCINE, V31, P5789, DOI 10.1016/j.vaccine.2013.10.020; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Siliciano JD, 2013, CURR OPIN HIV AIDS, V8, P318, DOI 10.1097/COH.0b013e328361eaca; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sun Y, 2011, J VIROL, V85, P6906, DOI 10.1128/JVI.00326-11; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	66	274	279	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					989	999		10.1016/j.cell.2014.07.043	http://dx.doi.org/10.1016/j.cell.2014.07.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25131989	Bronze, Green Accepted			2022-12-24	WOS:000340945000006
J	Kranzusch, PJ; Lee, ASY; Wilson, SC; Solovykh, MS; Vance, RE; Berger, JM; Doudna, JA				Kranzusch, Philip J.; Lee, Amy S. Y.; Wilson, Stephen C.; Solovykh, Mikhail S.; Vance, Russell E.; Berger, James M.; Doudna, Jennifer A.			Structure-Guided Reprogramming of Human cGAS Dinucleotide Linkage Specificity	CELL			English	Article							CYCLIC GMP-AMP; DNA SENSOR; 2ND-MESSENGER; REVEALS; SYNTHASE; ROLES; MODEL	Cyclic dinucleotides (CDNs) play central roles in bacterial pathogenesis and innate immunity. The mammalian enzyme cGAS synthesizes a unique cyclic dinucleotide (cGAMP) containing a 2'-5' phosphodiester linkage essential for optimal immune stimulation, but the molecular basis for linkage specificity is unknown. Here, we show that the Vibrio cholerae pathogenicity factor DncV is a prokaryotic cGAS-like enzyme whose activity provides a mechanistic rationale for the unique ability of cGAS to produce 2'-5' cGAMP. Three high-resolution crystal structures show that DncV and human cGAS generate CDNs in sequential reactions that proceed in opposing directions. We explain 2' and 3' linkage specificity and test this model by reprogramming the human cGAS active site to produce 3'-5' cGAMP, leading to selective stimulation of alternative STING adaptor alleles in cells. These results demonstrate mechanistic homology between bacterial signaling and mammalian innate immunity and explain how active site configuration controls linkage chemistry for pathway-specific signaling.	[Kranzusch, Philip J.; Lee, Amy S. Y.; Solovykh, Mikhail S.; Vance, Russell E.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lee, Amy S. Y.; Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Berger, James M.] Johns Hopkins Univ, Sch Med, Dept Biophys, Baltimore, MD 21205 USA; [Kranzusch, Philip J.; Vance, Russell E.; Doudna, Jennifer A.] Univ Calif Berkeley, HHMI, Berkeley, CA 94720 USA; [Wilson, Stephen C.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Johns Hopkins University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Berger, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys, Baltimore, MD 21205 USA.	jmberger@jhmi.edu; doudna@berkeley.edu			HHMI; G. Harold and Leila Y. Mathers Foundation; National Cancer Institutes [CA077373]; National Institutes of Health [AI063302, AI080749, AI103817]; NIGMS Center for RNA Systems Biology; Life Sciences Research Foundation; American Cancer Society [PF-14-108-01-RMC]; NATIONAL CANCER INSTITUTE [R01CA077373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, R01AI080749, R21AI103817] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); G. Harold and Leila Y. Mathers Foundation; National Cancer Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS Center for RNA Systems Biology; Life Sciences Research Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	X-ray data were collected at Beamline 8.3.1 of the Lawrence Berkeley National Lab Advanced Light Source (ALS) and Beamlines 11.1 and 12.2 of the Stanford Synchrotron Radiation Lightsource (SSRL). The authors are grateful to J. Holton and G. Meigs (ALS); T. Doukov, S. Russi, and A. Gonzalez (SSRL) for technical assistance with data collection and processing; R. Nichiporuk (QB3 Mass Spectrometry Facility) for assistance with product determination; J. Cate, Y. Bai, S. Floor, R. Wilson, and members of the Doudna and Berger labs for helpful comments and discussion. This work was funded by HHMI (R.E.V. and J.A.D.); the G. Harold and Leila Y. Mathers Foundation (J.M.B.); National Cancer Institutes Grant CA077373 (J.M.B.); National Institutes of Health Grants AI063302, AI080749, and AI103817 (R.E.V.); and the NIGMS Center for RNA Systems Biology (A.S.Y.L. and J.A.D.). P.J.K. is supported as an HHMI Fellow of the Life Sciences Research Foundation, and A.S.Y.L. is supported as an American Cancer Society Postdoctoral Fellow (PF-14-108-01-RMC). R.E.V. and J.A.D. are HHMI Investigators.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Inn KS, 2011, MOL CELL, V41, P354, DOI 10.1016/j.molcel.2010.12.029; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kato K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076983; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Kranzusch PJ, 2011, P NATL ACAD SCI USA, V108, P19743, DOI 10.1073/pnas.1112742108; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Rahmeh AA, 2009, J VIROL, V83, P11043, DOI 10.1128/JVI.01426-09; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	33	73	85	3	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1011	1021		10.1016/j.cell.2014.07.028	http://dx.doi.org/10.1016/j.cell.2014.07.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25131990	Bronze, Green Accepted			2022-12-24	WOS:000340945000008
J	Cordova, JC; Olivares, AO; Shin, Y; Stinson, BM; Calmat, S; Schmitz, KR; Aubin-Tam, ME; Baker, TA; Lang, MJ; Sauer, RT				Cordova, Juan Carlos; Olivares, Adrian O.; Shin, Yongdae; Stinson, Benjamin M.; Calmat, Stephane; Schmitz, Karl R.; Aubin-Tam, Marie-Eve; Baker, Tania A.; Lang, Matthew J.; Sauer, Robert T.			Stochastic but Highly Coordinated Protein Unfolding and Translocation by the ClpXP Proteolytic Machine	CELL			English	Article							ATP-FUELED MACHINES; DEGRADATION MACHINE; PORE LOOPS; PLUS; DENATURATION; SPECIFICITY; STABILITY; DYNAMICS	ClpXP and other AAA+ proteases recognize, mechanically unfold, and translocate target proteins into a chamber for proteolysis. It is not known whether these remarkable molecular machines operate by a stochastic or sequential mechanism or how power strokes relate to the ATP-hydrolysis cycle. Single-molecule optical trapping allows ClpXP unfolding to be directly visualized and reveals translocation steps of similar to 1-4 nm in length, but how these activities relate to solution degradation and the physical properties of substrate proteins remains unclear. By studying single-molecule degradation using different multidomain substrates and ClpXP variants, we answer many of these questions and provide evidence for stochastic unfolding and translocation. We also present a mechanochemical model that accounts for single-molecule, biochemical, and structural results for our observation of enzymatic memory in translocation stepping, for the kinetics of translocation steps of different sizes, and for probabilistic but highly coordinated subunit activity within the ClpX ring.	[Cordova, Juan Carlos; Lang, Matthew J.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [Olivares, Adrian O.; Stinson, Benjamin M.; Calmat, Stephane; Schmitz, Karl R.; Baker, Tania A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Shin, Yongdae] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Calmat, Stephane; Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Aubin-Tam, Marie-Eve] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, NL-2628 CJ Delft, Netherlands; [Lang, Matthew J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA	Vanderbilt University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Delft University of Technology; Vanderbilt University	Lang, MJ (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.	matt.lang@vanderbilt.edu; bobsauer@mit.edu	Aubin-Tam, Marie-Eve/J-3337-2013	Aubin-Tam, Marie-Eve/0000-0001-9995-2623; /0000-0002-1081-285X; Shin, Yongdae/0000-0003-3441-1986; Schmitz, Karl/0000-0003-1411-7624; Sauer, Robert/0000-0002-1719-5399	NSF [0643745, MCB-1330792]; NIH [GM-101988]; Singapore-MIT Alliance for Re-search and Technology (SMART) program; HHMI; US Department of Education [P200A090323]; Samsung Foundation of Culture; Poitras predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101988] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT Alliance for Re-search and Technology (SMART) program(Singapore-MIT Alliance for Research & Technology Centre (SMART)); HHMI(Howard Hughes Medical Institute); US Department of Education(US Department of Education); Samsung Foundation of Culture(Samsung); Poitras predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NSF (Career Award 0643745; MCB-1330792), the NIH (GM-101988), the Singapore-MIT Alliance for Research and Technology (SMART) program, and HHMI. J.C.C. was supported by a GAANN fellowship from the US Department of Education under grant no. P200A090323. Y.S. was supported by a Samsung Scholarship from the Samsung Foundation of Culture. B.M.S. was supported by a Poitras predoctoral fellowship. T.A.B. is an employee of HHMI. We thank Jacob Kerssemakers for the MATLAB implementation of his step-finding algorithm.	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Little MA, 2011, BIOPHYS J, V101, P477, DOI 10.1016/j.bpj.2011.05.070; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; Popa I, 2013, J AM CHEM SOC, V135, P12762, DOI 10.1021/ja4056382; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Shin Y, 2009, P NATL ACAD SCI USA, V106, P19340, DOI 10.1073/pnas.0910484106; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5	29	90	91	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					647	658		10.1016/j.cell.2014.05.043	http://dx.doi.org/10.1016/j.cell.2014.05.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083874	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000340944300016
J	Ishimura, R; Nagy, G; Dotu, I; Zhou, HH; Yang, XL; Schimmel, P; Senju, S; Nishimura, Y; Chuang, JH; Ackerman, SL				Ishimura, Ryuta; Nagy, Gabor; Dotu, Ivan; Zhou, Huihao; Yang, Xiang-Lei; Schimmel, Paul; Senju, Satoru; Nishimura, Yasuharu; Chuang, Jeffrey H.; Ackerman, Susan L.			Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration	SCIENCE			English	Article							MESSENGER-RNA; IN-VIVO; TRANSLATION; MOUSE; DISSOCIATION; REVEALS; FAMILY; GTPBP2	In higher eukaryotes, transfer RNAs (tRNAs) with the same anticodon are encoded by multiple nuclear genes, and little is known about how mutations in these genes affect translation and cellular homeostasis. Similarly, the surveillance systems that respond to such defects in higher eukaryotes are not clear. Here, we discover that loss of GTPBP2, a novel binding partner of the ribosome recycling protein Pelota, in mice with a mutation in a tRNA gene that is specifically expressed in the central nervous system causes ribosome stalling and widespread neurodegeneration. Our results not only define GTPBP2 as a ribosome rescue factor but also unmask the disease potential of mutations in nuclear-encoded tRNA genes.	[Ishimura, Ryuta; Nagy, Gabor; Ackerman, Susan L.] Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; [Ishimura, Ryuta; Nagy, Gabor; Ackerman, Susan L.] Jackson Lab, Bar Harbor, ME 04609 USA; [Dotu, Ivan; Chuang, Jeffrey H.] Jackson Lab Genom Med, Farmington, CT 06030 USA; [Zhou, Huihao; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Senju, Satoru; Nishimura, Yasuharu] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Chuo Ku, Kumamoto 8608556, Japan	Howard Hughes Medical Institute; Jackson Laboratory; Jackson Laboratory; Scripps Research Institute; Kumamoto University	Ackerman, SL (corresponding author), Howard Hughes Med Inst, 600 Main St, Bar Harbor, ME 04609 USA.	susan.ackerman@jax.org	Yang, Xiang-Lei/AAR-7107-2020; ZHOU, HUIHAO/L-6133-2016	ZHOU, HUIHAO/0000-0002-9675-5007; Dotu, Ivan/0000-0002-0438-9557; Nagy, Gabor/0000-0001-7452-5174; Chuang, Jeffrey/0000-0002-3298-2358; Yang, Xiang-Lei/0000-0003-2554-084X	CORE grant [CA34196]; National Science Foundation [0850155]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085092, R21NS096600] Funding Source: NIH RePORTER	CORE grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Data were deposited in GenBank (GSE56127). We thank The Jackson Laboratory sequencing, histology, microinjection, and multimedia services for their assistance. We also thank K. Brown for mouse husbandry assistance and W. Frankel for comments on the manuscript. This work was supported in part by an institutional CORE grant CA34196 (JAX) and a National Science Foundation Award 0850155 to J.H.C. as part of the American Recovery and Reinvestment Act. S. L. A. is an investigator of the Howard Hughes Medical Institute.	Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Goldowitz D, 2004, MOL BRAIN RES, V132, P105, DOI 10.1016/j.molbrainres.2004.09.016; Goodenbour JM, 2006, NUCLEIC ACIDS RES, V34, P6137, DOI 10.1093/nar/gkl725; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kudo H, 2000, BIOCHEM BIOPH RES CO, V272, P456, DOI 10.1006/bbrc.2000.2763; LEVINGER L, 1995, J BIOL CHEM, V270, P18903, DOI 10.1074/jbc.270.32.18903; Levinger L, 2012, RNA BIOL, V9, P283, DOI 10.4161/rna.19025; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Rooijers K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3886; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Watanabe M, 2000, GENE, V256, P51, DOI 10.1016/S0378-1119(00)00346-2; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142	17	248	251	4	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					455	459		10.1126/science.1249749	http://dx.doi.org/10.1126/science.1249749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061210	Green Accepted			2022-12-24	WOS:000339655100044
J	Chong, SS; Chen, CY; Ge, H; Xie, XS				Chong, Shasha; Chen, Chongyi; Ge, Hao; Xie, X. Sunney			Mechanism of Transcriptional Bursting in Bacteria	CELL			English	Article							STOCHASTIC GENE-EXPRESSION; RNA-POLYMERASE MOLECULES; REAL-TIME OBSERVATION; SINGLE-MOLECULE; ESCHERICHIA-COLI; DNA GYRASE; FLUCTUATING ENVIRONMENTS; TOPOISOMERASE-I; OXOLINIC ACID; CENTRAL DOGMA	Transcription of highly expressed genes has been shown to occur in stochastic bursts. But the origin of such ubiquitous phenomenon has not been understood. Here, we present the mechanism in bacteria. We developed a high-throughput, in vitro, single-molecule assay to follow transcription on individual DNA templates in real time. We showed that positive supercoiling buildup on a DNA segment by transcription slows down transcription elongation and eventually stops transcription initiation. Transcription can be resumed upon gyrase binding to the DNA segment. Furthermore, using single-cell mRNA counting fluorescence in situ hybridization (FISH), we found that duty cycles of transcriptional bursting depend on the intracellular gyrase concentration. Together, these findings prove that transcriptional bursting of highly expressed genes in bacteria is primarily caused by reversible gyrase dissociation from and rebinding to a DNA segment, changing the supercoiling level of the segment.	[Chong, Shasha; Chen, Chongyi; Xie, X. Sunney] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Chen, Chongyi] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ge, Hao; Xie, X. Sunney] Peking Univ, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China; [Ge, Hao] Peking Univ, BICMR, Beijing 100871, Peoples R China	Harvard University; Harvard University; Peking University; Peking University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Chen, Chongyi/D-4178-2015	Chen, Chongyi/0000-0002-0504-5369; Chong, Shasha/0000-0002-5372-311X	NIH [1DP1OD000277, 5R01GM096450-02]; National Science Foundation of China [21373021]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201119]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Xiaowei Zhuang for the collaboration on bacterial chromosomal structure study, which prompted us to conduct the current study; N. Patrick Higgins for providing the plasmid containing strong gyrase site sequence; Gene-Wei Li for development of FISH protocol; Minbiao Ji for help with microscope construction; Rahul Roy for advice on data analysis; and James Wang, Long Cai, Gene-Wei Li, and Paul Choi for critical reading of the manuscript. This work was supported by NIH Pioneer Award (1DP1OD000277; to X.S.X.), NIH grant TR01 (5R01GM096450-02; to X.S.X.), National Science Foundation of China (21373021; to H.G.), and the Foundation for the Author of National Excellent Doctoral Dissertation of China (201119; to H.G.).	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Bai L, 2006, ANNU REV BIOPH BIOM, V35, P343, DOI 10.1146/annurev.biophys.35.010406.150153; BAKER TA, 1987, J BIOL CHEM, V262, P6877; Billingsley DJ, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/2/021001; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Deng S, 2004, P NATL ACAD SCI USA, V101, P3398, DOI 10.1073/pnas.0307550101; Deng S, 2005, MOL MICROBIOL, V57, P1511, DOI 10.1111/j.1365-2958.2005.04796.x; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Efron B., 1994, INTRO BOOTSTRAP; El Hanafi D, 2000, MOL MICROBIOL, V37, P583; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; FRANCO RJ, 1988, J MOL BIOL, V201, P229, DOI 10.1016/0022-2836(88)90449-4; Friedman LJ, 2012, CELL, V148, P679, DOI 10.1016/j.cell.2012.01.018; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gore J, 2006, NATURE, V439, P100, DOI 10.1038/nature04319; Guptasarma P, 1996, BIOESSAYS, V18, P325, DOI 10.1002/bies.950180411; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; Hebenstreit D, 2013, TRENDS GENET, V29, P333, DOI 10.1016/j.tig.2013.04.001; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; HIGGINS NP, 1982, NUCLEIC ACIDS RES, V10, P6833, DOI 10.1093/nar/10.21.6833; Hocine S, 2013, NAT METHODS, V10, P119, DOI 10.1038/nmeth.2305; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Leng FF, 2011, P NATL ACAD SCI USA, V108, P19973, DOI 10.1073/pnas.1109854108; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lim HM, 2003, BIOCHEMISTRY-US, V42, P10718, DOI 10.1021/bi030110t; Lionberger TA, 2010, BIOPHYS J, V99, P1139, DOI 10.1016/j.bpj.2010.04.074; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LYNCH AS, 1993, J BACTERIOL, V175, P1645, DOI 10.1128/JB.175.6.1645-1655.1993; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MAXWELL A, 1984, J BIOL CHEM, V259, P4472; Mitarai N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000109; MORRISON A, 1981, P NATL ACAD SCI-BIOL, V78, P1416, DOI 10.1073/pnas.78.3.1416; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RAU DC, 1987, J MOL BIOL, V193, P555, DOI 10.1016/0022-2836(87)90266-X; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Rovinskiy N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002845; Samul R, 2007, J MOL BIOL, V374, P925, DOI 10.1016/j.jmb.2007.10.011; Shundrovsky A, 2004, BIOPHYS J, V87, P3945, DOI 10.1529/biophysj.104.044081; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Skinner GM, 2004, J BIOL CHEM, V279, P3239, DOI 10.1074/jbc.M310471200; SNYDER M, 1979, J MOL BIOL, V131, P287, DOI 10.1016/0022-2836(79)90077-9; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; TENHEGGELERBORDIER B, 1992, EMBO J, V11, P667, DOI 10.1002/j.1460-2075.1992.tb05098.x; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; WILLMOTT CJR, 1994, J MOL BIOL, V242, P351, DOI 10.1006/jmbi.1994.1586; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; Zhang ZJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01775; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96	81	220	223	2	112	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					314	326		10.1016/j.cell.2014.05.038	http://dx.doi.org/10.1016/j.cell.2014.05.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036631	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000340943600012
J	Koton, S; Schneider, ALC; Rosamond, WD; Shahar, E; Sang, YY; Gottesman, RF; Coresh, J				Koton, Silvia; Schneider, Andrea L. C.; Rosamond, Wayne D.; Shahar, Eyal; Sang, Yingying; Gottesman, Rebecca F.; Coresh, Josef			Stroke Incidence and Mortality Trends in US Communities, 1987 to 2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; ISCHEMIC-STROKE; CARDIOVASCULAR-DISEASE; IMPROVED SURVIVAL; TEMPORAL TRENDS; INCIDENCE RATES; POPULATION; ATHEROSCLEROSIS; SEVERITY; AUCKLAND	IMPORTANCE Prior studies have shown decreases in stroke mortality over time, but data on validated stroke incidence and long-term trends by race are limited. OBJECTIVE To study trends in stroke incidence and subsequent mortality among black and white adults in the Atherosclerosis Risk in Communities (ARIC) cohort from 1987 to 2011. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of 14 357 participants (282 097 person-years) free of stroke at baseline was facilitated in 4 different US communities. Participants were recruited for the purpose of studying all stroke hospitalizations and deaths and for collection of baseline information on cardiovascular risk factors (via interviews and physical examinations) in 1987-1989. Participants were followed up (via examinations, annual phone interviews, active surveillance of discharges from local hospitals, and linkage with the National Death Index) through December 31, 2011. The study physician reviewers adjudicated all possible strokes and classified them as definite or probable ischemic or hemorrhagic events. MAIN OUTCOMES AND MEASURES Trends in rates of first-ever stroke per 10 years of calendar time were estimated using Poisson regression incidence rate ratios (IRRs), with subsequent mortality analyzed using Cox proportional hazards regression models and hazard ratios (HRs) overall and by race, sex, and age divided at 65 years. RESULTS Among 1051 (7%) participants with incident stroke, there were 929 with incident ischemic stroke and 140 with incident hemorrhagic stroke (18 participants had both during the study period). Crude incidence rates were 3.73 (95% CI, 3.51-3.96) per 1000 person-years for total stroke, 3.29 (95% CI, 3.08-3.50) per 1000 person-years for ischemic stroke, and 0.49 (95% CI, 0.41-0.57) per 1000 person-years for hemorrhagic stroke. Stroke incidence decreased over time in white and black participants (age-adjusted IRRs per 10-year period, 0.76 [95% CI, 0.66-0.87]; absolute decrease of 0.93 per 1000 person-years overall). The decrease in age-adjusted incidence was evident in participants age 65 years and older (age-adjusted IRR per 10-year period, 0.69 [95% CI, 0.59-0.81]; absolute decrease of 1.35 per 1000 person-years) but not evident in participants younger than 65 years (age-adjusted IRR per 10-year period, 0.97 [95% CI, 0.76-1.25]; absolute decrease of 0.09 per 1000 person-years) (P =.02 for interaction). The decrease in incidence was similar by sex. Of participants with incident stroke, 614 (58%) died through 2011. The mortality rate was higher for hemorrhagic stroke (68%) than for ischemic stroke (57%). Overall, mortality after stroke decreased over time (hazard ratio [HR], 0.80 [95% CI, 0.66-0.98]; absolute decrease of 8.09 per 100 strokes after 10 years [per 10-year period]). The decrease in mortality was mostly accounted for by the decrease at younger than age 65 years (HR, 0.65 [95% CI, 0.46-0.93]; absolute decrease of 14.19 per 100 strokes after 10 years [per 10-year period]), but was similar across race and sex. CONCLUSIONS AND RELEVANCE In a multicenter cohort of black and white adults in US communities, stroke incidence and mortality rates decreased from 1987 to 2011. The decreases varied across age groups, but were similar across sex and race, showing that improvements in stroke incidence and outcome continued to 2011. Copyright 2014 American Medical Association. All rights reserved.	[Koton, Silvia] Tel Aviv Univ, Sackler Fac Med, Stanley Steyer Sch Hlth Profess, IL-69978 Tel Aviv, Israel; [Koton, Silvia; Schneider, Andrea L. C.; Sang, Yingying; Gottesman, Rebecca F.; Coresh, Josef] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; [Rosamond, Wayne D.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Shahar, Eyal] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Div Epidemiol & Biostat, Tucson, AZ USA; [Gottesman, Rebecca F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA	Tel Aviv University; Sackler Faculty of Medicine; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of Arizona; Johns Hopkins University	Coresh, J (corresponding author), Johns Hopkins Univ, Dept Epidemiol, 2024 E Monument,Ste 2-630, Baltimore, MD 21287 USA.	coresh@jhu.edu	Gottesman, Rebecca/ABA-8468-2020	KOTON, SILVIA/0000-0002-9327-7505; Christman Schneider, Andrea Lauren/0000-0003-0026-5052	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Institutes of Health (NIH)/NHLBI [T32 HL007024]; NIH/NHLBI [R01 AG040282];  [U01 HL096812];  [HL096814];  [HL096899];  [HL096902];  [HL096917];  [R01-HL70825]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096902, U01HL096917, R01HL070825, T32HL007024, U01HL096812, U01HL096814, U01HL096899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040282] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH)/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Atherosclerosis Risk in Communities (ARIC) study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C) with neurocognitive studies supported by U01 HL096812, HL096814, HL096899, HL096902, HL096917, and with previous brain magnetic resonance imaging examinations funded by R01-HL70825. Dr Schneider reports receipt of grant support from the National Institutes of Health (NIH)/NHLBI T32 HL007024. Dr Gottesman reports receit of grant support from NIH/NHLBI R01 AG040282.	Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Anderson CS, 2005, STROKE, V36, P2087, DOI 10.1161/01.STR.0000181079.42690.bf; BRODERICK JP, 1989, STROKE, V20, P577, DOI 10.1161/01.STR.20.5.577; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Carter KN, 2007, CEREBROVASC DIS, V23, P162, DOI 10.1159/000097054; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Centers for Disease Control and Prevention National Center for Health Statistics, 2012, COMPL COMPR MORT FIL, V20; Chroinin DN, 2013, STROKE, V44, P448, DOI 10.1161/STROKEAHA.112.668277; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Islam SM, 2008, STROKE, V39, P776, DOI 10.1161/STROKEAHA.107.493643; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Kleindorfer DO, 2010, STROKE, V41, P1326, DOI 10.1161/STROKEAHA.109.575043; Koton S, 2010, NEUROEPIDEMIOLOGY, V34, P90, DOI 10.1159/000264826; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; MAY DS, 1994, STROKE, V25, P2343, DOI 10.1161/01.STR.25.12.2343; Medin J, 2004, STROKE, V35, P1047, DOI 10.1161/01.STR.0000125866.78674.96; Numminen H, 1996, STROKE, V27, P1487, DOI 10.1161/01.STR.27.9.1487; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rosengren A, 2013, STROKE, V44, P2388, DOI 10.1161/STROKEAHA.113.001170; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Schmidt M, 2014, NEUROLOGY, V82, P340, DOI 10.1212/WNL.0000000000000062; SHAHAR E, 1995, STROKE, V26, P1; Shahar E, 1997, STROKE, V28, P275, DOI 10.1161/01.STR.28.2.275; Sivenius J, 2004, STROKE, V35, P420, DOI 10.1161/01.STR.0000110220.63212.59; Thorvaldsen P, 1999, STROKE, V30, P2529, DOI 10.1161/01.STR.30.12.2529; Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	31	331	335	2	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					259	268		10.1001/jama.2014.7692	http://dx.doi.org/10.1001/jama.2014.7692			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	25027141	Bronze			2022-12-24	WOS:000338940300023
J	Brenguier, F; Campillo, M; Takeda, T; Aoki, Y; Shapiro, NM; Briand, X; Emoto, K; Miyake, H				Brenguier, F.; Campillo, M.; Takeda, T.; Aoki, Y.; Shapiro, N. M.; Briand, X.; Emoto, K.; Miyake, H.			Mapping pressurized volcanic fluids from induced crustal seismic velocity drops	SCIENCE			English	Article							TOHOKU EARTHQUAKE; FAULT; AFTERSHOCKS; SUBSIDENCE; ROCKS	Volcanic eruptions are caused by the release of pressure that has accumulated due to hot volcanic fluids at depth. Here, we show that the extent of the regions affected by pressurized fluids can be imaged through the measurement of their response to transient stress perturbations. We used records of seismic noise from the Japanese Hi-net seismic network to measure the crustal seismic velocity changes below volcanic regions caused by the 2011 moment magnitude (M-w) 9.0 Tohoku-Oki earthquake. We interpret coseismic crustal seismic velocity reductions as related to the mechanical weakening of the pressurized crust by the dynamic stress associated with the seismic waves. We suggest, therefore, that mapping seismic velocity susceptibility to dynamic stress perturbations can be used for the imaging and characterization of volcanic systems.	[Brenguier, F.; Campillo, M.; Briand, X.] Univ Grenoble 1, CNRS, Inst Sci Terre, F-38041 Grenoble, France; [Takeda, T.; Emoto, K.] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki, Japan; [Aoki, Y.; Miyake, H.] Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan; [Shapiro, N. M.] CNRS UMR7154, Sorbonne Paris Cite, Inst Phys Globe Paris, F-75238 Paris 5, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; National Research Institute for Earth Science & Disaster Resilience; University of Tokyo; UDICE-French Research Universities; Universite Paris Cite	Brenguier, F (corresponding author), Univ Grenoble 1, CNRS, Inst Sci Terre, F-38041 Grenoble, France.	florent.brenguier@ujf-grenoble.fr	Aoki, Yosuke/I-8801-2019; Brenguier, Florent/E-4843-2017; Campillo, Michel/K-6231-2012; Shapiro, Nikolai M/G-1049-2010; Campillo, Michel/AAC-5666-2019	Aoki, Yosuke/0000-0002-2539-4144; Brenguier, Florent/0000-0001-8684-7613; Campillo, Michel/0000-0001-6971-4499; Shapiro, Nikolai M/0000-0002-0144-723X; Campillo, Michel/0000-0001-6971-4499	Rhone-Alpes region [CPER07_13 CIRA]; France Grilles; CNRS MASTODONS program; French National Research Agency [2011-JAPN-006-NAMAZU]; Japan Science and Technology Agency [2011-JAPN-006-NAMAZU]; European Union through the projects European Research Council [227507, FP7 RI283542]; Grants-in-Aid for Scientific Research [25800244] Funding Source: KAKEN	Rhone-Alpes region(Region Auvergne-Rhone-Alpes); France Grilles; CNRS MASTODONS program; French National Research Agency(French National Research Agency (ANR)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); European Union through the projects European Research Council; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	All of the seismological data used in this study are archived at the Japanese National Research Institute for Earth Science and Disaster Prevention (NIED) (www.hinet.bosai.go.jp/?LANG=en and www.kyoshin.bosai.go.jp/). The seismological data used in this study are available upon request at the NIED data center. We thank Geospatial Information Authority of Japan for access to Global Navigation Satellite System data. All of the computations in this study were performed using the High-Performance Computing (CIMENT) infrastructure (https://ciment.ujf-grenoble.fr), which is supported by the Rhone-Alpes region (GRANT CPER07_13 CIRA: www.ci-ra.org), France Grilles (www.france-grilles.fr), and the CNRS MASTODONS program. We acknowledge the French National Research Agency and the Japan Science and Technology Agency for funding support (project 2011-JAPN-006-NAMAZU). We received support from the European Union through the projects European Research Council advanced grant 227507 "Whisper" and FP7 RI283542 "VERCE." We thank T. Nishimura, P. Johnson, G. Olivier, G. Hillers, C. Jaupart, and T. Lecocq for useful discussions.	Adams LH, 1923, J FRANKL INST, V195, P475, DOI 10.1016/S0016-0032(23)90314-5; Brenguier F, 2008, SCIENCE, V321, P1478, DOI 10.1126/science.1160943; Gomberg J, 1996, B SEISMOL SOC AM, V86, P212; Hirose F, 2011, EARTH PLANETS SPACE, V63, P513, DOI 10.5047/eps.2011.05.019; Husen S, 2004, GEOLOGY, V32, P537, DOI 10.1130/G20381.1; Husen S, 2004, J VOLCANOL GEOTH RES, V131, P397, DOI 10.1016/S0377-0273(03)00416-5; Lees JM, 2007, J VOLCANOL GEOTH RES, V167, P37, DOI 10.1016/j.jvolgeores.2007.06.008; LOCKNER DA, 1977, J GEOPHYS RES, V82, P5374, DOI 10.1029/JB082i033p05374; Pollitz FF, 2012, NATURE, V490, P250, DOI 10.1038/nature11504; Pritchard ME, 2013, NAT GEOSCI, V6, P632, DOI [10.1038/ngeo1855, 10.1038/NGEO1855]; Rubinstein JL, 2007, NATURE, V448, P579, DOI 10.1038/nature06017; Shapiro SA, 2003, GEOPHYSICS, V68, P482, DOI 10.1190/1.1567215; Takada Y, 2013, NAT GEOSCI, V6, P637, DOI [10.1038/ngeo1857, 10.1038/NGEO1857]; Wegler U, 2007, GEOPHYS J INT, V168, P1029, DOI 10.1111/j.1365-246X.2006.03284.x; Yukutake Y, 2011, EARTH PLANETS SPACE, V63, P737, DOI 10.5047/eps.2011.05.004; Zhao DP, 2002, PHYS EARTH PLANET IN, V132, P249, DOI 10.1016/S0031-9201(02)00082-1; Zigone D, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009160; Zinszner B, 1997, J GEOPHYS RES-SOL EA, V102, P8105, DOI 10.1029/96JB03225	18	165	170	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					80	82		10.1126/science.1254073	http://dx.doi.org/10.1126/science.1254073			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994652				2022-12-24	WOS:000338284400054
J	Qiao, S; Luo, QS; Zhao, Y; Zhang, XJC; Huang, YH				Qiao, Shuai; Luo, Qingshan; Zhao, Yan; Zhang, Xuejun Cai; Huang, Yihua			Structural basis for lipopolysaccharide insertion in the bacterial outer membrane	NATURE			English	Article							FUNCTIONAL-ANALYSIS; PROTEIN COMPLEX; CELL-ENVELOPE; TRANSPORT; IDENTIFICATION; MUTAGENESIS; BIOGENESIS; EXPORT; PLUG; LPTD	One of the fundamental properties of biological membranes is the asymmetric distribution of membrane lipids. In Gram-negative bacteria, the outer leaflet of the outer membrane is composed predominantly of lipopolysaccharides (LPS)(1). The export of LPS requires seven essential lipopolysaccharide transport (Lpt) proteins to move LPS from the inner membrane, through the periplasm to the surfac(2)e. Of the seven Lpt proteins, the LptD-LptE complex is responsible for inserting LPS into the external leaflet of the outer membrane(3,4). Here we report the crystal structure of the similar to 110-kilodalton membrane protein complex LptD-LptE from Shigella flexneri at 2.4 angstrom resolution. The structure reveals an unprecedented two-protein plug-and-barrel architecture with LptE embedded into a 26-stranded beta-barrel formed by LptD. Importantly, the secondary structures of the first two beta-strands are distorted by two proline residues, weakening their interactions with neighbouring beta-strands and creating a potential portal on the barrel wall that could allow lateral diffusion of LPS into the outer membrane. The crystal structure of the LptD-LptE complex opens the door to new antibiotic strategies targeting the bacterial outer membrane.	[Qiao, Shuai; Luo, Qingshan; Zhao, Yan; Zhang, Xuejun Cai; Huang, Yihua] Chinese Acad Sci, Inst Biophys, Natl Ctr Prot Sci Beijing, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Qiao, Shuai; Luo, Qingshan] Univ Chinese Acad Sci, Beijing 100101, Peoples R China; [Zhao, Yan] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Huang, YH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Ctr Prot Sci Beijing, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	yihuahuang@sun5.ibp.ac.cn		Qiao, Shuai/0000-0002-9573-8774	Ministry of Science and Technology [2012CB917302, 2013CB910603]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB080203]; National Natural Science Foundation of China [31170698]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Y. Shan for discussions, H. Wu, J. Deisenhofer, Y. Jiang, N. Huang, Z. Zhou, G. Li, Z. Liu and members of the Huang group for critically reading the manuscript. The diffraction data were collected at the Shanghai Synchrotron Radiation Facility (SSRF, China) and Beijing Synchrotron Radiation Facility of China (BSRF, China). This work was supported by grants from the Ministry of Science and Technology (2012CB917302 and 2013CB910603 to Y.H.), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB080203 to Y.H. and X.C.Z.) and the National Natural Science Foundation of China (31170698 to Y.H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; DeLano W. L., 2009, 238 ACS NAT M, V238; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Grabowicz M, 2013, J BACTERIOL, V195, P1327, DOI 10.1128/JB.02142-12; Khan MA, 2009, BIOCHEMISTRY-US, V48, P9745, DOI 10.1021/bi9013566; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MUHLRADT PF, 1975, EUR J BIOCHEM, V51, P343, DOI 10.1111/j.1432-1033.1975.tb03934.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; van den Berg B, 2010, CHEMBIOCHEM, V11, P1339, DOI 10.1002/cbic.201000105; Villa R, 2013, J BACTERIOL, V195, P1100, DOI 10.1128/JB.02057-12; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	30	169	176	3	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					108	U523		10.1038/nature13484	http://dx.doi.org/10.1038/nature13484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990751				2022-12-24	WOS:000338199400046
J	Pallotta, M; Schnurbusch, T; Hayes, J; Hay, A; Baumann, U; Paull, J; Langridge, P; Sutton, T				Pallotta, Margaret; Schnurbusch, Thorsten; Hayes, Julie; Hay, Alison; Baumann, Ute; Paull, Jeff; Langridge, Peter; Sutton, Tim			Molecular basis of adaptation to high soil boron in wheat landraces and elite cultivars	NATURE			English	Article							TRITICUM-AESTIVUM L.; TOXICITY TOLERANCE; AEGILOPS-TAUSCHII; DRAFT GENOME; BARLEY; GENES; IDENTIFICATION; EXPRESSION; EVOLUTION; SOFTWARE	Environmental constraints severely restrict crop yields inmost production environments, and expanding the use of variation will underpin future progress in breeding. In semi-arid environments boron toxicity constrains productivity, and genetic improvement is the only effective strategy for addressing the problem(1). Wheat breeders have sought and used available genetic diversity from landraces to maintain yield in these environments; however, the identity of the genes at the major tolerance loci was unknown. Here we describe the identification of near-identical, root-specific boron transporter genes underlying the two major-effect quantitative trait loci for boron tolerance in wheat, Bo1 and Bo4 (ref. 2). We show that tolerance to a high concentration of boron is associated with multiple genomic changes including tetraploid introgression, dispersed gene duplication, and variation in gene structure and transcript level. An allelic series was identified from a panel of bread and durum wheat cultivars and landraces originating from diverse agronomic zones. Our results demonstrate that, during selection, breeders have matched functionally different boron tolerance alleles to specific environments. The characterization of boron tolerance in wheat illustrates the power of the new wheat genomic resources to define key adaptive processes that have underpinned crop improvement.	[Pallotta, Margaret; Schnurbusch, Thorsten; Hayes, Julie; Hay, Alison; Baumann, Ute; Langridge, Peter; Sutton, Tim] Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Urrbrae, SA 5064, Australia; [Schnurbusch, Thorsten] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genebank Dept, D-06466 Gatersleben, Germany; [Paull, Jeff] Univ Adelaide, Sch Agr Food & Wine, Urrbrae, SA 5064, Australia	University of Adelaide; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Adelaide	Sutton, T (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Waite Campus, Urrbrae, SA 5064, Australia.	tim.sutton@acpfg.com.au	Langridge, Peter/G-5864-2010; Sutton, Tim/ABC-8454-2020; Schnurbusch, Thorsten/B-2249-2009	Langridge, Peter/0000-0001-9494-400X; Schnurbusch, Thorsten/0000-0002-5267-0677; Sutton, Timothy/0000-0002-9059-0774; Pallotta, Margaret/0000-0002-1642-5623; Hayes, Julie/0000-0001-8716-5024	Australian Research Council; Grains Research and Development Corporation; South Australian Government	Australian Research Council(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp); South Australian Government	We thank N. Collins, J. Dvorjak, H. Kuchel, D. Mares, S. Wu, the John Innes Centre, the Biotechnology and Biological Sciences Research Council, the Institut National de la Recherche Agronomique and the International Wheat Genome Sequencing Consortium for resources, and J. Tiong, T. Oz and A. Pohlen for assistance. The authors are supported by grants from the Australian Research Council, the Grains Research and Development Corporation and the South Australian Government.	Akhunov ED, 2007, MOL BIOL EVOL, V24, P539, DOI 10.1093/molbev/msl183; Allouis S, 2003, CEREAL RES COMMUN, V31, P331; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Chantachume Y, 1995, PLANT SOIL, V177, P249, DOI 10.1007/BF00010131; Chantachume Y., 1995, THESIS U ADELAIDE; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Jamjod S., 1996, THESIS U ADELAIDE; Jefferies SP, 1999, THEOR APPL GENET, V98, P1293, DOI 10.1007/s001220051195; Jefferies SP, 2000, THEOR APPL GENET, V101, P767, DOI 10.1007/s001220051542; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Lai KT, 2012, PLANT CELL PHYSIOL, V53, DOI 10.1093/pcp/pcr141; Leaungthitikanchana S, 2013, PLANT CELL PHYSIOL, V54, P1056, DOI 10.1093/pcp/pct059; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Mares D, 2008, J CEREAL SCI, V47, P6, DOI 10.1016/j.jcs.2007.01.005; Mathews KL, 2011, CROP PASTURE SCI, V62, P313, DOI 10.1071/CP10318; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; McDonald GK, 2012, CROP PASTURE SCI, V63, P1043, DOI 10.1071/CP12244; McIntosh R., 2008, P 11 INT WHEAT GEN S; Miwa K, 2010, ANN BOT-LONDON, V105, P1103, DOI 10.1093/aob/mcq044; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; Pallotta MA, 2000, THEOR APPL GENET, V101, P1100, DOI 10.1007/s001220051585; Pallotta MA, 2003, PROC INT WHEAT GENET, V2, P789; PAULL JG, 1991, EUPHYTICA, V55, P217, DOI 10.1007/BF00021242; PAULL JG, 1992, PLANT SOIL, V146, P251, DOI 10.1007/BF00012019; Paull JG, 1993, P 8 INT WHEAT GEN S, V2, P1065; Preuss CP, 2010, PLANT PHYSIOL, V152, P1431, DOI 10.1104/pp.109.152009; Reid R, 2007, PLANT CELL PHYSIOL, V48, P1673, DOI 10.1093/pcp/pcm159; Rerkasem B, 1997, EUPHYTICA, V96, P257, DOI 10.1023/A:1003093532561; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schnurbusch T, 2008, GENOME, V51, P963, DOI 10.1139/G08-084; Schnurbusch T, 2007, THEOR APPL GENET, V115, P451, DOI 10.1007/s00122-007-0579-0; Schnurbusch T, 2010, PLANT PHYSIOL, V153, P1706, DOI 10.1104/pp.110.158832; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yau SK, 2008, CROP SCI, V48, P854, DOI 10.2135/cropsci2007.10.0539	40	69	69	4	129	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					88	+		10.1038/nature13538	http://dx.doi.org/10.1038/nature13538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25043042				2022-12-24	WOS:000342420800041
J	Zhang, SY; Xu, M; Kamigaki, T; Do, JPH; Chang, WC; Jenvay, S; Miyamichi, K; Luo, LQ; Dan, Y				Zhang, Siyu; Xu, Min; Kamigaki, Tsukasa; Johnny Phong Hoang Do; Chang, Wei-Cheng; Jenvay, Sean; Miyamichi, Kazunari; Luo, Liqun; Dan, Yang			Long-range and local circuits for top-down modulation of visual cortex processing	SCIENCE			English	Article							FRONTAL EYE FIELD; FEATURE-BASED ATTENTION; AREA V4; SPATIAL ATTENTION; CORTICAL AREAS; INTERNEURONS; ORGANIZATION; MECHANISMS; NEURONS; SIGNALS	Top-down modulation of sensory processing allows the animal to select inputs most relevant to current tasks. We found that the cingulate (Cg) region of the mouse frontal cortex powerfully influences sensory processing in the primary visual cortex (V1) through long-range projections that activate local gamma-aminobutyric acid-ergic (GABAergic) circuits. Optogenetic activation of Cg neurons enhanced V1 neuron responses and improved visual discrimination. Focal activation of Cg axons in V1 caused a response increase at the activation site but a decrease at nearby locations (center-surround modulation). Whereas somatostatin-positive GABAergic interneurons contributed preferentially to surround suppression, vasoactive intestinal peptide-positive interneurons were crucial for center facilitation. Long-range corticocortical projections thus act through local microcircuits to exert spatially specific top-downmodulation of sensory processing.	[Zhang, Siyu; Xu, Min; Kamigaki, Tsukasa; Johnny Phong Hoang Do; Chang, Wei-Cheng; Jenvay, Sean; Dan, Yang] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst,Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Miyamichi, Kazunari; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Stanford University	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst,Howard Hughes Med Inst, Berkeley, CA 94720 USA.	ydan@berkeley.edu	Miyamichi, Kazunari/AAO-3705-2021; Xu, Min/AGD-5135-2022	Xu, Min/0000-0002-6936-7543; Zhang, Siyu/0000-0001-7298-1475; Kamigaki, Tsukasa/0000-0002-5184-708X; Luo, Liqun/0000-0001-5467-9264; Dan, Yang/0000-0002-3818-877X; Zhang, Siyu/0000-0003-1745-2532	NIH [R01 EY018861]; NSF [22250400-42533]; Uehara Memorial Foundation; Human Frontier Science Program; NATIONAL EYE INSTITUTE [R01EY018861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Human Frontier Science Program(Human Frontier Science Program); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank L. Pinto and Y. Zhu for help with data analysis; S. H. Lee and M. Zhao for technical assistance; Standford Neuroscience Gene Vector and Virus Core for AAV-DJ supply; K. Deisseroth, E. Callaway, B. Lim, and B. C. Weissbourd for virus and constructs; and R. Desimone, L. Wang, and M. A. Segraves for helpful discussions. This work was supported by NIH grant R01 EY018861, NSF grant 22250400-42533, a Uehara Memorial Foundation fellowship, and the Human Frontier Science Program. All primary histological, electrophysiological, and behavioral data are archived in the Department of Molecular and Cell Biology, University of California, Berkeley.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Ardid S, 2007, J NEUROSCI, V27, P8486, DOI 10.1523/JNEUROSCI.1145-07.2007; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Mysore SP, 2013, NAT NEUROSCI, V16, P473, DOI 10.1038/nn.3352; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zhou HH, 2011, NEURON, V70, P1205, DOI 10.1016/j.neuron.2011.04.032	40	419	422	8	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					660	665		10.1126/science.1254126	http://dx.doi.org/10.1126/science.1254126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104383	Green Accepted			2022-12-24	WOS:000339962800036
J	Paszek, MJ; DuFort, CC; Rossier, O; Bainer, R; Mouw, JK; Godula, K; Hudak, JE; Lakins, JN; Wijekoon, AC; Cassereau, L; Rubashkin, MG; Magbanua, MJ; Thorn, KS; Davidson, MW; Rugo, HS; Park, JW; Hammer, DA; Giannone, G; Bertozzi, CR; Weaver, VM				Paszek, Matthew J.; DuFort, Christopher C.; Rossier, Olivier; Bainer, Russell; Mouw, Janna K.; Godula, Kamil; Hudak, Jason E.; Lakins, Jonathon N.; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Magbanua, Mark J.; Thorn, Kurt S.; Davidson, Michael W.; Rugo, Hope S.; Park, John W.; Hammer, Daniel A.; Giannone, Gregory; Bertozzi, Carolyn R.; Weaver, Valerie M.			The cancer glycocalyx mechanically primes integrin-mediated growth and survival	NATURE			English	Article							CELL-ADHESION; X-RAY; MICROSCOPY; RECEPTOR; GLYCOPOLYMERS; HYALURONAN; SCATTERING; NANOSCALE; DYNAMICS; TENSION	Malignartcy is associated with altered expression of glycans and glycoprotems that contribute the cellular glycocalyx. We constructed a glycoprotein expression signature, which revealed that metastatic tumours upregulate expression of bulky glycoproteins. A computational model predicted that these glycoproteins would influence transmembrane receptor spatial organization and function. We tested this prediction by investigating whether bulky glycoproteins in the glycocalyx promote a tumour phenotype in human cells by increasing integrin adhesion and signalling. Our data revealed that a bulky glycocalyx facilitates integrin clustering by funnelling active integrins into adhesions and altering integrin state by applying tension to matrix-bound integrins, independent of actomyosin contractility. Expression of large tumour-associated glycoproteins in non-transformed mammary cells promoted focal adhesion assembly and facilitated integrin dependent growth factor signalling to support cell growth and survival. Clinical studies revealed that large glycoproteins are abundantly expressed on circulating tumour cells from patients with advanced disease. Thus, a bulky glycocalyx is a feature of tumour cells that could foster metastasis by mechanically enhancing cell-surface receptor function.	[Paszek, Matthew J.; DuFort, Christopher C.; Bainer, Russell; Mouw, Janna K.; Lakins, Jonathon N.; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Paszek, Matthew J.; DuFort, Christopher C.; Bainer, Russell; Mouw, Janna K.; Lakins, Jonathon N.; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Weaver, Valerie M.] Univ Calif San Francisco, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Paszek, Matthew J.; DuFort, Christopher C.; Bainer, Russell; Wijekoon, Amanda C.; Cassereau, Luke; Rubashkin, Matthew G.; Weaver, Valerie M.] Univ Calif Berkeley, Bay Area Phys Sci Oncol Program, Berkeley, CA 94720 USA; [Paszek, Matthew J.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Paszek, Matthew J.] Cornell Univ, Cornell Nanoscale Sci, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Paszek, Matthew J.] Cornell Univ, Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY 14853 USA; [Rossier, Olivier; Giannone, Gregory] Univ Bordeaux, UMR 5297, Interdisciplinary Inst Neurosci, F-33000 Bordeaux, France; [Rossier, Olivier; Giannone, Gregory] Univ Bordeaux, CNRS, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Godula, Kamil; Hudak, Jason E.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Godula, Kamil] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Magbanua, Mark J.; Rugo, Hope S.; Park, John W.; Weaver, Valerie M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Magbanua, Mark J.; Rugo, Hope S.; Park, John W.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Thorn, Kurt S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA; [Hammer, Daniel A.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Hammer, Daniel A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol Biol, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Cornell University; Cornell University; Cornell University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Pennsylvania; University of Pennsylvania; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.	Valerie.Weaver@ucsfmedctr.org	Rossier, Olivier M/I-6569-2013	Rossier, Olivier M/0000-0002-6932-931X; Thorn, Kurt/0000-0001-9310-288X; Weaver, Valerie marie/0000-0003-4786-6752; Mouw, Janna K/0000-0002-9846-8466; Giannone, Gregory/0000-0002-0932-1690	Kavli Institute; UCSF Program for Biomedical Breakthrough postdoctoral fellowships; DoD NDSEG Fellowship; NIH Pathway to Independence Award [K99 EB013446-02]; French Ministry of Research; CNRS; ANR grant Nanomotility; INSERM; Fondation ARC pour la Recherche sur le Cancer; Conseil Regional Aquitaine; NIH [AI082292-03A1, 2R01GM059907-13, GM59907]; Breast Cancer Research Foundation; BCRP DOD Era of Hope Scholar Expansion grant [BC122990]; NIH NCI [U54CA163155-01, U54CA143836-01, 1U01 E5019458-01, CA138818-01A1]; France BioImaging [ANR-10-INBS-04-01]; NATIONAL CANCER INSTITUTE [U54CA163155, R01CA138818, U54CA143836, U01CA151925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K99EB013446, R00EB013446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, R01GM059907] Funding Source: NIH RePORTER	Kavli Institute; UCSF Program for Biomedical Breakthrough postdoctoral fellowships; DoD NDSEG Fellowship; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministry of Research(Ministry of Research, FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR grant Nanomotility(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Conseil Regional Aquitaine(Region Nouvelle-Aquitaine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; BCRP DOD Era of Hope Scholar Expansion grant; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); France BioImaging(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Gendler, J. Goedhart and M. McMahon for cDNAs, as indicated in the Methods section. We thank A. Walker for bioinformatics support, L. Hauranieh for assistance in CTC analysis, H. Aaron for assistance with FLIM, J. B. Sibarita and M. Lagardere for support in sptPALM analysis, B. Hoffman in design of the FRET sensor, and T. Wittmann in assistance with pbFRET measurements. Image acquisition was partly performed at the Nikon Imaging Center and Biological Imaging Development Center at UCSF and the Berkeley Molecular Imaging Center. This work was supported by the Kavli Institute and UCSF Program for Biomedical Breakthrough postdoctoral fellowships to M.J.P.; DoD NDSEG Fellowship to M.G.R.; NIH GM59907 to C.R.B.; NIH Pathway to Independence Award K99 EB013446-02 to K.G.; French Ministry of Research, CNRS,ANR grant Nanomotility, INSERM, Fondation ARC pour la Recherche sur le Cancer, France BioImaging ANR-10-INBS-04-01, and Conseil Regional Aquitaine to O.R. and G.G.; NIH AI082292-03A1 to D.A.H.; The Breast Cancer Research Foundation to M.J.M., H.S.R. and J.W.P.; NIH 2R01GM059907-13 to C.R.B. and V.M.W.; and BCRP DOD Era of Hope Scholar Expansion grant BC122990, and NIH NCI grants U54CA163155-01, U54CA143836-01, 1U01 E5019458-01, and CA138818-01A1 to V.M.W.	Bono P, 2001, MOL BIOL CELL, V12, P891, DOI 10.1091/mbc.12.4.891; Bruns N, 2009, ANGEW CHEM INT EDIT, V48, P5666, DOI 10.1002/anie.200900554; Chen W, 2012, J CELL BIOL, V199, P497, DOI 10.1083/jcb.201201091; Comoletti D, 2007, STRUCTURE, V15, P693, DOI 10.1016/j.str.2007.04.010; Coombs D, 2004, BIOPHYS J, V86, P1408, DOI 10.1016/S0006-3495(04)74211-3; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dustin ML, 2012, J CLIN INVEST, V122, P1149, DOI 10.1172/JCI58705; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Friedrichs J, 2010, NAT PROTOC, V5, P1353, DOI 10.1038/nprot.2010.89; Godula K, 2009, J AM CHEM SOC, V131, P10263, DOI 10.1021/ja903114g; Godula K, 2009, ANGEW CHEM INT EDIT, V48, P4973, DOI 10.1002/anie.200805756; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Groves JT, 2007, ANNU REV PHYS CHEM, V58, P697, DOI 10.1146/annurev.physchem.56.092503.141216; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lakins Johnathon N, 2012, Methods Mol Biol, V916, P317, DOI 10.1007/978-1-61779-980-8_24; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lundmark R, 2010, SEMIN CELL DEV BIOL, V21, P363, DOI 10.1016/j.semcdb.2009.11.014; Magbanua MJM, 2013, CANCER RES, V73, P30, DOI 10.1158/0008-5472.CAN-11-3017; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Pankov Roumen, 2009, V522, P261, DOI 10.1007/978-1-59745-413-1_18; Paszek MJ, 2012, NAT METHODS, V9, DOI [10.1038/nmeth.2077, 10.1038/NMETH.2077]; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Varki A., 2009, ESSENTIALS GLYCOBIOL; Walker JL, 2005, CYTOKINE GROWTH F R, V16, P395, DOI 10.1016/j.cytogfr.2005.03.003	35	427	430	15	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					319	+		10.1038/nature13535	http://dx.doi.org/10.1038/nature13535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030168	Green Accepted			2022-12-24	WOS:000338992200029
J	Mahonen, AP; ten Tusscher, K; Siligato, R; Smetana, O; Diaz-Trivino, S; Salojarvi, J; Wachsman, G; Prasad, K; Heidstra, R; Scheres, B				Maehoenen, Ari Pekka; ten Tusscher, Kirsten; Siligato, Riccardo; Smetana, Ondrej; Diaz-Trivino, Sara; Salojaervi, Jarkko; Wachsman, Guy; Prasad, Kalika; Heidstra, Renze; Scheres, Ben			PLETHORA gradient formation mechanism separates auxin responses	NATURE			English	Article							INFLAMMATORY BREAST-CANCER; CHEMOATTRACTANT PROTEIN-1; TRANSCRIPTION FACTORS; CARCINOMA CELLS; ARABIDOPSIS; ROOT; ANGIOGENESIS; EXPRESSION; TRANSPORT; GROWTH	During plant growth, dividing cells in meristems must coordinate transitions from division to expansion and differentiation, thus generating three distinct developmental zones: the meristem, elongation zone and differentiation zone(1). Simultaneously, plants display tropisms, rapid adjustments of their direction of growth to adapt to environmental conditions. It is unclear how stable zonation is maintained during transient adjustments in growth direction. In Arabi-dopsis roots, many aspects of zonation are controlled by the phytohormone auxin and auxin-induced PLETHORA(PLT) transcription factors, both of which display a graded distribution with a maximum near the root tip(2-12). In addition, auxin is also pivotal for tropic responses(13,14). Here, using an iterative experimental and computational approach, we show how an interplay between auxin and PLTs controls zonation and gravitropism. We find that the PLT gradient is not a direct, proportionate readout of the auxin gradient. Rather, prolonged high auxin levels generate a narrow PLT transcription domain from which a gradient of PLT protein is subsequently generated through slow growth dilution and cell-to-cell movement. The resulting PLT levels define the location of developmental zones. In addition to slowly promoting PLT transcription, auxin also rapidly influences division, expansion and differentiation rates. We demonstrate how this specific regulatory design in which auxin cooperates with PLTs through different mechanisms and on different time scales enables both the fast tropic environmental responses and stable zonation dynamics necessary for coordinated cell differentiation.	[Maehoenen, Ari Pekka; Siligato, Riccardo; Smetana, Ondrej] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Maehoenen, Ari Pekka; Diaz-Trivino, Sara; Wachsman, Guy; Prasad, Kalika; Heidstra, Renze; Scheres, Ben] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Maehoenen, Ari Pekka; Siligato, Riccardo; Smetana, Ondrej; Salojaervi, Jarkko] Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland; [ten Tusscher, Kirsten] Univ Utrecht, NL-3584 CH Utrecht, Netherlands; [Diaz-Trivino, Sara; Heidstra, Renze; Scheres, Ben] Wageningen Univ Res, NL-6708 PB Wageningen, Netherlands	University of Helsinki; Utrecht University; University of Helsinki; Utrecht University; Wageningen University & Research	Mahonen, AP (corresponding author), Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland.	AriPekka.Mahonen@helsinki.fi; ben.scheres@wur.nl	Tusscher, Kirsten HWJ ten/B-9427-2011; Mähönen, Ari Pekka/B-9764-2015; Salojärvi, Jarkko/E-9103-2016; Prasad, Kalika/AAS-6293-2020	Mähönen, Ari Pekka/0000-0001-6051-866X; Salojärvi, Jarkko/0000-0002-4096-6278; Prasad, Kalika/0000-0001-8666-856X; Scheres, Ben/0000-0001-5400-9578; Siligato, Riccardo/0000-0002-1310-2757	Human Frontier Science Program fellowship; European Research Council Advanced Investigator Fellowship SysArc; SPINOZA award; ALW-NWO European Research Area Network Plant Genomics (ERAPG) grant [855.50.017]; Academy of Finland; Biocentrum Helsinki; University of Helsinki; Integrative Life Science Doctoral Program; Marie Curie Intra-European Fellowship [IEF-2008-237643]; Netherlands Organisation for Scientific Research (NWO)-Horizon grant; NWO-ALW grant; EMBO Long-term fellowship	Human Frontier Science Program fellowship(Human Frontier Science Program); European Research Council Advanced Investigator Fellowship SysArc; SPINOZA award; ALW-NWO European Research Area Network Plant Genomics (ERAPG) grant; Academy of Finland(Academy of Finland); Biocentrum Helsinki; University of Helsinki; Integrative Life Science Doctoral Program; Marie Curie Intra-European Fellowship(European Commission); Netherlands Organisation for Scientific Research (NWO)-Horizon grant(Netherlands Organization for Scientific Research (NWO)); NWO-ALW grant; EMBO Long-term fellowship(European Molecular Biology Organization (EMBO))	We thank M. Grebe, P. Benfey and K.-i. Hayashi for materials; the Light Microscopy Unit (Institute of Biotechnology), S. El-Showk, A.-M. Bagman, J. van Amerongen and F. Kindt for technical advice or assistance. This work is supported by a Human Frontier Science Program fellowship (A. P. M.), European Research Council Advanced Investigator Fellowship SysArc (B. S.), SPINOZA award (B. S., K.t.T., K. P.), ALW-NWO European Research Area Network Plant Genomics (ERAPG) grant 855.50.017 (S.D.-T.), the Academy of Finland (A. P. M., R. S., O.S., J. S.), Biocentrum Helsinki and University of Helsinki (A. P. M., R. S., O.S.), Integrative Life Science Doctoral Program (R. S.), Marie Curie Intra-European Fellowship (IEF-2008-237643) (S.D.-T.), the Netherlands Organisation for Scientific Research (NWO)-Horizon grant (R. H.), NWO-ALW grant (G. W.), and EMBO Long-term fellowship (A. P. M., K.P.).	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Band LR, 2014, PLANT CELL, V26, P862, DOI 10.1105/tpc.113.119495; Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; Beemster GTS, 2000, PLANT PHYSIOL, V124, P1718, DOI 10.1104/pp.124.4.1718; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bonapace L, 2012, J MAMMARY GLAND BIOL, V17, P125, DOI 10.1007/s10911-012-9250-8; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; DOLAN L, 1993, DEVELOPMENT, V119, P71; Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F; Goldman M, 2013, NUCLEIC ACIDS RES, V41, pD949, DOI 10.1093/nar/gks1008; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hayashi K, 2012, ACS CHEM BIOL, V7, P590, DOI 10.1021/cb200404c; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Hofhuis H, 2013, CURR BIOL, V23, P956, DOI 10.1016/j.cub.2013.04.048; Ibanes M, 2006, MOL SYST BIOL, V2, DOI 10.1038/mbs4100098; Ishida T, 2010, DEVELOPMENT, V137, P63, DOI 10.1242/dev.035840; Karnoub Antoine E, 2006, Breast Dis, V26, P75; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; PALANGIE T, 1994, EUR J CANCER, V30A, P921, DOI 10.1016/0959-8049(94)90115-5; Petersson SV, 2009, PLANT CELL, V21, P1659, DOI 10.1105/tpc.109.066480; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Pinon V, 2013, P NATL ACAD SCI USA, V110, P1107, DOI 10.1073/pnas.1213497110; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Schmittgen TD, 2001, METHODS, V25, P383, DOI 10.1006/meth.2001.1260; Strachan DC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26968; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Valkovic T, 1998, PATHOL RES PRACT, V194, P335, DOI 10.1016/S0344-0338(98)80057-5; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Wani AA, 2011, ONCOGENE, V30, P2778, DOI 10.1038/onc.2010.644; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Wu S, 2012, CURR OPIN PLANT BIOL, V15, P645, DOI 10.1016/j.pbi.2012.09.010; Wyckoff Jeffrey, 2011, Cold Spring Harb Protoc, V2011, P1167, DOI 10.1101/pdb.top065904; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	62	232	240	3	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					125	+		10.1038/nature13663	http://dx.doi.org/10.1038/nature13663			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25156253	Green Accepted			2022-12-24	WOS:000344187500043
J	Meyerson, JR; Kumar, J; Chittori, S; Rao, P; Pierson, J; Bartesaghi, A; Mayer, ML; Subramaniam, S				Meyerson, Joel R.; Kumar, Janesh; Chittori, Sagar; Rao, Prashant; Pierson, Jason; Bartesaghi, Alberto; Mayer, Mark L.; Subramaniam, Sriram			Structural mechanism of glutamate receptor activation and desensitization	NATURE			English	Article							LIGAND-BINDING DOMAIN; ION-CHANNEL; CRYSTAL-STRUCTURES; AMPA; GLUR2; VISUALIZATION; RESOLUTION; BEHAVIOR; LIPIDS; TILT	Ionotropic glutamate receptors are ligand-gated ion channels that mediate excitatory synaptic transmission in the vertebrate brain. To gain a better understanding of how structural changes gate ion flux across the membrane, we trapped rat AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) and kainate receptor subtypes in their major functional states and analysed the resulting structures using cryo-electron microscopy. We show that transition to the active state involves a 'corkscrew' motion of the receptor assembly, driven by closure of the ligand-binding domain. Desensitization is accompanied by disruption of the amino-terminal domain tetramer in AMPA, but not kainate, receptors with a two-fold to four-fold symmetry transition in the ligand-binding domains in both subtypes. The 7.6 angstrom structure of a desensitized kainate receptor shows how these changes accommodate channel closing. These findings integrate previous physiological, biochemical and structural analyses of glutamate receptors and provide a molecular explanation for key steps in receptor gating.	[Meyerson, Joel R.; Rao, Prashant; Bartesaghi, Alberto; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kumar, Janesh; Chittori, Sagar; Mayer, Mark L.] NICHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Pierson, Jason] FEI Co, Hillsboro, OR 97124 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Thermo Fisher Scientific; FEI Company	Subramaniam, S (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	mayerm@mail.nih.gov; ss1@nih.gov	Mayer, Mark/AAE-7356-2019; Kumar, Janesh/AAG-3002-2019; Chittori, Sagar/B-9412-2009	Mayer, Mark/0000-0003-4378-8451; Kumar, Janesh/0000-0003-0767-3788; Chittori, Sagar/0000-0003-1417-6552; Subramaniam, Sriram/0000-0003-4231-4115	NCI; NICHD, NIH; IATAP program at NIH; NIH-FEI Living Lab for Structural Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010824, ZIABC010278] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); IATAP program at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-FEI Living Lab for Structural Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural programs of the NCI, and NICHD, NIH, the IATAP program at NIH and the NIH-FEI Living Lab for Structural Biology. We thank D. Bleakman, Eli Lilly and Company for the gift of LY451646, Y. J. Eun for discussions on preparation of cryo-EM samples, X. Wu for discussions on fitting crystallographic coordinates to cryo-EM maps, D. Bliss for assistance with preparing schematic illustrations, L. Earl, M. J. Borgnia and J. L. S. Milne for discussions, and S. Fellini, S. Chacko and their colleagues for continued support with use of the Biowulf cluster for computing at NIH.	Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Alushin GM, 2011, NEUROPHARMACOLOGY, V60, P126, DOI 10.1016/j.neuropharm.2010.06.002; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Barrera NP, 2013, TRENDS CELL BIOL, V23, P1, DOI 10.1016/j.tcb.2012.08.007; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Carbone AL, 2012, NEURON, V74, P845, DOI 10.1016/j.neuron.2012.04.020; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Chaudhry C, 2009, EMBO J, V28, P1518, DOI 10.1038/emboj.2009.86; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Dong H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1362; Furukawa H, 2012, J PHYSIOL-LONDON, V590, P63, DOI 10.1113/jphysiol.2011.213850; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; Hald H, 2009, J MOL BIOL, V391, P906, DOI 10.1016/j.jmb.2009.07.002; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Jiang QX, 2012, CURR OPIN STRUC BIOL, V22, P529, DOI 10.1016/j.sbi.2012.03.009; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Liao MF, 2014, CURR OPIN STRUC BIOL, V27, P1, DOI 10.1016/j.sbi.2014.02.005; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miu P, 2001, NEUROPHARMACOLOGY, V40, P976, DOI 10.1016/S0028-3908(01)00027-2; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Nayeem N, 2009, MOL PHARMACOL, V76, P534, DOI 10.1124/mol.109.056598; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Prieto ML, 2010, J NEUROSCI, V30, P4449, DOI 10.1523/JNEUROSCI.5613-09.2010; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky A. I., 2013, J PHYSL LOND; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; WL D, 2002, PYMOL MOL GRAPHICS S; Zhao HY, 2012, J GEN PHYSIOL, V139, P371, DOI 10.1085/jgp.201210770	53	164	165	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					328	+		10.1038/nature13603	http://dx.doi.org/10.1038/nature13603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25119039	Green Accepted			2022-12-24	WOS:000342988600043
J	Fridman, O; Goldberg, A; Ronin, I; Shoresh, N; Balaban, NQ				Fridman, Ofer; Goldberg, Amir; Ronin, Irine; Shoresh, Noam; Balaban, Nathalie Q.			Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations	NATURE			English	Article							ESCHERICHIA-COLI; PERSISTENCE; AMPICILLIN; RESISTANCE; EVOLUTION	The great therapeutic achievements of antibiotics have been dramatically undercut by the evolution of bacterial strategies that overcome antibiotic stress(1),(2). These strategies fall into two classes. 'Resistance' makes it possible for a microorganism to grow in the constant presence of the antibiotic, provided that the concentration of the antibiotic is not too high. 'Tolerance' allows a microorganism to survive antibiotic treatment, even at high antibiotic concentrations, as long as the duration of the treatment is limited. Although both resistance and tolerance are important reasons for the failure of antibiotic treatments(3-6), the evolution of resistance(7-9) is much better understood than that of tolerance. Here we followed the evolution of bacterial populations under intermittent exposure to the high concentrations of antibiotics used in the clinic and characterized the evolved strains in terms of both resistance and tolerance. We found that all strains adapted by specific genetic mutations, which became fixed in the evolved populations. By monitoring the phenotypic changes at the population and single-cell levels, we found that the first adaptive change to antibiotic stress was the development of tolerance through a major adjustment in the single-cell lag-time distribution, without a change in resistance. Strikingly, we found that the lag time of bacteria before regrowth was optimized to match the duration of the antibiotic-exposure interval. Whole genome sequencing of the evolved strains and restoration of the wild-type alleles allowed us to identify target genes involved in this antibiotic-driven phenotype: 'tolerance by lag' (tbl). Better understanding of lag-time evolution as a key determinant of the survival of bacterial populations under high antibiotic concentrations could lead to new approaches to impeding the evolution of antibiotic resistance.	[Fridman, Ofer; Goldberg, Amir; Ronin, Irine; Balaban, Nathalie Q.] Hebrew Univ Jerusalem, Sudarsky Ctr Computat Biol, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Fridman, Ofer; Goldberg, Amir; Ronin, Irine; Balaban, Nathalie Q.] Hebrew Univ Jerusalem, Ctr NanoSci, IL-91904 Jerusalem, Israel; [Shoresh, Noam] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Balaban, NQ (corresponding author), Hebrew Univ Jerusalem, Sudarsky Ctr Computat Biol, Racah Inst Phys, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	nathalieqb@phys.huji.ac.il	Balaban, Nathalie/AAH-1004-2019; Balaban, Nathalie/AGI-1487-2022	Balaban, Nathalie/0000-0001-8018-0766; Balaban, Nathalie/0000-0001-8018-0766	European Research Council [260871]; Israel Science Foundation [592/10]; Levtzion Fellowship	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Levtzion Fellowship	We thank I. Levin-Riesman for discussions and technical help with the ScanLag system, S. Belkin for strains, and the National BioResource Project and National Institute of Genetics, Japan, for the Keio collection deletion mutants. The work was supported by the European Research Council (Starting Grant no. 260871) and the Israel Science Foundation (no. 592/10). O.F. acknowledges support from the Levtzion Fellowship.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baranyi J, 2002, INT J FOOD MICROBIOL, V73, P203, DOI 10.1016/S0168-1605(01)00650-X; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Collignon PJ, 2002, MED J AUSTRALIA, V177, P325, DOI 10.5694/j.1326-5377.2002.tb04794.x; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865; Girgis HS, 2012, P NATL ACAD SCI USA, V109, P12740, DOI 10.1073/pnas.1205124109; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Kaspy I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4001; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Levin-Reisman I, 2010, NAT METHODS, V7, P737, DOI 10.1038/nmeth.1485; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Nahata MC, 1999, ANTIMICROB AGENTS CH, V43, P1225, DOI 10.1128/AAC.43.5.1225; OLSSON O, 1983, P NATL ACAD SCI-BIOL, V80, P7556, DOI 10.1073/pnas.80.24.7556; Oxman E, 2008, EVOLUTION, V62, P1547, DOI 10.1111/j.1558-5646.2008.00397.x; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; WOLFSON JS, 1990, ANTIMICROB AGENTS CH, V34, P1938, DOI 10.1128/AAC.34.10.1938	30	314	324	18	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					418	+		10.1038/nature13469	http://dx.doi.org/10.1038/nature13469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043002				2022-12-24	WOS:000341814900060
J	Halassa, MM; Chen, Z; Wimmer, RD; Brunetti, PM; Zhao, SL; Zikopoulos, B; Wang, F; Brown, EN; Wilson, MA				Halassa, Michael M.; Chen, Zhe; Wimmer, Ralf D.; Brunetti, Philip M.; Zhao, Shengli; Zikopoulos, Basilis; Wang, Fan; Brown, Emery N.; Wilson, Matthew A.			State-Dependent Architecture of Thalamic Reticular Subnetworks	CELL			English	Article							NEURONS IN-VIVO; NEURAL MECHANISMS; SLEEP SPINDLES; ATTENTION; NUCLEUS; CORTEX; INFORMATION; COGNITION; OSCILLATIONS; DYNAMICS	Behavioral state is known to influence interactions between thalamus and cortex, which are important for sensation, action, and cognition. The thalamic reticular nucleus (TRN) is hypothesized to regulate thalamo-cortical interactions, but the underlying functional architecture of this process and its state dependence are unknown. By combining the first TRN ensemble recording with psychophysics and connectivity-based optogenetic tagging, we found reticular circuits to be composed of distinct subnetworks. While activity of limbic-projecting TRN neurons positively correlates with arousal, sensory-projecting neurons participate in spindles and show elevated synchrony by slow waves during sleep. Sensory-projecting neurons are suppressed by attentional states, demonstrating that their gating of thalamo-cortical interactions is matched to behavioral state. Bidirectional manipulation of attentional performance was achieved through subnetwork-specific optogenetic stimulation. Together, our findings provide evidence for differential inhibition of thalamic nuclei across brain states, where the TRN separately controls external sensory and internal limbic processing facilitating normal cognitive function.	[Halassa, Michael M.; Wimmer, Ralf D.] NYU, Langone Med Ctr, Inst Neurosci, New York, NY 10016 USA; [Halassa, Michael M.; Wimmer, Ralf D.] NYU, Langone Med Ctr, Dept Neurosci & Physiol, New York, NY 10016 USA; [Halassa, Michael M.; Chen, Zhe; Wimmer, Ralf D.] NYU, Langone Med Ctr, Dept Psychiat, New York, NY 10016 USA; [Halassa, Michael M.; Wimmer, Ralf D.; Brunetti, Philip M.; Wilson, Matthew A.] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Zhao, Shengli; Wang, Fan] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Zikopoulos, Basilis] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA; [Zikopoulos, Basilis] Boston Univ, Program Neurosci, Boston, MA 02215 USA; [Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Emery N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Harvard Mit Div Hlth Sci & Technol, Inst Med Engn & Sci, Cambridge, MA 02139 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Massachusetts Institute of Technology (MIT); Northwell Health; Duke University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Halassa, MM (corresponding author), NYU, Langone Med Ctr, Inst Neurosci, New York, NY 10016 USA.	michael.halassa@nyumc.org	Zikopoulos, Basilis/K-2443-2012	Chen, Zhe (Sage)/0000-0002-6483-6056; Zikopoulos, Vasileios/0000-0002-8834-5104	NIH from the NINDS [K99 NS 078115]; NARSAD Young Investigator Award; NSF-CRCNS [IIS-1307645]; Early Career Award (Mathematical Biosciences Institute); NIMH [R01MH101209, R01MH057414]; NSF [SBE-0354378]; NIH [R01NS077986, DP1MH103908, R01-MH061976]; transformative R01 award [TR01-GM10498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057414, DP1MH103908, R01MH061976, R01MH101209, R25MH094612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077986, R00NS078115, K99NS078115] Funding Source: NIH RePORTER	NIH from the NINDS; NARSAD Young Investigator Award(NARSAD); NSF-CRCNS(National Science Foundation (NSF)NSF - Office of the Director (OD)); Early Career Award (Mathematical Biosciences Institute); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); transformative R01 award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Acsady and T. Fellin for helpful comments, as well as all members of the M.A.W. laboratory. M.M.H. is supported by an NIH pathway to independence career award (K99 NS 078115) from the NINDS and a NARSAD Young Investigator Award. Z.C. is supported by an NSF-CRCNS grant (award IIS-1307645) and an Early Career Award (Mathematical Biosciences Institute). B.Z. is supported by grants from NIMH (R01MH101209 and R01MH057414) and NSF (CELEST and SBE-0354378). F.W. is supported by NIH grants (R01NS077986 and DP1MH103908). E.N.B. and M.A.W. are supported by a transformative R01 award (TR01-GM10498). M.A.W. is additionally supported by NIH grant R01-MH061976.	Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Bazhenov M, 2000, J NEUROPHYSIOL, V84, P1076, DOI 10.1152/jn.2000.84.2.1076; Briggs F, 2013, NATURE, V499, P476, DOI 10.1038/nature12276; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Coe BP, 2012, AM J MED GENET C, V160C, P118, DOI 10.1002/ajmg.c.31327; CONTRERAS D, 1993, J PHYSIOL-LONDON, V470, P273, DOI 10.1113/jphysiol.1993.sp019858; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; Deisseroth K, 2013, NEURON, V80, P568, DOI 10.1016/j.neuron.2013.10.032; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Ferrarelli F, 2010, AM J PSYCHIAT, V167, P1339, DOI 10.1176/appi.ajp.2010.09121731; Fitzgerald KD, 2000, BIOL PSYCHIAT, V47, P174, DOI 10.1016/S0006-3223(99)00286-3; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gardner RJ, 2013, J NEUROSCI, V33, P18469, DOI 10.1523/JNEUROSCI.2197-13.2013; Gonzalez-Burgos G, 2012, SCHIZOPHRENIA BULL, V38, P950, DOI 10.1093/schbul/sbs010; Hahn TTG, 2012, NAT NEUROSCI, V15, P1531, DOI 10.1038/nn.3236; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Issa EB, 2011, J NEUROSCI, V31, P2965, DOI 10.1523/JNEUROSCI.4920-10.2011; Jones E G, 1981, Int Rev Physiol, V25, P173; Jones EG, 2002, PROG BRAIN RES, V136, P333; Kahn JB, 2012, LEARN MEMORY, V19, P513, DOI 10.1101/lm.026302.112; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Keshavan MS, 2011, SCHIZOPHR RES, V131, P231, DOI 10.1016/j.schres.2011.05.027; Kimura A, 2012, NEUROSCIENCE, V226, P208, DOI 10.1016/j.neuroscience.2012.09.016; KOCH C, 1993, CURR OPIN NEUROBIOL, V3, P203, DOI 10.1016/0959-4388(93)90211-G; Kubanek J, 2013, NEUROIMAGE, V83, P795, DOI 10.1016/j.neuroimage.2013.06.085; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Magnin M, 2010, P NATL ACAD SCI USA, V107, P3829, DOI 10.1073/pnas.0909710107; MARKS GA, 1993, BRAIN RES, V623, P241, DOI 10.1016/0006-8993(93)91434-T; Marlinski V, 2012, J NEUROSCI, V32, P15823, DOI 10.1523/JNEUROSCI.0782-12.2012; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Miller EK, 2013, CURR OPIN NEUROBIOL, V23, P216, DOI 10.1016/j.conb.2012.11.011; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Rolls E.T., 2013, CORTEX; Roth JK, 2009, NEUROIMAGE, V48, P601, DOI 10.1016/j.neuroimage.2009.07.002; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1986, J NEUROSCI, V6, P68; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vaingankar V, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00118; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; Wimmer RD, 2012, J NEUROSCI, V32, P13917, DOI 10.1523/JNEUROSCI.2313-12.2012; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Zikopoulos B, 2012, J NEUROSCI, V32, P5338, DOI 10.1523/JNEUROSCI.4793-11.2012	62	179	182	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					808	821		10.1016/j.cell.2014.06.025	http://dx.doi.org/10.1016/j.cell.2014.06.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126786	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000340944700012
J	Huerta-Sanchez, E; Jin, X; Asan; Bianba, Z; Peter, BM; Vinckenbosch, N; Liang, Y; Yi, X; He, MZ; Somel, M; Ni, PX; Wang, B; Ou, XH; Huasang; Luosang, JB; Cuo, ZXP; Li, K; Gao, GY; Yin, Y; Wang, W; Zhang, XQ; Xu, X; Yang, HM; Li, YR; Wang, J; Wang, J; Nielsen, R				Huerta-Sanchez, Emilia; Jin, Xin; Asan; Bianba, Zhuoma; Peter, Benjamin M.; Vinckenbosch, Nicolas; Liang, Yu; Yi, Xin; He, Mingze; Somel, Mehmet; Ni, Peixiang; Wang, Bo; Ou, Xiaohua; Huasang; Luosang, Jiangbai; Cuo, Zha Xi Ping; Li, Kui; Gao, Guoyi; Yin, Ye; Wang, Wei; Zhang, Xiuqing; Xu, Xun; Yang, Huanming; Li, Yingrui; Wang, Jian; Wang, Jun; Nielsen, Rasmus			Altitude adaptation in Tibetans caused by introgression of Denisovan-like DNA	NATURE			English	Article							HEMOGLOBIN CONCENTRATION; POSITIVE SELECTION; GENOME SEQUENCE; RECOMBINATION; SAMPLES; PIGMENTATION; PREGNANCY; ANCESTRY; SIGNALS	As modern humans migrated out of Africa, they encountered many new environmental conditions, including greater temperature extremes, different pathogens and higher altitudes. These diverse environments are likely to have acted as agents of natural selection and to have led to local adaptations. One of the most celebrated examples in humans is the adaptation of Tibetans to the hypoxic environment of the high-altitude Tibetan plateau(1-3). A hypoxia pathway gene, EPAS1, was previously identified as having the most extreme signature of positive selection in Tibetans(4-10), and was shown to be associated with differences in haemoglobin concentration at high altitude. Re-sequencing the region around EPAS1 in 40 Tibetan and 40 Han individuals, we find that this gene has a highly unusual haplotype structure that can only be convincingly explained by introgression of DNA from Denisovan or Denisovan-related individuals into humans. Scanning a larger set of worldwide populations, we find that the selected haplotype is only found in Denisovans and in Tibetans, and at very low frequency among Han Chinese. Furthermore, the length of the haplotype, and the fact that it is not found in any other populations, makes it unlikely that the haplotype sharing between Tibetans and Denisovans was caused by incomplete ancestral lineage sorting rather than introgression. Our findings illustrate that admixture with other hominin species has provided genetic variation that helped humans to adapt to new environments.	[Huerta-Sanchez, Emilia; Jin, Xin; Asan; Liang, Yu; Yi, Xin; He, Mingze; Somel, Mehmet; Ni, Peixiang; Wang, Bo; Ou, Xiaohua; Huasang; Luosang, Jiangbai; Yin, Ye; Wang, Wei; Zhang, Xiuqing; Xu, Xun; Yang, Huanming; Li, Yingrui; Wang, Jian; Wang, Jun; Nielsen, Rasmus] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Huerta-Sanchez, Emilia; Peter, Benjamin M.; Vinckenbosch, Nicolas; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Huerta-Sanchez, Emilia] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Jin, Xin] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Asan; Liang, Yu; Yi, Xin] BGI Tianjin, Binhai Genom Inst, Tianjin 300308, Peoples R China; [Asan; Liang, Yu; Yi, Xin] BGI Tianjin, Tianjin Translat Genom Ctr, Tianjin 300308, Peoples R China; [Bianba, Zhuoma] Peoples Hosp Lhasa, Lhasa 850000, Peoples R China; [He, Mingze] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA; [Somel, Mehmet] Middle E Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey; [Cuo, Zha Xi Ping] Second Peoples Hosp Tibet Autonomous Reg, Lhasa 850000, Peoples R China; [Li, Kui] Peoples Hosp Tibet Autonomous Reg, Lhasa 850000, Peoples R China; [Gao, Guoyi] Hosp XiShuangBanNa Dai Nationalities, Autonomous Jinghong 666100, Yunnan, Peoples R China; [Zhang, Xiuqing] BGI Shenzhen, Guangdong Enterprise Key Lab Human Dis Genom, Shenzhen 518083, Peoples R China; [Zhang, Xiuqing] BGI Shenzhen, Shenzhen Key Lab Trans Biotechnol, Shenzhen 518083, Peoples R China; [Yang, Huanming; Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Yang, Huanming; Wang, Jian] James D Watson Inst Genome Sci, Hangzhou 310008, Zhejiang, Peoples R China; [Wang, Jun; Nielsen, Rasmus] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong 999077, Hong Kong, Peoples R China; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Beijing Genomics Institute (BGI); University of California System; University of California Berkeley; University of California System; University of California Merced; South China University of Technology; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Iowa State University; Middle East Technical University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); King Abdulaziz University; University of Copenhagen; Macau University of Science & Technology; University of Hong Kong; University of California System; University of California Berkeley	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangjian@genomics.cn; wangj@genomics.cn; rasmus_nielsen@berkeley.edu	Li, Yingrui/K-1064-2015; Jin, Xin/ABF-1329-2020; Xu, Xun/AAI-6763-2020; Somel, Mehmet/B-1471-2016; Nielsen, Rasmus/D-4405-2009; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Jin, Xin/0000-0001-7554-4975; Xu, Xun/0000-0002-5338-5173; He, Mingze/0000-0002-8164-2480; Nielsen, Rasmus/0000-0003-0513-6591; Wang, Jun/0000-0002-8540-8931; Somel, Mehmet/0000-0002-3138-1307; Wang, Jun/0000-0002-2113-5874	973 Program [2011CB809203, 2012CB518201, 2011CB809201, 2011CB809202]; State Key Development Program for Basic Research of China; China National GeneBank-Shenzhen; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; US NIH [R01HG003229, R01HG003229-08S2]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); China National GeneBank-Shenzhen; Shenzhen Key Laboratory of Transomics Biotechnologies; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was funded by the State Key Development Program for Basic Research of China, 973 Program (2011CB809203, 2012CB518201, 2011CB809201, 2011CB809202), China National GeneBank-Shenzhen and Shenzhen Key Laboratory of Transomics Biotechnologies (no. CXB201108250096A). This work was also supported by research grants from the US NIH; R01HG003229 to R.N. and R01HG003229-08S2 to E.H.S. We thank F. Jay, M. Liang and F. Casey for useful discussions.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moore LG, 2004, PLACENTA, V25, pS60, DOI 10.1016/j.placenta.2004.01.008; Moore LG, 2001, AM J HUM BIOL, V13, P635, DOI 10.1002/ajhb.1102; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Niermeyer S, 2009, ARCH DIS CHILD, V94, P806, DOI 10.1136/adc.2008.141838; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sankararaman S, 2014, NATURE; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Teshima KM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-166; Vargas EE, 2006, HIGH ALT MED BIOL, V7, P138, DOI 10.1089/ham.2006.7.138; Vernot B., 2014, SCIENCE; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yip R, 2000, AM J CLIN NUTR, V72, p272S, DOI 10.1093/ajcn/72.1.272S	43	551	577	33	492	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					194	+		10.1038/nature13408	http://dx.doi.org/10.1038/nature13408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043035	Green Submitted, Green Accepted			2022-12-24	WOS:000340200700032
J	Whitney, JB; Hill, AL; Sanisetty, S; Penaloza-MacMaster, P; Liu, JY; Shetty, M; Parenteau, L; Cabral, C; Shields, J; Blackmore, S; Smith, JY; Brinkman, AL; Peter, LE; Mathew, SI; Smith, KM; Borducchi, EN; Rosenbloom, DIS; Lewis, MG; Hattersley, J; Li, B; Hesselgesser, J; Geleziunas, R; Robb, ML; Kim, JH; Michael, NL; Barouch, DH				Whitney, James B.; Hill, Alison L.; Sanisetty, Srisowmya; Penaloza-MacMaster, Pablo; Liu, Jinyan; Shetty, Mayuri; Parenteau, Lily; Cabral, Crystal; Shields, Jennifer; Blackmore, Stephen; Smith, Jeffrey Y.; Brinkman, Amanda L.; Peter, Lauren E.; Mathew, Sheeba I.; Smith, Kaitlin M.; Borducchi, Erica N.; Rosenbloom, Daniel I. S.; Lewis, Mark G.; Hattersley, Jillian; Li, Bei; Hesselgesser, Joseph; Geleziunas, Romas; Robb, Merlin L.; Kim, Jerome H.; Michael, Nelson L.; Barouch, Dan H.			Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys	NATURE			English	Article							ANTIRETROVIRAL THERAPY; LATENT RESERVOIR; HIV-1 INFECTION; REPLICATION; VACCINE; PREVENTION; INITIATION; DYNAMICS; DEPENDS; ASSAY	The viral reservoir represents a critical challenge for human immunodeficiency virus type 1 (HIV-1) eradication strategies(1-5). However, it remains unclear when and where the viral reservoir is seeded during acute infection and the extent to which it is susceptible to early anti-retroviral therapy (ART). Here we show that the viral reservoir is seeded rapidly after mucosal simian immunodeficiency virus (SIV) infection of rhesus monkeys and before systemic viraemia. We initiated suppressive ART in groups of monkeys on days 3, 7, 10 and 14 after intrarectal SIVMAC251 infection. Treatment with ART on day 3 blocked the emergence of viral RNA and proviral DNA in peripheral blood and also substantially reduced levels of proviral DNA in lymph nodes and gastrointestinal mucosa as compared with treatment at later time points. In addition, treatment on day 3 abrogated the induction of SIV-specific humoral and cellular immune responses. Nevertheless, after discontinuation of ART following 24 weeks of fully suppressive therapy, virus rebounded in all animals, although the monkeys that were treated on day 3 exhibited a delayed viral rebound as compared with those treated on days 7, 10 and 14. The time to viral rebound correlated with total viraemia during acute infection and with proviral DNA at the time of ART discontinuation. These data demonstrate that the viral reservoir is seeded rapidly after intrarectal SIV infection of rhesus monkeys, during the 'eclipse' phase, and before detectable viraemia. This strikingly early seeding of the refractory viral reservoir raises important new challenges for HIV-1 eradication strategies.	[Whitney, James B.; Sanisetty, Srisowmya; Penaloza-MacMaster, Pablo; Liu, Jinyan; Shetty, Mayuri; Parenteau, Lily; Cabral, Crystal; Shields, Jennifer; Blackmore, Stephen; Smith, Jeffrey Y.; Brinkman, Amanda L.; Peter, Lauren E.; Mathew, Sheeba I.; Smith, Kaitlin M.; Borducchi, Erica N.; Barouch, Dan H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Whitney, James B.; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Hill, Alison L.; Rosenbloom, Daniel I. S.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Hattersley, Jillian; Li, Bei; Hesselgesser, Joseph; Geleziunas, Romas] Gilead Sci Inc, Foster City, CA 94404 USA; [Robb, Merlin L.; Kim, Jerome H.; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; BIOQUAL Inc.; Gilead Sciences; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Barouch, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019; Hill, Alison Lynn/W-7839-2019	Hill, Alison Lynn/0000-0002-6583-3623; Peter, Lauren/0000-0002-2105-7503; Brinkman, Amanda/0000-0002-2845-6494	US Army Medical Research and Material Command; US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine [W81XWH-07-2-0067, W81XWH-11-2-0174]; NIH [AI060354, AI078526, AI084794, AI095985, AI096040, AI100645]; Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084794, U19AI095985, UM1AI100645, T32AI007245, P30AI060354, UM1AI100663, U19AI096040, R56AI091514, U19AI078526] Funding Source: NIH RePORTER	US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH, MIT and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Pensiero, M. Marovich, C. Dieffenbach, W. Wagner, C. Gittens, J. Yalley-Ogunro, M. Nowak, R. Siliciano, D. Persaud, S. Deeks, N. Chomont, J. Ananworanich, L. Picker, F. Stephens, R. Hamel, K. Kelly and L. Dunne for advice, assistance and reagents. The SIV<INF>MAC239</INF> peptides were obtained from the National Institutes of Health (NIH) AIDS Research and Reference Reagent Program. We acknowledge support from the US Army Medical Research and Material Command and the US Military HIV Research Program through its cooperative agreement with the Henry M. Jackson Foundation for the Advancement of Military Medicine (W81XWH-07-2-0067, W81XWH-11-2-0174); the NIH (AI060354, AI078526, AI084794, AI095985, AI096040, AI100645); and the Ragon Institute of MGH, MIT and Harvard. The views expressed in this manuscript are those of the authors and do not represent the official views of the Department of the Army or the Department of Defense.	Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cline AN, 2005, J MED PRIMATOL, V34, P303; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hocqueloux L, 2013, J ANTIMICROB CHEMOTH, V68, P1169, DOI 10.1093/jac/dks533; Liu JY, 2012, J VIROL, V86, P7829, DOI 10.1128/JVI.00512-12; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Rosenberg ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010555; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Steingrover R, 2008, AIDS, V22, P1583, DOI 10.1097/QAD.0b013e328305bd77; Stohr W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078287; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; von Wyl V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027463; Whitney JB, 2009, J VIROL, V83, P10840, DOI 10.1128/JVI.01202-09; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	28	393	406	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					74	+		10.1038/nature13594	http://dx.doi.org/10.1038/nature13594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25042999	Green Submitted, Green Accepted			2022-12-24	WOS:000339908000034
J	Northcott, PA; Lee, C; Zichner, T; Stutz, AM; Erkek, S; Kawauchi, D; Shih, DJH; Hovestadt, V; Zapatka, M; Sturm, D; Jones, DTW; Kool, M; Remke, M; Cavalli, FMG; Zuyderduyn, S; Bader, GD; VandenBerg, S; Esparza, LA; Ryzhova, M; Wang, W; Wittmann, A; Stark, S; Sieber, L; Seker-Cin, H; Linke, L; Kratochwil, F; Jager, N; Buchhalter, I; Imbusch, CD; Zipprich, G; Raeder, B; Schmidt, S; Diessl, N; Wolf, S; Wiemann, S; Brors, B; Lawerenz, C; Eils, J; Warnatz, HJ; Risch, T; Yaspo, ML; Weber, UD; Bartholomae, CC; von Kalle, C; Turanyi, E; Hauser, P; Sanden, E; Darabi, A; Siesjo, P; Sterba, J; Zitterbart, K; Sumerauer, D; van Sluis, P; Versteeg, R; Volckmann, R; Koster, J; Schuhmann, MU; Ebinger, M; Grimes, HL; Robinson, GW; Gajjar, A; Mynarek, M; von Hoff, K; Rutkowski, S; Pietsch, T; Scheurlen, W; Felsberg, J; Reifenberger, G; Kulozik, AE; von Deimling, A; Witt, O; Eils, R; Gilbertson, RJ; Korshunov, A; Taylor, MD; Lichter, P; Korbel, JO; Wechsler-Reya, RJ; Pfister, SM				Northcott, Paul A.; Lee, Catherine; Zichner, Thomas; Stuetz, Adrian M.; Erkek, Serap; Kawauchi, Daisuke; Shih, David J. H.; Hovestadt, Volker; Zapatka, Marc; Sturm, Dominik; Jones, David T. W.; Kool, Marcel; Remke, Marc; Cavalli, Florence M. G.; Zuyderduyn, Scott; Bader, Gary D.; VandenBerg, Scott; Esparza, Lourdes Adriana; Ryzhova, Marina; Wang, Wei; Wittmann, Andrea; Stark, Sebastian; Sieber, Laura; Seker-Cin, Huriye; Linke, Linda; Kratochwil, Fabian; Jaeger, Natalie; Buchhalter, Ivo; Imbusch, Charles D.; Zipprich, Gideon; Raeder, Benjamin; Schmidt, Sabine; Diessl, Nicolle; Wolf, Stephan; Wiemann, Stefan; Brors, Benedikt; Lawerenz, Chris; Eils, Juergen; Warnatz, Hans-Joerg; Risch, Thomas; Yaspo, Marie-Laure; Weber, Ursula D.; Bartholomae, Cynthia C.; von Kalle, Christof; Turanyi, Eszter; Hauser, Peter; Sanden, Emma; Darabi, Anna; Siesjoe, Peter; Sterba, Jaroslav; Zitterbart, Karel; Sumerauer, David; van Sluis, Peter; Versteeg, Rogier; Volckmann, Richard; Koster, Jan; Schuhmann, Martin U.; Ebinger, Martin; Grimes, H. Leighton; Robinson, Giles W.; Gajjar, Amar; Mynarek, Martin; von Hoff, Katja; Rutkowski, Stefan; Pietsch, Torsten; Scheurlen, Wolfram; Felsberg, Joerg; Reifenberger, Guido; Kulozik, Andreas E.; von Deimling, Andreas; Witt, Olaf; Eils, Roland; Gilbertson, Richard J.; Korshunov, Andrey; Taylor, Michael D.; Lichter, Peter; Korbel, Jan O.; Wechsler-Reya, Robert J.; Pfister, Stefan M.			Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma	NATURE			English	Article							FINGER PROTEIN GFI-1; SUPER-ENHANCERS; CELL IDENTITY; GENOME; GENE; MYC; MUTATIONS; SUBGROUP; MODEL; PIM-1	Medulloblastoma is a highly malignant paediatric brain tumour currently treated with a combination of surgery, radiation and chemotherapy, posing a considerable burden of toxicity to the developing child. Genomics has illuminated the extensive intertumoral heterogeneity of medulloblastoma, identifying four distinct molecular subgroups. Group 3 and group 4 subgroup medulloblastomas account for most paediatric cases; yet, oncogenic drivers for these subtypes remain largely unidentified. Here we describe a series of prevalent, highly disparate genomic structural variants, restricted to groups 3 and 4, resulting in specific and mutually exclusive activation of the growth factor independent 1 family proto-oncogenes, GFI1 and GFI1B. Somatic structural variants juxtapose GFI1 or GFI1B coding sequences proximal to active enhancer elements, including super-enhancers, instigating oncogenic activity. Our results, supported by evidence from mouse models, identify GFI1 and GFI1B as prominent medulloblastoma oncogenes and implicate 'enhancer hijacking' as an efficient mechanism driving oncogene activation in a childhood cancer.	[Northcott, Paul A.; Erkek, Serap; Kawauchi, Daisuke; Sturm, Dominik; Jones, David T. W.; Kool, Marcel; Wittmann, Andrea; Stark, Sebastian; Sieber, Laura; Seker-Cin, Huriye; Linke, Linda; Kratochwil, Fabian; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Lee, Catherine] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Lee, Catherine; Esparza, Lourdes Adriana; Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA; [Zichner, Thomas; Stuetz, Adrian M.; Erkek, Serap; Raeder, Benjamin; Korbel, Jan O.] European Mol Biol Lab EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Shih, David J. H.; Remke, Marc; Cavalli, Florence M. G.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; [Hovestadt, Volker; Zapatka, Marc; Wang, Wei; Weber, Ursula D.; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Zuyderduyn, Scott; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [VandenBerg, Scott] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, Moscow 125047, Russia; [Jaeger, Natalie; Buchhalter, Ivo; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Imbusch, Charles D.; Zipprich, Gideon; Lawerenz, Chris; Eils, Juergen] German Canc Res Ctr, Data Management Facil, D-69120 Heidelberg, Germany; [Schmidt, Sabine; Diessl, Nicolle; Wolf, Stephan; Wiemann, Stefan] German Canc Res Ctr, Genom & Prote Core Facil, D-69120 Heidelberg, Germany; [Warnatz, Hans-Joerg; Risch, Thomas; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Bartholomae, Cynthia C.; von Kalle, Christof] German Canc Res Ctr, Div Translat Oncol, D-69120 Heidelberg, Germany; [Bartholomae, Cynthia C.; von Kalle, Christof] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [von Kalle, Christof; Eils, Roland; Lichter, Peter] Heidelberg Ctr Personalised Oncol DKFZ HIPO, D-69120 Heidelberg, Germany; [Turanyi, Eszter] Semmelweis Univ SE, Dept Pathol & Expt Canc Res 1, H-1094 Budapest, Hungary; [Hauser, Peter] Semmelweis Univ, Dept Pediat 2, H-1094 Budapest, Hungary; [Sanden, Emma; Darabi, Anna; Siesjoe, Peter] Lund Univ, Div Neurosurg, Glioma Immunotherapy Grp, S-22100 Lund, Sweden; [Sanden, Emma; Darabi, Anna; Siesjoe, Peter] Lund Univ, Dept Clin Sci, S-22100 Lund, Sweden; [Sterba, Jaroslav; Zitterbart, Karel] Masaryk Univ, Dept Pediat Oncol, Brno 61300, Czech Republic; [Sterba, Jaroslav; Zitterbart, Karel] Univ Hosp, Brno 61300, Czech Republic; [Sumerauer, David] Charles Univ Prague, Dept Pediat Hematol & Oncol, Fac Med 2, Prague 15006, Czech Republic; [Sumerauer, David] Univ Hosp Motol, Prague 15006, Czech Republic; [van Sluis, Peter; Versteeg, Rogier; Volckmann, Richard; Koster, Jan] Univ Amsterdam, AMC, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Schuhmann, Martin U.; Ebinger, Martin] Tubingen Univ Hosp, Dept Neurosurg, D-72076 Tubingen, Germany; [Grimes, H. Leighton] Cincinnati Childrens Hosp Med Ctr, Program Hematol Malignancies, Program Canc Pathol, Div Immunobiol,Div Expt Hematol & Pathol,Canc & B, Cincinnati, OH 45229 USA; [Robinson, Giles W.; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Robinson, Giles W.; Gajjar, Amar; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; Univ Med Ctr Hamburg Eppendorf, Dept Paediat Haematol & Oncol, D-20246 Hamburg, Germany; [Pietsch, Torsten] Univ Bonn, Dept Neuropathol, D-53105 Bonn, Germany; [Scheurlen, Wolfram] Nurnberg Childrens Hosp, Cnopfsche Kinderklin, D-90419 Nurnberg, Germany; [Felsberg, Joerg; Reifenberger, Guido] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Kulozik, Andreas E.; Witt, Olaf; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [von Deimling, Andreas; Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Korbel, Jan O.] European Bioinformat Inst EMBL EBI, EMBL, Saffron Walden CB10 1SD, Essex, England	Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; European Molecular Biology Laboratory (EMBL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University of California System; University of California San Diego; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Semmelweis University; Semmelweis University; Lund University; Lund University; Masaryk University Brno; University Hospital Brno; Charles University Prague; Motol University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); European Molecular Biology Laboratory (EMBL)	Northcott, PA (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.macleod@dkfz-heidelberg.de; korbel@embl.de; rwreya@sanfordburnham.org; s.pfister@dkfz-heidelberg.de	Shih, David J. H./AAE-8726-2019; Kawauchi, Daisuke/ABE-9133-2021; Versteeg, Rogier/AAQ-1765-2020; Kulozik, Andreas/AAO-2432-2020; Brors, Benedikt/E-5620-2013; Northcott, Paul A/N-4022-2018; Eils, Roland/B-6121-2009; Pfister, Stefan M/F-6860-2013; Jones, David TW/G-9588-2013; Jones, David T. W./Z-1963-2019; Koster, Jan/C-5934-2008; Korbel, Jan O/G-6470-2012; von Deimling, Andreas/F-7774-2013; Reifenberger, Guido/AAE-3599-2019; Mynarek, Martin/AAY-6129-2020; Kool, Marcel/H-2541-2013; Sterba, Jaroslav/N-6156-2016; Shih, David J H/H-3186-2011; Ebinger, Martin/O-4936-2016; Gilbertson, Richard James/ABE-1346-2021; Gajjar, Amar/N-8059-2018; Zapatka, Marc/G-9896-2013; Erkek, Serap/AAV-5549-2020; Sturm, Dominik/AAL-3689-2020; Ryzhova, Marina/G-4178-2014; Wiemann, Stefan/E-4424-2013; Bader, Gary/C-1176-2009; Robinson, Giles W/N-8095-2018	Shih, David J. H./0000-0002-9802-4937; Brors, Benedikt/0000-0001-5940-3101; Northcott, Paul A/0000-0002-1220-5252; Eils, Roland/0000-0002-0034-4036; Pfister, Stefan M/0000-0002-5447-5322; Jones, David TW/0000-0002-2036-5141; Koster, Jan/0000-0002-0890-7585; Korbel, Jan O/0000-0002-2798-3794; von Deimling, Andreas/0000-0002-5863-540X; Shih, David J H/0000-0002-9802-4937; Ebinger, Martin/0000-0002-4229-8058; Gilbertson, Richard James/0000-0001-7539-9472; Zapatka, Marc/0000-0001-8287-5967; Sturm, Dominik/0000-0003-0250-1696; Ryzhova, Marina/0000-0001-7206-6365; Wiemann, Stefan/0000-0003-4683-3174; Bader, Gary/0000-0003-0185-8861; Robinson, Giles W/0000-0001-7441-9486; Stuetz, Adrian/0000-0001-7650-3470; Grimes, H. Leighton/0000-0001-8162-6758; Versteeg, Rogier/0000-0001-7172-0388; Darabi, Anna/0000-0003-4326-8149; Cavalli, Florence M. G./0000-0002-4409-9642; Korshunov, Andrey/0000-0002-5257-3623; Buchhalter, Ivo/0000-0003-0764-5832; von Hoff, Katja/0000-0002-5669-8546; Zichner, Thomas/0000-0001-9848-7598; Jaeger, Natalie/0000-0002-9589-7580; Mynarek, Martin/0000-0003-3302-2719; Taylor, Michael/0000-0001-7009-3466; Raeder, Benjamin/0000-0002-9494-8884; Hovestadt, Volker/0000-0002-3480-6649; Lee, Catherine/0000-0002-3105-3557; Remke, Marc/0000-0002-9404-9993; Warnatz, Hans-Jorg/0000-0002-0327-9209; Erkek, Serap/0000-0003-4439-5203; Sterba, Jaroslav/0000-0002-8482-8352	PedBrain Tumor Project - German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A, MedSys 0315416C, NGFNplus 01GS0883]; German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); EMBL International PhD Programme; Dutch Cancer Foundation KWF [2010-4713]; Dutch Cancer Foundation KIKA; US National Institutes of Health, National Center for Research Resources [P41 GM103504]; CancerSys grant MYC-NET (German Federal Ministry of Education and Research, BMBF) [0316076A]; European Commission [Health-F2-2010-260791]; Helmholtz Alliance PCCC [HA-305]; Hertie Foundation; DKFZ; California Institute for Regenerative Medicine [CIRM LA1-01747]; National Cancer Institute [5P30CA030199, R01 CA159859]; CureSearch for Children's Cancer Foundation; NATIONAL CANCER INSTITUTE [P30CA030199, R01CA159859, R01CA129541, P01CA096832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	PedBrain Tumor Project - German Cancer Aid; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); EMBL International PhD Programme; Dutch Cancer Foundation KWF(KWF Kankerbestrijding); Dutch Cancer Foundation KIKA; US National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CancerSys grant MYC-NET (German Federal Ministry of Education and Research, BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Helmholtz Alliance PCCC; Hertie Foundation; DKFZ(Helmholtz Association); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CureSearch for Children's Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For technical support and expertise we thank: the DKFZ Genomics and Proteomics Core Facility; B. Haase, D. Pavlinic and B. Baying (EMBL Genomics Core Facility); M. Knopf (NCT Heidelberg); the Sanford-Burnham Animal Facility and Cell Imaging, Tissue & Histopathology Shared Resource; and the UCSD Flow Cytometry Core Facility. We also thank Active Motif for the preparation of histone ChIP libraries. This work was principally supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by the German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants 01KU1201A, MedSys 0315416C and NGFNplus 01GS0883). Additional support came from the German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the EMBL International PhD Programme (T.Z.), Dutch Cancer Foundations KWF (2010-4713) and KIKA (M.Ko.), the US National Institutes of Health, National Center for Research Resources (P41 GM103504; G.D.B.), the CancerSys grant MYC-NET (German Federal Ministry of Education and Research, BMBF, 0316076A), the European Commission (Health-F2-2010-260791), and the Helmholtz Alliance PCCC (grant number HA-305). PAN is a Roman Herzog Postdoctoral Fellow funded by the Hertie Foundation and the DKFZ. R.J.W.-R. is the recipient of a Research Leadership Award from the California Institute for Regenerative Medicine (CIRM LA1-01747) and obtained additional support from the National Cancer Institute (5P30CA030199 and R01 CA159859), and the CureSearch for Children's Cancer Foundation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bhatia B, 2009, CANCER RES, V69, P7224, DOI 10.1158/0008-5472.CAN-09-1299; Boutros PC, 2010, CANCER INFORM, V9, P197; Cairns J, 2011, BIOINFORMATICS, V27, P713, DOI 10.1093/bioinformatics/btq685; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Zhukova N, 2013, J CLIN ONCOL, V31, P2927, DOI 10.1200/JCO.2012.48.5052; Zornig M, 1996, ONCOGENE, V12, P1789	46	378	387	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					428	+		10.1038/nature13379	http://dx.doi.org/10.1038/nature13379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043047	Green Published, Green Accepted			2022-12-24	WOS:000339335700038
J	Briand, S; Bertherat, E; Cox, P; Formenty, P; Kieny, MP; Myhre, JK; Roth, C; Shindo, N; Dye, C				Briand, Sylvie; Bertherat, Eric; Cox, Paul; Formenty, Pierre; Kieny, Marie-Paule; Myhre, Joel K.; Roth, Cathy; Shindo, Nahoko; Dye, Christopher			The International Ebola Emergency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Briand, Sylvie; Bertherat, Eric; Cox, Paul; Formenty, Pierre; Kieny, Marie-Paule; Myhre, Joel K.; Roth, Cathy; Shindo, Nahoko; Dye, Christopher] World Hlth Org, Geneva, Switzerland	World Health Organization	Briand, S (corresponding author), World Hlth Org, Geneva, Switzerland.		Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019; Dye, Christopher/AIC-4659-2022	Kieny, Marie-Paule/0000-0002-5943-6488; Dye, Christopher/0000-0002-2957-1793	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		ANDERSON R M, 1991; Baize S, NEW ENGL J MED, DOI [10.1065/NEJMoa1404505, DOI 10.1065/NEJMOA1404505]; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217; World Health Organization (WHO), 2014, EB VIR DIS EVD	5	152	161	1	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1180	1183		10.1056/NEJMp1409858	http://dx.doi.org/10.1056/NEJMp1409858			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP4WH	25140855	Bronze			2022-12-24	WOS:000342079700003
J	Bass, AJ; Thorsson, V; Shmulevich, I; Reynolds, SM; Miller, M; Bernard, B; Hinoue, T; Laird, PW; Curtis, C; Shen, H; Weisenberger, DJ; Schultz, N; Shen, RL; Weinhold, N; Keiser, DP; Bowlby, R; Sipahimalani, P; Cherniack, AD; Getz, G; Liu, YC; Noble, MS; Pedamallu, C; Sougnez, C; Taylor-Weiner, A; Akbani, R; Lee, JS; Liu, WB; Mills, GB; Yang, D; Zhang, W; Pantazi, A; Parfenov, M; Gulley, M; Piazuelo, MB; Schneider, BG; Kim, J; Boussioutas, A; Sheth, M; Demchok, JA; Rabkin, CS; Willis, JE; Ng, S; Garman, K; Beer, DG; Pennathur, A; Raphael, BJ; Wu, HT; Odze, R; Kim, HK; Bowen, J; Leraas, KM; Lichtenberg, TM; Weaver, L; McLellan, M; Wiznerowicz, M; Sakai, R; Getz, G; Sougnez, C; Lawrence, MS; Cibulskis, K; Lichtenstein, L; Fisher, S; Gabriel, SB; Lander, ES; Ding, L; Niu, BF; Ally, A; Balasundaram, M; Birol, I; Bowlby, R; Brooks, D; Butterfield, YSN; Carlsen, R; Chu, A; Chu, J; Chuah, E; Chun, HJE; Clarke, A; Dhalla, N; Guin, R; Holt, RA; Jones, SJM; Kasaian, K; Lee, D; Li, HYA; Lim, E; Ma, Y; Marra, MA; Mayo, M; Moore, RA; Mungall, AJ; Mungall, KL; Nip, KM; Robertson, AG; Schein, JE; Sipahimalani, P; Tam, A; Thiessen, N; Beroukhim, R; Carter, SL; Cherniack, AD; Cho, J; Cibulskis, K; DiCara, D; Frazer, S; Fisher, S; Gabriel, SB; Gehlenborg, N; Heiman, DI; Jung, J; Kim, J; Lander, ES; Lawrence, MS; Lichtenstein, L; Lin, P; Meyerson, M; Ojesina, AI; Pedamallu, CS; Saksena, G; Schumacher, SE; Sougnez, C; Stojanov, P; Tabak, B; Taylor-Weiner, A; Voet, D; Rosenberg, M; Zack, TI; Zhang, HL; Zou, LH; Protopopov, A; Santoso, N; Parfenov, M; Lee, S; Zhang, J; Mahadeshwar, HS; Tang, JB; Ren, XJ; Seth, S; Yang, LX; Xu, AW; Song, XZ; Pantazi, A; Xi, RB; Bristow, CA; Hadjipanayis, A; Seidman, J; Chin, L; Park, PJ; Kucherlapati, R; Akbani, R; Ling, SY; Liu, WB; Rao, A; Weinstein, JN; Kim, SB; Lee, JS; Lu, YL; Mills, G; Hinoue, T; Weisenberger, DJ; Bootwalla, MS; Lai, PH; Shen, H; Triche, T; Van Den Berg, DJ; Baylin, SB; Herman, JG; Getz, G; Chin, L; Liu, YC; Murray, BA; Noble, MS; Askoy, BA; Ciriello, G; Dresdner, G; Gao, JJ; Gross, B; Jacobsen, A; Lee, W; Ramirez, R; Sander, C; Schultz, N; Senbabaoglu, Y; Sinha, R; Sumer, SO; Sun, YC; Weinhold, N; Thorsson, V; Bernard, B; Iype, L; Kramer, RW; Kreisberg, R; Miller, M; Reynolds, SM; Rovira, H; Tasman, N; Shmulevich, I; Ng, S; Haussler, D; Stuart, JM; Akbani, R; Ling, SY; Liu, WB; Rao, A; Weinstein, JN; Verhaak, RGW; Mills, GB; Leiserson, MDM; Raphael, BJ; Wu, HT; Taylor, BS; Black, AD; Bowen, J; Carney, JA; Gastier-Foster, JM; Helsel, C; Leraas, KM; Lichtenberg, TM; McAllister, C; Ramirez, NC; Tabler, TR; Wise, L; Zmuda, E; Penny, R; Crain, D; Gardner, J; Lau, K; Curely, E; Mallery, D; Morris, S; Paulauskis, J; Shelton, T; Shelton, C; Sherman, M; Benz, C; Lee, JH; Fedosenko, K; Manikhas, G; Voronina, O; Belyaev, D; Dolzhansky, O; Rathmell, WK; Brzezinski, J; Ibbs, M; Korski, K; Kycler, W; Lazniak, R; Leporowska, E; Mackiewicz, A; Murawa, D; Murawa, P; Spychala, A; Suchorska, WM; Tatka, H; Teresiak, M; Wiznerowicz, M; Abdel-Misih, R; Bennett, J; Brown, J; Iacocca, M; Rabeno, B; Kwon, SY; Penny, R; Gardner, J; Kemkes, A; Mallery, D; Morris, S; Shelton, T; Shelton, C; Curley, E; Alexopoulou, I; Engel, J; Bartlett, J; Albert, M; Park, DY; Dhir, R; Luketich, J; Landreneau, R; Janjigian, YY; Kelsen, DP; Cho, E; Ladanyi, M; Tang, L; McCall, SJ; Park, YS; Cheong, JH; Ajani, J; Camargo, MC; Alonso, S; Ayala, B; Jensen, MA; Pihl, T; Raman, R; Walton, J; Wan, YH; Demchok, JA; Eley, G; Shaw, KRM; Sheth, M; Tarnuzzer, R; Wang, ZN; Yang, LM; Zenklusen, JC; Davidsen, T; Hutter, CM; Sofia, HJ; Burton, R; Chudamani, S; Liu, J				Bass, Adam J.; Thorsson, Vesteinn; Shmulevich, Ilya; Reynolds, Sheila M.; Miller, Michael; Bernard, Brady; Hinoue, Toshinori; Laird, Peter W.; Curtis, Christina; Shen, Hui; Weisenberger, Daniel J.; Schultz, Nikolaus; Shen, Ronglai; Weinhold, Nils; Keiser, David P.; Bowlby, Reanne; Sipahimalani, Payal; Cherniack, Andrew D.; Getz, Gad; Liu, Yingchun; Noble, Michael S.; Pedamallu, Chandra; Sougnez, Carrie; Taylor-Weiner, Amaro; Akbani, Rehan; Lee, Ju-Seog; Liu, Wenbin; Mills, Gordon B.; Yang, Da; Zhang, Wei; Pantazi, Angeliki; Parfenov, Michael; Gulley, Margaret; Piazuelo, M. Blanca; Schneider, Barbara G.; Kim, Jihun; Boussioutas, Alex; Sheth, Margi; Demchok, John A.; Rabkin, Charles S.; Willis, Joseph E.; Ng, Sam; Garman, Katherine; Beer, David G.; Pennathur, Arjun; Raphael, Benjamin J.; Wu, Hsin-Ta; Odze, Robert; Kim, Hark K.; Bowen, Jay; Leraas, Kristen M.; Lichtenberg, Tara M.; Weaver, Lichtenberg; McLellan, Michael; Wiznerowicz, Maciej; Sakai, Ryo; Getz, Gad; Sougnez, Carrie; Lawrence, Michael S.; Cibulskis, Kristian; Lichtenstein, Lee; Fisher, Sheila; Gabriel, Stacey B.; Lander, Eric S.; Ding, Li; Niu, Beifang; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Bowlby, Reanne; Brooks, Denise; Butterfield, Yaron S. N.; Carlsen, Rebecca; Chu, Andy; Chu, Justin; Chuah, Eric; Chun, Hye-Jung E.; Clarke, Amanda; Dhalla, Noreen; Guin, Ranabir; Holt, Robert A.; Jones, Steven J. M.; Kasaian, Katayoon; Lee, Darlene; Li, Haiyan A.; Lim, Emilia; Ma, Yussanne; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Mungall, Karen L.; Nip, Ka Ming; Robertson, A. Gordon; Schein, Jacqueline E.; Sipahimalani, Payal; Tam, Angela; Thiessen, Nina; Beroukhim, Rameen; Carter, Scott L.; Cherniack, Andrew D.; Cho, Juok; Cibulskis, Kristian; DiCara, Daniel; Frazer, Scott; Fisher, Sheila; Gabriel, Stacey B.; Gehlenborg, Nils; Heiman, David I.; Jung, Joonil; Kim, Jaegil; Lander, Eric S.; Lawrence, Michael S.; Lichtenstein, Lee; Lin, Pei; Meyerson, Matthew; Ojesina, Akinyemi I.; Pedamallu, Chandra Sekhar; Saksena, Gordon; Schumacher, Steven E.; Sougnez, Carrie; Stojanov, Petar; Tabak, Barbara; Taylor-Weiner, Amaro; Voet, Doug; Rosenberg, Mara; Zack, Travis I.; Zhang, Hailei; Zou, Lihua; Protopopov, Alexei; Santoso, Netty; Parfenov, Michael; Lee, Semin; Zhang, Jianhua; Mahadeshwar, Harshad S.; Tang, Jiabin; Ren, Xiaojia; Seth, Sahil; Yang, Lixing; Xu, Andrew W.; Song, Xingzhi; Pantazi, Angeliki; Xi, Ruibin; Bristow, Christopher A.; Hadjipanayis, Angela; Seidman, Jonathan; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Akbani, Rehan; Ling, Shiyun; Liu, Wenbin; Rao, Arvind; Weinstein, John N.; Kim, Sang-Bae; Lee, Ju-Seog; Lu, Yiling; Mills, Gordon; Hinoue, Toshinori; Weisenberger, Daniel J.; Bootwalla, Moiz S.; Lai, Phillip H.; Shen, Hui; Triche, Timothy, Jr.; Van Den Berg, David J.; Baylin, Stephen B.; Herman, James G.; Getz, Gad; Chin, Lynda; Liu, Yingchun; Murray, Bradley A.; Noble, Michael S.; Askoy, B. Arman; Ciriello, Giovanni; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Lee, William; Ramirez, Ricardo; Sander, Chris; Schultz, Nikolaus; Senbabaoglu, Yasin; Sinha, Rileen; Sumer, S. Onur; Sun, Yichao; Weinhold, Nils; Thorsson, Vesteinn; Bernard, Brady; Iype, Lisa; Kramer, Roger W.; Kreisberg, Richard; Miller, Michael; Reynolds, Sheila M.; Rovira, Hector; Tasman, Natalie; Shmulevich, Ilya; Ng, Sam; Haussler, David; Stuart, Josh M.; Akbani, Rehan; Ling, Shiyun; Liu, Wenbin; Rao, Arvind; Weinstein, John N.; Verhaak, Roeland G. W.; Mills, Gordon B.; Leiserson, Mark D. M.; Raphael, Benjamin J.; Wu, Hsin-Ta; Taylor, Barry S.; Black, Aaron D.; Bowen, Jay; Carney, Julie Ann; Gastier-Foster, Julie M.; Helsel, Carmen; Leraas, Kristen M.; Lichtenberg, Tara M.; McAllister, Cynthia; Ramirez, Nilsa C.; Tabler, Teresa R.; Wise, Lisa; Zmuda, Erik; Penny, Robert; Crain, Daniel; Gardner, Johanna; Lau, Kevin; Curely, Erin; Mallery, David; Morris, Scott; Paulauskis, Joseph; Shelton, Troy; Shelton, Candace; Sherman, Mark; Benz, Christopher; Lee, Jae-Hyuk; Fedosenko, Konstantin; Manikhas, Georgy; Voronina, Olga; Belyaev, Dmitry; Dolzhansky, Oleg; Rathmell, W. Kimryn; Brzezinski, Jakub; Ibbs, Matthew; Korski, Konstanty; Kycler, Witold; Lazniak, Radoslaw; Leporowska, Ewa; Mackiewicz, Andrzej; Murawa, Dawid; Murawa, Pawel; Spychala, Arkadiusz; Suchorska, Wiktoria M.; Tatka, Honorata; Teresiak, Marek; Wiznerowicz, Maciej; Abdel-Misih, Raafat; Bennett, Joseph; Brown, Jennifer; Iacocca, Mary; Rabeno, Brenda; Kwon, Sun-Young; Penny, Robert; Gardner, Johanna; Kemkes, Ariane; Mallery, David; Morris, Scott; Shelton, Troy; Shelton, Candace; Curley, Erin; Alexopoulou, Iakovina; Engel, Jay; Bartlett, John; Albert, Monique; Park, Do-Youn; Dhir, Rajiv; Luketich, James; Landreneau, Rodney; Janjigian, Yelena Y.; Kelsen, David P.; Cho, Eunjung; Ladanyi, Marc; Tang, Laura; McCall, Shannon J.; Park, Young S.; Cheong, Jae-Ho; Ajani, Jaffer; Camargo, M. Constanza; Alonso, Shelley; Ayala, Brenda; Jensen, Mark A.; Pihl, Todd; Raman, Rohini; Walton, Jessica; Wan, Yunhu; Demchok, John A.; Eley, Greg; Shaw, Kenna R. Mills; Sheth, Margi; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Zenklusen, Jean Claude; Davidsen, Tanja; Hutter, Carolyn M.; Sofia, Heidi J.; Burton, Robert; Chudamani, Sudha; Liu, Jia		Canc Genome Atlas Res Network	Comprehensive molecular characterization of gastric adenocarcinoma	NATURE			English	Article							SOMATIC MUTATIONS; GENE-EXPRESSION; CELL LYMPHOMAS; EBV-INFECTION; CANCER; EXOME; METHYLATION; SUBTYPES; KINASE; CLASSIFICATION	Gastric cancer is a leading cause of cancer deaths, but analysis of molecular and clinical characteristics has been complicated by histological and aetiological heterogeneity. Here we describe a comprehensive molecular evaluation of 295 primary gastric adenocarcinomas as part of The Cancer Genome Atlas (TCGA) project. We propose a molecular classification dividing gastric cancer into four subtypes: tumours positive for Epstein-Barr virus, which display recurrent PIK3CA mutations, extreme DNA hypermethylation, and amplification of JAK2, CD274 (also known as PD-L1) and PDCD1LG2 (also known as PD-L2); microsatellite unstable tumours, which show elevated mutation rates, including mutations of genes encoding targetable oncogenic signalling proteins; genomically stable tumours, which are enriched for the diffuse histological variant and mutations of RHOA or fusions involving RHO-family GTPase-activating proteins; and tumours with chromosomal instability, which show marked aneuploidy and focal amplification of receptor tyrosine kinases. Identification of these subtypes provides a roalmap for patient stratification and trials of targeted therapies.	[Bass, Adam J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Bass, Adam J.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Thorsson, Vesteinn; Shmulevich, Ilya; Reynolds, Sheila M.; Miller, Michael; Bernard, Brady; Iype, Lisa; Kramer, Roger W.; Kreisberg, Richard; Rovira, Hector; Tasman, Natalie] Inst Syst Biol, Seattle, WA 98109 USA; [Hinoue, Toshinori; Laird, Peter W.; Shen, Hui; Weisenberger, Daniel J.; Bootwalla, Moiz S.; Lai, Phillip H.; Triche, Timothy, Jr.; Van Den Berg, David J.] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Curtis, Christina] Univ So Calif, Dept Prevent Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Schultz, Nikolaus; Weinhold, Nils; Askoy, B. Arman; Ciriello, Giovanni; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Lee, William; Ramirez, Ricardo; Sander, Chris; Senbabaoglu, Yasin; Sinha, Rileen; Sumer, S. Onur; Sun, Yichao] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Keiser, David P.; Janjigian, Yelena Y.; Kelsen, David P.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Bowlby, Reanne; Sipahimalani, Payal; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Brooks, Denise; Butterfield, Yaron S. N.; Carlsen, Rebecca; Chu, Andy; Chu, Justin; Chuah, Eric; Chun, Hye-Jung E.; Clarke, Amanda; Dhalla, Noreen; Guin, Ranabir; Holt, Robert A.; Jones, Steven J. M.; Kasaian, Katayoon; Lee, Darlene; Li, Haiyan A.; Lim, Emilia; Ma, Yussanne; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Mungall, Karen L.; Nip, Ka Ming; Robertson, A. Gordon; Schein, Jacqueline E.; Tam, Angela; Thiessen, Nina] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Cherniack, Andrew D.; Getz, Gad; Liu, Yingchun; Noble, Michael S.; Pedamallu, Chandra; Sougnez, Carrie; Taylor-Weiner, Amaro; Lawrence, Michael S.; Cibulskis, Kristian; Lichtenstein, Lee; Fisher, Sheila; Gabriel, Stacey B.; Lander, Eric S.; Beroukhim, Rameen; Carter, Scott L.; Cho, Juok; DiCara, Daniel; Frazer, Scott; Gehlenborg, Nils; Heiman, David I.; Jung, Joonil; Kim, Jaegil; Lin, Pei; Meyerson, Matthew; Ojesina, Akinyemi I.; Pedamallu, Chandra Sekhar; Saksena, Gordon; Schumacher, Steven E.; Stojanov, Petar; Tabak, Barbara; Voet, Doug; Rosenberg, Mara; Zack, Travis I.; Zhang, Hailei; Zou, Lihua; Murray, Bradley A.] Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Akbani, Rehan; Lee, Ju-Seog; Liu, Wenbin; Ling, Shiyun; Rao, Arvind; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Mills, Gordon B.; Kim, Sang-Bae; Lee, Ju-Seog; Lu, Yiling; Mills, Gordon] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Yang, Da; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Pantazi, Angeliki; Parfenov, Michael; Santoso, Netty; Ren, Xiaojia; Hadjipanayis, Angela; Seidman, Jonathan; Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Gulley, Margaret] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Piazuelo, M. Blanca; Schneider, Barbara G.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Kim, Jihun; Park, Young S.] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul 138736, South Korea; [Boussioutas, Alex] Univ Melbourne, Sir Peter MacCallum Canc Dept Oncol, East Melbourne 3002, Australia; [Sheth, Margi; Demchok, John A.; Eley, Greg; Shaw, Kenna R. Mills; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Zenklusen, Jean Claude] NCI, Bethesda, MD 20892 USA; [Rabkin, Charles S.; Camargo, M. Constanza] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Willis, Joseph E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Ng, Sam; Haussler, David; Stuart, Josh M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Haussler, David; Stuart, Josh M.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Garman, Katherine] Duke Univ, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Beer, David G.] Univ Michigan, Ctr Canc, Dept Thorac Surg, Ann Arbor, MI 48109 USA; [Pennathur, Arjun; Dhir, Rajiv; Luketich, James; Landreneau, Rodney] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Raphael, Benjamin J.; Wu, Hsin-Ta; Leiserson, Mark D. M.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Wu, Hsin-Ta; Leiserson, Mark D. M.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Odze, Robert] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kim, Hark K.] Natl Canc Ctr, Goyang 410769, South Korea; [Bowen, Jay; Leraas, Kristen M.; Lichtenberg, Tara M.; Weaver, Lichtenberg; Black, Aaron D.; Carney, Julie Ann; Gastier-Foster, Julie M.; Helsel, Carmen; McAllister, Cynthia; Ramirez, Nilsa C.; Tabler, Teresa R.; Wise, Lisa; Zmuda, Erik] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [McLellan, Michael; Ding, Li; Niu, Beifang] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Wiznerowicz, Maciej; Brzezinski, Jakub; Ibbs, Matthew; Korski, Konstanty; Kycler, Witold; Lazniak, Radoslaw; Leporowska, Ewa; Mackiewicz, Andrzej; Murawa, Dawid; Murawa, Pawel; Spychala, Arkadiusz; Suchorska, Wiktoria M.; Tatka, Honorata; Teresiak, Marek] Greater Poland Canc Ctr, PL-61866 Poznan, Poland; [Sakai, Ryo] Katholieke Univ Leuven, Dept Elect Engn ESAT STADIUS, Leuven, Belgium; [Protopopov, Alexei; Zhang, Jianhua; Mahadeshwar, Harshad S.; Tang, Jiabin; Seth, Sahil; Song, Xingzhi; Bristow, Christopher A.; Chin, Lynda; Verhaak, Roeland G. W.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Dept Genom Med, Houston, TX 77054 USA; [Lee, Semin; Yang, Lixing; Xu, Andrew W.; Xi, Ruibin; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Baylin, Stephen B.; Herman, James G.] Johns Hopkins Univ, Canc Biol Div, Baltimore, MD 21231 USA; [Taylor, Barry S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Penny, Robert; Crain, Daniel; Gardner, Johanna; Lau, Kevin; Curely, Erin; Mallery, David; Morris, Scott; Paulauskis, Joseph; Shelton, Troy; Shelton, Candace; Sherman, Mark; Kemkes, Ariane] Int Genom Consortium, Phoenix, AZ 85004 USA; [Benz, Christopher] Buck Inst Res Aging, Novato, CA 94945 USA; [Lee, Jae-Hyuk] Chonnam Natl Univ, Sch Med, Kwangju 501746, South Korea; [Fedosenko, Konstantin; Manikhas, Georgy] City Clin Oncol Dispensary, St Petersburg 198255, Russia; [Voronina, Olga; Belyaev, Dmitry; Dolzhansky, Oleg] Cureline Inc, San Francisco, CA 94080 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Abdel-Misih, Raafat; Bennett, Joseph; Brown, Jennifer; Iacocca, Mary; Rabeno, Brenda] Christiana Care Hlth Syst, Helen Graham Canc Ctr & Res Inst, Newark, DE 19713 USA; [Kwon, Sun-Young] Keimyung Univ, Sch Med, Taegu 700712, South Korea; [Alexopoulou, Iakovina] St Josephs Healthcare Hamilton, Ontario Tumour Bank, Hamilton, ON L8N 3Z5, Canada; [Engel, Jay] Kingston Gen Hosp, Ontario Tumour Bank, Kingston, ON K7L 5H6, Canada; [Bartlett, John; Albert, Monique] Ontario Inst Canc Res, Ontario Tumour Bank, Toronto, ON M5G 0A3, Canada; [Park, Do-Youn] Pusan Natl Univ Hosp, Pusan 602739, South Korea; [Cho, Eunjung; Ladanyi, Marc; Tang, Laura] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [McCall, Shannon J.] Duke Univ, Dept Pathol, Durham, NC 27710 USA; [Cheong, Jae-Ho] Yonsei Univ, Coll Med, Dept Surg, Seoul 120752, South Korea; [Ajani, Jaffer] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Alonso, Shelley; Ayala, Brenda; Jensen, Mark A.; Pihl, Todd; Raman, Rohini; Walton, Jessica; Wan, Yunhu] SRA Int, Fairfax, VA 22033 USA; [Davidsen, Tanja] NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD 20850 USA; [Hutter, Carolyn M.; Sofia, Heidi J.] NHGRI, Bethesda, MD 20892 USA; [Burton, Robert; Chudamani, Sudha; Liu, Jia] SAIC Frederick Inc, Frederick, MD 21702 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Institute for Systems Biology (ISB); University of Southern California; University of Southern California; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; British Columbia Cancer Agency; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; University of Ulsan; Asan Medical Center; Peter Maccallum Cancer Center; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Duke University; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; Brown University; Harvard University; Brigham & Women's Hospital; National Cancer Center - Korea (NCC); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Washington University (WUSTL); Wielkopolskie Centrum Onkologii; KU Leuven; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Johns Hopkins University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; International Genomics Consortium; Buck Institute for Research on Aging; Chonnam National University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Keimyung University; McMaster University; Queens University - Canada; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Pusan National University; Pusan National University Hospital; Memorial Sloan Kettering Cancer Center; Duke University; Yonsei University; Yonsei University Health System; University of Texas System; UTMD Anderson Cancer Center; SRA International; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Science Applications International Corporation (SAIC); SAIC-Frederick	Bass, AJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	adam_bass@dfci.harvard.edu	Akbani, Rehan/AAG-1490-2019; Jones, Steven J/C-3621-2009; Gao, JianJiong/B-5673-2016; Holt, Robert A/C-3303-2009; Suchorska, Wiktoria/CAG-0479-2022; Shen, Hui/AAO-4387-2020; Kucherlapati, Raju/ABC-8807-2021; luketich, james/AAY-6230-2020; Van Den Berg, David J/G-8598-2017; Verhaak, Roel/ABE-7058-2020; Schultz, Nikolaus/ABE-6347-2020; Lee, Semin/S-2629-2016; LIU, YING/GZL-7252-2022; Seth, Sahil/I-5809-2019; Ibbs, Matthew/AAU-1511-2021; Camargo, M. Constanza/R-9891-2016; Lawrence, Michael/AAC-8202-2020; Stojanov, Petar/GQI-4462-2022; liu, ying/GXF-4294-2022; Birol, Inanc/G-5440-2011; Cibulskis, Kristian/AAC-7380-2019; Pedamallu, Chandra Sekhar/AAV-6745-2020; Cherniack, Andrew/AAC-5310-2019; Mungall, Andrew J./U-7067-2018; Pedamallu, Chandra Sekhar/AAV-6723-2020; Skanderup, Anders Jacobsen/K-1081-2013; Laird, Peter W/G-8683-2012; Weisenberger, Daniel/AAA-8314-2020; Marra, Marco A/B-5987-2008; Cherniack, Andrew D./AAY-8132-2020; Ling, Shiyun/P-2242-2014; Schein, Jacquie E/G-3674-2015; Ladanyi, Marc/AAG-8585-2019; Lee, Ju-Seog/X-1786-2018; Senbabaoglu, Yasin/I-4922-2013	Jones, Steven J/0000-0003-3394-2208; Gao, JianJiong/0000-0002-5739-1781; Holt, Robert A/0000-0002-7259-1247; Van Den Berg, David J/0000-0002-5404-5218; Lee, Semin/0000-0002-9015-6046; Seth, Sahil/0000-0003-4579-3959; Ibbs, Matthew/0000-0003-2510-3447; Camargo, M. Constanza/0000-0002-1065-2198; Stojanov, Petar/0000-0001-7815-776X; Birol, Inanc/0000-0003-0950-7839; Mungall, Andrew J./0000-0002-0905-2742; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Laird, Peter W/0000-0001-9117-3641; Weisenberger, Daniel/0000-0001-8303-2603; Marra, Marco A/0000-0001-7146-7175; Cherniack, Andrew D./0000-0003-0470-0111; Lee, Ju-Seog/0000-0002-5666-9753; MCLELLAN, MICHAEL/0000-0002-2703-8784; Yang, Da/0000-0002-8336-9457; Meyerson, Matthew/0000-0002-9133-8108; McCall, Shannon/0000-0003-3957-061X; Shen, Hui/0000-0001-9767-4084; Triche, Tim/0000-0001-5665-946X; Tarnuzzer, Roy/0000-0002-3725-4173; Cheong, Jae-Ho/0000-0002-1703-1781; Jensen, Mark/0000-0001-5215-101X; Sinha, Rileen/0000-0001-5497-5055; Ajani, Jaffer A/0000-0001-9946-0629; Xi, Ruibin/0000-0001-7545-7361; Weinstein, John/0000-0001-9401-6908; Schultz, Nikolaus/0000-0002-0131-4904; Gehlenborg, Nils/0000-0003-0327-8297; Heiman, David/0000-0001-7895-4259; Suchorska, Wiktoria/0000-0003-4742-2465; Rosenberg, Mara/0000-0001-6400-3161; Park, Peter/0000-0001-9378-960X; Curtis, Christina/0000-0003-0166-3802; Senbabaoglu, Yasin/0000-0003-0958-958X; Schneider, Barbara/0000-0003-4421-1355; Bowen, Jay/0000-0001-6861-9043; Bootwalla, Moiz/0000-0001-6158-7114; Ciriello, Giovanni/0000-0003-2021-8683; Stuart, Joshua/0000-0002-2171-565X; Cibulskis, Kristian/0000-0003-1343-1582; Ojesina, Akinyemi/0000-0003-0755-3639; Boussioutas, Alex/0000-0002-8109-6897	Intramural Research Program; United States National Institutes of Health [5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273, P30CA16672]; NATIONAL CANCER INSTITUTE [U24CA143867, U24CA180951, P30CA016672, K08CA134931, U24CA143866, U24CA143840, U24CA143845, U24CA126543, U24CA143883, U24CA143848, K99CA166729, P01CA028842, U24CA143799, U24CA143835, U24CA143843, P30CA006973, P50CA098258, U24CA144025, R01CA180006, U24CA143858, U24CA143882] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005690, U54HG003273, U54HG003079, U54HG003067] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [1016648] Funding Source: National Science Foundation	Intramural Research Program; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We are grateful to all the patients and families who contributed to this study and to C. Gunter and J. Weinstein for scientific editing, to M. Sheth for administrative support and to L. Omberg for support with the Sage Bionetworks Synapse platform. This work was supported by the Intramural Research Program and the following grants from the United States National Institutes of Health: 5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273 and P30CA16672.	Aznar S, 2001, MOL BIOL CELL, V12, P3282, DOI 10.1091/mbc.12.10.3282; Bernal M, 2012, CANCER IMMUNOL IMMUN, V61, P1359, DOI 10.1007/s00262-012-1321-6; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Boussioutas A, 2003, CANCER RES, V63, P2569; Chen BJ, 2013, CLIN CANCER RES, V19, P3462, DOI 10.1158/1078-0432.CCR-13-0855; Doherty GJ, 2011, MOL BIOL CELL, V22, P4380, DOI 10.1091/mbc.E10-12-0936; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Ferlay J., 2013, IARC CANCERBASE, V11; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Geddert H, 2010, ANAL CELL PATHOL, V33, P143, DOI [10.1155/2010/453764, 10.3233/ACP-CLO-2010-0540]; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Greulich H, 2012, P NATL ACAD SCI USA, V109, P14476, DOI 10.1073/pnas.1203201109; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; International Agency for Research on Cancer, 2010, WHO CLASSIFICATION T; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Keller G, 1996, INT J CANCER, V68, P571; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038892; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Matsusaka K, 2011, CANCER RES, V71, P7187, DOI 10.1158/0008-5472.CAN-11-1349; Murphy G, 2009, GASTROENTEROLOGY, V137, P824, DOI 10.1053/j.gastro.2009.05.001; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Strong MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003341; Sukawa Y, 2012, WORLD J GASTROENTERO, V18, P6577, DOI 10.3748/wjg.v18.i45.6577; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Toyota M, 1999, CANCER RES, V59, P5438; Tureci O, 2011, GENE, V481, P83, DOI 10.1016/j.gene.2011.04.007; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	40	3528	3680	38	423	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					202	209		10.1038/nature13480	http://dx.doi.org/10.1038/nature13480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25079317	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000341362800044
J	Furuta, KM; Yadav, SR; Lehesranta, S; Belevich, I; Miyashima, S; Heo, JO; Vaten, A; Lindgren, O; De Rybel, B; Van Isterdael, G; Somervuo, P; Lichtenberger, R; Rocha, R; Thitamadee, S; Tahtiharju, S; Auvinen, P; Beeckman, T; Jokitalo, E; Helariutta, Y				Furuta, Kaori Miyashima; Yadav, Shri Ram; Lehesranta, Satu; Belevich, Ilya; Miyashima, Shunsuke; Heo, Jung-ok; Vaten, Anne; Lindgren, Ove; De Rybel, Bert; Van Isterdael, Gert; Somervuo, Panu; Lichtenberger, Raffael; Rocha, Raquel; Thitamadee, Siripong; Tahtiharju, Sari; Auvinen, Petri; Beeckman, Tom; Jokitalo, Eija; Helariutta, Yka			Arabidopsis NAC45/86 direct sieve element morphogenesis culminating in enucleation	SCIENCE			English	Article							PHLOEM; CELL; DIFFERENTIATION; PROTEIN	Photoassimilates such as sugars are transported through phloem sieve element cells in plants. Adapted for effective transport, sieve elements develop as enucleated living cells. We used electron microscope imaging and three-dimensional reconstruction to follow sieve element morphogenesis in Arabidopsis. We show that sieve element differentiation involves enucleation, in which the nuclear contents are released and degraded in the cytoplasm at the same time as other organelles are rearranged and the cytosol is degraded. These cellular reorganizations are orchestrated by the genetically redundant NAC domain-containing transcription factors, NAC45 and NAC86 (NAC45/86). Among the NAC45/86 targets, we identified a family of genes required for enucleation that encode proteins with nuclease domains. Thus, sieve elements differentiate through a specialized autolysis mechanism.	[Furuta, Kaori Miyashima; Yadav, Shri Ram; Lehesranta, Satu; Belevich, Ilya; Miyashima, Shunsuke; Heo, Jung-ok; Vaten, Anne; Lindgren, Ove; Somervuo, Panu; Lichtenberger, Raffael; Rocha, Raquel; Thitamadee, Siripong; Tahtiharju, Sari; Auvinen, Petri; Jokitalo, Eija; Helariutta, Yka] Univ Helsinki, Inst Biotechnol, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [De Rybel, Bert; Van Isterdael, Gert; Beeckman, Tom] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [De Rybel, Bert; Van Isterdael, Gert; Beeckman, Tom] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Helariutta, Yka] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Helariutta, Yka] Univ Cambridge, Sainsbury Lab, Cambridge CB2 1LR, England	University of Helsinki; Ghent University; Flanders Institute for Biotechnology (VIB); Cardiff University; University of Cambridge	Helariutta, Y (corresponding author), Univ Helsinki, Inst Biotechnol, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland.	eija.jokitalo@helsinki.fi; yrjo.helariutta@slcu.cam.ac.uk	Auvinen, Petri/D-5044-2009; Beeckman, Tom/ABI-1703-2020; Jokitalo, Eija/C-8375-2009; Helariutta, Yrjo/AAE-8149-2020; Miyashima, Shunsuke/AAV-1196-2021; Beeckman, Tom/ABA-1164-2020; Auvinen, Petri/AAP-8117-2021	Auvinen, Petri/0000-0002-3947-4778; Beeckman, Tom/0000-0001-8656-2060; Jokitalo, Eija/0000-0002-4159-6934; Helariutta, Yrjo/0000-0002-7287-8459; Van Isterdael, Gert/0000-0001-6626-1316; Vaten, Anne/0000-0003-1788-5127; Belevich, Ilya/0000-0003-2190-4909; Miyashima, Shunsuke/0000-0001-8267-3978; De Rybel, Bert/0000-0002-9551-042X	Japanese Society for the Promotion of Science; Research Foundation-Flanders [FWO - GO20011N]; Belgian Federal Science Policy Office; Academy of Finland; Biocenter Finland; University of Helsinki; Academy of Finland Centre of Excellence programme; European Research Council; Tekes (the Finnish Funding Agency for Technology and Innovation); Gatsby Foundation	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Foundation-Flanders(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Academy of Finland(Academy of Finland); Biocenter Finland; University of Helsinki; Academy of Finland Centre of Excellence programme(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); Tekes (the Finnish Funding Agency for Technology and Innovation)(Finnish Funding Agency for Technology & Innovation (TEKES)); Gatsby Foundation	We thank K. Kainulainen, M. Herpola, M. Lindman, A. Salminen, and I. Sevilem for technical assistance; R. Siligato, A. Mahonen, the University of Ghent, the Arabidopsis Biological Resource Center, and the Nottingham Arabidopsis Stock Centre for published materials; A. Mahonen, E.-L. Eskelinen, A. Suomalainen-Wartiovaara, and P. Runeberg-Roos for discussions; and P. Benfey, K. Nakajima, and S. El-Showk for their critical comments. The serial block-face electron microscopy was supported by Biocenter Finland. S. M. was financially supported by the Japanese Society for the Promotion of Science. Work in the lab of T. B. was partly financed by grants of the Research Foundation-Flanders (project FWO - GO20011N) and the Interuniversity Attraction Poles Programme from the Belgian Federal Science Policy Office. Work in the E. J. laboratory is funded by the Academy of Finland, Biocenter Finland, and the University of Helsinki. Financial support for the lab of Y. H. was provided by the Academy of Finland Centre of Excellence programme, the University of Helsinki, the European Research Council Advanced Investigator Grant Symdev, Tekes (the Finnish Funding Agency for Technology and Innovation), and the Gatsby Foundation. The supplementary materials contain additional data.	BESSIS M, 1952, Rev Hematol, V7, P407; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Busse JS, 1999, INT J PLANT SCI, V160, P241, DOI 10.1086/314117; CRONSHAW J, 1968, J CELL BIOL, V38, P292, DOI 10.1083/jcb.38.2.292; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; ELEFTHERIOU EP, 1982, PROTOPLASMA, V113, P221, DOI 10.1007/BF01280911; ESAU K, 1950, BOT REV, V16, P67, DOI 10.1007/BF02919553; ESAU K, 1972, ANN BOT-LONDON, V36, P703, DOI 10.1093/oxfordjournals.aob.a084626; Imlau A, 1999, PLANT CELL, V11, P309, DOI 10.1105/tpc.11.3.309; Liu ML, 2012, EUKARYOT CELL, V11, P494, DOI 10.1128/EC.05296-11; Lucas WJ, 2013, J INTEGR PLANT BIOL, V55, P294, DOI 10.1111/jipb.12041; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mijaljica D, 2013, J CELL SCI, V126, P4325, DOI 10.1242/jcs.133090; Sjolund RD, 1997, PLANT CELL, V9, P1137, DOI 10.1105/tpc.9.7.1137; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; van Doorn WG, 2011, CELL DEATH DIFFER, V18, P1241, DOI 10.1038/cdd.2011.36; Wang LK, 2008, PROTOPLASMA, V234, P87, DOI 10.1007/s00709-008-0023-6; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Wu H, 2003, ACTA BOT SIN, V45, P322	19	124	145	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					933	937		10.1126/science.1253736	http://dx.doi.org/10.1126/science.1253736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25081480				2022-12-24	WOS:000340524700047
J	Elsworth, B; Matthews, K; Nie, CQ; Kalanon, M; Charnaud, SC; Sanders, PR; Chisholm, SA; Counihan, NA; Shaw, PJ; Pino, P; Chan, JA; Azevedo, MF; Rogerson, SJ; Beeson, JG; Crabb, BS; Gilson, PR; de Koning-Ward, TF				Elsworth, Brendan; Matthews, Kathryn; Nie, Catherine Q.; Kalanon, Ming; Charnaud, Sarah C.; Sanders, Paul R.; Chisholm, Scott A.; Counihan, Natalie A.; Shaw, Philip J.; Pino, Paco; Chan, Jo-Anne; Azevedo, Mauro F.; Rogerson, Stephen J.; Beeson, James G.; Crabb, Brendan S.; Gilson, Paul R.; de Koning-Ward, Tania F.			PTEX is an essential nexus for protein export in malaria parasites	NATURE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; PARASITOPHOROUS VACUOLE; CHONDROITIN SULFATE; PLACENTAL MALARIA; SURFACE; VIRULENCE; INVASION; ANTIBODIES; ANTIGEN	During the blood stages of malaria, several hundred parasite-encoded proteins are exported beyond the double-membrane barrier that separates the parasite from the host cell cytosol(1-6). These proteins have a variety of roles that are essential to virulence or parasite growth(7). There is keen interest in understanding how proteins are exported and whether common machineries are involved in trafficking the different classes of exported proteins(8,9). One potential trafficking machine is a protein complex known as the Plasmodium translocon of exported proteins (PTEX)(10). Although PTEX has been linked to the export of one class of exported proteins(10,11), there has been no direct evidence for its role and scope in protein translocation. Here we show, through the generation of two parasite lines defective for essential PTEX components (HSP101 or PTEX150), and analysis of a line lacking the non-essential component TRX2 (ref. 12), greatly reduced trafficking of all classes of exported proteins beyond the double membrane barrier enveloping the parasite. This includes proteins containing the PEXEL motif (RxLxE/Q/D)(1,2) and PEXEL-negative exported proteins (PNEPs)(6). Moreover, the export of proteins destined for expression on the infected erythrocyte surface, including the major virulence factor PfEMP1 in Plasmodium falciparum, was significantly reduced in PTEX knockdown parasites. PTEX function was also essential for blood-stage growth, because even a modest knockdown of PTEX components had a strong effect on the parasite's capacity to complete the erythrocytic cycle both in vitro and in vivo. Hence, as the only known nexus for protein export in Plasmodium parasites, and an essential enzymic machine, PTEX is a prime drug target.	[Elsworth, Brendan; Nie, Catherine Q.; Charnaud, Sarah C.; Sanders, Paul R.; Chan, Jo-Anne; Azevedo, Mauro F.; Beeson, James G.; Crabb, Brendan S.; Gilson, Paul R.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia; [Elsworth, Brendan; Charnaud, Sarah C.; Beeson, James G.; Crabb, Brendan S.; Gilson, Paul R.] Monash Univ, Clayton, Vic 3800, Australia; [Matthews, Kathryn; Kalanon, Ming; Chisholm, Scott A.; Counihan, Natalie A.; de Koning-Ward, Tania F.] Deakin Univ, Waurn Ponds, Vic 3216, Australia; [Shaw, Philip J.] Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani 12120, Thailand; [Pino, Paco] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Rogerson, Stephen J.; Beeson, James G.; Crabb, Brendan S.] Univ Melbourne, Parkville, Vic 3010, Australia	Burnet Institute; Monash University; Deakin University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Geneva; University of Melbourne	de Koning-Ward, TF (corresponding author), Deakin Univ, Waurn Ponds, Vic 3216, Australia.	crabb@burnet.edu.au; gilson@burnet.edu.au; taniad@deakin.edu.au	de Koning-Ward, Tania F/N-3572-2017; Chisholm, Scott/K-2661-2019; Azevedo, Mauro/H-6180-2012	de Koning-Ward, Tania F/0000-0001-5810-8063; Chisholm, Scott/0000-0002-3833-8854; Azevedo, Mauro/0000-0002-5233-2037; Charnaud, Sarah/0000-0002-9029-9696; Rogerson, Stephen/0000-0003-4287-1982	National Health and Medical Research Council (NHMRC) of Australia [1021560, 1025665, 637406]; Victorian State Government; Australian Postgraduate Awards	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Australian Postgraduate Awards(Australian Government)	We thank T. Templeton, B. Franke-Fayard, C. Janse, A. Cowman, J. Boddey, B. Cooke, M. Duffy, L. Tilley, R. Anders, F. Fowkes, A. McLean and D. Bursac for reagents and/or other assistance with aspects of this study; D. Stanisic, F. Baiwog and I. Mueller for contributions to clinical studies of pregnant women; and P. Siba. We also thank the Australian Red Cross Blood Bank for the provision of human blood and serum. This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (1021560, 1025665 and 637406) and the Victorian State Government Operational Infrastructure Support Scheme. T.F.d.K.-W. is an NHMRC Career Development Fellow, and J.G.B. is a NHMRC Senior Research Fellow. B.E. and K.M. are the recipients of Australian Postgraduate Awards.	Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Cooke BM, 1996, BLOOD, V88, P4040, DOI 10.1182/blood.V88.10.4040.bloodjournal88104040; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991; de Koning-Ward TF, 2008, MOL BIOCHEM PARASIT, V159, P69, DOI 10.1016/j.molbiopara.2008.01.005; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; Elsworth B, 2014, CELL MICROBIOL, V16, P355, DOI 10.1111/cmi.12261; Haase S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061482; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matthews K, 2013, MOL MICROBIOL, V89, P1167, DOI 10.1111/mmi.12334; Matz JM, 2013, MOL BIOCHEM PARASIT, V191, P44, DOI 10.1016/j.molbiopara.2013.09.003; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; POLOGE LG, 1986, NATURE, V322, P474, DOI 10.1038/322474a0; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Riglar DT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2449; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084	42	167	170	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					587	+		10.1038/nature13555	http://dx.doi.org/10.1038/nature13555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043043				2022-12-24	WOS:000339566300034
J	McKenney, RJ; Huynh, W; Tanenbaum, ME; Bhabha, G; Vale, RD				McKenney, Richard J.; Huynh, Walter; Tanenbaum, Marvin E.; Bhabha, Gira; Vale, Ronald D.			Activation of cytoplasmic dynein motility by dynactin-cargo adapter complexes	SCIENCE			English	Article							MICROTUBULE-BINDING; PROCESSIVITY; TRANSPORT; MOTOR; PROTEIN; LIS1; INCREASES; DOMAIN	Cytoplasmic dynein is a molecular motor that transports a large variety of cargoes (e. g., organelles, messenger RNAs, and viruses) along microtubules over long intracellular distances. The dynactin protein complex is important for dynein activity in vivo, but its precise role has been unclear. Here, we found that purified mammalian dynein did not move processively on microtubules in vitro. However, when dynein formed a complex with dynactin and one of four different cargo-specific adapter proteins, the motor became ultraprocessive, moving for distances similar to those of native cargoes in living cells. Thus, we propose that dynein is largely inactive in the cytoplasm and that a variety of adapter proteins activate processive motility by linking dynactin to dynein only when the motor is bound to its proper cargo.	[Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	vale@ucsf.edu			NIH [F32GM096484, R01GM097312]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097312, F32GM096484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Ori-McKenney for helpful discussions and analysis. This work was supported by NIH F32 postdoctoral grant F32GM096484 (to R.J.M.) and R01GM097312 (to R.D.V.). G. B. is the Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2136-12).	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Lazarus JE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001611; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Miura M, 2010, FEBS LETT, V584, P2351, DOI 10.1016/j.febslet.2010.04.016; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Ori-McKenney KM, 2010, NAT CELL BIOL, V12, P1228, DOI 10.1038/ncb2127; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Soundararajan HC, 2014, ELIFE, V3, DOI 10.7554/eLife.01596; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Stuurman N, 1999, EUR J CELL BIOL, V78, P278, DOI 10.1016/S0171-9335(99)80061-2; Tanenbaum ME, 2013, ELIFE, V2, DOI 10.7554/eLife.00943; Tokito MK, 1996, MOL BIOL CELL, V7, P1167, DOI 10.1091/mbc.7.8.1167; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Zhang J, 2014, J CELL BIOL, V204, P1009, DOI 10.1083/jcb.201308009	30	302	306	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					337	341		10.1126/science.1254198	http://dx.doi.org/10.1126/science.1254198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	25035494	Green Accepted			2022-12-24	WOS:000339400700054
J	McKinley, KL; Cheeseman, IM				McKinley, Kara L.; Cheeseman, Iain M.			Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres	CELL			English	Article							CYTOKINESIS; RECRUITMENT; REVEALS; PLK1; MAINTENANCE; INHIBITOR; BI-2536; M18BP1; HJURP	To ensure the stable transmission of the genome during vertebrate cell division, the mitotic spindle must attach to a single locus on each chromosome, termed the centromere. The fundamental requirement for faithful centromere inheritance is the controlled deposition of the centromere-specifying histone, CENP-A. However, the regulatory mechanisms that ensure the precise control of CENP-A deposition have proven elusive. Here, we identify polo-like kinase 1 (Plk1) as a centromere-localized regulator required to initiate CENP-A deposition in human cells. We demonstrate that faithful CENP-A deposition requires integrated signals from Plk1 and cyclin-dependent kinase (CDK), with Plk1 promoting the localization of the key CENP-A deposition factor, the Mis18 complex, and CDK inhibiting Mis18 complex assembly. By bypassing these regulated steps, we uncoupled CENP-A deposition from cell-cycle progression, resulting in mitotic defects. Thus, CENP-A deposition is controlled by a two-step regulatory paradigm comprised of Plk1 and CDK that is crucial for genomic integrity.	[McKinley, Kara L.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Whitehead Inst, Cambridge, MA 02142 USA; [McKinley, Kara L.; Cheeseman, Iain M.] MIT, Cambridge Ctr 9, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Cheeseman, IM (corresponding author), MIT, Cambridge Ctr 9, Whitehead Inst, Cambridge, MA 02142 USA.	icheese@wi.mit.edu		McKinley, Kara/0000-0001-6283-9168; Cheeseman, Iain/0000-0002-3829-5612	Scholar Award from the Leukemia & Lymphoma Society; NIH/National Institute of General Medical Sciences [GM088313]; American Cancer Society [121776]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, R01GM088313] Funding Source: NIH RePORTER	Scholar Award from the Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the I.M.C. laboratory, Defne Yarar, David Sabatini, Peter Reddien, Steve Bell, Frank Solomon, Terry Orr-Weaver, and Rick Young for discussions and critical reading of the manuscript. We are grateful to Daniel Lim and Michael Yaffe (MIT) for providing the GST-Plk1-PBD and advice on working with Plk1. We thank Aaron Straight (Stanford University) for the CENP-A-SNAP cell line, Prasad Jallepalli (Sloan Kettering) for the Rpe1-Plk1<SUP>as</SUP> cell line, and Lars Jansen (Gulbenkian Institute) for the M18BP1 cDNA and CENP-A-SNAP plasmids. We thank Paul Fields and Laurie Boyer (MIT) and Chikdu Shivalila and Rudolf Jaenisch (Whitehead Institute and MIT) for advice and reagents for CRISPR/Cas9-mediated genome editing. This work was supported by a Scholar Award from the Leukemia & Lymphoma Society, a grant from the NIH/National Institute of General Medical Sciences (GM088313), and a Research Scholar Grant (121776) from the American Cancer Society to I.M. C.I.M.C. is a Thomas D. and Virginia W. Cabot Career Development Professor of Biology.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Black BE, 2010, COLD SH Q B, V75, P403, DOI 10.1101/sqb.2010.75.038; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Cheeseman I. M., 2005, SCI STKE, V266, P1; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dambacher S, 2012, NUCLEUS-PHILA, V3, P101, DOI 10.4161/nucl.18955; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Gascoigne KE, 2013, CHROMOSOME RES, V21, P407, DOI 10.1007/s10577-013-9368-6; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Gomez-Rodriguez M, 2013, CURR OPIN GENET DEV, V23, P219, DOI 10.1016/j.gde.2012.11.002; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Moree B, 2011, J CELL BIOL, V194, P855, DOI 10.1083/jcb.201106079; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Silva MCC, 2012, DEV CELL, V22, P52, DOI 10.1016/j.devcel.2011.10.014; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Wang H, 2013, CELL, V153; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110	37	97	97	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					397	411		10.1016/j.cell.2014.06.016	http://dx.doi.org/10.1016/j.cell.2014.06.016			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036634	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000340943600018
J	Rechavi, O; Houri-Ze'evi, L; Anava, S; Goh, WSS; Kerk, SY; Hannon, GJ; Hobert, O				Rechavi, Oded; Houri-Ze'evi, Leah; Anava, Sarit; Goh, Wee Siong Sho; Kerk, Sze Yen; Hannon, Gregory J.; Hobert, Oliver			Starvation-Induced Transgenerational Inheritance of Small RNAs in C. elegans	CELL			English	Article							GERMLINE GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; EPIGENETIC INHERITANCE; NUTRITIONAL CONTROL; PRENATAL EXPOSURE; MEMORY; PIRNAS; AMPLIFICATION; INTERFERENCE; LONGEVITY	Evidence from animal studies and human famines suggests that starvation may affect the health of the progeny of famished individuals. However, it is not clear whether starvation affects only immediate offspring or has lasting effects; it is also unclear how such epigenetic information is inherited. Small RNA-induced gene silencing can persist over several generations via transgenerationally inherited small RNA molecules in C. elegans, but all known transgenerational silencing responses are directed against foreign DNA introduced into the organism. We found that starvation-induced developmental arrest, a natural and drastic environmental change, leads to the generation of small RNAs that are inherited through at least three consecutive generations. These small, endogenous, transgenerationally transmitted RNAs target genes with roles in nutrition. We defined genes that are essential for this multigenerational effect. Moreover, we show that the F3 offspring of starved animals show an increased lifespan, corroborating the notion of a transgenerational memory of past conditions.	[Rechavi, Oded; Houri-Ze'evi, Leah; Anava, Sarit] Tel Aviv Univ, Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Rechavi, Oded; Houri-Ze'evi, Leah; Anava, Sarit] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Rechavi, Oded; Kerk, Sze Yen; Hobert, Oliver] Columbia Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Goh, Wee Siong Sho; Hannon, Gregory J.] Watson Sch Biol Sci, Howard Hughes Med Inst, Cold Spring Harbor Lab, New York, NY 11724 USA	Tel Aviv University; Tel Aviv University; Columbia University; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Rechavi, O (corresponding author), Tel Aviv Univ, Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	odedrechavi@gmail.com	Hannon, Gregory/AAB-3568-2019; Houri-Zeevi, Leah/AAR-2327-2021; Goh, Sho/AAG-6762-2021	Goh, Sho/0000-0003-4355-3927; Hobert, Oliver/0000-0002-7634-2854; Kerk, Sze Yen/0000-0003-2358-9674	Alon fellowship; Bikura fellowship; Yad Hanadiv fellowship; CBRC grant; Teva NNE grant; ISF grant; ERC grant; Howard Hughes Medical Institute; Cancer Research UK [21143] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER	Alon fellowship; Bikura fellowship; Yad Hanadiv fellowship; CBRC grant; Teva NNE grant(Teva Pharmaceutical Industries); ISF grant; ERC grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yoav Benjamini for help with the statistical methods. We thank Scott Kennedy for providing the hrde-1 strain. We also thank Assaf Gordon, Michal lineal, Shelly Mahlab, and all members of the Rechavi and Hobert lab for their helpful comments. Oded Rechavi, Leah Houri-Ze'evi, and Sarit Anava were supported by funds from the Alon, Bikura, and Yad Hanadiv fellowships, and by the CBRC, Teva NNE, ISF, and ERC grants. This work was supported by the Howard Hughes Medical Institute.	Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Bygren LO, 2001, ACTA BIOTHEOR, V49, P53, DOI 10.1023/A:1010241825519; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Conine CC, 2013, CELL, V155, P1532, DOI 10.1016/j.cell.2013.11.032; DePina Ana S., 2011, BMC Physiology, V11, P11, DOI 10.1186/1472-6793-11-11; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer S. E. J., 2014, C ELEGANS RES COMMUN; Fischer SEJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002369; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grishok A, 2013, ADV GENET, V83, P1, DOI 10.1016/B978-0-12-407675-4.00001-8; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Hall SE, 2013, RNA, V19, P306, DOI 10.1261/rna.036418.112; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; Harvey SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025840; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hellwig S, 2008, P NATL ACAD SCI USA, V105, P12897, DOI 10.1073/pnas.0805118105; Jablonka E, 2008, GENET MOL BIOL, V31, P389, DOI 10.1590/S1415-47572008000300001; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kamminga LM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002702; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-42; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Mansisidor AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002299; Maxwell CS, 2012, GENOME RES, V22, P1920, DOI 10.1101/gr.133587.111; Meloche S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003163; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Rechavi O, 2014, TRENDS CELL BIOL, V24, P212, DOI 10.1016/j.tcb.2013.10.003; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Remy JJ, 2010, CURR BIOL, V20, pR877, DOI 10.1016/j.cub.2010.08.013; Remy JJ, 2005, SCIENCE, V309, P787, DOI 10.1126/science.1114209; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Song SG, 2009, SOC SCI MED, V68, P1315, DOI 10.1016/j.socscimed.2009.01.027; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Sterken MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089760; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Wedeles CJ, 2013, DEV CELL, V27, P664, DOI 10.1016/j.devcel.2013.11.016; Zhang XC, 2011, P NATL ACAD SCI USA, V108, P17997, DOI 10.1073/pnas.1105982108	53	286	296	3	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					277	287		10.1016/j.cell.2014.06.020	http://dx.doi.org/10.1016/j.cell.2014.06.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25018105	Bronze, Green Accepted			2022-12-24	WOS:000340943600009
J	Dvir, D; Webb, JG; Bleiziffer, S; Pasic, M; Waksman, R; Kodali, S; Barbanti, M; Latib, A; Schaefer, U; Rodes-Cabau, J; Treede, H; Piazza, N; Hildick-Smith, D; Himbert, D; Walther, T; Hengstenberg, C; Nissen, H; Bekeredjian, R; Presbitero, P; Ferrari, E; Segev, A; de Weger, A; Windecker, S; Moat, NE; Napodano, M; Wilbring, M; Cerillo, AG; Brecker, S; Tchetche, D; Lefevre, T; De Marco, F; Fiorina, C; Petronio, AS; Teles, RC; Testa, L; Laborde, JC; Leon, MB; Kornowski, R				Dvir, Danny; Webb, John G.; Bleiziffer, Sabine; Pasic, Miralem; Waksman, Ron; Kodali, Susheel; Barbanti, Marco; Latib, Azeem; Schaefer, Ulrich; Rodes-Cabau, Josep; Treede, Hendrik; Piazza, Nicolo; Hildick-Smith, David; Himbert, Dominique; Walther, Thomas; Hengstenberg, Christian; Nissen, Henrik; Bekeredjian, Raffi; Presbitero, Patrizia; Ferrari, Enrico; Segev, Amit; de Weger, Arend; Windecker, Stephan; Moat, Neil E.; Napodano, Massimo; Wilbring, Manuel; Cerillo, Alfredo G.; Brecker, Stephen; Tchetche, Didier; Lefevre, Thierry; De Marco, Federico; Fiorina, Claudia; Petronio, Anna Sonia; Teles, Rui C.; Testa, Luca; Laborde, Jean-Claude; Leon, Martin B.; Kornowski, Ran		Valve In Valve Int Data Registry	Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSTHESIS-PATIENT MISMATCH; HIGH-RISK PATIENTS; HEART-VALVES; NATIONAL DATABASE; ELDERLY-PATIENTS; REPLACEMENT; STENOSIS; IMPACT; ENLARGEMENT; SURVIVAL	IMPORTANCE Owing to a considerable shift toward bioprosthesis implantation rather than mechanical valves, it is expected that patients will increasingly present with degenerated bioprostheses in the next few years. Transcatheter aortic valve-in-valve implantation is a less invasive approach for patients with structural valve deterioration; however, a comprehensive evaluation of survival after the procedure has not yet been performed. OBJECTIVE To determine the survival of patients after transcatheter valve-in-valve implantation inside failed surgical bioprosthetic valves. DESIGN, SETTING, AND PARTICIPANTS Correlates for survivalwere evaluated using a multinational valve-in-valve registry that included 459 patients with degenerated bioprosthetic valves undergoing valve-in-valve implantation between 2007 and May 2013 in 55 centers (mean age, 77.6 [SD, 9.8] years; 56% men; median Society of Thoracic Surgeons mortality prediction score, 9.8%[interquartile range, 7.7%-16%]). Surgical valves were classified as small (<= 21 mm; 29.7%), intermediate (> 21 and < 25 mm; 39.3%), and large (<= 25 mm; 31%). Implanted devices included both balloon-and self-expandable valves. MAIN OUTCOMES AND MEASURES Survival, stroke, and New York Heart Association functional class. RESULTS Modes of bioprosthesis failure were stenosis (n = 181 [39.4%]), regurgitation (n = 139 [30.3%]), and combined (n = 139 [30.3%]). The stenosis group had a higher percentage of small valves (37% vs 20.9% and 26.6% in the regurgitation and combined groups, respectively; P =.005). Within 1 month following valve-in-valve implantation, 35 (7.6%) patients died, 8 (1.7%) had major stroke, and 313 (92.6%) of surviving patients had good functional status (New York Heart Association class I/II). The overall 1-year Kaplan-Meier survival rate was 83.2%(95% CI, 80.8%-84.7%; 62 death events; 228 survivors). Patients in the stenosis group had worse 1-year survival (76.6%; 95% CI, 68.9%-83.1%; 34 deaths; 86 survivors) in comparison with the regurgitation group (91.2%; 95% CI, 85.7%-96.7%; 10 deaths; 76 survivors) and the combined group (83.9%; 95% CI, 76.8%-91%; 18 deaths; 66 survivors) (P =.01). Similarly, patients with small valves had worse 1-year survival (74.8%[95% CI, 66.2%-83.4%]; 27 deaths; 57 survivors) vs with intermediate-sized valves (81.8%; 95% CI, 75.3%-88.3%; 26 deaths; 92 survivors) and with large valves (93.3%; 95% CI, 85.7%-96.7%; 7 deaths; 73 survivors) (P =.001). Factors associated with mortality within 1 year included having small surgical bioprosthesis (<= 21 mm; hazard ratio, 2.04; 95% CI, 1.14-3.67; P =.02) and baseline stenosis (vs regurgitation; hazard ratio, 3.07; 95% CI, 1.33-7.08; P =.008). CONCLUSIONS AND RELEVANCE In this registry of patients who underwent transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic valves, overall 1-year survival was 83.2%. Survival was lower among patients with small bioprostheses and those with predominant surgical valve stenosis.	[Dvir, Danny; Webb, John G.; Barbanti, Marco] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Bleiziffer, Sabine] German Heart Ctr, Munich, Germany; [Pasic, Miralem] Deutsch Herzzentrum Berlin, Berlin, Germany; [Waksman, Ron] Washington Hosp Ctr, Washington, DC 20010 USA; [Kodali, Susheel; Leon, Martin B.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Kodali, Susheel; Leon, Martin B.] Cardiovasc Res Fdn, New York, NY USA; [Latib, Azeem] Ist Sci San Raffaele, I-20132 Milan, Italy; [Schaefer, Ulrich] Asklepios Clin St Georg, Hamburg, Germany; [Rodes-Cabau, Josep] Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Treede, Hendrik] Univ Heart Ctr Hamburg, Hamburg, Germany; [Piazza, Nicolo] McGill Univ, Ctr Hlth, Dept Intervent Cardiol, Montreal, PQ, Canada; [Hildick-Smith, David] Sussex Cardiac Ctr, Brighton, E Sussex, England; [Himbert, Dominique] Hosp Bichat, Paris, France; [Walther, Thomas] Kerckhoff Heart Ctr, Bad Nauheim, Germany; [Hengstenberg, Christian] Univ Klinikum Regensburg, Regensburg, Germany; [Nissen, Henrik] Odense Univ Hosp, DK-5000 Odense, Denmark; [Bekeredjian, Raffi] Heidelberg Univ, Heidelberg, Germany; [Presbitero, Patrizia] IRCCS Ist Clin Humanitas, Hemodynam & Invas Cardiol Unit, Milan, Italy; [Ferrari, Enrico] Univ Lausanne Hosp, Lausanne, Switzerland; [Segev, Amit] Sheba Med Ctr, Ramat Gan, Israel; [de Weger, Arend] Leids Univ Med Ctr, Leiden, Netherlands; [Windecker, Stephan] Univ Hosp Bern, CH-3010 Bern, Switzerland; [Moat, Neil E.] Royal Brompton Hosp, London SW3 6LY, England; [Napodano, Massimo] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Wilbring, Manuel] Univ Heart Ctr Dresden, Dresden, Germany; [Cerillo, Alfredo G.] G Pasquinucci Hosp, Massa, Italy; [Brecker, Stephen; Laborde, Jean-Claude] Univ London St Georges Hosp, London, England; [Tchetche, Didier] Clin Pasteur, Toulouse, France; [Lefevre, Thierry] Hop Jacques Cartier, Massy, France; [De Marco, Federico] Osped Niguarda Ca Granda, Milan, Italy; [Fiorina, Claudia] Azienda Osped Spedali Civili Brescia, Brescia, Italy; [Petronio, Anna Sonia] Azienda Osped Univ Pisana, Pisa, Italy; [Teles, Rui C.] Hosp Santa Cruz, Lisbon, Portugal; [Testa, Luca] Clin Inst S Ambrogio, Milan, Italy; [Kornowski, Ran] Rabin Med Ctr, Tel Aviv, Israel; [Kornowski, Ran] Tel Aviv Univ, IL-69978 Tel Aviv, Israel	St. Paul's Hospital; University of Saskatchewan; German Heart Centre Munich; German Heart Center Berlin; MedStar Washington Hospital Center; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Asklepios Klinik St. Georg; Quebec Heart & Lung Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Kerckhoff Clinic; University of Regensburg; University of Southern Denmark; Odense University Hospital; Ruprecht Karls University Heidelberg; Humanitas University; IRCCS Humanitas Research Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Chaim Sheba Medical Center; University of Bern; University Hospital of Bern; Royal Brompton Hospital; University of Padua; Technische Universitat Dresden; St Georges University London; Jacques Cartier Private Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Hospital Spedali Civili Brescia; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Universidade de Lisboa; Rabin Medical Center; Tel Aviv University	Dvir, D (corresponding author), St Pauls Hosp, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	ddvir@providencehealth.bc.ca	Ferrari, Enrico/AAD-2897-2020; De Marco, Federico/AAB-4605-2021; Testa, Luca/J-8226-2018; Hengstenberg, Christian/U-5485-2019; Doğan, Ali/AAN-5331-2020; Barbanti, Marco/AAP-4373-2020; Bleiziffer, Sabine/AAU-2081-2020; Treede, Hendrik/I-3630-2017; Latib, Azeem/B-4165-2008	Ferrari, Enrico/0000-0002-2837-3242; De Marco, Federico/0000-0003-3554-6938; Barbanti, Marco/0000-0002-4903-5437; Latib, Azeem/0000-0001-9035-343X; SEgev, Amit/0000-0002-2290-0400; testa, luca/0000-0003-4687-3686; Cerillo, Alfredo Giuseppe/0000-0003-3430-2333	Edwards Lifesciences; Medtronic; Boston Scientific; St Jude; Biotronik; Abbott; Cordis	Edwards Lifesciences; Medtronic(Medtronic); Boston Scientific(Boston Scientific); St Jude(St. Jude Medical); Biotronik; Abbott(Abbott Laboratories); Cordis	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Webb reports grants and personal fees from Edwards Lifesciences. Dr Bleiziffer reports serving as proctor for Medtronic and JenaValve. Dr Kodali reports consultancy for Edwards Lifesciences, Claret Medical, and Merril Lifesciences and serving on the scientific advisory board for Thubrikar. Dr Latib reports serving on the scientific advisory board for Medtronic and as a consultant and proctor for Direct Flow Medical Inc. Dr Rodes-Cabau reports consultancy for Edwards Lifesciences and St Jude Medical. Dr Piazza reports receipt of grants and serving as a proctor for Medtronic. Dr Hildick-Smith reports personal fees from Medtronic, Edwards Lifesciences, and Boston Scientific. Dr Himbert reports serving as a consultant and proctor for Edwards Lifesciences and Medtronic. Dr Hengstenberg reports lecture/speakers bureau fees and travel reimbursement from Edwards Lifesciences. Dr Segev reports personal fees from Medtronic and Edwards Lifesciences. Dr Windecker reports receipt of grants from St Jude and Biotronik. Dr Moat reports personal fees from Medtronic. Dr Brecker reports serving as a proctor for Medtronic. Dr Lefevre reports serving as a proctor and receipt of fees for Edwards Lifesciences and travel reimbursement from Directflow and Symetis. Dr Petronio reports serving as a proctor for Medtronic. Dr Teles reports personal fees from Medtronic, Abbott, and Cordis. No other disclosures were reported.	Bedogni F, 2011, JACC-CARDIOVASC INTE, V4, P1228, DOI 10.1016/j.jcin.2011.10.002; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Brennan JM, 2013, CIRCULATION, V127, P1647, DOI 10.1161/CIRCULATIONAHA.113.002003; Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015; Castro LJ, 2002, ANN THORAC SURG, V74, P31, DOI 10.1016/S0003-4975(02)03680-9; Connolly HM, 2000, CIRCULATION, V101, P1940, DOI 10.1161/01.CIR.101.16.1940; David TE, 2001, J THORAC CARDIOV SUR, V121, P268, DOI 10.1067/mtc.2001.112208; Dvir D, 2012, CIRCULATION, V126, P2335, DOI 10.1161/CIRCULATIONAHA.112.104505; Eggebrecht H, 2011, JACC-CARDIOVASC INTE, V4, P1218, DOI 10.1016/j.jcin.2011.07.015; Flameng W, 2010, CIRCULATION, V121, P2123, DOI 10.1161/CIRCULATIONAHA.109.901272; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Glower DD, 1998, ANN THORAC SURG, V66, pS44, DOI 10.1016/S0003-4975(98)01114-X; Gurvitch R, 2011, J AM COLL CARDIOL, V58, P2196, DOI 10.1016/j.jacc.2011.09.009; HE GW, 1995, ANN THORAC SURG, V59, P1056, DOI 10.1016/0003-4975(95)00075-V; Head SJ, 2012, EUR HEART J, V33, P1518, DOI 10.1093/eurheartj/ehs003; Khawaja MZ, 2010, J AM COLL CARDIOL, V55, P97, DOI 10.1016/j.jacc.2009.06.060; Kirsch M, 2004, J HEART VALVE DIS, V13, P991; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Maganti M, 2009, ANN THORAC SURG, V87, P521, DOI 10.1016/j.athoracsur.2008.09.030; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Nishida T, 2013, GEN THORAC CARDIOVAS, V61, P182, DOI 10.1007/s11748-013-0202-z; Peterson MD, 2007, ANN THORAC SURG, V83, P2044, DOI 10.1016/j.athoracsur.2007.01.059; Piazza N, 2011, JACC-CARDIOVASC INTE, V4, P733, DOI 10.1016/j.jcin.2011.05.007; Pibarot P, 2006, HEART, V92, P1022, DOI 10.1136/hrt.2005.067363; Pibarot P, 2009, CIRCULATION, V119, P1034, DOI 10.1161/CIRCULATIONAHA.108.778886; Rosenhek R, 2003, J AM SOC ECHOCARDIOG, V16, P1116, DOI 10.1067/S0894-7317(03)00638-2; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Sommers KE, 1997, ANN THORAC SURG, V63, P1608, DOI 10.1016/S0003-4975(97)00127-6; Tasca G, 2006, CIRCULATION, V113, P570, DOI 10.1161/CIRCULATIONAHA.105.587022; Urso S, 2009, J HEART VALVE DIS, V18, P248; Webb JG, 2013, CIRCULATION, V127, P2542, DOI 10.1161/CIRCULATIONAHA.113.000631; Webb JG, 2010, CIRCULATION, V121, P1848, DOI 10.1161/CIRCULATIONAHA.109.924613; WHEATLEY DJ, 1987, J THORAC CARDIOV SUR, V94, P367	35	614	632	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					162	170		10.1001/jama.2014.7246	http://dx.doi.org/10.1001/jama.2014.7246			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	25005653	Green Published, Bronze			2022-12-24	WOS:000338511200022
J	Dore, AS; Okrasa, K; Patel, JC; Serrano-Vega, M; Bennett, K; Cooke, RM; Errey, JC; Jazayeri, A; Khan, S; Tehan, B; Weir, M; Wiggin, GR; Marshall, FH				Dore, Andrew S.; Okrasa, Krzysztof; Patel, Jayesh C.; Serrano-Vega, Maria; Bennett, Kirstie; Cooke, Robert M.; Errey, James C.; Jazayeri, Ali; Khan, Samir; Tehan, Ben; Weir, Malcolm; Wiggin, Giselle R.; Marshall, Fiona H.			Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; ALLOSTERIC MODULATORS; HEPTAHELICAL DOMAIN; CRYSTAL-STRUCTURE; BINDING POCKETS; ACTIVATION; FAMILY; THERMOSTABILIZATION; ANTAGONISTS; MUTATIONS	Metabotropic glutamate receptors are class C G-protein-coupled receptors which respond to the neurotransmitter glutamate. Structural studies have been restricted to the amino-terminal extracellular domain, providing little understanding of the membrane-spanning signal transduction domain. Metabotropic glutamate receptor 5 is of considerable interest as a drug target in the treatment of fragile X syndrome, autism, depression, anxiety, addiction and movement disorders. Here we report the crystal structure of the transmembrane domain of the human receptor in complex with the negative allosteric modulator, mavoglurant. The structure provides detailed insight into the architecture of the transmembrane domain of class C receptors including the precise location of the allosteric binding site within the transmem-branedomain and key micro-switches which regulate receptor signalling. This structure also provides a model for all class CG-protein-coupled receptors and may aid in the design of new small-molecule drugs for the treatment of brain disorders.	[Dore, Andrew S.; Okrasa, Krzysztof; Patel, Jayesh C.; Serrano-Vega, Maria; Bennett, Kirstie; Cooke, Robert M.; Errey, James C.; Jazayeri, Ali; Khan, Samir; Tehan, Ben; Weir, Malcolm; Wiggin, Giselle R.; Marshall, Fiona H.] Heptares Therapeut Ltd, Welwyn Garden City AL7 3AX, Herts, England	Heptares Therapeutics Ltd.	Marshall, FH (corresponding author), Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England.	fiona.marshall@heptares.com	Marshall, Fiona/AAZ-9626-2020	Wiggin, Giselle/0000-0003-4436-9208; Marshall, Fiona/0000-0002-8681-005X				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Beqollari D, 2009, MOL PHARMACOL, V76, P992, DOI 10.1124/mol.109.058628; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chang WH, 2000, J BIOL CHEM, V275, P19955, DOI 10.1074/jbc.M909613199; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gasparini F, 2002, BIOORG MED CHEM LETT, V12, P407, DOI 10.1016/S0960-894X(01)00767-3; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Gregory KJ, 2013, MOL PHARMACOL, V83, P991, DOI 10.1124/mol.112.083949; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hu JX, 2007, J CELL MOL MED, V11, P908, DOI 10.1111/j.1582-4934.2007.00096.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Levenga J, 2011, NEUROBIOL DIS, V42, P311, DOI 10.1016/j.nbd.2011.01.022; Li GY, 2013, PHARM PAT ANAL, V2, P767, DOI [10.4155/PPA.13.58, 10.4155/ppa.13.58]; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; Malherbe P, 2006, J NEUROCHEM, V98, P601, DOI 10.1111/j.1471-4159.2006.03886.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; O'Brien JA, 2003, MOL PHARMACOL, V64, P731, DOI 10.1124/mol.64.3.731; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stauffer SR, 2011, ACS CHEM NEUROSCI, V2, P450, DOI 10.1021/cn2000519; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489	50	315	327	6	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					557	+		10.1038/nature13396	http://dx.doi.org/10.1038/nature13396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25042998				2022-12-24	WOS:000339566300027
J	Kelly, BT; Graham, SC; Liska, N; Dannhauser, PN; Honing, S; Ungewickell, EJ; Owen, DJ				Kelly, Bernard T.; Graham, Stephen C.; Liska, Nicole; Dannhauser, Philip N.; Hoening, Stefan; Ungewickell, Ernst J.; Owen, David J.			AP2 controls clathrin polymerization with a membrane-activated switch	SCIENCE			English	Article							ADAPTER COMPLEX; COATED VESICLES; PROTEINS; CARGO; RECRUITMENT; PIT; ENDOCYTOSIS; DYNAMIN	Clathrin-mediated endocytosis (CME) is vital for the internalization of most cell-surface proteins. In CME, plasma membrane-binding clathrin adaptors recruit and polymerize clathrin to form clathrin-coated pits into which cargo is sorted. Assembly polypeptide 2 (AP2) is the most abundant adaptor and is pivotal to CME. Here, we determined a structure of AP2 that includes the clathrin-binding beta 2 hinge and developed an AP2-dependent budding assay. Our findings suggest that an autoinhibitory mechanism prevents clathrin recruitment by cytosolic AP2. A large-scale conformational change driven by the plasma membrane phosphoinositide phosphatidylinositol 4,5-bisphosphate and cargo relieves this autoinhibition, triggering clathrin recruitment and hence clathrin-coated bud formation. This molecular switching mechanism can couple AP2's membrane recruitment to its key functions of cargo and clathrin binding.	[Kelly, Bernard T.; Liska, Nicole; Owen, David J.] Univ Cambridge, CIMR, Dept Clin Biochem, Cambridge CB2 0XY, England; [Graham, Stephen C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Dannhauser, Philip N.; Ungewickell, Ernst J.] Hannover Med Sch, Dept Cell Biol, Ctr Anat, D-30625 Hannover, Germany; [Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Cambridge; University of Cambridge; Hannover Medical School; University of Cologne; University of Cologne	Kelly, BT (corresponding author), Univ Cambridge, CIMR, Dept Clin Biochem, Hills Rd, Cambridge CB2 0XY, England.	btk1000@cam.ac.uk; djo30@cam.ac.uk	Dannhauser, Philip/A-5675-2018	Dannhauser, Philip/0000-0002-6749-7678; Graham, Stephen/0000-0003-4547-4034	Wellcome Trust [090909/Z/09/Z, 079895]; German Science Foundation [SFB 635, TP A3]; Royal Society [098406/Z/12/Z]	Wellcome Trust(Wellcome Trust); German Science Foundation(German Research Foundation (DFG)); Royal Society(Royal Society of London)	We would like to thank the I02, I03, and I04-1 beamline staff at the Diamond Lightsource; A. McCoy and P. Evans for crystallographic advice; C. Oubridge for advice and assistance with SeMet mapping of the hinge residues; N. Bright, C. Savva, and S. Miller for advice and assistance with EM; C. Smith for reagents; and H. B ning and H. Ungewickell for expert technical assistance. D.J.O. and B. T. K. are supported by a Wellcome Trust Principal Research fellowship (090909/Z/09/Z). S. H. is supported by a grant of the German Science Foundation (SFB 635, TP A3). S. C. G. is supported by a Sir Henry Dale fellowship from the Wellcome Trust and the Royal Society (098406/Z/12/Z). CIMR is supported by a Wellcome Trust Strategic Award (079895). Coordinates have been deposited in the Protein Data Bank with PDB ID 4uqi.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Dannhauser PN, 2012, NAT CELL BIOL, V14, P634, DOI 10.1038/ncb2478; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Hirst J, 2013, MOL BIOL CELL, V24, P2558, DOI 10.1091/mbc.E13-03-0170; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LINDNER R, 1992, J BIOL CHEM, V267, P16567; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Traub LM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001037; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; ZAREMBA S, 1983, J CELL BIOL, V97, P1339, DOI 10.1083/jcb.97.5.1339	24	138	139	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					459	463		10.1126/science.1254836	http://dx.doi.org/10.1126/science.1254836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	25061211	Green Accepted			2022-12-24	WOS:000339655100045
J	Cong, PY; Ma, XY; Hou, XG; Edgecombe, GD; Strausfeld, NJ				Cong, Peiyun; Ma, Xiaoya; Hou, Xianguang; Edgecombe, Gregory D.; Strausfeld, Nicholas J.			Brain structure resolves the segmental affinity of anomalocaridid appendages	NATURE			English	Article							BURGESS SHALE; ARTHROPOD; EVOLUTION; ONYCHOPHORA; ORIGIN; PERIPATOPSIDAE; ORGANIZATION; MORPHOLOGY; SUGGESTS; LABRUM	Despite being among the most celebrated taxa from Cambrian biotas, anomalocaridids (order Radiodonta) have provoked intense debate about their affinities within the moulting-animal clade that includes Arthropoda. Current alternatives identify anomalocaridids as either stem-group euarthropods(1-3), crown-group euarthropods near the ancestry of chelicerates(4), or a segmented ecdysozoan lineage with convergent similarity to arthropods in appendage construction(5). Determining unambiguous affinities has been impeded by uncertainties about the segmental affiliation of anomalocaridid frontal appendages. These structures are variably homologized with jointed appendages of the second (deutocerebral) head segment, including antennae and 'great appendages' of Cambrian arthropods, or with the paired antenniform frontal appendages of living Onychophora and some Cambrian lobopodians. Here we describe Lyrarapax unguis-pinus, a new anomalocaridid from the early Cambrian Chengjiang biota, southwest China, nearly complete specimens of which preserve traces of muscles, digestive tract and brain. The traces of brain provide the first direct evidence for the segmental composition of the anomalocaridid head and its appendicular organization. Carbon-rich areas in the head resolve paired pre-protocerebral ganglia at the origin of paired frontal appendages. The ganglia connect to areas indicative of a bilateral pre-oral brain that receives projections from the eyestalk neuropils and compound retina. The dorsal, segmented brain of L. unguispinus reinforces an alliance between anomalocaridids and arthropods rather than cycloneuralians. Correspondences in brain organization between anomalocaridids and Onychophora resolve pre-protocerebral ganglia, associated with pre-ocular frontal appendages, as characters of the last common ancestor of euarthropods and onychophorans. A position of Radiodonta on the euarthropod stem-lineage implies the transformation of frontal appendages to another structure in crown-group euarthropods, with gene expression and neuroanatomy providing strong evidence that the paired, pre-oral labrum is the remnant of paired frontal appendages(1).	[Cong, Peiyun; Ma, Xiaoya; Hou, Xianguang] Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China; [Ma, Xiaoya; Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Strausfeld, Nicholas J.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Strausfeld, Nicholas J.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA	Yunnan University; Natural History Museum London; University of Arizona; University of Arizona	Hou, XG (corresponding author), Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China.	xghou@ynu.edu.cn; flybrain@neurobio.arizona.edu	Cong, Pei-yun/D-2537-2009; Strausfeld, Nicholas James/AAF-4566-2021	Cong, Pei-yun/0000-0001-9910-6478; Strausfeld, Nicholas James/0000-0002-1115-1774; Edgecombe, Gregory/0000-0002-9591-8011	National Natural Science Foundation of China [U1302232, 41372031, 40962001]; Leverhulme Trust [F/00 696/T]; Center for Insect Science, University of Arizona; Air Force Research Laboratory [FA86511010001]; Natural Environment Research Council [NE/L011751/1] Funding Source: researchfish; NERC [NE/L011751/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leverhulme Trust(Leverhulme Trust); Center for Insect Science, University of Arizona; Air Force Research Laboratory; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the National Natural Science Foundation of China (U1302232, 41372031 and 40962001), a Leverhulme Trust Research Project Grant (F/00 696/T), by the Center for Insect Science, University of Arizona, and by a grant from the Air Force Research Laboratory (FA86511010001) to N.J.S. We thank T. Goral for assistance with energy dispersive X-ray spectroscopy. We acknowledge A. Daley's advice about anomalocaridid anatomy.	Boxshall GA, 2004, BIOL REV, V79, P253, DOI 10.1017/S1464793103006274; Boyan GS, 2002, ARTHROPOD STRUCT DEV, V31, P65, DOI 10.1016/S1467-8039(02)00016-6; Browne WE, 2005, GENESIS, V42, P124, DOI 10.1002/gene.20145; Budd GE, 1998, LETHAIA, V31, P197, DOI 10.1111/j.1502-3931.1998.tb00508.x; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Daley AC, 2014, J PALEONTOL, V88, P68, DOI 10.1666/13-067; Daley AC, 2012, NATURWISSENSCHAFTEN, V99, P501, DOI 10.1007/s00114-012-0910-8; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Eriksson BJ, 2009, DEV GENES EVOL, V219, P249, DOI 10.1007/s00427-009-0287-7; Haas MS, 2001, DEV GENES EVOL, V211, P96, DOI 10.1007/s004270000129; Haug JT, 2012, PALAEONTOLOGY, V55, P369, DOI 10.1111/j.1475-4983.2011.01124.x; Hou Xiang, 2006, P139; Legg DA, 2013, LETHAIA, V46, P540, DOI 10.1111/let.12032; Legg DA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3485; Ma XY, 2012, NATURE, V490, P258, DOI 10.1038/nature11495; Mayer G, 2008, J COMP NEUROL, V507, P1196, DOI 10.1002/cne.21603; Mayer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-255; Mayer G, 2009, DEV BIOL, V335, P263, DOI 10.1016/j.ydbio.2009.08.011; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Schurmann F.-W., 1987, P159; Stein M, 2010, ZOOL J LINN SOC-LOND, V158, P477, DOI 10.1111/j.1096-3642.2009.00562.x; Strausfeld N. J., 2012, ARTHROPOD BRAINS EVO, P427; Strausfeld NJ, 2006, ARTHROPOD STRUCT DEV, V35, P169, DOI 10.1016/j.asd.2006.06.002; Strausfeld NJ, 2006, P ROY SOC B-BIOL SCI, V273, P1857, DOI 10.1098/rspb.2006.3536; Tanaka G, 2013, NATURE, V502, P364, DOI 10.1038/nature12520; Vinther J, 2014, NATURE, V507, P496, DOI 10.1038/nature13010; WIGGLESWORTH VB, 1957, PROC R SOC SER B-BIO, V147, P185, DOI 10.1098/rspb.1957.0043	28	117	120	5	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					538	+		10.1038/nature13486	http://dx.doi.org/10.1038/nature13486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043032				2022-12-24	WOS:000342075800038
J	Cox, N; Retegan, M; Neese, F; Pantazis, DA; Boussac, A; Lubitz, W				Cox, Nicholas; Retegan, Marius; Neese, Frank; Pantazis, Dimitrios A.; Boussac, Alain; Lubitz, Wolfgang			Electronic structure of the oxygenevolving complex in photosystem II prior to O-O bond formation	SCIENCE			English	Article							OXYGEN-EVOLVING COMPLEX; SPECTROSCOPIC PROPERTIES; PARAMAGNETIC-RESONANCE; MANGANESE COMPLEX; EPR SPECTROSCOPY; S-2 STATE; WATER; CLUSTER; MECHANISM; OXIDATION	The photosynthetic protein complex photosystem II oxidizes water to molecular oxygen at an embedded tetramanganese-calcium cluster. Resolving the geometric and electronic structure of this cluster in its highest metastable catalytic state (designated S-3) is a prerequisite for understanding the mechanism of O-O bond formation. Here, multifrequency, multidimensional magnetic resonance spectroscopy reveals that all four manganese ions of the catalyst are structurally and electronically similar immediately before the final oxygen evolution step; they all exhibit a 4+ formal oxidation state and octahedral local geometry. Only one structural model derived fromquantum chemicalmodeling is consistentwith allmagnetic resonance data; its formation requires the binding of an additional water molecule. O-O bond formation would then proceed by the coupling of two proximalmanganese-bound oxygens in the transition state of the cofactor.	[Cox, Nicholas; Retegan, Marius; Neese, Frank; Pantazis, Dimitrios A.; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Boussac, Alain] Commissariat Energie Atom CEA Saclay, CNRS UMR 8221, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France	Max Planck Society; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cox, N (corresponding author), Max Planck Inst Chem Energy Convers, Stiftstr 34-36, D-45470 Mulheim, Germany.	nicholas.cox@cec.mpg.de; wolfgang.lubitz@cec.mpg.de	Retegan, Marius/I-4184-2016; Neese, Frank/J-4959-2014; Cox, Nicholas/J-8047-2014; Pantazis, Dimitrios/A-2434-2010	Retegan, Marius/0000-0002-1525-1094; Neese, Frank/0000-0003-4691-0547; Cox, Nicholas/0000-0002-7815-6115; Pantazis, Dimitrios/0000-0002-2146-9065	Max-Planck-Gesellschaft; "Bioenergie" program from the CEA; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]	Max-Planck-Gesellschaft(Max Planck Society); "Bioenergie" program from the CEA; French Infrastructure for Integrated Structural Biology (FRISBI)	The authors acknowledge A. Savitsky (Max-Planck-Institut fur Chemische Energiekonversion Mulheim) for his assistance with the EPR measurements and M. Sugiura (Ehime University, Japan) for the gift of the T. elongatus strains. Financial support was provided by the Max-Planck-Gesellschaft, the "Bioenergie" program from the CEA, and by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01.	Ahrling KA, 1997, BIOCHEMISTRY-US, V36, P13148, DOI 10.1021/bi971815w; Boussac A, 1996, BIOCHEMISTRY-US, V35, P6984, DOI 10.1021/bi960636w; Boussac A, 2009, J AM CHEM SOC, V131, P5050, DOI 10.1021/ja900680t; Cox N, 2013, BBA-BIOENERGETICS, V1827, P1020, DOI 10.1016/j.bbabio.2013.01.013; Cox N, 2013, ACCOUNTS CHEM RES, V46, P1588, DOI 10.1021/ar3003249; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; DEXHEIMER SL, 1992, J AM CHEM SOC, V114, P2821, DOI 10.1021/ja00034a010; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; Glockner C, 2013, J BIOL CHEM, V288, P22607, DOI 10.1074/jbc.M113.476622; Haddy A, 2004, BIOPHYS J, V87, P2885, DOI 10.1529/biophysj.104.040238; Haddy A, 2007, PHOTOSYNTH RES, V92, P357, DOI 10.1007/s11120-007-9194-9; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Hillier W, 2005, ADV PHOTO RESPIRAT, V22, P567; Horner O, 1998, J AM CHEM SOC, V120, P7924, DOI 10.1021/ja981330a; Klauss A, 2012, P NATL ACAD SCI USA, V109, P16035, DOI 10.1073/pnas.1206266109; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Krewald V, 2013, J AM CHEM SOC, V135, P5726, DOI 10.1021/ja312552f; Kulik LV, 2007, J AM CHEM SOC, V129, P13421, DOI 10.1021/ja071487f; Limburg J, 1999, J CHEM SOC DALTON, P1353, DOI 10.1039/a807583b; Lohmiller T, 2013, APPL MAGN RESON, V44, P691, DOI 10.1007/s00723-012-0437-3; Messinger J, 1997, J AM CHEM SOC, V119, P11349, DOI 10.1021/ja972696a; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; Mukherjee S, 2012, P NATL ACAD SCI USA, V109, P2257, DOI 10.1073/pnas.1115290109; Navarro MP, 2013, P NATL ACAD SCI USA, V110, P15561, DOI 10.1073/pnas.1304334110; Noguchi T, 2008, PHILOS T R SOC B, V363, P1189, DOI 10.1098/rstb.2007.2214; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; Peloquin JM, 2000, J AM CHEM SOC, V122, P10926, DOI 10.1021/ja002104f; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; RANDALL DW, 1995, J AM CHEM SOC, V117, P11780, DOI 10.1021/ja00152a021; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; Retegan M, 2014, PHYS CHEM CHEM PHYS, V16, P11901, DOI 10.1039/c4cp00696h; RUTHERFORD AW, 1989, TRENDS BIOCHEM SCI, V14, P227, DOI 10.1016/0968-0004(89)90032-7; Sanakis Y., 2008, PHOTOSYNTHESIS ENERG, P479, DOI [10.1007/978-1-4020-6709-9_108, DOI 10.1007/978-1-4020-6709-9_108]; Schafer KO, 1998, J AM CHEM SOC, V120, P13104, DOI 10.1021/ja9827548; Siegbahn PEM, 2006, CHEM-EUR J, V12, P9217, DOI 10.1002/chem.200600774; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wiechen M, 2012, CHEM SCI, V3, P2330, DOI 10.1039/c2sc20226c; Yamaguchi K, 2013, INT J QUANTUM CHEM, V113, P453, DOI 10.1002/qua.24280; Yamauchi T, 1997, BIOCHEMISTRY-US, V36, P7520, DOI 10.1021/bi962791g; ZIMMERMANN JL, 1984, BIOCHIM BIOPHYS ACTA, V767, P160, DOI 10.1016/0005-2728(84)90091-4	43	351	353	3	356	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					804	808		10.1126/science.1254910	http://dx.doi.org/10.1126/science.1254910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124437				2022-12-24	WOS:000340593100042
J	Cahan, P; Li, H; Morris, SA; da Rocha, EL; Daley, GQ; Collins, JJ				Cahan, Patrick; Li, Hu; Morris, Samantha A.; da Rocha, Edroaldo Lummertz; Daley, George Q.; Collins, James J.			CellNet: Network Biology Applied to Stem Cell Engineering	CELL			English	Article							DIRECT CONVERSION; TRANSCRIPTION FACTORS; HUMAN FIBROBLASTS; EXPRESSION; GENERATION; INDUCTION; NEURONS	Somatic cell reprogramming, directed differentiation of pluripotent stem cells, and direct conversions between differentiated cell lineages represent powerful approaches to engineer cells for research and regenerative medicine. We have developed CellNet, a network biology platform that more accurately assesses the fidelity of cellular engineering than existing methodologies and generates hypotheses for improving cell derivations. Analyzing expression data from 56 published reports, we found that cells derived via directed differentiation more closely resemble their in vivo counterparts than products of direct conversion, as reflected by the establishment of target cell-type gene regulatory networks (GRNs). Furthermore, we discovered that directly converted cells fail to adequately silence expression programs of the starting population and that the establishment of unintended GRNs is common to virtually every cellular engineering paradigm. CellNet provides a platform for quantifying how closely engineered cell populations resemble their target cell type and a rational strategy to guide enhanced cellular engineering.	[Cahan, Patrick; Morris, Samantha A.; Daley, George Q.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Howard Hughes Med Inst, Div Pediat Hematol & Oncol,Stem Cell Transplantat, Boston, MA 02115 USA; [Cahan, Patrick; Morris, Samantha A.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Cahan, Patrick; Morris, Samantha A.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Cahan, Patrick; Morris, Samantha A.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Hu] Mayo Clin, Coll Med, Ctr Individualized Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [da Rocha, Edroaldo Lummertz; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA USA; [da Rocha, Edroaldo Lummertz; Collins, James J.] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA; [da Rocha, Edroaldo Lummertz] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [da Rocha, Edroaldo Lummertz] Univ Fed Santa Catarina, Grad Program Mat Sci & Engn, BR-88040900 Florianopolis, SC, Brazil	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Mayo Clinic; Boston University; Howard Hughes Medical Institute; Boston University; Harvard University; Universidade Federal de Santa Catarina (UFSC)	Daley, GQ (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Howard Hughes Med Inst, Div Pediat Hematol & Oncol,Stem Cell Transplantat, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; jcollins@bu.edu		Cahan, Patrick/0000-0003-3652-2540; Lummertz da Rocha, Edroaldo/0000-0003-0537-4223	NIH [R24DK092760]; HHMI; NIH (Progenitor Cell Biology Consortium) [R24DK092760, UO1-HL100001, P50HG005550]; Ellison Medical Foundation; Doris Duke Medical Foundation; Boston Children's Hospital Stem Cell Program; NIDDK [K01DK096013]; NHLBI [T32HL066987, T32HL007623]; Alex's Lemonade Stand Foundation; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; National Council for Scientific and Technological Development; program Science Without Borders (CNPq, Brazil); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987, U01HL100001, T32HL007623] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK096013, R24DK092760] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NIH (Progenitor Cell Biology Consortium)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Doris Duke Medical Foundation(Doris Duke Charitable Foundation (DDCF)); Boston Children's Hospital Stem Cell Program; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Alex's Lemonade Stand Foundation; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); program Science Without Borders (CNPq, Brazil); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	J.J.C. is supported by NIH grant R24DK092760 and the HHMI. G.Q.D. is supported by grants from the NIH (Progenitor Cell Biology Consortium UO1-HL100001, R24DK092760, and P50HG005550), the Ellison Medical Foundation, Doris Duke Medical Foundation, and Boston Children's Hospital Stem Cell Program, and is an affiliate member of the Broad Institute. P.C. is supported by NIDDK (K01DK096013) and received support from NHLBI (T32HL066987 and T32HL007623). S.A.M. is supported by a Young Investigator Award from Alex's Lemonade Stand Foundation. H.L. is supported by Mayo Clinic Center for Individualized Medicine and Mayo Clinic Center for Regenerative Medicine. E.L.d.R. is supported by National Council for Scientific and Technological Development and the program Science Without Borders (CNPq, Brazil).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chowdhury D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-130; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063577; Correa-Cerro LS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00167; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakano H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2569; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Peng ZF, 2012, J CELL MOL MED, V16, P41, DOI 10.1111/j.1582-4934.2011.01288.x; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; STRAIN AJ, 1994, GUT, V35, P433, DOI 10.1136/gut.35.4.433; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Xu HL, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat045; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	45	341	348	3	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					903	915		10.1016/j.cell.2014.07.020	http://dx.doi.org/10.1016/j.cell.2014.07.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126793	Green Accepted, Bronze			2022-12-24	WOS:000340944700019
J	Hwang, WL; Deindl, S; Harada, BT; Zhuang, XW				Hwang, William L.; Deindl, Sebastian; Harada, Bryan T.; Zhuang, Xiaowei			Histone H4 tail mediates allosteric regulation of nucleosome remodelling by linker DNA	NATURE			English	Article							SINGLE-MOLECULE; CORE PARTICLE; CHROMATIN; ISWI; ACF; COMPLEXES; RESOLUTION; CONTAINS; DYNAMICS; SUBUNITS	Imitation switch (ISWI)-family remodelling enzymes regulate access to genomic DNA by mobilizing nucleosomes(1). These ATP-dependent chromatin remodellers promote heterochromatin formation and transcriptional silencing(1) by generating regularly spaced nucleosome arrays(2-5). The nucleosome-spacing activity arises from the dependence of nucleosome translocation on the length of extranucleosomal linker DNA(6-10), but the underlying mechanism remains unclear. Here we study nucleosome remodelling by human ATP-dependent chromatin assembly and remodelling factor (ACF), an ISWI enzyme comprising a catalytic subunit, Snf2h, and an accessory subunit, Acf1 (refs 2, 11-13). We find that ACF senses linker DNA length through an interplay between its accessory and catalytic subunits mediated by the histone H4 tail of the nucleosome. Mutation of AutoN, an auto-inhibitory domain within Snf2h that bears sequence homology to the H4 tail(14), abolishes the linker-length sensitivity in remodelling. Addition of exogenous H4-tail peptide or deletion of the nucleosomal H4 tail also diminishes the linker-length sensitivity. Moreover, Acf1 binds both the H4-tail peptide and DNA in an amino (N)-terminal domain dependent manner, and in the ACF-bound nucleosome, lengthening the linker DNA reduces the Acf1-H4 tail proximity. Deletion of the N-terminal portion of Acf1 (or itshomologue in yeast) abolishes linker-length sensitivity in remodelling and leads to severe growth defects in vivo. Taken together, our results suggest a mechanism for nucleosome spacing where linker DNA sensing by Acf1 is allosterically transmitted to Snf2h through the H4 tail of the nucleosome. For nucleosomes with short linker DNA, Acf1 preferentially binds to the H4 tail, allowing AutoN to inhibit the ATPase activity of Snf2h. As the linker DNA lengthens, Acf1 shifts its binding preference to the linker DNA, freeing the H4 tail to compete Auto N off the ATPase and thereby activating ACF.	[Hwang, William L.; Deindl, Sebastian; Harada, Bryan T.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Hwang, William L.; Harada, Bryan T.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Hwang, William L.] Harvard Univ, Sch Med, Harvard MIT MD PhD Program, Boston, MA 02115 USA; [Deindl, Sebastian; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Harada, Bryan T/AAW-3169-2020	Harada, Bryan T/0000-0002-9683-782X; Deindl, Sebastian/0000-0001-6807-8654	National Institutes of Health [GM105637, T32G007753]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM105637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Narlikar, T. Tsukiyama, J. Vaughan, J. Moffitt and E. Sun for discussions, S. Mukherji for assistance in designing the yeast experiments, S. Trauger, K. L. Hwang, R. Magnusson, G. Hilinski and J. McGee for assistance with protein characterization and biochemistry, and G. Narlikar for providing Snf2h and Acf1 expression vectors and purification protocols. This work was supported in part by the National Institutes of Health (GM105637 to X.Z.). W.L.H. acknowledges support from the National Institutes of Health T32G007753 Training Grant. S.D. was a Merck Fellow of the Jane Coffin Childs Foundation. X.Z. is a Howard Hughes Medical Investigator.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Deindl S, 2013, CELL, V152, P442, DOI 10.1016/j.cell.2012.12.040; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Fyodorov DV, 2002, MOL CELL BIOL, V22, P6344, DOI 10.1128/MCB.22.18.6344-6353.2002; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; He X, 2008, BIOCHEMISTRY-US, V47, P7025, DOI 10.1021/bi702304p; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Killian JL, 2012, CURR OPIN STRUC BIOL, V22, P80, DOI 10.1016/j.sbi.2011.11.003; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Narlikar GJ, 2010, CURR OPIN CHEM BIOL, V14, P660, DOI 10.1016/j.cbpa.2010.08.001; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170	36	60	60	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					213	+		10.1038/nature13380	http://dx.doi.org/10.1038/nature13380			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043036	Green Accepted, Green Submitted			2022-12-24	WOS:000340200700036
J	Pinot, M; Vanni, S; Pagnotta, S; Lacas-Gervais, S; Payet, LA; Ferreira, T; Gautier, R; Goud, B; Antonny, B; Barelli, H				Pinot, Mathieu; Vanni, Stefano; Pagnotta, Sophie; Lacas-Gervais, Sandra; Payet, Laurie-Anne; Ferreira, Thierry; Gautier, Romain; Goud, Bruno; Antonny, Bruno; Barelli, Helene			Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins	SCIENCE			English	Article							FATTY-ACIDS; ALPHA-SYNUCLEIN; LIPID-BILAYERS; DYNAMIN; PACKING; CONSTRICTION; CHOLESTEROL; OMEGA-3	Phospholipids (PLs) with polyunsaturated acyl chains are extremely abundant in a few specialized cellular organelles such as synaptic vesicles and photoreceptor discs, but their effect on membrane properties is poorly understood. Here, we found that polyunsaturated PLs increased the ability of dynamin and endophilin to deform and vesiculate synthetic membranes. When cells incorporated polyunsaturated fatty acids into PLs, the plasma membrane became more amenable to deformation by a pulling force and the rate of endocytosis was accelerated, in particular, under conditions in which cholesterol was limiting. Molecular dynamics simulations and biochemical measurements indicated that polyunsaturated PLs adapted their conformation to membrane curvature. Thus, by reducing the energetic cost of membrane bending and fission, polyunsaturated PLs may help to support rapid endocytosis.	[Pinot, Mathieu; Vanni, Stefano; Gautier, Romain; Antonny, Bruno; Barelli, Helene] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Pinot, Mathieu; Vanni, Stefano; Gautier, Romain; Antonny, Bruno; Barelli, Helene] CNRS, F-06560 Valbonne, France; [Pinot, Mathieu; Goud, Bruno] Inst Curie, UMR 144, F-75248 Paris, France; [Pinot, Mathieu; Goud, Bruno] CNRS, F-75248 Paris, France; [Pagnotta, Sophie; Lacas-Gervais, Sandra] Univ Nice Sophia Antipolis, Ctr Commun Microscopie Appl, F-06000 Nice, France; [Payet, Laurie-Anne; Ferreira, Thierry] Univ Poitiers, Poitiers, France; [Payet, Laurie-Anne; Ferreira, Thierry] CNRS, Poitiers, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Antonny, B (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France.	antonny@ipmc.cnrs.fr	Vanni, Stefano/AAO-3144-2020; Antonny, Bruno/ABH-7434-2020; Pinot, Mathieu/P-8192-2014; Goud, Bruno/GWC-4807-2022; soler, martha maricel m gomez/L-6025-2014; Vanni, Stefano/D-6414-2011	Vanni, Stefano/0000-0003-2146-1140; Antonny, Bruno/0000-0002-9166-8668; soler, martha maricel m gomez/0000-0002-4412-8108; Vanni, Stefano/0000-0003-2146-1140; BARELLI, Helene/0000-0001-6376-863X; Pinot, mathieu/0000-0003-4029-3437; GAUTIER, Romain/0000-0001-6678-132X	CNRS; European Research Council [268888]; Agence Nationale de la Recherche (ANR) [ANR-11-LABX-0028-01]; ANR [ANR09-JCJC-0020-01]; Fondation Pierre Gilles de Gennes; Swiss National Science Foundation [PBELP3_141118]; Inserm	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Fondation Pierre Gilles de Gennes; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank M. de Saint-Jean, C. Thonont, and F. Brau for technical help; A. Lurick for some experiments; J. B. Manneville for training and the microscope setup; J. Bigay, B. Mesmin, and A. Copic for comments on the manuscript; and all members of our laboratories for discussion. This work was supported by the CNRS, the European Research Council (advanced grant 268888), and the Agence Nationale de la Recherche (ANR) (ANR-11-LABX-0028-01). M.P. was supported by the ANR (ANR09-JCJC-0020-01) and the Fondation Pierre Gilles de Gennes. S.V. was supported by the Swiss National Science Foundation (PBELP3_141118). H.B. was supported by Inserm. Additional data described in this work can be found in the supplementary materials. Author contributions: M.P. performed experiments with GUVs; M.P. and H.B. performed mechanical experiments on cells; H.B. designed and performed endocytosis experiments; S.V. and R.G. conducted and analyzed MD simulations; L.-A.P. and T.F. performed phospholipid analysis; S.P., S.L.-G., and B.A. performed electron microscopy; B.A. designed the project, performed biochemical experiments, and wrote the manuscript with the help of B.G., S.V., H.B., and M.P.	Baoukina S, 2012, BIOPHYS J, V102, P1866, DOI 10.1016/j.bpj.2012.03.048; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Bruckner RJ, 2009, BIOPHYS J, V97, P3113, DOI 10.1016/j.bpj.2009.09.025; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Gawrisch K, 2003, LIPIDS, V38, P445, DOI 10.1007/s11745-003-1082-0; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Marza E, 2008, MOL BIOL CELL, V19, P833, DOI 10.1091/mbc.E07-07-0719; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Mitchell DC, 2001, J BIOL CHEM, V276, P42801, DOI 10.1074/jbc.M105772200; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Rajamoorthi K, 2005, J AM CHEM SOC, V127, P1576, DOI 10.1021/ja046453b; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Risselada HJ, 2009, PHYS CHEM CHEM PHYS, V11, P2056, DOI 10.1039/b818782g; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TIXIERVIDAL A, 1986, NEUROSCIENCE, V17, P115, DOI 10.1016/0306-4522(86)90230-7; Vamparys L, 2013, BIOPHYS J, V104, P585, DOI 10.1016/j.bpj.2012.11.3836; Vasquez V, 2014, CELL REP, V6, P70, DOI 10.1016/j.celrep.2013.12.012; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; Yang HJ, 2012, J BIOL CHEM, V287, P5290, DOI 10.1074/jbc.M111.316877; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355	30	207	209	6	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					693	697		10.1126/science.1255288	http://dx.doi.org/10.1126/science.1255288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104391				2022-12-24	WOS:000339962800044
J	Tao, T; Xin, KL				Tao, Tao; Xin, Kunlun			A sustainable plan for China's drinking water	NATURE			English	Editorial Material							COUNTRIES		[Tao, Tao; Xin, Kunlun] Tongji Univ, Coll Environm Sci & Engn, Shanghai 200092, Peoples R China; [Tao, Tao; Xin, Kunlun] Tongji Univ, Key Lab Yangtze River Water Environm, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Tao, T (corresponding author), Tongji Univ, Coll Environm Sci & Engn, Shanghai 200092, Peoples R China.	taotao@tongji.edu.cn; xkl@tongji.edu.cn						Clasen TF, 2008, ENVIRON SCI TECHNOL, V42, P4255, DOI 10.1021/es7024802; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Gadgil A, 1998, ANNU REV ENERG ENV, V23, P253, DOI 10.1146/annurev.energy.23.1.253; Ministry of Water Resources of the People's Republic of China, 2012, CHIN WAT RES B 2011; Qiu J., 2009, NATURE; Qiu J, 2011, SCIENCE, V334, P745, DOI 10.1126/science.334.6057.745; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Sobsey MD, 2008, ENVIRON SCI TECHNOL, V42, P4261, DOI 10.1021/es702746n	8	104	113	19	276	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					527	528		10.1038/511527a	http://dx.doi.org/10.1038/511527a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079539	Bronze			2022-12-24	WOS:000339566300012
J	Sandler, VM; Lis, R; Liu, Y; Kedem, A; James, D; Elemento, O; Butler, JM; Scandura, JM; Rafii, S				Sandler, Vladislav M.; Lis, Raphael; Liu, Ying; Kedem, Alon; James, Daylon; Elemento, Olivier; Butler, Jason M.; Scandura, Joseph M.; Rafii, Shahin			Reprogramming human endothelial cells to haematopoietic cells requires vascular induction	NATURE			English	Article							STEM-CELLS; HAEMOGENIC ENDOTHELIUM; ANGIOCRINE SIGNALS; PROGENITOR CELLS; SELF-RENEWAL; CORD BLOOD; B-CELLS; DIFFERENTIATION; REGENERATION; NICHE	Generating engraftable human haematopoietic cells from autologous tissues is a potential route to new therapies for blood diseases. However, directed differentiation of pluripotent stem cells yields haematopoietic cells that engraft poorly. Here, we have devised a method to phenocopy the vascular-niche microenvironment of haemogenic cells, thereby enabling reprogramming of human endothelial cells into engraftable haematopoietic cells without transition through a pluripotent intermediate. Highly purifiednon-haemogenic human umbilical vein endothelial cells or adult dermalmicrovascular endothelial cells were transduced with the transcription factors FOSB, GFI1, RUNX1 and SPI1 (hereafter referred to as FGRS), and then propagated on serum-free instructive vascular niche monolayers to induce outgrowth of haematopoietic colonies containing cells with functional and immunophenotypic features of multipotent progenitor cells (MPPs). These endothelial cells that have been reprogrammed into human MPPs (rEC-hMPPs) acquire colony-forming-cell potential and durably engraft into immune-deficient mice after primary and secondary transplantation, producing long-term rEC-hMPP-derived myeloid (granulocytic/monocytic, erythroid, megakaryocytic) and lymphoid (natural killer and B cell) progenies. Conditional expression of FGRS transgenes, combined with vascular induction, activates endogenous FGRS genes, endowing rEC-hMPPs with a transcriptional and functional profile similar to that of self-renewing MPPs. Our approach underscores the role of inductive cues from the vascular niche in coordinating and sustaining haematopoietic specification and may prove useful for engineering autologous haematopoietic grafts to treat inherited and acquired blood disorders.	[Sandler, Vladislav M.; Lis, Raphael; Liu, Ying; Kedem, Alon; James, Daylon; Butler, Jason M.; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA; [Sandler, Vladislav M.; Lis, Raphael; Liu, Ying; Kedem, Alon; James, Daylon; Butler, Jason M.; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10065 USA; [Lis, Raphael; Kedem, Alon; James, Daylon] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; [Scandura, Joseph M.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Scandura, Joseph M.] New York Presbyterian Hosp, New York, NY 10065 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital	Rafii, S (corresponding author), Weill Cornell Med Coll, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA.	srafii@med.cornell.edu		Scandura, Joseph/0000-0002-9525-143X; Rafii, Shahin/0000-0001-5605-1067	Empire State Stem Cell Board (ESSCB); New York State Department of Health [NYSDH C026878]; Ansary Stem Cell Institute (ASCI); HHMI; ESSCB/NYSDH [C024180, C026438, C026878, C028117]; NHLBI [R01HL097797, R01HL119872, U01 HL099997, HL119872, HL055748, U01-HL099997]; NIDDK [R01DK095039]; NCI [U54CA163167, CA159175, CA163167]; Qatar National Priorities Research Foundation [NPRP08-663-3-140]; Qatar Foundation BioMedical Research Program; Starr Foundation and a Leukemia & Lymphoma Society Scholar award; American Society of Hematology Scholar Award; Angiocrine Bioscience; ASCI; NATIONAL CANCER INSTITUTE [U54CA163167, R21CA159175] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119872, R01HL115128, R01HL097797, R01HL055748, U01HL099997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER	Empire State Stem Cell Board (ESSCB); New York State Department of Health; Ansary Stem Cell Institute (ASCI); HHMI(Howard Hughes Medical Institute); ESSCB/NYSDH; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Qatar National Priorities Research Foundation; Qatar Foundation BioMedical Research Program(Qatar National Research Fund (QNRF)); Starr Foundation and a Leukemia & Lymphoma Society Scholar award; American Society of Hematology Scholar Award; Angiocrine Bioscience; ASCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	V.M.S. is supported by Empire State Stem Cell Board (ESSCB) and New York State Department of Health (NYSDH C026878). S. R. is supported by Ansary Stem Cell Institute (ASCI), HHMI, ESSCB/NYSDH (C024180, C026438, C026878, C028117), NHLBI (R01HL097797, R01HL119872, U01 HL099997), NIDDK (R01DK095039), NCI (U54CA163167), Qatar National Priorities Research Foundation grant NPRP08-663-3-140 and the Qatar Foundation BioMedical Research Program. J.M.S. is supported by grants from NCI (CA159175 and CA163167), NHLBI (HL119872 and HL055748), Starr Foundation and a Leukemia & Lymphoma Society Scholar award. J.M.B. is supported by an American Society of Hematology Scholar Award, NHLBI U01-HL099997 and Angiocrine Bioscience and ASCI. We acknowledge the contribution of J. Z. Xiang and Agnes J. Viale for enabling and executing molecular profiling, and E. Gars for technical support. We appreciate W. Schachterle for recommendations and edits of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doan PL, 2013, STEM CELLS, V31, P327, DOI 10.1002/stem.1275; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Gordon-Keylock S, 2013, BLOOD, V122, P2338, DOI 10.1182/blood-2012-12-470971; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Lancrin C, 2012, BLOOD, V120, P314, DOI 10.1182/blood-2011-10-386094; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Marcelo KL, 2013, DEV CELL, V27, P504, DOI 10.1016/j.devcel.2013.11.004; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; RAFII S, 1994, BLOOD, V84, P10; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Rafii S, 2013, BLOOD, V121, P770, DOI 10.1182/blood-2012-07-444208; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Sandler VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018265; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Sturgeon CM, 2013, NAT BIOTECHNOL, V31, P416, DOI 10.1038/nbt.2571; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Wu X, 2007, STEM CELLS, V25, P2770, DOI 10.1634/stemcells.2006-0783; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yoshimoto M, 2008, CELL STEM CELL, V3, P583, DOI 10.1016/j.stem.2008.11.002; Zou GM, 2005, P NATL ACAD SCI USA, V102, P13236, DOI 10.1073/pnas.0506218102; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	43	155	165	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					312	+		10.1038/nature13547	http://dx.doi.org/10.1038/nature13547			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030167	Green Accepted			2022-12-24	WOS:000338992200028
J	Lopez-Rios, J; Duchesne, A; Speziale, D; Andrey, G; Peterson, KA; Germann, P; Unal, E; Liu, J; Floriot, S; Barbey, S; Gallard, Y; Muller-Gerbl, M; Courtney, AD; Klopp, C; Rodriguez, S; Ivanek, R; Beisel, C; Wicking, C; Iber, D; Robert, B; McMahon, AP; Duboule, D; Zeller, R				Lopez-Rios, Javier; Duchesne, Amandine; Speziale, Dario; Andrey, Guillaume; Peterson, Kevin A.; Germann, Philipp; Uenal, Erkan; Liu, Jing; Floriot, Sandrine; Barbey, Sarah; Gallard, Yves; Mueller-Gerbl, Magdalena; Courtney, Andrew D.; Klopp, Christophe; Rodriguez, Sabrina; Ivanek, Robert; Beisel, Christian; Wicking, Carol; Iber, Dagmar; Robert, Benoit; McMahon, Andrew P.; Duboule, Denis; Zeller, Rolf			Attenuated sensing of SHH by Ptch1 underlies evolution of bovine limbs	NATURE			English	Article							GENE REGULATORY NETWORKS; SONIC-HEDGEHOG; BAC LIBRARY; DEVELOPMENTAL BASIS; DIGIT NUMBER; EXPRESSION; CONSTRUCTION; RANGE; MORPHOGEN; REDUCTION	The large spectrum of limb morphologies reflects the wide evolutionary diversification of the basic pentadactyl pattern in tetrapods. In even-toed ungulates (artiodactyls, including cattle), limbs are adapted for running as a consequence of progressive reduction of their distal skeleton to symmetrical and elongated middle digits with hoofed phalanges. Here we analyse bovine embryos to establish that polarized gene expression is progressively lost during limb development in comparison to the mouse. Notably, the transcriptional upregulation of the Ptch1 gene, which encodes a Sonic hedgehog (SHH) receptor, is disrupted specifically in the bovine limb bud mesenchyme. This is due to evolutionary alteration of a Ptch1 cis-regulatory module, which no longer responds to graded SHH signalling during bovine handplate development. Our study provides a molecular explanation for the loss of digit asymmetry in bovine limb buds and suggests that modifications affecting the Ptch1 cis-regulatory landscape have contributed to evolutionary diversification of artiodactyl limbs.	[Lopez-Rios, Javier; Duchesne, Amandine; Speziale, Dario; Uenal, Erkan; Ivanek, Robert; Zeller, Rolf] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Duchesne, Amandine; Floriot, Sandrine; Rodriguez, Sabrina] INRA, Genet Anim & Biol Integrat, F-78350 Jouy En Josas, France; [Andrey, Guillaume; Duboule, Denis] Fed Inst Technol Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Peterson, Kevin A.; Liu, Jing; McMahon, Andrew P.] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90089 USA; [Germann, Philipp; Uenal, Erkan; Beisel, Christian; Iber, Dagmar] Fed Inst Technol Zurich, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Germann, Philipp; Uenal, Erkan; Ivanek, Robert; Beisel, Christian; Iber, Dagmar] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Barbey, Sarah; Gallard, Yves] INRA, Domaine Expt Pin Haras, F-61310 Exmes, France; [Mueller-Gerbl, Magdalena] Univ Basel, Dept Biomed, Inst Anat, CH-4056 Basel, Switzerland; [Courtney, Andrew D.; Wicking, Carol] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Klopp, Christophe] INRA, Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France; [Robert, Benoit] Inst Pasteur, F-75015 Paris, France; [Robert, Benoit] CNRS, URA 2578, F-75015 Paris, France; [Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland	University of Basel; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Southern California; Swiss Institute of Bioinformatics; INRAE; University of Basel; University of Queensland; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Geneva	Zeller, R (corresponding author), Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.	amandine.duchesne@jouy.inra.fr; rolf.zeller@unibas.ch	Zeller, Rolf/C-2610-2013; Lopez-Rios, Javier/D-8094-2014; Iber, Dagmar/V-2846-2019; Andrey, Guillaume/AAL-4397-2020; Klopp, Christophe/J-3164-2019; Germann, Philipp/M-6769-2015; McMahon, Andrew P/ABE-7520-2020; Wicking, Carol/J-1814-2014	Zeller, Rolf/0000-0002-3186-7403; Lopez-Rios, Javier/0000-0001-6731-3798; Iber, Dagmar/0000-0001-8051-1035; Klopp, Christophe/0000-0001-7126-5477; Germann, Philipp/0000-0002-2057-4883; Duchesne, Amandine/0000-0002-9713-2274; duboule, denis/0000-0001-9961-2960; Beisel, Christian/0000-0001-5360-2193; Wicking, Carol/0000-0002-7225-3803; Andrey, Guillaume/0000-0002-0911-4907; Ivanek, Robert/0000-0002-8403-056X	SNF [31003A_130803/146248]; University of Basel; EU [PERG-GA-2009-246576]; SystemsX.ch iPhD Grant [20101078]; INRA; ANR grant [06-MRAR-027-01]; EPFL; ERC grant SystemsHox.ch; NIH grant [NS 033642]; Australian National Health; Medical Research Council [569713]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033642, R01NS033642] Funding Source: NIH RePORTER	SNF; University of Basel; EU(European Commission); SystemsX.ch iPhD Grant; INRA; ANR grant(French National Research Agency (ANR)); EPFL; ERC grant SystemsHox.ch; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Cooper and C. Tabin for sharing their results before publication and providing camel genomic DNA. Dolphin samples were received from C. Frere and D. Duffield. Pigmy hippopotamus mouth swabs for DNA extraction were provided by S. Furrer and B. Zimmerman from the Zoo of Zurich, whereas all other artiodactyl blood samples were donated from available frozen stocks by S. and M. Hoby from the Zoo of Basel. B. Wainwright provided the Ptch1 conditional mouse line. We are grateful to E. Terszowska and A. Offinger for mouse care; V. Metis and M. Rondon for assistance in colony maintenance and collection of Prx1-Cre Ptch1<SUP>Delta c/Delta c</SUP> mouse embryos; and N. Dumesnil for assistance in collecting bovine embryos. All lentivector-mediated transgenic mouse embryos were produced by the EPFL transgenic platform, whereas conventional mouse transgenic embryos were produced commercially by Cyagen Biosciences Inc. We thank S. Beck-Cormier, A. Gritli-Linde, D. Haag-Wackernagel, Y. Lallemand, P. Zimmermann, G. Nusspaumer and A. Zuniga for technical advice and input and M. Bertaud, I. Ginez, D. Jardet and M. Moroldo for technical assistance. We are grateful to V. Taylor and members of our research groups for critical discussions and input on the manuscript. This research was supported by SNF grants 31003A_130803/146248 and the University of Basel (to R.Z.), EU reintegration grant PERG-GA-2009-246576 (to J.L.-R.), SystemsX.ch iPhD Grant 20101078 (to D.I. and R.Z.), INRA (to A.D.), ANR grant No. 06-MRAR-027-01 (to B.R.), the EPFL and ERC grant SystemsHox.ch (to D.D.), NIH grant no. NS 033642 (to A.P.M.) and Australian National Health and Medical Research Council grant no. 569713 (to C.W.).	Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bouldin CM, 2010, P NATL ACAD SCI USA, V107, P5489, DOI 10.1073/pnas.0912818107; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Budras K-D, 2011, BOVINE ANATOMY, Vsecond; Butterfield NC, 2009, DEVELOPMENT, V136, P3515, DOI 10.1242/dev.037507; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Clifford AB, 2010, J VERTEBR PALEONTOL, V30, P1827, DOI 10.1080/02724634.2010.521216; Cooper K. L., NATURE IN PRESS; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; de Bakker MAG, 2013, NATURE, V500, P445, DOI 10.1038/nature12336; Eggen A, 2001, GENET SEL EVOL, V33, P543, DOI 10.1051/gse:2001132; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Friedli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015741; Galli A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000901; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Koyama E, 2001, DEV DYNAM, V222, P178, DOI 10.1002/dvdy.1186; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lopez-Rios J, 2012, DEV CELL, V22, P837, DOI 10.1016/j.devcel.2012.01.006; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Polly P. David, 2007, P245; Prothero D.R., 2007, EVOLUTION ARTIODACTY; Quintana Laura, 2011, Cold Spring Harb Protoc, V2011, P664, DOI 10.1101/pdb.prot5639; Rogel-Gaillard C, 1999, CYTOGENET CELL GENET, V85, P205, DOI 10.1159/000015294; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Ross DGF, 2009, SEX DEV, V3, P273, DOI 10.1159/000252791; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sagai T, 2004, MAMM GENOME, V15, P23, DOI 10.1007/s00335-033-2317-5; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Schibler L, 1998, MAMM GENOME, V9, P119, DOI 10.1007/s003359900701; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sears KE, 2011, EVOL DEV, V13, P533, DOI 10.1111/j.1525-142X.2011.00509.x; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; Stern DL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0028; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; Vaiman D, 1999, MAMM GENOME, V10, P585, DOI 10.1007/s003359901049; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; van den Brandt J, 2004, GENESIS, V39, P94, DOI 10.1002/gene.20037; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	62	76	77	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					46	+		10.1038/nature13289	http://dx.doi.org/10.1038/nature13289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990743				2022-12-24	WOS:000338199400032
J	Wang, F; Chan, C; Weir, NR; Denic, V				Wang, Fei; Chan, Charlene; Weir, Nicholas R.; Denic, Vladimir			The Get1/2 transmembrane complex is an endoplasmic-reticulum membrane protein insertase	NATURE			English	Article							ER MEMBRANE; TAIL; MECHANISM; BIOGENESIS	Hundreds of tail-anchored proteins, including soluble N-ethylmaleimide-sensitive factor attachment receptors (SNAREs) involved in vesicle fusion, are inserted post-translationally into the endoplasmic reticulum membrane by a dedicated protein-targeting pathway(1-4). Before insertion, the carboxy-terminal transmembrane domains of tail-anchored proteins are shielded in the cytosol by the conserved targeting factor Get3 (in yeast; TRC40 inmammals)(5-7). The Get3 endoplasmic-reticulum receptor comprises the cytosolic domains of the Get1/2 (WRB/CAML) transmembrane complex, which interact individually with the targeting factor to drive a conformational change that enables substrate release and, as a consequence, insertion(8-11). Because tail-anchored protein insertion is not associated with significant translocation of hydrophilic protein sequences across the membrane, it remains possible that Get1/2 cytosolic domains are sufficient to place Get3 in proximity with the endoplasmic-reticulum lipid bilayer and permit spontaneous insertion to occur(12,13). Here we use cell reporters and biochemical reconstitution to define mutations in the Get1/2 transmembrane domain that disrupt tail-anchored protein insertion without interfering with Get1/2 cytosolic domain function. These mutations reveal a novel Get1/2 insertase function, in the absence of which substrates stay bound to Get3 despite their proximity to the lipid bilayer; as a consequence, the notion of spontaneous transmembrane domain insertion is a non sequitur. Instead, the Get1/2 transmembrane domain helps to release substrates from Get3 by capturing their transmembrane domains, and these transmembrane interactions define a bona fide pre-integrated intermediate along a facilitated route for tail-anchor entry into the lipid bilayer. Our work sheds light on the fundamental point of convergence between co-translational and post-translational endoplasmic-reticulum membrane protein targeting and insertion: a mechanism for reducing the ability of a targeting factor to shield its substrates enables substrate handover to a transmembrane-domain-docking site embedded in the endoplasmic-reticulum membrane.	[Wang, Fei; Chan, Charlene; Weir, Nicholas R.; Denic, Vladimir] Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA	Harvard University	Denic, V (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA.	vdenic@mcb.harvard.edu		Chan, Charlene/0000-0002-0479-3373	National Institutes of Health [RO1GM0999943-01]; Sara Elizabeth O'Brien Trust Postdoctoral Fellowship Program, Bank of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sara Elizabeth O'Brien Trust Postdoctoral Fellowship Program, Bank of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Brandman and R. Hegde for reagents, members of the Denic laboratory for scientific advice, and J. Weissman, A. Murray, B. Stern and C. Patil for comments on the manuscript. This work was supported by the National Institutes of Health (RO1GM0999943-01) and a postdoctoral fellowship from the Sara Elizabeth O'Brien Trust Postdoctoral Fellowship Program, Bank of America, Co-Trustee (to F.W.).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Brachmann CB, 1998, YEAST, V14, P115; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Denic V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013334; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Joglekar AP, 2008, METHOD CELL BIOL, V85, P127, DOI 10.1016/S0091-679X(08)85007-8; Kubota K, 2012, J MOL BIOL, V422, P366, DOI 10.1016/j.jmb.2012.05.045; Leznicki P, 2011, BIOCHEM J, V436, P719, DOI 10.1042/BJ20101737; Li J, 2002, P NATL ACAD SCI USA, V99, P11605, DOI 10.1073/pnas.192439299; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038	24	76	76	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					441	U486		10.1038/nature13471	http://dx.doi.org/10.1038/nature13471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25043001	Green Accepted			2022-12-24	WOS:000340840600036
J	Karzbrun, E; Tayar, AM; Noireaux, V; Bar-Ziv, RH				Karzbrun, Eyal; Tayar, Alexandra M.; Noireaux, Vincent; Bar-Ziv, Roy H.			Programmable on-chip DNA compartments as artificial cells	SCIENCE			English	Article							FREE EXPRESSION; NETWORKS; CIRCUITS; STEP	The assembly of artificial cells capable of executing synthetic DNA programs has been an important goal for basic research and biotechnology. We assembled two-dimensional DNA compartments fabricated in silicon as artificial cells capable of metabolism, programmable protein synthesis, and communication. Metabolism is maintained by continuous diffusion of nutrients and products through a thin capillary, connecting protein synthesis in the DNA compartment with the environment. We programmed protein expression cycles, autoregulated protein levels, and a signaling expression gradient, equivalent to a morphogen, in an array of interconnected compartments at the scale of an embryo. Gene expression in the DNA compartment reveals a rich, dynamic system that is controlled by geometry, offering a means for studying biological networks outside a living cell.	[Karzbrun, Eyal; Tayar, Alexandra M.; Bar-Ziv, Roy H.] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel; [Noireaux, Vincent] Univ Minnesota, Dept Phys, Minneapolis, MN 55455 USA	Weizmann Institute of Science; University of Minnesota System; University of Minnesota Twin Cities	Bar-Ziv, RH (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	roy.bar-ziv@weizmann.ac.il		Karzbrun, Eyal/0000-0001-8724-7855; noireaux, vincent/0000-0002-5213-273X; Tayar, alexandra/0000-0002-1418-2058	Israel Science Foundation; Minerva Foundation; U.S.-Israel Binational Science Foundation; NSF [PHY-0750133]; Azrieli Foundation	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NSF(National Science Foundation (NSF)); Azrieli Foundation	We thank A. Yoffe, S. Garussi, and Y. Barak of the Helen and Martin Kimmel Center for Nanoscale Science for guidance and assistance; I. Kaplan-Ashiri for scanning electron microscopy imaging; J. Hasty, University of California San Diego, for the generous gift of positive-feedback construct; and S. S. Daube and A. Libchaber for helpful discussions. This work was supported by the Israel Science Foundation (R.H.B.-Z.), the Minerva Foundation (R.H.B.-.Z), the U.S.-Israel Binational Science Foundation (R.H.B.-Z. and V.N.), NSF grant PHY-0750133 (V.N.), and the Azrieli Foundation (E.K.).	Bracha D, 2014, ACCOUNTS CHEM RES, V47, P1912, DOI 10.1021/ar5001428; Buxboim A, 2007, SMALL, V3, P500, DOI 10.1002/smll.200600489; Franco E, 2011, P NATL ACAD SCI USA, V108, pE784, DOI 10.1073/pnas.1100060108; Gerber D, 2009, NAT METHODS, V6, P71, DOI [10.1038/NMETH.1289, 10.1038/nmeth.1289]; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heyman Y, 2012, NAT NANOTECHNOL, V7, P374, DOI [10.1038/nnano.2012.65, 10.1038/NNANO.2012.65]; Hockenberry AJ, 2012, CURR OPIN CHEM BIOL, V16, P253, DOI 10.1016/j.cbpa.2012.05.179; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Kim J, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100099; Matthies D, 2011, J MOL BIOL, V413, P593, DOI 10.1016/j.jmb.2011.08.055; Muller P, 2013, DEVELOPMENT, V140, P1621, DOI 10.1242/dev.083519; Niederholtmeyer H, 2013, P NATL ACAD SCI USA, V110, P15985, DOI 10.1073/pnas.1311166110; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Noireaux V, 2003, P NATL ACAD SCI USA, V100, P12672, DOI 10.1073/pnas.2135496100; Shin J, 2012, ACS SYNTH BIOL, V1, P408, DOI 10.1021/sb300049p; Shin J, 2012, ACS SYNTH BIOL, V1, P29, DOI 10.1021/sb200016s; Shin Jonghyeon, 2010, J Biol Eng, V4, P9, DOI 10.1186/1754-1611-4-9; Shin Jonghyeon, 2010, J Biol Eng, V4, P8, DOI 10.1186/1754-1611-4-8; SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996	22	173	179	4	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					829	832		10.1126/science.1255550	http://dx.doi.org/10.1126/science.1255550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124443				2022-12-24	WOS:000340593100049
J	Oye, KA; Esvelt, K; Appleton, E; Catteruccia, F; Church, G; Kuiken, T; Lightfoot, SBY; McNamara, J; Smidler, A; Collins, JP				Oye, Kenneth A.; Esvelt, Kevin; Appleton, Evan; Catteruccia, Flaminia; Church, George; Kuiken, Todd; Lightfoot, Shlomiya Bar-Yam; McNamara, Julie; Smidler, Andrea; Collins, James P.			BIOTECHNOLOGY Regulating gene drives	SCIENCE			English	Editorial Material									[Oye, Kenneth A.] MIT, Polit Sci Dept, Cambridge, MA 02139 USA; [Oye, Kenneth A.; Lightfoot, Shlomiya Bar-Yam; McNamara, Julie] MIT, Engn Syst Div, Cambridge, MA 02139 USA; [Esvelt, Kevin; Church, George] Harvard Univ, Wyss Inst, Cambridge, MA 02138 USA; [Appleton, Evan] Boston Univ, Boston, MA 02215 USA; [Catteruccia, Flaminia; Smidler, Andrea] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Catteruccia, Flaminia] Univ Perugia, I-06100 Perugia, Italy; [Kuiken, Todd] Woodrow Wilson Int Ctr Scholars, Washington, DC USA; [Smidler, Andrea] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Collins, James P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; University of Perugia; Harvard University; Arizona State University; Arizona State University-Tempe	Oye, KA (corresponding author), MIT, Polit Sci Dept, Cambridge, MA 02139 USA.	oye@mit.edu	Kuiken, Todd/U-3476-2019; Kuiken, Todd/A-3784-2016	Kuiken, Todd/0000-0001-7851-6232; Kuiken, Todd/0000-0001-7851-6232; Esvelt, Kevin/0000-0001-8797-3945; Catteruccia, Flaminia/0000-0003-3295-6683; Smidler, Andrea/0000-0002-3281-1161; church, george/0000-0001-6232-9969	Direct For Biological Sciences [1337431] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		[Anonymous], 1972, PROD STOCKP BACT BIO; Australia Group, 2012, GUID TRANSF SENS CHE; Bar Yam S., 2012, REGULATION SYNTHETIC; Benedict M, 2008, VECTOR-BORNE ZOONOT, V8, P127, DOI 10.1089/vbz.2007.0273; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Center for Veterinary Medicine (CVM) Food and Drug Administration U. S. Department of Health and Human Services, 2009, REG GEN ENG AN CONT; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Drinkwater K, 2014, CREATING RES AGENDA; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Kuiken T., 2014, J ENVIRON STUD SCI, V4, P191, DOI [10.1007/s13412-014-0171-2, DOI 10.1007/S13412-014-0171-2]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Reeves RG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001502; U. S. Science and Technology Office, 2013, US GOV POL I OV LIF; United Nations, 2003, CART PROT BIOS CONV; United Nations, 1925, 1925 GEN PROT; World Health Organization, 2009, PROGR PROSP US GEN M	16	212	223	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					626	628		10.1126/science.1254287	http://dx.doi.org/10.1126/science.1254287			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25035410				2022-12-24	WOS:000339962800022
J	Gerard, A; Patino-Lopez, G; Beemiller, P; Nambiar, R; Ben-Aissa, K; Liu, Y; Totah, FJ; Tyska, MJ; Shaw, S; Krummel, MF				Gerard, Audrey; Patino-Lopez, Genaro; Beemiller, Peter; Nambiar, Rajalakshmi; Ben-Aissa, Khadija; Liu, Yin; Totah, Fadi J.; Tyska, Matthew J.; Shaw, Stephen; Krummel, Matthew F.			Detection of Rare Antigen-Presenting Cells through T Cell-Intrinsic Meandering Motility, Mediated by Myo1g	CELL			English	Article							MYOSIN-I; MEMBRANE TENSION; PLASMA-MEMBRANE; DENDRITIC CELLS; LYMPH-NODES; LEVY WALKS; MIGRATION; CHEMOKINES; EFFECTOR; CYTOSKELETON	To mount an immune response, T lymphocytes must successfully search for foreign material bound to the surface of antigen-presenting cells. How T cells optimize their chances of encountering and responding to these antigens is unknown. T cell motility in tissues resembles a random or Levy walk and is regulated in part by external factors including chemokines and lymph-node topology, but motility parameters such as speed and propensity to turn may also be cell intrinsic. Here we found that the unconventional myosin 1g (Myo1g) motor generates membrane tension, enforces cell-intrinsic meandering search, and enhances T-DC interactions during lymph-node surveillance. Increased turning and meandering motility, as opposed to ballistic motility, is enhanced by Myo1g. Myo1g acts as a "turning motor'' and generates a form of cellular "flanerie.'' Modeling and antigen challenges show that these intrinsically programmed elements of motility search are critical for the detection of rare cognate antigen-presenting cells.	[Gerard, Audrey; Beemiller, Peter; Totah, Fadi J.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Patino-Lopez, Genaro; Ben-Aissa, Khadija; Liu, Yin; Shaw, Stephen] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Nambiar, Rajalakshmi; Tyska, Matthew J.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37205 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave,HSW512, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu	Patiño López, Genaro/GQI-4414-2022; Patino-Lopez, Genaro/O-3484-2018	Patino-Lopez, Genaro/0000-0002-8716-722X; Beemiller, Peter/0000-0002-2736-3405	NIH [DK075555, AI052116]; American Heart Association; NIH Intramural Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, R01AI052116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075555] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Biological Imaging Development Center personnel for technical assistance with imaging. We thank G. A. Bizarri, F. Bartumeus, G. Altan-Bonnet, D. Barber D. Erle, and S. Dumont for helpful comments and suggestions and the ImmGen consortium for array data. We thank M. B. Headley for critical reading of the manuscript. This work was supported by grants from NIH (DK075555) and American Heart Association to M.J.T., The NIH Intramural Research Program to S. S., and NIH (AI052116) to M. F. K.	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Beauchemin C, 2007, J IMMUNOL, V178, P5505, DOI 10.4049/jimmunol.178.9.5505; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Beltman JB, 2009, J IMMUNOL METHODS, V347, P54, DOI 10.1016/j.jim.2009.05.013; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; Friedman RS, 2010, J EXP MED, V207, P2733, DOI 10.1084/jem.20091201; Fukui Y, 2002, CELL BIOL INT, V26, P933, DOI 10.1006/cbir.2002.0959; Gerard A, 2013, NAT IMMUNOL, V14, P356, DOI 10.1038/ni.2547; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Graw F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002436; Greenberg MJ, 2013, TRENDS CELL BIOL, V23, P81, DOI 10.1016/j.tcb.2012.10.008; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; JAY PY, 1995, J CELL SCI, V108, P387; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; Kim SV, 2008, CELL MOL LIFE SCI, V65, P2128, DOI 10.1007/s00018-008-7435-5; Kim SV, 2006, SCIENCE, V314, P136, DOI 10.1126/science.1131920; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Maravillas-Montero JL, 2011, J IMMUNOL, V187, P3053, DOI 10.4049/jimmunol.1004018; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miramontes O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034317; Mrass P, 2010, SEMIN IMMUNOPATHOL, V32, P257, DOI 10.1007/s00281-010-0212-1; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; OSTER GF, 1987, J CELL SCI, P35; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Preston SP, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011910; Reynolds AM, 2009, J THEOR BIOL, V260, P98, DOI 10.1016/j.jtbi.2009.05.033; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Textor J, 2011, P NATL ACAD SCI USA, V108, P12401, DOI 10.1073/pnas.1102288108; Usherwood EJ, 1999, J IMMUNOL, V162, P3350; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; ZHDANOV VP, 1988, CATAL REV, V30, P501, DOI 10.1080/01614948808071752	53	78	81	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					492	505		10.1016/j.cell.2014.05.044	http://dx.doi.org/10.1016/j.cell.2014.05.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083865	Green Accepted, Bronze			2022-12-24	WOS:000340944300005
J	Kumar, A; Mazzanti, M; Mistrik, M; Kosar, M; Beznoussenko, GV; Mironov, AA; Garre, M; Parazzoli, D; Shivashankar, GV; Scita, G; Bartek, J; Foiani, M				Kumar, Amit; Mazzanti, Michele; Mistrik, Martin; Kosar, Martin; Beznoussenko, Galina V.; Mironov, Alexandre A.; Garre, Massimiliano; Parazzoli, Dario; Shivashankar, G. V.; Scita, Giorgio; Bartek, Jiri; Foiani, Marco			ATR Mediates a Checkpoint at the Nuclear Envelope in Response to Mechanical Stress	CELL			English	Article							CELL-CYCLE ARREST; DNA-DAMAGE; EXTRACELLULAR-MATRIX; REPLICATION STRESS; FORK PROGRESSION; POTENT TOOL; ACTIVATION; CHROMATIN; GENOME; STABILITY	ATR controls chromosome integrity and chromatin dynamics. We have previously shown that yeast Mec1/ATR promotes chromatin detachment from the nuclear envelope to counteract aberrant topological transitions during DNA replication. Here, we provide evidence that ATR activity at the nuclear envelope responds to mechanical stress. Human ATR associates with the nuclear envelope during S phase and prophase, and both osmotic stress and mechanical stretching relocalize ATR to nuclear membranes throughout the cell cycle. The ATR-mediated mechanical response occurs within the range of physiological forces, is reversible, and is independent of DNA damage signaling. ATR-defective cells exhibit aberrant chromatin condensation and nuclear envelope breakdown. We propose that mechanical forces derived from chromosome dynamics and torsional stress on nuclear membranes activate ATR to modulate nuclear envelope plasticity and chromatin association to the nuclear envelope, thus enabling cells to cope with the mechanical strain imposed by these molecular processes.	[Kumar, Amit; Beznoussenko, Galina V.; Mironov, Alexandre A.; Garre, Massimiliano; Parazzoli, Dario; Scita, Giorgio; Foiani, Marco] Fdn Ist FIRC Oncol Mol IFOM, I-20139 Milan, Italy; [Mazzanti, Michele; Scita, Giorgio; Foiani, Marco] Univ Milan, I-20122 Milan, Italy; [Mistrik, Martin; Bartek, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc 77115, Czech Republic; [Kosar, Martin; Bartek, Jiri] Danish Canc Soc Res Ctr, DK-2100 Copenhagen, Denmark; [Kosar, Martin; Bartek, Jiri] Acad Sci Czech Republ, Inst Mol Genet, Vvi, CR-14220 Prague, Czech Republic; [Shivashankar, G. V.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Shivashankar, G. V.] Natl Univ Singapore, Dept Biol Sci, Singapore 117411, Singapore	IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); University of Milan; Palacky University Olomouc; Danish Cancer Society; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; National University of Singapore; National University of Singapore	Bartek, J (corresponding author), Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc 77115, Czech Republic.	jb@cancer.dk; marco.foiani@ifom.eu	Foiani, Marco/M-8234-2014; Kosar, Martin/B-7143-2018	Foiani, Marco/0000-0003-4795-834X; Kosar, Martin/0000-0002-9400-2327; Kumar, Amit/0000-0003-1732-440X; Mistrik, Martin/0000-0002-2321-0348; Mazzanti, Michele/0000-0002-1819-3811; Scita, Giorgio/0000-0001-7984-1889; Garre', Massimiliano/0000-0001-9332-0270	European Molecular Biology Organization fellowship; Marie Curie Intra-European fellowship [274093]; Fondazione Umberto Veronesi postdoctoral fellowship; Associazione Italiana per la Ricerca sul Cancro; Association for International Cancer Research; Telethon-Italy; CEN-Italy; Ministero dell'Istruzione Universitaria e della Ricerca; Danish Cancer Society; Lundbeck Foundation; Danish Council for Independent Research; European Commission; Mechanobiology Institute, NUS, Singapore; Novo Nordisk Fonden [NNF12OC0002290] Funding Source: researchfish	European Molecular Biology Organization fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Intra-European fellowship(European Commission); Fondazione Umberto Veronesi postdoctoral fellowship; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Association for International Cancer Research; Telethon-Italy(Fondazione Telethon); CEN-Italy; Ministero dell'Istruzione Universitaria e della Ricerca; Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); European Commission; Mechanobiology Institute, NUS, Singapore(National University of Singapore); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank Nancy Kleckner (Harvard University) for stimulating discussions, Karlene Cimprich (Stanford University), Oscar F. Capetillo (CNIO) for reagents and suggestions, Gururaj Kidiyoor (IFOM) and Radhakrishnan (MBI-NUS) for assistance, the imaging department of CEN and IFOM for support, and Michele Giannattasio, Dana Branzei, and our groups for discussions. A.K. was supported by a long-term European Molecular Biology Organization fellowship, a Marie Curie Intra-European (under grant agreement 274093) fellowship, and a Fondazione Umberto Veronesi postdoctoral fellowship. This work was supported by grants from Associazione Italiana per la Ricercasul Cancro, Association for International Cancer Research, Telethon-Italy, CEN-Italy, Ministero dell'Istruzione Universitaria e della Ricerca, the Danish Cancer Society, the Lundbeck Foundation, the Danish Council for Independent Research, and the European Commission (projects DDResponse, aDDRess, Biomedreg). G.V.S. is funded by the Mechanobiology Institute, NUS, Singapore.	Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; Bermejo R, 2012, TRENDS CELL BIOL, V22, P465, DOI 10.1016/j.tcb.2012.05.007; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; BOURGEOIS CA, 1979, J ULTRA MOL STRUCT R, V68, P328, DOI 10.1016/S0022-5320(79)90165-5; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; COMINGS DE, 1980, HUM GENET, V53, P131, DOI 10.1007/BF00273484; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Enserink JM, 2006, J CELL BIOL, V175, P729, DOI 10.1083/jcb.200605080; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; FUJIKAWAYAMAMOTO K, 1989, CELL STRUCT FUNCT, V14, P485, DOI 10.1247/csf.14.485; Gerlitz G, 2010, J CELL SCI, V123, P2207, DOI 10.1242/jcs.058271; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Hashash N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002978; Hu SH, 2005, BIOCHEM BIOPH RES CO, V329, P423, DOI 10.1016/j.bbrc.2005.02.026; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kultz D, 2001, P NATL ACAD SCI USA, V98, P1999, DOI 10.1073/pnas.98.4.1999; Kumar A, 2006, MOL CELL BIOL, V26, P9116, DOI 10.1128/MCB.00783-06; Kumar A, 2011, MOL CELL BIOL, V31, P2122, DOI 10.1128/MCB.01313-10; Kumar A, 2010, P NATL ACAD SCI USA, V107, P7491, DOI 10.1073/pnas.0914242107; Kweon HS, 2004, MOL BIOL CELL, V15, P4710, DOI 10.1091/mbc.E03-12-0881; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Martins RP, 2012, ANNU REV BIOMED ENG, V14, P431, DOI [10.1146/annurev-bioeng-071910-124638, 10.1146/annurev.bioeng-071910-124638]; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mazumder A, 2008, BIOPHYS J, V95, P3028, DOI 10.1529/biophysj.108.132274; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Mironov AA, 2009, J MICROSC-OXFORD, V235, P308, DOI 10.1111/j.1365-2818.2009.03222.x; Mironov AA, 2012, METHOD ENZYMOL, V504, P201, DOI 10.1016/B978-0-12-391857-4.00010-0; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ostlund C, 2006, BIOCHEMISTRY-US, V45, P1374, DOI 10.1021/bi052156n; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Polishchuk RS, 1999, EUR J CELL BIOL, V78, P170, DOI 10.1016/S0171-9335(99)80096-X; Rowat AC, 2006, BIOPHYS J, V91, P4649, DOI 10.1529/biophysj.106.086454; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Vigh L, 2007, ANN NY ACAD SCI, V1113, P40, DOI 10.1196/annals.1391.027; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195; Zhang XH, 2007, J CELL SCI, V120, P4134, DOI 10.1242/jcs.015834; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	65	132	133	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					633	646		10.1016/j.cell.2014.05.046	http://dx.doi.org/10.1016/j.cell.2014.05.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083873	Green Published, hybrid			2022-12-24	WOS:000340944300015
J	Satpute-Krishnan, P; Ajinkya, M; Bhat, S; Itakura, E; Hegde, RS; Lippincott-Schwartz, J				Satpute-Krishnan, Prasanna; Ajinkya, Monica; Bhat, Savithri; Itakura, Eisuke; Hegde, Ramanujan S.; Lippincott-Schwartz, Jennifer			ER Stress-Induced Clearance of Misfolded GPI-Anchored Proteins via the Secretory Pathway	CELL			English	Article							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; PRION PROTEIN; PLASMA-MEMBRANE; TRANSCRIPTION FACTOR; CELL; RECEPTOR; TRANSPORT; GOLGI; TRAFFICKING	Proteins destined for the cell surface are first assessed in the endoplasmic reticulum (ER) for proper folding before release into the secretory pathway. This ensures that defective proteins are normally prevented from entering the extracellular environment, where they could be disruptive. Here, we report that, when ER folding capacity is saturated during stress, misfolded glycosylphosphatidylinositol-anchored proteins dissociate from resident ER chaperones, engage export receptors, and quantitatively leave the ER via vesicular transport to the Golgi. Clearance from the ER commences within minutes of acute ER stress, before the transcriptional component of the unfolded protein response is activated. These aberrant proteins then access the cell surface transiently before destruction in lysosomes. Inhibiting this stress-induced pathway by depleting the ER-export receptors leads to aggregation of the ER-retained misfolded protein. Thus, this rapid response alleviates the elevated burden of misfolded proteins in the ER at the onset of ER stress, promoting protein homeostasis in the ER.	[Satpute-Krishnan, Prasanna; Ajinkya, Monica; Bhat, Savithri; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, Bethesda, MD 20892 USA; [Itakura, Eisuke; Hegde, Ramanujan S.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); MRC Laboratory Molecular Biology	Hegde, RS (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	rhegde@mrc-lmb.cam.ac.uk; lippincj@mail.nih.gov	BHAT, SAVITHRI/AAU-6982-2020; Itakura, Eisuke/AAY-7977-2021; Satpute-Krishnan, Prasanna/ABE-5421-2020	Itakura, Eisuke/0000-0001-7248-9333; BHAT, SAVITHRI/0000-0003-3918-0726; Hegde, Ramanujan/0000-0001-8338-852X	Intramural Research Program of the National Institutes of Health; HHMI summer research grant at Swarthmore College; UK Medical Research Council [MC_UP_A022_1007]; JSPS postdoctoral fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A022_1007] Funding Source: researchfish; MRC [MC_UP_A022_1007] Funding Source: UKRI	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI summer research grant at Swarthmore College; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); JSPS postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Weare grateful to Drs. Prabuddha Sengupta, Schuyler Van Engelenburg, Angelika Rambold, Peter Kim, Dale Hailey, Aarthi Ashok, Carolyn Suzuki, Yihong Ye, Linda Hendershot, Graham Diering, Michael Lizardo, and Chand Khanna for critical discussions, reagents, and assistance. We are grateful to Dr. Ajay Sharma, Nora Tsai, and Rafael Villasmil of the NEI Flow Cytometry Core Facility for invaluable technical support. This work was supported by the Intramural Research Program of the National Institutes of Health (J.L.-S. and P.S.-K.), the HHMI summer research grant at Swarthmore College (M. A.), the UK Medical Research Council (MC_UP_A022_1007 to R.S.H.), and a JSPS postdoctoral fellowship (E. I.).	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Apaja PM, 2010, J CELL BIOL, V191, P553, DOI 10.1083/jcb.201006012; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Boltz KA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-212; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Brunsing R, 2008, J BIOL CHEM, V283, P17954, DOI 10.1074/jbc.M801395200; Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3; Diehl JA, 2011, GASTROENTEROLOGY, V141, P38, DOI 10.1053/j.gastro.2011.05.018; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Ferguson M. A. J., 2009, ESSENTIALS GLYCOBIOL; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Grapp M, 2012, BRAIN, V135, P2022, DOI 10.1093/brain/aws122; Gu YP, 2007, J MOL NEUROSCI, V32, P90, DOI 10.1007/s12031-007-0023-6; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Negro A, 2001, MOL CELL NEUROSCI, V17, P521, DOI 10.1006/mcne.2000.0953; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; Nickel W, 1997, P NATL ACAD SCI USA, V94, P11393, DOI 10.1073/pnas.94.21.11393; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459	49	102	102	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					522	533		10.1016/j.cell.2014.06.026	http://dx.doi.org/10.1016/j.cell.2014.06.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083867	Green Published, hybrid			2022-12-24	WOS:000340944300007
J	Marcussen, T; Sandve, SR; Heier, L; Spannagl, M; Pfeifer, M; Jakobsen, KS; Wulff, BBH; Steuernagel, B; Mayer, KFX; Olsen, OA; Rogers, J; Dolezel, J; Pozniak, C; Eversole, K; Feuillet, C; Gill, B; Friebe, B; Lukaszewski, AJ; Sourdille, P; Endo, TR; Kubalakova, M; Cihalikova, J; Dubska, Z; Vrana, J; Sperkova, R; Simkova, H; Febrer, M; Clissold, L; Mclay, K; Singh, K; Chhuneja, P; Singh, NK; Khurana, J; Akhunov, E; Choulet, F; Alberti, A; Barbe, V; Wincker, P; Kanamori, H; Kobayashi, F; Itoh, T; Matsumoto, T; Sakai, H; Tanaka, T; Wu, JZ; Ogihara, Y; Handa, H; Maclachlan, PR; Sharpe, A; Klassen, D; Edwards, D; Batley, J; Lien, S; Caccamo, M; Ayling, S; Ramirez-Gonzalez, RH; Clavijo, BJ; Wright, J; Martis, MM; Mascher, M; Chapman, J; Poland, JA; Scholz, U; Barry, K; Waugh, R; Rokhsar, DS; Muehlbauer, GJ; Stein, N; Gundlach, H; Zytnicki, M; Jamilloux, V; Quesneville, H; Wicker, T; Faccioli, P; Colaiacovo, M; Stanca, AM; Budak, H; Cattivelli, L; Glover, N; Pingault, L; Paux, E; Sharma, S; Appels, R; Bellgard, M; Chapman, B; Nussbaumer, T; Bader, KC; Rimbert, H; Wang, SC; Knox, R; Kilian, A; Alaux, M; Alfama, F; Couderc, L; Guilhot, N; Viseux, C; Loaec, M; Keller, B; Praud, S				Marcussen, Thomas; Sandve, Simen R.; Heier, Lise; Spannagl, Manuel; Pfeifer, Matthias; Jakobsen, Kjetill S.; Wulff, Brande B. H.; Steuernagel, Burkhard; Mayer, Klaus F. X.; Olsen, Odd-Arne; Rogers, Jane; Dolezel, Jaroslav; Pozniak, Curtis; Eversole, Kellye; Feuillet, Catherine; Gill, Bikram; Friebe, Bernd; Lukaszewski, Adam J.; Sourdille, Pierre; Endo, Takashi R.; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana; Febrer, Melanie; Clissold, Leah; McLay, Kirsten; Singh, Kuldeep; Chhuneja, Parveen; Singh, Nagendra K.; Khurana, Jitendra; Akhunov, Eduard; Choulet, Frederic; Alberti, Adriana; Barbe, Valerie; Wincker, Patrick; Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Ogihara, Yasunari; Handa, Hirokazu; Maclachlan, P. Ron; Sharpe, Andrew; Klassen, Darrin; Edwards, David; Batley, Jacqueline; Lien, Sigbjorn; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan; Martis, Mihaela M.; Mascher, Martin; Chapman, Jarrod; Poland, Jesse A.; Scholz, Uwe; Barry, Kerrie; Waugh, Robbie; Rokhsar, Daniel S.; Muehlbauer, Gary J.; Stein, Nils; Gundlach, Heidrun; Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Wicker, Thomas; Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Budak, Hikmet; Cattivelli, Luigi; Glover, Natasha; Pingault, Lise; Paux, Etienne; Sharma, Sapna; Appels, Rudi; Bellgard, Matthew; Chapman, Brett; Nussbaumer, Thomas; Bader, Kai Christian; Rimbert, Helene; Wang, Shichen; Knox, Ron; Kilian, Andrzej; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Guilhot, Nicolas; Viseux, Claire; Loaec, Mikael; Keller, Beat; Praud, Sebastien		Int Wheat Genome Sequencing	Ancient hybridizations among the ancestral genomes of bread wheat	SCIENCE			English	Article							AEGILOPS-TAUSCHII; DRAFT GENOME; A-GENOME; EVOLUTION; TRITICUM; DOMESTICATION; ALIGNMENT; PACKAGE; GENES	The allohexaploid bread wheat genome consists of three closely related subgenomes (A, B, and D), but a clear understanding of their phylogenetic history has been lacking. We used genome assemblies of bread wheat and five diploid relatives to analyze genome-wide samples of gene trees, as well as to estimate evolutionary relatedness and divergence times. We show that the A and B genomes diverged from a common ancestor similar to 7 million years ago and that these genomes gave rise to the D genome through homoploid hybrid speciation 1 to 2 million years later. Our findings imply that the present-day bread wheat genome is a product of multiple rounds of hybrid speciation (homoploid and polyploid) and lay the foundation for a new framework for understanding the wheat genome as a multilevel phylogenetic mosaic.	[Marcussen, Thomas; Sandve, Simen R.; Olsen, Odd-Arne] Norwegian Univ Life Sci, Dept Plant Sci, N-1432 As, Norway; [Spannagl, Manuel; Pfeifer, Matthias; Mayer, Klaus F. X.] Helmholtz Ctr Munich, D-85764 Neuherberg, Germany; [Jakobsen, Kjetill S.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; [Wulff, Brande B. H.; Steuernagel, Burkhard] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Spannagl, Manuel; Pfeifer, Matthias; Mayer, Klaus F. X.; Martis, Mihaela M.; Gundlach, Heidrun; Sharma, Sapna; Nussbaumer, Thomas; Bader, Kai Christian] Helmholtz Zentrum Munich, Plant Genome & Syst Biol, Ingolstadter Landstrasse 1, D-85764 Neuherberg, Germany; [Rogers, Jane; Eversole, Kellye] Eversole Associates, IWGSC, 5207 Wyoming Rd, Bethesda 20816, MD USA; [Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana] Inst Expt Bot, Ctr Plant Struct & Funct Genom, Slechtitelu 31, Olomouc 78371, Czech Republic; [Pozniak, Curtis; Maclachlan, P. Ron] Univ Saskatchewan, Coll Agr & Bioresources, Dept Plant Sci, Ctr Crop Dev, 51 Campus Dr, Saskatoon, SK, Canada; [Feuillet, Catherine] Bayer Crop Sci, 3500 Paramount Pkwy, Morrisville, NC 27560 USA; [Gill, Bikram; Friebe, Bernd; Akhunov, Eduard; Wang, Shichen] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Lukaszewski, Adam J.] Univ Calif, Coll Nat & Agr Sci Bot & Plant Sci, Riverside, CA 92521 USA; [Endo, Takashi R.] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Kyoto 6068502, Japan; [Febrer, Melanie] Univ Dundee, Genom Sequenc Unit, Dow St, Dundee DD1 5EH, Scotland; [Clissold, Leah; McLay, Kirsten; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan] Genome Anal Ctr, Res Pk, Norwich NR4 7UH, Norfolk, England; [Singh, Kuldeep; Chhuneja, Parveen] Punjab Agr Univ, Sch Agrictural Biotechnol, Ludhiana 141004, Punjab, India; [Singh, Nagendra K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Khurana, Jitendra] Univ Delhi, Dept Plant Mol, Interdisciplinary Ctr Plant Genom, South Campus, New Delhi 110021, India; [Sourdille, Pierre; Choulet, Frederic; Glover, Natasha; Pingault, Lise; Paux, Etienne; Guilhot, Nicolas] INRA Univers Blaise Pascal UMR1095 Genet, Div & Ecophysiol Cereals, 5 Chemin Beaulieu, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Wincker, Patrick] Ctr Natl Sequencage, Commissariat IEnergie Atom Genoscope, 2 rue Gaston Cremieux, F-91057 Evry, France; [Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Handa, Hirokazu] Natl Inst Agrobiol Sci, Plant Genome Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan; [Ogihara, Yasunari] Yokohama City Univ, Kihara Inst Biol Res, Maioka cho 641-12 Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Sharpe, Andrew; Klassen, Darrin] Natl Res Council Canada, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada; [Edwards, David; Batley, Jacqueline] Univ Queensland, Sch Agr & Food Sci, Australian Ctr Plant Funct Genom, St Lucia, Qld 4072, Australia; [Edwards, David; Batley, Jacqueline] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia; [Sandve, Simen R.; Olsen, Odd-Arne] Norwegian Univ Life Sci, Dept Plant Sci, Ctr Integrat Genet CIGENE, N-1432 As, Norway; [Olsen, Odd-Arne] Hedmark Univ Coll, Dept Nat Sci & Technol, N-2318 Oslo, Norway; [Wulff, Brande B. H.; Steuernagel, Burkhard] Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Mascher, Martin; Scholz, Uwe] Leibniz Inst Plant Genet & Crop Plant Res IPK, Bioinformat & Informat Technol, D-06466 Seeland OT Gatersleben, Germany; [Chapman, Jarrod; Barry, Kerrie; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA; [Poland, Jesse A.] Kansas State Univ, Dept Agron, USDA ARS Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Waugh, Robbie] James Hutton Inst, Invergowrie, Dundee DD2 5DA, Scotland; [Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, Dept Plant Biol, St Paul, MN 55108 USA; [Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genome Div, D-06466 Seeland OT Gatersleben, Germany; [Jamilloux, Veronique; Quesneville, Hadi; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Viseux, Claire; Loaec, Mikael] INRA Versailles, UR1164 URGI Research Unit Genom Info, INRA, Route Saint Cyr, F-78026 Versailles, France; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, Zollikerstrasse 107, CH-8008 Zurich, Switzerland; [Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Cattivelli, Luigi] Consiglio Ric Sperimentazione Agricoltura Gen Res, Via San Protaso 302, I-29017 Fjorenzuola dArda, Italy; [Budak, Hikmet] Sabanci Univ, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Appels, Rudi; Bellgard, Matthew; Chapman, Brett] Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia; [Knox, Ron] Semiarid Prairie Agr Res Ctr, Post Off Box 1030, Swift Current, SK S9H 3X2, Canada; [Kilian, Andrzej] Div Arrays Technol Pty Ltd, 1 Wilf Crane Crescent, Yarralumla ACT2600, Australia; [Rimbert, Helene] Ctr Rech Chappes, Biogemma, Route dEnnezat, F-63720 Chappes, France; [Lien, Sigbjorn] Norwegian Univ Life Sci, Dept Anim & Aquicultural Sci, CIGENE, Arboretvelen 6, N-1432 As, Norway	Norwegian University of Life Sciences; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oslo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Saskatchewan; Bayer AG; Bayer CropScience; Kansas State University; University of California System; University of California Riverside; Kyoto University; University of Dundee; The Genome Analysis Centre (TGAC); Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); University of Delhi; INRAE; UDICE-French Research Universities; Universite Paris Saclay; National Institute of Agrobiological Sciences - Japan; Yokohama City University; National Research Council Canada; University of Queensland; University of Western Australia; Norwegian University of Life Sciences; Inland Norway University of Applied Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Kansas State University; James Hutton Institute; University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Zurich; Sabanci University; Murdoch University; Norwegian University of Life Sciences	Sandve, SR (corresponding author), Norwegian Univ Life Sci, Dept Plant Sci, N-1432 As, Norway.	simen.sandve@nmbu.no	Eversole, Kellye/AAN-6141-2020; Sharma, Sapna/N-6357-2017; Wang, Shichen/E-6213-2012; Stein, Nils/F-7507-2017; Edwards, David/H-3710-2015; Batley, Jacqueline/A-5723-2008; Budak, Hikmet/U-8517-2019; Kubaláková, Marie/F-8269-2014; Mayer, Klaus FX/M-7941-2015; Dolezel, Jaroslav/B-7716-2008; Ramírez, Ricardo/H-4808-2019; cattivelli, luigi/AAE-7046-2020; Wu, Jian/AAU-5221-2020; Pfeifer, Matthias/GRJ-4579-2022; Wulff, Brande BH/C-7465-2013; Marcussen, Thomas/I-7768-2019; Wulff, Brande B/N-4273-2013; Pingault, Lise/AAQ-8602-2020; Simkova, Hana/F-7734-2014; Quesneville, Hadi/AAG-1048-2020; Wicker, Thomas/Z-1978-2019; Barry, Kerrie Whitelaw/AAA-5500-2020; Budak, Hikmet/S-5835-2017; Sourdille, Pierre/CAF-2780-2022; Wu, Jian/AAU-5221-2020	Eversole, Kellye/0000-0002-8784-4913; Wang, Shichen/0000-0003-1441-2252; Stein, Nils/0000-0003-3011-8731; Edwards, David/0000-0001-7599-6760; Batley, Jacqueline/0000-0002-5391-5824; Budak, Hikmet/0000-0002-2556-2478; Mayer, Klaus FX/0000-0001-6484-1077; Dolezel, Jaroslav/0000-0002-6263-0492; Ramírez, Ricardo/0000-0001-5745-7085; cattivelli, luigi/0000-0002-6067-4600; Wu, Jian/0000-0001-9933-7364; Wulff, Brande BH/0000-0003-4044-4346; Pingault, Lise/0000-0002-6149-1267; Simkova, Hana/0000-0003-4159-7619; Quesneville, Hadi/0000-0003-3001-4908; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Budak, Hikmet/0000-0002-2556-2478; Keller, Beat/0000-0003-2379-9225; , Thomas/0000-0002-6777-7135; Marcussen, Thomas/0000-0002-1960-9508; Colaiacovo, Moreno/0000-0003-1320-0506; Spannagl, Manuel/0000-0003-0701-7035; Singh, Kuldeep/0000-0001-5239-6586; Steuernagel, Burkhard/0000-0002-8284-7728; Wu, Jian/0000-0002-3394-1507; Sourdille, Pierre/0000-0002-1027-2224; Gundlach, Heidrun/0000-0002-6757-0943; Jamilloux, Veronique/0000-0002-6898-4910; Alaux, Michael/0000-0001-9356-4072; Bellgard, Matthew/0000-0002-6303-9469; Kilian, Andrzej/0000-0002-2730-7462; Scholz, Uwe/0000-0001-6113-3518; Martis, Mihaela-Maria/0000-0001-7509-2446	Norwegian Research Council [199387]; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BB/J003166/1] Funding Source: researchfish; Division Of Computer and Network Systems [1126709] Funding Source: National Science Foundation; BBSRC [BBS/E/T/000PR6193, BB/J003166/1] Funding Source: UKRI	Norwegian Research Council(Research Council of NorwayEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was financed by Norwegian Research Council grant 199387 to Norwegian University of Life Sciences and Graminor AS to O.-A.O. The phylogenetic analyses were run, in part, on the Bioportal supercomputing facility at the University of Oslo. We thank C.-P. Antoine and two anonymous reviewers for valuable comments on the manuscript and S. Saebo for help on implementation of the OpenBUGS analyses in R. Ortholog alignments, gene trees, and the OpenBUGS model used for multispecies coalescent modeling can be downloaded from Dryad (data available from the Dryad Digital Repository: http://doi.org/10.5061/dryad.f6c34).	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Akhunov ED, 2005, THEOR APPL GENET, V111, P1617, DOI 10.1007/s00122-005-0093-1; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Doyle JJ, 2010, NEW PHYTOL, V186, P73, DOI 10.1111/j.1469-8137.2009.03118.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Eroukhmanoff F, 2013, CURR ZOOL, V59, P667, DOI 10.1093/czoolo/59.5.667; Escobar JS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-181; Fan X, 2013, BIOCHEM SYST ECOL, V50, P346, DOI 10.1016/j.bse.2013.05.010; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lev-Yadun S, 2000, SCIENCE, V288, P1602, DOI 10.1126/science.288.5471.1602; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lotsy J. P., 1916, EVOLUTION BY MEANS O; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Pfeifer M, 2014, SCIENCE, V345, DOI 10.1126/science.1250091; Riehl S, 2013, SCIENCE, V341, P65, DOI 10.1126/science.1236743; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Than C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-322; Vigeland MD, 2013, NEW PHYTOL, V199, P1060, DOI 10.1111/nph.12337; Yu Y, 2013, SYST BIOL, V62, P738, DOI 10.1093/sysbio/syt037	35	418	445	19	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1250092	10.1126/science.1250092	http://dx.doi.org/10.1126/science.1250092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035499				2022-12-24	WOS:000343420300003
J	Baruch, K; Deczkowska, A; David, E; Castellano, JM; Miller, O; Kertser, A; Berkutzki, T; Barnett-Itzhaki, Z; Bezalel, D; Wyss-Coray, T; Amit, I; Schwartz, M				Baruch, Kuti; Deczkowska, Aleksandra; David, Eyal; Castellano, Joseph M.; Miller, Omer; Kertser, Alexander; Berkutzki, Tamara; Barnett-Itzhaki, Zohar; Bezalel, Dana; Wyss-Coray, Tony; Amit, Ido; Schwartz, Michal			Aging-induced type I interferon response at the choroid plexus negatively affects brain function	SCIENCE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; PERSISTENT LCMV INFECTION; CENTRAL-NERVOUS-SYSTEM; IMMUNE SURVEILLANCE; COGNITIVE FUNCTION; T-CELLS; BLOCKADE; REJUVENATION; INFLAMMATION; RECRUITMENT	Aging-associated cognitive decline is affected by factors produced inside and outside the brain. By using multiorgan genome-wide analysis of aged mice, we found that the choroid plexus, an interface between the brain and the circulation, shows a type I interferon (IFN-I)-dependent gene expression profile that was also found in aged human brains. In aged mice, this response was induced by brain-derived signals, present in the cerebrospinal fluid. Blocking IFN-I signaling within the aged brain partially restored cognitive function and hippocampal neurogenesis and reestablished IFN-II-dependent choroid plexus activity, which is lost in aging. Our data identify a chronic aging-induced IFN-I signature, often associated with antiviral response, at the brain's choroid plexus and demonstrate its negative influence on brain function, thereby suggesting a target for ameliorating cognitive decline in aging.	[Baruch, Kuti; Deczkowska, Aleksandra; Miller, Omer; Kertser, Alexander; Berkutzki, Tamara; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [David, Eyal; Barnett-Itzhaki, Zohar; Bezalel, Dana; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Castellano, Joseph M.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Weizmann Institute of Science; Weizmann Institute of Science; Stanford University	Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ido.amit@weizmann.ac.il; michal.schwartz@weizmann.ac.il	Baruch, Kuti/I-3535-2016; Castellano, Joseph M/ABD-7639-2021; Barnett-Itzhaki, Zohar/AAA-4029-2021; Wyss-Coray, Tony/AAF-3380-2019	Baruch, Kuti/0000-0002-1466-8795; Barnett-Itzhaki, Zohar/0000-0001-9891-9397; Wyss-Coray, Tony/0000-0001-5893-0831; Castellano, Joseph/0000-0002-8026-6292	European Research Council (E.R.C.) [232835]; European Union [279017, 309788]; Israeli Science Foundation [1782/11]; National Institute on Aging [AG045034]; Jane Coffin Childs Postdoctoral fellowship; Medical Research Council [MR/L022656/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG045034] Funding Source: NIH RePORTER; MRC [MR/L022656/1] Funding Source: UKRI	European Research Council (E.R.C.)(European Research Council (ERC)European Commission); European Union(European Commission); Israeli Science Foundation(Israel Science Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Jane Coffin Childs Postdoctoral fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Esiri and A. Troen for their help in obtaining human brain sections, K. I. Mosher for technical assistance in parabiosis experiments, and A. Tsitsou-Kampeli and A. Hutzler for assistance in immunohistochemistry experiments. Supported by a European Research Council (E.R.C.) grant (232835), a European Union Seventh Framework Program (FP7) grant (279017) given to M. S., an E. R. C. grant (309788), and an Israeli Science Foundation grant given to I. A. (1782/11), a National Institute on Aging grant given to T. W.-C. (AG045034), and a Jane Coffin Childs Postdoctoral fellowship given to J.M.C.	Axtell RC, 2008, IMMUNITY, V28, P600, DOI 10.1016/j.immuni.2008.04.006; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Falcao AM, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00034; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Hofer MJ, 2013, CYTOKINE GROWTH F R, V24, P257, DOI 10.1016/j.cytogfr.2013.03.006; Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Kunis G, 2013, BRAIN, V136, P3427, DOI 10.1093/brain/awt259; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Schwartz M, 2014, EMBO J, V33, P7, DOI 10.1002/embj.201386609; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Stranahan AM, 2012, NAT REV NEUROSCI, V13, P209, DOI 10.1038/nrn3151; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wichers M, 2002, INT J NEUROPSYCHOPH, V5, P375, DOI 10.1017/S1461145702003103; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Yeoman M, 2012, NAT REV NEUROSCI, V13, P435, DOI 10.1038/nrn3230; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	30	325	336	7	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2014	346	6205					89	93		10.1126/science.1252945	http://dx.doi.org/10.1126/science.1252945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ0BR	25147279	Green Accepted			2022-12-24	WOS:000342446900057
J	Wolfe, AL; Singh, K; Zhong, Y; Drewe, P; Rajasekhar, VK; Sanghvi, VR; Mavrakis, KJ; Jiang, M; Roderick, JE; Van der Meulen, J; Schatz, JH; Rodrigo, CM; Zhao, CY; Rondou, P; de Stanchina, E; Teruya-Feldstein, J; Kelliher, MA; Speleman, F; Porco, JA; Pelletier, J; Ratsch, G; Wendel, HG				Wolfe, Andrew L.; Singh, Kamini; Zhong, Yi; Drewe, Philipp; Rajasekhar, Vinagolu K.; Sanghvi, Viraj R.; Mavrakis, Konstantinos J.; Jiang, Man; Roderick, Justine E.; Van der Meulen, Joni; Schatz, Jonathan H.; Rodrigo, Christina M.; Zhao, Chunying; Rondou, Pieter; de Stanchina, Elisa; Teruya-Feldstein, Julie; Kelliher, Michelle A.; Speleman, Frank; Porco, John A., Jr.; Pelletier, Jerry; Raetsch, Gunnar; Wendel, Hans-Guido			RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; OF-FUNCTION MUTATIONS; C-MYC; INITIATION; EIF4E; CAP; AKT; TRANSCRIPTION; INHIBITION; MOTIF	The translational control of oncoprotein expression is implicated in many cancers. Here we report an eIF4A RNA helicase-dependent mechanism of translational control that contributes to oncogenesis and underlies the anticancer effects of silvestrol and related compounds. For example, eIF4A promotes T-cell acute lymphoblastic leukaemia development in vivo and is required for leukaemia maintenance. Accordingly, inhibition of eIF4A with silvestrol has powerful therapeutic effects against murine and human leukaemic cells in vitro and in vivo. We use transcriptome-scale ribosome footprinting to identify the hallmarks of eIF4A-dependent transcripts. These include 5' untranslated region (UTR) sequences such as the 12-nucleotide guanine quartet (CGG)(4) motif that can form RNA G-quadruplex structures. Notably, among the most eIF4A-dependent and silvestrol-sensitive transcripts are a number of oncogenes, superenhancer-associated transcription factors, and epigenetic regulators. Hence, the 5' UTRs of select cancer genes harbour a targetable requirement for the eIF4A RNA helicase.	[Wolfe, Andrew L.; Singh, Kamini; Sanghvi, Viraj R.; Mavrakis, Konstantinos J.; Jiang, Man; Van der Meulen, Joni; Schatz, Jonathan H.; Zhao, Chunying; Wendel, Hans-Guido] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Wolfe, Andrew L.] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Zhong, Yi; Drewe, Philipp; Raetsch, Gunnar] Mem Sloan Kettering Canc Ctr, Computat Biol Dept, New York, NY 10065 USA; [Rajasekhar, Vinagolu K.] Mem Sloan Kettering Canc Ctr, Stem Cell Ctr, New York, NY 10065 USA; [Rajasekhar, Vinagolu K.] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Roderick, Justine E.; Kelliher, Michelle A.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Van der Meulen, Joni; Rondou, Pieter; Speleman, Frank] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Schatz, Jonathan H.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Rodrigo, Christina M.; Porco, John A., Jr.] Boston Univ, Dept Chem, Ctr Chem Methodol & Lib Dev, Boston, MA 02215 USA; [de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, New York, NY 10065 USA; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Pelletier, Jerry] McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada; [Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; Ghent University; Memorial Sloan Kettering Cancer Center; Boston University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; McGill University; McGill University; McGill University	Wendel, HG (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	Ratschg@mskcc.org; wendelh@mskcc.org	Van der Meulen, Joni/AFS-1616-2022; speleman, frank/AAR-5184-2020; Rätsch, Gunnar/O-5914-2017	Van der Meulen, Joni/0000-0002-1916-2769; speleman, frank/0000-0002-6628-8559; Rätsch, Gunnar/0000-0001-5486-8532; Sanghvi, Viraj/0000-0001-6526-7820; Wolfe, Andrew/0000-0003-0418-716X; Vinagolu, Rajasekhar/0000-0002-7364-2675; van der Meulen, Jan/0000-0002-9451-2335; Schatz, Jonathan/0000-0003-1842-228X; Boss, Philipp/0000-0002-5459-9771	National Cancer Institute [R01-CA142798-01]; Leukemia Research Foundation; Experimental Therapeutics Center; American Cancer Society [10284, PF-11-077-01-CDD]; European Union [PITN-GA-2012-316861]; Fund for Scientific Research FWO Flanders [G.0198.08, G.0869.10N]; GOA-UGent [12051203]; Stichting tegen Kanker; Belgian Program of Interuniversity Poles of Attraction; Belgian Foundation Against Cancer; Lymphoma Research Foundation; National Institutes of Health [GM-067041, GM-073855]; Canadian Institutes of Health Research [MOP-10653]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA142798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067041, R01GM073855] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation; Experimental Therapeutics Center; American Cancer Society(American Cancer Society); European Union(European Commission); Fund for Scientific Research FWO Flanders(FWO); GOA-UGent; Stichting tegen Kanker; Belgian Program of Interuniversity Poles of Attraction; Belgian Foundation Against Cancer; Lymphoma Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of A.L.W.'s thesis committee: N. Rosen, A. M. Brown and S. W. Lowe. For reagents and advice we thank J. T. Barata, W. S. Pear, R. Cencic, S. Shuman, J. Cools, A. A. Ferrando, C. S. Fraser, N. J. Lajkiewicz, A. Luz, J. F. Glickman, C. Y. Park, P. Yellen, A. Heguy, K. Huberman and A. Viale. H.-G. W. is a Scholar of the Leukemia and Lymphoma Society. This research was supported by National Cancer Institute R01-CA142798-01 (H.-G. W.), the Leukemia Research Foundation (H.-G. W.), the Experimental Therapeutics Center (H.-G. W.), the American Cancer Society 10284 (H.-G. W.), European Union grant no. PITN-GA-2012-316861 (Y.Z.), the Fund for Scientific Research FWO Flanders (J.V.d.M. and P. R.), grants G.0198.08 and G.0869.10N (F. S.), the GOA-UGent 12051203 (F. S.), Stichting tegen Kanker (F. S.), the Belgian Program of Interuniversity Poles of Attraction (F. S.), the Belgian Foundation Against Cancer (F. S.), the American Cancer Society PF-11-077-01-CDD (C. M. R.), the Lymphoma Research Foundation (J. H. S.), National Institutes of Health grants GM-067041 and GM-073855 (J. A. P.), and the Canadian Institutes of Health Research MOP-10653 (J.P.).	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drewe P, 2013, NUCLEIC ACIDS RES, V41, P5189, DOI 10.1093/nar/gkt211; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Galicia-Vazquez G, 2012, RNA, V18, P1373, DOI 10.1261/rna.033209.112; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jean G., 2010, BIOINFORMATICS, V32; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Menten B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-124; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Morris MJ, 2010, J AM CHEM SOC, V132, P17831, DOI 10.1021/ja106287x; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Rodrigo CM, 2012, J MED CHEM, V55, P558, DOI 10.1021/jm201263k; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Sadlish H, 2013, ACS CHEM BIOL, V8, P1519, DOI 10.1021/cb400158t; Schatz JH, 2011, J EXP MED, V208, P1799, DOI 10.1084/jem.20110846; Shahid R, 2010, BIOCHEMISTRY-US, V49, P8300, DOI 10.1021/bi100957h; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zuurbier L, 2012, HAEMATOL-HEMATOL J, V97, P1405, DOI 10.3324/haematol.2011.059030	56	378	385	3	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					65	+		10.1038/nature13485	http://dx.doi.org/10.1038/nature13485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25079319	Green Accepted			2022-12-24	WOS:000341174800030
J	Kwan, A; Abraham, RS; Currier, R; Brower, A; Andruszewski, K; Abbott, JK; Baker, M; Ballow, M; Bartoshesky, LE; Bonilla, FA; Brokopp, C; Brooks, E; Caggana, M; Celestin, J; Church, JA; Comeau, AM; Connelly, JA; Cowan, MJ; Cunningham-Rundles, C; Dasu, T; Dave, N; De La Morena, MT; Duffner, U; Fong, CT; Forbes, L; Freedenberg, D; Gelfand, EW; Hale, JE; Hanson, IC; Hay, BN; Hu, D; Infante, A; Johnson, D; Kapoor, N; Kay, DM; Kohn, DB; Lee, R; Lehman, H; Lin, ZL; Lorey, F; Abdel-Mageed, A; Manning, A; McGhee, S; Moore, TB; Naides, SJ; Notarangelo, LD; Orange, JS; Pai, SY; Porteus, M; Rodriguez, R; Romberg, N; Routes, J; Ruehle, M; Rubenstein, A; Saavedra-Matiz, CA; Scott, G; Scott, PM; Secord, E; Seroogy, C; Shearer, WT; Siegel, S; Silvers, SK; Stiehm, ER; Sugerman, RW; Sullivan, JL; Tanksley, S; Tierce, ML; Verbsky, J; Vogel, B; Walker, R; Walkovich, K; Walter, JE; Wasserman, RL; Watson, MS; Weinberg, GA; Weiner, LB; Wood, H; Yates, AB; Puck, JM				Kwan, Antonia; Abraham, Roshini S.; Currier, Robert; Brower, Amy; Andruszewski, Karen; Abbott, Jordan K.; Baker, Mei; Ballow, Mark; Bartoshesky, Louis E.; Bonilla, Francisco A.; Brokopp, Charles; Brooks, Edward; Caggana, Michele; Celestin, Jocelyn; Church, Joseph A.; Comeau, Anne Marie; Connelly, James A.; Cowan, Morton J.; Cunningham-Rundles, Charlotte; Dasu, Trivikram; Dave, Nina; De La Morena, Maria T.; Duffner, Ulrich; Fong, Chin-To; Forbes, Lisa; Freedenberg, Debra; Gelfand, Erwin W.; Hale, Jaime E.; Hanson, I. Celine; Hay, Beverly N.; Hu, Diana; Infante, Anthony; Johnson, Daisy; Kapoor, Neena; Kay, Denise M.; Kohn, Donald B.; Lee, Rachel; Lehman, Heather; Lin, Zhili; Lorey, Fred; Abdel-Mageed, Aly; Manning, Adrienne; McGhee, Sean; Moore, Theodore B.; Naides, Stanley J.; Notarangelo, Luigi D.; Orange, Jordan S.; Pai, Sung-Yun; Porteus, Matthew; Rodriguez, Ray; Romberg, Neil; Routes, John; Ruehle, Mary; Rubenstein, Arye; Saavedra-Matiz, Carlos A.; Scott, Ginger; Scott, Patricia M.; Secord, Elizabeth; Seroogy, Christine; Shearer, William T.; Siegel, Subhadra; Silvers, Stacy K.; Stiehm, E. Richard; Sugerman, Robert W.; Sullivan, John L.; Tanksley, Susan; Tierce, Millard L.; Verbsky, James; Vogel, Beth; Walker, Rosalyn; Walkovich, Kelly; Walter, Jolan E.; Wasserman, Richard L.; Watson, Michael S.; Weinberg, Geoffrey A.; Weiner, Leonard B.; Wood, Heather; Yates, Anne B.; Puck, Jennifer M.			Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OMENN SYNDROME; CHILDREN; MUTATIONS; TRANSPLANTATION; IDENTIFICATION; EXPERIENCE; PHENOTYPES; TTC7A; AGE	IMPORTANCE Newborn screening for severe combined immunodeficiency (SCID) using assays to detect T-cell receptor excision circles (TRECs) began in Wisconsin in 2008, and SCID was added to the national recommended uniform panel for newborn screened disorders in 2010. Currently 23 states, the District of Columbia, and the Navajo Nation conduct population-wide newborn screening for SCID. The incidence of SCID is estimated at 1 in 100 000 births. OBJECTIVES To present data from a spectrum of SCID newborn screening programs, establish population-based incidence for SCID and other conditions with T-cell lymphopenia, and document early institution of effective treatments. DESIGN Epidemiological and retrospective observational study. SETTING Representatives in states conducting SCID newborn screening were invited to submit their SCID screening algorithms, test performance data, and deidentified clinical and laboratory information regarding infants screened and cases with nonnormal results. Infants born from the start of each participating program from January 2008 through the most recent evaluable date prior to July 2013 were included. Representatives from 10 states plus the Navajo Area Indian Health Service contributed data from 3 030 083 newborns screened with a TREC test. MAIN OUTCOMES AND MEASURES Infants with SCID and other diagnoses of T-cell lymphopenia were classified. Incidence and, where possible, etiologies were determined. Interventions and survival were tracked. RESULTS Screening detected 52 cases of typical SCID, leaky SCID, and Omenn syndrome, affecting 1 in 58 000 infants (95% CI, 1/46 000-1/80 000). Survival of SCID-affected infants through their diagnosis and immune reconstitution was 87% (45/52), 92% (45/49) for infants who received transplantation, enzyme replacement, and/or gene therapy. Additional interventions for SCID and non-SCID T-cell lymphopenia included immunoglobulin infusions, preventive antibiotics, and avoidance of live vaccines. Variations in definitions and follow-up practices influenced the rates of detection of non-SCID T-cell lymphopenia. CONCLUSIONS AND RELEVANCE Newborn screening in 11 programs in the United States identified SCID in 1 in 58 000 infants, with high survival. The usefulness of detection of non-SCID T-cell lymphopenias by the same screening remains to be determined.	[Kwan, Antonia; Cowan, Morton J.; Puck, Jennifer M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Kwan, Antonia; Cowan, Morton J.; Puck, Jennifer M.] Univ Calif San Francisco, Benioff Childrens Hosp, San Francisco, CA USA; [Abraham, Roshini S.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Currier, Robert; Lorey, Fred] Calif Dept Publ Hlth, Genet Dis Screening Program, Richmond, CA USA; [Brower, Amy; Watson, Michael S.] Amer Coll Med Genet & Genom, Newborn Screening Translat Res Network, Bethesda, MD USA; [Andruszewski, Karen; Wood, Heather] Michigan Dept Community Hlth, Lansing, MI USA; [Abbott, Jordan K.; Gelfand, Erwin W.] Natl Jewish Hlth, Div Allergy & Immunol, Dept Pediat, Denver, CO USA; [Baker, Mei] Wisconsin State Lab Hyg, Newborn Screening Lab, Madison, WI USA; [Baker, Mei] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Ballow, Mark; Lehman, Heather] Women & Childrens Hosp Buffalo, Buffalo, NY USA; [Bartoshesky, Louis E.] Christiana Care Hlth Syst, Dept Pediat, Wilmington, DE USA; [Bonilla, Francisco A.; Notarangelo, Luigi D.; Pai, Sung-Yun] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Bonilla, Francisco A.; Notarangelo, Luigi D.; Pai, Sung-Yun] Harvard Univ, Sch Med, Boston, MA USA; [Brokopp, Charles] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Brooks, Edward; Infante, Anthony] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA; [Caggana, Michele; Kay, Denise M.; Saavedra-Matiz, Carlos A.; Vogel, Beth] New York State Dept Hlth, Newborn Screening Program, Wadsworth Ctr, Albany, NY 12237 USA; [Celestin, Jocelyn] Albany Med Coll, Div Allergy & Immunol, Albany, NY 12208 USA; [Church, Joseph A.; Kapoor, Neena] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Church, Joseph A.; Kapoor, Neena] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Comeau, Anne Marie; Hale, Jaime E.] Univ Massachusetts, Sch Med, New England Newborn Screening Program, Jamaica Plain, MA USA; [Connelly, James A.; Walkovich, Kelly] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA; [Cunningham-Rundles, Charlotte] Mt Sinai Med Ctr, New York, NY 10029 USA; [Dasu, Trivikram] Med Coll Wisconsin, Clin Immunodiagnost & Res Lab, Milwaukee, WI 53226 USA; [Dave, Nina; Rodriguez, Ray; Walker, Rosalyn; Yates, Anne B.] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS USA; [De La Morena, Maria T.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Duffner, Ulrich; Abdel-Mageed, Aly] Helen DeVos Childrens Hosp, Div Blood & Bone Marrow Transplantat, Grand Rapids, MI USA; [Fong, Chin-To; Weinberg, Geoffrey A.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Forbes, Lisa; Hanson, I. Celine; Orange, Jordan S.; Shearer, William T.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Forbes, Lisa; Hanson, I. Celine; Orange, Jordan S.; Shearer, William T.] Texas Childrens Hosp, Houston, TX 77030 USA; [Freedenberg, Debra; Johnson, Daisy; Scott, Ginger; Tanksley, Susan] Texas Dept State Hlth Serv, Austin, TX USA; [Comeau, Anne Marie; Hay, Beverly N.; Sullivan, John L.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Hu, Diana] Tuba City Reg Hlth Care, Tuba City, AZ USA; [Kohn, Donald B.; Moore, Theodore B.; Stiehm, E. Richard] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Lin, Zhili] PerkinElmer Genet, Bridgeville, PA USA; [Manning, Adrienne] Connecticut Dept Publ Hlth Lab, Rocky Hill, CT USA; [McGhee, Sean; Porteus, Matthew] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [McGhee, Sean; Porteus, Matthew] Lucille Packard Childrens Hosp, Palo Alto, CA USA; [Naides, Stanley J.] Quest Diagnost Nichols Inst, Dept Immunol, San Juan Capistrano, CA USA; [Romberg, Neil] Yale Univ, Sch Med, Dept Pediat, Div Allergy & Clin Immunol, New Haven, CT 06510 USA; [Routes, John; Verbsky, James] Med Coll Wisconsin, Dept Pediat, Childrens Res Inst, Milwaukee, WI 53226 USA; [Ruehle, Mary; Secord, Elizabeth; Tierce, Millard L.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Rubenstein, Arye] Montefiore Med Pk, Div Allergy & Immunol, Bronx, NY USA; [Scott, Patricia M.] Delaware Publ Hlth Lab, Newborn Screening Program, Smyrna, DE USA; [Seroogy, Christine] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA; [Siegel, Subhadra] New York Med Coll, Westchester Med Ctr, Valhalla, NY 10595 USA; [Silvers, Stacy K.; Sugerman, Robert W.; Wasserman, Richard L.] Med City Childrens Hosp, Dallas, TX USA; [Walter, Jolan E.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Walter, Jolan E.] Harvard Univ, Sch Med, Boston, MA USA; [Weiner, Leonard B.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic; California Department of Public Health; MDHHS - Michigan Department of Health & Human Services; National Jewish Health; University of Wisconsin System; University of Wisconsin Madison; Women & Children's Hospital of Buffalo; Christiana Care Health System; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health San Antonio; State University of New York (SUNY) System; Wadsworth Center; Albany Medical College; University of Southern California; Children's Hospital Los Angeles; University of Massachusetts System; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; Medical College of Wisconsin; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Rochester; Baylor College of Medicine; Baylor College of Medicine; Texas Department of State Health Services; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles; Stanford University; Lucile Packard Children's Hospital (LPCH); Nichols Institute; Yale University; Medical College of Wisconsin; Children's Hospital of Michigan; Montefiore Medical Center; University of Wisconsin System; University of Wisconsin Madison; New York Medical College; Westchester Medical Center; Medical City Dallas Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Puck, JM (corresponding author), Univ Calif San Francisco, Dept Pediat, HSE-301A,513 Parnassus Ave, San Francisco, CA 94143 USA.	puckj@peds.ucsf.edu	Weinberg, Geoffrey A./W-7510-2019; Lehman, Heather/AAZ-4560-2021; Routes, john/AAA-4833-2021; Notarangelo, Luigi D/F-9718-2016; Abbott, Jordan K/P-2509-2016; Pai, Sung-Yun/AAH-7762-2019	Weinberg, Geoffrey A./0000-0002-3900-379X; Routes, john/0000-0001-8378-3773; Notarangelo, Luigi D/0000-0002-8335-0262; Abbott, Jordan K/0000-0001-6334-5266; Pai, Sung-Yun/0000-0002-0158-8147; Bonagura, Vincent/0000-0002-0681-2099; Hanson, Imelda/0000-0001-9457-0757; Shearer, William/0000-0002-2483-2130; orange, jordan/0000-0001-7117-7725; Kay, Denise/0000-0002-9928-2698; Romberg, Neil/0000-0002-1881-5318; Currier, Robert/0000-0001-9168-5604	California: National Institutes of Health (NIH) [HHSN267200603430C]; National Institutes of Health (NIH) through New York [R01 FD003005-01, U01 AI1087628, RO1 AI078248, AI105776]; HCA International Foundation Travelling Scholarship; Jeffrey Modell Foundation; Perkin Elmer Genetics; Colorado: Colorado Department of Public Heath and Environment; Delaware: Centers for Disease Control and Prevention (CDC) [U01 EH000454]; Massachusetts: CDC [UO1 EH000362]; New England Newborn Screening Program funds; Michigan: CDC [U01 EH000936]; Mississippi: Mississippi State Department of Health; Navajo Nation: NIH [RO3HD060311]; New York: NIH [HHSN26720060343OC]; New York State Department of Health; Texas: CDC through New England Newborn Screening Program; Texas: Jeffery Modell Foundation; Children's Hospital of Wisconsin; Wisconsin State Laboratory of Hygiene; CDC [U01 EH000365]; Primary Immunodeficiency Treatment Consortium [U54 A1082973, R13-A1094943]; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH [HHSN27520080001C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD060311] Funding Source: NIH RePORTER; FOOD AND DRUG ADMINISTRATION [R01FD003005] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U24CA076518] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000362, U01EH000365, U01EH000454, U01EH000936] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R18AI048693, K08AI103035, U24AI086037, R13AI065141, U54AI082973, R13AI100548, R13AI088855, R13AI082823, R13AI094943, R13AI066891, R01AI105776, R01AI078248, R13AI069762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS064808] Funding Source: NIH RePORTER	California: National Institutes of Health (NIH); National Institutes of Health (NIH) through New York(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HCA International Foundation Travelling Scholarship; Jeffrey Modell Foundation; Perkin Elmer Genetics; Colorado: Colorado Department of Public Heath and Environment; Delaware: Centers for Disease Control and Prevention (CDC); Massachusetts: CDC; New England Newborn Screening Program funds; Michigan: CDC; Mississippi: Mississippi State Department of Health; Navajo Nation: NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York: NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health; Texas: CDC through New England Newborn Screening Program; Texas: Jeffery Modell Foundation; Children's Hospital of Wisconsin; Wisconsin State Laboratory of Hygiene; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Primary Immunodeficiency Treatment Consortium; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study received support from the following institutions: in California: National Institutes of Health (NIH) (HHSN267200603430C through New York, R01 FD003005-01, U01 AI1087628 [D. B. K.]; RO1 AI078248, AI105776 [J. M.P.]); HCA International Foundation Travelling Scholarship (A. K.); Jeffrey Modell Foundation; and Perkin Elmer Genetics. In Colorado: Colorado Department of Public Heath and Environment. In Connecticut: state appropriation, pursuant to Public Act 11-48, Sections 38 and 39, which mandated the inclusion of testing for severe combined immunodeficiency (SCID) in the Connecticut Newborn Screening Disorders Panel and provided increased agency funding to accomplish this mandate. In Delaware: Centers for Disease Control and Prevention (CDC) (U01 EH000454) and state funding. In Massachusetts: CDC (UO1 EH000362) and New England Newborn Screening Program funds. In Michigan: CDC (U01 EH000936). In Mississippi: Mississippi State Department of Health. In the Navajo Nation: NIH (RO3HD060311 [J. M. P.]) and a gift to Navajo-area delivering hospitals from PerlkinElmer Genetics, Bridgeville, Pennsylvania. In New York: NIH (HHSN26720060343OC), Jeffrey Modell Foundation, and New York State Department of Health. In Texas: CDC grant through New England Newborn Screening Program (pilot phase), Jeffrey Modell Foundation, and the Texas Department of State Health Services. In Wisconsin: Jeffery Modell Foundation, Children's Hospital of Wisconsin, Wisconsin State Laboratory of Hygiene, CDC (U01 EH000365), and Primary Immunodeficiency Treatment Consortium (U54 A1082973 [M. J. C.], R13-A1094943 [M. J. C., L.D.N.]). The Newborn Screening Translational Research Network (NBSTRN) is a contract to the American College of Medical Genetics and Genomics by Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH (HHSN27520080001C).	Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Andrews LB, 1994, ASSESSING GENETIC RI, P39; Bakare N, 2010, VACCINE, V28, P6609, DOI 10.1016/j.vaccine.2010.07.039; Borte S, 2012, BLOOD, V119, P2552, DOI 10.1182/blood-2011-08-371021; Brown L, 2011, BLOOD, V117, P3243, DOI 10.1182/blood-2010-08-300384; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Centers for Disease Control and Prevention [CDC], NEWB SCREEN QUAL ASS; Chan A, 2011, CLIN IMMUNOL, V138, P3, DOI 10.1016/j.clim.2010.09.010; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Chen R, 2013, J ALLERGY CLIN IMMUN, V132, P656, DOI 10.1016/j.jaci.2013.06.013; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dvorak CC, 2013, J CLIN IMMUNOL, V33, P1156, DOI 10.1007/s10875-013-9917-y; FASTH A, 1982, J CLIN IMMUNOL, V2, P86, DOI 10.1007/BF00916891; Fischer A, 2013, GENE, V525, P170, DOI 10.1016/j.gene.2013.03.092; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Gerstel-Thompson JL, 2010, CLIN CHEM, V56, P1466, DOI 10.1373/clinchem.2010.144915; Giampietro PF, 2013, AM J MED GENET A, V161A, P1432, DOI 10.1002/ajmg.a.35885; Haldane JBS, 2004, J GENET, V83, P235, DOI 10.1007/BF02717892; Hale JE, 2010, J ALLERGY CLIN IMMUN, V126, P1073, DOI 10.1016/j.jaci.2010.08.043; Hamilton Brady E., 2014, NATL VITAL STAT REP, V64, P1; Hannon WH, 2014, NBS06A CLSI; Howell RR, 2011, REPORT NEWBORN SCREE; JONES JF, 1991, HUM BIOL, V63, P669; Kuo CY, 2013, J ALLERGY CLIN IMMUN, V131, P1693, DOI 10.1016/j.jaci.2013.01.019; Kwan A, 2013, J ALLERGY CLIN IMMUN, V132, P140, DOI 10.1016/j.jaci.2013.04.024; la Marca G, 2013, J ALLERGY CLIN IMMUN, V131, P1604, DOI 10.1016/j.jaci.2012.08.054; Li LY, 2002, J IMMUNOL, V168, P6323, DOI 10.4049/jimmunol.168.12.6323; Mallott J, 2013, J CLIN IMMUNOL, V33, P540, DOI 10.1007/s10875-012-9846-1; Marquardt G, 2012, GENET MED, V14, P648, DOI 10.1038/gim.2012.2; McHugh DMS, 2011, GENET MED, V13, P230, DOI 10.1097/GIM.0b013e31820d5e67; Morinishi Y, 2009, J PEDIATR-US, V155, P829, DOI 10.1016/j.jpeds.2009.05.026; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; REESER SLT, 1992, AM J MED GENET, V42, P815, DOI 10.1002/ajmg.1320420614; Routes JM, 2009, JAMA-J AM MED ASSOC, V302, P2465, DOI 10.1001/jama.2009.1806; RYSER O, 1988, J CLIN IMMUNOL, V8, P479, DOI 10.1007/BF00916954; Samuels ME, 2013, J MED GENET, V50, P324, DOI 10.1136/jmedgenet-2012-101483; SANTISTEBAN I, 1995, HUM MOL GENET, V4, P2081, DOI 10.1093/hmg/4.11.2081; Savic RM, 2013, BIOL BLOOD MARROW TR, V19, P1608, DOI 10.1016/j.bbmt.2013.08.014; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P961, DOI 10.1016/j.jaci.2013.11.043; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P1092, DOI 10.1016/j.jaci.2013.09.044; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; STEPHAN JL, 1993, J PEDIATR-US, V123, P564, DOI 10.1016/S0022-3476(05)80951-5; Strauss KA, 2008, CLIN IMMUNOL, V128, P31, DOI 10.1016/j.clim.2008.02.016; Verbsky JW, 2012, J CLIN IMMUNOL, V32, P82, DOI 10.1007/s10875-011-9609-4; Villa A, 2008, J ALLERGY CLIN IMMUN, V122, P1082, DOI 10.1016/j.jaci.2008.09.037; Vogel BH, 2014, J CLIN IMMUNOL, V34, P289, DOI 10.1007/s10875-014-0006-7	47	406	418	2	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					729	738		10.1001/jama.2014.9132	http://dx.doi.org/10.1001/jama.2014.9132			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25138334	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000340438700021
J	Kim, G; LeBlanc, ML; Wafula, EK; Depamphilis, CW; Westwood, JH				Kim, Gunjune; LeBlanc, Megan L.; Wafula, Eric K.; dePamphilis, Claude W.; Westwood, James H.			Genomic-scale exchange of mRNA between a parasitic plant and its hosts	SCIENCE			English	Article							LONG-DISTANCE TRANSPORT; GENE-TRANSFER; PHLOEM; MOBILE; TRAFFICKING; TRANSCRIPTS; DODDER; QUANTIFICATION; TRANSLOCATION; TRANSMISSION	Movement of RNAs between cells of a single plant is well documented, but cross-species RNA transfer is largely unexplored. Cuscuta pentagona (dodder) is a parasitic plant that forms symplastic connections with its hosts and takes up host messenger RNAs (mRNAs). We sequenced transcriptomes of Cuscuta growing on Arabidopsis and tomato hosts to characterize mRNA transfer between species and found that mRNAs move in high numbers and in a bidirectional manner. The mobile transcripts represented thousands of different genes, and nearly half the expressed transcriptome of Arabidopsis was identified in Cuscuta. These findings demonstrate that parasitic plants can exchange large proportions of their transcriptomes with hosts, providing potential mechanisms for RNA-based interactions between species and horizontal gene transfer.	[Kim, Gunjune; LeBlanc, Megan L.; Westwood, James H.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Wafula, Eric K.; dePamphilis, Claude W.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Wafula, Eric K.; dePamphilis, Claude W.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Virginia Polytechnic Institute & State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Westwood, JH (corresponding author), Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	westwood@vt.edu	dePamphilis, Claude W/P-6652-2016	Westwood, James/0000-0001-5127-7294	National Center for Biotechnology Information BioProject [PRJNA257158]; NSF [IOS-0843372]; NSF Plant Genome Research Program [DBI-0701748, IOS-1238057]; U.S. Department of Agriculture Hatch Project [135997]; Direct For Biological Sciences [0843372] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1238057] Funding Source: National Science Foundation	National Center for Biotechnology Information BioProject; NSF(National Science Foundation (NSF)); NSF Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); U.S. Department of Agriculture Hatch Project; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Data are archived at National Center for Biotechnology Information BioProject ID PRJNA257158. This research was supported by NSF award IOS-0843372 to J.H.W. and NSF Plant Genome Research Program awards DBI-0701748 and IOS-1238057 to J.H.W. and C. W. D., with additional support to J.H.W. from the U.S. Department of Agriculture Hatch Project no. 135997. This work was facilitated by resources provided by the iPlant Collaborative. We are grateful to T. Lanini for supplying C. pentagona seeds. Additional data are in supplementary materials.	Alakonya A, 2012, PLANT CELL, V24, P3153, DOI 10.1105/tpc.112.099994; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Banerjee AK, 2009, PLANT PHYSIOL, V151, P1831, DOI 10.1104/pp.109.144428; Birschwilks M, 2006, J EXP BOT, V57, P911, DOI 10.1093/jxb/erj076; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; David-Schwartz R, 2008, NEW PHYTOL, V179, P1133, DOI 10.1111/j.1469-8137.2008.02540.x; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; Deeken R, 2008, PLANT J, V55, P746, DOI 10.1111/j.1365-313X.2008.03555.x; Doering-Saad C, 2006, J EXP BOT, V57, P3183, DOI 10.1093/jxb/erl082; Dorst H. J. M. van, 1974, Netherlands Journal of Plant Pathology, V80, P85, DOI 10.1007/BF01980613; Goldwasser Y, 2001, WEED SCI, V49, P520, DOI 10.1614/0043-1745(2001)049[0520:TOTVTL]2.0.CO;2; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Hannapel DJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00257; Hannapel DJ, 2010, J INTEGR PLANT BIOL, V52, P40, DOI 10.1111/j.1744-7909.2010.00911.x; Haupt S, 2001, J EXP BOT, V52, P173, DOI 10.1093/jexbot/52.354.173; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; HOSFORD RM, 1967, BOT REV, V33, P387, DOI 10.1007/BF02858742; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jiang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081389; Kaminska M, 1999, ACTA PHYSIOL PLANT, V21, P21, DOI 10.1007/s11738-999-0023-y; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; LeBlanc M, 2013, NEW PHYTOL, V200, P1225, DOI 10.1111/nph.12439; Li CY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00073; Lucas WJ, 2013, J INTEGR PLANT BIOL, V55, P294, DOI 10.1111/jipb.12041; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Mower JP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-150; Mower JP, 2004, NATURE, V432, P165, DOI 10.1038/432165b; Notaguchi M, 2012, J INTEGR PLANT BIOL, V54, P760, DOI 10.1111/j.1744-7909.2012.01155.x; Roney JK, 2007, PLANT PHYSIOL, V143, P1037, DOI 10.1104/pp.106.088369; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; Sarkies P, 2013, SCIENCE, V341, P467, DOI 10.1126/science.1243175; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turnbull CGN, 2013, NEW PHYTOL, V198, P33, DOI 10.1111/nph.12167; Vaughn KC, 2003, PROTOPLASMA, V220, P189, DOI 10.1007/s00709-002-0038-3; Vaughn KC, 2006, INT J PLANT SCI, V167, P1099, DOI 10.1086/507872; Westwood JH, 2009, PEST MANAG SCI, V65, P533, DOI 10.1002/ps.1727; Yoshida S, 2010, SCIENCE, V328, P1128, DOI 10.1126/science.1187145; Zhang DL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-19; Zhang YT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-48	39	172	185	12	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					808	811		10.1126/science.1253122	http://dx.doi.org/10.1126/science.1253122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124438				2022-12-24	WOS:000340593100043
J	Deng, WL; Rupon, JW; Krivega, I; Breda, L; Motta, I; Jahn, KS; Reik, A; Gregory, PD; Rivella, S; Dean, A; Blobel, GA				Deng, Wulan; Rupon, Jeremy W.; Krivega, Ivan; Breda, Laura; Motta, Irene; Jahn, Kristen S.; Reik, Andreas; Gregory, Philip D.; Rivella, Stefano; Dean, Ann; Blobel, Gerd A.			Reactivation of Developmentally Silenced Globin Genes by Forced Chromatin Looping	CELL			English	Article							FETAL-HEMOGLOBIN EXPRESSION; LOCUS-CONTROL REGION; SICKLE-CELL-DISEASE; GAMMA-GLOBIN; ORDER; ORGANIZATION; HYDROXYUREA; PROTEINS; REQUIRES; GATA-1	Distal enhancers commonly contact target promoters via chromatin looping. In erythroid cells, the locus control region (LCR) contacts beta-type globin genes in a developmental stage-specific manner to stimulate transcription. Previously, we induced LCR-promoter looping by tethering the self-association domain (SA) of Ldb1 to the beta-globin promoter via artificial zinc fingers. Here, we show that targeting the SA to a developmentally silenced embryonic globin gene in adult murine erythroblasts triggers its transcriptional reactivation. This activity depends on the LCR, consistent with an LCR-promoter looping mechanism. Strikingly, targeting the SA to the fetal gamma-globin promoter in primary adult human erythroblasts increases gamma-globin promoter-LCR contacts, stimulating transcription to approximately 85% of total beta-globin synthesis, with a reciprocal reduction in adult beta-globin expression. Our findings demonstrate that forced chromatin looping can override a stringent developmental gene expression program and suggest a novel approach to control the balance of globin gene transcription for therapeutic applications.	[Deng, Wulan; Rupon, Jeremy W.; Jahn, Kristen S.; Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Deng, Wulan] Howard Hughes Med Inst, Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Krivega, Ivan; Dean, Ann] NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Breda, Laura; Motta, Irene; Rivella, Stefano] Weill Cornell Med Coll, Dept Pediat, Div Hematol Oncol, New York, NY 10021 USA; [Reik, Andreas; Gregory, Philip D.] Sangamo BioSci, Richmond, CA 94804 USA; [Rivella, Stefano] Weill Cornell Med Coll, Dept Cell & Biol Dev, Div Hematol Oncol, New York, NY 10021 USA; [Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cornell University; Sangamo Therapeutics, Inc.; Cornell University; University of Pennsylvania; Pennsylvania Medicine	Blobel, GA (corresponding author), Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA.	blobel@email.chop.edu	Krivega, Ivan/G-9247-2015; Motta, Irene/AAC-3087-2019; Deng, Wulan/ABX-6870-2022; Breda, Laura/T-3997-2017	Krivega, Ivan/0000-0002-3473-4198; Rivella, Stefano/0000-0002-0938-6558; Motta, Irene/0000-0001-5701-599X; Gregory, Philip/0000-0001-9249-2468; Breda, Laura/0000-0003-2133-4432	NIH [5R37DK058044, 1RO1HL119479, NHLBI-5R01HL102449, DK015508]; American Heart Association postdoctoral fellowship [13POST16950014]; NIDDK; Associazione Veneta per la Lotta alla Talassemia (AVLT, IT); European Community [FP7-HEALTH-2012-INNOVATION]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119479, R01HL102449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015508, R01DK058044, R37DK058044, ZIADK075033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Associazione Veneta per la Lotta alla Talassemia (AVLT, IT); European Community(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Andrew Wilber for the GG1 constructs. We are grateful to Hongxin Wang for technical assistance, Jongjoo Lee for help with mouse experiments, and members of the laboratory for valuable discussions. This work was supported by NIH grants (5R37DK058044 and 1RO1HL119479) (to G.A.B.). J.W.R. was supported by an American Heart Association postdoctoral fellowship (13POST16950014). A.D. and I.K. were supported by the intramural program of the NIDDK, NIH (DK015508). Additional support was provided by the Associazione Veneta per la Lotta alla Talassemia (AVLT, IT) (to L.B.), by an NIH grant (NHLBI-5R01HL102449) (to S.R.), and by a European Community grant (FP7-HEALTH-2012-INNOVATION) (to L.B. and S.R.). A.R. and P.D.G. are employees of Sangamo Biosciences Inc.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Atweh G, 2010, HEMATOL ONCOL CLIN N, V24, P1131, DOI 10.1016/j.hoc.2010.08.001; Bartsevich VV, 2003, STEM CELLS, V21, P632, DOI 10.1634/stemcells.21-6-632; Bauchwitz R, 2000, HUM MOL GENET, V9, P561, DOI 10.1093/hmg/9.4.561; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; FIBACH E, 1993, BLOOD, V81, P1630; Graslund T, 2005, J BIOL CHEM, V280, P3707, DOI 10.1074/jbc.M406809200; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Hardison RC, 2013, SCIENCE, V342, P206, DOI 10.1126/science.1245813; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Kiefer CM, 2011, BLOOD, V118, P6200, DOI 10.1182/blood-2011-06-363101; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; OU CN, 1993, CLIN CHEM, V39, P820; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Palstra RJ, 2008, ADV GENET, V61, P107, DOI 10.1016/S0065-2660(07)00004-1; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; PETERSON KR, 1993, MOL CELL BIOL, V13, P4836, DOI 10.1128/MCB.13.8.4836; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Pope SH, 2000, EUR J HAEMATOL, V64, P292, DOI 10.1034/j.1600-0609.2000.90032.x; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Smith RD, 2000, BLOOD, V95, P863, DOI 10.1182/blood.V95.3.863.003k12_863_869; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Wilber A, 2010, BLOOD, V115, P3033, DOI 10.1182/blood-2009-08-240556; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310	47	273	286	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					849	860		10.1016/j.cell.2014.05.050	http://dx.doi.org/10.1016/j.cell.2014.05.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126789	Green Accepted, Bronze			2022-12-24	WOS:000340944700015
J	Feng, YQ; Arvey, A; Chinen, T; Van der Veeken, JD; Gasteiger, G; Rudensky, AY				Feng, Yongqiang; Arvey, Aaron; Chinen, Takatoshi; van der Veeken, Joris; Gasteiger, Georg; Rudensky, Alexander Y.			Control of the Inheritance of Regulatory T Cell Identity by a cis Element in the Foxp3 Locus	CELL			English	Article							IN-VIVO; EXPRESSION; INDUCTION; GENE; DIFFERENTIATION; PLASTICITY; LINEAGE; DEMETHYLATION; STIMULATION; ACTIVATION	In multicellular organisms, specialized functions are delegated to distinct cell types whose identity and functional integrity are maintained upon challenge. However, little is known about the mechanisms enabling lineage inheritance and their biological implications. Regulatory T (Treg) cells, which express the transcription factor Foxp3, suppress fatal auto-immunity throughout the lifespan of animals. Here, we show that a dedicated Foxp3 intronic element CNS2 maintains Treg cell lineage identity by acting as a sensor of the essential Treg cell growth factor IL-2 and its downstream target STAT5. CNS2 sustains Foxp3 expression during division of mature Treg cells when IL-2 is limiting and counteracts proinflammatory cytokine signaling that leads to the loss of Foxp3. CNS2-mediated stable inheritance of Foxp3 expression is critical for adequate suppression of diverse types of chronic inflammation by Treg cells and prevents their differentiation into inflammatory effector cells. The described mechanism may represent a general principle of the inheritance of differentiated cell states.	[Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Program Immunol, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Feng, Yongqiang/N-2731-2018; Feng, Yongqiang/AAR-7719-2021	Feng, Yongqiang/0000-0002-2320-5063; Feng, Yongqiang/0000-0002-2320-5063; Arvey, Aaron/0000-0002-8789-0290; Gasteiger, Georg/0000-0001-6986-127X	Cancer Center Support Grant [CCSG P30 CA008748]; Postdoctoral Fellowship of the Cancer Research Institute; NIH [AI034206]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034206, R37AI034206, R29AI034206] Funding Source: NIH RePORTER	Cancer Center Support Grant; Postdoctoral Fellowship of the Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank MSKCC Genomics and Bioinformatics Core facilities for RNA sequencing and Flow Cytometry Core facility for assistance with cell sorting. We thank W. Hu for assistance with the analysis of bisulfite sequencing data and P. DeRoos, S. Hemmers, Q. Li, G. Loeb, and S. Dikiy for technical assistance. MSKCC core facilities are supported by Cancer Center Support Grant CCSG P30 CA008748. Y.F. was supported by a Postdoctoral Fellowship of the Cancer Research Institute. This study was supported by NIH grant AI034206 and the Howard Hughes Medical Institute (A.Y.R.).	Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Pachner AR, 2011, CURR OPIN NEUROL, V24, P291, DOI 10.1097/WCO.0b013e328346c226; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zhang Q, 2005, P NATL ACAD SCI USA, V102, P6948, DOI 10.1073/pnas.0501959102; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	39	258	270	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					749	763		10.1016/j.cell.2014.07.031	http://dx.doi.org/10.1016/j.cell.2014.07.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126783	Green Accepted, Bronze			2022-12-24	WOS:000340944700008
J	Ghavi-Helm, Y; Klein, FA; Pakozdi, T; Ciglar, L; Noordermeer, D; Huber, W; Furlong, EEM				Ghavi-Helm, Yad; Klein, Felix A.; Pakozdi, Tibor; Ciglar, Lucia; Noordermeer, Daan; Huber, Wolfgang; Furlong, Eileen E. M.			Enhancer loops appear stable during development and are associated with paused polymerase	NATURE			English	Article							GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; ABDOMINAL-B; TRANSCRIPTION; ORGANIZATION; BINDING; RANGE; TRANSFORMATION; CONSERVATION; ELEMENTS	Developmental enhancers initiate transcription and are fundamental to our understanding of developmental networks, evolution and disease. Despite their importance, the properties governing enhancer-promoter interactions and their dynamics during embryogenesis remain unclear. At the beta-globin locus, enhancer-promoter interactions appear dynamic and cell-type specific(1,2), whereas at the HoxD locus they are stable and ubiquitous, being present in tissues where the target genes are not expressed(3,4). The extent to which preformed enhancer-promoter conformations exist at other, more typical, loci and how transcription is eventually triggered is unclear. Here we generated a high-resolution map of enhancer three-dimensional contacts during Drosophila embryogenesis, covering two developmental stages and tissue contexts, at unprecedented resolution. Although local regulatory interactions are common, long-range interactions are highly prevalent within the compact Drosophila genome. Each enhancer contacts multiple enhancers, and promoters with similar expression, suggesting a role in their co-regulation. Notably, most interactions appear unchanged between tissue context and across development, arising before gene activation, and are frequently associated with paused RNA polymerase. Our results indicate that the general topology governing enhancer contacts is conserved from flies to humans and suggest that transcription initiates from preformed enhancer-promoter loops through release of paused polymerase.	[Ghavi-Helm, Yad; Klein, Felix A.; Pakozdi, Tibor; Ciglar, Lucia; Huber, Wolfgang; Furlong, Eileen E. M.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Noordermeer, Daan] Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland	European Molecular Biology Laboratory (EMBL); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Furlong, EEM (corresponding author), European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany.	furlong@embl.de	Noordermeer, Daan/F-3306-2011	Noordermeer, Daan/0000-0002-9296-7002; Huber, Wolfgang/0000-0002-0474-2218; Pakozdi, Tibor/0000-0002-7633-7529; Ghavi-Helm, Yad/0000-0003-2397-9576; Furlong, Eileen/0000-0002-9544-8339	DFG [FU 750]; EMBO; EC	DFG(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); EC(European CommissionEuropean Commission Joint Research Centre)	This work was technically supported by the EMBL Genomics Core and FACS core facilities. We thank all members of the Furlong laboratory for discussions and comments, in particular D. Garfield, J. Reddington and I. Schor for important suggestions. Embryo images in Fig. 3c were used with permission from Development<SUP>27</SUP> and Nature Publishing Group<SUP>26</SUP> as these fly strains no longer exist. This work was supported by a DFG (FU 750) grant to E.E.M.F., an EMBO post-doctoral fellowship to Y.G.-H., and the EC FP7 project 'Radiant' grant to F.A.K. and W.H.	Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Bonn S, 2012, NAT PROTOC, V7, P978, DOI 10.1038/nprot.2012.049; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; BUSTURIA A, 1993, EMBO J, V12, P1415, DOI 10.1002/j.1460-2075.1993.tb05785.x; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Capovilla M, 2001, DEVELOPMENT, V128, P1221; Chen K, 2013, ELIFE, V2, DOI 10.7554/eLife.00861; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Fanucchi S, 2013, CELL, V155, P606, DOI 10.1016/j.cell.2013.09.051; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gaertner B, 2012, CELL REP, V2, P1670, DOI 10.1016/j.celrep.2012.11.024; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Lai WKM, 2012, BIOINFORMATICS, V28, P1021, DOI 10.1093/bioinformatics/bts063; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Saunders A, 2013, GENE DEV, V27, P1146, DOI 10.1101/gad.215459.113; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Scuderi A, 2006, DEV BIOL, V291, P110, DOI 10.1016/j.ydbio.2005.12.014; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tolhuis B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001343; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wilczynski B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002798; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhou JM, 1999, DEVELOPMENT, V126, P3057; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	55	323	324	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					96	+		10.1038/nature13417	http://dx.doi.org/10.1038/nature13417			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043061				2022-12-24	WOS:000339908000039
J	Tseng, YY; Moriarity, BS; Gong, WM; Akiyama, R; Tiwari, A; Kawakami, H; Ronning, P; Reuland, B; Guenther, K; Beadnell, TC; Essig, J; Otto, GM; O'Sullivan, MG; Largaespada, DA; Schwertfeger, KL; Marahrens, Y; Kawakami, Y; Bagchi, A				Tseng, Yuen-Yi; Moriarity, Branden S.; Gong, Wuming; Akiyama, Ryutaro; Tiwari, Ashutosh; Kawakami, Hiroko; Ronning, Peter; Reuland, Brian; Guenther, Kacey; Beadnell, Thomas C.; Essig, Jaclyn; Otto, George M.; O'Sullivan, M. Gerard; Largaespada, David A.; Schwertfeger, Kathryn L.; Marahrens, York; Kawakami, Yasuhiko; Bagchi, Anindya			PVT1 dependence in cancer with MYC copy-number increase	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER; C-MYC; TRANSCRIPTION FACTORS; MAMMARY-GLAND; CHROMOSOME 8Q; CELL-LINES; EXPRESSION; AMPLIFICATION; MICE	'Gain' of supernumerary copies of the 8q24.21 chromosomal region has been shown to be common in many human cancers(1-13) and is associated with poor prognosis(7,10,14). The well-characterized myelocytomatosis (MYC) oncogene resides in the 8q24.21 region and is consistently co-gained with an adjacent 'gene desert' of approximately 2 megabases that contains the long non-coding RNA gene PVT1, the CCDC26 gene candidate and the GSDMC gene. Whether low copy-number gain of one or more of these genes drives neoplasia is not known. Here we use chromosome engineering in mice to show that a single extra copy of either the Myc gene or the region encompassing Pvt1, Ccdc26 and Gsdmc fails to advance cancer measurably, whereas a single supernumerary segment encompassing all four genes successfully promotes cancer. Gain of PVT1 long non-coding RNA expression was required for high MYC protein levels in 8q24-amplified human cancer cells. PVT1 RNA and MYC protein expression correlated in primary human tumours, and copy number of PVT1 was co-increased in more than 98% of MYC-copy-increase cancers. Ablation of PVT1 from MYC-driven colon cancer line HCT116 diminished its tumorigenic potency. As MYC protein has been refractory to small-molecule inhibition, the dependence of high MYC protein levels on PVT1 long non-coding RNA provides a much needed therapeutic target.	[Tseng, Yuen-Yi; Gong, Wuming; Akiyama, Ryutaro; Kawakami, Hiroko; Ronning, Peter; Reuland, Brian; Guenther, Kacey; Essig, Jaclyn; Largaespada, David A.; Marahrens, York; Kawakami, Yasuhiko; Bagchi, Anindya] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Moriarity, Branden S.; Gong, Wuming; Tiwari, Ashutosh; Otto, George M.; O'Sullivan, M. Gerard; Largaespada, David A.; Schwertfeger, Kathryn L.; Bagchi, Anindya] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Akiyama, Ryutaro; Kawakami, Hiroko; Kawakami, Yasuhiko] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Beadnell, Thomas C.; Schwertfeger, Kathryn L.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bagchi, A (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	bagch005@umn.edu	Tseng, Yuen-Yi/C-2148-2015; Tiwari, Ashutosh/ABG-9394-2020; Gong, Wuming/GQH-9157-2022; Gong, Wuming/GQH-1435-2022	Tseng, Yuen-Yi/0000-0002-8757-4087; Gong, Wuming/0000-0002-3147-4028; Kawakami, Yasuhiko/0000-0002-0043-9705; Tiwari, Ashutosh/0000-0003-3404-8881	Masonic Cancer Center Laboratory; Institute of Prostate and Urologic Cancer, University of Minnesota; American Cancer Society [118198-IRG-58-001-52-IRG92]; Indo-US fellowship from the Indo-US Science and Technology Forum; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064195] Funding Source: NIH RePORTER	Masonic Cancer Center Laboratory; Institute of Prostate and Urologic Cancer, University of Minnesota; American Cancer Society(American Cancer Society); Indo-US fellowship from the Indo-US Science and Technology Forum; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. T. Vogel for writing statistical analysis scripts; Research Animal Resources, University of Minnesota, for maintaining the mouse colony; S. Horn and L. Oseth for embryonic stem cell blastocyst injection and FISH analysis respectively. This work was supported by Masonic Cancer Center Laboratory start-up funds (to A.B.), and by grants from the Masonic Scholar Award (to A.B.), the Karen Wyckoff Rein in Sarcoma Fund (to A.B.), Translational Workgroup Pilot Project Awards by the Institute of Prostate and Urologic Cancer, University of Minnesota (to A.B.) and an American Cancer Society Institutional Research Grant (award 118198-IRG-58-001-52-IRG92, to A.B.). A.T. was supported by an Indo-US fellowship from the Indo-US Science and Technology Forum.	Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; BORG A, 1992, INT J CANCER, V51, P687, DOI 10.1002/ijc.2910510504; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Itou J, 2012, DEVELOPMENT, V139, P4133, DOI 10.1242/dev.079756; Jain AN, 2001, P NATL ACAD SCI USA, V98, P7952, DOI 10.1073/pnas.151241198; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Le Beau MM, 2002, BLOOD, V99, P2985, DOI 10.1182/blood.V99.8.2985; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Moriarity BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096114; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Park K, 2005, HUM PATHOL, V36, P634, DOI 10.1016/j.humpath.2005.04.016; Rahrmann EP, 2013, NAT GENET, V45, P756, DOI 10.1038/ng.2641; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reed JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045877; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Schwertfeger KL, 2006, CANCER RES, V66, P5676, DOI 10.1158/0008-5472.CAN-05-3781; van Duin M, 2007, CYTOGENET GENOME RES, V118, P130, DOI 10.1159/000108293; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Yamada T, 2000, CANCER GENET CYTOGEN, V120, P11, DOI 10.1016/S0165-4608(99)00240-X; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P2790, DOI 10.1073/pnas.1100764108; Zitterbart K, 2011, J NEURO-ONCOL, V102, P25, DOI 10.1007/s11060-010-0289-3	37	519	543	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					82	+		10.1038/nature13311	http://dx.doi.org/10.1038/nature13311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043044	Green Accepted			2022-12-24	WOS:000339908000036
J	Goodrich, JK; Di Rienzi, SC; Poole, AC; Koren, O; Walters, WA; Caporaso, JG; Knight, R; Ley, RE				Goodrich, Julia K.; Di Rienzi, Sara C.; Poole, Angela C.; Koren, Omry; Walters, William A.; Caporaso, J. Gregory; Knight, Rob; Ley, Ruth E.			Conducting a Microbiome Study	CELL			English	Article							HUMAN GUT MICROBIOTA; INTESTINAL MICROBIOTA; BACTERIAL; HOST; CLASSIFICATION; IMPACT; MICE; IDENTIFICATION; AMPLIFICATION; DIVERSITY	Human microbiome research is an actively developing area of inquiry, with ramifications for our lifestyles, our interactions with microbes, and how we treat disease. Advances depend on carefully executed, controlled, and reproducible studies. Here, we provide a Primer for researchers from diverse disciplines interested in conducting microbiome research. We discuss factors to be considered in the design, execution, and data analysis of microbiome studies. These recommendations should help researchers to enter and contribute to this rapidly developing field.	[Goodrich, Julia K.; Di Rienzi, Sara C.; Poole, Angela C.; Koren, Omry; Ley, Ruth E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Goodrich, Julia K.; Di Rienzi, Sara C.; Poole, Angela C.; Koren, Omry; Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Walters, William A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Walters, William A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Caporaso, J. Gregory] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Cornell University; Cornell University; University of Colorado System; University of Colorado Boulder; Northern Arizona University; United States Department of Energy (DOE); Argonne National Laboratory; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Ley, RE (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	rel222@cornell.edu	Ley, Ruth E/M-8542-2014; Di Rienzi, Sara C./U-1035-2019; Knight, Rob/D-1299-2010; Koren, Omry/A-5222-2016; Goodrich, Julia/ABD-8368-2021	Ley, Ruth E/0000-0002-9087-1672; Di Rienzi, Sara C./0000-0002-6188-663X; Koren, Omry/0000-0002-7738-1337; Caporaso, Greg/0000-0002-8865-1670; Poole, Angela/0000-0003-0278-7655; Knight, Rob/0000-0002-0975-9019	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD011389] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG004872] Funding Source: Medline; NIDDK NIH HHS [P01 DK078669] Funding Source: Medline; NIGMS NIH HHS [T32 GM008759, T32 GM142607] Funding Source: Medline; NIMHD NIH HHS [R01 MD011389] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bai GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036934; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016900; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Chassaing B, 2012, ADV IMMUNOL, V116, P93, DOI 10.1016/B978-0-12-394300-2.00003-X; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jack PJM, 2009, VET MICROBIOL, V133, P145, DOI 10.1016/j.vetmic.2008.05.030; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sergeant MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038094; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Smith Birgitte, 2011, Open Microbiol J, V5, P14, DOI 10.2174/1874285801105010014; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Tanner MA, 1998, APPL ENVIRON MICROB, V64, P3110; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	98	425	435	2	179	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					250	262		10.1016/j.cell.2014.06.037	http://dx.doi.org/10.1016/j.cell.2014.06.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036628	Green Accepted, Bronze			2022-12-24	WOS:000340943600007
J	Hallmann, CA; Foppen, RPB; van Turnhout, CAM; de Kroon, H; Jongejans, E				Hallmann, Caspar A.; Foppen, Ruud P. B.; van Turnhout, Chris A. M.; de Kroon, Hans; Jongejans, Eelke			Declines in insectivorous birds are associated with high neonicotinoid concentrations	NATURE			English	Article							FARMLAND BIRDS; INSECTICIDES; PESTICIDES; SCALE; BEES	Recent studies have shown that neonicotinoid insecticides have adverse effects on non-target invertebrate species(1-6). Invertebrates constitute a substantial part of the diet of many bird species during the breeding season and are indispensable for raising offspring(7). We investigated the hypothesis that the most widely used neonicotinoid insecticide, imidacloprid, has a negative impact on insectivorous bird populations. Here we show that, in the Netherlands, local population trends were significantly more negative in areas with higher surface-water concentrations of imidacloprid. At imidacloprid concentrations of more than 20 nanograms per litre, bird populations tended to decline by 3.5 per cent on average annually. Additional analyses revealed that this spatial pattern of decline appeared only after the introduction of imidacloprid to the Netherlands, in the mid-1990s. We further show that the recent negative relationship remains after correcting for spatial differences in land-use changes that are known to affect bird populations in farmland. Our results suggest that the impact of neonicotinoids on the natural environment is even more substantial than has recently been reported and is reminiscent of the effects of persistent insecticides in the past. Future legislation should take into account the potential cascading effects of neonicotinoidson ecosystems.	[Hallmann, Caspar A.; de Kroon, Hans; Jongejans, Eelke] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, NL-6500 GL Nijmegen, Netherlands; [Hallmann, Caspar A.; de Kroon, Hans; Jongejans, Eelke] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6500 GL Nijmegen, Netherlands; [Hallmann, Caspar A.; Foppen, Ruud P. B.; van Turnhout, Chris A. M.] Dutch Ctr Field Ornithol, Sovon, NL-6503 GA Nijmegen, Netherlands; [Foppen, Ruud P. B.] Birdlife Netherlands, NL-3700 AX Zeist, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Hallmann, CA (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, POB 9100 Mail Box 31, NL-6500 GL Nijmegen, Netherlands.	c.hallmann@science.ru.nl	de Kroon, Hans/B-3359-2009; Serrano, Jose/A-2854-2009; Jongejans, Eelke/B-4832-2008	de Kroon, Hans/0000-0001-6151-3561; Serrano, Jose/0000-0002-1565-5216; Jongejans, Eelke/0000-0003-1148-7419	Dutch Ministry of EZ; NWO [840.11.001, 841.11.007]	Dutch Ministry of EZ; NWO(Netherlands Organization for Scientific Research (NWO))	We thank A. J. van Dijk, H. Sierdsema and D. Zoetebier for processing the bird data sets and J. P. van der Sluijs for sharing the database with imidacloprid concentration measurements. The Breeding Bird Monitoring Program is organised in close collaboration with Statistics Netherlands and provinces and is funded by the Dutch Ministry of EZ. We thank Sovon volunteers for their efforts in the field. The study was supported by NWO grants 840.11.001 and 841.11.007 and was the result of a collaboration within the Center for Avian Population Studies.	[Anonymous], 2011, FINE CHEM IND BUSINE, DOI DOI 10.1002/9780470946404; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Chamberlain DE, 2000, AGR ECOSYST ENVIRON, V78, P1, DOI 10.1016/S0167-8809(99)00105-X; Cramp S., 1994, BIRDS W PALEARCTIC; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Easton AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054819; Fuller RJ, 2000, ECOLOGY AND CONSERVATION OF LOWLAND FARMLAND BIRDS, P5; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Institute of Environmental Sciences Leiden University and Rijkswaterstaat-Water Services, 2009, DUTCH PEST ATL; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Newton I., 1998, POPULATION LIMITATIO; Poulin B, 2010, J APPL ECOL, V47, P884, DOI 10.1111/j.1365-2664.2010.01821.x; Roessink I, 2013, ENVIRON TOXICOL CHEM, V32, P1096, DOI 10.1002/etc.2201; Statistics Netherlands, 2013, STATLINE DAT; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Van Turnhout CAM, 2007, BIOL CONSERV, V134, P505, DOI 10.1016/j.biocon.2006.09.011; Van Turnhout CAM, 2010, BIOL CONSERV, V143, P173, DOI 10.1016/j.biocon.2009.09.023; VANDIJK AJ, 2004, HANDLEIDING BROEDVOG; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	28	547	590	35	772	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					341	+		10.1038/nature13531	http://dx.doi.org/10.1038/nature13531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030173				2022-12-24	WOS:000338992200034
J	Carlson, JM; Schaefer, M; Monaco, DC; Batorsky, R; Claiborne, DT; Prince, J; Deymier, MJ; Ende, ZS; Klatt, NR; DeZiel, CE; Lin, TH; Peng, J; Seese, AM; Shapiro, R; Frater, J; Ndung'u, T; Tang, JM; Goepfert, P; Gilmour, J; Price, MA; Kilembe, W; Heckerman, D; Goulder, PJR; Allen, TM; Allen, S; Hunter, E				Carlson, Jonathan M.; Schaefer, Malinda; Monaco, Daniela C.; Batorsky, Rebecca; Claiborne, Daniel T.; Prince, Jessica; Deymier, Martin J.; Ende, Zachary S.; Klatt, Nichole R.; DeZiel, Charles E.; Lin, Tien-Ho; Peng, Jian; Seese, Aaron M.; Shapiro, Roger; Frater, John; Ndung'u, Thumbi; Tang, Jianming; Goepfert, Paul; Gilmour, Jill; Price, Matt A.; Kilembe, William; Heckerman, David; Goulder, Philip J. R.; Allen, Todd M.; Allen, Susan; Hunter, Eric			Selection bias at the heterosexual HIV-1 transmission bottleneck	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLASS-I ALLELES; REPLICATION CAPACITY; DISCORDANT COUPLES; ESCAPE MUTATIONS; VIRAL-LOAD; SEXUAL TRANSMISSION; CHRONIC INFECTION; IMMUNE CONTROL; SH3 DOMAIN	Heterosexual transmission of HIV-1 typically results in one genetic variant establishing systemic infection. We compared, for 137 linked transmission pairs, the amino acid sequences encoded by non-envelope genes of viruses in both partners and demonstrate a selection bias for transmission of residues that are predicted to confer increased in vivo fitness on viruses in the newly infected, immunologically naive recipient. Although tempered by transmission risk factors, such as donor viral load, genital inflammation, and recipient gender, this selection bias provides an overall transmission advantage for viral quasispecies that are dominated by viruses with high in vivo fitness. Thus, preventative or therapeutic approaches that even marginally reduce viral fitness may lower the overall transmission rates and offer long-term benefits even upon successful transmission.	[Carlson, Jonathan M.; DeZiel, Charles E.; Lin, Tien-Ho; Peng, Jian] Microsoft Res, Redmond, WA 98052 USA; [Schaefer, Malinda; Monaco, Daniela C.; Claiborne, Daniel T.; Prince, Jessica; Deymier, Martin J.; Ende, Zachary S.; Klatt, Nichole R.; Hunter, Eric] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Batorsky, Rebecca; Seese, Aaron M.; Ndung'u, Thumbi; Allen, Todd M.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02114 USA; [Shapiro, Roger] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Frater, John] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 7BN, England; [Frater, John] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford OX3 7LE, England; [Frater, John] Univ Oxford, Oxford Martin Sch, Oxford OX1 3BD, England; [Ndung'u, Thumbi; Goulder, Philip J. R.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4013 Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infekt Biol, D-10117 Berlin, Germany; [Tang, Jianming; Goepfert, Paul] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gilmour, Jill] Int AIDS Vaccine Initiat, London SW10 9NH, England; [Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, London SW10 9NH, England; [Price, Matt A.] Int AIDS Vaccine Initiat, San Francisco, CA 94105 USA; [Price, Matt A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94105 USA; [Kilembe, William; Allen, Susan; Hunter, Eric] Zambia Emory HIV Res Project, Rwanda Zambia HIV Res Grp, Lusaka, Zambia; [Heckerman, David] Microsoft Res, Los Angeles, CA USA; [Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Oxford OX1 3SY, England; [Allen, Susan; Hunter, Eric] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA	Microsoft; Emory University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Beth Israel Deaconess Medical Center; University of Oxford; University of Oxford; University of Oxford; University of Kwazulu Natal; Max Planck Society; University of Alabama System; University of Alabama Birmingham; International AIDS Vaccine Initiative; Imperial College London; International AIDS Vaccine Initiative; University of California System; University of California San Francisco; Microsoft; University of Oxford; Emory University; Emory University; Rollins School Public Health	Carlson, JM (corresponding author), Univ Washington, Washington Natl Primate Res Ctr, Dept Pharmaceut, Seattle, WA 98121 USA.	carlson@microsoft.com; ehunte4@emory.edu	Ende, Zachary/AAD-3800-2019; Allen, Todd/F-5473-2011; Price, Matt/AAK-6881-2021; Tang, Jianming "James"/O-4980-2019	Allen, Todd/0000-0002-6609-1318; Price, Matt/0000-0002-2918-1373; Tang, Jianming "James"/0000-0003-0137-7486; Frater, John/0000-0001-7163-7277; Peng, Jian/0000-0002-1736-2978; Ndung'u, Thumbi/0000-0003-2962-3992	International AIDS Vaccine Initiative; American people through the U.S. Agency for International Development (USAID); Virology Core at the Emory Center for AIDS Research [P30 AI050409]; Yerkes National Primate Research Center through the National Center for Research Resources [2P51RR000165-51, P51RR165]; Office of Research Infrastructure Programs/OD [P51OD11132]; NIAID [P01-AI074415, U01 AI 66454]; Multidisciplinary AIDS Training Grant NIH [T32-AI007387]; Action Cycling Fellowships; South African Department of Science and Technology; National Research Foundation through the South Africa Research Chairs Initiative; Howard Hughes Medical Institute; Victor Daitz Foundation;  [R01 AI64060];  [R37 AI51231]; MRC [G108/626] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI064060, U01AI066454, R01AI046995, T32AI007387, R37AI051231, P01AI074415] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132, P51OD010425] Funding Source: NIH RePORTER; Medical Research Council [G108/626] Funding Source: researchfish	International AIDS Vaccine Initiative; American people through the U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Virology Core at the Emory Center for AIDS Research; Yerkes National Primate Research Center through the National Center for Research Resources; Office of Research Infrastructure Programs/OD; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Multidisciplinary AIDS Training Grant NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Action Cycling Fellowships; South African Department of Science and Technology; National Research Foundation through the South Africa Research Chairs Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Victor Daitz Foundation; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all the volunteers in Zambia who participated in this study and all the staff at the Zambia Emory HIV Research Project in Lusaka who made this study possible. We would like to thank J. Allen and M. Hurlston for technical assistance and sample management; P. Farmer, Ph.D., for database design and management; and I. Brill, K. Wall, X. Li, C. Lippert, N. Fusi, J. Listgarten, and Z. Brumme for helpful discussions. This study was funded by R01 AI64060 and R37 AI51231 (E. H.) and the International AIDS Vaccine Initiative (to S. A.), and made possible in part by the support of the American people through the U.S. Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID or the U.S. government. This work was also supported, in part, by the Virology Core at the Emory Center for AIDS Research (grant P30 AI050409); the Yerkes National Primate Research Center base grant (2P51RR000165-51) through the National Center for Research Resources P51RR165 and by the Office of Research Infrastructure Programs/OD P51OD11132; NIAID grants P01-AI074415 (T. M. A.) and U01 AI 66454 (R. S.); and Multidisciplinary AIDS Training Grant NIH T32-AI007387 (R. B.). J. P., D. T. C., and M. S. were supported in part by Action Cycling Fellowships. T. N. was supported by the International AIDS Vaccine Initiative, the South African Department of Science and Technology and the National Research Foundation through the South Africa Research Chairs Initiative, by an International Early Career Scientist award from the Howard Hughes Medical Institute, and by the Victor Daitz Foundation. E. H. is a Georgia Eminent Scholar. All viral sequences not previously published have been submitted to GenBank-accession numbers JN014076-JN014465, JQ219842, and KM048382-KM050767. The data reported in this paper are tabulated in the supplementary online material.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Bates D., 2013, LME4 LINEAR MIXED EF; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Boutwell CL, 2013, J VIROL, V87, P3952, DOI 10.1128/JVI.03233-12; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Cotton LA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004295; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; DEVINCENZI I, 1992, BRIT MED J, V304, P809; Efron B., 1981, CANADIAN J STATISTIC, V9, P139, DOI [10.1093/jtm/taab016, DOI 10.1093/jtm/taab016]; Etemad B, 2009, J VIROL, V83, P9694, DOI 10.1128/JVI.00925-09; Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Frater AJ, 2006, J VIROL, V80, P7226, DOI 10.1128/JVI.02014-05; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; Hollingsworth TD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000876; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; Huang KHG, 2009, ANTIVIR THER, V14, P975, DOI 10.3851/IMP1416; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Listgarten J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000016; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; McKenna SL, 1997, AIDS, V11, pS103; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; PIGUET V, 1999, HUMAN RETROVIRUSES A, P448; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Robbins AH, 2010, ACTA CRYSTALLOGR D, V66, P233, DOI 10.1107/S0907444909054298; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shaw GM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006965; Song W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023469; Tang JM, 2008, J IMMUNOL, V181, P2626, DOI 10.4049/jimmunol.181.4.2626; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WONG GY, 1985, J AM STAT ASSOC, V80, P513, DOI 10.2307/2288464; Wright JK, 2011, J VIROL, V85, P3996, DOI 10.1128/JVI.02520-10; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10; Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475; Yue L, 2013, J VIROL, V87, P708, DOI 10.1128/JVI.02118-12	72	170	176	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193							1254031	10.1126/science.1254031	http://dx.doi.org/10.1126/science.1254031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013080	Green Accepted			2022-12-24	WOS:000339409900043
J	Watanabe, H; Schmidt, HA; Kuhn, A; Hoger, SK; Kocagoz, Y; Laumann-Lipp, N; Ozbek, S; Holstein, TW				Watanabe, Hiroshi; Schmidt, Heiko A.; Kuhn, Anne; Hoeger, Stefanie K.; Kocagoez, Yigit; Laumann-Lipp, Nico; Oezbek, Suat; Holstein, Thomas W.			Nodal signalling determines biradial asymmetry in Hydra	NATURE			English	Article							MAXIMUM-LIKELIHOOD PHYLOGENIES; CARTESIAN COORDINATE SYSTEM; LEFT-RIGHT AXIS; HEAD ORGANIZER; GENE FAMILY; BODY AXES; EVOLUTION; WNT; EXPRESSION; EMBRYO	In bilaterians, three orthogonal body axes define the animal form, with distinct anterior-posterior, dorsal-ventral and left-right asymmetries. The key signalling factors are Wnt family proteins for the anterior-posterior axis, Bmp family proteins for the dorsal-ventral axis and Nodal for the left-right axis(1). Cnidarians, the sister group to bilaterians, are characterized by one oral-aboral body axis, which exhibits a distinct biradiality of unknown molecular nature. Here we analysed the biradial growth pattern in the radially symmetrical cni-darian polyp Hydra, and we report evidence of Nodal ina pre-bilaterian clade. We identified aNodal-related gene (Ndr) inHydra magnipa-pillata, and this gene is essential for setting up an axial asymmetry along the main body axis. This asymmetry defines a lateral signalling centre, inducing a new body axis of a budding polyp orthogonal to the mother polyp's axis. Ndr is expressed exclusively in the lateral bud anlage and induces Pitx, which encodes an evolutionarily conserved transcription factor that functions downstream of Nodal. Reminiscent of its function in vertebrates(2,3), Nodal acts downstream of beta-Catenin signalling. Our data support an evolutionary scenario in which a 'core-signalling cassette' consisting of b-Catenin, Nodal and Pitx pre-dated the cnidarian-bilaterian split. We presume that this cassette was co-opted for various modes of axial patterning: for example, for lateral branching in cnidarians and left-right patterning in bilaterians.	[Watanabe, Hiroshi; Kuhn, Anne; Hoeger, Stefanie K.; Kocagoez, Yigit; Laumann-Lipp, Nico; Oezbek, Suat; Holstein, Thomas W.] Heidelberg Univ, Dept Mol Evolut & Genom, Ctr Organismal Studies COS, D-69120 Heidelberg, Germany; [Schmidt, Heiko A.] Univ Vienna, Med Univ Vienna, Ctr Integrat Bioinformat Vienna CIBIV, Max F Perutz Labs MFPL, A-1030 Vienna, Austria	Ruprecht Karls University Heidelberg; Medical University of Vienna; University of Vienna	Holstein, TW (corresponding author), Heidelberg Univ, Dept Mol Evolut & Genom, Ctr Organismal Studies COS, D-69120 Heidelberg, Germany.	hiroshi.watanabe@cos.uni-heidelberg.de; thomas.holstein@cos.uni-heidelberg.de	Watanabe, Hiroshi/GOP-0177-2022; Kocagöz, Yigit/ABG-2596-2021; Schmidt, Heiko A/AAC-4650-2022; Özbek, Suat/D-3701-2014	Watanabe, Hiroshi/0000-0001-8887-5407; Schmidt, Heiko A/0000-0002-2311-8592; Holstein, Thomas/0000-0003-0480-4674; Ozbek, Suat/0000-0003-2569-3942	TOYOBO Biotechnology Foundation; Alexander von Humboldt Foundation; Heidelberg Excellence Cluster Cellular Networks; German science foundation (DFG) [FOR 1036/TP1, SFB 873/A1, FOR 1036/TP2]	TOYOBO Biotechnology Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Heidelberg Excellence Cluster Cellular Networks; German science foundation (DFG)(German Research Foundation (DFG))	We thank R. Steele for providing the transgenic Hydra strains before publication, for setting up the Cladonema pacificum genome Blast server and for permission to provide the URL; R. Yamada, T. Katsuki and R. Greenspan for providing unpublished C. pacificum sequence data; B. Hobmayer for providing a Hydra scheme from an unpublished manuscript; and H. Yuzawa-Watanabe for technical assistance. We thank O. Simakov, H. Meinhardt, I. Somorjai and B. Hobmayer for discussions and comments on the manuscript. This study was supported by the TOYOBO Biotechnology Foundation and the Alexander von Humboldt Foundation (initial fellowships to H. W.), the Heidelberg Excellence Cluster Cellular Networks, and grants from the German science foundation (DFG) to T. W. H. (FOR 1036/TP1 and SFB 873/A1) and S.O. (FOR 1036/TP2).	BAIRD RV, 1967, J EMBRYOL EXP MORPH, V17, P35; Bode Hans, 2008, V469, P69, DOI 10.1007/978-1-60327-469-2_7; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Brusca RC, 2002, INVERTEBRATES; Chea HK, 2005, DEV DYNAM, V234, P269, DOI 10.1002/dvdy.20549; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Glauber KM, 2013, DEVELOPMENT, V140, P4788, DOI 10.1242/dev.094490; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Holstein TW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007922; Inui M, 2012, P NATL ACAD SCI USA, V109, P15354, DOI 10.1073/pnas.1203000109; Khalturin K, 2008, PLOS BIOL, V6, P2436, DOI 10.1371/journal.pbio.0060278; Kuhn A., 1914, ERG FORTSCHR ZOOL, P1; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lengfeld T, 2009, DEV BIOL, V330, P186, DOI 10.1016/j.ydbio.2009.02.004; Meinhardt H, 2001, INT J DEV BIOL, V45, P177; Meinhardt H, 2006, DEV DYNAM, V235, P2907, DOI 10.1002/dvdy.20952; Minh BQ, 2005, BIOINFORMATICS, V21, P3794, DOI 10.1093/bioinformatics/bti594; Nakamura Y, 2011, P NATL ACAD SCI USA, V108, P9137, DOI 10.1073/pnas.1018109108; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Reinhardt B, 2004, DEV BIOL, V267, P43, DOI 10.1016/j.ydbio.2003.10.031; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Srivastava M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-4; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Warner JF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001404; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yu JK, 2002, EVOL DEV, V4, P418, DOI 10.1046/j.1525-142X.2002.02030.x	35	65	67	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					112	+		10.1038/nature13666	http://dx.doi.org/10.1038/nature13666			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25156256				2022-12-24	WOS:000344187500040
J	Engineer, CB; Ghassemian, M; Anderson, JC; Peck, SC; Hu, HH; Schroeder, JI				Engineer, Cawas B.; Ghassemian, Majid; Anderson, Jeffrey C.; Peck, Scott C.; Hu, Honghong; Schroeder, Julian I.			Carbonic anhydrases, EPF2 and a novel protease mediate CO2 control of stomatal development	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; SIGNAL-TRANSDUCTION; SECRETORY PEPTIDE; ABSCISIC-ACID; DENSITY; KINASE; DIFFERENTIATION; REVEALS	Environmental stimuli, including elevated carbon dioxide levels, regulate stomatal development(1-3); however, the key mechanisms mediating the perception and relay of the CO2 signal to the stomatal development machinery remain elusive. To adapt CO2 intake to water loss, plants regulate the development of stomatal gas exchange pores in the aerial epidermis. A diverse range of plant species show a decrease in stomatal density in response to the continuing rise in atmospheric CO2 (ref. 4). To date, one mutant that exhibits deregulation of this CO2-controlled stomatal development response, hic (which is defective in cell-wall wax biosynthesis, ref. 5), has been identified. Here we show that recently isolated Arabidopsis thaliana beta-carbonic anhydrase double mutants (cal ca4)(6) exhibit an inversion in their response to elevated CO2, showing increased stomatal development at elevated CO2 levels. We characterized the mechanisms mediating this response and identified an extracellular signalling pathway involved in the regulation of CO2-controlled stomatal development by carbonic anhydrases. RNA-seq analyses of transcripts show that the extracellular pro-peptide-encoding gene EPIDERMAL PATTERNING FACTOR 2 (EPF2)(7,8), but not EPFI (ref. 9), is induced in wild-type leaves but not in cal ca4 mutant leaves at elevated CO2 levels. Moreover, EPF2 is essential for CO2 control of stomatal development. Using cell-wall proteomic analyses and CO2-dependent transcriptomic analyses, we identified a novel CO2-induced extracellular protease, CRSP (CO2 RESPONSE SECRETED PROTEASE), as a mediator of CO2-controlled stomatal development. Our results identify mechanisms and genes that function in the repression of stomatal development in leaves during atmospheric CO2 elevation, including the carbonic-anhydrase-encoding genes CA1 and CA4 and the secreted protease CRSP, which cleaves the pro-peptide EPF2, in turn repressing stomatal development. Elucidation of these mechanisms advances the understanding of how plants perceive and relay the elevated CO2 signal and provides a framework to guide future research into how environmental challenges can modulate gas exchange in plants.	[Engineer, Cawas B.; Hu, Honghong; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Anderson, Jeffrey C.; Peck, Scott C.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Missouri System; University of Missouri Columbia	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	jischroeder@ucsd.edu	Anderson, Jeff/I-1316-2017	Anderson, Jeff/0000-0001-9446-7100	National Science Foundation [MCB0918220, MCB1414339, IOS-1025837]; National Institutes of Health [GM060396-ES010337]; BAYER-UC Discovery grant; seed grant from the UCSD-SDCSB [GM085764]; Systems Biology Center; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-03ER15449]; Direct For Biological Sciences [1414339] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396, P50GM085764] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BAYER-UC Discovery grant; seed grant from the UCSD-SDCSB; Systems Biology Center; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Knepper for conducting independent CO<INF>2</INF>-dependent stomatal development analyses. We thank A. Ries for help with generating the CA-YFP-fusion complementation lines. We thank D. Bergmann for providing the epfl6 mutant line and DNA constructs for MUTEpro::nucGFP expression; K. Toni for providing DNA constructs for MUTEpro::MUTE-GFP expression, erecta mutants and the oestradiol-inducible EPF constructs; T. Altmann for providing the sdd1-1 mutant; and M. Estelle, Y. Zhao, A. Stephan and M. Facette for comments on the manuscript. This project was funded by grants from the National Science Foundation (MCB0918220 and MCB1414339 to J.I.S. and IOS-1025837 to S.C.P.) and the National Institutes of Health (GM060396-ES010337 to J.I.S.), a BAYER-UC Discovery grant (J.I.S.) and a seed grant from the UCSD-SDCSB (GM085764) Systems Biology Center (C.B.E.). A grant from the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DE-FG02-03ER15449) to J.I.S. funded complementation and localization analyses.	Abrash EB, 2010, DEVELOPMENT, V137, P447, DOI 10.1242/dev.040931; Anderson JC, 2008, PLANT J, V55, P881, DOI 10.1111/j.1365-313X.2008.03550.x; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kondo T, 2010, PLANT CELL PHYSIOL, V51, P1, DOI 10.1093/pcp/pcp180; Lake JA, 2008, NEW PHYTOL, V179, P397, DOI 10.1111/j.1469-8137.2008.02485.x; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Niehl A, 2013, J PROTEOME RES, V12, P2491, DOI 10.1021/pr3010698; Ohki S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1520; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Pillitteri LJ, 2011, PLANT CELL, V23, P3260, DOI 10.1105/tpc.111.088583; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Uchida N, 2013, J EXP BOT, V64, P5335, DOI 10.1093/jxb/ert196; Woodward FI, 2002, NEW PHYTOL, V153, P477, DOI 10.1046/j.0028-646X.2001.00338.x; Woodward FI, 2002, CURR OPIN PLANT BIOL, V5, P207, DOI 10.1016/S1369-5266(02)00253-4; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; Xue SW, 2011, EMBO J, V30, P1645, DOI 10.1038/emboj.2011.68; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6	40	144	166	5	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					246	+		10.1038/nature13452	http://dx.doi.org/10.1038/nature13452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25043023	Green Accepted			2022-12-24	WOS:000341362800053
J	Baldwin, MW; Toda, Y; Nakagita, T; O'Connell, MJ; Klasing, KC; Misaka, T; Edwards, SV; Liberles, SD				Baldwin, Maude W.; Toda, Yasuka; Nakagita, Tomoya; O'Connell, Mary J.; Klasing, Kirk C.; Misaka, Takumi; Edwards, Scott V.; Liberles, Stephen D.			Evolution of sweet taste perception in hummingbirds by transformation of the ancestral umami receptor	SCIENCE			English	Article							MAMMALIAN SWEET; MOLECULAR-BASIS; GENES; SENSE	Sensory systems define an animal's capacity for perception and can evolve to promote survival in new environmental niches. We have uncovered a noncanonical mechanism for sweet taste perception that evolved in hummingbirds since their divergence from insectivorous swifts, their closest relatives. We observed the widespread absence in birds of an essential subunit (T1R2) of the only known vertebrate sweet receptor, raising questions about how specialized nectar feeders such as hummingbirds sense sugars. Receptor expression studies revealed that the ancestral umami receptor (the T1R1-T1R3 heterodimer) was repurposed in hummingbirds to function as a carbohydrate receptor. Furthermore, the molecular recognition properties of T1R1-T1R3 guided taste behavior in captive and wild hummingbirds. We propose that changing taste receptor function enabled hummingbirds to perceive and use nectar, facilitating the massive radiation of hummingbird species.	[Baldwin, Maude W.; Edwards, Scott V.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Baldwin, Maude W.; Edwards, Scott V.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Toda, Yasuka; Nakagita, Tomoya; Misaka, Takumi] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [O'Connell, Mary J.] Dublin City Univ, Sch Biotechnol, Bioinformat & Mol Evolut Grp, Dublin 9, Ireland; [Klasing, Kirk C.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Liberles, Stephen D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard University; University of Tokyo; Dublin City University; University of California System; University of California Davis; Harvard University; Harvard Medical School	Baldwin, MW (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	maudebaldwin@gmail.com; stephen_liberles@hms.harvard.edu	Edwards, Scott V./D-9071-2018	Edwards, Scott V./0000-0003-2535-6217; O'Connell, Mary/0000-0002-1877-1001; Toda, Yasuka/0000-0001-5912-6730; Liberles, Stephen/0000-0002-2177-9741; Misaka, Takumi/0000-0002-9547-5767	NSF [DDIG 1110487]; Society for Integrative and Comparative Biology; Sigma Xi; Fulbright Commission; Science Foundation Ireland [EOB2673]; NIH [RO1DC013289]; Japan Society for the Promotion of Science [LS037]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013289] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Society for Integrative and Comparative Biology; Sigma Xi; Fulbright Commission; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank those who supported these experiments (see the supplementary materials for the full list). Grants to M. W. B. (NSF grant DDIG 1110487, Society for Integrative and Comparative Biology, and Sigma Xi); M. J. O'C. (Fulbright Commission and Science Foundation Ireland Research Frontiers Program, grant EOB2673); S. D. L. (NIH, grant RO1DC013289); S. V. E. (NSF); and T. M. (Japan Society for the Promotion of Science, grant LS037) are acknowledged. T1R sequences and alignments are available at GenBank and Dryad.	Brown Joseph W., 2009, P454; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Dyke G., 2011, LIVING DINOSAURS EVO; Feng P, 2013, CHINESE SCI BULL, V58, P2198, DOI 10.1007/s11434-013-5811-5; Ferrero DM, 2012, ACS CHEM BIOL, V7, P1184, DOI 10.1021/cb300111e; Glaser D, 2002, PURE APPL CHEM, V74, P1153, DOI 10.1351/pac200274071153; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Ishimaru Y, 2005, MECH DEVELOP, V122, P1310, DOI 10.1016/j.mod.2005.07.005; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Kessler D, 2007, PLANT J, V49, P840, DOI 10.1111/j.1365-313X.2006.02995.x; Kuang DH, 2006, P NATL ACAD SCI USA, V103, P14050, DOI 10.1073/pnas.0604717103; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; McGuire JA, 2014, CURR BIOL, V24, P910, DOI 10.1016/j.cub.2014.03.016; Medina-Tapia N, 2012, COMP BIOCHEM PHYS A, V161, P307, DOI 10.1016/j.cbpa.2011.11.012; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Oike H, 2007, J NEUROSCI, V27, P5584, DOI 10.1523/JNEUROSCI.0651-07.2007; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Toda Y, 2013, J BIOL CHEM, V288, P36863, DOI 10.1074/jbc.M113.494443; Toda Y, 2011, J AGR FOOD CHEM, V59, P12131, DOI 10.1021/jf2029835; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhao HB, 2010, MOL BIOL EVOL, V27, P2669, DOI 10.1093/molbev/msq153	25	109	113	7	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					929	933		10.1126/science.1255097	http://dx.doi.org/10.1126/science.1255097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146290	Green Published, Green Accepted			2022-12-24	WOS:000340524700046
J	Arranz, L; Sanchez-Aguilera, A; Martin-Perez, D; Isern, J; Langa, X; Tzankov, A; Lundberg, P; Muntion, S; Tzeng, YS; Lai, DM; Schwaller, J; Skoda, RC; Mendez-Ferrer, S				Arranz, Lorena; Sanchez-Aguilera, Abel; Martin-Perez, Daniel; Isern, Joan; Langa, Xavier; Tzankov, Alexandar; Lundberg, Pontus; Muntion, Sandra; Tzeng, Yi-Shiuan; Lai, Dar-Ming; Schwaller, Juerg; Skoda, Radek C.; Mendez-Ferrer, Simon			Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms	NATURE			English	Article							TYROSINE KINASE JAK2; ACTIVATING MUTATION; POLYCYTHEMIA-VERA; BONE; JAK2-V617F	Myeloproliferative neoplasms (MPNs) are diseases caused by mutations in the haematopoietic stem cell (HSC) compartment. Most MPN patients have a common acquired mutation of Janus kinase 2 (JAK2) gene in HSCs1-4 that renders this kinase constitutively active, leading to uncontrolled cell expansion. The bone marrow microenvironment might contribute to the clinical outcomes of this common event. We previously showed that bone marrow nestin(+) mesenchymal stem cells (MSCs) innervated by sympathetic nerve fibres regulate normal HSCs5,6. Here we demonstrate that abrogation of this regulatory circuit is essential for MPN pathogenesis. Sympathetic nerve fibres, supporting Schwann cells and nestin(+) MSCs are consistently reduced in the bone marrow of MPN patients and mice expressing the human JAK2(V617F) mutation in HSCs. Unexpectedly, MSC reduction is not due to differentiation but is caused by bone marrow neural damage and Schwann cell death triggered by interleukin-1 beta produced by mutant HSCs. In turn, in vivo depletion of nestin(+) cells or their production of CXCL12 expanded mutant HSC number and accelerated MPN progression. In contrast, administration of neuroprotective or sympathomimetic drugs prevented mutant HSC expansion. Treatment with beta(3)-adrenergic agonists that restored the sympathetic regulation of nestin(+) MSCs5,6 prevented the loss of these cells and blocked MPN progression by indirectly reducing the number of leukaemic stem cells. Our results demonstrate that mutant-HSC-driven niche damage critically contributes to disease manifestation in MPN and identify niche-forming MSCs and their neural regulation as promising therapeutic targets.	[Arranz, Lorena; Sanchez-Aguilera, Abel; Martin-Perez, Daniel; Isern, Joan; Langa, Xavier; Mendez-Ferrer, Simon] CNIC, Stem Cell Niche Pathophysiol Grp, Madrid 28029, Spain; [Tzankov, Alexandar; Lundberg, Pontus; Schwaller, Juerg; Skoda, Radek C.] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Muntion, Sandra] IBSAL Hosp Univ Salamanca, Dept Haematol, Salamanca 37007, Spain; [Tzeng, Yi-Shiuan; Lai, Dar-Ming] Natl Taiwan Univ, Taipei 10002, Taiwan	Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Basel; National Taiwan University	Mendez-Ferrer, S (corresponding author), CNIC, Stem Cell Niche Pathophysiol Grp, Madrid 28029, Spain.	smendez@cnic.es	Martín Pérez, Daniel/AFW-0499-2022; Tzankov, Alexandar/H-5656-2019; Pérez, Daniel Martín/M-4264-2018; Arranz, Lorena/Z-3635-2019; Méndez-Ferrer, Simón/L-8088-2014; Schwaller, Juerg/A-3044-2016; Isern, Joan/C-1250-2017; Méndez-Ferrer, Simón/ABG-8547-2020	Martín Pérez, Daniel/0000-0001-6125-2955; Tzankov, Alexandar/0000-0002-1100-3819; Pérez, Daniel Martín/0000-0001-6125-2955; Arranz, Lorena/0000-0002-5896-4238; Méndez-Ferrer, Simón/0000-0002-9805-9988; Schwaller, Juerg/0000-0001-8616-0096; Isern, Joan/0000-0002-1401-9779; Méndez-Ferrer, Simón/0000-0002-9805-9988; Muntion Olave, Sandra/0000-0001-7164-0767	Fundacion CNIC; Spanish Ministry of Economy and Competitiveness (TerCel, Spanish Cell Therapy Network) [SAF-2011-30308]; ConSEPOC-Comunidad de Madrid [S2010/BMD-2542]; Ramon y Cajal Program [RYC-2009-04703/2011-09726]; Marie Curie grants [FP7-PEOPLE-2011-RG-294262/294096]; Swiss National Science Foundation [310000-120724/1, 32003BB_135712/1]; Swiss Cancer League [KLS-02398-02-2009]; European Hematology Association; Howard Hughes Medical Institute	Fundacion CNIC; Spanish Ministry of Economy and Competitiveness (TerCel, Spanish Cell Therapy Network); ConSEPOC-Comunidad de Madrid; Ramon y Cajal Program(Spanish Government); Marie Curie grants(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; European Hematology Association; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank S. Martin-Salamanca, A. M. Martin, A. B. Ricote, J. M. Ligos, S. Bartlett and the CNIC Comparative Medicine, Genomics and Bioinformatics Units for assistance; members of S.M.-F. and B. Ibanez groups and M. Garcia-Fernandez for data discussion; G. Enikolopov, G. Fishell and D. Riethmacher for providing mice. This work was supported by Fundacion CNIC, Spanish Ministry of Economy and Competitiveness (TerCel, Spanish Cell Therapy Network; Plan Nacional SAF-2011-30308) and ConSEPOC-Comunidad de Madrid S2010/BMD-2542 grants to S.M.-F.; Ramon y Cajal Program grants RYC-2009-04703/2011-09726 and Marie Curie grants FP7-PEOPLE-2011-RG-294262/294096 to A.S.-A. and S.M.-F.; Swiss National Science Foundation 310000-120724/1, 32003BB_135712/1 and Swiss Cancer League KLS-02398-02-2009 grants to R.C.S.; A.S.-A. received a Research Fellowship from the European Hematology Association. S.M.-F. is supported in part by an International Early Career Scientist grant of the Howard Hughes Medical Institute.	Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Irichishima H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030557; Isern J, 2013, CELL REP, V3, P1714, DOI 10.1016/j.celrep.2013.03.041; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kubovcakova L, 2013, BLOOD, V121, P1188, DOI 10.1182/blood-2012-03-415646; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Pajtler Kristian, 2010, J Vis Exp, DOI 10.3791/2380; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; RAMESHWAR P, 1994, J IMMUNOL, V153, P2819; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053	35	290	299	5	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					78	+		10.1038/nature13383	http://dx.doi.org/10.1038/nature13383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043017				2022-12-24	WOS:000339908000035
J	Moda, F; Gambetti, P; Notari, S; Concha-Marambio, L; Catania, M; Park, KW; Maderna, E; Suardi, S; Haik, S; Brandel, JP; Ironside, J; Knight, R; Tagliavini, F; Soto, C				Moda, Fabio; Gambetti, Pierluigi; Notari, Silvio; Concha-Marambio, Luis; Catania, Marcella; Park, Kyung-Won; Maderna, Emanuela; Suardi, Silvia; Haik, Stephane; Brandel, Jean-Philippe; Ironside, James; Knight, Richard; Tagliavini, Fabrizio; Soto, Claudio			Prions in the Urine of Patients with Variant Creutzfeldt- Jakob Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MISFOLDING CYCLIC AMPLIFICATION; BLOOD-TRANSFUSION; INFECTIOUS PRIONS; PROTEIN; TRANSMISSION; EXCRETION; TISSUES; HUMANS; AGENT; VCJD	BACKGROUND Prions, the infectious agents responsible for transmissible spongiform encephalopathies, consist mainly of the misfolded prion protein (PrPSc). The unique mechanism of transmission and the appearance of a variant form of Creutzfeldt-Jakob disease, which has been linked to consumption of prion-contaminated cattle meat, have raised concerns about public health. Evidence suggests that variant Creutzfeldt-Jakob disease prions circulate in body fluids from people in whom the disease is silently incubating. METHODS To investigate whether PrPSc can be detected in the urine of patients with variant Creutzfeldt-Jakob disease, we used the protein misfolding cyclic amplification (PMCA) technique to amplify minute quantities of PrPSc, enabling highly sensitive detection of the protein. We analyzed urine samples from several patients with various transmissible spongiform encephalopathies (variant and sporadic Creutzfeldt-Jakob disease and genetic forms of prion disease), patients with other degenerative or nondegenerative neurologic disorders, and healthy persons. RESULTS PrPSc was detectable only in the urine of patients with variant Creutzfeldt-Jakob disease and had the typical electrophoretic profile associated with this disease. PrPSc was detected in 13 of 14 urine samples obtained from patients with variant Creutzfeldt-Jakob disease and in none of the 224 urine samples obtained from patients with other neurologic diseases and from healthy controls, resulting in an estimated sensitivity of 92.9% (95% confidence interval [CI], 66.1 to 99.8) and a specificity of 100.0% (95% CI, 98.4 to 100.0). The PrPSc concentration in urine calculated by means of quantitative PMCA was estimated at 1x10(-16) g per milliliter, or 3x10(-21) mol per milliliter, which extrapolates to approximately 40 to 100 oligomeric particles of PrPSc per milliliter of urine. CONCLUSIONS Urine samples obtained from patients with variant Creutzfeldt-Jakob disease contained minute quantities of PrPSc.	[Moda, Fabio; Concha-Marambio, Luis; Park, Kyung-Won; Soto, Claudio] Univ Texas Med Sch Houston, Mitchell Ctr Res Alzheimers Dis & Related Brain D, Houston, TX 77030 USA; [Moda, Fabio; Catania, Marcella; Maderna, Emanuela; Suardi, Silvia; Tagliavini, Fabrizio] Fdn Carlo Besta Neurol Inst, Milan, Italy; [Gambetti, Pierluigi; Notari, Silvio] Case Western Reserve Univ, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [Concha-Marambio, Luis] Univ Los Andes, Fac Med, Santiago, Chile; [Haik, Stephane; Brandel, Jean-Philippe] Univ Paris 06, Grp Hosp Pitie Salpetriere, Assistance Publ Hop Paris,INSERM,U1127, Cellule Natl Reference Malad Creutzfeldt Jakob, Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] CNRS, UMR, Paris, France; [Ironside, James; Knight, Richard] Univ Edinburgh, Western Gen Hosp, Natl CJD Res & Surveillance Unit, Edinburgh, Midlothian, Scotland	University of Texas System; University of Texas Health Science Center Houston; IRCCS Istituto Neurologico Besta; Case Western Reserve University; Universidad de los Andes - Chile; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); University of Edinburgh	Soto, C (corresponding author), Univ Texas Med Sch Houston, 6431 Fannin St, Houston, TX 77030 USA.	claudio.soto@uth.tmc.edu	Catania, Marcella/K-1430-2016; maderna, emanuela/F-1420-2019; Tagliavini, Fabrizio/AAO-7891-2021; Haik, Stephane/M-7247-2018; Moda, Fabio/J-6445-2018; Concha-Marambio, Luis/V-3247-2019	Catania, Marcella/0000-0003-0370-1905; maderna, emanuela/0000-0002-5736-3166; Tagliavini, Fabrizio/0000-0003-1039-7315; Moda, Fabio/0000-0002-2820-9880; Concha-Marambio, Luis/0000-0002-9454-8389; Ironside, James/0000-0001-5869-2108	National Institutes of Health [P01AI077774, R42NS079060, R01NS049173, R01NS078745]; PrioNet Canada; Italian Ministry of Health; Associazione Italiana Encefalopatie da Prioni; Ministero dell'Universita e della Ricerca [RBAP11FRE9]; Charles S. Britton Fund [P01AG14359]; U.K. Department of Health; Scottish Government; Merck Serono; Medical Research Council [G0900580, G0600953] Funding Source: researchfish; MRC [G0600953, G0900580] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173, R01NS078745, R42NS079060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PrioNet Canada; Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana Encefalopatie da Prioni; Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Charles S. Britton Fund; U.K. Department of Health; Scottish Government; Merck Serono(Merck & Company); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institutes of Health (P01AI077774, R42NS079060, R01NS049173, and R01NS078745, to Dr. Soto), PrioNet Canada and Merck Serono (to Dr. Soto), the Italian Ministry of Health, Associazione Italiana Encefalopatie da Prioni, and Ministero dell'Universita e della Ricerca (RBAP11FRE9, to Dr. Tagliavini), the Charles S. Britton Fund (P01AG14359, to Dr. Gambetti), and the U.K. Department of Health and the Scottish Government (to Drs. Ironside and Knight).	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; [Anonymous], 2004, NAT REV MICROBIOL, V2, P809; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Brandner S, 2008, PHILOS T R SOC B, V363, P3755, DOI 10.1098/rstb.2008.0091; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Hill AF, 2003, BRIT MED BULL, V66, P161, DOI 10.1093/bmb/66.1.161; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Newman PK, 2014, J NEUROL NEUROSURG P; Notari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008765; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	34	119	125	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					530	539		10.1056/NEJMoa1404401	http://dx.doi.org/10.1056/NEJMoa1404401			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25099577	Green Published, Green Accepted			2022-12-24	WOS:000339899100007
J	Taipale, M; Tucker, G; Peng, J; Krykbaeva, I; Lin, ZY; Larsen, B; Choi, H; Berger, B; Gingras, AC; Lindquist, S				Taipale, Mikko; Tucker, George; Peng, Jian; Krykbaeva, Irina; Lin, Zhen-Yuan; Larsen, Brett; Choi, Hyungwon; Berger, Bonnie; Gingras, Anne-Claude; Lindquist, Susan			A Quantitative Chaperone Interaction Network Reveals the Architecture of Cellular Protein Homeostasis Pathways	CELL			English	Article							E3 UBIQUITIN LIGASE; HSP90 CO-CHAPERONE; KINASE; CANCER; EVOLUTION; COMPLEX; DOMAIN; DEGRADATION; SPECIFICITY; RECOGNITION	Chaperones are abundant cellular proteins that promote the folding and function of their substrate proteins (clients). In vivo, chaperones also associate with a large and diverse set of cofactors (cochaperones) that regulate their specificity and function. However, how these cochaperones regulate protein folding and whether they have chaperone-independent biological functions is largely unknown. We combined mass spectrometry and quantitative high-throughput LUMIER assays to systematically characterize the chaperone-cochaperone-client interaction network in human cells. We uncover hundreds of chaperone clients, delineate their participation in specific cochaperone complexes, and establish a surprisingly distinct network of protein-protein interactions for cochaperones. As a salient example of the power of such analysis, we establish that NUDC family cochaperones specifically associate with structurally related but evolutionarily distinct beta-propeller folds. We provide a framework for deciphering the proteostasis network and its regulation in development and disease and expand the use of chaperones as sensors for drug-target engagement.	[Taipale, Mikko; Krykbaeva, Irina; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02114 USA; [Tucker, George; Peng, Jian; Berger, Bonnie] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Tucker, George; Peng, Jian; Berger, Bonnie] MIT, Dept Math, Cambridge, MA 02139 USA; [Lin, Zhen-Yuan; Larsen, Brett; Gingras, Anne-Claude] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol,Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Choi, Hyungwon] Natl Univ Singapore, Singapore 117597, Singapore; [Choi, Hyungwon] Natl Univ Hlth Syst, Singapore 117597, Singapore; [Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; National University of Singapore; National University of Singapore; University of Toronto; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Gingras, AC (corresponding author), Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Ctr Syst Biol,Dept Mol Genet, Toronto, ON M5G 1X5, Canada.	gingras@lunenfeld.ca; lindquist_admin@wi.mit.edu	Choi, Hyungwon/S-8824-2019; Gingras, Anne-Claude/ABA-8341-2020; Gingras, Anne-Claude/E-9982-2010	Choi, Hyungwon/0000-0002-6687-3088; Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Taipale, Mikko/0000-0003-3811-1761; Krykbaeva, Irina/0000-0003-1380-7607; Peng, Jian/0000-0002-1736-2978	Canadian Institutes of Health Research [MOP-84314]; NIH [5R01GM94231, GM081871]; HFSP; Margaret and Herman Sokol Postdoctoral Award; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871, R01GM094231] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSP(Human Frontier Science Program); Margaret and Herman Sokol Postdoctoral Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Freyzon and M. Fischer for technical help, M. Shair for OSW-1, and A. Nesvizhskii and members of S. L. and A.-C.G.'s labs for comments and suggestions. We are grateful to M. Vidal and D. Hill for providing the human ORFeome. The website http://prohits-web.lunenfeld.ca is designed and maintained by J. Zhang and G. Liu. This work was supported by the Canadian Institutes of Health Research (MOP-84314 to A.-C.G.) and the NIH (5R01GM94231 to A.-C.G. and GM081871 to B.B.). M.T. was supported by the HFSP and a Margaret and Herman Sokol Postdoctoral Award. A.-C.G. holds the Canada Chair in Functional Proteomics and the Lea Reichmann Chair in Cancer Proteomics. S.L. is an investigator of the Howard Hughes Medical Institute.	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Briknarova K, 2002, J BIOL CHEM, V277, P31172, DOI 10.1074/jbc.M202792200; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chadli A, 2008, J BIOL CHEM, V283, P9509, DOI 10.1074/jbc.C800017200; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Echtenkamp FJ, 2011, MOL CELL, V43, P229, DOI 10.1016/j.molcel.2011.05.029; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Hudson Andrew M., 2008, V48, P6, DOI 10.1007/978-0-387-09595-0_2; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kean MJ, 2012, METHODS, V57, P400, DOI 10.1016/j.ymeth.2012.06.002; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Scholz GM, 2001, J BIOL CHEM, V276, P30971, DOI 10.1074/jbc.M103889200; Schuyler SC, 2012, J CELL SCI, V125, P4197, DOI 10.1242/jcs.107037; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zheng MY, 2011, J MOL BIOL, V409, P722, DOI 10.1016/j.jmb.2011.04.018	50	254	254	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					434	448		10.1016/j.cell.2014.05.039	http://dx.doi.org/10.1016/j.cell.2014.05.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036637	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000340943600021
J	Law, KL; Thompson, RC				Law, Kara Lavender; Thompson, Richard C.			Microplastics in the seas	SCIENCE			English	Editorial Material							MARINE DEBRIS; ACCUMULATION; POLLUTANTS; CHEMICALS; WORMS		[Law, Kara Lavender] Sea Educ Assoc, Dept Oceanog, Woods Hole, MA 02543 USA; [Thompson, Richard C.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England	University of Plymouth	Law, KL (corresponding author), Sea Educ Assoc, Dept Oceanog, Woods Hole, MA 02543 USA.	klavender@sea.edu	Thompson, Richard C/J-8879-2014	Law, Kara/0000-0002-5298-6751; Thompson, Richard/0000-0003-2262-6621	Division Of Ocean Sciences [1260403] Funding Source: National Science Foundation	Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bakir A, 2014, ENVIRON POLLUT, V185, P16, DOI 10.1016/j.envpol.2013.10.007; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Browne MA, 2013, CURR BIOL, V23, P2388, DOI 10.1016/j.cub.2013.10.012; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Collignon A, 2012, MAR POLLUT BULL, V64, P861, DOI 10.1016/j.marpolbul.2012.01.011; Law KL, 2014, ENVIRON SCI TECHNOL, V48, P4732, DOI 10.1021/es4053076; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; Obbard R. W., 2014, EARTHS FUTURE; Ogata Y, 2009, MAR POLLUT BULL, V58, P1437, DOI 10.1016/j.marpolbul.2009.06.014; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Wright SL, 2013, CURR BIOL, V23, pR1031, DOI 10.1016/j.cub.2013.10.068; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	15	688	769	80	913	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					144	145		10.1126/science.1254065	http://dx.doi.org/10.1126/science.1254065			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013051				2022-12-24	WOS:000339409900026
J	Qin, N; Yang, FL; Li, A; Prifti, E; Chen, YF; Shao, L; Guo, J; Le Chatelier, E; Yao, J; Wu, LJ; Zhou, JW; Ni, SJ; Liu, L; Pons, N; Batto, JM; Kennedy, SP; Leonard, P; Yuan, CH; Ding, WC; Chen, YT; Hu, XJ; Zheng, BW; Qian, GR; Xu, W; Ehrlich, SD; Zheng, SS; Li, LJ				Qin, Nan; Yang, Fengling; Li, Ang; Prifti, Edi; Chen, Yanfei; Shao, Li; Guo, Jing; Le Chatelier, Emmanuelle; Yao, Jian; Wu, Lingjiao; Zhou, Jiawei; Ni, Shujun; Liu, Lin; Pons, Nicolas; Batto, Jean Michel; Kennedy, Sean P.; Leonard, Pierre; Yuan, Chunhui; Ding, Wenchao; Chen, Yuanting; Hu, Xinjun; Zheng, Beiwen; Qian, Guirong; Xu, Wei; Ehrlich, S. Dusko; Zheng, Shusen; Li, Lanjuan			Alterations of the human gut microbiome in liver cirrhosis	NATURE			English	Article							BACTERIAL TRANSLOCATION; INTESTINAL MICROBIOTA; OBESITY; CATALOG; GENOMES; IMPACT; LONG	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Here we characterize the gut microbiome in liver cirrhosis by comparing 98 patients and 83 healthy control individuals. We build a reference gene set for the cohort containing 2.69 million genes, 36.1% of which are novel. Quantitative metagenomics reveals 75,245 genes that differ in abundance between the patients and healthy individuals (false discovery rate < 0.0001) and can be grouped into 66 clusters representing cognate bacterial species; 28 are enriched in patients and 38 in control individuals. Most (54%) of the patient-enriched, taxonomically assigned species are of buccal origin, suggesting an invasion of the gut from the mouth in liver cirrhosis. Biomarkers specific to liver cirrhosis at gene and function levels are revealed by a comparison with those for type 2 diabetes and inflammatory bowel disease. On the basis of only 15 biomarkers, a highly accurate patient discrimination index is created and validated on an independent cohort. Thus microbiota-targeted biomarkers may be a powerful tool for diagnosis of different diseases.	[Qin, Nan; Yang, Fengling; Li, Ang; Chen, Yanfei; Shao, Li; Guo, Jing; Yao, Jian; Wu, Lingjiao; Zhou, Jiawei; Ni, Shujun; Liu, Lin; Yuan, Chunhui; Ding, Wenchao; Chen, Yuanting; Hu, Xinjun; Zheng, Beiwen; Qian, Guirong; Xu, Wei; Li, Lanjuan] Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Qin, Nan; Shao, Li; Yao, Jian; Zheng, Beiwen; Zheng, Shusen; Li, Lanjuan] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Prifti, Edi; Le Chatelier, Emmanuelle; Pons, Nicolas; Batto, Jean Michel; Kennedy, Sean P.; Leonard, Pierre; Ehrlich, S. Dusko] INRA, Metagenopolis, F-78350 Jouy En Josas, France; [Ehrlich, S. Dusko] Kings Coll London, Dent Inst Cent Off, Guys Hosp, Ctr Host Microbiome Interact, London SE1 9RT, England; [Zheng, Shusen] Zhejiang Univ, Affiliated Hosp 1, Minist Publ Hlth, Key Lab Combined Multiorgan Transplantat, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	dusko.ehrlich@jouy.inra.fr; zyzsss@zju.edu.cn; ljli@zju.edu.cn	LE CHATELIER, Emmanuelle/O-1243-2017; Prifti, Edi/F-3967-2019; Ehrlich, S./Y-2423-2019; Jian, YAO/AAT-4231-2021	LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Prifti, Edi/0000-0001-8861-1305; Ehrlich, S./0000-0002-7563-4046; Jian, YAO/0000-0002-3746-1279; LI, Lanjuan/0000-0001-6945-0593; Kennedy, Sean/0000-0002-3932-8922; Yuan, Chunhui/0000-0002-0922-4209	National Program on Key Basic Research Project [2013CB531401]; National Natural Science Foundation of China [81301475, 81330011]; Science Fund for Creative Research Groups of the National Natural Science Foundation of China [81121002]; Technology Group Project for Infectious Disease Control of Zhejiang Province [2009R50041]; Metagenopolis [ANR-11-DPBS-0001]	National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Group Project for Infectious Disease Control of Zhejiang Province; Metagenopolis	This work was supported by the National Program on Key Basic Research Project (2013CB531401), the National Natural Science Foundation of China (81301475 and 81330011), the Science Fund for Creative Research Groups of the National Natural Science Foundation of China (81121002), the Technology Group Project for Infectious Disease Control of Zhejiang Province (2009R50041) and the Metagenopolis grant ANR-11-DPBS-0001. We thank Q. Cao, K. Su, J. Shao and A. Ghozlane for help with data computation, and H. Zhang, H. Lu, Q. Bao, J. Ge, J. Jiang, Z. Ren and M. Ye for assistance with sample collection. We are thankful to the MetaHIT consortium for generating the gut gene set and the Human Microbiome Project for generating the reference genomes from human gut microbes.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Bauer TM, 2002, AM J GASTROENTEROL, V97, P2364; Benten D, 2012, J HEPATOL, V56, P1221, DOI 10.1016/j.jhep.2012.03.003; Cesaro C, 2011, DIGEST LIVER DIS, V43, P431, DOI 10.1016/j.dld.2010.10.015; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; FERENCI P, 1983, LANCET, V2, P811; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Garcia-Tsao G, 2004, BEST PRACT RES CL GA, V18, P353, DOI 10.1016/j.bpg.2003.10.005; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hwang Jow-Jyh, 2002, Journal of Microbiology Immunology and Infection, V35, P65; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; KRIEGER D, 1995, LANCET, V346, P270, DOI 10.1016/S0140-6736(95)92164-8; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Marchandin H, 2001, EUR J CLIN MICROBIOL, V20, P340, DOI 10.1007/PL00011273; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MINUK GY, 1985, HEPATO-GASTROENTEROL, V32, P171; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nielsen H. B., 2014, NATURE BIOTECHNOL; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Wiest R, 2012, GUT, V61, P297, DOI 10.1136/gutjnl-2011-300779; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu M, 2012, MICROB ECOL, V63, P304, DOI 10.1007/s00248-011-9925-5; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	55	1146	1247	18	471	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					59	+		10.1038/nature13568	http://dx.doi.org/10.1038/nature13568			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25079328				2022-12-24	WOS:000341174800029
J	Hanage, WP				Hanage, William P.			Microbiome science needs a healthy dose of scepticism	NATURE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hanage, WP (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	whanage@hsph.harvard.edu	Hanage, Bill/CAF-1813-2022					Blaser MJ, 2014, MISSING MICROBES OVE; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Shanahan F, 2012, NUTR REV, V70, pS31, DOI 10.1111/j.1753-4887.2012.00502.x; Wilkins MR, 2006, PROTEOMICS, V6, P4, DOI 10.1002/pmic.200500856	9	136	139	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					247	248		10.1038/512247a	http://dx.doi.org/10.1038/512247a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN3SF	25143098	Bronze			2022-12-24	WOS:000340508200011
J	Duan, X; Krishnaswamy, A; De la Huerta, I; Sanes, JR				Duan, Xin; Krishnaswamy, Arjun; De la Huerta, Irina; Sanes, Joshua R.			Type II Cadherins Guide Assembly of a Direction-Selective Retinal Circuit	CELL			English	Article							N-CADHERIN; DIFFERENTIAL EXPRESSION; CLASSIC CADHERINS; GANGLION-CELLS; BIPOLAR CELLS; IDENTIFICATION; ORGANIZATION; DENDRITES; PROTOCADHERINS; MORPHOGENESIS	Complex retinal circuits process visual information and deliver it to the brain. Few molecular determinants of synaptic specificity in this system are known. Using genetic and optogenetic methods, we identified two types of bipolar interneurons that convey visual input from photoreceptors to a circuit that computes the direction in which objects are moving. We then sought recognition molecules that promote selective connections of these cells with previously characterized components of the circuit. We found that the type II cadherins, cdh8 and cdh9, are each expressed selectively by one of the two bipolar cell types. Using loss- and gain-of-function methods, we showed that they are critical determinants of connectivity in this circuit and that perturbation of their expression leads to distinct defects in visually evoked responses. Our results reveal cellular components of a retinal circuit and demonstrate roles of type II cadherins in synaptic choice and circuit function.	[Duan, Xin; Krishnaswamy, Arjun; De la Huerta, Irina; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Duan, Xin; Krishnaswamy, Arjun; De la Huerta, Irina; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Sanes, JR (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu	De la Huerta, Irina/V-1308-2018		NIH [NS029169, EY022073]; Natural Sciences and Engineering Research Council (NSERC); Banting Fellowship; Howard Hughes Medical Institute-Life Sciences Research Foundation (HHMI-LSRF) Fellowship; NATIONAL EYE INSTITUTE [R01EY022073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029169, R37NS029169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Banting Fellowship; Howard Hughes Medical Institute-Life Sciences Research Foundation (HHMI-LSRF) Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Takeichi for Cdh8<SUP>LacZ</SUP> mice, H. Zeng for Al27 mice; P. Arlotta for 5HT3R-GFP mice; M. Williams for the cdh9 cDNA; M. Yamagata, I-J. Kim, J. Kay, E. Soucy, and J. Greenwood for advice and assistance; J. Johnson (Penn Vector Core) for advice on AAV serotypes; and the Genome Modification Facility (GMF) at Harvard for generating mouse lines. This work was supported by grants from NIH (NS029169 and EY022073 to J.R.S.), a Natural Sciences and Engineering Research Council (NSERC) Fellowship to I.D.l.H., NSERC and Banting Fellowships to A.K., and a Howard Hughes Medical Institute-Life Sciences Research Foundation (HHMI-LSRF) Fellowship to X.D.	Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Biswas S, 2010, J CELL BIOL, V191, P1029, DOI 10.1083/jcb.201007008; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; De la Huerta I, 2012, P NATL ACAD SCI USA, V109, P17663, DOI 10.1073/pnas.1215806109; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Emanuela P, 2009, J COMP NEUROL, V517, P737, DOI 10.1002/cne.22200; Etzrodt J, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-153; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2009, NEUROSCIENCE, V160, P126, DOI 10.1016/j.neuroscience.2009.01.081; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Hong YK, 2011, J COMP NEUROL, V519, P1691, DOI 10.1002/cne.22595; Honjo M, 2000, INVEST OPHTH VIS SCI, V41, P546; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Kay JN, 2012, NATURE, V483, P465, DOI 10.1038/nature10877; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; Krishna-K K, 2011, NEUROSCIENCE, V175, P37, DOI 10.1016/j.neuroscience.2010.11.056; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; Morita H, 2010, DEVELOPMENT, V137, P1315, DOI 10.1242/dev.043190; Morrow EM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-2; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Pagnamenta AT, 2011, J MED GENET, V48, P48, DOI 10.1136/jmg.2010.079426; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Redies C, 1996, DEV BIOL, V180, P413, DOI 10.1006/dbio.1996.0315; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Sun LO, 2013, SCIENCE, V342, P590, DOI 10.1126/science.1241974; Suzuki SC, 2007, J NEUROSCI, V27, P3466, DOI 10.1523/JNEUROSCI.0243-07.2007; Tanabe K, 2006, DEVELOPMENT, V133, P4085, DOI 10.1242/dev.02566; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Trenholm S, 2011, NEURON, V71, P683, DOI 10.1016/j.neuron.2011.06.020; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wei W, 2011, TRENDS NEUROSCI, V34, P638, DOI 10.1016/j.tins.2011.08.002; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Wohrn JCP, 1998, J COMP NEUROL, V396, P20; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2006, MOL CELL NEUROSCI, V33, P296, DOI 10.1016/j.mcn.2006.08.001; Yamagata M, 2012, J NEUROSCI, V32, P14402, DOI 10.1523/JNEUROSCI.3193-12.2012; Yonehara K, 2013, NEURON, V79, P1078, DOI 10.1016/j.neuron.2013.08.005	67	132	133	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					793	807		10.1016/j.cell.2014.06.047	http://dx.doi.org/10.1016/j.cell.2014.06.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126785	Bronze			2022-12-24	WOS:000340944700011
J	Homem, CCF; Steinmann, V; Burkard, TR; Jais, A; Esterbauer, H; Knoblich, JA				Homem, Catarina C. F.; Steinmann, Victoria; Burkard, Thomas R.; Jais, Alexander; Esterbauer, Harald; Knoblich, Juergen A.			Ecdysone and Mediator Change Energy Metabolism to Terminate Proliferation in Drosophila Neural Stem Cells	CELL			English	Article							REGULATES SELF-RENEWAL; BRAIN-TUMOR; TRANSCRIPTION FACTORS; ASYMMETRIC SEGREGATION; LARVAL NEUROBLASTS; TEMPORAL IDENTITY; FACS PURIFICATION; NERVOUS-SYSTEM; BREAST-CANCER; PROTEIN	Stem cells are highly abundant during early development but become a rare population in most adult organs. The molecular mechanisms causing stem cells to exit proliferation at a specific time are not well understood. Here, we show that changes in energy metabolism induced by the steroid hormone ecdysone and the Mediator initiate an irreversible cascade of events leading to cell-cycle exit in Drosophila neural stem cells. We show that the timely induction of oxidative phosphorylation and the mitochondrial respiratory chain are required in neuroblasts to uncouple the cell cycle from cell growth. This results in a progressive reduction in neuroblast cell size and ultimately in terminal differentiation. Brain tumor mutant neuroblasts fail to undergo this shrinkage process and continue to proliferate until adulthood. Our findings show that cell size control can be modified by systemic hormonal signaling and reveal a unique connection between metabolism and proliferation in stem cells.	[Homem, Catarina C. F.; Steinmann, Victoria; Burkard, Thomas R.; Knoblich, Juergen A.] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Jais, Alexander; Esterbauer, Harald] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna	Knoblich, JA (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Jais, Alexander/AAQ-9102-2021	Knoblich, Juergen A/0000-0002-6751-3404; Jais, Alexander/0000-0002-9897-4983; Homem, Catarina/0000-0003-4243-0298; Esterbauer, Harald/0000-0001-7343-7455; Burkard, Thomas/0000-0002-0884-2929	Austrian Academy of Sciences; Austrian Science Fund (FWF) [I_552-B19, Z_153_B09]; European Research Council (ERC); Austrian Science Fund (FWF) [Z 153, I 1281] Funding Source: researchfish	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank T. Lendl, E. Eroglu, C. Jueschke, P. Serrano, J. Steinmann, I. Reichardt, H. Harzer, and M. Lancaster for experimental help and manuscript input. We thank the Vienna Drosophila Resource Center (VDRC), the Bloomington Drosophila Stock Center, G. Schmauss, G. Steng, P. Pasierbek, IMBA's fly-house, and the Campus Science Support Facilities Next Generation Sequencing Unit for technical support. We thank all the members of the J.A.K. laboratory for discussions. We thank J. Treisman, K. Keleman, and C. Doe for fly stocks and reagents. Work in the J.A.K. laboratory is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF; grants I_552-B19 and Z_153_B09), and an advanced grant of the European Research Council (ERC).	Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Berger C, 2012, CELL REP, V2, P407, DOI 10.1016/j.celrep.2012.07.008; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Cai JL, 2002, DEV BIOL, V251, P221, DOI 10.1006/dbio.2002.0828; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Ceron J, 2006, EUR J CELL BIOL, V85, P567, DOI 10.1016/j.ejcb.2006.02.006; Chai PC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001494; Chang KC, 2012, BIOESSAYS, V34, P301, DOI 10.1002/bies.201100090; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; COONEY GJ, 1981, BIOCHEM J, V200, P701, DOI 10.1042/bj2000701; Culig Z, 2014, CANCER METAST REV, V33, P413, DOI 10.1007/s10555-013-9474-0; Fernandez-Hernandez I, 2013, CELL REP, V3, P1857, DOI 10.1016/j.celrep.2013.05.034; FRERMAN FE, 1985, P NATL ACAD SCI USA, V82, P4517, DOI 10.1073/pnas.82.13.4517; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Harzer H, 2013, NAT PROTOC, V8, P1088, DOI 10.1038/nprot.2013.062; HAY BA, 1994, DEVELOPMENT, V120, P2121; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; Homem CCF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079588; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Iglesias-Bartolome R, 2011, CURR OPIN CELL BIOL, V23, P716, DOI 10.1016/j.ceb.2011.08.002; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalyani AJ, 1998, BIOCHEM CELL BIOL, V76, P1051, DOI 10.1139/bcb-76-6-1051; Kamoshida Y, 2012, BIOCHEM BIOPH RES CO, V421, P203, DOI 10.1016/j.bbrc.2012.03.135; Kirilly D, 2011, NEURON, V72, P86, DOI 10.1016/j.neuron.2011.08.003; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Kohlmaier A, 2008, CURR OPIN CELL BIOL, V20, P699, DOI 10.1016/j.ceb.2008.10.002; Kozlova T, 2002, DEVELOPMENT, V129, P1739; Kucherenko MM, 2012, EMBO J, V31, P4511, DOI 10.1038/emboj.2012.298; Kugler SJ, 2011, GENETICS, V188, P127, DOI 10.1534/genetics.111.127795; Laporte D, 2011, J CELL BIOL, V192, P949, DOI 10.1083/jcb.201009028; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; LONGO N, 1992, J BIOL CHEM, V267, P12416; Loop T, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-24; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; Napoli C, 2012, BIOCHIMIE, V94, P579, DOI 10.1016/j.biochi.2011.09.016; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Ou QX, 2013, CURR TOP DEV BIOL, V103, P35, DOI 10.1016/B978-0-12-385979-2.00002-2; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Tretter L, 2000, J NEUROSCI, V20, P8972; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; von Trotha JW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-9; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; ZELHOF AC, 1995, MOL CELL BIOL, V15, P6736; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	76	125	127	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					874	888		10.1016/j.cell.2014.06.024	http://dx.doi.org/10.1016/j.cell.2014.06.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126791	Bronze			2022-12-24	WOS:000340944700017
J	Michaletz, ST; Cheng, DL; Kerkhoff, AJ; Enquist, BJ				Michaletz, Sean T.; Cheng, Dongliang; Kerkhoff, Andrew J.; Enquist, Brian J.			Convergence of terrestrial plant production across global climate gradients	NATURE			English	Article							NET PRIMARY PRODUCTION; GENERAL QUANTITATIVE THEORY; TROPICAL FORESTS; TREE SIZE; TEMPERATURE-DEPENDENCE; USE EFFICIENCY; GROWTH; ECOSYSTEM; RESPIRATION; PRECIPITATION	Variation in terrestrial net primary production (NPP) with climate is thought to originate from a direct influence of temperature and precipitation on plant metabolism. However, variation in NPP may also result from an indirect influence of climate by means of plant age, stand biomass, growing season length and local adaptation. To identify the relative importance of direct and indirect climate effects, we extend metabolic scaling theory to link hypothesized climate influences with NPP, and assess hypothesized relationships using a global compilation of ecosystem woody plant biomass and production data. Notably, age and biomass explained most of the variation in production whereas temperature and precipitation explained almost none, suggesting that climate indirectly (not directly) influences production. Furthermore, our theory shows that variation in NPP is characterized by a common scaling relationship, suggesting that global change models can incorporate the mechanisms governing this relationship to improve predictions of future ecosystem function.	[Michaletz, Sean T.; Enquist, Brian J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Cheng, Dongliang] Fujian Normal Univ, Minist Educ, Key Lab Humid Subtrop Ecogeog Proc, Fuzhou 350007, Fujian, Peoples R China; [Kerkhoff, Andrew J.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Enquist, Brian J.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Enquist, Brian J.] The iPlant Collaborat, Tucson, AZ 85721 USA; [Enquist, Brian J.] Aspen Ctr Environm Studies, Aspen, CO 81611 USA	University of Arizona; Fujian Normal University; Kenyon College; The Santa Fe Institute	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	chengdl@fjnu.edu.cn; benquist@email.arizona.edu	Enquist, Brian J/B-6436-2008; Michaletz, Sean/AAO-8175-2021	Enquist, Brian J/0000-0002-6124-7096; Michaletz, Sean/0000-0003-2158-6525; Kerkhoff, Andrew/0000-0001-9617-8687	NSF [1065861]; Aspen Center for Environmental Studies; National Natural Science Foundation of China [31170374, 31370589]; Fujian Natural Science Funds for Distinguished Young Scholar [2013J06009]; National Science Foundation [1065861]; Emerging Frontiers [1065861] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Aspen Center for Environmental Studies; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Natural Science Funds for Distinguished Young Scholar; National Science Foundation(National Science Foundation (NSF)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	S.T.M. and B.J.E. were supported by an NSF MacroSystems award (1065861) and a fellowship from the Aspen Center for Environmental Studies. D.C. was supported by the National Natural Science Foundation of China (31170374 and 31370589) and Fujian Natural Science Funds for Distinguished Young Scholar (2013J06009). A.J.K. was supported by a sabbatical supplement from Kenyon College, and by a National Science Foundation ROA supplement (1065861) to the NSF MacroSystems award (1065861) to B.J.E.	Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; BONAN GB, 1993, TELLUS B, V45, P397, DOI 10.1034/j.1600-0889.1993.t01-4-00001.x; Brett MT, 2004, OIKOS, V105, P647, DOI 10.1111/j.0030-1299.2004.12777.x; Brooks JR, 2010, NAT GEOSCI, V3, P100, DOI 10.1038/NGEO722; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Cannell MGR, 1982, WORLD FOREST BIOMASS; Chapin FS, 2003, ANN BOT-LONDON, V91, P455, DOI 10.1093/aob/mcg041; Clark DA, 2001, ECOL APPL, V11, P371, DOI 10.1890/1051-0761(2001)011[0371:NPPITF]2.0.CO;2; DeLucia EH, 2007, GLOBAL CHANGE BIOL, V13, P1157, DOI 10.1111/j.1365-2486.2007.01365.x; Enquist B.J., 2012, METAB ECOL SCALING A, P164, DOI [10.1002/, DOI 10.1002/9781119968535.CH14]; Enquist BJ, 2007, NATURE, V449, P218, DOI 10.1038/nature06061; Enquist BJ, 2007, GLOBAL CHANGE BIOL, V13, P591, DOI 10.1111/j.1365-2486.2006.01222.x; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; Fredlund D. G., 2012, UNSATURATED SOIL MEC; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Gower ST, 1996, TRENDS ECOL EVOL, V11, P378, DOI 10.1016/0169-5347(96)10042-2; Hasler R, 1999, PHYTON-ANN REI BOT A, V39, P47; Helliker BR, 2008, NATURE, V454, P511, DOI 10.1038/nature07031; Huston MA, 2012, ECOL MONOGR, V82, P277, DOI 10.1890/11-1927.1; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; Kerkhoff AJ, 2006, ECOL LETT, V9, P419, DOI 10.1111/j.1461-0248.2006.00888.x; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Larjavaara M, 2010, FUNCT ECOL, V24, P701, DOI 10.1111/j.1365-2435.2010.01698.x; Lieth H, 1975, PRIMARY PRODUCTIVITY; Luo T. X., 1996, THESIS CHINESE ACAD; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Niklas KJ, 2003, ECOL LETT, V6, P405, DOI 10.1046/j.1461-0248.2003.00440.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Ryan T., 1997, MODERN REGRESSION ME; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; WHITTAKER RH, 1970, COMMUNITIES ECOSYSTE; Wright IJ, 1999, J ECOL, V87, P85, DOI 10.1046/j.1365-2745.1999.00330.x; Yvon-Durocher G, 2012, NATURE, V487, P472, DOI 10.1038/nature11205	49	204	223	21	318	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					39	+		10.1038/nature13470	http://dx.doi.org/10.1038/nature13470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043056				2022-12-24	WOS:000339908000026
J	Muller, PA; Koscso, B; Rajani, GM; Stevanovic, K; Berres, ML; Hashimoto, D; Mortha, A; Leboeuf, M; Li, XM; Mucida, D; Stanley, ER; Dahan, S; Margolis, KG; Gershon, MD; Merad, M; Bogunovic, M				Muller, Paul Andrew; Koscso, Balazs; Rajani, Gaurav Manohar; Stevanovic, Korey; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Li, Xiu-Min; Mucida, Daniel; Stanley, E. Richard; Dahan, Stephanie; Margolis, Kara Gross; Gershon, Michael David; Merad, Miriam; Bogunovic, Milena			Crosstalk between Muscularis Macrophages and Enteric Neurons Regulates Gastrointestinal Motility	CELL			English	Article							IRRITABLE-BOWEL-SYNDROME; INTERSTITIAL-CELLS; SYNAPTIC GROWTH; NERVOUS-SYSTEM; BACTERIAL OVERGROWTH; LANGERHANS CELLS; DENDRITIC CELL; RECEPTOR; MICE; 5-HYDROXYTRYPTAMINE	Intestinal peristalsis is a dynamic physiologic process influenced by dietary and microbial changes. It is tightly regulated by complex cellular interactions; however, our understanding of these controls is incomplete. A distinct population of macrophages is distributed in the intestinal muscularis externa. We demonstrate that, in the steady state, muscularis macrophages regulate peristaltic activity of the colon. They change the pattern of smooth muscle contractions by secreting bone morphogenetic protein 2 (BMP2), which activates BMP receptor (BMPR) expressed by enteric neurons. Enteric neurons, in turn, secrete colony stimulatory factor 1 (CSF1), a growth factor required for macrophage development. Finally, stimuli from microbial commensals regulate BMP2 expression by macrophages and CSF1 expression by enteric neurons. Our findings identify a plastic, microbiotadriven crosstalk between muscularis macrophages and enteric neurons that controls gastrointestinal motility.	[Muller, Paul Andrew; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Merad, Miriam; Bogunovic, Milena] Mt Sinai Hosp, Icahn Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Muller, Paul Andrew; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Merad, Miriam; Bogunovic, Milena] Mt Sinai Hosp, Icahn Sch Med, Tisch Canc Inst, New York, NY 10029 USA; [Muller, Paul Andrew; Berres, Marie-Luise; Hashimoto, Daigo; Mortha, Arthur; Leboeuf, Marylene; Merad, Miriam; Bogunovic, Milena] Mt Sinai Hosp, Icahn Sch Med, Inst Immunol, New York, NY 10029 USA; [Dahan, Stephanie] Mt Sinai Hosp, Icahn Sch Med, Dept Med, Div Clin Immunol, New York, NY 10029 USA; [Li, Xiu-Min] Mt Sinai Hosp, Icahn Sch Med, Dept Pediat, Div Allergy & Immunol, New York, NY 10029 USA; [Li, Xiu-Min] Mt Sinai Hosp, Icahn Sch Med, Jaffe Food Allergy Inst, New York, NY 10029 USA; [Koscso, Balazs; Rajani, Gaurav Manohar; Bogunovic, Milena] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Koscso, Balazs; Rajani, Gaurav Manohar; Bogunovic, Milena] Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Stevanovic, Korey; Margolis, Kara Gross] Columbia Univ, Morgan Stanley Childrens Hosp, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Gershon, Michael David] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Muller, Paul Andrew; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Columbia University; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	Merad, M (corresponding author), Mt Sinai Hosp, Icahn Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	miriam.merad@mssm.edu; mbogunovich@hmc.psu.edu	Mortha, Arthur/ABE-6250-2020; Rajani, Gaurav Manohar/AAX-9919-2021; Stanley, Evan R/J-9154-2013; Berres, Marie-Luise/AAN-5351-2021; Hashimoto, Daigo/O-1013-2013	Stanley, Evan R/0000-0002-2910-2065; Hashimoto, Daigo/0000-0001-9489-9704; Mortha, Arthur/0000-0003-2673-0485; Stevanovic, Korey/0000-0003-4453-1631; Koscso, Balazs/0000-0001-9676-2066; Muller, Paul/0000-0002-1957-4763; Mucida, Daniel/0000-0002-0000-0452	NIH [AI09561, CA173861, AI104848, CA32551, R21-AI105047]; Career Development Award from the CCFA; PCARS from the NIAID; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA032551, R01CA173861, R01CA154947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095611, R01AI104848, R21AI105047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK093786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award from the CCFA; PCARS from the NIAID; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Immgen Project (http://www.immgen.org) for performing a whole-mouse genome microarray and the Penn State Hershey Flow Cytometry Core Facility and the Mount Sinai Flow Cytometry Core for assistance with our experiments. We also thank Frederico Costa Pinta (Rockefeller University, New York, NY, and School of Veterinary Medicine, University of Sao Paulo, Brazil), Hongyan Zou (Icahn School of Medicine at Mount Sinai Hospital, New York, NY), and Florent Ginhoux (Singapore Immunology Network and Agency for Science, Technology and Research, Singapore) for productive discussions regarding the study, and Aron Lukacher (Penn State University College of Medicine, Hershey, PA) for help with the manuscript. This work was supported in part by grants from the NIH (AI09561, CA173861, and AI104848 to M.M.; CA32551 to E.R.S; and R21-AI105047 to D.M.), as well as a Career Development Award from the CCFA and PCARS from the NIAID (M.B.).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; ABRAMS GD, 1967, P SOC EXP BIOL MED, V126, P301; Anderson L, 2010, AM J PHYSIOL-REG I, V298, pR833, DOI 10.1152/ajpregu.00534.2009; Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Bogunovic M, 2012, IMMUNOL RES, V54, P37, DOI 10.1007/s12026-012-8323-5; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; BULBRING E, 1959, J PHYSIOL-LONDON, V146, P29; BULBRING E, 1959, J PHYSIOL-LONDON, V146, P18; Chalazonitis A, 2004, J NEUROSCI, V24, P4266, DOI 10.1523/JNEUROSCI.3688-03.2004; Chalazonitis A, 2008, J COMP NEUROL, V509, P474, DOI 10.1002/cne.21770; Chalazonitis A, 2011, DEV BIOL, V350, P64, DOI 10.1016/j.ydbio.2010.11.017; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Dahan S, 2011, GASTROENTEROLOGY, V140, P550, DOI 10.1053/j.gastro.2010.10.057; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Faure C, 2007, DEV DYNAM, V236, P44, DOI 10.1002/dvdy.20943; Flores-Langarica A, 2005, P NATL ACAD SCI USA, V102, P19039, DOI 10.1073/pnas.0504253102; FRIGO GM, 1970, BRIT J PHARMACOL, V39, P346, DOI 10.1111/j.1476-5381.1970.tb12898.x; Fu M, 2006, DEV BIOL, V299, P137, DOI 10.1016/j.ydbio.2006.07.016; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Goldstein AM, 2005, MECH DEVELOP, V122, P821, DOI 10.1016/j.mod.2005.03.003; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; GUSTAFSSON BE, 1970, SCAND J GASTROENTERO, V5, P309; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Helbing T, 2011, BLOOD, V118, P5040, DOI 10.1182/blood-2011-03-339762; Heredia DJ, 2013, J PHYSIOL-LONDON, V591, P5939, DOI 10.1113/jphysiol.2013.256230; Hoffman SM, 2010, CELL BIOCHEM FUNCT, V28, P686, DOI 10.1002/cbf.1709; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Li ZS, 2006, J NEUROSCI, V26, P2798, DOI 10.1523/JNEUROSCI.4720-05.2006; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Mikkelsen HB, 2010, J CELL MOL MED, V14, P818, DOI 10.1111/j.1582-4934.2010.01025.x; MIKKELSEN HB, 1985, ANAT REC, V213, P77, DOI 10.1002/ar.1092130111; Mikkelsen HB, 1999, CELL TISSUE RES, V295, P485, DOI 10.1007/s004410051254; MIKKELSEN HB, 1992, CELL TISSUE RES, V270, P273, DOI 10.1007/BF00328013; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Nahm M, 2013, NEURON, V77, P680, DOI 10.1016/j.neuron.2012.12.015; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Peralta S, 2009, WORLD J GASTROENTERO, V15, P2628, DOI 10.3748/wjg.15.2628; Pimentel M, 2003, AM J GASTROENTEROL, V98, P412, DOI 10.1016/S0002-9270(02)05902-6; Pimentel M, 2002, DIGEST DIS SCI, V47, P2639, DOI 10.1023/A:1021039032413; Pimentel M, 2000, AM J GASTROENTEROL, V95, P3503, DOI 10.1111/j.1572-0241.2000.03368.x; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reigstad CS, 2013, NEUROGASTROENT MOTIL, V25, P358, DOI 10.1111/nmo.12134; Rumessen JJ, 2003, INT REV CYTOL, V229, P115, DOI 10.1016/S0074-7696(03)29004-5; Sudo T, 1995, ONCOGENE, V11, P2469; Swapna I, 2012, P NATL ACAD SCI USA, V109, P16336, DOI 10.1073/pnas.1202818109; Tornblom H, 2002, GASTROENTEROLOGY, V123, P1972, DOI 10.1053/gast.2002.37059; Uramatsu M, 2010, MICROBIOL IMMUNOL, V54, P330, DOI 10.1111/j.1348-0421.2010.00217.x; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Wiktor-Jedrzejczak W., 1991, NATURE, V19, P1049; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang HB, 1996, DEVELOPMENT, V122, P2977	65	339	346	4	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					300	313		10.1016/j.cell.2014.04.050	http://dx.doi.org/10.1016/j.cell.2014.04.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036630	Green Accepted, Bronze			2022-12-24	WOS:000340943600011
J	Lu, M; Lawrence, DA; Marsters, S; Acosta-Alvear, D; Kimmig, P; Mendez, AS; Paton, AW; Paton, JC; Walter, P; Ashkenazi, A				Lu, Min; Lawrence, David A.; Marsters, Scot; Acosta-Alvear, Diego; Kimmig, Philipp; Mendez, Aaron S.; Paton, Adrienne W.; Paton, James C.; Walter, Peter; Ashkenazi, Avi			Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEPENDENT UP-REGULATION; ER STRESS; DOWN-REGULATION; CELL-DEATH; PATHWAY; ACTIVATION; EXPRESSION; CASPASE-2; TRAIL	Protein folding by the endoplasmic reticulum (ER) is physiologically critical; its disruption causes ER stress and augments disease. ER stress activates the unfolded protein response (UPR) to restore homeostasis. If stress persists, the UPR induces apoptotic cell death, but the mechanisms remain elusive. Here, we report that unmitigated ER stress promoted apoptosis through cell-autonomous, UPR-controlled activation of death receptor 5 (DR5). ER stressors induced DR5 transcription via the UPR mediator CHOP; however, the UPR sensor IRE1 alpha transiently catalyzed DR5 mRNA decay, which allowed time for adaptation. Persistent ER stress built up intracellular DR5 protein, driving ligand-independent DR5 activation and apoptosis engagement via caspase-8. Thus, DR5 integrates opposing UPR signals to couple ER stress and apoptotic cell fate.	[Lu, Min; Lawrence, David A.; Marsters, Scot; Ashkenazi, Avi] Genentech Inc, Canc Immunol, San Francisco, CA 94080 USA; [Acosta-Alvear, Diego; Kimmig, Philipp; Mendez, Aaron S.; Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Acosta-Alvear, Diego; Kimmig, Philipp; Mendez, Aaron S.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Roche Holding; Genentech; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Adelaide	Walter, P (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	peter@walterlab.ucsf.edu; aa@gene.com	Acosta-Alvear, Diego/V-8048-2019; Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589; Acosta-Alvear, Diego/0000-0002-1139-8486	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM032384, T32 GM064337] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337, R01GM032384] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Korennykh A, 2012, ANNU REV CELL DEV BI, V28, P251, DOI 10.1146/annurev-cellbio-101011-155826; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Martin-Perez R, 2012, APOPTOSIS, V17, P349, DOI 10.1007/s10495-011-0673-2; Niederreiter L, 2013, J EXP MED, V210, P2041, DOI 10.1084/jem.20122341; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Salvesen GS, 2011, CELL, V147, DOI 10.1016/j.cell.2011.09.030; Sandow JJ, 2014, CELL DEATH DIFFER, V21, P475, DOI 10.1038/cdd.2013.168; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	25	379	400	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					98	101		10.1126/science.1254312	http://dx.doi.org/10.1126/science.1254312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24994655	Green Accepted			2022-12-24	WOS:000338284400059
J	Moura-Alves, P; Fae, K; Houthuys, E; Dorhoi, A; Kreuchwig, A; Furkert, J; Barison, N; Diehl, A; Munder, A; Constant, P; Skrahina, T; Guhlich-Bornhof, U; Klemm, M; Koehler, AB; Bandermann, S; Goosmann, C; Mollenkopf, HJ; Hurwitz, R; Brinkmann, V; Fillatreau, S; Daffe, M; Tummler, B; Kolbe, M; Oschkinat, H; Krause, G; Kaufmann, SHE				Moura-Alves, Pedro; Fae, Kellen; Houthuys, Erica; Dorhoi, Anca; Kreuchwig, Annika; Furkert, Jens; Barison, Nicola; Diehl, Anne; Munder, Antje; Constant, Patricia; Skrahina, Tatsiana; Guhlich-Bornhof, Ute; Klemm, Marion; Koehler, Anne-Britta; Bandermann, Silke; Goosmann, Christian; Mollenkopf, Hans-Joachim; Hurwitz, Robert; Brinkmann, Volker; Fillatreau, Simon; Daffe, Mamadou; Tuemmler, Burkhard; Kolbe, Michael; Oschkinat, Hartmut; Krause, Gerd; Kaufmann, Stefan H. E.			AhR sensing of bacterial pigments regulates antibacterial defence	NATURE			English	Article							ARYL-HYDROCARBON RECEPTOR; LIGAND-BINDING DOMAIN; PSEUDOMONAS-AERUGINOSA; GENE BATTERY; PYOCYANIN; ACTIVATION; EXPRESSION; TOXICITY; DIFFERENTIATION; IDENTIFICATION	The aryl hydrocarbon receptor (AhR) is a highly conserved ligand-dependent transcription factor that senses environmental toxins and endogenous ligands, thereby inducing detoxifying enzymes and modulating immune cell differentiation and responses. We hypothesized that AhR evolved to sense not only environmental pollutants but also microbial insults. We characterized bacterial pigmented virulence factors, namely the phenazines from Pseudomonas aeruginosa and the naphthoquinone phthiocol from Mycobacterium tuberculosis, as ligands of AhR Upon ligand binding, AhR activation leads to virulence factor degradation and regulated cytokine and chemokine production The relevance of AhR to host defence is underlined by heightened susceptibility of AhR-deficient mice to both P. aeruginosa and M. tuberculosis. Thus, we demonstrate that AhR senses distinct bacterial virulence factors and controls antibacterial responses, supporting a previously unidentified role for AhR as an intracellular pattern recognition receptor, and identify bacterial pigments as a new class of pathogen-associated molecular patterns.	[Moura-Alves, Pedro; Fae, Kellen; Houthuys, Erica; Dorhoi, Anca; Skrahina, Tatsiana; Guhlich-Bornhof, Ute; Klemm, Marion; Koehler, Anne-Britta; Bandermann, Silke; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany; [Kreuchwig, Annika; Furkert, Jens; Diehl, Anne; Oschkinat, Hartmut; Krause, Gerd] Leibniz Inst Mol Pharmacol FMP, D-13125 Berlin, Germany; [Barison, Nicola; Kolbe, Michael] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Munder, Antje; Tuemmler, Burkhard] Hannover Med Sch, Clin Res Grp, Clin Pediat Pneumol Allergol & Neonatol, D-30625 Hannover, Germany; [Constant, Patricia; Daffe, Mamadou] CNRS, IPBS, F-31077 Toulouse 04, France; [Constant, Patricia; Daffe, Mamadou] Univ Toulouse 3, F-31077 Toulouse 04, France; [Goosmann, Christian; Brinkmann, Volker] Max Planck Inst Infect Biol, Dept Immunol, Microscopy Core Facil, D-10117 Berlin, Germany; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Dept Immunol, Microarray Core Facil, D-10117 Berlin, Germany; [Hurwitz, Robert] Max Planck Inst Infect Biol, Prot Purificat Core Facil, D-10117 Berlin, Germany; [Fillatreau, Simon] German Rheumatism Res Ctr Berlin DRFZ, D-10117 Berlin, Germany	Max Planck Society; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Max Planck Society; Hannover Medical School; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Max Planck Society; Max Planck Society; Max Planck Society; Deutsches Rheuma-Forschungszentrum (DRFZ)	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Charitepl 1, D-10117 Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Mollenkopf, Hans-Joachim/AAH-2500-2019; Brinkmann, Volker/A-6015-2009; Moura-Alves, Pedro/R-7727-2016; Alves, Pedro Moura/AAX-6854-2020; Kaufmann, Stefan HE/I-5454-2014	Moura-Alves, Pedro/0000-0003-4337-9113; Fillatreau, Simon/0000-0002-7730-9917; Diehl, Anne/0000-0001-7295-9972; Mollenkopf, Hans-Joachim/0000-0003-1167-4783; Kaufmann, Stefan HE/0000-0001-9866-8268; Oschkinat, Hartmut/0000-0002-4384-9544; Munder, Antje/0000-0002-3198-8336	European Union [Health-F3-2009-241745, Health-F4-2008-223451]	European Union(European Commission)	The authors are highly grateful to J. Welch for his contribution in the early stage of research, and for support in AhR ligand screening,A. Zychlinsky and L. E. Dietrich for discussions, H.-G. Hoymann for support in lung function measurements and interpretation of results, U. Klemm for mouse breeding and M. L. Grossman for excellent support in preparing the manuscript. Ahr<SUP>-/-</SUP> mice were provided by B. Stockinger and shRNA constructs by D. Krastev and F. Buchholz. The PA14 WT2 and PA14 Delta phz1/2 were a gift from D. K. Newman and L. E. Dietrich. M. Kolbe acknowledges grant support from the European Union's Seventh Framework Programmes (EU-FP7/2007-2013). S.H.E.K. acknowledges grant support from the European Union's Seventh Framework Programmes (EU-FP7) NEWTBVAC (Health-F3-2009-241745) and PHAGOSYS (Health-F4-2008-223451).	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Barouki Robert, 2012, Drug Metabolism and Drug Interactions, V27, P3, DOI 10.1515/dmdi-2011-0035; Bisson WH, 2009, J MED CHEM, V52, P5635, DOI 10.1021/jm900199u; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Casado FL, 2010, BLOOD CELL MOL DIS, V44, P199, DOI 10.1016/j.bcmd.2010.01.005; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cheon H, 2007, EXP MOL MED, V39, P524, DOI 10.1038/emm.2007.58; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Denning GM, 2003, AM J PHYSIOL-LUNG C, V285, pL584, DOI 10.1152/ajplung.00086.2003; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Echenique P, 2007, MOL PHYS, V105, P3057, DOI 10.1080/00268970701757875; Eisele NA, 2011, J PATHOG, V2011, DOI 10.4061/2011/249802; Fan MQ, 2009, ANAL BIOCHEM, V384, P279, DOI 10.1016/j.ab.2008.10.003; Farmahin R, 2013, TOXICOL SCI, V131, P139, DOI 10.1093/toxsci/kfs259; Fraccalvieri D, 2013, BIOCHEMISTRY-US, V52, P714, DOI 10.1021/bi301457f; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Gardner PR, 1996, ARCH BIOCHEM BIOPHYS, V333, P267, DOI 10.1006/abbi.1996.0390; Goldberg JB, 2000, TRENDS MICROBIOL, V8, P514, DOI 10.1016/S0966-842X(00)01872-2; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jensen Brenda A, 2003, Environ Health, V2, P16, DOI 10.1186/1476-069X-2-16; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kerr J.R., 2000, INFECT DIS REV, V2, P184; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lai ZW, 1996, CHEM-BIOL INTERACT, V100, P97, DOI 10.1016/0009-2797(96)03691-5; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Lee YC, 2011, AM J RESP CELL MOL, V45, P270, DOI 10.1165/rcmb.2010-0313OC; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morrissey JP, 2004, PSEUDOMONAS, VOL 3: BIOSYNTHESIS OF MACROMOLECULES AND MOLECULAR METABOLISM, P637; Motto I, 2011, J CHEM INF MODEL, V51, P2868, DOI 10.1021/ci2001617; Muller M, 2011, FREE RADICAL BIO MED, V50, P971, DOI 10.1016/j.freeradbiomed.2011.01.012; Munder A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-148; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; Reszka KJ, 2012, AM J PHYSIOL-LUNG C, V302, pL1044, DOI 10.1152/ajplung.00172.2011; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schrenk D, 1998, BIOCHEM PHARMACOL, V55, P1155; SCHUSTER MG, 1994, AIDS, V8, P1437, DOI 10.1097/00002030-199410000-00010; Smith KJ, 2011, J PHARMACOL EXP THER, V338, P318, DOI 10.1124/jpet.110.178392; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vogel CFA, 2009, BIOCHEM PHARMACOL, V77, P734, DOI 10.1016/j.bcp.2008.09.036; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; WILSON R, 1987, J CLIN INVEST, V79, P221, DOI 10.1172/JCI112787; WILSON R, 1988, INFECT IMMUN, V56, P2515, DOI 10.1128/IAI.56.9.2515-2517.1988; Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109	67	230	245	6	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					387	U332		10.1038/nature13684	http://dx.doi.org/10.1038/nature13684			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25119038				2022-12-24	WOS:000340840600024
J	Nguyen, PD; Hollway, GE; Sonntag, C; Miles, LB; Hall, TE; Berger, S; Fernandez, KJ; Gurevich, DB; Cole, NJ; Alaei, S; Ramialison, M; Sutherland, RL; Polo, JM; Lieschke, GJ; Currie, PD				Phong Dang Nguyen; Hollway, Georgina Elizabeth; Sonntag, Carmen; Miles, Lee Barry; Hall, Thomas Edward; Berger, Silke; Fernandez, Kristine Joy; Gurevich, David Baruch; Cole, Nicholas James; Alaei, Sara; Ramialison, Mirana; Sutherland, Robert Lyndsay; Polo, Jose Maria; Lieschke, Graham John; Currie, Peter David			Haematopoietic stem cell induction by somite-derived endothelial cells controlled by meox1	NATURE			English	Article							TRANSGENIC ZEBRAFISH; AORTIC ENDOTHELIUM; SMOOTH-MUSCLE; PROGENITORS; BLOOD; EXPRESSION; HEDGEHOG; IDENTIFICATION; MESODERM; DATABASE	Haematopoietic stem cells (HSCs) are self-renewing stem cells capable of replenishing all blood lineages. In all vertebrate embryos that have been studied, definitive HSCs are generated initially within the dorsal aorta (DA) of the embryonic vasculature by a series of poorly understood inductive events(1-3). Previous studies have identified that signalling relayed from adjacent somites coordinates HSC induction, but the nature of this signal has remained elusive(4). Here we reveal that somite specification of HSCs occurs via the deployment of a specific endothelial precursor population, which arises within a sub-compartment of the zebrafish somite that we have defined as the endotome. Endothelial cells of the endotomeare specified within the nascent somite by the activity of the homeobox genemeox(1). Specified endotomal cells consequently migrate and colonize the DA, where they induce HSC formation through the deployment of chemokine signalling activated in these cells during endotome formation. Loss of meox(1) activity expands the endotome at the expense of a second somitic cell type, the muscle precursors of the dermomyotomal equivalent in zebrafish, the external cell layer. The resulting increase in endotome-derived cells that migrate to colonize the DA generates a dramatic increase in chemokine-dependent HSC induction. This study reveals the molecular basis for a novel somite lineage restriction mechanism and defines a new paradigm in induction of definitive HSCs.	[Phong Dang Nguyen; Sonntag, Carmen; Miles, Lee Barry; Hall, Thomas Edward; Berger, Silke; Gurevich, David Baruch; Alaei, Sara; Ramialison, Mirana; Polo, Jose Maria; Lieschke, Graham John; Currie, Peter David] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Hollway, Georgina Elizabeth; Fernandez, Kristine Joy; Sutherland, Robert Lyndsay] Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia; [Hollway, Georgina Elizabeth; Fernandez, Kristine Joy; Sutherland, Robert Lyndsay] Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Hollway, Georgina Elizabeth; Sutherland, Robert Lyndsay] Univ New S Wales, Fac Med, St Vincents Clin Sch, Kensington, NSW 2052, Australia; [Cole, Nicholas James] Univ Sydney, Sch Med, Dept Anat, Camperdown, NSW 2006, Australia; [Cole, Nicholas James] Macquarie Univ, Australian Sch Adv Med, MND Res Program, N Ryde, NSW 2109, Australia; [Alaei, Sara] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Currie, Peter David] Monash Univ, EMBL Australia, Clayton, Vic 3800, Australia	Australian Regenerative Medicine Institute; Monash University; Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney; Macquarie University; Monash University; European Molecular Biology Laboratory (EMBL); Monash University	Currie, PD (corresponding author), Monash Univ, Australian Regenerat Med Inst, Level 1,Bldg 75,Wellington Rd, Clayton, Vic 3800, Australia.	peter.currie@monash.edu	Ramialison, Mirana/AEG-6305-2022; Hollway, Georgina E/E-6764-2010; cole, nicholas/M-7010-2016; Hall, Thomas/J-2125-2014	Cole, Nicholas/0000-0003-1006-2662; Ramialison, Mirana/0000-0001-6315-4777; Alaei, Sara/0000-0003-4897-6339; Hall, Thomas/0000-0002-7718-7614; Currie, Peter/0000-0001-8874-8862; Nguyen, Phong Dang/0000-0003-1889-3276; Gurevich, David/0000-0002-7194-7520; Sonntag, Carmen/0000-0003-2560-1710; Lieschke, Graham/0000-0003-0325-798X; Miles, Lee/0000-0002-2718-1353; Polo, Jose M/0000-0002-2531-778X	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council; Cancer Institute NSW (CINSW); Australian Postgraduate Award; NHMRC; CINSW; RT Hall Foundation; State Government of Victoria; Australian Federal Government	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cancer Institute NSW (CINSW); Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CINSW; RT Hall Foundation; State Government of Victoria; Australian Federal Government(Australian Government)	We thank G. Kardon and B. Hogan for reading and critique of the manuscript. We also thank C.-H. Wang, F. Ellett, V. Nikolova-Krstevski and Fishcore staff for technical assistance. This work was supported by a National Health and Medical Research Council of Australia (NHMRC) grant to P. D. C. and an Australian Research Council grant to P. D. C. and G. E. H.; G. E. H. was supported by a Cancer Institute NSW (CINSW) Career Development Fellowship, R. L. S. by the CINSW and RT Hall Foundation, P.D.N. by an Australian Postgraduate Award, G.J.L. by a NHMRC Senior Research Fellowship and P. D. C. by a NHMRC Principal Research Fellowship. The Australian Regenerative Medicine Institute is supported by funds from the State Government of Victoria and the Australian Federal Government.	Ben-Yair R, 2008, J CELL BIOL, V180, P607, DOI 10.1083/jcb.200707206; Berger J, 2013, GENESIS, V51, P443, DOI 10.1002/dvg.22385; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140; Cerdan C, 2010, INT J DEV BIOL, V54, P955, DOI 10.1387/ijdb.103067cc; Cha YR, 2012, DEV CELL, V22, P824, DOI 10.1016/j.devcel.2012.01.011; Childs S, 2002, DEVELOPMENT, V129, P973; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Esner M, 2006, DEVELOPMENT, V133, P737, DOI 10.1242/dev.02226; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Hollway GE, 2007, DEV CELL, V12, P207, DOI 10.1016/j.devcel.2007.01.001; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Johnson JLFA, 2012, DEV BIOL, V368, P193, DOI 10.1016/j.ydbio.2012.05.007; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kohli V, 2013, DEV CELL, V25, P196, DOI 10.1016/j.devcel.2013.03.017; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li Q, 2005, J NEUROSCI, V25, P1711, DOI 10.1523/JNEUROSCI.4393-04.2005; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Ma DD, 2011, BLOOD, V118, P289, DOI 10.1182/blood-2010-12-327403; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Neyt C, 2000, NATURE, V408, P82, DOI 10.1038/35040549; NODEN DM, 1989, AM REV RESPIR DIS, V140, P1097, DOI 10.1164/ajrccm/140.4.1097; PARDANAUD L, 1995, ANAT EMBRYOL, V192, P301, DOI 10.1007/BF00710099; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Pouget C, 2006, DEVELOPMENT, V133, P1013, DOI 10.1242/dev.02269; Proulx K, 2010, DEV BIOL, V348, P34, DOI 10.1016/j.ydbio.2010.08.036; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Seo HC, 1998, MECH DEVELOP, V70, P49, DOI 10.1016/S0925-4773(97)00175-5; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Stellabotte F, 2007, DEVELOPMENT, V134, P1253, DOI 10.1242/dev.000067; Svetic V, 2007, DEVELOPMENT, V134, P1011, DOI 10.1242/dev.02789; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Whitesell TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090590; Williams C, 2010, DEV BIOL, V341, P196, DOI 10.1016/j.ydbio.2010.02.028; WILTING J, 1995, DEV DYNAM, V202, P165, DOI 10.1002/aja.1002020208; Yabe T, 2012, DEV BIOL, V370, P213, DOI 10.1016/j.ydbio.2012.07.029; Zhang XY, 2007, DEV BIOL, V307, P179, DOI 10.1016/j.ydbio.2007.04.002; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	54	81	84	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					314	+		10.1038/nature13678	http://dx.doi.org/10.1038/nature13678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119043				2022-12-24	WOS:000340508200036
J	Yacoub, MH; El-Hamamsy, I; Sievers, HH; Carabello, BA; Bonow, RO; Stelzer, P; da Costa, FDA; Schafers, HJ; Skillington, P; Charitos, EI; Luciani, GB; Takkenberg, JJM				Yacoub, Magdi H.; El-Hamamsy, Ismail; Sievers, Hans-Hinrich; Carabello, Blase A.; Bonow, Robert O.; Stelzer, Paul; da Costa, Francisco D. A.; Schaefers, Hans J.; Skillington, Peter; Charitos, Efstratios I.; Luciani, Giovanni Battista; Takkenberg, Johanna J. M.			Under-use of the Ross operation-a lost opportunity	LANCET			English	Editorial Material							AORTIC-VALVE DISEASE; QUALITY-OF-LIFE; REPLACEMENT; HOMOGRAFT; AUTOGRAFT; ROOT		[Yacoub, Magdi H.] Univ London Imperial Coll Sci Technol & Med, Magdi Yacoub Inst, London UB9 6JH, England; [El-Hamamsy, Ismail] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Sievers, Hans-Hinrich; Charitos, Efstratios I.] Univ Hosp Lubeck, Lubeck, Germany; [Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Carabello, Blase A.; Stelzer, Paul] Mt Sinai Hosp, New York, NY 10029 USA; [da Costa, Francisco D. A.] Dept Cardiovasc Surg, Santa Casa De Curitiba, Brazil; [Schaefers, Hans J.] Univ Saarland, Med Ctr, Homburg, Germany; [Skillington, Peter] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Luciani, Giovanni Battista] Univ Verona, I-37100 Verona, Italy; [Takkenberg, Johanna J. M.] Erasmus MC, Dept Cardiothorac Surg, Rotterdam, Netherlands	Imperial College London; Universite de Montreal; University of Lubeck; Northwestern University; Feinberg School of Medicine; Icahn School of Medicine at Mount Sinai; Saarland University; Royal Melbourne Hospital; University of Verona; Erasmus University Rotterdam; Erasmus MC	Yacoub, MH (corresponding author), Univ London Imperial Coll Sci Technol & Med, Magdi Yacoub Inst, London UB9 6JH, England.	m.yacoub@imperial.ac.uk	Charitos, Efstratios/AAG-2005-2020; Takkenberg, Johanna/B-9368-2009; Luciani, Giovanni Battista/AAC-3939-2022	Takkenberg, Johanna/0000-0001-9809-5623; Luciani, Giovanni Battista/0000-0003-0931-018X				Aicher D, 2011, J THORAC CARDIOV SUR, V142, pE19, DOI 10.1016/j.jtcvs.2011.02.006; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Charitos EI, 2012, J THORAC CARDIOV SUR, V144, P813, DOI 10.1016/j.jtcvs.2012.07.005; El-Hamamsy I, 2010, LANCET, V376, P524, DOI 10.1016/S0140-6736(10)60828-8; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Notzold A, 2001, J AM COLL CARDIOL, V37, P1963, DOI 10.1016/S0735-1097(01)01267-0; Sievers HH, 2010, J THORAC CARDIOV SUR, V140, P816, DOI 10.1016/j.jtcvs.2009.11.042; Skillington Peter D, 2013, Glob Cardiol Sci Pract, V2013, P383, DOI 10.5339/gcsp.2013.46; Svensson LG, 2013, ANN THORAC SURG, V95, pS1, DOI 10.1016/j.athoracsur.2013.01.083; Treasure T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2466; United Nations (UN), WORLD POP PROSP; Yacoub MH, 1999, ANN THORAC SURG, V68, pS37, DOI 10.1016/S0003-4975(99)00745-6; Yacoub N, 2005, NAT CLIN PRACT CARD, V2, P60, DOI 10.1038/ncpcardio0112	13	45	45	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					559	560		10.1016/S0140-6736(14)61090-4	http://dx.doi.org/10.1016/S0140-6736(14)61090-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN4QR	25131967				2022-12-24	WOS:000340573300004
J	Ganem, NJ; Cornils, H; Chiu, SY; O'Rourke, KP; Arnaud, J; Yimlamai, D; Thery, M; Camargo, FD; Pellman, D				Ganem, Neil J.; Cornils, Hauke; Chiu, Shang-Yi; O'Rourke, Kevin P.; Arnaud, Jonathan; Yimlamai, Dean; Thery, Manuel; Camargo, Fernando D.; Pellman, David			Cytokinesis Failure Triggers Hippo Tumor Suppressor Pathway Activation	CELL			English	Article							CELL-CYCLE PROGRESSION; MAMMALIAN-CELLS; CENTROSOME AMPLIFICATION; CHROMOSOMAL INSTABILITY; CLEAVAGE FAILURE; CANCER; YAP; TETRAPLOIDY; PLOIDY; LIVER	Genetically unstable tetraploid cells can promote tumorigenesis. Recent estimates suggest that similar to 37% of human tumors have undergone a genome-doubling event during their development. This potentially oncogenic effect of tetraploidy is countered by a p53-dependent barrier to proliferation. However, the cellular defects and corresponding signaling pathways that trigger growth suppression in tetraploid cells are not known. Here, we combine RNAi screening and in vitro evolution approaches to demonstrate that cytokinesis failure activates the Hippo tumor suppressor pathway in cultured cells, as well as in naturally occurring tetraploid cells in vivo. Induction of the Hippo pathway is triggered in part by extra centrosomes, which alter small G protein signaling and activate LATS2 kinase. LATS2 in turn stabilizes p53 and inhibits the transcriptional regulators YAP and TAZ. These findings define an important tumor suppression mechanism and uncover adaptive mechanisms potentially available to nascent tumor cells that bypass this inhibitory regulation.	[Ganem, Neil J.; Cornils, Hauke; Chiu, Shang-Yi; O'Rourke, Kevin P.; Pellman, David] Harvard Univ, Sch Med, Childrens Hosp, Dana Farber Canc Inst,Howard Hughes Med Inst,Dept, Boston, MA 02115 USA; [Ganem, Neil J.; Cornils, Hauke; Chiu, Shang-Yi; O'Rourke, Kevin P.; Pellman, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Arnaud, Jonathan; Thery, Manuel] CEA UJF INRA CNRS, Inst Rech Technol & Sci Vivant, UMR5168, F-38054 Grenoble, France; [Yimlamai, Dean; Camargo, Fernando D.] Childrens Hosp Boston, Stem Cell Program, Boston, MA 02115 USA; [Thery, Manuel] Univ Paris Diderot, Hop St Louis, AP HP, INSERM,Inst Univ Hematol, F-75010 Paris, France	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Harvard University; Boston Children's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ganem, NJ (corresponding author), Boston Univ, Sch Med, Ctr Canc, Dept Pharmacol & Expt Therapeut,Div Hematol & Onc, Boston, MA 02118 USA.	nganem@bu.edu; david_pellman@dfci.harvard.edu	Yimlamai, Dean/AAA-6607-2020	Yimlamai, Dean/0000-0002-7936-7168; Ganem, Neil/0000-0003-0269-6585	NIH [1S10RR026582-01, DK099559, GM083299-1]; NCI K99 award [K99CA154531-01]; ERC [31047]; BCH Career Development Award; Manton Center for Orphan Disease Research; NATIONAL CANCER INSTITUTE [K99CA154531, R00CA154531] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK105351, R01DK099559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083299] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI K99 award; ERC(European Research Council (ERC)European Commission); BCH Career Development Award; Manton Center for Orphan Disease Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank S. Jhaveri-Schneider and A. Salic for comments on the manuscript; members of the ICCB screening facility; K. Lunquist for technical assistance; H. Li, K. Ross, and K. Stegmaier for assistance with microarray analysis; R. Beroukhim for assistance with ploidy analysis of the CCLE collection; S. Godinho for reagents; P. Nagaruri Gonchi and D. Williams for discussions; and T. Vignaud, F. Senger, and J.-L. Martiel for advice on traction force microscopy. NIH grant 1S10RR026582-01 to C. Shamu supported the IsoCyte/Velos laser scanning cytometer. N.J.G. is supported by an NCI K99 award (K99CA154531-01) and is a member of the Shamim and Ashraf Dahod Breast Cancer Research Laboratories; H.C. is a fellow of the Leukemia and Lymphoma Society; M.T. is supported by ERC grant 31047; D.Y. is supported by a BCH Career Development Award and is a George Ferry Young Investigator of NASPGHAN; F.D.C. is supported by the Manton Center for Orphan Disease Research and NIH grant DK099559; and D.P. is a HHMI investigator and is supported by NIH grant GM083299-1.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; CARTER SB, 1967, NATURE, V213, P261, DOI 10.1038/213261a0; Davoli T, 2012, CANCER CELL, V21, P765, DOI 10.1016/j.ccr.2012.03.044; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Krzywicka-Racka A, 2011, J CELL BIOL, V194, P199, DOI 10.1083/jcb.201101073; Kuffer C, 2013, CHROMOSOMA, V122, P305, DOI 10.1007/s00412-013-0414-0; Kurinna S, 2013, HEPATOLOGY, V57, P2004, DOI 10.1002/hep.26233; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Nakamura K, 2011, INT J CANCER, V128, P2613, DOI 10.1002/ijc.25606; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; WRIGHT WE, 1972, EXP CELL RES, V74, P187, DOI 10.1016/0014-4827(72)90496-X; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	38	239	241	4	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					833	848		10.1016/j.cell.2014.06.029	http://dx.doi.org/10.1016/j.cell.2014.06.029			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126788	Green Accepted, Bronze			2022-12-24	WOS:000340944700014
J	Osborne, LC; Monticelli, LA; Nice, TJ; Sutherland, TE; Siracusa, MC; Hepworth, MR; Tomov, VT; Kobuley, D; Tran, SV; Bittinger, K; Bailey, AG; Laughlin, AL; Boucher, JL; Wherry, EJ; Bushman, FD; Allen, JE; Virgin, HW; Artis, D				Osborne, Lisa C.; Monticelli, Laurel A.; Nice, Timothy J.; Sutherland, Tara E.; Siracusa, Mark C.; Hepworth, Matthew R.; Tomov, Vesselin T.; Kobuley, Dmytro; Tran, Sara V.; Bittinger, Kyle; Bailey, Aubrey G.; Laughlin, Alice L.; Boucher, Jean-Luc; Wherry, E. John; Bushman, Frederic D.; Allen, Judith E.; Virgin, Herbert W.; Artis, David			Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation	SCIENCE			English	Article							GUT MICROBIOTA; INFLAMMATION; INFECTIONS; CHITINASE; CELLS; YM1; BACTERIA; IMMUNITY; MICROFLORA; INDUCTION	The mammalian intestine is colonized by beneficial commensal bacteria and is a site of infection by pathogens, including helminth parasites. Helminths induce potent immunomodulatory effects, but whether these effects are mediated by direct regulation of host immunity or indirectly through eliciting changes in the microbiota is unknown. We tested this in the context of virus-helminth coinfection. Helminth coinfection resulted in impaired antiviral immunity and was associated with changes in the microbiota and STAT6-dependent helminth-induced alternative activation of macrophages. Notably, helminth-induced impairment of antiviral immunity was evident in germ-free mice, but neutralization of Ym1, a chitinase-like molecule that is associated with alternatively activated macrophages, could partially restore antiviral immunity. These data indicate that helminth-induced immunomodulation occurs independently of changes in the microbiota but is dependent on Ym1.	[Osborne, Lisa C.; Monticelli, Laurel A.; Siracusa, Mark C.; Hepworth, Matthew R.; Kobuley, Dmytro; Tran, Sara V.; Bittinger, Kyle; Bailey, Aubrey G.; Laughlin, Alice L.; Bushman, Frederic D.; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Osborne, Lisa C.; Monticelli, Laurel A.; Siracusa, Mark C.; Hepworth, Matthew R.; Kobuley, Dmytro; Tran, Sara V.; Wherry, E. John; Artis, David] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nice, Timothy J.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Sutherland, Tara E.; Allen, Judith E.] Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; [Hepworth, Matthew R.; Tomov, Vesselin T.] Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Boucher, Jean-Luc] Univ Paris 05, Chim & Biochim Pharmacol & Toxicol Lab, Paris, France; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Washington University (WUSTL); University of Edinburgh; University of Pennsylvania; Pennsylvania Medicine; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania	Artis, D (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Osborne, Lisa/K-3027-2015; Bittinger, Kyle/ABG-2342-2020; Allen, Judith E/C-9198-2011; Wherry, John/ABI-1280-2020; Nice, Timothy/X-9114-2019; Sutherland, Tara/S-1427-2019	Osborne, Lisa/0000-0002-7170-3235; Allen, Judith E/0000-0002-3829-066X; Nice, Timothy/0000-0002-4471-7666; Sutherland, Tara/0000-0001-9334-8206; Virgin, Herbert/0000-0001-8580-7628; Bailey, Aubrey/0000-0002-0712-217X; Artis, David/0000-0002-1753-4100; Hepworth, Matthew/0000-0002-9613-7858	NIH Tetramer Core Facility [HHSN272201300006C]; University of Pennsylvania Matthew J. Ryan Veterinary Hospital Pathology Lab; NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases [P30-DK050306]; Penn Center for AIDS Research [P30-AI045008]; Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory; National Cancer Institute Comprehensive Cancer Center [2-P30 CA016520]; NIH [AI061570, AI074878, AI087990, AI095466, AI095608, AI097333, AI106697, AI102942, T32-AI007532, F32-AI085828, AI083022, AI082630, K08-DK097301, 5T32A100716334]; Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Edmond J. Safra Foundation/Cancer Research Institute Irvington Fellowship; Medical Research Council UK [MR/J001929/1]; Cancer Research Institute; American Cancer Society; Crohn's and Colitis Genetics Initiative grant [274415]; Broad Foundation [IBD-0357];  [R01 AI 084887]; Medical Research Council [MR/J001929/1] Funding Source: researchfish; MRC [MR/J001929/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102942, U01AI095608, R21AI087990, T32AI007532, P01AI106697, U19AI082630, R01AI061570, P30AI045008, R01AI074878, U19AI083022, R01AI097333, R01AI084887, R01AI095466, F32AI085828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, K08DK097301] Funding Source: NIH RePORTER	NIH Tetramer Core Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Matthew J. Ryan Veterinary Hospital Pathology Lab; NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Penn Center for AIDS Research; Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory; National Cancer Institute Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Edmond J. Safra Foundation/Cancer Research Institute Irvington Fellowship; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research Institute; American Cancer Society(American Cancer Society); Crohn's and Colitis Genetics Initiative grant; Broad Foundation; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Artis laboratory for discussions and critical reading of the manuscript; F. Finkelman for providing anti-IL-4 clone 1D11.2; the NIH Tetramer Core Facility (contract HHSN272201300006C) for providing MHCII IA<SUP>b</SUP> tetramers; the University of Pennsylvania Matthew J. Ryan Veterinary Hospital Pathology Lab, the NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306), and its core facilities (Molecular Pathology and Imaging, Molecular Biology, Cell Culture, and Transgenic and Chimeric Mouse); the Penn Center for AIDS Research (P30-AI045008) for assistance and support; and the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory for technical advice and support. The ACC Flow Cytometry and Cell Sorting Shared Resource is partially supported by a National Cancer Institute Comprehensive Cancer Center Support grant (2-P30 CA016520). The data tabulated in this paper are reported in the main paper and in the supplementary materials. Illumina MiSeq data can be found in the National Center for Biotechnology Information Sequence Read Archive with accession number SRP043964. Research in the Artis lab is supported by the NIH (AI061570, AI074878, AI087990, AI095466, AI095608, AI097333, AI106697, and AI102942 to D. A.; T32-AI007532 to L. A. M.; and F32-AI085828 to M. C. S.), the Crohn's and Colitis Foundation of America (D. A. and M. R. H.), the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (D. A.), and the Edmond J. Safra Foundation/Cancer Research Institute Irvington Fellowship (L.C.O.). E. J. W. and V. T. T. are supported by NIH grants AI083022, AI082630, and K08-DK097301. T. E. S. and J. E. A. were supported by the Medical Research Council UK (MR/J001929/1). T.J.N. was supported by NIH training grant 5T32A100716334 and postdoctoral fellowships from the Cancer Research Institute and American Cancer Society. H. W. V. was supported by grant R01 AI 084887, the Crohn's and Colitis Genetics Initiative grant 274415, and the Broad Foundation grant IBD-0357. Washington University and H. W. V. receive income based on licenses for MNV technology. The authors declare no other potential conflicts of interest.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Arora M, 2006, P NATL ACAD SCI USA, V103, P7777, DOI 10.1073/pnas.0508492103; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bancroft AJ, 2012, TRENDS PARASITOL, V28, P93, DOI 10.1016/j.pt.2011.12.001; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Ford AQ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-6; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Leung JM, 2013, INT J PARASITOL, V43, P253, DOI 10.1016/j.ijpara.2012.10.015; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Metenou S, 2012, CURR OPIN HIV AIDS, V7, P231, DOI 10.1097/COH.0b013e3283522c3d; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Stelekati E, 2012, CELL HOST MICROBE, V12, P458, DOI 10.1016/j.chom.2012.10.001; Sutherland TE, 2009, CLIN EXP ALLERGY, V39, P943, DOI 10.1111/j.1365-2222.2009.03243.x; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wolff MJ, 2012, TRENDS PARASITOL, V28, P187, DOI 10.1016/j.pt.2012.02.008; Zhao J, 2013, PARASITOL RES, V112, P2689, DOI 10.1007/s00436-013-3436-x	40	186	191	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					578	582		10.1126/science.1256942	http://dx.doi.org/10.1126/science.1256942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082704	Green Accepted			2022-12-24	WOS:000339651300049
J	Rohr, RP; Saavedra, S; Bascompte, J				Rohr, Rudolf P.; Saavedra, Serguei; Bascompte, Jordi			On the structural stability of mutualistic systems	SCIENCE			English	Article							FACILITATE BIODIVERSITY MAINTENANCE; GENERALIZED VOLTERRA TYPE; COEVOLUTIONARY NETWORKS; GLOBAL STABILITY; DISENTANGLING NESTEDNESS; ECOLOGICAL-SYSTEMS; ECOSYSTEMS; MODEL; COMMUNITIES; COMPETITION	In theoretical ecology, traditional studies based on dynamical stability and numerical simulations have not found a unified answer to the effect of network architecture on community persistence. Here, we introduce a mathematical framework based on the concept of structural stability to explain such a disparity of results. We investigated the range of conditions necessary for the stable coexistence of all species in mutualistic systems. We show that the apparently contradictory conclusions reached by previous studies arise as a consequence of overseeing either the necessary conditions for persistence or its dependence on model parameterization. We show that observed network architectures maximize the range of conditions for species coexistence. We discuss the applicability of structural stability to study other types of interspecific interactions.	[Rohr, Rudolf P.; Saavedra, Serguei; Bascompte, Jordi] CSIC, EBD, Integrat Ecol Grp, E-41092 Seville, Spain; [Rohr, Rudolf P.] Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Fribourg	Bascompte, J (corresponding author), CSIC, EBD, Integrat Ecol Grp, Calle Americo Vespucio S-N, E-41092 Seville, Spain.	bascompte@ebd.csic.es	Rohr, Rudolf Philippe/K-9232-2015; Bascompte, Jordi/B-7596-2008	Rohr, Rudolf Philippe/0000-0002-6440-2696; Bascompte, Jordi/0000-0002-0108-6411	European Research Council; FP7-REGPOT-2010-1 program [264125 EcoGenes]	European Research Council(European Research Council (ERC)European Commission); FP7-REGPOT-2010-1 program	We thank U. Bastolla, L.-F. Bersier, V. Dakos, A. Ferrera, M. A. Fortuna, L. J. Gilarranz, S. Kefi, J. Lever, B. Luque, A. M. Neutel, A. Pascual-Garcia, D. B. Stouffer, and J. Tylianakis for insightful discussions. We thank S. Baigent for pointing out the counter-example in (53). Funding was provided by the European Research Council through an Advanced Grant (J. B.) and FP7-REGPOT-2010-1 program under project 264125 EcoGenes (R.P.R.). The data are publicly available at www.web-of-life.es.	ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Alberch P., 1989, GEOBIOS, V12, P21, DOI DOI 10.1016/S0016-6995(89)80006-3; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Arnold V.I., 1988, GEOMETRICAL METHODS, V2nd; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2005, J THEOR BIOL, V235, P521, DOI 10.1016/j.jtbi.2005.02.005; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Case T. J., 2000, AN ILLUSTRATED GUIDE; CASE TJ, 1990, P NATL ACAD SCI USA, V87, P9610, DOI 10.1073/pnas.87.24.9610; CASE TJ, 1979, AM NAT, V113, P705, DOI 10.1086/283427; GOH BS, 1979, AM NAT, V113, P261, DOI 10.1086/283384; GOH BS, 1977, AM NAT, V111, P135, DOI 10.1086/283144; Holland JN, 2006, SCIENCE, V313, P1887, DOI 10.1126/science.1129547; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kolmogorov A., 1936, GIORNALE ISTITUTO DE, V7, P74; Kuznetsov Yu. A., 2004, ELEMENTS OF APPLIED; Logofet D. O., 1992, MATRICES AND GRAPHS; Logofet DO, 2005, LINEAR ALGEBRA APPL, V398, P75, DOI 10.1016/j.laa.2003.04.001; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Margalef R, 1968, PERSPECTIVES IN ECOL; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCullagh P. N., 1989, GENERALIZED LINEAR M; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; Pimm SL, 2002, FOOD WEBS; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; ROBERTS A, 1974, NATURE, V251, P607, DOI 10.1038/251607a0; Rohr R. P., 2013, ARXIV 1310 4633; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Saavedra S, 2013, NATURE, V500, pE1, DOI 10.1038/nature12380; Saavedra S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3350; SOLE RV, 1992, J THEOR BIOL, V155, P87, DOI 10.1016/S0022-5193(05)80550-8; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Svirezhev Y. M., 1982, STABILITY OF BIOLOGI; TAKEUCHI Y, 1980, J MATH BIOL, V10, P401, DOI 10.1007/BF00276098; TAKEUCHI Y, 1978, MATH BIOSCI, V42, P119, DOI 10.1016/0025-5564(78)90010-X; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thom R., 1994, STRUCTURAL STABILITY; Thompson D. A. W., 1992, ON GROWTH AND FORM; Thompson JN, 2005, THE GEOGRAPHIC MOSAI; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; VANDERMEER J H, 1970, American Naturalist, V104, P73, DOI 10.1086/282641; VANDERMEER JH, 1975, SCIENCE, V188, P253, DOI 10.1126/science.1118725; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; WRIGHT DH, 1989, AM NAT, V134, P664, DOI 10.1086/285003	52	294	300	15	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					416	+		10.1126/science.1253497	http://dx.doi.org/10.1126/science.1253497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7PY	25061214	Green Submitted			2022-12-24	WOS:000349821000001
J	Forbes, HJ; Bhaskaran, K; Thomas, SL; Smeeth, L; Clayton, T; Langan, SM				Forbes, Harriet J.; Bhaskaran, Krishnan; Thomas, Sara L.; Smeeth, Liam; Clayton, Tim; Langan, Sinead M.			Quantification of risk factors for herpes zoster: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTHERPETIC NEURALGIA; RHEUMATOID-ARTHRITIS; IMMUNE DYSFUNCTION; LONG-TERM; VACCINE; VIRUS; EPIDEMIOLOGY; INFECTION; DISEASES; ASTHMA	Objectives To quantify the effects of possible risk factors for herpes zoster at different ages. Design Case-control study. Setting UK Clinical Practice Research Datalink primary care data. Participants 144 959 adults diagnosed with zoster between 2000 and 2011; 549 336 age, sex, and practice matched controls. Main outcome measures Conditional logistic regression was used to generate adjusted odds ratios to estimate the strength of association of each potential risk factor with zoster and assess effect modification by age. Results The median age of the cases and controls was 62 years. Factors associated with increased risk of zoster included rheumatoid arthritis (3111 (2.1%) v 8029 (1.5%); adjusted odds ratio 1.46, 99% confidence interval 1.38 to 1.55), inflammatory bowel disease (1851 (1.3%) v 5118 (0.9%); 1.36, 1.26 to 1.46), chronic obstructive pulmonary disease (6815 (4.7%) v 20 201 (3.7%); 1.32, 1.27 to 1.37), asthma (10 243 (7.1%) v 31 865 (5.8%); 1.21, 1.17 to 1.25), chronic kidney disease (8724 (6.0%) v 29 437 (5.4%); 1.14, 1.09 to 1.18), and depression (6830 (4.7%) v 22 052 (4.0%); 1.15, 1.10 to 1.20). Type 1, but not type 2, diabetes showed some association with zoster (adjusted odds ratio 1.27, 1.07 to 1.50). The relative effects of many assessed risk factors were larger in younger patients. Patients with severely immunosuppressive conditions were at greatest risk of zoster-for example, patients with lymphoma (adjusted odds ratio 3.90, 3.21 to 4.74) and myeloma (2.16, 1.84 to 2.53), who are not eligible for zoster vaccination. Conclusions A range of conditions were associated with increased risk of zoster. In general, the increased risk was proportionally greater in younger age groups. Current vaccines are contraindicated in people at the greatest risk of zoster, highlighting the need for alternative risk reduction strategies in these groups.	[Forbes, Harriet J.; Bhaskaran, Krishnan; Thomas, Sara L.; Smeeth, Liam; Clayton, Tim; Langan, Sinead M.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Forbes, HJ (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	harriet.forbes@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022; Forbes, Harriet/0000-0001-6888-2212; Bhaskaran, Krishnan/0000-0001-5364-8757; Langan, Sinead/0000-0002-7022-7441; Clayton, Tim/0000-0002-1266-3288	National Institute for Health Research (NIHR) [NIHR/CS/010/014]; NIHR [PDF-2011-04-007, CDF-2010-03-32]; Wellcome Trust; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [CDF-2010-03-32, NIHR/CS/010/014, PDF-2011-04-007, NF-SI-0510-10090] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research supported by a National Institute for Health Research (NIHR) clinician scientist fellowship (to SML; grant number NIHR/CS/010/014). KB is supported by an NIHR postdoctoral fellowship (PDF-2011-04-007). LS is supported by a Wellcome Trust senior research fellowship in clinical science. SLT is supported by an NIHR career development fellowship (CDF-2010-03-32). All authors carried out this research independently of the funding bodies. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the UK Department of Health.	[Anonymous], 2004, INVESTING GEN PRACTI; [Anonymous], 2011, READ COD; Arana A, 2011, EPIDEMIOLOGY, V22, P876, DOI [10.1097/EDE.0b013e3182093a0f, 10.1097/EDE.0b013e31823198fc]; Blank LJ, 2012, JAIDS-J ACQ IMM DEF, V61, P203, DOI 10.1097/QAI.0b013e318266cd3c; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Campbell J, 2013, PHARMACOEPIDEM DR S, V22, P280; Centers for Disease Control and Prevention, 2008, PREV HERP ZOST REC A; Choo PW, 1997, ARCH INTERN MED, V157, P1217, DOI 10.1001/archinte.157.11.1217; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; CUPPS TR, 1982, IMMUNOL REV, V65, P133, DOI 10.1111/j.1600-065X.1982.tb00431.x; Drolet M, 2010, J PAIN, V11, P1211, DOI 10.1016/j.jpain.2010.02.020; DWORKIN RH, 1992, J ABNORM PSYCHOL, V101, P200, DOI 10.1037/0021-843X.101.1.200; Ernst P, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-59; Gauthier A, 2009, EPIDEMIOL INFECT, V137, P38, DOI 10.1017/S0950268808000678; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V40, P169, DOI 10.1097/01.qai.0000178408.62675.b0; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Hauser AB, 2008, PERITON DIALYSIS INT, V28, pS183; Heymann AD, 2008, INFECTION, V36, P226, DOI 10.1007/s15010-007-6347-x; Hope-Simpson R E, 1975, J R Coll Gen Pract, V25, P571; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Irwin M, 1998, J INFECT DIS, V178, pS104, DOI 10.1086/514272; Irwin MR, 2013, CLIN INFECT DIS, V56, P1085, DOI 10.1093/cid/cis1208; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Joesoef RM, 2012, MAYO CLIN PROC, V87, P961, DOI 10.1016/j.mayocp.2012.05.021; Kanbayashi Y, 2012, CLIN J PAIN, V28, P712, DOI 10.1097/AJP.0b013e318243ee01; Katz J, 2005, J PAIN, V6, P782, DOI 10.1016/j.jpain.2005.07.006; Kim BS, 2013, J PEDIATR-US, V163, P816, DOI 10.1016/j.jpeds.2013.03.010; Kuo CC, 2012, AM J KIDNEY DIS, V59, P428, DOI 10.1053/j.ajkd.2011.10.049; KUSNECOV AW, 1994, INT ARCH ALLERGY IMM, V105, P107, DOI 10.1159/000236812; Langan SM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001420; Lasserre A, 2012, J CLIN VIROL, V55, P153, DOI 10.1016/j.jcv.2012.06.020; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Long MD, 2013, ALIMENT PHARM THER, V37, P420, DOI 10.1111/apt.12182; Lua PJ, 2009, VACCINE, V27, P882, DOI 10.1016/j.vaccine.2008.11.077; Morgan D, 2001, AIDS, V15, P223, DOI 10.1097/00002030-200101260-00012; NAGASAWA K, 1990, ANN RHEUM DIS, V49, P630, DOI 10.1136/ard.49.8.630; Oldroyd J, 2005, POSTGRAD MED J, V81, P486, DOI 10.1136/pgmj.2004.029124; Opstelten W, 2002, FAM PRACT, V19, P471, DOI 10.1093/fampra/19.5.471; Opstelten W, 2007, ANN FAM MED, V5, P305, DOI 10.1370/afm.707; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Rubben A, 1997, BRIT J DERMATOL, V137, P259, DOI 10.1046/j.1365-2133.1997.18161913.x; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; Takabatake N, 2005, RESP MED, V99, P485, DOI 10.1016/j.rmed.2004.09.013; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Tyring SK, 2007, VACCINE, V25, P1877, DOI 10.1016/j.vaccine.2006.10.027; van Hoek AJ, 2009, VACCINE, V27, P1454, DOI 10.1016/j.vaccine.2008.12.024; Veetil BMA, 2013, ARTHRIT CARE RES, V65, P854, DOI 10.1002/acr.21928; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wu MY, 2012, AM J KIDNEY DIS, V60, P548, DOI 10.1053/j.ajkd.2012.03.018; Yang IA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002991.pub3; Yang YW, 2011, J EUR ACAD DERMATOL, V25, P447, DOI 10.1111/j.1468-3083.2010.03811.x; Yang YW, 2011, CAN MED ASSOC J, V183, pE275, DOI 10.1503/cmaj.101137	55	134	139	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2014	348								g2911	10.1136/bmj.g2911	http://dx.doi.org/10.1136/bmj.g2911			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5CN	25134101	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000336146200003
J	Bekker, LG; Johnson, L; Cowan, F; Overs, C; Besada, D; Hillier, S; Cates, W				Bekker, Linda-Gail; Johnson, Leigh; Cowan, Frances; Overs, Cheryl; Besada, Donela; Hillier, Sharon; Cates, Willard, Jr.			Combination HIV prevention for female sex workers: what is the evidence?	LANCET			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; HIGH-RISK; POPULATION-LEVEL; CONDOM USE; HETEROSEXUAL MEN; HIV/STI RISK; DOUBLE-BLIND; VIRAL LOAD	Sex work occurs in many forms and sex workers of all genders have been affected by HIV epidemics worldwide. The determinants of HIV risk associated with sex work occur at several levels, including individual biological and behavioural, dyadic and network, and community and social environmental levels. Evidence indicates that effective HIV prevention packages for sex workers should include combinations of biomedical, behavioural, and structural interventions tailored to local contexts, and be led and implemented by sex worker communities. A model simulation based on the South African heterosexual epidemic suggests that condom promotion and distribution programmes in South Africa have already reduced HIV incidence in sex workers and their clients by more than 70%. Under optimistic model assumptions, oral pre-exposure prophylaxis together with test and treat programmes could further reduce HIV incidence in South African sex workers and their clients by up to 40% over a 10-year period. Combining these biomedical approaches with a prevention package, including behavioural and structural components as part of a community-driven approach, will help to reduce HIV infection in sex workers in different settings worldwide.	[Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7705 Observatory, South Africa; [Johnson, Leigh] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7705 Observatory, South Africa; [Cowan, Frances] UCL, Res Dept Infect & Populat Hlth, London, England; [Cowan, Frances] Ctr Sexual Hlth & HIV AIDS Res CeSHHAR Zimbabwe, Harare, Zimbabwe; [Overs, Cheryl] Michael Kirby Ctr Publ Hlth & Human Rights, Melbourne, Vic, Australia; [Besada, Donela] Desmond Tutu HIV Fdn, Cape Town, South Africa; [Hillier, Sharon] Unvers Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Cates, Willard, Jr.] FHI 360, Durham, NC USA	University of Cape Town; University of Cape Town; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; FHI 360	Bekker, LG (corresponding author), Univ Cape Town, Fac Hlth Sci, Desmond Tutu HIV Ctr, Anzio Rd, ZA-7705 Observatory, South Africa.	Linda-Gail.Bekker@hiv-research.org.za	Bekker, Linda-Gail/AAZ-8929-2020	Cowan, Frances/0000-0003-3087-4422; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Besada, Donela/0000-0002-2020-5244	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); UCT CTU grant [2UM1AI069519-08]; NIH [1R01AI094586-01]; Hasso Plattner Foundation; NIAID; Microbicide Trials Network [1UM1AI068633]; USAID Preventive Technologies [GHO-A-00-09-00016-00]; NIH HIV Prevention Trials Network [1U01A1068619-01]; Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation; United Nations Family Planning Association (UNFPA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069519, UM1AI068633, R01AI094586] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCT CTU grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hasso Plattner Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Microbicide Trials Network; USAID Preventive Technologies(United States Agency for International Development (USAID)); NIH HIV Prevention Trials Network; Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); United Nations Family Planning Association (UNFPA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	L-GB is supported in part by National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), UCT CTU grant 2UM1AI069519-08. LJ received support from NIH (1R01AI094586-01) and Hasso Plattner Foundation. SH received support from NIAID, Microbicide Trials Network (1UM1AI068633). WC received support from USAID Preventive Technologies Agreement (GHO-A-00-09-00016-00) and NIAID, NIH HIV Prevention Trials Network (1U01A1068619-01). This article and The Lancet Series on HIV and sex workers was supported by grants to the Center for Public Health and Human Rights at Johns Hopkins Bloomberg School of Public Health from The Bill & Melinda Gates Foundation and from The United Nations Family Planning Association (UNFPA).	Abdool Karim Quarraisha, 2010, Science, V329, P1168, DOI 10.1126/science.1193748; Ainsworth M, 2003, HEALTH POLICY, V64, P13, DOI 10.1016/S0168-8510(02)00079-9; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; [Anonymous], 2008, OPEN DEMOGRAPHY J, DOI [DOI 10.2174/1874918600801010001, 10.2174/1874918600801010001]; [Anonymous], 2013, 20 C RETR OPP INF AT, DOI DOI 10.1056/NEJM0A1402269; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, JAIDS-J ACQ IMM DEF, V63, pS122, DOI 10.1097/QAI.0b013e3182986f69; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral SD, 2015, LANCET, V385, P260, DOI 10.1016/S0140-6736(14)60801-1; Baral SD, 2013, LANCET INFECT DIS, V13, P13, DOI 10.1016/S1473-3099(12)70319-5; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; Birungi J, 2012, J INT AIDS SOC, V15, P144; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Boily MC, 2013, AIDS, V27, P1449, DOI 10.1097/QAD.0b013e32835fba81; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Braunstein SL, 2011, JAIDS-J ACQ IMM DEF, V57, pE70, DOI 10.1097/QAI.0b013e3182170fd3; Brown, 2021, PEOPLE MANAGEMENT; Brown B, 2012, SEX WORKERS INTRO MA; Buzdugan R, 2009, TROP MED INT HEALTH, V14, P673, DOI 10.1111/j.1365-3156.2009.02278.x; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Centers for Disease Control and Prevention, 2021, PREEXP PROPH PREV HI; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cornman H, 2012, 1 USAID AIDSTARONE; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; de Walque D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000747; Delva W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028363; Diabate S, 2011, WORLD J AIDS, V1, P94, DOI [10.4236/wja.2011.13014, DOI 10.4236/WJA.2011.13014]; Dickinson C, 2009, B WORLD HEALTH ORGAN, V87, P846, DOI 10.2471/BLT.08.059279; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2005, INT J STD AIDS, V16, P256, DOI 10.1258/0956462053420220; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; FACTS Consortium, FACTS 001 STUD DES; Folch C, 2009, MED CLIN-BARCELONA, V132, P385, DOI 10.1016/j.medcli.2008.05.019; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; French PP, 2003, SEX TRANSM DIS, V30, P433, DOI 10.1097/00007435-200305000-00010; Galarraga O, EUR J HLTH EC, V15, P41; Ghose T, 2011, QUAL HEALTH RES, V21, P587, DOI 10.1177/1049732310395328; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; GOSTIN LO, 1994, JAMA-J AM MED ASSOC, V271, P1436, DOI 10.1001/jama.271.18.1436; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; GROSSKURTH H, 1995, AIDS, V9, P927, DOI 10.1097/00002030-199508000-00015; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; Guest PP BJ, 2007, SURVEY SEXUAL REPROD; Hallett TB, 2008, INT J EPIDEMIOL, V37, P77, DOI 10.1093/ije/dym232; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Harcourt C, 2010, AUST NZ J PUBL HEAL, V34, P482, DOI 10.1111/j.1753-6405.2010.00594.x; Hargreaves J, 2013, 17 ICASA C CAP TOWN; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; Heise L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18615; Holmes K, 2007, LANCET INFECT DIS, V7, P516; Hong Y, 2008, SEX TRANSM DIS, V35, P662, DOI 10.1097/OLQ.0b013e31816b322c; Hong Y, 2012, AIDS BEHAV, V16, P44, DOI 10.1007/s10461-011-9960-8; Huet Charlotte, 2011, BMC Public Health, V11, P700, DOI 10.1186/1471-2458-11-700; Human Rights Watch, 2003, FANN FLAM HUM RIGHTS; Illife J., 2006, AFRICAN AIDS EPIDEMI; Izulla P, 2013, JAIDS-J ACQ IMM DEF, V62, P220, DOI 10.1097/QAI.0b013e318278ba1b; Jana S, 2006, LANCET, V367, P814, DOI 10.1016/S0140-6736(06)68331-1; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Johnson LFD, 2021, THEMBISA VERSION 4 4; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Kahle EM, 2013, JAIDS-J ACQ IMM DEF, V62, P339, DOI 10.1097/QAI.0b013e31827e622d; KARIM QA, 1995, AM J PUBLIC HEALTH, V85, P1521, DOI 10.2105/AJPH.85.11.1521; Karim QA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-67; Karmon E, 2003, JAIDS-J ACQ IMM DEF, V34, P71, DOI 10.1097/00126334-200309010-00011; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Kayigamba FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036792; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kerrigan D., 2001, Culture, Health & Sexuality, V3, P221, DOI 10.1080/136910501750153049; Kerrigan D, 2014, LANCET; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Kriitmaa K, 2010, AIDS, V24, pS61, DOI 10.1097/01.aids.0000386735.87177.2a; Kulkarni Prasad S., 2003, AIDS Reviews, V5, P87; Labbe AC, 2003, 15 BIENN C INT SOC S, P27; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Lippman SA, 2010, AM J PUBLIC HEALTH, V100, pS216, DOI 10.2105/AJPH.2008.147462; Lowndes CM, 2003, SEX TRANSM DIS, V30, P46, DOI 10.1097/00007435-200301000-00010; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Mamaev T., 2007, MIKROBIOL EPIDEMIOL, V3, P72; Manhart LE, 2005, J INFECT DIS, V191, pS7, DOI 10.1086/425275; Marum E, 2012, JAIDS-J ACQ IMM DEF, V60, pS63, DOI 10.1097/QAI.0b013e31825f313b; McClelland RS, 2010, AIDS, V24, P891, DOI 10.1097/QAD.0b013e32833616c7; Michael M, 2013, HEALTH TECHNOL SOC, P1, DOI 10.1057/9781137316677; MILLS E.J., 2005, BMC INT HEALTH HUM R, V5, P1; Morar NS, 1998, S AFR MED J, V88, P470; Mugwanya KK, 2013, LANCET INFECT DIS, V13, P1021, DOI 10.1016/S1473-3099(13)70226-3; Munoz J, 2010, SAHARA J-J SOC ASP H, V7, P52, DOI 10.1080/17290376.2010.9724957; Murnane PM, 2013, AIDS, V27, P2155, DOI 10.1097/QAD.0b013e3283629037; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Nel AM, 2011, J WOMENS HEALTH, V20, P1207, DOI 10.1089/jwh.2010.2476; Ng M, 2011, LANCET, V378, P1643, DOI 10.1016/S0140-6736(11)61390-1; Ngo AD, 2007, AIDS CARE, V19, P878, DOI 10.1080/09540120601163078; Ngugi EN BE, 1999, PREVENTING HIV DEV C, P205; Nnorom J, 2008, W AFRICA HIV AIDS EP; Overs C, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18459; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Pathfinder International, 2004, COMB PREV HIV TECHN; Pickles M, 2013, LANCET GLOB HEALTH, V1, pE289, DOI 10.1016/S2214-109X(13)70083-4; Pleaner M, 2009, RHRU SUPPORT SEX WOR; Population Council, COMM APPR GOV POL RE; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ramjee G, 1998, SEX TRANSM DIS, V25, P346, DOI 10.1097/00007435-199808000-00004; Roberts L, 2011, 18 C RETR OPP INF FE; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Rou KM, 2010, INT J EPIDEMIOL, V39, pII38, DOI 10.1093/ije/dyq211; Rustomjee R, 1999, AIDS, V13, P1511, DOI 10.1097/00002030-199908200-00011; Scambler G, 2008, SOC SCI MED, V66, P1848, DOI 10.1016/j.socscimed.2008.01.002; Scheibe A, 2012, SAHARA J-J SOC ASP H, V9, P167, DOI 10.1080/17290376.2012.743809; Scorgie F, 2011, I EXPECT ABUSED I HA; Sex Workers Education and Advocacy Taskforce, SEX WORK S AFR RAP P; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shannon K, 2005, J URBAN HEALTH, V82, P488, DOI 10.1093/jurban/jti076; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Sibongile Mtetwa FMC, SISTERS VOICE; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Steen R, 2012, AIDS, V26, P437, DOI 10.1097/QAD.0b013e32834ed991; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; SWEAT, 2004, WORK WIS SEX WORK HD; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tucker JD, 2013, CURR OPIN INFECT DIS, V26, P73, DOI 10.1097/QCO.0b013e32835c21b0; Ulibarri MD, 2010, PSYCHOL TRAUMA-US, V2, P318, DOI 10.1037/a0017500; UNAIDS, 2006, RISK NEGL 4 KEY POP; UNAIDS, 2012, GLOB REP GLOB AIDS E; UNAIDS, 2013, GLOB HIV AIDS REP; UNAIDS, 2010, REP GLOB AIDS EP; UNAIDS A, 2007, GOOD PART PRACT GUID; UNAIDS World Bank, 2009, GLOB EC CRIS PREV TR; Underhill K, 2010, JAIDS-J ACQ IMM DEF, V55, P8, DOI 10.1097/QAI.0b013e3181e8efe4; UNFPA, 2010, HIV SEX WORK PREV HI; USAID, 2013, DHS COMP REPORTS, V30; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS BEHAV, V16, P1775, DOI 10.1007/s10461-012-0215-0; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Varga C A, 1997, Afr J Reprod Health, V1, P74, DOI 10.2307/3583277; Verma R, 2010, SEX TRANSM INFECT, V86, pI76, DOI 10.1136/sti.2009.039115; Vickerman P, 2006, SEX TRANSM DIS, V33, P397, DOI 10.1097/01.olq.0000218974.77208.cc; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Watts C, 2010, SEX TRANSM INFECT, V86, P85, DOI 10.1136/sti.2010.044602; Weeks MR, 2004, SEX TRANSM DIS, V31, P682, DOI 10.1097/01.olq.0000143113.04524.a5; WELLER SC, 1993, SOC SCI MED, V36, P1635, DOI 10.1016/0277-9536(93)90352-5; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; WHO (World Health Organization), 2005, VIOL WOM HIV AIDS CR; Wirtz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088047; Witte SS, 1999, INT J STD AIDS, V10, P162, DOI 10.1258/0956462991913826; World Health Organization, 2012, GU OR PRE PROPHYL PR; World Health Organization, 2011, PREV HIV SEX WORK SU; World Health Organization, 2013, PREP DEM PROJ FRAM C; Yam EA, 2013, SEX TRANSM DIS, V40, P406, DOI 10.1097/OLQ.0b013e318283c16d; Yao XD, 2014, MUCOSAL IMMUNOL, V7, P268, DOI 10.1038/mi.2013.44	173	148	153	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					72	87		10.1016/S0140-6736(14)60974-0	http://dx.doi.org/10.1016/S0140-6736(14)60974-0			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX8IW	25059942				2022-12-24	WOS:000347154200029
J	Xue, W; Chen, SD; Yin, H; Tammela, T; Papagiannakopoulos, T; Joshi, NS; Cai, WX; Yang, GL; Bronson, R; Crowley, DG; Zhang, F; Anderson, DG; Sharp, PA; Jacks, T				Xue, Wen; Chen, Sidi; Yin, Hao; Tammela, Tuomas; Papagiannakopoulos, Thales; Joshi, Nikhil S.; Cai, Wenxin; Yang, Gillian; Bronson, Roderick; Crowley, Denise G.; Zhang, Feng; Anderson, Daniel G.; Sharp, Phillip A.; Jacks, Tyler			CRISPR-mediated direct mutation of cancer genes in the mouse liver	NATURE			English	Article							ONE-STEP GENERATION; P53 RESTORATION; MICE; CAS9; SPECIFICITY	The study of cancer genes in mouse models has traditionally relied on genetically-engineered strains made via transgenesis or gene targeting in embryonic stem cells(1). Here we describe a new method of cancer model generation using the CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) system in vivo in wild-type mice. We used hydrodynamic injection to deliver a CRISPR plasmid DNA expressing Cas9 and single guide RNAs (sgRNAs)(2-4) to the liver that directly target the tumour suppressor genes Pten (ref. 5) and p53 (also known as TP53 and Trp53) (ref. 6), alone and in combination. CRISPR-mediated Pten mutation led to elevated Akt phosphorylation and lipid accumulation in hepatocytes, phenocopying the effects of deletion of the gene using Cre-LoxP technology(7,8). Simultaneous targeting of Pten and p53 induced liver tumours that mimicked those caused by Cre-loxP-mediated deletion of Pten and p53. DNA sequencing of liver and tumour tissue revealed insertion or deletion mutations of the tumour suppressor genes, including bi-allelic mutations of both Pten and p53 in tumours. Furthermore, co-injection of Cas9 plasmids harbouring sgRNAs targeting the beta-catenin gene and a single-stranded DNA oligonucleotide donor carrying activating point mutations led to the generation of hepatocytes with nuclear localization of b-catenin. This study demonstrates the feasibility of direct mutation of tumour suppressor genes and oncogenes in the liver using the CRISPR/Cas system, which presents a new avenue for rapid development of liver cancer models and functional genomics.	[Xue, Wen; Chen, Sidi; Yin, Hao; Tammela, Tuomas; Papagiannakopoulos, Thales; Joshi, Nikhil S.; Cai, Wenxin; Yang, Gillian; Crowley, Denise G.; Anderson, Daniel G.; Sharp, Phillip A.; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Bronson, Roderick] Tufts Univ, Boston, MA 02115 USA; [Bronson, Roderick] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Zhang, Feng] MIT, Broad Inst, Cambridge, MA 02142 USA; [Zhang, Feng] Harvard, Cambridge, MA 02142 USA; [Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02142 USA; [Anderson, Daniel G.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Anderson, Daniel G.] MIT, Inst Med Engn & Sci, Cambridge, MA 02142 USA; [Sharp, Phillip A.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02142 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Tufts University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.	tjacks@mit.edu	Macrae, Rhiannon/AAX-1536-2020; CHEN, SIDI/D-8284-2016	CHEN, SIDI/0000-0002-3819-5005; /0000-0003-3675-6961; Joshi, Nikhil/0000-0002-7045-7837; Xue, Wen/0000-0002-9797-8042	National Institutes of Health [2-PO1-CA42063, RO1-EB000244, RO1-CA115527, RO1-CA132091]; Cancer Center Support (core) grant from the National Cancer Institute [P30-CA14051]; NIH [R01-CA133404]; Casimir-Lambert Fund; NIH Centers for Cancer Nanotechnology Excellence [5-U54-CA151884-04]; Harvard-MIT Center of Cancer Nanotechnology Excellence; American Association for Cancer Research; Leukemia Lymphoma Society;  [1K99CA169512]; NATIONAL CANCER INSTITUTE [U54CA151884, R00CA169512, R01CA115527, R01CA132091, R01CA133404, P30CA014051, K99CA169512, P01CA042063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000244, R37EB000244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support (core) grant from the National Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Casimir-Lambert Fund; NIH Centers for Cancer Nanotechnology Excellence; Harvard-MIT Center of Cancer Nanotechnology Excellence; American Association for Cancer Research; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. McFadden, N. Dimitrova, E. Snyder, A. Farago, M. Muzumdar, F. Sanchez-Rivera, J. Doench, L. Cong and S. Levine for discussions and for sharing reagents. We thank the Koch Institute Swanson Biotechnology Center (SBC) for technical support, specifically the Hope Babette Tang (1983) Histology Facility and K. Cormier. This work was supported by grants 2-PO1-CA42063, RO1-EB000244, RO1-CA115527 and RO1-CA132091 from the National Institutes of Health and supported in part by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. This work was supported, in part, by NIH Grant R01-CA133404 and Casimir-Lambert Fund to P. A. S. H.Y. is supported by 5-U54-CA151884-04 NIH Centers for Cancer Nanotechnology Excellence and the Harvard-MIT Center of Cancer Nanotechnology Excellence. S. C. is a Damon Runyon Fellow (DRG-2117-12). W. X. was supported by fellowships from the American Association for Cancer Research and the Leukemia Lymphoma Society and is currently supported by grant 1K99CA169512. T. J. is a Howard Hughes Medical Institute (HHMI) Investigator, the David H. Koch Professor of Biology, and a Daniel K. Ludwig Scholar.	Chen SD, 2014, GENE DEV, V28, P1054, DOI 10.1101/gad.239681.114; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katz SF, 2012, GASTROENTEROLOGY, V142, P1229, DOI 10.1053/j.gastro.2012.02.009; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Xue W, 2011, CANCER DISCOV, V1, P236, DOI 10.1158/2159-8290.CD-11-0073; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	33	497	562	19	427	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					380	+		10.1038/nature13589	http://dx.doi.org/10.1038/nature13589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25119044	Green Submitted, Green Accepted			2022-12-24	WOS:000342988600055
J	Behjati, S; Huch, M; van Boxtel, R; Karthaus, W; Wedge, DC; Tamuri, AU; Martincorena, I; Petljak, M; Alexandrov, LB; Gundem, G; Tarpey, PS; Roerink, S; Blokker, J; Maddison, M; Mudie, L; Robinson, B; Nik-Zainal, S; Campbell, P; Goldman, N; van de Wetering, M; Cuppen, E; Clevers, H; Stratton, MR				Behjati, Sam; Huch, Meritxell; van Boxtel, Ruben; Karthaus, Wouter; Wedge, David C.; Tamuri, Asif U.; Martincorena, Inigo; Petljak, Mia; Alexandrov, Ludmil B.; Gundem, Gunes; Tarpey, Patrick S.; Roerink, Sophie; Blokker, Joyce; Maddison, Mark; Mudie, Laura; Robinson, Ben; Nik-Zainal, Serena; Campbell, Peter; Goldman, Nick; van de Wetering, Marc; Cuppen, Edwin; Clevers, Hans; Stratton, Michael R.			Genome sequencing of normal cells reveals developmental lineages and mutational processes	NATURE			English	Article							LGR5(+VE) STEM-CELLS; 21 BREAST CANCERS; SOMATIC MUTATIONS; SMALL-INTESTINE; SELF-RENEWAL; IN-VITRO; LGR5; COLON; FATE; HOMEOSTASIS	The somatic mutations present in the genome of a cell accumulate over the lifetime of a multicellular organism. These mutations can provide insights into the developmental lineage tree(1), the number of divisions that each cell has undergone and the mutational processes that have been operative(2). Here we describe whole genomes of clonal lines(3) derived from multiple tissues of healthy mice. Using somatic base substitutions, we reconstructed the early cell divisions of each animal, demonstrating the contributions of embryonic cells to adult tissues. Differences were observed between tissues in the numbers and types of mutations accumulated by each cell, which likely reflect differences in the number of cell divisions they have undergone and varying contributions of different mutational processes. If somatic mutation rates are similar to those in mice, the results indicate that precise insights into development and mutagenesis of normal human cells will be possible.	[Behjati, Sam; Wedge, David C.; Martincorena, Inigo; Petljak, Mia; Alexandrov, Ludmil B.; Gundem, Gunes; Tarpey, Patrick S.; Roerink, Sophie; Maddison, Mark; Mudie, Laura; Robinson, Ben; Nik-Zainal, Serena; Campbell, Peter; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge CB2 2XY, England; [Huch, Meritxell; van Boxtel, Ruben; Karthaus, Wouter; Blokker, Joyce; van de Wetering, Marc; Cuppen, Edwin; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, CancerGenom Nl, NL-3584 CT Utrecht, Netherlands; [Huch, Meritxell; van Boxtel, Ruben; Karthaus, Wouter; Blokker, Joyce; van de Wetering, Marc; Cuppen, Edwin; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Goldman, Nick] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SA, Cambs, England; [Nik-Zainal, Serena] Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge CB2 0QQ, England	Wellcome Trust Sanger Institute; University of Cambridge; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; European Molecular Biology Laboratory (EMBL); University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	mrs@sanger.ac.uk	Wedge, David/AAC-4977-2021; Nik-Zainal, Serena/ABD-4437-2020; Alexandrov, Ludmil/AAS-1454-2021; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016	Alexandrov, Ludmil/0000-0003-3596-4515; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Nik-Zainal, Serena/0000-0001-5054-1727; van Boxtel, Ruben/0000-0003-1285-2836; Martincorena, Inigo/0000-0003-1122-4416; Goldman, Nick/0000-0001-8486-2211; Wedge, David/0000-0002-7572-3196; Behjati, Sam/0000-0002-6600-7665; Tamuri, Asif/0000-0001-6633-3789; Karthaus, Wouter R./0000-0002-9234-9044	Wellcome Trust [077012/Z/05/Z]; Kadoorie Charitable Foundation; Louis-Jeantet Foundation; Marie Curie IEF fellowship [EU/236954]; ERC [232814]; Netherlands Genomics Initiative [935.12.003]; Centre for Biomedical Genetics, Utrecht; EMBO Long Term Fellowship [ALTF-1287-2012]; Wellcome Trust Intermediate Clinical Fellowship [WT100183MA]; Wellcome-Beit Prize Fellowship; Wellcome Trust Research Training Fellowship for Clinicians; Wellcome Trust Senior Research Fellowship in Clinical Science	Wellcome Trust(Wellcome TrustEuropean Commission); Kadoorie Charitable Foundation; Louis-Jeantet Foundation; Marie Curie IEF fellowship(European Commission); ERC(European Research Council (ERC)European Commission); Netherlands Genomics Initiative; Centre for Biomedical Genetics, Utrecht; EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); Wellcome-Beit Prize Fellowship; Wellcome Trust Research Training Fellowship for Clinicians; Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust)	We thank M. Zernicka-Goetz and the Goldman group for discussion of our findings. This work was supported by funding from the Wellcome Trust (grant reference 077012/Z/05/Z), the Kadoorie Charitable Foundation and the Louis-Jeantet Foundation. Individual authors were supported as follows: M. H., Marie Curie IEF fellowship (EU/236954) and ERC grant (232814); R. B. and E. C., Zenith grant of the Netherlands Genomics Initiative (935.12.003); W. K., Centre for Biomedical Genetics, Utrecht; I. M., EMBO Long Term Fellowship (ALTF-1287-2012); S.N.Z., Wellcome Trust Intermediate Clinical Fellowship (WT100183MA) and Wellcome-Beit Prize Fellowship 2013; S. B., Wellcome Trust Research Training Fellowship for Clinicians; and P. C., Wellcome Trust Senior Research Fellowship in Clinical Science.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bruce AW, 2010, CURR OPIN GENET DEV, V20, P485, DOI 10.1016/j.gde.2010.05.006; Carlson CA, 2012, NAT METHODS, V9, P78, DOI [10.1038/nmeth.1781, 10.1038/NMETH.1781]; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009; Lasken RS, 2013, NAT BIOTECHNOL, V31, P211, DOI 10.1038/nbt.2523; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leushacke M, 2013, CELL REP, V5, P349, DOI 10.1016/j.celrep.2013.09.025; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Salipante SJ, 2006, P NATL ACAD SCI USA, V103, P5448, DOI 10.1073/pnas.0601265103; Salipante SJ, 2007, CURR TOP DEV BIOL, V79, P157, DOI 10.1016/S0070-2153(06)79006-8; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shibata D, 2006, CELL CYCLE, V5, P610, DOI 10.4161/cc.5.6.2570; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Wasserstrom A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001939; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Zhou WY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-39	30	222	226	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					422	+		10.1038/nature13448	http://dx.doi.org/10.1038/nature13448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043003	Green Accepted			2022-12-24	WOS:000341814900061
J	Bernier, R; Golzio, C; Xiong, B; Stessman, HA; Coe, BP; Penn, O; Witherspoon, K; Gerdts, J; Baker, C; Vulto-van Silfhout, AT; Schuurs-Hoeijmakers, JH; Fichera, M; Bosco, P; Buono, S; Alberti, A; Failla, P; Peeters, H; Steyaert, J; Vissers, LELM; Francescatto, L; Mefford, HC; Rosenfeld, JA; Bakken, T; O'Roak, BJ; Pawlus, M; Moon, R; Shendure, J; Amaral, DG; Lein, E; Rankin, J; Romano, C; de Vries, BBA; Katsanis, N; Eichler, EE				Bernier, Raphael; Golzio, Christelle; Xiong, Bo; Stessman, Holly A.; Coe, Bradley P.; Penn, Osnat; Witherspoon, Kali; Gerdts, Jennifer; Baker, Carl; Vulto-van Silfhout, Anneke T.; Schuurs-Hoeijmakers, Janneke H.; Fichera, Marco; Bosco, Paolo; Buono, Serafino; Alberti, Antonino; Failla, Pinella; Peeters, Hilde; Steyaert, Jean; Vissers, Lisenka E. L. M.; Francescatto, Ludmila; Mefford, Heather C.; Rosenfeld, Jill A.; Bakken, Trygve; O'Roak, Brian J.; Pawlus, Matthew; Moon, Randall; Shendure, Jay; Amaral, David G.; Lein, Ed; Rankin, Julia; Romano, Corrado; de Vries, Bert B. A.; Katsanis, Nicholas; Eichler, Evan E.			Disruptive CHD8 Mutations Define a Subtype of Autism Early in Development	CELL			English	Article							DE-NOVO MUTATIONS; HEART-DISEASE; GENE; ABNORMALITIES; EXPRESSION; CHILDREN; 16P11.2; PROTEIN; RISK	Autism spectrum disorder (ASD) is a heterogeneous disease in which efforts to define subtypes behaviorally have met with limited success. Hypothesizing that genetically based subtype identification may prove more productive, we resequenced the ASD-associated gene CHD8 in 3,730 children with developmental delay or ASD. We identified a total of 15 independent mutations; no truncating events were identified in 8,792 controls, including 2,289 unaffected siblings. In addition to a high likelihood of an ASD diagnosis among patients bearing CHD8 mutations, characteristics enriched in this group included macrocephaly, distinct faces, and gastrointestinal complaints. chd8 disruption in zebrafish recapitulates features of the human phenotype, including increased head size as a result of expansion of the forebrain/midbrain and impairment of gastrointestinal motility due to a reduction in postmitotic enteric neurons. Our findings indicate that CHD8 disruptions define a distinct ASD subtype and reveal unexpected comorbidities between brain development and enteric innervation.	[Bernier, Raphael; Gerdts, Jennifer] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Golzio, Christelle; Francescatto, Ludmila; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Xiong, Bo; Coe, Bradley P.; Penn, Osnat; Witherspoon, Kali; Baker, Carl; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Vulto-van Silfhout, Anneke T.; Schuurs-Hoeijmakers, Janneke H.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Fichera, Marco; Bosco, Paolo; Buono, Serafino; Alberti, Antonino; Failla, Pinella; Romano, Corrado] IRCCS Associaz Oasi Maria Santissima, I-94018 Troina, Italy; [Fichera, Marco] Univ Catania, I-95123 Catania, Italy; [Peeters, Hilde] Katholieke Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Peeters, Hilde; Steyaert, Jean] Leuven Autism Res LAuRes, B-3000 Leuven, Belgium; [Steyaert, Jean] Katholieke Univ Leuven, Dept Child & Adolescent Psychiat, B-3000 Leuven, Belgium; [Steyaert, Jean] Maastricht Univ, Acad Hosp Maastricht, Dept Clin Genet, NL-6200 MD Maastricht, Netherlands; [Steyaert, Jean] Maastricht Univ, Res Inst Growth & Dev GROW, NL-6200 MD Maastricht, Netherlands; [Mefford, Heather C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rosenfeld, Jill A.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Bakken, Trygve] Allen Inst Brain Sci, Seattle, WA 98103 USA; [O'Roak, Brian J.] OHSU, Portland, OR 97208 USA; [Pawlus, Matthew; Moon, Randall] Univ Washington, Dept Pharmacol, Seattle, WA 98109 USA; [Amaral, David G.] Univ Calif Davis, MIND Inst, Autism Phenome Project, Sacramento, CA 95817 USA; [Rankin, Julia] Peninsula Clin Genet Serv, Exeter EX1 2ED, Devon, England; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Duke University; University of Washington; University of Washington Seattle; Radboud University Nijmegen; University of Catania; KU Leuven; University Hospital Leuven; KU Leuven; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; University of Washington; University of Washington Seattle; Allen Institute for Brain Science; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of California System; University of California Davis; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Buono, Serafino/D-8568-2017; Coe, Bradley/A-2878-2009; Shendure, Jay/AAU-3684-2021; AT, Vulto-van Silfhout/H-4199-2015; Fichera, Marco/K-9220-2016; Alberti, Antonino/D-5653-2017; Vissers, Lisenka ELM/A-2598-2015; Romano, Corrado/B-9695-2008; Xiong, Bo/M-3605-2014; Peeters, Hilde/AAA-7338-2020; Moon, Randall/M-5605-2019; Bakken, Trygve E./R-4622-2017; Failla, Pinella/AAE-9963-2019; Steyaert, Jean/B-5326-2015	Buono, Serafino/0000-0002-3786-3323; Fichera, Marco/0000-0002-8225-6880; Alberti, Antonino/0000-0001-6742-7429; Vissers, Lisenka ELM/0000-0001-6470-5497; Romano, Corrado/0000-0003-1049-0683; Moon, Randall/0000-0002-9352-1408; Bakken, Trygve E./0000-0003-3373-7386; Failla, Pinella/0000-0003-3969-7266; Shendure, Jay/0000-0002-1516-1865; Peeters, Hilde/0000-0002-7295-3375; Pawlus, Matthew/0000-0001-6007-7198; Katsanis, Nicholas/0000-0002-2480-0171; O'Roak, Brian/0000-0002-4141-0095; Golzio, Christelle/0000-0002-4420-3921; Stessman, Holly/0000-0002-0764-3493; Steyaert, Jean/0000-0003-2512-4694; Xiong, Bo/0000-0002-2695-9100; Coe, Bradley/0000-0001-8471-4016	Simons Foundation Autism Research Initiative (SFARI) [303241]; NIH/NIMH [R01MH101221]; SFARI [239983]; NIH [P50MH094268]; NARSAD Young Investigator Grant from BBRF; European Commission; GENCODYS [241995]; Dutch Organisation for Health Research and Development (ZON-MW) [917-86-319, 912-12-109]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221, P50MH094268] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative (SFARI); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); SFARI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Grant from BBRF(NARSAD); European Commission(European CommissionEuropean Commission Joint Research Centre); GENCODYS; Dutch Organisation for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Simons Foundation Autism Research Initiative (SFARI) 303241 and NIH/NIMH R01MH101221 to E.E.E.; by SFARI 239983 and NIH P50MH094268 to N.K.; by a NARSAD Young Investigator Grant from BBRF to C.G.; and by the European Commission: GENCODYS grant 241995 under FP7 and the Dutch Organisation for Health Research and Development (ZON-MW grants 917-86-319 and 912-12-109) to B.B.A.d.V. E.E.E. is an Investigator of the Howard Hughes Medical Institute and is on the scientific advisory board for DNAnexus, Inc. N.K. is a Distinguished Brumley Professor. We thank all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, E. Hanson, D. Grice, A. Klin, R. Kochel, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, and E. Wijsman). We are grateful to D. Raible and H. S. Zimmermann for providing zebrafish resources and for helpful discussions, to T. Brown for help with manuscript preparation, and to J. Huddleston and M. Malig for sequencing support.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Chaste P, 2013, BIOL PSYCHIAT, V74, P576, DOI 10.1016/j.biopsych.2013.04.018; CIMENT G, 1983, NATURE, V305, P424, DOI 10.1038/305424a0; Cocchiaro JL, 2013, JOVE-J VIS EXP, DOI 10.3791/4434; D'Autreaux F, 2007, DEVELOPMENT, V134, P2237, DOI 10.1242/dev.003814; Field HA, 2009, NEUROGASTROENT MOTIL, V21, P304, DOI 10.1111/j.1365-2982.2008.01234.x; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hennekam RCM, 2012, HUM MUTAT, V33, P884, DOI 10.1002/humu.22048; HITTNER HM, 1979, J PEDIAT OPHTH STRAB, V16, P122; Houdayer C, 2011, METHODS MOL BIOL, V760, P269, DOI 10.1007/978-1-61779-176-5_17; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Lord C, 2012, ARCH GEN PSYCHIAT, V69, P306, DOI 10.1001/archgenpsychiatry.2011.148; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sawada G, 2013, ONCOL REP, V30, P1137, DOI 10.3892/or.2013.2597; Schulze TG, 2004, HUM HERED, V58, P131, DOI 10.1159/000083539; Shen EH, 2012, TRENDS NEUROSCI, V35, P711, DOI 10.1016/j.tins.2012.09.005; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Stessman HA, 2014, CELL, V156, P872, DOI 10.1016/j.cell.2014.02.002; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Westerfield M., 1995, ZEBR BOOK GUID LAB U; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288	43	450	466	4	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					263	276		10.1016/j.cell.2014.06.017	http://dx.doi.org/10.1016/j.cell.2014.06.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	24998929	Green Accepted, Bronze			2022-12-24	WOS:000340943600008
J	Sham, LT; Butler, EK; Lebar, MD; Kahne, D; Bernhardt, TG; Ruiz, N				Sham, Lok-To; Butler, Emily K.; Lebar, Matthew D.; Kahne, Daniel; Bernhardt, Thomas G.; Ruiz, Natividad			MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis	SCIENCE			English	Article							ESCHERICHIA-COLI; MUREIN SYNTHESIS; IDENTIFICATION; RODA; MVIN; GENE; FTSW	Peptidoglycan (PG) is a polysaccharide matrix that protects bacteria from osmotic lysis. Inhibition of its biogenesis is a proven strategy for killing bacteria with antibiotics. The assembly of PG requires disaccharide-pentapeptide building blocks attached to a polyisoprene lipid carrier called lipid II. Although the stages of lipid II synthesis are known, the identity of the essential flippase that translocates it across the cytoplasmic membrane for PG polymerization is unclear. We developed an assay for lipid II flippase activity and used a chemical genetic strategy to rapidly and specifically block flippase function. We combined these approaches to demonstrate that MurJ is the lipid II flippase in Escherichia coli.	[Sham, Lok-To; Bernhardt, Thomas G.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Butler, Emily K.; Ruiz, Natividad] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Lebar, Matthew D.; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kahne, Daniel] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Harvard University; Harvard University; Harvard Medical School	Bernhardt, TG (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	thomas_bernhardt@hms.harvard.edu; ruiz.82@osu.edu	Sham, Lok To/L-8149-2016	Ruiz, Natividad/0000-0002-6369-2206; Butler, Emily K./0000-0003-2906-0595; Lebar, Matthew/0000-0003-4910-1438; Sham, Lok To/0000-0001-9047-0310	American Heart Association; National Institutes of Health (NIH) [F32GM103056, R01GM100951, R01AI099144, R01GM76710]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100951, F32GM103056, R01GM076710] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Mengin-Lecreulx for the generous gift of plasmids for ColM production and H. Joseph and R. M. Davis for their technical assistance. Research was supported by funds from the American Heart Association (L.S.) and the National Institutes of Health (NIH) under award numbers F32GM103056 (M.D.L.), R01GM100951 (N.R.), R01AI099144 (T.G.B.), and R01GM76710 (D.K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. For additional data, see the supplementary materials.	Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Butler EK, 2013, J BACTERIOL, V195, P4639, DOI 10.1128/JB.00731-13; de Pedro MA, 2001, J BACTERIOL, V183, P4115, DOI 10.1128/JB.183.14.4115-4126.2001; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; HEPPEL LA, 1967, SCIENCE, V156, P1451, DOI 10.1126/science.156.3781.1451; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Inoue A, 2008, J BACTERIOL, V190, P7298, DOI 10.1128/JB.00551-08; KHATTAR MM, 1994, J BACTERIOL, V176, P7140, DOI 10.1128/JB.176.23.7140-7147.1994; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Touze T, 2012, BIOCHEM SOC T, V40, P1522, DOI 10.1042/BST20120189; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677	13	188	193	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					220	222		10.1126/science.1254522	http://dx.doi.org/10.1126/science.1254522			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013077	Green Accepted			2022-12-24	WOS:000339409900055
J	Brooks-Pollock, E; Roberts, GO; Keeling, MJ				Brooks-Pollock, Ellen; Roberts, Gareth O.; Keeling, Matt J.			A dynamic model of bovine tuberculosis spread and control in Great Britain	NATURE			English	Article							MOUTH EPIDEMIC; CATTLE; TRANSMISSION; ENGLAND; FOOT	Bovine tuberculosis (TB) is one of the most complex, persistent and controversial problems facing the British cattle industry, costing the country an estimated 100 pound million per year(1). The low sensitivity of the standard diagnostic test leads to considerable ambiguity in determining the main transmission routes of infection, which exacerbates the continuing scientific debate(2-6). In turn this uncertainty fuels the fierce public and political disputes on the necessity of controlling badgers to limit the spread of infection. Here we present a dynamic stochastic spatial model for bovine TB in Great Britain that combines within-farm and between-farm transmission. At the farmscale the model incorporates stochastic transmission of infection, maintenance of infection in the environment and a testing protocol that mimics historical government policy. Between-farm transmission has a short-range environmental component and is explicitly driven by movements of individual cattle between farms, as recorded in the Cattle Tracing System(2). The resultant model replicates the observed annual increase of infection over time as well as the spread of infection into new areas. Given that our model is mechanistic, it can ascribe transmission pathways to each new case; the majority of newly detected cases involve several transmission routes with moving infected cattle, reinfection from an environmental reservoir and poor sensitivity of the diagnostic test all having substantive roles. This underpins our findings on the implications of control measures. Very few of the control options tested have the potential to reverse the observed annual increase, with only intensive strategies such as whole-herd culling or additional national testing proving highly effective, whereas controls focused on a single transmission route are unlikely to be highly effective.	[Brooks-Pollock, Ellen] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge CB3 0ES, England; [Brooks-Pollock, Ellen; Keeling, Matt J.] Univ Warwick, Math Inst, WIDER Ctr, Coventry CV4 7AL, W Midlands, England; [Brooks-Pollock, Ellen; Keeling, Matt J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Roberts, Gareth O.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England	University of Cambridge; University of Warwick; University of Warwick; University of Warwick	Keeling, MJ (corresponding author), Univ Warwick, Math Inst, WIDER Ctr, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	M.J.Keeling@warwick.ac.uk	Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765; Brooks-Pollock, Ellen/0000-0002-5984-4932	BBSRC; Wellcome Trust; EPSRC; Biotechnology and Biological Sciences Research Council [BB/H00811X/1, BB/I013482/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H027270/1, EP/D002060/1] Funding Source: researchfish; BBSRC [BB/I013482/1, BB/H00811X/1] Funding Source: UKRI; EPSRC [EP/H027270/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by BBSRC, the Wellcome Trust and EPSRC. We would like to thank G. Medley, L. Green, O. Courtenay, A. Ramirez-Villaescusa, J. Wood and L. Danon for helpful discussions on bovine TB dynamics. Thanks to A. Conlan and T. J. McKinley for advice on implementing SMC-ABC and to A. Conlan to setting up the Marx Bros cluster. The breakdown and reactor data was supplied by the AHVLA team (particularly A. Mitchell and R. Blackwell), the RADAR team and DEFRA.	Barlow ND, 1997, PREV VET MED, V32, P57, DOI 10.1016/S0167-5877(97)00002-0; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Brooks-Pollock E, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-97; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Cox DR, 2005, P NATL ACAD SCI USA, V102, P17588, DOI 10.1073/pnas.0509003102; Department for Environment Food and Rural Affairs, 2013, BOV TUB EV PLAN; Department for Environment Food and Rural Affairs, 2011, BOV TB ER PROGR ENGL; Donnelly C. A., 2010, STAT COMMUN INFECT D, V2, P1; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; Godfray HCJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1634; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Green LE, 2005, PREV VET MED, V70, P293, DOI 10.1016/j.prevetmed.2005.05.005; Independent Scientific Group on Cattle TB, 2007, BOV TB SCI EV; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Krebs J., 1997, PB3423 HMSO; MONAGHAN ML, 1994, VET MICROBIOL, V40, P111, DOI 10.1016/0378-1135(94)90050-7; National Audit Office, 2003, ID TRACK LIV ENGL; O'Hare A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0248; Pollock JM, 2001, TUBERCULOSIS, V81, P103, DOI 10.1054/tube.2000.0258; Reynolds D, 2006, VET MICROBIOL, V112, P119, DOI 10.1016/j.vetmic.2005.11.042; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Waddington K, 2004, MED HIST, V48, P29, DOI 10.1017/S0025727300007043; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331	26	147	149	1	185	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					228	+		10.1038/nature13529	http://dx.doi.org/10.1038/nature13529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008532				2022-12-24	WOS:000338649800045
J	De Raedt, T; Beert, E; Pasmant, E; Luscan, A; Brems, H; Ortonne, N; Helin, K; Hornick, JL; Mautner, V; Kehrer-Sawatzki, H; Clapp, W; Bradner, J; Vidaud, M; Upadhyaya, M; Legius, E; Cichowski, K				De Raedt, Thomas; Beert, Eline; Pasmant, Eric; Luscan, Armelle; Brems, Hilde; Ortonne, Nicolas; Helin, Kristian; Hornick, Jason L.; Mautner, Victor; Kehrer-Sawatzki, Hildegard; Clapp, Wade; Bradner, James; Vidaud, Michel; Upadhyaya, Meena; Legius, Eric; Cichowski, Karen			PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies	NATURE			English	Article							BET BROMODOMAIN INHIBITION; NF1 MICRODELETION PATIENTS; NEUROFIBROMATOSIS TYPE-1; CANCER; TUMORS; GENE; SUPPRESSOR; MUTATIONS; MICE; EZH2	The polycomb repressive complex 2 (PRC2) exerts oncogenic effects in many tumour types(1). However, loss-of-function mutations in PRC2 components occur in a subset of haematopoietic malignancies, suggesting that this complex plays a dichotomous and poorly understood role in cancer(2,3). Here we provide genomic, cellular, and mouse modelling data demonstrating that the polycomb group gene SUZ12 functions as tumour suppressor in PNS tumours, high-grade gliomas and melanomas by cooperating with mutations in NF1. NF1 encodes a Ras GTPase-activating protein (RasGAP) and its loss drives cancer by activating Ras(4). We show that SUZ12 loss potentiates the effects of NF1 mutations by amplifying Ras-driven transcription through effects on chromatin. Importantly, however, SUZ12 inactivation also triggers an epigenetic switch that sensitizes these cancers to bromodomain inhibitors. Collectively, these studies not only reveal an unexpected connection between the PRC2 complex, NF1 and Ras, but also identify a promising epigenetic-based therapeutic strategy that may be exploited for a variety of cancers.	[De Raedt, Thomas; Cichowski, Karen] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [De Raedt, Thomas; Bradner, James; Cichowski, Karen] Harvard Univ, Sch Med, Boston, MA 02115 USA; [De Raedt, Thomas; Cichowski, Karen] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA 02115 USA; [Beert, Eline; Brems, Hilde; Legius, Eric] Katholieke Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Pasmant, Eric; Luscan, Armelle; Ortonne, Nicolas; Vidaud, Michel] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, INSERM UMR S745, F-75006 Paris, France; [Pasmant, Eric; Luscan, Armelle; Ortonne, Nicolas; Vidaud, Michel] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, EA7331, F-75006 Paris, France; [Pasmant, Eric; Luscan, Armelle; Ortonne, Nicolas; Vidaud, Michel] Hop Cochin, AP HP, Serv Biochim & Genet Mol, F-75014 Paris, France; [Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr Danstem, DK-2200 Copenhagen, Denmark; [Hornick, Jason L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Mautner, Victor] Univ Med Ctr, Dept Maxillofacial Surg, D-20246 Hamburg, Germany; [Kehrer-Sawatzki, Hildegard] Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany; [Clapp, Wade] Indiana Univ Sch Med, Dept Pediat, Herman Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Bradner, James] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Upadhyaya, Meena] Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Legius, Eric] Univ Hosp Leuven, Ctr Human Genet, B-3000 Leuven, Belgium	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; KU Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; University of Copenhagen; University of Copenhagen; Harvard University; Brigham & Women's Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Indiana University System; Indiana University Bloomington; Harvard University; Dana-Farber Cancer Institute; Cardiff University; KU Leuven; University Hospital Leuven	Cichowski, K (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	Eric.Legius@uzleuven.be; kcichowski@rics.bwh.harvard.edu	Brems, Hilde/AAN-4075-2020; De Raedt, Thomas/AAC-3172-2021; Helin, Kristian/K-2526-2019; Pasmant, Eric/O-7249-2017; Vidaud, Michel/O-7346-2017; Luscan, Armelle/O-8081-2017; Helin, Kristian/HDM-8306-2022	Pasmant, Eric/0000-0002-1881-8762; Helin, Kristian/0000-0003-1975-6097; De Raedt, Thomas/0000-0002-7492-851X; Hornick, Jason/0000-0001-6475-8345	US Department of Defense [W81XWH-11-1-0138]; Ludwig Center at DF/HCC and the Children's Tumor Foundation; Children's Tumor Foundation; FWO-Flanders [G.0784.10N]; Emmanuel Vanderschueren Fellowship from the Vlaamse Liga tegen Kanker	US Department of Defense(United States Department of Defense); Ludwig Center at DF/HCC and the Children's Tumor Foundation; Children's Tumor Foundation; FWO-Flanders(FWO); Emmanuel Vanderschueren Fellowship from the Vlaamse Liga tegen Kanker	This work was supported by the following organizations: The US Department of Defense (W81XWH-11-1-0138), the Ludwig Center at DF/HCC and the Children's Tumor Foundation (K.C.); T.D. was a recipient of the Young Investigator Award of the Children's Tumor Foundation; FWO-Flanders G.0784.10N (E.L.). E.B. was a recipient of an Emmanuel Vanderschueren Fellowship from the Vlaamse Liga tegen Kanker. Association Neurofibromatoses et Recklinghausen, Ligue Francaise Contre les Neurofibromatoses, Association pour la Recherche sur le Cancer, Comite de Paris de la Ligue Contre le Cancer, the French Clinical Research program (PHRC 2002, P. Wolkenstein) and INSERM (Nf1GeneModif project) (M.V. and E.P.). We thank the Platform of Biological Resources, Assistance Publique Hopitaux de Paris, Hopital Henri Mondor, Creteil, France, for providing tissue samples.	Beert E, 2011, GENE CHROMOSOME CANC, V50, P1021, DOI 10.1002/gcc.20921; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chang T, 2013, J CLIN INVEST, V123, P335, DOI 10.1172/JCI63193; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; De Raedt T, 2004, GENOMICS, V84, P346, DOI 10.1016/j.ygeno.2004.03.006; De Raedt T, 2003, AM J HUM GENET, V72, P1288, DOI 10.1086/374821; De Raedt T, 2011, CANCER CELL, V20, P400, DOI 10.1016/j.ccr.2011.08.014; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; LEGIUS E, 1994, GENE CHROMOSOME CANC, V10, P250, DOI 10.1002/gcc.2870100405; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Maertens Ophelia, 2014, Advances in Biological Regulation, V55, P1, DOI 10.1016/j.jbior.2014.04.002; Mautner VF, 2010, J MED GENET, V47, P623, DOI 10.1136/jmg.2009.075937; McGillicuddy LT, 2009, CANCER CELL, V16, P44, DOI 10.1016/j.ccr.2009.05.009; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Widemann BC, 2009, CURR ONCOL REP, V11, P322, DOI 10.1007/s11912-009-0045-z; Xu J, 2013, CANCER DISCOV, V3, P993, DOI 10.1158/2159-8290.CD-13-0096; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	33	299	301	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					247	+		10.1038/nature13561	http://dx.doi.org/10.1038/nature13561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119042				2022-12-24	WOS:000342663100046
J	Pan, L; Wang, S; Lu, TL; Weng, CJ; Song, XQ; Park, JK; Sun, J; Yang, ZH; Yu, JJ; Tang, H; McKearin, DM; Chamovitz, DA; Ni, JQ; Xie, T				Pan, Lei; Wang, Su; Lu, Tinglin; Weng, Changjiang; Song, Xiaoqing; Park, Joseph K.; Sun, Jin; Yang, Zhi-Hao; Yu, Junjing; Tang, Hong; McKearin, Dennis M.; Chamovitz, Daniel A.; Ni, Jianquan; Xie, Ting			Protein competition switches the function of COP9 from self-renewal to differentiation	NATURE			English	Article							GERMLINE STEM-CELLS; BAG-OF-MARBLES; DROSOPHILA OVARY; SIGNALOSOME; MELANOGASTER; MAINTENANCE; DIVISION; NICHE; TRANSCRIPTION; DEGRADATION	The balance between stem cell self-renewal and differentiation is controlled by intrinsic factors and niche signals(1,2). In the Drosophila melanogaster ovary, some intrinsic factors promote germline stem cell (GSC) self-renewal, whereas others stimulate differentiation(3). However, it remains poorly understood how the balance between self-renewal and differentiation is controlled. Here we use D. mel-anogaster ovarian GSCs to demonstrate that the differentiation factor Bam controls the functional switch of the COP9 complex from self-renewal to differentiation via protein competition. The COP9 complex is composed of eight Csn subunits, Csn1-8, and removes Nedd8 modifications from target proteins(4,5). Genetic results indicated that the COP9 complex is required intrinsically for GSC self-renewal, whereas other Csn proteins, with the exception of Csn4, were also required for GSC progeny differentiation. Bam-mediated Csn4 sequestration from the COP9 complex via protein competition inactivated the self-renewing function of COP9 and allowed other Csn proteins to promote GSC differentiation. Therefore, this study reveals a protein-competition-based mechanism for controlling the balance between stem cell self-renewal and differentiation. Because numerous self-renewal factors are ubiquitously expressed throughout the stem cell lineage in various systems, protein competition may function as an important mechanism for controlling the self-renewal-to-differentiation switch.	[Pan, Lei; Wang, Su; Weng, Changjiang; Song, Xiaoqing; Yu, Junjing; Xie, Ting] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Pan, Lei; Yu, Junjing; Tang, Hong] Chinese Acad Sci, Key Lab Infect & Immun, Inst Biophys, Beijing 100101, Peoples R China; [Wang, Su; Xie, Ting] Univ Kansas, Sch Med, Dept Cell Biol & Anat, Kansas City, KS 66160 USA; [Lu, Tinglin; Sun, Jin; Yang, Zhi-Hao; Ni, Jianquan] Tsinghua Univ, Sch Med, Ctr Life Sci, Beijing 100084, Peoples R China; [Park, Joseph K.; McKearin, Dennis M.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Park, Joseph K.; McKearin, Dennis M.] Univ Texas SW Med Ctr Dallas, Grad Sch Biomed Sci, Dallas, TX 75390 USA; [Park, Joseph K.; McKearin, Dennis M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Chamovitz, Daniel A.] Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel	Stowers Institute for Medical Research; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Kansas; University of Kansas Medical Center; Tsinghua University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Tel Aviv University	Xie, T (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	tgx@stowers.org	weng, changjiang/HHR-8479-2022; Chamovitz, Daniel/S-5021-2019	Chamovitz, Daniel/0000-0002-2815-2909; Pan, Lei/0000-0002-0500-8904; Park, Joseph/0000-0003-1699-3951	Stowers Institute for Medical Research; National Institutes of Health [GM64428]; National Natural Science Foundation of China [31370909]; Ministry of Science and Technology of China [2012CB518900]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064428] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Yamashita, the Developmental Studies Hybridoma Bank and the Bloomington Drosophila Stock Center for reagents, Xie laboratory members for discussions, and D. Chao and R. Krumlauf for critical comments on the manuscript. This work was supported by the Stowers Institute for Medical Research (T.X.), the National Institutes of Health (GM64428, T.X.), the National Natural Science Foundation of China (31370909, L.P.) and the Ministry of Science and Technology of China (2012CB518900, L.P.).	Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Djagaeva I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007577; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; LIN HF, 1994, DEVELOPMENT, V120, P947; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Oron E, 2002, DEVELOPMENT, V129, P4399; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Shen R, 2009, P NATL ACAD SCI USA, V106, P11623, DOI 10.1073/pnas.0903325106; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xie T, 2013, WIRES DEV BIOL, V2, P261, DOI 10.1002/wdev.60; Yu JJ, 2010, J BIOL CHEM, V285, P8454, DOI 10.1074/jbc.M109.075036	28	35	35	4	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					233	+		10.1038/nature13562	http://dx.doi.org/10.1038/nature13562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119050				2022-12-24	WOS:000342663100043
J	Han, P; Li, W; Lin, CH; Yang, J; Shang, C; Nurnberg, ST; Jin, KK; Xu, WH; Lin, CY; Lin, CJ; Xiong, YQ; Chien, HC; Zhou, B; Ashley, E; Bernstein, D; Chen, PS; Chen, HSV; Quertermous, T; Chang, CP				Han, Pei; Li, Wei; Lin, Chiou-Hong; Yang, Jin; Shang, Ching; Nurnberg, Sylvia T.; Jin, Kevin Kai; Xu, Weihong; Lin, Chieh-Yu; Lin, Chien-Jung; Xiong, Yiqin; Chien, Huan-Chieh; Zhou, Bin; Ashley, Euan; Bernstein, Daniel; Chen, Peng-Sheng; Chen, Huei-Sheng Vincent; Quertermous, Thomas; Chang, Ching-Pin			A long noncoding RNA protects the heart from pathological hypertrophy	NATURE			English	Article							CARDIAC-HYPERTROPHY; STRUCTURAL BASIS; IN-VIVO; CHROMATIN; TRANSCRIPTION; GROWTH; DOMAIN; GENE; MORPHOGENESIS; RECOGNITION	The role of long noncoding RNA(lncRNA) in adult hearts is unknown; also unclear is how lncRNA modulates nucleosome remodelling. An estimated 70% of mouse genes undergo antisense transcription(1), including myosin heavy chain 7 (Myh7), which encodes molecular motor proteins for heart contraction(2). Here we identify a cluster of lncRNA transcripts from Myh7 loci and demonstrate a new lncRNA-chromatin mechanism for heart failure. In mice, these transcripts, which we named myosin heavy-chain-associated RNA transcripts (Myheart, orMhrt), are cardiac-specific and abundant in adult hearts. Pathological stress activates the Brg1-Hdac-Parp chromatin repressor complex(3) to inhib-it Mhrt transcription in the heart. Such stress-induced Mhrt repression is essential for cardiomyopathy to develop: restoring Mhrt to the prestress level protects the heart from hypertrophy and failure. Mhrt antagonizes the function of Brg1, a chromatin-remodelling factor that is activated by stress to trigger aberrant gene expression and cardiac myopathy(3). Mhrt prevents Brg1 from recognizing its genomic DNA targets, thus inhibiting chromatin targeting and gene regulation by Brg1. It does so by binding to the helicase domain of Brg1, a domain that is crucial for tethering Brg1 to chromatinized DNA targets. Brg1 helicase has dual nucleic-acid-binding specificities: it is capable of binding lncRNA(Mhrt) and chromatinized-but not naked-DNA. This dual-binding feature of helicase enables a competitive inhibition mechanism by which Mhrt sequesters Brg1 from its genomic DNA targets to prevent chromatin remodelling. A Mhrt-Brg1 feedback circuit is thus crucial for heart function. Human MHRT also originates from MYH7 loci and is repressed in various types of myopathic hearts, suggesting a conserved lncRNA mechanism in human cardiomyopathy. Our studies identify a cardioprotective lncRNA, define a new targeting mechanism for ATP-dependent chromatin-remodelling factors, and establish a new paradigm for lncRNA chromatin interaction.	[Han, Pei; Li, Wei; Yang, Jin; Chen, Peng-Sheng; Chang, Ching-Pin] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Han, Pei; Li, Wei; Yang, Jin; Chen, Peng-Sheng; Chang, Ching-Pin] Indiana Univ, Sch Med, Div Cardiol, Dept Med, Indianapolis, IN 46202 USA; [Han, Pei; Li, Wei; Lin, Chiou-Hong; Shang, Ching; Nurnberg, Sylvia T.; Jin, Kevin Kai; Lin, Chieh-Yu; Lin, Chien-Jung; Xiong, Yiqin; Chien, Huan-Chieh; Ashley, Euan; Quertermous, Thomas] Stanford Univ, Sch Med, Cardiovasc Inst, Div Cardiovasc Med, Stanford, CA 94305 USA; [Xu, Weihong] Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; [Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Dept Genet Pediat & Med Cardiol, Bronx, NY 10461 USA; [Bernstein, Daniel] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Chen, Huei-Sheng Vincent] Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, La Jolla, CA 92037 USA; [Chang, Ching-Pin] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chang, Ching-Pin] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Stanford University; Stanford University; Yeshiva University; Albert Einstein College of Medicine; Stanford University; Sanford Burnham Prebys Medical Discovery Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Chang, CP (corresponding author), Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.	changcp@iu.edu	Xu, Weihong/C-4175-2012; Xiong, Yiqin/H-1710-2012; Lin, Chiou-Hong/L-1749-2015	Xu, Weihong/0000-0002-3988-3571; Quertermous, Thomas/0000-0002-7645-9067; Nurnberg, Sylvia/0000-0002-0869-484X; Bernstein, Daniel/0000-0001-7761-5853	American Heart Association (AHA) [12EIA8960018]; National Institutes of Health (NIH) [HL118087, HL121197]; March of Dimes Foundation [6-FY11-260]; California Institute of Regenerative Medicine (CIRM) [RN2-00909]; Oak Foundation; Baxter Foundation; Stanford Heart Center Research Program; Indiana University (IU) School of Medicine-IU Health Strategic Research Initiative; IU Physician-Scientist Initiative; AHA; Lucile Packard Children's Foundation; NIH [HL109512, HL105194, HL78931, HL71140, HL116997, HL111770]; CIRM [RB2-01512, RB4-06276]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111770, R01HL118087, R01HL071140, R56HL071140, R01HL109512, R01HL116997, P01HL078931, R01HL121197, R01HL105194] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Oak Foundation; Baxter Foundation; Stanford Heart Center Research Program; Indiana University (IU) School of Medicine-IU Health Strategic Research Initiative; IU Physician-Scientist Initiative; AHA(American Heart Association); Lucile Packard Children's Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank C.-H. Chen for assisting with echocardiography; L. Chen, A. Kuo and G. Crabtree for transgene injection and northern blot; M. Ecarkt and E. Zuo for ribosome analysis. C.-P. C. was supported by the American Heart Association (AHA; Established Investigator Award 12EIA8960018), National Institutes of Health (NIH; HL118087, HL121197), March of Dimes Foundation (#6-FY11-260), California Institute of Regenerative Medicine (CIRM; RN2-00909), Oak Foundation, Baxter Foundation, Stanford Heart Center Research Program, Indiana University (IU) School of Medicine-IU Health Strategic Research Initiative, and the IU Physician-Scientist Initiative, endowed by Lilly Endowment. W. L. and Y.X. were supported by the Oak Foundation; Y.X. by the AHA and Lucile Packard Children's Foundation; C. S. by an NIH fellowship; T. Q. by NIH (HL109512); H.-S.V.C. by CIRM (RB2-01512, RB4-06276) and NIH (HL105194); P.-S.C. by NIH (HL78931, HL71140); B.Z. by NIH (HL116997, HL111770).	Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Fu Xue-Mei, 2005, Sichuan Da Xue Xue Bao Yi Xue Ban, V36, P641; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haddad F, 2003, J BIOL CHEM, V278, P37132, DOI 10.1074/jbc.M305911200; Hahn MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018844; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; LOMPRE AM, 1979, NATURE, V282, P105, DOI 10.1038/282105a0; Lopez BA, 2013, CARDIOVASC RES, V99, P111, DOI 10.1093/cvr/cvt100; Mallam AL, 2012, NATURE, V490, P121, DOI 10.1038/nature11402; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1266, DOI 10.1038/nsmb.2435; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Szabo G, 2002, CIRC RES, V90, P100, DOI 10.1161/hh0102.102657; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van der Vlag J, 2000, J BIOL CHEM, V275, P697, DOI 10.1074/jbc.275.1.697; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wei KV, 2008, J MOL MED, V86, P161, DOI 10.1007/s00109-007-0261-7; Wu BR, 2010, GENESIS, V48, P63, DOI 10.1002/dvg.20573; Xiong YQ, 2013, DEV CELL, V25, P169, DOI 10.1016/j.devcel.2013.03.015; Yang J, 2008, MOL CELL BIOCHEM, V310, P215, DOI 10.1007/s11010-007-9683-3; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	51	513	550	4	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					102	+		10.1038/nature13596	http://dx.doi.org/10.1038/nature13596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25119045	Green Accepted, Green Submitted			2022-12-24	WOS:000342420800044
J	Stingele, J; Schwarz, MS; Bloemeke, N; Wolf, PG; Jentsch, S				Stingele, Julian; Schwarz, Michael S.; Bloemeke, Nicolas; Wolf, Peter G.; Jentsch, Stefan			A DNA-Dependent Protease Involved in DNA-Protein Crosslink Repair	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; TOPOISOMERASE-I; HOMOLOGOUS RECOMBINATION; DVC1 C1ORF124; UBIQUITIN; SUMO; REPLICATION; CDC48; P97; REGULATOR	Toxic DNA-protein crosslinks (DPCs) arise by ionizing irradiation and UV light, are particularly caused by endogenously produced reactive compounds such as formaldehyde, and also occur during compromised topoisomerase action. Although nucleotide excision repair and homologous recombination contribute to cell survival uponDPCs, hardly anything is known about mechanisms that target the protein component of DPCs directly. Here, we identify the metalloprotease Wss1 as being crucial for cell survival upon exposure to formaldehyde and topoisomerase 1-dependent DNA damage. Yeast mutants lacking Wss1 accumulate DPCs and exhibit gross chromosomal rearrangements. Notably, in vitro assays indicate that substrates such as topoisomerase 1 are processed by the metalloprotease directly and in a DNA-dependent manner. Thus, our data suggest that Wss1 contributes to survival of DPC-harboring cells by acting on DPCs proteolytically. We propose that DPC proteolysis enables repair of these unique lesions via downstream canonical DNA repair pathways.	[Stingele, Julian; Schwarz, Michael S.; Bloemeke, Nicolas; Wolf, Peter G.; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de	Stingele, Julian/K-7490-2012	Stingele, Julian/0000-0001-6020-2075	Max Planck Society; Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; ERC Advanced Grant; Louis-Jeantet Foundation	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; ERC Advanced Grant; Louis-Jeantet Foundation	We thank A. Strasser for technical assistance, J. Rech for help with robot-based techniques, the MPIB Microchemistry Core Facility for help with protein purification, and S. Bergink, M. Kern, C. Lademann, B. Pfander, I. Psakhye, and J. Renkawitz for discussions. S.J. is supported by the Max Planck Society, Deutsche Forschungsgemeinschaft, Center for Integrated Protein Science Munich, RUBICON EU Network of Excellence, ERC Advanced Grant, and the Louis-Jeantet Foundation.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Biggins S, 2001, GENETICS, V159, P453; BJORNSTI MA, 1989, CANCER RES, V49, P6318; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Friedberg EC, 2014, DNA REPAIR MUTAGENES; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Ghosal G, 2012, J BIOL CHEM, V287, P34225, DOI 10.1074/jbc.M112.400135; Grogan D, 2012, MUTAT RES-FUND MOL M, V731, P92, DOI 10.1016/j.mrfmmm.2011.12.004; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Juhasz S, 2012, NUCLEIC ACIDS RES, V40, P10795, DOI 10.1093/nar/gks850; Kanellis P, 2007, PLOS GENET, V3, P1438, DOI 10.1371/journal.pgen.0030134; Kim MS, 2013, NUCLEIC ACIDS RES, V41, P1661, DOI 10.1093/nar/gks1267; Kohn KW, 2000, CELL BIOCHEM BIOPHYS, V33, P175, DOI 10.1385/CBB:33:2:175; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Mieczkowski PA, 2006, DNA REPAIR, V5, P1010, DOI 10.1016/j.dnarep.2006.05.027; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Mullen JR, 2011, GENETICS, V187, P73, DOI 10.1534/genetics.110.124347; Mullen JR, 2010, MOL CELL BIOL, V30, P3737, DOI 10.1128/MCB.01649-09; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2013, J BIOL CHEM, V288, P4649, DOI 10.1074/jbc.M112.419358; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Sale JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012708; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Su D, 2010, MOL CELL BIOL, V30, P3734, DOI 10.1128/MCB.00673-10; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Vaz Bruno, 2013, Frontiers in Genetics, V4, P60, DOI 10.3389/fgene.2013.00060; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	55	169	176	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					327	338		10.1016/j.cell.2014.04.053	http://dx.doi.org/10.1016/j.cell.2014.04.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	24998930	Bronze			2022-12-24	WOS:000340943600013
J	Di Mitri, D; Toso, A; Chen, JJ; Sarti, M; Pinton, S; Jost, TR; D'Antuono, R; Montani, E; Garcia-Escudero, R; Guccini, I; Da Silva-Alvarez, S; Collado, M; Eisenberger, M; Zhang, Z; Catapano, C; Grassi, F; Alimonti, A				Di Mitri, Diletta; Toso, Alberto; Chen, Jing Jing; Sarti, Manuela; Pinton, Sandra; Jost, Tanja Rezzonico; D'Antuono, Rocco; Montani, Erica; Garcia-Escudero, Ramon; Guccini, Ilaria; Da Silva-Alvarez, Sabela; Collado, Manuel; Eisenberger, Mario; Zhang, Zhe; Catapano, Carlo; Grassi, Fabio; Alimonti, Andrea			Tumour-infiltrating Gr-1(+) myeloid cells antagonize senescence in cancer	NATURE			English	Article							CELLULAR SENESCENCE; PTEN; DEFICIENT; SECRETION; SCREEN; GENES; MICE	Aberrant activation of oncogenes or loss of tumour suppressor genes opposes malignant transformation by triggering a stable arrest in cell growth, which is termed cellular senescence(1-3). This process is finely tuned by both cell-autonomous and non-cell-autonomous mechanisms that regulate the entry of tumour cells to senescence(4-6). Whether tumour-infiltrating immune cells can oppose senescence is unknown. Here we show that at the onset of senescence, PTEN null prostate tumours inmice(2,7) are massively infiltrated by a population of CD11b(+)Gr-1(+) myeloid cells that protect a fraction of proliferating tumour cells from senescence, thus sustaining tumour growth. Mechanistically, we found that Gr-1(+) cells antagonize senescence in a paracrine manner by interfering with the senescence-associated secretory phenotype of the tumour through the secretion of interleukin-1 receptor antagonist (IL-1RA). Strikingly, Pten-loss-induced cellular senescence was enhanced in vivo when Il1ra knockout myeloid cells were adoptively transferred to PTEN null mice. Therapeutically, docetaxel-induced senescence and efficacy were higher in PTEN null tumours when the percentage of tumour-infiltrating CD11b(+)Gr-1(+)myeloid cells was reduced using an antagonist of CXC chemokine receptor 2 (CXCR2)(8). Taken together, our findings identify a novel non-cell-autonomous network, established by innate immunity, that controls senescence evasion and chemoresistance. Targeting this network provides novel opportunities for cancer therapy.	[Di Mitri, Diletta; Toso, Alberto; Chen, Jing Jing; Sarti, Manuela; Pinton, Sandra; Garcia-Escudero, Ramon; Guccini, Ilaria; Catapano, Carlo; Alimonti, Andrea] Oncol Inst Southern Switzerland, Inst Oncol Res IOR, CH-6500 Bellinzona, Switzerland; [Chen, Jing Jing; Alimonti, Andrea] Univ Lausanne UNIL, Fac Biol & Med, CH-1011 Lausanne, Switzerland; [Jost, Tanja Rezzonico; D'Antuono, Rocco; Montani, Erica; Grassi, Fabio] Inst Res Biomed IRB, CH-6500 Bellinzona, Switzerland; [Garcia-Escudero, Ramon] CIEMAT, Mol Oncol Unit, E-28040 Madrid, Spain; [Da Silva-Alvarez, Sabela; Collado, Manuel] Clin Univ Hosp CHUS, StemCHUS Hlth Res Inst Santiago de Compostela IDI, Lab Stem Cells Canc & Aging, E-15706 Santiago De Compostela, Spain; [Eisenberger, Mario] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Zhang, Zhe] Johns Hopkins Univ, Div Biostat, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Grassi, Fabio] Univ Milan, Dept Med Biotechnol & Translat Med, I-20100 Milan, Italy	Institute of Oncology Research (IOR); Universita della Svizzera Italiana; University of Lausanne; Universita della Svizzera Italiana; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Milan	Alimonti, A (corresponding author), Oncol Inst Southern Switzerland, Inst Oncol Res IOR, CH-6500 Bellinzona, Switzerland.	andrea.alimonti@ior.iosi.ch	D'Antuono, Rocco/HDM-4063-2022; Collado, Manuel/K-8140-2014; Garcia-Escudero, Ramon/A-2735-2012; Di Mitri, Diletta/AAA-4273-2019; GUCCINI, Ilaria/E-8262-2018	D'Antuono, Rocco/0000-0003-0180-6500; Collado, Manuel/0000-0002-0330-0880; Garcia-Escudero, Ramon/0000-0001-5640-6542; Catapano, Carlo V./0000-0002-7079-557X; DI MITRI, DILETTA/0000-0002-9626-4259; GRASSI, FABIO/0000-0003-3348-1712; Alimonti, Andrea/0000-0002-9362-2313; Chen, Jingjing/0000-0001-6994-0074; Da Silva Alvarez, Sabela/0000-0003-2702-8524; GUCCINI, Ilaria/0000-0002-3644-0679	Department of Defense Prostate Cancer Research Program [W81XWH-10-2-0056, W81XWH-10-2-0046]; Swiss national science foundation (SNF) grant Ambizione [PZ00P3_136612/1]; European Society for Medical Oncology (ESMO) translational research award; Swiss Bridge Award; PEOPLE-IRG [22484]; European Research Council [ERCsg 261342]; ABREOC; Train COFUND Marie Curie; Fondazione IBSA	Department of Defense Prostate Cancer Research Program(United States Department of Defense); Swiss national science foundation (SNF) grant Ambizione(Swiss National Science Foundation (SNSF)); European Society for Medical Oncology (ESMO) translational research award; Swiss Bridge Award; PEOPLE-IRG; European Research Council(European Research Council (ERC)European Commission); ABREOC; Train COFUND Marie Curie; Fondazione IBSA(Fondazione CarifeFondazione Caritro)	We thank L. Buhler for providing the Il1ra knockout mice, the F. Grassi laboratory and all members of the IRB animal core facility for technical assistance and the animal work, F. Stoffel for providing human samples, D. Jarrossay for helping with the flow cytometry analysis and cell sorting experiments, and all members of the Alimonti laboratory for scientific discussions. We thank C. Pissot-Soldermann, who developed NVP-BSK805. We thank T. Radimersky for providing NVP-BSK805. The human tissue microarray (as described in ref. 26) was obtained from the Department of Defense Prostate Cancer Research Program, Awards W81XWH-10-2-0056 and W81XWH-10-2-0046, Prostate Cancer Biorepository Network (PCBN). We thank G. Chiorino, I. Gregnanin, P. Ostano and L. Sacchetto for the gene expression analysis performed on myeloid and tumour cells. This work was supported by Swiss national science foundation (SNF) grant Ambizione (PZ00P3_136612/1), the European Society for Medical Oncology (ESMO) translational research award to A. A., the Swiss Bridge Award to A. A., PEOPLE-IRG (22484), a European Research Council starting grant (ERCsg 261342), ABREOC, the Train COFUND Marie Curie to D. D. M. and Fondazione IBSA.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Antonarakis ES, 2012, CANCER-AM CANCER SOC, V118, P6063, DOI 10.1002/cncr.27689; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Ruiz EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4175; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schwarze SR, 2005, NEOPLASIA, V7, P816, DOI 10.1593/neo.05250; Sgroi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025442; Tamassia N, 2010, FASEB J, V24, P1365, DOI 10.1096/fj.09-145573; Tasdemir N, 2013, EMBO J, V32, P1975, DOI 10.1038/emboj.2013.139; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	31	205	208	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					134	+		10.1038/nature13638	http://dx.doi.org/10.1038/nature13638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25156255				2022-12-24	WOS:000344187500044
J	Ntziachristos, P; Tsirigos, A; Welstead, GG; Trimarchi, T; Bakogianni, S; Xu, LY; Loizou, E; Holmfeldt, L; Strikoudis, A; King, B; Mullenders, J; Becksfort, J; Nedjic, J; Paietta, E; Tallman, MS; Rowe, JM; Tonon, G; Satoh, T; Kruidenier, L; Prinjha, R; Akira, S; Van Vlierberghe, P; Ferrando, AA; Jaenisch, R; Mullighan, CG; Aifantis, I				Ntziachristos, Panagiotis; Tsirigos, Aristotelis; Welstead, G. Grant; Trimarchi, Thomas; Bakogianni, Sofia; Xu, Luyao; Loizou, Evangelia; Holmfeldt, Linda; Strikoudis, Alexandros; King, Bryan; Mullenders, Jasper; Becksfort, Jared; Nedjic, Jelena; Paietta, Elisabeth; Tallman, Martin S.; Rowe, Jacob M.; Tonon, Giovanni; Satoh, Takashi; Kruidenier, Laurens; Prinjha, Rab; Akira, Shizuo; Van Vlierberghe, Pieter; Ferrando, Adolfo A.; Jaenisch, Rudolf; Mullighan, Charles G.; Aifantis, Iannis			Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia	NATURE			English	Article							INITIATING CELL-ACTIVITY; ACUTE MYELOID-LEUKEMIA; H3K27 DEMETHYLASE; EXPRESSION PROFILES; JMJD3 CONTRIBUTES; STEM-CELL; UTX; MUTATIONS; ACTIVATION; GENOME	T-cell acute lymphoblastic leukaemia (T-ALL) is a haematological malignancy with a dismal overall prognosis, including a relapse rate of up to 25%, mainly because of the lack of non-cytotoxic targeted therapy options. Drugs that target the function of key epigenetic factors have been approved in the context of haematopoietic disorders(1), and mutations that affect chromatin modulators in a variety of leukaemias have recently been identified(2,3); however, epigenetic drugs are not currently used for T-ALL treatment. Recently, we described that the polycomb repressive complex 2 (PRC2) has a tumour-suppressor role in T-ALL(4). Here we delineated the role of the histone 3 lysine 27 (H3K27) demethylases JMJD3 and UTX in T-ALL. We show that JMJD3 is essential for the initiation and maintenance of T-ALL, as it controls important oncogenic gene targets by modulating H3K27 methylation. By contrast, we found that UTX functions as a tumour suppressor and is frequently genetically inactivated in T-ALL. Moreover, we demonstrated that the small molecule inhibitor GSKJ4 (ref. 5) affects T-ALL growth, by targeting JMJD3 activity. These findings show that two proteins with a similar enzymatic function can have opposing roles in the context of the same disease, paving the way for treating haematopoietic malignancies with a new category of epigenetic inhibitors.	[Ntziachristos, Panagiotis; Tsirigos, Aristotelis; Trimarchi, Thomas; Bakogianni, Sofia; Loizou, Evangelia; Strikoudis, Alexandros; King, Bryan; Mullenders, Jasper; Nedjic, Jelena; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Ntziachristos, Panagiotis; Tsirigos, Aristotelis; Trimarchi, Thomas; Bakogianni, Sofia; Loizou, Evangelia; Strikoudis, Alexandros; King, Bryan; Mullenders, Jasper; Nedjic, Jelena; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Ntziachristos, Panagiotis; Trimarchi, Thomas; Bakogianni, Sofia; Loizou, Evangelia; Strikoudis, Alexandros; King, Bryan; Mullenders, Jasper; Nedjic, Jelena; Aifantis, Iannis] NYU, Sch Med, NYU Canc Inst, New York, NY 10016 USA; [Ntziachristos, Panagiotis; Trimarchi, Thomas; Bakogianni, Sofia; Loizou, Evangelia; Strikoudis, Alexandros; King, Bryan; Mullenders, Jasper; Nedjic, Jelena; Aifantis, Iannis] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA; [Tsirigos, Aristotelis] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Welstead, G. Grant; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Welstead, G. Grant; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Xu, Luyao; Van Vlierberghe, Pieter; Ferrando, Adolfo A.] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Holmfeldt, Linda; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Becksfort, Jared] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Paietta, Elisabeth] Montefiore Med Ctr North, Bronx, NY 10467 USA; [Tallman, Martin S.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Rowe, Jacob M.] Technion Israel Inst Technol, IL-31096 Haifa, Israel; [Rowe, Jacob M.] Shaare Zedek Med Ctr, IL-9103102 Jerusalem, Israel; [Tonon, Giovanni] Ist Sci San Raffaele, IRCCS, Div Mol Oncol, Funct Genom Canc Unit, I-20132 Milan, Italy; [Satoh, Takashi; Akira, Shizuo] Osaka Univ, WPI IFReC, Lab Host Def, Suita, Osaka 5650871, Japan; [Satoh, Takashi; Akira, Shizuo] Osaka Univ, RIMD, Dept Host Def, Suita, Osaka 5650871, Japan; [Kruidenier, Laurens; Prinjha, Rab] GlaxoSmithKline R&D, Med Res Ctr, Immunoinflammat Therapy Area, Epinova DPU, Stevenage SG1 2NY, Herts, England; [Van Vlierberghe, Pieter] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Ferrando, Adolfo A.] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Ferrando, Adolfo A.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; New York University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Columbia University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Montefiore Medical Center; Memorial Sloan Kettering Cancer Center; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Osaka University; Osaka University; GlaxoSmithKline; Ghent University; Ghent University Hospital; Columbia University; Columbia University	Tsirigos, A (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	Aristotelis.Tsirigos@nyumc.org; charles.mullighan@stjude.org	Tonon, Giovanni/J-9804-2018; Mullenders, Jasper/J-2398-2015; Ntziachristos, Panagiotis/CAG-2071-2022; Mullighan, Charles/H-3253-2011; xu, Luyao/F-2381-2015; Akira, Shizuo/C-3134-2009; Van Vlierberghe, Pieter/G-8894-2013	Tonon, Giovanni/0000-0003-2973-5038; Mullenders, Jasper/0000-0003-3737-6901; Mullighan, Charles/0000-0002-1871-1850; Van Vlierberghe, Pieter/0000-0001-9063-7205; Tsirigos, Aristotelis/0000-0002-7512-8477; Holmfeldt, Linda/0000-0003-4140-3423	National Institutes of Health (NIH)/National Cancer Institute (NCI) grant [P30 CA016087-30]; NIH/NCI [5P30CA16087-31, K99CA188293]; NIH [1R01CA133379, 1R01CA105129, 1R01CA149655, 5R01CA173636, 5R01CA169784, 5 T32 CA009161-37, R37-HD04502, R01CA120196]; Damon Runyon Cancer Research Foundation; NYU Cell and Molecular Biology Training Program; Lady Tata Memorial Trust for leukaemia; American Society of Hematology; Research Foundation Flanders; Odysseus type II grant; NCI [U24 CA114737, U10 CA21115]; Stand Up To Cancer Innovative Research Award; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society; Ralph S. French Charitable Foundation Trust; Chemotherapy Foundation; V Foundation for Cancer Research; St. Baldrick's Foundation; ECOG tumour bank; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U10CA180820, R01CA120196, R01CA173636, R01CA149655, R01CA133379, U10CA180827, R01CA105129, U10CA021115, U24CA114737, P30CA016087, R01CA169784, P30CA014051, P30CA021765, T32CA009161, K99CA188293] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute (NCI) grant; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NYU Cell and Molecular Biology Training Program; Lady Tata Memorial Trust for leukaemia; American Society of Hematology; Research Foundation Flanders(FWO); Odysseus type II grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up To Cancer Innovative Research Award; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Ralph S. French Charitable Foundation Trust; Chemotherapy Foundation; V Foundation for Cancer Research; St. Baldrick's Foundation; ECOG tumour bank; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Aifantis laboratory and J. Siegle for discussions throughout the duration of the project; S. Shen for discussions on the analysis of sequencing data; GlaxoSmithKline for the GSKJ4 and GSKJ5 inhibitory compounds; A. Heguy and the NYU Genome Technology Center (supported in part by National Institutes of Health (NIH)/National Cancer Institute (NCI) grant P30 CA016087-30) for assistance with sequencing experiments; the NYU Flow Cytometry facility (supported in part by NIH/NCI grant 5P30CA16087-31) for cell sorting; the NYU Histology Core (5P30CA16087-31) and the NYU mouse facility (NYU Cancer Institute Center Grant 5P30CA16087-31); G. Natoli for providing the anti-JMJ D3 antibody; J. Zhang for help with the analysis of the mutation data; and I. Rigo for technical support. I.A. was supported by the NIH (grants 1R01CA133379, 1R01CA105129, 1R01CA149655, 5R01CA173636 and 5R01CA169784). J.N. was supported by the Damon Runyon Cancer Research Foundation. B.K. was supported by the NYU Cell and Molecular Biology Training Program. P.N. was supported by fellowships from Lady Tata Memorial Trust for leukaemia and the American Society of Hematology and NIH/NCI (K99CA188293). T.T. is supported by the NIH training grant 5 T32 CA009161-37. P.V.V. was supported by the Research Foundation Flanders and an Odysseus type II grant Moreover, this study was supported by an NIH grant (R37-HD04502) to R.J., the ECOG tumour bank, an NIH grant (R01CA120196) to A.A.F.; NCI grants (U24 CA114737 and U10 CA21115) to E.P. and the Stand Up To Cancer Innovative Research Award (A.A.F.). I.A. was also supported by the William Lawrence and Blanche Hughes Foundation, The Leukemia & Lymphoma Society, the Ralph S. French Charitable Foundation Trust, The Chemotherapy Foundation, The V Foundation for Cancer Research and the St. Baldrick's Foundation. I.A. is a Howard Hughes Medical Institute Early Career Scientist. A.T. carried out part of this work while at the Computational Biology Center, IBM Research, Yorktown Heights, New York.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Armstrong F, 2009, BLOOD, V113, P1730, DOI 10.1182/blood-2008-02-138172; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Hubner MR, 2010, COLD SH Q B, V75, P43, DOI 10.1101/sqb.2010.75.020; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Mar BG, 2012, LEUKEMIA, V26, P1881, DOI 10.1038/leu.2012.56; Marks DI, 2009, BLOOD, V114, P5136, DOI 10.1182/blood-2009-08-231217; Mullighan CG, 2011, METHODS MOL BIOL, V730, P235, DOI 10.1007/978-1-61779-074-4_17; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Torres CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060020; Tsirigos A, 2012, BIOINFORMATICS, V28, P282, DOI 10.1093/bioinformatics/btr646; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	47	260	272	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					513	+		10.1038/nature13605	http://dx.doi.org/10.1038/nature13605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25132549	Green Accepted, Green Submitted			2022-12-24	WOS:000343775900045
J	Raspopovic, J; Marcon, L; Russo, L; Sharpe, J				Raspopovic, J.; Marcon, L.; Russo, L.; Sharpe, J.			Digit patterning is controlled by a Bmp-Sox9-Wnt Turing network modulated by morphogen gradients	SCIENCE			English	Article							REACTION-DIFFUSION MODEL; LIMB DEVELOPMENT; VERTEBRATE LIMB; MOUSE LIMB; TRANSCRIPTION FACTOR; GENE-EXPRESSION; EMBRYONIC LIMB; BETA-CATENIN; FACTOR SOX9; CHICK LIMB	During limb development, digits emerge from the undifferentiated mesenchymal tissue that constitutes the limb bud. It has been proposed that this process is controlled by a self-organizing Turing mechanism, whereby diffusible molecules interact to produce a periodic pattern of digital and interdigital fates. However, the identities of the molecules remain unknown. By combining experiments and modeling, we reveal evidence that a Turing network implemented by Bmp, Sox9, and Wnt drives digit specification. We develop a realistic two-dimensional simulation of digit patterning and show that this network, when modulated by morphogen gradients, recapitulates the expression patterns of Sox9 in the wild type and in perturbation experiments. Our systems biology approach reveals how a combination of growth, morphogen gradients, and a self-organizing Turing network can achieve robust and reproducible pattern formation.	[Raspopovic, J.; Marcon, L.; Russo, L.; Sharpe, J.] CRG, Syst Biol Program, Barcelona 08003, Spain; [Raspopovic, J.; Marcon, L.; Russo, L.; Sharpe, J.] Univ Pompeu Fabra, Barcelona 08003, Spain; [Sharpe, J.] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Sharpe, J (corresponding author), CRG, Syst Biol Program, Dr Aiguader 88, Barcelona 08003, Spain.	james.sharpe@crg.eu	Marcon, Luciano/AAK-5535-2020; Sharpe, James/AAB-7948-2019; Marcon, Luciano LM/X-9975-2018; Sharpe, James/L-1150-2014	Marcon, Luciano/0000-0003-0957-9170; Marcon, Luciano LM/0000-0003-0957-9170; Sharpe, James/0000-0002-1434-9743; Raspopovic, Jelena/0000-0003-3233-3806	CRG; ICREA; Fundacao para a Ciencia e Tecnologia; Ministerio de Economia y Competitividad (MINECO) [BFU2010-16428]; Centro de Excelencia Severo Ochoa [SEV-2012-0208]; ICREA Funding Source: Custom	CRG; ICREA(ICREA); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Ministerio de Economia y Competitividad (MINECO); Centro de Excelencia Severo Ochoa; ICREA(ICREA)	The Sox9-EGFP mouse line was kindly provided by H. Akiyama and P. Jay. The mRNA probe for Bmp2 was kindly provided by C. Pujades. We thank R. Zeller for the Smad4 mutant limbs; A. R. Moreno for in situs of Fgf4, 8 and Twist1; and D. Barcena for the help with the micromass cultures. J.S. was supported by CRG and ICREA, L. R. by Ministerio de Economia y Competitividad (MINECO) BFU2010-16428, and Centro de Excelencia Severo Ochoa, SEV-2012-0208, and L. M. by the CRG; J.R. was funded by a Ph.D. Fellowship from the Fundacao para a Ciencia e Tecnologia. Confocal microscopy was done in the CRG Advanced Light Microscopy Unit, and FACS and microarrays in the CRG Core Facilities. The microarray data discussed in this publication are accessible through Gene Expression Omnibus series accession number GSE58158.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Badugu A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00991; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Benazet JD, 2012, DEVELOPMENT, V139, P4250, DOI 10.1242/dev.084822; Bhat R, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-6; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Crampin EJ, 1999, B MATH BIOL, V61, P1093, DOI 10.1006/bulm.1999.0131; Georgiadis V, 2007, DEV DYNAM, V236, P1014, DOI 10.1002/dvdy.21123; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Hentschel HGE, 2004, P ROY SOC B-BIOL SCI, V271, P1713, DOI 10.1098/rspb.2004.2772; Hill TP, 2006, DEVELOPMENT, V133, P1219, DOI 10.1242/dev.02298; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Kulyk WM, 2000, EXP CELL RES, V255, P327, DOI 10.1006/excr.1999.4784; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Marcon L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001071; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Mercader N, 2000, DEVELOPMENT, V127, P3961; Miura T, 2000, DEV DYNAM, V217, P241, DOI 10.1002/(SICI)1097-0177(200003)217:3<241::AID-DVDY2>3.0.CO;2-K; Miura T, 2006, J THEOR BIOL, V240, P562, DOI 10.1016/j.jtbi.2005.10.016; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; NEWMAN SA, 1979, SCIENCE, V205, P662, DOI 10.1126/science.462174; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sheth R, 2012, SCIENCE, V338, P1476, DOI 10.1126/science.1226804; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Zehentner BK, 1999, J BONE MINER RES, V14, P1734, DOI 10.1359/jbmr.1999.14.10.1734; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; ZWILLING E, 1964, DEV BIOL, V9, P20, DOI 10.1016/0012-1606(64)90012-0	34	276	277	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					566	570		10.1126/science.1252960	http://dx.doi.org/10.1126/science.1252960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082703				2022-12-24	WOS:000339651300046
J	Ouyang, H; Xue, YC; Lin, Y; Zhang, XH; Xi, L; Patel, S; Cai, HM; Luo, J; Zhang, MX; Zhang, M; Yang, Y; Li, G; Li, HR; Jiang, W; Yeh, E; Lin, J; Pei, M; Zhu, J; Cao, GQ; Zhang, LF; Yu, B; Chen, SC; Fu, XD; Liu, YZ; Zhang, K				Ouyang, Hong; Xue, Yuanchao; Lin, Ying; Zhang, Xiaohui; Xi, Lei; Patel, Sherrina; Cai, Huimin; Luo, Jing; Zhang, Meixia; Zhang, Ming; Yang, Yang; Li, Gen; Li, Hairi; Jiang, Wei; Yeh, Emily; Lin, Jonathan; Pei, Michelle; Zhu, Jin; Cao, Guiqun; Zhang, Liangfang; Yu, Benjamin; Chen, Shaochen; Fu, Xiang-Dong; Liu, Yizhi; Zhang, Kang			WNT7A and PAX6 define corneal epithelium homeostasis and pathogenesis	NATURE			English	Article							STEM-CELLS; P63; MORPHOGENESIS; PATHWAY; DIFFERENTIATION; EXPRESSION; KERATINS; LIMB; SKIN	The surface of the cornea consists of a unique type of non-keratinized epithelial cells arranged in an orderly fashion, and this is essential for vision by maintaining transparency for light transmission. Cornea epithelial cells (CECs) undergo continuous renewal from limbal stem or progenitor cells (LSCs)(1,2), and deficiency in LSCs or corneal epithelium-which turns cornea into a non-transparent, keratinized skin-like epithelium-causes corneal surface disease that leads to blindness in millions of people worldwide(3). How LSCs are maintained and differentiated into corneal epithelium in healthy individuals and which key molecular events are defective in patients have been largely unknown. Here we report establishment of an in vitro feeder-cell-free LSC expansion and three-dimensional corneal differentiation protocol in which we found that the transcription factors p63 (tumour protein 63) and PAX6 (paired box protein PAX6) act together to specify LSCs, and WNT7A controls corneal epithelium differentiation through PAX6. Loss of WNT7A or PAX6 induces LSCs into skin-like epithelium, a critical defect tightly linked to common human corneal diseases. Notably, transduction of PAX6 in skin epithelial stem cells is sufficient to convert them to LSC-like cells, and upon transplantation onto eyes in a rabbit corneal injury model, these reprogrammed cells are able to replenish CECs and repair damaged corneal surface. These findings suggest a central role of the WNT7A-PAX6 axis in corneal epithelial cell fate determination, and point to a new strategy for treating corneal surface diseases.	[Ouyang, Hong; Lin, Ying; Xi, Lei; Liu, Yizhi; Zhang, Kang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Ouyang, Hong; Lin, Ying; Zhang, Xiaohui; Xi, Lei; Patel, Sherrina; Luo, Jing; Yang, Yang; Yeh, Emily; Lin, Jonathan; Pei, Michelle; Zhu, Jin; Zhang, Liangfang; Chen, Shaochen; Fu, Xiang-Dong; Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Ouyang, Hong; Lin, Ying; Zhang, Xiaohui; Xi, Lei; Patel, Sherrina; Luo, Jing; Yang, Yang; Yeh, Emily; Lin, Jonathan; Pei, Michelle; Zhu, Jin; Zhang, Liangfang; Chen, Shaochen; Fu, Xiang-Dong; Zhang, Kang] Univ Calif San Diego, Biomat & Tissue Engn Ctr, Inst Engn Med, La Jolla, CA 92093 USA; [Xue, Yuanchao; Li, Hairi; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Cai, Huimin; Zhang, Meixia; Zhang, Ming; Li, Gen; Jiang, Wei; Cao, Guiqun; Zhang, Kang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Cai, Huimin] Guangzhou KangRui Biol Pharmaceut Technol Co Ltd, Guangzhou 510005, Guangdong, Peoples R China; [Zhang, Liangfang; Chen, Shaochen] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Yu, Benjamin] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Yu, Benjamin; Fu, Xiang-Dong; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Zhang, Kang] Vet Adm Healthcare Syst, San Diego, CA 92093 USA	Sun Yat Sen University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sichuan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhang, K (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.	xdfu@ucsd.edu; yzliu62@yahoo.com; kangzhang@ucsd.edu	Zhang, Kang/Y-2740-2019; liu, yi/GXE-9662-2022	Zhang, Kang/0000-0002-4549-1697; XUE, YUANCHAO/0000-0002-8113-2333; Luo, Jing/0000-0002-8905-9388; Zhang, Ming/0000-0003-0151-7813; Yu, Benjamin/0000-0001-6663-6616; Ouyang, Hong/0000-0002-7622-7733; Lin, Jonathan/0000-0002-7438-6941	973 program [2013CB967504, 2014CB964900]; Project of Fundamental Research Funds [2012KF03]; State Key laboratory of Ophthalmology; NIH [GM049369]; KACST-UCSD Center of Excellence in Nanomedicine; NIH Director's Transformative R01 Program [R01 EY021374]; CIRM; NATIONAL EYE INSTITUTE [R01EY021374, R01EY020846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049369] Funding Source: NIH RePORTER	973 program(National Basic Research Program of China); Project of Fundamental Research Funds; State Key laboratory of Ophthalmology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KACST-UCSD Center of Excellence in Nanomedicine; NIH Director's Transformative R01 Program; CIRM(California Institute for Regenerative Medicine); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported in part by the 973 program (2013CB967504 and 2014CB964900), Project of Fundamental Research Funds (no.2012KF03), State Key laboratory of Ophthalmology, NIH (GM049369), KACST-UCSD Center of Excellence in Nanomedicine, NIH Director's Transformative R01 Program (R01 EY021374) and CIRM.	Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; EICHNER R, 1984, J CELL BIOL, V98, P1388, DOI 10.1083/jcb.98.4.1388; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fox-Walsh K, 2011, GENOMICS, V98, P266, DOI 10.1016/j.ygeno.2011.04.003; KOPAN R, 1989, GENE DEV, V3, P1, DOI 10.1101/gad.3.1.1; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; LAUWERYNS B, 1993, INVEST OPHTH VIS SCI, V34, P1991; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037	22	157	170	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					358	+		10.1038/nature13465	http://dx.doi.org/10.1038/nature13465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030175	Green Accepted			2022-12-24	WOS:000338992200038
J	Ottesen, EA; Young, CR; Gifford, SM; Eppley, JM; Marin, R; Schuster, SC; Scholin, CA; DeLong, EF				Ottesen, Elizabeth A.; Young, Curtis R.; Gifford, Scott M.; Eppley, John M.; Marin, Roman, III; Schuster, Stephan C.; Scholin, Christopher A.; DeLong, Edward F.			Multispecies diel transcriptional oscillations in open ocean heterotrophic bacterial assemblages	SCIENCE			English	Article							BACTERIOPLANKTON; POPULATIONS; EXPRESSION; PATTERNS; SEA	Oscillating diurnal rhythms of gene transcription, metabolic activity, and behavior are found in all three domains of life. However, diel cycles in naturally occurring heterotrophic bacteria and archaea have rarely been observed. Here, we report time-resolved whole-genome transcriptome profiles of multiple, naturally occurring oceanic bacterial populations sampled in situ over 3 days. As anticipated, the cyanobacterial transcriptome exhibited pronounced diel periodicity. Unexpectedly, several different heterotrophic bacterioplankton groups also displayed diel cycling in many of their gene transcripts. Furthermore, diel oscillations in different heterotrophic bacterial groups suggested population-specific timing of peak transcript expression in a variety of metabolic gene suites. These staggered multispecies waves of diel gene transcription may influence both the tempo and the mode of matter and energy transformation in the sea.	[Ottesen, Elizabeth A.; Young, Curtis R.; Gifford, Scott M.; Eppley, John M.; DeLong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Ottesen, Elizabeth A.; Young, Curtis R.; Gifford, Scott M.; Eppley, John M.; DeLong, Edward F.] Univ Hawaii, C MORE, Honolulu, HI 96822 USA; [Ottesen, Elizabeth A.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Marin, Roman, III; Scholin, Christopher A.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Schuster, Stephan C.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [DeLong, Edward F.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Hawaii System; University System of Georgia; University of Georgia; Monterey Bay Aquarium Research Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	edelong@hawaii.edu			Gordon and Betty Moore Foundation GBMF [492.01, 3777]; NSF [EF0424599, OCE-0314222]; NASA [NNG06GB34G, NNX09AB78G]; Gordon and Betty Moore Foundation [731, 2728]; David and Lucile Packard Foundation	Gordon and Betty Moore Foundation GBMF(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	We thank the officers and crew of the Kilo Moana, J. Robidart, S. Wilson, and the ESP engineering and science team (J. Ryan, J. Birch, C. Preston, G. Massion, S. Jensen, and B. Roman) for all of the able assistance. This work was supported by grants from the Gordon and Betty Moore Foundation GBMF nos. 492.01 and 3777 (E.F.D.) and NSF grant EF0424599 (E.F.D.). Development of the ESP was supported by NSF grant OCE-0314222 (to C.A.S.), NASA Astrobiology grants NNG06GB34G and NNX09AB78G (to C.A.S.), the Gordon and Betty Moore Foundation nos. 731 and 2728 (C.A.S.), and the David and Lucile Packard Foundation. This work is a contribution of C-MORE. Sequences reported in this paper have been deposited in the GenBank database (accession no. SRP041215). The Monterey Bay Aquarium Research Institute holds rights to C. A. Scholin et al., U.S. Patent 6187530 (2001). C.A.S. is disqualified from receiving any royalties that might arise from licensing agreements. The ESP is available commercially from Spyglass Technologies and MacLane Research Laboratories; C.A.S. has no financial interest in either company and is not compensated in any way for giving advice on ESP technology transfer.	Axmann I. M., 2014, MAR GENOMICS; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Flint JF, 2005, J BACTERIOL, V187, P7460, DOI 10.1128/JB.187.21.7460-7470.2005; Gali M, 2013, GLOBAL BIOGEOCHEM CY, V27, P620, DOI 10.1002/gbc.20047; Gasol JM, 1998, MAR ECOL PROG SER, V164, P107, DOI 10.3354/meps164107; Gifford SM, 2013, ISME J, V7, P281, DOI 10.1038/ismej.2012.96; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009894; Liu ZQ, 2011, BIOINFORMATICS, V27, P3242, DOI 10.1093/bioinformatics/btr547; Okansen J., 2012, PACKAGE VEGAN COMMUN; Ottesen EA, 2013, P NATL ACAD SCI USA, V110, pE488, DOI 10.1073/pnas.1222099110; Ottesen EA, 2011, ISME J, V5, P1881, DOI 10.1038/ismej.2011.70; Preston CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022522; Steindler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019725; Tomasch J, 2011, ISME J, V5, P1957, DOI 10.1038/ismej.2011.68; Whitehead K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005485; Wier AM, 2010, P NATL ACAD SCI USA, V107, P2259, DOI 10.1073/pnas.0909712107; Winter C, 2004, AQUAT MICROB ECOL, V35, P207, DOI 10.3354/ame035207; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	19	152	153	4	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					207	212		10.1126/science.1252476	http://dx.doi.org/10.1126/science.1252476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013074	Green Submitted, Green Accepted			2022-12-24	WOS:000339409900052
J	Yu, M; Bardia, A; Aceto, N; Bersani, F; Madden, MW; Donaldson, MC; Desai, R; Zhu, HL; Comaills, V; Zheng, ZL; Wittner, BS; Stojanov, P; Brachtel, E; Sgroi, D; Kapur, R; Shioda, T; Ting, DT; Ramaswamy, S; Getz, G; Iafrate, AJ; Benes, C; Toner, M; Maheswaran, S; Haber, DA				Yu, Min; Bardia, Aditya; Aceto, Nicola; Bersani, Francesca; Madden, Marissa W.; Donaldson, Maria C.; Desai, Rushil; Zhu, Huili; Comaills, Valentine; Zheng, Zongli; Wittner, Ben S.; Stojanov, Petar; Brachtel, Elena; Sgroi, Dennis; Kapur, Ravi; Shioda, Toshihiro; Ting, David T.; Ramaswamy, Sridhar; Getz, Gad; Iafrate, A. John; Benes, Cyril; Toner, Mehmet; Maheswaran, Shyamala; Haber, Daniel A.			Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility	SCIENCE			English	Article							CANCER; INHIBITOR; IDENTIFICATION; MUTATIONS; DISCOVERY; FAMILY; POTENT; DOMAIN; ALPHA	Circulating tumor cells (CTCs) are present at low concentrations in the peripheral blood of patients with solid tumors. It has been proposed that the isolation, ex vivo culture, and characterization of CTCs may provide an opportunity to noninvasively monitor the changing patterns of drug susceptibility in individual patients as their tumors acquire new mutations. In a proof-of-concept study, we established CTC cultures from six patients with estrogen receptor-positive breast cancer. Three of five CTC lines tested were tumorigenic in mice. Genome sequencing of the CTC lines revealed preexisting mutations in the PIK3CA gene and newly acquired mutations in the estrogen receptor gene (ESR1), PIK3CA gene, and fibroblast growth factor receptor gene (FGFR2), among others. Drug sensitivity testing of CTC lines with multiple mutations revealed potential new therapeutic targets. With optimization of CTC culture conditions, this strategy may help identify the best therapies for individual cancer patients over the course of their disease.	[Yu, Min; Bardia, Aditya; Aceto, Nicola; Bersani, Francesca; Madden, Marissa W.; Donaldson, Maria C.; Desai, Rushil; Zhu, Huili; Comaills, Valentine; Zheng, Zongli; Wittner, Ben S.; Sgroi, Dennis; Shioda, Toshihiro; Ting, David T.; Ramaswamy, Sridhar; Getz, Gad; Iafrate, A. John; Benes, Cyril; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Yu, Min; Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Bardia, Aditya; Shioda, Toshihiro; Ting, David T.; Ramaswamy, Sridhar; Benes, Cyril; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; [Zheng, Zongli; Brachtel, Elena; Sgroi, Dennis; Getz, Gad; Iafrate, A. John] Harvard Univ, Sch Med, Dept Pathol, Charlestown, MA 02129 USA; [Zheng, Zongli] Karolinska Insitutet, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Stojanov, Petar; Getz, Gad] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Kapur, Ravi; Toner, Mehmet] Harvard Univ, Sch Med, Ctr Bioengn Med, Charlestown, MA 02129 USA; [Toner, Mehmet; Maheswaran, Shyamala] Harvard Univ, Sch Med, Dept Surg, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard University; Karolinska Institutet; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University	Maheswaran, S (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	maheswaran@helix.mgh.harvard.edu; haber@helix.mgh.harvard.edu	Stojanov, Petar/GQI-4462-2022; Sgroi, Dennis/AAV-2487-2021; zheng, zongli/C-7309-2008; zheng, zongli/B-2917-2011; COMAILLS, VALENTINE/AAX-1697-2021; Aceto, Nicola/O-2484-2014; Ting, David/F-4389-2017	Stojanov, Petar/0000-0001-7815-776X; zheng, zongli/0000-0003-4849-4903; COMAILLS, VALENTINE/0000-0001-8857-6976; Donaldson Collier, Maria/0000-0001-6403-6713; Bersani, Francesca/0000-0002-0343-7078; Aceto, Nicola/0000-0001-9579-6918; Yu, Min/0000-0002-3969-8720; Ting, David/0000-0002-3261-2322	Breast Cancer Research Foundation; Stand Up to Cancer; Wellcome TrustNational Foundation for Cancer Research; NIH [CA129933]; NIBIB [EB008047]; Susan G. Komen for the Cure [KG09042]; National Cancer Institute-MGH Proton Federal Share Program; MGH-Johnson and Johnson Center for Excellence in CTCs; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA129933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008047, U01EB012493, P41EB002503] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Stand Up to Cancer; Wellcome TrustNational Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Cancer Institute-MGH Proton Federal Share Program; MGH-Johnson and Johnson Center for Excellence in CTCs; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We are grateful to all the patients who participated in this study. We thank Dr. Lecia Sequist for coordinating the clinical studies, A. McGovern, C. Hart, and the Massachusetts General Hospital (MGH) clinical research coordinators P. Spuhler, A. Shah, J. Ciciliano, and V. Pai for bioengineering technical support; R. Milano, K. Lynch, H. Robinson, and M. Liebers for technical support; L. Collins (Beth Israel Deaconess Medical Center) for providing pathological specimens; and L. Libby for mouse studies. N. Aceto is a fellow of the Human Frontiers Science Program, the Swiss National Science Foundation, and the Swiss Foundation for Grants in Biology and Medicine. This work was supported by grants from the Breast Cancer Research Foundation (D. A. H), Stand Up to Cancer (D. A. H., M. T., S. M.), the Wellcome Trust (D. A. H., C. B.), National Foundation for Cancer Research (D. A. H.), NIH CA129933 (D. A. H.), NIBIB EB008047 (M. T., D. A. H.), Susan G. Komen for the Cure KG09042 (S. M.), National Cancer Institute-MGH Proton Federal Share Program (S. M.), the MGH-Johnson and Johnson Center for Excellence in CTCs (M. T., S. M.), and the Howard Hughes Medical Institute (M.Y., D. A. H.). A. J. I. holds equity in, and is a paid consultant for, Enzymatics, Inc. M. T., D. A. H., and the Massachusetts General Hospital have filed for patent protection for the CTC-iChip technology. RNA-Seq reads have been deposited into Gene Expression Omnibus: uncultured CTCs (accession no. GSE51827); the six cultured CTC lines (accession no. GSE55807).	Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Merenbakh-Lamin K, 2013, CANCER RES, V73, P6856, DOI 10.1158/0008-5472.CAN-13-1197; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Wang YS, 2010, CURR OPIN INVEST DR, V11, P1466; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Zhang QX, 1997, CANCER RES, V57, P1244	26	661	720	9	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					216	220		10.1126/science.1253533	http://dx.doi.org/10.1126/science.1253533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	25013076	Green Submitted, Green Accepted			2022-12-24	WOS:000339409900054
J	Flach, J; Bakker, ST; Mohrin, M; Conroy, PC; Pietras, EM; Reynaud, D; Alvarez, S; Diolaiti, ME; Ugarte, F; Forsberg, EC; Le Beau, MM; Stohr, BA; Mendez, J; Morrison, CG; Passegue, E				Flach, Johanna; Bakker, Sietske T.; Mohrin, Mary; Conroy, Pauline C.; Pietras, Eric M.; Reynaud, Damien; Alvarez, Silvia; Diolaiti, Morgan E.; Ugarte, Fernando; Forsberg, E. Camilla; Le Beau, Michelle M.; Stohr, Bradley A.; Mendez, Juan; Morrison, Ciaran G.; Passegue, Emmanuelle			Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells	NATURE			English	Article							DNA-DAMAGE-RESPONSE; ORIGIN; MAINTENANCE; DEFICIENCY; EXPRESSION; MUTATIONS; PROTEINS; COMPLEX; REPAIR; CYCLE	Haematopoietic stem cells (HSCs) self-renew for life, thereby making them one of the few blood cells that truly age(1,2). Paradoxically, although HSCs numerically expand with age, their functional activity declines over time, resulting in degraded blood production and impaired engraftment following transplantation(2). While many drivers of HSC ageing have been proposed(2-5), the reason why HSC function degrades with age remains unknown. Here we show that cycling old HSCs in mice have heightened levels of replication stress associated with cell cycle defects and chromosome gaps or breaks, which are due to decreased expression of mini-chromosome maintenance (MCM) helicase components and altered dynamics of DNA replication forks. Nonetheless, old HSCs survive replication unless confronted with a strong replication challenge, such as transplantation. Moreover, once old HSCs re-establish quiescence, residual replication stress on ribosomal DNA (rDNA) genes leads to the formation of nucleolar-associated gamma H2AX signals, which persist owing to ineffective H2AX dephosphorylation by mislocalized PP4c phosphatase rather than ongoing DNA damage. Persistent nucleolar gamma H2AX also acts as a histone modification marking the transcriptional silencing of rDNA genes and decreased ribosome biogenesis in quiescent old HSCs. Our results identify replication stress as a potent driver of functional decline in old HSCs, and highlight the MCM DNA helicase as a potential molecular target for rejuvenation therapies.	[Flach, Johanna; Bakker, Sietske T.; Mohrin, Mary; Pietras, Eric M.; Reynaud, Damien; Passegue, Emmanuelle] Univ Calif San Francisco, Dept Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Hem Onc Div, San Francisco, CA 94143 USA; [Flach, Johanna] Ctr Comprehens Canc, Inst Expt Canc Res, D-89081 Ulm, Germany; [Conroy, Pauline C.; Morrison, Ciaran G.] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Alvarez, Silvia; Mendez, Juan] Spanish Natl Canc Res Ctr CNIO, E-28049 Madrid, Spain; [Diolaiti, Morgan E.; Stohr, Bradley A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Ugarte, Fernando; Forsberg, E. Camilla] Univ Calif Santa Cruz, Inst Biol Stem Cells, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Le Beau, Michelle M.] Univ Chicago, Sect Hematol Oncol, Chicago, IL 60637 USA; [Le Beau, Michelle M.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA	University of California System; University of California San Francisco; Ulm University; Ollscoil na Gaillimhe-University of Galway; Centro Nacional de Investigaciones Oncologicas (CNIO); University of California System; University of California San Francisco; University of California System; University of California Santa Cruz; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago	Passegue, E (corresponding author), Univ Calif San Francisco, Dept Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Hem Onc Div, San Francisco, CA 94143 USA.	PassegueE@stemcell.ucsf.edu	Morrison, Ciaran/B-6568-2008; Morrison, Ciaran/AAH-2034-2019; Mendez, Juan/K-8001-2014	Morrison, Ciaran/0000-0003-2401-7029; Morrison, Ciaran/0000-0003-2401-7029; Mendez, Juan/0000-0002-3235-2559; Bakker, Sietske/0000-0003-4962-3594; Reynaud, Damien/0000-0001-8765-8419; Alvarez Nanez, Silvia/0000-0003-0664-650X; Passegue, Emmanuelle/0000-0002-3516-297X	National Institutes of Health (NIH) [F32 HL106989]; Science Foundation Ireland PI award [10/IN.1/B2972]; CIRM New Faculty Award [RN2-00934, NIH R01 HL092471]; California Institute for Regenerative Medicine (CIRM); NATIONAL CANCER INSTITUTE [R01CA184014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL106989, R01HL115158, R01HL092471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland PI award(Science Foundation Ireland); CIRM New Faculty Award; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Brunet and S. Villeda for providing some old C57BL/6 mice, B. McStay for advice on nucleolar analyses, C. Klijn for assistance with microarray analyses, S. Katzman for the SNP analyses, E. Davis for help with cytogenetic studies, I. Grummt for the rDNA plasmid, M. Kissner and M. Lee for management of our Flow Cytometry Core Facility, and all members of the Passegue laboratory for critical insights and suggestions. S. T. B. and M. M. were supported by a California Institute for Regenerative Medicine (CIRM) training grant and E. M. P. by National Institutes of Health (NIH) F32 HL106989. This work was supported by Science Foundation Ireland PI award 10/IN.1/B2972 to C. G. M. and a CIRM New Faculty Award RN2-00934 and NIH R01 HL092471 to E.P.	Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Bersenev A, 2012, AGING CELL, V11, P949, DOI 10.1111/j.1474-9726.2012.00862.x; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cooley C, 2009, MOL BIOL CELL, V20, P2563, DOI 10.1091/mbc.E08-10-1019; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Narla A, 2011, INT J HEMATOL, V93, P144, DOI 10.1007/s12185-011-0776-0; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Will B, 2013, NAT IMMUNOL, V14, P437, DOI 10.1038/ni.2572; Zhong Y, 2013, J CELL BIOL, V201, P373, DOI 10.1083/jcb.201208060	36	381	390	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					198	+		10.1038/nature13619	http://dx.doi.org/10.1038/nature13619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25079315	Green Accepted, Green Published			2022-12-24	WOS:000340200700033
J	Vande Walle, L; Van Opdenbosch, N; Jacques, P; Fossoul, A; Verheugen, E; Vogel, P; Beyaert, R; Elewaut, D; Kanneganti, TD; van Loo, G; Lamkanfi, M				Vande Walle, Lieselotte; Van Opdenbosch, Nina; Jacques, Peggy; Fossoul, Amelie; Verheugen, Eveline; Vogel, Peter; Beyaert, Rudi; Elewaut, Dirk; Kanneganti, Thirumala-Devi; van Loo, Geert; Lamkanfi, Mohamed			Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis	NATURE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; ACTIVATION; INHIBITOR; SUSCEPTIBILITY; ASSOCIATION; CASPASE-1; VARIANTS; RECEPTOR; TNFAIP3	Rheumatoid arthritis is a chronic autoinflammatory disease that affects 1-2% of the world's population and is characterized by widespread joint inflammation. Interleukin-1 is an important mediator of cartilage destruction in rheumatic diseases(1), but our understanding of the upstream mechanisms leading to production of interleukin-1 beta in rheumatoid arthritis is limited by the absence of suitable mouse models of the disease in which inflammasomes contribute to pathology. Myeloid-cell-specific deletion of the rheumatoid arthritis susceptibility gene A20/Tnfaip3 in mice (A20(myel-KO) mice) triggers a spontaneous erosive polyarthritis that resembles rheumatoid arthritis in patients(2). Rheumatoid arthritis in A20(myel-KO) mice is not rescued by deletion of tumour necrosis factor receptor 1 (ref. 2). Here we show, however, that it crucially relies on the Nlrp3 inflammasome and interleukin-1 receptor signalling. Macrophages lacking A 20 have increased basal and lipopolysaccharide-induced expression levels of the inflammasome adaptor Nlrp3 and proIL-beta b. As a result, A 20-deficiency in macrophages significantly enhances Nlrp3 inflammasome- mediated caspase-1 activation, pyroptosis and interleukin-1 beta secretion by soluble and crystalline Nlrp3 stimuli. In contrast, activation of the Nlrc4 and AIM2 inflammasomes is not altered. Importantly, increased Nlrp3 inflammasome activation contributes to the pathology of rheumatoid arthritis in vivo, because deletion of Nlrp3, caspase-1 and the interleukin-1 receptor markedly protects against rheumatoid-arthritis-associated inflammation and cartilage destruction in A20(myel-KO) mice. These results reveal A20 as a novel negative regulator of Nlrp3 inflammasome activation, and describe A(20myel-KO) mice as the first experimental model to study the role of inflammasomes in the pathology of rheumatoid arthritis.	[Vande Walle, Lieselotte; Van Opdenbosch, Nina; Fossoul, Amelie; Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Vande Walle, Lieselotte; Van Opdenbosch, Nina; Fossoul, Amelie; Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Jacques, Peggy; Verheugen, Eveline; Elewaut, Dirk] Univ Ghent, Dept Rheumatol, B-9000 Ghent, Belgium; [Vogel, Peter; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Beyaert, Rudi; van Loo, Geert] Univ Ghent VIB, Inflammat Res Ctr, B-9052 Ghent, Belgium; [Beyaert, Rudi; van Loo, Geert] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; St Jude Children's Research Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Lamkanfi, M (corresponding author), Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium.	mohamed.lamkanfi@vib-ugent.be	Vogel, Peter/N-2490-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; Elewaut, Dirk/K-6831-2014; , van Loo Geert/AAD-1220-2019; van Loo, Geert/C-1505-2009; Beyaert, Rudi/B-2589-2009; Kanneganti, Thirumala-Devi/M-9435-2018	Vogel, Peter/0000-0002-7535-0545; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; , van Loo Geert/0000-0002-8427-4775; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Jacques, Peggy/0000-0001-9227-257X; Beyaert, Rudi/0000-0002-5704-582X; Elewaut, Dirk/0000-0002-7468-974X	Ghent University [BOF14/GOA/013]; European Research Council [281600]; FWO [G030212N, 1.2.201.10.N.00, 1.5.122.11.N.00, Odysseus-G091908, G061910N, G016812N]; Queen Elisabeth Medical Foundation; Ghent University Group-ID MRP; National Institutes of Health [AR056296, CA163507, AI101935]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA163507, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935, R37AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	Ghent University(Ghent University); European Research Council(European Research Council (ERC)European Commission); FWO(FWO); Queen Elisabeth Medical Foundation; Ghent University Group-ID MRP(Ghent University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Flavell and V. Dixit for supplying mutant mice. L.V.W. is a postdoctoral fellow with the Fund for Scientific Research-Flanders (FWO). This work was supported by the Ghent University Concerted Research Actions (grant BOF14/GOA/013) and grants from the European Research Council (Grant 281600) and the FWO (grants G030212N, 1.2.201.10.N.00 and 1.5.122.11.N.00) to M.L., and by FWO research grants (Odysseus-G091908, G061910N and G016812N) and a Queen Elisabeth Medical Foundation grant to G.V.L., and by the Ghent University Group-ID MRP to G.V.L., R.B. and D.E.T.-D.K. is supported by grants from the National Institutes of Health (AR056296, CA163507 and AI101935) and the American Lebanese Syrian Associated Charities.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Ben Hamad M, 2012, INT J IMMUNOGENET, V39, P131, DOI 10.1111/j.1744-313X.2011.01070.x; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burger D, 2006, BEST PRACT RES CL RH, V20, P879, DOI 10.1016/j.berh.2006.06.004; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dieguez-Gonzalez R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2650; Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kastbom A, 2008, RHEUMATOLOGY, V47, P415, DOI 10.1093/rheumatology/kem372; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin KM, 2014, P NATL ACAD SCI USA, V111, P775, DOI 10.1073/pnas.1320294111; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mathews RJ, 2014, ANN RHEUM DIS, V73, P1202, DOI 10.1136/annrheumdis-2013-203276; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Schott WH, 2004, DIABETES, V53, P99, DOI 10.2337/diabetes.53.1.99; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	26	320	328	10	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					69	+		10.1038/nature13322	http://dx.doi.org/10.1038/nature13322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043000	Green Accepted			2022-12-24	WOS:000339908000033
J	Kwiatkowski, N; Zhang, TH; Rahl, PB; Abraham, BJ; Reddy, J; Ficarro, SB; Dastur, A; Amzallag, A; Ramaswamy, S; Tesar, B; Jenkins, CE; Hannett, NM; McMillin, D; Sanda, T; Sim, T; Kim, ND; Look, T; Mitsiades, CS; Weng, AP; Brown, JR; Benes, CH; Marto, JA; Young, RA; Gray, NS				Kwiatkowski, Nicholas; Zhang, Tinghu; Rahl, Peter B.; Abraham, Brian J.; Reddy, Jessica; Ficarro, Scott B.; Dastur, Anahita; Amzallag, Arnaud; Ramaswamy, Sridhar; Tesar, Bethany; Jenkins, Catherine E.; Hannett, Nancy M.; McMillin, Douglas; Sanda, Takaomi; Sim, Taebo; Kim, Nam Doo; Look, Thomas; Mitsiades, Constantine S.; Weng, Andrew P.; Brown, Jennifer R.; Benes, Cyril H.; Marto, Jarrod A.; Young, Richard A.; Gray, Nathanael S.			Targeting transcription regulation in cancer with a covalent CDK7 inhibitor	NATURE			English	Article							RNA-POLYMERASE-II; ACTIVATING KINASE; SUPER-ENHANCERS; FACTOR TFIIH; CTD KINASE; PHOSPHORYLATION; ELONGATION; COMPLEX; IDENTIFICATION; DISCOVERY	Tumour oncogenes include transcription factors that co-opt the general transcriptional machinery to sustain the oncogenic state', but direct pharmacological inhibition of transcription factors has so far proven difficult(2). However, the transcriptional machinery contains various enzymatic cofactors that can be targeted for the development of new therapeutic candidates', including cyclin-dependent kinases (CDKs)(4). Here we present the discovery and characterization of a covalent CDK7 inhibitor, THZ1, which has the unprecedented ability to target a remote cysteine residue located outside of the canonical kinase domain, providing an unanticipated means of achieving selectivity for CDK7. Cancer cell-line profiling indicates that a subset of cancer cell lines, including human T-cell acute lymphoblastic leukaemia (T-ALL), have exceptional sensitivity to THZ1. Genome-wide analysis in Jurkat T-ALL cells shows that THZ1 disproportionally affects transcription of RUNXI and suggests that sensitivity to THZ I may be due to vulnerability conferred by the RUNX1 super-enhancer and the key role of RUNXI in the core transcriptional regulatory circuitry of these tumour cells. Pharmacological modulation of CDK7 Ifinase activity may thus provide an approach to identify and treat tumour types that are dependent on transcription for maintenance of the oncogenic state.	[Kwiatkowski, Nicholas; Zhang, Tinghu; Ficarro, Scott B.; Marto, Jarrod A.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Kwiatkowski, Nicholas; Zhang, Tinghu; Ficarro, Scott B.; Marto, Jarrod A.; Gray, Nathanael S.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Kwiatkowski, Nicholas; Rahl, Peter B.; Abraham, Brian J.; Reddy, Jessica; Hannett, Nancy M.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Reddy, Jessica; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02115 USA; [Dastur, Anahita; Amzallag, Arnaud; Ramaswamy, Sridhar; Benes, Cyril H.] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Charlestown, MA 02129 USA; [Dastur, Anahita; Amzallag, Arnaud; Ramaswamy, Sridhar; Benes, Cyril H.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Amzallag, Arnaud; Ramaswamy, Sridhar] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Tesar, Bethany; McMillin, Douglas; Mitsiades, Constantine S.; Brown, Jennifer R.] Harvard Univ, Dana Farber Canc Inst, Dept Med Oncol, Sch Med, Boston, MA 02115 USA; [Tesar, Bethany; McMillin, Douglas; Mitsiades, Constantine S.; Brown, Jennifer R.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Jenkins, Catherine E.; Weng, Andrew P.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Sanda, Takaomi; Look, Thomas] Harvard Univ, Dana Farber Canc Inst, Dept Pediat Oncol, Sch Med, Boston, MA 02215 USA; [Sanda, Takaomi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Sim, Taebo] Korea Inst Sci & Technol, Chem Kinom Res Ctr, Seoul 136791, South Korea; [Sim, Taebo] KU KIST Grad Sch Converging Sci & Technol, Seoul 136713, South Korea; [Kim, Nam Doo] Daegu Gyeongbuk Med Innovat Fdn, Taegu 706010, South Korea; [Look, Thomas] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; British Columbia Cancer Agency; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National University of Singapore; Korea Institute of Science & Technology (KIST); Korea University; Harvard University; Boston Children's Hospital	Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	young@wi.mit.edu; nathanael_gray@dfci.harvard.edu	Abraham, Brian/C-2230-2019; Amzallag, Arnaud/Y-5802-2019; Young, Richard A/F-6495-2012	Abraham, Brian/0000-0001-8085-3027; Amzallag, Arnaud/0000-0001-7467-1227; Young, Richard A/0000-0001-8855-8647	National Institutes of Health [R01 CA130876-04, U54 HG006097-02, CA178860-01, P01 N5047572-10, HG002668, CA109901]; American Cancer Society Postdoctoral Fellowship [120272-PF-11-042-01-DMC]; Translational Research Program of the Leukemia Lymphoma Society; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA179483, R01CA130876, R21CA178860, P01CA109901, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097, R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society); Translational Research Program of the Leukemia Lymphoma Society; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Gray and Young laboratories for helpful discussions; D. Orlando, L. Lawton and L. Anders for advice; and C. Thoreen and D. Sabatini, as well as S. Cheng and G. Morin, for reagents. We thank K. Jones and N. Kohl for performing mouse studies and K. Jones and C. Christensen for prepping mouse tissues. We thank S. Riddle for performing LanthaScreen Eu Kinase Assays. This work was supported by the National Institutes of Health (R01 CA130876-04 and U54 HG006097-02 to N.S.G.; CA178860-01 and P01 N5047572-10 to J.A.M.; HG002668 and CA109901 to R.A.Y.), and the American Cancer Society Postdoctoral Fellowship 120272-PF-11-042-01-DMC (P.B.R.). J.R.B. is a Scholar in Clinical Research of the Leukemia Lymphoma Society and is supported by the Translational Research Program of the Leukemia Lymphoma Society and by the American Cancer Society.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Berg T, 2008, CURR OPIN CHEM BIOL, V12, P464, DOI 10.1016/j.cbpa.2008.07.023; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lu Q, 2012, J BIOMOL SCREEN, V17, P555, DOI 10.1177/1087057112437763; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Sanso M, 2013, TRANSCR-AUSTIN, V4, P146, DOI 10.4161/trns.25146; Schachter MM, 2013, MOL CELL, V50, P250, DOI 10.1016/j.molcel.2013.04.003; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Watanabe Y, 2000, GENES CELLS, V5, P407, DOI 10.1046/j.1365-2443.2000.00336.x; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024	30	520	552	10	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					616	+		10.1038/nature13393	http://dx.doi.org/10.1038/nature13393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043025	Green Accepted, Green Submitted			2022-12-24	WOS:000339566300040
J	Cimermancic, P; Medema, MH; Claesen, J; Kurita, K; Brown, LCW; Mavrommatis, K; Pati, A; Godfrey, PA; Koehrsen, M; Clardy, J; Birren, BW; Takano, E; Sali, A; Linington, RG; Fischbach, MA				Cimermancic, Peter; Medema, Marnix H.; Claesen, Jan; Kurita, Kenji; Brown, Laura C. Wieland; Mavrommatis, Konstantinos; Pati, Amrita; Godfrey, Paul A.; Koehrsen, Michael; Clardy, Jon; Birren, Bruce W.; Takano, Eriko; Sali, Andrej; Linington, Roger G.; Fischbach, Michael A.			Insights into Secondary Metabolism from a Global Analysis of Prokaryotic Biosynthetic Gene Clusters	CELL			English	Article							POLYMERASE EXTENSION CLONING; GENOMICS-DRIVEN DISCOVERY; IN-VITRO RECONSTITUTION; NATURAL-PRODUCT; STAPHYLOCOCCUS-AUREUS; POLYKETIDE; SEQUENCE; IDENTIFICATION; XANTHOMONADIN; BACTERIAL	Although biosynthetic gene clusters (BGCs) have been discovered for hundreds of bacterial metabolites, our knowledge of their diversity remains limited. Here, we used a novel algorithm to systematically identify BGCs in the extensive extant microbial sequencing data. Network analysis of the predicted BGCs revealed large gene cluster families, the vast majority uncharacterized. We experimentally characterized the most prominent family, consisting of two subfamilies of hundreds of BGCs distributed throughout the Proteobacteria; their products are aryl polyenes, lipids with an aryl head group conjugated to a polyene tail. We identified a distant relationship to a third subfamily of aryl polyene BGCs, and together the three subfamilies represent the largest known family of biosynthetic gene clusters, with more than 1,000 members. Although these clusters are widely divergent in sequence, their small molecule products are remarkably conserved, indicating for the first time the important roles these compounds play in Gram-negative cell biology.	[Cimermancic, Peter; Claesen, Jan; Sali, Andrej; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Cimermancic, Peter; Claesen, Jan; Sali, Andrej; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Medema, Marnix H.; Takano, Eriko] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Microbial Physiol, NL-9747 AG Groningen, Netherlands; [Medema, Marnix H.] Univ Groningen, Groningen Bioinformat Ctr, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Kurita, Kenji; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Brown, Laura C. Wieland] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Mavrommatis, Konstantinos; Pati, Amrita] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Godfrey, Paul A.; Koehrsen, Michael; Birren, Bruce W.] Broad Inst, Cambridge, MA 02142 USA; [Sali, Andrej] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Groningen; University of Groningen; University of California System; University of California Santa Cruz; Indiana University System; Indiana University Bloomington; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Fischbach, MA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	fischbach@fischbachgroup.org	Linington, Roger/ABD-5582-2021; Medema, Marnix H./AAR-3138-2021	Linington, Roger/0000-0003-1818-4971; Medema, Marnix H./0000-0002-2191-2821; Fischbach, Michael/0000-0003-3079-8247; Takano, Eriko/0000-0002-6791-3256; Mavrommatis, Konstantinos/0000-0003-4549-385X; Claesen, Jan/0000-0002-0755-7974	HHMI Predoctoral Fellowship; Boehringer Ingelheim Fonds; GenBiotics programme of the Dutch Technology Foundation STW [10463]; NIH [TW006634, OD007290, AI101018, AI101722, GM081879]; James and Eleanor Delfino Charitable Trust; Medical Research Program Grant from the W.M. Keck Foundation; David and Lucile Packard Foundation; DARPA [HR0011-12-C-0067]; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services [HHSN272200900018C]; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818, R21AI101722, R01AI101018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, T32GM067547] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007290] Funding Source: NIH RePORTER	HHMI Predoctoral Fellowship(Howard Hughes Medical Institute); Boehringer Ingelheim Fonds(Boehringer Ingelheim); GenBiotics programme of the Dutch Technology Foundation STW; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Eleanor Delfino Charitable Trust; Medical Research Program Grant from the W.M. Keck Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Fischbach lab for helpful discussions and Rainer Breitling and an anonymous reviewer for constructive feedback on the manuscript. We thank Edward Ruby (University of Wisconsin) for providing us with V. fischeri ES114, Didier Mazel (Institut Pasteur) for plasmid pSW8197, and Mervyn Bibb (John Innes Centre) for plasmids pIJ773, pIJ790 and pIJ10257. This work was supported by an HHMI Predoctoral Fellowship (P.C.), a Boehringer Ingelheim Fonds travel grant (M.H.M.), Grant 10463 from the GenBiotics programme of the Dutch Technology Foundation STW to ET (M.H.M.), NIH grant TW006634 (R.G.L.), the James and Eleanor Delfino Charitable Trust (K.K.), a Medical Research Program Grant from the W.M. Keck Foundation (M.A.F.), a Fellowship for Science and Engineering from the David and Lucile Packard Foundation (M.A.F.), DARPA award HR0011-12-C-0067 (M.A.F.), and NIH grants OD007290, AI101018, AI101722, and GM081879 (M.A.F.). This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, under Contract No.: HHSN272200900018C. M.A.F. is on the scientific advisory board of Warp Drive Bio.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; FAUTZ E, 1979, PHYTOCHEMISTRY, V18, P957, DOI 10.1016/S0031-9422(00)91457-2; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Flatt PM, 2007, NAT PROD REP, V24, P358, DOI 10.1039/b603816f; Franke J, 2012, ANGEW CHEM INT EDIT, V51, P11611, DOI 10.1002/anie.201205566; Frasch HJ, 2013, CURR OPIN BIOTECH, V24, P1144, DOI 10.1016/j.copbio.2013.03.006; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goel AK, 2002, J BACTERIOL, V184, P3539, DOI 10.1128/JB.184.13.3539-3548.2002; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; JENKINS CL, 1982, CURR MICROBIOL, V7, P195, DOI 10.1007/BF01568797; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kahne D, 2005, CHEM REV, V105, P425, DOI 10.1021/cr030103a; Kersten RD, 2013, P NATL ACAD SCI USA, V110, pE4407, DOI 10.1073/pnas.1315492110; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Letzel AC, 2013, NAT PROD REP, V30, P392, DOI 10.1039/c2np20103h; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li MHT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-185; Lin K, 2006, BIOINFORMATICS, V22, P2081, DOI 10.1093/bioinformatics/btl366; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lowry B, 2013, J AM CHEM SOC, V135, P16809, DOI 10.1021/ja409048k; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; Oliynyk M, 2007, NAT BIOTECHNOL, V25, P447, DOI 10.1038/nbt1297; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pelzer S, 1999, ANTIMICROB AGENTS CH, V43, P1565, DOI 10.1128/AAC.43.7.1565; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Poplawsky AR, 2000, APPL ENVIRON MICROB, V66, P5123, DOI 10.1128/AEM.66.12.5123-5127.2000; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Rajagopal L, 1997, FEBS LETT, V415, P125, DOI 10.1016/S0014-5793(97)01109-5; Rehm BHA, 2010, NAT REV MICROBIOL, V8, P578, DOI 10.1038/nrmicro2354; REICHENBACH H, 1980, ARCH MICROBIOL, V126, P291, DOI 10.1007/BF00409934; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Starcevic A, 2008, NUCLEIC ACIDS RES, V36, P6882, DOI 10.1093/nar/gkn685; STARR MP, 1977, ARCH MICROBIOL, V113, P1, DOI 10.1007/BF00428572; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066633; Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; Winter JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/j.cbpa.2010.10.020	68	545	562	16	192	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					412	421		10.1016/j.cell.2014.06.034	http://dx.doi.org/10.1016/j.cell.2014.06.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036635	Green Accepted, Bronze			2022-12-24	WOS:000340943600019
J	Tubio, JMC; Li, YL; Ju, YS; Martincorena, I; Cooke, SL; Tojo, M; Gundem, G; Pipinikas, CP; Zamora, J; Raine, K; Menzies, A; Roman-Garcia, P; Fullam, A; Gerstung, M; Shlien, A; Tarpey, PS; Papaemmanuil, E; Knappskog, S; Van Loo, P; Ramakrishna, M; Davies, HR; Marshall, J; Wedge, DC; Teague, J; Butler, AP; Nik-Zainal, S; Alexandrov, L; Behjati, S; Yates, LR; Bolli, N; Mudie, L; Hardy, C; Martin, S; McLaren, S; O'Meara, S; Anderson, E; Maddison, M; Gamble, S; Foster, C; Warren, AY; Whitaker, H; Brewer, D; Eeles, R; Cooper, C; Neal, D; Lynch, AG; Visakorpi, T; Isaacs, WB; van't Veer, L; Caldas, C; Desmedt, C; Sotiriou, C; Aparicio, S; Foekens, JA; Eyfjord, JE; Lakhani, SR; Thomas, G; Myklebost, O; Span, PN; Borresen-Dale, AL; Richardson, AL; Van de Vijver, M; Vincent-Salomon, A; Van den Eynden, GG; Flanagan, AM; Futreal, PA; Janes, SM; Bova, GS; Stratton, MR; McDermott, U; Campbell, PJ				Tubio, Jose M. C.; Li, Yilong; Ju, Young Seok; Martincorena, Inigo; Cooke, Susanna L.; Tojo, Marta; Gundem, Gunes; Pipinikas, Christodoulos P.; Zamora, Jorge; Raine, Keiran; Menzies, Andrew; Roman-Garcia, Pablo; Fullam, Anthony; Gerstung, Moritz; Shlien, Adam; Tarpey, Patrick S.; Papaemmanuil, Elli; Knappskog, Stian; Van Loo, Peter; Ramakrishna, Manasa; Davies, Helen R.; Marshall, John; Wedge, David C.; Teague, Jonw.; Butler, Adam P.; Nik-Zainal, Serena; Alexandrov, Ludmil; Behjati, Sam; Yates, Lucy R.; Bolli, Niccolo; Mudie, Laura; Hardy, Claire; Martin, Sancha; McLaren, Stuart; O'Meara, Sarah; Anderson, Elizabeth; Maddison, Mark; Gamble, Stephen; Foster, Christopher; Warren, Anne Y.; Whitaker, Hayley; Brewer, Daniel; Eeles, Rosalind; Cooper, Colin; Neal, David; Lynch, Andy G.; Visakorpi, Tapio; Isaacs, William B.; van't Veer, Laura; Caldas, Carlos; Desmedt, Christine; Sotiriou, Christos; Aparicio, Sam; Foekens, John A.; Eyfjord, Jorunn Erla; Lakhani, Sunil R.; Thomas, Gilles; Myklebost, Ola; Span, Paul N.; Borresen-Dale, Anne-Lise; Richardson, Andrea L.; Van de Vijver, Marc; Vincent-Salomon, Anne; Van den Eynden, Gert G.; Flanagan, Adrienne M.; Futreal, P. Andrew; Janes, Sam M.; Bova, G. Steven; Stratton, Michael R.; McDermott, Ultan; Campbell, Peter J.		ICGC Breast Canc Grp; ICGC Bone Canc Grp; ICGC Prostate Canc Grp	Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes	SCIENCE			English	Article							SOMATIC RETROTRANSPOSITION; HUMAN BRAIN; MUTATIONS; EVOLUTION; ELEMENTS; CARCINOMAS; LANDSCAPE; SEQUENCE; OVARIAN; CELLS	Long interspersed nuclear element-1 (L1) retrotransposons are mobile repetitive elements that are abundant in the human genome. L1 elements propagate through RNA intermediates. In the germ line, neighboring, nonrepetitive sequences are occasionally mobilized by the L1 machinery, a process called 3' transduction. Because 3' transductions are potentially mutagenic, we explored the extent to which they occur somatically during tumorigenesis. Studying cancer genomes from 244 patients, we found that tumors from 53% of the patients had somatic retrotranspositions, of which 24% were 3' transductions. Fingerprinting of donor L1s revealed that a handful of source L1 elements in a tumor can spawn from tens to hundreds of 3' transductions, which can themselves seed further retrotranspositions. The activity of individual L1 elements fluctuated during tumor evolution and correlated with L1 promoter hypomethylation. The 3' transductions disseminated genes, exons, and regulatory elements to new locations, most often to heterochromatic regions of the genome.	[Tubio, Jose M. C.; Li, Yilong; Ju, Young Seok; Martincorena, Inigo; Cooke, Susanna L.; Gundem, Gunes; Zamora, Jorge; Raine, Keiran; Menzies, Andrew; Roman-Garcia, Pablo; Fullam, Anthony; Gerstung, Moritz; Shlien, Adam; Tarpey, Patrick S.; Papaemmanuil, Elli; Knappskog, Stian; Van Loo, Peter; Ramakrishna, Manasa; Davies, Helen R.; Marshall, John; Wedge, David C.; Teague, Jonw.; Butler, Adam P.; Nik-Zainal, Serena; Alexandrov, Ludmil; Behjati, Sam; Yates, Lucy R.; Bolli, Niccolo; Mudie, Laura; Hardy, Claire; Martin, Sancha; McLaren, Stuart; O'Meara, Sarah; Anderson, Elizabeth; Maddison, Mark; Gamble, Stephen; Futreal, P. Andrew; Stratton, Michael R.; McDermott, Ultan; Campbell, Peter J.; ICGC Breast Canc Grp; ICGC Bone Canc Grp] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Tojo, Marta] Univ Santiago de Compostela, Inst Invest Sanitarias, Ctr Res Mol Med & Chron Dis, Dept Physiol,Sch Med, Santiago De Compostela, Spain; [Pipinikas, Christodoulos P.; Janes, Sam M.] UCL, Rayne Inst, Lungs Living Res Ctr, London, England; [Knappskog, Stian] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Knappskog, Stian] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Van Loo, Peter] VIB, Dept Human Genet, Human Genome Lab, Leuven, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Leuven, Belgium; [Brewer, Daniel; Eeles, Rosalind; Cooper, Colin] Inst Canc Res, London SW3 6JB, England; [Whitaker, Hayley; Neal, David; Lynch, Andy G.; Caldas, Carlos; ICGC Prostate Canc Grp] Univ Cambridge, Canc Res UK CRUK Cambridge Inst, Cambridge, England; [Foster, Christopher] Univ Liverpool, London, England; [Foster, Christopher] HCA Pathol Labs, London, England; [Nik-Zainal, Serena; Warren, Anne Y.; Campbell, Peter J.] Cambridge Univ Hosp Natl Hlth Serv NHS Fdn Trust, Cambridge, England; [Brewer, Daniel; Cooper, Colin] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Visakorpi, Tapio; Bova, G. Steven] Univ Tampere, Inst Biosci & Med Technol BioMediTech, FIN-33101 Tampere, Finland; [Visakorpi, Tapio; Bova, G. Steven] Tampere Univ Hosp, Tampere, Finland; [Isaacs, William B.] Johns Hopkins Univ, Baltimore, MD USA; [van't Veer, Laura] Netherlands Canc Inst, Amsterdam, Netherlands; [Desmedt, Christine; Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium; [Aparicio, Sam] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Foekens, John A.] Erasmus Univ, Med Ctr, Erasmus Med Ctr, Dept Med Oncol,Canc Inst, Rotterdam, Netherlands; [Eyfjord, Jorunn Erla] Univ Iceland, Canc Res Lab, Reykjavik, Iceland; [Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Pathol Queensland, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Thomas, Gilles] Univ Lyon 1, Inst Natl Canc INCa Synergie, F-69365 Lyon, France; [Myklebost, Ola; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Inst Canc Res, Oslo, Norway; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Van de Vijver, Marc] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Vincent-Salomon, Anne] Inst Bergonie, F-33076 Bordeaux, France; [Vincent-Salomon, Anne] Inst Curie, Dept Tumor Biol, F-75248 Paris 05, France; [Van den Eynden, Gert G.] GZA Hosp, Translat Canc Res Unit, Antwerp, Belgium; [Van den Eynden, Gert G.] GZA Hosp, Dept Pathol, Antwerp, Belgium; [Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp, Stanmore, Middx, England; [Flanagan, Adrienne M.] UCL, UCL Canc Inst, London, England; [Futreal, P. Andrew] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Bolli, Niccolo; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England	Wellcome Trust Sanger Institute; Universidade de Santiago de Compostela; University of London; King's College London; University College London; University of Bergen; University of Bergen; Haukeland University Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Liverpool; University of East Anglia; Tampere University; Tampere University; Tampere University Hospital; Johns Hopkins University; Netherlands Cancer Institute; Institut Jules Bordet; Universite Libre de Bruxelles; British Columbia Cancer Agency; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Iceland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Oslo; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Dana-Farber Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; UNICANCER; Institut Bergonie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; University of Texas System; UTMD Anderson Cancer Center; University of Cambridge	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Hinxton, Cambs, England.	pc8@sanger.ac.uk	Nik-Zainal, Serena/ABD-4437-2020; Roman-Garcia, Pablo/D-7368-2016; Alexandrov, Ludmil/AAS-1454-2021; Myklebost, Ola/E-9335-2010; Bolli, Niccolo/D-4057-2011; Caldas, Carlos/U-7250-2019; Lakhani, Sunil R/I-1970-2018; Span, Paul/G-4710-2012; Stunnenberg, Hendrik G./D-6875-2012; Tubio, Jose M.C./H-5076-2015; Ju, Young Seok/E-1324-2012; Brewer, Daniel S/D-6201-2018; Wedge, David/AAC-4977-2021; Tubio, Jose/AAG-7345-2019; Ehinger, Anna/I-8516-2014; Sweep, C.G.J./H-8096-2014; Desmedt, Christine/P-7438-2017; Simpson, Peter/F-1225-2010; Gamble, Stephen/D-1417-2011	Alexandrov, Ludmil/0000-0003-3596-4515; Myklebost, Ola/0000-0002-2866-3223; Bolli, Niccolo/0000-0002-1018-5139; Caldas, Carlos/0000-0003-3547-1489; Lakhani, Sunil R/0000-0003-4067-2760; Span, Paul/0000-0002-1930-6638; Stunnenberg, Hendrik G./0000-0002-0066-1576; Tubio, Jose M.C./0000-0003-3540-2459; Ju, Young Seok/0000-0002-5514-4189; Brewer, Daniel S/0000-0003-4753-9794; Tubio, Jose/0000-0003-3540-2459; Ehinger, Anna/0000-0001-9225-7396; Sweep, C.G.J./0000-0003-1103-3070; Desmedt, Christine/0000-0002-5223-5579; Simpson, Peter/0000-0002-4816-8289; Fullam, Anthony/0000-0002-0884-8124; Martincorena, Inigo/0000-0003-1122-4416; Roman-Garcia, Pablo/0000-0003-1904-5674; McDermott, Ultan/0000-0001-9032-4700; Gamble, Stephen/0000-0002-0867-3723; Berney, Daniel/0000-0001-5474-8696; Massie, Charlie/0000-0003-2314-4843; Aparicio, Samuel/0000-0002-0487-9599; Knappskog, Stian/0000-0002-4153-1655; Wedge, David/0000-0002-7572-3196; Van Loo, Peter/0000-0003-0292-1949; Eeles, Rosalind/0000-0002-3698-6241; Visakorpi, Tapio/0000-0002-5004-0364; Raine, Keiran/0000-0002-5634-1539; chin, suet-feung/0000-0001-5697-1082; Flanagan, Adrienne/0000-0002-2832-1303; Nik-Zainal, Serena/0000-0001-5054-1727; Gerstung, Moritz/0000-0001-6709-963X; van de Vijver, Marc/0000-0002-0385-4787; Martin, Sancha/0000-0001-6213-5259; Dudderidge, Tim/0000-0001-6373-3613; Bova, George/0000-0003-1639-3104; Janes, Sam/0000-0002-6634-5939; Mithen, Richard/0000-0001-7307-4324	Marie Curie Fellowship [328264]; Wellcome Trust [WT100183MA]; Chordoma Foundation; Skeletal Cancer Action Trust; European Molecular Biology Organization [LTF 1203-2012, 1287-2012]; CRUK Clinician Scientist fellowship; National Institute for Health Research; University College London Hospitals Biomedical Research Centre; Cancer Research UK University College London Experimental Cancer Centre; Brussels Region-Impulse Programme Life Sciences; European Union (BASIS); Wellcome Trust; CRUK [C5047/A14835]; Dallaglio Foundation; Bob Champion Trust; Orchid Cancer appeal; RoseTrees Trust; North West Cancer Research Fund, Big C; Grand Charity of Freemasons; Research Foundation Flanders (FWO); 14M Genomics Limited; BBSRC [BBS/E/F/00044431, BBS/E/F/00042686] Funding Source: UKRI; MRC [G0900871] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044431, BBS/E/F/00042686] Funding Source: researchfish; Cancer Research UK [14835, 17528, 15007, 16942, 19556] Funding Source: researchfish; Medical Research Council [G0900871] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish; Rosetrees Trust [M35-F1-CD1] Funding Source: researchfish	Marie Curie Fellowship(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Chordoma Foundation; Skeletal Cancer Action Trust; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); CRUK Clinician Scientist fellowship; National Institute for Health Research(National Institute for Health Research (NIHR)); University College London Hospitals Biomedical Research Centre(General Electric); Cancer Research UK University College London Experimental Cancer Centre; Brussels Region-Impulse Programme Life Sciences; European Union (BASIS); Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); Dallaglio Foundation; Bob Champion Trust; Orchid Cancer appeal; RoseTrees Trust(Rosetrees Trust); North West Cancer Research Fund, Big C; Grand Charity of Freemasons; Research Foundation Flanders (FWO)(FWO); 14M Genomics Limited; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust)	J.M.C.T. is supported by a Marie Curie Fellowship FP7-PEOPLE-2012-IEF (project number 328264) and thanks H. Kazazian and S. Solyom for providing with L1Hs specific oligonucleotide primer sequences. We thank the TCGA project team and their specimen donors for providing sequencing data. This work was supported by the Wellcome Trust, the Chordoma Foundation, and the Skeletal Cancer Action Trust. Y.S.J. and I. M. are supported by European Molecular Biology Organization long-term fellowships (LTF 1203-2012 and 1287-2012). P.J.C. and S.M.J. are Wellcome Trust Senior Clinical Fellows. P. V. L. is a postdoctoral researcher of the Research Foundation Flanders (FWO). S.N.-Z. is funded by a Wellcome Trust Intermediate Clinical Research Fellowship (WT100183MA). U. M. is supported by a CRUK Clinician Scientist fellowship. Support was provided to A. M. F. by the National Institute for Health Research, the University College London Hospitals Biomedical Research Centre, and the Cancer Research UK University College London Experimental Cancer Centre. C. D. is supported by a grant from the Brussels Region-Impulse Programme Life Sciences. Samples from Addenbrooke's Hospital were collected with support from the NIHR Cambridge Biomedical Resource Centre. The ICGC Breast Cancer Consortium was supported by a grant from the European Union (BASIS) and the Wellcome Trust. The ICGC Prostate UK Cancer Consortium is funded by CRUK grant C5047/A14835, by the Dallaglio Foundation, and the Wellcome Trust. We also acknowledge support from the Bob Champion Trust, the Orchid Cancer appeal, the RoseTrees Trust, the North West Cancer Research Fund, Big C, the Grand Charity of Freemasons, and the Research Foundation Flanders (FWO). We acknowledge the Biomedical Research Centre at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust. We thank the NIHR, Hutchison Whampoa Limited, Human Research Tissue Bank (Addenbrookes Hospital), CRUK Cambridge Research Institute Histopathology, In-situ Hybridisation Core Facility, Genomics Core Facility Cambridge, and Cambridge University Hospitals Media Studio. P.J.C. holds equity in, and is a paid consultant for, 14M Genomics Limited.	Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cooke SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4644; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ejima Y, 2003, HUM MOL GENET, V12, P1321, DOI 10.1093/hmg/ddg138; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r22; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hur K, 2014, GUT, V63, P635, DOI 10.1136/gutjnl-2012-304219; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Macfarlane CM, 2013, HUM MUTAT, V34, P974, DOI 10.1002/humu.22327; McBride DJ, 2012, J PATHOL, V227, P446, DOI 10.1002/path.4042; Menendez L, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-12; MIKI Y, 1992, CANCER RES, V52, P643; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Szak ST, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r30; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	36	240	244	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					531	531	1251343	10.1126/science.1251343	http://dx.doi.org/10.1126/science.1251343			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082706	Green Accepted			2022-12-24	WOS:000339651300037
J	Wagner, TA; McLaughlin, S; Garg, K; Cheung, CYK; Larsen, BB; Styrchak, S; Huang, HC; Edlefsen, PT; Mullins, JI; Frenkel, LM				Wagner, Thor A.; McLaughlin, Sherry; Garg, Kavita; Cheung, Charles Y. K.; Larsen, Brendan B.; Styrchak, Sheila; Huang, Hannah C.; Edlefsen, Paul T.; Mullins, James I.; Frenkel, Lisa M.			Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GENOME-WIDE ANALYSIS; ANTIRETROVIRAL THERAPY; LATENT RESERVOIR; T-CELLS; REPLICATION; EXPRESSION; MUTATIONS; LANDSCAPE; SELECTION	Antiretroviral treatment (ART) of HIV infection suppresses viral replication. Yet if ART is stopped, virus reemerges because of the persistence of infected cells. We evaluated the contribution of infected-cell proliferation and sites of proviral integration to HIV persistence. A total of 534 HIV integration sites (IS) and 63 adjacent HIV env sequences were derived from three study participants over 11.3 to 12.7 years of ART. Each participant had identical viral sequences integrated at the same position in multiple cells, demonstrating infected-cell proliferation. Integrations were overrepresented in genes associated with cancer and favored in 12 genes across multiple participants. Over time on ART, a greater proportion of persisting proviruses were in proliferating cells. HIV integration into specific genes may promote proliferation of HIV-infected cells, slowing viral decay during ART.	[Wagner, Thor A.; McLaughlin, Sherry; Styrchak, Sheila; Huang, Hannah C.; Frenkel, Lisa M.] Seattle Childrens Res Inst, Seattle, WA 98101 USA; [Wagner, Thor A.; McLaughlin, Sherry; Larsen, Brendan B.; Edlefsen, Paul T.; Mullins, James I.; Frenkel, Lisa M.] Univ Washington, Seattle, WA 98195 USA; [Garg, Kavita; Cheung, Charles Y. K.; Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Frenkel, LM (corresponding author), Seattle Childrens Res Inst, 1900 9th Ave, Seattle, WA 98101 USA.	lfrenkel@uw.edu			Molecular Profiling and Computational Biology Core of the University of Washington's Center for AIDS Research [P30 AI027757]; Canadian Institutes of Health (HIV/AIDS Research Initiative award) [201311CVI-322424-244686];  [R01AI091550];  [K23AI077357];  [R01 AI111806]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, R01AI111806, K23AI077357, P01AI057005, R01AI091550] Funding Source: NIH RePORTER	Molecular Profiling and Computational Biology Core of the University of Washington's Center for AIDS Research; Canadian Institutes of Health (HIV/AIDS Research Initiative award); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to express gratitude to the study participants who donated their time and provided specimens, and to N. H. Tobin, A. J. Melvin, and K. M. Mohan for their contributions to this study. Additionally, we thank Y. C. Ho, R. and J. Siliciano, H. Imamichi and C. Lane, and N. Malani and F. Bushman for providing their HIV integration site data. HIV env sequences generated from specific integration sites were deposited in GenBank under accession numbers (KM025062 to KM025124 and KM201287 to KM201295). Additional HIV env sequences were deposited in GenBank under accession numbers AY075701 to AY077450 (44), AY483287 to AY484389 (2), and KC314011 to KC315287 (8). Sequences of HIV-3'-LTR and adjacent chromosome integration sites are available in table S3. Other data are tabulated in the main paper and in the supplementary materials. Integration site sequences and HIV sequence alignments are available for download at http://mullinslab.microbiol.washington.edu/publications/supplemental.html. These studies were funded by R01AI091550 (L. M. F.), K23AI077357 (T. A. W.), R01 AI111806 (J. I. M.), the Molecular Profiling and Computational Biology Core of the University of Washington's Center for AIDS Research (P30 AI027757), and the Canadian Institutes of Health (HIV/AIDS Research Initiative award 201311CVI-322424-244686) (C. Y. K. C.). We wish to thank A. Embry and D. Lawrence at the National Institutes of Health for their support. The authors report no conflicts of interest related to this research.	Anderson JA, 2011, J VIROL, V85, P5220, DOI 10.1128/JVI.00284-11; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Eipers PG, 2011, VIROLOGY, V410, P151, DOI 10.1016/j.virol.2010.11.001; Fan H, 2011, VIRUSES-BASEL, V3, P398, DOI 10.3390/v3040398; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Friedman J, 2011, J VIROL, V85, P9078, DOI 10.1128/JVI.00836-11; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Ikeda T, 2007, J INFECT DIS, V195, P716, DOI 10.1086/510915; Imai K, 2010, J BIOL CHEM, V285, P16538, DOI 10.1074/jbc.M110.103531; Imamichi H., 2014, AIDS, V1; Josefsson L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003432; Soto MJ, 2011, AIDS RES HUM RETROV, V27, P547, DOI 10.1089/aid.2010.0182; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Liu JH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-2; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Mok HP, 2007, GENE THER, V14, P741, DOI 10.1038/sj.gt.3302923; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Plaisier CL, 2012, GENOME RES, V22, P2302, DOI 10.1101/gr.133991.111; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sherrill-Mix S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-90; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Swaminathan S, 2013, NAT MED, V19, P1014, DOI 10.1038/nm.3247; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Tsukumo S, 2013, P NATL ACAD SCI USA, V110, P10735, DOI 10.1073/pnas.1306691110; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagner TA, 2013, J VIROL, V87, P1770, DOI 10.1128/JVI.01985-12; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	45	426	432	5	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					570	573		10.1126/science.1256304	http://dx.doi.org/10.1126/science.1256304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25011556	Green Accepted			2022-12-24	WOS:000339651300047
J	Sabo, A; Kress, TR; Pelizzola, M; de Pretis, S; Gorski, MM; Tesi, A; Morelli, MJ; Bora, P; Doni, M; Verrecchia, A; Tonelli, C; Faga, G; Bianchi, V; Ronchi, A; Low, D; Muller, H; Guccione, E; Campaner, S; Amati, B				Sabo, Arianna; Kress, Theresia R.; Pelizzola, Mattia; de Pretis, Stefano; Gorski, Marcin M.; Tesi, Alessandra; Morelli, Marco J.; Bora, Pranami; Doni, Mirko; Verrecchia, Alessandro; Tonelli, Claudia; Faga, Giovanni; Bianchi, Valerio; Ronchi, Alberto; Low, Diana; Mueller, Heiko; Guccione, Ernesto; Campaner, Stefano; Amati, Bruno			Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis	NATURE			English	Article							C-MYC; IN-VIVO; EXPRESSION ANALYSIS; MAMMALIAN GENOMES; PROTEIN-SYNTHESIS; GLOBAL REGULATION; GENE-EXPRESSION; RNA-SEQ; CHROMATIN; CELLS	The c-myc proto-oncogene product, Myc, is a transcription factor that binds thousands of genomic loci(1). Recent work suggested that rather than up-and downregulating selected groups of genes(1-3), Myc targets all active promoters and enhancers in the genome (a phenomenon termed 'invasion') and acts as a general amplifier of transcription(4,5). However, the available data did not readily discriminate between direct and indirect effects of Myc on RNA biogenesis. We addressed this issue with genome-wide chromatin immunoprecipitation and RNA expression profiles during B-cell lymphomagenesis in mice, in cultured B cells and fibroblasts. Consistent with long-standing observations(6), we detected general increases in total RNA or messenger RNA copies per cell (hereby termed 'amplification')(4,5) when comparing actively proliferating cells with control quiescent cells: this was true whether cells were stimulated by mitogens (requiring endogenous Myc for a proliferative response)(7,8) or by deregulated, oncogenic Myc activity. RNA amplification and promoter/enhancer invasion by Myc were separable phenomena that could occur without one another. Moreover, whether or not associated with RNA amplification, Myc drove the differential expression of distinct subsets of target genes. Hence, although having the potential to interact with all active or poised regulatory elements in the genome(4,5,9-11), Myc does not directly act as a global transcriptional amplifier(4,5). Instead, our results indicate that Myc activates and represses transcription of discrete gene sets, leading to changes in cellular state that can in turn feed back on global RNA production and turnover.	[Sabo, Arianna; Kress, Theresia R.; Pelizzola, Mattia; de Pretis, Stefano; Tesi, Alessandra; Morelli, Marco J.; Bora, Pranami; Bianchi, Valerio; Ronchi, Alberto; Mueller, Heiko; Campaner, Stefano; Amati, Bruno] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, I-20139 Milan, Italy; [Sabo, Arianna; Kress, Theresia R.; Gorski, Marcin M.; Doni, Mirko; Verrecchia, Alessandro; Tonelli, Claudia; Faga, Giovanni; Amati, Bruno] European Inst Oncol IEO, Dept Expt Oncol, I-20139 Milan, Italy; [Low, Diana; Guccione, Ernesto] Inst Mol & Cell Biol, Singapore 138673, Singapore	Istituto Italiano di Tecnologia - IIT; IRCCS European Institute of Oncology (IEO); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Amati, B (corresponding author), Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, Via Adamello 16, I-20139 Milan, Italy.	bruno.amati@iit.it	Doni, Mirko/AAN-6027-2020; de Pretis, Stefano/T-9728-2019; Doni, Mirko/ABA-9174-2021; Verrecchia, Alessandro/AAQ-6454-2020; Sabò, Arianna/J-9531-2018; Faga, Giovanni/AAB-5540-2021; Amati, Bruno/AAM-3418-2020; Morelli, Marco/AAN-1879-2020	Doni, Mirko/0000-0001-7099-2701; Verrecchia, Alessandro/0000-0002-8596-6650; Sabò, Arianna/0000-0002-9542-0045; Morelli, Marco/0000-0003-1862-667X; CAMPANER, Stefano/0000-0003-4547-6849; Muller, Heiko/0000-0001-9873-3146; Gorski, Marcin M./0000-0002-8276-3866; Low, Diana/0000-0002-6054-8524; Tonelli, Claudia/0000-0002-5626-3403; de Pretis, Stefano/0000-0003-1103-7688; Bianchi, Valerio/0000-0001-9025-7923; Pelizzola, Mattia/0000-0001-6672-9636; Amati, Bruno/0000-0002-2958-1799	European School of Molecular Medicine; European Community [305626, 200720, 259743]; European Research Council; Association for International Cancer Research (AICR); Italian Health Ministry; Fondazione Cariplo; Italian Association for Cancer Research (AIRC); Worldwide Cancer Research [10-0245] Funding Source: researchfish	European School of Molecular Medicine; European Community; European Research Council(European Research Council (ERC)European Commission); Association for International Cancer Research (AICR); Italian Health Ministry; Fondazione Cariplo(Fondazione Cariplo); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Worldwide Cancer Research	We thank A. Piontini, P. Nicoli, A. Gobbi and M. Capillo for their help with the management of mouse colonies; S. Bianchi, L. Rotta and T. Capra for assistance with the Illumina HiSeq and NanoString platforms; S. Barozzi, A. Oldani and D. Parazzoli for assistance with imaging technologies; S. Bonifacio and G. Diaferia for discussions about DNase I sequencing; and G. Natoli for comments on the manuscript. We are grateful to C.-L. Wei and collaborators (Genome Institute of Singapore) for the sequencing of ChIP-seq samples in a preliminary phase of this study. T.R.K. was supported by the Structured International Post Doc program of the European School of Molecular Medicine. This work was supported by funding from the European Community's Seventh Framework Programme (FP7/2007-2013), project RADIANT (grant agreement no. 305626) to M.P. and projects EuroSystem (grant agreement no. 200720) and MODHEP (grant agreement no. 259743) to B.A., as well as grants from the European Research Council, the Association for International Cancer Research (AICR), the Italian Health Ministry, Fondazione Cariplo and the Italian Association for Cancer Research (AIRC) to B.A.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; DARZYNKIEWICZ Z, 1980, CYTOMETRY, V1, P98, DOI 10.1002/cyto.990010203; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fan JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009691; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerondakis S, 2007, IMMUNOL CELL BIOL, V85, P471, DOI 10.1038/sj.icb.7100097; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guertin MJ, 2013, CURR OPIN GENET DEV, V23, P116, DOI 10.1016/j.gde.2012.11.008; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murn J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-323; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Perna D, 2012, ONCOGENE, V31, P1695, DOI 10.1038/onc.2011.359; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Sabo A, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014191; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	56	307	316	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					488	+		10.1038/nature13537	http://dx.doi.org/10.1038/nature13537			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043028	Green Accepted			2022-12-24	WOS:000339335700051
J	Conway, TM; John, SG				Conway, Tim M.; John, Seth G.			Quantification of dissolved iron sources to the North Atlantic Ocean	NATURE			English	Article							CONTINENTAL-SHELF; AEROSOL IRON; ISOTOPES; SEAWATER; DUST; FE; CONSTRAINTS; CYCLE; FLUX	Dissolved iron is an essential micronutrient for marine phytoplankton, and its availability controls patterns of primary productivity and carbon cycling throughout the oceans(1,2). The relative importance of different sources of iron to the oceans is not well known, however, and flux estimates from atmospheric dust, hydrothermal vents and oceanic sediments vary by orders of magnitude. Here we present a high-resolution transect of dissolved stable iron isotope ratios (delta Fe-56) and iron concentrations ([Fe]) along a section of the North Atlantic Ocean. The different iron sources can be identified by their unique delta Fe-56 signatures, which persist throughout the water column. This allows us to calculate the relative contribution from dust, hydrothermal venting and reductive and non-reductive sedimentary release to the dissolved phase. We find that Saharan dust aerosol is the dominant source of dissolved iron along the section, contributing 71-87 per cent of dissolved iron. Additional sources of iron are non-reductive release from oxygenated sediments on the North American margin (10-19 per cent), reductive sedimentary dissolution on the African margin (1-4 per cent) and hydrothermal venting at the Mid-Atlantic Ridge (2-6 per cent). Our data also indicate that hydrothermal vents in the North Atlantic are a source of isotopically light iron, which travels thousands of kilometres from vent sites, potentially influencing surface productivity. Changes in the relative importance of the different iron sources through time may affect interactions between the carbon cycle and climate.	[Conway, Tim M.; John, Seth G.] Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Conway, TM (corresponding author), ETH, Inst Geochem & Petrol, NWD81-4,Clausiusstr 25, CH-8092 Zurich, Switzerland.	conway.tm@gmail.com		John, Seth/0000-0002-8257-626X	National Science Foundation [OCE-1131387]	National Science Foundation(National Science Foundation (NSF))	We thank the Captain, crew and GEOTRACES sampling team on RV Knorr on both USGT10 and USGT11; A. Rosenberg for technical assistance; J. Wu, R. Middag, K. Bruland and P. Sedwick for supplying concentration data that informed double-spike calculations; and C. Hayes for calibrating transmissometry data. We thank W. Jenkins, W. Smethie, E. Boyle and G. Cutter for water mass observations. The Ocean Data Facility supplied temperature, PSS-78 salinity, fluorescence, transmissometry, dissolved oxygen and nutrient data from both cruises. Figures were created with Matlab and Adobe Illustrator. This study was funded by National Science Foundation grant OCE-1131387.	Beard BL, 2003, GEOLOGY, V31, P629, DOI 10.1130/0091-7613(2003)031<0629:IICOFC>2.0.CO;2; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Carazzo G, 2013, EARTH PLANET SC LETT, V382, P66, DOI 10.1016/j.epsl.2013.09.008; Conway TM, 2013, ANAL CHIM ACTA, V793, P44, DOI 10.1016/j.aca.2013.07.025; Elrod VA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020216; Fitzsimmons JN, 2013, MAR CHEM, V154, P87, DOI 10.1016/j.marchem.2013.05.009; Homoky WB, 2009, GEOLOGY, V37, P751, DOI 10.1130/G25731A.1; Homoky WB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3143; Ilina SM, 2013, GEOCHIM COSMOCHIM AC, V101, P96, DOI 10.1016/j.gca.2012.10.023; Jeandel C., 2011, EOS, V92, P217, DOI DOI 10.1029/2011E0260001; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; John SG, 2012, GEOCHIM COSMOCHIM AC, V93, P14, DOI 10.1016/j.gca.2012.06.003; John SG, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004043; John SG, 2010, MAR CHEM, V119, P65, DOI 10.1016/j.marchem.2010.01.001; Kohfeld KE, 2009, GEOPHYS MONOGR SER, V187, P251, DOI 10.1029/2008GM000845; Lacan F, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035841; Lacan F, 2010, ANAL CHEM, V82, P7103, DOI 10.1021/ac1002504; Mahowald NM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002402; Mead C, 2013, GEOPHYS RES LETT, V40, P5722, DOI 10.1002/2013GL057713; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; Palter JB, 2005, NATURE, V437, P687, DOI 10.1038/nature03969; Radic A, 2011, EARTH PLANET SC LETT, V306, P1, DOI 10.1016/j.epsl.2011.03.015; Saito MA, 2013, NAT GEOSCI, V6, P775, DOI [10.1038/ngeo1893, 10.1038/NGEO1893]; Severmann S, 2004, EARTH PLANET SC LETT, V225, P63, DOI 10.1016/j.epsl.2004.06.001; Tagliabue A, 2010, NAT GEOSCI, V3, P252, DOI 10.1038/NGEO818; Toner BM, 2012, OCEANOGRAPHY, V25, P209, DOI 10.5670/oceanog.2012.19; Toner BM, 2009, NAT GEOSCI, V2, P197, DOI 10.1038/NGEO433; Waeles M, 2007, ENVIRON CHEM, V4, P233, DOI 10.1071/EN07013	28	240	256	20	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					212	+		10.1038/nature13482	http://dx.doi.org/10.1038/nature13482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008528				2022-12-24	WOS:000338649800041
J	Mayer-Barber, KD; Andrade, BB; Oland, SD; Amaral, EP; Barber, DL; Gonzales, J; Derrick, SC; Shi, RR; Kumar, NP; Wei, W; Yuan, X; Zhang, GL; Cai, Y; Babu, S; Catalfamo, M; Salazar, AM; Via, LE; Barry, CE; Sher, A				Mayer-Barber, Katrin D.; Andrade, Bruno B.; Oland, Sandra D.; Amaral, Eduardo P.; Barber, Daniel L.; Gonzales, Jacqueline; Derrick, Steven C.; Shi, Ruiru; Kumar, Nathella Pavan; Wei, Wang; Yuan, Xing; Zhang, Guolong; Cai, Ying; Babu, Subash; Catalfamo, Marta; Salazar, Andres M.; Via, Laura E.; Barry, Clifton E., III; Sher, Alan			Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; INDUCTION; SUSCEPTIBILITY; INFLAMMATION; INFECTION; IMMUNITY; INNATE	Tuberculosis remains second only to HIV/AIDS as the leading cause of mortality worldwide due to a single infectious agent(1). Despite chemotherapy, the global tuberculosis epidemic has intensified because of HIV co-infection, the lack of an effective vaccine and the emergence of multi-drug-resistant bacteria(2-5). Alternative host-directed strategies could be exploited to improve treatment efficacy and outcome, contain drug-resistant strains and reduce disease severity and mortality(6). The innate inflammatory response elicited by Mycobacterium tuberculosis (Mtb) represents a logical host target(7). Here we demonstrate that interleukin-1 (IL-1) confers host resistance through the induction of eicosanoids that limit excessive type I interferon (IFN) production and foster bacterial containment. We further show that, in infected mice and patients, reduced IL-1 responses and/or excessive type I IFN induction are linked to an eicosanoid imbalance associated with disease exacerbation. Host-directed immunotherapy with clinically approved drugs that augment prostaglandin E2 levels in these settings prevented acute mortality of Mtb-infected mice. Thus, IL-1 and type I IFNs represent two major counter-regulatory classes of inflammatory cytokines that control the outcome of Mtb infection and are functionally linked via eicosanoids. Our findings establish proof of concept for host-directed treatment strategies that manipulate the host eicosanoid network and represent feasible alternatives to conventional chemotherapy.	[Mayer-Barber, Katrin D.; Andrade, Bruno B.; Oland, Sandra D.; Amaral, Eduardo P.; Sher, Alan] NIAID, Immunobiol Sect, LPD, NIH, Bethesda, MD 20892 USA; [Amaral, Eduardo P.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil; [Barber, Daniel L.] NIAID, Lymphocyte Biol Unit T, LPD, NIH, Bethesda, MD 20892 USA; [Gonzales, Jacqueline; Via, Laura E.; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Derrick, Steven C.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Shi, Ruiru; Wei, Wang; Yuan, Xing] Henan Chest Hosp, Zhengzhou 450003, Peoples R China; [Kumar, Nathella Pavan; Babu, Subash] Int Ctr Excellence Res, NIH, Madras 600031, Tamil Nadu, India; [Kumar, Nathella Pavan] NIRT, Madras 600031, Tamil Nadu, India; [Zhang, Guolong] SinoUS Int Res Ctr TB, Zhengzhou 450003, Peoples R China; [Zhang, Guolong] Henan Publ Hlth Ctr, Zhengzhou 450003, Peoples R China; [Babu, Subash] NIAID, Helminth Immunol Sect, LPD, NIH, Bethesda, MD 20892 USA; [Catalfamo, Marta] NIAID, Clin & Mol Retrovirol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC 20008 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mayer-Barber, KD (corresponding author), NIAID, Immunobiol Sect, LPD, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mayerk@niaid.nih.gov	Andrade, Bruno/J-9111-2012; Kumar, Nathella Pavan/AAU-2328-2021; Barry, III, Clifton/H-3839-2012; Andrade, Bruno/AAI-2248-2020; Amaral, Eduardo EP/M-2456-2014; Barry, Clifton E/ABE-7992-2020; Via, Laura/AAD-3917-2021; Babu, Subash/GXG-4746-2022; Zhang, Guolong/HCI-5587-2022	Andrade, Bruno/0000-0001-6833-3811; Barry, III, Clifton/0000-0002-2927-270X; Amaral, Eduardo EP/0000-0001-5465-8113; Barry, Clifton E/0000-0002-2927-270X; Via, Laura/0000-0001-6074-9521; 	NIAID Intramural Research program; Concept Acceleration Program-Award from DMID, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001065, ZIAAI001081, ZIAAI000734, ZIAAI001171, ZIAAI001044, ZIAAI000783] Funding Source: NIH RePORTER	NIAID Intramural Research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Concept Acceleration Program-Award from DMID, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIAID Intramural Research program and a Concept Acceleration Program-Award (K.D.M.-B., B.B.A. and A.S.) from DMID, NIAID. We are grateful to K. Elkins, S. Morris, M. Belcher as well as the NIAID ABSL3 support staff for facilitating our animal studies. We thank R. Chen, L. Goldfeder and Q. Gao for sharing their clinical trial expertise and research facilities, respectively. We also thank K. Kauffman, R. Thompson, S. Hieny, P. Dayal, D. Surman, L. Meng, Z. Li, L. Lifa, Q. Shen and Z. Huang for technical assistance, H. Boshoff for help with direct anti-mycobacterial activity assays and M. S. Jawahar, V. V. Banurekha and R. Sridhar for recruitment and clinical evaluation of patients in Chennai, India. We are grateful to F. Andrade Neto, H. Remold, K. Arora, J. Aliberti, M. Moayeri, P. Murphy, A. O'Garra, R. Germain and C. Serhan for discussion or critical reading of the manuscript. Finally, we thank the patients, volunteer participants, and clinical staff of the Tuberculosis department of Henan Chest Hospital in Zhengzhou, China and the Department of Clinical Research (NIRT) and Department of Thoracic Medicine (Government Stanley Medical Hospital) in Chennai, India for their participation in our clinical studies.	Andrade BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062618; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bishai W, 2013, NAT MED, V19, P410, DOI 10.1038/nm.3153; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Humason G. L., 1979, ANIMAL TISSUE TECHNI, P355; Kaufmann SHE, 2013, CURR OPIN IMMUNOL, V25, P441, DOI 10.1016/j.coi.2013.05.005; Kirtikara K, 1998, J EXP MED, V187, P517, DOI 10.1084/jem.187.4.517; Kuo HP, 2000, AM J RESP CRIT CARE, V161, P192, DOI 10.1164/ajrccm.161.1.9902113; Law K, 1996, AM J RESP CRIT CARE, V153, P799, DOI 10.1164/ajrccm.153.2.8564135; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Nathan C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003081; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Redford PS, 2014, J INFECT DIS, V209, P270, DOI 10.1093/infdis/jit424; Rousu J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003018; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Tsao T.C.Y., 1999, Tubercle and Lung Disease, V79, P279, DOI 10.1054/tuld.1999.0215; Wang C H, 2001, Respirology, V6, P79	32	480	495	1	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					99	U491		10.1038/nature13489	http://dx.doi.org/10.1038/nature13489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990750	Green Accepted, Green Published			2022-12-24	WOS:000338199400044
J	Suh, JM; Jonker, JW; Ahmadian, M; Goetz, R; Lackey, D; Osborn, O; Huang, ZF; Liu, WL; Yoshihara, E; van Dijk, TH; Havinga, R; Fan, WW; Yin, YQ; Yu, RT; Liddle, C; Atkins, AR; Olefsky, JM; Mohammadi, M; Downes, M; Evans, RM				Suh, Jae Myoung; Jonker, Johan W.; Ahmadian, Maryam; Goetz, Regina; Lackey, Denise; Osborn, Olivia; Huang, Zhifeng; Liu, Weilin; Yoshihara, Eiji; van Dijk, Theo H.; Havinga, Rick; Fan, Weiwei; Yin, Yun-Qiang; Yu, Ruth T.; Liddle, Christopher; Atkins, Annette R.; Olefsky, Jerrold M.; Mohammadi, Moosa; Downes, Michael; Evans, Ronald M.			Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer	NATURE			English	Article							GROWTH-FACTOR-I; PPAR-GAMMA-FGF1 AXIS; PPAR-GAMMA; FIBROBLAST; HOMEOSTASIS; MICE; SUPPRESSION; METABOLISM; RATS	Fibroblast growth factor 1 (FGF1) is an autocrine/paracrine regulator whose binding to heparan sulphate proteoglycans effectively precludes its circulation(1,2). Although FGF1 is known as a mitogenic factor, FGF1 knockout mice develop insulin resistance when stressed by a high-fat diet, suggesting a potential role in nutrient homeostasis(3,4). Here we show that parenteral delivery of a single dose of recombinant FGF1(rFGF1) results in potent, insulin-dependent lowering of glucose levels in diabetic mice that is dose-dependent but does not lead to hypoglycaemia. Chronic pharmacological treatment with rFGF1 increases insulin-dependent glucose uptake in skeletal muscle and suppresses the hepatic production of glucose to achieve whole-body insulin sensitization. The sustained glucose lowering and insulin sensitization attributed to rFGF1 are not accompanied by the side effects of weight gain, liver steatosis and bone loss associated with current insulin-sensitizing therapies. We also show that the glucose-lowering activity of FGF1 can be dissociated from its mitogenic activity and is mediated predominantly via FGF receptor 1 signalling. Thus we have uncovered an unexpected, neomorphic insulin-sensitizing action for exogenous non-mitogenic human FGF1 with therapeutic potential for the treatment of insulin resistance and type 2 diabetes.	[Suh, Jae Myoung; Ahmadian, Maryam; Yoshihara, Eiji; Fan, Weiwei; Yin, Yun-Qiang; Yu, Ruth T.; Atkins, Annette R.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Jonker, Johan W.; Liu, Weilin; van Dijk, Theo H.; Havinga, Rick] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9713 GZ Groningen, Netherlands; [Jonker, Johan W.; Liu, Weilin; van Dijk, Theo H.; Havinga, Rick] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Lab Med, NL-9713 GZ Groningen, Netherlands; [Goetz, Regina; Huang, Zhifeng; Mohammadi, Moosa] New York Univ Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Lackey, Denise; Osborn, Olivia; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Liddle, Christopher] Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of Groningen; University of Groningen; New York University; University of California System; University of California San Diego; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	downes@salk.edu; evans@salk.edu	kasaei, fahime/T-7197-2018; Evans, Ronald/AAF-4001-2019; Mohammadi, Moosa/ABA-6745-2020; osborn, olivia/R-1460-2018; Suh, Jae Myoung/B-3268-2015; Jonker, Johan W./ABE-6853-2020; Goetz, Regina/M-2411-2019; Frank, Viki/GXZ-9902-2022	Evans, Ronald/0000-0002-9986-5965; Mohammadi, Moosa/0000-0003-2434-9437; osborn, olivia/0000-0003-0516-7937; Suh, Jae Myoung/0000-0001-8097-4662; Jonker, Johan W./0000-0002-3919-5437; Goetz, Regina/0000-0003-3681-4703; Yu, Ruth/0000-0002-9527-9627; Yoshihara, Eiji/0000-0001-6324-6495; Atkins, Annette/0000-0003-2558-7058	National Institutes of Health (NIH) [DK057978, DK090962, HL088093, HL105278, ES010337]; Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure; California Institute for Regenerative Medicine; The Ellison Medical Foundation; National Health and Medical Research Council [512354, 632886, 1043199]; European Research Council [IRG-277169]; Human Frontier Science Program [CDA00013/2011-C]; Netherlands Organisation for Scientific Research (VIDI grant) [016.126.338]; Dutch Digestive Foundation [WO 11-67]; Dutch Diabetes Foundation [2012.00.1537]; NIH [DK-033651, DK-074868, T32-DK-007494, DK-063491, P01-DK054441-14A1]; Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH [U54-HD-012303-25]; National Institute of Dental and Craniofacial Research [DE13686]; F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093, R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, T32DK007494, R37DK057978, R01DK033651, P01DK054441, P30DK063491, R24DK090962, P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure(Ipsen); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); The Ellison Medical Foundation(Lawrence Ellison Foundation); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); Netherlands Organisation for Scientific Research (VIDI grant); Dutch Digestive Foundation; Dutch Diabetes Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank L. Chong, J. Alvarez, S. Kaufman, B. Collins, X. Zhao, S. Liu, A. Jurdzinski, A. Bleeker, K. Bijsterveld, D. Oh and G. Bandyopadhyay for technical assistance, and L. Ong and C. Brondos for administrative assistance. Computed tomography was performed at the Veterans Medical Research Foundation. R. M. E. is a Howard Hughes Medical Institute Investigator at the Salk Institute and March of Dimes Chair, and is supported by National Institutes of Health (NIH) grants (DK057978, DK090962, HL088093, HL105278 and ES010337), the Glenn Foundation for Medical Research, the Leona M. and Harry B. Helmsley Charitable Trust, Ipsen/Biomeasure, the California Institute for Regenerative Medicine and The Ellison Medical Foundation. C. L. and M. D. are funded by the National Health and Medical Research Council (grants 512354, 632886 and 1043199); J. W. J. by the European Research Council (grant IRG-277169), the Human Frontier Science Program (CDA00013/2011-C), the Netherlands Organisation for Scientific Research (VIDI grant 016.126.338), the Dutch Digestive Foundation (grant WO 11-67) and the Dutch Diabetes Foundation (grant 2012.00.1537); J.M.O. by NIH grants (DK-033651, DK-074868, T32-DK-007494, DK-063491 and P01-DK054441-14A1) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH through cooperative agreement of U54-HD-012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research; M. M. by the National Institute of Dental and Craniofacial Research grant (DE13686); and M.A. by an F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases).	Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Lee J, 2009, J MOL BIOL, V393, P113, DOI 10.1016/j.jmb.2009.08.026; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li AJ, 1998, NEUROSCI LETT, V255, P41, DOI 10.1016/S0304-3940(98)00701-0; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; SASAKI K, 1994, PHYSIOL BEHAV, V56, P211, DOI 10.1016/0031-9384(94)90186-4; Sun K, 2012, CELL RES, V22, P1416, DOI 10.1038/cr.2012.94; Suzuki S, 2001, EUR J NEUROSCI, V13, P2299, DOI 10.1046/j.0953-816x.2001.01606.x; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Zinn KR, 2000, NUCL MED BIOL, V27, P407, DOI 10.1016/S0969-8051(00)00090-1	18	157	188	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					436	+		10.1038/nature13540	http://dx.doi.org/10.1038/nature13540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043058	Green Accepted			2022-12-24	WOS:000341814900064
J	Cox, LM; Yamanishi, S; Sohn, J; Alekseyenko, AV; Leung, JM; Cho, I; Kim, SG; Li, H; Gao, Z; Mahana, D; Rodriguez, JGZ; Rogers, AB; Robine, N; Loke, P; Blaser, MJ				Cox, Laura M.; Yamanishi, Shingo; Sohn, Jiho; Alekseyenko, Alexander V.; Leung, Jacqueline M.; Cho, Ilseung; Kim, Sungheon G.; Li, Huilin; Gao, Zhan; Mahana, Douglas; Rodriguez, Jorge G. Zarate; Rogers, Arlin B.; Robine, Nicolas; Loke, P'ng; Blaser, Martin J.			Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences	CELL			English	Article							DIET-INDUCED OBESITY; GUT MICROBIOTA; INDIGENOUS MICROBES; DELIVERY MODE; WEIGHT-GAIN; MICE; ANTIBIOTICS; FAT; ADIPOSITY; CHILDHOOD	Acquisition of the intestinal microbiota begins at birth, and a stable microbial community develops from a succession of key organisms. Disruption of the microbiota during maturation by low-dose antibiotic exposure can alter host metabolism and adiposity. We now show that low-dose penicillin (LDP), delivered from birth, induces metabolic alterations and affects ileal expression of genes involved in immunity. LDP that is limited to early life transiently perturbs the microbiota, which is sufficient to induce sustained effects on body composition, indicating that microbiota interactions in infancy may be critical determinants of long-term host metabolic effects. In addition, LDP enhances the effect of high-fat diet induced obesity. The growth promotion phenotype is transferrable to germ-free hosts by LDP-selected microbiota, showing that the altered microbiota, not antibiotics per se, play a causal role. These studies characterize important variables in early-life microbe-host metabolic interaction and identify several taxa consistently linked with metabolic alterations.	[Cox, Laura M.; Leung, Jacqueline M.; Mahana, Douglas; Loke, P'ng; Blaser, Martin J.] NYU, Langone Med Ctr, Dept Microbiol, New York, NY 10016 USA; [Cox, Laura M.; Yamanishi, Shingo; Sohn, Jiho; Alekseyenko, Alexander V.; Cho, Ilseung; Gao, Zhan; Blaser, Martin J.] NYU, Langone Med Ctr, Dept Med, New York, NY 10016 USA; [Alekseyenko, Alexander V.] NYU, Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Kim, Sungheon G.] NYU, Langone Med Ctr, Dept Radiol, New York, NY 10016 USA; [Li, Huilin] NYU, Langone Med Ctr, Dept Populat Hlth Biostatist, New York, NY 10016 USA; [Li, Huilin] NYU, Langone Med Ctr, Dept Environm Med, New York, NY 10016 USA; [Rogers, Arlin B.] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA; [Rodriguez, Jorge G. Zarate] NYU, Dept Biol, Abu Dhabi, U Arab Emirates; [Robine, Nicolas] New York Genome Ctr, New York, NY 10013 USA; [Blaser, Martin J.] Vet Affairs Med Ctr, New York Harbor Dept, New York, NY 10010 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Tufts University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Blaser, MJ (corresponding author), NYU, Langone Med Ctr, Dept Microbiol, New York, NY 10016 USA.	martin.blaser@nyumc.org	Loke, Png/X-2278-2019; Blaser, Martin/ABF-6878-2021; Cox, Laura/ABG-5883-2020; Zarate, Jorge/GLR-3294-2022	Cox, Laura/0000-0002-9564-9894; Zarate, Jorge/0000-0002-6790-7729; Li, Huilin/0000-0002-8288-7068; Kim, S. Gene/0000-0002-6288-0678; Robine, Nicolas/0000-0001-5698-8183; Gao, Zhan/0000-0003-0976-8836; Alekseyenko, Alexander/0000-0002-5748-2085; Cho, Ilseung/0000-0002-7308-8707; Leung, Jacqueline/0000-0002-1963-3380; Sohn, Jiho/0000-0001-6728-136X	NIH [R01 DK 090989, 1UL1RR029893]; Diane Belfer Program in Human Microbial Ecology; Knapp Family Foundation; Daniel Ziff Foundation; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diane Belfer Program in Human Microbial Ecology; Knapp Family Foundation; Daniel Ziff Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge assistance with sequencing from Argonne National Laboratory and NYULMC Genome Technology Center and help from the NYULMC Histology Core and the New York Genome Center. These studies were supported by NIH grants R01 DK 090989 and 1UL1RR029893, the Diane Belfer Program in Human Microbial Ecology, Knapp Family Foundation, and Daniel Ziff Foundation.	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Anders S., 2014, HTSEQ PYTHON FRAMEWO; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 1849, P NATL ACAD SCI PHIL; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Antunes LCM, 2011, GUT MICROBES, V2, P105, DOI 10.4161/gmic.2.2.15610; Beijerinck MW., 1901, ARCH NEERLANDAISES S, V6, P212; Blaser MJ, 2006, EMBO REP, V7, P956, DOI 10.1038/sj.embor.7400812; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Blustein J, 2013, INT J OBESITY, V37, P900, DOI 10.1038/ijo.2013.49; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Clavenna A, 2011, ARCH DIS CHILD, V96, P590, DOI 10.1136/adc.2010.183541; COATES ME, 1963, BRIT J NUTR, V17, P141, DOI 10.1079/BJN19630015; COLLINS MD, 1985, SYST APPL MICROBIOL, V6, P79, DOI 10.1016/S0723-2020(85)80015-1; Cox LM, 2013, CELL METAB, V17, P883, DOI 10.1016/j.cmet.2013.05.004; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; DAVIS CP, 1976, INFECT IMMUN, V13, P180, DOI 10.1128/IAI.13.1.180-188.1976; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; DUBOS R, 1963, J EXP MED, V117, P245, DOI 10.1084/jem.117.2.245; Erturk-Hasdemir D, 2013, CURR OPIN IMMUNOL, V25, P450, DOI 10.1016/j.coi.2013.06.001; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gaskins HR, 2002, ANIM BIOTECHNOL, V13, P29, DOI 10.1081/ABIO-120005768; Goyal A., 2012, GLOBAL J MED RES, V12, P39; Greetham HL, 2004, ANAEROBE, V10, P301, DOI 10.1016/j.anaerobe.2004.06.004; Grudell April B M, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P52, DOI 10.1097/MED.0b013e3280123119; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jiang HQ, 2001, INFECT IMMUN, V69, P3611, DOI 10.1128/IAI.69.6.3611-3617.2001; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Karlsson CLJ, 2011, BRIT J NUTR, V106, P887, DOI 10.1017/S0007114511001036; KNITTLE JL, 1968, J CLIN INVEST, V47, P2091, DOI 10.1172/JCI105894; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P409, DOI 10.1016/j.bbadis.2008.09.005; Murphy R, 2013, INT J OBES LOND; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Pettersson US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046057; Rasouli N, 2007, DIABETES OBES METAB, V9, P1, DOI 10.1111/j.1463-1326.2006.00590.x; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Reeder SB, 2004, MAGNET RESON MED, V51, P35, DOI 10.1002/mrm.10675; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; SCHAEDLER RW, 1965, J EXP MED, V122, P59, DOI 10.1084/jem.122.1.59; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; VISEK WJ, 1978, J ANIM SCI, V46, P1447, DOI 10.2527/jas1978.4651447x; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	70	1109	1179	22	317	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					705	721		10.1016/j.cell.2014.05.052	http://dx.doi.org/10.1016/j.cell.2014.05.052			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126780	Green Accepted, Bronze			2022-12-24	WOS:000340944700005
J	Merolla, PA; Arthur, JV; Alvarez-Icaza, R; Cassidy, AS; Sawada, J; Akopyan, F; Jackson, BL; Imam, N; Guo, C; Nakamura, Y; Brezzo, B; Vo, I; Esser, SK; Appuswamy, R; Taba, B; Amir, A; Flickner, MD; Risk, WP; Manohar, R; Modha, DS				Merolla, Paul A.; Arthur, John V.; Alvarez-Icaza, Rodrigo; Cassidy, Andrew S.; Sawada, Jun; Akopyan, Filipp; Jackson, Bryan L.; Imam, Nabil; Guo, Chen; Nakamura, Yutaka; Brezzo, Bernard; Vo, Ivan; Esser, Steven K.; Appuswamy, Rathinakumar; Taba, Brian; Amir, Arnon; Flickner, Myron D.; Risk, William P.; Manohar, Rajit; Modha, Dharmendra S.			A million spiking-neuron integrated circuit with a scalable communication network and interface	SCIENCE			English	Article							ARCHITECTURE	Inspired by the brain's structure, we have developed an efficient, scalable, and flexible non-von Neumann architecture that leverages contemporary silicon technology. To demonstrate, we built a 5.4-billion-transistor chip with 4096 neurosynaptic cores interconnected via an intrachip network that integrates 1 million programmable spiking neurons and 256 million configurable synapses. Chips can be tiled in two dimensions via an interchip communication interface, seamlessly scaling the architecture to a cortexlike sheet of arbitrary size. The architecture is well suited to many applications that use complex neural networks in real time, for example, multiobject detection and classification. With 400-pixel-by-240-pixel video input at 30 frames per second, the chip consumes 63 milliwatts.	[Merolla, Paul A.; Arthur, John V.; Alvarez-Icaza, Rodrigo; Cassidy, Andrew S.; Akopyan, Filipp; Jackson, Bryan L.; Esser, Steven K.; Appuswamy, Rathinakumar; Taba, Brian; Amir, Arnon; Flickner, Myron D.; Risk, William P.; Modha, Dharmendra S.] IBM Res Almaden, San Jose, CA 95120 USA; [Sawada, Jun; Vo, Ivan] IBM Res Austin, Austin, TX 78758 USA; [Imam, Nabil] Cornell Univ, Ithaca, NY 14853 USA; [Guo, Chen] IBM Engn & Technol Serv, San Jose Design Ctr, San Jose, CA 95120 USA; [Nakamura, Yutaka] IBM Res Tokyo, Koto Ku, Tokyo 1358511, Japan; [Brezzo, Bernard] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Manohar, Rajit] Cornell Tech, New York, NY 10011 USA	International Business Machines (IBM); Cornell University; International Business Machines (IBM); International Business Machines (IBM)	Modha, DS (corresponding author), IBM Res Almaden, 650 Harry Rd, San Jose, CA 95120 USA.	dmodha@us.ibm.com		Alvarez-Icaza, Rodrigo/0000-0002-5737-3719	Defense Advanced Research Projects Agency (DARPA) [HR0011-09-C-0002]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This research was sponsored by Defense Advanced Research Projects Agency (DARPA) under contract no. HR0011-09-C-0002. The views and conclusions contained herein are those of the authors and should not be interpreted as representing the official policies, either expressly or implied, of DARPA or the U.S. Government. U.S. patents 8473439 and 8515885 and U.S. patent applications 13/235,341 and 13/434,733 pertain to aspects of this work. We are grateful to many collaborators: A. Agrawal, A. Andreopoulos, S. Asaad, C. Baks, D. Barch, M Beakes, R. Bellofatto, D. Berg, J. Bong, T. Christensen, A. Cox, P. Datta, D. Friedman, S. Gilson, J. Guan, S. Hall, R. Haring, C. Haymes, J. Ho, S. Iyer, J. Krawiecki, J. Kusnitz, J. Liu, J. B. Kuang, E. McQuinn, R. Mousalli, B. Nathanson, T. Nayak, D. Nguyen, H. Nguyen, T. Nguyen, N. Pass, K. Prasad, M. Ohmacht, C. Ortega-Otero, Z. Saliba, D. L. Satterfield, J.-s. Seo, B. Shaw, K. Shimohashi, K. Shiraishi, A. Shokoubakhsh, R. Singh, T. Takken, F. Tsai, J. Tierno, K. Wecker, S.-y. Wang, and T. Wong. We thank two anonymous reviewers for their thoughtful comments.	[Anonymous], INT JOINT C NEUR NET; [Anonymous], 2013, INT JT C NEURAL NETW, DOI DOI 10.1109/IJCNN.2013.6707077; [Anonymous], THESIS PRINCETON U P; [Anonymous], 1994, SPRINGER INT SERIES; [Anonymous], 2011, DIGITAL NEUROSYNAPTI; [Anonymous], CUST INT CIRC C CICC; [Anonymous], 2013, P 2013 INT JOINT C N, DOI DOI 10.1109/IJCNN.2013.6706927; BACKUS J, 1978, COMMUN ACM, V21, P613, DOI 10.1145/359576.359579; Benjamin B, 2014, P IEEE, V102, P699, DOI 10.1109/JPROC.2014.2313565; Churchland PS, 2017, COMPUT NEUROSCI-MIT; Dally WJ, 2001, DES AUT CON, P684, DOI 10.1109/DAC.2001.935594; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Indiveri G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00073; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Liu SC, 2010, CURR OPIN NEUROBIOL, V20, P288, DOI 10.1016/j.conb.2010.03.007; MAHOWALD M, 1991, NATURE, V354, P515, DOI 10.1038/354515a0; Mead C.A., 1989, ANALOG VLSI NEURAL S; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Modha DS, 2010, P NATL ACAD SCI USA, V107, P13485, DOI 10.1073/pnas.1008054107; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Ohno T, 2011, NAT MATER, V10, P591, DOI [10.1038/NMAT3054, 10.1038/nmat3054]; Preissl R, 2012, INT CONF HIGH PERFOR; Schemmel Johannes, 2012, 2012 IEEE International Symposium on Circuits and Systems - ISCAS 2012, DOI 10.1109/ISCAS.2012.6272131; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Teifel J, 2004, INT SYMP ASYNCHRON C, P17, DOI 10.1109/ASYNC.2004.1299284; Von Neumann J., 2012, COMPUTER BRAIN; Yu T, 2012, BIOMED CIRC SYST C, P21, DOI 10.1109/BioCAS.2012.6418479	30	2109	2177	72	715	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					668	673		10.1126/science.1254642	http://dx.doi.org/10.1126/science.1254642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104385				2022-12-24	WOS:000339962800038
J	Chung, WH; Chang, WC; Lee, YS; Wu, YY; Yang, CH; Ho, HC; Chen, MJ; Lin, JY; Hui, RCY; Ho, JC; Wu, WM; Chen, TJ; Wu, T; Wu, YR; Hsih, MS; Tu, PH; Chang, CN; Hsu, CN; Wu, TL; Choon, SE; Hsu, CK; Chen, DY; Liu, CS; Lin, CY; Kaniwa, N; Saito, Y; Takahashi, Y; Nakamura, R; Azukizawa, H; Shi, YY; Wang, TH; Chuang, SS; Tsai, SF; Chang, CJ; Chang, YS; Hung, SI				Chung, Wen-Hung; Chang, Wan-Chun; Lee, Yun-Shien; Wu, Ying-Ying; Yang, Chih-Hsun; Ho, Hsin-Chun; Chen, Ming-Jing; Lin, Jing-Yi; Hui, Rosaline Chung-Yee; Ho, Ji-Chen; Wu, Wei-Ming; Chen, Ting-Jui; Wu, Tony; Wu, Yih-Ru; Hsih, Mo-Song; Tu, Po-Hsun; Chang, Chen-Nen; Hsu, Chien-Ning; Wu, Tsu-Lan; Choon, Siew-Eng; Hsu, Chao-Kai; Chen, Der-Yuan; Liu, Chin-San; Lin, Ching-Yuang; Kaniwa, Nahoko; Saito, Yoshiro; Takahashi, Yukitoshi; Nakamura, Ryosuke; Azukizawa, Hiroaki; Shi, Yongyong; Wang, Tzu-Hao; Chuang, Shiow-Shuh; Tsai, Shih-Feng; Chang, Chee-Jen; Chang, Yu-Sun; Hung, Shuen-Iu		Taiwan Severe Cutaneous Adverse; Japan Pharmacogenomics Data Sci	Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; INDUCED HYPERSENSITIVITY REACTIONS; DRUG-REACTIONS; ANTIEPILEPTIC DRUGS; HAN CHINESE; HLA-B-ASTERISK-1502 ALLELE; RISK-FACTOR; HLA-B; CARBAMAZEPINE	IMPORTANCE The antiepileptic drug phenytoin can cause cutaneous adverse reactions, ranging from maculopapular exanthema to severe cutaneous adverse reactions, which include drug reactions with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, and toxic epidermal necrolysis. The pharmacogenomic basis of phenytoin-related severe cutaneous adverse reactions remains unknown. OBJECTIVE To investigate the genetic factors associated with phenytoin-related severe cutaneous adverse reactions. DESIGN, SETTING, AND PARTICIPANTS Case-control study conducted in 2002-2014 among 105 cases with phenytoin-related severe cutaneous adverse reactions (n=61 Stevens-Johnson syndrome/toxic epidermal necrolysis and n=44 drug reactions with eosinophilia and systemic symptoms), 78 cases with maculopapular exanthema, 130 phenytoin-tolerant control participants, and 3655 population controls from Taiwan, Japan, and Malaysia. A genome-wide association study (GWAS), direct sequencing of the associated loci, and replication analysis were conducted using the samples from Taiwan. The initial GWAS included samples of 60 cases with phenytoin-related severe cutaneous adverse reactions and 412 population controls from Taiwan. The results were validated in (1) 30 cases with severe cutaneous adverse reactions and 130 phenytoin-tolerant controls from Taiwan, (2) 9 patients with Stevens-Johnson syndrome/toxic epidermal necrolysis and 2869 population controls from Japan, and (3) 6 cases and 374 population controls from Malaysia. MAIN OUTCOMES AND MEASURES Specific genetic factors associated with phenytoin-related severe cutaneous adverse reactions. RESULTS The GWAS discovered a cluster of 16 single-nucleotide polymorphisms in CYP2C genes at 10q23.33 that reached genome-wide significance. Direct sequencing of CYP2C identified missense variant rs1057910 (CYP2C9*3) that showed significant association with phenytoin-related severe cutaneous adverse reactions (odds ratio, 12; 95% CI, 6.6-20; P=1.1 x 10-1). The statistically significant association between CYP2C9*3 and phenytoin-related severe cutaneous adverse reactions was observed in additional samples from Taiwan, Japan, and Malaysia. Ameta-analysis using the data from the 3 populations showed an overall odds ratio of 11 (95% CI, 6.2-18; z=8.58; P < .00001) for CYP2C9* 3 association with phenytoin-related severe cutaneous adverse reactions. Delayed clearance of plasma phenytoin was detected in patients with severe cutaneous adverse reactions, especially CYP2C9* 3 carriers, providing a functional link of the associated variants to the disease. CONCLUSIONS AND RELEVANCE This study identified CYP2C variants, including CYP2C9* 3, known to reduce drug clearance, as important genetic factors associated with phenytoin-related severe cutaneous adverse reactions.	[Chung, Wen-Hung; Ho, Hsin-Chun; Lin, Jing-Yi] Chang Gung Mem Hosp, Dept Dermatol, Keelung, Taiwan; [Chung, Wen-Hung; Yang, Chih-Hsun; Chen, Ming-Jing; Hui, Rosaline Chung-Yee] Chang Gung Mem Hosp, Dept Dermatol, Drug Hypersensit Clin & Res Ctr, Linkou, Taiwan; [Chung, Wen-Hung; Yang, Chih-Hsun; Ho, Hsin-Chun; Chen, Ming-Jing; Lin, Jing-Yi; Hui, Rosaline Chung-Yee; Ho, Ji-Chen; Wu, Wei-Ming; Wu, Tony; Wu, Yih-Ru; Hsih, Mo-Song; Tu, Po-Hsun; Chang, Chen-Nen; Hsu, Chien-Ning; Wu, Tsu-Lan; Wang, Tzu-Hao; Chuang, Shiow-Shuh; Chang, Chee-Jen] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chang, Wan-Chun; Wu, Ying-Ying; Chen, Ting-Jui; Hung, Shuen-Iu] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei 112, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Ho, Hsin-Chun; Wu, Wei-Ming] Chang Gung Mem Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Chen, Ting-Jui] Taipei Med Univ, Wan Fang Hosp, Dept Dermatol, Taipei, Taiwan; [Wu, Tony; Wu, Yih-Ru; Hsih, Mo-Song] Chang Gung Mem Hosp, Dept Neurol, Linkou, Taiwan; [Tu, Po-Hsun; Chang, Chen-Nen] Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan; [Hsu, Chien-Ning] Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan; [Wu, Tsu-Lan] Chang Gung Mem Hosp, Dept Lab Med, Linkou, Taiwan; [Choon, Siew-Eng] Hosp Sultanah Aminah Johor Bahru, Dept Dermatol, Johor Baharu, Malaysia; [Hsu, Chao-Kai] Natl Cheng Kung Univ, Coll Med, Dept Dermatol, Tainan 70101, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Rheumatol, Taichung, Taiwan; [Liu, Chin-San] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Lin, Ching-Yuang] China Med Univ, Dept Pediat, Taichung, Taiwan; [Kaniwa, Nahoko; Saito, Yoshiro; Nakamura, Ryosuke] Natl Inst Hlth Sci, Div Med Safety Sci, Tokyo, Japan; [Takahashi, Yukitoshi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Dept Clin Res, Shizuoka, Japan; [Azukizawa, Hiroaki] Osaka Univ, Grad Sch Med, Course Integrated Med, Dept Dermatol, Suita, Osaka, Japan; [Shi, Yongyong] Shanghai Genome Pilot Inst Genom & Human Hlth, Shanghai, Peoples R China; [Wang, Tzu-Hao] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Linkou, Taiwan; [Wang, Tzu-Hao] Chang Gung Mem Hosp, Genom Med Res Core Lab, Linkou, Taiwan; [Chuang, Shiow-Shuh] Chang Gung Mem Hosp, Dept Plast Surg, Linkou, Taiwan; [Chuang, Shiow-Shuh] Chang Gung Mem Hosp, Burn Ctr, Linkou, Taiwan; [Tsai, Shih-Feng] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan; [Chang, Chee-Jen] Chang Gung Mem Hosp, Biostat Ctr Clin Res, Linkou, Taiwan; [Chang, Yu-Sun] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Ming Chuan University; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Cheng Kung University; Taichung Veterans General Hospital; Changhua Christian Hospital; China Medical University Taiwan; National Institute of Health Sciences - Japan; Osaka University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University	Chung, WH (corresponding author), Chang Gung Mem Hosp, Dept Dermatol, 5 Fusing St, Taoyuan 333, Taiwan.	chung1@cgmh.org.tw; sihung@ym.edu.tw	Hsu, Chien-Ning/GLS-4014-2022; Shi, Yongyong/GSO-1627-2022; CHOON, SIEW ENG/AAU-8192-2021; Hung, Shuen-Iu/ABB-2139-2021; Chang, Wan-Chun/AAG-3728-2020; Tsai, Shih-Feng/E-3997-2010; Hung, Shuen-Iu/HHS-9012-2022	Hsu, Chien-Ning/0000-0001-7470-528X; Shi, Yongyong/0000-0003-1710-1505; CHOON, SIEW ENG/0000-0002-7796-5746; Hung, Shuen-Iu/0000-0001-6531-5538; Chang, Wan-Chun/0000-0001-7069-7083; Takahashi, Yukitoshi/0000-0002-1922-8967; Chang, Yu-Sun/0000-0002-6457-3890; Hsu, Chao-Kai/0000-0003-4365-4533; Chang, Chee Jen/0000-0002-7725-7555	National Science Council, Taiwan [NSC101-2320-B-010-072-MY3, NSC101-2321-B-010-027, NSC101-2628-B-182-001-MY3, NSC101-2321-B-182008, NSC102-2314-B-010-014-MY3]; National Core Facility Program for Biotechnology (Bioinformatics Consortium of Taiwan [NSC100-2319-B-010-002]; Chang Gung Memorial Hospital [OMRPG-2C0011, OMRPG-2C0021, CMRPG-290051-3, CMRPG-3D0351]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Core Facility Program for Biotechnology (Bioinformatics Consortium of Taiwan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the National Science Council, Taiwan (grants NSC101-2320-B-010-072-MY3, NSC101-2321-B-010-027, NSC101-2628-B-182-001-MY3, NSC101-2321-B-182008, and NSC102-2314-B-010-014-MY3), the National Core Facility Program for Biotechnology (Bioinformatics Consortium of Taiwan; grant NSC100-2319-B-010-002) for statistical assistance, and Chang Gung Memorial Hospital (grants OMRPG-2C0011, OMRPG-2C0021, CMRPG-290051-3, and CMRPG-3D0351).	Arif H, 2007, NEUROLOGY, V68, P1701, DOI 10.1212/01.wnl.0000261917.83337.db; Cheung YK, 2013, EPILEPSIA, V54, P1307, DOI 10.1111/epi.12217; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Depondt C, 2011, EUR J NEUROL, V18, P1159, DOI 10.1111/j.1468-1331.2011.03361.x; Fields MC, 2013, JAMA NEUROL, V70, P360, DOI 10.1001/2013.jamaneurol.337; Goldstein JA, 2001, BRIT J CLIN PHARMACO, V52, P349, DOI 10.1046/j.0306-5251.2001.01499.x; HANDE KR, 1984, AM J MED, V76, P47, DOI 10.1016/0002-9343(84)90743-5; Hu FY, 2011, SEIZURE-EUR J EPILEP, V20, P431, DOI 10.1016/j.seizure.2011.01.005; Hung SI, 2010, PHARMACOGENOMICS, V11, P349, DOI 10.2217/PGS.09.162; Hung SL, 2006, PHARMACOGENET GENOM, V16, P297, DOI 10.1097/01.fpc.0000199500.46842.4a; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Kardaun SH, 2007, BRIT J DERMATOL, V156, P609, DOI 10.1111/j.1365-2133.2006.07704.x; Kesavan R, 2010, EUR J CLIN PHARMACOL, V66, P689, DOI 10.1007/s00228-010-0817-2; Knowles SR, 2012, EXPERT OPIN DRUG SAF, V11, P767, DOI 10.1517/14740338.2012.705828; Ko TM, 2011, J ALLERGY CLIN IMMUN, V128, P1266, DOI 10.1016/j.jaci.2011.08.013; Komatsu T, 2000, DRUG METAB DISPOS, V28, P1361; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P2845, DOI 10.1001/jama.2008.890; Lee AY, 2004, EUR J CLIN PHARMACOL, V60, P155, DOI 10.1007/s00228-004-0753-0; Locharernkul C, 2008, EPILEPSIA, V49, P2087, DOI 10.1111/j.1528-1167.2008.01719.x; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Man CBL, 2007, EPILEPSIA, V48, P1015, DOI 10.1111/j.1528-1167.2007.01022.x; McCormack M, 2012, PHARMACOGENOMICS, V13, P399, DOI [10.2217/PGS.11.165, 10.2217/pgs.11.165]; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; McCorry D, 2004, LANCET NEUROL, V3, P729, DOI 10.1016/S1474-4422(04)00935-4; Mockenhaupt M, 2005, NEUROLOGY, V64, P1134, DOI 10.1212/01.WNL.0000156354.20227.F0; Nakamoto K, 2007, PHARMACOGENET GENOM, V17, P103, DOI 10.1097/FPC.0b013e32801152c2; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Ngow HA, 2009, SINGAP MED J, V50, P490; Niinuma Y, 2014, PHARMACOGENOMICS J, V14, P107, DOI 10.1038/tpj.2013.22; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Sassolas B, 2010, CLIN PHARMACOL THER, V88, P60, DOI 10.1038/clpt.2009.252; Stamp LK, 2012, ARTHRITIS RHEUM-US, V64, P2529, DOI 10.1002/art.34488; Takanashi K, 2000, PHARMACOGENETICS, V10, P95, DOI 10.1097/00008571-200003000-00001; Thorn CF, 2012, PHARMACOGENET GENOM, V22, P466, DOI 10.1097/FPC.0b013e32834aeedb; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Wei CY, 2012, J ALLERGY CLIN IMMUN, V129, P1562, DOI 10.1016/j.jaci.2011.12.990; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Yang CY, 2011, NEUROLOGY, V77, P2025, DOI 10.1212/WNL.0b013e31823b478c; Yun J, 2013, CLIN EXP ALLERGY, V43, P1246, DOI 10.1111/cea.12184	40	185	191	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					525	534		10.1001/jama.2014.7859	http://dx.doi.org/10.1001/jama.2014.7859			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	25096692	Bronze			2022-12-24	WOS:000339808600021
J	Morris, S; Hunter, RM; Ramsay, AIG; Boaden, R; McKevitt, C; Perry, C; Pursani, N; Rudd, AG; Schwamm, LH; Turner, SJ; Tyrrell, PJ; Wolfe, CDA; Fulop, NJ				Morris, Stephen; Hunter, Rachael M.; Ramsay, Angus I. G.; Boaden, Ruth; McKevitt, Christopher; Perry, Catherine; Pursani, Nanik; Rudd, Anthony G.; Schwamm, Lee H.; Turner, Simon J.; Tyrrell, Pippa J.; Wolfe, Charles D. A.; Fulop, Naomi J.			Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE ISCHEMIC-STROKE; UNIT CARE; IMPLEMENTATION; PERFORMANCE; ENGLAND; MODELS	Objective To investigate whether centralisation of acute stroke services in two metropolitan areas of England was associated with changes in mortality and length of hospital stay. Design Analysis of difference-in-differences between regions with patient level data from the hospital episode statistics database linked to mortality data supplied by the Office for National Statistics. Setting Acute stroke services in Greater Manchester and London, England. Participants 258 915 patients with stroke living in urban areas and admitted to hospital in January 2008 to March 2012. Interventions "Hub and spoke" model for acute stroke care. In London hyperacute care was provided to all patients with stroke. In Greater Manchester hyperacute care was provided to patients presenting within four hours of developing symptoms of stroke. Main outcome measures Mortality from any cause and at any place at 3, 30, and 90 days after hospital admission; length of hospital stay. Results In London there was a significant decline in risk adjusted mortality at 3, 30, and 90 days after admission. At 90 days the absolute reduction was -1.1% (95% confidence interval -2.1 to -0.1; relative reduction 5%), indicating 168 fewer deaths (95% confidence interval 19 to 316) during the 21 month period after reconfiguration in London. In both areas there was a significant decline in risk adjusted length of hospital stay: -2.0 days in Greater Manchester (95% confidence interval -2.8 to -1.2; 9%) and -1.4 days in London (-2.3 to -0.5; 7%). Reductions in mortality and length of hospital stay were largely seen among patients with ischaemic stroke. Conclusions A centralised model of acute stroke care, in which hyperacute care is provided to all patients with stroke across an entire metropolitan area, can reduce mortality and length of hospital stay.	[Morris, Stephen; Ramsay, Angus I. G.; Turner, Simon J.; Fulop, Naomi J.] UCL, Dept Appl Hlth Res, London WC1E 7HB, England; [Hunter, Rachael M.] UCL, Res Dept Primary Care & Populat Hlth, London NW3 2PF, England; [Boaden, Ruth; Perry, Catherine] Univ Manchester, Manchester Business Sch, Manchester M15 6PB, Lancs, England; [McKevitt, Christopher; Wolfe, Charles D. A.] Kings Coll London, Div Hlth & Social Care Res, Sch Med, London SE1 3QD, England; [Pursani, Nanik] Kings Coll London, Stroke Res Patients & Family Grp, Sch Med, Div Hlth & Social Care Res, London SE1 3QD, England; [Rudd, Anthony G.] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, London SE1 7EH, England; [Schwamm, Lee H.] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Tyrrell, Pippa J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Salford Royal Hosp NHS Fdn Trust, Stroke & Vasc Ctr, Salford M6 8HD, Lancs, England; [Wolfe, Charles D. A.] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth, Res Comprehens Biomed Res Ctr, London SE1 7EH, England; [Wolfe, Charles D. A.] Kings Coll London, London SE1 3QD, England	University of London; University College London; University of London; University College London; University of Manchester; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Harvard University; Harvard Medical School; Massachusetts General Hospital; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Morris, S (corresponding author), UCL, Dept Appl Hlth Res, London WC1E 7HB, England.	steve.morris@ucl.ac.uk	mckevitt, christopher/AAN-7271-2021; Hunter, Rachael Maree/H-7846-2019; Boaden, Ruth/L-3443-2016	Hunter, Rachael Maree/0000-0002-7447-8934; Boaden, Ruth/0000-0003-1927-6405; Fulop, Naomi/0000-0001-5306-6140; MCKEVITT, CHRISTOPHER/0000-0002-5290-4613; Morris, Stephen/0000-0002-5828-3563; Perry, Catherine/0000-0002-8496-6923; Schwamm, Lee/0000-0003-0592-9145; Ramsay, Angus/0000-0002-4446-6916; Tyrrell, Pippa/0000-0001-9609-1231	Department of Health [10/1009/09]; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre at King's College London; NIHR Collaboration for Leadership in Applied Health Research and Care Funding scheme; National Institute for Health Research [10/1009/09, NF-SI-0510-10060, RP-PG-0407-10184] Funding Source: researchfish	Department of Health; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre at King's College London; NIHR Collaboration for Leadership in Applied Health Research and Care Funding scheme; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the health services and delivery research programme of the National Institute for Health Research (NIHR), funded by the Department of Health (study reference 10/1009/09). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. CDAW was supported by the NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, and also by the NIHR Collaboration for Leadership in Applied Health Research and Care Funding scheme.	Audebert Heinrich J, 2009, Cerebrovasc Dis, V27 Suppl 4, P15, DOI 10.1159/000213054; Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Bray BD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2827; Cadilhac DA, 2013, STROKE, V44, P2848, DOI 10.1161/STROKEAHA.113.001258; Craig P, 2012, J EPIDEMIOL COMMUNIT; Data.gov.uk, IND MULT DEPR 2004; Demaerschalk BM, 2009, MAYO CLIN PROC, V84, P53, DOI 10.1016/S0025-6196(11)60808-2; Department of Health, 2007, NAT STROK STRAT; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Fosbol EL, 2013, CIRCULATION, V127, P604, DOI 10.1161/CIRCULATIONAHA.112.118463; Fulop N, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-5; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Greater Manchester and Cheshire Cardiac and Stroke Network Support Team, 2011, DEV STROK SERV GREAT; Health and Social Care Information Centre, HOS EP STAT; Health and Social Care Information Centre, LINK HES ONS MORT DA; Higashida R, 2013, STROKE, V44, P2961, DOI 10.1161/STR.0b013e3182a6d2b2; Hunter RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070420; Imbens GW, 2008, RECENT DEV ECONOMETR; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK; Lahr MMH, 2013, J NEUROL, V260, P960, DOI 10.1007/s00415-012-6647-7; Lahr MMH, 2012, STROKE, V43, P1336, DOI 10.1161/STROKEAHA.111.641795; Langhorne P, 2013, STROKE, V44, P3044, DOI 10.1161/STROKEAHA.113.001564; Langhorne P, 2010, J NEUROL NEUROSUR PS, V81, P1301, DOI 10.1136/jnnp.2009.195131; Mackay J, 2004, ATLAS HEART DIS STRO; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; National Audit Office, 2010, 291 HC NAT AUD OFF C; Office for National Statistics, 2012, 2011 CENS US RES POP; Office for National Statistics, 2001 URB CLASS; Prabhakaran S, 2013, JAMA NEUROL, V70, P1126, DOI 10.1001/jamaneurol.2013.293; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ramelyte M, 2012, STROKE ANN REPORT 20; Royal College of Physicians, 2013, SINAP LAT RES; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Silva GS, 2012, STROKE, V43, P2078, DOI 10.1161/STROKEAHA.111.645861; Slot KB, 2009, ACTA NEUROL SCAND, V120, P270, DOI 10.1111/j.1600-0404.2009.01162.x; Smith Eric E, 2008, Crit Pathw Cardiol, V7, P173, DOI 10.1097/HPC.0b013e318184e2bc; Sudlow C, 2009, BMJ, V338; Sutton M, 2012, NEW ENGL J MED, V367, P1821, DOI 10.1056/NEJMsa1114951; Townsend N, 2012, CORONARY HEART DIS S; Weir NU, 2005, J NEUROL NEUROSUR PS, V76, P863, DOI 10.1136/jnnp.2004.053462; Williams D., 2011, MAJOR RECONFIGURATIO; Woo YL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007945.pub2	42	136	138	4	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2014	349								g4757	10.1136/bmj.g4757	http://dx.doi.org/10.1136/bmj.g4757			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MP	25098169	Green Published, hybrid			2022-12-24	WOS:000340206000004
J	Rabar, S; Harker, M; O'Flynn, N; Wierzbicki, AS				Rabar, Silvia; Harker, Martin; O'Flynn, Norma; Wierzbicki, Anthony S.		Guideline Dev Grp	GUIDELINES Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHOLESTEROL; METAANALYSIS; THERAPY		[Rabar, Silvia; Harker, Martin; O'Flynn, Norma] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Wierzbicki, Anthony S.] Guys & St Thomas Hosp, London SE1 9RT, England	Royal College of Physicians; Guy's & St Thomas' NHS Foundation Trust	Rabar, S (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	silvia.rabar@rcplondon.ac.uk	Wierzbicki, Anthony/AAP-1735-2020	Wierzbicki, Anthony/0000-0003-2756-372X; Khan, Michael/0000-0002-8591-384X; Harker, Martin/0000-0001-6154-3517	Merck-Sharp-Dohme; Amgen; Pfizer; NICE	Merck-Sharp-Dohme(Merck & Company); Amgen(Amgen); Pfizer(Pfizer); NICE	We have read and understood BMJ policy on declaration of interests and declare the following interests: ASW declares contracts held by his institution and a role as principal site investigator for phase II and phase III studies on lipid lowering agents sponsored by Merck-Sharp-Dohme, Amgen, and Pfizer; these include phase III outcome studies that were sponsored by these companies but whose design and analysis are independent. These agents are not mentioned in the article because they are not licensed and are not likely to be licensed before the guideline is reviewed (2017). NICE did not consider these declared interests to be competing interests for this guideline. SR, MH, and NO'F are employed by the National Clinical Guideline Centre, which was funded by NICE to develop this guideline. The authors' statements can be viewed at www.bmj.com/content/bmj/349/bmj.g4356/related#datasupp.	[Anonymous], 2014, JBS3 RISK CALC; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Department of Health, 2013, NHS HLTH CHECK VASC; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; National Institue for Health and Care Excellence, 2013, DEV NICE CLIN GUID; National Institute for Health and Care Excellence, 2014, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2006, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2011, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2008, CLIN GUIDELINE; National Institute for Health and Clinical Excellence, 2008, CLIN GUIDELINE	14	140	148	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2014	349								g4356	10.1136/bmj.g4356	http://dx.doi.org/10.1136/bmj.g4356			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7PI	25035388				2022-12-24	WOS:000339326400003
J	Wright, KE; Hjerrild, KA; Bartlett, J; Douglas, AD; Jin, J; Brown, RE; Illingworth, JJ; Ashfield, R; Clemmensen, SB; de Jongh, WA; Draper, SJ; Higgins, MK				Wright, Katherine E.; Hjerrild, Kathryn A.; Bartlett, Jonathan; Douglas, Alexander D.; Jin, Jing; Brown, Rebecca E.; Illingworth, Joseph J.; Ashfield, Rebecca; Clemmensen, Stine B.; de Jongh, Willem A.; Draper, Simon J.; Higgins, Matthew K.			Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; SIZE-DISTRIBUTION ANALYSIS; PLASMODIUM-FALCIPARUM; PFRH5 POLYMORPHISMS; HOMOLOG; ULTRACENTRIFUGATION; CONSTRAINTS; PREDICTION; RECEPTOR; SYSTEM	Invasion of host erythrocytes is essential to the life cycle of Plasmodium parasites and development of the pathology of malaria. The stages of erythrocyte invasion, including initial contact, apical reorientation, junction formation, and active invagination, are directed by coordinated release of specialized apical organelles and their parasite protein contents'. Among these proteins, and central to invasion by all species, are two parasite protein families, the reticulocyte-binding protein homologue (RH) and erythrocyte-binding like proteins, which mediate host-parasite interactions(2). RH5 from Plasmodium falciparum (PfRH5) is the only member of either family demonstrated to be necessary for erythrocyte invasion in all tested strains, through its interaction with the erythrocyte surface protein basigin (also known as CD 147 and EMMPRIN)(3,4). Antibodies targeting PfRH5 or basigin efficiently block parasite invasion in vitro(4-9), making PfRH5 an excellent vaccine candidate. Here we present crystal structures of PfRH5 in complex with basigin and two distinct inhibitory antibodies. PfRH5 adopts a novel fold in which two three-helical bundles come together in a kite-like architecture, presenting binding sites for basigin and inhibitory antibodies at one tip. This provides the first structural insight into erythrocyte binding by the Plasmodium RH protein family and identifies novel inhibitory epitopes to guide design of a new generation of vaccines against the blood-stage parasite.	[Wright, Katherine E.; Bartlett, Jonathan; Higgins, Matthew K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Hjerrild, Kathryn A.; Douglas, Alexander D.; Jin, Jing; Brown, Rebecca E.; Illingworth, Joseph J.; Ashfield, Rebecca; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England; [Clemmensen, Stine B.; de Jongh, Willem A.] ExpreS2 Biotechnol, DK-2970 Horsholm, Denmark	University of Oxford; University of Oxford; Jenner Institute	Higgins, MK (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	simon.draper@ndm.ox.ac.uk; matthew.higgins@bioch.ox.ac.uk	Douglas, Alexander/E-7040-2012; Draper, Simon J/F-1758-2011; Bartlett, Jonathan D/AAF-8293-2020	Douglas, Alexander/0000-0002-5410-7562; Draper, Simon J/0000-0002-9415-1357; Bartlett, Jonathan D/0000-0001-9133-1953; Higgins, Matthew/0000-0002-2870-1955; Wright, Katherine/0000-0003-3968-5468	UK Medical Research Council (MRC) [G1000527]; European Vaccine Initiative(EVI)(InnoMalVac); UK MRC [MR/K025554/1]; European Community [242095 EVIMalaR]; Wellcome Trust [089455/2/09/z]; Medical Research Council [G1000527, MR/K025554/1] Funding Source: researchfish; MRC [MR/K025554/1, G1000527] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Vaccine Initiative(EVI)(InnoMalVac); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	M.K.H. is a Wellcome Trust Investigator (101020/Z/13/Z). K.E.W. is funded by a Wellcome Trust PhD studentship. S.J.D. holds a UK Medical Research Council (MRC) Career Development Fellowship (G1000527), and is a Jenner Investigator and Lister Institute Research Prize Fellow. The project was also funded by the European Vaccine Initiative(EVI)(InnoMalVac); the UK MRC(MR/K025554/1); the European Community's Seventh Framework Programme (FP7/2007-2013, grant agreement number 242095 EVIMalaR); and a Wellcome Trust Training Fellowship (089455/2/09/z to ADD). We thank J. Furze and D. Alanine; D. Staunton and E. Lowe; A. Round (ESRF); and R. Flaig and J. Brandao-Neto (Diamond Light Source).	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Birmanns S, 2011, J STRUCT BIOL, V173, P428, DOI 10.1016/j.jsb.2010.11.002; Bricogne G., 2011, BUSTER VERSION 2 10; Bustamante LY, 2013, VACCINE, V31, P373, DOI 10.1016/j.vaccine.2012.10.106; Chen L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002199; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Douglas AD, 2014, J IMMUNOL, V192, P245, DOI 10.4049/jimmunol.1302045; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guinier A., 1955, SMALL ANGLE SCATTERI; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Hayton K, 2013, MOL BIOCHEM PARASIT, V187, P103, DOI 10.1016/j.molbiopara.2012.12.005; Higgins MK, 2014, PROTEIN SCI, V23, P354, DOI 10.1002/pro.2428; Hirose S, 2007, BIOINFORMATICS, V23, P2046, DOI 10.1093/bioinformatics/btm302; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Porod G., 1982, GEN THEORY SMALL ANG; Reddy KS, 2014, INFECT IMMUN, V82, P152, DOI 10.1128/IAI.00970-13; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tran TM, 2014, J INFECT DIS, V209, P789, DOI 10.1093/infdis/jit553; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wanaguru M, 2013, P NATL ACAD SCI USA, V110, P20735, DOI 10.1073/pnas.1320771110; Williams AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002991; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	47	129	134	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					427	+		10.1038/nature13715	http://dx.doi.org/10.1038/nature13715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25132548	Green Accepted			2022-12-24	WOS:000345770600049
J	Colegio, OR; Chu, NQ; Szabo, AL; Chu, T; Rhebergen, AM; Jairam, V; Cyrus, N; Brokowski, CE; Eisenbarth, SC; Phillips, GM; Cline, GW; Phillips, AJ; Medzhitov, R				Colegio, Oscar R.; Ngoc-Quynh Chu; Szabo, Alison L.; Chu, Thach; Rhebergen, Anne Marie; Jairam, Vikram; Cyrus, Nika; Brokowski, Carolyn E.; Eisenbarth, Stephanie C.; Phillips, Gillian M.; Cline, Gary W.; Phillips, Andrew J.; Medzhitov, Ruslan			Functional polarization of tumour-associated macrophages by tumour-derived lactic acid	NATURE			English	Article							ANGIOGENESIS; ACTIVATION; CELLS; INFLAMMATION; HYPOXIA; GROWTH	Macrophages have an important role in the maintenance of tissue homeostasis(1). To perform this function, macrophages must have the capacity to monitor the functional states of their 'client cells': namely, the parenchymal cells in the various tissues in which macrophages reside. Tumours exhibit many features of abnormally developed organs, including tissue architecture and cellular composition(2). Similarly to macrophages in normal tissues and organs, macrophages in tumours (tumour-associated macrophages) perform some key homeostatic functions that allow tumour maintenance and growth(3-5). However, the signals involved in communication between tumours and macrophages are poorly defined. Here we show that lactic acid produced by tumour cells, as a by-product of aerobic or anaerobic glycolysis, has a critical function in signalling, through inducing the expression of vascular endothelial growth factor and the M2-like polarization of tumour-associated macrophages. Furthermore, we demonstrate that this effect of lactic acid is mediated by hypoxia-inducible factor 1 alpha (HIF1 alpha). Finally, we show that the lactate-induced expression of arginase 1 by macrophages has an important role in tumour growth. Collectively, these findings identify a mechanism of communication between macrophages and their client cells, including tumour cells. This communication most probably evolved to promote homeostasis in normal tissues but can also be engaged in tumours to promote their growth.	[Colegio, Oscar R.; Ngoc-Quynh Chu; Szabo, Alison L.; Chu, Thach; Rhebergen, Anne Marie; Jairam, Vikram; Cyrus, Nika; Brokowski, Carolyn E.; Eisenbarth, Stephanie C.; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Colegio, Oscar R.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Colegio, Oscar R.] Yale Univ, Sch Med, Yale New Haven Transplantat Ctr, New Haven, CT 06519 USA; [Colegio, Oscar R.; Medzhitov, Ruslan] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA; [Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Phillips, Gillian M.; Phillips, Andrew J.] Yale Univ, Sch Med, Dept Chem, New Haven, CT 06520 USA; [Cline, Gary W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Medzhitov, Ruslan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA.	ruslan.medzhitov@yale.edu		Colegio, Oscar/0000-0002-6519-3718; Cyrus, Nika/0000-0002-7511-8631; Colegio, Oscar/0000-0002-9524-6235; Eisenbarth, Stephanie/0000-0002-1244-208X	National Cancer Institute [1K08CA172580-01]; Yale Center for Clinical Investigation [5KL2RR024138]; Yale SPORE in Skin Cancer [1 P50 CA121974]; Damon Runyon Cancer Research Foundation [DRG 108-09]; Dermatology Foundation; Blavatnik Family Foundation; National Institutes of Health [AI046688, AI089771, CA157461]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA157461, K08CA172580, P50CA121974, P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI046688, R01AI089771] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Yale Center for Clinical Investigation; Yale SPORE in Skin Cancer; Damon Runyon Cancer Research Foundation; Dermatology Foundation; Blavatnik Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Medzhitov laboratory for discussions, L. Xu, C. Annicelli, S. Cronin and G. Tokmoulina for animal care and technical help, and N. Palm for critical feedback on the manuscript. O.R.C. is supported by the National Cancer Institute (1K08CA172580-01), the Yale Center for Clinical Investigation (5KL2RR024138), the Yale SPORE in Skin Cancer (1 P50 CA121974), the Damon Runyon Cancer Research Foundation (DRG 108-09) and the Dermatology Foundation. R.M.'s laboratory is supported by The Blavatnik Family Foundation, grants from the National Institutes of Health (AI046688, AI089771 and CA157461) and the Howard Hughes Medical Institute.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Chang CI, 2001, CANCER RES, V61, P1100; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354	23	1429	1478	32	402	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					559	+		10.1038/nature13490	http://dx.doi.org/10.1038/nature13490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043024	Green Accepted			2022-12-24	WOS:000342075800043
J	Kir, S; White, JP; Kleiner, S; Kazak, L; Cohen, P; Baracos, VE; Spiegelman, BM				Kir, Serkan; White, James P.; Kleiner, Sandra; Kazak, Lawrence; Cohen, Paul; Baracos, Vickie E.; Spiegelman, Bruce M.			Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia	NATURE			English	Article							HORMONE-RELATED PROTEIN; SKELETAL-MUSCLE; MONOCLONAL-ANTIBODY; NUDE-MICE; MECHANISMS; CELL; THERMOGENESIS; ACTIVATION; SURVIVAL	Cachexia is a wasting disorder of adipose and skeletal muscle tissues that leads to profound weight loss and frailty. About half of all cancer patients suffer from cachexia, which impairs quality of life, limits cancer therapy and decreases survival. One key characteristic of cachexia is higher resting energy expenditure levels than in healthy individuals, which has been linked to greater thermogenesis by brown fat(1-6). How tumours induce brown fat activity is unknown. Here, using a Lewis lung carcinoma model of cancer cachexia, we show that tumour-derived parathyroid-hormone-related protein (PTHrP) has an important role in wasting, through driving the expression of genes involved in thermogenesis in adipose tissues. Neutralization of PTHrP in tumour-bearing mice blocked adipose tissue browning and the loss of muscle mass and strength. Our results demonstrate that PTHrP mediates energy wasting in fat tissues and contributes to the broader aspects of cancer cachexia. Thus, neutralization of PTHrP might hold promise for ameliorating cancer cachexia and improving patient survival.	[Kir, Serkan; White, James P.; Kleiner, Sandra; Kazak, Lawrence; Cohen, Paul; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Baracos, Vickie E.] Univ Alberta, Div Palliat Care Med, Dept Oncol, Edmonton, AB T6G 1Z2, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Alberta	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	bruce_spiegelman@dfci.harvard.edu		Baracos, Vickie/0000-0002-9609-1001	American Cancer Society [PF-13-385-01-TBE]; National Institutes of Health [DK31405]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031405, R37DK031405] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Mourtzakis and C. Prado for their help with the human study. S. Kir is a Robert Black Fellow of the Damon Runyon Cancer Research Foundation (DRG-2153-13), and J.P.W. is supported by a postdoctoral fellowship from the American Cancer Society (PF-13-385-01-TBE). This work was supported by National Institutes of Health grant DK31405 to B.M.S.	BIANCHI A, 1989, HORM METAB RES, V21, P640, DOI 10.1055/s-2007-1009308; Bing C, 2000, CANCER RES, V60, P2405; BROOKS SL, 1981, BIOSCIENCE REP, V1, P509, DOI 10.1007/BF01121584; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Iguchi H, 2006, J BONE MINER METAB, V24, P16, DOI 10.1007/s00774-005-0640-5; Iguchi H, 2001, INT J CANCER, V94, P24, DOI 10.1002/ijc.1425; Lieffers JR, 2009, AM J CLIN NUTR, V89, P1173, DOI 10.3945/ajcn.2008.27273; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Mundy GR, 2008, J AM SOC NEPHROL, V19, P672, DOI 10.1681/ASN.2007090981; OVESEN L, 1993, J CLIN ONCOL, V11, P2043, DOI 10.1200/JCO.1993.11.10.2043; Penna F, 2010, EXPERT OPIN BIOL TH, V10, P1241, DOI 10.1517/14712598.2010.503773; Prado Carla M M, 2012, Can J Diet Pract Res, V73, pe298, DOI 10.3148/73.4.2012.e298; Roe S, 1996, METABOLISM, V45, P645, DOI 10.1016/S0026-0495(96)90037-2; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; SATO K, 1993, J BONE MINER RES, V8, P849; SHELLOCK FG, 1986, J CANCER RES CLIN, V111, P82, DOI 10.1007/BF00402783; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tsoli M, 2012, CANCER RES, V72, P4372, DOI 10.1158/0008-5472.CAN-11-3536; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	24	379	393	4	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					100	+		10.1038/nature13528	http://dx.doi.org/10.1038/nature13528			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043053	Green Accepted			2022-12-24	WOS:000341174800038
J	Behnia, R; Clark, DA; Carter, AG; Clandinin, TR; Desplan, C				Behnia, Rudy; Clark, Damon A.; Carter, Adam G.; Clandinin, Thomas R.; Desplan, Claude			Processing properties of ON and OFF pathways for Drosophila motion detection	NATURE			English	Article							VISUAL INTERNEURONS; OPTIC LOBE; WILD-TYPE; MELANOGASTER; PATTERNS; MEDULLA; CIRCUIT; LAMINA	The algorithms and neural circuits that process spatio-temporal changes in luminance to extract visual motion cues have been the focus of intense research. An influential model, the Hassenstein-Reichardt correlator(1), relies on differential temporal filtering of two spatially separated input channels, delaying one input signal with respect to the other. Motion in a particular direction causes these delayed and non-delayed luminance signals to arrive simultaneously at a subsequent processing step in the brain; these signals are then nonlinearly amplified to produce a direction-selective response. Recent work in Drosophila has identified two parallel pathways that selectively respond to either moving light or dark edges(2,3). Each of these pathways requires two critical processing steps to be applied to incoming signals: differential delay between the spatial input channels, and distinct processing of brightness increment and decrement signals. Here we demonstrate, using in vivo patch-clamp recordings, that four medulla neurons implement these two processing steps. The neurons Mi1 and Tm3 respond selectively to brightness increments, with the response of Mi1 delayed relative to Tm3. Conversely, Tm1 and Tm2 respond selectively to brightness decrements, with the response of Tm1 delayed compared with Tm2. Remarkably, constraining Hassenstein-Reichardt correlator models using these measurements produces outputs consistent with previously measured properties of motion detectors, including temporal frequency tuning and specificity for light versus dark edges. We propose that Mi1 and Tm3 perform critical processing of the delayed and non-delayed input channels of the correlator responsible for the detection of light edges, while Tm1 and Tm2 play analogous roles in the detection of moving dark edges. Our data show that specific medulla neurons possess response properties that allow them to implement the algorithmic steps that precede the correlative operation in the Hassenstein-Reichardt correlator, revealing elements of the long-sought neural substrates of motion detection in the fly.	[Behnia, Rudy; Desplan, Claude] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA; [Clark, Damon A.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Clark, Damon A.; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Carter, Adam G.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Desplan, Claude] New York Univ Abu Dhabi Inst, Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates	New York University; Yale University; Stanford University; New York University	Behnia, R (corresponding author), NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA.	rb141@nyu.edu; damon.clark@yale.edu		Desplan, Claude/0000-0002-6914-1413; Clark, Damon/0000-0001-8487-700X; Behnia, Rudy/0000-0001-7258-1885	National Institutes of Health (NIH) [R01EY017916]; New York University Abu Dhabi Institute [G1205C]; EMBO; Human Frontier Science Program; NIH [R01EY022638, DP1 OD003530]; NIH; Jane Coffin Childs postdoctoral fellowship; McKnight Foundation; NATIONAL EYE INSTITUTE [R01EY017916, R01EY022638] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003530] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Abu Dhabi Institute; EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs postdoctoral fellowship; McKnight Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Turner for his initial help on whole-cell recordings; X. Li for providing the confocal image of the 686-Gal4 flip-out clone, and N. Vogt, J. Rister and members of the Clandin in laboratory, as well as H. S. Seung and S.A. Baccus, for reading of the manuscript. We also thank D. B. Chklovskii for suggesting recording from Tm3 and T. Erclick for identifying the Tm3 Gal4 line. This work was supported by a grant from the National Institutes of Health (NIH) (R01EY017916) and a grant from New York University Abu Dhabi Institute (G1205C) to C.D.; R.B. was supported by fellowships from EMBO and the Human Frontier Science Program. This work was also supported by grants from the NIH to T.R.C. (R01EY022638 and DP1 OD003530). D.A.C. was partly supported by an NIH T32 Vision Training Grant and a Jane Coffin Childs postdoctoral fellowship. A.G.C. was supported by a Scholar Award from The McKnight Foundation.	Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; BORST A, 1986, BIOL CYBERN, V55, P59, DOI 10.1007/BF00363978; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Franceschini N., 1989, FACETS VISION, P360; Freifeld L, 2013, NEURON, V78, P1075, DOI 10.1016/j.neuron.2013.04.024; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; MARMARELIS PZ, 1973, KYBERNETIK, V12, P74, DOI 10.1007/BF00272463; Meier M., 2014, CURRENT BIOL; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Morante Javier, 2011, Cold Spring Harb Protoc, V2011, P652, DOI 10.1101/pdb.prot5629; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; Shinomiya K, 2014, CURR BIOL, V24, P1062, DOI 10.1016/j.cub.2014.03.051; Silies M, 2013, NEURON, V79, P111, DOI 10.1016/j.neuron.2013.04.029; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tuthill JC, 2013, NEURON, V79, P128, DOI 10.1016/j.neuron.2013.05.024; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	38	135	135	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					427	U443		10.1038/nature13427	http://dx.doi.org/10.1038/nature13427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25043016	Green Accepted			2022-12-24	WOS:000340840600033
J	Gao, F; Bonsignori, M; Liao, HX; Kumar, A; Xia, SM; Lu, XZ; Cai, FP; Hwang, KK; Song, HS; Zhou, TQ; Lynch, RM; Alam, SM; Moody, MA; Ferrari, G; Berrong, M; Kelsoe, G; Shaw, GM; Hahn, BH; Montefiori, DC; Kamanga, G; Cohen, MS; Hraber, P; Kwong, PD; Korber, BT; Mascola, JR; Kepler, TB; Haynes, BF				Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Zhou, Tongqing; Lynch, Rebecca M.; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Shaw, George M.; Hahn, Beatrice H.; Montefiori, David C.; Kamanga, Gift; Cohen, Myron S.; Hraber, Peter; Kwong, Peter D.; Korber, Bette T.; Mascola, John R.; Kepler, Thomas B.; Haynes, Barton F.			Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies	CELL			English	Article							CD4 BINDING-SITE; HIV-1-INFECTED INDIVIDUALS; CONFORMATIONAL EPITOPE; MONOCLONAL-ANTIBODIES; BROAD NEUTRALIZATION; IMMUNE-RESPONSES; GERMINAL-CENTERS; HIV-1 INFECTION; AFFINITY; MUTATIONS	Development of strategies for induction of HIV-1 broadly neutralizing antibodies (bnAbs) by vaccines is a priority. Determining the steps of bnAb induction in HIV-1-infected individuals who make bnAbs is a key strategy for immunogen design. Here, we study the B cell response in a bnAb-producing individual and report cooperation between two B cell lineages to drive bnAb development. We isolated a virus-neutralizing antibody lineage that targeted an envelope region (loop D) and selected virus escape mutants that resulted in both enhanced bnAb lineage envelope binding and escape mutant neutralization-traits associated with increased B cell antigen drive. Thus, in this individual, two B cell lineages cooperated to induce the development of bnAbs. Design of vaccine immunogens that simultaneously drive both helper and broadly neutralizing B cell lineages may be important for vaccine-induced recapitulation of events that transpire during the maturation of neutralizing antibodies in HIV-1-infected individuals.	[Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Med, Durham, NC 27710 USA; [Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Surg, Durham, NC 27710 USA; [Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Pediat & Immunol, Durham, NC 27710 USA; [Gao, Feng; Bonsignori, Mattia; Liao, Hua-Xin; Kumar, Amit; Xia, Shi-Mao; Lu, Xiaozhi; Cai, Fangping; Hwang, Kwan-Ki; Song, Hongshuo; Alam, S. Munir; Moody, M. Anthony; Ferrari, Guido; Berrong, Mark; Kelsoe, Garnett; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Ctr HIV AIDS Vaccine Immunol Immunogen Discovery, Durham, NC 27710 USA; [Zhou, Tongqing; Lynch, Rebecca M.; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Kamanga, Gift] UNC Project, Lilongwe, Malawi; [Kamanga, Gift] Univ N Carolina, Dept Hlth Policy, Chapel Hill, NC 27599 USA; [Kamanga, Gift] Univ N Carolina, Dept Management, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Hraber, Peter; Korber, Bette T.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87544 USA; [Kepler, Thomas B.] Boston Univ, Dept Microbiol, Boston, MA 02215 USA	Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Los Alamos National Laboratory; Boston University	Gao, F (corresponding author), Duke Univ, Sch Med, Human Vaccine Inst, Dept Med, Durham, NC 27710 USA.	fgao@duke.edu; barton.haynes@duke.edu	Alam, S. Munir/AAC-6711-2019; Bonsignori, Mattia/AAE-7678-2019; Moody, M/AAB-6947-2020; Ferrari, Guido/Z-2137-2019; Zhou, Tongqing/A-6880-2010; Mascola, John/AAI-7193-2021; Ferrari, Guido/A-6088-2015	Bonsignori, Mattia/0000-0003-2973-2101; Moody, M/0000-0002-3890-5855; Zhou, Tongqing/0000-0002-3935-4637; Ferrari, Guido/0000-0001-7747-3349; Kelsoe, Garnett/0000-0002-8770-040X; Korber, Bette/0000-0002-2026-5757; Hahn, Beatrice/0000-0002-9400-9887; Hraber, Peter/0000-0002-2920-4897	Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery grant (CHAVI-ID) [UM1 AI100645]; Duke University Center for AIDS Research (CFAR) [P30-AI-64518]; intramural research program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, P30AI064518, P30AI045008, UM1AI100645, ZIAAI005024] Funding Source: NIH RePORTER	Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery grant (CHAVI-ID); Duke University Center for AIDS Research (CFAR); intramural research program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Center For HIV/AIDS Vaccine Immunology-Immunogen Discovery grant (CHAVI-ID; UM1 AI100645), the Duke University Center for AIDS Research (CFAR; P30-AI-64518), and the intramural research program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH. We thank Mark Hallen and Jiang Zhu for assistance and discussion on calculation of binding affinity and Daniel M Kozink, Abby Cooper, and Florence Perrin for technical assistance. Provisional patents have been filed by B. F. H., H.-X. L., R. M. L., T.Z., F. G., G. M. S., B. H. H., T. B. K., B. T. K., P. D. K., J.R.M., and P. H. M. S. C. served at Advisory Board of Roche Molecular Systems, Expert Advisory Panel of Gates Foundation, and Pipeline Advisory Board of Janssen Global Services.	Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Bonsignori M, 2014, J CLIN INVEST, V124, P1835, DOI 10.1172/JCI73441; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Cox JH, 2006, METHODS, V38, P274, DOI 10.1016/j.ymeth.2005.11.006; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Fera D, 2014, P NATL ACAD SCI USA, V111, P10275, DOI 10.1073/pnas.1409954111; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Kirchherr JL, 2007, J VIROL METHODS, V143, P104, DOI 10.1016/j.jviromet.2007.02.015; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2013, J VIROL, V87, P4185, DOI 10.1128/JVI.02297-12; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Montefiori D.C., 2004, CURRENT PROTOCOLS IM; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Moore PL, 2009, CURR OPIN HIV AIDS, V4, P358, DOI 10.1097/COH.0b013e32832ea7e8; Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Sattentau Quentin J, 2010, F1000 Biol Rep, V2, P60, DOI 10.3410/B2-60; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Song HS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-89; Stamatatos L, 2012, CURR OPIN IMMUNOL, V24, P316, DOI 10.1016/j.coi.2012.04.006; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	51	197	210	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					481	491		10.1016/j.cell.2014.06.022	http://dx.doi.org/10.1016/j.cell.2014.06.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25065977	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000340944300004
J	Zhang, XR; Zuo, XX; Yang, B; Li, ZR; Xue, YC; Zhou, Y; Huang, J; Zhao, XL; Zhou, J; Yan, Y; Zhang, HQ; Guo, PP; Sun, H; Guo, L; Zhang, Y; Fu, XD				Zhang, Xiaorong; Zuo, Xinxin; Yang, Bo; Li, Zongran; Xue, Yuanchao; Zhou, Yu; Huang, Jie; Zhao, Xiaolu; Zhou, Jie; Yan, Yun; Zhang, Huiqiong; Guo, Peipei; Sun, Hui; Guo, Lin; Zhang, Yi; Fu, Xiang-Dong			MicroRNA Directly Enhances Mitochondrial Translation during Muscle Differentiation	CELL			English	Article							LIVER-MITOCHONDRIA; TRANSCRIPTION MACHINERY; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; UP-REGULATION; RNA; PROTEIN; ARGONAUTE; REPRESSION; GW182	MicroRNAs are well known to mediate translational repression and mRNA degradation in the cytoplasm. Various microRNAs have also been detected in membrane-compartmentalized organelles, but the functional significance has remained elusive. Here, we report that miR-1, a microRNA specifically induced during myogenesis, efficiently enters the mitochondria where it unexpectedly stimulates, rather than represses, the translation of specific mitochondrial genome-encoded transcripts. We show that this positive effect requires specific miR:mRNA base-pairing and Ago2, but not its functional partner GW182, which is excluded from the mitochondria. We provide evidence for the direct action of Ago2 in mitochondrial translation by crosslinking immuno-precipitation coupled with deep sequencing (CLIP-seq), functional rescue with mitochondria-targeted Ago2, and selective inhibition of the microRNA machinery in the cytoplasm. These findings unveil a positive function of microRNA in mitochondrial translation and suggest a highly coordinated myogenic program via miR-1-mediated translational stimulation in the mitochondria and repression in the cytoplasm.	[Zhang, Xiaorong; Zuo, Xinxin; Yang, Bo; Li, Zongran; Xue, Yuanchao; Huang, Jie; Zhao, Xiaolu; Zhou, Jie; Yan, Yun; Zhang, Huiqiong; Guo, Peipei; Sun, Hui; Guo, Lin; Zhang, Yi; Fu, Xiang-Dong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Xue, Yuanchao; Zhou, Yu; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Fu, Xiang-Dong] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Wuhan University; University of California System; University of California San Diego; University of California System; University of California San Diego	Fu, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	xdfu@ucsd.edu	Yan, Yun/GPC-5871-2022; Zhou, Yu/AAP-9964-2021	Yan, Yun/0000-0002-3701-9608; Zhang, Xiaorong/0000-0002-6194-7746; Zhou, Yu/0000-0002-2102-9377; Huang, Jie/0000-0003-3842-6181; XUE, YUANCHAO/0000-0002-8113-2333; Zhang, Yi/0000-0003-1035-6134	China 973 pro-gram [2011CB811300, 2012CB910800]; Chinese 111 program [B06018]; NIH [GM049369, GM052872]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052872, R01GM049369] Funding Source: NIH RePORTER	China 973 pro-gram(National Basic Research Program of China); Chinese 111 program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Immo Scheffler, Amy Pasquinelli, Shobha Vasudevan, and David Chan for insightful discussion during the course of this investigation, Dr. Xiaoyan Ding for providing the C2C12 cell line, and Dr. Anna Lombes for the gift of anti-ND1 antibody. This work was supported by the China 973 pro-gram (2011CB811300, 2012CB910800), the Chinese 111 program grant (B06018), and NIH grants (GM049369 and GM052872).	Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Barrey E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020220; Bestwick ML, 2013, TRENDS BIOCHEM SCI, V38, P283, DOI 10.1016/j.tibs.2013.03.006; Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; BOSMANN HB, 1972, J CELL BIOL, V55, P147, DOI 10.1083/jcb.55.1.147; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Franko A, 2008, MOL CELL BIOL, V28, P2446, DOI 10.1128/MCB.00980-07; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Iwasaki S, 2009, FLY, V3, P204; Jakymiw A, 2007, J CELL SCI, V120, P1317, DOI 10.1242/jcs.03429; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Mortensen RD, 2011, P NATL ACAD SCI USA, V108, P8281, DOI 10.1073/pnas.1105401108; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Sripada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044873; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Surovtseva YV, 2011, P NATL ACAD SCI USA, V108, P17921, DOI 10.1073/pnas.1108852108; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	53	290	306	5	112	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					607	619		10.1016/j.cell.2014.05.047	http://dx.doi.org/10.1016/j.cell.2014.05.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083871	Green Accepted, Bronze			2022-12-24	WOS:000340944300013
J	Beck, JR; Muralidharan, V; Oksman, A; Goldberg, DE				Beck, Josh R.; Muralidharan, Vasant; Oksman, Anna; Goldberg, Daniel E.			PTEX component HSP101 mediates export of diverse malaria effectors into host erythrocytes	NATURE			English	Article							PLASMODIUM-FALCIPARUM PROTEIN; PLASMEPSIN V; FOOD VACUOLE; VIRULENCE; BIOSYNTHESIS; LOCALIZATION; TRANSLOCON; PARASITES; MEMBRANE; CELLS	To mediate its survival and virulence, the malaria parasite Plasmodium falciparum exports hundreds of proteins into the host erythrocyte(1). To enter the host cell, exported proteins must cross the parasitophorous vacuolar membrane (PVM) within which the parasite resides, but the mechanism remains unclear. A putative Plasmodium translocon of exported proteins (PTEX) has been suggested to be involved for at least one class of exported proteins; however, direct functional evidence for this has been elusive(2-4). Here we show that export across the PVM requires heat shock protein 101 (HSP101), a ClpB-likeAAA+ ATPase component of PTEX. Using a chaperone auto-inhibition strategy, we achieved rapid, reversible ablation of HSP101 function, resulting in a nearly complete block in export with substrates accumulating in the vacuole in both asexual and sexual parasites. Surprisingly, this block extended to all classes of exported proteins, revealing HSP101-dependent translocation across the PVM as a convergent step in the multi-pathway export process. Under export-blocked conditions, association between HSP101 and other components of the PTEX complex was lost, indicating that the integrity of the complex is required for efficient protein export. Our results demonstrate an essential and universal role for HSP101 in protein export and provide strong evidence for PTEX function in protein translocation into the host cell.	[Beck, Josh R.; Oksman, Anna; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Muralidharan, Vasant; Oksman, Anna; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Muralidharan, Vasant; Oksman, Anna; Goldberg, Daniel E.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	dgoldberg@wustl.edu		Muralidharan, Vasant/0000-0001-6367-6284	National Institutes of Health [AI047798, T32-AI007172, AI099156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172, K99AI099156, R01AI047798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI047798 to D.E.G., T32-AI007172 to J.R.B. and AI099156 to V.M. We thank J. McBride, D. Cavanagh and EMRR for anti-EXP2 antibody, J. Adams and ATCC (MR4) for anti-BiP antibody, D. Taylor for anti-HRP2 antibody, R. Anders for anti-RESA antibody, C. Braun-Breton for anti-SBP1 antibody, K. Williamson for anti-PfGECO and anti-Pfs16 antibodies, T. Spielmann for anti-REX2, anti-REX3 and anti-MSRP6 antibodies, L. Tilley for anti-REX1 and anti-PfEMP1 antibodies, S. Desai for anti-CLAG3 antibody, A. Cowman for anti-KAHRP antibody, J. Przyborski and K. Lingelbach for anti-SERP antibody, W. Beatty for assistance with electron microscopy, B. Vaupel and T. Butler for technical assistance and P. Sigala and N. Spillman for suggestions.	Babbitt SE, 2012, P NATL ACAD SCI USA, V109, pE3278, DOI 10.1073/pnas.1209823109; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Eksi S, 2005, MOL BIOCHEM PARASIT, V143, P90, DOI 10.1016/j.molbiopara.2005.05.010; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; Frankland S, 2007, EUKARYOT CELL, V6, P1584, DOI 10.1128/EC.00063-07; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; Hawthorne PL, 2004, MOL BIOCHEM PARASIT, V136, P181, DOI 10.1016/j.molbiopara.2004.03.013; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; KIRK K, 1994, J BIOL CHEM, V269, P3339; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matthews K, 2013, MOL MICROBIOL, V89, P1167, DOI 10.1111/mmi.12334; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Morahan BJ, 2011, EUKARYOT CELL, V10, P1492, DOI 10.1128/EC.05155-11; Mundwiler-Pachlatko E, 2013, P NATL ACAD SCI USA, V110, P19987, DOI 10.1073/pnas.1309247110; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Riglar DT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2449; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Spielmann T, 2006, MOL BIOL CELL, V17, P3613, DOI 10.1091/mbc.E06-04-0291; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	40	158	158	0	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					592	+		10.1038/nature13574	http://dx.doi.org/10.1038/nature13574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25043010	Green Accepted			2022-12-24	WOS:000339566300035
J	Anderson, SJ; Cherutich, P; Kilonzo, N; Cremin, I; Fecht, D; Kimanga, D; Harper, M; Masha, RL; Ngongo, PB; Maina, W; Dybul, M; Hallett, TB				Anderson, Sarah-Jane; Cherutich, Peter; Kilonzo, Nduku; Cremin, Ide; Fecht, Daniela; Kimanga, Davies; Harper, Malayah; Masha, Ruth Laibon; Ngongo, Prince Bahati; Maina, William; Dybul, Mark; Hallett, Timothy B.			Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study	LANCET			English	Article							MALE CIRCUMCISION; EFFECTIVE RESPONSE; SPATIAL-ANALYSIS; HIGH-RISK; HIV/AIDS; INTERVENTIONS; INFECTION; IMPACT; STRATEGIES; MALARIA	Background Epidemiological data show substantial variation in the risk of HIV infection between communities within African countries. We hypothesised that focusing appropriate interventions on geographies and key populations at high risk of HIV infection could improve the effect of investments in the HIV response. Methods With use of Kenya as a case study, we developed a mathematical model that described the spatiotemporal evolution of the HIV epidemic and that incorporated the demographic, behavioural, and programmatic differences across subnational units. Modelled interventions (male circumcision, behaviour change communication, early antiretoviral therapy, and pre-exposure prophylaxis) could be provided to different population groups according to their risk behaviours or their location. For a given national budget, we compared the effect of a uniform intervention strategy, in which the same complement of interventions is provided across the country, with a focused strategy that tailors the set of interventions and amount of resources allocated to the local epidemiological conditions. Findings A uniformly distributed combination of HIV prevention interventions could reduce the total number of new HIV infections by 40% during a 15-year period. With no additional spending, this effect could be increased by 14% during the 15 years-almost 100 000 extra infections, and result in 33% fewer new HIV infections occurring every year by the end of the period if the focused approach is used to tailor resource allocation to reflect patterns in local epidemiology. The cumulative difference in new infections during the 15-year projection period depends on total budget and costs of interventions, and could be as great as 150 000 (a cumulative difference as great as 22%) under different assumptions about the unit costs of intervention. Interpretation The focused approach achieves greater effect than the uniform approach despite exactly the same investment. Through prioritisation of the people and locations at greatest risk of infection, and adaption of the interventions to reflect the local epidemiological context, the focused approach could substantially increase the efficiency and effectiveness of investments in HIV prevention.	[Anderson, Sarah-Jane; Cremin, Ide; Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Fecht, Daniela] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, SAHSU, London W2 1PG, England; [Cherutich, Peter; Kimanga, Davies; Maina, William] Natl AIDS & STI Control Programme NASCOP, Nairobi, Kenya; [Kilonzo, Nduku] Liverpool VCT Care & Treatment, Nairobi, Kenya; [Harper, Malayah; Masha, Ruth Laibon] UNAIDS, Nairobi, Kenya; [Ngongo, Prince Bahati] IAVI, Nairobi, Kenya; [Dybul, Mark] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	Imperial College London; Imperial College London; International AIDS Vaccine Initiative	Anderson, SJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.	sarah-jane.anderson@imperial.ac.uk	; Maina, William/L-6650-2017	Hallett, Timothy/0000-0002-9681-0424; Fecht, Daniela/0000-0002-0738-0013; Maina, William/0000-0002-3184-9854; Cremin, Ide/0000-0003-2560-6247	Bill & Melinda Gates Foundation; UNAIDS; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UNAIDS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by the Bill & Melinda Gates Foundation and UNAIDS.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beyrer C, 2012, LANCET; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cooke GS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-585; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Government of India Ministry of Health and Family Welfare, 1999, NAT OP GUID ART SER; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Halli SS, 2009, SEX TRANSM DIS, V36, P556, DOI 10.1097/OLQ.0b013e3181a8cdcf; Health Protection Agency, 2012, HIV UK 2012 REP; http://www.who.int/hiv/pub/surveillance/en/cds_edc_2000_5.pdf, 2000, GUID 2 GEN HIV SURV; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, S AFRICA; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, LOC LOC CONN PEOPL F; Jones A, 2014, LANCET; Kabatereine NB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-232; Kandala NB, 2012, HIV AIDS-RES PALLIAT, V4, P95, DOI 10.2147/HIV.S30537; Kenya National AIDS and STI Control Program (NASCOP), 2013, COUNT HIV SERV DEL P; Kenya National AIDS and STI Control Programme (NASCOP), 2011, SENT SURV HIV SYPH I; Kenya National AIDS and STI Control Programme (NASCOP) National AIDS Control Council (NACC), 2012, GEOGR MAPP MOST RISK; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2010, KEN DEM HLTH SURV 20; Lafort Y, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-144; Larmarange J, 2014, CYBERGEO EUROPEAN J; Law DCG, 2004, SEX TRANSM INFECT, V80, P294, DOI 10.1136/sti.2003.006700; Leydon NG, S AFR MED J, V100, P420; LowBeer D, 1997, NAT MED, V3, P553, DOI 10.1038/nm0597-553; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magalhaes RJS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001200; Meyer-Rath G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001247; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032324; Moran D, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-22; Musenge E, 2013, GLOBAL HEALTH ACTION, V6, P38, DOI 10.3402/gha.v6i0.19266; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; Piot P, 2013, NEW ENGL J MED, V368, P2210, DOI 10.1056/NEJMra1201533; Qian HZ, 2006, AIDS CARE, V18, pS6, DOI 10.1080/09540120600839074; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sgaier SK, 2012, SEX TRANSM INFECT, V88, P240, DOI 10.1136/sextrans-2011-050382; Shepard D, 1968, P 1968 ACM NAT C NEW; Shisana O, 2013, 6 SA AIDS C DURB S A; Sumartojo E, 1997, AIDS, V11, P1201, DOI 10.1097/00002030-199710000-00002; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; Tanzania Commission for HIV and AIDS, UNGASS REP 2010 TANZ; The Global Fund, 2013, NEW FUND MOD 2013; The United States President's Emergency Plan for AIDS Relief (PEPFAR), 2012, PEPFAR BLUEPR CREAT; US Centers for Disease Control and Prevention, 2013, HIV AIDS US GEOGR DI; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Verguet Stephane, 2013, Cost Eff Resour Alloc, V11, P1, DOI 10.1186/1478-7547-11-1; Weir SS, 2002, MEASURE EVALUATION B, V2002, P1; Williams BG, 2000, S AFR J SCI, V96, P297; Wilson DP, 2005, PLOS MED, V2, P132, DOI 10.1371/journal.pmed.0020050; World Health Organization, 2013, GUID 2 GEN HIV SURV; Yao J, 2013, SOC SCI MED, V96, P60, DOI [10.1016/j.socscimed.2013.07.025, 10.1016/j.socscimed.2012.11.005]	58	171	172	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					249	256		10.1016/S0140-6736(14)61053-9	http://dx.doi.org/10.1016/S0140-6736(14)61053-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	25042235	Green Submitted			2022-12-24	WOS:000339384100026
J	Smith, CJ; Ryom, L; Weber, R; Morlat, P; Pradier, C; Reiss, P; Kowalska, JD; de Wit, S; Law, M; el Sadr, W; Kirk, O; Friis-Moller, N; Monforte, AD; Phillips, AN; Sabin, CA; Lundgren, JD				Smith, Colette J.; Ryom, Lene; Weber, Rainer; Morlat, Philippe; Pradier, Christian; Reiss, Peter; Kowalska, Justyna D.; de Wit, Stephane; Law, Matthew; el Sadr, Wafaa; Kirk, Ole; Friis-Moller, Nina; Monforte, Antonella d'Arminio; Phillips, Andrew N.; Sabin, Caroline A.; Lundgren, Jens D.		D A D Study Grp	Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS-DEFINING CANCERS; ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; DATA-COLLECTION; ADVERSE EVENTS; RISK-FACTORS; HEPATITIS-C; MORTALITY; INFECTION	Background With the advent of effective antiretroviral treatment, the life expectancy for people with HIV is now approaching that seen in the general population. Consequently, the relative importance of other traditionally non-AIDS-related morbidities has increased. We investigated trends over time in all-cause mortality and for specific causes of death in people with HIV from 1999 to 2011. Methods Individuals from the Data collection on Adverse events of anti-HIV Drugs (D: A: D) study were followed up from March, 1999, until death, loss to follow-up, or Feb 1, 2011, whichever occurred first. The D: A: D study is a collaboration of 11 cohort studies following HIV-1-positive individuals receiving care at 212 clinics in Europe, USA, and Australia. All fatal events were centrally validated at the D: A: D coordinating centre using coding causes of death in HIV (CoDe) methodology. We calculated relative rates using Poisson regression. Findings 3909 of the 49 731 D: A: D study participants died during the 308 719 person-years of follow-up (crude incidence mortality rate, 12 7 per 1000 person-years [95% CI 12.3-13.1]). Leading underlying causes were: AIDS-related (1123 [29%] deaths), non-AIDS-defining cancers (590 [15%] deaths), liver disease (515 [13%] deaths), and cardiovascular disease (436 [11%] deaths). Rates of all-cause death per 1000 person-years decreased from 17 5 in 1999-2000 to 9 1 in 2009-11; we saw similar decreases in death rates per 1000 person-years over the same period for AIDS-related deaths (5 9 to 2 0), deaths from liver disease (2 7 to 0 9), and cardiovascular disease deaths (1 8 to 0 9). However, non-AIDS cancers increased slightly from 1 6 per 1000 person-years in 1999-2000 to 2 1 in 2009-11 (p=0.58). After adjustment for factors that changed over time, including CD4 cell count, we detected no decreases in AIDS-related death rates (relative rate for 2009-11 vs 1999-2000: 0 92 [0.70-1.22]). However, all-cause (0 72 [0.61-0.83]), liver disease (0 48 [0.32-0.74]), and cardiovascular disease (0 33 [0.20-0.53) death rates still decreased over time. The percentage of all deaths that were AIDS-related (87/256 [34%] in 1999-2000 and 141/627 [22%] in 2009-11) and liver-related (40/256 [16%] in 1999-2000 and 64/627 [10%] in 2009-11) decreased over time, whereas non-AIDS cancers increased (24/256 [9%] in 1999-2000 to 142/627 [23%] in 2009-11). Interpretation Recent reductions in rates of AIDS-related deaths are linked with continued improvement in CD4 cell count. We hypothesise that the substantially reduced rates of liver disease and cardiovascular disease deaths over time could be explained by improved use of non-HIV-specific preventive interventions. Non-AIDS cancer is now the leading non-AIDS cause and without any evidence of improvement.	[Smith, Colette J.; Phillips, Andrew N.; Sabin, Caroline A.] UCL, Res Dept Infect & Populat Hlth, London NW3 2PF, England; [Ryom, Lene; Kirk, Ole; Lundgren, Jens D.] Univ Copenhagen, Rigshosp, CHIP, Dept Infect Dis 2100, DK-1168 Copenhagen, Denmark; [Weber, Rainer] Univ Zurich, Univ Zurich Hosp, Div Infect Dis, Zurich, Switzerland; [Morlat, Philippe] Univ Bordeaux Segalen, CHU Bordeaux, Serv Med Intern & Malad Infect, Bordeaux, France; [Pradier, Christian] Nice Univ Hosp, Dept Publ Hlth, Nice, France; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Reiss, Peter] Stichting HIV Monitoring, Amsterdam, Netherlands; [Kowalska, Justyna D.] Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland; [de Wit, Stephane] Hop Univ St Pierre, Dept Infect Dis, B-1000 Brussels, Belgium; [Law, Matthew] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [el Sadr, Wafaa] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Friis-Moller, Nina] Odense Univ Hosp, Dept Infect Dis, Odense, Denmark; [Monforte, Antonella d'Arminio] San Paolo Univ Hosp, Dept Hlth Sci, Milan, Italy	University of London; University College London; Rigshospitalet; University of Copenhagen; University of Zurich; University Zurich Hospital; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Nice; University of Amsterdam; Academic Medical Center Amsterdam; Medical University of Warsaw; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of New South Wales Sydney; Kirby Institute; Columbia University; University of Southern Denmark; Odense University Hospital	Smith, CJ (corresponding author), UCL, Res Dept Infect & Populat Hlth, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	c.smith@ucl.ac.uk	van der Ven, A.J.A.M./H-8102-2014; Phillips, Andrew N/B-4427-2008; Pradier, Christian/AFE-8255-2022; kirk, ole/ABB-4746-2021; Koopmans, Peter/O-9276-2015; Weber, Rainer/D-5175-2012; Lundgren, Jens/AAE-6876-2019; Ippolito, Giuseppe/J-7207-2017; Sabin, Caroline/C-2464-2008; VELLA, STEFANO/V-8440-2019; Vandekerckhove, Linos/J-6420-2013; Soriano, Vicente/O-5730-2018; Buonfrate, Dora/N-2965-2016; Harding, Richard/G-9729-2012; Ostergaard, Lars/AAA-3020-2020; Pradier, Christian/AAE-9669-2022; Pantaleo, Giuseppe/K-6163-2016; perno, carlo federico/O-1544-2016; Torres, Ferran/D-1296-2011	van der Ven, A.J.A.M./0000-0003-1833-3391; Phillips, Andrew N/0000-0003-2384-4807; Sabin, Caroline/0000-0001-5173-2760; VELLA, STEFANO/0000-0003-2347-5984; Vandekerckhove, Linos/0000-0002-8600-1631; Soriano, Vicente/0000-0002-4624-5199; Buonfrate, Dora/0000-0003-0108-6822; Ostergaard, Lars/0000-0003-2459-0511; Torres, Ferran/0000-0002-7355-7913; Ippolito, Giuseppe/0000-0002-1076-2979; COSTANTINI, ANDREA/0000-0003-1588-7030; McManus, Hamish/0000-0002-7264-8848; CAMANNI, GUIDO/0000-0003-0881-5426; Colebunders, Robert/0000-0002-1919-1340; Ristola, Matti/0000-0001-5115-2811; Smith, Colette/0000-0003-2847-3355; Katzenstein, Terese L/0000-0002-2233-500X; LIBOIS, Agnes/0000-0002-6078-878X; d'Arminio Monforte, Antonella/0000-0003-0073-1789; Lo Caputo, Sergio/0000-0002-4729-7548; CAUDA, Roberto/0000-0002-1498-4229; Rijnders, Bart/0000-0003-3343-9610; Law, Matthew/0000-0002-3540-8837; Leen, Clifford/0000-0001-8439-7719; Ostergaard, Lars/0000-0002-7619-605X; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Lundgren, Jens/0000-0001-8901-7850	Oversight Committee for the Evaluation of Metabolic Complications of HAART; MRC [G0701639] Funding Source: UKRI; Medical Research Council [G0701639] Funding Source: researchfish	Oversight Committee for the Evaluation of Metabolic Complications of HAART; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Oversight Committee for the Evaluation of Metabolic Complications of HAART, with representatives from academia, patient community, US Food and Drug Administration, European Medicines Agency and consortium of AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, ViiV Healthcare, Merck, Pfizer, F Hoffmann-La Roche, and Janssen Pharmaceuticals.	[Anonymous], 2012, INT J EPIDEMIOL, V41, P433; Antiretroviral Therapy Cohort Collaboration, 1996, CLIN INFECT DIS, V50, P1387; Berenguer J, 2012, AIDS, V26, P2241, DOI 10.1097/QAD.0b013e3283574e94; Blanco F, 2011, J VIRAL HEPATITIS, V18, P11, DOI 10.1111/j.1365-2893.2009.01261.x; Bruyand M, 2013, 20 C RETR OPP INF CR; Buchacz K, 2013, ANTIVIR THER, V18, P65, DOI 10.3851/IMP2450; Conigliaro J, 2003, JAIDS-J ACQ IMM DEF, V33, P521, DOI 10.1097/00126334-200308010-00014; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Helleberg M, 2012, INFECTION, V40, P627, DOI 10.1007/s15010-012-0293-y; Hernando V, 2012, AIDS, V26, P1829, DOI 10.1097/QAD.0b013e328352ada4; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Horvath KJ, 2012, AM J PREV MED, V43, pS214, DOI 10.1016/j.amepre.2012.07.032; Kovari H, 2013, CLIN INFECT DIS, V56, P870, DOI 10.1093/cid/cis919; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Lundgren JD, 2012, 19 INT AIDS C WASH D; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Pinzone MR, 2012, EUR REV MED PHARMACO, V16, P1377; Sabin C, 2013, 20 C RETR OPP INF CR; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Scarborough P, 2010, CORONARY HEART DIS S; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simard EP, 2012, AIDS, V26, P1311, DOI 10.1097/QAD.0b013e328353f38e; Soriano V, 2012, INFECT DIS CLIN N AM, V26, P931, DOI 10.1016/j.idc.2012.08.004; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Worm SW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-471; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Worm SW, 2012, 19 C RETR OPP INF CR	33	620	657	1	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					241	248		10.1016/S0140-6736(14)60604-8	http://dx.doi.org/10.1016/S0140-6736(14)60604-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	25042234	Green Submitted			2022-12-24	WOS:000339384100025
J	Lucas, JS; Zhang, YJ; Dudko, OK; Murre, C				Lucas, Joseph S.; Zhang, Yaojun; Dudko, Olga K.; Murre, Cornelis			3D Trajectories Adopted by Coding and Regulatory DNA Elements: First-Passage Times for Genomic Interactions	CELL			English	Article							IMMUNOGLOBULIN-HEAVY-CHAIN; V(D)J RECOMBINATION; B-CELLS; LYMPHOCYTE DEVELOPMENT; ANOMALOUS DIFFUSION; SEQUENCING REVEALS; ALLELIC EXCLUSION; VARIABLE REGION; MONTE-CARLO; IGH LOCUS	During B lymphocyte development, immunoglobulin heavy-chain variable (V-H), diversity (D-H), and joining (J(H)) segments assemble to generate a diverse antigen receptor repertoire. Here, we have marked the distal V-H and D-H-J(H)-E-mu regions with Tet-operator binding sites and traced their 3D trajectories in proB cells transduced with a retrovirus encoding Tetrepressor-EGFP. We found that these elements displayed fractional Langevin motion (fLm) due to the viscoelastic hindrance from the surrounding network of proteins and chromatin fibers. Using fractional Langevin dynamics modeling, we found that, with high probability, D(H)J(H) elements reach a V-H elementwithin minutes. Spatial confinement emerged as the dominant parameter that determined the frequency of such encounters. We propose that the viscoelastic nature of the nuclear environment causes coding elements and regulatory elements to bounce back and forth in a spring-like fashion until specific genomic interactions are established and that spatial confinement of topological domains largely controls first-passage times for genomic interactions.	[Lucas, Joseph S.; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, San Diego, CA 92093 USA; [Zhang, Yaojun; Dudko, Olga K.] Univ Calif San Diego, Dept Phys, San Diego, CA 92093 USA; [Zhang, Yaojun; Dudko, Olga K.] Univ Calif San Diego, Ctr Theoret Biol Phys, San Diego, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dudko, OK (corresponding author), Univ Calif San Diego, Dept Phys, San Diego, CA 92093 USA.	dudko@physics.ucsd.edu; murre@biomail.ucsd.edu			National Institutes of Health [AI00880, AI082850]; National Science Foundation Faculty Early Career Development Award [MCB-0845099]; National Science Foundation Center for Theoretical Biological Physics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000880, R01AI100880, R01AI082850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Faculty Early Career Development Award(National Science Foundation (NSF)); National Science Foundation Center for Theoretical Biological Physics(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Peter Geiduschek, Alex Bortnick, and Roy Riblet for editing the manuscript. We thank John Sedat, Richard Flavell, Cornelia Zorca, and Lena Koslover for stimulating discussions. We thank Claudia Bossen, Joe Pogliano, and Ralf Metzler for advice. We thank James Fitzpatrick and Jamie Kasuboski (Waitt Advanced Biophotonics Center Core Facility) for help with imaging and image analysis. J.S.L. was supported by a training grant from the National Institutes of Health (Cellular and Molecular Genetics). The studies were supported by the National Science Foundation Faculty Early Career Development Award (MCB-0845099) to O.K.D., by the grant from the National Institutes of Health (AI00880 and AI082850) to C.M., and by the National Science Foundation Center for Theoretical Biological Physics.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boveri T., 1909, ARCH ZELLFORSCH, V3, P181; Bronstein I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018102; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Dietrich CR, 1997, SIAM J SCI COMPUT, V18, P1088, DOI 10.1137/S1064827592240555; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hawley RG, 1996, ANN NY ACAD SCI, V795, P341, DOI 10.1111/j.1749-6632.1996.tb52687.x; Hewitt SL, 2010, IMMUNOL REV, V237, P43, DOI 10.1111/j.1600-065X.2010.00931.x; Jeon JH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021103; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Lucas JS, 2011, CURR OPIN CELL BIOL, V23, P318, DOI 10.1016/j.ceb.2010.11.007; Lutz E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051106; MANZ J, 1988, J EXP MED, V168, P1363, DOI 10.1084/jem.168.4.1363; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; MONTROLL EW, 1965, J MATH PHYS, V6, P167, DOI 10.1063/1.1704269; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; NUSSENZWEIG MC, 1988, J EXP MED, V167, P1969, DOI 10.1084/jem.167.6.1969; Onozawa M, 2012, GENE CHROMOSOME CANC, V51, P525, DOI 10.1002/gcc.21942; Rabl C, 1885, MORPHOL JB, V10, P214; Retter I, 2007, J IMMUNOL, V179, P2419, DOI 10.4049/jimmunol.179.4.2419; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Sayegh CE, 2003, NAT IMMUNOL, V4, P586, DOI 10.1038/ni923; Sedat J., 1978, S QUANT BIOL, V42, P331; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Weber SC, 2012, BIOPHYS J, V102, P2443, DOI 10.1016/j.bpj.2012.03.062; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	54	143	144	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					339	352		10.1016/j.cell.2014.05.036	http://dx.doi.org/10.1016/j.cell.2014.05.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	24998931	Green Accepted, Bronze			2022-12-24	WOS:000340943600014
J	Preitner, N; Quan, J; Nowakowski, DW; Hancock, ML; Shi, JH; Tcherkezian, J; Young-Pearse, TL; Flanagan, JG				Preitner, Nicolas; Quan, Jie; Nowakowski, Dan W.; Hancock, Melissa L.; Shi, Jianhua; Tcherkezian, Joseph; Young-Pearse, Tracy L.; Flanagan, John G.			APC Is an RNA-Binding Protein, and Its Interactome Provides a Link to Neural Development and Microtubule Assembly	CELL			English	Article							TUMOR-SUPPRESSOR PROTEIN; POLYPOSIS-COLI PROTEIN; CANONICAL WNT PATHWAY; BETA-TUBULIN; CELL-MIGRATION; MESSENGER-RNAS; GENE; CYTOSKELETON; TRANSLATION; GROWTH	Adenomatous polyposis coli (APC) is a microtubule plus-end scaffolding protein important in biology and disease. APC is implicated in RNA localization, although the mechanisms and functional significance remain unclear. We show APC is an RNA-binding protein and identify an RNA interactome by HITS-CLIP. Targets were highly enriched for APC-related functions, including microtubule organization, cell motility, cancer, and neurologic disease. Among the targets is beta 2B-tubulin, known to be required in human neuron and axon migration. We show beta 2B-tubulin is synthesized in axons and localizes preferentially to dynamic microtubules in the growth cone periphery. APC binds the beta 2B-tubulin 3' UTR; experiments interfering with this interaction reduced beta 2B-tubulin mRNA axonal localization and expression, depleted dynamic microtubules and the growth cone periphery, and impaired neuron migration. These results identify APC as a platform binding functionally related protein and RNA networks, and suggest a self-organizing model for the microtubule to localize synthesis of its own subunits.	[Preitner, Nicolas; Quan, Jie; Nowakowski, Dan W.; Hancock, Melissa L.; Shi, Jianhua; Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Preitner, Nicolas; Quan, Jie; Nowakowski, Dan W.; Hancock, Melissa L.; Shi, Jianhua; Flanagan, John G.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Tcherkezian, Joseph] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Lab Therapeut Dev, Montreal, PQ H3G 1Y6, Canada; [Young-Pearse, Tracy L.] Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; McGill University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020; Shi, Jianhua/L-8463-2016	Shi, Jianhua/0000-0002-5351-406X; Young-Pearse, Tracy/0000-0001-7846-1542	NIH; Charles A. King Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069913] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Kyoko Okada, Philippe Roux, David Van Vactor, Peter Park, Xinmin Li, Rebecca Meyer, Inke Nathke, Olivier Pertz, Antonina Andreeva, and Alexey Murzin for help, reagents, advice, and/or comments on the manuscript. We thank Jiangwen Zhang, Christian Daly, and the Bauer Center for Genomic Research for support with deep sequencing and Jennifer Waters, Josh Rosenberg, Lauren Piedmont, Lara Petrak, Gaudenz Danuser, Hunter Elliott, Yichao Xu, the Nikon Imaging Center, and the Image and Data Analysis Core at Harvard Medical School for imaging equipment and expertise. This work was supported by grants from the NIH and a fellowship from the Charles A. King Trust (to N.P.).	Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Bahi-Buisson N, 2014, BRAIN, V137, P1676, DOI 10.1093/brain/awu082; Barth AIM, 2008, SEMIN CELL DEV BIOL, V19, P245, DOI 10.1016/j.semcdb.2008.02.003; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cederquist GY, 2012, HUM MOL GENET, V21, P5484, DOI 10.1093/hmg/dds393; Chang L, 2006, J CELL BIOL, V172, P747, DOI 10.1083/jcb.200511033; Chen YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024335; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Condeelis J, 2005, BIOL CELL, V97, P97; Cui DH, 2005, MOL PSYCHIATR, V10, P669, DOI 10.1038/sj.mp.4001653; Darnell RB, 2013, ANNU REV NEUROSCI, V36, P243, DOI 10.1146/annurev-neuro-062912-114322; Deka J, 1999, ONCOGENE, V18, P5654, DOI 10.1038/sj.onc.1202944; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dyson HJ, 2012, MOL BIOSYST, V8, P97, DOI 10.1039/c1mb05258f; Eng H, 1999, J NEUROSCI, V19, P1; Gerdes JM, 2005, CELL MOL LIFE SCI, V62, P1556, DOI 10.1007/s00018-005-5007-5; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hall KB, 2002, CURR OPIN STRUC BIOL, V12, P283, DOI 10.1016/S0959-440X(02)00323-8; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jones KJ, 2008, GLIA, V56, P1401, DOI 10.1002/glia.20707; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Kalkman HO, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-10; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Minde DP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-101; Myers KA, 2006, NEUROSCIENTIST, V12, P107, DOI 10.1177/1073858405283428; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Pellegrini F, 2005, CANCER INVEST, V23, P264, DOI 10.1081/CNV-200055970; Qian J, 2008, GASTROENTEROLOGY, V135, P152, DOI 10.1053/j.gastro.2008.03.074; Romaniello R, 2012, DEV MED CHILD NEUROL, V54, P765, DOI 10.1111/j.1469-8749.2012.04316.x; Salinas PC, 2007, TRENDS CELL BIOL, V17, P333, DOI 10.1016/j.tcb.2007.07.003; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Tischfield MA, 2010, BIOSCIENCE REP, V30, P319, DOI 10.1042/BSR20100025; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Xing L, 2013, TRAFFIC, V14, P2, DOI 10.1111/tra.12004; Yasuda K, 2013, J CELL BIOL, V203, P737, DOI 10.1083/jcb.201306058; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	52	110	112	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 17	2014	158	2					368	382		10.1016/j.cell.2014.05.042	http://dx.doi.org/10.1016/j.cell.2014.05.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QU	25036633	Green Accepted, Bronze			2022-12-24	WOS:000340943600016
J	Li, J; Hou, B; Tumova, S; Muraki, K; Bruns, A; Ludlow, MJ; Sedo, A; Hyman, AJ; McKeown, L; Young, RS; Yuldasheva, NY; Majeed, Y; Wilson, LA; Rode, B; Bailey, MA; Kim, HR; Fu, ZJ; Carter, DAL; Bilton, J; Imrie, H; Ajuh, P; Dear, TN; Cubbon, RM; Kearney, MT; Prasad, KR; Evans, PC; Ainscough, JFX; Beech, DJ				Li, Jing; Hou, Bing; Tumova, Sarka; Muraki, Katsuhiko; Bruns, Alexander; Ludlow, Melanie J.; Sedo, Alicia; Hyman, Adam J.; McKeown, Lynn; Young, Richard S.; Yuldasheva, Nadira Y.; Majeed, Yasser; Wilson, Lesley A.; Rode, Baptiste; Bailey, Marc A.; Kim, Hyejeong R.; Fu, Zhaojun; Carter, Deborah A. L.; Bilton, Jan; Imrie, Helen; Ajuh, Paul; Dear, T. Neil; Cubbon, Richard M.; Kearney, Mark T.; Prasad, K. Raj; Evans, Paul C.; Ainscough, Justin F. X.; Beech, David J.			Piezol integration of vascular architecture with physiological force	NATURE			English	Article							ACTIVATED CATION CHANNELS; FLUID SHEAR-STRESS; ENDOTHELIAL-CELLS; PROTEOME ANALYSIS; DISTURBED FLOW; CALPAIN; MECHANOTRANSDUCTION; TISSUES; GENE; MICE	The mechanisms by which physical forces regulate endothelial cells to determine the complexities of vascular structure and function are enigmatic(1-5). Studies of sensory neurons have suggested Piezo proteins as subunits of Ca2+-permeable non-selective cationic channels for detection of noxious mechanical impact(6-8). Here we show Piezol (Fam38a) channels as sensors of frictional force (shear stress) and determinants of vascular structure in both development and adult physiology. Global or endothelial-specific disruption of mouse Piezol profoundly disturbed the developing vasculature and was embryonic lethal within days of the heart beating. Haploinsufficiency was not lethal but endothelial abnormality was detected in mature vessels. The importance of Piezol channels as sensors of blood flow was shown by Piezol dependence of shear-stress-evoked ionic current and calcium influx in endothelial cells and the ability of exogenous Piezol to confer sensitivity to shear stress on otherwise resistant cells. Down-stream of this calcium influx there was protease activation and spatial reorganization of endothelial cells to the polarity of the applied force. The data suggest that Piezol channels function as pivotal integrators in vascular biology.	[Li, Jing; Hou, Bing; Tumova, Sarka; Bruns, Alexander; Ludlow, Melanie J.; Sedo, Alicia; Hyman, Adam J.; McKeown, Lynn; Young, Richard S.; Yuldasheva, Nadira Y.; Majeed, Yasser; Wilson, Lesley A.; Rode, Baptiste; Bailey, Marc A.; Fu, Zhaojun; Carter, Deborah A. L.; Bilton, Jan; Imrie, Helen; Dear, T. Neil; Cubbon, Richard M.; Kearney, Mark T.; Ainscough, Justin F. X.; Beech, David J.] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [Li, Jing; Hou, Bing; Tumova, Sarka; Bruns, Alexander; Ludlow, Melanie J.; Sedo, Alicia; Hyman, Adam J.; McKeown, Lynn; Young, Richard S.; Yuldasheva, Nadira Y.; Majeed, Yasser; Wilson, Lesley A.; Rode, Baptiste; Bailey, Marc A.; Fu, Zhaojun; Carter, Deborah A. L.; Bilton, Jan; Imrie, Helen; Dear, T. Neil; Cubbon, Richard M.; Kearney, Mark T.; Ainscough, Justin F. X.; Beech, David J.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England; [Muraki, Katsuhiko] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Prasad, K. Raj] St James Univ Hosp, Dept Hepatobiliary & Transplant Surg, Leeds LS9 7TF, W Yorkshire, England; [Kim, Hyejeong R.; Evans, Paul C.] Univ Sheffield, Sheffield S10 2RX, S Yorkshire, England; [Ajuh, Paul] Dundee Cell Prod Ltd, Dundee DD1 5JJ, Scotland	University of Leeds; University of Leeds; Aichi Gakuin University; Saint James's University Hospital; University of Sheffield	Beech, DJ (corresponding author), Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England.	d.j.beech@leeds.ac.uk	HOU, BING/AAC-5247-2022; McKeown, Lynn/AAC-6037-2020; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Tumova, Sarka/AAD-6353-2019; Majeed, Yasser/ABG-3662-2021	HOU, BING/0000-0002-8348-3831; McKeown, Lynn/0000-0003-2326-7595; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Tumova, Sarka/0000-0003-2044-4998; Ainscough, Justin/0000-0003-0231-433X; Beech, David/0000-0002-7683-9422; Hyman, Adam/0000-0003-0874-6678; Bailey, Marc/0000-0001-5038-1970; Evans, Paul/0000-0001-7975-681X; Ludlow, Melanie/0000-0002-0720-5581	Wellcome Trust; Medical Research Council; Leeds Teaching Hospitals Trust Charitable Foundation; British Heart Foundation; University of Leeds; China Scholarship Council; BBSRC PhD Studentship; Cancer Research UK Clinical Fellowship; BBSRC-AstraZeneca PhD Studentship; British Heart Foundation Fellowship; Biotechnology and Biological Sciences Research Council [1360947] Funding Source: researchfish; British Heart Foundation [RG/13/1/30042, FS/12/80/29821, FS/14/22/30734, FS/12/54/29671] Funding Source: researchfish; Medical Research Council [G1002076, MR/L019051/1] Funding Source: researchfish; MRC [MR/L019051/1, G1002076] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leeds Teaching Hospitals Trust Charitable Foundation; British Heart Foundation(British Heart Foundation); University of Leeds; China Scholarship Council(China Scholarship Council); BBSRC PhD Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK Clinical Fellowship; BBSRC-AstraZeneca PhD Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation Fellowship(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was supported by research grants from the Wellcome Trust, the Medical Research Council, the Leeds Teaching Hospitals Trust Charitable Foundation, and the British Heart Foundation. B.H. was supported by a Scholarship from the University of Leeds and the China Scholarship Council. A.J.H. was supported by a BBSRC PhD Studentship. R.S.Y. was supported by a Cancer Research UK Clinical Fellowship. L.A.W. was supported by a BBSRC-AstraZeneca PhD Studentship. M.A.B. was supported by a British Heart Foundation Fellowship.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Ando J, 2013, CARDIOVASC RES, V99, P260, DOI 10.1093/cvr/cvt084; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Babaei F, 2013, J PROTEOME RES, V12, P1580, DOI 10.1021/pr3009226; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Brakemeier S, 2002, CARDIOVASC RES, V53, P209, DOI 10.1016/S0008-6363(01)00476-X; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Conway Daniel, 2012, F1000 Biol Rep, V4, P1, DOI 10.3410/B4-1; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dolan JM, 2013, ANN BIOMED ENG, V41, P1411, DOI 10.1007/s10439-012-0695-0; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson BD, 2011, VASC MED, V16, P365, DOI 10.1177/1358863X11422109; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; LANGILLE BL, 1981, CIRC RES, V48, P481, DOI 10.1161/01.RES.48.4.481; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Miyazaki T, 2007, AM J PHYSIOL-CELL PH, V293, pC1216, DOI 10.1152/ajpcell.00083.2007; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Warboys CM, 2014, ARTERIOSCL THROM VAS, V34, P985, DOI 10.1161/ATVBAHA.114.303415; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253; Zhuang XD, 2011, BIOCHEM SOC T, V39, P1571, DOI 10.1042/BST20110746	37	516	543	20	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					279	U308		10.1038/nature13701	http://dx.doi.org/10.1038/nature13701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25119035	Green Accepted			2022-12-24	WOS:000344631400053
J	Ko, SY; Pegu, A; Rudicell, RS; Yang, ZY; Joyce, MG; Chen, XJ; Wang, KY; Bao, S; Kraemer, TD; Rath, T; Zeng, M; Schmidt, SD; Todd, JP; Penzak, SR; Saunders, KO; Nason, MC; Haase, AT; Rao, SS; Blumberg, RS; Mascola, JR; Nabel, GJ				Ko, Sung-Youl; Pegu, Amarendra; Rudicell, Rebecca S.; Yang, Zhi-yong; Joyce, M. Gordon; Chen, Xuejun; Wang, Keyun; Bao, Saran; Kraemer, Thomas D.; Rath, Timo; Zeng, Ming; Schmidt, Stephen D.; Todd, John-Paul; Penzak, Scott R.; Saunders, Kevin O.; Nason, Martha C.; Haase, Ashley T.; Rao, Srinivas S.; Blumberg, Richard S.; Mascola, John R.; Nabel, Gary J.			Enhanced neonatal Fc receptor function improves protection against primate SHIV infection	NATURE			English	Article							NEUTRALIZING ANTIBODIES; HALF-LIFE; HIV-1 VACCINE; HUMAN IGG1; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; IN-VIVO; TRANSPORT; CHALLENGE; IMMUNITY	To protect against human immunodeficiency virus (HIV-1) infection, broadly neutralizing antibodies (bnAbs) must be active at the portals of viral entry in the gastrointestinal or cervicovaginal tracts. The localization and persistence of antibodies at these sites is influenced by the neonatal Fc receptor (FcRn)(1,2), whose role in protecting against infection in vivo has not been defined. Here, we show that a bnAb with enhanced FcRn binding has increased gut mucosal tissue localization, which improves protection against lentiviral infection in non-human primates. A bnAb directed to the CD4-binding site of the HIV-1 envelope (Env) protein (denoted VRC01)(3) was modified by site-directed mutagenesis to increase its binding affinity for FcRn. This enhanced FcRn-binding mutant bnAb, denoted VRC01-LS, displayed increased transcytosis across human FcRn-expressing cellular monolayers in vitro while retaining Fc gamma RIIIa binding and function, including antibody-dependent cell-mediated cytotoxicity (ADCC) activity, at levels similar to VRC01 (the wild type). VRC01-LS had a threefold longer serum half-life than VRC01 in non-human primates and persisted in the rectal mucosa even when it was no longer detectable in the serum. Notably, VRC01-LSmediated protection superior to that afforded by VRC01 against intrarectal infection with simian-human immunodeficiency virus (SHIV). These findings suggest that modification of FcRn binding provides a mechanism not only to increase serum half-life but also to enhance mucosal localization that confers immune protection. Mutations that enhance FcRn function could therefore increase the potency and durability of passive immunization strategies to prevent HIV-1 infection.	[Ko, Sung-Youl; Pegu, Amarendra; Rudicell, Rebecca S.; Yang, Zhi-yong; Joyce, M. Gordon; Chen, Xuejun; Wang, Keyun; Bao, Saran; Schmidt, Stephen D.; Todd, John-Paul; Saunders, Kevin O.; Rao, Srinivas S.; Mascola, John R.; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Kraemer, Thomas D.; Rath, Timo; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Dept Med, Boston, MA 02115 USA; [Zeng, Ming; Haase, Ashley T.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Penzak, Scott R.] NIH, Clin Pharmacokinet Lab, Dept Pharm, Bethesda, MD 20814 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Brigham & Women's Hospital; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), Sanofi, 640 Mem Dr, Cambridge, MA 02139 USA.	jmascola@nih.gov; Gary.Nabel@sanofi.com	Pegu, Amarendra/X-1361-2019; Schmidt, Stephen/B-5398-2012; Mascola, John/AAI-7193-2021; Schmidt, Stephen/AAC-6967-2019	Pegu, Amarendra/0000-0003-3564-6453; Rath, Timo/0000-0002-7728-9338	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Foundation for the National Institutes of Health; Collaboration for AIDS Vaccine Discovery (CAVD) award from the Bill & Melinda Gates Foundation [OPP1039775]; NIH [DK044319, DK051362, DK053056, DK088199]; Harvard Digestive Diseases Center [DK0034854]; German research foundation (DFG) [RA 2040/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005009, ZIAAI005002, ZIAAI005122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044319, R56DK053056, R01DK044319, P30DK034854, R01DK051362, R01DK053056, R01DK088199] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Foundation for the National Institutes of Health; Collaboration for AIDS Vaccine Discovery (CAVD) award from the Bill & Melinda Gates Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; German research foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Roederer for advice on the design and statistical analysis of animal studies. This research was supported by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), and in part by a grant from the Foundation for the National Institutes of Health with support from the Collaboration for AIDS Vaccine Discovery (CAVD), award OPP1039775, from the Bill & Melinda Gates Foundation. R. S. B. is supported by the NIH (DK044319, DK051362, DK053056 and DK088199) and the Harvard Digestive Diseases Center (DK0034854). T. R. is supported by the German research foundation (DFG; RA 2040/1-1). The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agencies.	Baker K, 2013, IMMUNITY, V39, P1095, DOI 10.1016/j.immuni.2013.11.003; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Claypool SM, 2002, J BIOL CHEM, V277, P28038, DOI 10.1074/jbc.M202367200; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; GASTINEL LN, 1992, P NATL ACAD SCI USA, V89, P638, DOI 10.1073/pnas.89.2.638; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klein K, 2013, J VIROL, V87, P11604, DOI 10.1128/JVI.01361-13; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; ONORATO IM, 1991, J INFECT DIS, V163, P1, DOI 10.1093/infdis/163.1.1; Pegu A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008992; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shu Y, 2007, VACCINE, V25, P1398, DOI 10.1016/j.vaccine.2006.10.046; SICINSKI P, 1990, GASTROENTEROLOGY, V98, P56, DOI 10.1016/0016-5085(90)91290-M; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	37	228	235	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					642	+		10.1038/nature13612	http://dx.doi.org/10.1038/nature13612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25119033	Green Accepted			2022-12-24	WOS:000343801500052
J	Shi, JJ; Zhao, Y; Wang, YP; Gao, WQ; Ding, JJ; Li, P; Hu, LY; Shao, F				Shi, Jianjin; Zhao, Yue; Wang, Yupeng; Gao, Wenqing; Ding, Jingjin; Li, Peng; Hu, Liyan; Shao, Feng			Inflammatory caspases are innate immune receptors for intracellular LPS	NATURE			English	Article							LIPOPOLYSACCHARIDE RECOGNITION; ACTIVATION; PROTEIN; MECHANISMS; PYROPTOSIS; FLAGELLIN; PROMOTES; BACTERIA; BINDING; TLR4	The murine caspase-11 non-canonical inflammasome responds to various bacterial infections. Caspase-11 activation-induced pyroptosis, in response to cytoplasmic lipopolysaccharide (LPS), is critical for endotoxic shock in mice. The mechanism underlying cytosolic LPS sensing and the responsible pattern recognition receptor are unknown. Here we show that human monocytes, epithelial cells and keratinocytes undergo necrosis upon cytoplasmic delivery of LPS. LPS-induced cytotoxicity was mediated by human caspase-4 that could functionally complement murine caspase-11. Human caspase-4 and the mouse homologue caspase-11 (hereafter referred to as caspase-4/11) and also human caspase-5, directly bound to LPS and lipid A with high specificity and affinity. LPS associated with endogenous caspase-11 in pyroptotic cells. Insect-cell purified caspase-4/11 underwent oligomerization upon LPS binding, resulting in activation of the caspases. Underacylated lipid IVa and lipopolysaccharide from Rhodobacter sphaeroides (LPS-RS) could bind to caspase-4/11 but failed to induce their oligomerization and activation. LPS binding was mediated by the CARD domain of the caspase. Binding-deficient CARD-domain point mutants did not respond to LPS with oligomerization or activation and failed to induce pyroptosis upon LPS electroporation or bacterial infections. The function of caspase-4/5/11 represents a new mode of pattern recognition in immunity and also an unprecedented means of caspase activation.	[Shi, Jianjin; Shao, Feng] Natl Inst Biol Sci, Peking Univ Tsinghua Univ Natl Inst Biol Sci Join, Beijing 102206, Peoples R China; [Shi, Jianjin; Zhao, Yue; Wang, Yupeng; Gao, Wenqing; Ding, Jingjin; Li, Peng; Hu, Liyan; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Ding, Jingjin; Shao, Feng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Shao, Feng] Natl Inst Biol Sci, Collaborat Innovat Ctr Canc Med, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing; Tsinghua University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing	Shao, F (corresponding author), Natl Inst Biol Sci, Peking Univ Tsinghua Univ Natl Inst Biol Sci Join, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Zhao, Yue/A-5285-2018	Zhao, Yue/0000-0003-1509-9261; Ding, Jingjin/0000-0001-9941-7997; Shi, Jianjin/0000-0001-8048-5180	International Early Career Scientist grant from the Howard Hughes Medical Institute; Beijing Scholar Program; National Basic Research Program of China 973 Program [2012CB518700]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020202]; China National Science Foundation Program for Distinguished Young Scholars [31225002]	International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Beijing Scholar Program; National Basic Research Program of China 973 Program(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China National Science Foundation Program for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC))	We thank Y. Fujimoto and K. Fukase for providing biotin-conjugated lipid A and lipid IVa and B. Finlay for S. typhimurium Delta sifA strain. We also thank W. Li at Tsinghua University for assistance in SLS and AU analyses and members of the Shao laboratory for discussions and technical assistance. The research was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute and the Beijing Scholar Program to F.S. This work was also supported by the National Basic Research Program of China 973 Program (2012CB518700), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08020202) and China National Science Foundation Program for Distinguished Young Scholars (31225002) to F.S.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Brumell JH, 2002, INFECT IMMUN, V70, P3264, DOI 10.1128/IAI.70.6.3264-3270.2002; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Ferguson AD, 2000, STRUCTURE, V8, P585; Ge JN, 2012, P NATL ACAD SCI USA, V109, P6193, DOI 10.1073/pnas.1117490109; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kobayashi T, 2013, CELL HOST MICROBE, V13, P570, DOI 10.1016/j.chom.2013.04.012; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Qureshi N, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P687; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Raymond AA, 2007, BRIT J DERMATOL, V156, P420, DOI 10.1111/j.1365-2133.2006.07656.x; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Shin HJ, 2007, MOL CELLS, V24, P119; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Yoon SI, 2010, P NATL ACAD SCI USA, V107, P10990, DOI 10.1073/pnas.1004153107; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107	39	1171	1240	21	558	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					187	+		10.1038/nature13683	http://dx.doi.org/10.1038/nature13683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119034				2022-12-24	WOS:000342663100033
J	Shipony, Z; Mukamel, Z; Cohen, NM; Landan, G; Chomsky, E; Zeliger, SR; Fried, YC; Ainbinder, E; Friedman, N; Tanay, A				Shipony, Zohar; Mukamel, Zohar; Cohen, Netta Mendelson; Landan, Gilad; Chomsky, Elad; Zeliger, Shlomit Reich; Fried, Yael Chagit; Ainbinder, Elena; Friedman, Nir; Tanay, Amos			Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells	NATURE			English	Article							DNA METHYLATION PATTERNS; STEM-CELLS; GENOME; PLASTICITY; CHROMATIN; ELEMENTS; DOMAINS; REGIONS	Stable maintenance of gene regulatory programs is essential for normal function in multicellular organisms. Epigenetic mechanisms, and DNA methylation in particular, are hypothesized to facilitate such maintenance by creating cellular memory(1-4) that can be written during embryonic development(5,6) and then guide cell-type-specific gene expression(7). Here we develop new methods for quantitative inference of DNA methylation turnover rates, and show that human embryonic stem cells preserve their epigenetic state by balancing antagonistic processes that add and remove methylation marks rather than by copying epigenetic information from mother to daughter cells. In contrast, somatic cells transmit considerable epigenetic information to progenies. Paradoxically, the persistence of the somatic epigenome makes it more vulnerable to noise, since random epimutations can accumulate to massively perturb the epigenomic ground state. The rate of epigenetic perturbation depends on the genomic context, and, in particular, DNA methylation loss is coupled to late DNA replication dynamics. Epigenetic perturbation is not observed in the pluripotent state, because the rapid turnover-based equilibrium continuously reinforces the canonical state. This dynamic epigenetic equilibrium also explains how the epigenome can be reprogrammed quickly(8) and to near perfection(9) after induced pluripotency.	[Shipony, Zohar; Mukamel, Zohar; Cohen, Netta Mendelson; Landan, Gilad; Chomsky, Elad; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Shipony, Zohar; Mukamel, Zohar; Cohen, Netta Mendelson; Landan, Gilad; Chomsky, Elad; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Chomsky, Elad] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Zeliger, Shlomit Reich; Friedman, Nir] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Fried, Yael Chagit; Ainbinder, Elena] Weizmann Inst Sci, Dept Biol Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	amos.tanay@weizmann.ac.il			European Research Council (EVOEPIC); EU BLUEPRINT project; Israel Science Foundation [1050/12]; Israel Ministry of Science; Helen and Martin Kimmel Award	European Research Council (EVOEPIC); EU BLUEPRINT project; Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Helen and Martin Kimmel Award	We thank E. Kenigsberg, E. Yaffe and the Tanay group for discussions. Research in the Tanay group was supported by the European Research Council (EVOEPIC), the EU BLUEPRINT project, the Israel Science Foundation (1050/12 and I-Core) the Israel Ministry of Science and the Helen and Martin Kimmel Award.	Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Milyavsky M, 2003, CANCER RES, V63, P7147; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P61, DOI 10.1073/pnas.79.1.61; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	36	93	100	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					115	+		10.1038/nature13458	http://dx.doi.org/10.1038/nature13458			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25043040				2022-12-24	WOS:000341174800041
J	Jamuar, SS; Lam, ATN; Kircher, M; D'Gama, AM; Wang, J; Barry, BJ; Zhang, XC; Hill, RS; Partlow, JN; Rozzo, A; Servattalab, S; Mehta, BK; Topcu, M; Amrom, D; Andermann, E; Dan, B; Parrini, E; Guerrini, R; Scheffer, IE; Berkovic, SF; Leventer, RJ; Shen, YP; Wu, BL; Barkovich, AJ; Sahin, M; Chang, BS; Bamshad, M; Nickerson, DA; Shendure, J; Poduri, A; Yu, TW; Walsh, CA				Jamuar, Saumya S.; Lam, Anh-Thu N.; Kircher, Martin; D'Gama, Alissa M.; Wang, Jian; Barry, Brenda J.; Zhang, Xiaochang; Hill, Robert Sean; Partlow, Jennifer N.; Rozzo, Aldo; Servattalab, Sarah; Mehta, Bhaven K.; Topcu, Meral; Amrom, Dina; Andermann, Eva; Dan, Bernard; Parrini, Elena; Guerrini, Renzo; Scheffer, Ingrid E.; Berkovic, Samuel F.; Leventer, Richard J.; Shen, Yiping; Wu, Bai Lin; Barkovich, A. James; Sahin, Mustafa; Chang, Bernard S.; Bamshad, Michael; Nickerson, Deborah A.; Shendure, Jay; Poduri, Annapurna; Yu, Timothy W.; Walsh, Christopher A.			Somatic Mutations in Cerebral Cortical Malformations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE INTELLECTUAL DISABILITY; EXOME; MOSAICISM; DISEASE; DYNC1H1; TUBB2B; AKT3	BACKGROUND Although there is increasing recognition of the role of somatic mutations in genetic disorders, the prevalence of somatic mutations in neurodevelopmental disease and the optimal techniques to detect somatic mosaicism have not been systematically evaluated. METHODS Using a customized panel of known and candidate genes associated with brain malformations, we applied targeted high-coverage sequencing (depth, = 200x) to leukocyte-derived DNA samples from 158 persons with brain malformations, including the double-cortex syndrome (subcortical band heterotopia, 30 persons), polymicrogyria with megalencephaly (20), periventricular nodular heterotopia (61), and pachygyria (47). We validated candidate mutations with the use of Sanger sequencing and, for variants present at unequal read depths, subcloning followed by colony sequencing. RESULTS Validated, causal mutations were found in 27 persons (17%; range, 10 to 30% for each phenotype). Mutations were somatic in 8 of the 27 (30%), predominantly in persons with the double-cortex syndrome (in whom we found mutations in DCX and LIS1), persons with periventricular nodular heterotopia (FLNA), and persons with pachygyria (TUBB2B). Of the somatic mutations we detected, 5 (63%) were undetectable with the use of traditional Sanger sequencing but were validated through subcloning and subsequent sequencing of the subcloned DNA. We found potentially causal mutations in the candidate genes DYNC1H1, KIF5C, and other kinesin genes in persons with pachygyria. CONCLUSIONS Targeted sequencing was found to be useful for detecting somatic mutations in patients with brain malformations. High-coverage sequencing panels provide an important complement to whole-exome and whole-genome sequencing in the evaluation of somatic mutations in neuropsychiatric disease. (Funded by the National Institute of Neurological Disorders and Stroke and others.)	[Jamuar, Saumya S.; Lam, Anh-Thu N.; D'Gama, Alissa M.; Barry, Brenda J.; Zhang, Xiaochang; Hill, Robert Sean; Partlow, Jennifer N.; Rozzo, Aldo; Servattalab, Sarah; Mehta, Bhaven K.; Yu, Timothy W.; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet & Gen, Manton Ctr Orphan Dis Res, Howard Hughes Med Inst, Boston, MA USA; [Wang, Jian; Shen, Yiping; Wu, Bai Lin] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Sahin, Mustafa; Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Jamuar, Saumya S.; Lam, Anh-Thu N.; D'Gama, Alissa M.; Barry, Brenda J.; Zhang, Xiaochang; Hill, Robert Sean; Partlow, Jennifer N.; Rozzo, Aldo; Servattalab, Sarah; Mehta, Bhaven K.; Yu, Timothy W.; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Jamuar, Saumya S.; Lam, Anh-Thu N.; D'Gama, Alissa M.; Barry, Brenda J.; Zhang, Xiaochang; Hill, Robert Sean; Partlow, Jennifer N.; Rozzo, Aldo; Servattalab, Sarah; Mehta, Bhaven K.; Sahin, Mustafa; Poduri, Annapurna; Yu, Timothy W.; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Shen, Yiping; Wu, Bai Lin] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chang, Bernard S.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Yu, Timothy W.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Jamuar, Saumya S.] KK Womens & Childrens Hosp, Dept Paediat, Singapore, Singapore; [Kircher, Martin; Bamshad, Michael; Nickerson, Deborah A.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wang, Jian; Shen, Yiping] Shanghai Childrens Med Ctr, Dept Lab Med, Shanghai, Peoples R China; [Topcu, Meral] Hacettepe Univ, Sch Med, Dept Pediat, Div Neurol, TR-06100 Ankara, Turkey; [Amrom, Dina; Andermann, Eva] McGill Univ, Montreal Neurol Hosp & Inst, Neurogenet Unit, Montreal, PQ, Canada; [Andermann, Eva] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Dan, Bernard] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Neurol, Brussels, Belgium; [Parrini, Elena; Guerrini, Renzo] Univ Florence, Childrens Hosp A Meyer, Pediat Neurol Unit & Labs, Florence, Italy; [Scheffer, Ingrid E.; Berkovic, Samuel F.] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic 3010, Australia; [Scheffer, Ingrid E.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Leventer, Richard J.] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia; [Shen, Yiping; Wu, Bai Lin] Claritas Genom, Cambridge, MA USA; [Walsh, Christopher A.] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02139 USA; [Walsh, Christopher A.] Harvard, Cambridge, MA USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Barkovich, A. James] USCF, Benioff Childrens Hosp, San Francisco, CA USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; KK Women's & Children's Hospital; University of Washington; University of Washington Seattle; Shanghai Jiao Tong University; Hacettepe University; McGill University; McGill University; Universite Libre de Bruxelles; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Francisco	Walsh, CA (corresponding author), Boston Childrens Hosp, Ctr Life Sci, Div Genet & Gen, 15062-2,3 Blackfan Circle, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Shendure, Jay/AAU-3684-2021; jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013; SAHIN, MUSTAFA/I-8653-2019; Kircher, Martin/HDL-9392-2022; Yu, Timothy W./AAF-5738-2019; Kircher, Martin/H-6909-2019; Parrini, Elena/K-5283-2016; Zhang, Xiaochang/G-4857-2014	Scheffer, Ingrid E/0000-0002-2311-2174; SAHIN, MUSTAFA/0000-0001-7044-2953; Yu, Timothy W./0000-0003-2988-7701; Kircher, Martin/0000-0001-9278-5471; Walsh, Christopher/0000-0002-0156-2238; Parrini, Elena/0000-0001-8933-7694; Dan, Bernard/0000-0002-2051-9876; Mehta, Bhaven/0000-0003-1077-7895; Guerrini, Renzo/0000-0002-7272-7079; Shendure, Jay/0000-0002-1516-1865; Berkovic, Samuel/0000-0003-4580-841X; Zhang, Xiaochang/0000-0001-5768-7470	National Institute of Neurological Disorders and Stroke; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, U54HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079277, R01NS073601, R01NS035129, R37NS035129, K23NS069784] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institute of Neurological Disorders and Stroke and others.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Cushion TD, 2013, BRAIN, V136, P536, DOI 10.1093/brain/aws338; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Huisman SA, 2013, J MED GENET, V50, P339, DOI 10.1136/jmedgenet-2012-101477; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jamuar S, 2012, EUR J MED GENET, V55, P167, DOI 10.1016/j.ejmg.2012.01.019; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Opitz JM, 2011, NEW ENGL J MED, V365, P660, DOI 10.1056/NEJMe1107384; Pagnamenta AT, 2012, J HUM GENET, V57, P70, DOI 10.1038/jhg.2011.128; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rohlin A, 2009, HUM MUTAT, V30, P1012, DOI 10.1002/humu.20980; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Willemsen MH, 2012, J MED GENET, V49, P179, DOI 10.1136/jmedgenet-2011-100542; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	27	215	220	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					733	743		10.1056/NEJMoa1314432	http://dx.doi.org/10.1056/NEJMoa1314432			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140959	Green Accepted			2022-12-24	WOS:000340509900008
J	Lu, PL; Bai, XC; Ma, D; Xie, T; Yan, CY; Sun, LF; Yang, GH; Zhao, YY; Zhou, R; Scheres, SHW; Shi, YG				Lu, Peilong; Bai, Xiao-chen; Ma, Dan; Xie, Tian; Yan, Chuangye; Sun, Linfeng; Yang, Guanghui; Zhao, Yanyu; Zhou, Rui; Scheres, Sjors H. W.; Shi, Yigong			Three-dimensional structure of human gamma-secretase	NATURE			English	Article							INTRAMEMBRANE PROTEOLYSIS; TRANSMEMBRANE DOMAIN-4; PRESENILIN; NICASTRIN; COMPLEX; BINDING; PROTEIN; RESOLUTION; APH-1; MODEL	The gamma-secretase complex, comprising presenilin 1 (PS1), PEN-2, APH-1 and nicastrin, is a membrane-embedded protease that controls a number of important cellular functions through substrate cleavage. Aberrant cleavage of the amyloid precursor protein (APP) results in aggregation of amyloid-beta, which accumulates in the brain and consequently causes Alzheimer's disease. Here we report the three-dimensional structure of an intact human gamma-secretase complex at 4.5 angstrom resolution, determined by cryo-electron-microscopy single-particle analysis. The gamma-secretase complex comprises a horseshoe-shaped transmembrane domain, which contains 19 transmembrane segments (TMs), and a large extracellular domain (ECD) from nicastrin, which sits immediately above the hollow space formed by the TM horseshoe. Intriguingly, nicastrin ECD is structurally similar to a large family of peptidases exemplified by the glutamate carboxypeptidase PSMA. This structure serves as an important basis for understanding the functional mechanisms of the gamma-secretase complex.	[Lu, Peilong; Ma, Dan; Xie, Tian; Sun, Linfeng; Zhao, Yanyu; Zhou, Rui; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Lu, Peilong; Ma, Dan; Xie, Tian; Yan, Chuangye; Sun, Linfeng; Yang, Guanghui; Zhao, Yanyu; Zhou, Rui; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Lu, Peilong; Ma, Dan; Xie, Tian; Yan, Chuangye; Sun, Linfeng; Yang, Guanghui; Zhao, Yanyu; Zhou, Rui; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China; [Bai, Xiao-chen; Scheres, Sjors H. W.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Yan, Chuangye; Yang, Guanghui] Tsinghua Univ, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; MRC Laboratory Molecular Biology; Tsinghua University	Scheres, SHW (corresponding author), MRC Lab Mol Biol, Cambridge Biomed Campus, Cambridge CB2 0QH, England.	scheres@mrc-lmb.cam.ac.uk; shi-lab@tsinghua.edu.cn	Scheres, Sjors H.W./AAY-2265-2021; Yan, Chuangye/AAJ-5832-2021; Bai, Xiao-chen/HGV-1244-2022	Scheres, Sjors H.W./0000-0002-0462-6540; Bai, Xiao-chen/0000-0002-4234-5686; Lu, Peilong/0000-0001-5894-9268; Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X; Xie, Tian/0000-0002-5445-664X	Ministry of Science and Technology of China [2009CB918801]; National Natural Science Foundation of China [30888001, 31021002, 31130002]; European Union Marie Curie Fellowship; UK Medical Research Council [MC_UP_A025_1013]; Medical Research Council [MC_UP_A025_1013] Funding Source: researchfish; MRC [MC_UP_A025_1013] Funding Source: UKRI	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Union Marie Curie Fellowship(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Wolfeand D. Selkoe for support and encouragement, and S. Chen, C. Savva, J. Grimmett and T. Darling for technical support. This work was funded by the Ministry of Science and Technology of China (2009CB918801 to Y.S.), National Natural Science Foundation of China (projects 30888001, 31021002 and 31130002 to Y.S.), a European Union Marie Curie Fellowship (to X. C. B.), and the UK Medical Research Council (MC_UP_A025_1013, to S.H.W.S.).	Alexandrov A, 2004, MOL CELL PROTEOMICS, V3, P934, DOI 10.1074/mcp.T400008-MCP200; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Bammens L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216978; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li Y, 2014, STRUCTURE, V22, P125, DOI 10.1016/j.str.2013.09.018; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Ogura T, 2006, BIOCHEM BIOPH RES CO, V345, P543, DOI 10.1016/j.bbrc.2006.04.025; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renzi F, 2011, J BIOL CHEM, V286, P21440, DOI 10.1074/jbc.M110.193326; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tang Ya-Ping, 2003, Dialogues Clin Neurosci, V5, P17; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Zhang AX, 2010, J AM CHEM SOC, V132, P12711, DOI 10.1021/ja104591m	60	253	268	8	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					166	+		10.1038/nature13567	http://dx.doi.org/10.1038/nature13567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043039	Green Accepted			2022-12-24	WOS:000340200700025
J	Wang, Y; Waters, J; Leung, ML; Unruh, A; Roh, W; Shi, XQ; Chen, K; Scheet, P; Vattathil, S; Liang, H; Multani, A; Zhang, H; Zhao, R; Michor, F; Meric-Bernstam, F; Navin, NE				Wang, Yong; Waters, Jill; Leung, Marco L.; Unruh, Anna; Roh, Whijae; Shi, Xiuqing; Chen, Ken; Scheet, Paul; Vattathil, Selina; Liang, Han; Multani, Asha; Zhang, Hong; Zhao, Rui; Michor, Franziska; Meric-Bernstam, Funda; Navin, Nicholas E.			Clonal evolution in breast cancer revealed by single nucleus genome sequencing	NATURE			English	Article							GROWTH-RATE; CARCINOMAS; MUTATIONS; HETEROGENEITY; REARRANGEMENT; HYBRIDIZATION; NUCLEOTIDE; PATTERNS; EXPRESS	Sequencing studies of breast tumour cohorts have identified many prevalent mutations, but provide limited insight into the genomic diversity within tumours. Here we developed a whole-genome and exome single cell sequencing approach called nuc-seq that uses G2/M nuclei to achieve 91% mean coverage breadth. We applied this method to sequence single normal and tumour nuclei from an oestrogen-receptor-positive(ER+) breast cancer and a triple-negative ductal carcinoma. In parallel, we performed single nuclei copy number profiling. Our data show that aneuploid rearrangements occurred early in tumour evolution and remained highly stable as the tumour masses clonally expanded. In contrast, point mutations evolved gradually, generating extensive clonal diversity. Using targeted single-molecule sequencing, many of the diverse mutations were shown to occur at low frequencies (<10%) in the tumour mass. Using mathematical modelling we found that the triple-negative tumour cells had an increased mutation rate (13.3x), whereas the ER+ tumour cells did not. These findings have important implications for the diagnosis, therapeutic treatment and evolution of chemoresistance in breast cancer.	[Wang, Yong; Waters, Jill; Leung, Marco L.; Unruh, Anna; Roh, Whijae; Shi, Xiuqing; Multani, Asha; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Leung, Marco L.; Scheet, Paul; Vattathil, Selina; Navin, Nicholas E.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Chen, Ken; Liang, Han; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Scheet, Paul] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Zhang, Hong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Zhao, Rui; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Zhao, Rui; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center	Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	nnavin@mdanderson.org	Leung, Marco/AAH-3178-2021; Chen, Ken/AAU-1432-2021	Chen, Ken/0000-0003-4013-5279; Casasent, Anna/0000-0002-7857-179X; Roh, Whijae/0000-0002-7395-9939; Wang, Yong/0000-0001-7183-3737	NIH [R21CA174397-01, TR000371, U24CA143883]; NCI [1RO1CA169244-01, RO1CA172652, CA016672]; T.C. Hsu and the Alice-Reynolds Kleberg Foundation; Center for Genetics Genomics; Susan Komen [SAC10006]; PS-OC [U54CA143798]; Dell Foundation; ALA; NATIONAL CANCER INSTITUTE [R01CA169244, P30CA016672, R21CA174397, U24CA143883, P50CA098258, R01CA172652, U54CA143798] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); T.C. Hsu and the Alice-Reynolds Kleberg Foundation; Center for Genetics Genomics; Susan Komen(Susan G. Komen Breast Cancer Foundation); PS-OC; Dell Foundation; ALA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank L. Ramagli, H. Tang, E. Thompson, K. Khanna, W. Schober and J. Tyler. We are grateful to S. Kennedy and L. Loeb for help with the duplex protocols. We thank M. Edgerton, J. Hicks, M. Wigler and J. Kendall for discussions. We thank R. Krahe and M. Rui for reviewing the manuscript. N.E.N. is a Nadia's Gift Foundation Damon Runyon-Rachleff Innovator (DRR-25-13). This research was supported by grants to N.E.N. from NIH (R21CA174397-01) and NCI (1RO1CA169244-01). N.E.N. was supported by T. C. Hsu and the Alice-Reynolds Kleberg Foundation. N.E.N. and P. S. were supported by the Center for Genetics & Genomics. F.M.-B was supported by an NIH UL1 (TR000371) and Susan Komen (SAC10006). K. C. was supported by the NCI (RO1CA172652). H. L. was supported by the NIH (U24CA143883). F. M. was supported by PS-OC (U54CA143798). K. C. and H. L. were supported by the Dell Foundation. M. L. L. is a CPRIT scholar and is supported by ALA. This work was also supported by an NCI center grant (CA016672). A.U. is a Rosalie B. Hite Fellow.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dichosa AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037387; Drake JW, 1998, GENETICS, V148, P1667; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grubor V, 2009, BLOOD, V113, P1294, DOI 10.1182/blood-2008-05-158865; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; KUROISHI T, 1990, JPN J CANCER RES, V81, P454, DOI 10.1111/j.1349-7006.1990.tb02591.x; Kytola S, 2000, GENE CHROMOSOME CANC, V28, P308, DOI 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; Lorenz MO, 1905, J AM STAT ASSOC, V9, P209; Luria SE, 1943, GENETICS, V28, P491; McClintock B, 1941, GENETICS, V26, P234; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Michaelson J., 2003, J WOMENS IMAGING, V5, P11; Nachman MW, 2000, GENETICS, V156, P297; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	51	673	706	3	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					155	+		10.1038/nature13600	http://dx.doi.org/10.1038/nature13600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25079324	Green Submitted, Green Accepted			2022-12-24	WOS:000340200700023
J	Meckenstock, RU; von Netzer, F; Stumpp, C; Lueders, T; Himmelberg, AM; Hertkorn, N; Schmitt-Kopplin, P; Harir, M; Hosein, R; Haque, S; Schulze-Makuch, D				Meckenstock, Rainer U.; von Netzer, Frederick; Stumpp, Christine; Lueders, Tillmann; Himmelberg, Anne M.; Hertkorn, Norbert; Schmitt-Kopplin, Philipp; Harir, Mourad; Hosein, Riad; Haque, Shirin; Schulze-Makuch, Dirk			Water droplets in oil are microhabitats for microbial life	SCIENCE			English	Article							DEEP SUBSURFACE; ANAEROBIC DEGRADATION; BIODEGRADATION	Anaerobic microbial degradation of hydrocarbons, typically occurring at the oil-water transition zone, influences the quality of oil reservoirs. In Pitch Lake, Trinidad and Tobago-the world's largest asphalt lake-we found that microorganisms are metabolically active in minuscule water droplets (1 to 3 microliters) entrapped in oil. Pyrotag sequencing of individual droplet microbiomes revealed complex methanogenic microbial communities actively degrading the oil into a diverse range of metabolites, as shown by nuclear magnetic resonance and Fourier transform ion cyclotron resonance mass spectrometry. High salinity and water-stable isotopes of the droplets indicate a deep subsurface origin. The 13.5% water content and the large surface area of the droplets represent an underestimated potential for biodegradation of oil away from the oil-water transition zone.	[Meckenstock, Rainer U.; von Netzer, Frederick; Stumpp, Christine; Lueders, Tillmann; Himmelberg, Anne M.] Helmholtz Zentrum Munchen, Inst Groundwater Ecol, D-85764 Neuherberg, Germany; [Hertkorn, Norbert; Schmitt-Kopplin, Philipp; Harir, Mourad] Helmholtz Zentrum Munchen, Res Unit Biogeochem, D-85764 Neuherberg, Germany; [Hosein, Riad] Univ W Indies, Fac Sci & Agr, Dept Chem, St Augustine, Trinidad Tobago; [Haque, Shirin] Univ W Indies, Fac Sci & Agr, Dept Phys, St Augustine, Trinidad Tobago; [Schulze-Makuch, Dirk] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Schulze-Makuch, Dirk] Tech Univ Berlin, Ctr Astron & Astrophys, D-10623 Berlin, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University West Indies Mona Jamaica; University West Indies Saint Augustine; University West Indies Mona Jamaica; University West Indies Saint Augustine; Washington State University; Technical University of Berlin	Meckenstock, RU (corresponding author), Univ Duisburg Essen, Biofilm Ctr, D-45141 Essen, Germany.	rainer.meckenstock@uni-due.de	Schmitt-Kopplin, Philippe/H-6271-2011; Himmelberg, Anne/A-7237-2015; Lueders, Tillmann/B-1486-2013; Stumpp, Christine/AGG-8290-2022; Hertkorn, Norbert/AAA-5990-2022; Meckenstock, Rainer/K-6894-2012; Stumpp, Christine/K-6934-2012; von Netzer, Frederick/E-1442-2013	Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Himmelberg, Anne/0000-0001-7535-0134; Lueders, Tillmann/0000-0002-9361-5009; Stumpp, Christine/0000-0001-9041-2735; Schulze-Makuch, Dirk/0000-0002-1923-9746	Helmholtz Zentrum Munchen; DFG [SPP1319]	Helmholtz Zentrum Munchen(Helmholtz Association); DFG(German Research Foundation (DFG))	We thank G. Barthel, K. Hormann, and M. Stockl for technical assistance and B. Horsefield for helpful discussions. Funding was provided by Helmholtz Zentrum Munchen and the DFG priority program SPP1319. Pyrotag sequencing data for community analyses are deposited at NCBI BioSample (www.ncbi.nlm.nih.gov/biosample) under accession number SRP036082. Original data from FTICR-MS analyses are provided in the supplementary materials.	Aitken CM, 2004, NATURE, V431, P291, DOI 10.1038/nature02922; An DS, 2013, ENVIRON SCI TECHNOL, V47, P10708, DOI 10.1021/es4020184; Annweiler E, 2002, APPL ENVIRON MICROB, V68, P852, DOI 10.1128/AEM.68.2.852-858.2002; Battani B., 2010, SHALE TECTONICS, V93, P225; Bennett B, 2013, ORG GEOCHEM, V56, P94, DOI 10.1016/j.orggeochem.2012.12.011; Clark I., 1997, ENV ISOTOPES HYDROLO; Eberlein C, 2013, MOL MICROBIOL, V88, P1032, DOI 10.1111/mmi.12238; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Horita J, 2005, ISOTOPES IN THE WATER CYCLE: PAST, PRESENT AND FUTURE OF A DEVELOPING SCIENCE, P271, DOI 10.1007/1-4020-3023-1_17; Jones DM, 2008, NATURE, V451, P176, DOI 10.1038/nature06484; Kim JS, 2007, APPL ENVIRON MICROB, V73, P4579, DOI 10.1128/AEM.01372-06; Meckenstock RU, 2011, CURR OPIN BIOTECH, V22, P406, DOI 10.1016/j.copbio.2011.02.009; Schatzinger R. A., 1999, RESERVOIR CHARACTERI; Schulze-Makuch D, 2011, ASTROBIOLOGY, V11, P241, DOI 10.1089/ast.2010.0488	15	91	97	3	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					673	676		10.1126/science.1252215	http://dx.doi.org/10.1126/science.1252215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104386				2022-12-24	WOS:000339962800039
J	Hotchkiss, RS; Moldawer, LL				Hotchkiss, Richard S.; Moldawer, Lyle L.			Parallels between Cancer and Infectious Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMMUNOTHERAPY		[Hotchkiss, Richard S.] Washington Univ, Dept Anesthesiol, Sch Med, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Dept Surg, Sch Med, St Louis, MO 63130 USA; [Moldawer, Lyle L.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; University of Florida	Hotchkiss, RS (corresponding author), Washington Univ, Dept Anesthesiol, Sch Med, St Louis, MO 63130 USA.			Moldawer, Lyle/0000-0002-9041-9838				Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Deloitte CIO Journal Editor, 2014, WALL STREET J; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel A, 2010, J ANTIMICROB CHEMOTH, V65, P2697, DOI 10.1093/jac/dkq359	7	128	132	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					380	383		10.1056/NEJMcibr1404664	http://dx.doi.org/10.1056/NEJMcibr1404664			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054723	Green Published			2022-12-24	WOS:000339339800017
J	Goubau, D; Schlee, M; Deddouche, S; Pruijssers, AJ; Zillinger, T; Goldeck, M; Schuberth, C; Van der Veen, AG; Fujimura, T; Rehwinkel, J; Iskarpatyoti, JA; Barchet, W; Ludwig, J; Dermody, TS; Hartmann, G; Sousa, CRE				Goubau, Delphine; Schlee, Martin; Deddouche, Safia; Pruijssers, Andrea J.; Zillinger, Thomas; Goldeck, Marion; Schuberth, Christine; Van der Veen, Annemarthe G.; Fujimura, Tsutomu; Rehwinkel, Jan; Iskarpatyoti, Jason A.; Barchet, Winfried; Ludwig, Janos; Dermody, Terence S.; Hartmann, Gunther; Reis e Sousa, Caetano			Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5 '-diphosphates	NATURE			English	Article							DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; 5'-TRIPHOSPHATE RNA; DENDRITIC CELLS; INNATE IMMUNITY; VIRUS; INFECTION; ACID; GENERATION; INSIGHTS	Mammalian cells possess mechanisms to detect and defend themselves from invading viruses. In the cytosol, the RIG-I-like receptors (RLRs), RIG-I (retinoic acid-inducible gene I; encoded by DDX58) and MDA5 (melanoma differentiation-associated gene 5; encoded by IFIH1) sense atypical RNAs associated with virus infection(1,2). Detection triggers a signalling cascade via the adaptor MAVS that culminates in the production of type I interferons (IFN-alpha and beta; hereafter IFN), which are key antiviral cytokines. RIG-I and MDA5 are activated by distinct viral RNA structures and much evidence indicates that RIG-I responds to RNAs bearing a triphosphate (ppp) moiety in conjunction with a blunt-ended, base-paired region at the 5'-end (reviewed in refs 1-3). Here we show that RIG-I also mediates antiviral responses to RNAs bearing 5'-diphosphates (5'pp). Genomes from mammalian reoviruses with 5'pp termini, 5'pp-RNA isolated from yeast L-A virus, and base-paired 5'pp-RNAs made by in vitro transcription or chemical synthesis, all bind to RIG-I and serve as RIG-I agonists. Furthermore, a RIG-I-dependent response to 5'pp-RNA is essential for controlling reovirus infection in cultured cells and in mice. Thus, the minimal determinant for RIG-I recognition is a base-paired RNA with 5'pp. Such RNAs are found in some viruses but not in uninfected cells, indicating that recognition of 5'pp-RNA, like that of 5'ppp-RNA, acts as a powerful means of self/non-self discrimination by the innate immune system.	[Goubau, Delphine; Deddouche, Safia; Van der Veen, Annemarthe G.; Rehwinkel, Jan; Reis e Sousa, Caetano] Canc Res UK, London Res Inst, Immunobiol Lab, London WC2A 3LY, England; [Schlee, Martin; Zillinger, Thomas; Goldeck, Marion; Schuberth, Christine; Barchet, Winfried; Ludwig, Janos; Hartmann, Gunther] Univ Klinikum Bonn, Inst Klin Chem, D-53127 Bonn, Germany; [Schlee, Martin; Zillinger, Thomas; Goldeck, Marion; Schuberth, Christine; Barchet, Winfried; Ludwig, Janos; Hartmann, Gunther] Univ Klinikum Bonn, Klin Pharmakol, D-53127 Bonn, Germany; [Pruijssers, Andrea J.; Iskarpatyoti, Jason A.; Dermody, Terence S.] Vanderbilt Univ, Dept Pediat, Sch Med, Nashville, TN 37232 USA; [Pruijssers, Andrea J.; Iskarpatyoti, Jason A.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37232 USA; [Fujimura, Tsutomu] Univ Salamanca, Inst Biol Func & Genom, Consejo Super Invest Cient, Salamanca 37007, Spain; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Cancer Research UK; University of Bonn; University of Bonn; Vanderbilt University; Vanderbilt University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Vanderbilt University	Goubau, D (corresponding author), Canc Res UK, London Res Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	delphine.goubau@cancer.org.uk; caetano@cancer.org.uk	Schlee, Martin/AAL-1238-2021; Goldeck, Marion/AAX-5599-2020; Reis e Sousa, Caetano/ABD-7322-2021; Ludwig, Janos/I-3544-2013; Hartmann, Gunther/P-7492-2017; Fujimura, Tsutomu/K-5807-2014; Reis e Sousa, Caetano/O-1657-2014; Zillinger, Thomas/AAD-7320-2020; Pruijssers, Andrea J/S-5725-2018; Rehwinkel, Jan/CAG-1436-2022	Reis e Sousa, Caetano/0000-0001-7392-2119; Hartmann, Gunther/0000-0003-1021-2018; Fujimura, Tsutomu/0000-0002-9457-6769; Reis e Sousa, Caetano/0000-0001-7392-2119; Zillinger, Thomas/0000-0002-0866-4835; Pruijssers, Andrea J/0000-0001-7910-626X; Rehwinkel, Jan/0000-0003-3841-835X; Goldeck, Marion/0000-0003-1899-4763; Barchet, Winfried/0000-0002-6745-6606; Schlee, Martin/0000-0003-3671-7639	Cancer Research UK; European Research Council (ERC Advanced Researcher Grant) [AdG-2010-268670]; Public Health Service award [R37 AI038296]; Elizabeth B. Lamb Center for Pediatric Research; Fundacion Ramon Areces; Deutsche Forschungsgemeinschaft [SFB670, DFG SCHL1930/1-1, SFB704, SFB832, KFO177]; DFG Excellence Cluster ImmunoSensation; German Center of Infectious Disease (DZIF); MRC [MC_UU_12010/8] Funding Source: UKRI; Cancer Research UK [15689] Funding Source: researchfish; Medical Research Council [MC_UU_12010/8] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050800, R01AI038296, R37AI038296] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); European Research Council (ERC Advanced Researcher Grant); Public Health Service award(United States Department of Health & Human ServicesUnited States Public Health Service); Elizabeth B. Lamb Center for Pediatric Research; Fundacion Ramon Areces; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Excellence Cluster ImmunoSensation(German Research Foundation (DFG)); German Center of Infectious Disease (DZIF); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Akira and J. Tschopp (deceased) for gifts of mice and cells, as well as N. O'Reilly, the LRI Equipment Park (D. Phillips), and the LRI Protein Analysis and Proteomics Facility (R. George and S. Kjaer) for technical assistance. We also thank P. Maillard and K. Snelgrove for reading the manuscript, P. Tortora, G. Deho and M. Freire for their insights on the synthesis of poly(I: C) and all members of the CRUK Immunobiology Laboratory for helpful discussions and comments. C. R. S., D. G., S. D. and A. G. V. V. are funded by Cancer Research UK, a prize from Fondation Bettencourt-Schueller, and a grant from the European Research Council (ERC Advanced Researcher Grant AdG-2010-268670). A. J. P. and T. S. D. are supported by Public Health Service award R37 AI038296 and the Elizabeth B. Lamb Center for Pediatric Research. T. F. is supported by the Fundacion Ramon Areces. G. H., M. S. and W. B. are supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de; SFB670 to M. S., W. B. and G. H., DFG SCHL1930/1-1 to M. S., SFB704 to G. H. and W. B., SFB832 and KFO177 to G. H.). G. H. and M. S. are supported by the DFG Excellence Cluster ImmunoSensation. G. H. is supported by the German Center of Infectious Disease (DZIF).	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Boehme KW, 2011, J VIROL, V85, P11781, DOI 10.1128/JVI.02289-10; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Dermody TS, 2013, FIELDS VIROLOGY, P1304; DIAZRUIZ JR, 1978, PREP BIOCHEM, V8, P1, DOI 10.1080/00327487808068215; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Fujimura T, 2011, P NATL ACAD SCI USA, V108, P17667, DOI 10.1073/pnas.1111900108; Fujimura T, 2010, J BIOL CHEM, V285, P22909, DOI 10.1074/jbc.M110.138982; Gerlier D, 2011, MICROBIOL MOL BIOL R, V75, P468, DOI 10.1128/MMBR.00007-11; Goldeck M, 2014, ANGEW CHEM INT EDIT, V53, P4694, DOI 10.1002/anie.201400672; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; GRUNBERGMANAGO M, 1955, SCIENCE, V122, P907, DOI 10.1126/science.122.3176.907; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Kohlway A, 2013, EMBO REP, V14, P772, DOI 10.1038/embor.2013.108; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rehwinkel J, 2013, CURR OPIN MICROBIOL, V16, P485, DOI 10.1016/j.mib.2013.04.009; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Schlee M, 2013, IMMUNOBIOLOGY, V218, P1322, DOI 10.1016/j.imbio.2013.06.007; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Vela A, 2012, J BIOL CHEM, V287, P42564, DOI 10.1074/jbc.M112.385146; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863	34	364	376	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					372	+		10.1038/nature13590	http://dx.doi.org/10.1038/nature13590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25119032	Green Accepted, Bronze			2022-12-24	WOS:000342988600053
J	Marusyk, A; Tabassum, DP; Altrock, PM; Almendro, V; Michor, F; Polyak, K				Marusyk, Andriy; Tabassum, Doris P.; Altrock, Philipp M.; Almendro, Vanessa; Michor, Franziska; Polyak, Kornelia			Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity	NATURE			English	Article							IL-6 FAMILY CYTOKINE; CANCER; EVOLUTION; MODEL; TUMORIGENESIS; INFLAMMATION; COMPETITION; MUTATIONS; SELECTION; LEUKEMIA	Cancers arise through a process of somatic evolution that can result in substantial sub-clonal heterogeneity within tumours. The mechanisms responsible for the coexistence of distinct sub-clones and the biological consequences of this coexistence remain poorly understood. Here we used a mouse xenograft model to investigate the impact of sub-clonal heterogeneity on tumour phenotypes and the competitive expansion of individual clones. We found that tumour growth can be driven by a minor cell subpopulation, which enhances the proliferation of all cells within a tumour by overcoming environmental constraints and yet can be outcompeted by faster proliferating competitors, resulting in tumour collapse. We developed a mathematical modelling framework to identify the rules underlying the generation of intra-tumour clonal heterogeneity. We found that non-cell-autonomous driving of tumour growth, together with clonal interference, stabilizes sub-clonal heterogeneity, thereby enabling inter-clonal interactions that can lead to new phenotypic traits.	[Marusyk, Andriy; Tabassum, Doris P.; Almendro, Vanessa; Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Marusyk, Andriy; Almendro, Vanessa; Polyak, Kornelia] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Marusyk, Andriy; Almendro, Vanessa; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Tabassum, Doris P.; Polyak, Kornelia] Harvard Univ, Sch Med, BBS Program, Boston, MA 02115 USA; [Altrock, Philipp M.; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Altrock, Philipp M.; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Altrock, Philipp M.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Polyak, Kornelia] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Polyak, Kornelia] Broad Inst, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Polyak, K (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	kornelia_polyak@dfci.harvard.edu	Kessenbrock, Kai/B-6936-2011; Altrock, Philipp/X-9063-2018	Altrock, Philipp/0000-0001-7731-3345	Dana-Farber Cancer Institute Physical Sciences-Oncology Center [U54CA143798]; CDRMP Breast Cancer Research Program [W81XWH-09-1-0561]; Cellex Foundation; Deutsche Akademie der Naturforscher Leopoldina [LPDS2012-12]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute Physical Sciences-Oncology Center; CDRMP Breast Cancer Research Program; Cellex Foundation; Deutsche Akademie der Naturforscher Leopoldina; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. DeGregori, A. Goldman, A. Rozhok, M. Gonen and members of the Polyak and Michor laboratories for their critical reading of this manuscript and discussions. We thank L. Cameron in the DFCI Confocal Microscopy for her technical support. This work was supported by the Dana-Farber Cancer Institute Physical Sciences-Oncology Center (U54CA143798 to F. M.), CDRMP Breast Cancer Research Program W81XWH-09-1-0561 (A. M.), Cellex Foundation (V. A.), Deutsche Akademie der Naturforscher Leopoldina LPDS2012-12 (P. M. A.) and the Breast Cancer Research Foundation (K.P.).	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; DeGregori J, 2013, ONCOGENE, V32, P1869, DOI 10.1038/onc.2012.281; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Maley CC, 2004, CANCER EPIDEM BIOMAR, V13, P1375; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Nagy JD, 2004, B MATH BIOL, V66, P663, DOI 10.1016/j.bulm.2003.10.001; Navin NE, 2010, MOL ONCOL, V4, P267, DOI 10.1016/j.molonc.2010.04.010; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Putoczki T, 2010, J LEUKOCYTE BIOL, V88, P1109, DOI 10.1189/jlb.0410226; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Weinberg RA, 2007, BIOL CANC; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702	29	378	391	3	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					54	+		10.1038/nature13556	http://dx.doi.org/10.1038/nature13556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25079331	Green Submitted, Green Accepted			2022-12-24	WOS:000342420800033
J	Zid, BM; O'Shea, EK				Zid, Brian M.; O'Shea, Erin K.			Promoter sequences direct cytoplasmic localization and translation of mRNAs during starvation in yeast	NATURE			English	Article							SHOCK TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; HEAT-SHOCK; PROCESSING BODIES; STRESS GRANULES; P-BODIES; IN-VIVO; GENE; STABILITY; EXPRESSION	A universal feature of the response to stress and nutrient limitation is transcriptional upregulation of genes that encode proteins important for survival. Under many such conditions, the overall protein synthesis level is reduced, thereby dampening the stress response at the level of protein expression(1). For example, during glucose starvation in Saccharomyces cerevisiae (yeast), translation is rapidly repressed, yet the transcription of many stress-and glucose-repressed genes is increased(2,3). Here we show, using ribosomal profiling and microscopy, that this transcriptionally upregulated gene set consists of two classes: one class produces messenger RNAs that are translated during glucose starvation and are diffusely localized in the cytoplasm, including many heat-shock protein mRNAs; and the other class produces mRNAs that are not efficiently translated during glucose starvation and are concentrated in foci that co-localize with P bodies and stress granules, a class that isenriched for mRNAs involved in glucose metabolism. Surprisingly, the information specifying the differential localization and protein production of these two classes of mRNA is encoded in the promoter sequence: promoter responsiveness to heat-shock factor 1 (Hsf1) specifies diffuse cytoplasmic localization and higher protein production on glucose starvation. Thus, promoter sequences can influence not only the levels of mRNAs but also the subcellular localization of mRNAs and the efficiency with which they are translated, enabling cells to tailor protein production to the environmental conditions.	[Zid, Brian M.; O'Shea, Erin K.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Zid, Brian M.; O'Shea, Erin K.] Harvard Univ, Ctr Syst Biol, Fac Arts & Sci, Cambridge, MA 02138 USA; [O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	O'Shea, EK (corresponding author), Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA.	Erin_Oshea@harvard.edu		Zid, Brian/0000-0003-1876-2479	American Cancer Society; New England Division Funding A Cure initiative; Howard Hughes Medical Institute	American Cancer Society(American Cancer Society); New England Division Funding A Cure initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank A. Subramaniam, S. Mukherji, V. Denic, B. Stern and M. Waldram for feedback on the paper, members of the O'Shea, Denic, and Calarco laboratories for discussions, and C. Daly for sequencing assistance. This research was supported by the American Cancer Society and the New England Division Funding A Cure initiative (B.M.Z.) and the Howard Hughes Medical Institute (E.K.O.).	Arribere JA, 2011, MOL CELL, V44, P745, DOI 10.1016/j.molcel.2011.09.019; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cook KE, 2012, G3-GENES GENOM GENET, V2, P1129, DOI 10.1534/g3.112.003251; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Haim-Vilmovsky L, 2009, NAT PROTOC, V4, P1274, DOI 10.1038/nprot.2009.115; Hansen AS, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.56; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lutfiyya LL, 1998, GENETICS, V150, P1377; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Simpson CE, 2012, BIOCHEM SOC T, V40, P794, DOI 10.1042/BST20120078; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; SUSEK RE, 1990, MOL CELL BIOL, V10, P6362, DOI 10.1128/MCB.10.12.6362; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X	29	127	129	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					117	+		10.1038/nature13578	http://dx.doi.org/10.1038/nature13578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25119046	Green Accepted, Green Submitted			2022-12-24	WOS:000342420800047
J	Schiering, C; Krausgruber, T; Chomka, A; Frohlich, A; Adelmann, K; Wohlfert, EA; Pott, J; Griseri, T; Bollrath, J; Hegazy, AN; Harrison, OJ; Owens, BMJ; Lohning, M; Belkaid, Y; Fallon, PG; Powrie, F				Schiering, Chris; Krausgruber, Thomas; Chomka, Agnieszka; Froehlich, Anja; Adelmann, Krista; Wohlfert, Elizabeth A.; Pott, Johanna; Griseri, Thibault; Bollrath, Julia; Hegazy, Ahmed N.; Harrison, Oliver J.; Owens, Benjamin M. J.; Loehning, Max; Belkaid, Yasmine; Fallon, Padraic G.; Powrie, Fiona			The alarmin IL-33 promotes regulatory T-cell function in the intestine	NATURE			English	Article							AMELIORATES EXPERIMENTAL COLITIS; INFLAMMATORY-BOWEL-DISEASE; TRANSCRIPTION FACTOR FOXP3; ULCERATIVE-COLITIS; DEPENDENT COLITIS; SOLUBLE ST2; CYTOKINE; MICE; RESPONSES; COMPLEX	FOXP3+ regulatory T cells (T-reg cells) are abundant in the intestine, where they prevent dysregulated inflammatory responses to self and environmental stimuli. It is now appreciated that T-reg cells acquire tissue-specific adaptations that facilitate their survival and function(1); however, key host factors controlling theT(reg) response in the intestine are poorly understood. The interleukin (IL)-1 family member IL-33 is constitutively expressed in epithelial cells at barrier sites(2), where it functions as an endogenous danger signal, or alarmin, in response to tissue damage(3). Recent studies in humans have described high levels of IL-33 in inflamed lesions of inflammatory bowel disease patients(4-7), suggesting a role for this cytokine in disease pathogenesis. In the intestine, both protective and pathological roles for IL-33 have been described in murine models of acute colitis(8-11), but its contribution to chronic inflammation remains ill defined. Here we show in mice that the IL-33 receptor ST2 is preferentially expressed on colonic T-reg cells, where it promotes T-reg function and adaptation to the inflammatory environment. IL-33 signalling in T cells stimulates T-reg responses in several ways. First, it enhances transforming growth factor (TGF)-beta 1-mediated differentiation of T-reg cells and, second, it provides a necessary signal for T-reg-cell accumulation and maintenance in inflamed tissues. Strikingly, IL-23, a key pro-inflammatory cytokine in the pathogenesis of inflammatory bowel disease, restrained T-reg responses through inhibition of IL-33 responsiveness. These results demonstrate a hitherto unrecognized link between an endogenous mediator of tissue damage and a major anti-inflammatory pathway, and suggest that the balance between IL-33 and IL-23 may be a key controller of intestinal immune responses.	[Schiering, Chris; Krausgruber, Thomas; Chomka, Agnieszka; Adelmann, Krista; Griseri, Thibault; Bollrath, Julia; Hegazy, Ahmed N.; Owens, Benjamin M. J.; Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Nuffield Dept Clin Med,Expt Med Div, Oxford OX3 9DU, England; [Froehlich, Anja; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Froehlich, Anja; Loehning, Max] German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Wohlfert, Elizabeth A.; Belkaid, Yasmine] NIAID, Program Barrier Immun & Repair, Mucosal Immunol Sect, Lab Parasit Dis,NIH, Bethesda, MD 20892 USA; [Pott, Johanna; Harrison, Oliver J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Fallon, Padraic G.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Dublin 2, Ireland	University of Oxford; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; Trinity College Dublin	Powrie, F (corresponding author), Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Nuffield Dept Clin Med,Expt Med Div, Oxford OX3 9DU, England.	fiona.powrie@path.ox.ac.uk	wohlfert, beth/ABA-2255-2020; Krausgruber, Thomas/H-8490-2018; Fallon, Padraic/Y-2711-2019; Löhning, Max/AAL-2967-2021	Krausgruber, Thomas/0000-0002-1374-0329; Fallon, Padraic/0000-0002-8401-7293; Löhning, Max/0000-0001-6382-7281; Hegazy, Ahmed N./0000-0002-2946-8251; Schiering, Chris/0000-0001-7902-6024; Harrison, Oliver/0000-0003-1515-9586; Stockenhuber, Krista/0000-0003-3608-064X; Pott, Johanna/0000-0003-4439-725X; Owens, Benjamin/0000-0003-4710-6841; Belkaid, Yasmine/0000-0001-9962-3571	Wellcome Trust; Fondation Louis Jeantet; European Molecular Biology Organization long-term fellowship [ALTF 116-2012]; Science Foundation Ireland; Volkswagen Foundation (Lichtenberg Program); BMBF (e:Bio/T-Sys); Oxford-UCB Pharma Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001133, ZIAAI001132] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I005609/1] Funding Source: researchfish; Wellcome Trust [095688/Z/11/Z] Funding Source: researchfish; BBSRC [BB/I005609/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Fondation Louis Jeantet; European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Volkswagen Foundation (Lichtenberg Program); BMBF (e:Bio/T-Sys)(Federal Ministry of Education & Research (BMBF)); Oxford-UCB Pharma Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	C. S., K. A., A. C., O.J.H. and F. P. are supported by the Wellcome Trust. F. P. is also supported by the Fondation Louis Jeantet. A.N.H. is supported by a European Molecular Biology Organization long-term fellowship (ALTF 116-2012). P. G. F. is supported by Science Foundation Ireland. M. L. and A. F. are supported by the Volkswagen Foundation (Lichtenberg Program) and BMBF (e:Bio/T-Sys). B.M.J.O. is supported by an Oxford-UCB Pharma Postdoctoral Fellowship. We thank all members of the Oxford Translational Gastroenterology Unit for assistance and support. We are grateful to H. Ferry and K. Alford for essential flow cytometry support and the staff of the University of Oxford for animal care. We are also grateful to D. Baban for conducting microarray hybridizations.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Beltran CJ, 2010, INFLAMM BOWEL DIS, V16, P1097, DOI 10.1002/ibd.21175; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Diaz-Jimenez D, 2011, WORLD J GASTROENTERO, V17, P2181, DOI 10.3748/wjg.v17.i17.2181; Duan LH, 2012, MOL MED, V18, P753, DOI 10.2119/molmed.2011.00428; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Gross P, 2012, INFLAMM BOWEL DIS, V18, P1900, DOI 10.1002/ibd.22900; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sedhom MAK, 2013, GUT, V62, P1714, DOI 10.1136/gutjnl-2011-301785; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wasserman A, 2012, ISR MED ASSOC J, V14, P620; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	36	637	651	7	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					564	+		10.1038/nature13577	http://dx.doi.org/10.1038/nature13577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25043027	Green Accepted			2022-12-24	WOS:000342075800044
J	Gragert, L; Eapen, M; Williams, E; Freeman, J; Spellman, S; Baitty, R; Hartzman, R; Rizzo, JD; Horowitz, M; Confer, D; Maiers, M				Gragert, Loren; Eapen, Mary; Williams, Eric; Freeman, John; Spellman, Stephen; Baitty, Robert; Hartzman, Robert; Rizzo, J. Douglas; Horowitz, Mary; Confer, Dennis; Maiers, Martin			HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORD BLOOD TRANSPLANTATION; UNRELATED DONOR; RETROSPECTIVE ANALYSIS; HAPLOTYPE FREQUENCIES; ACUTE-LEUKEMIA; BONE-MARROW; NATIONAL REGISTRY; OUTCOMES; IMPACT; ADULTS	BACKGROUND Hematopoietic stem-cell transplantation (HSCT) is a potentially lifesaving therapy for several blood cancers and other diseases. For patients without a suitable related HLA-matched donor, unrelated-donor registries of adult volunteers and banked umbilical cord-blood units, such as the Be the Match Registry operated by the National Marrow Donor Program (NMDP), provide potential sources of donors. Our goal in the present study was to measure the likelihood of finding a suitable donor in the U. S. registry. METHODS Using human HLA data from the NMDP donor and cord-blood-unit registry, we built population-based genetic models for 21 U. S. racial and ethnic groups to predict the likelihood of identifying a suitable donor (either an adult donor or a cord-blood unit) for patients in each group. The models incorporated the degree of HLA matching, adult-donor availability (i.e., ability to donate), and cord-blood-unit cell dose. RESULTS Our models indicated that most candidates for HSCT will have a suitable (HLA-matched or minimally mismatched) adult donor. However, many patients will not have an optimal adult donor - that is, a donor who is matched at high resolution at HLA-A, HLA-B, HLA-C, and HLA-DRB1. The likelihood of finding an optimal donor varies among racial and ethnic groups, with the highest probability among whites of European descent, at 75%, and the lowest probability among blacks of South or Central American descent, at 16%. Likelihoods for other groups are intermediate. Few patients will have an optimal cord-blood unit - that is, one matched at the antigen level at HLA-A and HLA-B and matched at high resolution at HLA-DRB1. However, cord-blood units mismatched at one or two HLA loci are available for almost all patients younger than 20 years of age and for more than 80% of patients 20 years of age or older, regardless of racial and ethnic background. CONCLUSIONS Most patients likely to benefit from HSCT will have a donor. Public investment in donor recruitment and cord-blood banks has expanded access to HSCT.	[Gragert, Loren; Williams, Eric; Freeman, John; Confer, Dennis; Maiers, Martin] Natl Marrow Donor Program Be Match, Minneapolis, MN 55413 USA; [Eapen, Mary; Spellman, Stephen; Rizzo, J. Douglas; Horowitz, Mary] Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI USA; [Eapen, Mary; Spellman, Stephen; Rizzo, J. Douglas; Horowitz, Mary] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA; [Baitty, Robert] Hlth Resources & Serv Adm, Blood Stem Cell Transplantat Program, Div Transplantat, Washington, DC USA; [Hartzman, Robert] Dept Navy, CW Bill Young Marrow Donor Recruitment & Res Pro, Dept Def Marrow Donor Recruitment, Washington, DC USA; [Hartzman, Robert] Dept Navy, Res Program, Bone Marrow Res Directorate, Naval Med Res Ctr, Washington, DC USA	National Marrow Donor Program; Center for International Blood & Marrow Transplant Research; Center for International Blood & Marrow Transplant Research; United States Health Resources & Service Administration (HRSA); Naval Medical Research Center (NMRC)	Gragert, L (corresponding author), Natl Marrow Donor Program Be Match, 3001 Broadway St NE,Suite 100, Minneapolis, MN 55413 USA.	lgragert@nmdp.org	horowitz, Mary/ABH-2173-2021	Maiers, Martin/0000-0002-0198-2064; Eapen, Mary/0000-0001-6193-4243	Office of Naval Research, Department of the Navy; Health Resources and Services Administration, Department of Health and Human Services	Office of Naval Research, Department of the Navy; Health Resources and Services Administration, Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Funded by the Office of Naval Research, Department of the Navy, and the Health Resources and Services Administration, Department of Health and Human Services.	Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; Beatty PG, 2000, HUM IMMUNOL, V61, P834, DOI 10.1016/S0198-8859(00)00138-5; BEATTY PG, 1995, TRANSPLANTATION, V60, P778, DOI 10.1097/00007890-199510270-00003; Brunstein CG, 2007, BLOOD, V110, P3064, DOI 10.1182/blood-2007-04-067215; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Eapen M, 2007, LANCET, V369, P1947, DOI 10.1016/S0140-6736(07)60915-5; Eapen M, 2014, BLOOD, V123, P133, DOI 10.1182/blood-2013-05-506253; Eapen M, 2011, LANCET ONCOL, V12, P1214, DOI 10.1016/S1470-2045(11)70260-1; Eapen M, 2010, LANCET ONCOL, V11, P653, DOI 10.1016/S1470-2045(10)70127-3; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Furst D, 2013, BLOOD, V122, P3220, DOI 10.1182/blood-2013-02-482547; Gluckman E, 2004, EXP HEMATOL, V32, P397, DOI 10.1016/j.exphem.2004.01.002; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Gratwohl A, 2009, CANCER-AM CANCER SOC, V115, P4715, DOI 10.1002/cncr.24531; Horan J, 2012, BLOOD, V120, P2918, DOI 10.1182/blood-2012-03-417758; Howard DH, 2008, MED DECIS MAKING, V28, P243, DOI 10.1177/0272989X07308750; Humes KR, 2011, OVERVIEW RACE HISPAN; Kollman C, 2004, TRANSPLANTATION, V78, P89, DOI 10.1097/01.TP.0000132327.40702.97; Kollman C, 2007, HUM IMMUNOL, V68, P950, DOI 10.1016/j.humimm.2007.10.009; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Mori M, 1996, Biol Blood Marrow Transplant, V2, P134; Pidala J, 2013, BONE MARROW TRANSPL, V48, P346, DOI 10.1038/bmt.2012.150; Rocha V, 2009, BRIT J HAEMATOL, V147, P262, DOI 10.1111/j.1365-2141.2009.07883.x; Scaradavou A, 2013, BLOOD, V121, P752, DOI 10.1182/blood-2012-08-449108; Schmidt AH, 2007, BONE MARROW TRANSPL, V40, P823, DOI 10.1038/sj.bmt.1705832; Spellman SR, 2012, BLOOD, V120, P259, DOI 10.1182/blood-2012-03-379032; Woolfrey A, 2011, BIOL BLOOD MARROW TR, V17, P885, DOI 10.1016/j.bbmt.2010.09.012	30	580	584	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					339	348		10.1056/NEJMsa1311707	http://dx.doi.org/10.1056/NEJMsa1311707			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL7TY	25054717	Green Accepted			2022-12-24	WOS:000339339800010
J	Wasmuth, EV; Januszyk, K; Lima, CD				Wasmuth, Elizabeth V.; Januszyk, Kurt; Lima, Christopher D.			Structure of an Rrp6-RNA exosome complex bound to poly(A) RNA	NATURE			English	Article							CRYSTAL-STRUCTURE; DEGRADATION; RRP6P; CORE; RECONSTITUTION; EXONUCLEASE; COFACTOR; BINDING	The eukaryotic RNA exosome processes and degrades RNA by directing substrates to the distributive or processive 3' to 5' exoribonuclease activities of Rrp6 or Rrp44, respectively. The non-catalytic nine-subunit exosome core (Exo9) features a prominent central channel. Although RNA can pass through the channel to engage Rrp44, it is not clear how RNA is directed to Rrp6 or whether Rrp6 uses the central channel. Here we report a 3.3 angstrom crystal structure of a ten-subunit RNA exosome complex from Saccharomyces cerevisiae composed of the Exo9 core and Rrp6 bound to single-stranded poly(A) RNA. The Rrp6 catalytic domain rests on top of the Exo9 S1/KH ring above the central channel, the RNA 3' end is anchored in the Rrp6 active site, and the remaining RNA traverses the S1/KH ring in an opposite orientation to that observed in a structure of a Rrp44-containing exosome complex. Solution studies with human and yeast RNA exosome complexes suggest that the RNA path to Rrp6 is conserved and dependent on the integrity of the S1/KH ring. Although path selection to Rrp6 or Rrp44 is stochastic in vitro, the fate of a particular RNA may be determined in vivo by the manner in which cofactors present RNA to the RNA exosome.	[Wasmuth, Elizabeth V.; Januszyk, Kurt; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Wasmuth, Elizabeth V.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Louis Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Lima, Christopher D.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	limac@mskcc.org		Lima, Christopher/0000-0002-9163-6092; Wasmuth, Elizabeth/0000-0003-1474-4935	US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; National Institute of General Medical Sciences of the National Institutes of Health [F31GM097910, R01GM079196]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P41GM103473, F31GM097910, P41GM103403, R01GM079196] Funding Source: NIH RePORTER	US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank NE-CAT beamlines (Advanced Photon Source) supported by P41GM103403 (NIH NIGMS). APS is supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Beamline X29 (National Synchrotron Light Source) supported by the US Department of Energy, the Office of Basic Energy Sciences and P41RR012408 (NIH NCRR) and P41GM103473 (NIH NIGMS). Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award numbers F31GM097910 (E.V.W.) and R01GM079196 (C.D.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. C.D.L. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Assenholt J, 2008, RNA, V14, P2305, DOI 10.1261/rna.1108008; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Drazkowska K, 2013, NUCLEIC ACIDS RES, V41, P3845, DOI 10.1093/nar/gkt060; Effantin G, 2010, J BIOL CHEM, V285, P14834, DOI 10.1074/jbc.M109.090498; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Greimann JC, 2008, METHOD ENZYMOL, V448, P185, DOI 10.1016/S0076-6879(08)02610-4; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Januszyk K, 2011, RNA, V17, P1566, DOI 10.1261/rna.2763111; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Liu JJ, 2014, NAT STRUCT MOL BIOL, V21, P95, DOI 10.1038/nsmb.2736; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Makino DL, 2013, NAT REV MOL CELL BIO, V14, P654, DOI 10.1038/nrm3657; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Wasmuth EV, 2012, ENZYMES, V31, P53, DOI 10.1016/B978-0-12-404740-2.00003-3; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	36	102	103	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					435	+		10.1038/nature13406	http://dx.doi.org/10.1038/nature13406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25043052	Green Accepted			2022-12-24	WOS:000339335700039
J	Ksander, BR; Kolovou, PE; Wilson, BJ; Saab, KR; Guo, Q; Ma, J; McGuire, SP; Gregory, MS; Vincent, WJB; Perez, VL; Cruz-Guilloty, F; Kao, WWY; Call, MK; Tucker, BA; Zhan, Q; Murphy, GF; Lathrop, KL; Alt, C; Mortensen, LJ; Lin, CP; Zieske, JD; Frank, MH; Frank, NY				Ksander, Bruce R.; Kolovou, Paraskevi E.; Wilson, Brian J.; Saab, Karim R.; Guo, Qin; Ma, Jie; McGuire, Sean P.; Gregory, Meredith S.; Vincent, William J. B.; Perez, Victor L.; Cruz-Guilloty, Fernando; Kao, Winston W. Y.; Call, Mindy K.; Tucker, Budd A.; Zhan, Qian; Murphy, George F.; Lathrop, Kira L.; Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.; Zieske, James D.; Frank, Markus H.; Frank, Natasha Y.			ABCB5 is a limbal stem cell gene required for corneal development and repair	NATURE			English	Article							OCULAR SURFACE; CHEMORESISTANCE; MELANOMA; MICE; POPULATION; DEFICIENCY; MICROSCOPY; PHENOTYPE; THERAPY	Corneal epithelial homeostasis and regeneration are sustained by limbal stem cells (LSCs)(1-3), and LSC deficiency is a major cause of blindness worldwide(4). Transplantation is often the only therapeutic option available to patients with LSC deficiency. However, while transplant success depends foremost on LSC frequency within grafts(5), a gene allowing for prospective LSC enrichment has not been identified so far(5). Here we show that ATP-binding cassette, sub-family B, member(5) (ABCB5)(6,7) marks LSCs and is required for LSC maintenance, corneal development and repair. Furthermore, we demonstrate that prospectively isolated humanor murine ABCB5-positive LSCs possess the exclusive capacity to fully restore the cornea upon grafting to LSC-deficient mice in xenogeneic or syngeneic transplantation models. ABCB5 is preferentially expressed on label-retaining LSCs2 in mice and p63 alpha-positive LSCs8 in humans. Consistent with these findings, ABCB5-positive LSC frequency is reduced in LSC-deficient patients. Abcb5 loss of function in Abcb5 knockout mice causes depletion of quiescent LSCs due to enhanced proliferation and apoptosis, and results in defective corneal differentiation and wound healing. Our results from gene knockout studies, LSC tracing and transplantation models, as well as phenotypic and functional analyses of human biopsy specimens, provide converging lines of evidence that ABCB5 identifies mammalian LSCs. Identification and prospective isolation of molecularly defined LSCs with essential functions in corneal development and repair has important implications for the treatment of corneal disease, particularly corneal blindness due to LSC deficiency.	[Ksander, Bruce R.; Kolovou, Paraskevi E.; McGuire, Sean P.; Gregory, Meredith S.; Vincent, William J. B.; Zieske, James D.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02114 USA; [Ksander, Bruce R.; Kolovou, Paraskevi E.; McGuire, Sean P.; Gregory, Meredith S.; Vincent, William J. B.; Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.; Zieske, James D.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Wilson, Brian J.; Saab, Karim R.; Guo, Qin; Ma, Jie; Frank, Markus H.; Frank, Natasha Y.] Boston Childrens Hosp, Div Nephrol, Transplant Res Program, Boston, MA 02115 USA; [Wilson, Brian J.; Saab, Karim R.; Guo, Qin; Ma, Jie; Frank, Markus H.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Wilson, Brian J.; Guo, Qin; Frank, Natasha Y.] VA Boston Healthcare Syst, Dept Med, Boston, MA 02130 USA; [Perez, Victor L.; Cruz-Guilloty, Fernando] Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Perez, Victor L.; Cruz-Guilloty, Fernando] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA; [Kao, Winston W. Y.; Call, Mindy K.] Univ Cincinnati, Med Ctr, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Tucker, Budd A.] Univ Iowa, Stephen A Wynn Inst Vis Res, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Zhan, Qian; Murphy, George F.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lathrop, Kira L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA; [Lathrop, Kira L.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15213 USA; [Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Alt, Clemens; Mortensen, Luke J.; Lin, Charles P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Frank, Markus H.; Frank, Natasha Y.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02138 USA; [Frank, Natasha Y.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Bascom Palmer Eye Institute; University of Miami; University System of Ohio; University of Cincinnati; University of Iowa; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Frank, NY (corresponding author), Boston Childrens Hosp, Div Nephrol, Transplant Res Program, Boston, MA 02115 USA.	markus.frank@childrens.harvard.edu; nfrank@partners.org	Perez, Victor L./AAY-8633-2020; Gregory-Ksander, Meredith/AAG-1413-2019; Mortensen, Luke/N-2640-2018; Frank, Markus/O-1625-2014	Gregory-Ksander, Meredith/0000-0002-7193-0032; Mortensen, Luke/0000-0002-4331-4099; Tucker, Budd/0000-0003-2178-1742; Zieske, James/0000-0002-3730-6180; Frank, Markus/0000-0002-1312-0488	National Institutes of Health (NIH)/National Institutes of Neurological Disorders and Stroke [K08NS051349]; VA BLRD [1I01BX000516]; VA RRD [1I01RX000989]; Harvard Stem Cell Institute; NIH/National Cancer Institute [R01CA113796, R01CA158467, R01CA138231]; Department of Defense [PR0332453]; NIH [R01CA138231, R01EY018624, P30EY014801, R01EY021768, DP2OD007483, R01 EB017274, U01HL100402, P41EB015903]; Corley Research Foundation; Western Pennsylvania Medical Eye Bank Core Grant for Vision Research [EY08098]; NATIONAL CANCER INSTITUTE [R01CA138231, R01CA113796, R01CA158467] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021768, P30EY014801, R01EY018624, P30EY003790, P30EY008098] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017274, P41EB015903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS051349] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007483] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000989, I01BX000516] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institutes of Neurological Disorders and Stroke; VA BLRD; VA RRD; Harvard Stem Cell Institute; NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Corley Research Foundation; Western Pennsylvania Medical Eye Bank Core Grant for Vision Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank R. Maas for critical reading of the manuscript. We also thank P. Mallen for assistance with graphic illustrations; the Heartland Lions Eye Bank for providing clinical specimens; G. Berg for assistance with mouse colony maintenance; D. Dombkowski, F. Preffer and R. Huang for their assistance with cell sorting and viability studies. This work was supported by National Institutes of Health (NIH)/National Institutes of Neurological Disorders and Stroke grant K08NS051349, VA BLR&D 1I01BX000516 and VA RR&D 1I01RX000989 Merit Review Awards, and a Harvard Stem Cell Institute grant to N.Y.F., NIH/National Cancer Institute grants R01CA113796, R01CA158467 and R01CA138231 to M. H. F., Department of Defense grant PR0332453 to B. R. K., NIH R01EY018624 and P30EY014801 grants to V. L. P., NIH grant R01EY021768 to W. W. K., NIH New Innovator Award DP2OD007483 and a Corley Research Foundation grant to B. A. T., NIH R01CA138231 to G. F. M., Western Pennsylvania Medical Eye Bank Core Grant for Vision Research (EY08098) to K. L. L., and NIH grants R01 EB017274, U01HL100402 and P41EB015903 to C. P. L. F. C. G. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation.	Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Dua HS, 2003, EYE, V17, P877, DOI 10.1038/sj.eye.6700573; Frank NY, 2011, CANCER RES, V71, P1474, DOI 10.1158/0008-5472.CAN-10-1660; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Hutcheon AEK, 2007, EXP EYE RES, V84, P32, DOI 10.1016/j.exer.2006.08.011; Hutcheson DA, 2009, CELL CYCLE, V8, P3675, DOI 10.4161/cc.8.22.9992; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; Klocke J, 2011, INVEST OPHTH VIS SCI, V52, P256, DOI 10.1167/iovs.10-5566; Krulova M, 2008, INVEST OPHTH VIS SCI, V49, P3903, DOI 10.1167/iovs.08-1987; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lathrop KL, 2012, INVEST OPHTH VIS SCI, V53, P1381, DOI 10.1167/iovs.11-8524; Lin JY, 2013, BIOCHEM BIOPH RES CO, V436, P536, DOI 10.1016/j.bbrc.2013.06.006; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo YC, 2012, J INVEST DERMATOL, V132, P2440, DOI 10.1038/jid.2012.161; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Meyer-Blazejewska EA, 2011, STEM CELLS, V29, P57, DOI 10.1002/stem.550; Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109; Notara M, 2008, CELL TISSUE RES, V331, P135, DOI 10.1007/s00441-007-0458-7; Pal-Ghosh S, 2008, EXP EYE RES, V87, P478, DOI 10.1016/j.exer.2008.08.013; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Rocco A, 2012, LAB INVEST, V92, P1407, DOI 10.1038/labinvest.2012.100; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Wang K, 2012, BIOMED OPT EXPRESS, V3, P1972, DOI 10.1364/BOE.3.001972; Wilson BJ, 2011, CANCER RES, V71, P5307, DOI 10.1158/0008-5472.CAN-11-0221	32	167	176	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					353	+		10.1038/nature13426	http://dx.doi.org/10.1038/nature13426			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	25030174	Green Accepted			2022-12-24	WOS:000338992200037
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Is Coca-Cola's antiobesity scheme the real thing?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2009, ASA ADJ COC COL GREA; [Anonymous], 2011, ASA ADJ COC COL GREA; [Anonymous], 2014, BIRMINGHAM NEWS 0526; [Anonymous], GLAC; [Anonymous], 2014, INDEPENDENT; Newham London, COC COL ZER PARKLIVE	6	3	3	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2014	349								g4340	10.1136/bmj.g4340	http://dx.doi.org/10.1136/bmj.g4340			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2ZD	25007793	Green Published, Bronze			2022-12-24	WOS:000338993500008
J	Keung, AJ; Bashor, CJ; Kiriakov, S; Collins, JJ; Khalil, AS				Keung, Albert J.; Bashor, Caleb J.; Kiriakov, Szilvia; Collins, James J.; Khalil, Ahmad S.			Using Targeted Chromatin Regulators to Engineer Combinatorial and Spatial Transcriptional Regulation	CELL			English	Article							HISTONE MODIFICATIONS; SYNTHETIC BIOLOGY; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; YEAST; ACTIVATION; PROMOTER; CELLS; MAP; ACETYLATION	The transcription of genomic information in eukaryotes is regulated in large part by chromatin. How a diverse array of chromatin regulator (CR) proteins with different functions and genomic localization patterns coordinates chromatin activity to control transcription remains unclear. Here, we take a synthetic biology approach to decipher the complexity of chromatin regulation by studying emergent transcriptional behaviors from engineered combinatorial, spatial, and temporal patterns of individual CRs. We fuse 223 yeast CRs to programmable zinc finger proteins. Site-specific and combinatorial recruitment of CRs to distinct intralocus locations reveals a range of transcriptional logic and behaviors, including synergistic activation, long-range and spatial regulation, and gene expression memory. Comparing these transcriptional behaviors with annotated CR complex and function terms provides design principles for the engineering of transcriptional regulation. This work presents a bottom-up approach to investigating chromatin-mediated transcriptional regulation and introduces chromatin-based components and systems for synthetic biology and cellular engineering.	[Keung, Albert J.; Bashor, Caleb J.; Collins, James J.; Khalil, Ahmad S.] Boston Univ, Dept Biomed Engn & Ctr Synthet Biol, Boston, MA 02215 USA; [Kiriakov, Szilvia] Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA 02215 USA; [Keung, Albert J.; Bashor, Caleb J.; Collins, James J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Collins, James J.; Khalil, Ahmad S.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA	Boston University; Boston University; Howard Hughes Medical Institute; Harvard University	Khalil, AS (corresponding author), Boston Univ, Dept Biomed Engn & Ctr Synthet Biol, Boston, MA 02215 USA.	akhalil@bu.edu	Keung, Albert/AAU-3870-2021		NIH-NIGMS Ruth L. Kirschstein Postdoctoral Fellowship [1F32GM105272-01A1]; Boehringer Ingelheim Fonds PhD Fellowship; Defense Advanced Research Projects Agency [DARPA-BAA-11-23]; startup funds from the Department of Biomedical Engineering at Boston University; National Science Foundation CAREER Award [MCB-1350949]; Wyss Institute for Biologically Inspired Engineering [PRJ-0329]; Howard Hughes Medical Institute; Direct For Biological Sciences [1350949] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105272] Funding Source: NIH RePORTER	NIH-NIGMS Ruth L. Kirschstein Postdoctoral Fellowship; Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); startup funds from the Department of Biomedical Engineering at Boston University; National Science Foundation CAREER Award(National Science Foundation (NSF)); Wyss Institute for Biologically Inspired Engineering; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the J.J.C. and A. S. K. laboratories for helpful discussions. Emily Egan and the Moazed laboratory provided valuable technical advice on ChIP experiments. We thank the Siggers laboratory for use of their sonicator. We thank Sylvain Meylan and Kwan T. Chow for engaging discussions and manuscript feedback. This work was supported by a NIH-NIGMS Ruth L. Kirschstein Postdoctoral Fellowship (1F32GM105272-01A1 to A.J.K.), a Boehringer Ingelheim Fonds PhD Fellowship (to S. K.), a Defense Advanced Research Projects Agency grant (DARPA-BAA-11-23 to A. S. K. and J.J.C.), startup funds from the Department of Biomedical Engineering at Boston University (to A. S. K.), a National Science Foundation CAREER Award (MCB-1350949 to A. S. K.), the Wyss Institute for Biologically Inspired Engineering (PRJ-0329 to J.J.C.), and the Howard Hughes Medical Institute (to J.J.C.).	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Martens C, 2001, MOL MICROBIOL, V40, P1009, DOI 10.1046/j.1365-2958.2001.02445.x; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ptashne M, 2013, P NATL ACAD SCI USA, V110, P7101, DOI 10.1073/pnas.1305399110; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Raveh-Sadka T, 2012, NAT GENET, V44, P743, DOI 10.1038/ng.2305; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Weber W, 2010, CURR OPIN BIOTECH, V21, P690, DOI 10.1016/j.copbio.2010.07.006; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Ye HF, 2013, CURR OPIN CHEM BIOL, V17, P910, DOI 10.1016/j.cbpa.2013.10.006; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	46	88	95	3	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					110	120		10.1016/j.cell.2014.04.047	http://dx.doi.org/10.1016/j.cell.2014.04.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995982	Green Accepted, Bronze			2022-12-24	WOS:000340943100011
J	Rothwell, PE; Fuccillo, MV; Maxeiner, S; Hayton, SJ; Gokce, O; Lim, BK; Fowler, SC; Malenka, RC; Sudhof, TC				Rothwell, Patrick E.; Fuccillo, Marc V.; Maxeiner, Stephan; Hayton, Scott J.; Gokce, Ozgun; Lim, Byung Kook; Fowler, Stephen C.; Malenka, Robert C.; Suedhof, Thomas C.			Autism-Associated Neuroligin-3 Mutations Commonly Impair Striatal Circuits to Boost Repetitive Behaviors	CELL			English	Article							NUCLEUS-ACCUMBENS; SYNAPTIC PATHOPHYSIOLOGY; BASAL GANGLIA; SOCIAL REWARD; MOUSE MODEL; DE-NOVO; MICE; PLASTICITY; SKILL; ACQUISITION	In humans, neuroligin-3 mutations are associated with autism, whereas in mice, the corresponding mutations produce robust synaptic and behavioral changes. However, different neuroligin-3 mutations cause largely distinct phenotypes in mice, and no causal relationship links a specific synaptic dysfunction to a behavioral change. Using rotarod motor learning as a proxy for acquired repetitive behaviors in mice, we found that different neuroligin-3 mutations uniformly enhanced formation of repetitive motor routines. Surprisingly, neuroligin-3 mutations caused this phenotype not via changes in the cerebellum or dorsal striatum but via a selective synaptic impairment in the nucleus accumbens/ventral striatum. Here, neuroligin-3 mutations increased rotarod learning by specifically impeding synaptic inhibition onto D1-dopamine receptor-expressing but not D2-dopamine receptor-expressing medium spiny neurons. Our data thus suggest that different autism-associated neuroligin-3 mutations cause a common increase in acquired repetitive behaviors by impairing a specific striatal synapse and thereby provide a plausible circuit substrate for autism pathophysiology.	[Rothwell, Patrick E.; Fuccillo, Marc V.; Maxeiner, Stephan; Gokce, Ozgun; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Rothwell, Patrick E.; Fuccillo, Marc V.; Hayton, Scott J.; Lim, Byung Kook; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Fowler, Stephen C.] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Kansas	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA.	malenka@stanford.edu; tcs1@stanford.edu	Maxeiner, Stephan/Y-7692-2019	Maxeiner, Stephan/0000-0002-4472-695X; Fuccillo, Marc/0000-0002-6569-706X; Lim, Byungkook/0000-0002-3766-5415; Rothwell, Patrick/0000-0003-0514-2510; gokce, ozgun/0000-0001-6319-404X	NIMH [P50 MH086403, K99 MH099243, F32 MH096491]; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH096491, P50MH086403, K99MH099243] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Darvishzadeh, A. Afjei, G. Sun, S. Ghosh, and N. Huang for technical assistance, C. Foldy for advice, and all Malenka and Sudhof lab members for helpful discussions. This work was supported by grants from the NIMH (P50 MH086403 to R.C.M. and T.C.S., K99 MH099243 to M.V.F., and F32 MH096491 to P.E.R.); initial stages were also supported by the Simons Foundation (to R.C.M. and T.C.S.).	Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Groenewegen HJ, 1996, PROG BRAIN RES, V107, P485; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Haber SN, 2000, J NEUROSCI, V20, P2369; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Howes SR, 2000, PSYCHOPHARMACOLOGY, V151, P55, DOI 10.1007/s002130000451; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lin CW, 2010, NEURON, V65, P32, DOI 10.1016/j.neuron.2009.12.001; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Presti MF, 2004, PHARMACOL BIOCHEM BE, V77, P501, DOI 10.1016/j.pbb.2003.12.004; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scott-Van Zeeland AA, 2010, AUTISM RES, V3, P53, DOI 10.1002/aur.122; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Trezza V, 2011, J NEUROSCI, V31, P6362, DOI 10.1523/JNEUROSCI.5492-10.2011; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	46	281	286	4	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					198	212		10.1016/j.cell.2014.04.045	http://dx.doi.org/10.1016/j.cell.2014.04.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995986	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000340943100018
J	Sackton, KL; Dimova, N; Zeng, X; Tian, W; Zhang, MM; Sackton, TB; Meaders, J; Pfaff, KL; Sigoillot, F; Yu, HT; Luo, XL; King, RW				Sackton, Katharine L.; Dimova, Nevena; Zeng, Xing; Tian, Wei; Zhang, Mengmeng; Sackton, Timothy B.; Meaders, Johnathan; Pfaff, Kathleen L.; Sigoillot, Frederic; Yu, Hongtao; Luo, Xuelian; King, Randall W.			Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; DEGRON RECOGNITION; SUBSTRATE-BINDING; DESTRUCTION; DEGRADATION; ACTIVATOR; CDC20; COMPLEX/CYCLOSOME; ENGAGEMENT	Protein machines are multi-subunit protein complexes that orchestrate highly regulated biochemical tasks. An example is the anaphase promoting complex/cyclosome (APC/C), a 13-subunit ubiquitin ligase that initiates the metaphase-anaphase transition and mitotic exit by targeting proteins such as securin and cyclin B1 for ubiquitin-dependent destruction by the proteasome(1,2). Because blocking mitotic exit is an effective approach for inducing tumour cell death(3,4), the APC/Crepresents a potential novel target for cancer therapy. APC/C activation in mitosis requires binding of Cdc20 (ref. 5), which forms a co-receptor with the APC/C to recognize substrates containing a destruction box(D-box)(6-14). Here we demonstrate that we can synergistically inhibit APC/C-dependent proteolysis and mitotic exit by simultaneously disrupting two protein-protein interactions within the APC/C-Cdc20-substrate ternary complex. We identify a small molecule, called apcin (APC inhibitor), which binds to Cdc20 and competitively inhibits the ubiquitylation of D-box-containing substrates. Analysis of the crystal structure of the apcin-Cdc20 complex suggests that apcin occupies the D-box-binding pocket on the side face of the WD40-domain. The ability of apcin to block mitotic exit is synergistically amplified by co-addition of tosyl-L-arginine methyl ester, a small molecule that blocks the APC/C-Cdc20 interaction(15,16). This work suggests that simultaneous disruption of multiple, weak protein-protein interactions is an effective approach for inactivating a protein machine.	[Sackton, Katharine L.; Dimova, Nevena; Zeng, Xing; Zhang, Mengmeng; Meaders, Johnathan; Pfaff, Kathleen L.; Sigoillot, Frederic; King, Randall W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Tian, Wei; Yu, Hongtao; Luo, Xuelian] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Sackton, Timothy B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Yu, Hongtao] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Howard Hughes Medical Institute	King, RW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu		Sackton, Timothy/0000-0003-1673-9216; Yu, Hongtao/0000-0002-8861-049X; tian, wei/0000-0003-3207-375X; Sigoillot, Frederic/0000-0002-8695-4838	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Institutes of Health [GM085004, GM066492]; Lynch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066492, R56GM066492, R01GM085004] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lynch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Harper for providing constructs for WD40-containing proteins, T. Gahman for assistance with apcin synthesis and D. Tomchick for assistance with structure refinement. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This work was supported by grants from the National Institutes of Health (GM085004 to X. L. and GM066492 to R. W. K.) and by a grant from the Lynch Foundation to R.W.K.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Buschhorn BA, 2011, NAT STRUCT MOL BIOL, V18, P6, DOI 10.1038/nsmb.1979; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Di Fiore B, 2010, J CELL BIOL, V190, P501, DOI 10.1083/jcb.201001083; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lara-Gonzalez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049041; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Salic A, 2005, METHOD ENZYMOL, V399, P567, DOI 10.1016/S0076-6879(05)99038-1; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Sedgwick GG, 2013, EMBO J, V32, P303, DOI 10.1038/emboj.2012.335; Sigoillot FD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025511; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; van Zon W, 2010, J CELL BIOL, V190, P587, DOI 10.1083/jcb.200912084; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zeng X, 2012, NAT CHEM BIOL, V8, P383, DOI [10.1038/nchembio.801, 10.1038/NCHEMBIO.801]; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010	40	171	177	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					646	+		10.1038/nature13660	http://dx.doi.org/10.1038/nature13660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25156254	Green Accepted			2022-12-24	WOS:000343801500053
J	Findlay, GM; Boyle, EA; Hause, RJ; Klein, JC; Shendure, J				Findlay, Gregory M.; Boyle, Evan A.; Hause, Ronald J.; Klein, Jason C.; Shendure, Jay			Saturation editing of genomic regions by multiplex homology-directed repair	NATURE			English	Article							GENETIC SCREENS	Saturation mutagenesis(1,2)-coupled to an appropriate biological assay-represents a fundamental means of achieving a high-resolution understanding of regulatory(3) and protein-coding(4) nucleic acid sequences of interest. However, mutagenized sequences introduced in trans on episomes or via random or "safe-harbour'' integration fail to capture the native context of the endogenous chromosomal locus(5). This shortcoming markedly limits the interpretability of the resulting measurements of mutational impact. Here, we couple CRISPR/Cas9 RNA-guided cleavage(6) with multiplex homology-directed repair using a complex library of donor templates to demonstrate saturation editing of genomic regions. In exon 18 of BRCA1, we replace a six-base-pair (bp) genomic region with all possible hexamers, or the full exon with all possible single nucleotide variants (SNVs), and measure strong effects on transcript abundance attributable to nonsense-mediated decay and exonic splicing elements. We similarly perform saturation genome editing of a well-conserved coding region of an essential gene, DBR1, and measure relative effects on growth that correlate with functional impact. Measurement of the functional consequences of large numbers of mutations with saturation genome editing will potentially facilitate high-resolution functional dissection of both cis-regulatory elements and trans-acting factors, as well as the interpretation of variants of uncertain significance observed in clinical sequencing.	[Findlay, Gregory M.; Boyle, Evan A.; Hause, Ronald J.; Klein, Jason C.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	gf2@uw.edu; shendure@uw.edu	Findlay, Gregory/AAX-9029-2020; Shendure, Jay/AAU-3684-2021	Findlay, Gregory/0000-0002-7767-8608; Klein, Jason/0000-0001-9566-6347; Boyle, Evan/0000-0003-4494-9771; Shendure, Jay/0000-0002-1516-1865; Hause, Ronald/0000-0002-5229-7366	National Institutes of Health [DP1HG007811]; UW Medical Scientist Training Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP1HG007811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Medical Scientist Training Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Zhang and his laboratory for the CRISPR/Cas9 backbone constructs used in this study and G. Church and his laboratory for providing reagents used to establish CRISPR/Cas9 editing techniques in our lab. We also thank members of the Shendure laboratory for helpful discussions and D. Prunkard for assistance with FACS. This work was supported by the National Institutes of Health (DP1HG007811 to J.S.) and the UW Medical Scientist Training Program (G. M. F. and J.K.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BOTSTEIN D, 1985, SCIENCE, V229, P1193, DOI 10.1126/science.2994214; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Goina E, 2008, MOL CELL BIOL, V28, P3850, DOI 10.1128/MCB.02253-07; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Ke SD, 2011, GENOME RES, V21, P1360, DOI 10.1101/gr.119628.110; Khalid MF, 2005, NUCLEIC ACIDS RES, V33, P6349, DOI 10.1093/nar/gki934; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mazoyer S, 1998, AM J HUM GENET, V62, P713, DOI 10.1086/301768; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Smurnyy Y, 2014, NAT CHEM BIOL, V10, P623, DOI 10.1038/nchembio.1550; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-90	35	198	218	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					120	+		10.1038/nature13695	http://dx.doi.org/10.1038/nature13695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25141179	Green Accepted			2022-12-24	WOS:000341174800042
J	Chowdhury, S; Jarecki, BW; Chanda, B				Chowdhury, Sandipan; Jarecki, Brian W.; Chanda, Baron			A Molecular Framework for Temperature-Dependent Gating of Ion Channels	CELL			English	Article							SHAKER K+-CHANNEL; PROTEIN-FOLDING THERMODYNAMICS; FOCUSED ELECTRIC-FIELD; VOLTAGE-SENSING DOMAIN; MOLAR HEAT-CAPACITY; AMINO-ACID-RESIDUES; TRP CHANNELS; COLD RECEPTOR; POTASSIUM CHANNELS; AQUEOUS-SOLUTION	Perception of heat or cold in higher organisms is mediated by specialized ion channels whose gating is exquisitely sensitive to temperature. The physicochemical underpinnings of this temperature-sensitive gating have proven difficult to parse. Here, we took a bottom-up protein design approach and rationally engineered ion channels to activate in response to thermal stimuli. By varying amino acid polarities at sites undergoing state-dependent changes in solvation, we were able to systematically confer temperature sensitivity to a canonical voltage-gated ion channel. Our results imply that the specific heat capacity change during channel gating is a major determinant of thermosensitive gating. We also show that reduction of gating charges amplifies temperature sensitivity of designer channels, which accounts for low-voltage sensitivity in all known temperature- gated ion channels. These emerging principles suggest a plausible molecular mechanism for temperature-dependent gating that reconcile how ion channels with an overall conserved transmembrane architecture may exhibit a wide range of temperature- sensing phenotypes.	[Chowdhury, Sandipan; Chanda, Baron] Univ Wisconsin, Grad Program Biophys, Madison, WI 53705 USA; [Chowdhury, Sandipan; Jarecki, Brian W.; Chanda, Baron] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chanda, B (corresponding author), Univ Wisconsin, Grad Program Biophys, 1111 Highland Ave, Madison, WI 53705 USA.	chanda@wisc.edu		Chanda, Baron/0000-0003-4954-7034	National Institutes of Health [RO1-NS081293]; Shaw Scientist award; Vilas Research foundation; NIH training grant [5T32HL007936-09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shaw Scientist award; Vilas Research foundation; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Q. Cui, M. Jackson, T. Record, C. Czajkwoski, and members of the Chanda laboratory for their comments and discussions; R. R. Trivedi (Khorana fellow) for early help with data collection; and K. M. Schuldt and T. R. Lingle for technical assistance. The project was supported by funds from the National Institutes of Health (RO1-NS081293), Shaw Scientist award, and Vilas Research foundation to B. C. B. W. J was partially supported by NIH training grant (5T32HL007936-09).	Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Butterwick JA, 2010, J MOL BIOL, V403, P591, DOI 10.1016/j.jmb.2010.09.012; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3501; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Chowdhury S, 2013, J GEN PHYSIOL, V141, P11, DOI 10.1085/jgp.201210860; Chowdhury S, 2012, J GEN PHYSIOL, V139, P3, DOI 10.1085/jgp.201110722; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Dib-Hajj SD, 2008, ADV GENET, V63, P85, DOI 10.1016/S0065-2660(08)01004-3; Gagnon DG, 2010, J GEN PHYSIOL, V136, P555, DOI 10.1085/jgp.201010487; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P160, DOI 10.1038/nsmb.2747; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MAKHATADZE GI, 1990, J MOL BIOL, V213, P375, DOI 10.1016/S0022-2836(05)80197-4; MAKHATADZE GI, 1994, BIOPHYS CHEM, V51, P291, DOI 10.1016/0301-4622(94)00050-6; MAKHATADZE GI, 1993, J MOL BIOL, V232, P639, DOI 10.1006/jmbi.1993.1416; MAKHATADZE GI, 1990, BIOPHYS CHEM, V38, P33, DOI 10.1016/0301-4622(90)80037-8; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nguyen TP, 2002, J GEN PHYSIOL, V120, P419, DOI 10.1085/jgp.20028636; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PRIVALOV PL, 1993, J MOL BIOL, V232, P660, DOI 10.1006/jmbi.1993.1417; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; Pusch M, 1997, J GEN PHYSIOL, V109, P105, DOI 10.1085/jgp.109.1.105; Rodriguez BM, 1996, NEUROPHARMACOLOGY, V35, P775, DOI 10.1016/0028-3908(96)00111-6; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; SCHELLMAN JA, 1981, BIOPOLYMERS, V20, P1989, DOI 10.1002/bip.1981.360200921; Schonherr R, 2002, NEURON, V35, P935, DOI 10.1016/S0896-6273(02)00869-3; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Xu YP, 2013, NAT STRUCT MOL BIOL, V20, P574, DOI 10.1038/nsmb.2535; Xu YP, 2010, CELL, V142, P580, DOI 10.1016/j.cell.2010.07.013; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yao J, 2010, BIOPHYS J, V99, P1743, DOI 10.1016/j.bpj.2010.07.022; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	62	71	71	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1148	1158		10.1016/j.cell.2014.07.026	http://dx.doi.org/10.1016/j.cell.2014.07.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25156949	Green Accepted, Bronze			2022-12-24	WOS:000340945000019
J	Fischer, ES; Bohm, K; Lydeard, JR; Yang, HD; Stadler, MB; Cavadini, S; Nagel, J; Serluca, F; Acker, V; Lingaraju, GM; Tichkule, RB; Schebesta, M; Forrester, WC; Schirle, M; Hassiepen, U; Ottl, J; Hild, M; Beckwith, REJ; Harper, JW; Jenkins, JL; Thoma, NH				Fischer, Eric S.; Boehm, Kerstin; Lydeard, John R.; Yang, Haidi; Stadler, Michael B.; Cavadini, Simone; Nagel, Jane; Serluca, Fabrizio; Acker, Vincent; Lingaraju, Gondichatnahalli M.; Tichkule, Ritesh B.; Schebesta, Michael; Forrester, William C.; Schirle, Markus; Hassiepen, Ulrich; Ottl, Johannes; Hild, Marc; Beckwith, Rohan E. J.; Harper, J. Wade; Jenkins, Jeremy L.; Thomae, Nicolas H.			Structure of the DDBI-CRBN E3 ubiquitin ligase in complex with thalidomide	NATURE			English	Article							MULTIPLE-MYELOMA; CONGENITAL ABNORMALITIES; MENTAL-RETARDATION; LENALIDOMIDE; POMALIDOMIDE; CEREBLON; PROTEIN; CELLS; RECOGNITION; CANCER	In the 1950s, the drug thalidomide, administered as a sedative to pregnant women, led to the birth of thousands of children with multiple defects. Despite the teratogenicity of thalidomide and its derivatives lenalidomide and pomalidomide, these immunomodulatory drugs (IMiDs) recently emerged as effective treatments for multiple myeloma and 5q-deletion-associated dysplasia. IMiDs target the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4(CRBN)) and promote the ubiquitination of the IKAROS family transcription factors IKZF1 and IKZF3 by CRL4(CRBN). Here we present crystal structures of the DDB1-CRBN complex bound to thalidomide, lenalidomide and pomalidomide. The structure establishes that CRBN is a substrate receptor within CRL4(CRBN) and enantioselectively binds IMiDs. Using an unbiased screen, we identified the homeobox transcription factor MEIS2 as an endogenous substrate of CRL4(CRBN). Our studies suggest that IMiDs block endogenous substrates (MEIS2) from binding to CRL4(CRBN) while the ligase complex is recruiting IKZF1 or IKZF3 for degradation. This dual activity implies that small molecules can modulate an E3 ubiquitin ligase and thereby upregulate or downregulate the ubiquitination of proteins.	[Fischer, Eric S.; Boehm, Kerstin; Stadler, Michael B.; Cavadini, Simone; Lingaraju, Gondichatnahalli M.; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Fischer, Eric S.; Boehm, Kerstin; Stadler, Michael B.; Cavadini, Simone; Lingaraju, Gondichatnahalli M.; Thomae, Nicolas H.] Univ Basel, CH-4003 Basel, Switzerland; [Lydeard, John R.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Yang, Haidi; Nagel, Jane; Serluca, Fabrizio; Tichkule, Ritesh B.; Schebesta, Michael; Forrester, William C.; Schirle, Markus; Hild, Marc; Beckwith, Rohan E. J.; Jenkins, Jeremy L.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Stadler, Michael B.] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Acker, Vincent; Hassiepen, Ulrich; Ottl, Johannes] Novartis Pharma AG, Inst Biomed Res, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel; Harvard University; Harvard Medical School; Novartis; Swiss Institute of Bioinformatics; Novartis; Universita della Svizzera Italiana	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nicolas.thoma@fmi.ch	高, 雨莉/HGU-8187-2022	Harper, Jeffrey/0000-0002-6944-7236; Thoma, Nicolas/0000-0003-2685-906X; Fischer, Eric S./0000-0001-7337-6306	Novartis Research Foundation; European Research Council [260481-MoBa-CS]; National Institutes of Health [AG011085]; Damon Runyon Postdoctoral Fellowship [DRG 2061-10]; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Postdoctoral Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Novartis Research Foundation and grants to N.H.T. from the European Research Council (ERC-2010-StG 260481-MoBa-CS) and to J.W.H. from the National Institutes of Health (AG011085). J.R.L. was supported by a Damon Runyon Postdoctoral Fellowship (DRG 2061-10). We acknowledge J. Reilly for performing immobilized artificial membrane (IAM) experiments. We thank J. Tallarico, J. Porter, W. Sellers, S. Cottens and M. Renatus for help and comments. D. Hess, R. Sack and J. Seebacher for the mass spectrometry analysis and J. Keusch and H. Gut for support. We thank W. Kaelin for kindly providing the IKZF1 reporter plasmid (pCMV-IRES-Renilla luciferase-IRES-Gateway-firefly luciferase). Part of this work was performed at the Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Crowley MA, 2010, AM J MED GENET A, V152A, P1326, DOI 10.1002/ajmg.a.33375; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hofmeister CC, 2011, J CLIN ONCOL, V29, P3427, DOI 10.1200/JCO.2010.32.4962; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Hur S, 2006, J BIOL CHEM, V281, P38969, DOI 10.1074/jbc.R600034200; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LENZ W, 1962, LANCET, V1, P45; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; MCBRIDE WG, 1961, LANCET, V2, P1358; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pan BQ, 2012, PHARMACOL THERAPEUT, V136, P56, DOI 10.1016/j.pharmthera.2012.07.004; Roche S, 2012, J CHROMATOGR B, V902, P16, DOI 10.1016/j.jchromb.2012.06.008; Ruchelman AL, 2013, BIOORG MED CHEM LETT, V23, P360, DOI 10.1016/j.bmcl.2012.10.071; Scrima A, 2011, FEBS LETT, V585, P2818, DOI 10.1016/j.febslet.2011.04.064; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; SHESKIN J, 1965, CLIN PHARMACOL THER, V6, P303; Shortt J, 2013, ONCOGENE, V32, P4191, DOI 10.1038/onc.2012.599; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Zhang L, 2012, CELL CYCLE, V11, P4378, DOI 10.4161/cc.22688; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228; Zhou SF, 2005, EUR J DRUG METAB PH, V30, P49, DOI 10.1007/BF03226408; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	42	529	584	20	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					49	+		10.1038/nature13527	http://dx.doi.org/10.1038/nature13527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25043012	Green Accepted, Green Submitted			2022-12-24	WOS:000339908000028
J	Zhao, L; Lee, X; Smith, RB; Oleson, K				Zhao, Lei; Lee, Xuhui; Smith, Ronald B.; Oleson, Keith			Strong contributions of local background climate to urban heat islands	NATURE			English	Article							CITIES; URBANIZATION; IMPACT; EXCHANGES; HEATWAVES; FORESTS; SYSTEM; MODEL	The urban heat island(UHI), a common phenomenon in which surface temperatures are higher in urban areas than in surrounding rural areas, represents one of the most significant human-induced changes to Earth's surface climate(1,2). Even though they are localized hotspots in the landscape, UHIs have a profound impact on the lives of urban residents, who comprise more than half of the world's population(3). A barrier to UHI mitigation is the lack of quantitative attribution of the various contributions to UHI intensity(4) (expressed as the temperature difference between urban and rural areas, Delta T). A common perception is that reduction in evaporative cooling in urban land is the dominant driver of DT (ref. 5). Here we use a climate model to show that, for cities across North America, geographic variations in daytime Delta T are largely explained by variations in the efficiency with which urban and rural areas convect heat to the lower atmosphere. If urban areas are aerodynamically smoother than surrounding rural areas, urban heat dissipation is relatively less efficient and urban warming occurs (and vice versa). This convection effect depends on the local background climate, increasing daytime Delta T by 3.06 +/- 0.3 kelvin (mean and standard error) in humid climates but decreasing Delta T by 1.5 +/- 0.2 kelvin in dry climates. In the humid eastern United States, there is evidence of higher Delta T in drier years. These relationship simply that UHIs will exacerbate heat wave stress on human health in wet climates where high temperature effects are already compounded by high air humidity(6,7) and in drier years when positive temperature anomalies may be reinforced by a precipitation temperature feedback(8). Our results support albedo management as a viable means of reducing Delta T on large scales(9,10).	[Zhao, Lei; Lee, Xuhui] Nanjing Univ Informat Sci & Technol, Yale NUIST Ctr Atmospher Environm, Nanjing 210044, Jiangsu, Peoples R China; [Zhao, Lei; Lee, Xuhui] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Smith, Ronald B.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Oleson, Keith] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Nanjing University of Information Science & Technology; Yale University; Yale University; National Center Atmospheric Research (NCAR) - USA	Lee, X (corresponding author), Nanjing Univ Informat Sci & Technol, Yale NUIST Ctr Atmospher Environm, Nanjing 210044, Jiangsu, Peoples R China.	xuhui.lee@yale.edu	Zhao, Lei/S-1855-2019; Oleson, Keith/A-9328-2008	Zhao, Lei/0000-0002-6481-3786; Oleson, Keith/0000-0002-0057-9900	Ministry of Education of China (grant PCSIRT); Yale Climate and Energy Institute; Yale Institute of Biospheric Studies; Yale University Graduate Fellowship; NASA [NNX10AK79G]; NCARWCIASP; US National Science Foundation	Ministry of Education of China (grant PCSIRT); Yale Climate and Energy Institute; Yale Institute of Biospheric Studies; Yale University Graduate Fellowship; NASA(National Aeronautics & Space Administration (NASA)); NCARWCIASP; US National Science Foundation(National Science Foundation (NSF))	This research was supported by the Ministry of Education of China (grant PCSIRT), the Yale Climate and Energy Institute, the Yale Institute of Biospheric Studies, and a Yale University Graduate Fellowship. K.O. acknowledges support from NASA grant NNX10AK79G (the SIMMER project) and the NCARWCIASP. NCAR is sponsored by the US National Science Foundation. The model simulations were supported by the Yale University Faculty of Arts and Sciences High Performance Computing Center.	Akbari H, 2009, CLIMATIC CHANGE, V94, P275, DOI 10.1007/s10584-008-9515-9; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Clinton N, 2013, REMOTE SENS ENVIRON, V134, P294, DOI 10.1016/j.rse.2013.03.008; Fischer EM, 2010, NAT GEOSCI, V3, P398, DOI 10.1038/NGEO866; Gallo KP, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002588; Garratt JR, 1994, ATMOSPHERIC BOUNDARY; Georgescu M, 2013, NAT CLIM CHANGE, V3, P37, DOI 10.1038/nclimate1656; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grimmond S, 2007, GEOGR J, V173, P83, DOI 10.1111/j.1475-4959.2007.232_3.x; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hung T, 2006, INT J APPL EARTH OBS, V8, P34, DOI 10.1016/j.jag.2005.05.003; Hurrell JW, 2013, B AM METEOROL SOC, V94, P1339, DOI 10.1175/BAMS-D-12-00121.1; Imhoff ML, 2010, REMOTE SENS ENVIRON, V114, P504, DOI 10.1016/j.rse.2009.10.008; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Li D, 2013, J APPL METEOROL CLIM, V52, P2051, DOI 10.1175/JAMC-D-13-02.1; Mackey CW, 2012, BUILD ENVIRON, V49, P348, DOI 10.1016/j.buildenv.2011.08.004; Nichol JE, 2009, ATMOS RES, V94, P276, DOI 10.1016/j.atmosres.2009.06.011; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; Oleson KW, 2008, J APPL METEOROL CLIM, V47, P1061, DOI 10.1175/2007JAMC1598.1; Oleson KW, 2011, INT J CLIMATOL, V31, P1848, DOI 10.1002/joc.2201; Oleson K. W., 2013, NCARTN478STR, DOI [10.5065/D6RR1W7M, DOI 10.5065/D6RR1W7M, DOI 10.5065/D6FB50WZ]; Oleson K, 2012, J CLIMATE, V25, P1390, DOI 10.1175/JCLI-D-11-00098.1; Peng SS, 2012, ENVIRON SCI TECHNOL, V46, P696, DOI 10.1021/es2030438; Qian TT, 2006, J HYDROMETEOROL, V7, P953, DOI 10.1175/JHM540.1; Rosenzweig C, 2009, B AM METEOROL SOC, V90, P1297, DOI 10.1175/2009BAMS2308.1; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; ROTH M, 1989, INT J REMOTE SENS, V10, P1699, DOI 10.1080/01431168908904002; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Smith TT, 2013, CLIMATIC CHANGE, V118, P811, DOI 10.1007/s10584-012-0659-2; Taha H, 1997, ENERG BUILDINGS, V25, P99, DOI 10.1016/S0378-7788(96)00999-1; Voogt JA, 2000, J APPL METEOROL, V39, P1679, DOI 10.1175/1520-0450-39.10.1679; Voogt JA, 2003, REMOTE SENS ENVIRON, V86, P370, DOI 10.1016/S0034-4257(03)00079-8; Zhou LM, 2004, P NATL ACAD SCI USA, V101, P9540, DOI 10.1073/pnas.0400357101	36	613	664	72	774	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					216	219		10.1038/nature13462	http://dx.doi.org/10.1038/nature13462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008529				2022-12-24	WOS:000338649800042
J	Rauskolb, C; Sun, SG; Sun, GP; Pan, YW; Irvine, KD				Rauskolb, Cordelia; Sun, Shuguo; Sun, Gongping; Pan, Yuanwang; Irvine, Kenneth D.			Cytoskeletal Tension Inhibits Hippo Signaling through an Ajuba-Warts Complex	CELL			English	Article							WING IMAGINAL DISC; F-ACTIN; CELL-PROLIFERATION; ALPHA-CATENIN; SIZE-CONTROL; DROSOPHILA; PATHWAY; GROWTH; MECHANISM; PROTEIN	Mechanical forces have been proposed to modulate organ growth, but a molecular mechanism that links them to growth regulation in vivo has been lacking. We report that increasing tension within the cytoskeleton increases Drosophila wing growth, whereas decreasing cytoskeletal tension decreases wing growth. These changes in growth can be accounted for by changes in the activity of Yorkie, a transcription factor regulated by the Hippo pathway. The influence of myosin activity on Yorkie depends genetically on the Ajuba LIM protein Jub, a negative regulator of Warts within the Hippo pathway. We further show that Jub associates with a-catenin and that its localization to adherens junctions and association with alpha-catenin are promoted by cytoskeletal tension. Jub recruits Warts to junctions in a tension-dependent manner. Our observations delineate a mechanism that links cytoskeletal tension to regulation of Hippo pathway activity, providing a molecular understanding of how mechanical forces can modulate organ growth.	[Rauskolb, Cordelia; Sun, Shuguo; Sun, Gongping; Pan, Yuanwang; Irvine, Kenneth D.] Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Rauskolb, Cordelia; Sun, Shuguo; Sun, Gongping; Pan, Yuanwang; Irvine, Kenneth D.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu		Sun, Gongping/0000-0002-0411-2697	Howard Hughes Medical Institute; National Institutes of Health [R01 GM078620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078620] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yongqiang Feng for Wts:V5-expressing flies, Spencer Irvine for initial characterization of rok RNAi phenotypes, and Martha Soto for helpful discussion in suggesting alpha-catenin experiments. We thank R. Basto, C. Bokel, R. Fehon, B. Hay, J. Jiang, D. Kiehart, L. Luo, G. Longmore, T. Lecuit, D. Pan, U. Tepass, J. Zallen, the Developmental Studies Hybridoma Bank, the Gene Disruption Project, the Bloomington Stock Center for antibodies and Drosophila stocks, and the Drosophila Genomics Resource Center for plasmids. This research was supported by the Howard Hughes Medical Institute and the National Institutes of Health (R01 GM078620).	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Aegerter-Wilmsen T, 2012, DEVELOPMENT, V139, P3221, DOI 10.1242/dev.082800; Aliee M, 2012, CURR BIOL, V22, P967, DOI 10.1016/j.cub.2012.03.070; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Bertet C, 2009, DEVELOPMENT, V136, P4199, DOI 10.1242/dev.040402; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Degoutin JL, 2013, NAT CELL BIOL, V15, P1176, DOI 10.1038/ncb2829; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Enderle L, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004208; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Herranz H, 2008, EMBO J, V27, P1633, DOI 10.1038/emboj.2008.84; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Huveneers S, 2013, J CELL SCI, V126, P403, DOI 10.1242/jcs.109447; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Major RJ, 2006, DEV DYNAM, V235, P3051, DOI 10.1002/dvdy.20966; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; OBROCHTA DA, 1987, DEV BIOL, V119, P137, DOI 10.1016/0012-1606(87)90215-6; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Rauskolb C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000624; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Schluck T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076171; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	57	218	223	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					143	156		10.1016/j.cell.2014.05.035	http://dx.doi.org/10.1016/j.cell.2014.05.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995985	Bronze, Green Accepted			2022-12-24	WOS:000340943100014
J	Sutendra, G; Kinnaird, A; Dromparis, P; Paulin, R; Stenson, TH; Haromy, A; Hashimoto, K; Zhang, N; Flaim, E; Michelakis, ED				Sutendra, Gopinath; Kinnaird, Adam; Dromparis, Peter; Paulin, Roxane; Stenson, Trevor H.; Haromy, Alois; Hashimoto, Kyoko; Zhang, Nancy; Flaim, Eric; Michelakis, Evangelos D.			A Nuclear Pyruvate Dehydrogenase Complex Is Important for the Generation of Acetyl-CoA and Histone Acetylation	CELL			English	Article							HEAT-SHOCK-PROTEIN; GENE-TRANSCRIPTION; KINASE M2; EXPRESSION; TRANSPORT; HYPOXIA; CANCER; HSP70; PROLIFERATION; REQUIRES	DNA transcription, replication, and repair are regulated by histone acetylation, a process that requires the generation of acetyl-coenzyme A (CoA). Here, we show that all the subunits of the mitochondrial pyruvate dehydrogenase complex (PDC) are also present and functional in the nucleus of mammalian cells. We found that knockdown of nuclear PDC in isolated functional nuclei decreased the de novo synthesis of acetyl-CoA and acetylation of core histones. Nuclear PDC levels increased in a cell-cycle-dependent manner and in response to serum, epidermal growth factor, or mitochondrial stress; this was accompanied by a corresponding decrease in mitochondrial PDC levels, suggesting a translocation from the mitochondria to the nucleus. Inhibition of nuclear PDC decreased acetylation of specific lysine residues on histones important for G1-S phase progression and expression of S phase markers. Dynamic translocation of mitochondrial PDC to the nucleus provides a pathway for nuclear acetyl-CoA synthesis required for histone acetylation and epigenetic regulation.	[Sutendra, Gopinath; Kinnaird, Adam; Dromparis, Peter; Paulin, Roxane; Stenson, Trevor H.; Haromy, Alois; Hashimoto, Kyoko; Michelakis, Evangelos D.] Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada; [Zhang, Nancy; Flaim, Eric] Univ Alberta, NanoFAB Fabricat & Characterizat Facil, Edmonton, AB T6G 2B7, Canada	University of Alberta; University of Alberta	Sutendra, G (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada.	gopinath.sutendra@ludwig.ox.ac.uk	; Kinnaird, Adam/O-3969-2017	Stenson, Trevor/0000-0001-7164-1137; Kinnaird, Adam/0000-0002-4115-4327	Canadian Institutes for Health Research; Alberta Innovation for Health Solutions; Hecht Foundation (Vancouver, Canada)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovation for Health Solutions; Hecht Foundation (Vancouver, Canada)	We would like to thank Dr. Ryan McKay of the Canadian National High Field NMR Centre (NANUC) and Chenomx for the NMR acquisition and data analysis, Dr. Nasser Tahbaz (University of Alberta) for the immunogold labeling and electron microscopy, and Dr. Gregg Semenza (Johns Hopkins University) for the adenoviruses encoding LacZ and CA5. This study was funded by the Canadian Institutes for Health Research, the Alberta Innovation for Health Solutions, and the Hecht Foundation (Vancouver, Canada) to E. D. M.	Alarcon-Vargas D, 2002, ONCOGENE, V21, P4384, DOI 10.1038/sj.onc.1205543; BEHAL RH, 1993, ANNU REV NUTR, V13, P497, DOI 10.1146/annurev.nu.13.070193.002433; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dhar S, 2009, P NATL ACAD SCI USA, V106, P22199, DOI 10.1073/pnas.0912276106; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Horner DS, 1999, MOL BIOL EVOL, V16, P1280, DOI 10.1093/oxfordjournals.molbev.a026218; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kiang JG, 2006, AM J PHYSIOL-GASTR L, V291, pG117, DOI 10.1152/ajpgi.00397.2005; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Koishi M, 2001, CLIN CANCER RES, V7, P215; Lodish H, 2000, MOL CELL BIOL; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; MILARSKI KL, 1986, P NATL ACAD SCI USA, V83, P9517, DOI 10.1073/pnas.83.24.9517; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Rodriguez MA, 1998, MICROB PATHOGENESIS, V25, P1, DOI 10.1006/mpat.1998.0202; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; SIEBERT GUNTHER, 1965, ADVANCE ENZYMOL, V27, P239; SUMEGI B, 1987, EUR J BIOCHEM, V169, P223, DOI 10.1111/j.1432-1033.1987.tb13601.x; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698; Zhou ZH, 2001, J BIOL CHEM, V276, P21704, DOI 10.1074/jbc.M101765200	39	345	350	3	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					84	97		10.1016/j.cell.2014.04.046	http://dx.doi.org/10.1016/j.cell.2014.04.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995980	Bronze			2022-12-24	WOS:000340943100009
J	Yelagandula, R; Stroud, H; Holec, S; Zhou, K; Feng, SH; Zhong, XH; Muthurajan, UM; Nie, X; Kawashima, T; Groth, M; Luger, K; Jacobsen, SE; Berger, F				Yelagandula, Ramesh; Stroud, Hume; Holec, Sarah; Zhou, Keda; Feng, Suhua; Zhong, Xuehua; Muthurajan, Uma M.; Nie, Xin; Kawashima, Tomokazu; Groth, Martin; Luger, Karolin; Jacobsen, Steven E.; Berger, Frederic			The Histone Variant H2A. W Defines Heterochromatin and Promotes Chromatin Condensation in Arabidopsis	CELL			English	Article							DNA METHYLATION; NUCLEOSOME; GENOME; MAINTENANCE; LINKER; GENES; SPKK; LOCALIZATION; EUCHROMATIN; ASSOCIATION	Histone variants play crucial roles in gene expression, genome integrity, and chromosome segregation. We report that the four H2A variants in Arabidopsis define different genomic features, contributing to overall genomic organization. The histone variant H2A. W marks heterochromatin specifically and acts in synergy with heterochromatic marks H3K9me2 and DNA methylation to maintain transposon silencing. In vitro, H2A. W enhances chromatin condensation by promoting fiber-to-fiber interactions via its conserved C-terminal motif. In vivo, H2A. W is required for heterochromatin condensation, demonstrating that H2A. W plays critical roles in heterochromatin organization. Similarities in conserved motifs between H2A. W and another H2A variant in metazoans suggest that plants and animals share common mechanisms for heterochromatin condensation.	[Yelagandula, Ramesh; Holec, Sarah; Nie, Xin; Kawashima, Tomokazu; Berger, Frederic] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117604, Singapore; [Yelagandula, Ramesh; Nie, Xin; Berger, Frederic] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Stroud, Hume; Feng, Suhua; Zhong, Xuehua; Groth, Martin; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Feng, Suhua; Groth, Martin; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Zhou, Keda; Muthurajan, Uma M.; Luger, Karolin] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA	National University of Singapore; National University of Singapore; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Colorado State University; Colorado State University; Howard Hughes Medical Institute	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu; fred@tll.org.sg	Stroud, Hume/ABF-1325-2021; Kawashima, Tomokazu/I-9333-2014; Kawashima, Tomo/AAM-9411-2021; zhou, keda/AAH-9343-2021	Kawashima, Tomokazu/0000-0003-3803-3070; Kawashima, Tomo/0000-0003-3803-3070; Berger, Frederic/0000-0002-3609-8260; Yelagandula, Ramesh/0000-0001-7418-4322; Groth, Martin/0000-0003-0547-5032; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	UCLA; NSF [1121245]; NIH [GM067777]; EMBO ALTF [986-2011]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067777, F32GM096483] Funding Source: NIH RePORTER	UCLA; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO ALTF; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.Y., S. H., X.N., and F. B. were funded by Temasek Life Sciences Laboratory. Sequencing was performed at the UCLA BSCRC BioSequencing Core facility. We thank Meredith Calvert for help with imaging and Mahnaz Akhavan for Illumina sequencing. We thank Dr. Maruyama for his comments and support with the graphical abstract. H. S. was supported by a Dissertation Year Fellowship from UCLA. X.Z. is a research fellow of Ruth L. Kirschstein National Research Service Award (F32GM096483-01). S. F. is a Special Fellow of the Leukemia & Lymphoma Society. Work in the Jacobsen lab was supported by NSF grant 1121245. K. L., U. M., and K.Z. are supported by NIH-GM067777. M. G. is supported by EMBO ALTF 986-2011 and HHMI. S.E.J. and K. L. are Investigators of the Howard Hughes Medical Institute.	Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bian Q, 2012, CURR OPIN CELL BIOL, V24, P359, DOI 10.1016/j.ceb.2012.03.003; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P10719, DOI 10.1093/nar/gks865; BRUTLAG DL, 1980, ANNU REV GENET, V14, P121, DOI 10.1146/annurev.ge.14.120180.001005; Buttinelli M, 1999, GENETICA, V106, P117, DOI 10.1023/A:1003745315540; Chakravarthy S, 2012, NUCLEIC ACIDS RES, V40, P8285, DOI 10.1093/nar/gks645; CHURCHILL MEA, 1989, EMBO J, V8, P4189, DOI 10.1002/j.1460-2075.1989.tb08604.x; Coleman-Derr D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002988; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; De Rop V, 2012, CHROMOSOMA, V121, P527, DOI 10.1007/s00412-012-0386-5; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fang YD, 2005, MOL BIOL CELL, V16, P5710, DOI 10.1091/mbc.E05-08-0706; Filipescu D, 2013, TRENDS GENET, V29, P630, DOI 10.1016/j.tig.2013.06.002; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Ingouff M, 2010, CURR BIOL, V20, P2137, DOI 10.1016/j.cub.2010.11.012; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kalashnikova AA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1022; Khadake JR, 1997, BIOCHEMISTRY-US, V36, P1041, DOI 10.1021/bi961617p; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindhout BI, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm618; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; LINDSEY GG, 1991, J MOL BIOL, V218, P805, DOI 10.1016/0022-2836(91)90268-B; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Lysak Martin, 2006, V323, P173; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2013, BIOCHEM J, V449, P567, DOI 10.1042/BJ20121646; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muthurajan UM, 2011, J BIOL CHEM, V286, P23852, DOI 10.1074/jbc.M111.244871; POCCIA DL, 1992, TRENDS BIOCHEM SCI, V17, P223, DOI 10.1016/0968-0004(92)90382-J; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; SUZUKI M, 1989, EMBO J, V8, P797, DOI 10.1002/j.1460-2075.1989.tb03440.x; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Talbert PB, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-7; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Talbert Paul B., 2009, P193, DOI 10.1007/978-0-387-69076-6_7; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Vaillant I, 2008, PLANT J, V54, P299, DOI 10.1111/j.1365-313X.2008.03413.x; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	62	149	156	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					98	109		10.1016/j.cell.2014.06.006	http://dx.doi.org/10.1016/j.cell.2014.06.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995981	Green Accepted, Bronze			2022-12-24	WOS:000340943100010
J	Jackson, RN; Golden, SM; van Erp, PBG; Carter, J; Westra, ER; Brouns, SJJ; van der Oost, J; Terwilliger, TC; Read, RJ; Wiedenheft, B				Jackson, Ryan N.; Golden, Sarah M.; van Erp, Paul B. G.; Carter, Joshua; Westra, Edze R.; Brouns, Stan J. J.; van der Oost, John; Terwilliger, Thomas C.; Read, Randy J.; Wiedenheft, Blake			Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli	SCIENCE			English	Article							BACTERIAL IMMUNE-SYSTEM; PROCESSES PRE-CRRNA; THERMUS-THERMOPHILUS; CAS SYSTEMS; INTERFERENCE COMPLEX; TARGET RECOGNITION; ANTIVIRAL DEFENSE; SEED SEQUENCE; DNA; CASCADE	Clustered regularly interspaced short palindromic repeats (CRISPRs) are essential components of RNA-guided adaptive immune systems that protect bacteria and archaea from viruses and plasmids. In Escherichia coli, short CRISPR-derived RNAs (crRNAs) assemble into a 405-kilodalton multisubunit surveillance complex called Cascade (CRISPR-associated complex for antiviral defense). Here we present the 3.24 angstrom resolution x-ray crystal structure of Cascade. Eleven proteins and a 61-nucleotide crRNA assemble into a seahorse-shaped architecture that binds double-stranded DNA targets complementary to the crRNA-guide sequence. Conserved sequences on the 3' and 5' ends of the crRNA are anchored by proteins at opposite ends of the complex, whereas the guide sequence is displayed along a helical assembly of six interwoven subunits that present five-nucleotide segments of the crRNA in pseudo-A-form configuration. The structure of Cascade suggests a mechanism for assembly and provides insights into the mechanisms of target recognition.	[Jackson, Ryan N.; Golden, Sarah M.; van Erp, Paul B. G.; Carter, Joshua; Wiedenheft, Blake] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Westra, Edze R.; Brouns, Stan J. J.; van der Oost, John] Wageningen Univ, Dept Agrotechnol & Food Sci, Lab Microbiol, NL-6703 HB Wageningen, Netherlands; [Terwilliger, Thomas C.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Read, Randy J.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England	Montana State University System; Montana State University Bozeman; Wageningen University & Research; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Cambridge	Wiedenheft, B (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	bwiedenheft@gmail.com	van+der+Oost, John/Y-2548-2019; Terwilliger, Thomas/AEF-4827-2022; Read, Randy J/L-1418-2013; Jackson, Ryan N/J-2209-2019; Terwilliger, Thomas C/K-4109-2012; Terwilliger, Thomas/AAM-4079-2020	Read, Randy J/0000-0001-8273-0047; Jackson, Ryan N/0000-0001-7403-3794; Terwilliger, Thomas C/0000-0001-6384-0320; Terwilliger, Thomas/0000-0001-6384-0320; Carter, Joshua/0000-0002-9194-7966; Brouns, Stan/0000-0002-9573-1724	European Union under REA grant [327606]; Netherlands Organization of Scientific Research [864.11.005]; Vici grant [865.05.001]; Wellcome Trust [082961/Z/07/Z]; NIH [GM063210, F32 GM108436, P20GM103500, R01GM108888]; Howard Hughes Medical Institute [52006931]; NSF Experimental Program to Stimulate Competitive Research [EPS-110134]; M. J. Murdock Charitable Trust; Montana State University Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P01GM063210, F32GM108436, R01GM108888, P20GM103500] Funding Source: NIH RePORTER	European Union under REA grant; Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Vici grant; Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF Experimental Program to Stimulate Competitive Research; M. J. Murdock Charitable Trust; Montana State University Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Richardson and D. Richardson for technical suggestions and discussion and A. McCoy for implementing the EM scale factor refinement in Phaser. X-ray diffraction data was collected with assistance from J. Nix at Advanced Light Source (ALS) beamline 4.2.2 (DE-AC02-05CH11231), R. Sanishvili and C. Ogata at Advanced Photon Source (APS) beamline 23-ID (Y1-GM-1104), the Structural Biology Center at APS 19-ID (DE-AC02-06CH11357), and Stanford Synchrotron Radiation Lightsource (DE-AC02-76SF00515 and P41GM103393). E.R.W. received funding from the People Program (Marie Curie Actions) of the European Union's Seventh Framework Program (FP7/2007-2013) under REA grant agreement 327606. S.J.J. B. is supported by a Vidi grant from the Netherlands Organization of Scientific Research (864.11.005) and J.v.d.O. by a Vici grant (865.05.001). R.J.R. is supported by a Principal Research Fellowship from the Wellcome Trust (grant 082961/Z/07/Z). T. C. T. and R.J.R. are supported by a grant (GM063210) from the NIH. J.C. is supported by a grant for undergraduate research from the Howard Hughes Medical Institute (52006931). R.N.J. is supported by a National Research Service Award postdoctoral fellowship (F32 GM108436) from the NIH. Research in the Wiedenheft lab is supported by the NIH (P20GM103500 and R01GM108888), the NSF Experimental Program to Stimulate Competitive Research (EPS-110134), the M. J. Murdock Charitable Trust, and the Montana State University Agricultural Experiment Station. Atomic coordinates have been deposited into the Protein Data Bank with accession code 4TVX.	Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Garside EL, 2012, RNA, V18, P2020, DOI 10.1261/rna.033100.112; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Hrle A, 2013, RNA BIOL, V10, P1670, DOI 10.4161/rna.26500; Jackson RN, 2014, CURR OPIN STRUC BIOL, V24, P106, DOI 10.1016/j.sbi.2014.01.001; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Koo Y, 2013, J MOL BIOL, V425, P3799, DOI 10.1016/j.jmb.2013.02.032; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mulepati S, 2012, J BIOL CHEM, V287, P22445, DOI 10.1074/jbc.C112.379503; Nam KH, 2012, FEBS LETT, V586, P3956, DOI 10.1016/j.febslet.2012.09.041; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Terwilliger Thomas C., 2013, Journal of Structural and Functional Genomics, V14, P91, DOI 10.1007/s10969-013-9157-7; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108	38	175	196	3	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1473	1479		10.1126/science.1256328	http://dx.doi.org/10.1126/science.1256328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25103409	Green Accepted			2022-12-24	WOS:000341752900034
J	Moy, RH; Cole, BS; Yasunaga, A; Gold, B; Shankarling, G; Varble, A; Molleston, JM; TenOever, BR; Lynch, KW; Cherry, S				Moy, Ryan H.; Cole, Brian S.; Yasunaga, Ari; Gold, Beth; Shankarling, Ganesh; Varble, Andrew; Molleston, Jerome M.; TenOever, Benjamin R.; Lynch, Kristen W.; Cherry, Sara			Stem-Loop Recognition by DDX17 Facilitates miRNA Processing and Antiviral Defense	CELL			English	Article							DEXD/H-BOX HELICASE; RNA INTERFERENCE; IMMUNE-RESPONSE; PROTEIN; REVEALS; VIRUS; P68; MICROPROCESSOR; BIOGENESIS; COMPLEX	DEAD-box helicases play essential roles in RNA metabolism across species, but emerging data suggest that they have additional functions in immunity. Through RNAi screening, we identify an evolutionarily conserved and interferon-independent role for the DEAD-box helicase DDX17 in restricting Rift Valley fever virus (RVFV), a mosquito-transmitted virus in the bunyavirus family that causes severe morbidity and mortality in humans and livestock. Loss of Drosophila DDX17 (Rm62) in cells and flies enhanced RVFV infection. Similarly, depletion of DDX17 but not the related helicase DDX5 increased RVFV replication in human cells. Using crosslinking immunoprecipitation high-throughput sequencing (CLIP-seq), we show that DDX17 binds the stem loops of host pri-miRNA to facilitate their processing and also an essential stem loop in bunyaviral RNA to restrict infection. Thus, DDX17 has dual roles in the recognition of stem loops: in the nucleus for endogenous microRNA (miRNA) biogenesis and in the cytoplasm for surveillance against structured non-self-elements.	[Moy, Ryan H.; Yasunaga, Ari; Gold, Beth; Molleston, Jerome M.; Cherry, Sara] Univ Penn, Perelman Sch Med, Penn Genome Frontiers Inst, Dept Microbiol, Philadelphia, PA 19104 USA; [Cole, Brian S.; Shankarling, Ganesh; Lynch, Kristen W.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Varble, Andrew; TenOever, Benjamin R.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Icahn School of Medicine at Mount Sinai	Cherry, S (corresponding author), Univ Penn, Perelman Sch Med, Penn Genome Frontiers Inst, Dept Microbiol, Philadelphia, PA 19104 USA.	cherrys@mail.med.upenn.edu		Moy, Ryan/0000-0002-0507-8590; Molleston, Jerome/0000-0003-3702-8317; tenOever, Benjamin/0000-0003-0324-3078; cherry, sara/0000-0003-3956-6610	National Institutes of Health [R01AI074951, U54AI057168, R01AI095500, RO1GM103383, T32AI007324]; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007324, R01AI095500, R56AI074951, U54AI057168, R01AI074951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103383, R01GM067719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Spradling for Rm62 mutant flies; A. Bowie for DDX17 siRNA sequences; E. Dardenne for DDX17 plasmid; and M. Tartell for technical help. This work was supported by grants from the National Institutes of Health to S.C. (R01AI074951, U54AI057168, and R01AI095500), K.W.L. (RO1GM103383), and R.H.M. (T32AI007324). S.C. and B.R.T. are recipients of the Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award.	Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Boeke J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020761; Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; Cziko AMJ, 2009, GENETICS, V182, P1051, DOI 10.1534/genetics.109.103234; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; EMERY VC, 1987, VIROLOGY, V156, P1, DOI 10.1016/0042-6822(87)90430-2; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Fullam A, 2013, BBA-GENE REGUL MECH, V1829, P854, DOI 10.1016/j.bbagrm.2013.03.012; Fuller-Pace FV, 2013, BBA-GENE REGUL MECH, V1829, P756, DOI 10.1016/j.bbagrm.2013.03.004; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hong SG, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003706; Hopkins KC, 2013, GENE DEV, V27, P1511, DOI 10.1101/gad.215384.113; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jalal C, 2007, NUCLEIC ACIDS RES, V35, P3590, DOI 10.1093/nar/gkm058; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020; Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458; Samaan S, 2014, NUCLEIC ACIDS RES, V42, P2197, DOI 10.1093/nar/gkt1216; Shankarling G, 2014, MOL CELL BIOL, V34, P71, DOI 10.1128/MCB.00740-13; Shapiro JS, 2014, P NATL ACAD SCI USA, V111, P7108, DOI 10.1073/pnas.1319635111; Shapiro JS, 2010, RNA, V16, P2068, DOI 10.1261/rna.2303610; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108; Zonta E, 2013, NUCLEIC ACIDS RES, V41, P554, DOI 10.1093/nar/gks1046	54	75	81	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					764	777		10.1016/j.cell.2014.06.023	http://dx.doi.org/10.1016/j.cell.2014.06.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126784	Green Accepted, Bronze			2022-12-24	WOS:000340944700009
J	Mayer, KFX; Rogers, J; Dolezel, J; Pozniak, C; Eversole, K; Feuillet, C; Gill, B; Friebe, B; Lukaszewski, AJ; Sourdille, P; Endo, TR; Dolezel, J; Kubalakova, M; Cihalikova, J; Dubska, Z; Vrana, J; Sperkova, R; Simkova, H; Rogers, J; Febrer, M; Clissold, L; McLay, K; Singh, K; Chhuneja, P; Singh, NK; Khurana, J; Akhunov, E; Choulet, F; Sourdille, P; Feuillet, C; Alberti, A; Barbe, V; Wincker, P; Kanamori, H; Kobayashi, F; Itoh, T; Matsumoto, T; Sakai, H; Tanaka, T; Wu, JZ; Ogihara, Y; Handa, H; Pozniak, C; Maclachlan, PR; Sharpe, A; Klassen, D; Edwards, D; Batley, J; Olsen, OA; Sandve, SR; Lien, S; Steuernagel, B; Wulff, B; Caccamo, M; Ayling, S; Ramirez-Gonzalez, RH; Clavijo, BJ; Steuernagel, B; Wright, J; Pfeifer, M; Spannagl, M; Mayer, KFX; Martis, MM; Akhunov, E; Choulet, F; Mayer, KFX; Mascher, M; Chapman, J; Poland, JA; Scholz, U; Barry, K; Waugh, R; Rokhsar, DS; Muehlbauer, GJ; Stein, N; Gundlach, H; Zytnicki, M; Jamilloux, V; Quesneville, H; Wicker, T; Mayer, KFX; Faccioli, P; Colaiacovo, M; Pfeifer, M; Stanca, AM; Budak, H; Cattivelli, L; Glover, N; Martis, MM; Choulet, F; Feuillet, C; Mayer, KFX; Pfeifer, M; Pingault, L; Mayer, KFX; Paux, E; Spannagl, M; Sharma, S; Mayer, KFX; Pozniak, C; Appels, R; Bellgard, M; Chapman, B; Pfeifer, M; Pfeifer, M; Sandve, SR; Nussbaumer, T; Bader, KC; Choulet, F; Feuillet, C; Mayer, KFX; Akhunov, E; Paux, E; Rimbert, H; Wang, SC; Poland, JA; Knox, R; Kilian, A; Pozniak, C; Alaux, M; Alfama, F; Couderc, L; Jamilloux, V; Guilhot, N; Viseux, C; Loaec, M; Quesneville, H; Rogers, J; Dolezel, J; Eversole, K; Feuillet, C; Keller, B; Mayer, KFX; Olsen, OA; Praud, S				Mayer, Klaus F. X.; Rogers, Jane; Dolezel, Jaroslav; Pozniak, Curtis; Eversole, Kellye; Feuillet, Catherine; Gill, Bikram; Friebe, Bernd; Lukaszewski, Adam J.; Sourdille, Pierre; Endo, Takashi R.; Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana; Rogers, Jane; Febrer, Melanie; Clissold, Leah; McLay, Kirsten; Singh, Kuldeep; Chhuneja, Parveen; Singh, Nagendra K.; Khurana, Jitendra; Akhunov, Eduard; Choulet, Frederic; Sourdille, Pierre; Feuillet, Catherine; Alberti, Adriana; Barbe, Valerie; Wincker, Patrick; Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Ogihara, Yasunari; Handa, Hirokazu; Pozniak, Curtis; Maclachlan, P. Ron; Sharpe, Andrew; Klassen, Darrin; Edwards, David; Batley, Jacqueline; Olsen, Odd-Arne; Sandve, Simen Rod; Lien, Sigbjorn; Steuernagel, Burkhard; Wulff, Brande; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Steuernagel, Burkhard; Wright, Jonathan; Pfeifer, Matthias; Spannagl, Manuel; Mayer, Klaus F. X.; Martis, Mihaela M.; Akhunov, Eduard; Choulet, Frederic; Mayer, Klaus F. X.; Mascher, Martin; Chapman, Jarrod; Poland, Jesse A.; Scholz, Uwe; Barry, Kerrie; Waugh, Robbie; Rokhsar, Daniel S.; Muehlbauer, Gary J.; Stein, Nils; Gundlach, Heidrun; Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Wicker, Thomas; Mayer, Klaus F. X.; Faccioli, Primetta; Colaiacovo, Moreno; Pfeifer, Matthias; Stanca, Antonio Michele; Budak, Hikmet; Cattivelli, Luigi; Glover, Natasha; Martis, Mihaela M.; Choulet, Frederic; Feuillet, Catherine; Mayer, Klaus F. X.; Pfeifer, Matthias; Pingault, Lise; Mayer, Klaus F. X.; Paux, Etienne; Spannagl, Manuel; Sharma, Sapna; Mayer, Klaus F. X.; Pozniak, Curtis; Appels, Rudi; Bellgard, Matthew; Chapman, Brett; Pfeifer, Matthias; Pfeifer, Matthias; Sandve, Simen Rod; Nussbaumer, Thomas; Bader, Kai Christian; Choulet, Frederic; Feuillet, Catherine; Mayer, Klaus F. X.; Akhunov, Eduard; Paux, Etienne; Rimbert, Helene; Wang, Shichen; Poland, Jesse A.; Knox, Ron; Kilian, Andrzej; Pozniak, Curtis; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Jamilloux, Veronique; Guilhot, Nicolas; Viseux, Claire; Loaec, Mikael; Quesneville, Hadi; Rogers, Jane; Dolezel, Jaroslav; Eversole, Kellye; Feuillet, Catherine; Keller, Beat; Mayer, Klaus F. X.; Olsen, Odd-Arne; Praud, Sebastien		IWGSC	A chromosome-based draft sequence of the hexaploid bread wheat (Triticum aestivum) genome	SCIENCE			English	Article							GENE-EXPRESSION; AEGILOPS-TAUSCHII; A-GENOME; EVOLUTION; REVEALS; TRANSCRIPTOME; ANNOTATION; DOMINANCE; RICE; POLYPLOIDIZATION	An ordered draft sequence of the 17-gigabase hexaploid bread wheat (Triticum aestivum) genome has been produced by sequencing isolated chromosome arms. We have annotated 124,201 gene loci distributed nearly evenly across the homeologous chromosomes and subgenomes. Comparative gene analysis of wheat subgenomes and extant diploid and tetraploid wheat relatives showed that high sequence similarity and structural conservation are retained, with limited gene loss, after polyploidization. However, across the genomes there was evidence of dynamic gene gain, loss, and duplication since the divergence of the wheat lineages. A high degree of transcriptional autonomy and no global dominance was found for the subgenomes. These insights into the genome biology of a polyploid crop provide a springboard for faster gene isolation, rapid genetic marker development, and precise breeding to meet the needs of increasing food demand worldwide.	[Mayer, Klaus F. X.; Pfeifer, Matthias; Spannagl, Manuel; Martis, Mihaela M.; Gundlach, Heidrun; Sharma, Sapna; Nussbaumer, Thomas; Bader, Kai Christian] Helmholtz Zentrum Munich, D-85764 Neuherberg, Germany; [Rogers, Jane; Eversole, Kellye] Eversole Associates, IWGSC, Bethesda, MD 20816 USA; [Dolezel, Jaroslav; Kubalakova, Marie; Cihalikova, Jarmila; Dubska, Zdenka; Vrana, Jan; Sperkova, Romana; Simkova, Hana] Ctr Plant Struct & Funct Genom, Inst Expt Bot, Olomouc 78371, Czech Republic; [Pozniak, Curtis; Maclachlan, P. Ron] Univ Saskatchewan, Ctr Crop Dev, Dept Plant Sci, Coll Agr & Bioresources, Saskatoon, SK S7N 0W0, Canada; [Feuillet, Catherine] Bayer Crop Sci, Morrisville, NC 27560 USA; [Gill, Bikram; Friebe, Bernd; Akhunov, Eduard; Wang, Shichen] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Lukaszewski, Adam J.] Univ Calif Riverside, Coll Nat & Agr Sci Bot & Plant Sci, Riverside, CA 92521 USA; [Endo, Takashi R.] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Kyoto 6068502, Japan; [Febrer, Melanie] Univ Dundee, Genom Sequencing Unit, Dundee DD1 5EH, Scotland; [Clissold, Leah; McLay, Kirsten; Caccamo, Mario; Ayling, Sarah; Ramirez-Gonzalez, Ricardo H.; Clavijo, Bernardo J.; Wright, Jonathan] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Singh, Kuldeep; Chhuneja, Parveen] Punjab Agr Univ, Sch Agrictural Biotechnol, Ludhiana 141004, Punjab, India; [Singh, Nagendra K.] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Khurana, Jitendra] Univ Delhi, Interdisciplinary Ctr Plant Genom, New Delhi 110021, India; [Khurana, Jitendra] Univ Delhi, Dept Plant Mol Biol, New Delhi 110021, India; [Sourdille, Pierre; Choulet, Frederic; Glover, Natasha; Pingault, Lise; Paux, Etienne; Guilhot, Nicolas] Univ Blaise Pascal, INRA, Genet Divers & Ecophysiol Cereals UMR1095, F-63039 Clermont Ferrand, France; [Alberti, Adriana; Barbe, Valerie; Wincker, Patrick] Commissariat Energie Atom Genoscope, Ctr Natl Sequencage, F-91057 Evry, France; [Kanamori, Hiroyuki; Kobayashi, Fuminori; Itoh, Takeshi; Matsumoto, Takashi; Sakai, Hiroaki; Tanaka, Tsuyoshi; Wu, Jianzhong; Handa, Hirokazu] Natl Inst Agrobiol Sci, Plant Genome Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Ogihara, Yasunari] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Sharpe, Andrew; Klassen, Darrin] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Edwards, David; Batley, Jacqueline] Univ Queensland, Australian Ctr Plant Funct Genom, Sch Agr & Food Sci, St Lucia, Qld 4072, Australia; [Edwards, David; Batley, Jacqueline] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia; [Olsen, Odd-Arne; Sandve, Simen Rod] Norwegian Univ Life Sci, Dept Plant Sci, Ctr Integrat Genet CIGENE, N-1432 As, Norway; [Olsen, Odd-Arne] Hedmark Univ Coll, Dept Nat Sci & Technol, N-2318 Elverum, Norway; [Steuernagel, Burkhard; Wulff, Brande] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Mascher, Martin; Scholz, Uwe] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Seeland Ot Gatersleben, Germany; [Chapman, Jarrod; Barry, Kerrie; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Poland, Jesse A.] Kansas State Univ, USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Poland, Jesse A.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Waugh, Robbie] James Hutton Inst, Dundee DD2 5DA, Scotland; [Muehlbauer, Gary J.] Univ Minnesota, Dept Plant Biol, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Seeland Ot Gatersleben, Germany; [Zytnicki, Matthias; Jamilloux, Veronique; Quesneville, Hadi; Alaux, Michael; Alfama, Francoise; Couderc, Loic; Viseux, Claire; Loaec, Mikael] INRA, URGI Res Unit Genom Info UR1164, F-78026 Versailles, France; [Wicker, Thomas; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Faccioli, Primetta; Colaiacovo, Moreno; Stanca, Antonio Michele; Cattivelli, Luigi] Genom Res Ctr, Consiglio Ric & Sperimentaz Agr, I-29017 Fiorenzuola Darda, Italy; [Budak, Hikmet] Sabanci Univ, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Appels, Rudi; Bellgard, Matthew; Chapman, Brett] Murdoch Univ, Ctr Comparat Genom, Perth, WA 6150, Australia; [Knox, Ron] Semiarid Prairie Agr Res Ctr, Swift Current, SK S9H 3X2, Canada; [Kilian, Andrzej] Divers Arrays Technol Pty Ltd, Yarralumla, ACT 2600, Australia; [Rimbert, Helene; Praud, Sebastien] Biogemma, Ctr Rech Chappes, F-63720 Chappes, France; [Lien, Sigbjorn] Norwegian Univ Life Sci, CIGENE, Dept Anim & Aquicultural Sci, N-1432 As, Norway	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Saskatchewan; Bayer AG; Bayer CropScience; Kansas State University; University of California System; University of California Riverside; Kyoto University; University of Dundee; The Genome Analysis Centre (TGAC); Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); University of Delhi; University of Delhi; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Universite Paris Saclay; National Institute of Agrobiological Sciences - Japan; Yokohama City University; National Research Council Canada; University of Queensland; University of Western Australia; Norwegian University of Life Sciences; Inland Norway University of Applied Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Kansas State University; United States Department of Agriculture (USDA); Kansas State University; James Hutton Institute; University of Minnesota System; University of Minnesota Twin Cities; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Zurich; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sabanci University; Murdoch University; Norwegian University of Life Sciences	Mayer, KFX (corresponding author), Helmholtz Zentrum Munich, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	k.mayer@helmholtz-muenchen.de; janerogersh@gmail.com; dolezel@ueb.cas.cz; curtis.pozniak@usask.ca; eversole@eversoleassociates.com; catherine.feuillet@bayer.com	Vrana, Jan/F-7306-2014; Barry, Kerrie Whitelaw/AAA-5500-2020; Singh, Nouratan/N-9377-2017; Batley, Jacqueline/A-5723-2008; Wu, Jian/AAU-5221-2020; Pfeifer, Matthias/GRJ-4579-2022; Budak, Hikmet/F-4708-2010; Stein, Nils/F-7507-2017; Kubaláková, Marie/F-8269-2014; Sourdille, Pierre/CAF-2780-2022; HANDA, Hirokazu/C-9781-2009; Budak, Hikmet/U-8517-2019; Budak, Hikmet/S-5835-2017; Dolezel, Jaroslav/B-7716-2008; Wicker, Thomas/Z-1978-2019; Eversole, Kellye/AAN-6141-2020; Mayer, Klaus FX/M-7941-2015; Wulff, Brande B/N-4273-2013; Sharma, Sapna/N-6357-2017; Simkova, Hana/F-7734-2014; cattivelli, luigi/AAE-7046-2020; Edwards, David/H-3710-2015; SAB, Parveen Chhuneja -/H-5456-2019; Ramírez, Ricardo/H-4808-2019; , 叮当๑/AAZ-9709-2020; Keller, Beat/K-3093-2019; Pingault, Lise/AAQ-8602-2020; Quesneville, Hadi/AAG-1048-2020; Wulff, Brande BH/C-7465-2013; Wang, Shichen/E-6213-2012; Wu, Jian/AAU-5221-2020	Vrana, Jan/0000-0001-6171-8516; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Singh, Nouratan/0000-0002-8063-8375; Batley, Jacqueline/0000-0002-5391-5824; Wu, Jian/0000-0001-9933-7364; Budak, Hikmet/0000-0002-2556-2478; Stein, Nils/0000-0003-3011-8731; HANDA, Hirokazu/0000-0003-2985-2883; Budak, Hikmet/0000-0002-2556-2478; Budak, Hikmet/0000-0002-2556-2478; Dolezel, Jaroslav/0000-0002-6263-0492; Eversole, Kellye/0000-0002-8784-4913; Mayer, Klaus FX/0000-0001-6484-1077; Simkova, Hana/0000-0003-4159-7619; cattivelli, luigi/0000-0002-6067-4600; Edwards, David/0000-0001-7599-6760; Ramírez, Ricardo/0000-0001-5745-7085; Keller, Beat/0000-0003-2379-9225; Pingault, Lise/0000-0002-6149-1267; Quesneville, Hadi/0000-0003-3001-4908; Wulff, Brande BH/0000-0003-4044-4346; Wang, Shichen/0000-0003-1441-2252; Dyer, Sarah/0000-0001-5690-9633; Steuernagel, Burkhard/0000-0002-8284-7728; Rokhsar, Daniel/0000-0002-8704-2224; Martis, Mihaela-Maria/0000-0001-7509-2446; Colaiacovo, Moreno/0000-0003-1320-0506; Wright, Jonathan/0000-0001-6471-8749; Sourdille, Pierre/0000-0002-1027-2224; Wu, Jian/0000-0002-3394-1507; Paux, Etienne/0000-0002-3094-7129; Jamilloux, Veronique/0000-0002-6898-4910; Alaux, Michael/0000-0001-9356-4072; Mascher, Martin/0000-0001-6373-6013; Knox, Ron/0000-0002-2030-3899; Choulet, Frederic/0000-0003-1788-7288; Kilian, Andrzej/0000-0002-2730-7462; Spannagl, Manuel/0000-0003-0701-7035; Itoh, Takeshi/0000-0002-6291-4233; , Thomas/0000-0002-6777-7135; Poland, Jesse/0000-0002-7856-1399; Bellgard, Matthew/0000-0002-6303-9469; Clavijo, Bernardo J./0000-0002-7597-2774; Tanaka, Tsuyoshi/0000-0003-3740-6832; Scholz, Uwe/0000-0001-6113-3518; Gundlach, Heidrun/0000-0002-6757-0943; Singh, Kuldeep/0000-0001-5239-6586	Institut National de la Recherche Agronomique (INRA); International Center for Agricultural Research in the Dry Areas; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/IWGSC/03/TF/2008]; Biotechnology and Biological Sciences Research Council (BBSRC UK); 3A-U.S. Department of Agriculture Agriculture and Food Research Initiative (USDA AFRI) Triticeae-CAP [2011-68002-30029]; Kansas Wheat Commission; French National Research Agency [ANR-09-GENM-025 3BSEQ]; France Agrimer; Ministry of Agriculture, Forestry and Fisheries of Japan [KGS-1003,1004, NGB-1003]; Nisshin Flour Milling Incorporated; Genome Canada; Genome Prairie; University of Saskatchewan Ministry of Agriculture, Western Grains Research Foundation; Norwegian Research Council [199387]; Graminor AS; Czech Science foundation [P501/12/G090, P501/12/2554]; BBSRC (UK); German Ministry for Education and Research (BMBF) Plant2030; TRITEX; Deutsche Forschungsgemeinschaft (DFG) [SFB 924]; EC Transplant; IWGSC; Arcadia Biosciences; Australian Centre for Plant Functional Genomics; Biogemma; Bayer CropScience; Commonwealth Science and Industrial Research Organisation; Centro Internacional de Mejoramiento de Maiz y Trigo; Cereales Vallee; Dow AgroSciences; Dupont; Evogene; Florimond Desprez; Grains Research and Development Corporation; Graminor; Heartland Plant Innovation; INRA; KWS; Limagrain; Monsanto; RAGT; Syngenta; European Commission Marie Curie Actions (FP7-MC-IIF-Noncollinear Genes); Division Of Computer and Network Systems [1126709] Funding Source: National Science Foundation; BBSRC [BB/I00663X/1, BBS/E/T/000PR5885, BB/J003166/1, BB/I026030/1, BB/J003743/1, BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I026030/1, BB/I00663X/1, BBS/E/T/000PR6193, BBS/E/T/000PR5885, BB/J003743/1, BB/J003166/1] Funding Source: researchfish	Institut National de la Recherche Agronomique (INRA); International Center for Agricultural Research in the Dry Areas; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Biotechnology and Biological Sciences Research Council (BBSRC UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 3A-U.S. Department of Agriculture Agriculture and Food Research Initiative (USDA AFRI) Triticeae-CAP; Kansas Wheat Commission; French National Research Agency(French National Research Agency (ANR)); France Agrimer; Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Nisshin Flour Milling Incorporated; Genome Canada(Genome Canada); Genome Prairie; University of Saskatchewan Ministry of Agriculture, Western Grains Research Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Graminor AS; Czech Science foundation(Grant Agency of the Czech Republic); BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Ministry for Education and Research (BMBF) Plant2030(Federal Ministry of Education & Research (BMBF)); TRITEX; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EC Transplant; IWGSC; Arcadia Biosciences; Australian Centre for Plant Functional Genomics; Biogemma; Bayer CropScience(Bayer AG); Commonwealth Science and Industrial Research Organisation; Centro Internacional de Mejoramiento de Maiz y Trigo; Cereales Vallee; Dow AgroSciences; Dupont; Evogene; Florimond Desprez; Grains Research and Development Corporation(Grains R&D Corp); Graminor; Heartland Plant Innovation; INRA; KWS; Limagrain; Monsanto; RAGT; Syngenta(Syngenta); European Commission Marie Curie Actions (FP7-MC-IIF-Noncollinear Genes); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to thank Graminor AS; Biogemma; Institut National de la Recherche Agronomique (INRA); International Center for Agricultural Research in the Dry Areas; Department of Biotechnology, Ministry of Science and Technology, Government of India (chr. 2A; grant no. BT/IWGSC/03/TF/2008); and the Biotechnology and Biological Sciences Research Council (BBSRC UK) for funding the chromosome sequencing at the Genome Analysis Centre. Chromosome sequencing at other centers was funded by the following: chr. 3A-U.S. Department of Agriculture Agriculture and Food Research Initiative (USDA AFRI) Triticeae-CAP (2011-68002-30029) and the Kansas Wheat Commission; chr. 3B-grants from the French National Research Agency (ANR-09-GENM-025 3BSEQ) and France Agrimer; chr. 6B-grants from the Ministry of Agriculture, Forestry and Fisheries of Japan "Genomics for agricultural innovation KGS-1003,1004", "Genomics based technology for agricultural improvement, NGB-1003," and Nisshin Flour Milling Incorporated; chr. 6D and Triticum durum cv. Strongfield-grants from Genome Canada, Genome Prairie, University of Saskatchewan Ministry of Agriculture, Western Grains Research Foundation; chr. 7B-grant no. 199387 from the Norwegian Research Council and from Graminor AS; chr. 7A and 7D sequence reads were provided by D. E.. Chromosome flow sorting and DNA preparation was supported through grants P501/12/G090 and P501/12/2554 from the Czech Science foundation. Chromosome sequence assembly was supported by the BBSRC (UK). K. F. X. M. acknowledges grants from the German Ministry for Education and Research (BMBF) Plant2030, TRITEX, Deutsche Forschungsgemeinschaft (DFG) SFB 924, and EC Transplant. K. E. and J.R. are supported by sponsors of the IWGSC, which include Arcadia Biosciences, Australian Centre for Plant Functional Genomics, Biogemma, Bayer CropScience, Commonwealth Science and Industrial Research Organisation, Centro Internacional de Mejoramiento de Maiz y Trigo, Cereales Vallee, Dow AgroSciences, Dupont, Evogene, Florimond Desprez, Grains Research and Development Corporation, Graminor, Heartland Plant Innovation, INRA, KWS, Kansas Wheat Commission, Limagrain, Monsanto, RAGT, and Syngenta. N. G. is supported by European Commission Marie Curie Actions (FP7-MC-IIF-Noncollinear Genes). T. W. is supported by the Swiss National Foundation and P. F., M. C., A. M. S., and L. C. are supported by the Italian Ministry of Agriculture special project "MAPPA-5A." H. B. acknowledges funding from Sabanci University and the Scientific and Technological Research Council of Turkey. B. W. and B. S. were funded by the Gatsby Charitable Foundation and the BBSRC (UK) Grant BB/J003166/1. R. W. is a Trustee Director of TGAC, Norwich, UK, and A. K. is a shareholder of Diversity Arrays Technology Pty Ltd. The POPSeq analysis carried out by the U. S. Department of Energy Joint Genome Institute was supported by the Office of Science of the U. S. Department of Energy under contract no. DE-AC02-05CH11231. Additional support for the work was funded from the Triticeae-CAP, USDA AFRI (2011-68002-30029) to G.J.M.; the Scottish Government Rural and Environment Science and Analytical Services Division Research Programme to R. W.; and the German Ministry of Research and Education (BMBF TRITEX 0315954) to N.S. Sequence reads and assembled sequences are available at European Molecular Biology Laboratory/GenBank/DNA Data Bank of Japan short read archives and sequence repositories, respectively (PRJEB3955-whole-genome sequences of T. aestivum 'Chinese Spring,' T. urartu, Ae. speltoides, Ae.; tauschii, T. turgidum; SRP004490.3-whole-genome sequencing of T. monococcum; SRP004490-whole-genome sequencing of Ae. tauschii; PRJEB4849 -whole-genome sequences of Ae. sharonensis; PRJEB4750-T. aestivum RNA-seq data; SRP037990-T. aestivum SynOpDH mapping population; SRP037781-T. aestivum synthetic opata M85; SRP037994-T. aestivum synthetic W7984). All data can be accessed via the IWGSC repository at Unite de Rercherche Genomique Info: http://wheat-urgi.versailles.inra.fr/Seq-Repository/.	Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Akhunov ED, 2013, PLANT PHYSIOL, V161, P252, DOI 10.1104/pp.112.205161; Allen AM, 2013, PLANT BIOTECHNOL J, V11, P279, DOI 10.1111/pbi.12009; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Berkman PJ, 2012, THEOR APPL GENET, V124, P423, DOI 10.1007/s00122-011-1717-2; Berkman PJ, 2011, PLANT BIOTECHNOL J, V9, P768, DOI 10.1111/j.1467-7652.2010.00587.x; Bernardo AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-251; Borchert Glen M, 2011, Mob Genet Elements, V1, P8; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chelaifa H, 2013, NEW PHYTOL, V197, P730, DOI 10.1111/nph.12108; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036442; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Civan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081955; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Coram TE, 2008, THEOR APPL GENET, V117, P401, DOI 10.1007/s00122-008-0784-5; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Eilam T, 2007, GENOME, V50, P1029, DOI 10.1139/G07-083; Escobar JS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-181; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization (FAO) of the United Nations, 2013, FAO CER SUPPL DEM BR; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; KANTAR M, 2012, GENOMICS, V12, P465, DOI DOI 10.1007/S10142-012-0285-0; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Knox RE, 2009, GENOME, V52, P741, DOI [10.1139/G09-042, 10.1139/g09-042]; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Krasileva KV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r66; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Lucas SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040859; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079329; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Martinez-Perez E, 2001, NATURE, V411, P204, DOI 10.1038/35075597; Martis MM, 2013, PLANT CELL, V25, P3685, DOI 10.1105/tpc.113.114553; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Nesbitt M., HULLED WHEATS PROMOT, P41; OECD/Food and Agriculture Organization of the United Nations, 2013, OECD FAO AGR OUTL 20, DOI [10.1787/agr_outlook-2013-en, DOI 10.1787/AGR_OUTLOOK-2013-EN]; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Pfeifer M, 2014, SCIENCE, V345, DOI 10.1126/science.1250091; Pumphrey M, 2009, GENETICS, V181, P1147, DOI 10.1534/genetics.108.096941; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Rapp RA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-18; Safar J, 2010, CYTOGENET GENOME RES, V129, P211, DOI 10.1159/000313072; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sears E. R., 1978, Proceedings of the fifth international wheat genetics symposium. Volume 1. Session IV. Cytogenetics., P389; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/G11-054, 10.1139/g11-054]; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tanaka T, 2014, DNA RES, V21, P103, DOI 10.1093/dnares/dst041; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wiebe K, 2010, THEOR APPL GENET, V121, P1047, DOI 10.1007/s00122-010-1370-1; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	86	1118	1138	31	440	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194			SI				1251788	10.1126/science.1251788	http://dx.doi.org/10.1126/science.1251788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR2MB	25035500				2022-12-24	WOS:000343420300004
J	Skowronska-Krawczyk, D; Ma, Q; Schwartz, M; Scully, K; Li, WB; Liu, ZJ; Taylor, H; Tollkuhn, J; Ohgi, KA; Notani, D; Kohwi, Y; Kohwi-Shigematsu, T; Rosenfeld, MG				Skowronska-Krawczyk, Dorota; Ma, Qi; Schwartz, Michal; Scully, Kathleen; Li, Wenbo; Liu, Zhijie; Taylor, Havilah; Tollkuhn, Jessica; Ohgi, Kenneth A.; Notani, Dimple; Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi; Rosenfeld, Michael G.			Required enhancer-matrin-3 network interactions for a homeodomain transcription program	NATURE			English	Article							NUCLEAR-MATRIX; ATTACHMENT REGION; DNA; PROTEIN; DOMAIN; PIT-1; ORGANIZATION; SCAFFOLD; GENOME; SATB1	Homeodomain proteins, described 30 years ago(1,2), exert essential roles in development as regulators of target gene expression(3,4); however, the molecular mechanisms underlying transcriptional activity of homeodomain factors remain poorly understood. Here investigation of a developmentally required POU-homeodomain transcription factor, Pit1 (also known as Pou1f1), has revealed that, unexpectedly, binding of Pit1-occupied enhancers(5) to a nuclear matrin-3-rich network/architecture(6,7) is a key event in effective activation of the Pit1-regulated enhancer/coding gene transcriptional program. Pit1 association with Satb1 (ref. 8) and beta-catenin is required for this tethering event. A naturally occurring, dominant negative, point mutation in human PIT1(R271W), causing combined pituitary hormone deficiency(9), results in loss of Pit1 association with beta-catenin and Satb1 and therefore the matrin-3-rich network, blocking Pit1-dependent enhancer/coding target gene activation. This defective activation can be rescued by artificial tethering of the mutant R271W Pit1 protein to the matrin-3 network, bypassing the pre-requisite association with beta-catenin and Satb1 otherwise required. The matrin-3 network-tethered R271W Pit1 mutant, but not the untethered protein, restores Pit1-dependent activation of the enhancers and recruitment of co-activators, exemplified by p300, causing both enhancer RNA transcription and target gene activation. These studies have thus revealed an unanticipated homeodomain factor/beta-catenin/Satb1-dependent localization of targetgene regulatory enhancer regions to a subnuclear architectural structure that serves as an underlying mechanism by which an enhancer-bound homeodomain factor effectively activates developmental gene transcriptional programs.	[Skowronska-Krawczyk, Dorota; Ma, Qi; Schwartz, Michal; Scully, Kathleen; Li, Wenbo; Liu, Zhijie; Taylor, Havilah; Tollkuhn, Jessica; Ohgi, Kenneth A.; Notani, Dimple; Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, Sch Med, La Jolla, CA 92093 USA; [Schwartz, Michal] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel; [Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Bar Ilan University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, Sch Med, La Jolla, CA 92093 USA.	dkrawczyk@ucsd.edu; mrosenfeld@ucsd.edu	Ma, Qi/C-9716-2015; li, wenbo/GZM-8930-2022	Tollkuhn, Jessica/0000-0001-5991-7620; Schwartz, Michal/0000-0001-5442-0201; Notani, Dimple/0000-0002-9460-8070; Ma, Qi/0000-0002-8705-4460	UCSD Neuroscience Microscopy Shared Facility [P30 NS047101]; NIH [NS034934, DK039949, DK018477, HL065445, CA173903]; EMBO Long Term Fellowship; Swiss National Science Foundation; San Diego Foundation; NATIONAL CANCER INSTITUTE [P30CA023100, R37CA039681, R01CA173903] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018477, R01DK039949, R37DK039949, P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS034934, R01NS048243] Funding Source: NIH RePORTER	UCSD Neuroscience Microscopy Shared Facility; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); San Diego Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Ghassemian for assistance with mass spectrometry; C. Nelson for cell culture assistance; J. Hightower for assistance with figures and manuscript preparation; T. Suter for help with images analysis. We acknowledge J. Santini and the UCSD Neuroscience Microscopy Shared Facility (Grant P30 NS047101) for imaging. These studies were supported by grants NS034934, DK039949, DK018477, HL065445, CA173903 to M.G.R. from NIH. D.S.-K. was supported by EMBO Long Term Fellowship, The Swiss National Science Foundation and The San Diego Foundation. M.G.R. is an Investigator with HHMI.	Affolter M, 1990, CURR OPIN CELL BIOL, V2, P485, DOI 10.1016/0955-0674(90)90132-X; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; Gasser SM, 1998, CHROMATIN PRACTICAL, P111; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Mancini MG, 1999, J CELL BIOCHEM, V72, P322, DOI 10.1002/(SICI)1097-4644(19990301)72:3<322::AID-JCB2>3.3.CO;2-0; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; NAKAYASU H, 1991, P NATL ACAD SCI USA, V88, P10312, DOI 10.1073/pnas.88.22.10312; Nickerson JA, 2001, J CELL SCI, V114, P463; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Prince KL, 2011, NAT REV ENDOCRINOL, V7, P727, DOI 10.1038/nrendo.2011.119; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; S'iakste N I, 2001, Mol Biol (Mosk), V35, P739; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Zeitz MJ, 2009, J CELL BIOCHEM, V108, P125, DOI 10.1002/jcb.22234; Zhu XY, 2007, CURR OPIN CELL BIOL, V19, P605, DOI 10.1016/j.ceb.2007.09.011	33	45	46	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					257	+		10.1038/nature13573	http://dx.doi.org/10.1038/nature13573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119036	Green Accepted, Green Submitted			2022-12-24	WOS:000342663100048
J	Chalhoub, B; Denoeud, F; Liu, SY; Parkin, IAP; Tang, HB; Wang, XY; Chiquet, J; Belcram, H; Tong, CB; Samans, B; Correa, M; Da Silva, C; Just, J; Falentin, C; Koh, CS; Le Clainche, I; Bernard, M; Bento, P; Noel, B; Labadie, K; Alberti, A; Charles, M; Arnaud, D; Guo, H; Daviaud, C; Alamery, S; Jabbari, K; Zhao, MX; Edger, PP; Chelaifa, H; Tack, D; Lassalle, G; Mestiri, I; Schnel, N; Le Paslier, MC; Fan, GY; Renault, V; Bayer, PE; Golicz, AA; Manoli, S; Lee, TH; Thi, VHD; Chalabi, S; Hu, Q; Fan, CC; Tollenaere, R; Lu, YH; Battail, C; Shen, JX; Sidebottom, CHD; Wang, XF; Canaguier, A; Chauveau, A; Berard, A; Deniot, G; Guan, M; Liu, ZS; Sun, FM; Lim, YP; Lyons, E; Town, CD; Bancroft, I; Wang, XW; Meng, JL; Ma, JX; Pires, JC; King, GJ; Brunel, D; Delourme, R; Renard, M; Aury, JM; Adams, KL; Batley, J; Snowdon, RJ; Tost, J; Edwards, D; Zhou, YM; Hua, W; Sharpe, AG; Paterson, AH; Guan, CY; Wincker, P				Chalhoub, Boulos; Denoeud, France; Liu, Shengyi; Parkin, Isobel A. P.; Tang, Haibao; Wang, Xiyin; Chiquet, Julien; Belcram, Harry; Tong, Chaobo; Samans, Birgit; Correa, Margot; Da Silva, Corinne; Just, Jeremy; Falentin, Cyril; Koh, Chu Shin; Le Clainche, Isabelle; Bernard, Maria; Bento, Pascal; Noel, Benjamin; Labadie, Karine; Alberti, Adriana; Charles, Mathieu; Arnaud, Dominique; Guo, Hui; Daviaud, Christian; Alamery, Salman; Jabbari, Kamel; Zhao, Meixia; Edger, Patrick P.; Chelaifa, Houda; Tack, David; Lassalle, Gilles; Mestiri, Imen; Schnel, Nicolas; Le Paslier, Marie-Christine; Fan, Guangyi; Renault, Victor; Bayer, Philippe E.; Golicz, Agnieszka A.; Manoli, Sahana; Lee, Tae-Ho; Vinh Ha Dinh Thi; Chalabi, Smahane; Hu, Qiong; Fan, Chuchuan; Tollenaere, Reece; Lu, Yunhai; Battail, Christophe; Shen, Jinxiong; Sidebottom, Christine H. D.; Wang, Xinfa; Canaguier, Aurelie; Chauveau, Aurelie; Berard, Aurelie; Deniot, Gwenaelle; Guan, Mei; Liu, Zhongsong; Sun, Fengming; Lim, Yong Pyo; Lyons, Eric; Town, Christopher D.; Bancroft, Ian; Wang, Xiaowu; Meng, Jinling; Ma, Jianxin; Pires, J. Chris; King, Graham J.; Brunel, Dominique; Delourme, Regine; Renard, Michel; Aury, Jean-Marc; Adams, Keith L.; Batley, Jacqueline; Snowdon, Rod J.; Tost, Jorg; Edwards, David; Zhou, Yongming; Hua, Wei; Sharpe, Andrew G.; Paterson, Andrew H.; Guan, Chunyun; Wincker, Patrick			Early allopolyploid evolution in the post-Neolithic Brassica napus oilseed genome	SCIENCE			English	Article							GENE; DOMINANCE; COTTON; PLANT	Oilseed rape (Brassica napus L.) was formed similar to 7500 years ago by hybridization between B. rapa and B. oleracea, followed by chromosome doubling, a process known as allopolyploidy. Together with more ancient polyploidizations, this conferred an aggregate 72x genome multiplication since the origin of angiosperms and high gene content. We examined the B. napus genome and the consequences of its recent duplication. The constituent A(n) and C-n subgenomes are engaged in subtle structural, functional, and epigenetic cross-talk, with abundant homeologous exchanges. Incipient gene loss and expression divergence have begun. Selection in B. napus oilseed types has accelerated the loss of glucosinolate genes, while preserving expansion of oil biosynthesis genes. These processes provide insights into allopolyploid evolution and its relationship with crop domestication and improvement.	[Chalhoub, Boulos; Belcram, Harry; Just, Jeremy; Le Clainche, Isabelle; Arnaud, Dominique; Jabbari, Kamel; Chelaifa, Houda; Mestiri, Imen; Vinh Ha Dinh Thi; Chalabi, Smahane; Lu, Yunhai; Canaguier, Aurelie] Univ Evry Val dEssone, Inst Natl Rech Agron INRA, Unite Rech Genom Vegetale, UMR1165, F-91057 Evry, France; [Denoeud, France; Correa, Margot; Da Silva, Corinne; Bernard, Maria; Bento, Pascal; Noel, Benjamin; Labadie, Karine; Alberti, Adriana; Battail, Christophe; Aury, Jean-Marc; Wincker, Patrick] Commissariat Energie Atom CEA, Inst Genom IG, F-91057 Evry, France; [Denoeud, France; Wincker, Patrick] Univ Evry Val dEssone, UMR 8030, F-91057 Evry, France; [Denoeud, France; Wincker, Patrick] Ctr Natl Rech Sci CNRS, UMR 8030, Evry, France; [Liu, Shengyi; Tong, Chaobo; Hu, Qiong; Wang, Xinfa; Hua, Wei] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr Peoples Republ China, Oil Crops Res Inst, Wuhan 430062, Peoples R China; [Parkin, Isobel A. P.] Agr & Agri Food Canada, Saskatoon, SK S7N 0X2, Canada; [Tang, Haibao; Town, Christopher D.] J Craig Venter Inst, Rockville, MD 20850 USA; [Tang, Haibao] Fujian Agr & Forestry Univ, Ctr Genom & Biotechnol, Fuzhou 350002, Fujian Province, Peoples R China; [Wang, Xiyin; Guo, Hui; Lee, Tae-Ho; Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Wang, Xiyin] Hebei United Univ, Sch Life Sci, Ctr Genom & Computat Biol, Tangshan 063000, Hebei, Peoples R China; [Chiquet, Julien] Univ Evry Val dEssone, Lab Math & Modelisat dEvry, CNRS, USC,INRA,UMR 8071, F-91057 Evry, France; [Samans, Birgit; Snowdon, Rod J.] Univ Giessen, Res Ctr Biosyst Land Use & Nutr, Dept Plant Breeding, D-35392 Giessen, Germany; [Falentin, Cyril; Lassalle, Gilles; Schnel, Nicolas; Deniot, Gwenaelle; Delourme, Regine; Renard, Michel] INRA, Inst Genet Environm & Protect Plantes IGEPP, UMR1349, F-35653 Le Rheu, France; [Koh, Chu Shin; Sidebottom, Christine H. D.; Sharpe, Andrew G.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Charles, Mathieu; Le Paslier, Marie-Christine; Chauveau, Aurelie; Berard, Aurelie; Brunel, Dominique] INRA, Ctr Natl Genotypage, CEA IG, US1279, F-91057 Evry, France; [Daviaud, Christian; Tost, Jorg] CEA IG, Ctr Natl Genotypage, Lab Epigenet & Environm, F-91000 Evry, France; [Alamery, Salman; Bayer, Philippe E.; Golicz, Agnieszka A.; Manoli, Sahana; Tollenaere, Reece; Batley, Jacqueline; Edwards, David] Univ Queensland, Australian Ctr Plant Funct Genom, Sch Agr & Food Sci, St Lucia, Qld 4072, Australia; [Jabbari, Kamel] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Zhao, Meixia; Ma, Jianxin] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Edger, Patrick P.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Tack, David; Adams, Keith L.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Fan, Guangyi; Sun, Fengming] Beijing Genome Inst Shenzhen, Shenzhen 518083, Peoples R China; [Renault, Victor] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France; [Fan, Chuchuan; Shen, Jinxiong; Meng, Jinling; Zhou, Yongming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Guan, Mei; Liu, Zhongsong; Guan, Chunyun] Hunan Agr Univ, Coll Agron, Changsha 410128, Hunan, Peoples R China; [Lim, Yong Pyo] Chungnam Natl Univ, Dept Hort, Mol Genet & Genom Lab, Taejon 305764, South Korea; [Lyons, Eric] Univ Arizona, Sch Plant Sci, IPlant Collaborat, Tucson, AZ USA; [Bancroft, Ian] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Wang, Xiaowu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Pires, J. Chris] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [King, Graham J.] So Cross Univ, Southern Cross Plant Sci, Lismore, NSW 2480, Australia; [Batley, Jacqueline; Edwards, David] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Agriculture & Agri Food Canada; J. Craig Venter Institute; Fujian Agriculture & Forestry University; University System of Georgia; University of Georgia; North China University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Justus Liebig University Giessen; INRAE; National Research Council Canada; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Queensland; University of Cologne; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Berkeley; University of British Columbia; Beijing Genomics Institute (BGI); Foundation Jean Dausset-CEPH; Huazhong Agricultural University; Hunan Agricultural University; Chungnam National University; University of Arizona; University of York - UK; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Missouri System; University of Missouri Columbia; Southern Cross University; University of Western Australia	Chalhoub, B (corresponding author), Univ Evry Val dEssone, Inst Natl Rech Agron INRA, Unite Rech Genom Vegetale, UMR1165, 2 Rue Gaston Cremieux, F-91057 Evry, France.	chalhoub@evry.inra.fr	Bancroft, Ian/AAH-3831-2020; Shen, Jinxiong/AAT-3318-2021; Chiquet, Julien/M-8347-2019; Alberti, Adriana/AAZ-2013-2021; King, Graham J/AAW-3368-2020; Parkin, Isobel/AAD-6625-2020; Edger, Patrick/ABE-6442-2020; Labadie, Karine/AAG-7355-2022; Bayer, Philipp Emanuel/L-4481-2018; ZHAO, MEIXIA/N-3124-2015; Tost, Joerg/H-7129-2019; Alberti, Adriana/E-7142-2017; Shen, Jinxiong/Z-3988-2019; Aury, Jean-Marc/N-1621-2019; Attia, KOTB A/U-4076-2017; Labadie, Karine/AFL-7408-2022; Pires, J. Chris/O-5122-2014; Tang, Haibao/A-6715-2011; Edwards, David/H-3710-2015; Wang, Xiaowu/L-2579-2019; Edger, Patrick/AAP-3846-2021; Batley, Jacqueline/A-5723-2008; Liu, Shengyi/S-6772-2016	Chiquet, Julien/0000-0002-3629-3429; Alberti, Adriana/0000-0003-3372-9423; King, Graham J/0000-0002-5975-6051; Labadie, Karine/0000-0001-7467-8509; Bayer, Philipp Emanuel/0000-0001-8530-3067; ZHAO, MEIXIA/0000-0001-8812-8217; Tost, Joerg/0000-0002-2683-0817; Alberti, Adriana/0000-0003-3372-9423; Aury, Jean-Marc/0000-0003-1718-3010; Attia, KOTB A/0000-0002-2992-1765; Labadie, Karine/0000-0001-7467-8509; Pires, J. Chris/0000-0001-9682-2639; Tang, Haibao/0000-0002-3460-8570; Edwards, David/0000-0001-7599-6760; Batley, Jacqueline/0000-0002-5391-5824; Mestiri, Imen/0000-0002-7528-2781; Koh, ChuShin/0000-0001-7313-2125; Battail, Christophe/0000-0001-6849-7824; Golicz, Agnieszka/0000-0002-9711-4826; Just, Jeremy/0000-0003-0842-9808; DINH, Thi Vinh Ha/0000-0002-5420-7352; DA SILVA, Corinne/0000-0002-7618-7831; Parkin, Isobel/0000-0002-5807-9466; Liu, Shengyi/0000-0002-4955-4763; Bernard, Maria/0000-0001-9005-5563; Lyons, Eric/0000-0002-3348-8845; Noel, Benjamin/0000-0002-5830-3253; Denoeud, France/0000-0001-8819-7634; FALENTIN, Cyril/0000-0002-9901-3412; Fan, Chuchuan/0000-0001-8443-7194; Bancroft, Ian/0000-0001-7707-1171	French ANR (Agence Nationale de la Recherche) [ANR-09-GENM-021]; Sofi-Proteol for bioinformatic personnnel; National Basic Research Program of China [2011CB109300]; Canadian Canola Genome Sequencing Initiative (Genome Alberta); Canadian Canola Genome Sequencing Initiative; Biotechnology and Biological Sciences Research Council [BB/E017363/1] Funding Source: researchfish; BBSRC [BB/E017363/1] Funding Source: UKRI	French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Sofi-Proteol for bioinformatic personnnel; National Basic Research Program of China(National Basic Research Program of China); Canadian Canola Genome Sequencing Initiative (Genome Alberta); Canadian Canola Genome Sequencing Initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Sequence Read Archive accession numbers of B. napus sequencing data are ERP005275 and PRJEB6069, and those of B. rapa and B. oleracea data are PRJNA248388 and PRJNA158027. The B. napus assembly is available at ENA (European Nucleotide Archive), in the WGS section for contigs (accession numbers CCCW010000001 to CCCW010044187) and the CON section for scaffolds, chromosomes, and annotation (accession numbers LK031787 to LK052685). The B. napus genome is also available at CoGe (https://genomevolution.org/CoGe/) and at (www.genoscope.cns.fr/brassicanapus) the Genoscope Genome Database, with additional tools for comparative genomic analysis. The B. napus segregating populations Darmor-bzh x Yudal and Darmor x Bristol are available at INRA-IGEPP, Rennes, France, under a material transfer agreement. This project was funded by the French ANR (Agence Nationale de la Recherche, www.agence-nationale-recherche.fr) 2009 (ANR-09-GENM-021) to B. C., P. W., D. B., and R. D., with additional funding from Sofi-Proteol for bioinformatic personnnel (J. J.); the National Basic Research Program of China (2011CB109300) for S. L., Y. Z., C. G., and W. H.; and the Canadian Canola Genome Sequencing Initiative (http://aafc-aac.usask.ca/canseq/, Genome Alberta, and industry partners) for I. A. P. P., A. G. S., C. K., and C. S. Research leaders are B. C., S. L., I. A. P. P., X. W., I. B., R. D., J. B., D. E., Y. Z., W. H., A. G. S., A. H. P., C. G., and P. W. Additional acknowledgements and author contributions are included in the supplementary materials.	Al-Shehbaz IA, 2012, TAXON, V61, P931, DOI 10.1002/tax.615002; Allender CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-54; Buggs RJA, 2011, CURR BIOL, V21, P551, DOI 10.1016/j.cub.2011.02.016; Darwin C., 1905, VARIATION ANIMALS PL, V2, P398; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; FOISSET N, 1995, THEOR APPL GENET, V91, P756, DOI 10.1007/BF00220955; Garsmeur O, 2014, MOL BIOL EVOL, V31, P448, DOI 10.1093/molbev/mst230; Ilut DC, 2012, AM J BOT, V99, P383, DOI 10.3732/ajb.1100312; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu H. L., 2000, RAPESEED GENETICS BR, P1; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Lynch M, 2000, GENETICS, V154, P459; Nagaharu U., 1935, JPN J BOT, V7, P389, DOI DOI 10.1038/35036519; Parkin IAP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r77; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Prakash S., 1980, Brassica crops and wild allies. [I]., P151; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Sharpe AG, 2003, GENOME, V46, P461, DOI 10.1139/G03-031; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Tang HB, 2012, GENETICS, V190, P1563, DOI 10.1534/genetics.111.137349; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wittkop B, 2009, EUPHYTICA, V170, P131, DOI 10.1007/s10681-009-9940-5; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Zou XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045751	24	1365	1507	49	567	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					950	953		10.1126/science.1253435	http://dx.doi.org/10.1126/science.1253435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146293				2022-12-24	WOS:000340524700051
J	Althoff, T; Hibbs, RE; Banerjee, S; Gouaux, E				Althoff, Thorsten; Hibbs, Ryan E.; Banerjee, Surajit; Gouaux, Eric			X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors	NATURE			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; COUPLING AGONIST BINDING; CRYSTAL-STRUCTURE; M2 DOMAIN; PHARMACOLOGY; ANTAGONISTS; PERMEATION; COMPLEXES	Cys-loop receptors are neurotransmitter-gated ion channels that are essential mediators of fast chemical neurotransmission and are associated with a large number of neurological diseases and disorders, as well as parasitic infections(1-4). Members of this ion channel superfamily mediate excitatory or inhibitory neurotransmission depending on their ligand and ion selectivity. Structural information for Cys-loop receptors comes from several sources including electron microscopic studies of the nicotinic acetylcholine receptor(5), high-resolution X-ray structures of extracellular domains(6) and X-ray structures of bacterial orthologues(7-10). In 2011 our group published structures of the Caenorhabditis elegans glutamate-gated chloride channel (GluCl) in complex with the allosteric partial agonist ivermectin, which provided insights into the structure of a possibly open state of a eukaryotic Cys-loop receptor, the basis for anion selectivity and channel block, and the mechanism by which ivermectin and related molecules stabilize the open state and potentiate neurotransmitter binding(11). However, there remain unanswered questions about the mechanism of channel opening and closing, the location and nature of the shut ion channel gate, the transitions between the closed/resting, open/activated and closed/desensitized states, and the mechanism by which conformational changes are coupled between the extracellular, orthosteric agonist binding domain and the transmembrane, ion channel domain. Here we present two conformationally distinct structures of C. elegans GluCl in the absence of ivermectin. Structural comparisons reveal a quaternary activation mechanism arising from rigid-body movements between the extracellular and transmembrane domains and a mechanism for modulation of the receptor by phospholipids.	[Althoff, Thorsten; Hibbs, Ryan E.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Banerjee, Surajit] Cornell Univ, NE CAT, Argonne, IL 60439 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Cornell University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Althoff, Thorsten/AAT-6968-2021	Gouaux, Eric/0000-0002-8549-2360; Althoff, Thorsten/0000-0001-5688-5328; Banerjee, Surajit/0000-0002-9414-7163	Deutsche Forschungsgemeinschaft [AL 1725-1/1]; NIH National Research Service Award [F32NS061404]; NIH; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM100400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS061404] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all staff of beamline 24-ID-C at the Advanced Photon Source. We thank L. Vaskalis and H. Owen for help in figure and manuscript preparation, respectively. D. Cawley at the Vaccine and Gene Therapy Institute, OHSU, provided the monoclonal antibody. We appreciate discussions with Gouaux laboratory members. This work was supported by a postdoctoral fellowship (Forschungsstipendium AL 1725-1/1) from the Deutsche Forschungsgemeinschaft to T. A. and an individual NIH National Research Service Award (F32NS061404) to R. E. H; E. G. is supported by the NIH and is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bali M, 2007, J GEN PHYSIOL, V129, P145, DOI 10.1085/jgp.200609639; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Boatin BA, 2006, ADV PARASIT, V61, P349, DOI 10.1016/S0065-308X(05)61009-3; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; DAMLE VN, 1980, BIOCHEMISTRY-US, V19, P3924, DOI 10.1021/bi00558a006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Gleitsman KR, 2009, CHEMBIOCHEM, V10, P1385, DOI 10.1002/cbic.200900092; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; HART HE, 1979, MOL IMMUNOL, V16, P265, DOI 10.1016/0161-5890(79)90065-8; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lee WY, 2008, J GEN PHYSIOL, V132, P265, DOI 10.1085/jgp.200810014; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lynagh T, 2010, INT J PARASITOL, V40, P1477, DOI 10.1016/j.ijpara.2010.07.010; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Velisetty P, 2014, J BIOL CHEM, V289, P3013, DOI 10.1074/jbc.M113.523050; Yoluk O, 2013, BIOPHYS J, V105, P640, DOI 10.1016/j.bpj.2013.06.037	46	192	194	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					333	+		10.1038/nature13669	http://dx.doi.org/10.1038/nature13669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25143115	Green Accepted			2022-12-24	WOS:000340508200040
J	Rich, PD; Liaw, HP; Lee, AK				Rich, P. Dylan; Liaw, Hua-Peng; Lee, Albert K.			Large environments reveal the statistical structure governing hippocampal representations	SCIENCE			English	Article							PLACE FIELDS; SPATIAL REPRESENTATION; SINGLE NEURONS; CA1; CELLS; DYNAMICS; MEMORY; BEHAVIOR; RECALL; BRAIN	The rules governing the formation of spatial maps in the hippocampus have not been determined. We investigated the large-scale structure of place field activity by recording hippocampal neurons in rats exploring a previously unencountered 48-meter-long track. Single-cell and population activities were well described by a two-parameter stochastic model. Individual neurons had their own characteristic propensity for forming fields randomly along the track, with some cells expressing many fields andmany exhibiting fewor none. Because of the particular distribution of propensities across cells, the number of neurons with fields scaled logarithmically with track length over a wide, ethological range. These features constrain hippocampal memory mechanisms, may allow efficient encoding of environments and experiences of vastly different extents and durations, and could reflect general principles of population coding.	[Rich, P. Dylan; Liaw, Hua-Peng; Lee, Albert K.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Rich, P. Dylan] Univ Cambridge, Dept Psychol, Cambridge CB2 3EB, England	Howard Hughes Medical Institute; University of Cambridge	Rich, PD (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	richp@janelia.hhmi.org; leea@janelia.hhmi.org			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank M. Karlsson, J. Osborne, M. Copeland, and J. Cox and the Vivarium staff for technical assistance and S. Druckmann, J. Dudman, A. Hantman, J. Cohen, and D. Lee for valuable comments on the manuscript. All primary electrophysiological and behavioral data are archived at the Janelia Farm Research Campus. This work was supported by the Howard Hughes Medical Institute.	Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; DAVIS DE, 1948, J MAMMAL, V29, P207, DOI 10.2307/1375387; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Fenton AA, 2008, J NEUROSCI, V28, P11250, DOI 10.1523/JNEUROSCI.2862-08.2008; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Greenwood M, 1920, J ROY STATIST SOC  A, V83, P255; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Jarsky T, 2008, J COMP NEUROL, V506, P535, DOI 10.1002/cne.21564; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lundberg O., 1940, RANDOM PROCESSES THE; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V230, P359, DOI 10.1113/jphysiol.1973.sp010192; Mizuseki K, 2011, NAT NEUROSCI, V14, P1174, DOI 10.1038/nn.2894; Muniak MA, 2007, J NEUROSCI, V27, P11687, DOI 10.1523/JNEUROSCI.1486-07.2007; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Tsodyks M, 1995, INT J NEURAL SYS S, V6, P81; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	31	80	80	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					814	817		10.1126/science.1255635	http://dx.doi.org/10.1126/science.1255635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124440				2022-12-24	WOS:000340593100045
J	Schwartz, N; Temkin, P; Jurado, S; Lim, BK; Heifets, BD; Polepalli, JS; Malenka, RC				Schwartz, Neil; Temkin, Paul; Jurado, Sandra; Lim, Byung Kook; Heifets, Boris D.; Polepalli, Jai S.; Malenka, Robert C.			Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens	SCIENCE			English	Article							MEDIUM SPINY NEURONS; NEUROPATHIC PAIN; INDIRECT PATHWAYS; ADENOSINE A(2A); ARCUATE NUCLEUS; MESSENGER-RNAS; BASAL GANGLIA; ANIMAL-MODELS; GALANIN; MECHANISMS	Several symptoms associated with chronic pain, including fatigue and depression, are characterized by reduced motivation to initiate or complete goal-directed tasks. However, it is unknown whether maladaptive modifications in neural circuits that regulate motivation occur during chronic pain. Here, we demonstrate that the decreased motivation elicited in mice by two different models of chronic pain requires a galanin receptor 1-triggered depression of excitatory synaptic transmission in indirect pathway nucleus accumbens medium spiny neurons. These results demonstrate a previously unknown pathological adaption in a key node of motivational neural circuitry that is required for one of the major sequela of chronic pain states and syndromes.	[Schwartz, Neil; Temkin, Paul; Jurado, Sandra; Lim, Byung Kook; Heifets, Boris D.; Polepalli, Jai S.; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Jurado, Sandra] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Lim, Byung Kook] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	Stanford University; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 265 Campus Dr, Stanford, CA 94305 USA.	malenka@stanford.edu	Temkin, Paul A/F-9262-2011; Jurado, Sandra/S-9936-2017	Jurado, Sandra/0000-0001-9864-9307; Heifets, Boris/0000-0003-1474-0379; Lim, Byungkook/0000-0002-3766-5415; Polepalli, Jai/0000-0003-2004-2163	Banting postdoctoral fellowship; NIH; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	Banting postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Malenka lab for helpful feedback and comments during the study. We thank S. Fang and A. Darvishzadeh for help with stereotaxic injections and P. Rothwell for setting up the operant behavior chambers and software. This work was supported by a Banting postdoctoral fellowship (N.S.) and the NIH (R.C.M.). All primary data (behavioral, electrophysiological, and immunohistochemical) are archived in the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine.	Anderson ME, 2013, BEHAV BRAIN RES, V239, P90, DOI 10.1016/j.bbr.2012.10.045; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Borsook D, 2007, EUR J PAIN, V11, P7, DOI 10.1016/j.ejpain.2005.12.005; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cobos EJ, 2012, PAIN, V153, P876, DOI 10.1016/j.pain.2012.01.016; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dersh J, 2002, PSYCHOSOM MED, V64, P773, DOI 10.1097/01.PSY.0000024232.11538.54; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Dong Y, 2006, J NEUROPHYSIOL, V95, P3228, DOI 10.1152/jn.01117.2005; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Einstein EB, 2013, EUR J NEUROSCI, V37, P1541, DOI 10.1111/ejn.12151; Farrar AM, 2010, NEUROSCIENCE, V166, P1056, DOI 10.1016/j.neuroscience.2009.12.056; Gu XL, 2007, BEHAV BRAIN RES, V179, P331, DOI 10.1016/j.bbr.2007.02.033; Imbe H, 2004, NEUROSCI LETT, V368, P102, DOI 10.1016/j.neulet.2004.06.073; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Jonsson T, 2011, ACTA ANAESTH SCAND, V55, P69, DOI 10.1111/j.1399-6576.2010.02329.x; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Lee BR, 2011, NEUROPHARMACOLOGY, V61, P1060, DOI 10.1016/j.neuropharm.2010.12.033; Lemos JC, 2012, NATURE, V490, P402, DOI 10.1038/nature11436; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; Max MB, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-14; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Nicholson B, 2004, PAIN MED, V5, pS9, DOI 10.1111/j.1526-4637.2004.04019.x; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; Nikolova YS, 2013, GENES BRAIN BEHAV, V12, P516, DOI 10.1111/gbb.12035; Nishii H, 2007, REGUL PEPTIDES, V141, P105, DOI 10.1016/j.regpep.2006.12.022; Norheim KB, 2011, RHEUMATOLOGY, V50, P1009, DOI 10.1093/rheumatology/keq454; O'Brien CP, 2005, PHARMACOL THERAPEUT, V108, P18, DOI 10.1016/j.pharmthera.2005.06.018; Roane HS, 2008, J APPL BEHAV ANAL, V41, P155, DOI 10.1901/jaba.2008.41-155; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Santerre JL, 2012, PHARMACOL BIOCHEM BE, V102, P477, DOI 10.1016/j.pbb.2012.06.009; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Sergeyev V, 2001, MOL BRAIN RES, V90, P93, DOI 10.1016/S0169-328X(01)00088-2; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Turk DC, 2010, MAYO CLIN PROC, V85, pS42, DOI 10.4065/mcp.2009.0648; Unschuld PG, 2008, J AFFECT DISORDERS, V105, P177, DOI 10.1016/j.jad.2007.05.006; Urban R, 2011, PAIN, V152, P990, DOI 10.1016/j.pain.2010.12.003; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Yalcin I, 2011, BIOL PSYCHIAT, V70, P946, DOI 10.1016/j.biopsych.2011.07.017; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	48	182	186	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					535	542		10.1126/science.1253994	http://dx.doi.org/10.1126/science.1253994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082697	Green Accepted			2022-12-24	WOS:000339651300039
J	Masri, S; Rigor, P; Cervantes, M; Ceglia, N; Sebastian, C; Xiao, CY; Roqueta-Rivera, M; Deng, CX; Osborne, TF; Mostoslavsky, R; Baldi, P; Sassone-Corsi, P				Masri, Selma; Rigor, Paul; Cervantes, Marlene; Ceglia, Nicholas; Sebastian, Carlos; Xiao, Cuiying; Roqueta-Rivera, Manuel; Deng, Chuxia; Osborne, Timothy F.; Mostoslavsky, Raul; Baldi, Pierre; Sassone-Corsi, Paolo			Partitioning Circadian Transcription by SIRT6 Leads to Segregated Control of Cellular Metabolism	CELL			English	Article							DEACETYLASE SIRT6; GENE-EXPRESSION; GENOMIC INSTABILITY; CLOCK; PROMOTER; IDENTIFICATION; ACETYLATION; CLOCK-BMAL1; ACTIVATION; REGULATORS	Circadian rhythms are intimately linked to cellular metabolism. Specifically, the NAD(+)-dependent deacetylase SIRT1, the founding member of the sirtuin family, contributes to clock function. Whereas SIRT1 exhibits diversity in deacetylation targets and subcellular localization, SIRT6 is the only constitutively chromatin-associated sirtuin and is prominently present at transcriptionally active genomic loci. Comparison of the hepatic circadian transcriptomes reveals that SIRT6 and SIRT1 separately control transcriptional specificity and therefore define distinctly partitioned classes of circadian genes. SIRT6 interacts with CLOCK:BMAL1 and, differently from SIRT1, governs their chromatin recruitment to circadian gene promoters. Moreover, SIRT6 controls circadian chromatin recruitment of SREBP-1, resulting in the cyclic regulation of genes implicated in fatty acid and cholesterol metabolism. This mechanism parallels a phenotypic disruption in fatty acid metabolism in SIRT6 null mice as revealed by circadian metabolome analyses. Thus, genomic partitioning by two independent sirtuins contributes to differential control of circadian metabolism.	[Masri, Selma; Cervantes, Marlene; Baldi, Pierre; Sassone-Corsi, Paolo] Univ Calif Irvine, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Masri, Selma; Cervantes, Marlene; Baldi, Pierre; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Rigor, Paul; Ceglia, Nicholas; Baldi, Pierre] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA; [Rigor, Paul; Ceglia, Nicholas; Baldi, Pierre; Sassone-Corsi, Paolo] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Sebastian, Carlos; Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Xiao, Cuiying; Deng, Chuxia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Roqueta-Rivera, Manuel; Osborne, Timothy F.] Sanford Burnham Med Res Inst, Metabol Dis Program, Orlando, FL 32827 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Sanford Burnham Prebys Medical Discovery Institute	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Ctr Epigenet & Metab, Irvine, CA 92697 USA.	psc@uci.edu	Sebastian, Carlos/CAG-6271-2022; deng, chuxia/N-6713-2016; Sebastian, Carlos/H-8014-2018	Sebastian, Carlos/0000-0001-6623-8028; Roqueta-Rivera, Manuel/0000-0001-6011-0226; Cervantes, Marlene/0000-0003-4619-6144; Masri, Selma/0000-0002-8619-8331	NIH [GM097899, LM010235, LM07443, AG043745]; NSF [IIS-1321053]; Merieux Research Grant [53923]; Sirtris Pharmaceuticals [SP-48984]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056009, ZIADK056011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG043745] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010235, T15LM007443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Merieux Research Grant; Sirtris Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Katrin Chua for reagents and helpful discussions. We thank all members of the Sassone-Corsi lab and Melanie Oakes, Seung-Ah Chung, Valentina Ciobanu, Yuzo Kanomata, and Andrea Eckhart for helpful discussion and technical assistance. Funding for S.M. was provided by NIH postdoctoral fellowship GM097899. Funding for P.B. was provided by NSF (IIS-1321053) and NIH (LM010235 and LM07443). Financial support for P.S.-C. was provided by NIH (AG043745), Merieux Research Grant (53923), and Sirtris Pharmaceuticals (SP-48984).	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Belden WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002166; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P3333, DOI 10.1073/pnas.1214266110; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Cretenet G, 2010, CELL METAB, V11, P47, DOI 10.1016/j.cmet.2009.11.002; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Elhanati S, 2013, CELL REP, V4, P905, DOI 10.1016/j.celrep.2013.08.006; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Hall JA, 2013, J CLIN INVEST, V123, P973, DOI 10.1172/JCI64094; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kawahara TLA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002153; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kiyohara YB, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn018; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Patel VR, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2111; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rozen S, 2000, Methods Mol Biol, V132, P365; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	59	200	204	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					659	672		10.1016/j.cell.2014.06.050	http://dx.doi.org/10.1016/j.cell.2014.06.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083875	Green Accepted, Bronze			2022-12-24	WOS:000340944300017
J	Scherz-Shouval, R; Santagata, S; Mendillo, ML; Sholl, LM; Ben-Aharon, I; Beck, AH; Dias-Santagata, D; Koeva, M; Stemmer, SM; Whitesell, L; Lindquist, S				Scherz-Shouval, Ruth; Santagata, Sandro; Mendillo, Marc L.; Sholl, Lynette M.; Ben-Aharon, Irit; Beck, Andrew H.; Dias-Santagata, Dora; Koeva, Martina; Stemmer, Salomon M.; Whitesell, Luke; Lindquist, Susan			The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy	CELL			English	Article							HEAT-SHOCK FACTOR-1; TRANSCRIPTION FACTOR HSF1; BREAST-CANCER; TGF-BETA; GENE-EXPRESSION; LUNG-CANCER; FIBROBLASTS; MICROENVIRONMENT; PROGRESSION; GROWTH	Stromal cells within the tumor microenvironment are essential for tumor progression and metastasis. Surprisingly little is known about the factors that drive the transcriptional reprogramming of stromal cells within tumors. We report that the transcriptional regulator heat shock factor 1 (HSF1) is frequently activated in cancer-associated fibroblasts (CAFs), where it is a potent enabler of malignancy. HSF1 drives a transcriptional program in CAFs that complements, yet is completely different from, the program it drives in adjacent cancer cells. This CAF program is uniquely structured to support malignancy in a non-cell-autonomous way. Two central stromal signaling molecules-TGF-beta and SDF1-play a critical role. In early-stage breast and lung cancer, high stromal HSF1 activation is strongly associated with poor patient outcome. Thus, tumors co-opt the ancient survival functions of HSF1 to orchestrate malignancy in both cell-autonomous and non-cell-autonomous ways, with far-reaching therapeutic implications.	[Scherz-Shouval, Ruth; Santagata, Sandro; Mendillo, Marc L.; Koeva, Martina; Whitesell, Luke; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Santagata, Sandro; Sholl, Lynette M.] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Santagata, Sandro] Dana Farber Canc Ctr, Dept Canc Biol, Boston, MA 02215 USA; [Ben-Aharon, Irit; Stemmer, Salomon M.] Rabin Med Ctr, Davidoff Ctr, Inst Oncol, IL-49100 Petah Tiqwa, Israel; [Ben-Aharon, Irit; Stemmer, Salomon M.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Ramat Aviv, Israel; [Beck, Andrew H.] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Dias-Santagata, Dora] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Dias-Santagata, Dora] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Koeva, Martina] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Whitesell, L (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	whitesell@wi.mit.edu; lindquist_admin@wi.mit.edu		scherz-shouval, ruth/0000-0002-4570-121X; Santagata, Sandro/0000-0002-7528-9668; Mendillo, Marc/0000-0001-8128-0128	Human Frontiers Science Program; Fulbright Program; Israel National Postdoctoral Award Program for Women in Science; Jared Branfman Sunflowers for Life Fund; V Foundation; NIH [K08 NS064168]; National Cancer Institute of the NIH [K99CA175293]; Komen Foundation [KG110450]; J&J COSAT focused funding program; Alexander and Margaret Stewart Trust; Koch Institute Frontier Research Program through the Kathy and Curt Marble Cancer Research Fund; NATIONAL CANCER INSTITUTE [K99CA175293, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Fulbright Program; Israel National Postdoctoral Award Program for Women in Science; Jared Branfman Sunflowers for Life Fund; V Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Komen Foundation(Susan G. Komen Breast Cancer Foundation); J&J COSAT focused funding program; Alexander and Margaret Stewart Trust; Koch Institute Frontier Research Program through the Kathy and Curt Marble Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Barrasa, G. Bell, S. Gupta, and T. DiCesare for bioinformatic analysis and graphical assistance. We thank M. Duquette and A. Topolszky (WIBR), K. Lynch (MGH), and A. Tuvar (Rabin Medical Center) for technical assistance. We thank C. K. Dai for cloning Bi-Tet-Hsf1 and R. Jaenisch and Y. Freyzon for construction of Bi-Tet-Hsf1 transgenic mice. We thank K. Polyak, P. Gupta, D. Pincus, L. Clayton, and members of the S. L. lab for helpful discussions and comments. We thank R. Weinberg for the gift of cell lines and for helpful discussions. R. S.-S. was supported by the Human Frontiers Science Program, the Fulbright Program, and the Israel National Postdoctoral Award Program for Women in Science. S. S. is supported by the Jared Branfman Sunflowers for Life Fund, the V Foundation, and by NIH grant K08 NS064168. M. L. M. was supported by the National Cancer Institute of the NIH under Award Number K99CA175293. L. W. was supported by the Komen Foundation, Grant KG110450, and by the J&J COSAT focused funding program. S. L. is an investigator of the Howard Hughes Medical Institute. Support for this study was also provided by the Alexander and Margaret Stewart Trust and the Koch Institute Frontier Research Program through the Kathy and Curt Marble Cancer Research Fund. D.D.-S. is a consultant for Bioreference Labs, submitted a patent application (pending) for the SNaPshot methods described here, has licensed SNaPshot technology, and receives royalties from Bioreference Labs.	Beck AH, 2008, LAB INVEST, V88, P591, DOI 10.1038/labinvest.2008.31; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fang F, 2012, CANCER-AM CANCER SOC, V118, P1782, DOI 10.1002/cncr.26482; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Henderson B, 2013, CELL STRESS CHAPERON, V18, P685, DOI 10.1007/s12192-013-0444-9; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Maity TK, 2011, CYTOKINE, V54, P61, DOI 10.1016/j.cyto.2010.12.017; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Pillai RN, 2014, MOL CANCER THER, V13, P557, DOI 10.1158/1535-7163.MCT-13-0669; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Sakurai H, 2010, FEBS J, V277, P4140, DOI 10.1111/j.1742-4658.2010.07829.x; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Sasaki H, 2002, J IMMUNOL, V168, P5178, DOI 10.4049/jimmunol.168.10.5178; Saturno Grazia, 2013, Oncotarget, V4, P1185; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249	44	231	241	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					564	578		10.1016/j.cell.2014.05.045	http://dx.doi.org/10.1016/j.cell.2014.05.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083868	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000340944300010
J	Dong, HH; Xiang, QJ; Gu, YH; Wang, ZS; Paterson, NG; Stansfeld, PJ; He, C; Zhang, YZ; Wang, WJ; Dong, CJ				Dong, Haohao; Xiang, Quanju; Gu, Yinghong; Wang, Zhongshan; Paterson, Neil G.; Stansfeld, Phillip J.; He, Chuan; Zhang, Yizheng; Wang, Wenjian; Dong, Changjiang			Structural basis for outer membrane lipopolysaccharide insertion	NATURE			English	Article							TRANSENVELOPE PROTEIN COMPLEX; BETA-BARREL; MOLECULAR SIMULATION; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; CELL-ENVELOPE; TRANSPORT; BIOGENESIS; LPTD; TRANSLOCON	Lipopolysaccharide (LPS) is essential for most Gram-negative bacteria and has crucial roles in protection of the bacteria fromharsh environments and toxic compounds, including antibiotics. Seven LPS transport proteins (that is, LptA-LptG) form a trans-envelope protein complex responsible for the transport of LPS from the inner membrane to the outer membrane, the mechanism for which is poorly understood. Here we report the first crystal structure of the unique integral membrane LPS translocon LptD-LptE complex. LptD forms a novel 26-stranded beta-barrel, which is to our knowledge the largest beta-barrel reported so far. LptE adopts a roll-like structure located inside the barrel of LptD to form an unprecedented two-protein 'barrel and plug' architecture. The structure, molecular dynamics simulations and functional assays suggest that the hydrophilic O-antigen and the core oligosaccharide of the LPS may pass through the barrel and the lipid A of the LPS may be inserted into the outer leaflet of the outer membrane through a lateral opening between strands beta 1 and beta 26 of LptD. These findings not only help us to understand important aspects of bacterial outer membrane biogenesis, but also have significant potential for the development of novel drugs against multi-drug resistant pathogenic bacteria.	[Dong, Haohao; Gu, Yinghong; Wang, Zhongshan; Dong, Changjiang] Univ E Anglia, Norwich Med Sch, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England; [Dong, Haohao; Xiang, Quanju; Wang, Zhongshan; He, Chuan] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Xiang, Quanju] Sichuan Agr Univ, Dept Microbiol, Coll Resource & Environm Sci, Yaan 625000, Peoples R China; [Wang, Zhongshan; Zhang, Yizheng] Sichuan Univ, Coll Life Sci, Chengdu 610065, Peoples R China; [Paterson, Neil G.] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Stansfeld, Phillip J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [He, Chuan] Wuhan Tech Coll Commun, Sch Elect & Informat, Wuhan 430065, Hubei, Peoples R China; [Wang, Wenjian] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Dept Surg, Guangzhou 510080, Guangdong, Peoples R China	University of East Anglia; University of St Andrews; Sichuan Agricultural University; Sichuan University; Diamond Light Source; University of Oxford; Sun Yat Sen University	Dong, CJ (corresponding author), Univ E Anglia, Norwich Med Sch, Biomed Res Ctr, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	wenjian166@googlemail.com; c.dong@uea.ac.uk	GU, Yinghong/D-2433-2010; xiang, quanju/AAI-3042-2020; Stansfeld, Phillip James/AAA-9228-2020	GU, Yinghong/0000-0002-9364-1389; Stansfeld, Phillip James/0000-0001-8800-7669; Wang, Zhongshan/0000-0002-1321-3916; Paterson, Neil/0000-0003-4292-6971	China Scholarship Council; BBSRC [BB/H000267/1, BB/L002558/1, BB/I019855/1] Funding Source: UKRI; EPSRC [EP/J010421/1] Funding Source: UKRI; MRC [G1100110] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BEP17032, B19456, BBS/B/16011, BB/I019855/1, BB/H000267/1, BB/L002558/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J010421/1] Funding Source: researchfish; Medical Research Council [G1100110] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. J. Silhavy for providing AM689 and AM661 cells, J. Naismith and C. Whitfield for support, and R. Field, A. Johnston and X. Tang for critical reading of the manuscript. We thank the staff at I24, I02, I03 and I04 of Diamond Light Source UK for beamtime (proposal mx7641) and their assistance with data collection. C.D. is a Wellcome Trust career development fellow (083501/Z/07/Z). Q.X. and Z.W. are the receipts of the Chinese overseas study scholarships of The China Scholarship Council.	Bos MP, 2011, J BIOL CHEM, V286, P28688, DOI 10.1074/jbc.M111.239673; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Colombo G, 2003, BIOPHYS J, V84, P2331, DOI 10.1016/S0006-3495(03)75038-3; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Grabowicz M, 2013, J BACTERIOL, V195, P1327, DOI 10.1128/JB.02142-12; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan MA, 2009, BIOCHEMISTRY-US, V48, P9745, DOI 10.1021/bi9013566; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Monticelli L, 2008, J COMPUT CHEM, V29, P1740, DOI 10.1002/jcc.20935; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J CHEM PHYS, V74, P1990, DOI 10.1063/1.441242; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Stansfeld PJ, 2013, STRUCTURE, V21, P810, DOI 10.1016/j.str.2013.03.005; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; Villa R, 2013, J BACTERIOL, V195, P1100, DOI 10.1128/JB.02057-12; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	44	173	176	2	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					52	U569		10.1038/nature13464	http://dx.doi.org/10.1038/nature13464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24990744	Green Accepted			2022-12-24	WOS:000338199400033
J	Viale, A; Pettazzoni, P; Lyssiotis, CA; Ying, HQ; Sanchez, N; Marchesini, M; Carugo, A; Green, T; Seth, S; Giuliani, V; Kost-Alimova, M; Muller, F; Colla, S; Nezi, L; Genovese, G; Deem, AK; Kapoor, A; Yao, WT; Brunetto, E; Kang, Y; Yuan, M; Asara, JM; Wang, YA; Heffernan, TP; Kimmelman, AC; Wang, HM; Fleming, JB; Cantley, LC; DePinho, RA; Draetta, GF				Viale, Andrea; Pettazzoni, Piergiorgio; Lyssiotis, Costas A.; Ying, Haoqiang; Sanchez, Nora; Marchesini, Matteo; Carugo, Alessandro; Green, Tessa; Seth, Sahil; Giuliani, Virginia; Kost-Alimova, Maria; Muller, Florian; Colla, Simona; Nezi, Luigi; Genovese, Giannicola; Deem, Angela K.; Kapoor, Avnish; Yao, Wantong; Brunetto, Emanuela; Kang, Ya'an; Yuan, Min; Asara, John M.; Wang, Y. Alan; Heffernan, Timothy P.; Kimmelman, Alec C.; Wang, Huamin; Fleming, Jason B.; Cantley, Lewis C.; DePinho, Ronald A.; Draetta, Giulio F.			Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function	NATURE			English	Article							INHIBITION; METABOLISM; AUTOPHAGY; GLUCOSE; IMATINIB; GROWTH; BRAF	Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in western countries, with a median survival of 6 months and an extremely low percentage of long-term surviving patients. KRAS mutations are known to be a driver event of PDAC(1), but targeting mutant KRAS has proved challenging(2). Targeting oncogene-driven signalling pathways is a clinically validated approach for several devastating diseases(3,4). Still, despite marked tumour shrinkage, the frequency of relapse indicates that a fraction of tumour cells survives shut down of oncogenic signalling(5,6). Here we explore the role of mutant KRAS in PDAC maintenance using a recently developed inducible mouse model of mutated Kras(1) (Kras(G12D), herein KRas) in a p53(LoxP/WT) background. We demonstrate that a subpopulation of dormant tumour cells surviving oncogene ablation (surviving cells) and responsible for tumour relapse has features of cancer stem cells and relies on oxidative phosphorylation for survival. Transcriptomic and metabolic analyses of surviving cells reveal prominent expression of genes governing mitochondrial function, autophagy and lysosome activity, as well as a strong reliance on mitochondrial respiration and a decreased dependence on glycolysis for cellular energetics. Accordingly, surviving cells show high sensitivity to oxidative phosphorylation inhibitors, which can inhibit tumour recurrence. Our integrated analyses illuminate a therapeutic strategy of combined targeting of the KRAS pathway and mitochondrial respiration to manage pancreatic cancer.	[Viale, Andrea; Pettazzoni, Piergiorgio; Ying, Haoqiang; Sanchez, Nora; Marchesini, Matteo; Carugo, Alessandro; Green, Tessa; Muller, Florian; Colla, Simona; Nezi, Luigi; Genovese, Giannicola; Deem, Angela K.; Kapoor, Avnish; Yao, Wantong; Wang, Y. Alan; Draetta, Giulio F.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Marchesini, Matteo; Carugo, Alessandro; Green, Tessa; Nezi, Luigi; Yao, Wantong; Draetta, Giulio F.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lyssiotis, Costas A.; Cantley, Lewis C.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Carugo, Alessandro] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Seth, Sahil; Giuliani, Virginia; Kost-Alimova, Maria; Heffernan, Timothy P.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Brunetto, Emanuela] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy; [Kang, Ya'an; Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Yuan, Min; Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02115 USA; [Kimmelman, Alec C.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Cornell University; IRCCS European Institute of Oncology (IEO); University of Texas System; UTMD Anderson Cancer Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Viale, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	aviale@mdanderson.org; gdraetta@mdanderson.org	Nezi, Luigi/AAB-1957-2019; Cantley, Lewis C/D-1800-2014; Seth, Sahil/I-5809-2019; Marchesini, Matteo/AAC-4629-2022; Pettazzoni, Piergiorgio/GRJ-3011-2022; Lyssiotis, Costas A/AAI-1923-2019; Grieshaber-Bouyer, Ricardo/R-7512-2016; Brunetto, Emanuela/AAB-2211-2019; Ying, Haoqiang/AAK-4325-2020	Nezi, Luigi/0000-0002-4670-7656; Cantley, Lewis C/0000-0002-1298-7653; Seth, Sahil/0000-0003-4579-3959; Lyssiotis, Costas A/0000-0001-9309-6141; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Brunetto, Emanuela/0000-0003-4246-5247; Genovese, Giannicola/0000-0003-1392-9954; DePinho, Ronald/0000-0002-5625-577X; Colla, Simona/0000-0001-6583-8910; Carugo, Alessandro/0000-0001-5182-3320; Muller, Florian/0000-0001-7568-2948; Marchesini, Matteo/0000-0001-9489-7899; Pettazzoni, Piergiorgio/0000-0001-9039-2463	Cancer Center Core Grant [CA16672]; National Cancer Institute (NCI) [CA016672]; MDACC Flow Cytometry and Cellular Imaging Core Facility - NCI [P30CA16672]; FACS; Hirshberg Foundation for Pancreatic Cancer Research; Harvard Stem Cell Institute; Sheikh Ahmed Center for Pancreatic Cancer Research; American Italian Cancer Foundation; National Institutes of Health (NIH) [P01CA117969]; NIH/NCI [P01CA120964]; Viragh Family Foundation; NATIONAL CANCER INSTITUTE [P01CA117969, P30CA016672, P50CA127003, P01CA120964] Funding Source: NIH RePORTER	Cancer Center Core Grant; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MDACC Flow Cytometry and Cellular Imaging Core Facility - NCI; FACS; Hirshberg Foundation for Pancreatic Cancer Research; Harvard Stem Cell Institute; Sheikh Ahmed Center for Pancreatic Cancer Research; American Italian Cancer Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Viragh Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Divakaruni, J. Dunn, C. Smith, K. McGirr and D. Ferrick for their support with the Seahorse Bioscience XF96 Analyser; T. Tieu for vector cloning and J. Kovacs for support with the YSI analyser; J. D. Lechleiter for the protocol to measure mitochondrial potential in vivo; H. Sandoval, C. Tacchetti, M. E. Di Francesco, J. Marszalek and P. Jones for discussions and suggestions; K. Dunner Jr and the High Resolution Electron Microscopy Facility at the MD Anderson Cancer Center (MDACC) for TEM (Cancer Center Core Grant CA16672); W. N. Hittelman and the Center for Targeted Therapy for confocal microscopy; the Dana-Farber Cancer Institute Microarray Core Facility for Affymetrix expression profiling and the MDACC Sequencing and Microarray Facility (SMF) funded by National Cancer Institute (NCI) grant CA016672 (SMF) for exome sequencing; the MDACC Flow Cytometry and Cellular Imaging Core Facility supported by grant NCI#P30CA16672 for flow cytometers and FACS; D. Jayanta for providing GFP-LC3 constructs; B. Perrazzona, U. Varadarajan and R. Dewan for lab management; and S. Jiang for assistance in maintenance of mouse colonies. A. V. is thankful to A. Fantino, S. Rapi, V. Giuliani and P. Viale for their continuous support. This study was supported by grants from the Hirshberg Foundation for Pancreatic Cancer Research to A. V., Harvard Stem Cell Institute to R. A. D. and A. V., Sheikh Ahmed Center for Pancreatic Cancer Research to G. F. D., T. P. H. and A. V., American Italian Cancer Foundation to G. F. D., National Institutes of Health (NIH) P01CA117969 to R. A. D., NIH/NCI P01CA120964 to J. M. A., The Viragh Family Foundation to J. B. F.; C. A. L. is a Pancreatic Cancer Action Network-AACR Pathway to Leadership Fellow.	Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Itoh Y, 2004, J CEREBR BLOOD F MET, V24, P993, DOI 10.1097/01.WCB.0000127661.07591.DE; Jang S, 2013, LANCET ONCOL, V14, pE60, DOI 10.1016/S1470-2045(12)70539-9; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu YB, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-98; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Quintas-Cardama A, 2009, NAT REV CLIN ONCOL, V6, P535, DOI 10.1038/nrclinonc.2009.112; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zheng W, 2013, J CEREBR BLOOD F MET, V33, P600, DOI 10.1038/jcbfm.2012.214	29	749	763	8	196	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					628	+		10.1038/nature13611	http://dx.doi.org/10.1038/nature13611			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25119024	Green Accepted			2022-12-24	WOS:000343801500049
J	Chera, S; Baronnier, D; Ghila, L; Cigliola, V; Jensen, JN; Gu, GQ; Furuyama, K; Thorel, F; Gribble, FM; Reimann, F; Herrera, PL				Chera, Simona; Baronnier, Delphine; Ghila, Luiza; Cigliola, Valentina; Jensen, Jan N.; Gu, Guoqiang; Furuyama, Kenichiro; Thorel, Fabrizio; Gribble, Fiona M.; Reimann, Frank; Herrera, Pedro L.			Diabetes recovery by age-dependent conversion of pancreatic delta-cells into insulin producers	NATURE			English	Article							ALPHA; GLUCOSE; HUMANS	Total or near-total loss of insulin-producing beta-cells occurs in type 1 diabetes(1,2). Restoration of insulin production in type 1 diabetes is thus a major medical challenge. We previously observed in mice in which beta-cells are completely ablated that the pancreas reconstitutes new insulin-producing cells in the absence of autoimmunity(3). The process involves the contribution of islet non-beta-cells; specifically, glucagon-producing alpha-cells begin producing insulin by a process of reprogramming (transdifferentiation) without proliferation(3). Here we show the influence of age on beta-cell reconstitution from heterologous islet cells after near-total beta-cell loss in mice. We found that senescence does not alter alpha-cell plasticity: alpha-cells can reprogram to produce insulin from puberty through to adulthood, and also in aged individuals, even a long time after beta-cell loss. In contrast, before puberty there is no detectable alpha-cell conversion, although beta-cell reconstitution after injury is more efficient, always leading to diabetes recovery. This process occurs through a newly discovered mechanism: the spontaneous en masse reprogramming of somatostatin-producing delta-cells. The juveniles display somatostatin-to-insulin delta-cell conversion, involving dedifferentiation, proliferation and re-expression of islet developmental regulators. This juvenile adaptability relies, at least in part, upon the combined action of FoxO1 and downstream effectors. Restoration of insulin producing-cells from non-beta-cell origins is thus enabled throughout life via delta- or alpha-cell spontaneous reprogramming. A landscape with multiple intra-islet cell interconversion events is emerging, offering new perspectives for therapy.	[Chera, Simona; Baronnier, Delphine; Ghila, Luiza; Cigliola, Valentina; Furuyama, Kenichiro; Thorel, Fabrizio; Herrera, Pedro L.] Univ Geneva, Fac Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Jensen, Jan N.] Novo Nordisk AS, DK-2820 Gentofte, Denmark; [Gu, Guoqiang] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Gribble, Fiona M.; Reimann, Frank] Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Geneva; Novo Nordisk; Vanderbilt University; University of Cambridge	Herrera, PL (corresponding author), Univ Geneva, Fac Med, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	pedro.herrera@unige.ch	CHERA, Simona/N-3207-2014; GHILA, Luiza/N-1372-2014; Cigliola, Valentina/AAM-9083-2020	CHERA, Simona/0000-0001-6310-3486; GHILA, Luiza/0000-0001-7173-6312; FURUYAMA, Kenichiro/0000-0003-4878-2841; Valentina, Cigliola/0000-0002-1596-7332; Herrera Merino, Pedro Luis/0000-0003-0771-9504; Gribble, Fiona/0000-0002-4232-2898; Reimann, Frank/0000-0001-9399-6377	Wellcome Trust [WT088357/Z/09/Z, WT084210/Z/07/Z]; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (Beta Cell Biology Consortium); Juvenile Diabetes Research Foundation; Swiss National Science Foundation [NRP63]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065949, U01DK089566, U01DK072522] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12012/3] Funding Source: researchfish; MRC [MC_UU_12012/3] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (Beta Cell Biology Consortium)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)NIH National Institute of Neurological Disorders & Stroke (NINDS)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to D. Belin, P. Vassalli, R. Stein,A. Cookson,A. Ruizi Altaba, M. Gonzalez Gaitan, B. Galliot and I. Rodriguez for comments, support and discussions,and to G. Gallardo, O. Fazio, K. Hammad and B. Polat for technical help. We thank G. Gradwohl for the Ngn3-YFP mice. F.M.G. and F.R. were funded by Wellcome Trust grants WT088357/Z/09/Z and WT084210/Z/07/Z, respectively. This work was funded with grants from the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (Beta Cell Biology Consortium), the Juvenile Diabetes Research Foundation and the Swiss National Science Foundation (NRP63) to P.L.H.	Al-Masri M, 2010, DIABETOLOGIA, V53, P699, DOI 10.1007/s00125-009-1632-0; Atkinson M. A., 2012, COLD SPRING HARB PER; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Desgraz R, 2011, TRENDS ENDOCRIN MET, V22, P34, DOI 10.1016/j.tem.2010.09.004; Desgraz R, 2009, DEVELOPMENT, V136, P3567, DOI 10.1242/dev.039214; Karges B, 2004, DIABETES CARE, V27, P1207, DOI 10.2337/diacare.27.5.1207; Karges B, 2006, DIABETES-METAB RES, V22, P184, DOI 10.1002/dmrr.600; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Morgan TH, 1901, SCIENCE, V14, P235, DOI 10.1126/science.14.346.235; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Talchai C, 2012, NAT GENET, V44, P406, DOI 10.1038/ng.2215; Tanaka H, 2010, EUR J PHARMACOL, V645, P185, DOI 10.1016/j.ejphar.2010.07.018; Thorel F, 2011, DIABETES, V60, P2872, DOI 10.2337/db11-0876; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yoneda S, 2013, J CLIN ENDOCR METAB, V98, P2053, DOI 10.1210/jc.2012-3832	23	261	272	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					503	+		10.1038/nature13633	http://dx.doi.org/10.1038/nature13633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25141178	Green Accepted, Green Published			2022-12-24	WOS:000343775900043
J	Chan, M				Chan, Margaret			Ebola Virus Disease in West Africa - No Early End to the Outbreak	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									World Hlth Org, Geneva, Switzerland	World Health Organization	Chan, M (corresponding author), World Hlth Org, Geneva, Switzerland.				World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)			0	139	147	0	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1183	1185		10.1056/NEJMp1409859	http://dx.doi.org/10.1056/NEJMp1409859			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP4WH	25140856				2022-12-24	WOS:000342079700004
J	Zhang, B; Wang, J; Wang, X; Zhu, J; Liu, Q; Shi, Z; Chambers, MC; Zimmerman, LJ; Shaddox, KF; Kim, S; Davies, SR; Wang, S; Wang, P; Kinsinger, CR; Rivers, RC; Rodriguez, H; Townsend, RR; Ellis, MJC; Carr, SA; Tabb, DL; Coffey, RJ; Slebos, RJC; Liebler, DC				Zhang, Bing; Wang, Jing; Wang, Xiaojing; Zhu, Jing; Liu, Qi; Shi, Zhiao; Chambers, Matthew C.; Zimmerman, Lisa J.; Shaddox, Kent F.; Kim, Sangtae; Davies, Sherri R.; Wang, Sean; Wang, Pei; Kinsinger, Christopher R.; Rivers, Robert C.; Rodriguez, Henry; Townsend, R. Reid; Ellis, Matthew J. C.; Carr, Steven A.; Tabb, David L.; Coffey, Robert J.; Slebos, Robbert J. C.; Liebler, Daniel C.		NCI CPTAC	Proteogenomic characterization of human colon and rectal cancer	NATURE			English	Article							RNA-SEQ DATA; PROTEIN EXPRESSION; COLORECTAL-CANCER; PEPTIDE IDENTIFICATION; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; ANALYSIS REVEALS; GENE; ABUNDANCE; HNF4-ALPHA	Extensive genomic characterization of human cancers presents the problem of inference from genomic abnormalities to cancer phenotypes. To address this problem, we analysed proteomes of colon and rectal tumours characterized previously by The Cancer Genome Atlas (TCGA) and perform integrated proteogenomic analyses. Somatic variants displayed reduced protein abundance compared to germline variants. Messenger RNA transcript abundance did not reliably predict protein abundance differences between tumours. Proteomics identified five proteomic subtypes in the TCGA cohort, two of which overlapped with the TCGA 'microsatellite instability/CpG island methylation phenotype' transcriptomic subtype, but had distinct mutation, methylation and protein expression patterns associated with different clinical outcomes. Although copy number alterations showed strong cis- and trans-effects on mRNA abundance, relatively few of these extend to the protein level. Thus, proteomics data enabled prioritization of candidate driver genes. The chromosome 20q amplicon was associated with the largest global changes at both mRNA and protein levels; proteomics data highlighted potential 20q candidates, including HNF4A(hepatocyte nuclear factor 4, alpha), TOMM34 (translocase of outer mitochondrial membrane 34) and SRC (SRC proto-oncogene, non-receptor tyrosine kinase). Integrated proteogenomic analysis provides functional context to interpret genomic abnormalities and affords a new paradigm for understanding cancer biology.	[Zhang, Bing; Wang, Jing; Wang, Xiaojing; Zhu, Jing; Liu, Qi; Chambers, Matthew C.; Tabb, David L.] Vanderbilt Univ Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA; [Zhang, Bing; Slebos, Robbert J. C.] Vanderbilt Univ Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Shi, Zhiao] Vanderbilt Univ, Adv Comp Ctr Res & Educ, Nashville, TN 37232 USA; [Shi, Zhiao] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37232 USA; [Zimmerman, Lisa J.; Liebler, Daniel C.] Vanderbilt Univ Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Zimmerman, Lisa J.; Shaddox, Kent F.; Slebos, Robbert J. C.; Liebler, Daniel C.] Vanderbilt Ingram Canc Ctr, Jim Ayers Inst Precanc Detect & Diag, Nashville, TN 37232 USA; [Kim, Sangtae] Pacific NW Natl Lab, Directorate Fundamental & Computat Sci, Richland, WA 99352 USA; [Davies, Sherri R.; Townsend, R. Reid; Ellis, Matthew J. C.] Washington Univ Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Wang, Sean] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Wang, Pei] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kinsinger, Christopher R.; Rivers, Robert C.; Rodriguez, Henry] NCI, Off Canc Clin Prote Res, Bethesda, MD 20892 USA; [Carr, Steven A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Coffey, Robert J.] Vanderbilt Univ Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington University (WUSTL); Fred Hutchinson Cancer Center; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Vanderbilt University	Liebler, DC (corresponding author), Vanderbilt Univ Sch Med, Dept Biochem, Nashville, TN 37232 USA.	daniel.liebler@vanderbilt.edu	Smith, Richard D/J-3664-2012; Carr, Steven A./AAH-8366-2019	Smith, Richard D/0000-0002-2381-2349; Mani, D. R./0000-0003-3914-133X; McGarvey, Peter/0000-0002-8312-6017; Payne, Samuel/0000-0002-8351-1994; Tabb, David/0000-0001-7223-578X; White, Forest/0000-0002-1545-1651; Davies, Sherri/0000-0002-7141-8354; McDermott, Jason/0000-0003-2961-2572; Liebler, Daniel/0000-0002-7873-3031; Fenyo, David/0000-0001-5049-3825; Levine, Douglas/0000-0003-1038-8232; Wang, Pei/0000-0002-6890-6453	National Cancer Institute (NCI) CPTAC awards [U24CA159988, U24CA160035, U24CA160034]; NCI SPORE award [P50CA095103]; NCI Cancer Center Support Grant [P30CA068485]; National Institutes of Health [GM088822]; Leidos Biomedical Research, Inc. [13XS029]; NATIONAL CANCER INSTITUTE [U24CA159988, R01CA046413, U24CA160034, P50CA095103, U24CA160019, U24CA160035, P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088822] Funding Source: NIH RePORTER	National Cancer Institute (NCI) CPTAC awards; NCI SPORE award; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leidos Biomedical Research, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute (NCI) CPTAC awards U24CA159988, U24CA160035, and U24CA160034; by NCI SPORE award P50CA095103 and NCI Cancer Center Support Grant P30CA068485; by National Institutes of Health grant GM088822; and by contract 13XS029 from Leidos Biomedical Research, Inc. Genomics data for this study were generated by The Cancer Genome Atlas pilot project established by the NCI and the National Human Genome Research Institute. Information about TCGA and the investigators and institutions comprising the TCGA research network can be found at http://cancergenome.nih.gov/.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cancer Genome Atlas Res. Netw, 2012, NATURE, V490, P292; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chellappa K, 2012, BIOMARK MED, V6, P297, DOI [10.2217/BMM.12.23, 10.2217/bmm.12.23]; Chellappa K, 2012, P NATL ACAD SCI USA, V109, P2302, DOI 10.1073/pnas.1106799109; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697; Dasari S, 2012, J PROTEOME RES, V11, P1686, DOI 10.1021/pr200874e; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Geiger T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001574; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Halvey PJ, 2014, CANCER RES, V74, P387, DOI 10.1158/0008-5472.CAN-13-2488; Halvey PJ, 2012, J PROTEOME RES, V11, P1184, DOI 10.1021/pr2009109; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Kiemer AK, 2001, ONCOGENE, V20, P6679, DOI 10.1038/sj.onc.1204872; Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731; Kim WK, 2013, CLIN CANCER RES, V19, P3369, DOI 10.1158/1078-0432.CCR-13-0684; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li M, 2010, J PROTEOME RES, V9, P4295, DOI 10.1021/pr100527g; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Licklider LJ, 2002, ANAL CHEM, V74, P3076, DOI 10.1021/ac025529o; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Q, 2013, MOL CELL PROTEOMICS, V12, P1900, DOI 10.1074/mcp.M112.025783; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Ma ZQ, 2011, BIOINFORMATICS, V27, P3214, DOI 10.1093/bioinformatics/btr544; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Peng J, 2010, ANN APPL STAT, V4, P53, DOI 10.1214/09-AOAS271; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saandi T, 2013, ONCOGENE, V32, P3782, DOI 10.1038/onc.2012.401; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz B, 2009, INT J CANCER, V124, P1081, DOI 10.1002/ijc.24041; Shi ZA, 2013, NAT METHODS, V10, P597, DOI 10.1038/nmeth.2517; Shimokawa T, 2006, INT J ONCOL, V29, P381; Slebos RJC, 2013, INT J CANCER, V132, P568, DOI 10.1002/ijc.27699; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang J, 2012, BRIEF BIOINFORM, V13, P216, DOI 10.1093/bib/bbr041; Wang P., 2010, STAT METHODS CGH ARR; Wang XJ, 2013, BIOINFORMATICS, V29, P3235, DOI 10.1093/bioinformatics/btt543; Wang XJ, 2012, J PROTEOME RES, V11, P1009, DOI 10.1021/pr200766z; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zhou JY, 2010, J PROTEOME RES, V9, P5698, DOI 10.1021/pr100508p; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	82	905	922	10	309	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					382	+		10.1038/nature13438	http://dx.doi.org/10.1038/nature13438			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043054	Green Accepted, Green Submitted			2022-12-24	WOS:000341814900052
J	Zhang, YN; Nicholatos, J; Dreier, JR; Ricoult, SJH; Widenmaier, SB; Hotamisligil, GS; Kwiatkowski, DJ; Manning, BD				Zhang, Yinan; Nicholatos, Justin; Dreier, John R.; Ricoult, Stephane J. H.; Widenmaier, Scott B.; Hotamisligil, Goekhan S.; Kwiatkowski, David J.; Manning, Brendan D.			Coordinated regulation of protein synthesis and degradation by mTORC1	NATURE			English	Article							ACTIVATION; HOMEOSTASIS; AUTOPHAGY; SREBP-1A; PATHWAY; COMPLEX; TARGET; GENES	Eukaryotic cells coordinately control anabolic and catabolic processes to maintain cell and tissue homeostasis. Mechanistic target of rapamycin complex 1 (mTORC1) promotes nutrient-consuming anabolic processes, such as protein synthesis(1). Here we show that as well as increasing protein synthesis, mTORC1 activation in mouse and human cells also promotes an increased capacity for protein degradation. Cells with activated mTORC1 exhibited elevated levels of intact and active proteasomes through a global increase in the expression of genes encoding proteasome subunits. The increase in proteasome gene expression, cellular proteasome content, and rates of protein turnover downstream of mTORC1 were all dependent on induction of the transcription factor nuclear factor erythroid-derived 2-related factor 1 (NRF1; also known as NFE2L1). Genetic activation of mTORC1 through loss of the tuberous sclerosis complex tumour suppressors, TSC1 or TSC2, or physiological activation of mTORC1 in response to growth factors or feeding resulted in increased NRF1 expression in cells and tissues. We find that this NRF1-dependent elevation in proteasome levels serves to increase the intracellular pool of amino acids, which thereby influences rates of new protein synthesis. Therefore, mTORC1 signalling increases the efficiency of proteasome-mediated protein degradation for both quality control and as a mechanism to supply substrate for sustained protein synthesis.	[Zhang, Yinan; Nicholatos, Justin; Ricoult, Stephane J. H.; Widenmaier, Scott B.; Hotamisligil, Goekhan S.; Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Dreier, John R.; Kwiatkowski, David J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Translat Med Div,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Manning, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021; Zhang, Yinan/N-6432-2014	Manning, Brendan/0000-0003-3895-5956; Zhang, Yinan/0000-0002-3471-6598; Widenmaier, Scott/0000-0001-5684-2707; Nicholatos, Justin/0000-0002-5433-3041	Department of Defense Tuberous Sclerosis Complex Research Program [W81XWH-10-1-0861]; National Institutes of Health [CA122617, CA120964]; Ellison Medical Foundation; National Science Foundation [DGE-1144152]; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [P01CA120964, R01CA122617] Funding Source: NIH RePORTER	Department of Defense Tuberous Sclerosis Complex Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank I. Ben-Sahra and L. Yang for technical assistance. This work was supported in part by Department of Defense Tuberous Sclerosis Complex Research Program grant W81XWH-10-1-0861 (B. D. M.), National Institutes of Health grants CA122617 (B. D. M.) and CA120964 (B. D. M. and D.J.K.), the Ellison Medical Foundation (B. D. M.), National Science Foundation fellowship DGE-1144152 (S.J.H.R.), and a Canadian Institutes of Health Research fellowship (S.B.W.).	Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Radhakrishnan SK, 2014, ELIFE, V3, DOI [10.7554/elife.01856, 10.7554/eLife.01856]; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yuan E, 2012, HUM MOL GENET, V21, P4286, DOI 10.1093/hmg/dds262; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1350, DOI 10.1016/j.bbalip.2012.07.006; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	27	208	212	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2014	513	7518					440	+		10.1038/nature13492	http://dx.doi.org/10.1038/nature13492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1GD	25043031	Green Accepted			2022-12-24	WOS:000341814900065
J	DebRoy, S; Gebbie, M; Ramesh, A; Goodson, JR; Cruz, MR; van Hoof, A; Winkler, WC; Garsin, DA				DebRoy, Sruti; Gebbie, Margo; Ramesh, Arati; Goodson, Jonathan R.; Cruz, Melissa R.; van Hoof, Ambro; Winkler, Wade C.; Garsin, Danielle A.			A riboswitch-containing sRNA controls gene expression by sequestration of a response regulator	SCIENCE			English	Article							ETHANOLAMINE UTILIZATION; ENTEROCOCCUS-FAECALIS; BINDING	The ethanolamine utilization (eut) locus of Enterococcus faecalis, containing at least 19 genes distributed over four polycistronic messenger RNAs, appears to be regulated by a single adenosyl cobalamine (AdoCbl)-responsive riboswitch. We report that the AdoCbl-binding riboswitch is part of a small, trans-acting RNA, EutX, which additionally contains a dual-hairpin substrate for the RNA binding-response regulator, EutV. In the absence of AdoCbl, EutX uses this structure to sequester EutV. EutV is known to regulate the eut messenger RNAs by binding dual-hairpin structures that overlap terminators and thus prevent transcription termination. In the presence of AdoCbl, EutV cannot bind to EutX and, instead, causes transcriptional read through of multiple eut genes. This work introduces riboswitch-mediated control of protein sequestration as a posttranscriptional mechanism to coordinately regulate gene expression.	[DebRoy, Sruti; Cruz, Melissa R.; van Hoof, Ambro; Garsin, Danielle A.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Gebbie, Margo; Goodson, Jonathan R.; Winkler, Wade C.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Ramesh, Arati] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Health Science Center Houston; University System of Maryland; University of Maryland College Park; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garsin, DA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	wwinkler@umd.edu; danielle.a.garsin@uth.tmc.edu		Ramesh, Arati/0000-0001-8655-0051; van Hoof, Ambro/0000-0002-7800-9764; Gebbie, Margo/0000-0002-2203-344X; Cruz, Melissa/0000-0003-2399-3343	NIH [R01AI076406, R56AI110432, R01GM099790]; NSF [MCB-1051440]; Welch Foundation [AU-1773]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI110432, R01AI110432, R01AI076406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The data reported are presented in the main paper and the supplementary materials. This work was supported by the NIH grants R01AI076406 (D. A. G.), R56AI110432 (D. A. G. and W. C. W.) and R01GM099790 (A. V. H.), a NSF grant MCB-1051440 (W. C. W.) and a Welch Foundation grant AU-1773 (A. V. H.). For transmission electron microscopy imaging, we thank S. Kolodziej and P. Navarro; J. R. Mellin and P. Cossart are acknowledged for valuable discussions.	Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Baker KA, 2011, J BACTERIOL, V193, P2575, DOI 10.1128/JB.00217-11; Del Papa MF, 2008, J BACTERIOL, V190, P7147, DOI 10.1128/JB.00952-08; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334; Johnson JE, 2012, NATURE, V492, P133, DOI 10.1038/nature11607; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Peselis A, 2012, NAT STRUCT MOL BIOL, V19, P1182, DOI 10.1038/nsmb.2405; Ramesh A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002666; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; SCARLETT FA, 1976, J GEN MICROBIOL, V95, P173, DOI 10.1099/00221287-95-1-173; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	14	90	94	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					937	940		10.1126/science.1255091	http://dx.doi.org/10.1126/science.1255091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25146291	Green Accepted			2022-12-24	WOS:000340524700048
J	Lara-Astiaso, D; Weiner, A; Lorenzo-Vivas, E; Zaretsky, I; Jaitin, DA; David, E; Keren-Shaul, H; Mildner, A; Winter, D; Jung, S; Friedman, N; Amit, I				Lara-Astiaso, David; Weiner, Assaf; Lorenzo-Vivas, Erika; Zaretsky, Irina; Jaitin, Diego Adhemar; David, Eyal; Keren-Shaul, Hadas; Mildner, Alexander; Winter, Deborah; Jung, Steffen; Friedman, Nir; Amit, Ido			Chromatin state dynamics during blood formation	SCIENCE			English	Article							MACROPHAGE; COMMITMENT; LANDSCAPE; ENHANCERS	Chromatin modifications are crucial for development, yet little is known about their dynamics during differentiation. Hematopoiesis provides a well-defined model to study chromatin state dynamics; however, technical limitations impede profiling of homogeneous differentiation intermediates. We developed a high-sensitivity indexing-first chromatin immunoprecipitation approach to profile the dynamics of four chromatin modifications across 16 stages of hematopoietic differentiation. We identify 48,415 enhancer regions and characterize their dynamics. We find that lineage commitment involves de novo establishment of 17,035 lineage-specific enhancers. These enhancer repertoire expansions foreshadow transcriptional programs in differentiated cells. Combining our enhancer catalog with gene expression profiles, we elucidate the transcription factor network controlling chromatin dynamics and lineage specification in hematopoiesis. Together, our results provide a comprehensive model of chromatin dynamics during development.	[Lara-Astiaso, David; Lorenzo-Vivas, Erika; Zaretsky, Irina; Jaitin, Diego Adhemar; David, Eyal; Keren-Shaul, Hadas; Mildner, Alexander; Winter, Deborah; Jung, Steffen; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Weiner, Assaf; Friedman, Nir] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel; [Weiner, Assaf; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Friedman, N (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel.	nir@cs.huji.ac.il; ido.amit@weizmann.ac.il	Jung, Steffen/K-1409-2012; mildner, alexander/GQA-3761-2022; Friedman, Nir/H-9692-2012; Winter, Deborah R./AAQ-9253-2020; Mildner, Alexander/ABG-6122-2020; mildner, alexander/AAF-9451-2022; mildner, alexander/AFK-2161-2022	Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; Friedman, Nir/0000-0002-9678-3550; Winter, Deborah R./0000-0003-1806-673X; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427	European Research Council [309788, 340712]; Israeli Science Foundation [1782/11]; Human Frontier Science Program, Career Development Award [CDA00028/2011-c]; European Molecular Biology Organization; National Human Genome Research Institute Center for Excellence in Genome Science [1P50HG006193]; Israeli Centers of Research Excellence (I-CORE); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Israeli Science Foundation(Israel Science Foundation); Human Frontier Science Program, Career Development Award; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Human Genome Research Institute Center for Excellence in Genome Science; Israeli Centers of Research Excellence (I-CORE); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Amit and Friedman laboratories for critical discussions. We thank G. Brodsky for artwork. This work was supported by grants from the European Research Council (nos. 309788 and 340712), the Israeli Science Foundation (1782/11), the Human Frontier Science Program, Career Development Award (CDA00028/2011-c) (I. A.), a European Molecular Biology Organization Young Investigator Award (I. A.), the National Human Genome Research Institute Center for Excellence in Genome Science (1P50HG006193), and the Israeli Centers of Research Excellence (I-CORE). RNA-seq, ChIP-seq, and ATAC-seq data are deposited in the Gene Expression Omnibus under accession number GSE60103. The data can be viewed from the following Web site: http://compbio.cs.huji.ac.il/blood-chromatin/index.html. A patent application for iChIP has been filed by Yeda, Weizmann Institute of Science, Israel.	Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ouyang WM, 2011, TRENDS IMMUNOL, V32, P26, DOI 10.1016/j.it.2010.10.005; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Shankaranarayanan P, 2011, NAT METHODS, V8, P565, DOI [10.1038/NMETH.1626, 10.1038/nmeth.1626]; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	27	507	522	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					943	949		10.1126/science.1256271	http://dx.doi.org/10.1126/science.1256271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25103404	Green Accepted			2022-12-24	WOS:000340524700050
J	Mozaffarian, D; Fahimi, S; Singh, GM; Micha, R; Khatibzadeh, S; Engell, RE; Lim, S; Danaei, G; Ezzati, M; Powles, J				Mozaffarian, Dariush; Fahimi, Saman; Singh, Gitanjali M.; Micha, Renata; Khatibzadeh, Shahab; Engell, Rebecca E.; Lim, Stephen; Danaei, Goodarz; Ezzati, Majid; Powles, John		Global Burden Dis Nutr Chronic Dis	Global Sodium Consumption and Death from Cardiovascular Causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; SALT REDUCTION; RACIAL-DIFFERENCES; RISK-FACTORS; DISEASE; HYPERTENSION; BURDEN; HEALTH; METAANALYSIS; ASSOCIATION	BACKGROUND High sodium intake increases blood pressure, a risk factor for cardiovascular disease, but the effects of sodium intake on global cardiovascular mortality are uncertain. METHODS We collected data from surveys on sodium intake as determined by urinary excretion and diet in persons from 66 countries (accounting for 74.1% of adults throughout the world), and we used these data to quantify the global consumption of sodium according to age, sex, and country. The effects of sodium on blood pressure, according to age, race, and the presence or absence of hypertension, were calculated from data in a new meta-analysis of 107 randomized interventions, and the effects of blood pressure on cardiovascular mortality, according to age, were calculated from a meta-analysis of cohorts. Cause-specific mortality was derived from the Global Burden of Disease Study 2010. Using comparative risk assessment, we estimated the cardiovascular effects of current sodium intake, as compared with a reference intake of 2.0 g of sodium per day, according to age, sex, and country. RESULTS In 2010, the estimated mean level of global sodium consumption was 3.95 g per day, and regional mean levels ranged from 2.18 to 5.51 g per day. Globally, 1.65 million annual deaths from cardiovascular causes (95% uncertainty interval [confidence interval], 1.10 million to 2.22 million) were attributed to sodium intake above the reference level; 61.9% of these deaths occurred in men and 38.1% occurred in women. These deaths accounted for nearly 1 of every 10 deaths from cardiovascular causes (9.5%). Four of every 5 deaths (84.3%) occurred in low-and middle-income countries, and 2 of every 5 deaths (40.4%) were premature (before 70 years of age). The rate of death from cardiovascular causes associated with sodium intake above the reference level was highest in the country of Georgia and lowest in Kenya. CONCLUSIONS In this modeling study, 1.65 million deaths from cardiovascular causes that occurred in 2010 were attributed to sodium consumption above a reference level of 2.0 g per day.	[Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Mozaffarian, Dariush; Fahimi, Saman; Singh, Gitanjali M.; Micha, Renata; Khatibzadeh, Shahab; Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Mozaffarian, Dariush] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Fahimi, Saman; Powles, John] Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, London, England; [Engell, Rebecca E.; Lim, Stephen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Cambridge; Imperial College London; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dariush.mozaffarian@tufts.edu	TURRINI, AIDA/P-2413-2019; Tsugane, Shoichiro/A-2424-2015; Bjerregaard, Peter/ABD-8894-2020; Koksal, Eda/AAW-2900-2021; Calleja, Neville/E-3895-2019; Steingrimsdottir, Laufey/L-3150-2015; Castetbon, Katia/F-2686-2017; Turrini, Aida/K-5353-2016; Fisberg, Regina M/C-4069-2012; Forsyth, Simon J/N-9522-2013; Mozaffarian, Dariush/ABC-2822-2020; Danaei, Goodarz/B-6085-2008; Panagiotakos, Demosthenes/C-9776-2013	TURRINI, AIDA/0000-0002-2188-9406; Tsugane, Shoichiro/0000-0003-4105-2774; Bjerregaard, Peter/0000-0001-7153-8447; Koksal, Eda/0000-0002-7930-9910; Calleja, Neville/0000-0003-1800-2103; Turrini, Aida/0000-0002-2188-9406; Fisberg, Regina M/0000-0002-4490-9035; Forsyth, Simon J/0000-0002-3100-3584; Panagiotakos, Demosthenes/0000-0001-8583-153X; Jackson, Maria/0000-0002-7031-7244; Ding, Eric/0000-0002-5881-8097; Neal, Bruce/0000-0002-0490-7465; Elliott, Paul/0000-0002-7511-5684; Chen, Yu/0000-0002-1519-4894; Waskiewicz, Anna/0000-0001-5091-2145	Bill and Melinda Gates Foundation; Medical Research Council [G0801056] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the Bill and Melinda Gates Foundation.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; [Anonymous], 2011, 2010 REP DIET GUID A; [Anonymous], 2003, DIET NUTR PREV CHRON; Asaria P, 2007, LANCET, V370, P2004; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; D'Elia L, 2011, J AM COLL CARDIOL, V57, P1210, DOI 10.1016/j.jacc.2010.09.070; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Department of Agriculture Department of Health and Human Services (US), 2011, DIET GUID AM 2010; Duc AH, 2011, HEALTH POLICY PLANN, V26, P210, DOI 10.1093/heapol/czq045; ELLIOTT P, 1988, BRIT MED J, V297, P319; Food and Nutrition Board Institute of Medicine, 2010, STRAT RED SOD INT US; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; General Assembly of the United Nations, 2011, HIGH LEV M NONC DIS; Graudal NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub3; He F. J., 2013, BMJ, V346; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; Institute of Medicine, 2013, SOD INT POP ASEV; Laatikainen T, 2006, EUR J CLIN NUTR, V60, P965, DOI 10.1038/sj.ejcn.1602406; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CMM, 2003, HYPERTENSION, V42, P69, DOI 10.1161/01.HYP.0000075083.04415.4B; Lewington S, 2003, LANCET, V361, P1060; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martikainen JA, 2011, EUR J CLIN NUTR, V65, P1148, DOI 10.1038/ejcn.2011.78; Micha R, 2012, EUR J CLIN NUTR, V66, P119, DOI 10.1038/ejcn.2011.147; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE, V25; O'Flaherty M, 2012, B WORLD HEALTH ORGAN, V90, P522, DOI 10.2471/BLT.11.092643; PARMER RJ, 1994, HYPERTENSION, V24, P752, DOI 10.1161/01.HYP.24.6.752; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Rubinstein A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-627; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Scientific Advisory Committee on Nutrition, 2003, SALT HLTH; Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174; Textor SC, 2012, AM J KIDNEY DIS, V59, P229, DOI 10.1053/j.ajkd.2011.09.023; Turban S, 2013, AM J KIDNEY DIS, V61, P88, DOI 10.1053/j.ajkd.2012.08.036; van Bommel E, 2012, INT J CLIN PHARM TH, V50, P478, DOI 10.5414/CP201724; Van Vliet BN, 2008, INT J OBESITY, V32, pS35, DOI 10.1038/ijo.2008.205; Whelton PK, 2012, CIRCULATION, V126, P2880, DOI 10.1161/CIR.0b013e318279acbf; Whelton PK, 2013, CIRCULATION, V27, pe263; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2012, WHO GUID SOD INT AD; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966	45	726	768	3	100	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					624	634		10.1056/NEJMoa1304127	http://dx.doi.org/10.1056/NEJMoa1304127			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZL	25119608	Green Published			2022-12-24	WOS:000340819600008
J	Shukla, AK; Westfield, GH; Xiao, KH; Reis, RI; Huang, LY; Tripathi-Shukla, P; Qian, J; Li, S; Blanc, A; Oleskie, AN; Dosey, AM; Su, M; Liang, CR; Gu, LL; Shan, JM; Chen, X; Hanna, R; Choi, MJ; Yao, XJ; Klink, BU; Kahsai, AW; Sidhu, SS; Koide, S; Penczek, PA; Kossiakoff, AA; Woods, VL; Kobilka, BK; Skiniotis, G; Lefkowitz, RJ				Shukla, Arun K.; Westfield, Gerwin H.; Xiao, Kunhong; Reis, Rosana I.; Huang, Li-Yin; Tripathi-Shukla, Prachi; Qian, Jiang; Li, Sheng; Blanc, Adi; Oleskie, Austin N.; Dosey, Anne M.; Su, Min; Liang, Cui-Rong; Gu, Ling-Ling; Shan, Jin-Ming; Chen, Xin; Hanna, Rachel; Choi, Minjung; Yao, Xiao Jie; Klink, Bjoern U.; Kahsai, Alem W.; Sidhu, Sachdev S.; Koide, Shohei; Penczek, Pawel A.; Kossiakoff, Anthony A.; Woods, Virgil L., Jr.; Kobilka, Brian K.; Skiniotis, Georgios; Lefkowitz, Robert J.			Visualization of arrestin recruitment by a G-protein-coupled receptor	NATURE			English	Article							BETA(2) ADRENERGIC-RECEPTOR; CONFORMATIONAL-CHANGES; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; VISUAL ARRESTIN; ACTIVATION; COMPLEX; BETA-ARRESTIN1; IMAGES; DOMAIN	G-protein-coupled receptors (GPCRs) are critically regulated by beta-arrestins, which not only desensitize G-protein signalling but also initiate a G-protein-independent wave of signalling(1-5). A recent surge of structural data on a number of GPCRs, including the beta(2) adrenergic receptor (beta(2)AR)-G-proteincomplex, has provided novel insights into the structural basis of receptor activation(6-11). However, complementary information has been lacking on the recruitment of beta-arrestins to activated GPCRs, primarily owing to challenges in obtaining stable receptor-beta-arrestin complexes for structural studies. Here we devised a strategy for forming and purifying a functional human beta(2)AR-beta-arrestin-1 complex that allowed us to visualize its architecture by single-particle negative-stain electron microscopy and to characterize the interactions between beta(2)AR and beta-arrestin 1 using hydrogen-deuterium exchange mass spectrometry (HDX-MS) and chemical crosslinking. Electron microscopy two-dimensional averages and three dimensional reconstructions reveal bimodal binding of beta-arrestin 1 to the beta(2)AR, involving two separate sets of interactions, one with the phosphorylated carboxy terminus of the receptor and the other with its seven-transmembrane core. Areas of reduced HDX together with identification of crosslinked residues suggest engagement of the finger loop of beta-arrestin 1 with the seven-transmembrane core of the receptor. In contrast, focal areas of raised HDX levels indicate regions of increased dynamics in both the N and C domains of beta-arrestin 1 when coupled to the beta(2)AR. A molecular model of the beta(2)AR-beta-arrestin signalling complex was made by docking activated beta-arrestin 1 and beta(2)AR crystal structures into the electron microscopymap densities with constraints provided by HDX-MS and crosslinking, allowing us to obtain valuable insights into the overall architecture of a receptor-arrestin complex. The dynamic and structural information presented here provides a framework for better understanding the basis of GPCR regulation by arrestins.	[Shukla, Arun K.; Xiao, Kunhong; Reis, Rosana I.; Huang, Li-Yin; Tripathi-Shukla, Prachi; Qian, Jiang; Blanc, Adi; Yao, Xiao Jie; Klink, Bjoern U.; Kahsai, Alem W.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Westfield, Gerwin H.; Oleskie, Austin N.; Dosey, Anne M.; Su, Min; Skiniotis, Georgios] Univ Michigan, Sch Med, Life Sci Inst, Ann Arbor, MI 48109 USA; [Westfield, Gerwin H.; Oleskie, Austin N.; Dosey, Anne M.; Su, Min; Skiniotis, Georgios] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Liang, Cui-Rong; Gu, Ling-Ling; Shan, Jin-Ming; Chen, Xin] Changzhou Univ, Sch Pharmaceut & Life Sci, Changzhou 213164, Jiangsu, Peoples R China; [Hanna, Rachel; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Choi, Minjung; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Koide, Shohei; Kossiakoff, Anthony A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Penczek, Pawel A.] Univ Texas Houston, Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77054 USA; [Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Changzhou University; University of Toronto; Duke University; University of Chicago; University of Texas System; University of Texas Health Science Center Houston; Stanford University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	kobilka@stanford.edu; skinioti@umich.edu; lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021; Xiao, Kunhong/AAG-4275-2020; dos Reis, Rosana Maria/E-3346-2012	Xiao, Kunhong/0000-0002-1069-1226; Koide, Shohei/0000-0001-5473-4358; dos Reis, Rosana Maria/0000-0001-9631-4167; Westfield, Gerwin/0000-0001-9634-2336; Reis, Rosana/0000-0002-0465-8331; Kobilka, Brian/0000-0001-5958-3990; shukla, arun/0000-0003-2910-8288; Skiniotis, Georgios/0000-0003-0238-7846; Choi, Minjung/0000-0002-2601-107X	National Institutes of Health [DK090165, NS028471, GM072688, GM087519, HL075443, HL16037, HL70631]; Mathers Foundation [GM60635]; Pew Scholars Program in Biomedical Sciences; Canadian Institutes of Health Research [MOP-93725]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, P01HL075443, R01HL070631, R01HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, R01GM072688, R01GM060635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Pew Scholars Program in Biomedical Sciences; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Capel for technical assistance, V. Ronk, D. Addison and Q. Lennon for administrative support, R. K. Sunahara for stimulating discussions and Alex R. B. Thomsen for critical reading of the manuscript. We acknowledge support from the National Institutes of Health Grants DK090165 (G. S.), NS028471 (B. K. K.), GM072688 and GM087519 (A. A. K. and S. K.), HL075443 (K. X.), HL16037 and HL70631 (R.J.L.), from the Mathers Foundation (B. K. K.), GM60635 (P. A. P.) and from the Pew Scholars Program in Biomedical Sciences (G. S.). R. H. and S. S. S. were supported by a research grant from the Canadian Institutes of Health Research (MOP-93725). R. I. R is supported by a postdoctoral fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. R.J.L. is an investigator with the Howard Hughes Medical Institute.	Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Gurevich VV, 2013, PROG MOL BIOL TRANSL, V118, P57, DOI 10.1016/B978-0-12-394440-5.00003-6; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Kang DS, 2009, J BIOL CHEM, V284, P29860, DOI 10.1074/jbc.M109.023366; Kim KM, 2008, BIOCHEM BIOPH RES CO, V366, P42, DOI 10.1016/j.bbrc.2007.11.055; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lohse Martin J, 2014, Handb Exp Pharmacol, V219, P15, DOI 10.1007/978-3-642-41199-1_2; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	36	340	344	10	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					218	+		10.1038/nature13430	http://dx.doi.org/10.1038/nature13430			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25043026	Green Accepted, Green Submitted			2022-12-24	WOS:000340200700037
J	De Rybel, B; Adibi, M; Breda, AS; Wendrich, JR; Smit, ME; Novak, O; Yamaguchi, N; Yoshida, S; Van Isterdael, G; Palovaara, J; Nijsse, B; Boekschoten, MV; Hooiveld, G; Beeckman, T; Wagner, D; Ljung, K; Fleck, C; Weijers, D				De Rybel, Bert; Adibi, Milad; Breda, Alice S.; Wendrich, Jos R.; Smit, Margot E.; Novak, Ondrej; Yamaguchi, Nobutoshi; Yoshida, Saiko; Van Isterdael, Gert; Palovaara, Joakim; Nijsse, Bart; Boekschoten, Mark V.; Hooiveld, Guido; Beeckman, Tom; Wagner, Doris; Ljung, Karin; Fleck, Christian; Weijers, Dolf			PLANT DEVELOPMENT Integration of growth and patterning during vascular tissue formation in Arabidopsis	SCIENCE			English	Article							DEPENDENT AUXIN GRADIENTS; SOLID-PHASE EXTRACTION; SHOOT APICAL MERISTEM; TRANSCRIPTION FACTOR; ROOT; CYTOKININS; PURIFICATION; EXPRESSION; TRANSPORT; GENES	Coordination of cell division and pattern formation is central to tissue and organ development, particularly in plants where walls prevent cell migration. Auxin and cytokinin are both critical for division and patterning, but it is unknown how these hormones converge upon tissue development. We identify a genetic network that reinforces an early embryonic bias in auxin distribution to create a local, nonresponding cytokinin source within the root vascular tissue. Experimental and theoretical evidence shows that these cells act as a tissue organizer by positioning the domain of oriented cell divisions. We further demonstrate that the auxin-cytokinin interaction acts as a spatial incoherent feed-forward loop, which is essential to generate distinct hormonal response zones, thus establishing a stable pattern within a growing vascular tissue.	[De Rybel, Bert; Breda, Alice S.; Wendrich, Jos R.; Smit, Margot E.; Yoshida, Saiko; Palovaara, Joakim; Weijers, Dolf] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands; [Adibi, Milad] LifeGlimmer GmbH, D-12163 Berlin, Germany; [Adibi, Milad] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Adibi, Milad; Nijsse, Bart; Fleck, Christian] Wageningen Univ, Lab Syst & Synthet Biol, NL-6703 HA Wageningen, Netherlands; [Novak, Ondrej; Ljung, Karin] SLU, Dept Forest Genet & Plant Physiol, Ume Plant Sci Ctr UPSC, SE-90183 Umea, Sweden; [Novak, Ondrej] Palacky Univ, Lab Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, CZ-78371 Olomouc, Czech Republic; [Novak, Ondrej] Inst Expt Bot AS CR, CZ-78371 Olomouc, Czech Republic; [Yamaguchi, Nobutoshi; Wagner, Doris] Univ Penn, Dept Biol, Philadelphia, PA USA; [Van Isterdael, Gert; Beeckman, Tom] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Van Isterdael, Gert; Beeckman, Tom] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Boekschoten, Mark V.; Hooiveld, Guido] Wageningen Univ, Div Human Nutr, NL-6703 HA Wageningen, Netherlands; [Boekschoten, Mark V.] TI Food & Nutr, NL-6703 HA Wageningen, Netherlands	Wageningen University & Research; University of Freiburg; Wageningen University & Research; Swedish University of Agricultural Sciences; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Pennsylvania; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Wageningen University & Research; Top Institute Food & Nutrition	Fleck, C (corresponding author), Wageningen Univ, Lab Syst & Synthet Biol, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.	christian.fleck@wur.nl; dolf.weijers@wur.nl	Wendrich, Jos/V-9061-2019; Yoshida, Saiko/AAE-5693-2019; Boekschoten, Mark/AAS-4597-2021; Ljung, Karin/AAE-8691-2019; Weijers, Dolf/A-2076-2010; Wendrich, Jos R/H-3686-2013; NOVAK, Ondrej/F-7031-2014; Beeckman, Tom/ABA-1164-2020; Yamaguchi, Nobutoshi/AAU-6928-2020; Beeckman, Tom/ABI-1703-2020; Hooiveld, Guido JEJ/F-4912-2010; Weijers, Dolf/ABI-1332-2020	Wendrich, Jos/0000-0002-6198-3763; Yoshida, Saiko/0000-0001-6111-9353; Boekschoten, Mark/0000-0002-2139-0795; Ljung, Karin/0000-0003-2901-189X; Weijers, Dolf/0000-0003-4378-141X; Wendrich, Jos R/0000-0002-6198-3763; NOVAK, Ondrej/0000-0003-3452-0154; Yamaguchi, Nobutoshi/0000-0003-3738-6157; Beeckman, Tom/0000-0001-8656-2060; Hooiveld, Guido JEJ/0000-0003-1954-3542; Weijers, Dolf/0000-0003-4378-141X; Van Isterdael, Gert/0000-0001-6626-1316; De Rybel, Bert/0000-0002-9551-042X; Smit, Margot/0000-0001-8285-5130; Fleck, Christian/0000-0002-6371-4495; Breda, Alice Sarah/0000-0002-5593-3620; Wagner, Doris/0000-0003-4656-2490	FEBS Fellowship; Marie Curie Fellowship [IEF-2009-252503]; Netherlands Organization for Scientific Research (NWO) [ALW-VIDI-864.06.012, ALW-820.02.019]; ERA-CAPS project EURO-PEC [849.13.006]; European Research Council (Starting Grant "CELLPATTERN") [281573]; European Union 7th framework project [305564]; Ministry of Education, Youth, and Sports of the Czech Republic [LK21306, LO1204]; grant agency of the Czech Republic [14-34792S]; NSF [IOS 1257111]; Austrian Science Fund (FWF) [I 1476] Funding Source: researchfish	FEBS Fellowship; Marie Curie Fellowship(European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ERA-CAPS project EURO-PEC; European Research Council (Starting Grant "CELLPATTERN"); European Union 7th framework project; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); grant agency of the Czech Republic(Grant Agency of the Czech Republic); NSF(National Science Foundation (NSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We would like to thank H. Sakakibara, Y. Helariutta, T. Laux, and B. Muller for sharing plant materials; J. Jansen for technical assistance with microarray hybridizations; and M. Glosov and H. Martinkova for their help with cytokinin analyses. B. D. R. was supported by long-term FEBS and Marie Curie Fellowships (IEF-2009-252503), and D. Weijers received funding from the Netherlands Organization for Scientific Research (NWO; ALW-VIDI-864.06.012 and ALW-820.02.019 and the ERA-CAPS project EURO-PEC; 849.13.006) and the European Research Council (Starting Grant "CELLPATTERN," contract no. 281573). M. A. was funded by the SysmedIBD project funded under the European Union 7th framework project (contract no. 305564). O.N. acknowledges the Ministry of Education, Youth, and Sports of the Czech Republic (The program "Navrat" for Research, Development, and Innovations, grant LK21306; the National Program for Sustainability I, grant LO1204) and grant funding no. 14-34792S provided by the grant agency of the Czech Republic. K. L. acknowledges the Swedish Governmental Agency for Innovations Systems (VINNOVA) and the Swedish Research Council (V.R.). D. Wagner was supported by NSF grant (IOS 1257111). The transcriptomics data files are available at GEO (accession no. GSE56868).	Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Besnard F, 2014, NATURE, V505, P417, DOI 10.1038/nature12791; Bishopp A, 2011, CURR BIOL, V21, P927, DOI 10.1016/j.cub.2011.04.049; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Rybel B, 2014, PHYSIOL PLANTARUM, V151, P126, DOI 10.1111/ppl.12091; De Rybel B, 2013, DEV CELL, V24, P426, DOI 10.1016/j.devcel.2012.12.013; De Rybel B, 2011, PLANT PHYSIOL, V156, P1292, DOI 10.1104/pp.111.177337; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; De Smet I, 2004, J MICROSC-OXFORD, V213, P76, DOI 10.1111/j.1365-2818.2004.01269.x; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Help H, 2011, PLANT SIGNAL BEHAV, V6, P1837, DOI 10.4161/psb.6.11.17600; Hoyerova K, 2006, PHYTOCHEMISTRY, V67, P1151, DOI 10.1016/j.phytochem.2006.03.010; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kierzkowski D, 2012, SCIENCE, V335, P1096, DOI 10.1126/science.1213100; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Llavata-Peris Cristina, 2013, Methods Mol Biol, V959, P137, DOI 10.1007/978-1-62703-221-6_8; LLOYD CW, 1991, DEVELOPMENT S, V1, P55; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Matsumoto-Kitano M, 2008, P NATL ACAD SCI USA, V105, P20027, DOI 10.1073/pnas.0805619105; Merks RMH, 2011, PLANT PHYSIOL, V155, P656, DOI 10.1104/pp.110.167619; Miyashima S, 2013, EMBO J, V32, P178, DOI 10.1038/emboj.2012.301; Muraro D, 2014, P NATL ACAD SCI USA, V111, P857, DOI 10.1073/pnas.1221766111; Ohashi-Ito K, 2007, DEVELOPMENT, V134, P2959, DOI 10.1242/dev.006296; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rupp HM, 1999, PLANT J, V18, P557, DOI 10.1046/j.1365-313X.1999.00472.x; Saiga S, 2008, DEVELOPMENT, V135, P1751, DOI 10.1242/dev.014993; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Saulsberry A, 2002, DEVELOPMENT, V129, P3403; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Svacinova J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-17; Tokunaga H, 2012, PLANT J, V69, P355, DOI 10.1111/j.1365-313X.2011.04795.x; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Yamaguchi Nobutoshi, 2014, Arabidopsis Book, V12, pe0170, DOI 10.1199/tab.0170; Yoshida S, 2014, DEV CELL, V29, P75, DOI 10.1016/j.devcel.2014.02.002; Zurcher E, 2013, PLANT PHYSIOL, V161, P1066, DOI 10.1104/pp.112.211763	50	192	195	13	259	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197							1255215	10.1126/science.1255215	http://dx.doi.org/10.1126/science.1255215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104393				2022-12-24	WOS:000339962800001
J	Reboldi, A; Dang, EV; McDonald, JG; Liang, GS; Russell, DW; Cyster, JG				Reboldi, Andrea; Dang, Eric V.; McDonald, Jeffrey G.; Liang, Guosheng; Russell, David W.; Cyster, Jason G.			25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon	SCIENCE			English	Article							LIVER-X-RECEPTORS; LIPID-METABOLISM; CELL-MIGRATION; INFLAMMASOMES; MACROPHAGES; ACTIVATION; PATHWAYS; EBI2; MICE	Type I interferon (IFN) protects against viruses, yet it also has a poorly understood suppressive influence on inflammation. Here, we report that activated mouse macrophages lacking the IFN-stimulated gene cholesterol 25-hydroxylase (Ch25h) and that are unable to produce the oxysterol 25-hydroxycholesterol (25-HC) overproduce inflammatory interleukin-1 (IL-1) family cytokines. 25-HC acts by antagonizing sterol response element-binding protein (SREBP) processing to reduce Il1b transcription and to broadly repress IL-1-activating inflammasomes. In accord with these dual actions of 25-HC, Ch25h-deficient mice exhibit increased sensitivity to septic shock, exacerbated experimental autoimmune encephalomyelitis, and a stronger ability to repress bacterial growth. These findings identify an oxysterol, 25-HC, as a critical mediator in the negative-feedback pathway of IFN signaling on IL-1 family cytokine production and inflammasome activity.	[Reboldi, Andrea; Dang, Eric V.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [McDonald, Jeffrey G.; Liang, Guosheng; Russell, David W.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu		Dang, Eric/0000-0002-2389-6167; Russell, David/0000-0002-0277-403X	UCSF; Clayton Foundation for Research; American Asthma Foundation; NIH [AI40098, 2P01HL20948]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040098, R01AI040098] Funding Source: NIH RePORTER	UCSF; Clayton Foundation for Research; American Asthma Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Hellman for help with the sepsis model, J. Bluestone for help with the EAE model, B. Y. Han for help with GEO submission, and Y. Xu and J. An for expert technical assistance. The data presented in the paper are tabulated in the main paper and in the supplementary materials. D.W.R. holds U.S. Patent No. 6,562,609 "Oxidoreductase for use in human therapeutics and diagnostics." A.R. was an Irvington Institute Postdoctoral Fellow at the Cancer Research Institute, E.V.D is supported by the UCSF Medical Scientist Training Program (MSTP) and the Biomedical Sciences (BMS) Graduate program and D.W.R. by the Clayton Foundation for Research. J.G.C. is an Investigator at the Howard Hughes Medical Institute and recipient of an award from the American Asthma Foundation. This work was supported by NIH grants AI40098 and 2P01HL20948. RNAseq data have been deposited in GEO under accession number GSE58993.	Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Diczfalusy U, 2013, BIOCHIMIE, V95, P455, DOI 10.1016/j.biochi.2012.06.016; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Inoue M, 2013, IMMUNOLOGY, V139, P11, DOI 10.1111/imm.12081; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Ludigs K, 2012, CELL MOL LIFE SCI, V69, P3395, DOI 10.1007/s00018-012-0989-2; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; McDonald JG, 2010, J LEUKOCYTE BIOL, V88, P1071, DOI 10.1189/jlb.0710418; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Zou T, 2011, INFECT IMMUN, V79, P1526, DOI 10.1128/IAI.01195-10	33	279	286	5	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					679	684		10.1126/science.1254790	http://dx.doi.org/10.1126/science.1254790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104388	Green Accepted			2022-12-24	WOS:000339962800041
J	Ripke, S; Neale, BM; Corvin, A; Walters, JTR; Farh, KH; Holmans, PA; Lee, P; Bulik-Sullivan, B; Collier, DA; Huang, HL; Pers, TH; Agartz, I; Agerbo, E; Albus, M; Alexander, M; Amin, F; Bacanu, SA; Begemann, M; Belliveau, RA; Bene, J; Bergen, SE; Bevilacqua, E; Bigdeli, TB; Black, DW; Bruggeman, R; Buccola, NG; Buckner, RL; Byerley, W; Cahn, W; Cai, GQ; Campion, D; Cantor, RM; Carr, VJ; Carrera, N; Catts, SV; Chambert, KD; Chan, RCK; Chen, RYL; Chen, EYH; Cheng, W; Cheung, EFC; Chong, SA; Cloninger, CR; Cohen, D; Cohen, N; Cormican, P; Craddock, N; Crowley, JJ; Curtis, D; Davidson, M; Davis, KL; Degenhardt, F; Del Favero, J; Demontis, D; Dikeos, D; Dinan, T; Djurovic, S; Donohoe, G; Drapeau, E; Duan, J; Dudbridge, F; Durmishi, N; Eichhammer, P; Eriksson, J; Escott-Price, V; Essioux, L; Fanous, AH; Farrell, MS; Frank, J; Franke, L; Freedman, R; Freimer, NB; Friedl, M; Friedman, JI; Fromer, M; Genovese, G; Georgieva, L; Giegling, I; Giusti-Rodriguez, P; Godard, S; Goldstein, JI; Golimbet, V; Gopal, S; Gratten, J; de Haan, L; Hammer, C; Hamshere, ML; Hansen, M; Hansen, T; Haroutunian, V; Hartmann, AM; Henskens, FA; Herms, S; Hirschhorn, JN; Hoffmann, P; Hofman, A; Hollegaard, MV; Hougaard, DM; Ikeda, M; Joa, I; Julia, A; Kahn, RS; Kalaydjieva, L; Karachanak-Yankova, S; Karjalainen, J; Kavanagh, D; Keller, MC; Kennedy, JL; Khrunin, A; Kim, Y; Klovins, J; Knowles, JA; Konte, B; Kucinskas, V; Kucinskiene, ZA; Kuzelova-Ptackova, H; Kahler, AK; Laurent, C; Keong, JLC; Lee, SH; Legge, SE; Lerer, B; Li, MX; Li, T; Liang, KY; Lieberman, J; Limborska, S; Loughland, CM; Lubinski, J; Lonnqvist, J; Macek, M; Magnusson, PKE; Maher, BS; Maier, W; Mallet, J; Marsal, S; Mattheisen, M; Mattingsdal, M; McCarley, RW; McDonald, C; McIntosh, AM; Meier, S; Meijer, CJ; Melegh, B; Melle, I; Mesholam-Gately, RI; Metspalu, A; Michie, PT; Milani, L; Milanova, V; Mokrab, Y; Morris, DW; Mors, O; Murphy, KC; Murray, RM; Myin-Germeys, I; Muller-Myhsok, B; Nelis, M; Nenadic, I; Nertney, DA; Nestadt, G; Nicodemus, KK; Nikitina-Zake, L; Nisenbaum, L; Nordin, A; O'Callaghan, E; O'Dushlaine, C; O'Neill, FA; Oh, SY; Olincy, A; Olsen, L; Van Os, J; Pantelis, C; Papadimitriou, GN; Papiol, S; Parkhomenko, E; Pato, MT; Paunio, T; Pejovic-Milovancevic, M; Perkins, DO; Pietilainen, O; Pimm, J; Pocklington, AJ; Powell, J; Price, A; Pulver, AE; Purcell, SM; Quested, D; Rasmussen, HB; Reichenberg, A; Reimers, MA; Richards, AL; Roffman, JL; Roussos, P; Ruderfer, DM; Salomaa, V; Sanders, AR; Schall, U; Schubert, CR; Schulze, TG; Schwab, SG; Scolnick, EM; Scott, RJ; Seidman, LJ; Shi, JX; Sigurdsson, E; Silagadze, T; Silverman, JM; Sim, K; Slominsky, P; Smoller, JW; So, HC; Spencer, CCA; Stahl, EA; Stefansson, H; Steinberg, S; Stogmann, E; Straub, RE; Strengman, E; Strohmaier, J; Stroup, TS; Subramaniam, M; Suvisaari, J; Svrakic, DM; Szatkiewicz, JP; Soderman, E; Thirumalai, S; Toncheva, D; Tosato, S; Veijola, J; Waddington, J; Walsh, D; Wang, D; Wang, Q; Webb, BT; Weiser, M; Wildenauer, DB; Williams, NM; Williams, S; Witt, SH; Wolen, AR; Wong, EHM; Wormley, BK; Xi, HS; Zai, CC; Zheng, XB; Zimprich, F; Wray, NR; Stefansson, K; Visscher, PM; Adolfsson, R; Andreassen, OA; Blackwood, DHR; Bramon, E; Buxbaum, JD; Borglum, AD; Cichon, S; Darvasi, A; Domenici, E; Ehrenreich, H; Esko, T; Gejman, PV; Gill, M; Gurling, H; Hultman, CM; Iwata, N; Jablensky, AV; Jonsson, EG; Kendler, KS; Kirov, G; Knight, J; Lencz, T; Levinson, DF; Li, QQS; Liu, JJ; Malhotra, AK; McCarroll, SA; McQuillin, A; Moran, JL; Mortensen, PB; Mowry, BJ; Nothen, MM; Ophoff, RA; Owen, MJ; Palotie, A; Pato, CN; Petryshen, TL; Posthuma, D; Rietschel, M; Riley, BP; Rujescu, D; Sham, PC; Sklar, P; St Clair, D; Weinberger, DR; Wendland, JR; Werge, T; Daly, MJ; Sullivan, PF; O'Donovan, MC				Ripke, Stephan; Neale, Benjamin M.; Corvin, Aiden; Walters, James T. R.; Farh, Kai-How; Holmans, Peter A.; Lee, Phil; Bulik-Sullivan, Brendan; Collier, David A.; Huang, Hailiang; Pers, Tune H.; Agartz, Ingrid; Agerbo, Esben; Albus, Margot; Alexander, Madeline; Amin, Farooq; Bacanu, Silviu A.; Begemann, Martin; Belliveau, Richard A., Jr.; Bene, Judit; Bergen, Sarah E.; Bevilacqua, Elizabeth; Bigdeli, Tim B.; Black, Donald W.; Bruggeman, Richard; Buccola, Nancy G.; Buckner, Randy L.; Byerley, William; Cahn, Wiepke; Cai, Guiqing; Campion, Dominique; Cantor, Rita M.; Carr, Vaughan J.; Carrera, Noa; Catts, Stanley V.; Chambert, Kimberly D.; Chan, Raymond C. K.; Chen, Ronald Y. L.; Chen, Eric Y. H.; Cheng, Wei; Cheung, Eric F. C.; Chong, Siow Ann; Cloninger, C. Robert; Cohen, David; Cohen, Nadine; Cormican, Paul; Craddock, Nick; Crowley, James J.; Curtis, David; Davidson, Michael; Davis, Kenneth L.; Degenhardt, Franziska; Del Favero, Jurgen; Demontis, Ditte; Dikeos, Dimitris; Dinan, Timothy; Djurovic, Srdjan; Donohoe, Gary; Drapeau, Elodie; Duan, Jubao; Dudbridge, Frank; Durmishi, Naser; Eichhammer, Peter; Eriksson, Johan; Escott-Price, Valentina; Essioux, Laurent; Fanous, Ayman H.; Farrell, Martilias S.; Frank, Josef; Franke, Lude; Freedman, Robert; Freimer, Nelson B.; Friedl, Marion; Friedman, Joseph I.; Fromer, Menachem; Genovese, Giulio; Georgieva, Lyudmila; Giegling, Ina; Giusti-Rodriguez, Paola; Godard, Stephanie; Goldstein, Jacqueline I.; Golimbet, Vera; Gopal, Srihari; Gratten, Jacob; de Haan, Lieuwe; Hammer, Christian; Hamshere, Marian L.; Hansen, Mark; Hansen, Thomas; Haroutunian, Vahram; Hartmann, Annette M.; Henskens, Frans A.; Herms, Stefan; Hirschhorn, Joel N.; Hoffmann, Per; Hofman, Andrea; Hollegaard, Mads V.; Hougaard, David M.; Ikeda, Masashi; Joa, Inge; Julia, Antonio; Kahn, Rene S.; Kalaydjieva, Luba; Karachanak-Yankova, Sena; Karjalainen, Juha; Kavanagh, David; Keller, Matthew C.; Kennedy, James L.; Khrunin, Andrey; Kim, Yunjung; Klovins, Janis; Knowles, James A.; Konte, Bettina; Kucinskas, Vaidutis; Kucinskiene, Zita Ausrele; Kuzelova-Ptackova, Hana; Kahler, Anna K.; Laurent, Claudine; Keong, Jimmy Lee Chee; Lee, S. Hong; Legge, Sophie E.; Lerer, Bernard; Li, Miaoxin; Li, Tao; Liang, Kung-Yee; Lieberman, Jeffrey; Limborska, Svetlana; Loughland, Carmel M.; Lubinski, Jan; Lonnqvist, Jouko; Macek, Milan, Jr.; Magnusson, Patrik K. E.; Maher, Brion S.; Maier, Wolfgang; Mallet, Jacques; Marsal, Sara; Mattheisen, Manuel; Mattingsdal, Morten; McCarley, Robert W.; McDonald, Colm; McIntosh, Andrew M.; Meier, Sandra; Meijer, Carin J.; Melegh, Bela; Melle, Ingrid; Mesholam-Gately, Raquelle I.; Metspalu, Andres; Michie, Patricia T.; Milani, Lili; Milanova, Vihra; Mokrab, Younes; Morris, Derek W.; Mors, Ole; Murphy, Kieran C.; Murray, Robin M.; Myin-Germeys, Inez; Mueller-Myhsok, Bertram; Nelis, Mari; Nenadic, Igor; Nertney, Deborah A.; Nestadt, Gerald; Nicodemus, Kristin K.; Nikitina-Zake, Liene; Nisenbaum, Laura; Nordin, Annelie; O'Callaghan, Eadbhard; O'Dushlaine, Colm; O'Neill, F. Anthony; Oh, Sang-Yun; Olincy, Ann; Olsen, Line; Van Os, Jim; Pantelis, Christos; Papadimitriou, George N.; Papiol, Sergi; Parkhomenko, Elena; Pato, Michele T.; Paunio, Tiina; Pejovic-Milovancevic, Milica; Perkins, Diana O.; Pietilainen, Olli; Pimm, Jonathan; Pocklington, Andrew J.; Powell, John; Price, Alkes; Pulver, Ann E.; Purcell, Shaun M.; Quested, Digby; Rasmussen, Henrik B.; Reichenberg, Abraham; Reimers, Mark A.; Richards, Alexander L.; Roffman, Joshua L.; Roussos, Panos; Ruderfer, Douglas M.; Salomaa, Veikko; Sanders, Alan R.; Schall, Ulrich; Schubert, Christian R.; Schulze, Thomas G.; Schwab, Sibylle G.; Scolnick, Edward M.; Scott, Rodney J.; Seidman, Larry J.; Shi, Jianxin; Sigurdsson, Engilbert; Silagadze, Teimuraz; Silverman, Jeremy M.; Sim, Kang; Slominsky, Petr; Smoller, Jordan W.; So, Hon-Cheong; Spencer, Chris C. A.; Stahl, Eli A.; Stefansson, Hreinn; Steinberg, Stacy; Stogmann, Elisabeth; Straub, Richard E.; Strengman, Eric; Strohmaier, Jana; Stroup, T. Scott; Subramaniam, Mythily; Suvisaari, Jaana; Svrakic, Dragan M.; Szatkiewicz, Jin P.; Soderman, Erik; Thirumalai, Srinivas; Toncheva, Draga; Tosato, Sarah; Veijola, Juha; Waddington, John; Walsh, Dermot; Wang, Dai; Wang, Qiang; Webb, Bradley T.; Weiser, Mark; Wildenauer, Dieter B.; Williams, Nigel M.; Williams, Stephanie; Witt, Stephanie H.; Wolen, Aaron R.; Wong, Emily H. M.; Wormley, Brandon K.; Xi, Hualin Simon; Zai, Clement C.; Zheng, Xuebin; Zimprich, Fritz; Wray, Naomi R.; Stefansson, Kari; Visscher, Peter M.; Adolfsson, Rolf; Andreassen, Ole A.; Blackwood, Douglas H. R.; Bramon, Elvira; Buxbaum, Joseph D.; Borglum, Anders D.; Cichon, Sven; Darvasi, Ariel; Domenici, Enrico; Ehrenreich, Hannelore; Esko, Tonu; Gejman, Pablo V.; Gill, Michael; Gurling, Hugh; Hultman, Christina M.; Iwata, Nakao; Jablensky, Assen V.; Jonsson, Erik G.; Kendler, Kenneth S.; Kirov, George; Knight, Jo; Lencz, Todd; Levinson, Douglas F.; Li, Qingqin S.; Liu, Jianjun; Malhotra, Anil K.; McCarroll, Steven A.; McQuillin, Andrew; Moran, Jennifer L.; Mortensen, Preben B.; Mowry, Bryan J.; Noethen, Markus M.; Ophoff, Roel A.; Owen, Michael J.; Palotie, Aarno; Pato, Carlos N.; Petryshen, Tracey L.; Posthuma, Danielle; Rietschel, Marcella; Riley, Brien P.; Rujescu, Dan; Sham, Pak C.; Sklar, Pamela; St Clair, David; Weinberger, Daniel R.; Wendland, Jens R.; Werge, Thomas; Daly, Mark J.; Sullivan, Patrick F.; O'Donovan, Michael C.		Psychiat Genomics Consortium; Psychosis Endophenotypes Int Conso; Wellcome Trust Case-Control Consor	Biological insights from 108 schizophrenia-associated genetic loci	NATURE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; CONFERRING RISK; MUTATIONS	Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain, providing biological plausibility for the findings. Many findings have the potential to provide entirely new insights into aetiology, but associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia.	[Ripke, Stephan; Neale, Benjamin M.; Farh, Kai-How; Lee, Phil; Bulik-Sullivan, Brendan; Huang, Hailiang; Fromer, Menachem; Goldstein, Jacqueline I.; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan; Neale, Benjamin M.; Lee, Phil; Bulik-Sullivan, Brendan; Belliveau, Richard A., Jr.; Bergen, Sarah E.; Bevilacqua, Elizabeth; Chambert, Kimberly D.; Fromer, Menachem; Genovese, Giulio; O'Dushlaine, Colm; Scolnick, Edward M.; Smoller, Jordan W.; McCarroll, Steven A.; Moran, Jennifer L.; Palotie, Aarno; Petryshen, Tracey L.; Daly, Mark J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Neale, Benjamin M.; Huang, Hailiang; Pers, Tune H.; Goldstein, Jacqueline I.; Hirschhorn, Joel N.; Price, Alkes; Stahl, Eli A.; Esko, Tonu; Daly, Mark J.] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA; [Neale, Benjamin M.; Lee, Phil; Fromer, Menachem; Smoller, Jordan W.; Palotie, Aarno] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Corvin, Aiden; Cormican, Paul; Donohoe, Gary; Morris, Derek W.; Gill, Michael] Univ Ireland Trinity Coll, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin 8, Ireland; [Walters, James T. R.; Holmans, Peter A.; Carrera, Noa; Craddock, Nick; Escott-Price, Valentina; Georgieva, Lyudmila; Hamshere, Marian L.; Kavanagh, David; Legge, Sophie E.; Pocklington, Andrew J.; Richards, Alexander L.; Ruderfer, Douglas M.; Williams, Nigel M.; Kirov, George; Owen, Michael J.; O'Donovan, Michael C.] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Inst Psychol Med & Clin Neurosci, Cardiff CF24 4HQ, S Glam, Wales; [Holmans, Peter A.; Craddock, Nick; Owen, Michael J.; O'Donovan, Michael C.] Cardiff Univ, Natl Ctr Mental Hlth, Cardiff CF24 4HQ, S Glam, Wales; [Collier, David A.; Mokrab, Younes] Eli Lilly & Co Ltd, Erl Wood Manor, Windlesham GU20 6PH, Surrey, England; [Collier, David A.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Pers, Tune H.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Pers, Tune H.; Hirschhorn, Joel N.; Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Pers, Tune H.; Hirschhorn, Joel N.; Esko, Tonu] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Agartz, Ingrid; Soderman, Erik; Jonsson, Erik G.] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat, N-0319 Oslo, Norway; [Agartz, Ingrid; Djurovic, Srdjan; Mattingsdal, Morten; Melle, Ingrid; Andreassen, Ole A.; Jonsson, Erik G.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, N-0424 Oslo, Norway; [Agerbo, Esben; Mortensen, Preben B.] Aarhus Univ, CIRRAU, Ctr Integrat Register Based Res, DK-8210 Aarhus, Denmark; [Agerbo, Esben; Mortensen, Preben B.] Aarhus Univ, Natl Ctr Register Based Res, DK-8210 Aarhus, Denmark; [Agerbo, Esben; Demontis, Ditte; Hansen, Thomas; Mattheisen, Manuel; Mors, Ole; Olsen, Line; Rasmussen, Henrik B.; Borglum, Anders D.; Mortensen, Preben B.; Werge, Thomas] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Albus, Margot] State Mental Hosp, D-85540 Haar, Germany; [Alexander, Madeline; Laurent, Claudine; Levinson, Douglas F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Amin, Farooq] Atlanta Vet Affairs Med Ctr, Dept Psychiat & Behav Sci, Atlanta, GA 30033 USA; [Amin, Farooq] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Bacanu, Silviu A.; Bigdeli, Tim B.; Webb, Bradley T.; Wormley, Brandon K.] Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [Begemann, Martin; Hammer, Christian; Papiol, Sergi; Ehrenreich, Hannelore] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Bene, Judit; Melegh, Bela] Univ Pecs, Dept Med Genet, H-7624 Pecs, Hungary; [Bene, Judit; Melegh, Bela] Univ Pecs, Szentagothai Res Ctr, H-7624 Pecs, Hungary; [Bergen, Sarah E.; Kahler, Anna K.; Magnusson, Patrik K. E.; Hultman, Christina M.; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Black, Donald W.] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 RB Groningen, Netherlands; [Buccola, Nancy G.] Louisiana State Univ, Hlth Sci Ctr, Sch Nursing, New Orleans, LA 70112 USA; [Buckner, Randy L.; Roffman, Joshua L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr, Boston, MA 02129 USA; [Buckner, Randy L.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Buckner, Randy L.; Roffman, Joshua L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Byerley, William] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Cahn, Wiepke; Kahn, Rene S.; Strengman, Eric; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, NL-3584 Utrecht, Netherlands; [Cai, Guiqing; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Human Genet, New York, NY 10029 USA; [Cai, Guiqing; Davis, Kenneth L.; Drapeau, Elodie; Friedman, Joseph I.; Haroutunian, Vahram; Parkhomenko, Elena; Reichenberg, Abraham; Silverman, Jeremy M.; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Campion, Dominique] Ctr Hosp Rouvray, F-76301 Rouen, France; [Campion, Dominique] INSERM, U1079, Fac Med, F-76301 Rouen, France; [Cantor, Rita M.; Ophoff, Roel A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Carr, Vaughan J.; Catts, Stanley V.; Henskens, Frans A.; Loughland, Carmel M.; Michie, Patricia T.; Pantelis, Christos; Schall, Ulrich; Scott, Rodney J.; Jablensky, Assen V.] Schizophrenia Res Inst, Sydney, NSW 2010, Australia; [Carr, Vaughan J.] Univ New S Wales, Sch Psychiat, Sydney, NSW 2031, Australia; [Catts, Stanley V.] Univ Queensland, Royal Brisbane & Womens Hosp, St Lucia, Qld 4072, Australia; [Chan, Raymond C. K.] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Chen, Ronald Y. L.; Chen, Eric Y. H.; Li, Miaoxin; So, Hon-Cheong; Wong, Emily H. M.; Sham, Pak C.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Chen, Eric Y. H.; Li, Miaoxin; Sham, Pak C.] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Cheng, Wei] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27514 USA; [Cheung, Eric F. C.] Castle Peak Hosp, Hong Kong, Hong Kong, Peoples R China; [Chong, Siow Ann; Keong, Jimmy Lee Chee; Sim, Kang; Subramaniam, Mythily] Inst Mental Hlth, Singapore 539747, Singapore; [Cloninger, C. Robert; Svrakic, Dragan M.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Cohen, David] Assistance Publ Hop Paris, Dept Child & Adolescent Psychiat, Pierre & Marie Curie Fac Med, F-75013 Paris, France; [Cohen, David] Inst Intelligent Syst & Robot, F-75013 Paris, France; [Cohen, Nadine] Blue Note Biosci, Princeton, NJ 08540 USA; [Crowley, James J.; Farrell, Martilias S.; Giusti-Rodriguez, Paola; Kim, Yunjung; Szatkiewicz, Jin P.; Williams, Stephanie; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Curtis, David] Queen Mary Univ London, Dept Psychol Med, London E1 1BB, England; [Curtis, David; Pimm, Jonathan; Gurling, Hugh; McQuillin, Andrew] UCL, Mol Psychiat Lab, Div Psychiat, London WC1E 6JJ, England; [Davidson, Michael; Weiser, Mark] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Degenhardt, Franziska; Herms, Stefan; Hoffmann, Per; Hofman, Andrea; Cichon, Sven; Noethen, Markus M.] Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Degenhardt, Franziska; Herms, Stefan; Hoffmann, Per; Hofman, Andrea; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Del Favero, Jurgen] Univ Antwerp VIB, Dept Mol Genet, Appl Mol Genom Unit, B-2610 Antwerp, Belgium; [Demontis, Ditte; Mattheisen, Manuel; Mors, Ole; Borglum, Anders D.] Aarhus Univ, iSEQ, Ctr Integrat Sequencing, DK-8000 Aarhus C, Denmark; [Demontis, Ditte; Mattheisen, Manuel; Borglum, Anders D.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Dikeos, Dimitris; Papadimitriou, George N.] Univ Athens, Sch Med, Dept Psychiat 1, Athens 11528, Greece; [Dinan, Timothy] Univ Coll Cork, Dept Psychiat, Cork, Ireland; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, N-0424 Oslo, Norway; [Donohoe, Gary; Morris, Derek W.] Natl Univ Ireland Galway, Cognit Genet & Therapy Grp, Sch Psychol, Galway, Ireland; [Donohoe, Gary; Morris, Derek W.] Natl Univ Ireland Galway, Discipline Biochem, Galway, Ireland; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] NorthShore Univ HealthSyst, Dept Psychiat & Biobehav Sci, Evanston, IL 60201 USA; [Dudbridge, Frank] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Durmishi, Naser] Univ Clin Psychiat, Dept Child & Adolescent Psychiat, Skopje 1000, North Macedonia; [Eichhammer, Peter] Univ Regensburg, Dept Psychiat, D-93053 Regensburg, Germany; [Eriksson, Johan] Univ Helsinki, Cent Hosp, Dept Gen Practice, FI-00014 Helsinki, Finland; [Eriksson, Johan] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan] Biomedicum Helsinki 1, FI-00290 Helsinki, Finland; [Eriksson, Johan; Salomaa, Veikko] Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland; [Essioux, Laurent] F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Translat Technol & Bioinformat, CH-4070 Basel, Switzerland; [Fanous, Ayman H.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC 20057 USA; [Fanous, Ayman H.] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Fanous, Ayman H.] Virginia Commonwealth Univ, Sch Med, Dept Psychiat, Richmond, VA 23298 USA; [Fanous, Ayman H.] Washington VA Med Ctr, Washington, DC 20422 USA; [Frank, Josef; Meier, Sandra; Schulze, Thomas G.; Strohmaier, Jana; Witt, Stephanie H.; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Franke, Lude; Karjalainen, Juha] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Freedman, Robert; Olincy, Ann] Univ Colorado Denver, Dept Psychiat, Aurora, CO 80045 USA; [Freimer, Nelson B.; Ophoff, Roel A.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Friedl, Marion; Giegling, Ina; Hartmann, Annette M.; Konte, Bettina; Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, D-06112 Halle, Germany; [Fromer, Menachem; Purcell, Shaun M.; Roussos, Panos; Ruderfer, Douglas M.; Stahl, Eli A.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY USA; [Giegling, Ina; Rujescu, Dan] Univ Munich, Dept Psychiat, D-80336 Munich, Germany; [Godard, Stephanie] Hop La Pitie Salpetriere, Dept Psychiat, INSERM, Inst Myol, F-75013 Paris, France; [Godard, Stephanie] Hop La Pitie Salpetriere, Dept Human & Mol Genet, INSERM, Inst Myol, F-75013 Paris, France; [Golimbet, Vera] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 115522, Russia; [Gopal, Srihari; Wang, Dai; Li, Qingqin S.] Janssen Res & Dev, Neurosci Therapeut Area, Raritan, NJ 08869 USA; [Gratten, Jacob; Lee, S. Hong; Wray, Naomi R.; Visscher, Peter M.; Mowry, Bryan J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [de Haan, Lieuwe; Meijer, Carin J.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Hansen, Mark] Illumina, La Jolla, CA 92122 USA; [Hansen, Thomas; Olsen, Line; Rasmussen, Henrik B.; Werge, Thomas] Mental Hlth Serv Copenhagen, Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, DK-4000 Roskilde, Denmark; [Haroutunian, Vahram; Buxbaum, Joseph D.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Haroutunian, Vahram] JJ Peters VA Med Ctr, Bronx, NY 10468 USA; [Henskens, Frans A.] Univ Newcastle, Prior Res Ctr Hlth Behav, Newcastle, NSW 2308, Australia; [Henskens, Frans A.] Univ Newcastle, Sch Elect Engn & Comp Sci, Newcastle, NSW 2308, Australia; [Herms, Stefan; Hoffmann, Per; Cichon, Sven] Univ Basel, Dept Biomed, Div Med Genet, CH-4058 Basel, Switzerland; [Hirschhorn, Joel N.; Esko, Tonu; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Hollegaard, Mads V.; Hougaard, David M.] Statens Serum Inst, Dept Clin Biochem Immunol & Genet, Sect Neonatal Screening & Hormones, DK-2300 Copenhagen, Denmark; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan; [Joa, Inge] Stavanger Univ Hosp, Dept Psychiat, Reg Ctr Clin Res Psychosis, N-4011 Stavanger, Norway; [Julia, Antonio; Marsal, Sara] Vall dHebron Res Inst, Rheumatol Res Grp, Barcelona 08035, Spain; [Kalaydjieva, Luba] Univ Western Australia, Ctr Med Res, Perth, WA 6009, Australia; [Kalaydjieva, Luba; Jablensky, Assen V.] Univ Western Australia, Perkins Inst Med Res, Perth, WA 6009, Australia; [Karachanak-Yankova, Sena; Toncheva, Draga] Med Univ, Dept Med Genet, Sofia 1431, Bulgaria; [Keller, Matthew C.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Kennedy, James L.; Zai, Clement C.; Knight, Jo] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON M5T 1R8, Canada; [Kennedy, James L.; Zai, Clement C.; Knight, Jo] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Kennedy, James L.; Knight, Jo] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Khrunin, Andrey; Limborska, Svetlana; Slominsky, Petr] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Klovins, Janis; Nikitina-Zake, Liene] Latvian Biomed Res & Study Ctr, LV-1067 Riga, Latvia; [Knowles, James A.; Pato, Michele T.; Pato, Carlos N.] Univ So Calif, Dept Psychiat, Los Angeles, CA 90089 USA; [Knowles, James A.; Pato, Michele T.; Pato, Carlos N.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Kucinskas, Vaidutis; Kucinskiene, Zita Ausrele] Vilnius State Univ, Fac Med, LT-01513 Vilnius, Lithuania; [Kuzelova-Ptackova, Hana; Macek, Milan, Jr.] 2nd Fac Med, Dept Biol & Med Genet, Prague 15006, Czech Republic; [Kuzelova-Ptackova, Hana; Macek, Milan, Jr.] Univ Hosp Motol, Prague 15006, Czech Republic; [Laurent, Claudine] Pierre & Marie Curie Fac Med, Dept Child & Adolescent Psychiat, F-75013 Paris, France; [Keong, Jimmy Lee Chee] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Lerer, Bernard] Hadassah Hebrew Univ, Med Ctr, Dept Psychiat, IL-91120 Jerusalem, Israel; [Li, Miaoxin; Sham, Pak C.] Univ Hong Kong, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Tao; Wang, Qiang] Sichuan Univ, Mental Hlth Ctr, Chengdu 610041, Sichuan, Peoples R China; [Li, Tao; Wang, Qiang] Sichuan Univ, West China Hosp, Psychiat Lab, Chengdu 610041, Sichuan, Peoples R China; [Liang, Kung-Yee] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Lieberman, Jeffrey; Stroup, T. Scott] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Loughland, Carmel M.; Schall, Ulrich] Univ Newcastle, Prior Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, PL-70453 Szczecin, Poland; [Lonnqvist, Jouko; Suvisaari, Jaana] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, FI-00271 Helsinki, Finland; [Maher, Brion S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-53127 Bonn, Germany; [Mallet, Jacques] Hop La Pitie Salpetriere, CNRS, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, F-75013 Paris, France; [Mattheisen, Manuel] Univ Bonn, Dept Genom Math, D-53127 Bonn, Germany; [Mattingsdal, Morten] Sorlandet Hosp, Res Unit, N-4604 Kristiansand, Norway; [McCarley, Robert W.; Mesholam-Gately, Raquelle I.; Seidman, Larry J.; Petryshen, Tracey L.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [McCarley, Robert W.] VA Boston Hlth Care Syst, Brockton, MA 02301 USA; [McDonald, Colm] Natl Univ Ireland Galway, Dept Psychiat, Galway, Ireland; [McIntosh, Andrew M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH16 4SB, Midlothian, Scotland; [McIntosh, Andrew M.; Blackwood, Douglas H. R.] Univ Edinburgh, Div Psychiat, Edinburgh EH16 4SB, Midlothian, Scotland; [Melle, Ingrid; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, N-0424 Oslo, Norway; [Mesholam-Gately, Raquelle I.; Seidman, Larry J.] Beth Israel Deaconess Med Ctr, Publ Psychiat Div, Massachusetts Mental Hlth Ctr, Boston, MA 02114 USA; [Metspalu, Andres; Milani, Lili; Nelis, Mari; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Michie, Patricia T.] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia; [Milanova, Vihra] Med Univ, Psychiat Clin 1, Sofia 1431, Bulgaria; [Mors, Ole; Borglum, Anders D.] Aarhus Univ Hosp, Dept P, DK-8240 Risskov, Denmark; [Murphy, Kieran C.] Royal Coll Surgeons Ireland, Dept Psychiat, Dublin 2, Ireland; [Murray, Robin M.; Powell, John] Kings Coll London, London SE5 8AF, England; [Myin-Germeys, Inez; Van Os, Jim] Maastricht Univ, Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, NL-6229 HX Maastricht, Netherlands; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80336 Munich, Germany; [Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Nenadic, Igor] Jena Univ Hosp, Dept Psychiat & Psychotherapy, D-07743 Jena, Germany; [Nertney, Deborah A.] Univ Queensland, Queensland Brain Inst, Dept Psychiat, St Lucia, Qld 4072, Australia; [Nertney, Deborah A.] Univ Queensland, Queensland Ctr Mental Hlth Res, St Lucia, Qld 4072, Australia; [Nestadt, Gerald; Pulver, Ann E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Nicodemus, Kristin K.] Univ Dublin Trinity Coll, Dept Psychiat, Dublin 2, Ireland; [Nisenbaum, Laura] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Nordin, Annelie; Adolfsson, Rolf] Umea Univ, Dept Clin Sci, SE-90187 Umea, Sweden; [O'Callaghan, Eadbhard] DETECT Early Intervent Serv Psychosis, Blackrock, Dublin, Ireland; [O'Neill, F. Anthony] Queens Univ Belfast, Inst Clin Sci, Ctr Publ Hlth, Belfast BT12 6AB, Antrim, North Ireland; [Oh, Sang-Yun] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Van Os, Jim] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Pantelis, Christos] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic 3053, Australia; [Pantelis, Christos] Melbourne Hlth, Melbourne, Vic 3053, Australia; [Paunio, Tiina] Univ Helsinki, Dept Psychiat, FI-00029 Helsinki, Finland; [Paunio, Tiina; Pietilainen, Olli] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, FI-00271 Helsinki, Finland; [Pejovic-Milovancevic, Milica] Univ Belgrade, Fac Med, Belgrade 11000, Serbia; [Perkins, Diana O.; Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Pietilainen, Olli; Palotie, Aarno] Univ Helsinki, FIMM, FI-00014 Helsinki, Finland; [Price, Alkes] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Quested, Digby] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Reimers, Mark A.; Wolen, Aaron R.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA; [Roussos, Panos; Sklar, Pamela] Icahn Sch Med Mt Sinai, Inst Multiscale Biol, New York, NY 10029 USA; [Schubert, Christian R.; Wendland, Jens R.] Pfizer Worldwide Res & Dev, Pharma Therapeut Clin Res, Cambridge, MA 02139 USA; [Schulze, Thomas G.] Univ Gottingen, Dept Psychiat & Psychotherapy, D-37073 Gottingen, Germany; [Schwab, Sibylle G.] Univ Erlangen Nurnberg, Psychiat & Psychotherapy Clin, D-91054 Erlangen, Germany; [Scott, Rodney J.] Hunter New England Hlth Serv, Newcastle, NSW 2308, Australia; [Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2308, Australia; [Shi, Jianxin] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Sigurdsson, Engilbert] Univ Iceland, Natl Univ Hosp, Landspitali, IS-101 Reykjavik, Iceland; [Silagadze, Teimuraz] Tbilisi State Med Univ TSMU, Dept Psychiat & Drug Addict, GE-0177 Tbilisi, Georgia; [Silverman, Jeremy M.] Bronx Vet Affairs Med Ctr, New York, NY 10468 USA; [Spencer, Chris C. A.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Stefansson, Hreinn; Steinberg, Stacy; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Stogmann, Elisabeth; Zimprich, Fritz] Med Univ Vienna, Dept Clin Neurol, A-1090 Vienna, Austria; [Straub, Richard E.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Strengman, Eric] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CG Utrecht, Netherlands; [Thirumalai, Srinivas] Berkshire Healthcare NHS Fdn Trust, Bracknell RG12 1BQ, Berks, England; [Tosato, Sarah] Univ Verona, Sect Psychiat, I-37134 Verona, Italy; [Veijola, Juha] Univ Oulu, Dept Psychiat, Oulu 90014, Finland; [Veijola, Juha] Univ Hosp Oulu, Oys 90029, Finland; [Waddington, John] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Walsh, Dermot] Hlth Res Board, Dublin 2, Ireland; [Wildenauer, Dieter B.; Jablensky, Assen V.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Xi, Hualin Simon] Pfizer Worldwide Res & Dev, Computat Sci CoE, Cambridge, MA 02139 USA; [Zheng, Xuebin; Liu, Jianjun] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Bramon, Elvira] UCL, London WC1E 6BT, England; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, D-52428 Julich, Germany; [Darvasi, Ariel] Hebrew Univ Jerusalem, Dept Genet, IL-91905 Jerusalem, Israel; [Domenici, Enrico] F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Neurosci Discovery & Translat Area, CH-4070 Basel, Switzerland; [Jablensky, Assen V.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Ctr Clin Res Neuropsychiat, Perth, WA 6000, Australia; [Kendler, Kenneth S.; Riley, Brien P.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23298 USA; [Kendler, Kenneth S.; Riley, Brien P.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Lencz, Todd; Malhotra, Anil K.] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Lencz, Todd; Malhotra, Anil K.] Hofstra NS LIJ Sch Med, Hempstead, NY 11549 USA; [Lencz, Todd; Malhotra, Anil K.] Zucker Hillside Hosp, Glen Oaks, NY 11004 USA; [Liu, Jianjun] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Mowry, Bryan J.] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld 4076, Australia; [Petryshen, Tracey L.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Petryshen, Tracey L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Posthuma, Danielle] Erasmus Univ, Med Ctr, Dept Child & Adolescent Psychiat, NL-3000 Rotterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Complex Trait Genet, NL-1081 Amsterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, NL-1081 Amsterdam, Netherlands; [St Clair, David] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Werge, Thomas] Univ Copenhagen, Dept Clin Med, DK-2200 Copenhagen, Denmark	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Trinity College Dublin; Cardiff University; Cardiff University; Eli Lilly; University of London; King's College London; Technical University of Denmark; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Karolinska Institutet; Diakonhjemmet Hospital; University of Oslo; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Virginia Commonwealth University; Max Planck Society; University of Pecs; University of Pecs; Karolinska Institutet; University of Iowa; University of Groningen; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Utrecht University; Utrecht University Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of New South Wales Sydney; Royal Brisbane & Women's Hospital; University of Queensland; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Hong Kong; University of Hong Kong; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of North Carolina; University of North Carolina Chapel Hill; University of London; Queen Mary University London; University of London; University College London; Chaim Sheba Medical Center; University of Bonn; University of Bonn; Flanders Institute for Biotechnology (VIB); University of Antwerp; Aarhus University; Aarhus University; Athens Medical School; National & Kapodistrian University of Athens; University College Cork; University of Oslo; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Chicago; NorthShore University Health System; University of London; London School of Hygiene & Tropical Medicine; University of Regensburg; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Finland National Institute for Health & Welfare; Roche Holding; Georgetown University; University of Southern California; Virginia Commonwealth University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Groningen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; Martin Luther University Halle Wittenberg; Icahn School of Medicine at Mount Sinai; University of Munich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Russian Academy of Medical Sciences; Johnson & Johnson; Janssen Pharmaceuticals; University of Queensland; University of Amsterdam; Academic Medical Center Amsterdam; Illumina; Icahn School of Medicine at Mount Sinai; University of Newcastle; University of Newcastle; University of Basel; Harvard University; Harvard Medical School; Statens Serum Institut; Fujita Health University; Stavanger University Hospital; University of Western Australia; University of Western Australia; Medical University Sofia; University of Colorado System; University of Colorado Boulder; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; Russian Academy of Sciences; Latvian Biomedical Research & Study Centre; University of Southern California; University of Southern California; Vilnius University; Charles University Prague; Motol University Hospital; UDICE-French Research Universities; Sorbonne Universite; National University of Singapore; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Hong Kong; Sichuan University; Sichuan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; University of Newcastle; Pomeranian Medical University; Finland National Institute for Health & Welfare; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Bonn; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Bonn; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Ollscoil na Gaillimhe-University of Galway; University of Edinburgh; University of Edinburgh; University of Oslo; Harvard University; Beth Israel Deaconess Medical Center; University of Tartu; University of Newcastle; Medical University Sofia; Aarhus University; Royal College of Surgeons - Ireland; University of London; King's College London; Maastricht University; University of Liverpool; Max Planck Society; University of Munich; Friedrich Schiller University of Jena; University of Queensland; Queensland Centre for Mental Health Research; University of Queensland; Johns Hopkins University; Trinity College Dublin; Eli Lilly; Umea University; Queens University Belfast; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of London; King's College London; University of Melbourne; University of Helsinki; Finland National Institute for Health & Welfare; University of Belgrade; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai; Pfizer; University of Gottingen; University of Erlangen Nuremberg; University of Newcastle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iceland; Tbilisi State Medical University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Oxford; Wellcome Centre for Human Genetics; Medical University of Vienna; Utrecht University; Utrecht University Medical Center; University of Verona; University of Oulu; Royal College of Surgeons - Ireland; Health Research Board - Ireland; University of Western Australia; Pfizer; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of London; University College London; Icahn School of Medicine at Mount Sinai; Helmholtz Association; Research Center Julich; Hebrew University of Jerusalem; Roche Holding; University of Western Australia; Virginia Commonwealth University; Virginia Commonwealth University; Northwell Health; Hofstra University; Northwell Health; National University of Singapore; Queensland Centre for Mental Health Research; University of Queensland; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Aberdeen; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Copenhagen	O'Donovan, MC (corresponding author), Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Inst Psychol Med & Clin Neurosci, Cardiff CF24 4HQ, S Glam, Wales.	odonovanmc@cardiff.ac.uk	Agerbo, Esben/A-2645-2012; Pantelis, Christos/H-7722-2014; Mattheisen, Manuel/B-4949-2012; blackwood, douglas/AIB-8874-2022; Hammer, Christian/C-5827-2014; Slominsky, Petr A/B-4640-2016; Zimprich, Fritz/O-1406-2019; Hougaard, David/AAD-6368-2019; Golimbet, V/E-2328-2016; Giegling, Ina/ABA-3677-2021; Limborska, Svetlana/A-5633-2016; Wang, Qiang/AAV-7131-2021; Catts, Stanley V/G-6917-2013; Bergen, Sarah/I-8313-2012; Bramon, Elvira/HHC-3809-2022; Perkins, Diana O/F-5213-2013; O'Neill, Francis A/C-5582-2008; St Clair, David/AAN-2412-2021; Donohoe, Gary/J-6481-2013; Zimprich, Fritz/W-1738-2017; Hoffmann, Per/A-5149-2010; Webb, Bradley T/B-1459-2009; Bramon, Elvira/A-9463-2011; Silverman, Jeremy M./AAO-4268-2020; Kendler, Kenneth/AAF-2876-2019; Zai, Clement C/AAA-5431-2022; Daly, Mark J/B-2453-2017; SCHALL, ULRICH ANDREAS/G-7452-2013; Herms, Stefan/J-1949-2014; Jablensky, Assen/H-5116-2014; Mattheisen, Manuel/S-3725-2019; Konte, Bettina/AAT-1142-2021; Klovins, Janis/C-5695-2011; Liu, Jianjun/AAK-4989-2020; Lieberman, Jeffrey/AAY-8239-2020; Domenici, Enrico/K-8194-2016; Slominsky, Petr/AAO-1852-2020; van Os, Jim/C-2113-2014; Franke, Lude/P-7036-2016; Dinan, Timothy/ABA-8284-2020; McDonald, Colm/C-1430-2009; Hansen, Thomas Folkmann/O-5965-2014; Petryshen, Tracey/X-5850-2019; Myin-Germeys, Inez/L-5106-2014; Meier, Sandra/AAB-1242-2021; Morris, Derek/AAW-8343-2021; van Os, Jim/V-8884-2019; Stroup, Thomas/AAB-7780-2019; Lee, Sang Hong/A-2569-2011; Fanous, Ayman H/O-1263-2017; Kennedy, James Lowery/AAZ-6947-2020; McQuillin, Andrew/C-1623-2008; Shenton, Martha/V-8780-2019; O'Donovan, Michael C/P-7005-2018; So, Hon-Cheong/I-1100-2016; Bigdeli, Tim B./AAX-7761-2020; Nelis, Mari/ABG-7775-2020; Holmans, Peter/F-4518-2015; Gratten, Jacob/G-1485-2011; Powell, John F/G-4412-2011; Mattingsdal, Morten/Q-9367-2016; Melle, Ingrid S/B-4858-2011; Knight, Jo/F-4946-2011; Lee, Jimmy/ABB-2919-2020; Ruderfer, Douglas M/M-5795-2016; Curtis, David/HGB-3921-2022; Milani, Lili/N-1097-2019; McIntosh, Andrew M/B-9379-2008; Walters, James/HCH-8835-2022; Reichenberg, Abraham/GQB-1227-2022; Roffman, Joshua/G-8228-2012; Buxbaum, Joseph D/G-6001-2010; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Limborska, Svetlana/S-2961-2019; Hartmann, Annette/AAS-6331-2021; Karachanak-Yankova, Sena/AAL-2721-2021; Stefansson, Kari/AAE-7187-2019; McCarley, Robert W/N-5562-2014; Rujescu, Dan/GRS-3875-2022; Wray, Naomi/C-8639-2015; Ripke, Stephan/AAK-5486-2021; Magnusson, Patrik KE/C-4458-2017; Karjalainen, Juha/P-8624-2016; Visscher, Peter/ABB-6151-2020; Zai, Clement C/G-7379-2015; Sigurdsson, Engilbert/D-2486-2014; Mortensen, Preben B/D-2358-2015; Collier, David A/D-1649-2011; Cloninger, Claude/F-5357-2012; Degenhardt, Franziska/H-4169-2017; Chan, Raymond CK/B-6717-2009; Tosato, Sarah/E-6045-2010; Mortensen, Preben/F-6758-2015; Andreassen, Ole A./AAY-7531-2020; Lencz, Todd/J-3418-2014; KUČINSKAS, Vaidutis/A-4798-2013; murray, robin/F-8658-2012; Scott, Rodney/B-2827-2013; Cichon, Sven/B-9618-2014; Mowry, Bryan/G-5046-2010; Ptackova, Hana/M-9763-2017	Agerbo, Esben/0000-0002-2849-524X; Pantelis, Christos/0000-0002-9565-0238; Mattheisen, Manuel/0000-0002-8442-493X; Hammer, Christian/0000-0003-4548-7548; Slominsky, Petr A/0000-0003-3530-0655; Zimprich, Fritz/0000-0002-6998-5480; Golimbet, V/0000-0002-9960-7114; Bergen, Sarah/0000-0002-5888-0034; Bramon, Elvira/0000-0003-1369-5983; O'Neill, Francis A/0000-0002-7531-7657; Donohoe, Gary/0000-0003-3037-7426; Zimprich, Fritz/0000-0002-6998-5480; Hoffmann, Per/0000-0002-6573-983X; Webb, Bradley T/0000-0002-0576-5366; Zai, Clement C/0000-0003-0496-7262; Daly, Mark J/0000-0002-0949-8752; SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; Herms, Stefan/0000-0002-2786-8200; Jablensky, Assen/0000-0003-0602-6810; Mattheisen, Manuel/0000-0002-8442-493X; Konte, Bettina/0000-0001-5287-308X; Liu, Jianjun/0000-0002-3255-3019; Domenici, Enrico/0000-0001-7436-6919; Slominsky, Petr/0000-0003-3530-0655; Franke, Lude/0000-0002-5159-8802; McDonald, Colm/0000-0003-1661-5192; Hansen, Thomas Folkmann/0000-0001-6703-7762; Petryshen, Tracey/0000-0002-7972-4612; Morris, Derek/0000-0002-3413-570X; van Os, Jim/0000-0002-7245-1586; Stroup, Thomas/0000-0002-3123-0672; Lee, Sang Hong/0000-0001-9701-2718; Kennedy, James Lowery/0000-0002-8733-3806; McQuillin, Andrew/0000-0003-1567-2240; O'Donovan, Michael C/0000-0001-7073-2379; Bigdeli, Tim B./0000-0003-2215-5946; Nelis, Mari/0000-0001-9748-1020; Holmans, Peter/0000-0003-0870-9412; Gratten, Jacob/0000-0003-1293-409X; Powell, John F/0000-0001-6124-439X; Mattingsdal, Morten/0000-0003-4440-0324; Melle, Ingrid S/0000-0002-9783-548X; Lee, Jimmy/0000-0002-7724-7445; Ruderfer, Douglas M/0000-0002-2365-386X; Curtis, David/0000-0002-4089-9183; Milani, Lili/0000-0002-5323-3102; McIntosh, Andrew M/0000-0002-0198-4588; Roffman, Joshua/0000-0003-4073-532X; Limborska, Svetlana/0000-0002-1697-6820; Karachanak-Yankova, Sena/0000-0001-6441-629X; McCarley, Robert W/0000-0001-5705-7495; Wray, Naomi/0000-0001-7421-3357; Magnusson, Patrik KE/0000-0002-7315-7899; Visscher, Peter/0000-0002-2143-8760; Sigurdsson, Engilbert/0000-0001-9404-7982; Mortensen, Preben B/0000-0002-5230-9865; Collier, David A/0000-0003-4087-1559; Cloninger, Claude/0000-0003-3096-4807; Chan, Raymond CK/0000-0002-3414-450X; Tosato, Sarah/0000-0002-9665-7538; Mortensen, Preben/0000-0002-4782-1450; Lencz, Todd/0000-0001-8586-338X; Eriksson, Johan/0000-0002-2516-2060; Powell, Joseph/0000-0002-5070-4124; IWATA, Nakao/0000-0003-3189-6076; Henskens, Frans/0000-0003-2358-5630; Buccola, Nancy/0000-0003-1378-4636; So, Hon-Cheong/0000-0002-7102-833X; Esko, Tonu/0000-0003-1982-6569; Dinan, Timothy/0000-0002-2316-7220; Andreassen, Ole A./0000-0002-4461-3568; Gopal, Srihari/0000-0001-5254-2192; Pocklington, Andrew/0000-0002-2137-0452; Goldstein, Jacqueline/0000-0003-1902-6916; Black, Donald/0000-0001-8038-1971; Julia Cano, Antonio/0000-0001-6064-3620; Demontis, Ditte/0000-0001-9124-2766; Toncheva, Draga/0000-0002-7451-6363; Klovins, Janis/0000-0001-8362-5505; Nothen, Markus/0000-0002-8770-2464; Chen, Eric/0000-0002-5247-3593; Pejovic Milovancevic, Milica/0000-0001-8902-2668; Legge, Sophie/0000-0001-6617-0289; Palotie, Aarno/0000-0002-2527-5874; Sim, Kang/0000-0003-3209-9626; Myin-Germeys, Inez/0000-0002-3731-4930; Corvin, Aiden/0000-0001-6717-4089; Bruggeman, Richard/0000-0002-3238-8471; Moran, Jennifer/0000-0002-5664-4716; Stefansson, Hreinn/0000-0002-9331-6666; Golimbet, Vera/0000-0002-0114-4300; Buxbaum, Joseph/0000-0001-8898-8313; Borglum, Anders/0000-0001-8627-7219; Stogmann, Elisabeth/0000-0003-4688-8482; Crowley, James/0000-0001-9051-1557; Jonsson, Erik/0000-0001-8368-6332; Milovancevic, Milos/0000-0002-7891-1010; Giusti-Rodriguez, Paola/0000-0002-1921-1305; /0000-0002-8114-7615; Oh, Sang-Yun/0000-0002-0364-5109; Freedman, Robert/0000-0002-2181-2898; Kirov, George/0000-0002-3427-3950; Posthuma, Danielle/0000-0001-7582-2365; Djurovic, Srdjan/0000-0002-8140-8061; Escott-Price, Valentina/0000-0003-1784-5483; Lubinski, Jan/0000-0003-2931-3003; Gill, Michael/0000-0003-0206-5337; Papiol, Sergi/0000-0001-9366-8728; murray, robin/0000-0003-0829-0519; Murphy, Kieran/0000-0003-2930-4465; Bacanu, Silviu-Alin/0000-0002-4364-1583; Huang, Hailiang/0000-0003-1461-5762; Walters, James/0000-0002-6980-4053; Pers, Tune/0000-0003-0207-4831; Hollegaard, Mads Vilhelm/0000-0003-1061-0091; marsal, sara/0000-0001-5515-3854; Scott, Rodney/0000-0001-7724-3404; Cichon, Sven/0000-0002-9475-086X; Suvisaari, Jaana/0000-0001-7167-0990; Adolfsson, Rolf/0000-0001-9785-8473; Ehrenreich, Hannelore/0000-0001-8371-5711; Mowry, Bryan/0000-0002-4115-5645; ripke, stephan/0000-0003-3622-835X; Agartz, Ingrid/0000-0002-9839-5391; Knight, Joanne/0000-0002-7148-1660; Quested, Digby/0000-0001-6155-3336; McCarroll, Steven/0000-0002-6954-8184; Mors, Ole/0000-0002-5660-0393; Perkins, Diana/0000-0001-9396-2206; Joa, Inge/0000-0002-5516-2336; Ptackova, Hana/0000-0002-5694-3695	US National Institute of Mental Health [U01 MH094421]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH096296, R01MH077139, U01MH094432, K99MH101367, U01MH094421, R01MH100141, T32MH020030, R01MH040799] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001356, I01BX002395] Funding Source: NIH RePORTER; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [1247950, MR/L010305/1, G0801418, G0601635, G1000718, G1100583, G0800509, G0901310] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/016] Funding Source: researchfish; Chief Scientist Office [SCD/12] Funding Source: researchfish; MRC [G0601635, G0901310, G1000718, G0801418, G1100583, G0800509] Funding Source: UKRI	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Core funding for the Psychiatric Genomics Consortium is from the US National Institute of Mental Health (U01 MH094421). We thank T. Lehner (NIMH). The work of the contributing groups was supported by numerous grants from governmental and charitable bodies as well as philanthropic donation. Details are provided in the Supplementary Notes. Membership of the Wellcome Trust Case Control Consortium and of the Psychosis Endophenotype International Consortium are provided in the Supplementary Notes.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], PREPRINT; [Anonymous], 2012, NATURE GENET; Begum F, 2012, NUCLEIC ACIDS RES, V40, P3777, DOI 10.1093/nar/gkr1255; Benros ME, 2012, ANN NY ACAD SCI, V1262, P56, DOI 10.1111/j.1749-6632.2012.06638.x; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Cichon S, 2009, MOL PSYCHIATR, V14, P10, DOI 10.1038/mp.2008.126; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Knapp M, 2004, SCHIZOPHRENIA BULL, V30, P279, DOI 10.1093/oxfordjournals.schbul.a007078; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lee SH, 2012, GENET EPIDEMIOL, V36, P214, DOI 10.1002/gepi.21614; Lencz T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3739; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lips ES, 2012, MOL PSYCHIATR, V17, P996, DOI 10.1038/mp.2011.117; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Rietschel M, 2012, MOL PSYCHIATR, V17, P906, DOI 10.1038/mp.2011.80; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, HUM MOL GENET, V20, P4076, DOI 10.1093/hmg/ddr325; Strange A, 2012, BIOL PSYCHIAT, V72, P620, DOI 10.1016/j.biopsych.2012.05.035; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; VANROSSUM JM, 1966, ARCH INT PHARMACOD T, V160, P492; World Health Organization, 2008, The global burden of disease: 2004 update; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979	50	4864	4923	42	902	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					421	+		10.1038/nature13595	http://dx.doi.org/10.1038/nature13595			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	25056061	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-24	WOS:000339335700037
J	Anders, C; Niewoehner, O; Duerst, A; Jinek, M				Anders, Carolin; Niewoehner, Ole; Duerst, Alessia; Jinek, Martin			Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease	NATURE			English	Article							RNA; CRISPR; SPECIFICITY; SYSTEM; REFINEMENT; DROSOPHILA	The CRISPR-associated protein Cas9 is anRNA-guided endonuclease that cleaves double-stranded DNA bearing sequences complementary to a 20-nucleotide segment in the guideRNA(1,2). Cas9 hase merged as a versatile molecular tool for genome editing and gene expression control(3). RNA-guided DNA recognition and cleavage strictly require the presence of a protospacer adjacent motif (PAM) in the target DNA(1,4-6). Here we report a crystal structure of Streptococcus pyogenes Cas9 in complex with a single-molecule guide RNA and a target DNA containing a canonical 5'-NGG-3' PAM. The structure reveals that the PAM motif resides in a base-paired DNA duplex. The non-complementary strand GG dinucleotide is read out via major-groove interactions with conserved arginine residues from the carboxyterminal domain of Cas9. Interactions with the minor groove of the PAM duplex and the phosphodiester group at the +1 position in the target DNA strand contribute to local strand separation immediately upstream of the PAM. These observations suggest a mechanism for PAM-dependent target DNA melting and RNA-DNA hybrid formation. Furthermore, this study establishes a framework for the rational engineering of Cas9 enzymes with novel PAM specificities.	[Anders, Carolin; Niewoehner, Ole; Duerst, Alessia; Jinek, Martin] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Jinek, M (corresponding author), Univ Zurich, Inst Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jinek@bioc.uzh.ch	Jinek, Martin/E-6621-2011	Jinek, Martin/0000-0002-7601-210X	European Research Council [337284 ANTIVIRNA]; University of Zurich	European Research Council(European Research Council (ERC)European Commission); University of Zurich	We are grateful to J. Doudna for agreement on research directions, helpful discussions and encouragement throughout the project. We thank B. Blattmann and C. Stutz-Ducommun for crystallization screening, N. Ban and M. Leibundgut for the gift of iridium hexamine, and R. Dutzler for sharing synchrotron beam time and crystallographic advice. We thank E. Charpentier, I. Fonfara, S. Sternberg, P. Sledz, A. May and S. Kassube for critical reading of the manuscript. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland. We thank T. Tomizaki, V. Olieric and M. Wang for assistance with X-ray data collection. This work was supported by the European Research Council Starting Grant no. 337284 ANTIVIRNA and by start-up funds from the University of Zurich.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Briner AE, 2014, APPL ENVIRON MICROB, V80, P994, DOI 10.1128/AEM.03015-13; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	36	735	831	10	359	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					569	+		10.1038/nature13579	http://dx.doi.org/10.1038/nature13579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25079318	Green Accepted			2022-12-24	WOS:000342075800045
J	Kraft, B; Tegetmeyer, HE; Sharma, R; Klotz, MG; Ferdelman, TG; Hettich, RL; Geelhoed, JS; Strous, M				Kraft, Beate; Tegetmeyer, Halina E.; Sharma, Ritin; Klotz, Martin G.; Ferdelman, Timothy G.; Hettich, Robert L.; Geelhoed, Jeanine S.; Strous, Marc			The environmental controls that govern the end product of bacterial nitrate respiration	SCIENCE			English	Article							REDUCTION; DENITRIFICATION; SEDIMENTS; ANAMMOX	In the biogeochemical nitrogen cycle, microbial respiration processes compete for nitrate as an electron acceptor. Denitrification converts nitrate into nitrogenous gas and thus removes fixed nitrogen from the biosphere, whereas ammonification converts nitrate into ammonium, which is directly reusable by primary producers. We combined multiple parallel long-term incubations of marine microbial nitrate-respiring communities with isotope labeling and metagenomics to unravel how specific environmental conditions select for either process. Microbial generation time, supply of nitrite relative to nitrate, and the carbon/nitrogen ratio were identified as key environmental controls that determine whether nitrite will be reduced to nitrogenous gas or ammonium. Our results define the microbial ecophysiology of a biogeochemical feedback loop that is key to global change, eutrophication, and wastewater treatment.	[Kraft, Beate; Tegetmeyer, Halina E.; Ferdelman, Timothy G.; Geelhoed, Jeanine S.; Strous, Marc] Max Planck Inst Marine Mikrobiol, D-28359 Bremen, Germany; [Tegetmeyer, Halina E.; Strous, Marc] Univ Bielefeld, Ctr Biotechnol, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany; [Sharma, Ritin; Hettich, Robert L.] Univ Tennessee, UT ORNL Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA; [Sharma, Ritin; Hettich, Robert L.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37830 USA; [Klotz, Martin G.] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA; [Klotz, Martin G.] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Peoples R China; [Geelhoed, Jeanine S.] NIOZ Royal Netherlands Inst Sea Res, NL-4401 NT Yerseke, Netherlands; [Strous, Marc] Univ Calgary, Dept Geosci, Calgary, AB T2N 1N4, Canada	Max Planck Society; University of Bielefeld; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of North Carolina; University of North Carolina Charlotte; Xiamen University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Calgary	Strous, M (corresponding author), Max Planck Inst Marine Mikrobiol, D-28359 Bremen, Germany.	mstrous@ucalgary.ca	Klotz, Martin G/AAC-3880-2020; Hettich, Robert L/N-1458-2016; Strous, Marc/B-4064-2017; Sharma, Ritin/AAB-4693-2021; Ferdelman, Timothy G/A-3758-2013; Kraft, Beate/AAK-7157-2021; Klotz, Martin G/D-2091-2009	Klotz, Martin G/0000-0002-1783-375X; Hettich, Robert L/0000-0001-7708-786X; Strous, Marc/0000-0001-9600-3828; Sharma, Ritin/0000-0001-8365-9916; Ferdelman, Timothy G/0000-0002-9701-3793; Klotz, Martin G/0000-0002-1783-375X; Kraft, Beate/0000-0003-0310-5206; Tegetmeyer, Halina E./0000-0003-1970-4457	European Research Council (ERC) [MASEM 242635]; ERC [StG 306933]; University of North Carolina at Charlotte; NSF [EF-0541797]; State Key Laboratory of Marine Environmental Science at Xiamen University, China; German Federal State Nordrhein-Westfalen; Max Planck Society; Direct For Biological Sciences [1202648] Funding Source: National Science Foundation	European Research Council (ERC)(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); University of North Carolina at Charlotte; NSF(National Science Foundation (NSF)); State Key Laboratory of Marine Environmental Science at Xiamen University, China; German Federal State Nordrhein-Westfalen; Max Planck Society(Max Planck SocietyFoundation CELLEX); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by European Research Council (ERC) starting grant MASEM 242635 (M.S.); ERC grant StG 306933 (J.S.G.); research incentive funds from the University of North Carolina at Charlotte, NSF grant EF-0541797, and a distinguished fellowship at the State Key Laboratory of Marine Environmental Science at Xiamen University, China (M.G.K.); the German Federal State Nordrhein-Westfalen; and the Max Planck Society. We thank I. Kattelmann and R. Vahrenhorst for their support in metagenomic sequencing and analysis, and T. Hargesheimer for CARD-FISH analysis. Raw sequencing data are publicly available under accession numbers SAMN02566827-30, SAMN02592751, SAMN02584197-8 (http://trace.ncbi.nlm.nih.gov/Traces/sra), JDSF00000000, JDSG00000000, and JDSH00000000 (www.ncbi.nlm.nih.gov/bioproject/231836).	AKUNNA JC, 1993, WATER RES, V27, P1303, DOI 10.1016/0043-1354(93)90217-6; Behrendt A, 2013, BIOGEOSCIENCES, V10, P7509, DOI 10.5194/bg-10-7509-2013; Bru D, 2011, ISME J, V5, P532, DOI 10.1038/ismej.2010.130; Brunet RC, 1996, FEMS MICROBIOL ECOL, V21, P131, DOI 10.1111/j.1574-6941.1996.tb00340.x; Dong LF, 2011, LIMNOL OCEANOGR, V56, P279, DOI 10.4319/lo.2011.56.1.0279; Dong LF, 2009, APPL ENVIRON MICROB, V75, P3171, DOI 10.1128/AEM.02511-08; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; Gao H, 2012, LIMNOL OCEANOGR, V57, P185, DOI 10.4319/lo.2012.57.1.0185; Hanke A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00231; JOYE SB, 1995, SCIENCE, V270, P623, DOI 10.1126/science.270.5236.623; Mazeas L, 2008, RAPID COMMUN MASS SP, V22, P1746, DOI 10.1002/rcm.3524; Ogilvie BG, 1997, FEMS MICROBIOL ECOL, V23, P11, DOI 10.1016/S0168-6496(97)00004-4; Schmidt CS, 2011, SOIL BIOL BIOCHEM, V43, P1607, DOI 10.1016/j.soilbio.2011.02.015; Strohm TO, 2007, APPL ENVIRON MICROB, V73, P1420, DOI 10.1128/AEM.02508-06; Tiedje J.M., 1983, ANTON LEEUW INT J G, V48, P569, DOI DOI 10.1007/BF00399542; Tugtas AE, 2007, BIOTECHNOL BIOENG, V98, P756, DOI 10.1002/bit.21487; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808	17	276	290	59	681	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					676	679		10.1126/science.1254070	http://dx.doi.org/10.1126/science.1254070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104387	Green Submitted			2022-12-24	WOS:000339962800040
J	Lu, KF; Psakhye, I; Jentsch, S				Lu, Kefeng; Psakhye, Ivan; Jentsch, Stefan			Autophagic Clearance of PolyQ Proteins Mediated by Ubiquitin-Atg8 Adaptors of the Conserved CUET Protein Family	CELL			English	Article							SELECTIVE AUTOPHAGY; MISFOLDED PROTEINS; PROTEASOME SYSTEM; DEGRADATION; BINDING; DOMAIN; TOLLIP; RECOGNITION; DISEASE; AGGREGATION	Selective ubiquitin-dependent autophagy plays a pivotal role in the elimination of protein aggregates, assemblies, or organelles and counteracts the cytotoxicity of proteins linked to neurodegenerative diseases. Following substrate ubiquitylation, the cargo is delivered to autophagosomes involving adaptors like human p62 that bind ubiquitin and the autophagosomal ubiquitin-like protein Atg8/LC3; however, whether similar pathways exist in lower eukaryotes remained unclear. Here, we identify by a screen in yeast a new class of ubiquitin-Atg8 adaptors termed CUET proteins, comprising the ubiquitin-binding CUE-domain protein Cue5 from yeast and its human homolog Tollip. Cue5 collaborates with Rsp5 ubiquitin ligase, and the corresponding yeast mutants accumulate aggregation-prone proteins and are vulnerable to polyQ protein expression. Similarly, Tollip depletion causes cytotoxicity toward polyQ proteins, whereas Tollip overexpression clears human cells from Huntington's disease-linked polyQ proteins by autophagy. We thus propose that CUET proteins play a critical and ancient role in autophagic clearance of cytotoxic protein aggregates.	[Lu, Kefeng; Psakhye, Ivan; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de		Lu, Kefeng/0000-0001-8200-9380; Psakhye, Ivan/0000-0003-3877-133X	Max Planck Society; Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich; ERC Advanced Grant; Louis-Jeantet Foundation	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; ERC Advanced Grant; Louis-Jeantet Foundation	We thank F. den Brave, F. Paasch, and F. Wilfling for comments on the manuscript; U. Hartl and E. Lemichez for materials; C. Boulegue for mass spectrometry analysis; B. Habermann for help with bioinformatic analysis; T. Ammon for help with mammalian cell culture techniques; and A. Strasser for technical assistance. S.J. is supported by Max Planck Society, Deutsche Forschungsgemeinschaft, Center for Integrated Protein Science Munich, ERC Advanced Grant, and the Louis-Jeantet Foundation.	Ankem G, 2011, BIOCHEM J, V435, P597, DOI 10.1042/BJ20102160; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bagola K, 2013, MOL CELL, V50, P528, DOI 10.1016/j.molcel.2013.04.005; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Capelluto DGS, 2012, MICROBES INFECT, V14, P140, DOI 10.1016/j.micinf.2011.08.018; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moreno-Borchart AC, 2001, EMBO J, V20, P6946, DOI 10.1093/emboj/20.24.6946; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Oguro A, 2011, NEUROSCI LETT, V503, P234, DOI 10.1016/j.neulet.2011.08.043; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Visvikis O, 2011, TRAFFIC, V12, P579, DOI 10.1111/j.1600-0854.2011.01174.x	47	224	230	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					549	563		10.1016/j.cell.2014.05.048	http://dx.doi.org/10.1016/j.cell.2014.05.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25042851	Bronze			2022-12-24	WOS:000340944300009
J	Trimarchi, T; Bilal, E; Ntziachristos, P; Fabbri, G; Dalla-Favera, R; Tsirigos, A; Aifantis, I				Trimarchi, Thomas; Bilal, Erhan; Ntziachristos, Panagiotis; Fabbri, Giulia; Dalla-Favera, Riccardo; Tsirigos, Aristotelis; Aifantis, Iannis			Genome-wide Mapping and Characterization of Notch-Regulated Long Noncoding RNAs in Acute Leukemia	CELL			English	Article							INITIATING CELL-ACTIVITY; DIVERGENT TRANSCRIPTION; PROSTATE-CANCER; CHROMATIN; REVEALS; ACTIVATION; ANNOTATION; REPRESSION; SUPPRESSOR; EXPRESSION	Notch signaling is a key developmental pathway that is subject to frequent genetic and epigenetic perturbations in many different human tumors. Here we investigate whether long noncoding RNA (lncRNA) genes, in addition to mRNAs, are key downstream targets of oncogenic Notch1 in human T cell acute lymphoblastic leukemia (T-ALL). By integrating transcriptome profiles with chromatin state maps, we have uncovered many previously unreported T-ALL-specific IncRNA genes, a fraction of which are directly controlled by the Notch1/Rpbjk activator complex. Finally we have shown that one specific Notch-regulated lncRNA, LUNAR1, is required for efficient T-ALL growth in vitro and in vivo due to its ability to enhance IGF1R mRNA expression and sustain IGF1 signaling. These results confirm that IncRNAs are important downstream targets of the Notch signaling pathway, and additionally they are key regulators of the oncogenic state in T-ALL.	[Trimarchi, Thomas; Ntziachristos, Panagiotis; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Trimarchi, Thomas; Ntziachristos, Panagiotis; Aifantis, Iannis] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA; [Trimarchi, Thomas; Ntziachristos, Panagiotis; Tsirigos, Aristotelis; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Bilal, Erhan] IBM Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA; [Fabbri, Giulia; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Fabbri, Giulia; Dalla-Favera, Riccardo] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Tsirigos, Aristotelis] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; International Business Machines (IBM); Columbia University; Columbia University; New York University	Tsirigos, A (corresponding author), NYU, Sch Med, Dept Pathol, 550 First Ave, New York, NY 10016 USA.	aristotelis.tsirigos@nyumc.org; iannis.aifantis@nyumc.org	Ntziachristos, Panagiotis/CAG-2071-2022	Tsirigos, Aristotelis/0000-0002-7512-8477	NIH/NCI [P30 CA016087-30]; Chair's Grant [U10 CA98543]; National Cancer Institute, National Institutes of Health (Bethesda, MD, USA) [U24 CA114766]; National Institutes of Health [1RO1CA133379, 1RO1CA105129, 1RO1CA149655, 5RO1CA173636, 5RO1CA169784, 1RO1GM088847, 5T32CA009161-37, 5T32GM0072-38]; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society [6340-11, 6373-13]; Chemotherapy Foundation; Irma T. Hirschl Trust; V Foundation for Cancer Research; St. Baldrick's Foundation; American Society of Hematology fellowship; NATIONAL CANCER INSTITUTE [R01CA173636, K99CA188293, R01CA105129, P30CA016087, R01CA149655, T32CA009161, R01CA133379, U10CA098543, R01CA169784, U24CA114766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chair's Grant; National Cancer Institute, National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Chemotherapy Foundation; Irma T. Hirschl Trust; V Foundation for Cancer Research; St. Baldrick's Foundation; American Society of Hematology fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the members of the I.A. laboratory for helpful discussions throughout the duration of the project. We thank Drs. Danny Reinberg, Roberto Bonasio, Howard Chang, and Adam Schmidtt for valuable discussions, technical advice, and reagents. We thank Drs. Sergei Koralov and Jane Skok for their continued support and helpful insight. We are grateful to Dr. Mignon Loh and the Children's Oncology Group for providing patient samples and to Dr. A. Heguy and the NYU Genome Technology Center (supported in part by NIH/NCI P30 CA016087-30 grant) for assistance with sequencing experiments. Research is supported by the Chair's Grant U10 CA98543 and Human Specimen Banking Grant U24 CA114766 of the Children's Oncology Group from the National Cancer Institute, National Institutes of Health (Bethesda, MD, USA). I.A. was supported by the National Institutes of Health (1RO1CA133379, 1RO1CA105129, 1RO1CA149655, 5RO1CA173636, 5RO1CA169784, and 1RO1GM088847). I.A. was also supported by the William Lawrence and Blanche Hughes Foundation, The Leukemia & Lymphoma Society (TRP#6340-11, LLS#6373-13), The Chemotherapy Foundation, The Irma T. Hirschl Trust, The V Foundation for Cancer Research, and the St. Baldrick's Foundation. T.T. is supported by NIH training grants 5T32CA009161-37 and 5T32GM0072-38. I.A. is a Howard Hughes Medical Institute Early Career Scientist. A.T. carried out a portion of this work while at the Computational Biology Center, IBM Research (Yorktown Heights, NY, USA). P.N. is supported by an American Society of Hematology fellowship.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Boumil RM, 2001, HUM MOL GENET, V10, P2225; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Du Z, 2013, NAT STRUCT MOL BIOL, V20, P908, DOI 10.1038/nsmb.2591; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Garding A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003373; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/nmeth.2148, 10.1038/NMETH.2148]; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lee CS, 2012, BLOOD, V120, P3288, DOI 10.1182/blood-2012-04-423061; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Li XY, 2011, J EXP MED, V208, P663, DOI 10.1084/jem.20102384; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Look A Thomas, 2004, Clin Adv Hematol Oncol, V2, P779; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Prensner JR, 2013, NAT GENET, V45, P1392, DOI 10.1038/ng.2771; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Yu L, 2011, LEUKEMIA, V25, P1042, DOI 10.1038/leu.2011.33; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	67	326	348	0	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					593	606		10.1016/j.cell.2014.05.049	http://dx.doi.org/10.1016/j.cell.2014.05.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083870	Bronze, Green Accepted			2022-12-24	WOS:000340944300012
J	Smith, ZD; Chan, MM; Humm, KC; Karnik, R; Mekhoubad, S; Regev, A; Eggan, K; Meissner, A				Smith, Zachary D.; Chan, Michelle M.; Humm, Kathryn C.; Karnik, Rahul; Mekhoubad, Shila; Regev, Aviv; Eggan, Kevin; Meissner, Alexander			DNA methylation dynamics of the human preimplantation embryo	NATURE			English	Article							STEM-CELLS; EPIGENETIC INHERITANCE; NONCODING RNA; MOUSE; RETROTRANSPOSONS; PLURIPOTENT; MAINTENANCE; LANDSCAPE; MECHANISM; EVOLUTION	In mammals, cytosine methylation is predominantly restricted to CpG dinudeotides and stably distributed across the genome, with local, cell-type-specific regulation directed by DNA binding factors(1-3). This comparatively static landscape is in marked contrast with the events of fertilization, during which the paternal genome is globally reprogrammed. Paternal genome demethylation includes the majority of CpGs, although methylation remains detectable at several notable features(4-7). These dynamics have been extensively characterized in the mouse, with only limited observations available in other mammals, and direct measurements are required to understand the extent to which early embryonic landscapes are conserved(8-10). We present genome-scale DNA methylation maps of human preimplantation development and embryonic stem cell derivation, confirming a transient state of global hypomethylation that includes most CpGs, while sites of residual maintenance are primarily restricted to gene bodies. Although most features share similar dynamics to those in mouse, maternally contributed methylation is divergently targeted to species-specific sets of CpG island promoters that extend beyond known imprint control regions. Retrotransposon regulation is also highly diverse, and transitions from maternally to embryonically expressed elements. Together, our data confirm that paternal genome demethylation is a general attribute of early mammalian development that is characterized by distinct modes of epigenetic regulation.	[Smith, Zachary D.; Chan, Michelle M.; Karnik, Rahul; Regev, Aviv; Eggan, Kevin; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Smith, Zachary D.; Karnik, Rahul; Eggan, Kevin; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Smith, Zachary D.; Humm, Kathryn C.; Karnik, Rahul; Mekhoubad, Shila; Eggan, Kevin; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Smith, Zachary D.; Mekhoubad, Shila; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Chan, Michelle M.] MIT, Computat & Syst Biol Program, Cambridge, MA 02142 USA; [Humm, Kathryn C.] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Boston, MA 02215 USA; [Humm, Kathryn C.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Humm, Kathryn C.] Boston IVF, Waltham, MA 02451 USA; [Humm, Kathryn C.; Regev, Aviv] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Cambridge, MA 02142 USA; [Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Howard Hughes Medical Institute	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	keggan@scrb.harvard.edu; alexander_meissner@harvard.edu	Eggan, Kevin/P-7119-2018	Karnik, Rahul/0000-0002-0400-635X	Harvard Stem Cell Institute; NIH Pioneer Award [5DP10D003958]; Burroughs Wellcome Career Award at the Scientific Interface; HHMI; Center for Excellence in Genome Science from the NHGRI [1P50HG006193-01]; New York Stem Cell Foundation;  [P01GM099117]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); HHMI(Howard Hughes Medical Institute); Center for Excellence in Genome Science from the NHGRI; New York Stem Cell Foundation; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank all members of the Meissner, Regev and Eggan laboratories, in particular M. Ziller for critical reading of the text and K. Koszka for supervising human embryo thawing. We also thank D. Sakkas and R. Holmes of Boston IVF for clinical assessment of embryo morphology and viability, as well as S. Levine, M. Gravina and K. Thai from the MIT BioMicro Center. Finally, we thank T. S. Mikkelsen, H. Gu, and A. Gnirke from the Broad Institute for their guidance and expertise. A.R. is an investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute. This work was supported by the Harvard Stem Cell Institute (K.E.), and NIH Pioneer Award (5DP10D003958), the Burroughs Wellcome Career Award at the Scientific Interface and HHMI (to A.R. and K.E.), P01GM099117 (to A.M. and K. E.) and a Center for Excellence in Genome Science from the NHGRI (1P50HG006193-01, to A.R. and A.M.). A.M. is a New York Stem Cell Foundation Robertson Investigator. This research was supported by The New York Stem Cell Foundation.	Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chenoweth JG, 2010, METHODS MOL BIOL, V636, P25, DOI 10.1007/978-1-60761-691-7_2; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fuchs NV, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-115; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kelsey G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0336; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lepikhov K, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-8; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mertineit C, 1998, DEVELOPMENT, V125, P889; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Santos F, 2010, HUM REPROD, V25, P2387, DOI 10.1093/humrep/deq151; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Wu GM, 2013, NAT CELL BIOL, V15, P1089, DOI 10.1038/ncb2816; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	31	378	398	4	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					611	+		10.1038/nature13581	http://dx.doi.org/10.1038/nature13581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079558	Green Submitted, Green Accepted			2022-12-24	WOS:000339566300039
J	McMahon, TA; Sears, BF; Venesky, MD; Bessler, SM; Brown, JM; Deutsch, K; Halstead, NT; Lentz, G; Tenouri, N; Young, S; Civitello, DJ; Ortega, N; Fites, JS; Reinert, LK; Rollins-Smith, LA; Raffel, TR; Rohr, JR				McMahon, Taegan A.; Sears, Brittany F.; Venesky, Matthew D.; Bessler, Scott M.; Brown, Jenise M.; Deutsch, Kaitlin; Halstead, Neal T.; Lentz, Garrett; Tenouri, Nadia; Young, Suzanne; Civitello, David J.; Ortega, Nicole; Fites, J. Scott; Reinert, Laura K.; Rollins-Smith, Louise A.; Raffel, Thomas R.; Rohr, Jason R.			Amphibians acquire resistance to live and dead fungus overcoming fungal immunosuppression	NATURE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRID FUNGUS; IMMUNE DEFENSES; INFECTION; CHYTRIDIOMYCOSIS; FROG; PATHOGEN; DECLINES; HOSTS; PLANT	Emerging fungal pathogens pose a greater threat to biodiversity than any other parasitic group(1), causing declines of many taxa, including bats, corals, bees, snakes and amphibians(1-4). Currently, there is little evidence that wild animals can acquire resistance to these pathogens(5). Batrachochytrium dendrobatidis is a pathogenic fungus implicated in the recent global decline of amphibians(6). Here we demonstrate that three species of amphibians can acquire behavioural or immunological resistance to B. dendrobatidis. Frogs learned to avoid the fungus after just one B. dendrobatidis exposure and temperature-induced clearance. In subsequent experiments in which B. dendrobatidis avoidance was prevented, the number of previous exposures was a negative predictor of B. dendrobatidis burden on frogs and B. dendrobatidis-induced mortality, and was a positive predictor of lymphocyte abundance and proliferation. These results suggest that amphibians can acquire immunity to B. dendrobatidis that overcomes pathogen-induced immunosuppression(7-9) and increases their survival. Importantly, exposure to dead fungus induced a similar magnitude of acquired resistance as exposure to live fungus. Exposure of frogs to B. dendrobatidis antigens might offer a practical way to protect pathogen-naive amphibians and facilitate the reintroduction of amphibians to locations in the wild where B. dendrobatidis persists. Moreover, given the conserved nature of vertebrate immune responses to fungi(5) and the fact that many animals are capable of learning to avoid natural enemies(10), these results offer hope that other wild animal taxa threatened by invasive fungi might be rescued by management approaches based on herd immunity.	[McMahon, Taegan A.; Sears, Brittany F.; Bessler, Scott M.; Brown, Jenise M.; Deutsch, Kaitlin; Halstead, Neal T.; Lentz, Garrett; Tenouri, Nadia; Young, Suzanne; Civitello, David J.; Ortega, Nicole; Rohr, Jason R.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA; [McMahon, Taegan A.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Venesky, Matthew D.] Allegheny Coll, Dept Biol, Meadville, PA 16335 USA; [Fites, J. Scott; Rollins-Smith, Louise A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Reinert, Laura K.; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Reinert, Laura K.; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Reinert, Laura K.; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Raffel, Thomas R.] Oakland Univ, Dept Biol, Rochester, MI 48309 USA	State University System of Florida; University of South Florida; University of Tampa; Allegheny College; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Oakland University	McMahon, TA (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	taeganmcmahon@gmail.com; jasonrohr@gmail.com	Rohr, Jason R./AAJ-5856-2021; Bessler, Scott/ABG-5280-2021	Lentz, Garrett/0000-0003-1588-8148; Sears, Brittany/0000-0002-8515-8573; Deutsch, Kaitlin/0000-0002-6492-366X	National Science Foundation [DEB 0516227, EF-1241889, IOS-1121758]; National Institutes of Health [R01GM109499]; US Department of Agriculture [NRI 2006-01370, 2009-35102-0543]; US Environmental Protection Agency [STAR R83-3835, CAREER 83518801]; NSF RCN "Refining and Diversifying Ecoimmunology"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109499] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); US Environmental Protection Agency(United States Environmental Protection Agency); NSF RCN "Refining and Diversifying Ecoimmunology"(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Holden and J. Pask for their assistance with the immunological assays, J. Cohen for comments on the manuscript, and our undergraduate assistants H. Folse, S. Lopez, L. Soto, S. Hekkanen and E. Creasey. We also thank V. Vasquez and J. Longcore for providing the Bd isolates used in these experiments. Funds were provided by grants from the National Science Foundation (DEB 0516227 and EF-1241889 to J. R. R. and IOS-1121758 to L.A.R.-S.), the National Institutes of Health (R01GM109499 to J. R. R.), the US Department of Agriculture (NRI 2006-01370 and 2009-35102-0543 to J. R. R.), the US Environmental Protection Agency grant (STAR R83-3835 and CAREER 83518801 to J. R. R.), and the NSF RCN "Refining and Diversifying Ecoimmunology". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender MC, 2011, EMERG INFECT DIS, V17, P2383, DOI 10.3201/eid1712.110240; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cashins SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056747; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kiesecker JM, 1999, P NATL ACAD SCI USA, V96, P9165, DOI 10.1073/pnas.96.16.9165; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; Murphy PJ, 2011, DIS AQUAT ORGAN, V95, P31, DOI 10.3354/dao02336; PAWELEC G, 1991, INT J IMMUNOPHARMACO, V13, P299, DOI 10.1016/0192-0561(91)90111-J; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Rohr JR, 2009, OECOLOGIA, V159, P447, DOI 10.1007/s00442-008-1208-6; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rollins-Smith Louise A, 2009, Front Biosci (Schol Ed), V1, P68; ROLLINSSMITH LA, 1984, IMMUNOLOGY, V52, P491; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Sexton AC, 2006, EUKARYOT CELL, V5, P1941, DOI 10.1128/EC.00277-06; Shaw SD, 2010, DIS AQUAT ORGAN, V92, P159, DOI 10.3354/dao02227; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Venesky MD, 2014, BIOL REV, V89, P477, DOI 10.1111/brv.12064; Venesky MD, 2012, CONSERV BIOL, V26, P586, DOI 10.1111/j.1523-1739.2012.01854.x; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	30	153	156	2	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					224	+		10.1038/nature13491	http://dx.doi.org/10.1038/nature13491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	25008531	Green Accepted			2022-12-24	WOS:000338649800044
J	Budkevich, TV; Giesebrecht, J; Behrmann, E; Loerke, J; Ramrath, DJF; Mielke, T; Ismer, J; Hildebrand, PW; Tung, CS; Nierhaus, KH; Sanbonmatsu, KY; Spahn, CMT				Budkevich, Tatyana V.; Giesebrecht, Jan; Behrmann, Elmar; Loerke, Justus; Ramrath, David J. F.; Mielke, Thorsten; Ismer, Jochen; Hildebrand, Peter W.; Tung, Chang-Shung; Nierhaus, Knud H.; Sanbonmatsu, Karissa Y.; Spahn, Christian M. T.			Regulation of the Mammalian Elongation Cycle by Subunit Rolling: A Eukaryotic-Specific Ribosome Rearrangement	CELL			English	Article							AMINOACYL-TRANSFER-RNA; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; EF-TU; GTP HYDROLYSIS; CRYO-EM; COMPLEX; TRANSLOCATION; MECHANISM; SELECTION	The extent to which bacterial ribosomes and the significantly larger eukaryotic ribosomes share the same mechanisms of ribosomal elongation is unknown. Here, we present subnanometer resolution cryoelectron microscopy maps of the mammalian 80S ribosome in the posttranslocational state and in complex with the eukaryotic eEF1A, Val-tRNA, GMPPNP ternary complex, revealing significant differences in the elongation mechanism between bacteria and mammals. Surprisingly, and in contrast to bacterial ribosomes, a rotation of the small subunit around its long axis and orthogonal to the well-known intersubunit rotation distinguishes the posttranslocational state from the classical pre-translocational state ribosome. We term this motion "subunit rolling.'' Correspondingly, a mammalian decoding complex visualized in substates before and after codon recognition reveals structural distinctions from the bacterial system. These findings suggest how codon recognition leads to GTPase activation in the mammalian system and demonstrate that in mammalia subunit rolling occurs during tRNA selection.	[Budkevich, Tatyana V.; Giesebrecht, Jan; Behrmann, Elmar; Loerke, Justus; Ramrath, David J. F.; Mielke, Thorsten; Ismer, Jochen; Hildebrand, Peter W.; Nierhaus, Knud H.; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Budkevich, Tatyana V.; Nierhaus, Knud H.] Max Planck Inst Mol Genet, Abt Vingron, D-14195 Berlin, Germany; [Budkevich, Tatyana V.] Inst Mol Biol & Genet, Grp Prot Biosynthesis, UA-03143 Kiev, Ukraine; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Tung, Chang-Shung; Sanbonmatsu, Karissa Y.] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Sanbonmatsu, Karissa Y.] New Mexico Consortium, Los Alamos, NM 87544 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory	Spahn, CMT (corresponding author), Charite, Inst Med Phys & Biophys, CharitePl 1, D-10117 Berlin, Germany.	christian.spahn@charite.de	Behrmann, Elmar/I-5808-2015	Behrmann, Elmar/0000-0001-6794-3669; Loerke, Justus/0000-0002-3424-8536	Deutsche Forschungsgemeinschaft DFG [SFB 740, 436 UKR 113/64/1-1, HI 1502]; HSFP and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); HFSP, NIH [R01-GM072686]; Los Alamos Institutional Computing; North-German Supercomputing Alliance (HLRN) [beb00001, bec00085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072686] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); HSFP and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); HFSP, NIH; Los Alamos Institutional Computing; North-German Supercomputing Alliance (HLRN); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Scott Blanchard for helpful discussion. The present work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (SFB 740 to C. M. T. S., P. W. H., and T. M.; 436 UKR 113/64/1-1 to T. B. and HI 1502 to P. W. H.), HSFP and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum). K.Y.S. was supported by HFSP, NIH Grant R01-GM072686 and Los Alamos Institutional Computing. We acknowledge the use of computational resources supplied by the North-German Supercomputing Alliance (HLRN; project beb00001 to C. M. T. S and bec00085 to P. W. H.).	Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bommer U, 1997, SUBCELLULAR FRACTION, P271; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; Budkevich TV, 2008, NUCLEIC ACIDS RES, V36, P4736, DOI 10.1093/nar/gkn424; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Fagan CE, 2013, P NATL ACAD SCI USA, V110, P9716, DOI 10.1073/pnas.1301585110; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2006, REP PROG PHYS, V69, P1383, DOI 10.1088/0034-4885/69/5/R03; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P9319, DOI 10.1093/nar/gks660; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; SCHILLINGBARTETZKO S, 1992, J BIOL CHEM, V267, P4703; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; STEITZ JA, 1969, COLD SPRING HARB SYM, V34, P621, DOI 10.1101/SQB.1969.034.01.072; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311	38	82	83	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2014	158	1					121	131		10.1016/j.cell.2014.04.044	http://dx.doi.org/10.1016/j.cell.2014.04.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QQ	24995983	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000340943100012
J	Savage, N				Savage, Neil			LOGISTICS Keeping cool	NATURE			English	Editorial Material																			0	30	31	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S8	S9		10.1038/507S8a	http://dx.doi.org/10.1038/507S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611169	Bronze			2022-12-24	WOS:000332224400004
J	Antoniou, AC; Casadei, S; Heikkinen, T; Barrowdale, D; Pylkas, K; Roberts, J; Lee, A; Subramanian, D; De Leeneer, K; Fostira, F; Tomiak, E; Neuhausen, SL; Teo, ZL; Khan, S; Aittomaki, K; Moilanen, JS; Turnbull, C; Seal, S; Mannermaa, A; Kallioniemi, A; Lindeman, GJ; Buys, SS; Andrulis, IL; Radice, P; Tondini, C; Manoukian, S; Toland, AE; Miron, P; Weitzel, JN; Domchek, SM; Poppe, B; Claes, KBM; Yannoukakos, D; Concannon, P; Bernstein, JL; James, PA; Easton, DF; Goldgar, DE; Hopper, JL; Rahman, N; Peterlongo, P; Nevanlinna, H; King, MC; Couch, FJ; Southey, MC; Winqvist, R; Foulkes, WD; Tischkowitz, M				Antoniou, A. C.; Casadei, S.; Heikkinen, T.; Barrowdale, D.; Pylkaes, K.; Roberts, J.; Lee, A.; Subramanian, D.; De Leeneer, K.; Fostira, F.; Tomiak, E.; Neuhausen, S. L.; Teo, Z. L.; Khan, S.; Aittomaeki, K.; Moilanen, J. S.; Turnbull, C.; Seal, S.; Mannermaa, A.; Kallioniemi, A.; Lindeman, G. J.; Buys, S. S.; Andrulis, I. L.; Radice, P.; Tondini, C.; Manoukian, S.; Toland, A. E.; Miron, P.; Weitzel, J. N.; Domchek, S. M.; Poppe, B.; Claes, K. B. M.; Yannoukakos, D.; Concannon, P.; Bernstein, J. L.; James, P. A.; Easton, D. F.; Goldgar, D. E.; Hopper, J. L.; Rahman, N.; Peterlongo, P.; Nevanlinna, H.; King, M. -C.; Couch, F. J.; Southey, M. C.; Winqvist, R.; Foulkes, W. D.; Tischkowitz, M.			Breast-Cancer Risk in Families with Mutations in PALB2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; ASCERTAINMENT SAMPLING PROBLEM; BRCA2-INTERACTING PROTEIN; ATAXIA-TELANGIECTASIA; SUSCEPTIBILITY GENE; PANCREATIC-CANCER; BRCA2; PENETRANCE; CARRIERS; WOMEN	BACKGROUND Germline loss-of-function mutations in PALB2 are known to confer a predisposition to breast cancer. However, the lifetime risk of breast cancer that is conferred by such mutations remains unknown. METHODS We analyzed the risk of breast cancer among 362 members of 154 families who had deleterious truncating, splice, or deletion mutations in PALB2. The age-specific breast-cancer risk for mutation carriers was estimated with the use of a modified segregation-analysis approach that allowed for the effects of PALB2 genotype and residual familial aggregation. RESULTS The risk of breast cancer for female PALB2 mutation carriers, as compared with the general population, was eight to nine times as high among those younger than 40 years of age, six to eight times as high among those 40 to 60 years of age, and five times as high among those older than 60 years of age. The estimated cumulative risk of breast cancer among female mutation carriers was 14% (95% confidence interval [CI], 9 to 20) by 50 years of age and 35% (95% CI, 26 to 46) by 70 years of age. Breast-cancer risk was also significantly influenced by birth cohort (P < 0.001) and by other familial factors (P = 0.04). The absolute breast-cancer risk for PALB2 female mutation carriers by 70 years of age ranged from 33% (95% CI, 25 to 44) for those with no family history of breast cancer to 58% (95% CI, 50 to 66) for those with two or more first-degree relatives with breast cancer at 50 years of age. CONCLUSIONS Loss-of-function mutations in PALB2 are an important cause of hereditary breast cancer, with respect both to the frequency of cancer-predisposing mutations and to the risk associated with them. Our data suggest the breast-cancer risk for PALB2 mutation carriers may overlap with that for BRCA2 mutation carriers.	[Antoniou, A. C.; Barrowdale, D.; Lee, A.; Easton, D. F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Easton, D. F.] Univ Cambridge, Dept Oncol, Cambridge, England; [Easton, D. F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Tischkowitz, M.] Univ Cambridge, Dept Med Genet, Cambridge, England; [Tischkowitz, M.] Univ Cambridge, Natl Inst Hlth Res Cambridge Biomed Res Ctr, Cambridge, England; [Roberts, J.; Subramanian, D.; Tischkowitz, M.] Addenbrookes Hosp, East Anglian Reg Genet Serv, Dept Clin Genet, Cambridge CB2 0QQ, England; [Seal, S.; Tondini, C.; Rahman, N.] Inst Canc Res, Oncogenet Team, London SW3 6JB, England; [Seal, S.; Tondini, C.; Rahman, N.] Royal Marsden Natl Hlth Serv Fdn Trust, London, England; [Casadei, S.; King, M. -C.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Heikkinen, T.; Khan, S.; Nevanlinna, H.] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Heikkinen, T.; Khan, S.; Nevanlinna, H.] Helsinki Univ Cent Hosp, Helsinki, Finland; [Aittomaeki, K.] Helsinki Univ Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Pylkaes, K.; Winqvist, R.] Univ Oulu, Dept Clin Chem, Lab Canc Genet & Tumor Biol, Oulu, Finland; [Pylkaes, K.; Winqvist, R.] Univ Oulu, Bioctr, Oulu, Finland; [Pylkaes, K.; Winqvist, R.] Oulu Univ Hosp, Lab Canc Genet & Tumor Biol, Northern Finland Lab Ctr NordLab, Oulu, Finland; [Moilanen, J. S.] Univ Oulu, Dept Clin Genet, Oulu, Finland; [Moilanen, J. S.] Oulu Univ Hosp, Oulu, Finland; [Mannermaa, A.] Univ Eastern Finland, Bioctr Kuopio, Kuopio, Finland; [Mannermaa, A.] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Kallioniemi, A.] Univ Tampere, Inst Biomed Technol Canc Genom, FIN-33101 Tampere, Finland; [De Leeneer, K.; Poppe, B.; Claes, K. B. M.] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Fostira, F.; Yannoukakos, D.] Natl Ctr Sci Res Demokritos, Inst Nucl & Radiol Sci & Technol Energy & Safety, Mol Diagnost Lab, Athens, Greece; [Tomiak, E.] Childrens Hosp Eastern Ontario, Dept Genet, Eastern Ontario Reg Genet Program, Ottawa, ON K1H 8L1, Canada; [Andrulis, I. L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Foulkes, W. D.] McGill Univ, Program Canc Genet, Dept Human Genet, Lady Davis Inst,Hlth Ctr, Montreal, PQ, Canada; [Foulkes, W. D.] McGill Univ, Program Canc Genet, Dept Oncol, Lady Davis Inst,Hlth Ctr, Montreal, PQ, Canada; [Foulkes, W. D.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Neuhausen, S. L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Weitzel, J. N.] City Hope Natl Med Ctr, Div Clin Canc Genet, Duarte, CA USA; [Teo, Z. L.; Southey, M. C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Lindeman, G. J.] Royal Melbourne Hosp, Familial Canc Ctr, Parkville, Vic 3050, Australia; [Lindeman, G. J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Stem Cells & Canc Div, Parkville, Vic 3050, Australia; [James, P. A.] Univ Melbourne, Peter MacCallum Canc Ctr, Familial Canc Ctr, Melbourne, Vic, Australia; [Hopper, J. L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Buys, S. S.; Goldgar, D. E.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT USA; [Radice, P.] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, I-20133 Milan, Italy; [Manoukian, S.] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, Dept Prevent & Predict Med, Unit Med Genet, I-20133 Milan, Italy; [Peterlongo, P.] Fdn Italiana Ric Canc, Ist Oncol Mol, Milan, Italy; [Turnbull, C.] Azienda Osped Papa Giovanni XXIII, Med Oncol Unit, Bergamo, Italy; [Toland, A. E.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Miron, P.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA; [Domchek, S. M.] Univ Penn, Abramson Canc Ctr, Basser Res Ctr, Philadelphia, PA 19104 USA; [Concannon, P.] Univ Florida, Genet Inst, Gainesville, FL USA; [Concannon, P.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Bernstein, J. L.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Couch, F. J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Couch, F. J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of Washington; University of Washington Seattle; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Eastern Finland; University of Eastern Finland; Tampere University; Ghent University; Ghent University Hospital; National Centre of Scientific Research "Demokritos"; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; McGill University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of Melbourne; Royal Melbourne Hospital; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; ASST Papa Giovanni XXIII; University System of Ohio; Ohio State University; Case Western Reserve University; University of Pennsylvania; Pennsylvania Medicine; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Memorial Sloan Kettering Cancer Center; Mayo Clinic; Mayo Clinic	Tischkowitz, M (corresponding author), Addenbrookes Hosp, Addenbrookes Treatment Ctr, Dept Med Genet, Box 134,Level 6,Hills Rd, Cambridge CB2 0QQ, England.	mdt33@cam.ac.uk	Radice, Paolo/O-3119-2013; De Leeneer, Kim/AFS-1595-2022; manoukian, siranoush/E-7132-2017; Peterlongo, Paolo/Q-4717-2018; Tischkowitz, Marc/O-4452-2018; Moilanen, Jukka S/G-2604-2012; Fostira, Florentia/Z-5730-2019; Andrulis, Irene L./E-7267-2013; Foulkes, William D./AAR-9586-2021; Claes, Kathleen/AFR-6830-2022; Turnbull, Clare/AAA-6596-2019; TONDINI, CARLO ALBERTO/AAB-7786-2019; Rahman, Nazneen/D-2802-2013	Radice, Paolo/0000-0001-6298-4111; De Leeneer, Kim/0000-0002-9319-411X; manoukian, siranoush/0000-0002-6034-7562; Peterlongo, Paolo/0000-0001-6951-6855; Tischkowitz, Marc/0000-0002-7880-0628; Moilanen, Jukka S/0000-0002-8041-3205; Foulkes, William D./0000-0001-7427-4651; Claes, Kathleen/0000-0003-0841-7372; TONDINI, CARLO ALBERTO/0000-0003-0635-8954; James, Paul/0000-0002-4361-4657; Khan, Sofia/0000-0003-4185-8882; Winqvist, Robert/0000-0003-0932-9104; Nevanlinna, Heli/0000-0002-0916-2976; King, Mary-Claire/0000-0001-9426-1743; Heikkinen, Tuomas/0000-0003-1154-6204; Turnbull, Clare/0000-0002-1734-5772; Rahman, Nazneen/0000-0003-4376-0440; Southey, Melissa/0000-0002-6313-9005; Thorne, Heather/0000-0003-3610-2511; Lindeman, Geoffrey/0000-0001-9386-2416; Kallioniemi, Anne/0000-0003-3552-8158; Barrowdale, Daniel/0000-0003-1661-3939; Concannon, Patrick/0000-0002-5801-1859; Yannoukakos, Drakoulis/0000-0001-7509-3510; Pylkas, Katri/0000-0002-2449-0521; Roberts, Jonathan/0000-0003-3153-1077	European Union Seventh Framework Program, European Research Council [310018]; Cancer Research UK [C12292/A11174]; National Institutes of Health [R01CA175716, CA128978, CA116167, CA116201, UM1 CA164920, RFA CA-06-503, U01 CA69467, U01 CA69417, U01 CA69398, U01 CA69631, U01 CA69446, U01 CA69638]; Academy of Finland [122715, 250083, 251314, 266528]; Finnish Cancer Foundation; Sigrid Juselius Foundation; University of Oulu; University of Oulu Support Foundation; Biocenter Oulu; special Finnish Government EVO funds; Helsinki University Central Hospital Research Fund; Nordic Cancer Union; Fund for Scientific Research Flanders [G.A044.10]; Ghent University [BOF10/GOA/019]; European Union European Social Fund; National Strategic Reference Framework Research Funding Program, General Secretariat for Research and Technology; Ohio State Comprehensive Cancer Center; Stefanie Spielman Fund for Breast Cancer Research; National Cancer Institute [RC4A153828, CA083178, CA097397, CA114236, CA129639]; Associazione Italiana per la Ricerca sul Cancro [IG 4017]; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori; National Health and Medical Research Council Australia [APP1029974]; Victorian Cancer Agency [CTTS07, EOI09_50]; Victorian Breast Cancer Research Consortium; Cancer Research UK [16563, 10118, 15106, 11174, 11022] Funding Source: researchfish; Cancer Foundation Finland sr [110135] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA069638, R01CA129639, R01CA157744, R01CA097397, R01CA116167, U01CA069446, U01CA083178, R01CA128978, P30CA016520, U01CA069467, R35CA197458, U01CA069631, P50CA116201, U01CA069417, RC4CA153828, R01CA114236, U01CA116167, R01CA175716, UM1CA164920, U01CA069398] Funding Source: NIH RePORTER	European Union Seventh Framework Program, European Research Council(European Research Council (ERC)); Cancer Research UK(Cancer Research UK); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Oulu; University of Oulu Support Foundation; Biocenter Oulu; special Finnish Government EVO funds; Helsinki University Central Hospital Research Fund; Nordic Cancer Union; Fund for Scientific Research Flanders(FWO); Ghent University(Ghent University); European Union European Social Fund(European Social Fund (ESF)European Commission); National Strategic Reference Framework Research Funding Program, General Secretariat for Research and Technology; Ohio State Comprehensive Cancer Center; Stefanie Spielman Fund for Breast Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency; Victorian Breast Cancer Research Consortium; Cancer Research UK(Cancer Research UK); Cancer Foundation Finland sr; National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the European Union Seventh Framework Program (2007-2013)/European Research Council (310018, to Dr. Tischkowitz); Cancer Research UK (C12292/A11174, to Dr. Antoniou); the National Institutes of Health (R01CA175716, to Drs. Casadei and King; CA128978, CA116167, and CA116201, to Dr. Couch; and RFA CA-06-503, UM1 CA164920, RFA CA-06-503, U01 CA69467, U01 CA69417, U01 CA69398, U01 CA69631, U01 CA69446, and U01 CA69638, to Drs. Teo, Southey, Andrulis, Goldgar, and Hopper); the Academy of Finland (122715, to Dr. Winqvist; 250083, to Dr. Pylkas; Center of Excellence 251314, to Dr. Winqvist; and 266528, to Dr. Nevanlinna); the Finnish Cancer Foundation (to Dr. Winqvist and to Dr. Nevanlinna); the Sigrid Juselius Foundation (to Dr. Winqvist and to Dr. Nevanlinna); the University of Oulu, the University of Oulu Support Foundation and Biocenter Oulu, and the special Finnish Government EVO funds for Oulu University Hospital-based research activities (to Dr. Winqvist); the Helsinki University Central Hospital Research Fund and the Nordic Cancer Union (to Dr. Nevanlinna); the Fund for Scientific Research Flanders (G.A044.10, to Dr. Claes); Ghent University (BOF10/GOA/019, to Dr. De Leeneer); the European Union European Social Fund and Greek national funds through the operational program "Education and Lifelong Learning" of the National Strategic Reference Framework Research Funding Program, General Secretariat for Research and Technology (to Dr. Yannoukakos); Ohio State Comprehensive Cancer Center and the Stefanie Spielman Fund for Breast Cancer Research (to Dr. Toland); the National Cancer Institute (RC4A153828, to Dr. Weitzel; and CA083178, CA097397, CA114236, and CA129639, to Drs. Concannon and Bernstein); Susan G. Komen (to Drs. Domchek and Foulkes); Associazione Italiana per la Ricerca sul Cancro (IG 4017, to Drs. Manoukian and Peterlongo); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori (to Dr. Peterlongo); and National Health and Medical Research Council Australia (APP1029974), the Victorian Cancer Agency (CTTS07, EOI09_50), and the Victorian Breast Cancer Research Consortium (to Dr. Southey).	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Barnes DR, 2013, BRIT J CANCER, V108, P2610, DOI 10.1038/bjc.2013.277; Begg CB, 2002, J NATL CANCER I, V94, P1221; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Blanco A, 2012, BREAST CANCER RES TR, V132, P307, DOI 10.1007/s10549-011-1842-2; Byrnes GB, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2099; CANNINGS C, 1977, CLIN GENET, V12, P208; Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958; Ding YC, 2011, BREAST CANCER RES TR, V126, P771, DOI 10.1007/s10549-010-1195-2; Erkko H, 2008, CLIN CANCER RES, V14, P4667, DOI 10.1158/1078-0432.CCR-08-0210; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Evans DG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3829; EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; Foulkes WD, 2002, J MED GENET, V39, P407, DOI 10.1136/jmg.39.6.407; Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Heikkinen T, 2009, CLIN CANCER RES, V15, P3214, DOI 10.1158/1078-0432.CCR-08-3128; Honrado E, 2006, CRIT REV ONCOL HEMAT, V59, P27, DOI 10.1016/j.critrevonc.2006.01.006; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Levy-Lahad E, 2001, P NATL ACAD SCI USA, V98, P3232, DOI 10.1073/pnas.051624098; Murphy CD, 2008, CANCER, V113, P3116, DOI 10.1002/cncr.23913; Olsen JH, 2005, BRIT J CANCER, V93, P260, DOI 10.1038/sj.bjc.6602658; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; SHUTE NCE, 1988, AM J HUM GENET, V43, P387; Sy SMH, 2009, J BIOL CHEM, V284, P18302, DOI 10.1074/jbc.M109.016717; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Tischkowitz M, 2010, CANCER RES, V70, P7353, DOI 10.1158/0008-5472.CAN-10-1012; Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055; Weischer M, 2008, J CLIN ONCOL, V26, P542, DOI 10.1200/JCO.2007.12.5922; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	38	543	553	1	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					497	506		10.1056/NEJMoa1400382	http://dx.doi.org/10.1056/NEJMoa1400382			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25337756	Green Published, Green Accepted			2022-12-24	WOS:000339899100004
